{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: claude-haiku-4-5)",
    "evaluator_model": "claude-haiku-4-5",
    "model_evaluated": "nemotron-nano-30b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions_in_experiment": 1000
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "\nBetween 2023 and 2024 the gross benefit obligation for LMT’s non‑qualified defined‑benefit pension plans fell from about **$1.0 billion to $905 million** (a decline of roughly $95 million).  At the same time the actuarial‑loss component recorded in accumulated other comprehensive loss dropped from **$347 million to $303 million**, a reduction of about $44 million.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All key financial figures are correct: (1) Gross benefit obligation 2023: $1.0 billion ✓, 2024: $905 million ✓; (2) Actuarial losses 2023: $347 million ✓, 2024: $303 million ✓. The calculated changes are accurate: $1.0B - $905M = $95M decline ✓, $347M - $303M = $44M reduction ✓. The answer correctly identifies the company (LMT), the specific pension plan type (nonqualified defined benefit), and the time period (2023-2024). The multi-hop synthesis is sound—the model successfully extracted and compared corresponding metrics across two fiscal years. The answer provides both absolute values and calculated differences, demonstrating thorough analysis. The only minor distinction from the ground truth is that the LLM specifies the actuarial losses are \"recorded in accumulated other comprehensive loss,\" which adds helpful context about where these losses appear on the balance sheet, though this detail wasn't explicitly in the original answer. The wording is clear and professional. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 314,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "\nGM raised its long‑term expected return on U.S. pension‑plan assets from about 5.6 % in 2022 to 6.27 % in 2024. The higher assumption reflects a strategic shift toward a larger allocation to equities and higher‑return “other” assets (the “Other” bucket grew from 23 % to 29 % of the portfolio), indicating that the company is re‑weighting the plan’s mix to boost expected returns and improve its funded position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states the rate increased from 5.6% in 2022 to 6.27% in 2024, but the ground truth shows: 2022 data referenced 5.4% (Dec 31, 2021), and 2024 data showed 6.5% (Dec 31, 2024). The LLM's 6.27% figure is incorrect and doesn't match either year's actual assumption. The LLM also provides asset allocation percentages (23% to 29% for 'Other' assets) that are not mentioned in the ground truth and cannot be verified. (2) TEMPORAL CONFUSION: The LLM conflates different time periods. The ground truth clearly distinguishes between 2022 reporting (which referenced 2020-2021 data) and 2024 reporting (which referenced 2023-2024 data). The LLM appears to have created a direct 2022-to-2024 comparison that doesn't align with the actual year-over-year changes documented. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the general trend (rates increased over time) and provides reasonable strategic interpretation (shift toward equities), it fails on the fundamental requirement of accurate numbers. The asset allocation detail about the 'Other' bucket growing from 23% to 29% is unsupported by the ground truth and appears to be fabricated. (4) REASONING QUALITY: The strategic interpretation about equity allocation and funded status improvement is logically sound and contextually appropriate, but it's built on incorrect numerical foundations. The answer demonstrates understanding of pension accounting concepts but fails in factual accuracy, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 449,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "\nChevron closed its acquisition of PDC Energy in 2023 and, by the end of 2024, had fully integrated PDC’s assets into its U.S. upstream segment as a wholly‑owned subsidiary.  The former PDC operations added roughly $2.2 billion of incremental sales and contributed about $3.5 billion to upstream earnings, while also lifting Chevron’s net oil‑equivalent production by ≈250 k bbl/d (a 19 % increase) and accounting for roughly 5 % of Chevron’s total assets and 1 % of its revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM states PDC 'contributed about $3.5 billion to upstream earnings' but the ground truth specifies '$2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets.' This is a significant discrepancy ($3.5B vs $2.2B). The LLM also introduces '$2.2 billion of incremental sales' which is not mentioned in the ground truth and appears to conflate different metrics. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes the shift from acquisition (2023) to operational integration (2024), with specific mention that PDC was 'excluded from Chevron's internal control assessment due to the business combination' in 2023. The LLM fails to capture this important distinction about the integration timeline and control assessment implications. (3) CORRECT ELEMENTS - The LLM correctly identifies: the 2023 acquisition closure, the 19% production increase, the ~250 k bbl/d contribution (which aligns with 19% increase), and the 2024 full-year integration. (4) EXTRANEOUS INFORMATION - The LLM adds details about 'wholly-owned subsidiary,' '5% of total assets,' and '1% of revenue' that are not in the ground truth and cannot be verified. (5) MULTI-HOP REASONING - While the LLM attempts to show evolution from acquisition to integration, it fails to properly synthesize the key financial impact ($2.2B vs claimed $3.5B) and misses the internal control assessment context that demonstrates the integration progression. The core factual error regarding the earnings contribution ($3.5B instead of $2.2B) is a critical failure in quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 442,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "\nSouthern Company continues to record its energy‑related derivatives that are designated as regulatory hedges at fair value, initially recognizing unrealized gains and losses as regulatory assets or liabilities that are later amortized into fuel expense.  In the 2022 filing the net regulatory balances for the traditional utilities were roughly $50 million of regulatory assets and $6 million of regulatory liabilities, whereas the 2024 filing shows substantially larger gross and net amounts (e.g., about $75 million gross and $45 million net regulatory assets for Southern Company), with the gains now split between current and non‑current regulatory assets/liabilities and presented net of offsetting collateral.  The underlying valuation method (fair‑value through regulatory assets/liabilities) has not changed, but the magnitude of unrealized gains and the way they are displayed on the balance sheet have increased.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n- The LLM provides specific dollar amounts ($50M regulatory assets, $6M regulatory liabilities in 2022; $75M gross and $45M net in 2024) that are NOT present in the ground truth answer\n- These numbers appear to be fabricated or unsupported by the knowledge graph, as the ground truth does not cite any specific dollar amounts\n- The LLM's claim about \"roughly $50 million\" and \"about $75 million\" cannot be verified against the ground truth\n\n2. CONCEPTUAL MISALIGNMENT:\n- The ground truth emphasizes a SHIFT in disclosure focus between 2022 and 2024: from reporting pre-tax effects of unrealized derivative gains/losses (2022) to fair value presentation as assets/liabilities on balance sheets (2024)\n- The LLM claims the \"underlying valuation method (fair-value through regulatory assets/liabilities) has not changed,\" which contradicts the ground truth's assertion of a change in both valuation approach AND presentation\n- The ground truth indicates a change in HOW derivatives are presented (from regulatory hedging instrument deferrals to balance sheet assets/liabilities), but the LLM suggests continuity\n\n3. MISSING KEY ELEMENTS:\n- The LLM does not adequately address the shift from regulatory hedging instrument treatment (2022) to fair value asset/liability presentation (2024)\n- The ground truth mentions presentation under 'Other' or 'Risk Management Activities' categories, which the LLM does not discuss\n- The ground truth references interest rate and foreign currency derivatives alongside energy derivatives in 2024, which the LLM omits\n\n4. MULTI-HOP REASONING:\n- The LLM fails to properly synthesize the temporal change between 2022 and 2024\n- It incorrectly characterizes the change as primarily quantitative (magnitude increase) rather than qualitative (presentation and valuation approach shift)\n- The reasoning about regulatory assets/liabilities amortization into fuel expense is not supported by the ground truth\n\n5. CONTEXTUAL ISSUES:\n- The LLM's discussion of collateral offsetting is not mentioned in the ground truth\n- The emphasis on \"current and non-current\" split is not addressed in the ground truth\n- The answer reads as if it has specific filing data, but the numbers cannot be verified and appear inconsistent with the ground truth's more general characterization of the changes",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 656,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "\nChevron’s holding in Tengizchevroil grew sharply – the investment’s carrying value rose from about **$3 billion at the end of 2022 to roughly $27.4 billion by the end of 2024** (the increase reflects the addition of a $4.5 billion loan and a re‑valuation of the stake).  At the same time, the company’s share of the joint‑venture’s earnings fell from **$4.39 billion in 2022 to $3.38 billion in 2023 and remained modest in 2024**, showing a transition from earnings‑driven participation to a larger balance‑sheet exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that undermine its credibility. (1) INVESTMENT CARRYING VALUE: The LLM claims the carrying value was 'about $3 billion at the end of 2022' but the ground truth states it was about $100 million higher than underlying equity in net assets in 2022 - this is a fundamental mischaracterization. The LLM then claims it rose to 'roughly $27.4 billion by end of 2024,' which aligns with the ground truth figure of $27,368 million in 2024, but the starting point is completely wrong. (2) EQUITY EARNINGS: The LLM states earnings fell from '$4.39 billion in 2022 to $3.38 billion in 2023' - the ground truth confirms $4,386 million in 2022 (correctly rounded to $4.39B), but the 2023 figure of $3.38 billion is INCORRECT. The ground truth provides $3,033 million in 2024, not 2023. The LLM appears to have fabricated or misplaced the 2023 earnings figure. (3) MULTI-HOP SYNTHESIS: While the LLM correctly identifies the $4.5 billion loan component and attempts to synthesize the investment growth narrative, it fails to accurately report the specific earnings trajectory. The claim that earnings 'remained modest in 2024' is vague and unsupported by the specific 2024 figure provided in ground truth ($3,033 million). (4) STRUCTURAL ISSUES: The LLM's framing of 'transition from earnings-driven participation to larger balance-sheet exposure' is interpretive and somewhat reasonable, but it's built on incorrect intermediate data points. The answer demonstrates partial understanding of the relationship evolution but fails on precision of financial metrics, which is critical for financial analysis questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 462,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s ownership in Alert Innovation did not change – it already owned 100 % of the company.  The 100 % stake was obtained in fiscal 2023 when Walmart completed a $0.4 billion acquisition of Alert Innovation, which had previously been consolidated only as a variable‑interest entity, thereby converting the relationship from a VIE to a wholly‑owned subsidiary.  (The entity was later sold and de‑consolidated in fiscal 2025.)",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer fundamentally misunderstands the question and provides incorrect information about the timeline. (1) QUANTITATIVE ACCURACY: The numbers are correct - $0.4 billion acquisition amount and 100% ownership stake are accurate. However, the fiscal year attribution is problematic. (2) MAJOR FACTUAL ERROR - TIMELINE: The ground truth states that by fiscal 2024, Walmart had sold and deconsolidated Alert Innovation (complete exit). The LLM answer claims the sale occurred in fiscal 2025, which contradicts the ground truth. The question specifically asks about the evolution between fiscal 2023 and fiscal 2024, and the correct answer is that Walmart went from 100% ownership in fiscal 2023 to NO ownership in fiscal 2024 (sold and deconsolidated). (3) INCOMPLETE ANSWER TO QUESTION: The LLM states 'ownership in Alert Innovation did not change – it already owned 100%' which is factually incorrect for the fiscal 2023 to fiscal 2024 period. The ownership DID change - from 100% to 0%. The LLM correctly identifies the fiscal 2023 acquisition but fails to address the critical fiscal 2024 transaction (the sale and deconsolidation). (4) MULTI-HOP REASONING FAILURE: The question requires synthesizing two key transactions: (a) the fiscal 2023 acquisition and (b) the fiscal 2024 sale/deconsolidation. The LLM only addresses the first transaction and incorrectly dates the second to fiscal 2025. (5) SEMANTIC MISMATCH: The ground truth explicitly states 'a full transformation from full ownership to no ownership within a single fiscal year' (fiscal 2023 to 2024), but the LLM answer suggests no change occurred between these years. This is a fundamental misunderstanding of what the question asks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 469,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 the “foreign‑currency‑other” derivative **asset** fell sharply—from about **$74 million** (the sum of the $39.9 m designated‑asset and $34.3 m non‑designated‑asset reported on Oct 2 2022) to roughly **$9 million** (≈$1.9 m designated + $7.5 m non‑designated on Oct 1 2023).  Its **liability** also contracted, dropping from roughly **$6 million** (≈$0.3 m designated + $5.8 m non‑designated on Oct 2 2022) to about **$2.5 million** (≈$2.0 m designated + $0.5 m non‑designated on Oct 1 2023).  \n\nThis contraction shows that Starbucks deliberately **scaled back its broad foreign‑currency‑other derivative program**, relying instead on more targeted natural hedges and net‑investment hedges to manage exposure.  The move reflects a strategic shift toward a leaner, more focused hedging approach rather than maintaining a large “other” derivative buffer.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims FY2022 foreign currency derivative assets were ~$74 million (sum of $39.9M + $34.3M), but the ground truth clearly states $55.3 million in AOCI. The LLM's breakdown into designated/non-designated components ($39.9M + $34.3M) does not match the ground truth figure of $55.3M. For FY2023, the LLM reports ~$9 million total assets ($1.9M + $7.5M), but ground truth shows only $3.6 million total ($1.9M current + $1.7M long-term). The LLM's $7.5M non-designated figure for FY2023 appears fabricated and contradicts the ground truth. For liabilities, the LLM claims ~$6M in FY2022 and ~$2.5M in FY2023, but ground truth shows $32.5M expected reclassification in FY2022 and $8.8M total liabilities in FY2023 ($4.7M + $4.1M). (2) MISSING CRITICAL CONTEXT: The ground truth emphasizes the AOCI position ($55.3M) and the 12-month reclassification expectation ($32.5M) in FY2022, which the LLM completely omits. This is a fundamental structural difference between the two years. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the balance sheet positions across both years. It appears to have invented or misread component figures (designated vs. non-designated) that don't align with actual filing data. (4) STRATEGIC INTERPRETATION: While the LLM's conclusion about a shift toward 'leaner, more focused hedging' is plausible, it is built on incorrect numerical foundations, making the analysis unreliable. The ground truth's characterization of a 'substantial reduction' and 'shift from unrealized gains in equity to more balanced positions' is more accurate given the actual data. The answer demonstrates poor data extraction and synthesis quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 497,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Medtronic eliminated its A Preferred Shares. In the third quarter of FY 2022 the company redeemed the 1,872 outstanding A Preferred Shares for $0.075 million, and subsequent filings show zero A Preferred Shares issued or outstanding in FY 2023 and FY 2024, indicating the series was fully retired and no further activity related to those shares has occurred.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: 1,872 shares redeemed in Q3 FY2022 for $0.075 million. The temporal framing is accurate (fiscal 2022-2024). The multi-hop reasoning is sound - the answer correctly synthesizes that: (1) redemption occurred in Q3 FY2022, (2) no shares remained outstanding by FY2022 end, and (3) no reissuance occurred through FY2024, demonstrating full discontinuation. The LLM answer uses slightly different phrasing than the ground truth ('eliminated' vs 'discontinued', 'fully retired' vs 'did not reissue or reintroduce') but conveys identical semantic meaning. The answer addresses both parts of the question: the specific 2022 action (redemption details) and the evolution through 2024 (no subsequent activity). Minor observation: the LLM adds 'subsequent filings show zero A Preferred Shares issued or outstanding in FY 2023 and FY 2024' which provides additional supporting detail not explicitly stated in the ground truth but is logically consistent and strengthens the answer. No factual errors, calculation errors, or omissions detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 319,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast’s equity income from its Atairos investment flipped from a **$537 million loss** to a **$789 million gain**—a swing of roughly **$1.3 billion**.  This change was driven by fair‑value adjustments on Atairos’ underlying investments, which moved from a **$(434) million loss** in 2022 to a **$1.1 billion gain** in 2023, thereby turning a negative contribution to investment income in 2022 into a positive one in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ERRORS: (1) The LLM introduces numbers NOT in the ground truth: claims a '$537 million loss' in 2022 and '$789 million gain' in 2023 for Comcast's equity income from Atairos. The ground truth only mentions $(434) million loss in 2022 and $1.1 billion income in 2023 related to fair value adjustments. (2) The LLM calculates a '$1.3 billion swing' which is mathematically incorrect even using its own stated numbers ($789M - (-$537M) = $1.326B, which rounds to $1.3B, but these numbers are fabricated). (3) The LLM conflates two different metrics: it appears to mix the fair value adjustment figures ($(434)M to $1.1B) with invented total equity income figures ($537M loss to $789M gain). WHAT WAS CORRECT: The LLM correctly identifies that there was a turnaround from negative to positive, correctly cites the $(434) million loss in 2022 and $1.1 billion gain in 2023 for fair value adjustments, and correctly attributes the change to fair value adjustments on underlying investments. MULTI-HOP REASONING: The reasoning structure is sound (comparing 2022 vs 2023, attributing changes to fair value adjustments), but the execution is flawed due to introduction of unsupported numbers. The answer demonstrates understanding of the question's intent but fails on factual accuracy by introducing spurious financial figures that don't appear in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 401,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "\nConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region slipped modestly from about **312 billion cubic feet (BCF) at the end of 2023 to roughly 296 BCF at the end of 2024** – a decline of roughly 5 %.  The drop is driven by a reduction in developed reserves (305 BCF → 289 BCF) while undeveloped reserves remained flat at 7 BCF, reflecting modest downward revisions and limited new discoveries in the region.  This pattern indicates that the company is maintaining a stable, non‑expansionary presence in Asia‑Pacific/Middle‑East, focusing instead on optimizing existing assets and allocating capital to higher‑return opportunities elsewhere.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and goes beyond the ground truth in several ways. QUANTITATIVE VERIFICATION: All numbers are correct - 312 BCF (2023) to 296 BCF (2024) matches ground truth exactly. The calculated 5% decline is accurate (16 BCF / 312 BCF ≈ 5.1%). The breakdown of developed reserves (305 BCF → 289 BCF, a 16 BCF decline) and undeveloped reserves (7 BCF flat) is additional detail not contradicted by ground truth. ENTITY ACCURACY: Company correctly identified as ConocoPhillips (COP), region correctly identified as Asia-Pacific/Middle-East, years correctly identified as 2023-2024, and metric correctly identified as proved natural gas reserves. MULTI-HOP REASONING: The answer successfully synthesizes the reserve data across two years and correctly interprets the trend. The interpretation that this indicates 'limited growth or strategic reallocation' (ground truth) is expanded with additional insight about 'maintaining a stable, non-expansionary presence' and 'allocating capital to higher-return opportunities elsewhere' - this represents sound logical inference from the data pattern. COMPLETENESS: The answer addresses both parts of the question: (1) how reserves evolved (with specific numbers and percentage change), and (2) what this indicates about strategic positioning (with nuanced interpretation). The additional breakdown of developed vs. undeveloped reserves provides valuable context without contradicting the ground truth. MINOR CONSIDERATION: The LLM provides more detailed analysis than the ground truth (breakdown of developed/undeveloped, specific interpretation of capital allocation strategy), but this represents value-added analysis rather than error. All core facts align perfectly with ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 480,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "\nENBREL’s Canadian sales fell sharply—from **$73 million in 2022** to **$47 million in 2023** (≈ 35 % decline) and then to **$28 million in 2024** (another ≈ 40 % drop). This consecutive year‑over‑year reduction, driven by lower net selling prices, inventory reductions and weaker volume, signals a **downward market trajectory** for the product in Canada, pointing to ongoing pricing pressure and eroding demand.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error in the 2022 baseline figure. Ground truth states ENBREL Canada revenue was $113 million in 2022, but the LLM claims $73 million—a $40 million discrepancy (35% understatement). This is a major error that undermines the entire analysis. The 2023 ($47M) and 2024 ($28M) figures are correct. CALCULATION VERIFICATION: The LLM's percentage decline calculations are mathematically correct given their stated numbers ($73M to $47M = 35.6% decline; $47M to $28M = 40.4% decline), but these calculations are based on the wrong 2022 baseline. Using the correct 2022 figure of $113M, the actual 2022-2023 decline is 58.4% (not 35%), and 2023-2024 is 40.4% (correct by coincidence). QUALITATIVE ASSESSMENT: The LLM correctly identifies the downward market trajectory and provides reasonable contextual explanation (pricing pressure, inventory reductions, volume weakness). The reasoning about market implications is sound and aligns with the ground truth conclusion. However, the severity of the decline is significantly understated due to the incorrect 2022 baseline. MULTI-HOP SYNTHESIS: The answer appropriately synthesizes revenue data across three years and connects it to market trajectory analysis, which is correct in approach. ENTITY ACCURACY: ENBREL and Canada are correctly identified. OVERALL: While the qualitative reasoning and 2023-2024 figures are accurate, the critical error in the 2022 baseline figure (off by $40M or 35%) represents a fundamental factual failure that cannot be overlooked in financial analysis. This is not a minor formatting issue but a substantive data error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 458,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 Qualcomm tightened the way human‑capital progress influences executive pay: in 2023 the bonus multiplier could vary roughly 0.8 to 1.2 (with human‑capital goals treated as one of several performance factors), whereas in 2024 the company explicitly uses progress on human‑capital advancements as a non‑financial performance modifier that can adjust the bonus by a multiplier of **0.9 to 1.1**. This change narrows the possible adjustment range and makes human‑capital achievements a direct, specified component of the executive compensation formula.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces an unsupported claim about fiscal 2023 having a 0.8 to 1.2 multiplier range. The ground truth states that in fiscal 2023, human capital advancements were merely 'indicated' to be 'considered' in determining fiscal 2024 bonuses - there is NO mention of a 0.8-1.2 multiplier range in 2023. This is a factual error not present in the original answer. (2) FISCAL 2024 MULTIPLIER - The LLM correctly identifies the 0.9 to 1.1 range for fiscal 2024, which matches the ground truth. (3) EVOLUTION NARRATIVE - The LLM correctly captures that there was a shift from general consideration to a quantified modifier, and correctly identifies the non-financial performance modifier concept. However, the characterization of 2023 as having a 0.8-1.2 range is fabricated. (4) MULTI-HOP REASONING - The LLM attempts to synthesize evolution across years but does so by introducing incorrect information about the 2023 baseline. The ground truth does not support the claim that 2023 had any specific multiplier range. (5) SEMANTIC ISSUES - The phrase 'tightened the way' and 'narrows the possible adjustment range' is misleading because the ground truth doesn't establish what the 2023 range was, making the comparison invalid. The core correct information (0.9-1.1 for 2024, shift to quantified modifier) is present, but the answer is compromised by the unsupported 2023 multiplier claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 400,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi moved from a late‑stage investigational CAR‑T product limited to the 2022 pipeline tables (which listed it only for Phase III trials in relapsed/refractory chronic lymphocytic leukemia and follicular lymphoma) to a series of regulatory approvals that broadened its therapeutic scope.  In 2024 the FDA granted accelerated approvals for relapsed/refractory CLL/SLL, relapsed/refractory follicular lymphoma and relapsed/refractory mantle‑cell lymphoma, and Japan’s MHLW approved Breyanzi for high‑risk follicular lymphoma after prior therapy (pages 43‑47 of BMY_10k_2024.pdf).  Thus, by 2024 the CAR‑T therapy had expanded from a single‑indication trial stage to multiple approved uses across several B‑cell malignancies.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that substantially undermine its accuracy. CRITICAL ERRORS: (1) The LLM claims Breyanzi received FDA accelerated approval for 'relapsed/refractory mantle-cell lymphoma' in 2024, but the ground truth makes no mention of mantle-cell lymphoma approval. This is a major factual error - an entirely fabricated indication. (2) The LLM mentions Japan's MHLW approval for 'high-risk follicular lymphoma after prior therapy' which is not documented in the ground truth. While the LLM may be referencing actual filings, this information cannot be verified against the provided ground truth and represents unsourced claims. CORRECT ELEMENTS: (1) The general narrative of evolution from Phase III trials in 2022 to FDA accelerated approvals in 2024 is accurate. (2) The identification of CLL/SLL and follicular lymphoma as approved indications is correct. (3) The characterization of the shift from investigational to approved status is appropriate. (4) The reference to CAR-T therapy and B-cell malignancies is contextually accurate. MISSING/INCOMPLETE INFORMATION: (1) The LLM fails to specify the approval dates (March 2024 for CLL/SLL, May 2024 for FL) which are important temporal details. (2) The specific prior therapy requirements mentioned in the ground truth (at least two prior lines, including BTK inhibitor and BCL-2 inhibitor for CLL/SLL) are omitted. (3) The trial names (TRANSCEND-CLL-004, TRANSCEND-FL) are not mentioned. MULTI-HOP REASONING: The LLM demonstrates reasonable multi-hop synthesis in connecting 2022 trial status to 2024 approvals, but the introduction of unverified information (mantle-cell lymphoma, Japan approval details) undermines the reliability of this synthesis. The core reasoning structure is sound, but execution is compromised by factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 497,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "\nThe Resorts‑and‑Vacations line posted $8.38 bn of revenue in FY 2024, up from $7.95 bn in FY 2023—a rise of roughly **5 %–5.4 %**, driven by higher cruise ticket prices, higher hotel room rates and slightly higher occupied room‑nights.  This growth is essentially in step with the **overall Parks & Experiences segment**, which grew from $32.55 bn to $34.15 bn, a **≈5 %** increase; thus the segment’s performance tracked the segment‑wide revenue expansion rather than outpacing it.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: (1) Resorts and Vacations 2024 revenue: $8.38bn vs ground truth $8,375M ($8.375bn) - correct with acceptable rounding; (2) Resorts and Vacations 2023 revenue: $7.95bn vs ground truth $7,949M ($7.949bn) - correct with acceptable rounding; (3) Growth calculation: LLM states 5%-5.4% which is accurate (426/7949 = 5.36%); ground truth states 5% which is rounded; (4) Parks & Experiences 2024: $34.15bn matches ground truth $34,151M - correct; (5) Parks & Experiences 2023: $32.55bn matches ground truth $32,549M - correct; (6) Parks & Experiences growth: LLM states ≈5% which matches ground truth 5% (1602/32549 = 4.92%, rounds to 5%) - correct. MULTI-HOP REASONING: The answer correctly synthesizes information across two levels: (a) Resorts and Vacations segment performance in isolation, (b) comparison to overall Parks & Experiences segment growth, and (c) the relationship between the two (tracking segment-wide expansion). COMPLETENESS: All parts of the multi-part question are addressed - evolution from 2023 to 2024 is shown, comparison to overall segment growth is made, and the relative performance is contextualized. ADDITIONAL STRENGTHS: The LLM provides explanatory context (cruise ticket prices, hotel room rates, occupied room-nights) that adds value beyond the ground truth while remaining accurate. The use of ≈ and ranges (5%-5.4%) demonstrates appropriate precision handling. MINOR CONSIDERATIONS: The ground truth states growth was 'slightly below' overall segment growth, while LLM states it 'tracked' the segment-wide expansion - these are semantically equivalent given both grew at approximately 5%. The LLM's more precise calculation (5.36% vs 5% rounded) is actually more accurate than the ground truth's rounding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 496,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "\nBetween 2023 and 2024 the forward‑contract component of CVS’s accelerated share‑repurchase (ASR) program stayed within the same fixed‑dollar ASR framework but evolved in size and accounting treatment. In 2023 the company executed a $2 billion ASR with Citibank, initially recording a $0.4 billion forward contract as equity (capital surplus) that was later re‑classified to treasury stock when the remaining shares were received in February 2023. In 2024 it entered a larger $3 billion ASR with Morgan Stanley, again splitting the purchase into an initial treasury‑stock entry and a $0.4 billion forward contract recorded in capital surplus, which was subsequently re‑classified to treasury stock after the final share delivery in March 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies key quantitative facts: the $2.0 billion 2023 ASR with Citibank, the $3.0 billion 2024 ASR with Morgan Stanley, the consistent $0.4 billion forward contract value in both years, and the share delivery dates (February 2023 and March 2024). However, there are significant omissions and inaccuracies in the accounting treatment details. The ground truth specifies that in 2023, the initial treasury stock transaction was $1.6 billion (with $0.4 billion forward contract), and in 2024 it was $2.6 billion (with $0.4 billion forward contract). The LLM answer mentions these splits exist but does not provide the specific dollar amounts for the initial treasury stock components ($1.6B and $2.6B), which are critical to understanding the evolution of the structure. Additionally, the LLM states the forward contract was 're-classified to treasury stock' upon share delivery, which is misleading—the ground truth indicates the forward contract remained classified as an equity instrument recorded in capital surplus, with the final shares received completing the transaction. The LLM also fails to explicitly highlight the key insight from the ground truth: that despite the ASR size increasing from $2.0B to $3.0B (a 50% increase), the forward contract component remained constant at $0.4B, representing a shift in the proportion allocated to the forward contract (20% in 2023 vs. 13.3% in 2024). The multi-hop reasoning is partially sound but incomplete—the answer synthesizes information across the two years but misses the proportional analysis that is central to understanding how the structure evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 448,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "\nFrom 2023 to 2024 Duke Energy made the fair‑value hierarchy explicit and more granular in its Master Retirement Trust disclosures. The 2024 filing adds a dedicated “Not Categorized (b)” column, separates Level 1, Level 2 and Level 3 amounts for each asset class, and includes a reconciliation of Level 3 balances (beginning/ending), whereas the 2023 tables only listed Level 1, Level 2, Level 3 and a combined “Not Categorized” figure without a movement schedule. Together with the updated target‑allocation percentages and clearer language about practical‑expedient measurements, the 2024 filing therefore improves transparency around how pension assets are valued and classified.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues with accuracy and completeness. CORRECT ELEMENTS: (1) The answer correctly identifies that Duke Energy added Level 3 reconciliation disclosures in 2024, which matches the ground truth statement about 'reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3).' (2) The answer correctly notes that 2024 improved transparency around fair value categorization. (3) The reference to practical expedient measurements is appropriate. SIGNIFICANT ISSUES: (1) The LLM introduces specific structural details ('dedicated \"Not Categorized (b)\" column', 'separates Level 1, Level 2 and Level 3 amounts for each asset class') that are NOT mentioned in the ground truth answer. These appear to be fabricated details not supported by the original answer. (2) The LLM claims the 2023 tables 'only listed Level 1, Level 2, Level 3 and a combined \"Not Categorized\" figure without a movement schedule' - this is a specific structural claim not verified in the ground truth. (3) The ground truth explicitly states that in 2023, Duke Energy 'noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy' - the LLM does not clearly convey this key 2023 disclosure point. (4) The ground truth mentions 'maintained the same allocation percentages' in 2024, but the LLM says 'updated target-allocation percentages,' which contradicts the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution across years but introduces unsupported details and misses the specific emphasis on the practical expedient disclosure in 2023. The reasoning about transparency improvement is sound but the supporting details are questionable. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is less critical, but the structural claims about table formats cannot be verified against ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 572,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer moved from a **$3.5 billion non‑cash revenue reversal in Q4 2023**—which reflected an estimated return of ≈ 6.5 million EUA‑labeled Paxlovid courses by the U.S. government—to a **$771 million favorable adjustment in Q1 2024** after 5.1 million courses were actually returned, and it began recognizing **$442 million of revenue in Q3 2024** for **1 million courses supplied to the newly created U.S. Strategic National Stockpile** (provided at no cost). The returned courses were converted into a **volume‑based credit** that funds a patient‑assistance program, and **deferred Paxlovid revenue fell from $5.1 billion at the end of 2023 to $2.2 billion at the end of 2024**, shifting revenue recognition from the reversal of prior sales to recognition of deliveries under the new commercial and stockpile agreements.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of all key financial figures and events. Verification of numbers: $3.5 billion revenue reversal (2023) ✓, 6.5 million EUA-labeled courses estimate ✓, $771 million favorable adjustment (2024) ✓, 5.1 million actual returns ✓, $442 million SNS revenue recognition ✓, 1.0 million SNS courses ✓. The deferred revenue figures ($5.1 billion end-2023 to $2.2 billion end-2024) are additional details not in the ground truth but appear consistent with the narrative. Multi-hop synthesis is sound: the answer correctly traces the progression from 2023 reversal through 2024 adjustment and new SNS recognition, showing understanding of how inventory returns and new agreements affected revenue recognition. The LLM provides additional context (Q4 2023, Q1 2024, Q3 2024 timing; volume-based credit for patient assistance; deferred revenue decline) that enriches the answer without contradicting ground truth. Minor deduction: The ground truth states SNS courses were provided 'for future pandemic preparedness' while LLM notes they were 'provided at no cost'—this is a reasonable inference but adds interpretation beyond the ground truth statement. The answer fully addresses the question's multi-part structure: (1) 2023 obligations/reversals, (2) 2024 adjustments, (3) SNS creation and revenue recognition, and (4) the shift between years. All calculations and comparisons are logically sound. The semantic equivalence is strong—the answer conveys the same essential information as ground truth while providing additional supporting details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 442,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "\nERLEADA (apalutamide) sales jumped from **$1.88 billion in 2022 to $2.39 billion in 2023**, a **~27 % year‑over‑year increase** (operational growth ~27.5 %).  This strong rise helped drive the overall Oncology segment’s 10.5 % sales growth and underscores ERLEADA’s growing market share in metastatic castration‑resistant prostate cancer.  Consequently, ERLEADA is emerging as a **key growth engine within J&J’s oncology portfolio**, complementing other flagship oncology products and reinforcing the company’s strategic focus on expanding its cancer‑therapy pipeline.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. Quantitative verification: ERLEADA sales of $1.88B (2022) to $2.39B (2023) match ground truth ($1,881M to $2,387M), with the ~27% growth rate correctly calculated (26.9% in ground truth, ~27% in LLM answer - acceptable rounding). The oncology segment's 10.5% growth is correctly cited. The LLM properly synthesizes multi-hop information by connecting ERLEADA's strong performance to its role in J&J's oncology portfolio and the overall segment growth. The answer correctly identifies ERLEADA as an emerging growth engine. Minor deviations from ground truth: (1) The LLM mentions 'operational growth ~27.5%' which adds specificity not in the original answer but is not contradictory; (2) The LLM references ERLEADA's market position in metastatic castration-resistant prostate cancer, which is contextually relevant but not explicitly stated in the ground truth; (3) The ground truth specifically mentions the decline in IMBRUVICA and ZYTIGA as contrasting products, which the LLM omits. This omission is a minor gap in completeness but doesn't affect the core answer's accuracy. The LLM's characterization of ERLEADA as a 'key growth engine' aligns well with the ground truth's assessment of it becoming 'more prominent' and 'increasingly important.' Overall, the answer is factually sound with excellent number accuracy and solid multi-hop reasoning, with only minor omissions of comparative context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 414,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "\nERLEADA’s worldwide sales surged from **$760 million in 2022 to $1.29 billion in 2023**, a **≈70 % increase** (the filing reports a 70.0 % change from 2022 to 2023, following a 96 % jump the prior year).  This rapid growth—driven by expanding use in metastatic castration‑resistant prostate cancer and broader geographic uptake—signals that ERLEADA is moving from early‑stage adoption into a **strong, accelerating market trajectory** with continued share gains expected in the coming years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth: (1) WRONG 2022 FIGURE: LLM states '$760 million in 2022' but ground truth shows $1,291 million - a 41% understatement. (2) WRONG 2023 FIGURE: LLM states '$1.29 billion in 2023' but ground truth shows $2,387 million - a 46% understatement. (3) WRONG GROWTH RATE: LLM claims '≈70% increase' from 2022 to 2023, but ground truth shows 26.9% growth for that period. The 70% figure actually refers to 2022's growth compared to 2021, not 2022-to-2023 growth. (4) INVERTED TIMELINE: LLM appears to have confused the years, presenting 2021 data as 2022 and 2022 data as 2023. (5) INCORRECT MARKET TRAJECTORY INTERPRETATION: LLM concludes ERLEADA is in 'strong, accelerating market trajectory' when the ground truth indicates a 'maturing growth phase' with deceleration (70% growth in 2022 slowing to 26.9% in 2023). The multi-hop synthesis is fundamentally broken - the model failed to correctly identify and synthesize the year-over-year progression. All quantitative claims are materially incorrect, making this answer unsuitable for financial analysis or decision-making.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 336,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 NVIDIA carried the 0.584 % Notes Due 2024 at essentially the same $1.25 billion carrying amount on its balance sheet (the notes were listed with a 0.4‑year remaining term and a 0.66 % effective rate in both years).  No repayment or refinancing of those notes occurred in 2024 – the only debt‑related action that year was the retirement of the older 0.309 % Notes Due 2023.  The company therefore held the 0.584 % notes through 2024, planning to settle them later (they were finally repaid in fiscal 2025).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides accurate financial details about NVDA's debt management of the 0.584% Notes Due 2024. STRENGTHS: (1) Correctly identifies the $1.25 billion ($1,250 million) carrying amount in both fiscal 2023 and 2024 - this matches the ground truth exactly. (2) Accurately states the 0.66% effective interest rate. (3) Correctly notes that no repayment or refinancing occurred in fiscal 2024. (4) Accurately identifies that the notes were finally repaid in fiscal 2025. (5) Provides additional context about the 0.309% Notes Due 2023 being retired in 2024, which adds relevant detail about the broader debt management strategy. (6) The multi-hop reasoning is sound - synthesizing information about what happened in FY2023, FY2024, and FY2025 to show the evolution of the debt management strategy. MINOR WEAKNESSES: (1) The ground truth emphasizes a 'shift in NVDA's debt management strategy' where it 'chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it,' but the LLM answer frames this more neutrally as simply 'planning to settle them later' without explicitly characterizing this as a strategic choice or shift. (2) The LLM answer could have been slightly more explicit about the strategic implications of retiring the notes on schedule rather than refinancing. However, the core factual content is accurate and the reasoning is sound. The answer successfully addresses the evolution question by showing the balance remained constant through FY2024 and then was repaid in FY2025, demonstrating the company's debt management approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 447,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell cut its holdings of mortgage‑backed and other asset‑backed securities in the pension portfolios.  In the U.S. plans the position fell from **$1.119 billion** (2022) to **$0.676 billion** (2023), a reduction of **$0.443 billion (≈40 %)**, and in the non‑U.S. plans it dropped from **$31 million** to **$10 million**, a decline of about **$21 million (≈68 %)**.  Overall the company trimmed roughly **$0.46 billion** (≈44 %) of its mortgage/asset‑backed securities exposure during the year.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect numbers that contradict the ground truth. Ground truth states: (1) 2022 U.S. Plans: $982 million, (2) 2023 Non-U.S. Plans: $10 million, (3) Total reduction: $972 million (98%). LLM claims: (1) 2022 U.S. Plans: $1.119 billion ($1,119 million) - INCORRECT, overstates by $137 million, (2) 2023 U.S. Plans: $0.676 billion - INCORRECT, ground truth shows shift to Non-U.S. Plans at $10 million, (3) 2022 Non-U.S. Plans: $31 million - NOT in ground truth, (4) Overall reduction: $0.46 billion - INCORRECT, should be $0.972 billion. The LLM fundamentally misrepresents the nature of the change: ground truth shows a major strategic shift where the entire position moved from U.S. Plans ($982M) to Non-U.S. Plans ($10M), representing a 98% reduction. The LLM instead portrays a gradual reduction across both plan types with different numbers entirely. The calculations in the LLM answer (40%, 68%, 44%) are mathematically consistent with the LLM's stated numbers but those numbers are factually wrong. The LLM correctly identifies the general trend (reduction in holdings) and the correct companies/years, but fails on the critical quantitative details that are essential to answering this financial question. This is a case where the model appears to have fabricated or misremembered specific financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 382,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One markedly increased its use of securitized debt: it issued roughly **$6.3 bn** of new securitized obligations in 2023 versus only **$1.3 bn** in 2022, expanding the proportion of its long‑term funding that comes from securitizations of credit‑card and auto‑loan assets and supporting continued loan‑portfolio growth.  These obligations remain measured at fair value and are disclosed in the fair‑value hierarchy as **Level 2** (with any related retained‑interest assets classified as Level 3).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims Capital One issued '$6.3 bn' of securitized obligations in 2023 versus '$1.3 bn' in 2022. The ground truth provides NO such issuance figures - it only states the carrying value was $18,043 million in 2023. The LLM appears to have fabricated these specific issuance amounts. (2) MISSING GROUND TRUTH DATA: The ground truth explicitly states the 2023 carrying value ($18,043M) and fair value ($18,067M), which the LLM completely omits. These are critical quantitative facts directly answering the question. (3) PARTIAL ACCURACY: The LLM correctly identifies Level 2 classification for securitized debt obligations, which matches the ground truth. The mention of Level 3 for retained-interest assets is reasonable but not explicitly confirmed in the provided ground truth. (4) INCOMPLETE SYNTHESIS: The LLM fails to address the ground truth's key insight about the evolution from 2022 (described as 'key component' without specific numbers) to 2023 (with detailed disclosure of carrying and fair values). The ground truth emphasizes a 'shift toward more detailed disclosure and potentially more structured risk management,' which the LLM misses entirely. (5) UNSUPPORTED CLAIMS: The LLM's narrative about 'markedly increased' use and specific issuance figures cannot be verified against the provided ground truth and appear to be hallucinated. The answer demonstrates poor multi-hop reasoning by failing to synthesize the actual data points provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 447,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "\nFrom 2023 to 2024 JPMorgan’s CECL‑related capital transition provision was fully phased‑in by January 1 2025.  The benefit that could be taken into CET1 capital fell from **$1.4 billion at the end of 2023** to **$720 million at the end of 2024**, a net reduction of roughly **$680 million** (the remaining $720 million was the balance that would be fully recognized in 2025).  This decline reflects the amortization of the transition provision as the firm moved from a larger, partially‑phased‑in benefit to the smaller, remaining amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key quantitative facts are correct: (1) 2023 CECL benefit of $1.4 billion - CORRECT, (2) 2024 CECL benefit of $720 million - CORRECT, (3) Net reduction calculation of $680 million ($1.4B - $720M) - CORRECT, (4) Full phase-in by January 1, 2025 - CORRECT. The answer successfully synthesizes the multi-hop information by connecting the year-over-year evolution of the CECL provision with the underlying phasing mechanism. The LLM provides additional helpful context by explaining that the $680 million reduction represents amortization of the transition provision and clarifying that the remaining $720 million would be fully recognized in 2025. The reasoning is sound and logically structured. Minor observation: The LLM's phrasing 'the remaining $720 million was the balance that would be fully recognized in 2025' is slightly interpretive but semantically consistent with the ground truth statement that provisions were 'fully phased in by January 1, 2025.' The answer directly addresses all components of the question: (1) how treatment evolved (phased reduction), (2) quantitative change (from $1.4B to $720M), and (3) the underlying mechanism (transition provisions under U.S. capital rules). No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 362,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Salesforce replaced its then‑existing revolving‑loan facility with a larger, longer‑dated one.  The original agreement (entered into in December 2020) provided a **$3 billion unsecured revolving credit facility that matured in December 2025** — the “Prior Credit Agreement” noted on page 49‑50 of the 2024 filing.  In October 2024 the company entered into a new **$5 billion unsecured revolving credit facility that now matures in October 2029** — the “Revolving Loan Credit Agreement” described on pages 51‑53 of the 2024 filing.  The new facility doubles the borrowing capacity and extends the maturity by more than four years, while still having no outstanding borrowings as of January 31 2024.  (Earlier administrative amendments in April 2022 and May 2023 only tweaked the prior $3 B facility.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) Fiscal 2023 facility: $3.0 billion unsecured revolving credit, maturity December 2025 - matches ground truth exactly. (2) Fiscal 2024 facility: $5.0 billion unsecured revolving credit, maturity October 2029 - matches ground truth exactly. (3) The comparison is accurate: capacity doubled ($3B to $5B) and maturity extended by more than four years (Dec 2025 to Oct 2029 = ~4 years 10 months). (4) Multi-hop synthesis is sound: the answer correctly identifies this as a replacement between fiscal years and provides proper context about the prior agreement's history (December 2020 entry, April 2022 and May 2023 amendments). The answer goes beyond the ground truth by providing additional helpful context (page references, no outstanding borrowings as of Jan 31, 2024, administrative amendment history) without introducing any inaccuracies. The reasoning is logical and the information is well-organized. Minor: The answer specifies 'October 2024' as when the new agreement was entered, which is slightly beyond the fiscal 2024 period (ending Jan 31, 2024), but this is contextually appropriate and accurate based on actual filing dates. The semantic meaning perfectly aligns with the ground truth regarding the evolution of terms and capacity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 371,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "\nUPS deepened its integration of Coyote’s truck‑load brokerage into its Supply‑Chain Solutions business—using Coyote’s network to give customers extra capacity and to bundle UPS services such as air freight and customs brokerage—​and then, in the third quarter of 2024, completed the divestiture of Coyote, recording a pre‑tax gain of **$156 million** ( $152 million after tax) that was reflected in UPS’s 2024 earnings.  \n\n*Source: “Gain on Divestiture of Coyote” in the 2024 MD&A (UPS_10k_2024.pdf, pp. 31‑32) and the “Truckload Brokerage” description (UPS_10k_2024.pdf, p. 30).*",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-sourced. QUANTITATIVE VERIFICATION: All financial figures are correct - the pre-tax gain of $156 million and after-tax gain of $152 million match the ground truth exactly. The timing (Q3 2024 completion) is accurate. COMPLETENESS: The answer addresses both parts of the multi-hop question: (1) the evolution of the relationship (from integration/deepening in 2022-2023 to divestiture in 2024), and (2) the financial impact ($156M pre-tax gain in 2024). ENTITY ACCURACY: UPS, Coyote, and all relevant metrics are correctly identified. The fiscal year 2024 is properly contextualized. REASONING: The multi-hop synthesis is sound - the answer correctly traces the relationship evolution from active integration (leveraging Coyote's network for bundled services) to complete divestiture, and properly connects this to the financial gain recorded in 2024. SEMANTIC EQUIVALENCE: The LLM's description of deepening integration before divestiture aligns with the ground truth's characterization of Coyote as an active business unit that was later divested. The sourcing to specific MD&A sections adds credibility. MINOR OBSERVATION: The LLM answer provides slightly more operational detail about how Coyote was integrated (bundling with air freight, customs brokerage) compared to the ground truth's more general description, but this is supplementary and not contradictory. The answer is well-structured, properly sourced, and factually accurate throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 412,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "\nBetween 2023 and 2024 Union Pacific cut its chassis fleet dramatically – total chassis fell from **48,340 units (30,635 owned + 17,705 leased) in 2023 to just 5,553 units (4,356 owned + 1,197 leased) in 2024**, a reduction of roughly 88 %.  Consequently, while the proportion of owned chassis rose slightly (from about 63 % to 78 % of the smaller fleet), the absolute number of owned and leased chassis both fell sharply, reflecting a strategic pull‑back from large‑scale chassis ownership and a move toward a leaner, more leased‑or‑partnered model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 2023 totals (48,340 units with 30,635 owned and 17,705 leased) and 2024 totals (5,553 units with 4,356 owned and 1,197 leased) match the ground truth exactly. The calculated reduction of approximately 88% is accurate (88.5% to be precise: (48,340-5,553)/48,340 = 0.885). The ownership percentages are also correct: 2023 owned percentage was 63.3% (30,635/48,340) and 2024 was 78.4% (4,356/5,553), both rounded appropriately in the answer. The multi-hop synthesis is sound - the answer correctly identifies the dramatic fleet reduction, the shift in ownership structure (higher proportion of owned units in the smaller fleet), and the strategic implications. The reasoning that absolute numbers fell while the proportion of owned units rose is logically sound and well-explained. The answer effectively addresses all aspects of the question: total units, ownership structure, and the evolution between the two years. The characterization of this as a 'strategic pull-back' and 'move toward a leaner, more leased-or-partnered model' is a reasonable interpretation, though the ground truth notes the fleet remains 'still mixed.' Minor: The phrase 'move toward a leaner, more leased-or-partnered model' could be slightly misleading since the proportion of owned units actually increased, but this is a minor interpretive nuance rather than a factual error. Overall, this is a high-quality response with accurate numbers, correct calculations, and sound multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 431,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "\nBoeing first identified its long‑term aluminum purchase and sales contracts as derivatives in the 2022 10‑K and disclosed that they were **not designated for hedge accounting**, so changes in their fair value would be recorded directly in earnings. The 2024 10‑K retains that treatment but adds a clearer time‑horizon: the aluminum agreements (and the related commodity contracts) are used for strategic sourcing and non‑U.S. business needs and are now described as having maturities that extend **through 2028** (with foreign‑currency forwards reaching 2031). Thus, the classification as undesignated derivatives is unchanged, but the 2024 filing provides more explicit disclosure of the contracts’ purpose, valuation method and the longer, up‑to‑four‑year horizon for the aluminum commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the multi-hop question about Boeing's aluminum agreement disclosures between 2022 and 2024. STRENGTHS: (1) All key facts are correct - the 2022 classification as undesignated derivatives with fair value changes recorded in earnings is accurately stated; (2) The 2024 evolution is correctly identified, including the shift to describing agreements as hedging forecasted transactions through 2028; (3) Numeric accuracy is excellent - the 2028 time horizon and 2031 foreign-currency forward horizon are both correct; (4) The multi-hop synthesis is sound, correctly comparing the 2022 and 2024 disclosures and identifying both continuities (undesignated derivative status) and changes (explicit time horizon disclosure); (5) The answer appropriately characterizes the evolution as moving from purely strategic sourcing language to more structured hedging strategy language with defined time horizons; (6) Additional context about foreign-currency forwards (2031) and the four-year horizon characterization adds helpful detail without introducing errors. MINOR CONSIDERATIONS: The LLM answer is slightly more detailed and nuanced than the ground truth (mentioning valuation method disclosure and foreign-currency forwards), but this represents appropriate elaboration rather than error. The phrasing 'up-to-four-year horizon' is accurate (2024 to 2028 = approximately 4 years). The answer maintains semantic equivalence with the ground truth while providing clearer exposition of the evolution. No factual errors, calculation errors, or entity misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 451,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "\nBetween FY 2023 and FY 2024 P&G’s currency‑risk profile was essentially unchanged.  The company continued to manage exchange‑rate risk mainly through short‑term forward contracts and currency swaps (maturities < 18 months) and by leveraging its diversified global operating footprint as a natural hedge.  In both years it asserted that, at a 95 % confidence level based on historical rate movements, any near‑term shift in currency rates would not have a material impact on its financial statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) CORRECTNESS: All factual information matches the ground truth. The answer correctly identifies that P&G's currency risk exposure remained materially unchanged between FY 2023 and FY 2024, accurately states the 95% confidence level, and correctly specifies the hedging instruments (forward contracts and currency swaps with <18 month maturities). (2) QUANTITATIVE ACCURACY: All numeric values are correct - the 95% confidence level is accurately cited, and the <18 months maturity threshold is correctly stated. No calculations are required for this question, and all dates/periods are accurate. (3) QUALITATIVE ACCURACY: The multi-hop reasoning is sound. The answer synthesizes information across two fiscal years and correctly compares the currency risk profiles, demonstrating that the exposure remained unchanged. The identification of hedging instruments and the confidence assessment are both accurate. (4) SEMANTIC EQUIVALENCE: The LLM uses slightly different wording than the ground truth (e.g., 'currency‑risk profile was essentially unchanged' vs 'exposure to currency rate risk remained materially unchanged'), but these are semantically equivalent. The LLM also adds the concept of 'natural hedge' from the company's diversified global operating footprint, which is a reasonable contextual addition that doesn't contradict the ground truth. (5) COMPLETENESS: The answer addresses all parts of the question - the evolution of exposure, hedging instruments, and confidence in mitigating near-term fluctuations. Minor note: The LLM's addition of 'natural hedge' concept is not explicitly mentioned in the ground truth but represents reasonable financial context and doesn't detract from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 479,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe expanded Frame.io from a niche video‑review service into a central collaboration hub that is tightly woven into the broader Adobe ecosystem.  The platform’s functional scope now covers end‑to‑end content creation and approval across Creative Cloud apps (Premiere Pro, After Effects, Photoshop, Lightroom), Document Cloud workflows (Acrobat Sign, PDF commenting), and the Experience Cloud stack (GenStudio, Firefly AI), adding features such as Camera‑to‑Cloud ingest, AI‑driven frame‑accurate annotations, and seamless cross‑app sharing.  This evolution positions Frame.io as the connective layer that links media‑production, document‑review and generative‑AI workflows into a single, AI‑enhanced collaboration layer.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Frame.io from 2022 to 2024, accurately mentions the integration with Creative Cloud apps (Premiere Pro, After Effects, Photoshop, Lightroom), and correctly identifies Camera-to-Cloud functionality and frame-accurate commenting as key features. The positioning as a collaboration hub is semantically aligned with the ground truth's description as a 'cloud-native creative collaboration platform.' The mention of GenStudio integration is accurate. WEAKNESSES: (1) The LLM introduces significant scope creep by claiming integration with Document Cloud (Acrobat Sign, PDF commenting) and Experience Cloud (Firefly AI) - these are NOT mentioned in the ground truth and appear to be speculative additions not supported by the source material. (2) The LLM mentions 'AI-driven frame-accurate annotations' which conflates two separate features (frame-accurate commenting and AI capabilities) in a way not explicitly stated in ground truth. (3) The answer overstates the 2022 baseline by implying Frame.io was a 'niche video-review service' when the ground truth only states it was 'listed among Adobe's trademarks' with 'no detailed description.' (4) The claim about 'seamless cross-app sharing' and positioning as 'connective layer' linking 'document-review and generative-AI workflows' goes beyond what the ground truth supports. MULTI-HOP REASONING: The answer demonstrates good synthesis of the evolution concept but introduces unsupported claims that suggest hallucination or over-inference. The core multi-hop requirement (comparing 2022 vs 2024 positioning) is addressed, but with added information not in the knowledge graph. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral (8/10 for not introducing false metrics). QUALITATIVE ACCURACY: Moderate - correctly identifies some integrations and features but adds unsupported claims about Document Cloud and Experience Cloud integration that reduce accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 548,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Company’s equity interest in the ATMP joint venture was still accounted for under the equity‑method, but the financial picture changed markedly.  The carrying value of the investment rose from roughly **$63 million at the end of 2022** to **about $99 million at the end of 2023**.  The 2023 filing also shows a sharp increase in related‑party activity – purchases from the JV jumped to **$1.7 billion** (versus $831 million in 2022), gains recognized in equity income rose to **$16 million** (compared with $5–6 million previously), and the balances of payables ($363 million vs. $78 million) and receivables ($9 million vs. $2 million) expanded accordingly.  All of these items continue to be disclosed as part of the equity‑method investment in the ATMP JV.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERRORS: The LLM claims the carrying value 'rose from roughly $63 million at the end of 2022 to about $99 million at the end of 2023,' but the ground truth explicitly states that in the 2023 filing, AMD 'omits any mention of the carrying value of the investment.' The ground truth shows the 2022 filing disclosed $69M (Dec 2021) and $63M (Dec 2020), but the 2023 filing contains NO carrying value disclosure whatsoever. The LLM fabricated a $99 million figure for 2023 that does not exist in the filings. (2) TRANSACTION FIGURES: The LLM states purchases were '$831 million in 2022' but the ground truth indicates $831 million was from 2020, not 2022. The LLM also claims purchases 'jumped to $1.7 billion' in 2023, but provides no corresponding 2022 figure for comparison, creating confusion. The ground truth mentions $1.1 billion in 2021 purchases. (3) EQUITY INCOME AND PAYABLES: The LLM introduces specific figures for equity income gains ($16M vs $5-6M) and payables/receivables ($363M vs $78M, $9M vs $2M) that are not mentioned in the ground truth at all. These appear to be fabricated details. (4) CORE MISUNDERSTANDING: The fundamental finding of the ground truth is that disclosure DECREASED from 2022 to 2023 (detailed figures in 2022, omitted in 2023). The LLM incorrectly portrays an INCREASE in both carrying value and disclosure detail. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the key insight that the 2023 filing represents a reduction in financial disclosure compared to 2022, instead inventing a narrative of financial growth and expanded disclosure. The answer is internally inconsistent with documented filing practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 481,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "\nHoneywell’s Commercial Aviation Original‑Equipment revenue slipped from **$2.397 billion in 2023 to $2.223 billion in 2024**, a decline of roughly **$174 million (≈7 %)**.  This dip points to a modest softening in OEM demand—likely tied to slower aircraft production or inventory adjustments—yet the segment remains a major contributor to Honeywell’s aerospace revenue, underscoring the company’s continued prominence in the sector despite short‑term market headwinds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: (1) Revenue figures are correct: $2.397 billion (2023) and $2.223 billion (2024) match the ground truth values of $2,397 million and $2,223 million respectively - the format variation (billions vs millions) is acceptable and equivalent. (2) Decline calculation is accurate: $2.397B - $2.223B = $0.174B = $174 million, correctly stated. (3) Percentage calculation is accurate: $174M / $2,397M ≈ 7.26%, appropriately rounded to '≈7%'. QUALITATIVE ASSESSMENT: The LLM correctly identifies this as a decline/contraction in the Commercial Aviation OEM segment and provides reasonable interpretations (slower aircraft production, inventory adjustments) that align with the ground truth's mention of 'weakening in original equipment demand or supply constraints.' The answer appropriately contextualizes this within Honeywell's broader aerospace position. MULTI-HOP REASONING: The answer successfully synthesizes the revenue comparison across two years and connects it to sector positioning, addressing both parts of the multi-part question. MINOR OBSERVATIONS: The LLM's interpretation adds slightly more nuance than the ground truth (mentioning 'short-term market headwinds' and 'continued prominence'), which represents reasonable analytical extension rather than error. The phrase 'modest softening' appropriately characterizes a 7% decline. All entities (Honeywell, Commercial Aviation OEM, Aerospace Technologies) are correctly identified. The answer is complete, accurate, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 435,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "\nThe Heart‑Failure device business grew from **$1.161 billion in 2023 to $1.279 billion in 2024**, an increase of **$118 million**, or **approximately 10.2 %** in total segment revenue over the one‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct financial figures and calculations. Verification of key metrics: (1) 2023 revenue of $1,161 million ($1.161 billion) - CORRECT; (2) 2024 revenue of $1,279 million ($1.279 billion) - CORRECT; (3) Dollar increase of $118 million ($1,279M - $1,161M = $118M) - CORRECT; (4) Percentage change of 10.2% ($118M / $1,161M = 10.16%, rounded to 10.2%) - CORRECT. The LLM properly converted between million and billion formats, which is acceptable. The multi-hop reasoning is sound, correctly synthesizing the year-over-year comparison and calculating both absolute and percentage changes. However, the LLM answer omits contextual details present in the ground truth regarding growth consistency across U.S. and international markets, minimal exchange rate impact, and underlying demand indicators. This omission represents a minor incompleteness in addressing the full scope of the original answer's context, though it does not affect the core factual accuracy of the direct question. The answer is well-structured, clear, and directly addresses the question asked with accurate calculations and proper entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1157,
        "completion_tokens": 334,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "\nIn the 2022 filing IBM listed the 0.300% Notes due 2028 as a separate line‑item in the Debt footnote (long‑term debt). By the 2023 filing the same series is shown only in the Section 12(b) registration table and is no longer presented as a distinct debt component, indicating that IBM has moved the detailed disclosure of these notes out of the 10‑K.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT CHARACTERIZATION OF 2022 TREATMENT: The LLM claims the notes were listed as a 'separate line-item in the Debt footnote (long-term debt)' in 2022, but the ground truth indicates they were referenced as part of a list with incorporation by reference to Exhibit 4.1 from a Form 8-K. This is a fundamental mischaracterization. (2) INCORRECT CHARACTERIZATION OF 2023 TREATMENT: The LLM states the notes appear 'only in the Section 12(b) registration table and is no longer presented as a distinct debt component,' suggesting removal from detailed disclosure. However, the ground truth indicates the opposite evolution - the 2023 filing shows MORE explicit disclosure with formal listing in the registered securities table with a specific trading symbol (IBM 28B) and explicit NYSE registration. The LLM's conclusion that disclosure moved OUT of the 10-K contradicts the ground truth showing movement toward MORE explicit disclosure. (3) DIRECTIONAL ERROR: The LLM describes a reduction in disclosure detail, while the ground truth describes an increase from incorporation by reference to explicit formal registration. (4) QUANTITATIVE ACCURACY: The dates (2022, 2023, 2028, February 10, 2020) and the note rate (0.300%) are correct, so quantitative elements score well. (5) MULTI-HOP REASONING: The model failed to correctly synthesize the evolution between filings - it inverted the direction of change and mischaracterized the nature of disclosure in both years. The core answer is fundamentally backwards from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 445,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "\nBetween 2022 and 2023 Apple’s Rest of Asia Pacific segment posted a 4.4 % rise in net sales, climbing from **$29.4 billion** in 2022 to **$30.7 billion** in 2023, and operating income grew 4.3 % over the same period, increasing from **$11.6 billion** to **$12.1 billion**.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN FINANCIAL DATA: The LLM answer contains significant factual inaccuracies in the core financial numbers that are the primary focus of the question. (1) NET SALES ERROR: LLM states 2023 net sales were $30.7 billion, but ground truth shows $29.615 million ($29.6 billion). This is a $1.1 billion overstatement (3.7% too high). LLM also states 2022 net sales as $29.4 billion (rounded), which is acceptable, but the 2023 figure is substantially wrong. (2) GROWTH RATE ERROR: LLM claims 4.4% growth in net sales, but correct calculation is ($29,615M - $29,375M) / $29,375M = $240M / $29,375M = 0.8%, not 4.4%. This is a major calculation error. (3) OPERATING INCOME: LLM states 2023 operating income as $12.1 billion, which matches ground truth of $12,066 million ($12.1 billion rounded). 2022 figure of $11.6 billion is acceptable rounding of $11,569 million. The 4.3% growth rate for operating income is correct: ($12,066M - $11,569M) / $11,569M = $497M / $11,569M = 4.3%. (4) MULTI-HOP SYNTHESIS: The LLM correctly identified the Rest of Asia Pacific segment and compared 2022 to 2023 data, showing proper understanding of the multi-year comparison requirement. However, the fundamental numerical errors undermine the entire analysis. The question is appropriately addressed in scope and structure, but the execution contains material factual errors that would mislead users about Apple's actual financial performance in this region.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 401,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "\nThe 2022 10‑K (pages 114‑118) notes that stock options granted **before 2022** under the 2007 Omnibus Incentive Plan “generally vest pro rata over a **five‑year** period,” while the 2024 10‑K (pages 94‑98) explains that options granted **after December 31, 2021** (i.e., under the amended plan) “generally vest pro rata over a **four‑year** period.” Thus, the vesting schedule was shortened from five years to four years for new grants, with the ten‑year expiration unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the multi-hop question. STRENGTHS: (1) All numeric values are correct - five-year vesting for pre-2022 grants and four-year vesting for post-December 31, 2021 grants are accurately stated; (2) Dates and time periods are correctly identified (2022 10-K, 2024 10-K, before 2022, after December 31, 2021); (3) The multi-hop synthesis is sound - the answer correctly synthesizes information from both the 2022 and 2024 10-K filings to show the evolution of vesting periods; (4) The core finding is accurate: a reduction from five to four years for new grants; (5) Page references (114-118 for 2022 10-K, 94-98 for 2024 10-K) provide appropriate specificity. MINOR CONSIDERATIONS: (1) The LLM answer is slightly more concise than the ground truth, omitting the phrase about 'consistent reduction' and the characterization of this as a 'structural change,' but this is not a factual error - it's a stylistic choice that doesn't diminish accuracy; (2) The mention of 'ten-year expiration unchanged' adds relevant context not explicitly in the ground truth but is consistent with standard stock option terms and doesn't contradict the original answer. The answer fully captures the essential finding that vesting periods evolved from five years (pre-2022) to four years (post-2021) across both filing years, demonstrating proper multi-hop reasoning across documents and time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 397,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "\nCVS continues to validate the fair‑value of its Level 2 debt securities by obtaining a single external price for each security and, on a quarterly basis, comparing that price to a secondary source and reviewing any variance that exceeds a preset threshold.  In both 2022 and 2023 the company performed this secondary‑source check, but it **did not adjust any of the Level 2 prices** at the reporting dates (i.e., no price revisions were made in either year).  Thus, the validation approach remained essentially the same from 2022 to 2023—routine secondary‑source comparison with no resulting price adjustments.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly captures the core validation methodology for CVS's Level 2 debt securities and accurately identifies that no price adjustments were made in either 2022 or 2023. The answer properly synthesizes the multi-hop information about the validation process (obtaining single prices, quarterly secondary source comparisons, variance threshold reviews) and correctly notes the consistency of approach across both years.\n\nSTRENGTHS:\n- Correctly identifies the single-price-per-security approach\n- Accurately states no adjustments were made in either year\n- Properly describes the quarterly secondary source comparison process\n- Correctly emphasizes the consistency/stability of the methodology from 2022 to 2023\n- Appropriate emphasis on the threshold variance review mechanism\n- Good synthesis of multi-hop information across years\n\nWEAKNESSES:\n- The original answer provides more historical context by mentioning December 31, 2021 and 2020 data points (\"did not adjust any of those prices at December 31, 2021 or 2020\"), which the LLM answer omits. While not critical to answering the 2022-2023 evolution question, this historical context was part of the ground truth.\n- The original answer mentions \"the investment team\" performing internal validation, which adds a specific organizational detail that the LLM answer lacks\n- The LLM answer uses slightly different phrasing (\"routine secondary-source comparison\") versus the ground truth's more detailed description of the process\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information across two years (2022 and 2023) and identifies the evolution (or lack thereof) in the validation approach. The reasoning is sound and logically structured.\n\nNUMERIC/FACTUAL VERIFICATION:\nNo specific numbers or calculations are involved in this question, so quantitative accuracy focuses on dates and factual statements. All dates (2022, 2023, reporting dates) are correct. The statement about no adjustments is factually accurate.\n\nThe answer is substantially correct but loses points for omitting some contextual details from the ground truth regarding historical years and the specific role of the investment team.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 590,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "\nBetween 2022 and 2023 CVS kept privately‑placed equity securities in **Level 3** of the fair‑value hierarchy.  The valuation approach remained an internal analysis of each investment’s financial statements and cash‑flow projections, using the same unobservable inputs—principally earnings and revenue multiples, a discount for lack of marketability and comparability adjustments.  What changed was the **size** of the Level 3 portfolio (up from $55 million to $79 million) and a slightly more explicit statement that any increase or decrease in those inputs would affect the fair‑value measurement, but the classification and core methodology did not shift.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) Correctly identifies Level 3 classification maintained in both 2022 and 2023; (2) Accurately describes the valuation methodology as internal analysis of financial statements and cash flow projections; (3) Correctly lists all unobservable inputs (earnings and revenue multiples, discount for lack of marketability, comparability adjustments); (4) Properly identifies the evolution: no change in classification/methodology, but increased emphasis on sensitivity analysis and impact of input changes; (5) Includes specific portfolio size figures ($55M to $79M) that demonstrate quantitative precision; (6) Effectively synthesizes multi-hop information across years. MINOR CONSIDERATIONS: (1) The ground truth mentions 'added emphasis on potential impact' and 'more detailed sensitivity analysis or increased scrutiny,' while the LLM states 'slightly more explicit statement' - these are semantically equivalent but the LLM's phrasing is slightly less detailed about the nature of the emphasis; (2) The LLM adds portfolio size information ($55M to $79M) which, while accurate and relevant, goes slightly beyond what the ground truth explicitly states, though this is a strength rather than weakness as it provides additional context. QUANTITATIVE VERIFICATION: The portfolio size figures ($55M to $79M) appear reasonable and specific, suggesting accurate data extraction. MULTI-HOP REASONING: The answer correctly synthesizes information across two years and identifies both continuity (classification, methodology, inputs) and evolution (emphasis on sensitivity). The logical structure is sound and addresses all components of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 467,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "\nThe total net revenue for Alphagan/Combigan fell sharply – it dropped about 22 % from $272 million in 2023 to $248 million in 2024 (at actual currency rates).  During the same period the international component showed a modest uptick, rising from roughly $151 million in 2023 to $153 million in 2024 (an increase of roughly 1–2 %).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN PERCENTAGE CALCULATION: The LLM states the revenue 'dropped about 22%' from $272M to $248M in 2024. This is mathematically incorrect. The actual decline is ($272M - $248M) / $272M = $24M / $272M = 8.8%, which matches the ground truth. The LLM's claimed 22% decline is a major calculation error that fundamentally misrepresents the magnitude of change. CORRECT ELEMENTS: (1) Total revenue figures are accurate: $272M (2023) and $248M (2024) - correctly stated. (2) International revenue figures are accurate: $151M (2023) and $153M (2024) - correctly stated. (3) International revenue growth percentage is approximately correct: LLM states '1-2%' vs ground truth of 1.5%, which is within reasonable rounding. (4) The direction of trends is correct: total revenue declined, international revenue increased. (5) The characterization of international growth as 'modest uptick' is semantically appropriate. MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two metrics (total revenue and international revenue) and two years (2023 and 2024), showing proper multi-hop reasoning. However, the percentage calculation error is severe and undermines the credibility of the analysis. The phrase 'at actual currency rates' adds unnecessary context not present in ground truth but doesn't contradict it. OVERALL ASSESSMENT: While the LLM correctly identified all dollar amounts and the direction of trends, the 22% figure is a significant quantitative error that would mislead readers about the severity of the revenue decline. This is a critical mistake in financial analysis where precision is essential.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1155,
        "completion_tokens": 447,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "\nChevron’s relationship with PDC Energy shifted in 2023 when it acquired the company and, by the end of 2024, fully integrated PDC’s upstream assets into its own operations.  The integration added roughly 0.3 million barrels of oil‑equivalent per day of net production—evidenced by the jump in U.S. net daily production from 1.349 MMbbl (2023) to 1.599 MMbbl (2024)—and helped lift worldwide oil‑equivalent output by about 7 % year‑over‑year, supporting Chevron’s 2025 production growth outlook.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the 2023 acquisition, the 7% worldwide production increase, and the transition of PDC from newly acquired to integrated operational component. The specific production figures (1.349 MMbbl in 2023 to 1.599 MMbbl in 2024) are provided with precise detail, and the calculation of approximately 0.3 MMbbl/day net addition is mathematically sound (1.599 - 1.349 = 0.25, which rounds to ~0.3). The multi-hop reasoning correctly synthesizes: (1) the 2023 acquisition event, (2) the 2024 integration status, and (3) the operational impact on production metrics. The answer appropriately addresses both parts of the question regarding relationship evolution and operational impact. Minor considerations: (1) The LLM adds context about 2025 production outlook which, while relevant, goes slightly beyond the ground truth's 2023-2024 focus; (2) The ground truth emphasizes PDC's exclusion from internal control assessment in 2023 due to acquisition timing, which the LLM omits—this is a notable detail about the relationship evolution but not critical to the core operational impact question. The quantitative data is accurate and properly contextualized. The semantic equivalence is strong: both answers convey that PDC transitioned from recent acquisition to integrated contributor, with the 7% production increase being the key operational metric. The LLM provides more specific production volume data than the ground truth, which enhances rather than detracts from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 426,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "\nFrom 2023 to 2024 UPS shifted from building a cold‑chain platform by acquiring temperature‑sensitive logistics firms — MNX Global Logistics and Bomi Group — to integrating those businesses and scaling the capability through additional automation and strategic investments; in 2024 it completed the purchase‑accounting for those 2023 acquisitions and announced the planned purchase of Germany‑based Frigo‑Trans and Biotech & Pharma Logistics, a move that expands its international cold‑chain network.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key acquisitions (MNX Global Logistics, Bomi Group in 2023; Frigo-Trans and Biotech & Pharma Logistics in 2024) and captures the general strategic shift toward international cold-chain expansion. However, there are significant issues: (1) QUANTITATIVE ERROR: The LLM fails to mention the $440 million acquisition price for the 2024 German acquisitions, which is a critical financial detail in the ground truth. (2) TEMPORAL AMBIGUITY: The LLM states the 2024 acquisitions were 'announced' and 'planned,' while the ground truth indicates they were 'completed' or 'acquired,' suggesting different timing/status. This is a material distinction in describing the evolution. (3) INCOMPLETE SYNTHESIS: The LLM adds context about 'integration' and 'automation' that isn't in the ground truth, which could be accurate but isn't verified. (4) MISSING KEY DETAIL: The specific $440 million valuation is a concrete metric that demonstrates the 'significant increase in international investment' mentioned in the ground truth - omitting this weakens the quantitative support for the answer. The multi-hop reasoning is sound (connecting 2023 and 2024 acquisitions to show evolution), and entity identification is correct, but the missing financial metric and temporal ambiguity represent material gaps in accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 374,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "\nBetween 2022 and 2024 Linde tightened governance of its non‑employee director RSU program by amending the 2021 Long‑Term Incentive Plan (First Amendment effective 29 Jan 2024, see Exhibit *10.03e) to add performance‑based vesting metrics (ROIC and total‑shareholder‑return) and to impose a minimum share‑ownership requirement, with the Board’s Compensation Committee gaining explicit oversight of the awards.  At the same time the company replaced the older fee‑deferral arrangement with a new Non‑employee Director Deferral Program (adopted 30 July 2024, see Exhibit *10.16), under which all director fees are converted to RSUs that follow the same performance‑linked schedule, thereby aligning director compensation more directly with long‑term shareholder value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Key issues: (1) DATES: The LLM claims a 'First Amendment effective 29 Jan 2024' and references 'Exhibit 10.03e' - these specific dates and exhibit numbers are not mentioned in the ground truth and appear to be fabricated. The ground truth only mentions the 2021 Long Term Incentive Plan framework established in 2022. (2) PERFORMANCE METRICS: The LLM introduces specific performance-based vesting metrics (ROIC and total-shareholder-return) and minimum share-ownership requirements that are NOT mentioned in the ground truth. This is a major factual error - the ground truth describes the 2022 program as 'tied to long-term performance metrics' generically, not these specific metrics. (3) GOVERNANCE CHANGES: The LLM claims the Compensation Committee gained 'explicit oversight' - this detail is not in the ground truth. (4) DEFERRAL PROGRAM DETAILS: While both answers mention the Non-employee Director Deferral Program adopted July 30, 2024 (correct date), the LLM's description that 'all director fees are converted to RSUs that follow the same performance-linked schedule' goes beyond what the ground truth states. The ground truth simply says it 'allows directors to defer receipt of stock units' without specifying that all fees are converted or that they follow performance-linked schedules. (5) REPLACEMENT CLAIM: The LLM states the new program 'replaced the older fee-deferral arrangement' - the ground truth does not characterize it as a replacement but rather as an expansion/enhancement. (6) MULTI-HOP SYNTHESIS: While the LLM attempts to synthesize evolution between 2022-2024, it does so by introducing unsupported details rather than accurately synthesizing the ground truth information. The core accurate elements (2021 LTI Plan, 2022 RSU awards, July 30 2024 Deferral Program adoption) are present but surrounded by fabricated specifics that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 539,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "\nBetween 2022 and 2024, GM kept its indemnification obligations to Stellantis—originating from the 2017 sale of Opel/Vauxhall—active, with the liabilities still capped, time‑limited and for which GM cannot quantify any potential loss; concurrently, the only investment‑related income from Stellantis was a modest $0.2 billion gain on warrants recorded in 2021, and no material change in such gains was reported in the subsequent years.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The $0.2 billion warrant gain figure is accurate; (2) The identification of indemnification obligations tied to the 2017 Opel/Vauxhall sale is correct; (3) The mention of emissions claims, product liabilities, and recalls is accurate; (4) The characterization of obligations as capped and time-limited is reasonable. PROBLEMATIC ELEMENTS: (1) CRITICAL ERROR - The LLM states the warrant gain was recorded in 2021, but the ground truth clearly indicates it was reported in 2022. This is a significant dating error for a multi-hop temporal question; (2) INCOMPLETE SYNTHESIS - The LLM fails to adequately capture the evolution/change between 2022 and 2024. The ground truth emphasizes that the relationship 'evolved' from positive financial benefits (2022 gains) to complex legal risks and contingent liabilities (2024). The LLM mentions both but doesn't effectively convey this temporal evolution or contrast; (3) MISSING CONTEXT - The LLM doesn't mention ongoing investigations into Opel's historical conduct in Europe, which the ground truth identifies as a source of potential future liabilities; (4) WEAK CHARACTERIZATION - The LLM's statement that 'no material change in such gains was reported in subsequent years' is vague and doesn't capture the shift from gains to contingent liabilities that the ground truth emphasizes. MULTI-HOP REASONING: The answer attempts to synthesize warrant gains with indemnification obligations but fails to properly establish the temporal evolution that is central to the question. The reasoning is somewhat disconnected rather than showing how the relationship evolved from 2022 to 2024. QUANTITATIVE ACCURACY: The $0.2 billion figure is correct, but the year attribution (2021 vs 2022) is wrong, which impacts the temporal analysis critical to this question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 509,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "\nFrom 2022 to 2024 Southern Company shifted from a concise, aggregate description of energy‑related derivatives—simply reporting cash‑flow and fair‑value hedge impacts on AOCI and income—to a far more granular, disaggregated presentation. The 2024 filing separates regulatory, cash‑flow and non‑designated derivatives, quantifies net volumes and the longest hedge/non‑hedge dates for each subsidiary, breaks out current versus non‑current derivative balances, and explicitly shows gross amounts, offsetting positions and the expected reclassifications from AOCI to earnings. This evolution gives investors a clearer view of how each derivative is categorized, where it appears on the balance sheet, and what financial effect it is expected to have.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misalignment with the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims the 2024 filing shows 'regulatory, cash-flow and non-designated derivatives' with 'net volumes' and 'longest hedge/non-hedge dates for each subsidiary' - these specific details are not mentioned in the ground truth and appear to be fabricated or hallucinated. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth clearly states the shift was FROM income statement focus (pre-tax effects reported on statements of income for 2021, 2020, 2019) TO balance sheet orientation (fair value categorized as assets/liabilities under 'Other' or 'Risk Management Activities'). The LLM instead describes a shift from 'concise, aggregate description' to 'granular, disaggregated presentation' with details about AOCI, offsetting positions, and reclassifications - none of which are mentioned in the ground truth. (3) MISSING KEY INFORMATION: The LLM fails to mention the critical shift from income statement reporting to balance sheet categorization, which is the core of the ground truth answer. (4) UNSUPPORTED CLAIMS: References to 'current versus non-current derivative balances,' 'gross amounts, offsetting positions,' and 'expected reclassifications from AOCI to earnings' are not substantiated by the ground truth and appear to be the LLM adding details not present in the source material. (5) SEMANTIC DIVERGENCE: While both answers discuss evolution in disclosure, they describe fundamentally different evolutions - the ground truth focuses on statement type (income vs. balance sheet), while the LLM focuses on granularity and disaggregation. The LLM answer reads as plausible but is largely disconnected from the actual ground truth, suggesting either hallucination or reliance on different/incorrect source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 504,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "\nBetween 2023 and early 2024 Gilead’s stake in Arcus grew sharply—from roughly 20 % (≈14.8 million shares, or 19.9 % of voting stock) after its mid‑2023 purchase to about 33 % following the January 2024 $320 million equity investment, which also triggered the payment of the $100 million fourth‑anniversary option fee.  At the same time, governance influence expanded: Arcus added a third Gilead‑appointed designee to its board, and the amended Collaboration Agreement gave Gilead additional opt‑in rights, milestone‑payment structures and a 50/50 U.S. profit‑share on co‑developed programs, cementing a deeper strategic and board‑level partnership.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Quantitative verification: (1) 2023 ownership of ~19.9% matches ground truth exactly; (2) January 2024 ownership increase to 33% is correct; (3) $320 million equity investment amount is accurate; (4) Board representation expansion from 2 to 3 designees is correct. The LLM provides additional context not in the ground truth (the $100 million fourth-anniversary option fee, amended Collaboration Agreement terms, 50/50 U.S. profit-share) which adds value without contradicting the original answer. Multi-hop synthesis is sound: the answer correctly traces the evolution across two time periods (2023 to 2024) and synthesizes both equity ownership and governance influence changes. The reasoning is logical and well-structured, showing how the financial investment correlated with increased board representation. Minor note: The LLM includes the share count (14.8 million shares) which is additional detail not in ground truth but appears consistent with the 19.9% figure. The answer fully addresses both parts of the multi-part question (equity ownership evolution AND governance influence evolution) with accurate numbers and proper temporal sequencing. No calculation errors detected. The semantic meaning aligns perfectly with the ground truth while providing richer contextual detail about the strategic relationship deepening.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 385,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the 2021 Multicurrency Credit Facility was first extended in the December 8 2021 amendment to a maturity of **June 30 2025** with a total commitment of **$6.0 billion** (including a $3.5 billion multicurrency sub‑limit). A further amendment on **June 29 2023** pushed the maturity out to **July 1 2026** and replaced the LIBOR benchmark with SOFR, while the **overall borrowing capacity remained $6.0 billion** (the multicurrency sub‑limit stayed at $3.5 billion). Thus, the facility’s maturity was extended by roughly one year and its borrowing limits were unchanged, though the interest‑rate structure was updated.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key facts are correct: (1) 2022 status: $6.0 billion capacity, June 30, 2025 maturity - matches ground truth exactly; (2) 2023 status: $6.0 billion capacity, July 1, 2026 maturity - matches ground truth exactly; (3) The one-year extension is correctly identified. The LLM answer goes beyond the ground truth by providing additional valuable context: specific amendment dates (December 8, 2021 and June 29, 2023), the multicurrency sub-limit details ($3.5 billion), and the LIBOR-to-SOFR benchmark change. These additions are factually accurate and enhance understanding without contradicting the ground truth. The multi-hop synthesis is sound - the answer correctly traces the facility's evolution across the 2022-2023 period and identifies both what changed (maturity date) and what remained constant (borrowing capacity). The reasoning is logical and well-structured. Minor deduction from perfect score only because the LLM includes information not explicitly in the ground truth (though this is actually a strength, not a weakness, as it demonstrates deeper knowledge). The answer directly and completely addresses the question about how maturity date and borrowing capacity evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 350,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "\nChevron’s share of imported crude in its U.S. refinery feedstocks stayed essentially steady—about 60 percent of inputs in both 2023 and 2024. What did change was the refinery utilization rate: average crude‑unit distillation capacity utilization fell from roughly 90.8 percent in 2023 to about 86.6 percent in 2024 (and from 89.8 percent to 87.9 percent for the consolidated U.S. system), indicating a noticeable drop in overall refinery capacity utilization over that period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key quantitative data points are correct: (1) imported crude oil share at ~60% in both 2023 and 2024 - matches ground truth exactly; (2) crude unit distillation capacity utilization of 90.8% in 2023 and 86.6% in 2024 - matches ground truth exactly; (3) the decline from 90.8% to 86.6% is correctly calculated and characterized as a 'noticeable drop.' The answer correctly synthesizes the multi-hop information: it identifies the stable imported crude dependency while simultaneously noting the declining refinery utilization, which is the key insight of the question. The LLM additionally provides supplementary data (consolidated U.S. system rates of 89.8% to 87.9%) that goes beyond the ground truth but is not contradictory and adds relevant context. The reasoning is sound - the model correctly identifies that stability in one metric (imported crude percentage) contrasts with decline in another (capacity utilization), which is the core analytical point. Minor deduction (1 point) only because the LLM introduces additional metrics (consolidated U.S. system rates) not explicitly mentioned in the ground truth, though these appear accurate and enhance rather than detract from the answer. The wording is clear, the entities are correctly identified (Chevron, U.S. refining operations, 2023-2024), and the temporal comparison is properly structured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 394,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "\nUPS trimmed the size of its financial hedge on British‑Pound exposure.  In the 2023 “Outstanding Positions” table the company reported GBP notional contracts of **$663 million**, but by the 2024 filing that figure had fallen to **$536 million** – a reduction of roughly **$127 million (about 19 %)**.  \n\nThis pull‑back in the GBP hedge shows that UPS is actively re‑balancing its currency‑risk program.  Rather than maintaining a static, fully‑hedged position, the company appears to be scaling the derivative coverage down as its forecasted GBP‑denominated cash flows change (e.g., shifting volume, pricing adjustments, or a lower exposure to Euro‑area shipments).  The move also suggests a greater reliance on operational hedging tools such as freight‑rate adjustments and fuel‑surcharge mechanisms, while still retaining a modest derivative hedge to protect against residual GBP volatility.  In short, the reduction signals a more dynamic, exposure‑driven approach to foreign‑currency risk management.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) All quantitative data is accurate - 2023 GBP position of 663 million, 2024 position of 536 million, reduction of 127 million, and 19% decrease are all correct. (2) The LLM correctly identified the metric as notional contracts and properly formatted the numbers. (3) The calculation verification is sound: 127/663 = 19.15%, which the LLM appropriately rounded to 19%. (4) Multi-hop synthesis is correct - the LLM properly compared positions across two fiscal years and drew appropriate conclusions. (5) The answer addresses both parts of the question: the evolution of the hedging position AND what it indicates about strategy. WEAKNESSES: (1) The LLM provides speculative interpretation beyond what the ground truth states. While the ground truth simply notes 'reassessed currency risk' and 'more conservative hedging approach or lower anticipated risk,' the LLM speculates about 'shifting volume, pricing adjustments, Euro-area shipments, operational hedging tools, fuel-surcharge mechanisms' - none of which are mentioned in the original answer or necessarily supported by the data. (2) The phrase 'Greater reliance on operational hedging tools' is an inference not present in the ground truth. (3) The characterization as 'dynamic, exposure-driven approach' goes beyond what can be definitively concluded from the hedge position reduction alone. ASSESSMENT: The core factual answer is completely accurate with proper quantitative support. However, the LLM adds interpretive layers that, while plausible, exceed the scope of what can be confirmed from the filing data. The ground truth takes a more conservative interpretive stance, while the LLM provides more detailed strategic speculation. This is not incorrect per se, but represents added interpretation rather than strict adherence to what the data demonstrates.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 498,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "\nThe fair‑value of Bank of America’s money‑market holdings grew from **$1.2 billion at the end of 2023 to $1.3 billion at the end of 2024** (an increase of roughly $0.1 billion, or about 8 %).  \n\nThis modest rise shows that the company is **maintaining a larger cushion of short‑term, low‑risk assets**, likely to capture slightly higher yields in a higher‑interest‑rate environment while preserving liquidity for funding and regulatory requirements. In other words, the shift signals a cautious short‑term investment strategy that emphasizes safety and liquidity over longer‑term or higher‑risk placements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - the starting value of $1.2 billion (Dec 31, 2023), ending value of $1.3 billion (Dec 31, 2024), the increase of $0.1 billion, and the calculated percentage increase of approximately 8% (0.1/1.2 = 8.33%) are all accurate. Dates are correctly identified. ENTITY ACCURACY: Bank of America is correctly identified, the metric (fair value of money market investments) is correct, and the time period (2023-2024) is properly specified. MULTI-HOP REASONING: The LLM successfully synthesizes the quantitative data with qualitative interpretation. It correctly identifies the trend (modest growth) and provides reasonable strategic context about liquidity management, regulatory requirements, and yield optimization in a higher-interest-rate environment. SEMANTIC EQUIVALENCE: The LLM answer goes beyond the ground truth by providing additional strategic context (capturing higher yields, regulatory requirements, emphasis on safety and liquidity). While the ground truth uses the phrase 'modest growth' and 'slight expansion in liquidity management,' the LLM uses 'modest rise' and 'maintaining a larger cushion' - these are semantically equivalent and appropriately contextualized. The characterization of the strategy as 'cautious' with emphasis on 'safety and liquidity over longer-term or higher-risk placements' is a reasonable inference from the data and aligns with the ground truth's indication of 'short-term investment strategy.' MINOR CONSIDERATION: The LLM provides interpretive analysis beyond what the ground truth explicitly states, but this analysis is reasonable, well-reasoned, and does not contradict the ground truth. The answer is more comprehensive while remaining factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 493,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "\nThe “sell‑back” feature that can be triggered on physical natural‑gas supply contracts fell sharply – from a total of **26 million mmBtu** across Southern Company’s subsidiaries in 2022 (6 mmBtu for Alabama Power, 8 mmBtu for Georgia Power, 4 mmBtu for Mississippi Power and 8 mmBtu for Southern Power) to **15 million mmBtu** in 2024 (4 mmBtu for Alabama Power, 6 mmBtu for Georgia Power, 2 mmBtu for Mississippi Power and 3 mmBtu for Southern Power).  In other words, the maximum expected sell‑back volume dropped by roughly **11 million mmBtu** (about a 42 % reduction) over the two‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: 2022 total of 26 million mmBtu with correct subsidiary breakdowns (Alabama Power 6, Georgia Power 8, Mississippi Power 4, Southern Power 8), and 2024 total of 15 million mmBtu with correct reductions (Alabama Power 4, Georgia Power 6, Mississippi Power 2, Southern Power 3). The calculated difference of 11 million mmBtu is accurate (26 - 15 = 11), and the percentage reduction of approximately 42% is correctly calculated (11/26 = 0.423 or ~42%). The multi-hop synthesis is sound, correctly identifying the change across all four subsidiaries and the parent company. The answer properly characterizes this as a 'consistent reduction across all entities' by showing each subsidiary experienced a decline. The terminology 'sell-back' feature is appropriately used and the answer clearly addresses the temporal comparison between 2022 and 2024. Minor note: The LLM uses 'mmBtu' without the 'million' prefix in some instances (e.g., '6 mmBtu' instead of '6 million mmBtu'), but this is a stylistic choice that doesn't affect accuracy since mmBtu already implies millions of British thermal units. The answer is well-structured, provides context about the magnitude of change, and directly answers the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 364,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Adobe expanded the Firefly Vector Model from a limited feature in Illustrator / Express into a core, cross‑product AI engine that is now natively embedded across Photoshop, Illustrator, Express, Acrobat, Stock and the Creative Cloud All‑Apps subscription.  The model’s capabilities were broadened (e.g., Generative Fill, Expand, Recolor), credit allocations were increased with paid‑credit plans, and enterprise‑grade indemnification and custom‑model services were added, allowing the Vector Model to drive end‑to‑end generative workflows throughout Adobe’s suite.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. MAJOR ISSUES: (1) The LLM claims the Firefly Vector Model was 'limited' in Illustrator/Express in 2023, but ground truth states it was integrated into Adobe Express in 2023 enabling image generation from text prompts in 100+ languages - this is not a 'limited' feature. (2) The LLM lists Photoshop, Acrobat, Stock, and Creative Cloud All-Apps as 2024 applications, but ground truth only confirms expansion to Adobe Illustrator by 2024 with Generative Recolor. The LLM appears to have fabricated or conflated product integrations not supported by the ground truth. (3) The LLM mentions 'Generative Fill, Expand, Recolor' as broadened capabilities, but ground truth only specifically mentions Generative Recolor for 2024. (4) The LLM introduces unsupported claims about 'credit allocations,' 'paid-credit plans,' 'enterprise-grade indemnification,' and 'custom-model services' - none of which appear in the ground truth answer. (5) The LLM's characterization of the evolution is fundamentally different: ground truth shows expansion from Express to Illustrator (two apps), while LLM claims expansion to six different products/services. The LLM answer demonstrates hallucination of product features and integrations not substantiated by the source material, making it unreliable despite using some correct terminology (Firefly Vector Model, Generative Recolor).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 401,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "\nBiktarvy’s sales rose sharply—from **$10.4 bn in 2022 to $11.9 bn in 2023**, and its share of total HIV revenue grew from roughly **61 % to about 65 %**—showing that the drug has become an even more dominant source of GILD’s HIV cash flow.  This accelerating contribution reinforces the company’s strategy of protecting and expanding Biktarvy’s market position (through pricing power, line‑extension and label‑expansion efforts) while using its strong commercial platform to fund next‑generation HIV R&D and mitigate competitive and reimbursement pressures.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "STRENGTHS: The LLM correctly identified the 2022-2023 sales figures ($10.4bn to $11.9bn) and accurately noted the growth trajectory. The percentage calculations (61% to 65% of HIV revenue) appear reasonable given the revenue figures provided. CRITICAL WEAKNESSES: (1) The LLM answer completely omits the 2024 data and analysis, which is explicitly required by the question asking about evolution 'from 2023 to 2024.' The ground truth specifically mentions that by 2024, GILD highlighted increased risks around reliance on HIV products and TAF-containing drugs like Biktarvy due to generic competition and treatment paradigm shifts. (2) The LLM's strategic interpretation focuses on 'protecting and expanding Biktarvy's market position' through pricing power and line extensions, which contradicts the ground truth's emphasis on mounting pressure to diversify and innovate within the HIV pipeline due to competitive threats. (3) The LLM fails to address the key implication mentioned in the ground truth: that while Biktarvy remained central, GILD faced pressure to sustain revenue growth through diversification, not just expansion of the existing asset. (4) The answer presents an overly optimistic view of Biktarvy's trajectory without acknowledging the risk factors and competitive pressures that emerged by 2024. The LLM essentially answered only the 2023 portion of a 2023-2024 comparison question, missing half the required analysis and the critical strategic implications about generic competition and the need for pipeline innovation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 424,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the Series 2018‑1A Securities kept the same fixed coupon of **3.652 %**; the balance rose only slightly from **≈ $496.1 million** (2022) to **≈ $496.8 million** (2023), reflecting modest interest accrual but no principal repayments or structural changes. Consequently, the securitization’s financial structure remained unchanged – the same 10‑year expected life and March 2048 final repayment date persisted, with the outstanding principal essentially stable over the two years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error regarding the 2022 principal amount. Ground truth states the 2022 aggregate principal was $500.0 million, but the LLM claims it was approximately $496.1 million. This is a material discrepancy of ~$3.9 million (0.78% error). The LLM correctly identifies the 2023 amount as $496.8 million and correctly states the interest rate remained at 3.652% for both years. DIRECTIONAL ERROR: The LLM incorrectly characterizes the principal movement as a 'rise' from 2022 to 2023 (from $496.1M to $496.8M), when the ground truth shows a DECREASE from $500.0M to $496.8M. This represents a fundamental misunderstanding of the financial evolution. POSITIVE ASPECTS: The LLM correctly identifies the fixed coupon rate (3.652%), correctly notes no structural changes, and appropriately mentions the March 2048 maturity date and 10-year expected life. The reasoning about interest accrual and no principal repayments is sound. MULTI-HOP SYNTHESIS: The answer attempts to synthesize information about both principal and interest rate changes across two years, but the foundational 2022 principal figure is wrong, undermining the entire comparison. The use of approximation symbols (≈) does not excuse the magnitude of the error when precise figures are available in the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 378,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 UPS moved from testing and impairing the Coyote trade‑name—recording a $111 million impairment charge in 2023 after reviewing strategic alternatives—to completing its divestiture in 2024, which generated a $156 million gain and eliminated Coyote’s revenue and expenses from the consolidated results. This sale signals a strategic shift away from the truckload‑brokerage unit toward expanding UPS’s Logistics and broader supply‑chain businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of the Coyote relationship evolution. Verification of key claims: (1) The $111 million impairment charge in 2023 is correctly stated and matches ground truth. (2) The September 2024 divestiture is correctly identified as the culminating action. (3) The $156 million gain from the sale is an additional detail not explicitly mentioned in the ground truth but represents accurate supplementary information about the divestiture transaction. (4) The multi-hop reasoning is sound: the answer correctly traces the progression from 2023 impairment → strategic review → 2024 divestiture, showing clear cause-and-effect relationship. (5) Entity identification is accurate: UPS, Coyote, Supply Chain Solutions, and Logistics are all correctly referenced. (6) The answer goes beyond the ground truth by providing the gain amount and strategic context about shifting toward Logistics and supply-chain businesses, which represents appropriate elaboration rather than error. The only minor consideration is that the ground truth emphasizes the impact on Supply Chain Solutions revenue decline, while the LLM answer emphasizes the strategic shift away from truckload-brokerage—both are valid interpretations of the same strategic direction. All numbers are accurate, calculations are sound, and the multi-hop synthesis across 2023-2024 is correctly executed. The answer is well-structured, complete, and directly addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 418,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "\nLinde plc’s Performance Share Unit awards that began in 2019 were originally tied to two metrics—Return on Capital (ROC) and Total Shareholder Return (TSR)—as specified in the Amended and Restated 2009 Praxair Long‑Term Incentive Plan (Exhibits 10.11N‑O). The 2021 LTIP retained those same ROC and TSR criteria, and the plan was subsequently amended in January 2024 (*10.03e) and again in March 2024 (*10.10c) to revise the performance‑metric definitions and thresholds—adding adjusted‑ROC and a modified TSR hurdle—while preserving the overall structure of the PSU awards.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) EXHIBIT REFERENCES: The LLM cites Exhibits 10.11N-O and 10.03e/10.10c, but the ground truth specifically references Exhibits 10.11k, 10.11l (2022) and 10.10l, 10.10m (2024). The LLM's exhibit citations appear to be incorrect or fabricated. (2) STRUCTURAL EVOLUTION: The ground truth clearly states that the dual structure (ROC and TSR metrics) remained unchanged between 2022 and 2024, with no new metrics introduced. The LLM incorrectly claims amendments in January and March 2024 that added 'adjusted-ROC' and 'modified TSR hurdle,' which contradicts the ground truth's finding of structural continuity. (3) TIMELINE CONFUSION: The LLM mentions '2021 LTIP' which is not referenced in the ground truth, and conflates different time periods. The question specifically asks about evolution between 2022 and 2024, not 2021. (4) METRIC ACCURACY: While the LLM correctly identifies ROC and TSR as the original metrics, it incorrectly suggests these were modified to 'adjusted-ROC' and 'modified TSR hurdle' in 2024, when the ground truth indicates the same forms remained in place. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the information showing continuity across the 2022-2024 period. Instead, it introduced unsupported claims about amendments and metric revisions. The answer fundamentally mischaracterizes the evolution as involving changes when the ground truth shows stability and consistency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 423,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "\nBetween 2023 and 2024 Trodelvy progressed from the FDA approvals it already had for metastatic triple‑negative and HR⁺/HER2⁻ breast cancers (and for UC) to a **Breakthrough‑Therapy designation in 2024 for extensive‑stage small‑cell lung cancer** (the second such designation for the drug).  This regulatory advance—moving from standard approvals in solid‑tumor indications to a Breakthrough‑Therapy status in a new cancer type—signals that the company’s development trajectory is expanding Trodelvy into additional oncology indications and that the FDA views its clinical data as sufficiently promising to accelerate further review.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question well. STRENGTHS: (1) Correctly identifies the 2023 indications (triple-negative breast cancer, HR+/HER2- breast cancer, and urothelial cancer); (2) Accurately states the 2024 Breakthrough Therapy designation for extensive-stage small cell lung cancer; (3) Properly characterizes this as a regulatory advancement and expansion into new indications; (4) Correctly interprets the development trajectory as strategic expansion into oncology indications with high unmet medical need; (5) Appropriately notes FDA's confidence in the clinical data. MINOR ISSUES: (1) The LLM parenthetically notes this is 'the second such designation for the drug' - the ground truth does not specify whether this is the first or second Breakthrough Therapy designation, so this additional detail cannot be verified against the provided ground truth and represents a potential factual claim not supported by the source material; (2) The phrasing 'moving from standard approvals...to a Breakthrough-Therapy status' is slightly imprecise - the 2023 indications were already approved (not just in development), while the 2024 designation is for a new indication still in development, which the LLM does capture but could be clearer. MULTI-HOP REASONING: The answer correctly synthesizes information across two time periods (2023 vs 2024) and properly connects the regulatory status changes to the development trajectory. The logic is sound - Breakthrough designation indicates FDA confidence and accelerated review pathway. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth with appropriate professional terminology and clear explanation of what the regulatory changes signify.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 480,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "\nFrom 2023 to 2024 Vertex AI shifted from a generic generative‑AI development platform—where developers could train, tune and deploy models such as Enterprise Search and Conversations—to a Gemini‑centric, multimodal hub that natively supports Gemini, Gemini 2.0, Imagen and Veo and supplies pre‑packaged AI agents for coding, testing, cybersecurity and other tasks. This expansion gives developers tighter integration with Google’s latest foundation models, broader multimodal capabilities, and seamless use across Google Cloud and Google Workspace.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) The ground truth does not mention Gemini 2.0, Imagen, Veo, or pre-packaged AI agents for coding, testing, cybersecurity - these appear to be fabricated or from sources outside the 10-K filings. (2) The ground truth specifically states 2023 capabilities included 'Enterprise Search and Conversations' and 2024 added 'vector search, grounding, and distillation' - the LLM answer incorrectly characterizes Enterprise Search and Conversations as 2023 models to be deployed rather than services. (3) The LLM introduces claims about 'Gemini-centric, multimodal hub' and 'Google Workspace' integration that are not supported by the ground truth. (4) While the LLM correctly identifies the evolution toward Gemini support, it adds substantial unsupported details about specific model versions and agent capabilities. (5) The ground truth emphasizes capabilities like 'test' and 'augment' which the LLM mentions 'test' but misses the specific service additions (vector search, grounding, distillation). The answer demonstrates partial understanding of the platform's evolution but fails to stick to documented facts and introduces hallucinated details that would be misleading to users relying on SEC filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 376,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "\nSouthern Company’s filings from 2022 through 2024 continue to treat weather‑related derivatives as immaterial, omitting their premium and intrinsic value from the reported fair‑value of derivatives. The only quantitative change is a modest increase in the cash‑collateral required for these contracts—from about $3 million in earlier disclosures to roughly $17 million in the 2024 filings—while the premium and intrinsic component remains deemed immaterial and is still excluded from derivative valuations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IN QUANTITATIVE DATA: The LLM answer contains a critical factual error regarding cash collateral amounts. The ground truth states cash collateral was $17 million at end of 2024 and $62 million at end of 2023. The LLM incorrectly claims the amount increased 'from about $3 million in earlier disclosures to roughly $17 million in the 2024 filings.' This is factually wrong on two counts: (1) there is no mention of $3 million in the ground truth, and (2) the LLM fails to mention the $62 million figure for 2023, which represents a DECREASE from 2023 to 2024, not an increase. This is a fundamental mischaracterization of the trend. PARTIAL CREDIT FOR CORRECT ELEMENTS: The LLM correctly identifies that weather derivatives are treated as immaterial and excluded from fair-value reporting across both years. It correctly names Southern Company (SO). MISSING INFORMATION: The LLM fails to address the key distinction in the ground truth about how disclosure evolved—that 2022 lacked specific amounts while 2024 provided more detailed context with specific dollar figures. The answer misses the $62 million 2023 figure entirely, which is essential to understanding the year-over-year change. REASONING QUALITY: The multi-hop synthesis is weak because the LLM appears to have fabricated or misremembered the $3 million figure and incorrectly characterized the directional change in collateral amounts. The claim of a 'modest increase' contradicts the actual data showing a decrease from $62M to $17M. This represents a fundamental failure in quantitative accuracy and multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 438,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Gilead’s disclosures show that Biktarvy’s **regulatory footprint was broadened** – in 2024 the FDA granted an expanded indication for patients with HIV who have M184V/I resistance and issued an updated label that includes safety and efficacy data for pregnant people, building on the product’s existing approval.  This label‑expansion work is part of a longer‑term lifecycle strategy that, together with its U.S. regulatory exclusivity (now set to expire in 2032) and patent protection that runs to 2033, helps sustain Biktarvy’s **market‑lead position** in the HIV arena despite the looming patent expiry, while the company continues to promote it as a cornerstone of its HIV portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key regulatory developments in 2024 (expanded indication for M184V/I resistance and updated label for pregnant people with HIV-1), accurately captures the shift from patent protection focus in 2023 to expanded therapeutic applications in 2024, and appropriately characterizes this as part of a lifecycle management strategy. The qualitative reasoning about market positioning and the multi-hop synthesis across years is sound. CRITICAL ERROR: The LLM states U.S. regulatory exclusivity expires in 2032, but the ground truth indicates the U.S. patent expiration is 2033. This is a factual error on a specific numeric date that was explicitly mentioned in the original answer. The LLM conflates or misrepresents the exclusivity timeline. MINOR ISSUES: The LLM adds contextual information about 'lifecycle strategy' and 'cornerstone of HIV portfolio' that, while reasonable inferences, are not explicitly stated in the ground truth answer. The ground truth focuses on the evolution of regulatory positioning and patent protection, while the LLM adds market strategy interpretation. COMPLETENESS: The answer addresses all major elements of the question - the 2023 baseline (patent protection to 2033), the 2024 developments (expanded indication and label update), and the overall evolution narrative. However, the date discrepancy (2032 vs 2033) is a material factual error that undermines confidence in the answer's accuracy. The quantitative accuracy score is reduced due to this specific numeric error, despite the overall qualitative reasoning being sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 440,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "\nBetween 2022 and 2023 AMT stepped up its use of the 2021 Multicurrency Credit Facility – it recorded roughly $850 million of net borrowings in 2022 (to fund acquisitions and repay maturing debt) and, after the facility was amended in June 2023, it added another $850 million of draws in early 2023, leaving a $723 million balance outstanding at year‑end 2023.  The June 2023 amendment kept the $6 billion commitment unchanged but extended the maturity to July 2026, added a $50 million swing‑line sub‑limit and replaced the LIBOR benchmark with SOFR‑based pricing, thereby increasing the facility’s flexibility and lowering financing costs even though the amount drawn remained modest relative to the available commitment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth data:\n\n1. CRITICAL QUANTITATIVE ERRORS:\n   - LLM claims '$850 million of net borrowings in 2022' - CORRECT\n   - LLM claims 'another $850 million of draws in early 2023' - INCORRECT. Ground truth shows $3.0 billion borrowed in 2023, not $850 million\n   - LLM claims '$723 million balance outstanding at year-end 2023' - NOT MENTIONED in ground truth and appears fabricated\n   - LLM completely omits the $6.1 billion repayment in 2023\n   - LLM completely omits the significant 842.6 million EUR ($919.1 million) repayment mentioned in ground truth\n   - LLM incorrectly states amendment was in 'June 2023' when ground truth only says '2023' without specifying June\n\n2. INCOMPLETE SYNTHESIS:\n   - Ground truth emphasizes the dramatic shift from $850M net borrowing in 2022 to $3.0B borrowed and $6.1B repaid in 2023 - a major transformation\n   - LLM mischaracterizes this as 'modest' usage and 'stepped up' when the actual pattern shows significant activity\n   - LLM fails to capture the net repayment position in 2023 (borrowed $3.0B but repaid $6.1B)\n\n3. AMENDMENT DETAILS:\n   - LLM correctly identifies: maturity extension to July 2026, $6B commitment maintained, LIBOR to SOFR replacement\n   - LLM adds '$50 million swing-line sub-limit' - NOT mentioned in ground truth\n   - LLM's characterization of 'modest' draws contradicts the actual $3.0B borrowing activity\n\n4. REASONING QUALITY:\n   - The multi-hop synthesis is fundamentally flawed\n   - LLM appears to have confused or conflated different borrowing amounts\n   - The narrative about 'flexibility and lowering financing costs' is reasonable but built on incorrect numbers\n\n5. SEMANTIC ISSUES:\n   - LLM's statement that amount 'remained modest relative to available commitment' is misleading given $3.0B was borrowed in 2023\n   - The characterization of the facility's usage pattern is inverted from reality\n\nThe answer demonstrates poor multi-hop reasoning and contains multiple fabricated or incorrect numbers that fundamentally misrepresent the actual facility usage between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 581,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "\nBetween 2023 and 2024 Alphabet continued to record the advertising inventory sold through Google Ad Manager as part of its Google Network properties on a **gross‑basis**—the full amount billed to customers is recognized as revenue and payments to network partners are recorded as cost of revenue.  However, the 2024 filing shows that Ad Manager’s revenue is now **integrated into the company’s multi‑performance‑obligation framework**, with revenue allocated to the platform based on relative standalone selling prices and with a more refined principal‑vs‑agent assessment.  This evolution tightens the linkage between Ad Manager transactions and Alphabet’s overall advertising‑revenue recognition model, aligning the timing and measurement of Ad Manager proceeds with the broader performance‑fee and revenue‑allocation methodology.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The gross-basis revenue recognition for Google Ad Manager is correctly identified in both years. (2) The characterization of 2024 showing a more refined principal-vs-agent assessment aligns with the ground truth's emphasis on control-based evaluation. (3) The mention of relative standalone selling prices and performance-obligation framework shows awareness of revenue recognition complexity. PROBLEMATIC ELEMENTS: (1) The LLM introduces a 'multi-performance-obligation framework' and 'performance-fee methodology' that are not mentioned in the ground truth answer. These appear to be inferences or potentially incorrect characterizations not supported by the original answer. (2) The ground truth emphasizes an evolution FROM 'transactional reporting model' TO 'control-driven justification,' but the LLM's framing of 'integration into multi-performance-obligation framework' doesn't clearly capture this strategic shift. (3) The LLM's description of 'relative standalone selling prices' and 'broader performance-fee and revenue-allocation methodology' introduces specific technical language not present in the ground truth, raising questions about accuracy. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution between 2023 and 2024, but the synthesis introduces elements (multi-performance-obligation framework, performance-fee methodology) that appear to be either fabricated or mischaracterized. The ground truth focuses on the shift in justification approach (transactional to control-based), while the LLM shifts focus to allocation methodologies. QUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided in either answer, so this dimension is neutral (8/10 for not introducing false numbers). QUALITATIVE ACCURACY: The core insight about control-based evaluation is present but obscured by potentially inaccurate technical characterizations. The answer partially captures the evolution but introduces questionable elements that undermine credibility (4/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 563,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "\nBetween 2023 and 2024 UPS moved from an outright goodw​ill write‑down on Roadie—$56 million of impairment was recorded in 2023—to a 2024 impairment test that found Roadie’s fair value only marginally above its carrying amount, leaving the unit with “limited excess” and flagging it as one of three reporting units most at risk of future impairment.  No new impairment was taken in 2024, but the company explicitly warned that a modest reduction in projected cash flows or a 100‑basis‑point rise in the cost of capital could trigger an impairment charge, highlighting that Roadie’s strategic role in Supply‑Chain Solutions is now balanced against an increased financial exposure to goodwill impairment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of UPS's Roadie financial exposure evolution. QUANTITATIVE VERIFICATION: The $56 million goodwill impairment charge for 2023 is correctly stated and matches the ground truth. The reference to no new impairment in 2024 is accurate. The mention of a 100-basis-point cost of capital threshold is a specific detail that adds precision without contradicting the ground truth. COMPLETENESS: The answer addresses all key aspects of the question: (1) 2023 impairment charge, (2) 2024 status with no new impairment, (3) identification as high-risk unit with limited excess fair value, (4) sensitivity to cost of capital and performance forecasts. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the temporal evolution from 2023 to 2024, showing the shift from active impairment to cautious monitoring. It properly connects the financial metrics (fair value vs. carrying amount) with strategic implications. ENTITY ACCURACY: UPS and Roadie are correctly identified; the reference to Supply-Chain Solutions segment is contextually appropriate and accurate. SEMANTIC EQUIVALENCE: The phrase 'limited excess of fair value over carrying value' in the ground truth is semantically equivalent to the LLM's 'fair value only marginally above its carrying amount.' The characterization of the shift from 'active impairment to cautious monitoring' aligns with the ground truth's description. MINOR STRENGTHS: The LLM answer adds valuable context by mentioning the specific risk factors (projected cash flows, cost of capital) and identifying Roadie as one of three reporting units at risk, which enhances understanding without introducing inaccuracy. The answer demonstrates sophisticated understanding of goodwill impairment mechanics and financial risk assessment. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 503,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "\nLinde’s helium business, which was a modest growth contributor in 2022, had become a drag by 2024, cutting the “Other” segment’s sales by about 2 % – roughly $32 million lower in 2024 – as helium volumes fell.  Despite that sales dip, operating profit in the segment still rose $19 million (≈44 %) in 2024, driven by an insurance recovery that more than offset the higher helium‑related cost pressure.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE CLAIMS: The LLM answer introduces specific dollar amounts ($32 million sales decrease, $19 million operating profit increase, 44% increase) that are NOT present in the ground truth. The ground truth only states: (1) 2% underlying sales decrease in 'Other' segment due to lower helium volumes, and (2) increased helium-related costs partially offset by insurance recovery. The LLM fabricated precise dollar figures without any basis in the provided ground truth. QUALITATIVE ACCURACY: The LLM correctly identifies the directional shift (helium from positive to negative), correctly names the 'Other' segment, and accurately captures the insurance recovery offsetting cost pressures. The characterization of helium as 'modest growth contributor in 2022' aligns with ground truth's 'positive or neutral role.' MULTI-HOP REASONING: The LLM properly synthesizes the 2022-to-2024 evolution and connects sales impact to operating profit dynamics. However, the synthesis is undermined by invented numbers. CRITICAL FLAW: The answer presents unsubstantiated quantitative claims as fact. While the qualitative narrative is largely sound, the introduction of specific dollar amounts ($32M, $19M, 44%) without ground truth support is a serious factual error that violates the evaluation principle of strict scrutiny on numbers. The answer should have either: (a) stated only the 2% figure provided, or (b) clearly indicated these were estimates/approximations. The confidence with which false numbers are presented makes this a significant accuracy failure despite correct directional reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 442,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "\nThe amount of loans covered by the long‑term credit‑protection agreements with FNMA and FHLMC slipped from roughly **$8.7 billion at the end of 2023 to about $8.0 billion at the end of 2024**.  Because these insured residential‑mortgage loans are fully guaranteed, the Corporation does not record an allowance for losses on them, so the decline signals a modest reduction in the volume of such protected exposure; however, the overall credit‑risk profile remains tied to the performance of the underlying insured portfolio, as reflected in stable non‑performing loan balances and only modest charge‑offs.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $8.7 billion in 2023 and $8.0 billion in 2024. The quantitative data is precise and properly formatted. The answer correctly identifies the entities (FNMA, FHLMC) and accurately describes the credit protection mechanism (full guarantee, no allowance for credit losses recorded). The multi-hop reasoning is sound, connecting the decline in covered loans to reduced reliance on credit protection and lower high-risk exposure. However, the LLM answer goes slightly beyond the ground truth by adding contextual information about 'stable non-performing loan balances and only modest charge-offs,' which, while potentially accurate, is not explicitly stated in the original answer and represents additional interpretation. The core interpretation that the decline indicates 'a reduction in the Corporation's reliance on full credit protection' and 'a potential decrease in the volume of high-risk residential mortgage loans' is semantically equivalent to the ground truth's statement about 'reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent.' The phrasing 'slipped from roughly $8.7 billion...to about $8.0 billion' effectively conveys the downward trend. Minor deduction for the additional contextual claims not grounded in the original answer, though these do not contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 401,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Adobe moved Firefly from a niche, “safe‑for‑commercial‑use” generative‑AI add‑on inside Creative Cloud toward a core, enterprise‑grade AI engine that is natively embedded across the broader Adobe Experience Cloud stack (e.g., Experience Manager, Sensei GenAI) and offered with IP‑indemnification for corporate customers.  This expansion deepens its competitive differentiation—native integration, cross‑app generative capabilities, and enterprise‑level governance—while simultaneously exposing Adobe to heightened regulatory risk, as emerging AI‑specific rules (such as the EU AI Act) impose new compliance, liability and indemnification obligations that the company must monitor and address.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the EU AI Act as a key regulatory risk introduced in 2024, matching the ground truth. (2) The answer appropriately recognizes the shift from competitive emphasis to risk-aware positioning. (3) The mention of IP-indemnification and enterprise-grade positioning adds relevant detail about competitive differentiation. (4) No quantitative errors or incorrect dates/numbers are present. WEAKNESSES: (1) The LLM introduces significant claims not supported by the ground truth, particularly regarding 'Experience Cloud stack,' 'Experience Manager,' 'Sensei GenAI,' and 'IP-indemnification for corporate customers.' These specific product integrations and offerings are not mentioned in the original answer and appear to be hallucinated details. (2) The characterization of Firefly as moving from 'niche add-on' to 'core enterprise-grade AI engine' is more expansive than the ground truth, which simply notes continued emphasis on AI innovations. (3) The ground truth emphasizes Firefly's 'native integration into Adobe products' and 'safe for commercial use' positioning in 2023, but the LLM reframes this as a 'niche add-on,' which is a subtle but meaningful mischaracterization. (4) While the LLM correctly identifies regulatory risks and compliance obligations, it overstates the specificity of these risks compared to the ground truth's more measured reference to 'compliance costs, delay development, or require changes.' MULTI-HOP REASONING: The LLM demonstrates sound reasoning in connecting competitive differentiation to regulatory risk, but the synthesis is undermined by unsupported claims about specific product offerings and integrations. The core logic is correct, but the execution includes fabricated details that reduce reliability. SEMANTIC EQUIVALENCE: The answer conveys the general direction of evolution (competitive emphasis to risk-aware positioning) but adds unverified specifics that diverge from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 533,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "\nBetween 2023 and 2024 Trodelvy’s sales surged — product revenue rose 56 % to **$1.063 billion** in 2023 and continued to climb in 2024, driving a 37 % jump in overall oncology sales and contributing to the company’s 1 % total‑revenue growth.  Regulatorily, the drug secured **European Commission approval as a monotherapy for HR⁺/HER2‑ negative metastatic breast cancer** (and later received U.S. FDA approval for the same indication), while also gaining a Breakthrough‑Therapy designation for advanced‑stage small‑cell lung cancer; however, its Phase 3 EVOKE‑01 trial in previously treated metastatic NSCLC failed to meet the primary overall‑survival endpoint, limiting further expansion in that setting.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2023 Trodelvy sales figure of $1,063 million ($1.063 billion) and the 56% growth rate. (2) The Breakthrough Therapy designation for small cell lung cancer is correctly mentioned. (3) The answer demonstrates awareness of multiple regulatory developments and clinical trial outcomes.\n\nWEAKNESSES: (1) CRITICAL ERROR - The ground truth specifies the Breakthrough Therapy designation was for 'extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy,' but the LLM vaguely states 'advanced-stage small-cell lung cancer' without the critical detail about platinum-based chemotherapy progression. This is a material omission of regulatory specificity. (2) SCOPE MISMATCH - The question asks specifically about evolution 'between 2023 and 2024,' but the LLM introduces information about European Commission approval, U.S. FDA approval for HR+/HER2- metastatic breast cancer, and the EVOKE-01 trial failure. While these may be factually accurate, they are NOT mentioned in the ground truth answer and appear to be extraneous information not directly addressing the 2023-2024 evolution requested. (3) The LLM provides 2024 sales information ('continued to climb in 2024, driving a 37% jump in overall oncology sales') that is not present in the ground truth, making it impossible to verify accuracy. (4) The ground truth focuses on the contrast between strong financial growth (56% increase to $1,063M in 2023) and regulatory advancement (second Breakthrough designation in 2024), but the LLM conflates multiple regulatory approvals without clearly delineating the 2023 vs 2024 timeline.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize financial and regulatory information but introduces unverified claims about European approval and trial failures that deviate from the ground truth narrative. The core 2023-2024 evolution is partially captured but obscured by additional details.\n\nCONCLUSION: While the LLM captures the key 2023 sales figure and mentions the Breakthrough designation, it fails to precisely match the ground truth's focus on the 2023-2024 evolution, introduces unverified regulatory details, and omits critical specificity about the platinum-based chemotherapy progression criterion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 610,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "\nChevron’s equity investment in Angola LNG Limited fell modestly—from about **$1.86 billion at year‑end 2022 to $1.66 billion at year‑end 2024**—reflecting a gradual reduction in the carried‑investment balance.  At the same time, equity‑method earnings from the joint venture remained robust, posting **$1.86 billion in 2023 and $0.51 billion in 2024**, driven by higher upstream realizations and the absence of the 2020‑era impairments that had previously weighed on results.  The company’s 2024 MD&A explicitly cites “higher upstream‑related earnings from … Angola LNG” as a key factor behind the uplift in overall upstream performance, underscoring a continued strategic emphasis on the LNG JV despite the slight decline in book value.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific investment values ($1.86B in 2022, $1.66B in 2024) and equity-method earnings ($1.86B in 2023, $0.51B in 2024) that are NOT mentioned in the ground truth. These appear to be fabricated or sourced from unreliable data. The ground truth only mentions $5,657M in total income from equity affiliates in 2022 (not specific to Angola LNG) and does not provide the specific investment balance figures the LLM cites. (2) MISSING CRITICAL INFORMATION: The LLM completely fails to mention the 36.4% ownership stake that is explicitly highlighted in the ground truth as a key 2024 disclosure. This is a major omission for a question specifically asking about 'specific disclosures regarding its equity investments.' (3) MULTI-HOP SYNTHESIS FAILURE: The ground truth emphasizes the evolution from general earnings mentions in 2022 to a clearly quantified 36.4% stake in 2024, showing improved disclosure specificity. The LLM misses this entirely and instead focuses on investment balance changes that aren't verified. (4) UNVERIFIED CLAIMS: The LLM's discussion of 'carried-investment balance' reductions and specific earnings figures lacks grounding in the provided ground truth. While the LLM correctly identifies Angola LNG as an LNG joint venture and mentions strategic emphasis, it does so while introducing unverified financial data. (5) PARTIAL CREDIT: The LLM does correctly identify Angola LNG as a key strategic asset and mentions upstream-related earnings, which aligns with the ground truth's emphasis on strategic positioning. However, this correct framing is undermined by the introduction of specific numbers that cannot be verified against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 497,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "\nFrom the end of 2023 to the end of 2024 Meta’s fixed‑rate senior unsecured notes grew sharply, rising from roughly **$18.5 billion** of outstanding principal to **$29 billion**.  This increase reflects new issuances of **$8.5 billion** of notes in May 2023 and a further **$10.5 billion** of notes issued in August 2024, expanding the total face amount and extending the maturity profile to 2027‑2064.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct but contains one significant numerical error that affects the quantitative accuracy score. CORRECT ELEMENTS: (1) Outstanding principal values are accurate: $18.5 billion at end of 2023 and $29 billion at end of 2024 - these match ground truth exactly. (2) August 2024 issuance of $10.5 billion is correct. (3) The characterization of growth and expanded maturity profile (2027-2064) is accurate and adds helpful context. (4) Multi-hop synthesis is sound - correctly connects 2023 and 2024 data points. (5) Entity identification (META, fixed-rate senior unsecured notes) is correct. CRITICAL ERROR: The LLM states '$8.5 billion of notes in May 2023' but the ground truth specifies '$8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May' 2023. While $8.5 billion could be considered a rounding of $8.46 billion, the ground truth is more precise at $8.46 billion, and the LLM's rounding introduces a minor inaccuracy. This is a borderline issue - the difference is only $40 million (0.47%), which could be acceptable rounding in some contexts, but strict evaluation of financial numbers penalizes such discrepancies. REASONING QUALITY: The multi-hop reasoning is sound - the LLM correctly synthesizes information across 2023 and 2024, identifies the two issuance events, and explains the overall growth trajectory. The answer appropriately addresses how the value and issuance activity evolved. COMPLETENESS: The answer addresses all key aspects of the question: value evolution ($18.5B to $29B), issuance activity (May 2023 and August 2024), and contextual information about maturity extension.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 451,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "\nIn the 2023 Form 10‑K (page 71 of LIN_10k_2023.pdf) helium is listed only as part of “Raw materials and supplies” with a $614 million balance and is characterized merely as a routine supply, with no special sourcing or price‑risk disclosures. The 2024 filing (page 61 of LIN_10k_2024.pdf) still reports helium under raw‑materials but reduces the inventory to $529 million and adds a risk‑factor statement that the company is now “highly dependent on external helium producers,” citing a double‑digit increase in purchase price and the need for long‑term supply agreements—signaling the shift from a simple supply to a critical dependency.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that fundamentally contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The ground truth specifies helium costs as 4.2% of total raw material expenses in 2023 and 6.8% in 2024. The LLM answer instead provides absolute dollar amounts ($614M in 2023, $529M in 2024) for inventory balances, which are entirely different metrics and not mentioned in the ground truth. These inventory figures appear to be fabricated or misattributed. The LLM does not provide the critical percentage metrics (4.2% vs 6.8%) that are central to the original answer. (2) ENTITY/METRIC CONFUSION: The LLM conflates raw material inventory balances with raw material cost percentages—these are distinct financial metrics. The ground truth focuses on helium's cost as a percentage of total raw material expenses, while the LLM discusses inventory dollar amounts and purchase price increases. (3) MISSING KEY DATA: The LLM fails to cite the specific cost percentages (4.2% in 2023, 6.8% in 2024) that are the quantitative foundation of the ground truth answer. Instead, it references vague 'double-digit increase in purchase price' without providing the actual percentage metrics. (4) MULTI-HOP REASONING: While the LLM correctly identifies the conceptual shift from 'supply' to 'dependency,' it does so without the precise financial metrics that substantiate this shift. The reasoning is qualitatively sound but quantitatively unsupported. (5) PAGE REFERENCES: The LLM provides specific page numbers and document citations that cannot be verified against the ground truth, raising questions about source accuracy. The ground truth makes no mention of these specific page numbers or inventory figures. The answer demonstrates understanding of the general narrative (shift from supply to dependency) but fails catastrophically on the specific financial metrics that are essential to answering this question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 532,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "\nBetween 2022 and 2023 the amount of European customer balances that PayPal could designate for credit activities fell from **$3.8 billion (≈ 37 % of European balances) in 2022 to $3.0 billion (≈ 39 % of European balances) in 2023**.  This represents a **year‑over‑year decline of roughly 21 %** in the approved credit‑activity funding amount.  The shift reflects a modest reduction in the absolute dollar amount approved, even as the proportion of balances made available for credit remained roughly stable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. All key quantitative facts are correct: (1) 2022 approved amount: $3.8 billion at ~37% of European balances - CORRECT; (2) 2023 approved amount: $3.0 billion at ~39% of European balances - CORRECT; (3) Year-over-year percentage decline calculation: ($3.8B - $3.0B) / $3.8B = $0.8B / $3.8B ≈ 21.05% - CORRECT. The LLM correctly synthesized the multi-hop information by comparing both the absolute dollar amounts and percentages across the two years. The reasoning is sound: the answer correctly identifies that while the absolute amount decreased significantly (21%), the percentage of balances actually increased slightly (37% to 39%), which the LLM appropriately characterizes as a 'more conservative approach' or 'modest reduction in absolute dollar amount.' The answer addresses all parts of the question: (1) how utilization evolved (decreased in absolute terms, increased in percentage terms), (2) the percentage change in approved amounts (21% decline). The semantic meaning matches the ground truth perfectly. Minor note: The LLM uses slightly different phrasing ('roughly stable' vs 'slightly increased') when describing the percentage change, but this is a reasonable characterization given the modest 2 percentage point increase and does not constitute a factual error. All entities are correctly identified (PayPal, European customer balances, credit activities, 2022-2023 timeframe).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 402,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "\nBetween the end of fiscal 2023 (Oct 1 2023) and the end of fiscal 2024 (Sep 29 2024) Starbucks’ foreign‑currency‑other hedging program contracted sharply.  The cumulative gain that remained in AOCI fell from **$39.6 million to $11.5 million**, and the fair‑value of the related derivatives also dropped – prepaid‑expense assets fell from **$32 million to $1.9 million** while accrued‑liability balances stayed relatively flat – signalling a smaller notional exposure.  Consequently, the amount of that AOCI gain that is expected to be re‑classified into earnings over the next 12 months fell from **$23.6 million (2023) to $28.2 million (2024)**, indicating a reduced future earnings impact from foreign‑currency hedges.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies in the core numerical claims. (1) AOCI GAIN COMPARISON - CORRECT: The LLM correctly states the cumulative gain in AOCI fell from $39.6 million to $11.5 million, matching the ground truth exactly. (2) FAIR VALUE - PARTIALLY INCORRECT: The ground truth states fair value of foreign currency-other instruments decreased from $1,164 million (2023) to $920 million (2024). The LLM mentions prepaid-expense assets fell from $32 million to $1.9 million, which appears to be a component of fair value but NOT the total fair value figure. The LLM fails to cite the primary fair value metrics ($1,164M and $920M). (3) RECLASSIFICATION AMOUNT - MAJOR ERROR: This is the most critical mistake. The ground truth clearly states the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million (2023) to $9.5 million (2024). The LLM states the opposite direction of change: '$23.6 million (2023) to $28.2 million (2024)' - not only are these numbers incorrect, but they show an INCREASE rather than the documented DECREASE. This is a fundamental factual error that contradicts the ground truth. (4) MULTI-HOP REASONING: The LLM attempts to synthesize information about the hedging program's contraction, which is conceptually sound, but the numerical foundation is flawed. The conclusion about 'reduced future earnings impact' contradicts the actual data showing the reclassification amount decreased significantly. (5) COMPLETENESS: The LLM addresses fair value and reclassification impact but misses or misrepresents key metrics. The answer is contextually relevant to the question but factually unreliable due to incorrect numbers on the most important metric (reclassification amount).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 489,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "\nFrom 2022 to 2023 the fair‑value of the energy‑related derivatives held by Alabama Power dropped from roughly **$55 million (asset) and $11 million (liability)** to **$15 million (asset) and $110 million (liability)**, while Georgia Power’s fell from about **$75 million (asset) and $8 million (liability)** to **$13 million (asset) and $124 million (liability)**. In each subsidiary the **asset side contracted** and the **liability side expanded**, moving both from a modest net‑asset/near‑zero position to a sizable net‑liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All numeric values are correct - Alabama Power 2022: $55M assets/$11M liabilities; 2023: $15M assets/$110M liabilities. Georgia Power 2022: $75M assets/$8M liabilities; 2023: $13M assets/$124M liabilities. All numbers match the ground truth exactly. (2) COMPLETENESS: The answer addresses all required components - both companies (Alabama Power and Georgia Power), both years (2022 and 2023), both asset and liability positions, and the directional changes. (3) ENTITY ACCURACY: Both subsidiaries correctly identified, years correctly specified, and financial metrics (fair value of energy-related derivatives, assets vs liabilities) properly labeled. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two companies and two years, correctly identifying the pattern of asset contraction and liability expansion for both entities. The characterization of the shift from 'modest net-asset/near-zero position to a sizable net-liability' is accurate (Alabama Power net position changed from +$44M to -$95M; Georgia Power from +$67M to -$111M). (5) SEMANTIC EQUIVALENCE: The wording 'dropped,' 'fell,' 'contracted,' and 'expanded' effectively conveys the directional changes. The phrase 'roughly' is appropriately cautious language that doesn't undermine accuracy. Minor note: The use of 'roughly' is slightly imprecise given that exact figures are available, but this is a negligible stylistic choice that doesn't affect factual correctness. The answer is comprehensive, well-structured, and accurately synthesizes the multi-hop financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 457,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "\nFrom 2022 to 2023 the U.S. Retiree Health Care plan shifted its asset mix markedly toward fixed‑income.  In 2022 the plan held about **65 % fixed‑income securities and 35 % equity securities** (≈ $182 m fixed‑income vs $98 m equity of a $280 m total).  By the end of 2023 the allocation was roughly **80 % fixed‑income and 20 % equity** (≈ $210 m fixed‑income vs $54 m equity of a $264 m total), moving the portfolio to the upper end of the plan’s target 65‑80 % fixed‑income range and the lower end of its 20‑35 % equity range.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All percentage allocations match ground truth exactly - 2022: 65% fixed income/35% equity; 2023: 80% fixed income/20% equity. The dollar amounts provided ($182M fixed income vs $98M equity in 2022; $210M fixed income vs $54M equity in 2023) are reasonable approximations that align with the stated percentages and total portfolio values ($280M in 2022, $264M in 2023). Spot-checking: $182M/$280M = 64.9% ≈ 65% ✓; $210M/$264M = 79.5% ≈ 80% ✓. COMPLETENESS: The answer fully addresses the question by clearly showing the evolution from 2022 to 2023 with specific percentage distributions for both fixed income and equity securities. ENTITY ACCURACY: Correctly identifies the U.S. Retiree Health Care Plan and the relevant time periods (2022 vs 2023). REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly identifies the shift toward a more conservative strategy and contextualizes it within the plan's target ranges (65-80% fixed income, 20-35% equity). The characterization of the 2023 allocation as being at the 'upper end' of the fixed income range and 'lower end' of the equity range is accurate and insightful. MINOR NOTE: The dollar amounts, while not explicitly stated in the ground truth, appear to be reasonable supporting details that enhance the answer without contradicting the core facts. The answer exceeds the ground truth by providing additional context about target ranges, which demonstrates deeper understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 422,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "\nBetween 2022 and 2023 the regulatory footprint of Trodelvy expanded — in 2022 it held only accelerated‑approval indications for metastatic triple‑negative breast cancer and for platinum‑treated metastatic urothelial cancer — and by the end of 2023 the FDA granted a new, non‑accelerated approval for Trodelvy as a monotherapy in advanced HR⁺/HER2⁻ breast cancer (after endocrine therapy and at least two prior systemic regimens), while the European Commission also granted marketing authorization for that same breast‑cancer indication. This added a major solid‑tumor indication beyond the original TNBC and urothelial cancer approvals.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification of key facts: (1) 2022 indications correctly identified - TNBC (unresectable locally advanced or metastatic, after 2+ prior systemic therapies) and metastatic urothelial cancer (after platinum-based chemotherapy and PD-1/PD-L1 inhibitor) match ground truth; (2) 2023 new indication correctly identified - HR+/HER2- breast cancer after endocrine-based therapy and at least 2 additional systemic therapies, with both FDA and EC approval granted; (3) The LLM correctly notes the 2022 approvals were accelerated approvals while the 2023 HR+/HER2- indication was non-accelerated FDA approval, adding useful context not explicitly in ground truth but consistent with it; (4) Multi-hop reasoning is sound - the answer successfully synthesizes the evolution from 2022 to 2023 and identifies the new indication as a significant expansion. Minor differences from ground truth: the LLM specifies 'non-accelerated approval' for the 2023 indication (ground truth doesn't explicitly state this distinction), and the LLM uses 'monotherapy' descriptor which is accurate but not mentioned in ground truth. The answer is semantically equivalent and factually correct on all material points. All dates, drug names, indications, and approval statuses are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 367,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the discussion of “user perception” moved from a broad warning that loss of users or engagement could hurt revenue (2023 Risk Factors – “If we fail to retain existing users… our revenue… may be significantly harmed”) to a more granular, multi‑dimensional risk statement.  In 2024 the company explicitly ties perceived problems—such as doubts about the platform’s usefulness, reliability, trustworthiness, data‑privacy practices, content‑moderation decisions, and the impact of new regulations (GDPR, DMA, DSA) or product changes (e.g., “subscription‑for‑no‑ads” in Europe)—to concrete business consequences: reduced user growth/engagement, lower ad‑impression volume, diminished advertiser demand, and ultimately a direct hit to revenue and financial results.  Thus, the 2024 disclosure deepens the risk by spelling out the specific trust‑related and regulatory drivers that can erode user perception and by linking those drivers more directly to operational and financial outcomes.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally contradicts the ground truth on the core finding. Ground truth states that 'explicit mention of user perception as a direct risk factor was notably reduced in 2024,' indicating a REDUCTION in emphasis. The LLM answer claims the opposite—that disclosure 'deepens the risk' and 'spells out' more specific drivers in 2024, suggesting an INCREASE in emphasis and granularity. This is a direct factual contradiction on the primary question. SPECIFIC PROBLEMS: (1) The LLM provides detailed 2024 risk language (trustworthiness, data-privacy, content-moderation, GDPR/DMA/DSA, subscription-for-no-ads) but the ground truth indicates these were emphasized in 2023, not 2024. (2) The LLM characterizes 2024 as showing 'deeper' and more 'granular' risk disclosure, when ground truth indicates a strategic shift AWAY from explicit user perception risks in 2024. (3) The LLM's narrative of 'evolution toward more specific operational/financial consequences' misses the key finding: that user perception risks became LESS prominent in 2024 disclosures. WHAT WAS CORRECT: The LLM correctly identifies that both years discussed user perception risks and their connection to business outcomes (revenue, engagement, advertiser demand). The mention of specific regulatory frameworks (GDPR, DMA, DSA) and product changes is appropriate context. MULTI-HOP REASONING: The LLM failed to synthesize the comparative evolution correctly—it described deepening/expansion when the ground truth indicates contraction/de-emphasis of user perception as a direct risk factor. This is a fundamental failure in the comparative analysis required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 457,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "\nThe notional amount of Lockheed Martin’s outstanding variable‑rate interest‑rate swaps grew from **$0.5 billion at the end of 2021** (reported in the 2022 10‑K, p. 64‑65) to **$1.3 billion by the end of 2023 and again in 2024** (reported in the 2024 10‑K, p. 52‑53).  This expansion shows that the company has deliberately increased its use of interest‑rate swaps to hedge the fair‑value exposure of its fixed‑rate debt, indicating a more robust strategy for managing interest‑rate risk as rates have risen.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-supported. Quantitative verification: (1) 2021 notional amount of $0.5 billion ($500 million) - CORRECT, matches ground truth exactly; (2) 2024 notional amount of $1.3 billion - CORRECT, matches ground truth exactly; (3) The LLM notes the amount was $1.3 billion 'by the end of 2023 and again in 2024,' which is a reasonable interpretation suggesting stability at that level, though the ground truth specifically references 2024. Multi-hop reasoning: The answer correctly synthesizes the evolution of the swap amounts across the 2021-2024 period and provides sound interpretation of the strategic shift. The LLM appropriately identifies this as a deliberate increase in hedging activity and connects it to interest rate environment changes. Entity accuracy: Lockheed Martin correctly identified, fiscal years correctly referenced (2021, 2023, 2024), financial metric (variable interest rate swaps notional amount) correctly identified. Semantic equivalence: The LLM's interpretation that this represents 'a more robust strategy for managing interest-rate risk as rates have risen' is semantically equivalent to the ground truth's statement about 'growing emphasis on converting fixed-rate borrowings to variable-rate borrowings.' The only minor distinction is that the LLM emphasizes hedging fair-value exposure while the ground truth emphasizes conversion strategy - both are valid interpretations of the same underlying activity. The citation of specific page numbers (2022 10-K p. 64-65, 2024 10-K p. 52-53) adds credibility, though these cannot be independently verified in this context. Overall, the answer demonstrates strong multi-hop synthesis across multiple years and documents with accurate financial data and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 484,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal modestly raised the expense it records for seller‑protection losses—the provision for transaction and credit losses grew from **$1.17 billion to $1.19 billion**—while the year‑end allowance for transaction losses stayed essentially unchanged, moving from **$278 million to $282 million**. This indicates a slight, more conservative adjustment to the estimated cost of potential transaction losses, but the overall reserve level was kept steady.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) WRONG NUMBERS: The LLM cites allowance for transaction losses of $278M-$282M, while the ground truth clearly states $66M in 2022 and $64M in 2023. This is a massive discrepancy (off by ~4-4.5x). (2) WRONG METRICS: The LLM discusses 'provision for transaction and credit losses' ($1.17B-$1.19B), which appears to be a different, broader metric than the 'allowance for transaction losses' that the ground truth specifically addresses. The LLM conflates or misidentifies the relevant financial metric. (3) INCORRECT CHARACTERIZATION: The ground truth emphasizes a shift from qualitative risk assessment (2022) to more structured, quantified financial disclosures (2023), with a slight decrease in the allowance ($66M to $64M). The LLM instead describes a 'modest raise' in expenses and 'slight, more conservative adjustment,' which misrepresents the direction and nature of the change. (4) MISSING KEY CONTEXT: The LLM completely omits the ground truth's important context about historical loss rates (0.09%-0.15% of TPV) and macroeconomic factors (COVID-19 impacts). (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the evolution of PayPal's approach between the two years. The ground truth shows a methodological shift toward more structured disclosure; the LLM merely reports different numbers without capturing this evolution. The answer demonstrates fundamental factual errors in the core numbers that form the basis of the analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 431,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "\nThe foreign‑currency‑other derivative **asset** fell from **$32.0 million** at the end of fiscal 2023 to **$1.9 million** at the end of fiscal 2024, a **$30.1 million decrease**; the foreign‑currency‑other derivative **liability** rose from **$2.0 million** to **$4.7 million**, an **increase of $2.7 million**.  Consequently, the net derivative position shifted from a net asset of roughly **$30 million** to a net liability of about **$2.8 million**, representing a total balance‑sheet swing of roughly **$33 million** between FY 2023 and FY 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a major factual error on the primary metric. For the derivative asset in 'Foreign currency - other,' the LLM states it fell from $32.0 million in FY2023 to $1.9 million in FY2024. However, the ground truth clearly indicates the FY2023 amount was $1,164 million (not $32.0 million), which then decreased to $1.9 million in FY2024. This is a massive discrepancy of $1,132 million on the opening balance - a fundamental error that undermines the entire answer. The LLM correctly identifies the FY2024 ending amount ($1.9 million) and correctly states the liability increased from $2.0 million to $4.7 million (a $2.7 million increase). However, the derivative asset opening balance error cascades through all subsequent calculations. The LLM calculates a $30.1 million decrease in assets (based on the incorrect $32.0M starting point), when the actual decrease should be $1,162.1 million ($1,164M - $1.9M). The net position calculations are therefore also incorrect - the LLM states a shift from roughly $30 million net asset to $2.8 million net liability, but the actual shift should be from approximately $1,162 million net asset ($1,164M - $2.0M) to approximately -$2.8 million net liability ($1.9M - $4.7M). While the LLM demonstrates understanding of the question structure and correctly identifies the liability movement, the fundamental misstatement of the asset position represents a critical failure in quantitative accuracy. The reasoning framework is sound (comparing FY2023 to FY2024, calculating changes, assessing balance sheet impact), but the execution is severely compromised by the incorrect starting number.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 460,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "\nThe data show that the benefit from the natural‑gas‑related hedges collapsed between the two years.  In 2022 the company recorded a **$134 million gain** on the energy‑related cash‑flow hedge that boosted natural‑gas revenues and a **$15 million gain** on the hedge that reduced the cost of natural gas; by 2023 those same hedges produced a **$117 million loss** on revenues and a **$27 million loss** on cost (see the “Gain (loss) on energy‑related cash flow hedges (a)” and non‑designated‑hedge tables).  As a result, the net financial impact swung from a **$149 million positive effect** in 2022 to a **$144 million adverse effect** in 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers and reversed the actual financial impacts. Specific errors: (1) 2022 figures are completely wrong - LLM states $134M gain on revenues and $15M gain on cost, but ground truth shows $117M negative impact on revenues and $27M negative impact on cost; (2) 2023 figures are inverted - LLM states $117M loss on revenues and $27M loss on cost, but ground truth shows $59M gain on cost and $0 on revenues; (3) The LLM's net calculations ($149M positive in 2022, $144M adverse in 2023) are based on these incorrect underlying numbers and don't match the ground truth; (4) The LLM appears to have confused the direction of impacts (gains vs losses) and potentially swapped years or misread the source data; (5) The narrative conclusion about 'benefit collapsing' is contradicted by the actual data showing improvement from 2022 to 2023 (from negative to positive/neutral). The multi-hop reasoning failed because the foundational numbers are incorrect, making all subsequent analysis unreliable. This is a critical failure on quantitative accuracy, which is the primary requirement for financial analysis questions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 329,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "\nBetween the 2023 and 2024 10‑K filings Walmart continued to disclose its Deferred Compensation Matching Plan as an “amended and restated” arrangement with an effective date of **November 8, 2023**. In the 2023 filing the plan appeared as Exhibit 10.1 and was described as newly amended and restated, while in the 2024 filing the same language and exhibit reference were retained, confirming that the plan remained documented in the same manner and that its effective date did not change.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN MULTI-HOP SYNTHESIS: The LLM answer fundamentally misses the key evolution described in the ground truth. The ground truth explicitly states that the plan's treatment CHANGED between filings: (1) In 2023, it was 'newly introduced' with the label 'amended and restated effective November 8, 2023'; (2) In 2024, it was 'no longer labeled as newly introduced' but instead 'incorporated by reference,' indicating a shift from newly introduced to established/ongoing status. The LLM answer incorrectly claims 'the same language and exhibit reference were retained' and that the plan 'remained documented in the same manner,' which directly contradicts the ground truth's core finding about the evolution from 'newly introduced' to 'incorporated by reference.' QUANTITATIVE ACCURACY: The date (November 8, 2023) is correct, and the exhibit reference (10.1) appears reasonable. However, the LLM provides no evidence or detail about the actual exhibit references in either filing. QUALITATIVE ACCURACY: The LLM failed to identify the critical distinction between how the plan was presented in 2023 versus 2024. The ground truth emphasizes a meaningful shift in documentation status and treatment, while the LLM suggests continuity and sameness. This represents a fundamental failure in multi-hop reasoning across the two filings. COMPLETENESS: The question specifically asks about evolution in 'documentation status and effective date.' While the LLM addresses the effective date correctly, it completely misses the documentation status evolution (newly introduced → incorporated by reference), which is the primary focus of the question. The answer is internally inconsistent with the actual filing treatment described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 476,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s disclosures treat LTIP Units in the same way: they are identified as “potentially dilutive securities” that are exchangeable into common stock or operating partnership units, but they are explicitly stated to have **no material dilutive effect** for any of the years presented. Consequently, the company does **not adjust net income attributable to common stockholders or the weighted‑average share (or unit) count** for any income allocated to limited partners or LTIP holders, and it continues to **accrue dividends on LTIP Units only when they are declared**, a policy that has remained unchanged from 2023 through 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about LTIP Units evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies LTIP Units as 'potentially dilutive securities' in both years, matching ground truth language; (2) Accurately states 'no material dilutive effect' for the years presented; (3) Correctly notes that the company does not adjust net income attributable to common stockholders or weighted average shares/units outstanding; (4) Accurately describes the accrual policy as distributions being accrued when declared; (5) Properly synthesizes the multi-hop comparison showing consistency between 2023 and 2024 disclosures; (6) Correctly concludes that treatment remained stable with no significant changes. MINOR CONSIDERATIONS: The LLM answer uses slightly more detailed language ('exchangeable into common stock or operating partnership units' vs. ground truth's 'convertible into units and exchangeable for common stock'), but this represents semantic equivalence rather than error. The phrasing about 'income allocated to limited partners or LTIP holders' adds helpful context not explicitly in the ground truth but is consistent with it. No quantitative errors detected. The answer successfully addresses all components of the question: disclosure evolution, dilutive effect treatment, and accrual policy consistency. The reasoning is sound and the synthesis across the two-year period is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 408,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "\nBetween 2023 and 2024 Meta moved from waiting for the EU‑U.S. Data Privacy Framework (DPF) to become operational to actively embedding it into its data‑transfer and compliance programmes.  In 2023 the company was still appealing the Irish Data Protection Commission’s €1.2 billion fine and corrective order that had invalidated its reliance on Standard Contractual Clauses, while publicly stating that the newly‑announced DPF‑adequacy decision would replace the expired Privacy‑Shield and SCC mechanisms.  By 2024 Meta had begun implementing the DPF’s safeguards—updating consent models, launching a “subscription‑for‑no‑ads” option, and aligning its advertising‑consent flows with the EU’s DMA and GDPR—while continuing to monitor the DPF’s legal resilience and preparing contingency plans in case the framework is later struck down.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies the €1.2 billion fine from IDPC. (2) Accurately mentions the 'subscription-for-no-ads' model introduced in November 2023. (3) Correctly notes the shift from foundational DPF compliance to more complex regulatory scrutiny. (4) Properly identifies the DMA as a key regulatory framework. (5) Correctly references the July 2024 preliminary findings regarding non-compliance. WEAKNESSES: (1) The LLM states Meta was 'still appealing' the fine in 2023, but the ground truth indicates Meta was 'in the process of implementing steps to comply with corrective orders'—this suggests acceptance/implementation rather than active appeal, which is a material mischaracterization of Meta's posture. (2) The LLM introduces claims about 'contingency plans in case the framework is later struck down' and 'monitoring the DPF's legal resilience' that are not mentioned in the ground truth and appear to be speculative additions not supported by the source material. (3) The LLM's description of 'updating consent models' and 'aligning advertising-consent flows' are vague generalizations not specifically grounded in the ground truth's more concrete details about corrective orders and specific regulatory actions. (4) The ground truth emphasizes the shift from SCC/Privacy Shield reliance to DPF implementation, then to navigating DMA scrutiny—the LLM captures this progression but adds unsupported details about contingency planning. MULTI-HOP REASONING: The LLM does synthesize information across 2023-2024 and connects the DPF framework to DMA compliance, which is correct. However, the addition of unsupported claims about contingency planning and legal resilience monitoring weakens the answer's fidelity to the ground truth. The core narrative arc is present but contaminated with speculative elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1475,
        "completion_tokens": 495,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "\nBetween 2023 and 2024 Linde moved from a general reference to “green hydrogen” produced by electrolysis using renewable energy (or biomethane) to a more explicit, metrics‑driven strategy.  The 2024 filing defines green hydrogen as electrolysis powered by renewable electricity and introduces a carbon‑intensity framework that distinguishes green from blue (low‑carbon) hydrogen made from fossil feedstocks with capture, while also noting that renewable hydrogen can be sourced from non‑fossil feedstocks.  This shift reflects a stronger emphasis on renewable‑energy‑driven production methods and positions green hydrogen as a central element of Linde’s clean‑energy portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy in capturing Linde's evolution in green hydrogen strategy between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from general references to metrics-driven strategy; (2) Accurately captures the 2024 emphasis on carbon intensity as a differentiating metric; (3) Properly distinguishes green hydrogen (electrolysis with renewable energy) from blue hydrogen (low-carbon, fossil-based with capture); (4) Correctly notes the expanded terminology to 'renewable hydrogen'; (5) Accurately reflects the positioning within clean energy portfolio; (6) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The phrase 'renewable hydrogen can be sourced from non-fossil feedstocks' is somewhat redundant/unclear compared to the ground truth's clearer statement about 'water as feedstock'; (2) The answer could have been slightly more explicit about the 2023 inclusion of 'biomethane' as an alternative production method, though this is mentioned; (3) The ground truth emphasizes 'water as feedstock' more explicitly in 2024, which the LLM answer doesn't directly state. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and correctly identifies the evolution in Linde's messaging and strategic emphasis. The comparison between 2023 and 2024 approaches is logically sound and well-structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential information from the ground truth with appropriate wording variations that maintain factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 427,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "\nSouthern Company’s exposure to Sequent ended after the July 1 2021 divestiture; by 2022 the company no longer held any ownership or regulatory‑rate rights in Sequent, and in 2023 there was no remaining financial relationship.  The only financial effects of the transaction were the $121 million pre‑tax gain (≈ $92 million after‑tax) recorded in 2021 and a subsequent $85 million increase in tax expense arising from state‑apportionment changes—after which Sequent generated no further earnings, cash flows, or regulatory assets for Southern Company.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer contains a critical and fundamental error regarding the timing of the Sequent divestiture. The ground truth clearly states that Southern Company Gas completed the sale of Sequent to Williams Field Services Group in 2022 for $159 million, with a $121 million pre-tax gain recognized in 2022. However, the LLM answer incorrectly claims the divestiture occurred on July 1, 2021, and that the $121 million gain was recorded in 2021. This is a major factual error that undermines the entire answer. Additionally, the LLM answer fails to mention the $159 million sale price, which is a key financial metric. The LLM does correctly identify the $121 million pre-tax gain and the $85 million tax expense from state apportionment changes, and correctly calculates the approximate after-tax gain (~$92 million), but these correct elements cannot compensate for the fundamental dating error. The question specifically asks about the evolution between 2022 and 2023, and the LLM's answer misplaces the transaction to 2021, making it factually incorrect regarding the timeframe. The LLM also fails to properly address the 2022-2023 evolution as requested, instead focusing on post-2021 status. The reasoning about complete separation is sound, but the temporal framework is wrong, which is critical for a question specifically about how the relationship evolved between two specific years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 386,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the company’s disclosures show that **Allswell remained on the list of Walmart‑owned private‑brand labels, but the 2024 filing expands the private‑brand narrative**—it is presented as a core component of a broader, deliberately curated portfolio that now also includes newer brands such as “bettergoods.”  The 2024 text emphasizes growing the assortment, margin contribution and strategic importance of these private‑brand lines, positioning Allswell as a key value‑oriented brand that reinforces Walmart’s everyday‑low‑price positioning while delivering higher‑margin, differentiated merchandise.  This evolution signals that Walmart is using Allswell (and the rest of its private‑brand suite) as a strategic lever to deepen its private‑brand portfolio and capture additional consumer trust and profitability.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Walmart's Allswell brand evolution between 2023 and 2024, with accurate core facts and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies that Allswell was introduced in 2023 and retained in 2024; (2) Accurately notes that by 2024, Allswell is positioned alongside other established private brands like 'bettergoods,' 'Equate,' and 'Great Value'; (3) Properly synthesizes the transition from newly introduced to established brand status; (4) Correctly interprets strategic positioning within the private brand portfolio; (5) No quantitative errors—dates and brand names are accurate. WEAKNESSES: (1) The LLM introduces additional interpretive details not explicitly stated in the ground truth, such as 'value-oriented brand,' 'everyday-low-price positioning,' 'higher-margin, differentiated merchandise,' and 'deepen profitability'—while these may be reasonable inferences, they go beyond what the ground truth explicitly confirms from the filings; (2) The phrase 'newer brands such as bettergoods' is potentially misleading, as the ground truth lists bettergoods alongside Equate and Great Value as 'mature private brands,' not necessarily newer ones; (3) The answer expands the narrative with strategic implications about 'margin contribution' and 'consumer trust' that, while plausible, are not directly supported by the ground truth provided. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and identifies the brand's evolution within the portfolio context. The logic is sound: introduction in 2023 → retention and explicit listing in 2024 → indicates establishment and strategic importance. SEMANTIC EQUIVALENCE: The core message aligns with ground truth—Allswell transitioned from new to established—though the LLM adds interpretive layers. The answer is contextually relevant and addresses the question comprehensively, but the additional strategic inferences, while reasonable, exceed the factual basis provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 550,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "\nEmbedded‑Processing’s contribution to TI’s sales grew noticeably from 2022 to 2023: its revenue rose 3 % to $3.37 billion while total company revenue fell 12.5 %, pushing the segment’s share of total revenue up from roughly 16 % in 2022 to about 19 % in 2023.  The MD&A explicitly lists Embedded Processing as one of the company’s two core strategic focus areas and highlights a shift in product mix toward higher‑value devices, underscoring a stronger strategic emphasis on this business line and prompting increased capital investment to expand its capacity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM claims Embedded Processing revenue was $3.37 billion in 2023, but the ground truth states total company revenue was $17.52 billion with no specific Embedded Processing revenue figure disclosed. The LLM's claim that EP revenue grew 3% to $3.37B cannot be verified and appears fabricated. The percentage calculations (16% to 19% share) are mathematically inconsistent with the stated figures and ground truth. (2) MISSING DISCLOSURE - The ground truth explicitly states 'no specific revenue figures were disclosed' for Embedded Processing in 2022, yet the LLM provides precise revenue numbers and growth percentages without any caveat about data availability. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies EP as a core strategic segment and mentions its compensatory role, it invents specific financial metrics not present in the source documents. The ground truth emphasizes that EP 'partially offset a decline in Analog revenue' but does not provide the specific revenue figures the LLM cites. (4) REASONING FLAW - The LLM's multi-hop reasoning appears sound in structure (comparing 2022 to 2023, noting strategic importance, discussing revenue mix), but it is built on false numerical foundations. The claim about 'increased capital investment to expand capacity' may be accurate but is not mentioned in the ground truth provided. The answer demonstrates a fundamental failure to distinguish between disclosed and undisclosed financial information, presenting invented data as fact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 446,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "\nChevron’s stake in Angola LNG remained a 36.4 % equity interest, but the 2022 10‑K (pp. 6‑10) shows the company reporting roughly 78 million barrels‑of‑oil‑equivalent of gas production from the project and emphasizing its role as a key African gas source. In the 2024 filing (pp. 83‑87) Chevron notes new long‑term natural‑gas delivery contracts through 2024 with variable, market‑linked pricing, positioning Angola LNG as a central pillar of its global LNG portfolio and underscoring a strategic shift toward securing high‑margin, long‑term LNG supply in Africa.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about Chevron's Angola LNG involvement but contains significant issues with factual accuracy and specificity. STRENGTHS: (1) Correctly identifies the 36.4% equity stake in Angola LNG, matching the ground truth; (2) Appropriately addresses the evolution from 2022 to 2024; (3) Provides reasonable strategic interpretation about long-term contracts and market positioning; (4) Cites specific page numbers from filings, suggesting document engagement. WEAKNESSES: (1) The claim about '78 million barrels-of-oil-equivalent of gas production' from 2022 cannot be verified against the ground truth and appears to be an unsupported specific number; (2) The statement about 'new long-term natural-gas delivery contracts through 2024 with variable, market-linked pricing' is not mentioned in the ground truth and may be fabricated or misattributed; (3) The ground truth emphasizes a shift from 'production volumes' context in 2022 to 'explicitly stated' equity stake in 2024, but the LLM conflates these by suggesting the stake 'remained' constant while adding production details; (4) Page number citations (pp. 6-10, pp. 83-87) cannot be verified and may be inaccurate. MULTI-HOP REASONING: The LLM attempts to synthesize information across years but introduces unverified details that go beyond the ground truth. The core insight about strategic positioning is sound, but the supporting evidence appears partially fabricated. The answer reads plausibly but lacks grounding in verifiable facts from the actual filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 426,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "\nBetween 2021 and 2024 the CH‑53K evolved from a modest contributor to a headline growth driver for RMS.  In 2021 the program helped lift RMS net sales by $794 million (≈5 %) and added roughly $183 million (≈11 %) to operating profit, but by 2024 the 10‑K explicitly cites “higher production volume on the CH‑53K program” as a principal reason for the segment’s product‑sales increase.  This shift shows that the CH‑53K has become a core, high‑margin platform within Lockheed Martin’s Rotary and Mission Systems division, underpinning its longer‑term revenue and profit trajectory.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual inaccuracies that fundamentally undermine its credibility. (1) WRONG NUMBERS FOR 2021: The LLM claims CH-53K contributed $794 million to RMS net sales increase in 2021, but the ground truth states $540 million. This is a 47% overstatement. Similarly, the LLM claims $183 million operating profit contribution vs. the correct $140 million - a 31% overstatement. These are not minor rounding differences but substantial misstatements of key financial metrics. (2) PERCENTAGE CALCULATIONS: The LLM provides percentages (≈5% and ≈11%) that appear to be calculated from the incorrect base numbers, making them doubly wrong. (3) 2024 DATA: While the LLM correctly identifies that CH-53K was in 'production ramp-up' phase by 2024 and contributed to higher product sales, it does not cite the specific $1.1 billion figure mentioned in the ground truth, which is a material omission. (4) MULTI-HOP SYNTHESIS: The LLM does attempt to synthesize the evolution narrative (2021 to 2024 transition), which is conceptually sound, but the foundation is built on incorrect numbers. The qualitative assessment that CH-53K evolved from 'modest contributor' to 'headline growth driver' is directionally correct but undermined by the quantitative errors. (5) ENTITY ACCURACY: The LLM correctly identifies Lockheed Martin, RMS division, and the CH-53K program. (6) REASONING QUALITY: While the narrative structure is logical (showing progression from early to mature phase), it is based on false premises. The conclusion about CH-53K becoming a 'core, high-margin platform' is reasonable but not supported by accurate data. The answer demonstrates understanding of the question's intent but fails on the most critical dimension: factual accuracy of financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 495,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal lengthened the forecasting horizon for its revolving‑credit loss curves from roughly a two‑year outlook to about a five‑year horizon and moved from relying mainly on historical loss data and earlier macro variables (e.g., unemployment and credit‑card charge‑off rates) to incorporating a broader set of externally sourced macroeconomic indicators such as household‑disposable‑income trends and retail‑e‑commerce sales. The 2023 update, rolled out in the second quarter, refined the loss‑rate model but did not materially affect the provision, reflecting a more forward‑looking and granular use of macroeconomic factors in the loss‑curve calculations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims the forecasting horizon was extended from 'roughly a two-year outlook to about a five-year horizon' - this specific quantitative claim is not present in the ground truth and appears to be fabricated. The LLM also states the update was 'rolled out in the second quarter' while the ground truth indicates it was 'after the first quarter of 2023' - these are contradictory timeframes. (2) INCOMPLETE/INACCURATE MACROECONOMIC FACTORS: The LLM correctly identifies that PayPal moved from unemployment and credit-card charge-off rates to household disposable income and retail e-commerce sales. However, it omits the critical detail that unemployment rates were specifically replaced 'after the first quarter of 2023,' which is an important temporal distinction in the ground truth. (3) UNSUPPORTED CLAIMS: The statement about 'not materially affecting the provision' is not mentioned in the ground truth and represents an addition not verified by the source material. (4) CORRECT ELEMENTS: The LLM does correctly identify the shift from earlier macro variables to a broader set of externally sourced indicators, and correctly names the specific macroeconomic factors (household disposable income, retail e-commerce sales). (5) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution between 2022 and 2023, it does so by introducing unsupported quantitative details (forecasting horizon lengths) that undermine the accuracy of the response. The core evolution is partially captured but obscured by incorrect additional details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 464,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 the foreign‑currency‑denominated debt gains recorded in AOCI fell from **$140.2 million** (Oct 1 2023) to **$135.2 million** (Sep 29 2024) – a decline of about **$5 million (≈3‑4 %)**.  This reduction shows that the unrealized benefit from hedging its foreign‑currency‑linked debt is shrinking, indicating that Starbucks’ exposure to foreign‑currency fluctuations is weakening (or that the current hedges are less effective), so future reclassifications of these gains to earnings will be modestly lower.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect numbers and misinterprets the ground truth data. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states the 2023 figure was $140.2 million, but the ground truth clearly shows it was a LOSS of $6.3 million (not a gain of $140.2 million). The LLM correctly identifies the 2024 figure as $135.2 million gain, but this is only half the answer correct. The LLM's calculation of a $5 million decline is mathematically based on wrong starting numbers. (2) MISINTERPRETATION OF METRICS: The ground truth indicates a shift FROM a loss ($6.3M loss in 2023) TO a gain ($135.2M gain in 2024) - this is a swing of approximately $141.5 million in the positive direction, not a $5 million decline. The LLM completely missed this critical reversal from loss to gain. (3) INCORRECT REASONING: The LLM's interpretation that 'unrealized benefit from hedging is shrinking' contradicts the ground truth narrative of a significant reversal from loss to substantial gain. The LLM's conclusion about weakening exposure is backwards - the data shows strengthening positive exposure. (4) MISSING KEY INSIGHT: The ground truth emphasizes the significance of the shift from loss to gain as indicating 'a reversal in the company's exposure to foreign currency fluctuations.' The LLM completely missed this major analytical point. (5) ENTITY/METRIC CONFUSION: The LLM appears to have confused different line items or misread the filing data, presenting a $140.2 million 2023 figure that doesn't match the ground truth's $6.3 million loss. This is a fundamental data accuracy failure that undermines the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 451,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "\nAlabama Power’s energy‑related derivative liability was essentially unchanged at roughly $110 million in both 2022 and 2023, while Georgia Power’s liability fell from about $156 million in 2022 to $124 million in 2023.  As a result, the combined liability for the two utilities dropped from approximately $266 million to $234 million—a decline of roughly $32 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors across multiple dimensions: (1) ALABAMA POWER 2022: Ground truth shows net liability of $144 million in 2022, but LLM claims it was 'roughly $110 million' - this is incorrect. The LLM conflates the 2023 liability figure ($110 million) with 2022. (2) GEORGIA POWER 2022: Ground truth does not provide a 2022 figure for Georgia Power's energy-related derivatives liability, but the LLM claims it was 'about $156 million' - this appears to be fabricated or confused with another metric. (3) COMBINED LIABILITIES: Ground truth shows combined net liability decreased from $255 million (2022) to $206 million (2023), a reduction of $49 million. The LLM claims the combined liability dropped from 'approximately $266 million to $234 million—a decline of roughly $32 million.' Both the starting figure ($266M vs $255M), ending figure ($234M vs $206M), and the calculated decline ($32M vs $49M) are incorrect. (4) MISSING CONTEXT: The LLM fails to mention that Alabama Power had $15 million in assets in 2023 and Georgia Power had $13 million in assets in 2023, which are important components of the net liability calculation. The answer also doesn't properly distinguish between gross liabilities and net liabilities (assets minus liabilities). (5) MULTI-HOP REASONING: While the LLM attempts to synthesize data across both companies and years, the underlying numbers are fundamentally wrong, making the synthesis invalid. The answer demonstrates a pattern of numerical inaccuracy rather than sound multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 429,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Walmart’s involvement with Alert Innovation shifted from acquisition to holding the company as a wholly‑owned subsidiary. In fiscal 2023 the retailer completed a roughly $0.4 billion purchase that gave it 100 % ownership of Alert Innovation (alongside a separate buy‑out of Massmart’s non‑controlling interest). No additional acquisition or disposal of Alert Innovation occurred in fiscal 2024; the next change came in fiscal 2025, when the Alert Innovation entity was sold and de‑consolidated.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer fundamentally contradicts the ground truth on the timing of the divestiture. Ground truth states that in fiscal 2024, Walmart 'sold and deconsolidated the Alert Innovation entity,' representing a complete exit within one year of acquisition. The LLM answer claims 'No additional acquisition or disposal of Alert Innovation occurred in fiscal 2024' and pushes the sale to 'fiscal 2025.' This is a major factual error that directly contradicts the core premise of the question about fiscal 2023-2024 evolution. QUANTITATIVE ACCURACY: The $0.4 billion acquisition amount and 100% ownership figures are correct. QUALITATIVE ACCURACY: The LLM correctly identifies the fiscal 2023 acquisition and 100% ownership, but fails on the critical multi-hop synthesis required by the question. The question specifically asks about evolution 'between fiscal 2023 and fiscal 2024,' and the ground truth shows a complete acquisition-to-divestiture cycle within that timeframe. The LLM's answer breaks this synthesis by incorrectly placing the divestiture in fiscal 2025. The mention of Massmart's non-controlling interest buyout is additional context not in the ground truth but not contradictory. CONTEXTUAL RELEVANCE: The answer addresses the wrong time period for the key event (divestiture), making it contextually misaligned with the question's specific focus on fiscal 2023-2024 evolution. The answer would be appropriate if the question asked about fiscal 2023-2025, but it does not.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 414,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy progressed from the 2021 approvals that gave it full U.S. marketing clearance for metastatic triple‑negative breast cancer (TNBC) and accelerated approval for urothelial cancer to a new European Commission approval in 2023 for monotherapy in HR⁺/HER2‑ breast cancer after prior endocrine therapy and systemic treatment. This label expansion adds a distinct solid‑tumor indication outside of TNBC and UC, underscoring Gilead’s strategy to broaden the therapeutic reach of its antibody‑drug conjugate platform and generate multiple growth drivers within oncology.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer contains significant factual errors that contradict the ground truth. (1) INCORRECT TIMELINE: The LLM references 2021 approvals for TNBC and urothelial cancer as context, but the question specifically asks about evolution BETWEEN 2022 AND 2023. The ground truth states that in 2022, Trodelvy was part of the marketed portfolio with no specific regulatory updates mentioned, and the key regulatory progress occurred in 2023. (2) WRONG INDICATION: The LLM states the 2023 approval was for 'monotherapy in HR+/HER2- breast cancer' but the ground truth specifies this was for 'HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies' - a more restrictive patient population. (3) INCOMPLETE REGULATORY DETAIL: The ground truth explicitly mentions BOTH FDA AND EC approvals in 2023, while the LLM only clearly references the EC approval. (4) REASONING QUALITY: While the LLM correctly identifies the strategic intent (broadening therapeutic reach, expanding oncology position), it does so by referencing incorrect prior approvals and timelines that weren't part of the 2022-2023 evolution being asked about. The answer conflates historical context (2021 approvals) with the specific 2022-2023 progression requested. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the specific regulatory progression between the two years as documented in the ground truth. The answer provides context about earlier approvals but doesn't accurately capture what changed between 2022 and 2023 specifically.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 441,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "\nBetween 2023 and early 2024 Simon Property Group’s equity stake in ABG was repeatedly diluted by ABG’s capital raises, producing a series of non‑cash gains from “deemed disposals” as the holding fell from roughly 11‑12 % to about 9.6 % and generated $10.3 million of pre‑tax gain in 2023 alone. In February 2024 the company completed the sale of its remaining ABG interest for $1.2 billion, recognizing a $414.8 million pre‑tax gain (net of $103.7 million tax expense), a move that strategically exits the partnership and frees cash for debt reduction and development. This progression reflects a shift from an active joint‑venture investment with ongoing capital transactions to a full divestiture, repositioning SPG’s capital toward its core retail property portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM claims a $414.8 million pre-tax gain from a February 2024 sale of SPG's remaining ABG interest for $1.2 billion. However, the ground truth explicitly states that in 2024, SPG 'no longer reported active capital transactions with ABG' and only 'referenced historical transactions.' The ground truth makes no mention of a $1.2 billion sale in February 2024 or a $414.8 million gain in 2024. (2) The LLM cites a $10.3 million gain in 2023, which is not mentioned in the ground truth. The ground truth specifically identifies gains of $36.4 million (Q2 2023) and $145.8 million (Q3 2023), totaling $182.2 million - not $10.3 million. (3) ENTITY/TIMELINE ERRORS - The LLM introduces a February 2024 transaction that appears to be fabricated or confused with actual events. The ground truth indicates 2024 filings only referenced historical transactions from 2021-2022, not new 2024 transactions. (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the key distinction between 2023 (active capital transactions with multiple gains) and 2024 (no active transactions, only historical references). Instead, it created a false narrative of a major 2024 divestiture. (5) The LLM's characterization of the relationship shift is directionally correct (from active to stable), but the specific facts supporting this conclusion are largely incorrect. The answer demonstrates a fundamental misunderstanding of the ground truth data, inventing specific numbers and transactions that do not appear in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 450,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "\nBetween 2022 and 2024 Chevron’s 50 % equity interest in Chevron Phillips Chemical Company LLC was reported as a distinct line‑item in the downstream segment and in Note 15 of the 10‑K filings.  The investment balance grew from roughly $6 billion (as summarized in the 2022 “Summarized Financial Data” on page 30‑31) to $7.77 billion in 2023 and $8.57 billion in 2024, reflecting additional capital contributions and the accumulation of Chevron’s share of the affiliate’s earnings, which are shown in the “Income (loss) from equity affiliates” and “Other income (loss)” line items of the segment earnings tables.  Consequently, the financial reporting of the relationship shifted from a simple summarized data note in 2022 to a more detailed segment‑level presentation in 2024, highlighting a larger equity‑method investment and a steadily increasing contribution to Chevron’s downstream earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a partially correct response with both accurate and inaccurate elements. CORRECT ELEMENTS: (1) The identification of Chevron Phillips Chemical as a 50% equity interest is accurate. (2) The investment values are substantially correct: $7.77 billion in 2023 and $8.57 billion in 2024 match the ground truth ($7,765M and $8,571M). (3) The general narrative about a shift from consolidated to equity method reporting is correct. (4) The mention of equity affiliate income and downstream segment reporting is appropriate. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM states the 2022 value was 'roughly $6 billion' but provides no specific citation or verification. The ground truth indicates 2022 was reported as a consolidated subsidiary in Note 8, not as an equity method investment with a disclosed value. The LLM's characterization of 2022 reporting is vague and potentially misleading. (2) The LLM cites 'Note 15' as the location for this information, but the ground truth specifically references Note 8 for 2022 and the Investments and Advances section for 2024. The note reference appears incorrect. (3) The LLM's description of the 2022 reporting as 'simple summarized data note' on pages 30-31 is not clearly verified against the ground truth, which states it was in Note 8 on page 70 as a consolidated subsidiary. (4) The LLM does not clearly articulate the fundamental shift from CONSOLIDATED subsidiary (2022) to EQUITY METHOD investee (2024), which is the core structural change. Instead, it implies the relationship was always equity method. QUANTITATIVE ACCURACY: The 2023 and 2024 figures are correct, but the 2022 figure lacks precision and proper sourcing. The calculation/accumulation narrative is reasonable but not verified. QUALITATIVE ACCURACY: The multi-hop reasoning about the evolution is partially sound, but the characterization of 2022 reporting is imprecise and potentially conflates different reporting methods. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution between 2022-2024 and financial reporting changes, though it misses the critical consolidated-to-equity-method transition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 581,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "\nBy the end of 2023 Meta had largely finished the facilities‑consolidation portion of its 2022 restructuring, but a few lease‑exit and sub‑lease activities continued into 2024. In 2024 the company recorded $389 million of pre‑tax restructuring charges—all tied to facilities consolidation ($31 M cost‑of‑revenue, $254 M R&D, $54 M marketing and $50 M G&A)—and the cumulative expense for the initiative fell to $305 million for the year, showing that the strategy was essentially completed with only minor residual costs remaining. The drop from $1.74 billion in 2023 to $305 million in 2024 reflects the winding down of lease‑termination activities, and the related accrued liabilities were fully resolved by 31 December 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific 2024 restructuring charges ($389M total, with $31M cost-of-revenue, $254M R&D, $54M marketing, $50M G&A) and claims cumulative expense 'fell to $305 million for the year' and references a drop 'from $1.74 billion in 2023 to $305 million in 2024.' These specific numbers are not mentioned in the ground truth and appear to be fabricated or misattributed. The ground truth does not provide these detailed breakdowns or comparative figures. (2) INCOMPLETE SYNTHESIS: The LLM correctly identifies that facilities consolidation was substantially completed by end of 2023 and fully completed by end of 2024, which aligns with the ground truth. However, it adds unsupported financial details that contradict the ground truth's statement that 'the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024)' - suggesting a cumulative retrospective view, not year-over-year comparisons. (3) REASONING FLAW: The LLM's claim about 'cumulative expense fell to $305 million for the year' is confusing and appears to misinterpret what 'cumulative' means in this context. The ground truth emphasizes that 2024 provided a retrospective quantification across all three years, not a year-specific figure. (4) MISSING CORE INSIGHT: The LLM fails to emphasize the key distinction in the ground truth - that 2024 provided explicit financial summary data for the entire 2022-2024 period that was not detailed in 2023. The answer focuses on operational details (lease-exit activities, accrued liabilities) that are reasonable inferences but not explicitly stated in the ground truth. The specific dollar amounts cited appear to be hallucinated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 501,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Lockheed Martin shifted hypersonics from an early‑stage R&D focus to a mature acquisition priority, elevating it as a dedicated growth pillar within its Missiles & Fire Control and Space segments and linking it to the company’s 21st‑Century Security and CJADC2 strategies.  The firm progressed from technology‑demonstration contracts (e.g., HAWC, SR‑72) to low‑rate production and integration contracts with the U.S. Air Force, Army and Navy, securing milestone‑driven funding that positions hypersonic strike weapons for early fielding in the mid‑2020s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from early-stage development to active production/acquisition priority between 2022-2024. It accurately captures the shift in strategic importance and mentions relevant organizational units (Missiles & Fire Control, Space segments). The connection to broader strategic initiatives (21st-Century Security, CJADC2) adds appropriate context. The mention of multiple service branches (Air Force, Army, Navy) aligns with the ground truth's reference to Air Force and Army programs.\n\nWEAKNESSES: (1) UNVERIFIED CLAIMS: The LLM introduces specific program names (HAWC, SR-72) and technical details (low-rate production, milestone-driven funding, mid-2020s fielding timeline) that are NOT present in the ground truth. While these may be factually accurate from SEC filings, they cannot be verified against the provided ground truth and represent potential hallucination or over-specification. (2) MISSING GROUND TRUTH LANGUAGE: The ground truth emphasizes the 2022 state as 'dependent on U.S. Government authorization and funding' with 'uncertain future funding' - this critical uncertainty qualifier is absent from the LLM answer. (3) SEMANTIC SHIFT: The LLM frames this as elevation to 'dedicated growth pillar' and 'mature acquisition priority,' which is more assertive than the ground truth's 'key growth area' description. (4) SPECIFICITY ISSUE: The ground truth uses measured language ('described as,' 'indicating'), while the LLM makes definitive claims about program status without hedging.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the 2022-to-2024 evolution and connects it to organizational strategy, demonstrating sound multi-hop reasoning. However, the introduction of unverified specific details (program names, timelines) suggests the model may have extrapolated beyond the source material.\n\nQUANTITATIVE ACCURACY: No specific numbers, dates, or financial metrics are provided in either answer, so this dimension is less applicable. However, the LLM's reference to 'mid-2020s' fielding is a temporal claim that cannot be verified against ground truth.\n\nCONCLUSION: The answer captures the essential evolution correctly but introduces unverified specificity that raises concerns about factual grounding. The core narrative is sound, but the addition of program names and specific timelines without ground truth support prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 648,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "\nSouthern Company continued to label its energy‑related derivatives as **regulatory‑hedging instruments** in both 2022 and 2023, but the 2023 disclosures show a marked change in the size and composition of that balance‑sheet exposure.  The net regulatory asset fell from a modest **$9 million gain in 2022** to a **$(257) million unrealized loss in 2023**, with current and deferred regulatory assets declining from $71 million/$23 million (2022) to $(180) million/$(87) million (2023), and the gross offsetting amounts rising sharply.  As a result, the related unrealized gains/losses recorded in AOCI grew (a **$(58) million net loss in 2023 versus $(67) million in 2022**), leading to larger reclassifications of gains/losses into earnings and a more pronounced financial impact from energy‑price volatility.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. CRITICAL ISSUES: (1) The LLM provides specific dollar amounts ($9 million gain in 2022, $(257) million loss in 2023, $(58) million vs $(67) million AOCI changes) that are NOT present in the ground truth and cannot be verified. These appear to be fabricated numbers. (2) The LLM focuses heavily on regulatory hedging instruments and balance sheet changes, but the ground truth explicitly states the KEY EVOLUTION was a shift from 'focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities' - specifically the addition of disclosure for derivatives NOT designated as hedging instruments. (3) The LLM completely misses the critical point that 2023 expanded disclosures to include 'energy-related derivatives not designated as hedging instruments' with multi-year comparisons (2023, 2022, 2021). (4) The LLM's narrative about 'marked change in size and composition' and 'net regulatory asset fell from $9 million to $(257) million' cannot be corroborated by the ground truth and appears to be hallucinated detail. (5) While the LLM correctly identifies Southern Company and the 2022-2023 timeframe, it fundamentally mischaracterizes the nature of the evolution - treating it as a quantitative change in existing regulatory hedging disclosures rather than a qualitative expansion to include non-designated derivatives. The answer demonstrates poor multi-hop reasoning by failing to synthesize the actual disclosure evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 445,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings, Gilead’s public patent disclosures for Truvada shifted from “protect‑and‑extend” language to an acknowledgement that the core composition‑of‑matter patents have now expired.  \n\n* In the 2022 filing (pages 35‑39, “Patents and Proprietary Rights”), Gilead noted that the U.S. composition‑of‑matter patents for Truvada were slated to expire in 2025 and that the company was pursuing patent‑term extensions, pediatric exclusivity and method‑of‑use claims to prolong protection.  \n* By the 2023 filing (pages 7‑11, the same “Patents and Proprietary Rights” section), Truvada no longer appears with pending composition‑of‑matter patents; the table of product‑specific expirations shows only a 2026 U.S. regulatory‑exclusivity date (extended to 2031 with pediatric exclusivity), and the narrative emphasizes that remaining U.S. rights are limited to dwindling method‑of‑use claims and that the company is focusing its IP effort on newer HIV assets rather than extending Truvada’s patent life.  \n\nThus, Gilead’s IP strategy for Truvada moved from actively seeking extensions and filing new patent families in 2022 to a more passive stance in 2023, reflecting that the key patents have expired and that protection now rests only on regulatory exclusivity and licensing arrangements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. Key issues: (1) MAJOR FACTUAL ERROR: The LLM claims Truvada's composition-of-matter patents expired between 2022-2023, but the ground truth explicitly states that in 2022, Gilead highlighted the October 2020 loss of exclusivity - meaning the patents had already expired by 2022, not between 2022-2023. (2) INCORRECT DATES: The LLM states composition-of-matter patents were 'slated to expire in 2025' in the 2022 filing, but this contradicts the ground truth which indicates the loss of exclusivity occurred in October 2020. (3) MISCHARACTERIZATION OF STRATEGY SHIFT: The LLM describes a shift from 'protect-and-extend' to acknowledging expired patents, but the ground truth describes a different evolution: from acknowledging a past loss of exclusivity (2022) to proactively disclosing future IP timelines (2023). (4) UNSUPPORTED CLAIMS: The LLM provides specific page numbers (35-39, 7-11) and detailed claims about patent-term extensions and pediatric exclusivity strategies that cannot be verified against the ground truth and appear to be fabricated details. (5) CORRECT ELEMENT: The LLM does correctly identify that the strategy evolved between 2022 and 2023 and that there was a shift in how Gilead presented its IP position, which aligns with the ground truth's core observation. However, the specific nature of that shift is fundamentally misrepresented. The answer demonstrates hallucination of specific filing details and misinterpretation of the timeline of patent expiration events.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 435,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "\nBetween 2022 and 2024 SPG’s use of the Supplemental Facility shifted from a short‑term liquidity tool to a strategic refinancing source.  In December 2021 it drew $1.05 billion to fund an early mortgage‑payoff and then repaid that amount in January 2022 with proceeds from a senior note issuance; in the following two years it was used to finance the optional redemption of floating‑rate notes and to retire larger Euro‑denominated borrowings (e.g., the €750 million repayment in November 2023), after which the outstanding balance fell to zero and the facility’s capacity was expanded and extended to 2026‑2027.  This evolution reflects a move from occasional draws for specific pay‑downs toward a broader role in rolling over and retiring higher‑cost debt while preserving ample borrowing headroom.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility:\n\n1. CRITICAL DATE ERROR: The LLM states the $1.05 billion draw occurred in 'December 2021' and was 'repaid in January 2022.' The ground truth clearly states the borrowing occurred in 'January 2022' and was 'repaid shortly after issuance.' This is a fundamental chronological error that misplaces the transaction by one month.\n\n2. INCORRECT MORTGAGE PAYOFF CHARACTERIZATION: The ground truth specifies that the $1.05 billion was used to fund 'early extinguishment of nine mortgages with a principal balance of $1.16 billion.' The LLM vaguely refers to 'an early mortgage-payoff' without the specific details about nine mortgages or the $1.16 billion principal balance.\n\n3. MISSING KEY DETAIL: The ground truth explicitly states the €750.0 million was 'repaid on November 17, 2023.' The LLM mentions the €750 million but incorrectly characterizes it as a 'repayment' of Euro-denominated borrowings rather than clarifying it was borrowed and then repaid the same day.\n\n4. UNSUPPORTED CLAIMS: The LLM introduces information not in the ground truth, such as:\n   - Claims about 'floating-rate notes' redemption (not mentioned in ground truth)\n   - Statements about facility 'capacity expansion and extension to 2026-2027' (not in ground truth)\n   - References to 'rolling over and retiring higher-cost debt' (interpretive, not explicitly stated)\n\n5. INCOMPLETE SYNTHESIS: While the LLM attempts to show evolution, it fails to accurately capture the 2024 refinancing strategy mentioned in the ground truth (issuance of new senior unsecured notes to redeem other outstanding notes at maturity).\n\n6. QUANTITATIVE ACCURACY: The €750 million figure and its USD equivalent ($815.4 million) are correct, but the temporal context and purpose are muddled.\n\nThe answer demonstrates partial understanding of the general concept (short-term facility usage) but contains material factual errors in dates, specific transaction details, and introduces unsupported claims that suggest hallucination or confusion with other financing activities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 571,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "\nFrom 2022 to 2024 MetLife moved cash‑buffer considerations from a peripheral risk‑management note to a central pillar of its capital‑management policy.  The 2024 filing explicitly ties dividend and share‑repurchase decisions to the size of a maintained liquidity buffer—roughly $12 bn of short‑term liquidity that is monitored daily and must stay above target levels to satisfy regulatory capital and stress‑testing requirements—so capital allocation now hinges on preserving that buffer.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the directional shift in MetLife's capital management strategy from 2022 to 2024, correctly identifying that cash buffer considerations became more central to capital allocation decisions. However, there are significant quantitative accuracy issues: (1) The LLM states 'roughly $12 bn of short-term liquidity' for 2024, but the ground truth specifies $12.4 billion for 2022 with no 2024 figure provided in the original answer. The LLM appears to conflate or generalize the 2022 figure without clarifying whether this remained constant through 2024. (2) The LLM omits the total liquid asset base of $223.0 billion mentioned in 2022, which is important context for understanding the scale of liquidity management. (3) The LLM does not provide specific 2024 liquidity figures, making it impossible to verify the evolution claim with concrete numbers. On the positive side: (1) The LLM correctly identifies the shift from peripheral to central role of cash buffers. (2) The reasoning about how larger cash buffers constrain capital allocation (dividends, share repurchases, acquisitions, innovation) aligns with the ground truth's statement about limiting capital for these purposes. (3) The mention of regulatory capital and stress-testing requirements is contextually appropriate. The answer demonstrates sound qualitative reasoning about the strategic evolution but lacks the specific quantitative detail needed to fully support the multi-hop comparison across years. The semantic equivalence is reasonable (e.g., 'central pillar' vs. 'strategic priority with pronounced implications'), but the missing 2024 data and incomplete numerical comparison weaken the overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 464,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the foreign‑currency‑other derivative position contracted on both the asset and liability sides.  Designated derivative assets fell from $39.9 million in prepaid expenses (current) plus $33.5 million in other long‑term assets in 2022 to $32.0 million (current) plus $22.9 million (long‑term) in 2023, while non‑designated assets dropped from $34.3 million (current) + $7.3 million (long‑term) to $7.5 million (current) + $1.8 million (long‑term).  Correspondingly, derivative liabilities moved from $0.3 million (current) and $5.8 million (current) in 2022 to $2.0 million (current) and $0.5 million (current) in 2023, with a modest increase in long‑term liability balances, reflecting a shift from a larger short‑term current‑asset/liability exposure to a smaller, more long‑dated position recorded partly in long‑term assets and liabilities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and appears to describe a completely different derivative position than what the ground truth specifies. Critical issues: (1) WRONG NUMBERS: The ground truth clearly states 'Foreign currency - other' derivatives were $0.3M liability (2022) and $1.9M asset/$4.7M liability (2023). The LLM answer cites $39.9M, $33.5M, $32.0M, $22.9M, $34.3M, $7.3M, $7.5M, $1.8M, $0.3M, $5.8M, $2.0M, $0.5M - none of which match the ground truth figures. (2) WRONG CLASSIFICATION: The LLM discusses 'designated' vs 'non-designated' derivatives and long-term vs current breakdowns that are not mentioned in the ground truth. The ground truth specifically identifies the 2022 position as 'accrued liabilities' only and the 2023 position as split between 'prepaid expenses and other current assets' (asset) and 'accrued liabilities' (liability). (3) WRONG NARRATIVE: The LLM describes a 'contraction' in the position, while the ground truth shows a significant INCREASE from $0.3M liability to $1.9M asset + $4.7M liability. (4) MULTI-HOP FAILURE: The LLM failed to correctly synthesize the year-over-year comparison. The ground truth shows a clear evolution: 2022 had only a small liability position ($0.3M), while 2023 shows both an asset ($1.9M) and larger liability ($4.7M), indicating increased exposure and more balanced treatment. The LLM answer appears to reference entirely different derivative categories or companies, making it fundamentally unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 410,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "\nFrom 2023 to 2024 the Company deepened its strategic tie‑up with Coca‑Cola FEMSA: it raised its equity‑method ownership to 28 % (the largest single bottler, accounting for roughly 42 % of global unit‑case volume) and the fair‑value‑carrying‑value gap for that investment grew to about $2.8 bn, while equity income and dividends from FEMSA rose sharply.  This reflects a more substantial financial stake and closer collaboration—still governed by long‑term bottler agreements and shared pricing initiatives—than in the prior year.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of the relationship from 2023 to 2024, correctly identifying the 28% ownership stake and the 42% unit case volume contribution. The answer appropriately characterizes the shift toward deeper financial commitment and closer collaboration. However, there are some issues: (1) The LLM introduces a $2.8 billion fair-value-carrying-value gap figure that is not present in the ground truth answer, which raises questions about whether this is accurate or an unsupported addition. (2) The LLM mentions 'equity income and dividends from FEMSA rose sharply' without providing specific numbers or evidence from the ground truth. (3) The reference to 'long-term bottler agreements and shared pricing initiatives' adds contextual detail not explicitly in the ground truth, though it may be reasonable inference. The quantitative accuracy is strong on the core metrics (28% ownership, 42% volume), but the introduction of the $2.8 billion figure without ground truth support is concerning. The qualitative reasoning about the transition from bottler to equity method investee is sound and well-articulated. The answer is contextually relevant and addresses the multi-hop nature of comparing 2023 vs 2024 positions, but the unsupported financial figures and claims about dividend/income changes prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 376,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "\nBetween 2022 and 2024 Intel shifted FPGAs from a discrete, niche offering in the Programmable Solutions Group (PSG) toward a core, cross‑segment programmable building block.  In the 2022 filing (p. 111) “Adjacent products” were defined as non‑platform items—including PSG FPGAs— that supplement the CCG, DCG and IOTG platform products, while the 2024 filing (p. 101) reiterates that PSG‑based FPGAs (along with eASIC, IPU and other programmable devices) are now integral to Intel’s AI‑centric, edge‑compute and networking platforms.  Consequently, Intel’s production focus moved to align FPGA manufacturing with its newer process nodes (Intel 7, Intel 4) and advanced packaging (EMIB/Foveros), positioning the technology as a unified programmable layer across its broader product portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) ENTITY MISMATCH - The LLM answer references 'Programmable Solutions Group (PSG)' as the organizational unit for FPGAs, but the ground truth explicitly states FPGAs were positioned within 'Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG)' in 2022. PSG is not mentioned in the ground truth answer. This is a fundamental factual error in entity identification. (2) POSITIONING CHARACTERIZATION - The ground truth describes FPGAs as 'adjacent products' (supplementary/supporting role) in 2022, then shifted to 'direct product definitions' (core offering) by 2024. The LLM answer characterizes the 2022 position as 'discrete, niche offering in PSG' which contradicts the ground truth's framing within major platform groups. (3) PAGE REFERENCES - The LLM cites specific page numbers (p. 111 for 2022, p. 101 for 2024) that cannot be verified against the ground truth, and the ground truth does not reference these pages. This introduces unverifiable claims. (4) PROCESS NODE DETAILS - The LLM adds specific manufacturing details (Intel 7, Intel 4, EMIB/Foveros) that are not present in the ground truth answer. While these may be factually accurate from filings, they represent information synthesis beyond what the ground truth establishes. (5) MULTI-HOP REASONING - The core multi-hop synthesis (comparing 2022 vs 2024 positioning) is partially correct in concept (shift from supplementary to core), but the organizational context is fundamentally wrong. The ground truth clearly ties FPGAs to CCG/DCG/IOTG, not PSG. (6) SEMANTIC ALIGNMENT - While both answers discuss a shift in strategic importance, the LLM's framing through PSG and the specific manufacturing details diverge significantly from the ground truth's simpler, clearer positioning within established platform groups. The answer demonstrates partial understanding of the evolution but contains material factual errors in entity identification that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 540,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "\nFrom 2022 to 2023 ConocoPhillips expanded its Lower 48 position by acquiring roughly $1.2 bn of new proved undeveloped reserves (the proved‑reserve base grew from about 1.27 bn to 2.78 bn BOE), and capital spending in that play rose to $6.5 bn.  As a result, depreciation, depletion and amortization expense for the Lower 48 segment increased to $5.73 bn in 2023, up from $4.85 bn in 2022, reflecting the larger asset base and the higher depletion of the newly acquired reserves.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on the core financial metrics requested. The depreciation, depletion, and amortization (DD&A) figures are correct: $4.85 billion in 2022 and $5.73 billion in 2023, matching the ground truth values of $4,854 million and $5,729 million respectively (minor formatting difference only). The calculated increase of approximately $875 million is accurate. The answer correctly identifies ConocoPhillips and the Lower 48 region, and properly addresses the time period (2022-2023). The multi-hop synthesis is sound, connecting asset acquisition activity to the resulting increase in DD&A expenses. The LLM provides additional context about proved undeveloped reserves growth and capital spending ($6.5 billion) that, while not explicitly mentioned in the ground truth, is relevant and contextually appropriate for understanding the financial evolution. The reasoning that larger asset bases and higher depletion of newly acquired reserves drove the DD&A increase is logically sound and consistent with the ground truth's conclusion about 'continued investment and asset utilization.' Minor strengths include the specific mention of the Concho acquisition context (implied in ground truth but not explicitly stated in the LLM answer). The answer is well-structured and directly addresses all parts of the multi-part question regarding asset acquisition and DD&A evolution. No calculation errors detected. The only minor limitation is that the LLM introduces some additional metrics (proved reserves, capital spending) that go slightly beyond what was explicitly in the ground truth, though these are accurate and relevant additions rather than errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 462,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s stake in AspenTech moved from a **55 % beneficial ownership (with the remaining 45 % held by former shareholders as non‑controlling interest)** – as disclosed in the 2022 10‑K (pages 55‑59) – to a **planned full acquisition**: on Nov 5 2024 the company announced a cash offer to buy the remaining shares, which would give it **100 % ownership** of AspenTech.  \n\nFinancially, the Heritage AspenTech purchase initially **boosted gross margin by about 0.6 percentage points** (2022‑2023 discussion of margin improvement), but the **subsequent amortization of the acquired inventory step‑up now drags margin down by roughly 1.3 percentage points**, offsetting part of that early benefit (see the 2024 gross‑margin discussion of the $231 inventory step‑up amortization).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies key facts: (1) the 0.6 percentage point gross margin boost in 2023, (2) the $231 million inventory step-up amortization in 2024, (3) the 1.3 percentage point negative margin impact from that amortization, (4) AspenTech's continued operation under ticker 'AZPN', and (5) the November 2024 announcement of a full acquisition offer. The reasoning about margin dynamics is sound and well-synthesized across multiple years.\n\nCRITICAL ERRORS: (1) MAJOR: The LLM states Emerson had '55% beneficial ownership' in 2022, but the ground truth indicates the 55% ownership was the 2024 position, not 2022. In 2022, Emerson completed the acquisition (implying control/majority stake), not a minority 55% position. This is a fundamental mischaracterization of the 2022 ownership structure. (2) MISSING: The LLM fails to mention the $6.0 billion cash payment or the $87.69 per share price paid to Heritage AspenTech stockholders - key financial details of the 2022 acquisition. (3) MISSING: The LLM does not mention the $168 million retained in AspenTech's balance sheet. (4) INCOMPLETE: The LLM does not clearly state that by 2024, the gross margin increased to 50.8% (the net result after all impacts). (5) TIMELINE CONFUSION: The answer conflates the 2022 acquisition completion with a 55% stake that actually existed in 2024, creating a reversed chronology of ownership evolution.\n\nMULTI-HOP REASONING: The synthesis of margin impacts across years is partially correct (identifying both the positive 0.6pp boost and negative 1.3pp drag), but the ownership structure evolution is inverted. The answer should have shown: 2022 (acquisition completed, majority control) → 2024 (55% ownership, non-controlling interest structure) → Nov 2024 (announcement of full acquisition). Instead, it presents 2022 as 55% ownership.\n\nQUANTITATIVE VERIFICATION: The margin percentages (0.6pp, 1.3pp) and the $231 million amortization are correct. However, the missing $6.0 billion acquisition cost, $87.69 share price, and $168 million retained balance represent significant omissions of quantitative data. The 50.8% final gross margin figure is also absent.\n\nSEMANTIC ISSUES: While the language about margin dynamics is clear, the fundamental ownership timeline is backwards, which is a semantic and factual error that undermines the answer's core claim about how the relationship 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 641,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "\nBetween 2022 and 2024 the pool of shares reserved for future issuance under the 2015 Director Stock Plan shrank from about **34.1 million** (the 34,073,114 shares remaining as of 31 Dec 2021 disclosed in the 2022 10‑K) to roughly **30.7 million** (the 30,660,961 shares remaining as of 31 Dec 2024 disclosed in the 2024 10‑K).  This decline reflects ongoing **share recovery**—shares that expired, were forfeited, settled in cash, or used for tax‑withholding are returned to the plan—but the recovery is more than offset by **new awards and imputed reinvested dividends** on deferred shares, which consume the reclaimed shares and reduce the net reserve by roughly **3.4 million** shares over the period.  The mechanics remain governed by the plan’s “one‑for‑one” issuance ratio (each award reduces the remaining‑available count by one share, with recovered shares re‑entering the reserve only after adjusting for the 2005‑plan ratio and any cash‑settlement or withholding effects).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effective multi-hop synthesis. STRENGTHS: (1) All key numbers are correct: 34,073,114 shares as of Dec 31, 2021 (2022 10-K disclosure), 30,660,961 shares as of Dec 31, 2024 (2024 10-K disclosure), and the calculated decline of ~3.4 million shares. (2) The quantitative comparison is accurate: the decline from ~34.1M to ~30.7M shares is correctly calculated and contextualized. (3) The multi-hop synthesis is sound: the answer correctly identifies that share recovery occurs but is offset by new awards and reinvested dividends, resulting in net reduction. (4) The mechanics explanation (one-for-one issuance ratio, share recovery conditions) aligns with the ground truth description. (5) The temporal framing (2022 to 2024) correctly addresses the question's scope. MINOR GAPS: (1) The LLM answer does not explicitly mention the total authorized shares (35,395,894 as of Jan 1, 2015) or total recovered shares (37,608,213 between 2015-2024) that appear in the ground truth. However, these are historical/cumulative figures that provide context rather than directly answering the evolution between 2022-2024. (2) The reference to '2005-plan ratio' in the mechanics explanation is somewhat vague and not fully explained, though it doesn't contradict the ground truth. CALCULATION VERIFICATION: The decline calculation (34,073,114 - 30,660,961 = 3,412,153 ≈ 3.4M) is accurate. The answer correctly characterizes this as a net reduction despite ongoing share recovery. The semantic equivalence is strong: the LLM answer effectively conveys the same substantive information as the ground truth, focusing on the most relevant metrics for the 2022-2024 period while explaining the underlying mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 477,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "\nIn fiscal 2022 the Global Coffee Alliance generated only about $216 million of “other” revenue and helped lift Channel‑Development sales ≈ 16%, but the alliance’s contribution weighed on operating margin because of a decline in the North American Coffee Partnership joint‑venture income.  By fiscal 2023 the partnership was repositioned as a strategic growth engine – Alliance‑related product sales and royalty income rose sharply and now represent a larger share of Starbucks’ total net revenues, signalling a shift from a peripheral licensing arrangement to a core driver of the company’s Channel‑Development strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims the Global Coffee Alliance generated 'about $216 million of other revenue' in fiscal 2022, but the ground truth states the Channel Development segment saw a $250 million increase driven by the alliance. The $216M figure is not supported by the ground truth and appears to be fabricated. The LLM also mentions a '16% lift' in Channel Development sales with no supporting evidence in the ground truth. (2) ENTITY/CONTEXT ERRORS: The LLM introduces 'North American Coffee Partnership joint-venture income' and discusses margin pressure from this partnership, which is not mentioned in the ground truth at all. This appears to be conflating different partnerships or introducing unsupported information. (3) MULTI-HOP REASONING ISSUES: While the LLM correctly identifies the evolution from fiscal 2022 to 2023 (peripheral to core strategic importance), it does so with incorrect supporting numbers and introduces unverified claims about margin impacts. (4) SEMANTIC ALIGNMENT: The LLM does capture the directional shift from 'peripheral licensing arrangement to core driver' which aligns with the ground truth's 'shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler.' However, this correct conceptual understanding is undermined by the false quantitative claims. (5) MISSING ELEMENTS: The LLM fails to accurately cite the $250 million revenue increase figure that is central to the fiscal 2022 narrative in the ground truth. The answer fabricates specific numbers ($216M, 16% lift) that cannot be verified and contradict the provided ground truth. This is a critical failure for a financial analysis task where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 495,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "\nBetween 2022 and 2023 NEE’s exposure to the Mountain Valley Pipeline shifted from an equity‑method investment that still appeared on its balance sheet to a fully impaired, essentially written‑off stake—​the 2022 impairment erased the remaining carrying amount and a further $2.4 billion charge in 2023 reduced the investment to near zero. This rapid write‑down signals that NEE is deliberately divesting from high‑risk, non‑regulated infrastructure projects such as MVP and redirecting capital toward more regulated utility and clean‑energy assets that offer steadier cash flows and align with its long‑term growth strategy.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM claims a '$2.4 billion charge in 2023' and that the investment was 'written-off' or 'reduced to near zero,' but the ground truth shows NEE's total equity method investments were $6,156 million in 2023 (nearly identical to 2022's $6,159 million), with the Mountain Valley Pipeline remaining a listed equity method investee. There is no evidence of a $2.4 billion impairment charge in 2023 or a write-off to near zero. (2) ENTITY/METRIC ERRORS: The LLM misidentifies the financial treatment—the ground truth indicates the MVP remained an equity method investment with ownership interests of 32.8%-52.6% in 2023, not an impaired/written-off asset. The mention of 'Nonrecurring Fair Value Measurements' in 2023 does not equate to a full impairment or write-off. (3) REASONING FAILURES: The LLM's multi-hop synthesis is fundamentally flawed. It invents a narrative of 'rapid write-down' and 'divestment' that is unsupported by the actual financial data. The ground truth shows stability in total equity method investments and a slight refinement in ownership ranges (32%-55% to 32.8%-52.6%), suggesting strategic adjustment, not abandonment. (4) SEMANTIC MISALIGNMENT: The LLM's characterization of NEE's strategy as 'deliberately divesting from high-risk, non-regulated infrastructure' contradicts the ground truth, which shows continued material investment in MVP as an equity method investee. The answer appears to confuse or conflate different financial events or companies. This is a complete failure to accurately synthesize the multi-hop information from the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 467,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Medtronic transformed the InterStim portfolio from a single‑device therapy into a family of neurostimulators—including the newly launched, recharge‑free **InterStim X** and the rechargeable **InterStim II** and **InterStim Micro**—and broadened its approved uses to cover **overactive bladder, urinary retention, bowel incontinence and chronic fecal incontinence** (with MRI‑conditional labeling). This expansion gave clinicians more options for tailoring therapy to individual patient needs while maintaining the same minimally invasive, sacral‑nerve stimulation approach.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM states InterStim Micro was 'rechargeable' in 2024, but the ground truth indicates InterStim Micro was only mentioned in 2022 and is not listed in 2024 offerings. (2) The LLM claims InterStim II and InterStim Micro are 'rechargeable' while InterStim X is 'recharge-free,' but the ground truth specifies that by 2024, both InterStim II and InterStim X are 'recharge-free' neurostimulators. (3) The LLM incorrectly characterizes the evolution as transforming 'from a single-device therapy into a family' - the ground truth shows InterStim was already a family of devices in 2022 (InterStim II, Micro, and X). CORRECT ELEMENTS: The LLM correctly identifies the therapeutic indications (overactive bladder, urinary retention, bowel incontinence, and chronic fecal incontinence), correctly notes the expansion of clinical applications, and appropriately mentions the sacral nerve stimulation approach. However, the product lineup characterization is fundamentally flawed. The multi-hop reasoning fails because the LLM misrepresents the 2022 baseline and incorrectly describes the 2024 product specifications, particularly regarding which devices are rechargeable vs. recharge-free. The answer demonstrates partial understanding of the therapeutic expansion but contains material errors in product specifications that would mislead readers about the actual device offerings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 409,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "\nFrom 2022 through 2024 Simon Property Group’s holding in Authentic Brands Group (ABG) was steadily reduced and ultimately eliminated.  After acquiring additional interests in 2021‑22, SPG’s non‑controlling stake fell to roughly 10 % and, following a 2023 capital‑transaction that diluted it to about 9.6 %, the company sold the remainder of its ABG equity in 2024 for $1.2 billion cash, ending the strategic partnership that had previously centered on joint licensing ventures such as Forever 21, Brooks Brothers and Eddie Bauer.  The evolution was marked by a series of equity purchases, dilution‑related gains and finally a full divestiture.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every factual claim. Specific errors: (1) STAKE TRAJECTORY: Ground truth shows SPG held 1.37% in 2022 and increased to 50% in SPARC Group, then made additional acquisitions for $100M in 2024. LLM claims the stake was 'steadily reduced' from ~10% to 9.6% and completely eliminated via $1.2B sale in 2024 - this is entirely fabricated. (2) QUANTITATIVE ERRORS: LLM cites a $1.2 billion divestiture in 2024 that does not appear in ground truth; ground truth shows $18.8M pre-tax gain from a partial sale and $100M acquisition. The $1.2B figure is completely unsupported. (3) DIRECTIONAL CONTRADICTION: Ground truth shows an INCREASE in strategic involvement (50% SPARC stake, $100M additional acquisition), while LLM describes a complete ELIMINATION of the stake. (4) MISSING KEY FACTS: LLM fails to mention the 1.37% initial stake, the 50% SPARC Group merger, the $18.8M gain, or the $100M acquisition - all critical to understanding the evolution. (5) TIMELINE ISSUES: LLM references 2021-22 acquisitions and 2023 dilution not clearly supported in ground truth narrative. (6) STRATEGIC RELATIONSHIP: While LLM correctly identifies Forever 21, Brooks Brothers, and Eddie Bauer as joint ventures, it incorrectly characterizes the relationship as 'ended' when ground truth shows continued and deepening involvement through 2024. The answer appears to describe a completely different transaction history than what occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 414,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "\nFrom 2021 through 2023 the depreciation, depletion and amortization (DDA) charge for ConocoPhillips’ Lower 48 operations rose steadily—$4.07 billion in 2021, $4.85 billion in 2022 and $5.73 billion in 2023.  The increase reflects the company’s growing reserve base and capital investment in the region (e.g., the Shell Permian and Concho acquisitions and expanded drilling in the Permian and other unconventional plays), which adds more assets to the depreciation/amortization schedule and drives higher DDA expenses each year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 2021 DD&A of $4,067 million ($4.07 billion), 2022 of $4,850 million ($4.85 billion), and 2023 of $5,729 million ($5.73 billion). The number format variations (millions vs. billions) are properly handled and semantically equivalent. The answer correctly identifies the metric (depreciation, depletion, and amortization) and the region (Lower 48). The multi-hop synthesis is sound, combining financial data across three years to show the evolution trend. The LLM goes beyond the ground truth by providing additional context about the drivers of the increase (Shell Permian and Concho acquisitions, expanded drilling in Permian and unconventional plays), which adds valuable explanatory depth without introducing factual errors. The reasoning that higher DD&A reflects growing reserve base and capital investment is logically sound and consistent with accounting principles. The only minor distinction is that the ground truth uses the acronym 'DD&A' while the LLM uses 'DDA' (both are acceptable variations of the same acronym). The answer fully addresses the question about how investment activity evolved from 2021 to 2023 in terms of DD&A expenses, showing a clear upward trend with specific numerical support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 367,
        "total_tokens": 1587
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "\nVerizon kept the same selection criteria for international bonds—high‑quality, non‑callable issues with at least $300 million of par outstanding—in both 2023 and 2024. However, in 2024 it applied a higher weighted‑average discount rate (5.8 % for pension liabilities versus 5.0 % in 2023), which reduced the present‑value valuation of those bonds and produced a net accounting credit, and the reported fair‑value of international bonds in the pension portfolio dropped sharply from $341 million to $113 million, indicating a deliberate reduction in exposure rather than a change in valuation methodology.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different topic than the ground truth. CRITICAL ERRORS: (1) The LLM discusses pension liabilities, discount rates (5.8% vs 5.0%), and pension portfolio valuations—none of which appear in the ground truth answer about fair value measurement disclosures. (2) The LLM cites specific dollar amounts ($341 million dropping to $113 million) that are completely different from the ground truth figures ($12 million total in 2024, with $10 million Level 1 and $2 million Level 2). (3) The LLM discusses selection criteria for 'high-quality, non-callable issues with at least $300 million of par outstanding'—this is not mentioned in the ground truth. (4) The ground truth specifically addresses fair value measurement hierarchy (Level 1 and Level 2 inputs) and disclosure transparency evolution, while the LLM discusses pension accounting and discount rate changes. (5) The LLM's core claim about 'sharp reduction in exposure from $341 million to $113 million' contradicts the ground truth's $12 million valuation figure. The LLM appears to have confused Verizon's international bonds treatment with an entirely different accounting topic (possibly pension accounting or a different asset class). The answer demonstrates a fundamental misunderstanding of the question, which asks about valuation approach and disclosure evolution in fair value measurement, not pension liability accounting or discount rate changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 408,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s stake in AspenTech grew from a **55 % equity interest** (secured after the May 2022 closing of the Heritage AspenTech transaction, which added $7.3 bn of goodwill and $4.5 bn of customer‑relationship intangibles) to a **proposed full acquisition** announced in November 2024, under which Emerson would purchase the remaining shares for roughly $15 bn.  The earlier integration was reflected in shared restructuring expense (AspenTech’s $7 m of restructuring costs in 2022), joint hedging of foreign‑currency and commodity exposures, and the inclusion of AspenTech’s debt and cash‑flow items in Emerson’s consolidated balance sheet (e.g., the $240 m revolving loan and the €1.5 bn euro‑denominated notes).  By 2024 the relationship had moved from a partial, jointly‑reported partnership to a planned **complete ownership and deeper operational integration** of AspenTech’s software and technology assets within Emerson’s portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) WRONG INITIAL STAKE: LLM claims Emerson had a '55% equity interest' in 2022 after the May 2022 Heritage AspenTech transaction, but ground truth shows Emerson had an $8,326 million financial stake (not explicitly stated as 55% at that point). The 55% stake mentioned in ground truth refers to the 2024 'New AspenTech' structure, not 2022. (2) WRONG NARRATIVE: LLM describes a progression toward 'full acquisition' with a November 2024 announcement to purchase remaining shares for ~$15bn. This is factually incorrect - the ground truth shows Emerson CONTRIBUTED the AspenTech Industrial Software Business PLUS $6.0 billion in cash to form 'New AspenTech' while RETAINING 55% ownership. This is a restructuring/contribution model, not an acquisition of remaining shares. (3) INCORRECT FINANCIAL DETAILS: LLM cites $7.3bn goodwill, $4.5bn customer-relationship intangibles, $240m revolving loan, and €1.5bn euro notes - these appear to be fabricated or misattributed numbers not supported by the ground truth. (4) MISUNDERSTOOD OPERATIONAL INTEGRATION: LLM frames the evolution as moving toward complete ownership through acquisition, when ground truth shows a strategic restructuring creating a majority-owned (55%) separate entity called 'New AspenTech.' The LLM fundamentally mischaracterizes the 2024 transaction as an acquisition rather than a contribution-based restructuring. The answer demonstrates poor multi-hop synthesis and contains multiple material factual errors regarding the nature, structure, and financial terms of Emerson's relationship with AspenTech.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 456,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Starbucks continued to treat its interest‑rate swaps as **designated fair‑value hedges of fixed‑rate debt**, but the size of the hedge contracted.  In the 2022 filing the swaps appeared as derivative liabilities of **$12 million in accrued liabilities and $34 million in other long‑term liabilities** (10‑K 2022, pp. 66‑67), with a cumulative fair‑value hedging adjustment of **$(52.3) million** recorded in the hedged long‑term debt.  By 2023 the same swaps were still classified as designated fair‑value hedges, yet the liability had fallen to **about $19 million in other long‑term liabilities** (and a much smaller accrued‑liability balance), and the cumulative adjustment in the debt balance dropped to **$(17.8) million**, reflecting a reduced notional amount and a lower fair‑value liability (10‑K 2023, pp. 70‑71).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS - 2022 Classification: Ground truth states $34.0 million in long-term liabilities only, but LLM claims $12 million in accrued liabilities AND $34 million in long-term liabilities (totaling $46M, not $34M). This is a critical error. 2023 Classification: Ground truth specifies $0.4 million in current accrued liabilities and $19.2 million in long-term liabilities (total $19.6M), but LLM states 'about $19 million in other long-term liabilities' with 'a much smaller accrued-liability balance' - the LLM fails to provide the specific $0.4 million figure and is vague about the current portion. (2) ADDITIONAL INFORMATION NOT IN GROUND TRUTH - The LLM introduces information about 'designated fair-value hedges of fixed-rate debt' and cumulative fair-value hedging adjustments of $(52.3) million in 2022 and $(17.8) million in 2023. While this additional context may be accurate from the filings, it was not part of the ground truth answer and represents information beyond what was verified. (3) MULTI-HOP REASONING - The LLM does correctly identify the evolution/shift in classification between years and notes the net decrease in liability, which aligns with ground truth reasoning. However, the specific numbers used to support this reasoning are incorrect. (4) CLASSIFICATION ACCURACY - The LLM correctly identifies that swaps moved from long-term only to both current and long-term, which matches ground truth. However, the 2022 baseline numbers are wrong, undermining the entire comparison. The answer demonstrates partial understanding of the question's intent but fails on the fundamental requirement of numerical accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 481,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "\nFrom 2022 to 2023 NextEra Energy Resources moved from an active equity investment in the Mountain Valley Pipeline to a largely written‑off position with only modest, contingent financial ties. In 2022 the company recorded an ≈ $0.8 billion impairment charge that completely wrote down its equity‑method stake (≈ $0.6 billion carrying amount) and created a ≈ $0.2 billion liability for future ARO costs. By 2023 its exposure was limited to modest, contingent commitments—principally a 20‑year natural‑gas transportation agreement that obligates about $70 million per year and equity contributions of roughly $1 billion in 2024‑2026 (plus a $1.065 billion joint obligation with NEECH that tapers to $5 million by 2026)—while the pipeline’s future remains uncertain.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant issues that prevent it from being considered substantially correct:\n\n1. QUANTITATIVE ACCURACY PROBLEMS:\n   - The LLM introduces specific numbers NOT in the ground truth: $0.6 billion carrying amount, $0.2 billion ARO liability, $1 billion equity contributions in 2024-2026, and $1.065 billion joint obligation. These appear to be fabricated details not supported by the original answer.\n   - The ground truth does NOT mention any breakdown of the $0.8B impairment into components ($0.6B + $0.2B), nor does it mention future equity contributions or joint obligations with NEECH.\n   - The LLM correctly states the $0.8B impairment charge and $70M annual transportation agreement, but adds unsupported financial details.\n\n2. ENTITY/FACT ACCURACY:\n   - The LLM correctly identifies NextEra Energy Resources and the 2022-2023 timeframe.\n   - However, the ground truth explicitly states that by 2023, NEER \"maintained a 32.8% equity investment\" - the LLM completely omits this key fact about the ongoing equity stake.\n   - The ground truth indicates the investment was NOT fully eliminated in 2023 (despite the 2022 write-off), but the LLM's framing of \"largely written-off position with only modest, contingent financial ties\" obscures the continued 32.8% equity ownership.\n\n3. MULTI-HOP REASONING:\n   - The LLM fails to synthesize the key evolution: the 2022 impairment charge wrote down the investment, BUT by 2023 NEER still maintained a 32.8% equity stake alongside the transportation agreement.\n   - This represents a critical gap in understanding the actual financial commitment evolution.\n\n4. COMPLETENESS:\n   - Missing the 32.8% equity investment percentage that is central to understanding 2023 involvement.\n   - Adds speculative details about future obligations not in the ground truth.\n   - The ground truth's mention of the investment being \"subject to the completion of construction\" is not captured.\n\n5. SEMANTIC ISSUES:\n   - The characterization of exposure as \"limited to modest, contingent commitments\" contradicts the ground truth's statement that NEER \"maintained a 32.8% equity investment,\" which is a substantial, ongoing commitment.\n   - The framing suggests the company largely exited the investment, when in fact it retained significant equity ownership.\n\nThe answer demonstrates partial understanding of the 2022 impairment and 2023 transportation agreement but introduces unsupported financial details and critically omits the 32.8% equity stake that defines the actual 2023 position.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 685,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "\nBetween 2023 and 2024 the captive insurance company that backs the group‑annuity reinsurance saw its solvency‑capital portfolio expand markedly: equity securities rose from **$1.643 billion** (as of 31 Dec 2023) to **$1.883 billion** (as of 31 Dec 2024), and debt securities increased from **$1.378 billion** to **$1.643 billion** over the same period.  This growth reflects a larger investment base that the captive uses to fund the group‑annuity contracts, with both equity and debt components rising by roughly 14–19 % year‑over‑year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The ground truth states total equity and debt securities were $1,643 million in 2023 and $1,883 million in 2024. However, the LLM breaks this down into separate equity and debt components ($1.643B equity and $1.378B debt in 2023; $1.883B equity and $1.643B debt in 2024) that do NOT match the ground truth. The LLM's 2023 figures ($1.643B + $1.378B = $3.021B total) and 2024 figures ($1.883B + $1.643B = $3.526B total) are completely inconsistent with the ground truth totals of $1.643M and $1.883M respectively. (2) CALCULATION ERRORS: The LLM claims 14-19% year-over-year growth, but this is based on incorrect component breakdowns. The actual growth from $1,643M to $1,883M represents only 14.6% growth, not the range claimed. (3) FUNDAMENTAL MISINTERPRETATION: The LLM appears to have fabricated separate equity and debt security figures that are not supported by the ground truth. The ground truth provides a single combined figure for 'equity and debt securities,' not separate line items. (4) MULTI-HOP REASONING: While the LLM correctly identifies the captive insurance company and group annuity contracts, it fails in the core synthesis task by introducing unsupported data points. The answer demonstrates contextual understanding of the topic but fails on factual accuracy, which is the primary requirement for financial data evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 414,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Intel moved the Intel 4 node from design and early risk‑reduction into full‑scale high‑volume manufacturing, with the node entering production at its Ireland fab in 2024 and already powering the Core Ultra Series 1 AI PCs and other 13th/14th‑gen Core processors. This makes Intel 4 a cornerstone of Intel’s roadmap—providing the flagship client and AI‑focused silicon while Intel 3 and the forthcoming Intel 18A node are positioned as the next‑generation process technologies for data‑center and future client products.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Intel 4 from early-stage to high-volume manufacturing and correctly identifies Ireland as the production location and Core Ultra as a key product. However, there are significant factual issues: (1) The LLM claims Intel 4 'already powering the Core Ultra Series 1 AI PCs and other 13th/14th-gen Core processors' - this is problematic because 13th/14th-gen Core processors (Raptor Lake) used Intel 7, not Intel 4. Intel 4 is specifically for Core Ultra (Meteor Lake), not legacy generations. This is a material factual error. (2) The ground truth states Intel 4 became 'the process node for the high-volume Intel Core Ultra processor' (singular focus), while the LLM incorrectly expands this to multiple processor generations. (3) The LLM adds contextual information about Intel 3 and Intel 18A positioning that, while potentially accurate, goes beyond what the ground truth establishes and introduces unverified claims. (4) The LLM correctly identifies the 2022-to-2024 transition from ramp-up to high-volume manufacturing, matching the ground truth's core narrative. (5) The mention of 'design and early risk-reduction' in 2022 aligns with the ground truth's reference to 'early-stage production challenges and investment.' The multi-hop reasoning is partially sound - the answer does synthesize the evolution across years - but the processor generation attribution error is a significant factual mistake that undermines credibility. The answer is contextually relevant and addresses the question's structure, but the processor generation confusion prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 444,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "\nBetween 2022 and 2024 Emerson’s stake in AspenTech moved from a **55 % equity interest** (secured in 2022 when it contributed two of its own industrial‑software businesses and about $6 billion of cash, giving Emerson a majority but still minority position) to a **proposed 100 % acquisition** announced in November 2024, under which Emerson would buy the remaining shares for $240 per share (implying a $15.3 billion fully‑diluted market value).  The 2024 proposal, to be financed with cash on hand and committed credit lines, marks a shift from an equity‑method investment to full consolidation, integrating AspenTech’s revenues, costs and cash flows into Emerson’s financial statements and giving Emerson complete control over its governance and strategic direction.  This evolution also reflects deeper financial integration, as Emerson’s earlier 55 % holding already provided board representation and collaborative product‑go‑to‑market initiatives, while the 2024 buy‑out would eliminate the remaining minority interest and fully absorb AspenTech into Emerson’s consolidated results.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) OWNERSHIP STRUCTURE ERROR: The LLM states Emerson had a '55% equity interest secured in 2022' and moved to a 'proposed 100% acquisition' in November 2024. However, the ground truth clearly states that in 2022 AspenTech was merely a 'strategic partner with no mention of ownership stakes,' and by 2024 Emerson had already merged its industrial software business with AspenTech and retained a 55% ownership stake in the newly formed entity. The LLM has the timeline backwards and mischaracterizes the 2022 position. (2) FINANCIAL DETAILS: The LLM introduces specific numbers ($6 billion cash contribution, $240 per share, $15.3 billion valuation) that are not mentioned in the ground truth and appear to be fabricated or from a different context. These numbers cannot be verified against the provided ground truth. (3) MISSING KEY INFORMATION: The LLM fails to mention the critical 2023-2024 period where the merger actually occurred, creating 'New AspenTech' with Emerson retaining 55% ownership. Instead, it focuses on a November 2024 'proposed' 100% acquisition that is not part of the ground truth narrative. (4) FINANCIAL INTEGRATION: While the LLM mentions financial integration, it does not address the specific impacts mentioned in the ground truth: the 0.6 percentage point positive impact on gross margins in 2023 and the influence on SG&A expenses in 2024. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution from 2022 (partnership) → 2023-2024 (merger with 55% stake) → potential future (100% acquisition). The answer presents a fundamentally different narrative than the ground truth, suggesting either hallucination or reliance on different source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 488,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "\nFrom 2022 – when Intel 4 was still being qualified as the company’s first EUV‑based node – to 2024, Intel has taken the process from early development to full‑scale, high‑volume manufacturing in its Irish fabs.  The node now powers the Core Ultra Series 1 AI PCs and other products and delivers roughly 20 % higher performance‑per‑watt (and greater density) than the preceding Intel 7 node, making it a central pillar of Intel’s 2024‑2025 product roadmap.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. Quantitative accuracy is excellent: the 20% performance-per-watt improvement is correctly stated, and the timeline (2022 qualification to 2024 full-scale manufacturing) matches the ground truth. The answer correctly identifies Intel 4 as Intel's first EUV-based node and accurately describes the evolution from early development/qualification phase to high-volume manufacturing in Irish fabs. Entity accuracy is strong: Intel, Intel 4, Intel 7, Core Ultra (referenced as 'Core Ultra Series 1 AI PCs'), and the manufacturing locations are all correctly identified. The multi-hop reasoning is sound, synthesizing the progression across years and connecting the technical specifications (20% performance-per-watt improvement, greater density) to actual product deployment. Minor differences from ground truth: (1) The LLM mentions 'Core Ultra Series 1 AI PCs' while ground truth references 'Intel Core Ultra processor' - both are semantically equivalent and accurate; (2) The LLM adds context about 2024-2025 product roadmap positioning, which is relevant but not explicitly in the ground truth (this is a minor enhancement rather than an error); (3) The ground truth specifically mentions Core Ultra 'began shipping in 2023' while the LLM focuses on 2024 deployment - both are technically correct as the processor was introduced in 2023 and continued production through 2024. The answer comprehensively addresses the question's focus on manufacturing readiness evolution and performance improvements with accurate numbers and proper synthesis of multi-year information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 454,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "\nBetween 2022 and 2024 the InterStim Micro moved from being simply one of several InterStim neurostimulators for pelvic‑health indications to a deliberately highlighted, rechargeable “micro” option within Medtronic’s expanded InterStim platform.  In the 2022 filing it was listed alongside InterStim X and InterStim II as a rechargeable device for overactive‑bladder, urinary‑retention and fecal‑incontinence therapy, while the 2024 filing explicitly groups it with the new recharge‑free InterStim X/II systems and emphasizes its smaller form‑factor, MRI‑conditional capability, and role in providing a rechargeable solution for the same indications.  Thus, its positioning shifted to a premium, rechargeable micro‑therapy that complements—and is marketed in parallel with—a broader suite of both rechargeable and recharge‑free pelvic‑health devices.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual contradiction that undermines its credibility. The ground truth states that in 2022, InterStim Micro was listed as ONE OF SEVERAL neurostimulators (alongside InterStim X and InterStim II), with NO SPECIFICATION about whether it was rechargeable in 2022. However, the LLM claims that 'In the 2022 filing it was listed alongside InterStim X and InterStim II as a rechargeable device.' This is an unsupported assertion not present in the ground truth. The ground truth explicitly states that by 2024, InterStim Micro was 'specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II' - meaning the rechargeable positioning was a 2024 development, not a 2022 characteristic. The LLM's claim that InterStim Micro was already identified as rechargeable in 2022 contradicts the ground truth's narrative of evolution/change between these years. Additionally, the LLM introduces details not in the ground truth (MRI-conditional capability, smaller form-factor emphasis, 'premium' positioning) that cannot be verified against the source material. The core correct elements are: (1) InterStim Micro was one of several neurostimulators in 2022, (2) it treats overactive bladder, urinary retention, and fecal incontinence, (3) by 2024 it was positioned as the rechargeable option, and (4) InterStim X and InterStim II are recharge-free. However, the temporal misplacement of the rechargeable designation and the introduction of unverified details represent material factual errors in a multi-hop synthesis question where accuracy about the evolution timeline is essential.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 466,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "\nFrom 2022 through 2024 the footnote on diluted earnings‑per‑share (and per unit) consistently identifies LTIP units as potentially dilutive but explicitly states that, for each of the reported periods (2021‑2022 in the 2022 filing and 2022‑2024 in the 2024 filing), no such securities produced a material dilutive effect, so the EPS/unit calculations are not adjusted for them. The wording simply updates the reference years while reaffirming that LTIP‑unit dilution is considered immaterial across the successive reporting periods.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that LTIP units are treated as potentially dilutive securities with no material dilutive effect across reporting periods, and accurately notes the year references (2021-2022 in 2022 filing, 2022-2024 in 2024 filing). However, there are significant gaps in addressing the core evolution described in the ground truth: (1) The LLM fails to capture the key change in disclosure approach - that 2022 explicitly referenced the exchangeability of LTIP units into common stock while 2024 did not. This is a material difference in disclosure detail that the question specifically asks about. (2) The LLM characterizes the evolution as merely 'updating reference years while reaffirming' immateriality, missing the reduction in detail about conversion features that the ground truth emphasizes. (3) The LLM does not clearly articulate that there was a simplification or reduction in disclosure detail from 2022 to 2024, which is the core finding of the ground truth. (4) While the LLM correctly states no material dilutive effect was found in both periods, it doesn't adequately explain how the disclosure itself evolved in terms of what information was provided about the LTIP units' characteristics. The answer is partially correct on the immateriality conclusion but incomplete on the disclosure evolution aspect, which is the primary focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 385,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "\nFrom the 2022 filing (pages 48‑52) MetLife had a $3 billion common‑stock repurchase authorization with roughly $1.5 billion still available at the end of 2021, and it repeatedly warned that legal‑regulatory limits and the need to preserve a cash buffer for claims and capital‑ratio requirements could curb future buy‑backs. The 2024 filing (pages 31‑35) shows that the remaining authorization had been reduced to about $0.8 billion and that any further repurchases are now explicitly conditioned on maintaining a strong liquidity buffer to meet claim‑paying, rating‑agency and regulatory capital needs, signalling a more conservative approach to stock repurchases.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of MetLife's evolving approach to stock repurchases and liquidity management from 2022 to 2024. STRENGTHS: (1) Correctly identifies the $3 billion authorization and ~$1.5 billion remaining in 2022 (matching ground truth); (2) Accurately captures the shift from more active repurchase posture to conservative liquidity strategy; (3) Properly synthesizes multi-hop information across 2022 and 2024 filings; (4) Correctly identifies key regulatory and capital ratio constraints; (5) Appropriately emphasizes the conditioning of future repurchases on liquidity buffer maintenance. QUANTITATIVE ACCURACY: The 2022 figures ($3B authorization, $1.5B remaining) are correct. The 2024 figure of ~$0.8 billion remaining authorization is presented with appropriate hedging language ('about $0.8 billion'), which is reasonable given the ground truth doesn't explicitly state this 2024 figure. The progression from $1.5B to $0.8B shows logical capital deployment. MINOR CONSIDERATIONS: (1) The ground truth doesn't explicitly mention the $0.8 billion 2024 figure, though the LLM's inference that authorization was reduced is reasonable given the context of increased conservatism and ongoing repurchases; (2) The LLM provides slightly more specific detail about page numbers and filing locations than the ground truth, which adds credibility but isn't verified; (3) The answer could have been slightly more explicit about the timeline of authorization reduction, though the overall narrative is clear. MULTI-HOP REASONING: Excellent synthesis connecting 2022 authorization status → 2024 reduced authorization → shift in capital allocation philosophy. The reasoning correctly identifies causality (regulatory/market factors driving the shift) and properly contextualizes both time periods. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while adding helpful specificity about the 2024 remaining authorization amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 539,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the foreign‑currency‑other derivative **asset** fell dramatically—from about **$74 million** ( $39.9 m recorded in “Prepaid expenses and other current assets” plus $33.5 m in “Other long‑term assets”) to roughly **$3.6 million** ( $1.9 m in current assets and $1.7 m in long‑term assets).  The corresponding **liability** balance also shrank, from roughly **$13 million** to about **$11 million**, with the current‑liability portion dropping from $7.5 m to $2.5 m and the long‑term‑liability portion from $5.4 m to $4.1 m.  The **balance‑sheet classifications did not change**—assets remained in “Prepaid expenses and other current assets” and “Other long‑term assets,” and liabilities in “Accrued liabilities” and “Other long‑term liabilities”—but the dollar amounts in each bucket shifted sharply, reflecting a much smaller current‑asset position and a modest re‑allocation between current and long‑term components.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that fundamentally undermine its credibility. (1) ASSET NUMBERS - The LLM reports FY2022 assets as ~$74M ($39.9M current + $33.5M long-term), but the ground truth shows FY2022 had $103.9M in OCI-recognized derivative assets before reclassifications. The LLM's FY2023 figure of $3.6M ($1.9M + $1.7M) matches the ground truth exactly, but the prior-year comparison is wrong. (2) LIABILITY NUMBERS - The LLM reports FY2022 liabilities as ~$13M and FY2023 as ~$11M, but provides no ground truth comparison point from the original answer. The FY2023 liability breakdown ($4.7M current + $4.1M long-term = $8.8M, not $11M) also doesn't match the LLM's stated total. (3) MISSING CONTEXT - The LLM completely omits the OCI recognition ($103.9M) and AOCI reclassification ($22.0M) information from FY2022, which are critical components of understanding the derivative position evolution. (4) BALANCE SHEET CLASSIFICATION - The LLM correctly identifies that classifications remained consistent (current assets, long-term assets, current liabilities, long-term liabilities), which aligns with the ground truth. However, the statement 'balance-sheet classifications did not change' is somewhat misleading given the significant dollar amount shifts. (5) MULTI-HOP SYNTHESIS - The LLM failed to synthesize the complete picture of derivative positions, focusing only on balance sheet line items while ignoring the OCI/AOCI components that are essential to understanding the full evolution. The answer demonstrates partial understanding of balance sheet mechanics but fails on quantitative accuracy for the prior year and omits critical derivative accounting information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 473,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 P&G expanded its restructuring program – annual pre‑tax charges rose from the historic $250‑$500 million range to $659 million in FY 24, including a $216 million non‑cash foreign‑currency translation loss from the liquidation of certain enterprise markets – and funded these initiatives with the company’s strong operating cash flow (up 18 % to $19.8 billion in FY 24) and continued access to capital markets.  As a result, cash generation remained robust enough to sustain dividend growth, share‑repurchase activity and debt refinancing, but corporate‑level earnings deteriorated, falling from a $485 million profit in FY 22 to a $1.43 billion loss in FY 24 driven by the impairment charge and incremental restructuring costs.  Consequently, the global cash‑management strategy shifted from simply supporting growth to deliberately channeling cash to finance an intensified productivity‑and‑cost‑savings agenda while preserving liquidity through high‑quality cash flow and stable credit ratings.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of P&G's cash management evolution and correctly identifies the major trends and key figures. STRENGTHS: (1) Correctly identifies restructuring cost increase from $250-500M range to $659M in FY24; (2) Accurately cites the $216M non-cash foreign currency translation loss; (3) Correctly states operating cash flow increased 18% to $19.8B in FY24; (4) Properly identifies the $1.4B Gillette impairment charge as a driver of earnings deterioration; (5) Accurately characterizes the strategic shift toward productivity/cost-savings agenda; (6) Correctly notes dividend growth and share repurchase continuation despite earnings pressure; (7) Multi-hop synthesis is sound, connecting restructuring activities to cash flow to earnings to strategy evolution. WEAKNESSES/DISCREPANCIES: (1) States corporate earnings fell to a '$1.43 billion loss' in FY24 - the ground truth indicates a '$1.0 billion decrease' in corporate net earnings, not a specific loss figure of $1.43B. The ground truth mentions the $1.4B impairment charge separately, which may have caused confusion in the LLM's interpretation; (2) Does not explicitly mention the $147M restructuring accruals as of June 30, 2022, though this is a minor detail; (3) Does not mention the $872M improvement in corporate net earnings in FY22 that was partly due to tax benefits, though this is contextual detail rather than core to the evolution narrative. The core narrative about the shift in strategy and the major financial drivers is accurate and well-synthesized. The quantitative discrepancy regarding the FY24 corporate earnings figure is the primary concern, though the underlying drivers (impairment + restructuring) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 475,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "\nBetween 2022 and 2023 NVIDIA moved Omniverse from a primarily collaborative 3‑D design tool for creators and early‑stage enterprise pilots to a core enterprise‑grade simulation and digital‑twin platform.  The company began offering it as a paid subscription for large‑scale deployments while keeping a free tier, and it embedded Omniverse in its automotive stack (e.g., DRIVE Sim for self‑driving validation and Omniverse Avatar for real‑time conversational AI) and in industrial workflows that build digital twins of factories, products and autonomous robots, all powered by NVIDIA’s AI‑accelerated computing and the broader AI Enterprise software ecosystem.  This deepened integration positioned Omniverse as the backbone for enterprise‑level, AI‑driven virtual‑world testing, validation and real‑time collaboration across multiple industries.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively captures the evolution of NVIDIA Omniverse between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from collaborative 3D design tool to enterprise-grade simulation/digital-twin platform; (2) Accurately mentions the subscription model evolution (paid for large-scale, free tier maintained); (3) Properly synthesizes integration with DRIVE Sim for automotive validation; (4) Correctly identifies industrial applications including digital twins of factories and real-time 3D product configurators; (5) Accurately links Omniverse to NVIDIA's AI-accelerated computing infrastructure; (6) No quantitative errors or incorrect dates/numbers. MINOR GAPS: (1) The LLM introduces 'Omniverse Avatar for real-time conversational AI' which, while potentially accurate, is not explicitly mentioned in the ground truth answer - this represents a minor addition beyond the provided knowledge graph; (2) The phrase 'core enterprise-grade simulation and digital-twin platform' is slightly more emphatic than the ground truth's 'more robust development platform and operating system,' though semantically equivalent; (3) The ground truth mentions specific use cases (virtual car showrooms, surgical training, architectural walkthroughs) that the LLM answer omits, though this is a minor completeness issue rather than an error. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2023 timeframe and correctly connects Omniverse's evolution to multiple enterprise domains (automotive, industrial, AI workflows). The reasoning is sound and logically structured. The answer appropriately emphasizes the progression from individual/early-stage use to enterprise-scale deployment. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1462,
        "completion_tokens": 495,
        "total_tokens": 1957
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 AMT trimmed its planned outlay for new communications‑site and data‑center infrastructure – 2023 capital spending was about **$1.8 billion**, while the company now projects **$1.545 billion–$1.655 billion** of total 2024 capital expenditures, with discretionary projects earmarked at **$790 million–$820 million** and ground‑lease purchases of only **$70 million–$90 million**.  At the same time, AMT’s future cash obligations have shifted toward larger debt‑service and lease commitments: it must meet **$3.69 billion of debt maturities in 2025** (rising to **$5.5 billion in 2027** and **$6.0 billion in 2028**) and **≈$1 billion of annual operating‑lease payments**, plus ongoing commitments for ground‑lease easements and potential acquisitions.  Thus, while 2024 spending on new sites is modestly lower than 2023, the company’s long‑term financial obligations for site‑related debt and lease payments remain substantial and are set to increase in the coming years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and fails to address the core question. CRITICAL ERRORS: (1) The ground truth states AMT anticipated ~$450 million in 2023 for data center assets related to 2,500-3,500 communications sites, but the LLM claims 2023 capital spending was $1.8 billion - this is a completely different figure and not supported by the ground truth. (2) The ground truth's key finding is the shift from $450M near-term spending in 2023 to $4.5 billion in undiscounted future cash outlay for asset retirement obligations in 2024. The LLM mentions $4.5 billion nowhere and instead focuses on 2024 capex projections ($1.545-1.655 billion) that are not mentioned in the ground truth. (3) The LLM discusses debt maturities ($3.69B in 2025, $5.5B in 2027, $6.0B in 2028) and operating lease payments (~$1B annually) which are entirely absent from the ground truth answer. (4) The LLM's conclusion about 'modestly lower' 2024 spending contradicts the ground truth's narrative of a 'significant increase in long-term financial exposure.' MULTI-HOP REASONING: The LLM failed to synthesize the correct information about the evolution from 2023 to 2024. The ground truth specifically highlights the shift from near-term capital allocation ($450M) to long-term obligations ($4.5B), but the LLM discusses different metrics entirely (total capex, debt maturities, lease payments). SEMANTIC MISMATCH: While the LLM discusses financial commitments and obligations, it addresses entirely different categories of commitments than those in the ground truth. The question asks about 'anticipated spending and future obligations' related to communications sites, and the ground truth answers this with specific figures ($450M → $4.5B), but the LLM provides unrelated financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 484,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "\nIn the 2023 10‑K the discussion of asset‑sale proceeds was largely procedural – it simply noted that “proceeds associated with sales of subsidiaries, property, plant and equipment” are included in cash‑flow from operations and that a regular review ensures assets “contribute to the Corporation’s strategic objectives,” without tying the cash to any specific strategic use. By contrast, the 2024 10‑K frames those proceeds as the outcome of a “disciplined portfolio‑optimization process” that divests assets no longer meeting its strategic objectives or that are “worth considerably more to others,” explicitly describing the cash as a key source to fund strategic growth priorities and to support shareholder distributions. Thus, the language shifted from a neutral, mechanical reference to a purposeful, strategy‑aligned characterization of divestiture proceeds.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) FACTUAL INACCURACY ON 2023 LANGUAGE: The ground truth states that in 2023, ExxonMobil described proceeds as 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments.' The LLM incorrectly quotes this as only 'proceeds associated with sales of subsidiaries, property, plant and equipment' - omitting the critical phrase 'and sales and returns of investments.' This is a material omission that changes the characterization. (2) MISCHARACTERIZATION OF 2024 LANGUAGE: The ground truth indicates that in 2024, the company used 'proceeds from asset sales and returns of investments' - a more consolidated/streamlined version. However, the LLM claims the 2024 language includes phrases like 'disciplined portfolio-optimization process' and references to assets being 'worth considerably more to others' and funding 'strategic growth priorities and shareholder distributions.' These specific phrases do not appear in the ground truth and represent fabrication or confusion with other company disclosures. (3) INVERTED CHARACTERIZATION: The ground truth describes the evolution as moving FROM detailed language (subsidiaries, property, plant and equipment) TO more consolidated language (asset sales and returns of investments). The LLM reverses this, claiming the 2023 language was 'neutral, mechanical' and 2024 became more 'purposeful, strategy-aligned.' This is backwards from what the ground truth indicates. (4) MISSING KEY DETAIL: The ground truth emphasizes that both years maintained 'strategic alignment rationale' - the shift was in consolidation of terminology, not in the strategic framing. The LLM incorrectly suggests the strategic framing was absent in 2023. (5) UNSUPPORTED CLAIMS: The LLM introduces specific strategic language ('disciplined portfolio-optimization,' 'worth considerably more to others') that are not mentioned in the ground truth, suggesting either hallucination or reliance on incorrect source material. The answer demonstrates poor multi-hop synthesis and contains multiple factual errors that fundamentally misrepresent the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 602,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "\nFrom 2022 to 2023 the consolidated exposure to Universal Beijing Resort fell sharply: the resort’s assets on Comcast’s balance sheet dropped from about **$9.7 billion** (reported for 2021) to **$7.8 billion** by the end of 2023, while its liabilities fell from roughly **$8.1 billion** to **$7.2 billion**.  This reduction in both assets and liabilities reflects a lower financial exposure to the joint venture over the two‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a significant factual error that undermines its accuracy. The ground truth clearly states the comparison is from 2022 to 2023, with 2022 baseline figures of $9.7 billion in assets and $8.1 billion in liabilities. However, the LLM answer incorrectly references 2021 figures ('reported for 2021') when stating the $9.7 billion asset figure, creating confusion about the time period being analyzed. The LLM then correctly identifies the 2023 endpoint figures ($7.8 billion assets, $7.2 billion liabilities), but the mislabeling of the starting year is a material error in a multi-hop temporal analysis. The asset decrease calculation ($9.7B to $7.8B = $1.9B or ~19.6% decline) and liability decrease ($8.1B to $7.2B = $0.9B or ~11.1% decline) are mathematically correct, and the qualitative interpretation about reduced financial exposure is sound and semantically equivalent to the ground truth. The answer appropriately addresses the question's core requirement to show how exposure evolved, and the reasoning about asset depreciation/debt repayment is logical. However, the year labeling error is a critical flaw in a question specifically asking about 2022-to-2023 changes, as it creates ambiguity about whether the analysis covers the correct time period. The answer would have scored 8-9 if the temporal references were accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 378,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "\nBetween 2023 and 2024 the risk of customer‑demand volatility shifted from being framed mainly as a cyclical, commodity‑price‑driven swing that could curb orders and force inventory write‑downs, to a broader macro‑economic uncertainty amplified by inflation, higher interest rates and pandemic‑related supply‑chain disruptions.  This evolution means that demand fluctuations now directly pressure Caterpillar’s revenue and cash flow while also tightening the supply‑chain window for meeting orders, forcing the company to adopt more flexible production and inventory controls to protect financial performance.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains significant factual errors and misrepresentations of the ground truth. (1) DIRECTIONAL ERROR - The LLM claims the 2023-2024 evolution shifted FROM 'commodity-price-driven' TO 'macro-economic uncertainty amplified by inflation, higher interest rates and pandemic-related supply-chain disruptions.' This is backwards. The ground truth states 2023 focused on pandemic effects/inflation/supply chain disruptions, while 2024 ADDED broader commodity price changes and material price increases. The LLM inverted the temporal sequence. (2) MISSING KEY ELEMENTS - The ground truth explicitly identifies that 2024 introduced 'broader commodity price changes' and 'material price increases' as NEW contributors. The LLM fails to capture this evolution toward supply-side challenges. (3) INCORRECT EMPHASIS - The LLM emphasizes 'higher interest rates' which is not mentioned in the ground truth at all. This is an unsupported addition. (4) INCOMPLETE SYNTHESIS - The ground truth clearly states the evolution shows 'a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.' The LLM's answer focuses on operational responses (flexible production/inventory controls) rather than the actual evolution of how the risk was characterized. (5) SEMANTIC MISALIGNMENT - While the LLM discusses supply chain pressures, it fundamentally mischaracterizes the nature of the evolution. The ground truth shows a shift in WHAT DRIVES the volatility (from pandemic-specific to broader systemic factors), not a shift in the TYPE of volatility itself. QUANTITATIVE: No specific numbers were required, so this scores well. QUALITATIVE: The reasoning is flawed due to the directional error and missing key risk factors. CONTEXTUAL: The answer addresses the question's structure but with incorrect content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 505,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "\nBetween 2022 and 2024 the reported fair‑value of net derivative assets (liabilities) grew from roughly **$5 million (2022)** to **$58 million (2023)** and **$69 million (2024)**, as shown in the Level‑3 roll‑forward tables.  This increase reflects larger notional positions and a greater share of the derivatives being classified as Level 3, but the underlying valuation methodology has not changed – Capital One continues to value these instruments with vendor‑based discounted‑cash‑flow models that use market‑observable inputs such as swap rates, yield curves, credit spreads and prepayment assumptions, supplemented only by unobservable assumptions when observable data are unavailable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) WRONG STARTING VALUE: LLM states 2022 value was 'roughly $5 million' but ground truth clearly shows $19 million as of December 31, 2021 (the 2022 baseline). This is a 73% understatement of the starting value. (2) WRONG ENDING VALUES: LLM claims 2024 value was $69 million, but ground truth only provides data through 2023 showing $58 million. The LLM appears to have fabricated a 2024 figure ($69M) that is not in the ground truth. (3) METHODOLOGY CLAIM ERROR: LLM states 'the underlying valuation methodology has not changed' and describes vendor-based DCF models with market-observable inputs. However, the ground truth explicitly states there WAS a 'methodological shift from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%).' This is a direct contradiction - the LLM missed the key methodological evolution that was central to the question. (4) MISSING KEY DETAILS: LLM fails to mention the specific derivative activity components (issuances $68M, settlements -$37M, transfers $6M) that explain the value changes. (5) MULTI-HOP SYNTHESIS FAILURE: The question asks how fair value AND methodology evolved - the LLM addressed only partial methodology details while getting the quantitative trajectory fundamentally wrong. The core answer is factually incorrect on both the numbers and the key methodological shift that occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 442,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "\nFrom 2022 to 2023 NVIDIA reframed GeForce NOW from a stand‑alone game‑streaming service into a flagship showcase of its broader GPU‑accelerated cloud platform.  The service now streams RTX‑enabled, AI‑enhanced titles using the same data‑center GPUs, CUDA‑based software stack, and Omniverse‑derived technologies that power the company’s AI, professional‑visualization and automotive offerings, positioning cloud gaming as the consumer‑facing edge of NVIDIA’s full‑stack accelerated‑computing ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the 2022-2023 timeframe and the evolution of GeForce NOW's positioning; (2) Accurately captures the shift from standalone service to integrated platform narrative; (3) Correctly mentions the connection to NVIDIA's broader GPU-accelerated computing ecosystem; (4) No quantitative errors (no specific numbers were claimed that could be wrong). WEAKNESSES: (1) The LLM introduces specific technical claims (RTX-enabled, AI-enhanced titles, CUDA-based software stack, Omniverse-derived technologies, data-center GPUs) that are NOT present in the ground truth answer and cannot be verified from the provided knowledge graph. These appear to be plausible inferences but represent factual additions beyond what was documented; (2) The ground truth specifically mentions vGPU for enterprise use and DGX Cloud as comparative platforms in 2023, which the LLM answer omits; (3) The ground truth emphasizes 'gaming as a service' positioning in 2023, while the LLM frames it as 'consumer-facing edge' - semantically similar but with different emphasis; (4) The LLM's characterization of GeForce NOW as a 'flagship showcase' is more assertive than the ground truth's more measured 'more specifically integrated' language. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years and connects it to the broader ecosystem, but adds unsupported technical details. The core insight about ecosystem integration is sound, but the execution introduces claims beyond the knowledge graph. SEMANTIC EQUIVALENCE: While the general narrative aligns, the LLM adds specificity that goes beyond the ground truth, which is problematic for factual accuracy even if the additions seem plausible.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 493,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "\nInlyta’s worldwide revenue rose modestly from about **$1.00 billion in 2022 to $1.04 billion in 2023** (≈3–5 % growth). The increase was driven primarily by stronger uptake of Inlyta in combination with immune‑checkpoint inhibitors for first‑line treatment of advanced renal‑cell carcinoma in the United States and continued expansion in emerging markets, although this was partially offset by lower volumes and price reductions in certain European markets.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with minor quantitative imprecision. STRENGTHS: (1) Revenue figures are approximately correct ($1.00B vs $1.003B in 2022, $1.04B vs $1.036B in 2023) with acceptable rounding for narrative context. (2) Growth percentage stated as '3-5%' is reasonable given the $33M increase ($33M/$1,003M = 3.3%), though the ground truth specifies exactly 3%. (3) All key qualitative factors are correctly identified: Inlyta combination therapy with immune checkpoint inhibitors for first-line RCC treatment in the U.S., emerging market growth, and European market headwinds (lower volumes and prices). (4) Multi-hop synthesis is sound - correctly connects revenue performance to underlying drivers across geographies. (5) Entity identification is accurate (Inlyta, RCC, U.S., European markets, emerging markets). (6) Semantic equivalence is strong - 'stronger uptake' = 'continued adoption', 'price reductions' = 'lower net prices', 'expansion' = 'growth'. MINOR WEAKNESSES: (1) The growth range of '3-5%' is slightly imprecise; ground truth specifies exactly 3% growth. The LLM's range may reflect rounding uncertainty but introduces minor ambiguity. (2) Uses 'worldwide' instead of 'global' (semantic equivalence, not an error). (3) Slightly informal phrasing ('rose modestly', 'about') compared to ground truth's more precise language, though this doesn't affect factual accuracy. CALCULATION VERIFICATION: $1.036B - $1.003B = $33M increase; $33M/$1.003B = 3.29% ≈ 3%, confirming ground truth's 3% figure. The LLM's 3-5% range is conservative but slightly overstates the upper bound. Overall, the answer demonstrates strong understanding of the multi-hop question and provides accurate information with only minor quantitative imprecision in the growth percentage range.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 488,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "\nFrom 2023 to 2024 the Company lengthened the amortization horizon for its network‑location intangibles—now tying them to the 30‑year useful life of towers and applying straight‑line amortization over that period, which reduced annual amortization expense (the weighted‑average amortization period is still reported around 15 years but is effectively extended). At the same time, the impairment review was sharpened to test each tower‑level intangible for recoverability using projected undiscounted cash flows and market‑based fair‑value comparisons, although the only intangible‑related impairments recorded in 2023 were the $322 M (India) and $80 M (Spain) goodwill charges, with no new network‑location intangible impairments reported in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - The LLM claims the company \"lengthened the amortization horizon\" to 30 years in 2024, but the ground truth states the weighted average amortization period remained 15 years as of December 31, 2023, with no evidence of a change to 30 years in 2024.\n   - The LLM contradicts itself by saying \"the weighted-average amortization period is still reported around 15 years but is effectively extended\"—this is internally inconsistent and unsupported.\n   - The LLM introduces $322M (India) and $80M (Spain) goodwill charges as \"intangible-related impairments,\" but these are goodwill impairments, not network location intangible impairments, conflating two different asset categories.\n\n2. MISSING KEY INFORMATION:\n   - The LLM fails to mention the $470 million increase in asset retirement obligations due to revised settlement dates, which the ground truth identifies as indirectly impacting valuation and useful life assumptions.\n   - The LLM does not adequately address the expanded disclosure in 2024 regarding impairment review processes on an individual tower basis.\n   - The LLM misses the specific impairment triggers mentioned in ground truth: lack of tenant leases or expenses exceeding revenues.\n\n3. QUANTITATIVE ACCURACY ISSUES:\n   - The $322M and $80M figures are introduced without proper context and appear to be misapplied to network location intangibles.\n   - No verification that these numbers relate to the specific question about network location intangibles evolution.\n\n4. REASONING QUALITY:\n   - The multi-hop synthesis is weak; the LLM conflates goodwill impairments with network location intangible impairments.\n   - The claim about \"30-year useful life of towers\" being applied to intangibles is not supported by the ground truth.\n   - The relationship between asset retirement obligations and intangible valuation is completely omitted.\n\n5. WHAT WAS CORRECT:\n   - The general acknowledgment that impairment review was enhanced/sharpened in 2024.\n   - The mention of straight-line amortization (though the period claim is incorrect).\n   - The acknowledgment that no new network-location intangible impairments were reported in 2024 (though the goodwill charges are irrelevant to this question).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 630,
        "total_tokens": 2060
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil shifted from confirming the size of the Stabroek Block to actively developing it—four new discoveries were made in 2023 and the Prosperity FPSO reached name‑plate capacity in January 2024. The company now plans to have six FPSO vessels on the block by the end of 2027 and is seeking regulatory approval for a sixth project (Whiptail), positioning Guyana as a core component of its upstream growth portfolio and a key driver of rising oil‑equivalent production.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several correct elements but has significant gaps and one notable inaccuracy when compared to the ground truth:\n\nCORRECT ELEMENTS:\n- Four discoveries on Stabroek Block in 2023: Correct\n- Prosperity FPSO startup/reaching capacity in early 2024: Correct (ground truth says \"startup\" in 2023, LLM says \"reached name-plate capacity in January 2024\" - both are accurate descriptions of different milestones)\n- Six FPSO vessels planned by end of 2027: Correct\n- Whiptail project mentioned: Correct\n- Guyana positioned as core component of upstream growth: Correct\n\nSIGNIFICANT OMISSIONS:\n- The LLM answer completely fails to mention the critical 2024 development: Guyana's formal categorization under 'Advantaged Assets' within updated earnings drivers. This is a major strategic shift that directly answers the question about how emphasis evolved.\n- Missing the specific production figure of \"nearly 440 kbd in Q4 2023\" which quantifies the production capacity milestone\n- Does not explicitly address the transition from \"discovery and early production phase\" to \"mature, financially impactful asset\" that characterizes the 2023-2024 evolution\n\nINACCURACY:\n- The LLM states the company \"shifted from confirming the size of the Stabroek Block to actively developing it\" - this framing is somewhat misleading. The ground truth doesn't indicate a shift from \"confirming size\" to \"developing\"; rather, it shows a shift from early production/discovery phase to mature asset status.\n\nMULTI-HOP REASONING:\nThe LLM answer addresses the evolution between years but misses the most important strategic evolution: the formal reclassification of Guyana as an 'Advantaged Asset' alongside Permian and LNG. This represents the core answer to how strategic emphasis evolved. The answer focuses more on operational/project development details rather than the strategic positioning shift.\n\nThe answer is partially correct on operational details but fails to capture the fundamental strategic evolution that the ground truth emphasizes - the elevation of Guyana's status in the company's earnings drivers and strategic portfolio.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 580,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "\nBetween 2022 and 2023 Comcast moved the X1 platform from the Flex streaming device—limited to Peacock‑premium and a few third‑party apps on a commission basis—to the Xumo Stream Box (formerly Flex) and the launch of the box‑free NOW service, which directly integrates a wider range of DTC services (e.g., Peacock, Disney+, Netflix) and free streaming channels into the X1 user experience.  This deeper integration lets Comcast keep subscribers inside its own ecosystem, slowing cord‑cutting and generating additional revenue streams (commissions and upsold streaming tiers) that boost average revenue per user.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about X1 platform evolution and strategic implications, but contains significant factual discrepancies with the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies the strategic pivot toward bundling and ecosystem retention, (2) Correctly mentions commission revenue generation and ARPU increase as strategic goals, (3) Appropriately references Disney+, Netflix, and Peacock as integrated services, (4) Correctly identifies cord-cutting reduction as a strategic objective. SIGNIFICANT ERRORS: (1) The LLM introduces 'Xumo Stream Box' and 'box-free NOW service' which are not mentioned in the ground truth answer - these appear to be fabricated or confused details not supported by the provided knowledge graph, (2) The LLM incorrectly frames the evolution as moving FROM Flex TO Xumo Stream Box, whereas the ground truth indicates X1 platform evolution (not Flex-specific), (3) The LLM mentions 'Flex streaming device' as the 2022 baseline, but ground truth specifies X1 platform with Disney+, Netflix, and Peacock premium access, (4) The ground truth specifically mentions Xumo Play, NBC, and Sky as part of NOW TV service in 2023, but the LLM conflates this into a 'box-free NOW service' without proper context. MULTI-HOP REASONING: The LLM correctly synthesizes the strategic implications (ecosystem lock-in, commission revenue, ARPU growth, cord-cutting reduction), but the factual foundation is compromised by introduced details not in the ground truth. The reasoning about how deeper integration supports business objectives is sound, but built on partially incorrect premises. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral, though the LLM's introduction of unverified product names (Xumo Stream Box, box-free NOW) represents factual inaccuracy. The answer demonstrates understanding of the strategic direction but fails on precise entity identification and service naming conventions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 540,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "\nBetween 2023 and 2024 Caterpillar trimmed the FG Wilson distributor base from **110 to 108** dealers, yet expanded the geographic reach of that network from **109 to 158 countries**.  This reflects a shift toward a more concentrated dealer lineup that still broadens market coverage for FG Wilson‑branded electric‑power‑generation systems.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - distributor count decreased from 110 to 108 (verified), geographic coverage expanded from 109 to 158 countries (verified). The numbers match the ground truth exactly with no calculation errors. ENTITY ACCURACY: Correctly identifies Caterpillar, FG Wilson, and the relationship between them. Properly specifies the context as electric power generation systems. Years 2023 and 2024 are correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two time periods, comparing distributor counts and geographic reach, and correctly identifies the strategic implication (optimization of distributor efficiency while broadening market access). SEMANTIC EQUIVALENCE: The LLM's phrasing 'trimmed the FG Wilson distributor base from 110 to 108 dealers' and 'expanded the geographic reach from 109 to 158 countries' conveys the same meaning as the ground truth. The interpretation of this as 'a shift toward a more concentrated dealer lineup that still broadens market coverage' aligns with the ground truth's characterization of 'a strategic shift toward optimizing distributor efficiency while broadening market access.' MINOR CONSIDERATIONS: The LLM uses 'dealers' as a synonym for 'distributors' which is semantically appropriate in this context. The answer is slightly more concise than the ground truth but captures all essential information. No factual errors, omissions of key data, or calculation mistakes detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 433,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "\nBased on the 2022 10‑K (pages 177‑181) Capital One reported a carrying amount of securitized debt obligations of roughly **$15 billion** (with a fair‑value estimate of about **$15.2 billion**). In the 2024 10‑K (pages 218‑222) that carrying amount had fallen to **$14.264 billion**, and the fair‑value estimate to **$14.335 billion**. Thus, between 2022 and 2024 the exposure to securitized debt obligations declined modestly on both the recorded carrying value and the estimated fair value.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures and reaches the opposite conclusion from the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2022 carrying value as ~$15 billion and 2024 as $14.264 billion, claiming a DECLINE. However, the ground truth shows 2024 carrying value was $18,043 million ($18.043 billion), not $14.264 billion - a difference of approximately $3.8 billion or 27%. The LLM's 2024 figure is significantly understated. The 2022 figure of ~$15 billion appears closer to actual but still imprecise. (2) DIRECTIONAL ERROR: The LLM concludes exposure 'declined modestly' between 2022 and 2024, but the ground truth indicates an INCREASE from approximately $15 billion in 2022 to $18.043 billion in 2024 - an increase of roughly $3 billion or 20%. This is a fundamental reversal of the correct trend. (3) FAIR VALUE ERRORS: The LLM reports 2024 fair value as $14.335 billion, but ground truth shows $18,067 million ($18.067 billion). Again, this is significantly understated by approximately $3.7 billion. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the 2022 and 2024 data from the respective 10-K filings. The page references cited (177-181 for 2022, 218-222 for 2024) may be incorrect or the LLM misread the data. (5) CONTEXTUAL ISSUE: While the LLM correctly identifies Capital One and securitized debt obligations, and attempts to address the carrying value and fair value components of the question, the numerical foundation is so flawed that the entire answer is unreliable. The ground truth indicates 'stable valuation and continued involvement' with an increase, while the LLM incorrectly suggests a decline. This represents a complete failure in quantitative accuracy and a reversal of the correct conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 491,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s refreshed its short‑term financing structure: the $15 bn borrowing authority that had been approved in 2022 was terminated and replaced with a new $15 bn multi‑year credit facility effective 2025, while the existing $4 bn committed line‑of‑credit was retained and continues to be the primary source for meeting day‑to‑day cash‑flow needs.  This line of credit, together with the commercial‑paper program, helped the company cover the rise in cash used for financing activities—$7.5 bn in 2024 versus $4.4 bn in 2023—as bond issuances declined, ensuring that financing outflows could still be funded without disrupting operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key financial metrics from the ground truth: (1) Cash used for financing activities of $4.4 billion in 2023 and $7.5 billion in 2024, (2) The $3.1 billion increase between years, (3) The decline in bond issuances as a driver, (4) The role of line of credit agreements and commercial paper in meeting funding needs. The numeric values are accurate and properly formatted.\n\nWEAKNESSES: (1) The LLM introduces specific information about a '$15 bn borrowing authority approved in 2022' being 'terminated and replaced with a new $15 bn multi-year credit facility effective 2025' and a '$4 bn committed line-of-credit' - these specific figures and details are NOT present in the ground truth and cannot be verified. This represents potential hallucination or introduction of unverified information. (2) The LLM fails to mention the cash and equivalents balances ($4.6 billion in 2023 and $1.1 billion in 2024), which are critical metrics in the ground truth showing the shift from surplus liquidity to cash-constrained environment. (3) The LLM does not address the broader context of how the company's liquidity position deteriorated year-over-year, which is a key aspect of the original answer's narrative about the evolution of financing strategy. (4) The explanation lacks the ground truth's emphasis on the timing of debt issuances and how 2023's higher cash balance funded 2024's outflows.\n\nMULTI-HOP REASONING: The LLM demonstrates partial multi-hop synthesis by connecting financing activities changes to credit facility usage, but it introduces unverified structural details about credit facility changes that go beyond what the ground truth supports. The core logic linking increased financing cash outflows to reliance on credit facilities is sound, but the specific credit facility details appear to be fabricated.\n\nQUANTITATIVE VERIFICATION: All cited numbers ($4.4B, $7.5B, $3.1B increase) are correct. However, the introduction of '$15 bn' and '$4 bn' figures without ground truth support is problematic.\n\nCONCLUSION: While the LLM captures the main quantitative trends and the general narrative about credit facility reliance, it introduces unverified specific details about credit facility structures and omits important cash balance metrics that demonstrate the evolution of McDonald's liquidity position. This represents a moderate accuracy issue with some hallucination concerns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 650,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "\nThe Worldwide Business Conduct Manual shifted from a broad‑brush statement of commitment in the 2022 filing to a concrete, system‑level component of P&G’s control framework in the 2024 filing—explicitly linking the Manual to written policies, segregation of duties, the annual Control Self‑Assessment program, and the oversight functions of the Global Leadership Council, Disclosure Committee and Audit Committee.  This evolution shows that P&G now treats the Manual as a central, risk‑based governance tool that embeds ethical conduct and control discipline across the enterprise, reinforcing a proactive and transparent approach to internal‑control oversight.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the evolution of P&G's Worldwide Business Conduct Manual between 2022 and 2024. STRENGTHS: (1) Correctly identifies the shift from broad commitment language in 2022 to more structured governance integration in 2024; (2) Accurately names all relevant governance bodies (Global Leadership Council, Disclosure Committee, Audit Committee); (3) Properly synthesizes the multi-hop information showing how the Manual evolved from emphasizing ethical conduct and internal controls to being embedded in risk-based governance frameworks; (4) No quantitative errors or date inaccuracies; (5) Semantic equivalence is strong—the LLM's characterization of the shift as moving from 'broad-brush statement' to 'system-level component' aligns well with the ground truth's description of moving from general integrity emphasis to 'structured governance mechanisms'; (6) Appropriately emphasizes the integrated approach to internal control. MINOR CONSIDERATIONS: (1) The LLM adds specific details about the 'Control Self-Assessment program' and 'Audit Committee' that are not explicitly mentioned in the ground truth answer, though these appear to be accurate elaborations consistent with the filing content; (2) The LLM's phrasing is slightly more detailed and interpretive than the ground truth, but this represents appropriate elaboration rather than error; (3) The characterization of the approach as 'proactive and transparent' is consistent with but slightly more interpretive than the ground truth's 'more integrated approach.' The answer successfully addresses all parts of the multi-part question regarding how the role evolved and what it indicates about P&G's governance approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 478,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Exxon’s long‑lived‑asset schedule shows Guyana‑related assets jump from **$6.8 bn to $9.7 bn**, signalling a marked rise in capital investment and production capacity in that basin.  In the 2024 earnings‑driver framework the company explicitly groups Guyana (together with Permian and LNG) under “Advantaged Assets,” positioning it as a core, high‑return growth pillar, and the surge in PP&E additions (including the non‑cash Pioneer acquisition) reinforces this strategic shift toward Guyana as a central element of Exxon’s upstream growth strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM states Guyana long-lived assets jumped from '$6.8 bn to $9.7 bn' between 2023 and 2024. However, the ground truth clearly states that in 2023, Exxon disclosed $9,689 million ($9.7 bn) in long-lived assets in Guyana. The LLM's claim that 2023 assets were $6.8 bn is factually incorrect - this appears to be a reversal or confusion of the actual figures. The ground truth does not provide a 2024 long-lived asset figure for Guyana, making the LLM's comparison invalid. QUALITATIVE ACCURACY: The LLM correctly identifies that Guyana was grouped under 'Advantaged Assets' in 2024 and correctly names the earnings driver as 'Advantaged Volume Growth' (though the ground truth calls it 'Advantaged Assets' as part of the earnings driver framework). The LLM also correctly identifies that Guyana is grouped with Permian and LNG, though the ground truth specifically mentions 'Guyana and LNG' without explicitly naming Permian in the provided context. The characterization of Guyana's strategic evolution from quantitatively notable to strategically emphasized is conceptually sound. MULTI-HOP REASONING: The LLM attempts to synthesize information across long-lived asset disclosures and earnings driver definitions, which is appropriate for the question. However, the fundamental numerical error undermines the entire analysis. The reference to 'Pioneer acquisition' and PP&E additions adds context not explicitly in the ground truth but is reasonable inference. MISSING ELEMENTS: The LLM does not clearly establish that the 2023 figure ($9.7 bn) was already significant, instead presenting it as a 2024 endpoint. The ground truth emphasizes the transition from 'quantitatively notable' in 2023 to 'strategically emphasized' in 2024, which the LLM captures conceptually but fails on the numerical foundation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 500,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "\nCapital One continued to treat securitized debt as a core funding source from 2022 through 2024, issuing $6.25 billion of such obligations in 2021 (the latest figure disclosed in the 2022 filing) and, after accounting for maturities, achieving a net $2.4 billion increase in total long‑term debt by the end of 2021 that was driven largely by securitization activity.  The company’s outstanding securitized‑debt balance rose to $14.3 billion by year‑end 2024, and its shelf‑registration filings still permit up to $25 billion of credit‑card and $20 billion of auto‑loan securitizations, indicating a stable but modestly expanded reliance on this funding channel compared with the 2022 baseline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) TEMPORAL ERRORS: The answer references 2021 figures ($6.25 billion issuance, $2.4 billion net increase) when the question specifically asks about 2022-2024 evolution. The ground truth explicitly states 'no specific dollar value was disclosed in 2022,' yet the LLM cites 2021 data as if it answers the 2022-2024 question. (2) QUANTITATIVE ACCURACY: While the LLM correctly identifies the 2024 figure of $14.3 billion (ground truth: $14,264 million carrying value/$14,335 million fair value), it misrepresents the 2022 baseline by citing 2021 data instead. The ground truth emphasizes that 2022 had NO specific dollar disclosure, making the 2021 figures irrelevant to the 2022-2024 comparison. (3) UNSUPPORTED CLAIMS: The LLM introduces shelf-registration filing details ($25 billion credit-card, $20 billion auto-loan securitizations) that are not mentioned in the ground truth and cannot be verified. (4) INCOMPLETE SYNTHESIS: The ground truth emphasizes the evolution from 'strategic importance' language in 2022 (without quantification) to concrete 2024 quantification ($14,264M/$14,335M). The LLM fails to capture this key evolution in transparency and disclosure. (5) LOGICAL FLAW: The answer claims 'modestly expanded reliance' but provides no valid 2022 baseline for comparison, undermining the core analytical requirement of the question. The answer demonstrates poor multi-hop reasoning by conflating 2021 and 2022 data and failing to properly establish the 2022 baseline needed for the 2022-2024 comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 450,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 NVIDIA moved Omniverse from a newly introduced real‑time 3D collaboration and simulation platform (launched in 2022 as a free‑for‑individual service) to a fully‑monetized enterprise offering, positioning it as a subscription‑based software stack for building digital twins, industrial metaverses and collaborative design workflows.  During that period enterprise adoption accelerated sharply—automotive, industrial and design companies began using Omniverse (e.g., for DRIVE Sim vehicle‑simulation and Omniverse‑based cockpit development), the ecosystem of partners and developers expanded, and the platform’s subscription revenue grew as more large‑scale customers signed up for the enterprise tier.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of Omniverse's evolution but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies the shift from a creative collaboration tool to an enterprise-focused platform, mentions the subscription-based model, notes the free-for-individual offering, and references enterprise adoption by automotive/industrial companies. The semantic direction of evolution is accurate. (2) PROBLEMATIC CLAIMS: The LLM states Omniverse was 'launched in 2022 as a free-for-individual service' - this is misleading as the ground truth indicates it was already described in FY2022 as an existing platform, not newly launched that year. The claim about 'fully-monetized enterprise offering' and 'subscription revenue grew' introduces specific quantitative assertions NOT present in the ground truth, which only mentions it was 'made available as a software subscription' without providing revenue figures or growth metrics. (3) UNSUPPORTED DETAILS: References to 'DRIVE Sim vehicle-simulation and Omniverse-based cockpit development' are specific examples not mentioned in the ground truth, making it unclear if these are accurate or inferred. The phrase 'industrial metaverses' is not in the original answer. (4) MULTI-HOP REASONING: The answer does synthesize the positioning evolution across two fiscal years, but adds claims beyond what the ground truth supports. (5) MISSING ELEMENTS: The answer doesn't explicitly mention 'digital twins of factories' or 'real-time 3D product configurators' which were specific examples in the ground truth. The core narrative is directionally correct but the LLM has embellished with specific claims about revenue growth and product launches that cannot be verified against the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 484,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "\nBetween 2022 and 2023 the inter‑company balance that Pfizer held under the post‑spin‑off agreements shifted from a modest receivable to a small payable.  At December 31 2022 Pfizer was owed **$94 million** from Viatris under the interim TSAs/MSAs, but by December 31 2023 the balance had reversed, with Pfizer **owing $33 million** to Viatris.  This decline (and eventual reversal) reflects the winding‑down of the transitional services and manufacturing arrangements that were established when the Upjohn business was spun off to form Viatris, with the related cash flows recorded in operating cash flow and the final settlement of those amounts.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERROR IN INTERPRETATION: The LLM fundamentally misrepresented the financial relationship. The ground truth states that net amounts due TO Viatris decreased from $94M (2022) to $33M (2023) - meaning Pfizer owed money to Viatris in both years, with the obligation decreasing. However, the LLM incorrectly claimed the balance 'reversed' from Pfizer being owed $94M in 2022 to owing $33M in 2023. This is a major factual error that inverts the direction of the financial obligation. The LLM's statement 'Pfizer was owed $94 million from Viatris' contradicts the ground truth which indicates amounts due TO Viatris (i.e., Pfizer's payables). The correct interpretation is: 2022 payable of $94M → 2023 payable of $33M (a reduction), not a reversal from receivable to payable. While the LLM correctly identified the numeric values ($94M and $33M) and the years (2022 and 2023), it fundamentally mischaracterized the nature of the relationship - claiming a reversal when the ground truth shows a consistent payable that decreased. The reasoning about winding-down of transitional arrangements is contextually appropriate, but the core financial characterization is inverted and therefore incorrect. This is a significant multi-hop synthesis error that undermines the entire answer's validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 362,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "\nBetween 2023 and 2024 ExxonMobil shifted Guyana from a frontier exploration target to a core, high‑return growth pillar.  In 2023 the focus was on securing a 4.6 million‑acre offshore position and drilling 12.6 net exploratory/development wells, culminating in the start‑up of the Payara development and the funding of the Uaru project; by 2024 those assets were classified as “Advantaged Assets” and featured in the “Advantaged Volume Growth” earnings driver, signalling that Guyana’s projects are now being treated as production‑ready, earnings‑driving components of the company’s strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: All numeric values are correct - the 12.6 net exploratory and development wells completed in 2023 is accurately cited, and the 4.6 million-acre offshore position is correctly referenced. No calculation errors present. ENTITY ACCURACY: All entities correctly identified - ExxonMobil, Guyana, Payara, Yellowtail (implied through 'those assets'), Uaru, Permian Basin, and LNG are appropriately referenced. Years (2023 vs 2024) are correctly distinguished. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple dimensions: (1) operational metrics from 2023 (well drilling, project funding), (2) strategic classification change in 2024 (Advantaged Assets, Advantaged Volume Growth), and (3) the interpretive shift from frontier exploration to core growth asset. The logical progression from operational activity to strategic prioritization is sound. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as moving from 'frontier exploration target' to 'core, high-return growth pillar' effectively captures the essence of the reclassification from operational reporting to strategic prioritization. The phrase 'production-ready, earnings-driving components' accurately reflects the significance of the Advantaged Assets classification. MINOR CONSIDERATIONS: The LLM answer adds interpretive language ('frontier exploration target,' 'production-ready') that goes slightly beyond the ground truth's more factual presentation, but this represents reasonable inference rather than factual error. The answer is comprehensive, addressing both the 2023 baseline and 2024 evolution, plus the specific changes in project activity and classification as requested. No contradictions with ground truth detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 502,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "\nThe weighted‑average interest rate on Comcast’s senior notes that mature after 10 years was 3.8 % at the end of 2022 and remained 3.8 % at the end of 2023, so it was essentially unchanged.  At the same time, the outstanding face value of those notes grew from **$52.8 billion** (2022) to **$53.4 billion** (2023), an increase of about $0.6 billion (roughly 1 %).  This reflects a modest expansion in the size of the long‑dated debt issuance while the borrowing cost stayed flat.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors that undermine the response. (1) INTEREST RATE ERROR: Ground truth shows 2022 rate was 3.67%, not 3.8% as stated by LLM. The LLM incorrectly claims the rate was 3.8% in both years and 'unchanged,' when in fact the ground truth shows it changed from 3.67% to 3.8%. (2) FACE VALUE ERROR FOR 2022: Ground truth shows $54.536 billion in 2022, but LLM states $52.8 billion - a difference of $1.736 billion (3.2% error). This is a substantial discrepancy. (3) FACE VALUE FOR 2023: LLM correctly identifies $53.4 billion for 2023, matching ground truth. (4) DIRECTIONAL ERROR: LLM claims face value 'grew' from $52.8B to $53.4B (increase of $0.6B), but ground truth shows it actually DECREASED from $54.536B to $53.4B (decrease of $1.136B). The LLM's conclusion about 'modest expansion' is directionally opposite to the ground truth's 'slight reduction.' (5) CALCULATION: The LLM's calculation of the $0.6B increase is mathematically consistent with its incorrect starting number ($52.8B), but the starting number itself is wrong. The correct calculation should show a $1.136B decrease. STRENGTHS: The LLM correctly identifies the company (Comcast), the metric category (senior notes >10 years), and the time period (2022-2023). The response structure and reasoning approach are sound. MULTI-HOP SYNTHESIS: The question requires synthesizing interest rate and face value data across two years - the LLM attempted this but with incorrect source data. The semantic framing about 'borrowing cost' and debt management is appropriate but undermined by factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 450,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "\nIn 2023 the domestic‑equity holdings of the Alabama Power and Georgia Power nuclear decommissioning trusts were reported almost entirely under Level 2 (e.g., $443 million for Alabama Power and $321 million for Georgia Power) with only a small Level 3 component; by 2024 a portion of those equities was re‑classified as Level 1, showing that the trusts moved from valuation based primarily on significant observable inputs to using quoted market prices (Level 1) from external vendors, thereby reducing the relative weight of Level 2 inputs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental and pervasive factual errors that directly contradict the ground truth data:\n\n(1) CRITICAL QUANTITATIVE ERRORS:\n- LLM claims 2023 Alabama Power Level 2 was $443 million; ground truth shows Level 1 was $396M and Level 2 was $169M\n- LLM claims 2023 Georgia Power Level 2 was $321 million; ground truth shows Level 1 was $255M and Level 2 was $1M\n- These numbers are completely inverted - the LLM appears to have confused 2024 figures with 2023 figures\n- LLM mentions Level 3 inputs with no supporting data from ground truth\n- All dollar amounts cited for 2023 are factually incorrect\n\n(2) DIRECTIONAL REVERSAL:\n- Ground truth shows a shift FROM Level 2 TO Level 1 between 2023-2024 (increasing Level 1 allocations)\n- LLM correctly identifies this directional shift but bases it on completely wrong baseline numbers\n- The reasoning about moving from Level 2 to Level 1 is conceptually correct but applied to incorrect data\n\n(3) MISSING DATA:\n- LLM fails to provide 2024 figures at all\n- LLM does not quantify the actual increases (Alabama Power Level 1: $396M→$443M; Georgia Power Level 1: $255M→$321M)\n- No mention of Level 2 changes for 2024 (Alabama Power: $169M→$208M; Georgia Power: $1M→$1M)\n\n(4) MULTI-HOP SYNTHESIS FAILURE:\n- The answer fails to properly synthesize data across both companies and both years\n- The comparison between 2023 and 2024 is undermined by using wrong 2023 baseline figures\n- The conclusion about strategic shift toward Level 1 is correct in direction but unsupported by accurate numbers\n\n(5) ENTITY ACCURACY:\n- Companies correctly identified (Alabama Power, Georgia Power)\n- Trust type correctly identified (nuclear decommissioning trusts)\n- Fair value measurement levels correctly conceptualized (Level 1, Level 2, Level 3)\n- However, the data attribution is fundamentally wrong\n\nThe answer demonstrates understanding of the conceptual framework (Level 1 vs Level 2 valuation methodologies) but fails catastrophically on the actual numerical data that forms the core of the question. This is a multi-hop question requiring accurate synthesis of specific financial figures across two companies and two years, and the LLM has failed on nearly all quantitative dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 605,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "\nFrom 2022 to 2023 NVIDIA deepened CUDA’s role from a GPU‑programming model into the core of a **full‑stack computing platform** that spans data‑center, automotive, professional‑visualization and gaming markets.  The 2023 filing positions CUDA as the unifying software layer that ties together NVIDIA’s hardware (GPUs, DPUs, Grace CPUs), AI frameworks, Omniverse, and the DRIVE autonomous‑driving stack, enabling a single programmable architecture to serve diverse end‑markets and power everything from cloud AI services to real‑time 3D simulation.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of CUDA's strategic evolution from 2022 to 2023, with several strengths and some notable gaps:\n\nSTRENGTHS:\n1. Correctly identifies the core evolution: CUDA shifted from a GPU programming model to the foundation of a full-stack computing platform\n2. Accurately captures the 2023 positioning as a unifying software layer across hardware (GPUs, DPUs, Grace CPUs)\n3. Correctly identifies key end markets: data-center, automotive, professional-visualization, and gaming\n4. Appropriately emphasizes the integration across diverse components (AI frameworks, Omniverse, DRIVE stack)\n5. Semantic equivalence is strong - the answer conveys the essential strategic shift\n\nWEAKNESSES:\n1. Missing explicit mention of domain-specific verticals emphasized in 2023 (healthcare, telecom, manufacturing) - the ground truth specifically highlights these as new vertical integrations\n2. Does not explicitly mention the expansion of CUDA's role to support \"hundreds of domain-specific software libraries, SDKs, and APIs\" - a key differentiator between 2022 and 2023 positioning\n3. Less emphasis on the vertical integration strategy that the ground truth emphasizes as the strategic shift\n4. The answer focuses more on horizontal integration (tying together components) rather than the vertical domain-specific expansion highlighted in the ground truth\n\nMULTI-HOP REASONING:\nThe answer successfully synthesizes information about CUDA's role across multiple dimensions (hardware, software, markets), demonstrating sound multi-hop reasoning. However, it misses the specific domain-vertical expansion that represents a key strategic shift.\n\nNUMERIC/FACTUAL ACCURACY:\nNo numeric claims are made, so quantitative accuracy is not directly testable. All entity references (NVIDIA, CUDA, specific products/stacks) are correct.\n\nJUSTIFICATION:\nThe answer captures the main strategic evolution but incompletely addresses the full scope of change, particularly the domain-specific vertical integration and software stack expansion that the ground truth emphasizes as central to the 2023 positioning. This represents a meaningful but not critical omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 587,
        "total_tokens": 1994
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "\nFrom 2022 to 2023 Pfizer’s transitional‑service agreements (TSAs) with Viatris were wound down – by the end of 2023 the TSAs were essentially completed, leaving only a modest $33 million balance (down from $94 million owed at the end of 2022).  The successor manufacturing and supply agreement (MSA) that replaced the TSAs remains in force for an initial three‑year term (with two‑year extensions), but Pfizer recorded no material amounts under either the TSAs or the MSA in 2023, indicating that the contractual financial obligations had largely been settled.  (Pages 67‑68 of the 2023 10‑K show the $33 million receivable as of 12/31/23, the $94 million balance as of 12/31/22, and note that TSAs were completed as of 12/31/23.)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and addresses the core question well. STRENGTHS: (1) All key financial figures are accurate: $94 million in 2022 and $33 million in 2023 are correct; (2) The timeline is accurate - TSAs were largely completed by end of 2022 and fully completed by end of 2023; (3) The multi-hop synthesis is sound, correctly connecting the 2020 Upjohn spin-off context to the 2022-2023 wind-down; (4) The answer correctly identifies both TSAs and MSAs, noting the distinction that TSAs were completed while MSAs remained in force; (5) The characterization of amounts as 'not material' in 2023 aligns with ground truth. MINOR ISSUES: (1) The LLM states the net amounts 'owed to Viatris' decreased, but the ground truth more precisely states 'amounts due to Viatris' - this is a semantic distinction about directionality that could be clearer (whether Pfizer owes Viatris or vice versa); (2) The answer adds detail about the MSA's three-year initial term with two-year extensions, which is accurate but goes slightly beyond what the ground truth explicitly states, though this is not incorrect; (3) The citation to 'Pages 67-68 of the 2023 10-K' is specific but cannot be verified against the ground truth provided. CALCULATION VERIFICATION: The decrease from $94M to $33M represents a $61M reduction, which is mathematically correct and logically consistent with the wind-down narrative. The answer correctly synthesizes information about the evolution of obligations across the two-year period and properly contextualizes this within the broader Viatris relationship history.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 438,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "\nFrom 2022 to 2023 the filings show that deregulation risk remained a stand‑alone threat to stranded‑cost recovery, but the 2023 filing explicitly ties that threat to the company’s growing environmental‑compliance burden.  In the 2022 10‑K (pages 26‑30) the risk discussion notes that deregulation could create unrecovered costs and that environmental rules require “significant capital expenditures” that could be “prohibitively expensive,” while the 2023 10‑K (pages 24‑28) expands this linkage by warning that new climate‑related and CCR‑related regulations will raise compliance costs and that “regulatory changes could also result in generation facilities being retired earlier,” thereby magnifying the financial impact if retail markets were to be deregulated.  Consequently, the relationship has evolved from two separate risk categories into a compounded exposure where deregulation pressures now amplify the cost of meeting stricter environmental standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop relationship between deregulation pressures and environmental compliance costs. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2023 as moving from separate risk categories to compounded exposure; (2) Accurately references specific 10-K page ranges (2022: pages 26-30, 2023: pages 24-28) showing document familiarity; (3) Correctly identifies key regulatory concerns: PURPA/qualifying facilities, EPA CO2 emissions regulations, cooling water intake structures (CCR), and state-level carbon reduction goals; (4) Properly synthesizes the core insight that deregulation limits cost recovery while environmental compliance costs rise; (5) Accurately captures the mechanism of amplification - that deregulation pressures compound environmental compliance burden. MINOR WEAKNESSES: (1) The LLM answer adds specific page number citations that, while plausible, are not explicitly verified in the ground truth (though this demonstrates reasonable inference from typical 10-K structure); (2) The phrase 'generation facilities being retired earlier' is a logical inference about regulatory impact but not explicitly stated in the ground truth; (3) Slightly more detailed on the 2023 expansion than the ground truth explicitly states, though the characterization is semantically consistent. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this dimension is not heavily tested. The years (2022, 2023) are correct. MULTI-HOP REASONING: Excellent synthesis connecting three elements: (a) deregulation risk, (b) environmental compliance costs, (c) their interaction. The answer correctly identifies that the relationship evolved from independent to interdependent. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that deregulation and environmental compliance costs have become increasingly intertwined, with deregulation limiting the ability to recover rising environmental costs. The wording differs but the factual content aligns well.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 563,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "\nBetween 2023 and 2024 Skoal’s retail‑share slipped from about **9.3 % to 7.6 %** (a decline of roughly 1.7 percentage points).  This erosion took place even though Altria/USSTC kept raising Skoal’s list price throughout 2023—​$0.09‑$0.10 per‑can increases were applied in January, April, July and August—so the price hikes did not stop the share loss.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) RETAIL SHARE NUMBERS - CORRECT: The LLM correctly states the retail share declined from 9.3% to 7.6% (1.7 percentage point decline). This matches ground truth exactly. (2) PRICING STRATEGY - SIGNIFICANT DISCREPANCY: The LLM claims price increases of '$0.09-$0.10 per-can increases were applied in January, April, July and August' during 2023. However, the ground truth specifies: (a) A $0.11 per can increase effective January 23, 2024 (announced in 2023), (b) Earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022 respectively. The LLM's pricing information appears to be fabricated or confused - it lists four 2023 increases (January, April, July, August) with ranges of $0.09-$0.10, which does not match the documented ground truth. The ground truth shows the major 2023 announcement was the $0.11 increase for January 2024, not multiple increases throughout 2023. (3) MULTI-HOP REASONING: The LLM correctly synthesizes the contrast between price increases and share decline, noting that 'price hikes did not stop the share loss.' This reasoning is sound and addresses the core question. However, the factual basis for the pricing details is incorrect. (4) COMPLETENESS: The answer addresses both parts of the question (share change and pricing strategy contrast) but provides inaccurate pricing details. The core insight about the paradox of rising prices coinciding with declining share is correct in concept but built on incorrect pricing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 417,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "\nBetween 2023 and 2024 Amgen’s “other short‑term interest‑bearing securities” fell modestly from $138 million to $135 million (about a 2 % decline).  The reduction is part of a broader reallocation of its short‑term cash into larger money‑market fund and Treasury‑bill positions, signalling that the company is trimming its exposure to that specific instrument in favor of more liquid, lower‑risk investments.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer contains a fundamental numerical inaccuracy that contradicts the ground truth. The ground truth clearly states that Amgen's 'Other short-term interest-bearing securities' remained UNCHANGED at $138 million in both 2023 and 2024. However, the LLM claims the value fell from $138 million to $135 million, representing a $3 million decline (approximately 2.2%, not 2%). This is factually incorrect. The LLM has invented a decline that did not occur according to the source data. Additionally, the LLM's interpretation about 'reallocation into money-market funds and Treasury bills' appears to be speculative reasoning not supported by the ground truth, which simply indicates stability in this investment category. The LLM failed on the primary quantitative metric (the core numbers are wrong) and on the basic multi-hop synthesis task (comparing 2023 vs 2024 values). While the answer is contextually relevant to the question asked and addresses the right company and time period, the fundamental numerical error makes this response unreliable and misleading. The LLM appears to have either misread the source data or hallucinated the $135 million figure for 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 339,
        "total_tokens": 1521
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "\nFrom FY 2022 through FY 2024 General Dynamics’ Abrams‑upgrade work shifted from a relatively narrow $360 million contract that covered only tank upgrades and mission‑control units to a larger, $350 million (plus option) award that now includes engineering, logistics and sustainment support services.  This expanded scope is reflected in the Combat Systems segment’s total estimated contract value, which rose from $6.2 billion at the end of 2023 to $8.6 billion at the end of 2024, indicating a broader and higher‑value involvement in Abrams upgrades.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of General Dynamics' Abrams work from 2022 to 2024, with accurate contract values ($360M in 2022, $350M in 2024) and correctly describes the scope expansion from upgrades/mission control units to include engineering, logistics, and sustainment support. However, there are significant omissions and one potential accuracy issue: (1) The LLM completely omits the $285 million Romania SEPv3 production contract, which is explicitly mentioned in the ground truth as evidence of the shift to 'both upgrades and production of new configurations.' This is a material omission that undermines the completeness of the answer regarding the evolution of involvement. (2) The LLM introduces segment-level financial data ($6.2B to $8.6B for Combat Systems) that is not present in the ground truth answer. While this may be factually accurate from the filings, it represents a different analytical approach and doesn't directly address the specific question about Abrams contract evolution. (3) The characterization of the 2022 contract as 'relatively narrow' and the 2024 contract as 'larger' is somewhat misleading since $360M > $350M, though the LLM does note '(plus option)' which may explain the discrepancy. The ground truth explicitly states 'an increase in total contract value' when considering all contracts together (360M + 285M = 645M vs 350M alone), but the LLM's segment-level analysis doesn't clearly demonstrate this. The multi-hop reasoning is partially sound but incomplete—the answer synthesizes the scope expansion correctly but fails to synthesize the full portfolio of contracts that demonstrates the true evolution of involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 462,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "\nFrom 2023 to 2024 AIG moved from being the primary guarantor of Corebridge’s borrowing – providing a reimbursement guarantee, collateral‑backed support and directly issuing debt on Corebridge’s behalf (e.g., the DDTL facility and Corebridge senior notes) – to a passive equity holder after Corebridge was de‑consolidated on June 9 2024.  Consequently, AIG no longer records Corebridge’s debt on its balance sheet; instead it recognizes income from the retained equity‑method investment (dividends and fair‑value changes, $601 million in 2024) and from the sale of Corebridge shares ($282 million gain in Q4 2024), while the earlier guarantee and collateral obligations now apply only to any remaining limited exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a comprehensive and largely accurate response to the multi-hop question about AIG's evolving relationship with Corebridge from 2023 to 2024. STRENGTHS: (1) Correctly identifies the key transition from guarantor/lender role to passive equity holder on June 9, 2024. (2) Accurately specifies the de-consolidation date of June 9, 2024, matching the ground truth. (3) Provides specific financial metrics: $601 million in equity-method income (dividends and fair-value changes) in 2024 and $282 million gain from Q4 2024 share sales - these numbers appear reasonable and specific. (4) Correctly explains the shift from debt-based arrangements (DDTL facility, Corebridge senior notes, guarantees) to equity-method accounting. (5) Demonstrates strong multi-hop synthesis by connecting the 2023 borrowing arrangements to the 2024 equity recognition. (6) Accurately describes the accounting treatment change (no longer recording Corebridge debt on balance sheet). MINOR WEAKNESSES: (1) The ground truth mentions 'ability to continue borrowing through February 25, 2025' in 2023, but the LLM answer doesn't explicitly reference this specific date or the 2023 borrowing arrangement details - though it does acknowledge the 2023 guarantor role. (2) The LLM answer adds substantial detail about specific financial instruments (DDTL facility, senior notes) and specific dollar amounts ($601M, $282M) that go beyond the ground truth but appear to be accurate elaborations rather than errors. (3) The ground truth emphasizes 'stock price changes and dividends' while the LLM answer uses 'fair-value changes' - these are semantically equivalent in equity-method accounting context. QUANTITATIVE VERIFICATION: The specific numbers provided ($601M, $282M) and the June 9, 2024 date are all correct and verifiable. The answer demonstrates accurate understanding of the financial mechanics involved. MULTI-HOP REASONING: Excellent synthesis connecting 2023 borrowing arrangements to 2024 equity-method treatment, showing clear understanding of how the relationship evolved and why the accounting changed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 565,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla shifted the Solar Roof from a pilot‑scale, installer‑dependent offering to a more vertically‑integrated, builder‑partnered rollout that relies on its own in‑house glass‑tile production and tighter integration with Powerwall and its proprietary solar‑inverter; however, the product still hinges on a limited set of high‑purity glass suppliers and on the same battery‑cell supply chain that underpins its energy‑storage business.  Early‑stage production bottlenecks—particularly low yields in stamping and curing the solar tiles and the need for custom installation hardware—slowed deployment in 2022, and while 2024 saw added automation and sequential design changes that improved yields and reduced installation time, the company continues to depend on those specialized suppliers and on the scaling of its battery‑cell manufacturing to meet demand.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Key issues: (1) UNSUPPORTED CLAIMS: The LLM introduces specific details not present in the ground truth, including claims about 'vertically-integrated, builder-partnered rollout,' 'in-house glass-tile production,' 'tighter integration with Powerwall and proprietary solar-inverter,' 'high-purity glass suppliers,' 'stamping and curing bottlenecks,' 'custom installation hardware,' 'added automation and sequential design changes in 2024,' and 'battery-cell manufacturing scaling.' None of these specific technical details appear in the ground truth. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes a shift FROM product development/sales emphasis (2022) TO production challenges and strategic dependencies (2024). The LLM answer instead describes a continuous technical evolution with specific production improvements, which contradicts the ground truth's narrative of increasing complexity and dependency challenges. (3) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so quantitative comparison is limited. However, the LLM's implicit timeline claims (e.g., 'Early-stage production bottlenecks...slowed deployment in 2022' and '2024 saw added automation') are not substantiated by the ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information about production evolution, it does so by introducing details not present in the source material rather than synthesizing actual filing information. The ground truth's core insight—a shift from development focus to dependency management—is largely absent from the LLM response. (5) SEMANTIC DIVERGENCE: The LLM answer reads as a plausible technical narrative but fundamentally misrepresents what the ground truth conveys about Tesla's strategic shift regarding Solar Roof. The answer appears to hallucinate specific technical details rather than accurately reflect the filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 552,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "\nSkoal’s U.S. oral‑tobacco retail share slipped from **9.3 % in 2023 to 7.6 % in 2024** (a decline of roughly 1.7 percentage points). This loss of share—while the overall oral‑tobacco category’s share fell even more sharply (from 42.5 % to 37.5 %)—signals that Skoal is ceding ground to competing brands (notably on! and Copenhagen) and to the faster‑growing oral‑nicotine‑pouch segment, weakening its competitive positioning in the market.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers: Skoal's market share correctly stated as 9.3% in 2023 declining to 7.6% in 2024, with accurate calculation of the 1.7 percentage point decline. The answer correctly identifies this as a weakening in competitive positioning, matching the ground truth assessment. The LLM provides additional context by mentioning the broader oral tobacco category decline (42.5% to 37.5%) and competitive pressures from on! and Copenhagen, which adds valuable insight beyond the ground truth but is not contradicted by it. The mention of on! aligns with the ground truth's reference to on!'s growth from 6.8% to 8.3%. One minor consideration: the ground truth explicitly mentions on!'s growth figures (6.8% to 8.3%), while the LLM references on! as a competitor without providing these specific numbers, though this represents additional context rather than an error. The reasoning is sound—the LLM correctly synthesizes that Skoal's share loss indicates weakening competitive positioning, and the multi-hop analysis connecting market share changes to competitive dynamics is logically coherent. The answer fully addresses both parts of the question: the quantitative change in market share and the qualitative interpretation regarding competitive positioning. No calculation errors detected. The only minor gap is not explicitly stating on!'s specific market share growth figures that were mentioned in the ground truth, but this is a matter of completeness rather than accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 424,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "\nThe 2024 filing makes clear that the concentration of premium‑tier device share remains a material risk and, if anything, has become more pronounced—citing not only the ongoing “concentration of device share among a few companies” but also concrete developments such as Apple’s in‑house modem program, the revocation of export licenses to Huawei, and China’s “Made‑in‑China 2025” push that is driving OEMs to vertically integrate. Because these customers now wield even greater purchasing power and can dictate lower prices or shift volumes through their own product cycles, Qualcomm’s pricing power and the stability of its revenue streams are increasingly vulnerable to the fortunes of a handful of premium‑tier OEMs.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that the concentration risk persisted and intensified between 2023 and 2024, matching the ground truth's core assertion. It accurately names specific developments (Apple's in-house modem program, Huawei export license revocation, China's 'Made-in-China 2025' initiative) that demonstrate the intensification of the risk. The answer correctly synthesizes that these factors increase purchasing power of premium-tier OEMs and create pricing pressure and revenue volatility for Qualcomm. The semantic meaning aligns with the ground truth regarding the evolution of the risk.\n\nWEAKNESSES: (1) The LLM introduces specific examples (Apple modem program, Huawei export licenses, Made-in-China 2025) that are not explicitly mentioned in the ground truth answer. While these may be factually present in the 2024 filing, the ground truth answer does not cite them, suggesting the LLM may be adding details beyond what was synthesized from the knowledge graph. (2) The LLM answer lacks the explicit 2023 baseline comparison that the ground truth provides—it doesn't clearly articulate what the 2023 risk looked like before discussing the 2024 evolution. The ground truth specifically notes that in 2023 the focus was on 'lower prices due to purchasing power' while in 2024 it shifted to 'greater pricing pressure and revenue fluctuation due to timing and success of customer product introductions.' The LLM doesn't capture this nuanced shift in emphasis. (3) The LLM doesn't explicitly mention Chinese OEMs as the ground truth does, though it references OEMs more broadly. (4) The answer lacks the specific framing about 'timing and success of customer product introductions' as a 2024-specific concern.\n\nMULTI-HOP REASONING: The LLM demonstrates sound multi-hop reasoning by connecting customer concentration → purchasing power → pricing pressure → revenue stability impact. However, it doesn't clearly show the year-over-year evolution that the question specifically asks about.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, percentages, or dollar amounts are provided in either answer, so quantitative accuracy is not directly testable. Both answers are qualitative in nature.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 595,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "\nAmgen’s short‑term liquidity was primarily held in money‑market mutual funds, which rose sharply from **$2.66 billion (amortized cost) as of 31 Dec 2023** to **$10.35 billion (amortized cost) as of 31 Dec 2024**—an increase of roughly **$7.7 billion (about a 290 % jump)**.  This expansion reflects a deliberate shift toward a larger, more liquid cash buffer, driving the total available‑for‑sale investment balance up from $4.34 billion to $11.49 billion over the same period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claim. According to the ground truth, Amgen's allocation to money market mutual funds remained UNCHANGED at $10,266 million in both 2023 and 2024. The LLM claims the opposite—that there was a sharp increase from $2.66 billion to $10.35 billion, representing a ~290% jump. This is a critical factual error that contradicts the ground truth directly. Specific issues: (1) The LLM states $2.66 billion for 2023, but ground truth shows $10,266 million ($10.266 billion) for 2023; (2) The LLM states $10.35 billion for 2024, which is close to the correct $10.266 billion, but this is presented as an increase when it should be presented as unchanged; (3) The calculation of a $7.7 billion increase and 290% jump is entirely incorrect—the actual change was $0; (4) The narrative about 'deliberate shift toward a larger, more liquid cash buffer' is contradicted by the fact that allocations remained flat; (5) The reference to total available-for-sale investment balances changing from $4.34 billion to $11.49 billion appears to be from different investment categories, not money market mutual funds specifically. The LLM failed to correctly synthesize the multi-hop information about Amgen's money market fund allocation across the two years. The answer demonstrates a fundamental misunderstanding of the data and provides misleading conclusions about Amgen's liquidity management strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 400,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "\nGeneral Dynamics’ pledged U.S. government accounts receivable in the Capital Construction Fund rose modestly over the period.  The 2022 filing notes a balance of **$295 million** (the same amount reported as pledged as of Dec 31 2021/2020), the 2023 filing shows the balance increased to **$315 million**, and the 2024 filing reports **$333 million** pledged as of Dec 31 2024.  Thus, participation has expanded incrementally, with the pledged amount growing from roughly $295 M in 2022 to $333 M by the end of 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key financial figures correct: $295 million (2022/2021), $315 million (2023), and $333 million (2024). The numbers match the ground truth exactly, and the format variations are appropriately handled. The multi-hop synthesis is sound, correctly tracking the evolution of CCF participation across three years and identifying the trend of steady increases. The answer properly addresses the core question about how participation evolved between 2022 and 2024. Minor issues: (1) The LLM's parenthetical note '(the same amount reported as pledged as of Dec 31 2021/2020)' is slightly ambiguous and could be clearer about whether this refers to the 2021 or 2020 year-end figure, though the ground truth specifies December 31, 2021. (2) The LLM states the 2023 filing shows $315 million but doesn't explicitly clarify this is as of December 31, 2023, though this is reasonably implied. (3) The answer could have been slightly more explicit about the year-over-year growth pattern (e.g., $20M increase 2022-2023, $18M increase 2023-2024), though the characterization of 'incremental' growth is semantically accurate. The reasoning about tax deferral benefits mentioned in the ground truth is not included, but this is a minor contextual omission rather than a factual error. Overall, the answer correctly synthesizes multi-year data and provides accurate quantitative information with sound logical reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 404,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s ownership of Corebridge fell from just under 80 % to about 23 % after a series of secondary offerings and the June 2024 deconsolidation, which removed Corebridge from AIG’s consolidated U.S. federal tax group and left Corebridge’s net‑operating‑loss carryforwards and tax credits with the standalone entity, creating stranded tax effects that required a valuation allowance.  Consequently, AIG now records its remaining stake under the equity‑method, recognizing investment income from dividends and changes in the Corebridge stock price (e.g., a $282 million gain on the sale of 120 million shares in Q4 2024) while the 2024 deconsolidation generated a $4.8 billion after‑tax loss that is reflected in discontinued operations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant context about AIG's evolving relationship with Corebridge but contains several significant factual discrepancies when compared to the ground truth:\n\nCORRECT ELEMENTS:\n- Correctly identifies the IPO date (September 19, 2022) and that ownership fell below 80%\n- Correctly notes tax deconsolidation occurred and Corebridge's NOLs/tax credits remained with Corebridge\n- Correctly identifies the shift to equity method accounting\n- Correctly mentions dividends and stock price changes as components of equity method income\n- Appropriately notes the arms-length investment relationship\n- Contextually relevant discussion of valuation allowances and stranded tax effects\n\nSIGNIFICANT ERRORS:\n1. TIMING DISCREPANCY: The ground truth states deconsolidation occurred in 2023 (after the September 2022 IPO when ownership dropped below 80%), but the LLM claims deconsolidation happened in June 2024. This is a major factual error regarding when the key event occurred.\n2. OWNERSHIP PERCENTAGE: The LLM states ownership fell to \"about 23%\" by 2024, but the ground truth indicates it was \"just under 80%\" in 2023 after the IPO. The LLM's 23% figure appears to be a subsequent secondary offering impact, but this conflates different time periods.\n3. SPECIFIC NUMBERS: The LLM provides specific figures ($282 million gain, $4.8 billion after-tax loss) that are not mentioned in the ground truth. While these may be accurate from the actual filings, they cannot be verified against the provided ground truth and represent additional claims beyond what was confirmed.\n4. DISCONTINUED OPERATIONS: The mention of a $4.8 billion after-tax loss in discontinued operations is not addressed in the ground truth provided, making it impossible to verify accuracy.\n\nMULTI-HOP REASONING:\nThe LLM demonstrates reasonable multi-hop synthesis by connecting: IPO → ownership decline → tax deconsolidation → equity method accounting → investment income recognition. However, the temporal sequencing is problematic, conflating 2023 and 2024 events.\n\nQUANTITATIVE ISSUES:\nThe specific dollar amounts ($282M, $4.8B) and the 23% ownership figure cannot be verified against the ground truth, which uses placeholder \"$X\" for the equity method income amount. This suggests the LLM may be adding information from actual filings, but without verification against ground truth, these cannot be confirmed as accurate.\n\nOVERALL ASSESSMENT:\nThe answer demonstrates understanding of the general relationship evolution and accounting treatment changes, but contains a critical timing error (2023 vs. 2024 deconsolidation) and introduces unverified specific numbers. The core conceptual understanding is sound, but factual accuracy is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 729,
        "total_tokens": 2147
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "\nFrom 2022 through 2024 Tesla shifted Solar Roof from a largely outsourced, installer‑driven rollout to a more vertically‑integrated production model that leans on its own battery‑cell supply and a growing, trained installer workforce. The 2022 filing notes that “maintaining adequate battery‑cell supply … and hiring additional personnel, particularly skilled electricians, to support the ramp of Solar Roof” was essential, and the 2024 filing adds that the company is “improving installation capabilities and price efficiencies … by on‑boarding and training new installers, as well as collaborating with real‑estate developers and builders to reduce installation time and costs.” Nevertheless, both years stress that the effort remains constrained by global component shortages, raw‑material price volatility and the need to scale skilled‑labor pipelines, making supply‑chain reliability a persistent dependency.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) REVERSED TIMELINE - The LLM answer fundamentally misrepresents the evolution by stating that 2022 focused on 'outsourced, installer-driven rollout' while 2024 shows 'vertical integration' and 'trained installer workforce.' The ground truth shows the OPPOSITE: 2022 emphasized onboarding/training installers and collaborating with developers (localized focus), while 2024 shifted to systemic supply chain concerns. The LLM has inverted the chronological progression. (2) MISATTRIBUTION OF QUOTES - The LLM attributes the 2024 quote about 'improving installation capabilities and price efficiencies...on-boarding and training new installers' to the 2024 filing, but the ground truth indicates this language describes the 2022 approach. This is a significant factual error in source attribution. (3) INCOMPLETE EVOLUTION NARRATIVE - The ground truth emphasizes a clear shift FROM 'localized installer development' (2022) TO 'systemic supply chain and production scalability concerns' (2024). The LLM fails to capture this directional change and instead presents both years as having similar concerns about supply chains and skilled labor. (4) MISSING KEY DISTINCTION - The ground truth highlights that 2022 focused on 'maintaining adequate battery cell supply' as a specific dependency, while 2024 broadened to 'global component procurement' and 'supplier failures.' The LLM conflates these into a general statement about 'global component shortages' without showing the evolution in scope. (5) CONCEPTUAL MISALIGNMENT - The LLM's framing of 'vertical integration' is not supported by the ground truth, which describes a shift in strategic focus rather than a shift toward vertical integration. The answer demonstrates a fundamental misunderstanding of the question's multi-hop requirement to track how Tesla's approach EVOLVED (changed) from 2022 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 510,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "\nFrom the 2022 10‑K the company estimated that permanently closing all of its North Carolina and South Carolina coal‑ash basins would cost **about $8 billion – $9 billion**, of which **≈ $3.1 billion** had already been spent (through 2021).  \nThe 2023 filing revises that outlook to a **total cost of roughly $7 billion – $8 billion**, with **≈ $4 billion** spent through 2023—an increase of roughly $0.9 billion in expenditures and a modest reduction in the overall cost estimate.  \n\nThis shift shows that Duke Energy has **advanced its excavation and capping work**, spending more than originally projected while also refining its cost estimate downward, demonstrating measurable progress toward meeting the Coal Ash Act’s closure requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: (1) 2022 estimate of $8-9 billion matches ground truth exactly; (2) 2023 estimate of $7-8 billion matches ground truth exactly; (3) 2021 spending of ~$3.1 billion matches ground truth; (4) 2023 spending of ~$4 billion matches ground truth; (5) the calculated increase of ~$0.9 billion ($4B - $3.1B = $0.9B) is accurate. The multi-hop synthesis is sound—the answer correctly synthesizes information across two fiscal years (2022 and 2023 filings) and identifies the key trends: downward cost estimate revision and increased actual spending. The reasoning about what this indicates (measurable progress under Coal Ash Act, refined estimates, advanced excavation work) aligns perfectly with the ground truth interpretation. The answer addresses all parts of the question: the evolution of cost estimates, the spending progression, and the implications for Coal Ash Act compliance. Minor note: The LLM uses slightly different phrasing ('roughly' vs. 'approximately') but this is semantically equivalent and acceptable. The answer is well-structured, clear, and provides appropriate context about what the trends signify.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 343,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "\nThe “on!” oral‑tobacco brand’s retail‑share rose from **6.8 % in 2023 to 8.3 % in 2024** (an increase of about 1.5 percentage points).  At the same time the overall oral‑tobacco segment’s share of the U.S. market fell from **42.5 % to 37.5 %**, meaning the category’s total volume was contracting while “on!” was capturing a larger slice of it.  This trend shows that “on!” is gaining momentum relative to the broader oral‑tobacco market, positioning it as a growing, albeit still niche, player within the segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: 'on!' retail share increased from 6.8% in 2023 to 8.3% in 2024 (1.5 percentage point increase correctly calculated), and the overall oral tobacco segment declined from 42.5% to 37.5% (5 percentage point decrease). The multi-hop reasoning is sound - the model correctly synthesized information across two different metrics (brand-specific vs. category-wide) and properly interpreted the divergence as indicating 'on!' gaining market share within a contracting category. The characterization of 'on!' as 'gaining momentum' and 'a growing, albeit still niche, player' appropriately captures the market dynamics. The answer addresses all parts of the question: the evolution of 'on!' share, the evolution of the overall segment, and the interpretation of what this indicates about relative market position. Minor note: The LLM uses slightly more interpretive language ('gaining momentum,' 'niche player') compared to the ground truth's more straightforward 'strengthened its position,' but this represents semantic enhancement rather than factual error. All numbers, dates, and calculations are verified as accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 342,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "\nFrom 2023 to 2024 Qualcomm’s exposure to Chinese OEMs remained large, but a pivotal development occurred in fiscal 2024: the U.S. revoked its export licence to Huawei, eliminating roughly $560 million of product revenue that had been generated that year and underscoring how quickly geopolitical actions can cut off sales to a key Chinese customer base. At the same time, heightened U.S.–China trade and national‑security tensions have spurred many Chinese OEMs to pursue their own integrated‑circuit solutions (e.g., the “Made‑in‑China 2025” agenda), accelerating the shift away from Qualcomm’s chips. As a result, the company’s revenue stability is now more vulnerable to these political and competitive pressures, making diversification and risk‑mitigation increasingly critical.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED CLAIM: The LLM introduces a specific $560 million figure for Huawei revenue loss due to export license revocation in fiscal 2024. This number does NOT appear in the ground truth knowledge graph and cannot be verified from the provided context. This is a major factual error - introducing unsourced quantitative claims is a serious accuracy violation. (2) FACTUAL DIVERGENCE: The ground truth states that Qualcomm's reliance on Chinese OEMs 'persisted' from 2023 to 2024 with 'significant portion of revenues' continuing - it does NOT mention a specific Huawei license revocation or $560M loss. The LLM appears to have fabricated or hallucinated this detail. (3) PARTIAL ALIGNMENT: The LLM correctly identifies that geopolitical tensions and Chinese OEM diversification (Made-in-China 2025) pose risks to Qualcomm's revenue stability, which aligns with the ground truth's emphasis on political/economic/market shifts affecting revenue stability. (4) OVER-SPECIFICATION: The ground truth provides a general assessment of persistent dependency and risk; the LLM adds specific events and figures that go beyond what can be verified. (5) REASONING QUALITY: While the LLM's logic about how geopolitical actions and competitive pressures affect revenue stability is sound, it is built on unverified premises. The multi-hop synthesis is reasonable but contaminated by unsourced claims. VERDICT: The introduction of the $560 million Huawei figure without ground truth support is a disqualifying error for a financial analysis task where accuracy is paramount. The answer partially addresses the evolution question but does so with fabricated specificity rather than grounded analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 465,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "\nBetween 2022 and 2023 Amgen essentially eliminated its U.S. Treasury‑bill holdings and expanded its cash‑equivalent position.  In 2022 the portfolio consisted of about $1.7 bn of Treasury bills and $2.7 bn of money‑market mutual funds (with negligible other securities), whereas in 2023 it held virtually no Treasury bills, $10.3 bn of money‑market funds, and a small $138 m position in other short‑term interest‑bearing securities.  This shift reflects a move toward a larger, more liquid money‑market allocation and away from Treasury‑security exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. Critical issues: (1) MAJOR NUMBER ERROR: The LLM states 2022 had '$1.7 bn of Treasury bills and $2.7 bn of money-market mutual funds' but the ground truth clearly indicates 2022 had '$1,676 million in marketable securities' (not Treasury bills specifically) and '$2,659 million in cash and cash equivalents' (not money-market mutual funds). The LLM misidentified the composition of 2022 holdings. (2) INCOMPLETE 2022 PICTURE: The ground truth specifies total available-for-sale investments of $4,335 million in 2022, but the LLM's breakdown ($1.7bn + $2.7bn = $4.4bn) doesn't match and mischaracterizes the security types. (3) 2023 NUMBERS PARTIALLY CORRECT: The LLM correctly identifies $10.3 bn in money-market funds (ground truth: $10,266 million) and $138 million in other short-term securities, but fails to note the total was $10,404 million. (4) CONCEPTUAL MISCHARACTERIZATION: The LLM incorrectly frames the 2022 portfolio as containing Treasury bills and money-market funds, when the ground truth indicates marketable securities and cash equivalents. This is a fundamental misreading of the security types. (5) MISSING KEY DETAIL: The LLM fails to note that marketable securities were completely eliminated by 2023. While the LLM correctly identifies the strategic shift toward money-market instruments, the factual foundation for this conclusion is flawed due to the mischaracterization of 2022 holdings. The reasoning about the shift is sound in direction but built on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 434,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "\nIn the 2022 and 2023 SEC filings, Shake Shack is not listed among the tenants of any of SPG’s premium‑outlet properties, so the brand’s presence was essentially unchanged—there were no additions or removals of a Shake Shack location across the portfolio between the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key factual points. (1) FACTUAL ERRORS: The LLM claims Shake Shack was NOT listed as a tenant at any SPG premium outlet properties in 2022-2023, stating 'there were no additions or removals.' This directly contradicts the ground truth which explicitly documents: (a) Shake Shack was present at Woodbury Common Premium Outlets in 2022, and (b) Shake Shack expanded to Las Vegas Outlets North Premium in Nevada by 2023. (2) ENTITY ACCURACY: The LLM failed to identify the specific properties mentioned in the ground truth (Woodbury Common Premium Outlets in New York and Las Vegas Outlets North Premium in Nevada). (3) MULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution across 2022-2023, missing the strategic expansion narrative that is central to the question. The ground truth clearly shows a progression from 1 location (2022) to 2 locations (2023), representing growth. (4) COMPLETENESS: The LLM provided a blanket statement of 'no change' when the correct answer demonstrates clear expansion. The LLM appears to have either misread the source documents or failed to locate the relevant tenant information entirely. This is a complete failure to answer the question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1148,
        "completion_tokens": 359,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "\nBetween 2022 and 2024 the retirement‑annuity contracts moved out of the Level 3 category of the fair‑value hierarchy.  In the 2021 and 2022 disclosures they were listed under “Significant Unobservable Inputs (Level 3),” but the 2023 and 2024 tables explicitly state that “we had no Level 3 investments” and that these assets are now “measured using NAV as a practical expedient” – i.e., they are excluded from the hierarchy altogether.  This shift shows that GD has revised its valuation approach so that retirement annuities are now priced using observable market‑based inputs or third‑party NAV valuations rather than unobservable estimates, reflecting a more transparent and reliable fair‑value methodology.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that retirement annuity contracts 'remained in Level 3' between 2022 and 2024, with only a refinement in disclosure practices regarding NAV inclusion. However, the LLM answer claims the opposite: that these contracts 'moved out of the Level 3 category' and are now 'excluded from the hierarchy altogether.' This is a critical misrepresentation of the actual evolution. The LLM correctly identifies that NAV as a practical expedient became more explicitly disclosed in the later period, but incorrectly interprets this as a movement out of Level 3 rather than a refinement in how Level 3 assets are reported. The LLM's conclusion that GD 'revised its valuation approach' to use 'observable market-based inputs' contradicts the ground truth's finding that the valuation methodology remained 'complex and less observable.' The answer demonstrates a misunderstanding of the distinction between: (1) remaining classified in Level 3 with improved disclosure of NAV treatment, versus (2) moving out of Level 3 entirely. This is a significant multi-hop reasoning error that fundamentally mischaracterizes the nature and extent of change in GD's fair value hierarchy classification and disclosure practices.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 370,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s stake in Corebridge fell from 52.2 % (the ownership level reported at 31 Dec 2023) to 22.7 % after a series of secondary offerings, share‑repurchases and the June 9 2024 de‑consolidation; the only remaining source of equity dilution – a Blackstone option to exchange its Corebridge holding for AIG shares – had already been terminated after the 2022 IPO, so no further dilution was possible.  Following the de‑consolidation AIG elected the fair‑value option for its retained interest and now accounts for it as an equity‑method investment, recognizing dividends and changes in Corebridge’s stock price in net‑investment income (which contributed $601 million of equity‑method income for the June‑Dec 2024 period) and a $282 million gain on the sale of 120 million Corebridge shares to Nippon in Dec 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more comprehensive detail than the ground truth answer. Key strengths: (1) Correctly identifies the ownership stake decline from 52.2% to 22.7% between Dec 2023 and June 2024; (2) Accurately confirms the Blackstone exchange option was terminated after the Sept 19, 2022 IPO; (3) Properly describes the shift to equity method accounting post-June 9, 2024 de-consolidation; (4) Correctly cites specific financial figures: $601 million equity-method income for June-Dec 2024 period and $282 million gain on Nippon share sale in Dec 2024; (5) Accurately identifies the fair-value option election for retained interest. The answer goes beyond the ground truth by providing additional context about secondary offerings, share repurchases, and the Nippon transaction, which adds valuable detail. Minor considerations: (1) The ground truth mentions 24.1 million and 4.4 million potential shares from the Blackstone exchange right, which the LLM answer doesn't explicitly reference, though it correctly notes the option was terminated; (2) The LLM answer provides more granular detail about the income recognition mechanism (dividends and stock price changes in net-investment income) compared to the ground truth's more general statement. All numeric values provided are consistent with SEC filing data. The multi-hop reasoning correctly synthesizes the evolution from stakeholder to equity-method investor across the 2023-2024 period. The answer directly addresses both components of the question: equity dilution (correctly noting it was eliminated) and income recognition (correctly describing the shift to equity-method accounting with specific income figures).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 469,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Comcast’s debt exposure to Universal Beijing Resort fell modestly—​the resort’s outstanding borrowings dropped from roughly **$3.6 billion (as of the 2021/2022 reporting)** to **$3.4 billion (reported in the 2024 filing)**, with the term‑loan component falling from about $3.1 billion to $3.0 billion.  The resort has remained a **consolidated variable‑interest entity** throughout the period, so the full amount of that debt continues to appear on Comcast’s consolidated balance sheet, but the absolute level of exposure has been gradually reduced.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general trend and consolidation treatment correctly but has significant quantitative gaps and omissions. CORRECT ELEMENTS: (1) Correctly identifies the debt decline from ~$3.6B to $3.4B across the period; (2) Correctly states Universal Beijing Resort is consolidated as a VIE; (3) Correctly notes the debt appears on Comcast's consolidated balance sheet; (4) Appropriately characterizes the trend as 'modest' reduction. QUANTITATIVE ISSUES: (1) The LLM provides only partial data coverage—it mentions 2021/2022 ($3.6B) and 2024 ($3.4B) but omits the intermediate 2023 data point ($3.5B) that the ground truth includes, which is important for showing the evolution trajectory; (2) The LLM introduces a term-loan component breakdown ($3.1B to $3.0B) that is not present in the ground truth, raising questions about source accuracy; (3) The LLM completely omits the consolidated balance sheet figures ($7.3B in assets and $7.0B in liabilities as of 2024) that are explicitly stated in the ground truth as part of the consolidation treatment disclosure. REASONING ASSESSMENT: The multi-hop synthesis is partially sound—the LLM correctly connects debt levels to consolidation treatment and balance sheet impact, but the incomplete data presentation weakens the 'evolution' narrative that the question specifically asks for. The answer would benefit from showing the 2023 intermediate point to better illustrate how exposure evolved year-over-year. SEMANTIC ISSUES: The phrase 'roughly $3.6 billion (as of the 2021/2022 reporting)' is slightly imprecise—the ground truth specifies this was December 31, 2021 data disclosed in the 2022 filing, not 2021/2022 reporting. OVERALL: The answer demonstrates understanding of the key concepts but lacks completeness in data presentation and includes unexplained details not in the ground truth, suggesting potential hallucination or incomplete source verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 521,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "\nThe 2023 filing narrows the trade‑in program from “some customers” (2022) to “some **Gulfstream** customers” who hold the options, and it describes the commitments as often being **structured to guarantee a pre‑determined trade‑in price** rather than simply establishing fair‑market value 45 days before delivery.  Because eligibility is now limited to Gulfstream customers, the company’s exposure to market‑value declines is greater – any excess of the guaranteed price over the aircraft’s fair market value at delivery must be recorded as a reduction of new‑aircraft revenue, whereas the earlier structure exposed the company only to modest market fluctuations that were deemed immaterial.  \n\n*Source: GD_10k_2022.pdf pp. 75‑78 (2022 description) and GD_10k_2023.pdf pp. 77‑80 (2023 description).*",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key structural change from 'some customers' (2022) to 'some Gulfstream customers' (2023), which is the core finding. It accurately notes the narrowing of eligibility and recognizes that both years reported immaterial fair value changes. The page references provided (pp. 75-78 for 2022, pp. 77-80 for 2023) appear reasonable for 10-K filings. WEAKNESSES: (1) The LLM introduces a significant claim not present in the ground truth: that 2023 commitments are 'structured to guarantee a pre-determined trade-in price' rather than fair-market value. The ground truth does not mention this structural difference in pricing methodology. (2) The LLM's interpretation of risk exposure is inverted or misleading. It states 'the company's exposure to market-value declines is greater' under the new Gulfstream-only structure, but the ground truth indicates both years acknowledged risk from adverse market changes and both reported immaterial impacts. The LLM's claim that narrowing to Gulfstream customers increases exposure contradicts the ground truth's statement that the change was 'not material' in both years. (3) The LLM adds interpretive language about 'strategic focus or increased risk concentration' that goes beyond what the ground truth supports. MULTI-HOP REASONING: The LLM attempts to synthesize across 2022 and 2023 filings but introduces unsupported claims about guaranteed pricing structures and increased risk exposure that are not substantiated by the ground truth. The core comparison (customer eligibility narrowing) is correct, but the risk analysis is problematic. FACTUAL ACCURACY: The customer eligibility change is accurate; however, the claims about guaranteed pricing and increased exposure are either unsupported or contradicted by the ground truth's statement that impacts remained immaterial.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 504,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla moved the Semi from a purely announced concept to a vehicle in **pilot production** at its Nevada factory, signaling that limited manufacturing readiness had been achieved but full‑scale volume production was still pending.  The Semi is still positioned as a **strategic commercial‑vehicle offering** within Tesla’s lineup—intended to leverage the company’s battery, powertrain and autonomous‑driving technologies alongside upcoming models such as the Cybertruck and next‑generation platforms—while remaining secondary to the consumer‑focused models (e.g., Model Y, Cybercab) in the overall rollout schedule.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core facts: (1) Correctly identifies the 2022-2024 timeframe and the progression from announced concept to pilot production; (2) Accurately specifies Nevada facility as the location for pilot production; (3) Properly characterizes the strategic positioning within Tesla's lineup. Quantitative accuracy is high - no numeric errors, dates are correct, and the timeline progression is accurate. The multi-hop reasoning is sound, synthesizing information about Tesla's product development strategy across the two-year period. The answer goes beyond the ground truth by adding contextual details about the Semi's strategic role (leveraging battery/powertrain/autonomous technologies, positioning relative to Cybertruck and consumer models), which demonstrates deeper understanding but is not contradicted by the original answer. Minor deduction: The ground truth emphasizes the shift from 'merely planning' to 'actively preparing for market entry,' while the LLM answer frames it as 'limited manufacturing readiness' with 'full-scale volume production still pending.' These are semantically equivalent and both accurate characterizations of pilot production status. The additional strategic context about the Semi being 'secondary to consumer-focused models' is reasonable inference from Tesla's product priorities but goes slightly beyond what the ground truth explicitly states. Overall, the answer is factually correct, well-reasoned, and appropriately addresses the multi-part question about production status and strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 440,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "\nThe valuation allowance recorded for the deferred‑tax assets tied to Altria’s Cronos investment rose only slightly—from roughly **$379 million in 2022 to $397 million in 2023 and $402 million in 2024**.  This modest increase shows that management continues to view the Cronos‑related tax assets as **more likely than not to remain unrealized** and therefore keeps a full valuation allowance on them.  In other words, Altria is signaling that it does not expect sufficient future taxable earnings from the Cronos stake to realize those deferred‑tax benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - $379 million in 2022, $397 million in 2023 (not explicitly in ground truth but consistent with the progression), and $402 million in 2024. The progression is accurate. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) how the valuation allowance evolved between 2022-2024, and (2) what this indicates about Altria's expectations regarding deferred tax asset realizability. ENTITY ACCURACY: Correctly identifies Altria, Cronos, and the specific financial metric (valuation allowance on deferred tax assets). REASONING: The multi-hop synthesis is sound - the LLM correctly connects the increasing valuation allowance to management's pessimistic outlook on future taxable earnings from the Cronos investment. The interpretation that the company maintains 'full valuation allowance' and expects assets to 'remain unrealized' is semantically equivalent to the ground truth's statement about 'significant uncertainty' and not expecting 'temporary difference to reverse in the foreseeable future.' MINOR NOTES: The LLM provides slightly more detailed interpretation by explicitly stating the 2023 figure ($397 million), which adds helpful context even though not required. The characterization of the increase as 'modest' is reasonable given the $23 million increase over two years. The semantic equivalence is strong - both answers convey that Altria maintains conservative expectations about realizing these tax benefits. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 434,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "\nBetween 2023 and 2024 Amgen’s accounting for its BeiGene stake shifted from the equity‑method to a fair‑value measurement with changes in fair value recognized directly in earnings. In 2023 the re‑measurement produced net gains that boosted “Other income (expense), net,” but in 2024 the same fair‑value approach generated net unrealized losses on the BeiGene investment, turning that line item negative and dampening overall earnings. Consequently, the financial impact of the BeiGene investment moved from a positive, gain‑driven contribution in 2023 to a drag on results in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Amgen's BeiGene investment evolution. STRENGTHS: (1) Correctly identifies the accounting method change from equity method to fair value in 2023, matching the ground truth exactly. (2) Accurately describes the 2023 outcome as net gains recognized in Other income (expense), net. (3) Correctly characterizes the 2024 outcome as net unrealized losses, also in Other income (expense), net. (4) Properly synthesizes the reversal narrative - from positive gains in 2023 to negative losses in 2024. (5) Uses appropriate financial terminology (fair-value measurement, unrealized losses, earnings impact). (6) Addresses both years comprehensively and shows clear understanding of the temporal evolution. MINOR CONSIDERATIONS: The LLM answer uses slightly more detailed language about the mechanics ('changes in fair value recognized directly in earnings') compared to the ground truth, but this is actually a helpful elaboration that enhances understanding without introducing inaccuracy. The phrase 'turning that line item negative' is a reasonable interpretation of the shift from gains to losses. No quantitative errors detected - no specific dollar amounts were provided in either answer, so no calculation verification was needed. The multi-hop reasoning is sound: the answer correctly synthesizes information across two fiscal years and two different accounting treatments to show the evolution of financial impact. All entities (Amgen, BeiGene, Other income/expense line item) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 440,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney re‑positioned Disney+ Hotstar from a stand‑alone, India‑focused DTC service that carried general‑entertainment, family and sports content to a distinct regional brand that is kept out of the company’s multi‑product bundles.  In 2023 the filing described Hotstar simply as “a DTC service primarily in India that offers general entertainment, family and sports programming,” whereas the 2024 filing notes that the former Star+ offering in Latin America was merged into a single Disney+ product and that Disney+ Hotstar remains a separate service (outside the U.S. and Canada) with its own branding and subscriber reporting.  Thus, Hotstar’s market strategy evolved to preserve its separate regional identity while the broader Disney+ portfolio was consolidated under a unified brand.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH CORE NARRATIVE: The LLM answer fundamentally misrepresents the evolution described in the ground truth. The ground truth states that Disney+ Hotstar was repositioned FROM a stand-alone service TO a distinct regional brand (implying consolidation/integration), while the LLM claims the opposite - that Hotstar was repositioned to be 'kept out of the company's multi-product bundles' and 'preserve its separate regional identity.' This is a critical semantic reversal of the actual strategic shift. CORRECT ELEMENTS: (1) The LLM correctly identifies that Star+ and Disney+ in Latin America were merged into a single Disney+ product by end of June 2024. (2) The LLM correctly notes that Disney+ Hotstar remains separate outside the U.S. and Canada. (3) The LLM correctly identifies the 2023 description of Hotstar as 'a DTC service primarily in India that offers general entertainment, family and sports programming.' INCORRECT/MISLEADING ELEMENTS: (1) The opening statement 'repositioned Disney+ Hotstar from a stand-alone, India-focused DTC service...to a distinct regional brand that is kept out of the company's multi-product bundles' contradicts the ground truth's characterization of the strategic shift toward consolidation. The ground truth emphasizes consolidation under the Disney+ umbrella, not separation from bundles. (2) The conclusion 'Hotstar's market strategy evolved to preserve its separate regional identity while the broader Disney+ portfolio was consolidated' misses the key point that the consolidation strategy applied differently to different regions - Latin America saw full consolidation while India/Southeast Asia maintained the Hotstar brand. MULTI-HOP REASONING: The LLM failed to properly synthesize the regional differences in consolidation strategy. The ground truth indicates a strategic shift toward consolidating services under Disney+ (as evidenced by Latin America), while maintaining regional branding where established (Hotstar in India/Southeast Asia). The LLM's framing suggests Hotstar was deliberately kept separate from bundles, which is not supported by the ground truth. QUANTITATIVE ACCURACY: The date (end of June 2024) is correct. No calculation errors present. QUALITATIVE ACCURACY: The reasoning is flawed due to the fundamental misinterpretation of the strategic direction and consolidation strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 631,
        "total_tokens": 2008
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "\nBetween 2023 and 2024 PayPal kept protection‑program costs on the books as a provision for transaction and credit losses, but the 2024 disclosure sharpened the focus on risk.  The company now reports a more granular loss‑rate metric, expands the scope of transactions covered by purchase‑and‑seller protection, and introduces new recovery tools—such as forward‑flow sales of BNPL receivables and tighter merchant‑recovery initiatives—while still noting that full recovery of disputed losses remains uncertain and can be affected by regulatory changes.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces specific mechanisms ('forward-flow sales of BNPL receivables,' 'tighter merchant-recovery initiatives,' 'more granular loss-rate metric') that are not mentioned in the ground truth. These appear to be fabricated details not supported by the original answer. (2) MISSING CORE INFORMATION: The ground truth emphasizes that in 2023, PayPal 'did not provide a separate service to customers under these programs' and that costs were recorded in 'transaction and credit losses.' The LLM fails to capture this important distinction about the nature of the programs. (3) INCOMPLETE SYNTHESIS: The ground truth highlights PayPal's shift toward 'more explicit risk acknowledgment' and notes challenges in 'recovering losses from merchants, especially in cases involving fraud or merchant insolvency.' The LLM mentions recovery uncertainty but misses the specific merchant recovery challenges and fraud/insolvency context. (4) HALLUCINATED DETAILS: The mention of 'forward-flow sales of BNPL receivables' and specific 'new recovery tools' cannot be verified against the ground truth and appear to be LLM fabrications. (5) PARTIAL ACCURACY: The LLM correctly identifies that protection program costs remain on the books and that regulatory changes are a concern, which aligns with the ground truth. However, these correct elements are overshadowed by the inaccurate additions. The answer demonstrates weak multi-hop reasoning by introducing unsupported mechanisms rather than accurately synthesizing the actual evolution described in the ground truth (shift from minimal disclosure to more explicit risk acknowledgment).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 486,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "\nFrom 2022 through 2024 NextEra shifted most solar assets from direct ownership to a “Class B‑membership” structure in which it retained a controlling interest but sold the economic upside (and, in some cases, redemption rights) to third‑party investors; these interests are reported as non‑controlling or, when redemption features exist, as redeemable non‑controlling interests on the balance sheet.  Because the projects are now consolidated variable‑interest entities, NextEra’s financial exposure is limited to contingent obligations—such as the potential repurchase of sold assets or return of proceeds (up to roughly $668 million) and payments tied to the achievement of commercial‑operation dates or a solar production‑tax‑credit—rather than to full equity ownership.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a different but partially complementary perspective on NextEra's solar strategy evolution. STRENGTHS: (1) Correctly identifies the shift from direct ownership to a more complex structure involving non-controlling interests and VIEs; (2) Accurately describes the 'Class B-membership' structure and the retention of controlling interest while selling economic upside; (3) Correctly identifies that projects are consolidated as VIEs; (4) Appropriately characterizes financial exposure as limited to contingent obligations rather than full equity ownership; (5) Mentions the $668 million contingent obligation figure. WEAKNESSES: (1) The LLM answer does NOT mention the specific 2022 transactions cited in ground truth (100% ownership of 100 MW Arizona solar facility sale, 90% ownership portfolio sale of four facilities); (2) Does NOT provide the 765 MW capacity figure for consolidated VIEs mentioned in ground truth; (3) Does NOT mention the 10% direct ownership interest in additional solar facilities; (4) The $668 million figure appears in the LLM answer but is not verified in the ground truth provided, creating uncertainty about its accuracy; (5) The answer focuses heavily on the structural mechanism (Class B-membership) but provides less detail on the actual evolution of ownership percentages and facility counts. MULTI-HOP REASONING: The LLM successfully synthesizes the relationship evolution across the 2022-2024 period and correctly identifies the strategic shift, but misses key quantitative details that demonstrate the scope of this transformation. The reasoning about financial exposure through VIEs and contingent obligations is sound and represents a more nuanced understanding than the ground truth summary, but this doesn't compensate for missing specific transaction details and capacity figures. QUANTITATIVE ISSUES: The $668 million figure needs verification; the absence of the 765 MW capacity and specific ownership percentages (100%, 90%, 10%) represents incomplete quantitative coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 549,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 the balance of ACN’s mutual‑fund debt‑security holdings in its non‑U.S. defined‑benefit plans was essentially unchanged – $379,989 million (shown as a Level 2 item) in both years – indicating only a modest, flat evolution of the position.  The valuation methodology did not shift; the securities remained classified as Level 2 in the fair‑value hierarchy, continue to be measured using quoted prices for similar instruments in active markets.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM states the balance was '$379,989 million' in both 2022 and 2023, claiming it was 'essentially unchanged' and 'flat.' This is completely incorrect. The ground truth shows: 2022: $379,989 (not million), 2023: $253,025 (not million). The actual change is a DECREASE of $126,964 (33.4% reduction), not 'flat' or 'unchanged.' The LLM appears to have misread the units and failed to recognize the significant year-over-year decline. (2) ENTITY/METRIC CONFUSION: The LLM incorrectly adds 'million' to the figures, suggesting these are in millions of dollars when the ground truth values are already in thousands or base units. This unit error is critical and makes all numerical comparisons invalid. (3) MULTI-HOP REASONING FAILURE: The question explicitly asks 'how did...evolve from 2022 to 2023' - requiring a comparison showing change. The LLM failed to perform this basic comparison and instead claimed no meaningful change occurred. (4) SEMANTIC CONTRADICTION: The ground truth explicitly states 'this investment decreased to $253,025' while the LLM claims the balance was 'essentially unchanged' in 'both years.' These are directly contradictory statements. (5) PARTIAL CREDIT: The LLM correctly identified that the valuation methodology remained Level 2 in both years and correctly described the Level 2 methodology (observable market data/quoted prices for similar instruments). However, this correct element cannot offset the fundamental failure to accurately report the primary quantitative finding - the significant decrease in investment value. The answer demonstrates a critical failure in multi-hop synthesis and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 488,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "\nChevron’s equity stake in Tengizchevroil remained at 50 percent, but the carrying value of its investment rose from **$26.5 bn (2022)** to **$26.9 bn (2023)**, and the share of earnings generated by the affiliate increased from **$2.83 bn (2022)** to **$3.38 bn (2023)**.  This growth reflects a modest increase in the loan to TCO (still about $4.5 bn) and higher earnings from the Tengiz and Korolev fields, underscoring a deepening financial involvement in the joint venture over the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significantly incorrect financial figures that contradict the ground truth. (1) CARRYING VALUE ERROR: LLM states carrying value rose from $26.5 bn (2022) to $26.9 bn (2023), but ground truth shows 2022 carrying value was $23,727 million ($23.727 bn), not $26.5 bn. The LLM overstates 2022 value by ~$2.8 billion. (2) EARNINGS ERROR: LLM claims earnings increased from $2.83 bn (2022) to $3.38 bn (2023), but ground truth shows 2022 equity in earnings was $1,238 million ($1.238 bn), not $2.83 bn. The LLM overstates 2022 earnings by ~$1.6 billion. (3) MISSING KEY INFORMATION: LLM fails to mention the critical 2023 disclosure about carrying value being approximately $80 million higher than underlying equity in net assets, which represents a significant change in valuation approach between years. (4) LOAN AMOUNT: LLM correctly identifies the $4.5 billion loan to Tengizchevroil for FGP/WPMP projects, which aligns with ground truth. (5) EQUITY STAKE: LLM correctly notes the 50% equity stake remained constant. (6) MULTI-HOP REASONING: While the LLM attempts to synthesize information about financial involvement evolution, the foundation is built on incorrect numbers, making the overall analysis unreliable. The ground truth emphasizes a 'significant deepening' through the loan provision and valuation complexity, while LLM focuses on modest carrying value increases based on false data. The answer demonstrates poor quantitative accuracy with fundamental calculation/data retrieval errors that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 431,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Disney has tightened ABC Network’s role as the primary broadcast outlet for its sports content, explicitly funding ESPN’s programming on ABC and positioning the network to carry the upcoming joint‑venture sports‑DTC service (Venu Sports) and a 2025 live‑stream offering of ESPN channels.  At the same time, ABC continues to generate strong affiliate‑fee and advertising revenue, reinforcing its status as a strategic bridge that links Disney’s traditional linear‑network business to its expanding direct‑to‑consumer and multi‑platform entertainment ecosystem.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to address the core evolution described in the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims ABC Network's role 'tightened' around sports content and ESPN programming, but the ground truth makes no mention of this sports-focused positioning. The ground truth emphasizes ABC's traditional linear networks role in 2023 and its shift toward DTC integration in 2024. (2) UNSUPPORTED CLAIMS: References to 'Venu Sports' and '2025 live-stream offering of ESPN channels' are not mentioned in the ground truth and appear to be hallucinated or confused with other Disney initiatives. (3) MISSING CORE EVOLUTION: The LLM completely omits the key strategic shift identified in the ground truth - the integration of ABC content into Hulu (one day after linear airing) and the move away from traditional linear distribution toward DTC platforms. (4) INCOMPLETE SYNTHESIS: While the LLM mentions affiliate fees and advertising revenue (which aligns with 2023 positioning), it fails to capture the 2024 shift toward streaming service contribution emphasized in the ground truth. (5) SEMANTIC MISMATCH: The ground truth describes a shift FROM linear emphasis TO digital integration; the LLM describes a tightening around sports/ESPN, which is a different narrative entirely. The answer demonstrates poor multi-hop reasoning by not synthesizing the actual evolution between the two years as documented in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 411,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "\nBetween 2022 and 2023 General Dynamics shifted the ASCOD from a peripheral “offered” tracked vehicle in the European Land Systems lineup to a highlighted, export‑focused centerpiece of that portfolio—explicitly calling it a “highly versatile tracked combat vehicle” and tying it to the company’s broader investment in robotic/autonomous platforms.  This emphasis, together with the rise in Combat Systems revenue (military‑vehicle sales up from $4.7 B in 2021 to $5.0 B in 2023) and the growing backlog of vehicle programs, signals that GD is reallocating production capacity and R&D spend toward tracked combat‑vehicle development (including ASCOD and related variants) to capture export growth and modernize its land‑systems focus.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains significant factual errors: (1) DIRECTIONAL ERROR: The ground truth states ASCOD positioning DECLINED from 'producing and upgrading' (2022) to merely 'offering' (2023), indicating reduced investment. The LLM claims the opposite—that ASCOD was elevated to a 'highlighted, export-focused centerpiece' with increased investment. This is a complete reversal of the actual trend. (2) QUANTITATIVE ISSUES: The LLM cites Combat Systems revenue growth from $4.7B (2021) to $5.0B (2023), but this is presented as evidence of ASCOD investment increase. However, the ground truth indicates ASCOD focus actually decreased while other programs (Piranha 5, AJAX) received continued emphasis. The revenue growth doesn't support the LLM's narrative about ASCOD becoming a centerpiece. (3) UNSUPPORTED CLAIMS: The LLM makes specific assertions about ASCOD being called 'highly versatile tracked combat vehicle' and being tied to 'robotic/autonomous platforms' without ground truth support. These characterizations appear fabricated or misattributed. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the 2022-2023 language shift. The ground truth explicitly notes the shift FROM 'producing and upgrading' TO 'offering'—a clear de-emphasis. The LLM inverted this relationship entirely. (5) MISSING KEY INSIGHT: The ground truth's core finding—that resource reallocation moved AWAY from ASCOD toward Piranha 5 and AJAX—is completely absent from the LLM answer. Instead, the LLM argues for increased ASCOD investment. This represents a fundamental misunderstanding of the question and the available evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 461,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the pool of European customer balances that PayPal can earmark for credit‑funding fell sharply—from about **$3.0 billion (≈ 39 % of European balances)** in 2023 to **$2.0 billion (≈ 26 % of European balances)** in 2024.  This reduction shows that PayPal is pulling back on its reliance on internal customer deposits as a source of credit capital and is instead leaning more on external financing (e.g., debt issuances, partnership funding) to support its loan and advance portfolios.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies all key quantitative facts: $3.0 billion (39%) in 2023 declining to $2.0 billion (26%) in 2024 for European customer balances approved for credit activities. The numerical values, percentages, and year-over-year comparison are accurate. The reasoning about PayPal shifting away from customer balance reliance toward external financing is sound and logically presented. However, the answer has a significant omission: it fails to mention the specific evidence provided in the ground truth about PayPal's multi-year agreement to sell consumer installment receivables, which showed $20.8 billion in loans sold in 2024 versus $5.5 billion in 2023. This concrete data point is crucial to substantiating the claim about external financing strategy and represents a material gap in the multi-hop synthesis. The LLM provides general examples of external financing (debt issuances, partnership funding) but misses the specific, quantifiable evidence from the filings. The answer is directionally correct and addresses the core question about the strategic shift, but lacks the comprehensive evidence that would elevate it to a complete answer. The semantic equivalence is strong (customer deposits = customer balances), and the reasoning quality is good, but the incompleteness prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 371,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "\nBetween the 2022 filing (which reports the 2021 year‑end balances) and the 2024 filing (which reports the 2024 year‑end balances), equity securities held in NEE’s Special Use Funds remained classified almost entirely as Level 1 or Level 2 in 2022—$2,538 M and $2,973 M for NEE, and $862 M and $2,690 M for FPL, with $0 M in Level 3. By 2024 the same funds showed a non‑zero Level 3 balance of $229 M for NEE and $204 M for FPL, while total equity holdings grew modestly (e.g., NEE’s equity securities rose from $5,511 M to $6,164 M).  \n\nThe emergence of a Level 3 component indicates that a larger share of the fund’s equity investments is now valued using unobservable inputs and significant management judgment, reflecting a shift toward more complex, less‑transparent assets in the fund’s composition.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth across multiple dimensions:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - Ground truth: 2022 NEE equity securities = $906M (carrying amount); 2024 NEE = $2,614M Level 1\n   - LLM claims: 2022 NEE = $5,511M total ($2,538M Level 1 + $2,973M Level 2); 2024 NEE = $6,164M\n   - These numbers are completely different from ground truth and appear to reference different years or incorrect data\n   - Ground truth: 2022 FPL = $672M; 2024 FPL = $1,028M Level 1\n   - LLM claims: 2022 FPL = $3,552M ($862M Level 1 + $2,690M Level 2); 2024 FPL = unspecified but with $204M Level 3\n   - The 2022 figures in the LLM answer are roughly 5x larger than ground truth values\n\n2. ENTITY/TEMPORAL ACCURACY:\n   - LLM incorrectly states \"2022 filing (which reports the 2021 year-end balances)\" - this is confusing and appears to conflate different reporting periods\n   - Ground truth clearly specifies 2022 vs 2024 year-end balances\n   - The LLM's reference to 2021 year-end balances in a 2022 filing is misleading\n\n3. CATEGORIZATION ACCURACY:\n   - Ground truth: 2022 had NO detailed Level 1/2/3 breakdown; 2024 introduced granular disclosures\n   - LLM claims: 2022 already had Level 1/2/3 categorization ($2,538M Level 1, $2,973M Level 2, $0M Level 3)\n   - This directly contradicts the ground truth statement that 2022 lacked \"detailed categorization by valuation levels\"\n   - LLM correctly identifies Level 3 emergence in 2024 but with wrong base numbers\n\n4. INTERPRETATION OF TRANSPARENCY:\n   - Ground truth: Evolution shows INCREASED transparency (from no breakdown to detailed Level 1/2/3 disclosure)\n   - LLM: Correctly identifies Level 3 emergence but frames it as \"shift toward more complex, less-transparent assets\" rather than improved transparency in reporting\n   - The LLM's interpretation of what Level 3 means is reasonable, but it misses the primary point about improved disclosure transparency\n\n5. MULTI-HOP REASONING:\n   - The LLM failed to correctly synthesize the 2022 vs 2024 comparison\n   - The answer uses entirely different baseline numbers that don't match the ground truth\n   - This suggests the LLM either accessed different source data or made significant calculation errors\n\nThe answer is fundamentally incorrect on the core quantitative facts needed to answer this question. While the LLM demonstrates some understanding of valuation levels and their implications, the numerical foundation is so flawed that the entire analysis is unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 682,
        "total_tokens": 2077
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 the company broadened the scope of its share‑repurchase authority – the open‑market program’s available authorization rose from $3.1 bn (as of Aug 2022) to about $6.1 bn after the September 2022 Board approval and continued to expand in FY 2023 – and increased the volume of purchases executed under that public program (≈2.0 million shares in Q4 FY 2023 versus 1.96 million shares in Q4 FY 2022).  At the same time, shares acquired through employee‑related transactions remained a tiny, separate slice of the total (roughly 0.1 million shares each year, acquired incidentally for payroll‑tax withholding and not part of the announced program).  Consequently, the public repurchase program’s utilization grew markedly, while employee‑related acquisitions stayed minimal and unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core narrative - that public program activity increased while employee-related transactions remained minimal and separate. The qualitative characterization of the shift is accurate. The LLM correctly notes that employee-related shares (roughly 0.1 million per year) are separate from the announced program and relate to payroll tax withholding.\n\nCRITICAL ERRORS: (1) The LLM states approximately 2.0 million shares were purchased in Q4 FY 2023 under the public program, but the ground truth explicitly states 'there is no mention of shares purchased under the public program' in fiscal 2023. This is a major factual error - the LLM appears to have fabricated or misinterpreted data about FY 2023 public program activity. (2) The LLM provides authorization amounts ($3.1bn, $6.1bn) that are not mentioned in the ground truth and cannot be verified against it. (3) The LLM references 'Q4 FY 2023' and 'Q4 FY 2022' comparisons, but the ground truth provides full-year FY 2022 data (1,964,612 shares for $576M) without quarterly breakdowns or any FY 2023 public program data.\n\nPARTIAL ACCURACY: The employee-related transaction figures (roughly 0.1 million shares, approximately 97,251 shares in FY 2022) align reasonably with ground truth. The characterization of these as minimal and unchanged is correct.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize evolution across fiscal years but fails on the key finding - it incorrectly claims increased public program activity in FY 2023 when the ground truth indicates no public program activity that year. This represents a fundamental failure in multi-hop synthesis.\n\nCONCLUSION: While the LLM captures the general narrative structure and correctly identifies employee-related transactions as separate and minimal, it makes a critical error by claiming FY 2023 public program activity when none is documented in the ground truth. The authorization figures appear unsupported. The answer is partially correct but contains significant factual inaccuracies that undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 560,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "\nBetween 2022 and 2023 Chevron continued to treat Chevron Phillips Chemical Company LLC (CPChem) as an **equity‑method investment**—it was never consolidated into Chevron’s financial statements.  The company’s share of CPChem’s earnings fell from **$1.662 billion in 2022 to $1.173 billion in 2023**, and the carrying amount of the investment reflected this change (CPChem’s net equity rose from $13.569 bn to $14.683 bn), but the reporting approach and consolidation status remained unchanged.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. Key issues: (1) CORE FACTUAL ERROR: The LLM states CPChem 'was never consolidated into Chevron's financial statements' and 'the reporting approach and consolidation status remained unchanged,' but the ground truth explicitly states that in 2022 CPChem WAS consolidated (evidenced by 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among consolidated subsidiaries), and in 2023 it transitioned to equity method accounting. This is a complete reversal of the actual evolution described in the ground truth. (2) MISUNDERSTANDING OF THE QUESTION: The question asks how the relationship 'evolved' between 2022 and 2023, implying a change. The ground truth identifies a significant structural change (consolidation → equity method). The LLM incorrectly claims no change occurred. (3) QUANTITATIVE DATA: While the LLM provides specific numbers ($1.662B in 2022, $1.173B in 2023, equity values of $13.569B and $14.683B), these cannot be verified against the ground truth which does not provide these specific figures. However, the presentation of these numbers as supporting 'unchanged reporting approach' is misleading given the actual consolidation status change. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to synthesize the key information that the consolidation status changed between years—this is the central point of the question. The answer demonstrates a fundamental misunderstanding of Chevron's accounting treatment evolution for this investment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 430,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "\nFrom 2022 into 2023 the Hydra‑70 rocket line moved from a single, modest $175 million production award (recorded in the 2021 Combat Systems contract list) to a strategic growth area for General Dynamics.  In 2023 OTS received new awards that explicitly expand its metal‑parts production from 18 k to 86 k rounds per month by 2025 and its propellant capacity from 4 M to 16 M lb/yr by 2028, signaling a deeper contract involvement and a planned scale‑up of Hydra‑70 output to meet rising Army and international demand.  This reflects a shift from a one‑off contract to an ongoing, capacity‑expansion‑focused commitment within the Combat Systems segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the $175 million contract from 2022, correctly names OTS (Orbital Technologies Corporation) as the relevant entity within Combat Systems, and accurately captures the core narrative of evolution from a single contract to capacity expansion. The qualitative framing of the shift from 'one-off contract to ongoing, capacity-expansion-focused commitment' is sound and well-reasoned. The answer appropriately addresses the multi-hop synthesis required (2022 contract → 2023 evolution → capacity expansion). CRITICAL ERRORS: (1) The LLM introduces propellant capacity expansion (4M to 16M lb/yr by 2028) which is NOT mentioned in the ground truth answer. This appears to be either fabricated or sourced from information not in the provided knowledge graph. (2) The LLM states the $175M contract was 'recorded in the 2021 Combat Systems contract list' - the ground truth clearly states it was received in 2022, not 2021. This is a factual error regarding the timing. (3) The metal parts production numbers (18k to 86k rounds per month by 2025) are correct and match ground truth. QUANTITATIVE ACCURACY ISSUES: While the core numbers that appear in ground truth are correct, the introduction of the propellant capacity metric (4M to 16M lb/yr by 2028) without ground truth support is problematic. The date attribution error (2021 vs 2022) for the original contract is a clear factual mistake. MULTI-HOP REASONING: The synthesis across 2022-2023 is logically sound, but the addition of unsupported information undermines confidence in the answer's reliability. The answer demonstrates good understanding of the question's structure but fails on factual precision in key details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 468,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "\nIn the 2023 Form 10‑K the Global Restricted Stock Unit Award Grant Notice was disclosed only as Exhibit 10.07+, a form that had been originally filed in 2015 and incorporated by reference; the notice itself was not separately reproduced in the 2023 filing. By the 2024 filing the same exhibit remains, but it is now presented as part of the “PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, as Amended and Restated” (Exhibit 10.03+) and is accompanied by a new Exhibit 10.08+ for performance‑based RSUs, showing that the grant‑notice language has been formally updated and explicitly incorporated into the current plan documentation.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements. CORRECT ELEMENTS: (1) The identification of Exhibit 10.07+ for the Global Restricted Stock Unit Award Grant Notice in both 2023 and 2024 is accurate. (2) The reference to the 2015 Equity Incentive Award Plan is correct. (3) The mention of Exhibit 10.08+ for performance-based RSUs in 2024 is accurate. (4) The general observation that the base RSU grant notice remained relatively unchanged while performance-based variants saw updates is directionally correct. PROBLEMATIC ELEMENTS: (1) The LLM states the 2024 exhibit is 'now presented as part of the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, as Amended and Restated (Exhibit 10.03+)' - this conflates the exhibit structure. The ground truth indicates Exhibit 10.07+ remained associated with the 2015 plan incorporated by reference from the May 14, 2015 10-12B/A filing in both years, not that it was newly presented as part of Exhibit 10.03+ in 2024. (2) The LLM claims the grant-notice language 'has been formally updated and explicitly incorporated into the current plan documentation' - the ground truth indicates the base RSU notice (10.07+) remained unchanged between years, with only the performance-based variant (10.08+) seeing active revision. (3) The LLM's characterization that the notice was 'not separately reproduced in the 2023 filing' is accurate but this detail doesn't clearly distinguish the evolution between years. MULTI-HOP REASONING: The LLM partially synthesizes the comparison between 2023 and 2024 but mischaracterizes the structural relationship and overstates the degree of change in the base RSU notice. The key distinction in the ground truth - that the base notice remained stable while the performance-based variant was updated - is somewhat muddled in the LLM response. QUANTITATIVE ACCURACY: Dates and exhibit numbers are correct (10.07+, 10.08+, May 14, 2015, April 30, 2024 reference). The numeric/date elements are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 536,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "\nOpdivo’s sales have risen steadily—from $6.99 bn in 2020 to $7.52 bn in 2021 and continued double‑digit growth through 2022‑2024—while the brand accumulated a series of new regulatory milestones (FDA approval of the subcutaneous formulation Opdivo Qvantig in Dec 2024, EC approval of the Opdivo + Yervoy first‑line colorectal‑cancer combo, Japan approvals for urothelial‑cancer and other indications, and expanded uses in melanoma, NSCLC and renal cancer).  These approvals broadened Opdivo’s therapeutic footprint and cemented its position as BMS’s flagship immuno‑oncology franchise and a primary growth engine within the company’s portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides revenue figures ($6.99bn in 2020, $7.52bn in 2021) that are NOT in the ground truth and appear to be fabricated or from unreliable sources. The ground truth only confirms $7,523 million ($7.523bn) for 2022. The LLM claims 'double-digit growth through 2022-2024' but provides no 2023 or 2024 revenue figures, contradicting its own assertion. (2) REGULATORY APPROVALS - The LLM mentions several approvals NOT mentioned in the ground truth: FDA approval of Opdivo Qvantig (subcutaneous formulation) in Dec 2024, EC approval for colorectal cancer combo, Japan approvals. The ground truth only mentions the March 2024 FDA approval for urothelial carcinoma in combination with cisplatin and gemcitabine. The LLM appears to have hallucinated or conflated multiple approvals. (3) MULTI-HOP REASONING - The LLM fails to properly synthesize the 2022-2024 evolution as requested. It jumps backward to 2020-2021 data not in the ground truth, then forward to 2024 with unverified approvals. The ground truth explicitly states 'despite not showing a significant revenue increase from earlier years,' which the LLM contradicts by claiming 'steady rise' and 'double-digit growth.' (4) ENTITY/METRIC ERRORS - The LLM mentions 'Opdivo Qvantig' and 'Yervoy' combinations without ground truth support. The colorectal cancer approval is not mentioned in the ground truth. (5) SEMANTIC ISSUES - While the LLM correctly identifies Opdivo as a flagship franchise, it fundamentally misrepresents the revenue trajectory and invents regulatory milestones. The answer is partially relevant to the question but contains substantial factual inaccuracies that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 469,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "\nChevron’s equity stake in Chevron Phillips Chemical Company LLC grew from $6.84 billion at the end of 2022 to $7.77 billion in 2023, reflecting an incremental capital infusion.  This additional funding was directed toward the two flagship CPChem projects that received final investment decisions in 2021—a 266 kt/yr on‑purpose 1‑hexene unit at Old Ocean, Texas, and a new C3 splitter at Cedar Bayou, Texas—both slated for start‑up in 2023.  Chevron kept its 50 % ownership structure but expanded the investment mix to include extra equity contributions and project‑specific loans to support these downstream petrochemical expansions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific equity stake values ($6.84B in 2022 and $7.77B in 2023) that are NOT mentioned in the ground truth and cannot be verified. These numbers appear fabricated. The ground truth does not cite any equity stake valuations. (2) MISSING CRITICAL INFORMATION - The LLM completely omits the most important 2023 development: Chevron's direct $387 million loan to fund the Golden Triangle Polymers Project in Orange, Texas (in which CPChem owns 51%). This is a key structural shift from 2022 to 2023 that the ground truth explicitly highlights as the main evolution. (3) PROJECT DETAILS - While the LLM correctly identifies the 1-hexene unit at Old Ocean and C3 splitter at Cedar Bayou with 2023 start-ups, it attributes these to 2021 final investment decisions rather than 2022 announcements. The ground truth emphasizes these as 2022 highlights. (4) STRUCTURAL EVOLUTION - The ground truth's core insight is the shift from 'general equity ownership and project announcements in 2022' to 'direct financial support and structured investment in specific projects in 2023.' The LLM mentions 'project-specific loans' vaguely but fails to identify the specific $387M loan to Golden Triangle Polymers as the defining 2023 development. (5) OWNERSHIP STRUCTURE - The LLM correctly maintains the 50% ownership for CPChem generally, but misses that the Golden Triangle Polymers Project involves a different ownership structure (CPChem owns 51%). The answer demonstrates partial understanding of the general investment trajectory but introduces unverified numbers and critically omits the most significant 2023 development that directly answers the question about how involvement 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 475,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 PayPal’s protection‑program reserves grew substantially – the allowance for transaction losses rose from **$64 million (2023) to $86 million (2024)** and the allowance for negative customer balances increased from **$218 million to $256 million**.  The 2024 filing now provides a detailed roll‑forward table (beginning balance, provision, realized losses, recoveries, ending balance) that explicitly discloses these movements and notes that the costs are recorded as transaction and credit losses at the time each payment is completed, reflecting both a larger financial commitment to covering potential losses and more transparent quantitative disclosures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative figures are correct: allowance for transaction losses ($64M in 2023 to $86M in 2024) and allowance for negative customer balances ($218M to $256M). The multi-hop synthesis is sound, correctly identifying the evolution of PayPal's protection programs across the two fiscal years. The answer goes beyond the ground truth by providing additional context about the roll-forward table and the timing of cost recognition (at payment completion), which adds valuable detail without contradicting the original answer. The reasoning is logically sound - the model correctly synthesizes that these increases represent both larger financial commitments and more transparent disclosures. The only minor distinction is that the LLM provides slightly more granular detail about the disclosure methodology (roll-forward table, cost recording timing) compared to the ground truth, but this is additive and accurate rather than contradictory. All entities (PayPal, years 2023-2024, specific reserve categories) are correctly identified. The semantic equivalence is strong - both answers convey the same core message about increased reserves and improved disclosures. No calculation errors are present, and the answer directly addresses all aspects of the question regarding financial commitments and disclosure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 386,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s continued to present franchising as the core of its business, but the way it described the franchise‑franchisee relationship grew more strategic.  In the 2022 filing the company merely noted that it “may co‑invest with franchisees to fund improvements” and that the heavily franchised model “generates stable and predictable revenue,” whereas the 2024 filing explicitly frames co‑investment as a deliberate partnership tool that “accelerates implementation of initiatives, modernizes restaurants and drives shared growth,” positioning franchising not just as a revenue source but as a collaborative platform for long‑term value creation.  This shift underscores a move from a descriptive view of co‑investment to a proactive, strategic emphasis on partnership‑driven expansion.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the strategic shift in McDonald's framing between 2022 and 2024. STRENGTHS: (1) Correctly identifies the core evolution from neutral/descriptive language to strategic/value-laden framing; (2) Accurately captures the shift in how co-investment is presented (from 'may co-invest' to deliberate partnership tool); (3) Properly synthesizes the multi-hop comparison across two years; (4) Uses appropriate supporting language ('accelerates implementation,' 'modernizes restaurants,' 'shared growth') that aligns with the ground truth's characterization of the 2024 framing; (5) Correctly identifies franchising as 'paramount' concept (implied through 'core of its business' and strategic emphasis). MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly use the word 'paramount' which appears in the ground truth as a key descriptor of the 2024 framing; (2) The 2022 characterization could be slightly more precise - the ground truth emphasizes 'neutral, structural terms' and 'division of responsibilities,' while the LLM focuses more on the revenue generation aspect; (3) The answer could more explicitly state that franchisees are presented as 'co-participants' in 2022 vs. strategic partners in 2024. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are required for this qualitative question, so this dimension scores high. QUALITATIVE ACCURACY: The reasoning is sound and the multi-hop synthesis across years is correct, though the characterization of 2022 framing could be slightly more nuanced. CONTEXTUAL RELEVANCE: The answer directly addresses all aspects of the question regarding the strategic framing change and the role of franchisee co-investment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 471,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "\nThe FDA’s stance on Marlboro HeatSticks shifted markedly between 2022 and 2023.  In the 2022 filing (MO 10‑K 2022, pp. 35‑39) the company notes that, after the September 2021 ITC cease‑and‑desist order that removed the product from the U.S. market, the FDA **authorized in March 2022 three new tobacco‑flavored HeatStick PMTAs** and extended the IQOS 3 marketing order as a Modified‑Risk Tobacco Product.  The 2023 filing (MO 10‑K 2023, pp. 33‑37) reports that the FDA **continued to recognize IQOS 3 as an MRTP and granted post‑market surveillance approvals**, reinforcing the earlier 2022 authorizations.  \n\nTogether, these actions show that Altria moved from a regulatory setback to securing FDA marketing authorizations for its heated‑tobacco products, indicating tangible regulatory progress in getting Marlboro HeatSticks back onto the U.S. market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a significant factual error regarding the timeline of FDA authorization. The LLM claims the FDA 'authorized in March 2022 three new tobacco-flavored HeatStick PMTAs,' but the ground truth states that by 2022, the FDA had NOT yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis. The ground truth clearly indicates that the FDA authorization of three new tobacco-flavored varieties occurred in January 2023, not March 2022. This is a fundamental dating error that undermines the entire answer. The LLM also mischaracterizes the 2022 status by claiming authorizations occurred in 2022 when they actually occurred in 2023. The reference to a September 2021 ITC cease-and-desist order is not mentioned in the ground truth and appears to be an unsupported detail. While the LLM correctly identifies that regulatory progress occurred and that IQOS 3 received MRTP recognition, the core claim about the timing of HeatSticks authorization is factually incorrect. The answer does address the multi-hop nature of comparing 2022 vs 2023 filings, but the synthesis is flawed due to the date error. The conclusion about 'moving from regulatory setback to securing FDA marketing authorizations' is reasonable in spirit but is based on incorrect temporal placement of events.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 374,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "\nThe fair‑value of ACN’s mutual‑fund equity securities rose from **$239 million at the end of fiscal 2022 to $274 million at the end of fiscal 2023**, an increase of roughly **14 %**. This jump reflects a deliberate shift toward a larger equity allocation in the company’s defined‑benefit pension portfolio, moving the assets closer to the 2023 target of **27 % equity** for non‑U.S. plans and signalling a strategic emphasis on growth‑oriented investments within that asset class.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all critical factual dimensions. (1) QUANTITATIVE ERRORS - The LLM states mutual fund equity securities were $239 million in 2022 and $274 million in 2023, but the ground truth shows $239,293 million in 2022 and $196,226 million in 2023. The LLM's numbers are off by a factor of 1,000 (missing three zeros). The LLM claims an increase of roughly 14%, but the ground truth shows a DECREASE of $43,067 million (approximately 18% decline). The direction of change is completely reversed. (2) CALCULATION ERRORS - The LLM's percentage calculation (14% increase) is mathematically inconsistent with even its own stated numbers ($239M to $274M would be ~14.6% increase), but more critically, it contradicts the ground truth which shows a clear decline. (3) ENTITY/METRIC ACCURACY - While the LLM correctly identifies ACN and mutual fund equity securities, it misidentifies the magnitude and direction of the valuation change. The reference to pension portfolio allocation targets and non-U.S. plans appears to be contextual information not supported by the ground truth answer. (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the year-over-year comparison. The conclusion about 'strategic emphasis on growth-oriented investments' contradicts the actual data showing a reduction in this asset class. The ground truth explicitly states the decline 'suggests a strategic shift or reallocation away from mutual fund equity securities,' which is the opposite of what the LLM concluded. This is a critical failure in both data accuracy and logical reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 441,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "\nChevron’s 36.4 % interest in Angola LNG Limited was unchanged from 2022 to 2023, but the company’s focus moved from simply keeping the Soyo plant running to actively developing the offshore gas that feeds it. In 2022 the emphasis was on sustaining plant throughput and tying in associated gas; by 2023 the emphasis shifted to investing in non‑associated gas discoveries and related infrastructure (e.g., the SLGC tie‑in project) to boost feedstock volume and expand LNG export capacity.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ACCURACY: The 36.4% interest figure is correct and matches ground truth. However, the LLM introduces specific operational details (Soyo plant, SLGC tie-in project, offshore gas development) that are NOT present in the ground truth and appear to be fabricated. (2) QUALITATIVE ACCURACY - MAJOR PROBLEM: The ground truth explicitly states the shift was from 'operational development' focus in disclosure to 'financial stake and integration within Chevron's global portfolio' - a shift in HOW information was disclosed, not in actual operational strategy. The LLM fundamentally misrepresents this as an actual operational shift from 'sustaining plant throughput' to 'developing offshore gas discoveries.' This is a semantic inversion of the ground truth. The ground truth indicates the company's actual operations remained stable (same 36.4% interest), but the disclosure emphasis changed. The LLM claims the operational focus itself changed. (3) ENTITY/CONTEXT ACCURACY: The LLM introduces specific project names (Soyo plant, SLGC tie-in) and operational details that cannot be verified in the ground truth and appear to be hallucinated. The ground truth mentions 'processing and liquefying associated natural gas' and 'developing non-associated gas resources' but does NOT specify these as a shift in emphasis between years - rather, both were mentioned as ongoing activities in 2022. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the key insight from the ground truth: the evolution was in disclosure/reporting emphasis, not operational strategy. The answer conflates disclosure changes with operational changes, which is a fundamental misunderstanding of the source material. The LLM's answer reads plausibly but is factually unsupported by the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 515,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "\nFrom 2022 to 2023 the amount of 3M’s investment in certificates of deposit/time deposits rose from **$21 million** (2022) to **$49 million** (2023).  This reflects an **increase of $28 million**, or roughly a **130 %‑140 % jump** in the size of the holding.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains critical factual errors in the primary numbers that undermine the entire response. (1) QUANTITATIVE ACCURACY FAILURES: The 2022 figure is stated as $21 million in the LLM answer, but the ground truth clearly states $14 million. This is a $7 million discrepancy (50% error on the 2022 baseline). The 2023 figure of $49 million is correct. The calculated increase of $28 million is mathematically consistent with the LLM's incorrect 2022 figure ($49M - $21M = $28M), but this is wrong because the 2022 starting point is incorrect. The correct increase should be $35 million ($49M - $14M = $35M). The percentage calculation is also wrong: the LLM states 130%-140%, but the correct percentage is approximately 250% ($35M / $14M = 2.5 or 250%). (2) ENTITY AND METRIC ACCURACY: The company (MMM/3M) and metric (Certificates of Deposit/Time Deposits) are correctly identified. The years (2022 to 2023) are correct. (3) MULTI-HOP REASONING: The structure of the answer correctly addresses the evolution question by comparing two years and calculating the change, but the foundational data is wrong, making the synthesis invalid. (4) COMPLETENESS: The answer addresses all parts of the question (evolution, magnitude, percentage change), but with incorrect values. The most critical failure is the 2022 baseline figure being $21 million instead of $14 million, which cascades into incorrect calculations for both the absolute change and percentage change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 406,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "\nBetween 2021 and 2024 the proportion of McDonald’s restaurants operated by franchisees grew modestly—from roughly **93 % of the system at the end of 2021 to about 95 % by the end of 2024**. This slight increase shows that McDonald’s has continued to expand its franchise model as the dominant ownership structure across its worldwide network.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-aligned with the ground truth. (1) CORRECTNESS: All key facts are correct - the 93% franchised restaurants in 2021 and approximately 95% in 2024 match the original answer exactly. The characterization of this as a 'modest' or 'slight' increase is semantically equivalent to the ground truth's description. (2) QUANTITATIVE ACCURACY: Both percentage figures (93% and 95%) are precisely correct with no calculation errors. The time period (2021 to 2024) is accurately specified. (3) QUALITATIVE ACCURACY: The LLM correctly identifies this as part of McDonald's strategic shift toward franchising and accurately synthesizes the multi-hop information about the evolution of the franchisee relationship. The reasoning that this represents continued expansion of the franchise model is sound and matches the ground truth's interpretation. (4) CONTEXTUAL RELEVANCE: The answer directly addresses the question about how McDonald's relationship with franchisees has evolved in terms of percentage of franchised restaurants. The LLM appropriately emphasizes that this is a deliberate strategic direction. Minor differences in wording ('roughly' vs. 'approximately', 'modest' vs. 'slight') are stylistic variations that don't affect factual accuracy. The answer is complete, accurate, and provides appropriate context about the strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 385,
        "total_tokens": 1549
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "\nThe 2015 Stock Compensation Plan for Non‑Employee Directors was originally adopted in 2015 and restated with an effective date of October 28 2015.  In the 2022 filing the plan was again amended and restated, this time effective October 26 2022, which updated the share‑reserve language and other administrative provisions.  By the 2023 filing the plan remained the same but the remaining shares available under the reserve fell from 703,256 (at the end of 2022) to 589,927 (at the end of 2023), reflecting the shares used for prior awards.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) DATE ERRORS - The LLM states the plan was 'restated with an effective date of October 28 2015' and then 'amended and restated, this time effective October 26 2022' in the 2022 filing. However, the ground truth clearly indicates that in 2022, the plan was described as 'amended and restated effective March 31, 2021' - not October 26, 2022. The October 26, 2022 date only appears in the 2023 filing according to ground truth. This is a significant chronological error. (2) STRUCTURAL EVOLUTION MISCHARACTERIZATION - The LLM fails to capture the actual evolution described in the ground truth: the plan went from being effective March 31, 2021 (as stated in 2022) to being effective October 26, 2022 (as stated in 2023). The LLM incorrectly places the October 26, 2022 effective date in the 2022 filing rather than the 2023 filing. (3) INCOMPLETE ANSWER TO QUESTION - The question specifically asks about evolution 'between 2022 and 2023,' and the ground truth provides a clear before-and-after comparison. The LLM's answer conflates the timeline and adds information about share reserves (703,256 to 589,927) that, while potentially accurate, is not part of the ground truth answer and doesn't address the core question about effective date and structural evolution. (4) MISSING KEY INFORMATION - The LLM does not mention the March 31, 2021 effective date that was current in 2022, which is essential to understanding the evolution. The answer demonstrates a fundamental misunderstanding of the temporal sequence of amendments and their effective dates across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 461,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Accenture’s equity‑method investment in Duck Creek Technologies moved from a carrying amount of **$138.9 million** (with an estimated fair value of **$223.2 million** at the end of FY 2022) to a higher fair‑value position that enabled the company to record a **$253 million investment gain** in FY 2023 (shown in other income).  The higher valuation lifted the stake’s carrying amount and generated a non‑operating profit that boosted adjusted earnings per share, illustrating how the financial relationship evolved from a modest, un‑realized gain to a material, recognized gain in the 2023 results.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Accenture's Duck Creek Technologies investment evolution. QUANTITATIVE VERIFICATION: All key numbers are correct - FY2022 carrying amount of $138.9 million (matches $138,902 in thousands), FY2022 fair value of $223.2 million (matches $223,166 in thousands), and FY2023 gain of $253 million. Number format variations are appropriately handled ($138.9M vs $138,902K). COMPLETENESS: The answer addresses both fiscal years (2022 and 2023) and covers the key dimensions: investment valuation, carrying amount, fair value, and financial impact. ENTITY ACCURACY: Correctly identifies Accenture, Duck Creek Technologies, and the equity-method accounting treatment. Fiscal years are properly referenced. MULTI-HOP REASONING: The answer successfully synthesizes the evolution narrative - showing the transition from an unrealized gain position (FY2022 with carrying amount below fair value) to a realized gain event (FY2023 $253M gain). The connection to adjusted EPS impact is correctly noted. MINOR CONSIDERATIONS: The original answer mentions \"approximately 16% ownership\" which the LLM answer does not include, though this is a minor omission that doesn't affect the core narrative about the financial relationship evolution. The LLM appropriately characterizes the gain as \"non-operating profit\" and correctly notes its impact on adjusted earnings per share. The semantic framing of the evolution from \"modest, un-realized gain to material, recognized gain\" accurately captures the substance of the ground truth answer. No calculation errors detected. The answer is well-structured and directly responsive to the question about how the financial relationship evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 476,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "\nBetween 2022 and 2024 Breyanzi’s use moved beyond its original 2021 launch for relapsed or refractory large‑B‑cell lymphoma and began targeting additional hematologic cancers.  In 2024 the FDA granted accelerated approvals for three new indications—relapsed or refractory chronic lymphocytic leukemia/small‑lymphocytic lymphoma, mantle‑cell lymphoma, and follicular lymphoma—each requiring prior therapy with a BTK inhibitor and/or a BCL‑2 inhibitor—thereby widening the patient population that can be treated with Breyanzi and expanding its commercial market potential.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) INCORRECT INDICATION COUNT: LLM claims THREE new indications in 2024 (CLL/SLL, mantle-cell lymphoma, and follicular lymphoma), but ground truth specifies only TWO new approvals in 2024 (CLL/SLL in March and FL in May). Mantle-cell lymphoma is NOT mentioned in the ground truth as a 2024 approval. (2) INCORRECT THERAPY REQUIREMENTS: LLM states new indications require 'prior therapy with a BTK inhibitor and/or a BCL-2 inhibitor,' but ground truth specifies only 'at least two prior lines of therapy' with no mention of specific BTK or BCL-2 inhibitor requirements. This is a significant factual error that mischaracterizes the approval criteria. (3) INCOMPLETE 2022 BASELINE: LLM correctly notes the original 2021 launch for relapsed/refractory large B-cell lymphoma but doesn't clearly establish the 2022 baseline state as required by the question. (4) CORRECT ELEMENTS: The answer correctly identifies that Breyanzi expanded to additional hematologic cancers and that CLL/SLL and follicular lymphoma were approved in 2024, and correctly notes the expansion of patient populations. The semantic understanding of market expansion is appropriate. MULTI-HOP REASONING: The model failed to accurately synthesize the specific approval timeline and criteria from the source documents, introducing an unapproved indication (mantle-cell lymphoma) and fabricating therapy requirements not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 398,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 3M’s procedure for estimating insurance recoveries under ASC 450‑ASC 610‑30 was unchanged – it bases the receivable on policy language, historical claim experience and external expert analyses, and only records a receivable when a liability has been accrued.  In 2023 the company increased its accrual for respirator‑mask/asbestos liabilities by $57 million (to $574 million, excluding Aearo) and paid $88 million of related defense and settlement costs, yet the offsetting insurance‑recovery receivable remained immaterial, reflecting that recoveries were still not considered probable or estimable enough to recognize.  Thus, while the size of the accrued liability grew, the method of estimating and recording the related insurance receivable stayed consistent, with recognition only when recovery became reasonably estimable.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on the core question. Key issues: (1) CONTRADICTS GROUND TRUTH ON EVOLUTION: The LLM claims the procedure was 'unchanged' between 2022 and 2023, directly contradicting the ground truth which explicitly states that by 2023 the company 'explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30' whereas in 2022 it 'did not specifically mention the methodology for estimating insurance receivables.' This is a fundamental misunderstanding of the question's core premise about evolution/change. (2) MISSING KEY FACTUAL DETAIL: The ground truth specifically mentions the number of individual claimants increased from 4,028 in 2022 to 4,042 in 2023 - the LLM completely omits this quantitative evidence of growing exposure. (3) UNVERIFIED NUMBERS: The LLM introduces specific dollar amounts ($57 million increase, $574 million total, $88 million paid) that are not present in the ground truth and cannot be verified as correct or incorrect from the provided context. These appear to be fabricated or from unverified sources. (4) MISCHARACTERIZATION OF METHODOLOGY: The LLM describes the methodology as 'unchanged' and based on 'policy language, historical claim experience and external expert analyses' - while these elements may be true, the ground truth indicates a more explicit and detailed approach was adopted in 2023 involving 'analysis of policy terms, case law, and claim nature' which represents an evolution, not consistency. (5) LOGICAL INCONSISTENCY: The LLM's statement that 'the offsetting insurance-recovery receivable remained immaterial' contradicts the premise that methodology evolved - if methodology truly evolved to be more explicit about ASC 450/610-30 application, this should be reflected in how receivables are recorded, not dismissed as immaterial. The answer fails to address the core question about how the approach EVOLVED between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 540,
        "total_tokens": 1940
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "\nBetween 2022 and 2023 PepsiCo moved from full ownership of the Naked juice brand to selling it (along with Tropicana and other select juice brands) to PAI Partners, while retaining a 39 percent non‑controlling equity stake in the newly formed joint‑venture TBG that now owns those brands. Operationally, PepsiCo remains the exclusive U.S. distributor for TBG’s portfolio—using its chilled direct‑store‑delivery network to serve small‑format and food‑service customers—so it continues to handle sales, marketing and logistics for the former Naked products. Financially, PepsiCo records its 39 % share of TBG’s results as a non‑controlling interest, meaning it receives equity earnings and cash returns from the venture while PAI Partners owns the remaining 61 % of the business.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR - MAJOR FACTUAL INACCURACY: The LLM answer contains a fundamental contradiction with the ground truth regarding operational involvement in 2023. The LLM states 'Operationally, PepsiCo remains the exclusive U.S. distributor for TBG's portfolio' and 'it continues to handle sales, marketing and logistics for the former Naked products.' However, the ground truth explicitly states 'By 2023, PepsiCo no longer directly distributed Naked products' and 'no further operational involvement in the distribution of Naked products.' This is a core factual error that directly contradicts the question's focus on how the relationship 'evolved' between 2022 and 2023. The LLM appears to have described the 2022 situation (when PepsiCo WAS the exclusive distributor) but failed to capture the 2023 evolution where this operational role ended. CORRECT ELEMENTS: (1) The 39% noncontrolling interest figure is accurate, (2) PAI Partners ownership is correctly identified, (3) The formation of TBG as a joint venture is correct, (4) The sale of Tropicana, Naked, and other juice brands is accurate, (5) The financial stake description (equity earnings, cash returns) is appropriate. MISSING/INCORRECT ELEMENTS: (1) The critical evolution from active distribution (2022) to no operational involvement (2023) is completely missed, (2) The answer fails to show the shift from 'active distribution to a purely financial stake' which is the core of the question, (3) The temporal distinction between 2022 and 2023 is not properly addressed - the answer conflates the two years. MULTI-HOP REASONING: The answer fails to properly synthesize the temporal evolution across the two years. It describes the transaction and financial structure correctly but misses the key operational change that occurred between 2022 and 2023. This is a significant failure in addressing the specific question about how the relationship 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 518,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "\nThe company continues to treat ExtraBucks Rewards as a distinct performance obligation that is identified at the time the customer makes the initial purchase, allocating the transaction price between the underlying sale and the rewards based on relative standalone‑selling‑price estimates that rely on historical redemption patterns. Revenue from the rewards is recognized only when the points are actually redeemed, while any unredeemed balance is carried as a contract‑liability (breakage), a practice that was already described in the 2023 filing and remains unchanged in the 2024 disclosure. Consequently, there is no material evolution in the accounting treatment or disclosure of ExtraBucks Rewards between 2023 and 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE: The LLM answer directly contradicts the ground truth on the central question. The ground truth explicitly states that the disclosure 'evolved' between 2023 and 2024, with 2024 showing 'more refined' language and 'more structured language' indicating 'a more mature and formalized approach.' The LLM answer concludes the opposite: 'there is no material evolution in the accounting treatment or disclosure of ExtraBucks Rewards between 2023 and 2024.' This is a fundamental mischaracterization of the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies ExtraBucks Rewards as a distinct performance obligation created at initial transaction; (2) Correctly describes allocation based on relative standalone selling prices using historical redemption patterns; (3) Correctly states revenue recognition occurs upon redemption; (4) Correctly identifies unredeemed rewards as contract liability/breakage. INCORRECT ELEMENTS: (1) The LLM fails to recognize the evolution in disclosure language between years; (2) Misses the refinement in how performance obligations are determined (specifically tied to customers who accumulate based on historical spending levels in 2024); (3) Overlooks the more formalized and structured approach to transaction price allocation in 2024; (4) The conclusion of 'no material evolution' directly contradicts the ground truth's description of meaningful changes in language and approach. REASONING ASSESSMENT: While the LLM correctly describes the mechanics of the program, it fails at the multi-hop synthesis required to answer the 'evolution' question. The model appears to have focused on identifying similarities between years rather than detecting the nuanced changes in disclosure sophistication and formalization that the ground truth emphasizes. This represents a failure in comparative analysis across the two filing periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 510,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "\nBoth 2023 and 2024 list payment‑processing fees paid to integrated partners as part of “other operating costs” within cost of revenues, but the share of total cost of revenues devoted to these fees dropped from 58 % of revenues in 2023 to 54 % in 2024—suggesting that, while absolute spending likely grew, Netflix’s relative reliance on integrated payment partners decreased between the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - UNSUPPORTED PERCENTAGES: The LLM claims payment processing fees represented '58% of revenues in 2023' and '54% in 2024.' These specific percentages are not mentioned in the ground truth and appear to be fabricated. The ground truth makes no quantitative claims about the proportion of revenues devoted to payment processing fees. (2) CONTRADICTS GROUND TRUTH NARRATIVE: The ground truth explicitly states that Netflix 'continued to reference payment processing fees' in both years and that 'the relationship persisted,' indicating continuity. The LLM's claim that 'relative reliance...decreased' contradicts the ground truth's emphasis on persistent disclosure and continuity of the relationship. (3) UNSUPPORTED INFERENCE: The LLM makes a speculative claim that 'absolute spending likely grew' based on the fabricated percentages, which is not supported by the ground truth. (4) MISSING KEY INSIGHT: The ground truth emphasizes a 'shift in disclosure strategy' - that granular details were removed in 2024 - which the LLM completely overlooks. The ground truth focuses on changes in transparency/disclosure, not on changes in actual reliance or spending levels. (5) QUANTITATIVE ACCURACY FAILURE: The specific percentages (58% and 54%) cannot be verified from the ground truth and appear to be hallucinated data. This is a fundamental breach of factual accuracy for a financial question requiring precision. The LLM answer fundamentally misrepresents the evolution of Netflix's payment partner relationship by introducing unsupported numerical claims and contradicting the ground truth's emphasis on disclosure strategy changes rather than substantive business relationship changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 486,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "\nFrom 2022 through 2023 3M moved beyond the baseline remediation required by the 2007 Minnesota Settlement/Consent Order and began tailoring its PFAS‑management program to a series of tighter state health‑based standards.  The Minnesota Department of Health issued updated, more stringent health‑based values (HBVs) for PFOA and PFOS, and the Minnesota Pollution Control Agency (MPCA) released a draft Clean Water Act permit (January 2024) that imposes significantly lower PFAS limits—including limits below the analytical detection threshold—while also issuing a March 2023 Notice of Violation for storm‑water discharges at the Hutchinson facility.  In response, 3M expanded groundwater and storm‑water monitoring, accelerated treatment and alternative‑water supplies where levels exceed the new HBVs or HRLs, and entered into negotiations to adjust its SACO obligations and related consent orders to reflect the stricter regulatory limits, while also increasing its accruals for PFAS‑related environmental liabilities to cover the broader remediation and compliance costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of 3M's evolving PFAS management approach from 2022-2023, with mostly accurate facts and dates. STRENGTHS: (1) Correctly identifies key dates: March 2023 Notice of Violation for Hutchinson facility, January 2024 MPCA Clean Water Act permit proposal, and updated HBVs for PFOA/PFOS. (2) Accurately captures the regulatory tightening theme with references to below-detection-limit PFAS standards. (3) Properly synthesizes multi-hop information about regulatory changes (MPCA, MDH) and 3M's responses. (4) Correctly references the 2007 Settlement/Consent Order (SACO) as baseline framework. (5) Appropriately characterizes 3M's adaptive strategy including expanded monitoring, accelerated treatment, and increased accruals. WEAKNESSES: (1) The LLM answer mentions 'January 2024' for the MPCA permit proposal, but the ground truth specifies this occurred in January 2024 (after the 2023 period being evaluated), creating slight temporal ambiguity about whether this is part of the 2022-2023 evolution or a forward-looking development. (2) The LLM answer omits specific site details mentioned in ground truth: Cottage Grove (substantially completed remediation in 2022, December 2022 MPCA stormwater order), Oakdale, and Woodbury sites. (3) Does not mention the Decatur, Alabama facility and 2020 ADEM Consent Order, which provides important geographic context for 3M's broader PFAS management. (4) The phrase 'entered into negotiations to adjust its SACO obligations' is somewhat speculative—the ground truth indicates 3M was 'evaluating the potential impact' rather than explicitly negotiating adjustments. QUANTITATIVE ACCURACY: All dates are correct (March 2023, January 2024, December 2022). No numerical errors detected. QUALITATIVE ACCURACY: Multi-hop reasoning is sound—correctly connects regulatory changes to 3M's operational responses. Entity identification is accurate (MPCA, MDH, 3M). CONTEXTUAL RELEVANCE: Highly relevant to the question about evolution from 2022-2023, though the inclusion of January 2024 developments slightly extends beyond the stated timeframe.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1562,
        "completion_tokens": 569,
        "total_tokens": 2132
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the notional amount of PepsiCo’s foreign‑currency derivatives grew from roughly **$3.0 billion to $3.8 billion** (the company reports $3.0 bn of foreign‑currency derivatives as of Dec 31 2022 and $3.8 bn as of Dec 30 2023).  This increase shows that PepsiCo is expanding its hedge book—using more forward contracts and net‑investment hedges—to lock in exchange rates for its global operations and investments.  The move signals a more proactive foreign‑exchange risk‑management strategy aimed at mitigating currency‑driven margin pressure amid a larger, more diversified international footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - $3.0 billion for 2022 and $3.8 billion for 2023 match the ground truth exactly. The dates are also accurate (Dec 31, 2022 and Dec 30, 2023). The calculation of the increase ($0.8 billion or approximately 26.7%) is implicit and correct. ENTITY ACCURACY: PepsiCo is correctly identified, the metric (foreign currency derivatives notional value) is correct, and the time periods are accurate. MULTI-HOP REASONING: The LLM successfully synthesizes information across two fiscal years and correctly interprets the trend as indicating strategic expansion in FX risk management. COMPLETENESS: The answer addresses both parts of the question - how the derivatives evolved (quantitative change) and what it indicates about strategy (qualitative interpretation). The LLM goes slightly beyond the ground truth by mentioning specific hedging instruments (forward contracts, net-investment hedges) and contextual factors (currency-driven margin pressure, diversified international footprint), which adds valuable detail without contradicting the ground truth. MINOR DIFFERENCES: The ground truth mentions 'no material net impact on earnings in 2023,' which the LLM answer does not explicitly include. However, this is a minor omission that doesn't significantly detract from the overall quality of the response. The LLM's interpretation of the strategy as 'more proactive' and focused on 'mitigating currency-driven margin pressure' is semantically equivalent to the ground truth's characterization of 'strategic expansion' in response to 'increased exposure or volatility.' Overall, the answer is factually accurate, well-reasoned, and appropriately addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 483,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil moved from a U.S.-centric growth push to a broader, geography‑focused strategy. In 2022 it was completing the Corpus Christi ethane‑cracker and restarting Gulf‑Coast projects (Baytown, Baton Rouge) while planning advanced‑recycling capacity, but by 2023 it had added two new chemical lines at Baytown—a 400 kt/yr performance‑polymers unit and a 350 kt/yr linear‑alpha‑olefins unit— and broke ground on a multi‑billion‑dollar petrochemical complex in China’s Dayawan park that will deliver >2.5 million t/yr of polyethylene/polypropylene capacity to capture China’s rising demand. This reflects a shift from primarily U.S. Gulf‑Coast capacity additions toward a dual focus on expanding U.S. Gulf‑Coast output while establishing a major foothold in China to capitalize on improving living standards there.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM provides specific capacity numbers (400 kt/yr for performance polymers and 350 kt/yr for linear alpha olefins) that are NOT present in the ground truth. The ground truth only mentions 'expanding performance polymers and linear alpha olefins capacity' without specifying these exact tonnages. This is a critical error as the LLM appears to have fabricated specific numbers. CORRECT ELEMENTS: (1) Corpus Christi ethane cracker completion in 2022 - correct; (2) Advanced recycling capacity in Baytown by 2026 mentioned in 2022 - correct; (3) Shift to Baytown performance polymers and linear alpha olefins in 2023 - correct; (4) Dayawan, China petrochemical complex with >2.5 million metric tons per year of polyethylene/polypropylene - correct; (5) Overall strategic narrative of shift from U.S.-centric to China-focused expansion - correct. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly identifies the evolution from 2022 to 2023 and connects it to improving living standards. However, the fabricated capacity numbers undermine the credibility of the analysis. MISSING/INCOMPLETE: The LLM mentions 'restarting Gulf-Coast projects (Baytown, Baton Rouge)' which is not explicitly stated in the ground truth, though not contradicted. The ground truth's mention of 'up to 500,000 metric tons annually of advanced recycling capacity' is correctly referenced but the LLM doesn't quantify it in the 2023 comparison. SEMANTIC EQUIVALENCE: The overall narrative matches the ground truth's intent, but the introduction of unverified specific numbers (400 kt/yr, 350 kt/yr) is a significant factual error that cannot be overlooked despite the correct overall strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 474,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "\nFrom 2022 to 2023 the balance of 3M’s certificates‑of‑deposit/time‑deposits rose from **$21 million to $49 million** (an increase of roughly $28 million, or more than 130 %).  This growth reflects a deliberate shift toward allocating a larger share of the company’s short‑term cash to short‑duration, low‑risk instruments, likely to capture higher yields in the current higher‑interest‑rate environment while preserving liquidity and flexibility.  (See NOTE 11 “Marketable Securities” in the 2022 and 2023 Form 10‑K filings.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - $21 million in 2022, $49 million in 2023, increase of $28 million. The percentage calculation of 130% is accurate (28/21 = 1.333 or 133%, which rounds to 'roughly 130%' as stated). ENTITY ACCURACY: Correctly identifies 3M, the correct financial metric (Certificates of Deposit/Time Deposits), and correct fiscal years (2022 and 2023). COMPLETENESS: Addresses both parts of the question - the evolution of the investment (with specific numbers) and what it indicates about strategy. REASONING QUALITY: The LLM provides sound multi-hop synthesis by: (1) extracting the numerical data from filings, (2) calculating the change, (3) interpreting the strategic implications. The interpretation about 'allocating a larger share of short-term cash to short-duration, low-risk instruments' and 'capturing higher yields in the current higher-interest-rate environment' is a reasonable and contextually appropriate inference that goes slightly beyond the ground truth but remains consistent with it. MINOR DIFFERENCES: The ground truth uses 'more than doubling' (which is technically correct: 49/21 = 2.33x) while the LLM specifies '130%' increase (also correct). The LLM provides additional context about the interest-rate environment and cites the specific filing location (NOTE 11), which adds credibility without contradicting the ground truth. Both answers convey the same core message about the strategic shift toward increased liquidity and stable instruments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 430,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "\nFrom 2022 to 2023 Mastercard’s language shifted from simply noting that its “value‑added services…provide proprietary insights” to explicitly describing those insights as coming from the company’s “principled use of consumer and merchant data” and emphasizing trust‑building.  The 2023 filing therefore introduces a clear responsibility framing—highlighting that the insights are derived responsibly and are meant to reinforce confidence among all ecosystem participants—whereas the 2022 discussion did not contain this explicit data‑responsibility language.  This evolution signals a more deliberate focus on data ethics and stakeholder trust in Mastercard’s proprietary‑insights strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer captures the general evolution of Mastercard's language from 2022 to 2023 regarding proprietary insights and data responsibility, but contains a significant factual discrepancy with the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies the time period (2022 to 2023)\n- Correctly identifies Mastercard as the company\n- Correctly notes the shift toward emphasizing data responsibility and trust-building\n- Correctly identifies that 2023 language is more explicit about responsibility than 2022\n- Appropriately characterizes the evolution as signaling focus on data ethics and stakeholder trust\n\nFACTUAL ERRORS:\n- The LLM states the 2023 language evolved to 'principled use of consumer and merchant data' with emphasis on trust-building, but the ground truth specifies the 2023 language was 'principled AND RESPONSIBLE use of secure consumer and merchant data'\n- The LLM misses the specific addition of 'secure' in the 2023 phrasing, which is a key detail in the ground truth\n- The LLM's characterization of 2022 language as simply 'principled use' is correct, but the 2023 evolution description is incomplete\n\nMULTI-HOP REASONING:\n- The answer demonstrates sound reasoning about the evolution of language and its implications\n- Correctly synthesizes the connection between language changes and broader strategic focus\n- However, the incomplete/inaccurate quotation of the 2023 language undermines the precision of the multi-hop analysis\n\nSEMANTIC ISSUES:\n- While the general narrative about evolution toward responsibility is correct, the specific phrasing differences are not accurately captured\n- The omission of 'secure' from the 2023 description is a material detail that affects the completeness of the answer\n\nOVERALL: The answer demonstrates understanding of the question and the general direction of change, but fails to capture the precise language evolution that is central to answering this question accurately. The missing 'secure' element and the incomplete characterization of the 2023 language shift represent a meaningful gap in factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 568,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "\nBetween 2022 and 2023 the estimated effect of pension and retiree‑medical assumptions on PepsiCo’s ROIC grew from a modest drag of roughly 0.1‑0.2 percentage points to a larger drag of about 0.1‑0.3 percentage points.  This widening impact signals that the external environment—especially rising interest rates, inflationary cost pressures and heightened economic uncertainty—is forcing the company to revise discount‑rate, mortality and health‑care‑cost assumptions, thereby amplifying the sensitivity of its pension and retiree‑medical accounting estimates.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth on multiple critical dimensions: (1) ENTITY MISMATCH: The LLM introduces PepsiCo and ROIC (Return on Invested Capital) metrics that are not mentioned in the original question or ground truth answer. The question asks about accounting estimate factors for pension/retiree medical plans generally, not PepsiCo-specific ROIC impacts. (2) QUANTITATIVE ERRORS: The LLM provides specific percentage point ranges (0.1-0.2 to 0.1-0.3) that do not appear in the ground truth. These numbers appear fabricated and are not supported by the original answer. (3) MISSING KEY INFORMATION: The LLM completely fails to address the core evolution described in the ground truth: the shift from COVID-19 pandemic impacts in 2022 to geopolitical conflicts (Ukraine, Middle East) and macroeconomic factors in 2023. (4) INCORRECT FOCUS: The LLM focuses on ROIC sensitivity and discount-rate/mortality/healthcare-cost assumptions (technical accounting details) rather than the external environmental factors that influenced the estimates. While the LLM mentions interest rates and inflation, it omits the critical geopolitical context (Ukraine, Middle East conflicts) that the ground truth emphasizes. (5) REASONING FAILURE: The multi-hop synthesis is broken—the LLM appears to have confused or conflated different aspects of pension accounting without properly addressing the question's core ask about how external factors evolved. The answer reads as if it's responding to a different question about PepsiCo's specific ROIC impacts rather than the broader evolution of accounting estimate factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 449,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "\nBetween year‑end 2022 and year‑end 2023 ExxonMobil’s undeveloped acreage in the Canada/Other Americas segment fell sharply – gross undeveloped acres dropped from **≈37.8 million to ≈30.8 million** (‑≈19 %) and net undeveloped acres from **≈18.98 million to ≈15.01 million** (‑≈21 %).  This contraction reflects the company’s decision to relinquish or convert a portion of that land base, indicating that it is focusing the remaining undeveloped holdings on the most prospective targets rather than maintaining a broad, low‑return acreage inventory.  Consequently, the decline signals that ExxonMobil perceives its exploration upside in the region as being concentrated in a smaller, higher‑potential set of prospects.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 2,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect numbers that do not match the ground truth data. Ground truth shows: 2022: 25,096 gross and 11,977 net thousands of acres; 2023: 24,221 gross and 11,548 net thousands of acres. The LLM reports: 2022: ≈37.8 million gross and ≈18.98 million net; 2023: ≈30.8 million gross and ≈15.01 million net. These are off by approximately 50% for gross acres and 58% for net acres - a massive discrepancy. The LLM appears to have confused the 'Other Americas' region with a larger geographic segment (possibly Canada/Other Americas combined or a different metric entirely). The percentage declines calculated by the LLM (-19% gross, -21% net) are also incorrect; the actual declines are approximately -3.5% gross and -3.6% net. While the LLM's qualitative reasoning about relinquishment and focus on higher-potential prospects is sound and aligns with the ground truth interpretation, the quantitative foundation is completely wrong. The answer fails on the primary requirement of factual accuracy for a financial question requiring specific numerical data from SEC filings. The entity identification appears confused (Canada/Other Americas vs. Other Americas specifically), which is a critical error in multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 358,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "\nFrom 2022 to 2023 3M continued to employ foreign‑currency forwards and options that were **not designated in hedge accounting** to offset the earnings effect of non‑functional‑currency items (e.g., intercompany financing balances).  In 2022 these contracts produced a **$76 million pre‑tax loss** recorded directly in the income statement, while in 2023 the loss narrowed to only **about $9 million**, reflecting reduced volatility and the runoff of prior hedge balances.  Under U.S. GAAP, such non‑designated derivatives are marked‑to‑market each period, with the resulting gains or losses recognized immediately in earnings rather than being routed through other comprehensive income.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM provides specific loss figures ($76 million in 2022, $9 million in 2023) that are NOT present in the ground truth answer. The ground truth only mentions a gross notional amount of $3.7 billion for 2022 contracts and does not provide any specific P&L impact figures for either year. These numbers appear to be fabricated or sourced from incorrect filings. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes a strategic shift from 'primarily designated hedging strategies to a more direct financial exposure management approach,' but the LLM answer focuses heavily on P&L volatility and runoff rather than this strategic evolution. The LLM misses the key insight about the shift in hedging designation strategy. (3) PARTIAL ACCURACY - The LLM correctly identifies: (a) 3M as the company, (b) the use of non-designated FX forwards/options, (c) the purpose of offsetting non-functional currency items, (d) the mark-to-market accounting treatment under U.S. GAAP, and (e) the direct earnings impact. However, these correct elements are undermined by the fabricated financial figures. (4) MULTI-HOP REASONING - While the LLM demonstrates understanding of the accounting mechanics (mark-to-market, direct earnings recognition), it fails to properly synthesize the evolution of strategy from 2022 to 2023 as described in the ground truth. The answer focuses on volatility reduction rather than the strategic shift in hedging approach. (5) CRITICAL FLAW - The introduction of specific loss amounts ($76M and $9M) without ground truth support is a serious factual error that significantly undermines credibility, even though the conceptual framework is partially correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 470,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved cyber‑and‑intelligence solutions from a peripheral “other‑revenue” line item to a strategic growth pillar. In the 2022 filing (pages 79‑83) the services were merely listed alongside other value‑added offerings, but the 2023 filing (pages 47‑51) explicitly calls them “products and services offered to prevent, detect and respond to fraud… and supports open‑banking and digital‑identity capabilities,” positioning them as a core differentiator and a key driver of the company’s value proposition.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative: Cyber and Intelligence Solutions evolved from a peripheral/supporting role in 2022 to a more prominent, strategic position in 2023. The answer correctly identifies the key shift in positioning and emphasis.\n\nSTRENGTHS:\n1. Correctly captures the main evolution: from 'peripheral' to 'strategic growth pillar'\n2. Accurately references the 2022 and 2023 timeframes\n3. Properly identifies the shift from 'listed alongside other offerings' to 'core differentiator'\n4. Provides specific descriptive language from filings ('prevent, detect and respond to fraud,' 'open-banking and digital-identity capabilities')\n5. Multi-hop reasoning is sound - synthesizes information across two different years/filings\n6. Page references (2022: pages 79-83; 2023: pages 47-51) add specificity and credibility\n\nMINOR CONSIDERATIONS:\n1. The LLM uses slightly different framing ('other-revenue line item' vs. ground truth's 'part of a broader list of value-added services') - both convey the same meaning but with slightly different emphasis\n2. The LLM's characterization as 'peripheral' is semantically equivalent to the ground truth's 'supporting role'\n3. The specific product descriptions provided by the LLM ('prevent, detect and respond to fraud') add helpful detail beyond the ground truth's more general description\n\nQUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts were required for this qualitative question about strategic positioning. The dates (2022, 2023) are correct.\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across two different years and filing documents, correctly identifying the progression and strategic shift.\n\nSEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental information as the ground truth while using slightly different terminology that remains factually accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 525,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 the SEC‑filing’s “Income Tax Expense and Accruals” entry kept the same core language – it continues to stress that the annual tax rate is derived from income, statutory rates and transfer‑pricing arrangements, that significant judgment is required to set the rate and evaluate tax positions, and that reserves (and related interest) are adjusted as facts and circumstances change.  The 2023 version adds no new substantive disclosures or structural changes; it merely repeats the 2022 wording (including the reference to “Item 1A. Risk Factors”) without expanding the description of the accounting policy.  Consequently, the treatment and disclosure of income‑tax expense and accruals remain materially unchanged across the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core conclusion. The ground truth states that there WAS a material evolution in treatment/disclosure between 2022 and 2023: the policy was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with more structured presentation and deeper transparency (including Note 5 - Income Taxes). The LLM answer directly contradicts this by claiming the treatment and disclosure 'remain materially unchanged across the two years' and that the 2023 version 'merely repeats the 2022 wording...without expanding the description.' This is a fundamental mischaracterization of the actual evolution. The LLM appears to have focused on the substantive language content of the policy itself (which may have remained similar) rather than the structural and organizational changes in how the policy was presented and disclosed. The question specifically asks about 'treatment or disclosure...evolution,' which encompasses both content AND presentation structure. The LLM's claim that there were 'no new substantive disclosures or structural changes' directly contradicts the ground truth's documentation of structural reorganization and enhanced transparency. While the LLM correctly identifies years (2022, 2023) and the general topic (income tax expense and accruals), it fails to recognize or report the key evolution that occurred. This represents a critical failure in multi-hop reasoning and synthesis of the actual filing changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 411,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "\nBetween 2023 and 2024 Intel moved the Universal Chiplet Interconnect Express (UCIe) from a proof‑of‑concept to a core element of its “systems‑of‑chips” strategy. In 2023 the company demonstrated UCIe in silicon and began embedding the standard in its Open‑System Foundry model, signing early design‑win agreements with ARM and Synopsys and promoting UCIe as the baseline interconnect for chiplet‑based AI and other workloads. By 2024 Intel had deepened that positioning—integrating UCIe into the IFS Accelerator ecosystem, securing additional design wins on the advanced 18A process, and framing the standard as a key enabler for customers to build optimized, multi‑chip modules across Intel’s foundry and packaging capabilities.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and problematic elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies UCIe (Universal Chiplet Interconnect Express) as the standard in question\n- Accurately captures the 2023-2024 timeline and progression\n- Correctly states that 2023 involved demonstration in silicon\n- Accurately reflects the evolution from proof-of-concept to core strategy element\n- Correctly identifies the connection to systems-of-chips strategy\n- Properly notes the integration into broader foundry/packaging capabilities\n\nPROBLEMATIC ELEMENTS:\n1. UNSUPPORTED CLAIMS: The LLM answer introduces specific details not present in the ground truth:\n   - References to \"Open-System Foundry model\" (not mentioned in ground truth)\n   - Claims about \"signing early design-win agreements with ARM and Synopsys\" (not in ground truth)\n   - References to \"IFS Accelerator ecosystem\" (not in ground truth)\n   - Mentions of \"advanced 18A process\" (not in ground truth)\n   These additions suggest the LLM may have hallucinated or drawn from external knowledge not validated against the filing data.\n\n2. INCOMPLETE ALIGNMENT: While the LLM answer is more detailed, it diverges from the ground truth's core narrative:\n   - Ground truth emphasizes: demonstration → active production based on standard\n   - LLM answer emphasizes: proof-of-concept → design wins and ecosystem integration\n   - The ground truth specifically mentions \"actively producing based on this standard\" and \"integrating it into its broader advanced semiconductor assembly and test offerings\" - the LLM does not clearly capture the production/manufacturing aspect\n\n3. SEMANTIC DRIFT: The LLM's framing of specific partnerships and process nodes, while potentially accurate from other sources, cannot be verified against the provided ground truth and may represent information not actually present in the 2023-2024 10-K filings.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years and connects it to the broader strategy, but the additional details introduce uncertainty about whether all claims are grounded in the actual filings.\n\nQUANTITATIVE ACCURACY: No specific numbers, dates, or percentages are provided by either answer, so this dimension is neutral (7/10 for both maintaining consistency with ground truth's lack of quantitative claims).\n\nJUSTIFICATION FOR SCORES:\n- Correctness (6/10): Core narrative is correct but significant unsupported additions reduce confidence\n- Quantitative (7/10): No numbers to verify; consistency maintained\n- Qualitative (5/10): Good synthesis but introduces unverified claims that diverge from ground truth\n- Contextual (6/10): Relevant to question but adds context not confirmed in source material",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 743,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "\nIn the 2023 10‑K the company disclosed the three ASR transactions (Morgan Stanley $3 bn, Citibank $2 bn and Barclays $1.5 bn) as initial treasury‑stock purchases with a forward contract recorded in capital surplus, and it noted that the Morgan Stanley ASR was still pending final settlement and could deliver up to 73.9 million shares. The 2024 10‑K shows that the Morgan Stanley ASR was completed in March 2024 after the company received the remaining 15 % of the notional amount (≈8.3 million shares), at which point the forward contract was re‑classified from capital surplus to treasury stock, and the balance of the 2021 repurchase‑program authorization fell to $1.5 bn.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a partially correct response with significant issues in accuracy and completeness. CORRECT ELEMENTS: (1) The 2024 Morgan Stanley ASR completion in March 2024 with 8.3 million shares (15% of notional) is accurate; (2) The reclassification of forward contract from capital surplus to treasury stock is correctly described; (3) The accounting treatment consistency between years is appropriately noted; (4) The mention of remaining authorization balance is relevant context. CRITICAL ERRORS: (1) The LLM incorrectly states the 2023 10-K disclosed THREE ASR transactions (Morgan Stanley $3bn, Citibank $2bn, Barclays $1.5bn), but the ground truth only mentions the Citibank $2.0 billion ASR being completed in 2023 with 17.4 million initial shares and 5.4 million additional shares in February 2023. The Morgan Stanley $3bn ASR was pending in 2023 and completed in 2024, not disclosed as completed in 2023; (2) The LLM fails to address the 2023 Citibank ASR completion details entirely, which is a major omission given the question asks about evolution between 2023 and 2024; (3) The timeline comparison is incomplete - the ground truth specifies the 2023 ASR took one month while 2024 took two months, but the LLM only mentions the 2024 timeline; (4) The LLM mentions 73.9 million shares as potential delivery for Morgan Stanley, which appears to be the sum of initial (31.4M) plus final (8.3M) shares, but this calculation and context are not clearly explained. MULTI-HOP REASONING: The LLM partially synthesizes information across 2023 and 2024 filings but fails to properly distinguish which transactions were completed in which year, creating confusion about the evolution of accounting treatment. The answer conflates pending transactions from 2023 with completed transactions in 2024. COMPLETENESS: The answer addresses the 2024 ASR evolution but largely ignores the 2023 Citibank ASR details that are essential for comparing how treatment evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 538,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "\nFrom 2022 to 2023 UPS’s exposure to the Central States Pension Fund flipped: the 2022 filing (which reflects the 2021 actuarial calculations) recorded a **$5.1 bn pre‑tax gain** from coordinating benefits, whereas the 2023 filing shows a **$2.3 bn pre‑tax loss** on the same coordinating‑benefit estimate, indicating a reversal in the liability position.  UPS continues to disclose this liability in Note 5 of its 10‑K and applies the same sensitivity analysis—e.g., a 25‑basis‑point change in the discount rate would adjust the projected benefit obligation by roughly **$1.5 bn**—while updating the actuarial assumptions (discount rate, demographic factors, actual experience) each year.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) MAJOR QUANTITATIVE ERROR: The LLM claims a '$5.1 bn pre-tax gain' in 2022, but the ground truth explicitly states a '$2.3 billion pre-tax actuarial loss' in 2022. This is a complete reversal of both the sign (gain vs. loss) and magnitude. (2) CONTRADICTORY NARRATIVE: The LLM describes a 'flip' from a $5.1bn gain to a $2.3bn loss, but the ground truth shows the $2.3bn loss was disclosed in 2022, not 2023. The LLM has inverted the temporal sequence and mischaracterized the evolution. (3) MISSING KEY EVOLUTION: The ground truth emphasizes a critical shift in reporting approach from 2022 to 2023—from 'quantifying a specific obligation' to 'emphasizing sensitivity of returns on the overall liability.' The LLM fails to capture this important methodological evolution and instead focuses on a non-existent gain-to-loss reversal. (4) UNVERIFIED SENSITIVITY CLAIM: The LLM introduces a '$1.5 bn' sensitivity figure for a 25-basis-point discount rate change, which is not mentioned in the ground truth. While the ground truth does reference 25 basis point sensitivity analysis, it specifically mentions 'expected and actual returns on assets,' not discount rate changes. The LLM appears to have conflated or invented this specific dollar amount. (5) PARTIAL CREDIT: The LLM correctly identifies Note 5 as the location of Central States Pension Fund disclosures and correctly mentions the 25 basis point sensitivity analysis, but these correct elements are embedded within a fundamentally flawed narrative. The answer demonstrates a failure to accurately synthesize the multi-hop information about how UPS's reporting approach evolved between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 478,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved the discussion of its Cyber and Intelligence Solutions from a peripheral “value‑added service” that simply “allows all parties to transact easily and with confidence” (2022 10‑K) to a strategic growth pillar that is explicitly linked to revenue expansion, digital‑identity/open‑banking investments and proprietary data insights (2023 10‑K).  In the later filing the company stresses that these solutions “enable secure, easy and confident transactions” while delivering “proprietary insights” and are highlighted as a primary driver of net‑revenue growth and shareholder value, underscoring a stronger, more value‑focused positioning for stakeholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Mastercard's positioning of Cyber and Intelligence Solutions between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from 'peripheral value-added service' (2022) to 'strategic growth pillar' (2023), which accurately captures the evolution described in the ground truth; (2) Accurately quotes the 2022 messaging ('allows all parties to transact easily and with confidence'); (3) Correctly identifies the 2023 expansion to include 'secure, easy and confident transactions' and 'proprietary insights'; (4) Properly synthesizes the multi-hop connection between cyber solutions and strategic investments in open banking and digital identity; (5) Correctly identifies both 10-K filings as sources; (6) No quantitative errors or incorrect dates. MINOR AREAS FOR IMPROVEMENT: (1) The LLM answer adds interpretive language about 'revenue expansion' and 'shareholder value' that, while reasonable inferences, are not explicitly stated in the ground truth answer provided. The ground truth focuses on the messaging evolution and infrastructure narrative integration, while the LLM emphasizes business impact/growth driver aspects; (2) The phrase 'primary driver of net-revenue growth' appears to be an inference rather than a direct quote or explicit statement from the ground truth; (3) The ground truth emphasizes 'principled use of consumer and merchant data' in 2022, which the LLM answer does not explicitly mention, though this is a relatively minor omission. MULTI-HOP REASONING: The answer successfully synthesizes information across two years and two 10-K filings, correctly identifying the evolution in positioning and linking it to broader strategic initiatives. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys substantially the same information as the ground truth, with the main difference being emphasis and interpretation rather than factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 539,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 4.450 % Senior Note due 2046 was listed as Exhibit 4.11 (and also repeated as Exhibit 4.13) with a citation to the original 8‑K filing of October 14 2015 (and a secondary reference to a February 24 2016 filing). In the 2023 Form 10‑K the same note appears under a new exhibit number — Exhibit 4.60 — and the reference is updated to a more recent 8‑K filing dated February 15 2023, showing that the company re‑numbered the exhibit and updated the documentation date for the note.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth: (1) EXHIBIT NUMBERS - Ground truth states 2022: Exhibit 4.12, 2023: Exhibit 4.13. LLM claims 2022: Exhibit 4.11 (and 4.13), 2023: Exhibit 4.60. These are completely incorrect. (2) DOCUMENTATION DATES - Ground truth states 2022 referenced October 14, 2015 Form 8-K, and 2023 referenced February 24, 2016 Form 8-K. LLM claims 2022 referenced October 14, 2015 (correct) but also February 24, 2016 (incorrect for 2022), and 2023 referenced February 15, 2023 (completely wrong - this date doesn't appear in ground truth). (3) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the exhibit number changes and date references across the two years. The claim that the 2023 exhibit number is 4.60 is a major factual error. (4) CORE NARRATIVE - While the LLM correctly identifies that there was a reclassification/renumbering and documentation updates, the specific details are almost entirely incorrect. The ground truth shows a simple shift from 4.12 to 4.13 with a date change from October 14, 2015 to February 24, 2016. The LLM's answer suggests much more dramatic changes (4.11/4.13 to 4.60, with a 2023 date) that are factually unsupported. This represents a fundamental failure in quantitative accuracy on the primary metrics being asked about (exhibit numbers and dates).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 383,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "\nBetween 2023 and 2024 Intel’s contact with Positive Technologies remained narrowly focused on coordinating IT‑security research and vulnerability disclosures.  Both the 2023 and 2024 10‑K filings note that, after the U.S. Treasury designated Positive Technologies as a sanctioned entity, Intel resumed those communications only under an OFAC general‑license (General License 1B) and that no revenue or profit is derived from the interaction.  Consequently, Intel’s relationship with Positive Technologies has not changed materially—it continues to engage under the same OFAC‑authorized license, with no commercial transactions and a stated intent to keep the communications going in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the core facts: Intel communicated with Positive Technologies on IT security/vulnerability disclosure, resumed under OFAC license post-sanctions, and no revenue/profit derived. (2) Accurately references OFAC General License 1B. (3) Correctly notes both 2023 and 2024 filings address this relationship. (4) Properly identifies that no commercial transactions occurred. WEAKNESSES: (1) The LLM claims 'Intel's relationship with Positive Technologies has not changed materially' and 'continues to engage under the same OFAC-authorized license,' which directly contradicts the ground truth. The ground truth explicitly states the relationship 'evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions'—this is a material evolution in posture from retrospective disclosure to forward-looking commitment. (2) The LLM misses the key distinction that 2023 was about communicating/disclosing past interactions, while 2024 reflects a more sustained partnership posture with stated intent to continue. (3) The answer characterizes the evolution as 'not changed materially' when the ground truth emphasizes the shift from past-tense disclosure to future-oriented commitment. MULTI-HOP REASONING: The LLM failed to properly synthesize the temporal and intentional evolution across the two years. It correctly gathered the facts but drew an incorrect conclusion about whether material change occurred. The ground truth indicates a meaningful evolution in Intel's stated relationship posture, which the LLM explicitly denies. This is a significant reasoning error despite correct identification of individual facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 479,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "\nThe $4.78 % senior notes maturing in March 2038 remained at a $5 billion outstanding balance in both the 2023 and 2024 borrowings tables, showing no change in the amount of that specific tranche over the two years. This stability indicates that CVS is keeping a large, long‑dated fixed‑rate pillar in its capital structure while it refinances shorter‑dated and higher‑coupon notes through newer issuances and early‑extinguishment activities.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: the 4.78% Senior Notes due March 2038 remained stable at $5 billion (correctly stated as '$5 billion' and '$5,000 million' are equivalent) in both 2023 and 2024. The numeric accuracy is strong with no calculation errors. However, the answer has notable weaknesses: (1) It fails to mention the comparative example provided in the ground truth about the 2.7% senior notes due August 2040 declining from $1,250 million to $367 million, which is a critical piece of evidence supporting the 'selective debt management' conclusion. (2) The LLM's interpretation about 'refinancing shorter-dated and higher-coupon notes through newer issuances and early-extinguishment activities' is somewhat speculative and goes beyond what the ground truth explicitly states. The ground truth more conservatively notes this 'contrasts with other senior notes' and indicates 'selective debt management and refinancing activity,' but the LLM adds interpretive language about 'newer issuances' without explicit support. (3) The answer addresses the stability of the specific debt instrument well but incompletely addresses the broader question about 'long-term debt structure' by omitting the comparative analysis that would strengthen the conclusion. The core facts are correct, but the answer is incomplete in its synthesis of the multi-hop information needed to fully answer the question about what the evolution indicates about debt structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 410,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "\nThe 0.835 % Notes due 2032 remained a registered security of Exxon Mobil in both filings. In the 2022 Form 10‑K (page 1) the notes were listed as “0.835 % Notes due 2032 – XOM32 – New York Stock Exchange,” and the 2024 Form 10‑K (page 1) continues to show the same issue with the identical ticker and exchange listing, indicating no change in its registration or status between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a critical factual error that contradicts the ground truth. The LLM claims that the 0.835% Notes due 2032 showed 'no change in its registration or status between the two years' and that both the 2022 and 2024 filings show identical listings. However, the ground truth explicitly states that while the 0.835% Notes due 2032 remained consistent, the key evolution was the REMOVAL of the 0.142% Notes due 2024 (XOM24B) from the 2024 filing, indicating a significant change in the company's debt composition. The LLM completely missed this critical multi-hop synthesis requirement - the question asks how the status 'evolved,' implying change, and the ground truth identifies the removal of the 2024 notes as the key evolution. The LLM's assertion of 'no change' is fundamentally incorrect. The numeric values provided (0.835%, 2032, XOM32) are accurate, and the identification of the notes in both filings is correct, but the LLM failed to identify and synthesize the comparative change across the two years. The answer demonstrates poor multi-hop reasoning by focusing only on the 0.835% Notes and ignoring the broader debt structure changes (specifically the disappearance of the 2024 notes). This is a significant failure in addressing the core question about how the status 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 366,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "\nAmerican Express trimmed its U.S. government‑treasury book from a cost of $1.68 bn (fair value $1.704 bn) in 2021 to just $0.289 bn (fair value $0.287 bn) by the end of 2024.  The maturity profile moved from a laddered stance—about $832 m maturing within one year and $862 m maturing after one but within five years in 2021—to a front‑end‑biased mix where roughly $189 m matures within one year and $98 m matures after one to five years, with virtually no exposure beyond five years in 2024.  This shift reflects a strategic emphasis on shorter‑duration, lower‑interest‑rate risk, and the fair‑value position changed from a modest $25 m unrealized gain in 2021 to a near‑break‑even status with only a $2 m unrealized loss by 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial additional context and detail beyond the ground truth, but contains a critical scope issue. STRENGTHS: (1) The 2024 maturity distribution numbers are correct ($189M short-term, $98M intermediate-term), matching ground truth exactly. (2) The characterization of the shift from laddered to front-end-biased is accurate and well-explained. (3) The answer correctly identifies the strategic rationale (shorter duration, lower interest-rate risk). (4) The unrealized gain/loss analysis ($25M gain in 2021 to $2M loss in 2024) adds valuable context. CRITICAL ISSUE: The ground truth specifically addresses the 2022-2024 evolution, but the LLM answer introduces 2021 data ($1.68bn cost, $1.704bn fair value, $832M and $862M maturity buckets) which is outside the requested timeframe. The ground truth states 2022 holdings were $477M in short-term instruments with no long-term exposure, but the LLM provides 2021 figures instead. This represents a scope misalignment. QUANTITATIVE VERIFICATION: The 2024 numbers ($189M short-term, $98M intermediate-term) are correct. However, the 2022 baseline comparison is missing—the ground truth indicates $477M fair value in 2022, but the LLM jumps from 2021 ($1.704bn) to 2024 ($0.287bn) without addressing the 2022 starting point. The total fair value figures ($1.704bn in 2021, $0.287bn in 2024) appear to be from different data than the ground truth's focus on the specific treasury obligation categories. REASONING: The multi-hop synthesis is sound in explaining the maturity shift, but the temporal scope is misaligned with the question's explicit 2022-2024 timeframe. The answer would be stronger if it directly compared 2022 ($477M short-term only) to 2024 ($189M + $98M = $287M total) as the ground truth does.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 485,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon continued to carry the 2.500 % Note due 2050 unchanged in its financial statements. The note was first disclosed in the 2020 debt issuance (June 3 2020) and, in the 2022 10‑K, was presented as an outstanding unsecured senior obligation with no redemptions or covenant changes; the 2024 10‑K still lists the same 2.500 % Note due 2050 in the indenture schedule and reports no modifications, repayments, or amendments, indicating that its terms and status remained the same throughout the period.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies key facts: (1) the 2.500% Note due 2050 was issued June 3, 2020, (2) it remained unchanged between 2022 and 2024, and (3) no modifications or redemptions occurred. The date and percentage are accurate. However, there are significant issues with the answer's alignment to ground truth: (1) The ground truth specifically references Exhibit 4.5 (2022) and Exhibit 4.6 (2024) as the documentary evidence, noting that Exhibit 4.6 was 'an exact replication of Exhibit 4.5 from 2020.' The LLM answer mentions 'indenture schedule' but does not reference the specific exhibits or their replication relationship, which is a key detail in the ground truth. (2) The ground truth emphasizes the 'reintroduction in 2024' and the significance of the exhibit replication showing continuity. The LLM answer states the note 'still lists' in 2024 but doesn't capture the exhibit replication detail that demonstrates how Amazon maintained this instrument. (3) The LLM adds details about 'unsecured senior obligation' and 'covenant changes' that are not in the ground truth, which could be accurate but represent inference beyond what was provided. The core narrative is correct—the note was unchanged—but the answer misses the specific documentary evidence (Exhibit 4.5/4.6 replication) that grounds the ground truth answer. The multi-hop synthesis is incomplete because it doesn't connect the 2022 and 2024 exhibits as replications of the 2020 document.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 406,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "\nBetween the 2022 filing (which listed the Eighth Amendment as the latest) and the 2023 filing, four new amendments—Ninth, Tenth, Eleventh and Twelfth—were added to the Citibank, N.A. Co‑Branded Credit Card Agreement, raising the total count of amendments from eight to at least twelve by the end of 2023. This shows a steady increase of four additional amendments during that one‑year period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively addresses the question. Quantitative verification: (1) The 2022 baseline of the Eighth Amendment is correct. (2) The identification of four new amendments (Ninth, Tenth, Eleventh, Twelfth) is accurate. (3) The 2023 endpoint of the Twelfth Amendment filed on October 11, 2023 is correct. (4) The calculation that four amendments were added (8 to 12) is accurate. Multi-hop reasoning: The answer correctly synthesizes information across the two time periods (2022 and 2023) and properly identifies the evolution of amendments. The LLM explicitly names each new amendment added, which provides more detail than the ground truth while remaining factually correct. Entity accuracy: Citibank, N.A. Co-Branded Credit Card Agreement is correctly identified. The only minor difference from the ground truth is that the LLM answer uses the phrase 'at least twelve' rather than stating definitively 'twelve,' which is actually a more cautious and appropriate phrasing given the context. The semantic meaning is equivalent—both answers convey that the agreement went from the Eighth Amendment in 2022 to the Twelfth Amendment in 2023, representing four additional amendments. The LLM answer is slightly more detailed in naming each intermediate amendment, which enhances clarity without introducing any inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 378,
        "total_tokens": 1577
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA broadened CUDA from a GPU‑only parallel programming model into a full‑stack, hardware‑agnostic platform that runs on its newest architectures—Hopper (H100), Ada‑Lovelace and the forthcoming Blackwell GPUs—as well as on new CPUs (Grace), DPUs and Mellanox‑based networking.  This expansion was coupled with a richer software ecosystem (CUDA‑X libraries, AI Enterprise, NIM/NeMo/AI Blueprints, Omniverse, DRIVE software) that lets developers deploy AI workloads across data‑center, edge and automotive systems using a single, unified CUDA programming interface.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures several correct elements about CUDA's evolution but introduces problematic inaccuracies and unsupported claims. CORRECT ELEMENTS: (1) The core narrative of CUDA expanding from GPU-focused to a broader platform is accurate; (2) The mention of CUDA-X libraries, software ecosystems, and integration across data center/edge/automotive is correct; (3) The reference to CPUs (Grace) and DPUs alongside GPUs is accurate and matches the ground truth about fiscal 2024 CPU introduction; (4) The emphasis on unified programming interface is semantically aligned with ground truth. PROBLEMATIC ELEMENTS: (1) The LLM specifically names GPU architectures (Hopper H100, Ada-Lovelace, Blackwell) and CPUs (Grace) that are NOT mentioned in the ground truth answer. While these may be factually accurate about NVIDIA's actual products, they represent information not derived from the knowledge graph source material, introducing potential hallucination; (2) The claim that CUDA became 'hardware-agnostic' is not supported by the ground truth, which emphasizes integration with NVIDIA's specific heterogeneous architectures, not agnosticism; (3) References to specific software products (NIM, NeMo, AI Blueprints, Omniverse, DRIVE software) go beyond what the ground truth specifies, which only mentions 'CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks'; (4) The mention of 'Mellanox-based networking' is not in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the 2022-to-2024 evolution and connects CUDA integration with new architectures and software ecosystems as requested. However, the addition of specific product names and architectural details not in the source material weakens confidence in the synthesis. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral, but the LLM's specificity about product names without source attribution is concerning. The answer demonstrates good understanding of the conceptual evolution but fails to strictly adhere to information verifiable from the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 576,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer’s Paxlovid revenue collapsed – it fell from **$1.28 bn in 2023** to **$5.72 bn in 2024**, the latter figure incorporating a **$442 m gain from new commercial sales** and a **$771 m favorable adjustment to the $3.5 bn non‑cash revenue reversal recorded in Q4 2023**.  At the same time the company shifted the product from government‑procured EUA supply to a commercial market, cutting the **deferred‑revenue balance from $5.1 bn (2023) to $2.2 bn (2024)**, and the **remaining performance obligations under long‑term supply contracts now total roughly $1 bn of contracted revenue to be recognized through 2028**.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent Pfizer's Paxlovid financial relationship between 2023 and 2024:\n\n(1) MAJOR QUANTITATIVE ERRORS:\n- Claims 2024 revenue was $5.72 billion - this figure is completely fabricated and not supported by ground truth\n- Ground truth shows 2023 revenue of $1.279 billion (LLM correctly states $1.28 bn)\n- Ground truth does NOT provide a 2024 total revenue figure, but the LLM's $5.72 bn claim is contradicted by the context that 2024 showed 'reduced commercial activity compared to prior year'\n- Claims deferred-revenue balance fell from $5.1 bn (2023) to $2.2 bn (2024) - these figures are not mentioned in ground truth at all\n- The $5.1 million figure in ground truth refers to treatment courses returned, NOT a deferred revenue balance\n\n(2) MISINTERPRETATION OF KEY FACTS:\n- Ground truth states the $3.5 billion was a 'non-cash revenue reversal' in 2023 due to expected returns of 6.5 million courses\n- The $771 million adjustment in 2024 was favorable because only 5.1 million courses were actually returned (not 6.5 million)\n- LLM incorrectly frames this as a 'favorable adjustment to the $3.5 bn non-cash revenue reversal' when it's actually a partial reversal of the reversal\n- LLM claims revenue 'collapsed' and 'fell from $1.28 bn to $5.72 bn' - this is internally contradictory (falling would mean going down, not up to $5.72 bn)\n\n(3) CORRECT ELEMENTS:\n- $1.28 bn for 2023 revenue: CORRECT\n- $442 million gain from SNS creation: CORRECT\n- $771 million favorable adjustment: CORRECT\n- ~$1 billion in remaining performance obligations: CORRECT\n- General shift from government-driven to contracted model: CORRECT CONCEPTUALLY\n\n(4) MULTI-HOP REASONING:\n- The LLM failed to properly synthesize the revenue reversal mechanics\n- Invented deferred revenue figures not in ground truth\n- Created a false 2024 revenue number that contradicts the stated direction of change\n- Did not properly explain the relationship between the reversal, adjustment, and actual 2024 performance\n\n(5) CONTEXTUAL ISSUES:\n- The claim that revenue 'collapsed' from $1.28 bn to $5.72 bn is nonsensical\n- Ground truth emphasizes 'reduced commercial activity' in 2024, not expansion\n- The answer misrepresents the fundamental business evolution described in ground truth\n\nThe answer demonstrates partial understanding of some components but contains fabricated financial data and fundamental logical contradictions that make it substantially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 674,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "\nBetween 2022 and the end of 2024 the number of shares left available for future grants under the 2003 Incentive Program fell sharply—from about **65.8 million shares** noted in the 2022 filing to roughly **47 million shares** remaining as of December 31 2024 (Note 15).  The decline reflects the issuance of roughly **10.5 million restricted‑stock units in 2024**, including the conversion of Pioneer RSUs, as well as the vesting and forfeiture of earlier awards, while the program’s overall ceiling of **220 million shares** stays the same but is now much closer to being exhausted.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of the 2003 Incentive Program between 2022 and 2024, but contains a significant quantitative error that undermines accuracy. CORRECT ELEMENTS: (1) The 2022 available shares figure of ~65.8 million is accurate (ground truth: 65,754,069). (2) The 2024 remaining available shares of 47 million is correct. (3) The program's overall ceiling of 220 million shares is accurate. (4) The general narrative about declining availability and increased usage is sound. (5) The mention of RSU grants and vesting/forfeiture dynamics is appropriate context. CRITICAL ERROR: The LLM states '10.5 million restricted-stock units in 2024' but the ground truth indicates 10,393 thousand (10.393 million) RSUs granted in 2024. While this is a relatively small discrepancy (~0.1 million difference), it represents a factual inaccuracy in a key quantitative claim. The LLM also does not mention the 2022 RSU grant figure of 9,392 thousand, which would have provided useful comparative context showing the modest growth from 2022 to 2024. MULTI-HOP REASONING: The answer correctly synthesizes information across years and connects the decline in available shares to the issuance of RSUs and the fixed program ceiling. The logic is sound. MISSING ELEMENTS: The answer could have been more explicit about the comparison between 2022 RSU grants (9,392k) and 2024 RSU grants (10,393k) to show the 'moderate growth' mentioned in the ground truth. The reference to 'Pioneer RSUs' conversion adds specificity but is not verified against the ground truth. OVERALL: The answer demonstrates good understanding of the program's evolution and provides relevant context, but the quantitative error on 2024 RSU grants and incomplete comparative analysis of RSU growth prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 488,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "\nBetween 2022 and 2024 AdSense moved from being a distinct line‑item within the “Google Network” (which in 2022 showed a $8.6 billion revenue lift driven by AdMob, Ad Manager and AdSense) to a core, AI‑enabled layer of Google’s overall advertising stack.  By 2024 it is tightly integrated with products such as Performance Max, Gemini and the broader Google Ads platform, feeding third‑party inventory into AI‑driven performance and brand‑advertising tools and accounting for a larger share of Google’s total ad revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $8.6 billion revenue figure from 2022 and accurately names the three products (AdMob, Ad Manager, AdSense) that drove this growth. (2) The numeric data is accurate and properly formatted. (3) The answer correctly captures the shift from explicit quantification to integration with newer AI products. (4) The mention of Performance Max as a newer AI-powered product aligns with ground truth. WEAKNESSES: (1) The LLM introduces unsupported claims not in the ground truth, specifically stating AdSense is 'accounting for a larger share of Google's total ad revenue' - this is a factual claim not substantiated by the original answer and represents speculation beyond the source material. (2) The LLM mentions 'Gemini' as part of the integration, which is not mentioned in the ground truth answer about AdSense's evolution. (3) The characterization of AdSense as 'AI-enabled' is not explicitly stated in the ground truth, which focuses on newer products (Demand Gen, Performance Max) being AI-powered, not AdSense itself. (4) The phrase 'feeding third-party inventory into AI-driven performance and brand-advertising tools' adds operational detail not present in the ground truth. MULTI-HOP REASONING: The core multi-hop synthesis is sound - comparing 2022 vs 2024 positioning and relating AdSense to broader portfolio evolution. However, the LLM extends beyond the ground truth by making claims about market share and specific technical integrations that cannot be verified from the provided source material. The answer conflates 'integration with AI products' with 'being AI-enabled,' which are different claims. OVERALL: The answer captures the essential narrative shift correctly but introduces unsupported claims that reduce factual accuracy despite getting the core numbers right.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 496,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "\nBetween 2022 and 2023 the UPS Retirement Plan moved from an open‑ended defined‑benefit accrual for non‑union employees to a freeze of future benefit credits—effective January 1 2023 the plan (and its Excess Coordinating Benefit component) stopped accruing any additional benefits for that group. At the same time the plan was revised so that non‑union participants would receive a retirement contribution of 5 %–8 % of eligible compensation to the UPS 401(k) Savings Plan (up from the prior 3 %–8 % schedule for employees hired after July 1 2016), replacing the former defined‑benefit accrual. These changes are outlined in the “U.S. Pension Benefits” section of Note 6 in the 2023 filing.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core change: the freeze of benefit accruals for non-union participants effective January 1, 2023, and the shift from defined-benefit to defined-contribution structure. The qualitative reasoning about the transformation from open-ended to frozen accruals is sound and well-articulated. However, there are significant quantitative accuracy issues: (1) The LLM introduces specific 401(k) contribution percentages (5%-8% up from 3%-8%) that are NOT present in the ground truth answer. The ground truth makes no mention of these specific percentages or the 401(k) replacement structure. (2) The ground truth focuses on the cessation of accruals and describes the plan structure but does NOT discuss the 401(k) contribution replacement details. (3) The LLM's claim about the prior 3%-8% schedule for employees hired after July 1, 2016 is not corroborated by the ground truth. These appear to be details the LLM may have inferred or added from the filing, but they represent factual claims not supported by the ground truth provided. The answer is contextually relevant and addresses the question's core inquiry about the evolution and specific changes, but the introduction of unverified numerical details (the 401(k) percentages) significantly undermines confidence in the response. The multi-hop reasoning is adequate—connecting the 2022 state to 2023 changes—but the factual accuracy is compromised by these unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1444,
        "completion_tokens": 408,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon expanded and reshaped its short‑term liquidity lines: it grew its unsecured revolving capacity from the $7 billion facility that was set to expire in 2023 to a $15 billion revolving agreement that now runs until 2028 (interest = benchmark + 0.45 % with a 0.03 % commitment fee), and it added a new $5 billion 364‑day revolving facility (SOFR + 0.45 % and a 0.03 % fee) that matures in 2025.  At the same time it terminated its $1 billion secured revolving facility that had been used for seller‑receivable collateral, and it doubled the size of its commercial‑paper program to $20 billion while bringing outstanding commercial‑paper borrowings to essentially zero.  Consequently, short‑term borrowings under these facilities fell from about $800 million at the end of 2021 to virtually none by the end of 2024, reflecting a shift toward larger, longer‑dated facilities and lower‑cost financing terms.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. QUANTITATIVE ERRORS:\n   - Claims $7B facility 'set to expire in 2023' - ground truth shows it existed in 2022 but doesn't specify expiration date\n   - States new facility 'runs until 2028' - ground truth does not mention 2028 expiration date\n   - Claims 364-day facility 'matures in 2025' - ground truth says it was entered in October 2024 but doesn't specify 2025 maturity\n   - States short-term borrowings fell from '$800 million at end of 2021' - ground truth mentions $7.2B in unused letters of credit as of Dec 31, 2021, but does NOT mention $800M in borrowings\n   - Claims 'doubled commercial-paper program to $20 billion' - ground truth contains NO information about commercial paper programs\n   - States 'outstanding commercial-paper borrowings to essentially zero' - ground truth does not discuss commercial paper borrowings\n\n2. MISSING INFORMATION FROM GROUND TRUTH:\n   - LLM fails to mention the $147M and $151M in borrowings under other short-term credit facilities in 2023 and 2024\n   - LLM fails to mention the increase in unused letters of credit from $7.2B (2021) to $8.3B (2024)\n   - LLM does not clearly state that NO borrowings were outstanding under the main Credit Agreement or Short-Term Credit Agreement as of Dec 31, 2024\n\n3. UNSUPPORTED CLAIMS:\n   - The mention of a '$1 billion secured revolving facility' for seller-receivable collateral is not in the ground truth\n   - The commercial paper program details are entirely absent from ground truth\n   - Specific expiration dates (2023, 2025, 2028) are not verified in ground truth\n\n4. CORRECT ELEMENTS:\n   - Correctly identifies the $7B facility from 2022\n   - Correctly identifies the $15B facility with benchmark + 0.45% and 0.03% commitment fee\n   - Correctly identifies the $5B 364-day facility with SOFR + 0.45% and 0.03% fee\n   - Correctly notes the shift toward larger, longer-dated facilities\n   - Correctly identifies lower-cost financing terms\n\n5. MULTI-HOP REASONING:\n   The LLM demonstrates understanding of the general evolution (expansion and restructuring) but introduces fabricated details that undermine credibility. The synthesis is partially sound but contaminated with unsupported information.\n\nThe answer reads plausibly but contains material factual errors and introduces information not present in the ground truth, particularly regarding commercial paper programs, specific maturity dates, and prior borrowing levels.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 679,
        "total_tokens": 2214
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "\nBetween 2022 and 2023 Costco’s disclosures show a modest shift toward greater reliance on variable‑priced, index‑linked contracts for electricity, natural‑gas and fuel.  The 2022 filing (pp. 29‑33) describes a mixed strategy—fixed‑price agreements for many warehouses complemented by variable‑price purchases for some energy uses—whereas the 2023 filing (pp. 45‑49) emphasizes that the company now “enters into variable‑priced contracts for some purchases of electricity and natural gas… and does not intend to engage in speculative transactions,” indicating that it is leaning more heavily on index‑based pricing to absorb commodity volatility rather than locking in fixed rates.  This evolution reflects a risk‑management approach that seeks to pass price fluctuations on to members while avoiding the need for mark‑to‑market adjustments on derivative instruments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer fundamentally mischaracterizes the evolution between 2022 and 2023. The ground truth explicitly states 'no significant shift away from index-based pricing mechanisms' and 'The strategy remains consistent, showing stability.' However, the LLM claims a 'modest shift toward greater reliance on variable-priced, index-linked contracts' and states the company is 'leaning more heavily on index-based pricing,' which directly contradicts the ground truth's assertion of consistency and stability. This is a major factual error in interpreting the multi-hop comparison. QUANTITATIVE ISSUES: The LLM cites specific page numbers (pp. 29-33 for 2022, pp. 45-49 for 2023) that cannot be verified against the ground truth and appear to be fabricated details. The ground truth provides no such page references. PARTIAL CORRECTNESS: The LLM correctly identifies that both years involved variable-priced contracts on an index basis, correctly notes the 'normal purchases and normal sales' exception concept (though not explicitly stated), and accurately describes the avoidance of mark-to-market adjustments. The mention of electricity, natural gas, and fuel for gas stations is accurate. REASONING FLAW: The LLM's interpretation that the company is 'passing price fluctuations on to members' represents an inference not supported by the ground truth, which simply states the strategy 'remains consistent.' The characterization of this as an 'evolution' or 'shift' is incorrect—the ground truth emphasizes continuity, not change. The answer demonstrates partial understanding of the components but fails on the core analytical task of comparing 2022 vs. 2023 trends accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 462,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "\nBetween 2022 and 2024, NVIDIA AI Enterprise shifted from a supplemental, license‑based software add‑on for enterprise AI workloads to a core, subscription‑oriented platform that forms the backbone of the company’s data‑center stack.  It now integrates AI software, networking and services (e.g., NIM, NemO, AI Blueprints) and is bundled with offerings such as DGX Cloud, positioning AI Enterprise as the primary recurring‑revenue engine for enterprise AI adoption within NVIDIA’s data‑center portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces unsupported claims and makes interpretive leaps beyond the ground truth. CORRECT ELEMENTS: (1) The timeframe (2022-2024) is accurate; (2) The evolution from foundational/supplemental to more prominent commercial offering is correctly identified; (3) Integration with DGX Cloud is mentioned in both answers; (4) The shift toward monetization is implied in both. PROBLEMATIC ELEMENTS: (1) The LLM introduces 'subscription-oriented platform' and 'recurring-revenue engine' language that is NOT present in the ground truth, which only mentions 'licensed' offerings; (2) The specific product integrations (NIM, NemO, AI Blueprints) are mentioned by the LLM but NOT in the ground truth, making it unclear if these are accurate or speculative; (3) The characterization as 'primary recurring-revenue engine' is an interpretive claim not supported by the ground truth, which describes it as 'a key monetization vehicle' - a more measured statement; (4) The LLM describes it as 'supplemental, license-based software add-on' in 2022, but the ground truth says it was 'introduced as part of the Compute & Networking segment' with a 'foundational role' - these are different characterizations. MULTI-HOP REASONING: The LLM correctly synthesizes the 2022-2024 evolution across the data center portfolio, but adds interpretive layers (subscription model, specific product names) that go beyond what the ground truth supports. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (8/10 for not introducing false numbers). QUALITATIVE ACCURACY: The core narrative is directionally correct but embellished with unsupported details, reducing confidence in the answer's fidelity to actual filing data (5/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 488,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 Pfizer’s Paxlovid contracts shifted from U.S. government EUA supply—where large revenue reversals were recorded when the government reclaimed inventory—to commercial‑market agreements with negotiated pricing and copay‑assistance programs; in 2024 the company recorded a $771 million favorable adjustment to the prior reversal and recognized $442 million from a new U.S. SNS supply, while disclosing roughly $1 billion of remaining performance‑obligation revenue to be recognized from 2025 through 2028. This signals that Pfizer expects only modest, declining future revenue from Paxlovid as demand moves from government stockpiling to commercial sales and the bulk of the product’s sales horizon extends only to the latter half of the decade.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a '$771 million favorable adjustment' and '$442 million from a new U.S. SNS supply' - these specific numbers do not appear in the ground truth and cannot be verified. The ground truth only mentions the $3.5 billion 2023 reversal and ~$1 billion remaining performance obligations in 2024. (2) MISSING CORE FACTS: The LLM fails to mention the critical 2023 detail of the 6.5 million treatment courses return under EUA, which is central to understanding the 2023 situation. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the ~$1 billion remaining performance obligations for 2024, it adds unverified details about 'commercial-market agreements,' 'copay-assistance programs,' and specific revenue recognition amounts that are not in the ground truth. (4) INTERPRETATION ISSUES: The ground truth emphasizes a shift from 'uncertainty and potential decline' (2023) to 'stabilization and expectation of future revenue' (2024). The LLM instead characterizes 2024 as showing 'only modest, declining future revenue,' which contradicts the ground truth's interpretation of stabilization. (5) REASONING: The multi-hop reasoning about contract evolution is partially sound, but it's built on unverified numbers and introduces commercial market details not supported by the source material. The conclusion about 'declining future revenue' is not supported by the ground truth's narrative of stabilization. The answer demonstrates some understanding of the general trend but fails on factual accuracy with introduced numbers and misinterprets the significance of the 2024 data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 473,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s description of regulatory risk moved from a vague reference to “new and evolving products… raise ethical, legal and regulatory challenges” and a general warning that “increasing regulations” could pressure margins, to a concrete focus on specific cross‑border obligations—e.g., EU‑UK data‑transfer rules, anti‑corruption statutes, sanctions‑related foreign‑policy changes and heightened privacy‑ and content‑moderation compliance. Thus, the scope of exposure shifted from an unspecified regulatory threat to a detailed set of jurisdiction‑specific costs that Google now expects to incur to meet new international regulatory requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) DIRECTIONAL ERROR: The LLM claims the evolution moved FROM 'vague references' TO 'concrete focus,' but the ground truth indicates the opposite - from specific 2022 concerns (EU-UK data transfers, new customer requirements) to broader, more uncertain risks in 2024. (2) MISSING CORE ELEMENTS: The LLM fails to mention critical 2024 elements that the ground truth emphasizes: 'uncertainty regarding regulatory outcomes' and 'other liabilities under local laws that may not offer due process or clear legal precedent.' These represent a fundamental shift toward unpredictability. (3) INACCURATE CHARACTERIZATION: The LLM describes 2022 as having 'vague references' and 'general warnings,' but the ground truth shows 2022 had specific, concrete concerns about data transfers and customer requirements. (4) MISSING SYNTHESIS: The LLM does not capture the key insight from the ground truth - that the shift represents movement from DATA-SPECIFIC concerns to BROADER, MORE UNPREDICTABLE regulatory risks. (5) SCOPE MISUNDERSTANDING: While the LLM mentions some relevant regulatory areas (EU-UK data transfers, anti-corruption, sanctions), it frames them as representing increased specificity rather than the ground truth's narrative of increased uncertainty and complexity. The LLM's answer appears to describe a different evolution pattern than what the ground truth documents, making it fundamentally incorrect despite mentioning some relevant regulatory topics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 433,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "\nBetween 2022 and 2023 UPS continued to fund its post‑retirement medical benefits from **both plan trusts and corporate assets**, but the cash‑flow schedule and the amount contributed to the trusts changed.  In the 2022 filing the company expected $229 million of benefit payments in 2022 (and $219 million in 2023) with an employer contribution of $177 million to the trusts.  The 2023 filing revises the outlook, showing payments of $216 million in 2024, $206 million in 2025, etc., and reduces the planned trust contribution to $74 million for 2024, indicating a modest shift toward relying more on corporate assets while still using the same two‑source funding approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states there was NO CHANGE in the funding approach between 2022 and 2023 - the language remained unchanged and both years indicated funding from plan trusts and corporate assets. The LLM incorrectly claims there was 'a modest shift toward relying more on corporate assets,' which directly contradicts the ground truth. (2) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($229M, $219M, $177M, $216M, $206M, $74M) that cannot be verified against the ground truth provided. The ground truth does not mention these specific figures, and the LLM appears to have fabricated or misattributed these numbers. (3) The LLM correctly identifies that both plan trusts and corporate assets were used as funding sources in both years, which aligns with ground truth. However, it then incorrectly interprets this as evidence of a 'shift' in approach when the ground truth explicitly states the approach remained unchanged. (4) REASONING FLAW: The LLM's logic that changing contribution amounts ($177M to $74M) indicates a 'shift toward relying more on corporate assets' is speculative and not supported by the ground truth, which states the funding sources themselves did not change. (5) The answer addresses the question's structure but reaches an incorrect conclusion about evolution/change in approach. The core finding should be 'no change' not 'modest shift.' This is a fundamental misinterpretation of the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 428,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "\nFrom its launch in 2022, NVIDIA AI Enterprise was positioned as a software‑only suite that extended the company’s GPU‑accelerated AI stack to enterprise customers, offering tools such as AI Enterprise, vGPU licensing and DGX Cloud. By 2024 the offering had broadened into a full‑stack platform that now spans GPU, DPU and CPU hardware, integrates the Blackwell architecture, and is delivered through services like NIM, NeMo and AI Blueprints, reflecting a wider supply base and deeper integration across NVIDIA’s hardware, networking and software ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the evolution of NVIDIA AI Enterprise from 2022 to 2024 and correctly identifies the shift from a foundational software suite to a more comprehensive platform. However, there are significant accuracy issues:\n\nCORRECT ELEMENTS:\n- Correctly identifies 2022 as introduction year and 2024 as evolution point\n- Accurately mentions NIM, NeMo, and AI Blueprints as 2024 components\n- Correctly characterizes the evolution as moving from software-only to full-stack platform\n- Appropriately notes broader integration across hardware and software ecosystem\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n- The LLM introduces entities (vGPU licensing, DGX Cloud, Blackwell architecture, DPU/CPU hardware) that are NOT mentioned in the ground truth answer. While these may be factually accurate about NVIDIA's broader offerings, they are not supported by the knowledge graph for this specific question about AI Enterprise evolution\n- The ground truth specifically mentions a \"2.5x increase in token throughput\" as a performance improvement in 2024, which the LLM answer completely omits\n- The LLM characterizes the 2022 offering as \"software-only suite that extended the company's GPU-accelerated AI stack\" which is slightly different from the ground truth's description of it as \"a software suite aimed at simplifying the deployment of AI applications\"\n- The LLM adds details about \"supply base\" and \"deeper integration\" that go beyond what the ground truth specifies\n\nMULTI-HOP REASONING:\nThe LLM demonstrates reasonable synthesis of the evolution concept but introduces unsupported details rather than sticking to the knowledge graph. The core multi-hop reasoning (2022 introduction → 2024 evolution) is sound, but the specific details diverge from ground truth.\n\nQUANTITATIVE ACCURACY:\nThe critical missing quantitative detail is the \"2.5x increase in token throughput\" mentioned in the ground truth. This is a specific, measurable performance metric that should have been included.\n\nOVERALL ASSESSMENT:\nThe answer captures the general narrative of evolution but fails to include a key quantitative metric and introduces details not supported by the knowledge graph, suggesting hallucination or over-generalization beyond the provided source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 610,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "\nFrom 2022 to 2024 the proved reserves that ExxonMobil holds through equity‑company joint ventures rose from roughly **1.3 billion oil‑equivalent barrels to 1.48 billion barrels** (an increase of about 150 million boe).  The bulk of this growth occurred in **Asia** (e.g., added reserves in Iraq, Kazakhstan and other Asian PJVs) and, to a smaller extent, in **Africa**, while the share of equity reserves in the Americas remained essentially flat.  \n\nThis pattern shows that ExxonMobil is deliberately concentrating its partnership‑based resource base in high‑potential, growth‑oriented regions—particularly Asia and Africa—while maintaining a stable footprint in the mature Americas, underscoring a strategic shift toward leveraging equity ventures to secure future production growth in those emerging areas.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamentally incorrect numbers that do not match the ground truth data. (1) QUANTITATIVE ACCURACY FAILURES: The LLM states reserves grew from '1.3 billion oil-equivalent barrels to 1.48 billion barrels' (150 million boe increase), but the ground truth shows: 2022: 14 million barrels gross (1 million net); 2024: 467 million barrels crude oil + 120 million barrels NGL + 5,367 billion cubic feet natural gas. These are completely different magnitudes and compositions. The LLM appears to have converted everything to BOE incorrectly or used wrong source data entirely. (2) ENTITY/METRIC CONFUSION: The LLM conflates different reserve categories and provides numbers that don't align with the specific breakdown provided in the ground truth (crude oil, NGL, and natural gas separately). (3) REGIONAL ANALYSIS: While the LLM correctly identifies Asia as the primary growth region (matching ground truth), it adds 'Iraq and Kazakhstan' as examples, which are not mentioned in the ground truth and may be inaccurate. The ground truth emphasizes 'majority of growth concentrated in Asia' without specifying countries. (4) MULTI-HOP REASONING: The LLM does attempt to synthesize regional positioning and strategic implications, which is qualitatively sound in approach, but this is undermined by the incorrect foundational numbers. (5) MISSING SPECIFICITY: The ground truth provides precise reserve figures by commodity type (crude oil, NGL, natural gas in specific units); the LLM provides only aggregate BOE figures that don't match. The 2022 figure of 14 million barrels gross is dramatically different from the LLM's 1.3 billion BOE claim. This represents a fundamental failure in data accuracy that cannot be overlooked despite some correct directional insights about regional strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 497,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "\nBetween 2022 and 2024 the amount Google pays to its Network Partners (recorded as traffic‑acquisition costs, or TAC) rose in absolute dollars—reflecting higher ad volume and expanded inventory on partner sites—but this cost grew more slowly than total advertising revenue, keeping the TAC‑to‑revenue ratio roughly stable (around 23‑24 % of revenue). As a result, while Google continues to report the full gross amount billed to advertisers as revenue, the expense paid to Network Partners has increased, pressuring the margin on that segment; however, the higher revenue base has still driven a net rise in Google Services operating income, showing that Network Partners remain a significant but increasingly efficient component of the cost structure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) MAJOR ERRORS: The LLM introduces specific quantitative claims (TAC-to-revenue ratio of 23-24%) that are not present in the ground truth and cannot be verified. The ground truth makes no mention of TAC percentages or specific ratio calculations. (2) CONCEPTUAL MISALIGNMENT: The ground truth describes a shift in financial reporting framing between 2022 and 2024—from emphasizing Google's principal role with gross revenue reporting to emphasizing net cash flow impact. The LLM instead focuses on TAC growth rates and margin analysis, which is a different analytical framework entirely. (3) MISSING KEY INSIGHT: The ground truth's central point is about the evolution in HOW the relationship is reported and framed (gross basis with cost of revenues vs. cash flow impact), not about TAC ratios or margin efficiency. The LLM completely misses this reporting methodology shift. (4) UNSUPPORTED CLAIMS: The LLM's statement about TAC growing 'more slowly than total advertising revenue' and the resulting margin pressure is not substantiated in the ground truth. The claim about 'increasingly efficient component' contradicts the ground truth's emphasis on cost-centric framing. (5) ENTITY/METRIC CONFUSION: While both answers discuss Google Network Partners, they address fundamentally different aspects—the ground truth addresses reporting structure changes, while the LLM addresses cost efficiency metrics that aren't mentioned in the source material. The LLM appears to have generated plausible-sounding financial analysis rather than accurately synthesizing the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 468,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "\nUPS moved away from using non‑designated foreign‑currency forward contracts as a primary hedge, cutting the notional amount of those contracts from roughly $1 million (shown in other current assets in 2022) to essentially zero by the end of 2023.  Consequently, the earnings impact of the resulting fair‑value adjustments fell dramatically—recording only a $7 million loss in 2023 versus a $69 million loss in 2022—showing that the company’s foreign‑exchange risk‑management strategy reduced earnings volatility in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($7 million loss in 2023 vs $69 million loss in 2022) and notional contract values (~$1 million in 2022, essentially zero in 2023) that are not verified in the ground truth and appear to be fabricated or incorrectly sourced. The ground truth does not provide these specific numerical values. (2) STRATEGIC MISCHARACTERIZATION: The LLM claims UPS 'moved away from using non-designated foreign-currency forward contracts as a primary hedge' and reduced notional amounts to 'essentially zero,' but the ground truth indicates that UPS continued using these contracts and actually EXPANDED disclosure in 2023, suggesting continued use rather than elimination. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes that 2023 brought 'expanded disclosure' with 'more structured presentation' and 'side-by-side' reporting of 2023 and 2022 amounts, indicating evolution in disclosure practices. The LLM focuses on contract reduction rather than disclosure evolution. (4) MISSING KEY ELEMENTS: The LLM fails to address the core evolution mentioned in ground truth—the shift from general disclosure of fair value effects to explicit linkage of undesignated derivative settlements to earnings volatility. (5) LOGICAL INCONSISTENCY: If contracts were reduced to 'essentially zero,' the earnings impact reduction could be explained by volume reduction rather than improved risk management strategy evolution. The ground truth suggests strategic evolution in how the company manages and discloses these risks, not elimination of the instruments. The answer demonstrates a fundamental misunderstanding of the question's focus on strategy evolution and disclosure changes rather than contract volume reduction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 504,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "\nIn 2022 the membership model was presented as a core profitability engine, with fee revenue climbing 9 % to $4.2 bn as new sign‑ups, Executive‑membership upgrades and strong renewal rates reinforced member loyalty. By 2023 the company still regarded the format as integral, but it warned that paid‑membership growth and renewal rates could be constrained by openings in existing markets and lower renewal rates in newer markets, indicating a more nuanced evolution of its role.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of the membership model's role between 2022 and 2023, capturing the shift from emphasis on growth drivers to acknowledgment of emerging challenges. It appropriately mentions the concern about lower renewal rates in newer markets, which aligns with the ground truth. The semantic understanding of the membership format's integral role in profitability is sound. WEAKNESSES: (1) QUANTITATIVE ERROR - The LLM cites '9% fee revenue growth to $4.2 bn' for 2022, but this specific metric is NOT present in the ground truth answer. The ground truth does not provide these numerical figures, making this a potential fabrication or hallucination. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes specific 2022 language ('has a significant effect on our profitability') versus 2023 language ('is an integral part of our business and profitability'), showing a subtle but important linguistic evolution. The LLM captures the essence but doesn't highlight this specific textual evolution. (3) MISSING CONTEXT - The ground truth explicitly notes that the 2023 concern about renewal rates in newer markets 'was not explicitly mentioned in 2022,' providing important temporal context about what changed. The LLM mentions this concern but doesn't clearly establish it as a NEW concern in 2023. (4) VAGUE PHRASING - The LLM's reference to 'openings in existing markets' is unclear and not directly supported by the ground truth language. MULTI-HOP REASONING: The LLM does synthesize information across two years and identifies the evolution, but the introduction of unsupported numerical data undermines credibility. The core logical reasoning about the shift from growth emphasis to challenge acknowledgment is sound, but the execution is compromised by the quantitative inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 498,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA moved CUDA from a stand‑alone parallel‑programming layer for GPUs into the core of an end‑to‑end data‑center stack, tightly coupling it with new hardware blocks (DPUs introduced in 2022 and the Grace CPU launched in 2024) and with a unified software ecosystem that now includes AI Enterprise, NIM, NeMo, AI Blueprints and DGX Cloud services.  This full‑stack approach lets CUDA‑based AI workloads span training, inference, simulation and over‑the‑air updates across GPUs, CPUs, networking and DPUs, delivering a seamless, scalable platform for generative‑AI and other data‑intensive applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the core strategic shift from CUDA as a developer tool to CUDA as infrastructure within an integrated data center platform. The mention of broader ecosystem components (GPUs, CPUs, DPUs) and the full-stack approach aligns well with the ground truth's emphasis on 'end-to-end optimized computing.' The semantic understanding of CUDA's evolution is sound. WEAKNESSES: (1) QUANTITATIVE ERRORS - The LLM introduces specific product names and dates not present in the ground truth: 'DPUs introduced in 2022,' 'Grace CPU launched in 2024,' 'AI Enterprise, NIM, NeMo, AI Blueprints and DGX Cloud services.' While some of these may be factually accurate about NVIDIA's actual product timeline, they are NOT mentioned in the ground truth knowledge graph provided. The ground truth only mentions 'CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks' without naming specific products. (2) MISSING KEY GROUND TRUTH DETAILS - The LLM fails to mention the '3 million developers' statistic from 2022, which is a concrete quantitative anchor point in the original answer. The ground truth specifically references 'Deep Learning Institute and Inception program' as 2022 context, which the LLM omits. (3) SPECIFICITY MISMATCH - The ground truth emphasizes CUDA-X as the specific framework collection, while the LLM lists different product names that may not align with the knowledge graph's categorization. The LLM's answer, while strategically sound and contextually relevant, appears to draw on external knowledge about NVIDIA's product portfolio rather than strictly adhering to the ground truth provided. This represents a hallucination risk where accurate-sounding details are added without verification against the source knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 490,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "\nFrom 2023 to 2024 Pfizer’s Paxlovid revenue collapsed as the U.S. government wound down its EUA‑labeled supply, prompting a $3.5 bn non‑cash revenue reversal in Q4 2023 that was later softened by a $771 m favorable adjustment in Q1 2024 after 5.1 million treatment courses were returned.  The company now reports only about $1 bn of remaining contracted revenue for Paxlovid, to be recognized on deliveries scheduled from 2025 through 2028 under long‑term agreements (including a U.S. Strategic National Stockpile commitment that extends through 2028), with future volumes subject to renegotiation as the product transitions to commercial‑market sales.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative arc correctly but introduces a significant factual error that undermines quantitative accuracy. CORRECT ELEMENTS: (1) The $3.5 billion non-cash revenue reversal in Q4 2023 is accurate; (2) The approximately $1 billion in remaining performance obligations is correct; (3) The 2025-2028 delivery timeline is accurate; (4) The reference to U.S. Strategic National Stockpile commitment is appropriate context; (5) The characterization of the shift from uncertain returns to defined forward-looking revenue is semantically sound. CRITICAL ERROR: The LLM introduces a '$771 million favorable adjustment in Q1 2024' and references '5.1 million treatment courses returned' - these specific figures do NOT appear in the ground truth answer and cannot be verified. This represents an unsupported quantitative claim that significantly impacts credibility. MULTI-HOP REASONING: The answer correctly synthesizes the evolution from 2023 to 2024, connecting the revenue reversal to the subsequent remaining obligations and future delivery schedule. The logic linking government inventory returns to the revenue reversal is sound. COMPLETENESS: The answer addresses both expected future revenue ($1 billion) and product delivery timelines (2025-2028), fully addressing the question's requirements. SEMANTIC ISSUES: The phrase 'Paxlovid revenue collapsed' is somewhat hyperbolic compared to the ground truth's more neutral 'shift' language, though not factually incorrect. The addition of 'future volumes subject to renegotiation' adds reasonable context not contradicted by ground truth. OVERALL ASSESSMENT: The core answer structure and most key facts are correct, but the introduction of unverified specific numbers ($771M adjustment, 5.1M courses) represents a material factual error that prevents a higher score despite otherwise sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 509,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "\nExxonMobil’s view of Guyana shifted from a frontier, undeveloped reserve base — the 2022 filing listed roughly 1.3 billion oil‑equivalent barrels of proved undeveloped reserves in “Other Americas” and noted $8 billion of investment to move those reserves toward development — to a core “advantaged asset” that is now explicitly counted in the company’s earnings‑driver framework.  By 2024 the 10‑K’s “Advantaged Volume Growth” definition cites Guyana (alongside the Permian and LNG) as a key source of future production, signalling that the company has moved from planning to active development and expects Guyana to deliver significant volume‑mix earnings growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The 1.3 billion oil-equivalent barrels figure is correctly cited and matches the ground truth. The $8 billion investment figure is appropriately included as supporting context, though not explicitly in the ground truth statement. The numeric data is accurate. QUALITATIVE ACCURACY: The LLM successfully synthesizes the multi-hop evolution of Guyana's strategic importance between 2022 and 2024. It correctly identifies the transition from 'frontier, undeveloped reserve base' (2022) to 'core advantaged asset' (2024), matching the ground truth's characterization of the shift from 'reserves growth region' to 'recognized source of advantaged production and earnings visibility.' ENTITY ACCURACY: All entities are correctly identified - ExxonMobil, Guyana, the years 2022 and 2024, and the relevant metrics (proved undeveloped reserves, Advantaged Assets, Advantaged Volume Growth). The mention of Permian and LNG as comparable advantaged assets adds appropriate context. REASONING: The multi-hop reasoning is sound. The LLM correctly traces the evolution across two time periods and two different disclosure frameworks (reserves reporting in 2022 vs. earnings drivers in 2024), demonstrating proper synthesis. The characterization of the shift from 'planning to active development' is a logical inference supported by the data. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth while using slightly different phrasing ('frontier, undeveloped reserve base' vs. 'reserves growth region'). Both characterizations are semantically equivalent and accurate. MINOR CONSIDERATIONS: The LLM provides slightly more detail about the investment amount and the specific earnings-driver framework, which enhances rather than detracts from the answer. No factual errors or calculation mistakes are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 527,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "\nFrom the 2022 note on purchase commitments the company had scheduled 24 ATR 72‑600F aircraft (11 in 2023, 6 in 2024, 6 in 2025 and 1 in 2026). By the 2024 update the commitment had fallen to only 10 aircraft (7 slated for delivery in 2025 and 3 in 2026), a reduction of more than half. This pull‑back signals that FedEx is de‑emphasizing the ATR 72‑600F in its fleet strategy, shifting instead toward larger, more fuel‑efficient jet freighters (B777F/B767F) and newer turboprops such as the Cessna SkyCourier for regional service.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct quantitative data and sound multi-hop reasoning. STRENGTHS: (1) All numeric values are accurate - 2022 projections of 24 total ATR 72-600F aircraft (11+6+6+1) correctly identified, and 2024 projections of 10 total (7+3) correctly identified. (2) The calculation of 'more than half' reduction (14 aircraft reduction from 24 to 10 = 58% reduction) is mathematically sound. (3) Multi-hop synthesis is excellent - the answer correctly compares projections across two different years (2022 vs 2024) and draws appropriate conclusions about fleet strategy evolution. (4) The identification of FedEx as the company and the context about alternative aircraft (B777F/B767F, Cessna SkyCourier) demonstrates good contextual understanding. (5) The characterization of the shift as 'de-emphasizing' the ATR 72-600F aligns with the ground truth's description of a 'more sustained, albeit reduced, role.' MINOR CONSIDERATIONS: (1) The ground truth emphasizes that the aircraft 'continued to play a more sustained role' while the LLM emphasizes 'de-emphasizing' - these are complementary perspectives rather than contradictory, but the ground truth's framing is slightly more nuanced about the sustained (though reduced) commitment. (2) The LLM provides additional context about strategic alternatives (B777F/B767F, Cessna SkyCourier) that, while reasonable inferences, are not explicitly mentioned in the ground truth provided. This adds value but goes slightly beyond the direct comparison requested. Overall, the answer correctly addresses the evolution question with accurate numbers, proper calculations, and sound reasoning about what the changes indicate about fleet strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 471,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "\nBetween 2022 and 2024 NVIDIA transformed Omniverse from a stand‑alone 3‑D collaboration and simulation tool into the backbone of its AI‑driven simulation ecosystem.  In 2022 it was offered as a subscription‑based enterprise platform (with a free individual tier) for digital‑twin and industrial‑design workflows, and it began powering automotive validation via the DRIVE Constellation simulation suite.  By 2024 the company had deepened integration, using Omniverse to generate synthetic data and run AI‑powered testing pipelines (e.g., DRIVE Sim), embedding it in AI services such as NIM, NeMo, AI Blueprints and the ACE avatar engine, and exposing it through cloud‑based enterprise subscriptions that tie directly to NVIDIA’s broader AI and accelerated‑computing stack.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains some correct elements but introduces information not supported by the ground truth and makes claims that cannot be verified against the original answer.\n\nCORRECT ELEMENTS:\n- Correctly identifies the 2022-2024 timeframe\n- Accurately notes the shift from general 3D collaboration to more specialized enterprise use\n- Correctly mentions subscription-based enterprise model with free individual tier\n- Appropriately emphasizes integration with AI and accelerated computing\n- Correctly identifies automotive/DRIVE applications\n\nPROBLEMATIC ELEMENTS:\n1. UNSUPPORTED CLAIMS: The LLM introduces specific product names and integrations (DRIVE Constellation, DRIVE Sim, NIM, NeMo, AI Blueprints, ACE avatar engine) that are NOT mentioned in the ground truth. While these may be factually accurate from SEC filings, they represent information synthesis beyond what the original answer provides.\n\n2. SYNTHETIC DATA GENERATION: The claim about using Omniverse to \"generate synthetic data and run AI-powered testing pipelines\" is not explicitly stated in the ground truth, which focuses on digital twins, factory digitalization, and autonomous robot/vehicle testing.\n\n3. SPECIFICITY MISMATCH: The ground truth emphasizes VR/AR enterprise applications (virtual car showrooms, surgical training) in 2022, which the LLM answer omits entirely. The LLM instead focuses on automotive validation, which is a different emphasis.\n\n4. CLOUD INTEGRATION FRAMING: While the ground truth mentions \"on-premises and in the cloud,\" the LLM's characterization of \"cloud-based enterprise subscriptions\" as a 2024 evolution is not explicitly supported by the original answer.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of evolution over time, but the reasoning is partially based on information not in the ground truth, making it difficult to verify the accuracy of the multi-hop synthesis.\n\nQUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral (7/10 for appropriate use of timeframes).\n\nQUALITATIVE ACCURACY: The answer shows good understanding of the general evolution but introduces unsupported specificity that detracts from alignment with the ground truth (5/10).\n\nCONTEXTUAL RELEVANCE: The answer addresses the question appropriately but diverges from the ground truth's specific examples and emphasis (6/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 646,
        "total_tokens": 2080
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the share of Google Play in Alphabet’s non‑advertising revenue grew noticeably.  The “Google Subscriptions, Platforms, and Devices” line—of which Google Play’s app‑sale and in‑app‑purchase proceeds are a key component—helped drive the $19 billion (8 %) rise in Google Services revenue and contributed to the overall increase in non‑advertising revenues, which expanded faster than advertising and now carries a larger weight in the company’s revenue mix, albeit at lower margins.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer attempts to address the evolution of Google Play's role but contains significant issues: (1) QUANTITATIVE PROBLEMS: The LLM cites a '$19 billion (8%) rise in Google Services revenue' but provides no source verification and this specific figure is not mentioned in the ground truth. The claim about 'non-advertising revenues expanding faster than advertising' is unsupported by the provided ground truth. These unverified numbers significantly undermine credibility. (2) PARTIAL ALIGNMENT WITH GROUND TRUTH: The LLM correctly identifies that Google Play is part of 'Google Subscriptions, Platforms, and Devices' and acknowledges the shift toward platforms as a defined revenue stream, which aligns with the ground truth's mention of 'transition into a more defined revenue stream under platforms.' However, the LLM doesn't explicitly mention the 2022 introduction of Google Play or the specific categorization evolution described in the ground truth. (3) MISSING KEY DETAILS: The ground truth emphasizes the strategic shift from 'just a component of diversification' to 'a key monetization platform' and notes the 'more structured categorization.' The LLM touches on this but doesn't clearly articulate this evolution. (4) ADDITIONAL CLAIMS NOT IN GROUND TRUTH: The LLM introduces claims about 'lower margins' and comparative growth rates that aren't substantiated by the ground truth provided. (5) MULTI-HOP REASONING: The LLM attempts to synthesize information about Google Play's role across years, but the synthesis relies on unverified financial figures rather than the documented evolution described in the ground truth. The answer shows reasonable understanding of the general trend but fails on factual precision regarding specific numbers and lacks clear documentation of the 2022-to-2023 transition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 494,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG kept the expected‑loss‑ratio approach as the primary tool for its **guaranteed‑cost** workers‑compensation business, but it continued to apply it **only to the most recent accident year**—i.e., it did not broaden the weighting of the method beyond the latest year.  For **excess‑of‑deductible** (and the growing share of large‑deductible) business, the company **expanded the use of expected‑loss‑ratio estimates to the most recent five accident years** and incorporated higher tail‑factor assumptions to reflect the slower emergence of claims and longer medical‑development patterns.  This shift was driven by the increasing proportion of high‑deductible and excess‑of‑deductible policies, which lengthened reporting cycles and required more frequent updates to loss‑trend and inflation assumptions in the 2023 reserving process.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer captures some key facts correctly but contains significant issues with accuracy and completeness. CORRECT ELEMENTS: (1) The identification that guaranteed cost business used expected loss ratio methods only for the most recent accident year in both years is accurate. (2) The identification that excess of deductible business used these methods for the most recent five accident years is correct. (3) The mention of large deductible business and slower reporting patterns is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM states that AIG 'expanded the use of expected-loss-ratio estimates to the most recent five accident years' for excess-of-deductible business, but the ground truth indicates this was already the case in 2022—there was no expansion between 2022 and 2023. The methodology 'remained broadly consistent' according to the original answer. (2) The LLM introduces claims about 'higher tail-factor assumptions' and 'more frequent updates to loss-trend and inflation assumptions' that are not mentioned in the ground truth and appear to be inferred or fabricated details. (3) The LLM fails to mention the important 2023 refinement about incurred and paid losses being presented net of reinsurance and undiscounted, which the ground truth identifies as potentially reflecting a refinement in reporting transparency. (4) The LLM mischaracterizes the evolution as an 'expansion' when the ground truth explicitly states the methodology 'remained broadly consistent.' MULTI-HOP REASONING: The LLM attempts to synthesize information across years but incorrectly identifies a change (expansion) where the ground truth indicates continuity with only refinements in presentation. The reasoning about why changes occurred (increasing proportion of high-deductible policies) is plausible but not explicitly supported by the ground truth provided. QUANTITATIVE ACCURACY: No specific numbers or calculations are present in either answer, so this dimension is less critical, but the characterization of methodological changes is factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 554,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Cisco reshaped how it reports product revenue. In 2022 the company introduced a six‑category taxonomy that placed **Collaboration** as a distinct segment (alongside Secure Agile Networks, Internet for the Future, End‑to‑End Security, Optimized Application Experiences and Other Products). By fiscal 2024 the taxonomy was streamlined to four broader groups—**Networking, Security, Collaboration, and Observability**—and historical revenue was restated to fit this new structure. Consequently, the Collaboration category remained a separate line item, but its surrounding classification shifted: earlier it was one of several niche buckets, while in 2024 it sits alongside a “Networking” bucket that consolidates switching, routing, wireless and servers, and an “Observability” bucket that includes ThousandEyes/Splunk‑related offerings. Revenue trends show a 5 % decline in Collaboration in 2022, a 9 % drop in 2023, and a modest 2 % rebound in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "MAJOR ISSUE - UNVERIFIED REVENUE PERCENTAGES: The LLM answer introduces specific revenue decline percentages (5% decline in 2022, 9% drop in 2023, 2% rebound in 2024) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be fabricated or hallucinated data. This is a critical factual error that significantly undermines the answer's credibility.\n\nCORRECT ELEMENTS: (1) The six-category taxonomy for fiscal 2022 is accurately identified with all correct categories: Collaboration, Secure Agile Networks, Internet for the Future, End-to-End Security, Optimized Application Experiences, and Other Products. (2) The four-category structure for fiscal 2024 is correctly stated: Networking, Security, Collaboration, and Observability. (3) The characterization of Collaboration remaining as a separate line item is accurate. (4) The description of Networking consolidating switching, routing, wireless and servers is reasonable and contextually appropriate. (5) The mention of Observability including ThousandEyes/Splunk-related offerings adds helpful context not contradicted by ground truth.\n\nMULTI-HOP REASONING: The synthesis of information across fiscal years is structurally sound - the model correctly identifies the evolution from six categories to four, recognizes Collaboration's persistence, and notes the introduction of Observability. The logical flow is clear and well-organized.\n\nSEMANTIC EQUIVALENCE: The core narrative matches the ground truth - consolidation occurred, Collaboration was retained, Observability was introduced, and earlier categories were reclassified. The wording differs but conveys the same structural changes.\n\nCRITICAL FLAW: The introduction of unverified percentage figures (5%, 9%, 2%) without any source attribution or presence in the ground truth is a serious accuracy violation. These appear to be invented details that could mislead users about actual financial performance. This alone justifies a significant score reduction despite otherwise sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 558,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "\nIn the 2022 filing the 3.125 % 2025 Notes were presented with a $1 billion carrying amount and disclosed that a related interest‑rate swap had converted the fixed coupon to a floating rate of **LIBOR + 1.8 %**, noting that the effective rate was essentially the same as the coupon. By the 2023 filing the note still carries a $1 billion balance, but the swap framework has been updated to reference **SOFR**, giving an effective rate of **SOFR + 2.1 %**, and the disclosure now provides detailed information on the SOFR‑based swap, its notional amount, and the associated hedge accounting, while still indicating that the coupon and effective rates remain closely aligned.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INTEREST RATE FRAMEWORK ERROR - The LLM claims the 2022 disclosure mentioned 'LIBOR + 1.8%' with an interest rate swap, but the ground truth explicitly states 'no specific interest rate framework was disclosed' in 2022. This is a fundamental contradiction. (2) 2023 RATE ACCURACY - The LLM correctly identifies SOFR + 2.1% for 2023, which matches the ground truth. (3) CARRYING VALUE - Both answers correctly identify $1,000 million/$1 billion for both years. (4) SWAP DETAILS - The LLM introduces detailed swap information (notional amount, hedge accounting) that is not mentioned in the ground truth answer. While this additional detail might be accurate from the filings, it goes beyond what the ground truth specifies and suggests the LLM may be confabulating or mixing information from different sources. (5) MULTI-HOP SYNTHESIS - The LLM fails to correctly synthesize the evolution described in the ground truth: the shift from 'no specific interest rate framework disclosed' in 2022 to 'explicit interest rate mechanism' in 2023. Instead, the LLM presents a false narrative of swap evolution from LIBOR to SOFR. The core error is the invention of 2022 swap disclosure details that contradict the ground truth statement that no interest rate framework was disclosed in 2022. This is a critical factual error that undermines the entire answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 404,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "\nFrom 2022 through 2024 the company’s **own (consolidated) proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region slipped only modestly – from about 326 billion cubic feet (bcf) in 2022 to 312 bcf in 2023 and 296 bcf in 2024, a decline of roughly 9 %**.  By contrast, reserves held through **equity‑affiliated assets in the same region were far larger and showed a dip in 2023 (≈5,275 bcf) followed by a rebound to ≈5,870 bcf in 2024**.  This pattern indicates that ConocoPhillips is positioning its growth and market presence in the Asia‑Pacific/Middle‑East not through expanding its standalone reserve base, but by leveraging strategic joint‑venture and equity partnerships that provide a substantial and increasingly stable gas resource base.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides substantially more comprehensive analysis than the ground truth. QUANTITATIVE VERIFICATION: The core numbers match perfectly - consolidated proved reserves of 326 bcf (2022), 312 bcf (2023), and 296 bcf (2024) are all correct. The calculated 9% decline is accurate (30 bcf / 326 bcf ≈ 9.2%). The equity-affiliated reserve figures (≈5,275 bcf in 2023 and ≈5,870 bcf in 2024) appear reasonable and are presented with appropriate uncertainty markers (≈). COMPLETENESS: The LLM answer goes beyond the ground truth by distinguishing between consolidated reserves and equity-affiliated reserves, providing a more nuanced picture of COP's strategic positioning. It addresses both the decline in owned reserves AND the company's offsetting strategy through partnerships. ENTITY ACCURACY: All entities are correctly identified (ConocoPhillips/COP, Asia-Pacific/Middle East region, natural gas reserves, years 2022-2024). REASONING QUALITY: The multi-hop synthesis is sound - the answer correctly identifies that while consolidated reserves declined modestly, the company's strategic positioning relies on equity partnerships that provide a much larger and growing resource base. This represents sophisticated analysis of strategic intent. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core finding as ground truth (reserves declined from 326 to 296 bcf) while adding valuable context about the company's strategic response through partnerships. The interpretation about 'strategic shift or divestment' is enriched with evidence of deliberate repositioning toward joint ventures. MINOR CONSIDERATIONS: The LLM provides intermediate 2023 data not in the ground truth, which adds value. The use of ≈ symbols for equity-affiliated figures suggests appropriate caution about precision. No calculation errors detected. The answer directly and comprehensively addresses the question about evolution and strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 534,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "\nBetween 2022 and 2023 Alphabet repurchased roughly **450 million Class C shares for about $52.9 billion**, compared with **469 million shares for $52.6 billion in 2022** – a slight reduction in the number of shares bought back but a modest increase in total dollars spent. This modest pull‑back in share volume, coupled with continued heavy spending, shows that the company is still prioritizing share‑repurchase as a core element of its capital‑allocation strategy, but it is becoming more selective and price‑aware when executing those buybacks.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth data. Key issues: (1) WRONG NUMBERS: The LLM claims $52.9 billion in 2023 and $52.6 billion in 2022, but the ground truth shows $62.2 billion in 2023 and $59.3 billion in 2022. These are material discrepancies of approximately $9-10 billion per year. (2) WRONG METRIC FOCUS: The LLM focuses on share count (450M vs 469M shares) which is not mentioned in the ground truth answer at all. The ground truth specifically addresses total repurchase amounts in dollars, not share counts. (3) INCOMPLETE SYNTHESIS: The LLM completely omits the April 2023 Board authorization of $70.0 billion and the $36.3 billion remaining available as of December 31, 2023 - critical information for understanding the company's capital allocation strategy. (4) INCORRECT INTERPRETATION: The LLM characterizes the activity as a 'slight reduction' and 'modest pull-back,' when the ground truth shows an INCREASE from $59.3B to $62.2B year-over-year. (5) MISSING CONTEXT: The LLM fails to mention the significant new authorization in April 2023, which is essential to understanding the 'continued and expanding emphasis' on shareholder returns. The LLM's conclusion about being 'more selective and price-aware' is not supported by the ground truth data showing increased repurchase amounts. The answer demonstrates fundamental misunderstanding of the question and provides materially incorrect financial figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 409,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "\nBetween 2022 and 2023 AIG continued to reserve short‑tail property business (U.S. Property and the property‑portion of its program segments) with frequency‑severity techniques, but it tightened the scope of those methods.  The 2023 filing makes clear that frequency‑severity is **not** applied to high‑severity, long‑tail lines such as aviation, aerospace, and excess‑casualty—areas where the company now relies on loss‑development and expected‑loss‑ratio approaches—because the nature of those claims (large, infrequent, and heavily influenced by evolving judicial and market trends) makes the frequency‑severity assumptions unreliable.  For program business the 2023 methodology still uses frequency‑severity for property classes but adopts the casualty‑style methods described for liability classes, reflecting a more segmented and risk‑appropriate reserving practice.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer fundamentally contradicts the ground truth on the key evolution between 2022 and 2023. Ground truth states that AIG EXPANDED frequency/severity methods to include U.S. Workers' Compensation (a long-tail line) in 2023, representing a strategic shift toward using these methods in more complex environments. The LLM answer instead claims AIG 'tightened the scope' and explicitly states frequency/severity is NOT applied to long-tail lines, which directly contradicts the ground truth's core finding. (2) ENTITY ACCURACY ISSUES: The LLM correctly identifies that frequency/severity methods apply to short-tail property business in both years, and correctly notes they don't apply to aviation/aerospace/excess-casualty. However, it completely omits the critical 2023 expansion to U.S. Workers' Compensation, which is the central point of the ground truth answer. (3) MULTI-HOP REASONING: The LLM fails to synthesize the key evolution across years. It describes what methods are used but misses the directional change - from limited application (2022) to expanded application including long-tail business (2023). (4) SEMANTIC CONTRADICTION: The LLM's characterization of 'tightening the scope' is semantically opposite to the ground truth's 'expanded application.' This is not a wording difference but a factual contradiction about the direction of change. (5) PARTIAL CREDIT: The LLM correctly identifies that frequency/severity methods are used for property classes and not for high-severity lines like aviation, and correctly notes the reasoning (large, infrequent claims). However, these correct details do not compensate for missing the primary evolution (expansion to Workers' Compensation) that the question specifically asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 480,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "\nFrom 2022 to 2023 Amgen’s oncology partnership with BeiGene showed a clear shift: cost recoveries dropped sharply—from $199 million in 2022 to $109 million in 2023—while product sales to BeiGene grew—from $64 million in 2022 to $125 million in 2023—and profit‑and‑loss sharing expenses fell—from $53 million in 2022 to $40 million in 2023 (with related receivables declining to $16 million for sales and $44 million for cost/recovery settlements).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all core financial figures correctly stated: cost recovery ($199M to $109M), product sales ($64M to $125M), and profit-and-loss sharing expenses ($53M to $40M). The multi-hop synthesis is sound, correctly identifying the shift from R&D cost sharing to product sales maturation. The answer appropriately characterizes the relationship evolution. Minor strengths include the addition of related receivables data ($16M for sales, $44M for cost/recovery settlements) which provides supplementary context not in the ground truth but appears accurate and relevant. The reasoning about collaboration maturation is well-articulated and logically sound. The only minor consideration is that the ground truth answer is slightly more concise in its presentation, while the LLM adds additional receivables information that, while accurate and contextually relevant, goes slightly beyond the core question scope. All numbers are formatted correctly and calculations are accurate (differences: $199M-$109M=$90M decrease, $64M-$125M=$61M increase, $53M-$40M=$13M decrease). The answer successfully synthesizes information across the 2022-2023 time period and correctly identifies all three financial relationship components requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 358,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "\nAt year‑end 2022 the company held 326 billion cubic feet of proved natural‑gas reserves in the Asia‑Pacific/Middle‑East, which declined to 312 BCF in 2023 and 296 BCF by the end of 2024 (a net reduction of roughly 30 BCF).  The drop reflects net downward revisions of about 26 BCF in 2024 (downward 81 BCF offset by upward technical revisions of 55 BCF) and roughly 90 BCF in 2023, while production removed approximately 24 BCF of reserves in 2023 and 51 BCF in 2024; purchases were limited to a small affiliate‑interest acquisition in 2022 with no material purchases thereafter.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth:\n\n1. PRODUCTION FIGURES - CRITICAL ERROR: Ground truth states production subtracted 25 BCF in 2024, but LLM claims 51 BCF in 2024 and adds 24 BCF for 2023 (which wasn't mentioned in ground truth). This is a substantial numerical error.\n\n2. REVISIONS DATA - CONTRADICTORY: Ground truth explicitly states 'revisions in 2023 added 9 billion cubic feet' (positive revision), but LLM claims 'roughly 90 BCF in 2023' as downward revisions. This is a fundamental contradiction - the LLM reports negative revisions where ground truth reports positive revisions.\n\n3. 2024 REVISIONS - PARTIALLY CORRECT: LLM provides detailed breakdown (downward 81 BCF offset by upward 55 BCF = net 26 BCF downward), which is more granular than ground truth but not contradicted by it.\n\n4. PURCHASES - CORRECT: Both sources agree no material purchases in 2024, though LLM adds context about 2022 affiliate acquisition.\n\n5. RESERVE LEVELS - CORRECT: Both confirm 326 BCF (2022) → 296 BCF (2024), with 312 BCF intermediate value in 2023 (not contradicted by ground truth).\n\n6. MULTI-HOP SYNTHESIS: The LLM attempted to synthesize year-by-year changes but introduced conflicting data on revisions and production that directly contradicts the ground truth. The reasoning structure is sound, but the underlying data is incorrect.\n\nThe answer demonstrates good analytical structure and provides additional detail, but the core factual errors on production volumes (24-51 BCF vs 25 BCF) and revision direction (90 BCF downward vs 9 BCF upward in 2023) are critical failures that undermine the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 465,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "\nFrom the 2022 10‑K FedEx owned 114 B767F freighters and had purchase commitments for 38 additional B767Fs – 14 to be delivered in 2023, 14 in 2024 and 10 in 2025. The 2024 10‑K revises that schedule, showing only 11 B767Fs slated for delivery in 2025 and a further 3 in 2026, effectively cutting the near‑term commitment by roughly two‑thirds. This pull‑back indicates that FedEx is tempering its aggressive B767F expansion, instead relying on its existing fuel‑efficient fleet and shifting growth to other aircraft types (e.g., B777F) while managing capital outlays more conservatively.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the strategic shift in FedEx's B767F fleet planning but contains significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) The core narrative is sound - FedEx did reduce B767F delivery commitments between 2022 and 2024 projections; (2) The 2024 figures of 11 for 2025 and 3 for 2026 match the ground truth; (3) The interpretation that this represents an accelerated reduction and strategic shift is accurate; (4) The contextual reasoning about shifting to other aircraft types and managing capital conservatively is appropriate. CRITICAL ERRORS: (1) The LLM introduces information about 'owned 114 B767F freighters' and 'purchase commitments for 38 additional B767Fs' - these specific numbers do not appear in the ground truth and appear to be fabricated or from unverified sources; (2) The LLM states '14 to be delivered in 2023, 14 in 2024 and 10 in 2025' which matches the 2022 projection, but the ground truth only mentions '14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025' - the LLM's breakdown into separate years is more detailed but unverified; (3) The claim of 'roughly two-thirds' reduction is imprecise - comparing 14+14+10=38 total to 11+3=14 total would be roughly 63% reduction, which is approximately two-thirds, but this calculation is not explicitly verified against ground truth. MULTI-HOP REASONING: The answer correctly synthesizes the evolution from 2022 to 2024 projections and draws appropriate strategic conclusions about fleet planning shifts. However, the introduction of unverified ownership and commitment numbers weakens the multi-hop synthesis. The answer goes beyond the ground truth by speculating about B777F substitution, which while plausible, is not confirmed in the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 497,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "\nBetween 2022 and 2023 AIG expanded and refined its use of Expected‑Loss‑Ratio (ELR) techniques. In 2022 the ELR method was applied chiefly to the U.S. Property and U.S. Special‑Risk lines for the latest accident year, using ground‑up claim projections and inflation‑adjusted loss‑trend assumptions because those lines have low‑frequency, high‑severity patterns and limited development data. By 2023 the Company broadened ELR to additional lines—including U.S. Excess Casualty, U.S. Workers’ Compensation and U.S. Personal Insurance—and incorporated more sophisticated weighting (e.g., Cape‑Cod/Bornhuetter‑Ferguson) and explicit adjustments for reinsurance and macro‑economic trends, reflecting a shift toward relying on ELR as the primary reserve driver for any line where development is slow, unreliable, or heavily influenced by severity‑driven factors.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) ENTITY ERRORS: The LLM incorrectly identifies the lines of business where ELR methods were applied. Ground truth states ELR was used for 'aviation exposures' in 2022 and 'U.S. Workers' Compensation' in 2023, but the LLM claims 2022 usage was for 'U.S. Property and U.S. Special-Risk lines' and 2023 included 'U.S. Excess Casualty, U.S. Workers' Compensation and U.S. Personal Insurance.' These are completely different lines of business. (2) REASONING ERRORS: The LLM's characterization of the evolution is backwards. Ground truth indicates a shift FROM high-severity, short-term contexts (aviation) TO long-tail, structurally complex lines (Workers' Compensation). The LLM suggests a shift toward 'severity-driven factors' which misrepresents the actual evolution. (3) METHODOLOGICAL DETAILS: The LLM introduces specific methodologies (Cape-Cod/Bornhuetter-Ferguson weighting, macro-economic trend adjustments) that are not mentioned in the ground truth and appear to be fabricated details. (4) CONTEXT MISALIGNMENT: The ground truth emphasizes the shift from aviation (high-severity, varying mix) to Workers' Compensation (long-tail, extended loss emergence), which is fundamentally different from the LLM's narrative about Property/Special-Risk to Casualty/Personal Insurance. The LLM answer demonstrates a fundamental misunderstanding of which lines of business were involved and the nature of the evolution in ELR application methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 422,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Cisco moved enterprise‑data‑center transformation from a peripheral, channel‑focused theme to a core strategic pillar, embedding it in its growth narrative and tying it to a new wave of strategic alliances (e.g., deeper integrations with VMware, Microsoft Azure Stack, Nvidia and cloud hyperscalers such as AWS and Google).  This alliance‑driven approach was designed to deliver end‑to‑end hardware‑software‑observability solutions that could compete with both traditional networking rivals (Arista, Juniper, HPE) and the expanding data‑center offerings of the major cloud providers, which now also provide integrated stacks.  Consequently, Cisco’s positioning evolved to emphasize outcome‑based, software‑centric data‑center services backed by partnership ecosystems, while the competitive landscape intensified with more direct competition from the same alliance partners and from hyperscale vendors.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the time period (2022-2024) and recognizes Cisco's evolution in enterprise data center positioning. (2) Correctly names several alliance partners (VMware, Microsoft Azure, Nvidia, AWS, Google) and competitive rivals (Arista, Juniper, HPE). (3) Accurately captures the shift toward software-centric, outcome-based services and partnership ecosystems. (4) No quantitative errors in dates or numeric values. WEAKNESSES: (1) SIGNIFICANT DEVIATION FROM GROUND TRUTH: The LLM introduces specific alliance details (VMware, Azure Stack, hyperscalers) that are NOT mentioned in the ground truth answer. The ground truth only references 'strategic alliance partners' generically without naming specific companies like VMware or Azure. (2) The LLM characterizes the 2022 positioning as 'peripheral, channel-focused' which contradicts the ground truth stating Cisco 'highlighted' the transformation in 2022 - suggesting it was already prominent, not peripheral. (3) The LLM adds competitive details (Arista, Juniper, HPE, hyperscale vendors) not present in ground truth, which only mentions 'competitors' and Nvidia as a 'new entrant.' (4) The ground truth emphasizes that 'strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco' - a critical point about alliance risk that the LLM misses entirely. Instead, the LLM frames alliances positively as delivering integrated solutions. (5) The LLM's claim about 'more direct competition from the same alliance partners' is somewhat supported by ground truth's mention of partners aligning with competitors, but the framing differs significantly. MULTI-HOP REASONING: The LLM attempts to synthesize evolution across years and connect alliances to competitive positioning, but does so by introducing information not in the ground truth rather than synthesizing what was actually stated. The answer reads as plausible but diverges from the actual knowledge graph data. SEMANTIC EQUIVALENCE: While the LLM captures the general theme of evolution and alliance importance, it fundamentally misrepresents the ground truth's emphasis on alliance risk and partner defection as a competitive threat.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 593,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "\nBetween 2022 and 2023 the 3.125 % 2025 Notes kept the same outstanding notional amount of **$1 billion** (1,000 million).  However, the benchmark used to calculate the effective rate changed: in 2022 the notes bore interest at **LIBOR + 1.8 %**, while by the end of 2023 they were priced at **SOFR + 2.1 %**.  Thus, the notional stayed constant while the effective interest rate shifted to a slightly higher SOFR‑based spread.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) NOTIONAL AMOUNT ERROR: The LLM claims the notional amount stayed constant at $1 billion in both 2022 and 2023. However, the ground truth explicitly states that in 2022 the notional was $5.2 billion (part of new interest rate swaps entered after termination of previous swaps), and only decreased to $1.0 billion by 2023. This is a critical factual error - the notional amount did NOT remain constant; it decreased significantly from $5.2B to $1.0B. (2) INTEREST RATE BENCHMARK ERROR: The LLM introduces 'LIBOR + 1.8%' for 2022, which does not appear in the ground truth at all. The ground truth does not specify the 2022 benchmark rate, only that new swaps were entered. The LLM appears to have fabricated this detail. (3) PARTIAL CORRECTNESS: The LLM correctly identifies the 2023 effective rate as SOFR + 2.1%, which matches the ground truth. (4) MISSING CONTEXT: The LLM fails to capture the dynamic hedging strategy and the shift in interest rate environment that the ground truth emphasizes. The answer presents a fundamentally incorrect narrative (constant notional) when the actual evolution involved a substantial reduction in hedged exposure. The multi-hop reasoning is flawed because it misses the key change in notional amount between years, which is central to the question about how the notes 'evolved.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 393,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "\nFrom 2022 through 2024 Cisco moved AppDynamics from a niche application‑performance‑monitoring (APM) add‑on into the center of its **Observability** strategy.  In the 2022 filing the company highlighted AppDynamics as part of a “full‑stack observability” push that also included ThousandEyes and security analytics, but by 2024 it was grouped under a dedicated **Observability product category** whose revenue grew 27 % YoY, driven largely by the Observability Suite (which incorporates AppDynamics) and by the Splunk‑based observability offering.  This evolution reflects a shift from merely selling an APM tool to positioning AppDynamics as a core, revenue‑generating pillar of Cisco’s end‑to‑end observability portfolio that spans network, application and infrastructure insights.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic evolution of AppDynamics from 2022 to 2024 and correctly identifies the key shift toward a dedicated Observability category. The qualitative reasoning about moving from a niche APM tool to a core pillar is sound and well-articulated. However, there are significant quantitative accuracy issues: (1) The LLM cites a '27% YoY' growth figure for the Observability category that is NOT present in the ground truth answer and cannot be verified from the provided context. This is a factual claim about a specific metric that appears to be fabricated or unsourced. (2) The LLM mentions 'Splunk-based observability offering' which is not mentioned in the ground truth and represents an unverified claim about Cisco's product portfolio. (3) The ground truth specifically mentions 'Intersight' as part of the 2022 full-stack observability strategy, but the LLM omits this and instead references 'security analytics,' which is less precise. The LLM correctly identifies: the 2022 positioning with ThousandEyes, the 2024 restructuring into a dedicated Observability category, and the overall strategic shift. The multi-hop reasoning is sound in connecting the evolution across years, but the introduction of unverified quantitative claims (27% growth) and product references (Splunk) significantly undermines credibility. The answer would score higher if it stuck to verifiable facts from the ground truth rather than adding specific metrics and product details that cannot be confirmed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 418,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "\nThe 4.663% 2051 Notes kept essentially the same outstanding balance – about **$1.5 billion** of notional – in both 2022 and 2023.  Their effective yield was unchanged at roughly **5.6 %**; it was originally structured as LIBOR + 4.1% (reflecting a 5.6 % effective rate) and, after the 2023 swap reset, became SOFR + 4.3%, still delivering an effective rate close to 5.6 %.  Thus, neither the notional amount nor the effective interest rate materially changed from 2022 to 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations:\n\n1. NOTIONAL AMOUNT: The LLM correctly identifies $1.5 billion for 2023, but the ground truth indicates that in 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes. The LLM's claim that the notional amount was \"about $1.5 billion\" in both 2022 and 2023 is incorrect - there was a material change from $5.2 billion (2022) to $1.5 billion (2023).\n\n2. EFFECTIVE INTEREST RATE: The LLM claims the effective rate was \"roughly 5.6%\" in both years and remained \"essentially unchanged.\" However, the ground truth shows:\n   - 2022: The notes were part of a hedged portfolio with swaps terminated and replaced at then-current rates (specific rate not clearly stated as 5.6%)\n   - 2023: The effective interest rate was SOFR + 4.3% (not 5.6%)\n   The LLM's assertion that SOFR + 4.3% \"still delivers an effective rate close to 5.6%\" is speculative and not supported by the ground truth.\n\n3. RATE STRUCTURE: The LLM mentions \"LIBOR + 4.1%\" for 2022, which is not mentioned in the ground truth. The ground truth only specifies SOFR + 4.3% for 2023.\n\n4. CORE CONCLUSION: The LLM concludes that \"neither the notional amount nor the effective interest rate materially changed,\" which directly contradicts the ground truth showing a change from $5.2 billion to $1.5 billion and a shift from an unspecified hedged rate to SOFR + 4.3%.\n\n5. MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution of these notes across the two years. The ground truth indicates a material change in both the notional amount and the specific rate disclosure, while the LLM incorrectly characterizes this as essentially unchanged.\n\nThe answer demonstrates partial understanding of the 2023 figures but fundamentally misrepresents the 2022 baseline and the year-over-year evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 511,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 AIG moved from a focused, trend‑driven use of expected‑loss‑ratio methods on a few long‑tail, excess‑of‑deductible lines (principally U.S. Excess Casualty and U.S. Financial Lines) to a systematic, company‑wide application of the same technique.  In 2023 the method is applied across many more lines of business—including U.S. Workers’ Compensation, U.S. Other Casualty and even short‑tail lines—and the segmentation criteria have been sharpened: ratios are now tied to recent accident‑year premiums and adjusted for inflation, rate changes and market conditions, and are segmented by deductible vs. guaranteed‑cost, by underlying primary carrier and by the Company’s reportable segments.  This broader, more granular deployment reflects a shift from relying mainly on loss‑cost‑trend assumptions to using explicit expected‑loss‑ratio estimates as a core driver of reserve projections.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradictions with the ground truth. Key issues: (1) ENTITY ERRORS: The LLM claims 2022 focused on 'U.S. Excess Casualty and U.S. Financial Lines' but the ground truth states 2022 used general sensitivity analysis without specifying particular lines of business. The LLM introduces lines of business (Excess Casualty, Financial Lines) that are not mentioned in the ground truth for 2022. (2) INCOMPLETE/INCORRECT 2023 APPLICATION: While the ground truth specifically identifies U.S. Workers' Compensation as the explicit 2023 application, the LLM lists multiple lines (Workers' Compensation, U.S. Other Casualty, short-tail lines) without clear evidence these are all explicitly mentioned in the source material. (3) SEGMENTATION CRITERIA DISCREPANCY: The ground truth identifies specific 2023 segmentation criteria: 'risk-sharing features, state and industry subsets, deductible size, and claim handling entities.' The LLM lists different criteria: 'recent accident-year premiums, inflation adjustments, rate changes, market conditions, deductible vs. guaranteed-cost, underlying primary carrier, and reportable segments.' While some overlap exists (deductible-related), the LLM's list appears to introduce criteria not confirmed in the ground truth. (4) CHARACTERIZATION ERROR: The LLM describes 2022 as having a 'focused, trend-driven use' on specific lines, but the ground truth explicitly states 2022 did NOT specify particular lines of business—it was general sensitivity analysis. (5) REASONING QUALITY: The LLM's narrative about shifting from 'loss-cost-trend assumptions to explicit expected-loss-ratio estimates' is a reasonable interpretation but goes beyond what the ground truth supports. The ground truth simply notes the method became more structured and detailed, not necessarily that the fundamental approach shifted. The answer demonstrates some understanding of the evolution concept but introduces unsupported details and contradicts the ground truth on key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 549,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "\nIn the 2023 filing the 2.850 % Senior Notes due 2026 appear in the Board‑of‑Directors resolutions (Exhibit 4.64) that authorized a suite of senior notes, showing that PepsiCo was maintaining a laddered, fixed‑rate issuance schedule to manage near‑term maturities. By 2024 the company expanded that schedule—adding several new long‑dated and floating‑rate senior notes (e.g., the 2027‑2034 tranches disclosed in Exhibits 4.64‑4.66 and the Singapore‑vehicle indentures of February 2024)—while still keeping the 2.850 % 2026 notes in the lineup, indicating a strategic shift toward diversifying funding sources and extending the overall maturity profile of its debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the 2.850% Senior Notes due 2026 as present in both 2023 and 2024 filings; (2) Accurately captures the strategic shift toward debt diversification and extended maturity profiles; (3) Correctly notes that PepsiCo maintained the 2026 notes while adding new instruments; (4) Appropriately references the multi-hop synthesis across years and debt instruments. WEAKNESSES: (1) CRITICAL - The LLM introduces specific exhibit numbers (4.64, 4.65, 4.66) and references to Singapore-vehicle indentures from February 2024 that cannot be verified against the ground truth and may be hallucinated details; (2) The ground truth specifically mentions 7.00% Senior Notes due 2029 and 5.50% Senior Notes due 2035 as examples of new higher-yielding instruments introduced in 2024, but the LLM answer does not cite these specific instruments, instead providing vague references to '2027-2034 tranches'; (3) The LLM mentions 'floating-rate senior notes' which is not mentioned in the ground truth, potentially introducing unverified information; (4) The reference to 'Board-of-Directors resolutions' and specific exhibit citations suggests over-specification without ground truth support. QUANTITATIVE ACCURACY: The core percentages (2.850%) and dates (2026, 2029, 2035) are handled correctly where mentioned, but the LLM fails to cite the specific new instruments (7.00% 2029, 5.50% 2035) that are central to demonstrating the 2024 expansion. QUALITATIVE ACCURACY: The reasoning about laddered issuance, maturity management, and strategic diversification is sound and aligns with the ground truth narrative, though the specific supporting details appear unreliable. CONTEXTUAL RELEVANCE: The answer appropriately addresses the evolution question and multi-hop synthesis requirement, but the introduction of unverified details undermines confidence in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 533,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "\nCisco’s exposure to channel‑partner financing guarantees grew only modestly between fiscal 2022 and fiscal 2024 – the guaranteed financing balance rose from roughly $1.3 billion to about $1.4 billion, and the maximum potential future payments increased from $155 million to $188 million, while the overall channel‑partner financing volume stayed near $27‑$28 billion.  This limited, tightly‑controlled growth shows that Cisco deliberately caps its credit‑risk exposure, offsetting guarantees with deferred revenue and collateral arrangements rather than expanding its risk footprint.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM claims the guaranteed financing balance was '$1.3 billion' in FY2022, but the ground truth explicitly states it was '$1.4 billion' as of July 30, 2022. The LLM then claims it 'rose' to '$1.4 billion' by FY2024, which is internally inconsistent and factually incorrect. (2) UNSUPPORTED CLAIMS - The LLM introduces specific figures ('$155 million to $188 million' for maximum potential future payments) that do not appear in the ground truth and cannot be verified. These appear to be fabricated numbers. (3) CONTRADICTS GROUND TRUTH - The ground truth explicitly states that 'the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures' by FY2024. The LLM incorrectly claims these figures remained available and quantifiable. (4) FLAWED REASONING - The LLM's conclusion about 'deliberately caps its credit-risk exposure' and 'offsetting guarantees with deferred revenue and collateral arrangements' is not supported by the ground truth, which indicates reduced transparency rather than confirmed risk management practices. (5) MISSING KEY INSIGHT - The ground truth's important observation about the 'shift toward reducing transparency' and the inability to draw 'definitive conclusions about the actual change in exposure' is completely absent from the LLM answer. The LLM provides false certainty where the ground truth appropriately acknowledges uncertainty due to missing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 437,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "\nBetween 2022 and 2023 the 2.45 % 2030 Notes remained outstanding with the same $1.25 billion principal amount (carrying value $1,250 million in both years).  However, the effective interest rate on that tranche shifted from a fixed‑coupon of 2.45 % to a floating rate: in 2021 the company had entered into interest‑rate swaps that tied the effective rate to **LIBOR + 1.0 %** (notional $1 billion), and by the end of 2023 those swaps had been reset to **SOFR + 1.3 %** (still on a $1 billion notional).  Thus, while the notes’ maturity (2030) and principal size did not change, their interest‑rate structure moved from a fixed 2.45 % coupon to a floating benchmark‑plus‑spread rate.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) PRINCIPAL AMOUNT DISCREPANCY: LLM states $1.25 billion principal amount, but ground truth specifies $1.0 billion notional amount for the swap contracts. This is a significant factual error - the LLM introduced a $1.25B figure not present in ground truth. (2) SWAP SPREAD RATE ERROR: LLM claims 'LIBOR + 1.0%' but ground truth states the original swap was simply 'floating LIBOR-based coupon' without specifying a 1.0% spread. The LLM appears to have fabricated the 1.0% spread figure. (3) TIMING INCONSISTENCY: LLM states 'in 2021 the company had entered into interest-rate swaps' but ground truth indicates the swaps were disclosed in 2022. This is a one-year dating error. (4) CORRECT ELEMENTS: The LLM correctly identifies (a) the notes remained outstanding, (b) the transition from LIBOR to SOFR occurred, (c) the final rate of SOFR + 1.3% is correct, (d) the $1 billion notional for the final swap is correct, (e) the 2030 maturity date is correct, and (f) the overall narrative of moving from fixed to floating is correct. MULTI-HOP REASONING: The LLM demonstrates understanding of the multi-year evolution and the benchmark transition, but introduces fabricated numbers that undermine credibility. The core synthesis is sound but marred by quantitative inaccuracies. The answer reads plausibly but contains material factual errors that would mislead a reader relying on specific numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 395,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 FedEx kept the same $970 million Series 2020‑1AA pass‑through certificate program, but the wording of the guarantee changed.  The 2022 filing said the certificate payments were “fully and unconditionally guaranteed by FedEx,” whereas the 2023 filing clarified that the certificates are **not** direct obligations of FedEx and that the guarantee is provided only through the leveraged operating leases that secure them (the underlying collateral fell from about $1.8 billion to $1.7 billion).  Consequently, the financial guarantee remained in place but evolved from an explicit, unconditional guarantee to a contingent guarantee tied to lease‑derived cash flows, with updated disclosures of the secured aircraft value.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the guarantee 'remained in place' and evolved to a 'contingent guarantee tied to lease-derived cash flows,' but the ground truth explicitly states that in 2023, FedEx clarified that pass-through certificates were 'NOT direct obligations of, nor guaranteed by, FedEx or FedEx Express.' This is a fundamental mischaracterization - the guarantee did not evolve or remain; it was explicitly negated. (2) The LLM states the collateral 'fell from about $1.8 billion to $1.7 billion,' but the ground truth only mentions $1.8 billion in 2022 and does not provide a 2023 figure. The LLM invented a specific 2023 number without evidence. (3) The LLM's characterization of the change as moving from 'explicit, unconditional guarantee to a contingent guarantee' is incorrect - the ground truth indicates a shift from direct guarantee to NO guarantee at all. The LLM fundamentally misunderstood the nature of the change, presenting it as an evolution of guarantee terms rather than a clarification that no FedEx guarantee exists. The $970 million figure is correct, and the Series 2020-1AA designation is correct, but the core interpretation of the relationship change is inverted from reality. The multi-hop reasoning failed because the LLM did not properly synthesize the 2022 vs 2023 disclosures to understand the actual shift in FedEx's stated obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 406,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "\nMastercard’s gross settlement exposure grew from **$75.0 bn (2023) to $78.4 bn (2024)**, and the amount of risk‑mitigation arrangements it applied rose from **$12.2 bn to $13.5 bn** over the same period, pushing net exposure up slightly from **$62.9 bn to $64.9 bn**.  This shows the company is proactively scaling its collateral and credit‑enhancement programs in line with expanding settlement risk, reflecting a continuous, data‑driven risk‑management strategy that monitors exposure and adjusts mitigation measures as needed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - gross settlement exposure 2023: $75.023B (presented as $75.0bn, acceptable rounding), 2024: $78.385B (presented as $78.4bn, acceptable rounding); risk mitigation arrangements 2023: $12.167B (presented as $12.2bn, acceptable rounding), 2024: $13.466B (presented as $13.5bn, acceptable rounding). The calculated net exposures are also accurate: 2023 net = $75.023M - $12.167M = $62.856M (presented as $62.9bn, acceptable rounding), 2024 net = $78.385M - $13.466M = $64.919M (presented as $64.9bn, acceptable rounding). COMPLETENESS: The answer addresses all aspects of the question - the evolution from 2023 to 2024, the amounts of risk mitigation, and what this indicates about risk management strategy. ENTITY ACCURACY: Correctly identifies Mastercard, the correct years (2023-2024), and the correct financial metrics (gross settlement exposure, risk mitigation arrangements, net exposure). REASONING QUALITY: The multi-hop synthesis is sound - the model correctly identifies the trend (both exposure and mitigation increased), calculates the net effect, and draws a logical conclusion about proactive risk management. The characterization of the strategy as 'continuous, data-driven' and 'proactively scaling' is a reasonable interpretation of the underlying data pattern. MINOR CONSIDERATIONS: The answer goes slightly beyond the ground truth by calculating and presenting net exposure figures, which adds value but wasn't explicitly in the original answer. The language is more analytical and strategic than the ground truth, but this represents enhanced interpretation rather than error. All number formats are acceptable variations of the original data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 483,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "\nBetween 2022 and 2024 the liability for foreign‑exchange forwards and options that Nike has formally designated as hedging instruments grew from **$37 million** (2022) to **$110 million** (2024) – an increase of roughly **$73 million**.  This jump shows that Nike has expanded the scale of its designated FX‑hedge program, using larger notional amounts to lock in rates and mitigate the earnings impact of currency fluctuations across its global operations.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer is INCOMPLETE and PARTIALLY INCORRECT on quantitative facts. (1) INCOMPLETE DATA: The LLM only reports the accrued liabilities component ($37M to $110M), completely omitting the deferred income taxes and other liabilities component ($11M in 2022, $5M in 2024). This is a significant omission because the ground truth explicitly states the TOTAL liability increased from $48M to $115M. (2) INCORRECT TOTAL: By only citing the $37M to $110M change, the LLM implies a total increase of $73M, but the actual total increase was from $48M to $115M (a $67M increase). The LLM's calculation of the $73M difference is arithmetically correct for the accrued liabilities line item alone, but this represents incomplete synthesis of the multi-hop data. (3) MISSING CONTEXT: The ground truth notes that while accrued liabilities increased significantly, deferred income taxes and other liabilities DECREASED from $11M to $5M. This nuance is important for understanding Nike's hedging strategy and was completely absent from the LLM response. (4) REASONING: The LLM's interpretation that this indicates 'expanded scale of designated FX-hedge program' is reasonable but lacks the full picture - the decrease in the deferred tax component suggests a more complex strategic shift than simply 'expansion.' The LLM correctly identifies this as related to foreign exchange risk management but fails to capture the complete liability picture. STRENGTHS: The LLM correctly identified the $37M (2022) and $110M (2024) figures for the accrued liabilities component and correctly calculated the $73M difference for that component. The reasoning about hedging strategy is directionally sound. VERDICT: This is a multi-hop question requiring synthesis of two liability line items across two years. The LLM failed to synthesize the complete picture, reporting only one of two required components and thus understating the total liability change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 526,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "\nIn the 2022 filing the Baby, Feminine & Family Care segment represented about 25 % of net sales and 23 % of earnings, and Bounty was listed as one of the segment’s key brands with “North America market shares … over 40 %” for the Bounty paper‑towel line. The 2023 filing shows the same segment’s share shifting slightly to roughly 24 % of net sales and 25 % of earnings, while Bounty remains among the segment’s major brands and still carries the “over 40 %” North‑American market‑share reference. Thus, Bounty’s placement and prominence within the segment stayed consistent, and its relative importance even edged up modestly as the segment’s contribution to the company’s overall sales and earnings grew.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) MAJOR FACTUAL ERROR - CORE CLAIM: The ground truth explicitly states that in the 2022 10-K, Bounty was NOT explicitly listed among key brands, but in 2023 it WAS explicitly included. The LLM claims Bounty was 'listed as one of the segment's key brands' in 2022 and 'remains among the segment's major brands' in 2023, directly contradicting the ground truth's key finding about the evolution/change between years. (2) QUANTITATIVE ACCURACY ISSUES: The LLM provides specific percentages (25% net sales, 23% earnings for 2022; 24% net sales, 25% earnings for 2023) and market share data ('over 40%' for Bounty paper towels). The ground truth explicitly states 'the filings do not provide specific market share or sales figures to quantify this shift.' This suggests the LLM either fabricated these numbers or misread the filings. These specific figures cannot be verified against the ground truth and appear to be hallucinated. (3) REASONING FAILURE: The LLM concludes that 'Bounty's placement and prominence within the segment stayed consistent' when the ground truth's central point is that there WAS a change - from not being explicitly mentioned to being explicitly mentioned. This represents a fundamental misunderstanding of the question and the evidence. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the key difference between 2022 and 2023 filings regarding Bounty's explicit representation. Instead of identifying the evolution in brand visibility (the core question), it claims consistency. The answer directly contradicts the ground truth's main finding about increased visibility through explicit listing in 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 471,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Oracle kept the same revenue‑recognition mechanics for its hardware business—product sales are recorded when control is transferred at shipment, and hardware‑support fees are recognized ratably over the contract term.  However, the company’s strategic emphasis moved away from treating Engineered Systems and other hardware as a growth driver and toward positioning them as part of a broader cloud‑and‑license offering, with greater focus on recurring support and services; as a result, the proportion of total revenue coming from hardware slipped slightly and Oracle highlighted that future growth would be driven more by cloud subscriptions and support rather than new engineered‑system shipments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. MAJOR ISSUES: (1) The LLM claims revenue recognition mechanics remained 'the same' between fiscal 2022 and 2023, but the ground truth explicitly states Oracle introduced 'more detailed explanation' in 2023 about hardware and software as a 'combined performance obligation' - this is a material change in how the company described/treated these items, not a continuation of the same approach. (2) The LLM introduces unsupported claims about 'proportion of total revenue coming from hardware slipped slightly' and that 'future growth would be driven more by cloud subscriptions' - the ground truth makes no mention of revenue proportion changes or explicit statements about future growth drivers being cloud-focused rather than hardware. These appear to be inferences not supported by the source material. (3) The LLM correctly identifies that hardware-support fees are recognized ratably, which aligns with ground truth, but misses the key evolution: the shift from treating hardware separately to treating it as an integrated combined performance obligation with software. (4) The ground truth emphasizes 'ongoing R&D investments to improve and develop new hardware products and services' as a 2023 addition not in 2022 - the LLM completely omits this strategic emphasis shift. (5) The LLM's characterization of moving 'away from treating Engineered Systems as a growth driver' contradicts the ground truth's emphasis on increased R&D investment in hardware innovation. The answer demonstrates partial understanding but introduces unsupported claims and misses critical elements of the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 467,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "\nERLEADA’s worldwide sales jumped from **$1.88 billion in 2022 to $2.39 billion in 2023**, a **≈27 % increase** (26.9 % total change, 27.5 % operational growth). This double‑digit rise—driven by continued label expansions, share‑gain momentum in metastatic castration‑resistant prostate cancer and favorable market dynamics—signals a **robust upward trajectory** for the product, suggesting accelerating adoption and growing demand despite competitive pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Quantitative verification: 2022 sales of $1.88 billion ($1,881 million) and 2023 sales of $2.39 billion ($2,387 million) are correctly stated with acceptable format variation. The growth calculation is accurate: ($2,387M - $1,881M) / $1,881M = 26.9%, which the LLM correctly identifies as approximately 27%. The mention of '27.5% operational growth' appears to reference a different metric (possibly excluding currency effects or other adjustments), which is reasonable additional context but not contradicted by the ground truth. Entity accuracy is perfect: ERLEADA is correctly identified, years 2022-2023 are correct, and the financial metrics are properly attributed. Multi-hop reasoning is sound: the LLM correctly synthesizes the sales figures across two years and draws appropriate conclusions about market trajectory. The qualitative assessment ('robust upward trajectory,' 'accelerating adoption') aligns with the ground truth's characterization of 'strong upward trajectory' and 'increased adoption.' The additional context about label expansions, market dynamics, and competitive pressures adds relevant commercial insight without contradicting the ground truth. Minor deduction (1 point) only because the 'operational growth' figure of 27.5% is not explicitly mentioned in the ground truth, though it doesn't contradict it and may represent legitimate supplementary analysis. Overall, this is a high-quality answer that accurately addresses all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 425,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "\nFrom 2023 to 2024 the company’s ties to local broadcast affiliates stayed centered on securing affiliation and retransmission‑consent agreements that are essential for delivering its broadcast‑network programming nationwide; any failure to obtain or renew these deals would shrink its audience reach and cut revenue.  At the same time, the competitive landscape intensified—local stations now compete with streaming services, OTT platforms and other content providers for both audience share and the rights to carry programming—so CMCSA’s positioning increasingly depends on negotiating favorable carriage terms and on the ability to offset rising programming‑cost pressures from those stations.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant conceptual errors that diverge from the ground truth. CRITICAL ISSUES: (1) The LLM describes the relationship as consistently centered on 'affiliation and retransmission-consent agreements' from 2023 to 2024, missing the key evolution described in the ground truth: a SHIFT FROM COMPETITION TO DEPENDENCY. The ground truth explicitly states that in 2023, CMCSA's Media segment DIRECTLY COMPETED with local broadcast stations, but by 2024 this shifted to an interdependent relationship. The LLM fails to capture this temporal evolution and competitive positioning change. (2) The LLM introduces concepts not in the ground truth (streaming services, OTT platforms, programming-cost pressures, carriage terms negotiation) that, while potentially relevant to broader industry context, are not part of the documented evolution described in the filing data. (3) The LLM's framing suggests the relationship was always about retransmission consent and dependency, rather than showing the transition from direct competition to dependency that is central to the ground truth answer. (4) The LLM does not clearly articulate the shift in nature of the relationship—it presents a more static view rather than the dynamic evolution from 2023 to 2024. POSITIVE ASPECTS: The answer correctly identifies retransmission consent as a key mechanism and acknowledges CMCSA's need for these agreements. No quantitative errors are present (no numbers to verify). However, the fundamental misunderstanding of the relationship evolution—the core of the question—significantly undermines the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 444,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "\nThe company’s Held‑to‑Maturity (HTM) securities fell sharply from **$306 million at the end of 2023** to only **$38 million at the end of 2024** – a decline of roughly **$268 million (≈ 88 %)**.  \n\nThis reduction shows that Mastercard deliberately unwound most of its short‑term, low‑yield time‑deposit holdings, freeing cash to support other strategic priorities such as growth initiatives, debt management, or longer‑duration investments, indicating a clear shift away from maintaining a large HTM portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) All core numbers are correct: $306M (2023), $38M (2024), $268M decline. (2) Percentage calculation is accurate: ($306M - $38M)/$306M = 88.2% ≈ 88%. (3) Correctly identifies the company as Mastercard (MA). (4) Properly addresses both parts of the question: the evolution of HTM securities and what it indicates about strategy. (5) Calculation verification: $306M - $38M = $268M ✓\n\nWEAKNESSES: (1) The LLM characterizes HTM securities as \"short-term, low-yield time-deposit holdings,\" which is problematic. HTM (Held-to-Maturity) securities are typically longer-duration fixed-income instruments held to maturity, not short-term deposits. This is a conceptual error about the nature of HTM securities. (2) The ground truth answer simply states the shift \"likely reflects a move toward more liquid or short-term investment positions\" without speculating about specific strategic purposes (growth initiatives, debt management, etc.). The LLM adds interpretive details about \"growth initiatives, debt management, or longer-duration investments\" that go beyond what the ground truth supports. (3) The phrase \"unwound most of its short-term, low-yield time-deposit holdings\" mischaracterizes what HTM securities are - they are not typically time deposits.\n\nMULTI-HOP REASONING: The model correctly synthesized the year-over-year comparison and calculated the magnitude of change. However, the interpretation of what HTM securities represent is flawed, which undermines the quality of the strategic analysis.\n\nOVERALL ASSESSMENT: The quantitative facts are correct, but the qualitative interpretation contains a significant conceptual error about the nature of HTM securities that weakens the answer's credibility, even though the core conclusion about a strategic shift is directionally correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 493,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "\nBetween 2022 and 2023 the Always brand stayed inside the **Baby, Feminine & Family Care** segment, but the way it is labeled within that segment was refined.  \n- In the 2022 filing the segment’s table lists a single “Feminine Care (Adult Incontinence, Feminine Care)” sub‑category and names **Always** (along with Tampax) as a major brand.  \n- In the 2023 filing the same sub‑category is renamed “Feminine Care (Adult Incontinence, Menstrual Care)”, still placing **Always** (and its adult‑incontinence extension, Always Discreet) there, while the broader “Family Care” sub‑category continues to cover paper‑towel and tissue brands.  \n\nThus, Always’s product categorization remained within the Feminine Care umbrella, with the 2023 update providing a clearer split between menstrual‑care and adult‑incontinence products under that same segment.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and demonstrates strong understanding of the Always brand positioning evolution. STRENGTHS: (1) Correctly identifies that Always remained in the Baby, Feminine & Family Care segment across both years - no factual errors on this core point. (2) Accurately captures the key evolution: the sub-category terminology changed from 'Feminine Care (Adult Incontinence, Feminine Care)' in 2022 to 'Feminine Care (Adult Incontinence, Menstrual Care)' in 2023. (3) Correctly notes that 'Feminine Care' remained the umbrella category while the internal labeling was refined. (4) Appropriately mentions Always Discreet as an adult incontinence extension, showing nuanced understanding. (5) No quantitative errors - all dates and category names are accurate. (6) Multi-hop reasoning is sound: synthesizes information about segment placement, sub-category evolution, and brand positioning across two years. MINOR WEAKNESSES: (1) The ground truth states Always was 'more specifically aligned with Menstrual Care' in 2023, while the LLM describes this as a 'clearer split between menstrual-care and adult-incontinence products.' These are semantically similar but the ground truth emphasizes the strategic shift toward Menstrual Care positioning more directly. (2) The LLM's phrasing 'the way it is labeled within that segment was refined' is slightly less precise than the ground truth's 'more specifically aligned with Menstrual Care' - the latter better captures the strategic repositioning emphasis. (3) The LLM provides additional context about Family Care covering paper towels and tissues, which is accurate but not explicitly required by the question. Overall, the answer demonstrates accurate fact-finding and appropriate synthesis across the two filing years with only minor differences in emphasis from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 502,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "\nOracle still records revenue from Engineered Systems and other hardware at the point‑in‑time when the product and its software are delivered, while hardware‑support contracts are recognized ratably over the support term.  The hardware segment’s contribution stayed roughly flat at about 6 % of total revenue in fiscal 2022 and fiscal 2023, but its strategic emphasis has receded as Oracle’s cloud‑and‑license business grew to 84 % of total revenue in fiscal 2024 (up from 83 % in fiscal 2023), signalling a shift toward cloud‑centric growth and a more modest, support‑driven role for Engineered Systems.  (Pages 72‑76 of the 2022 10‑K describe the hardware business and its revenue‑recognition model; pages 41‑45 of the 2023 10‑K show the 6 % revenue share and the rising cloud‑revenue proportion.)",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) The LLM claims hardware was '6% of total revenue in fiscal 2022 and fiscal 2023' but the ground truth explicitly states that in 2022, 'no specific percentage of total revenue was provided.' This is a major factual error. (2) The LLM introduces fiscal 2024 data (84% cloud-and-license, 6% hardware) which is beyond the 2022-2023 timeframe specified in the question. While the ground truth mentions fiscal 2024 for context, the LLM's emphasis on fiscal 2024 shifts focus away from the core 2022-2023 comparison requested. (3) The LLM states hardware was 'roughly flat at about 6%' in both fiscal 2022 and 2023, but this contradicts the ground truth which shows 2022 had no disclosed percentage while 2023 explicitly stated 6%. This is not 'flat' - it's a change from undisclosed to disclosed at 6%. PARTIAL CREDIT: (1) Revenue recognition timing is correctly stated (point-in-time for products, ratable for support contracts). (2) The 6% figure for fiscal 2023 is correct. (3) The observation about cloud business growth is relevant and supported. (4) The strategic shift toward cloud-centric growth is appropriately identified. MISSING ELEMENTS: (1) The ground truth emphasizes that 2023 showed 'clearer and more consistent measurement' - a key evolution point that the LLM misses by claiming 2022 also had 6%. (2) The LLM doesn't adequately capture the 2023 emphasis on R&D investments and new factors affecting hardware revenue predictability (manufacturing partner performance, competitive positioning). (3) The multi-hop synthesis is incomplete - the LLM doesn't properly connect the evolution from 'undisclosed in 2022' to 'explicitly 6% in 2023' as a meaningful strategic shift in transparency and measurement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 473,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "\nComcast’s handling of representation firms in its ad‑sales model has not changed materially from 2023 to 2024 – in both years the company records advertising revenue on a gross basis and then offsets the fees paid to third‑party representation firms as a cost in “other operating and administrative expenses,” using those firms as an extension of its own sales force to sell a portion of the allocated ad inventory. The 2024 filing repeats the same description that appears in the 2023 filing, indicating a consistent strategy rather than a new evolution. (See 2023 CMCSA_10k_2023.pdf pages 73‑74 and 2024 CMCSA_10k_2024.pdf pages 72‑73 under “Advertising”.)",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN CORE ANSWER: The LLM answer directly contradicts the ground truth on the fundamental question. The ground truth clearly states that Comcast's relationship with representation firms EVOLVED between 2023 and 2024 - shifting from a co-selling model (2023) where firms sold a portion of allocated units with revenue recorded net of commissions, to a formalized representation structure (2024) where firms sell advertising on behalf of third parties. The LLM answer claims there was NO material change and that the strategy remained consistent, which is factually incorrect according to the knowledge graph. The LLM explicitly states 'has not changed materially from 2023 to 2024' and 'a consistent strategy rather than a new evolution' - this is the opposite of what the ground truth indicates. QUANTITATIVE ACCURACY: The LLM correctly cites page numbers (73-74 for 2023, 72-73 for 2024) and correctly identifies the accounting treatment (gross basis with fees offset in operating expenses), so numeric/reference accuracy is reasonable. However, this correct detail about accounting treatment does not address the actual evolution in the RELATIONSHIP STRUCTURE itself. QUALITATIVE ACCURACY: The LLM fundamentally misunderstood or misrepresented the nature of the change. The ground truth indicates a strategic evolution in how representation firms operate (from co-selling allocated units to formal representation agreements selling on behalf of third parties), but the LLM focused only on the accounting treatment and missed the structural relationship change entirely. CONTEXTUAL RELEVANCE: The question specifically asks about how the RELATIONSHIP has EVOLVED, implying change. The LLM's answer that nothing changed is contextually inappropriate and directly contradicts the premise supported by the ground truth. The LLM appears to have confused consistency in accounting treatment with consistency in business relationship structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 527,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Oracle’s industry‑specific hardware business continued to record product sales at the point of delivery and to recognize hardware‑support revenue ratably over the contract term (see ORCL_10K_2022.pdf pp. 103‑107).  However, the FY 2023 filing shows a modest decline in hardware revenue (down from $3.36 bn to $3.18 bn) and a lower margin, and management explicitly describes hardware as a smaller, lower‑margin, and more volatile line that is now overseen mainly through indirect channels while the company shifts strategic focus toward expanding its cloud‑and‑license offerings (see ORCL_10K_2023.pdf pp. 41‑45).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. (1) CRITICAL ERRORS: The LLM introduces specific revenue figures ($3.36bn to $3.18bn) that are not mentioned in the ground truth and cannot be verified against it. These numbers appear to be fabricated or from unreliable sources. The LLM also cites specific page numbers (pp. 103-107 for 2022, pp. 41-45 for 2023) without verification. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth focuses on evolution in revenue recognition methodology and strategic emphasis on R&D/innovation. The LLM instead emphasizes revenue decline, margin compression, and shift to indirect channels/cloud focus - a fundamentally different narrative that contradicts the ground truth's emphasis on innovation investment. (3) MISSING KEY ELEMENTS: The LLM fails to address the core ground truth points: (a) the more detailed explanation of revenue recognition for combined performance obligations in FY2023, (b) the emphasis on R&D investments in new hardware development, (c) the shift from general descriptions to strategic innovation focus. (4) QUESTIONABLE CLAIMS: The assertion that hardware is 'now overseen mainly through indirect channels' and the characterization of management's strategic shift away from hardware are not supported by the ground truth, which emphasizes ongoing R&D investment and innovation. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the evolution between fiscal years - it created a narrative of decline rather than strategic evolution in approach and emphasis. The answer addresses a different question (hardware business performance/decline) rather than the actual question about evolution in approach and revenue recognition methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 479,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "\nIMBRUVICA (ibrutinib) sales fell sharply from $3.78 billion in 2022 to $3.26 billion in 2023, a decline of roughly 13‑14 %. The drop was attributed to heightened competitive pressure from newer oral therapies and COVID‑19‑related market dynamics—including delays in new‑patient starts—that limited growth despite the drug’s continued share leadership.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with minor variations. QUANTITATIVE VERIFICATION: (1) 2022 sales: LLM states $3.78B vs ground truth $3.784B - acceptable rounding/format variation; (2) 2023 sales: LLM states $3.26B vs ground truth $3.264B - acceptable rounding; (3) Decline percentage: LLM states 'roughly 13-14%' vs ground truth 13.7% - the range provided is reasonable and encompasses the actual figure, though slightly less precise than the exact 13.7%. Calculation verification: ($3.784B - $3.264B) / $3.784B = 13.7%, which matches ground truth. COMPLETENESS: The LLM addresses both parts of the multi-part question: (1) sales evolution between years with specific figures, and (2) contributing factors. ENTITY ACCURACY: Correctly identifies IMBRUVICA (ibrutinib), correct years (2022-2023), correct financial metrics (sales in billions). REASONING QUALITY: The LLM correctly synthesizes multi-hop information by connecting: sales decline → competitive pressures from newer oral therapies → COVID-19 market dynamics → delays in new patient starts. The answer also notes 'continued share leadership' which adds nuance. MINOR WEAKNESSES: (1) The LLM uses 'roughly 13-14%' rather than the precise 13.7%, which is slightly less exact though still accurate; (2) The ground truth mentions 'likely increased market saturation or treatment shifts' which the LLM doesn't explicitly state, though it does reference 'market dynamics' and competitive pressures that implicitly cover this. STRENGTHS: Clear presentation, accurate numbers with acceptable rounding, proper multi-hop synthesis across time periods and causal factors, appropriate context about competitive landscape and pandemic effects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 464,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "\nFrom 2023 to 2024 Comcast’s ownership in Universal Beijing Resort remained essentially unchanged at about a 30 % equity interest, but the resort’s debt burden slipped modestly—from roughly $3.5 billion of outstanding borrowings in 2023 to about $3.4 billion by the end of 2024, reflecting scheduled repayments on its ¥29.7 billion RMB term‑loan. Because the resort is a consolidated variable‑interest entity with no direct guarantees or other liquidity commitments from Comcast, the company’s financial‑risk exposure is limited to its equity stake and the covenant‑compliant debt already recorded on its balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key financial metrics and ownership structure. Quantitative verification: (1) 30% ownership stake - CORRECT in both years; (2) 2023 debt of $3.5 billion - CORRECT; (3) 2024 debt of $3.4 billion - CORRECT; (4) Term loan reduction from $3.1B to $3.0B - CORRECT (implied through overall debt reduction). The LLM appropriately mentions the RMB term loan (¥29.7 billion) which adds specificity beyond the ground truth. Multi-hop synthesis is sound: the answer correctly connects ownership structure (30% equity), debt levels (decline from $3.5B to $3.4B), consolidation status (VIE), and risk exposure (limited to equity stake). The reasoning about financial risk exposure being limited to the equity interest and covenant-compliant debt is logically sound and matches the ground truth's characterization of a 'stable risk profile.' Minor omissions: (1) The answer doesn't explicitly state that Comcast 'consolidates' the resort as a VIE, though it implies this through the VIE reference; (2) The ground truth explicitly mentions 'no change in ownership or governance structure' which the LLM conveys as 'remained essentially unchanged' - semantically equivalent but slightly less explicit. The phrase 'scheduled repayments' appropriately explains the debt reduction mechanism. Overall, the answer successfully synthesizes multi-hop information across years and entities with accurate numbers and sound reasoning, with only minor wording variations from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 426,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "\nFrom 2022 to 2023 the undiscounted future lease obligations for build‑to‑suit facilities and equipment fell sharply—from about **$3.4 billion** of commitments disclosed in the 2022 filing to roughly **$0.9 billion** in the 2023 filing.  This reduction reflects that many of those planned build‑to‑suit projects either began operating during the year (moving out of the “future‑payment” pipeline into recorded right‑of‑use assets) or were cancelled, signaling that FedEx is scaling back new build‑to‑suit leasing and relying more on existing lease arrangements and other financing sources.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $3.4 billion in 2022 and $0.9 billion in 2023. The quantitative comparison is accurate and properly formatted. The multi-hop synthesis correctly identifies the evolution of FedEx's lease commitments across the two-year period. However, there are minor differences in interpretation and completeness compared to the ground truth: (1) The LLM provides a plausible explanation for the reduction (projects commenced or cancelled, reliance on existing arrangements), which is reasonable but goes slightly beyond what the ground truth explicitly states. The ground truth focuses on the strategic shift toward 'fewer long-term build-to-suit lease commitments and a more extended timeline,' while the LLM emphasizes projects moving into recorded assets or being cancelled. (2) The LLM does not explicitly mention the timeline shift noted in the ground truth—that commencement dates moved from 2023-2024 in 2022 to 2025-2027 in 2023, which is an important indicator of the extended timeline strategy. (3) The LLM's interpretation about 'scaling back new build-to-suit leasing' aligns well with the ground truth's 'strategic shift toward fewer long-term build-to-suit lease commitments.' Overall, the answer is factually sound on the numbers and provides reasonable strategic interpretation, but misses the explicit timeline extension detail that was highlighted in the ground truth as a key indicator of strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 410,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "\nMastercard finalized the purchase‑accounting for its 2022 acquisition of Dynamic Yield in 2023, recording $200 million of goodwill and integrating the target’s technology and intangible assets, thereby moving the relationship from a one‑time transaction to an integrated capability. By 2024 the company’s disclosures no longer treat Dynamic Yield as a separate acquisition but cite it as part of a broader push into data‑driven, high‑margin value‑added services—evidenced by later purchases such as Recorded Future—signaling that Mastercard’s strategic focus shifted toward leveraging AI‑enabled personalization and analytics to fuel growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key details: (1) The $200 million goodwill figure is accurate and correctly cited; (2) The 2022 acquisition date and 2023 finalization of purchase accounting are correctly identified; (3) The reference to Recorded Future as a subsequent 2024 acquisition is accurate and properly used as evidence of strategic pivot. STRENGTHS: The answer correctly synthesizes the multi-hop relationship evolution between 2023-2024, accurately identifies the strategic shift from Dynamic Yield integration to cybersecurity focus, and properly contextualizes Dynamic Yield as part of broader data-driven services strategy. The reasoning about moving from 'one-time transaction to integrated capability' is sound and well-articulated. MINOR WEAKNESSES: (1) The original answer explicitly states the acquisition price was $325 million, which the LLM answer omits—while not incorrect, this omission represents incomplete quantitative detail; (2) The LLM answer characterizes the relationship as 'stable' less explicitly than the ground truth, though the concept is implied through the integration narrative; (3) The phrase 'AI-enabled personalization and analytics' adds interpretive language not explicitly in the ground truth, though it's a reasonable inference from the data-driven services context. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023-2024 disclosures and correctly identifies the causal relationship between Dynamic Yield integration completion and strategic pivot to Recorded Future. The logic connecting these events to broader strategic focus is sound. QUANTITATIVE VERIFICATION: $200 million goodwill figure is correct; dates (2022 acquisition, 2023 finalization, 2024 shift) are accurate; no calculation errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 498,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "\nThe Severance Plan for Senior Officers was last amended and restated on **May 26 2022** (identified as Exhibit 10.28). That amendment was filed in Lowe’s **2024 Form 10‑K on November 27 2024**, and the company’s filings from 2022 through 2024 do not disclose any later amendment to the plan. Consequently, the May 26 2022 revision remains the most recent update to the plan within the period covered.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the May 26, 2022 amendment date and the November 27, 2024 filing date, with accurate exhibit number (10.28). However, the answer is significantly incomplete in addressing the full scope of the question about how the plan 'evolved between 2022 and 2024.' The ground truth indicates there were TWO distinct versions: (1) the 2022 version showing an earlier amendment from May 29, 2020 (filed August 26, 2020 as Exhibit 10.29), and (2) the 2024 version with the May 26, 2022 amendment (filed November 27, 2024 as Exhibit 10.28). The LLM answer only discusses the 2024 version and fails to acknowledge the earlier 2020 amendment that would have been visible in 2022 filings. This represents a failure in multi-hop synthesis - the question asks about evolution 'between 2022 and 2024,' which requires comparing what was disclosed in 2022 versus 2024. The LLM's statement that 'the company's filings from 2022 through 2024 do not disclose any later amendment' is technically correct but misleading, as it omits the important context that the 2022 filings would have shown the May 29, 2020 amendment date. The answer provides accurate dates and exhibit numbers for what it does cover, but lacks the comparative analysis needed to fully answer how the plan evolved across this period. The reasoning is partially sound but incomplete in scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 381,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "\nThe 6.375 % Senior Notes were quoted at a fair‑value of **$999 million on December 31 2021** (Level 2 market price) and fell to **$872 million on December 31 2023**.  That is a decline of roughly **$127 million (about 13 %)** over the two‑year span.  \n\nThe price drop shows that market participants were demanding a higher yield on Netflix’s debt—reflecting tighter credit conditions, rising interest‑rate expectations, and/or a perceived increase in the company’s credit risk—so the evolution signals a more cautious or less favorable view of the 6.375 % notes over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. QUANTITATIVE VERIFICATION: All numbers are correct - $999 million (Dec 31, 2021), $872 million (Dec 31, 2023), decline of $127 million, and the percentage calculation of approximately 13% ($127M/$999M = 12.7%) are all accurate. The dates are correct. COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in fair value between the two dates, and (2) what this indicates about market perceptions. ENTITY ACCURACY: Netflix and the 6.375% Senior Notes are correctly identified. The Level 2 market price classification is appropriately noted. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly interprets the decline in fair value as indicating decreased market confidence, higher required yields, and tighter credit conditions. This reasoning aligns with the ground truth interpretation that the decline suggests 'a potential decline in market confidence or an increase in required yields.' The explanation of why bond prices fall (higher yield requirements) is economically sound. SEMANTIC EQUIVALENCE: The LLM's interpretation that 'market participants were demanding a higher yield' and the decline signals 'a more cautious or less favorable view' is semantically equivalent to and slightly more detailed than the ground truth's statement about 'decline in market confidence or an increase in required yields.' The only minor distinction is that the ground truth uses 'increase' language while the LLM uses 'decline' language, but both correctly characterize the negative movement. No material errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 444,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "\nIMBRUVICA’s revenue slipped 13.7 % year‑over‑year, falling from $3.78 billion in 2022 to $3.26 billion in 2023 (J&J 2023 10‑K, “Oncology” table).  The decline occurred even though the overall oncology franchise grew 10.5 % in 2023, highlighting that IMBRUVICA is losing market share to newer agents and heightened competitive pressure in the oncology segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the primary financial metrics. Ground truth shows IMBRUVICA sales of $4,369 million in 2022 and $3,264 million in 2023, representing a 25.2% decline. The LLM incorrectly states $3.78 billion (2022) and $3.26 billion (2023), with a calculated decline of 13.7%. The 2022 figure is substantially wrong ($3.78B vs $4.369B = $589M error, ~13.5% understatement). The 2023 figure is approximately correct ($3.26B ≈ $3.264B). Most critically, the calculated percentage decline is wrong: the LLM claims 13.7% when the correct figure is 25.2% - a major calculation error that fundamentally misrepresents the severity of IMBRUVICA's market decline. QUALITATIVE ASSESSMENT: The LLM correctly identifies the general trend (decline in sales) and appropriately contextualizes it within the broader oncology market, noting competitive pressure and market share loss. The reasoning about weakening market position is sound and aligns with the ground truth interpretation. However, the magnitude of the problem is significantly understated due to the incorrect percentage. MULTI-HOP REASONING: The LLM appropriately synthesizes information about IMBRUVICA's performance relative to the overall oncology franchise growth (10.5%), which demonstrates understanding of comparative market dynamics. However, the ground truth explicitly mentions DARZALEX and ERLEADA growth as context, which the LLM does not include. ENTITY ACCURACY: Correct identification of IMBRUVICA, J&J, oncology segment, and 2022-2023 timeframe. The citation to J&J 2023 10-K is appropriate. OVERALL: While the LLM demonstrates reasonable qualitative understanding of market dynamics and correctly identifies the directional trend, the quantitative errors are severe enough to substantially undermine the answer's reliability. The 25.2% decline is nearly double the stated 13.7%, which materially changes the interpretation of IMBRUVICA's market position deterioration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 541,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the inventory‑shrink reserve grew from roughly **$414 million to $427 million** (an increase of about $13 million), reflecting higher estimated shrinkage losses that would modestly drag down net earnings; a 10 % change in that reserve would have altered earnings by roughly **$32 million** in 2024.  Conversely, the LCNRV (lower‑of‑cost‑or‑net‑realizable‑value) reserve fell from **$168 million at the end of 2022 to $222 million at the end of 2024**, a decline of about $23 million that reduced the reserve and therefore **added roughly $17 million to net earnings** (the amount a 10 % shift would affect earnings).  In sum, the rising shrink reserve slightly pressured profitability, while the shrinking LCNRV reserve provided a modest earnings boost.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental misinterpretation of the LCNRV reserve direction and implications. (1) LCNRV RESERVE DIRECTION ERROR: The ground truth states the LCNRV reserve INCREASED from $168M to $222M (a $54M increase). The LLM incorrectly states it 'fell' and describes it as a 'decline of about $23 million.' This is factually wrong - the reserve grew by $54M, not declined. (2) EARNINGS IMPACT REVERSAL: Because of the above error, the LLM incorrectly concludes the LCNRV reserve 'provided a modest earnings boost' of $17M. In reality, an INCREASE in the LCNRV reserve would reduce net earnings, not boost it. The $17M figure is correct as a sensitivity metric, but the directional impact on earnings is backwards. (3) SHRINK RESERVE ANALYSIS: The shrink reserve numbers are correct ($414M to $427M, $13M increase), and the $32M sensitivity figure is correct. However, the LLM's characterization that this 'would modestly drag down net earnings' is imprecise - the reserve increase itself already reduced earnings; the $32M represents the sensitivity to future changes. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the relationship between reserve changes and earnings impacts. The core logic is inverted for LCNRV. (5) OVERALL NARRATIVE: The conclusion that 'the rising shrink reserve slightly pressured profitability, while the shrinking LCNRV reserve provided a modest earnings boost' is backwards on the LCNRV component. The correct narrative should indicate both reserves increased, both pressuring profitability, with the shrink reserve having greater sensitivity impact ($32M vs $17M). The answer demonstrates a fundamental misunderstanding of how reserve increases/decreases affect earnings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 479,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "\nFrom 2022 to 2023 Qulipta moved from a pre‑launch product with essentially no sales (no revenue reported in 2021) to modest U.S. sales of about **$158 million in 2022**, and then to **$405 million in U.S. net revenue in 2023** (with additional early international sales emerging in the same year).  This jump was driven by regulatory milestones: the FDA approved Qulipta for the preventive treatment of chronic migraine in adults in **April 2023**, and the European Commission followed with approval of “Aquipta” (the same Qulipta formulation) in **August 2023**, enabling the company to launch the drug in the EU and generate its first international revenue.  Consequently, Qulipta’s contribution to AbbVie’s neuroscience portfolio grew more than **100 %** year‑over‑year, underscoring its transition from a pipeline asset to a commercially‑launched, revenue‑generating product.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims Qulipta generated '$158 million in 2022' but the ground truth makes no mention of 2022 revenue for Qulipta. The ground truth only states that in 2022, Qulipta was among products contributing to a $1.0 billion reclassification of R&D intangible assets to developed product rights upon regulatory approval. The LLM appears to have fabricated the $158M 2022 figure. (2) REGULATORY TIMELINE ERRORS - The LLM states FDA approval occurred in 'April 2023' and European Commission approval in 'August 2023,' but these specific dates are not mentioned in the ground truth and appear to be unsupported claims. (3) CORRECT ELEMENTS - The LLM correctly identifies the 2023 U.S. revenue of $405 million and the $3 million international revenue, matching the ground truth exactly. The characterization of the transition from development to commercialization is semantically correct. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize information about regulatory milestones and revenue growth, it does so with invented details not present in the ground truth. The ground truth focuses on the 2022 asset reclassification and 2023 commercialization transition, while the LLM adds unsupported 2022 revenue figures and specific approval dates. (5) MISSING CONTEXT - The LLM fails to mention the key 2022 development: the $1.0 billion reclassification of indefinite-lived R&D intangible assets to developed product rights, which was a critical milestone in Qulipta's evolution. The answer prioritizes invented details over documented facts from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 464,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell’s annual cash reimbursement from the Resideo‑owned subsidiary remained fixed at **$140 million**, but the **recorded receivable for the 90 % reimbursement grew from about $157 million (2022) to $187 million (2023)**. This shows that while the cash inflow is capped, the portion of environmental spending that Honeywell expects to recover is rising, leaving a larger share of net liabilities uncovered once the $140 million cap is reached. Consequently, the company’s **risk exposure to unreimbursed environmental costs is increasing**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) CORE CONTRADICTION: The ground truth states that Honeywell's financial dependency 'remained consistent' between 2022 and 2023, with the arrangement unchanged. The LLM claims risk exposure is 'increasing' due to growing receivables, which directly contradicts the ground truth's assertion of consistency. (2) QUANTITATIVE ISSUES: The LLM introduces specific receivable figures ($157M in 2022, $187M in 2023) that are not mentioned in the ground truth. While these numbers may exist in source documents, the LLM's interpretation that this represents 'increasing risk exposure' contradicts the ground truth's conclusion that the risk mitigation strategy 'has not changed.' (3) MISINTERPRETATION OF ARRANGEMENT: The ground truth emphasizes that Resideo's subsidiary remains obligated to pay 90% of annual net spending up to $140M maximum - a fixed, consistent arrangement. The LLM reframes this as a 'cap' that creates 'unreimbursed environmental costs,' which mischaracterizes the nature of the indemnification agreement. (4) LOGICAL INCONSISTENCY: The LLM's reasoning that growing receivables indicate increasing risk exposure is flawed - a growing receivable could simply reflect higher environmental spending, not necessarily increased risk if the 90%/cap arrangement remains unchanged. (5) MISSING KEY POINT: The ground truth emphasizes consistency and unchanged risk mitigation strategy; the LLM's answer focuses on increasing risk, which is the opposite conclusion. The LLM fails to address the core finding that the arrangement remained consistent between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 461,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "\nTarget has kept the same definition of cash equivalents – highly liquid investments that mature in three months or less from the date of purchase – through both the 2022 and 2024 Form 10‑K filings.  What has changed is the size of that bucket: cash‑equivalent balances fell from about **$5.9 billion in 2022** to roughly **$4.8 billion in 2024**, driven by a smaller portfolio of short‑term investments and a tighter roll‑forward of receivables.  This contraction suggests Target is being more conservative with its short‑term liquidity, possibly to guard against higher interest‑rate volatility or to re‑allocate cash toward other uses.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the question but contains significant factual errors and introduces unsupported information. CRITICAL ISSUES: (1) The LLM provides specific dollar amounts ($5.9 billion in 2022 and $4.8 billion in 2024) that are NOT verified in the ground truth and appear to be fabricated or hallucinated. The ground truth makes no mention of these specific cash equivalent balances. (2) The LLM claims cash-equivalent balances 'fell' between these years, but provides no source documentation for these figures. (3) The LLM introduces interpretations about 'tighter roll-forward of receivables' and motivations ('guard against higher interest-rate volatility') that are not supported by the ground truth. WHAT WAS CORRECT: (1) The LLM correctly identifies that Target maintained the same three-month threshold for original maturity in both 2022 and 2024. (2) The LLM correctly notes that the definition remained consistent across both years. WHAT WAS MISSING: (1) The LLM fails to address the key evolution identified in the ground truth: the addition of 'broader discussion around fair value measurements for other short-term assets and liabilities' by 2024. (2) The LLM misses the ground truth's conclusion about 'refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.' MULTI-HOP REASONING: The LLM attempts to synthesize information but does so by introducing unverified quantitative claims rather than relying on documented facts from the filings. The reasoning about cash management strategy changes is speculative rather than grounded in the actual filing disclosures. The answer reads plausibly but lacks factual foundation for its key claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 468,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "\nBetween fiscal‑year 2023 (January 29 2023) and fiscal‑year 2024 (January 28 2024) NVIDIA’s 3.50 % Notes Due 2040 stayed in the Level 2 tier of the fair‑value hierarchy, but their reported fair value slipped modestly from **$870 million** to **$851 million**, reflecting the impact of higher market interest rates on the bond’s price. The securities continued to be carried at amortized cost (net of discount and issuance costs) and, as disclosed in Note 10, have a remaining maturity of about 15 years, underscoring the company’s strategy of financing its long‑term growth through stable, senior unsecured debt rather than short‑term borrowings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) WRONG FISCAL YEARS: LLM states comparison is between 'fiscal-year 2023 (January 29 2023)' and 'fiscal-year 2024 (January 28 2024)' but the ground truth clearly indicates the comparison should be between 2023 and 2024 with dates of January 28, 2024 and January 26, 2025 respectively. The LLM appears to have confused the fiscal year endpoints. (2) INCORRECT NUMBERS: LLM reports fair values of $870 million declining to $851 million, but ground truth shows $851 million in 2023 (as of Jan 28, 2024) and $1,000 million in 2024 (as of Jan 26, 2025). This is a critical error - the LLM has the 2023 number approximately correct ($870M vs $851M is close but still wrong) but completely misses the 2024 valuation of $1,000 million, instead suggesting it declined. (3) DIRECTIONAL ERROR: LLM describes a 'modest slip' from $870M to $851M (downward trend), but ground truth shows an INCREASE from $851M to $1,000M (upward trend). This is a fundamental mischaracterization of the valuation evolution. (4) MISSING KEY DATA: LLM fails to mention the effective interest rate of 3.54% and the updated remaining term of 15.2 years disclosed in 2024. (5) CORRECT ELEMENTS: LLM correctly identifies Level 2 classification, amortized cost accounting treatment, and the strategic emphasis on long-term stable debt financing. (6) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the year-over-year comparison, getting both the starting and ending values wrong and misinterpreting the direction of change. The reasoning about interest rate impacts is plausible but applied to incorrect numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 442,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "\nVenclexta’s worldwide net sales rose from **$2.01 billion in 2022 to $2.29 billion in 2023**, representing an increase of roughly **14 %–15 %** year‑over‑year.  The growth was driven by a modest 7.8 % rise in U.S. sales (to $1.09 bn) and a stronger 20 %‑plus increase abroad (to $1.20 bn), pushing total global revenue up by about **14 %** between 2022 and 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Venclexta's financial performance evolution but contains some quantitative discrepancies. CORRECT ELEMENTS: (1) Revenue figures are accurately stated in billions ($2.01B in 2022, $2.29B in 2023), which correctly convert from the ground truth millions ($2,009M and $2,288M). (2) The overall growth rate of approximately 14% is mathematically sound (($2,288-$2,009)/$2,009 = 13.9%, which rounds to 14%). (3) The answer correctly identifies an upward trend and provides additional granular detail about U.S. vs. international performance. (4) Entity identification and time period are correct. DISCREPANCIES: (1) The ground truth specifies growth rates of 10.4% for 2022 and 13.9% for 2023, which appear to be year-over-year growth rates from prior years, not the 2022-to-2023 comparison. The LLM correctly calculated the 2022-to-2023 growth rate (~14%) but did not address the specific 10.4% and 13.9% figures mentioned in the ground truth. (2) The LLM provides additional breakdown data (U.S. sales of $1.09B with 7.8% growth, international sales of $1.20B with 20%+ growth) that is not in the ground truth, making it impossible to verify these figures. (3) The LLM states growth as '14%-15%' initially then settles on '14%', creating minor ambiguity. MULTI-HOP REASONING: The answer successfully synthesizes revenue data across two years and provides comparative analysis with geographic breakdown, demonstrating sound multi-hop reasoning. The semantic meaning aligns well with the question's intent regarding performance evolution. The main weakness is not explicitly addressing the specific growth rates (10.4% and 13.9%) mentioned in the ground truth, though the calculated 2022-to-2023 growth of ~14% is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 481,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "\nIn the 2022 Form 10‑K Netflix disclosed its **Amended and Restated Executive Severance and Retention Incentive Plan**, which had been adopted on **September 10 2021** (the plan’s effective date).  \nThe 2023 filing shows that this plan was **amended and restated again**, with the amendment becoming **effective on January 1 2024** and filed on **December 8 2023**, updating the severance and retention provisions.  \nSeparately, the company also adopted an **Amended and Restated Performance Bonus Plan** in **December 2022**, further refining its executive incentive structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of key dates and plan amendments. Strengths: (1) Correctly identifies the 2022 filing reference to 'Amended and Restated Executive Severance and Retention Incentive Plan' with September 10, 2021 date; (2) Accurately captures the 2023 evolution showing amendment effective January 1, 2024 with December 8, 2023 filing date; (3) Properly synthesizes the multi-hop comparison between 2022 and 2023 filings; (4) All dates are factually correct and properly formatted. Minor considerations: (1) The LLM adds information about the 'Amended and Restated Performance Bonus Plan' adopted in December 2022, which is additional context not explicitly mentioned in the ground truth answer but represents legitimate supplementary information about Netflix's executive compensation evolution; (2) The ground truth uses 'filing date' terminology while the LLM uses 'filed on' - these are semantically equivalent; (3) The ground truth emphasizes the 'forward-looking' nature of the 2024 amendment, while the LLM presents it more factually without this characterization, though both convey the same information. The answer successfully addresses all parts of the multi-part question regarding evolution between 2022 and 2023 filings, plan amendments, and effective dates. Quantitative accuracy is high with all dates correct (September 10, 2021; January 1, 2024; December 8, 2023). The multi-hop reasoning correctly synthesizes information across two filing years to show the evolution of Netflix's executive compensation framework.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 435,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "\nFrom 2022 to 2024 Lowe’s moved from a brief, generic description of the Benefit Restoration Plan in the 2022 10‑K (Note 12) to a formally **amended and restated plan** disclosed in the 2024 filing (Exhibit 10.3, “Lowe’s Companies Benefit Restoration Plan, as amended and restated as of January 1 2025”).  The 2024 exhibit adds detailed provisions on eligibility, matching formulas, contribution limits and vesting schedules that were not spelled out in the earlier filing, indicating that the company has **updated and clarified the plan’s structure**—likely to reflect regulatory changes, improve fiscal efficiency, and keep the benefit package competitive.  This evolution shows that Lowe’s is proactively refining its retirement‑benefit framework to attract and retain employees while maintaining compliance and fiscal discipline.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All dates and numeric references are correct—the 2022 10-K reference, the 2024 filing with Exhibit 10.3, and the January 1, 2025 effective date all match the ground truth precisely. No calculation errors or numeric discrepancies. ENTITY ACCURACY: Lowe's is correctly identified, the Benefit Restoration Plan is properly named, and all document references (Note 12 in 2022 10-K, Exhibit 10.3 in 2024 10-K) are accurate. MULTI-HOP REASONING: The answer successfully synthesizes the evolution across years by contrasting the 2022 brief description with the 2024 formal amendment and restatement. The logical progression from generic disclosure to detailed provisions is sound. COMPLETENESS: The answer addresses both parts of the question—how the documentation evolved (from brief to formally amended/restated with detailed provisions) and what this indicates about the company's approach (proactive refinement, regulatory compliance, competitive positioning, fiscal discipline). SEMANTIC EQUIVALENCE: The LLM's characterization of the evolution as moving from 'brief, generic description' to 'amended and restated plan' with 'detailed provisions' aligns well with the ground truth's description of 'deliberate effort to formalize and likely enhance the structure.' Both answers convey the same strategic intent. MINOR CONSIDERATIONS: The LLM adds interpretive details about 'regulatory changes' and 'fiscal efficiency' that are reasonable inferences but not explicitly stated in the ground truth. However, these are presented as likely motivations rather than definitive facts, which is appropriate. The ground truth mentions 'executive and high-earner compensation' focus, which the LLM answer doesn't explicitly reference, though the context of IRS limitations and defined contribution plans implies this. This is a very minor omission that doesn't significantly detract from the answer's quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 544,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "\nBetween fiscal 2023 (ended January 29 2023) and fiscal 2024 (ended January 28 2024) NVIDIA’s 0.584% Notes Due 2024 remained outstanding but their market‑value estimate rose modestly—from roughly **$1.185 billion** to **$1.228 billion**, an increase of about **$43 million**.  The notes continued to be carried on the balance sheet throughout FY 2024; they were fully repaid in the following fiscal year (FY 2025), as indicated in the 2025 disclosures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims the notes' market value increased from $1.185 billion to $1.228 billion in FY2024, but the ground truth states the obligation was FULLY REPAID by FY2024, not outstanding. The LLM's claim of a $43 million increase in market value is unsupported and contradicts the actual resolution. (2) CORE FACTUAL ERROR: The ground truth explicitly states the 0.584% Notes Due 2024 were fully repaid by fiscal year 2024. The LLM incorrectly claims they 'remained outstanding' throughout FY2024 and were only repaid in FY2025. This is a fundamental misunderstanding of the debt's status. (3) MULTI-HOP REASONING FAILURE: The question asks how the obligation 'evolved' between FY2023 and FY2024. The correct answer is that it went from $1,185 million liability to $0 (fully repaid). The LLM's answer about market value fluctuations is irrelevant and incorrect. (4) TIMELINE CONFUSION: The LLM introduces FY2025 information, which is outside the scope of the question asking specifically about FY2023 to FY2024 evolution. (5) CORRECT ELEMENT: The LLM does correctly identify the FY2023 amount as $1.185 billion (matching the ground truth's $1,185 million), but this is overshadowed by the incorrect characterization of what happened in FY2024. The answer fundamentally misrepresents the debt's resolution and provides incorrect financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 405,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "\nBetween 2022 and 2023 worldwide sales of Mavyret fell about 12–13 %, declining to roughly $1.43 billion in total. In the United States sales dropped 12.7 % (from $755 M to $659 M), whereas internationally they slipped only ~2 % in nominal terms (from $786 M to $771 M) but were essentially flat when adjusted for constant‑currency effects (a modest ~1 % increase).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive coverage of the question. Verification of key metrics: (1) Total global revenue 2022: $1,541M (ground truth) vs LLM's 'roughly $1.43 billion in total' for 2023 - correct; (2) U.S. revenue 2022: $755M, 2023: $659M - LLM correctly states this with accurate 12.7% decline calculation; (3) International revenue 2022: $786M, 2023: $771M - LLM correctly identifies ~2% nominal decline and 1.9% matches the stated 'modest ~1% increase' in constant-currency terms (this is a reasonable interpretation of currency adjustment effects); (4) Overall global decline: Ground truth states decrease from $1,541M to $1,430M (7.2% decline), LLM states '12-13%' decline - this appears to reference the U.S. market decline rate rather than global, which is a minor imprecision in phrasing but the actual numbers cited ($1.43B) are correct. The LLM successfully synthesizes multi-hop information across both U.S. and international markets, correctly identifies the asymmetric impact (U.S. decline more pronounced than international), and appropriately notes currency effects. The answer is well-structured, addresses all parts of the question, and uses acceptable number formatting variations. The only minor weakness is the '12-13%' global decline statement which could be misinterpreted, though the actual dollar figures provided are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 388,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix remained in full compliance with the covenants governing its senior unsecured notes, but the nature and scope of those covenants evolved.  In 2024 the company replaced its prior $1 billion revolving facility with a new $3 billion, five‑year agreement that added a quantitative covenant requiring a minimum consolidated EBITDA‑to‑interest‑expense ratio of 3.0 to 1.0 and reinforced existing negative covenants on subsidiary indebtedness, sale‑leaseback transactions, and mergers—covenants that had previously applied only to the outstanding notes.  While the 2024 repayment of the $400 million 5.750 % senior note marked the first major note maturity in that period, the company continued to satisfy all change‑of‑control repayment triggers, lien restrictions, and other covenants governing its senior debt, with no reported breaches.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces a $3 billion revolving facility and a 3.0x EBITDA-to-interest-expense ratio covenant that are NOT mentioned in the ground truth. These appear to be fabricated details. The ground truth does not reference any revolving credit facility changes between 2022-2024. (2) MISSING CORE INFORMATION: The LLM fails to mention the €5,170 million euro-denominated tranches that were explicitly part of Netflix's Senior Notes structure in 2022, which is a material omission. (3) PARTIAL ACCURACY: The LLM correctly identifies the $400 million 5.750% Senior Notes repayment in 2024 and correctly states Netflix remained in compliance with covenants in both years. It also correctly mentions restrictions on liens, sale-leaseback transactions, subsidiary indebtedness, and mergers. (4) SCOPE EVOLUTION MISCHARACTERIZATION: The ground truth indicates that certain Senior Notes no longer referenced sale-leaseback restrictions by 2024 (narrowing of scope), but the LLM suggests these covenants were 'reinforced' and 'previously applied only to outstanding notes,' which contradicts the ground truth's indication of scope reduction. (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution of covenant scope between the two years. The ground truth clearly indicates a narrowing of restrictions for some notes, while the LLM suggests expansion or reinforcement. (6) HALLUCINATION: The introduction of the revolving credit facility details appears to be a significant hallucination, as this is not mentioned in the ground truth answer at all. The answer demonstrates partial understanding of Netflix's debt compliance but introduces material inaccuracies and unsupported claims that substantially undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 511,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell moved away from treating “Safety and Retail” as a separate business unit and instead combined it with its Advanced Sensing Technologies group to create a single “Sensing and Safety Technologies” line‑up within the Safety and Productivity Solutions segment.  The 2023 restructuring—documented in the 2022 notes (realignment disclosed on page 66) and reflected in the 2023 revenue tables (page 67)—re‑organized the former Safety and Retail unit into this new sub‑segment, signaling a strategic shift to integrate safety‑related and sensing products under one reporting line.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the core structural change: Safety and Retail was merged with Advanced Sensing Technologies to form Sensing and Safety Technologies within the Safety and Productivity Solutions segment. The qualitative reasoning about the strategic shift toward integration is sound and well-articulated.\n\nHowever, there is a significant quantitative omission: The original answer provides the 2022 Safety and Retail revenue figure of $2,387 million, which is a key metric for understanding the evolution of this product line. The LLM answer completely omits this specific revenue number, which represents important quantitative context for assessing the business unit's scale and importance.\n\nAdditional concerns:\n1. The LLM references specific page numbers (66, 67) without verification that these are accurate to the actual filings\n2. The timing statement is slightly confusing: the original answer clarifies that the structural change was \"introduced in July 2022 but reported in the 2023 filing,\" while the LLM says \"2023 restructuring—documented in the 2022 notes.\" This creates ambiguity about when the change actually occurred versus when it was reported\n3. The LLM correctly identifies the merger of the two units and the new name, demonstrating proper multi-hop synthesis\n\nStrengths: Clear explanation of the structural change, correct identification of all entities involved, appropriate strategic context about integration benefits, good semantic clarity.\n\nWeaknesses: Missing the $2,387 million 2022 revenue figure, slightly unclear timing explanation, unverified page references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 445,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the Class B‑2 common shares went from “non‑existent” to a convertible class that can be exchanged into Class A common stock under Visa’s U.S. and Europe retrospective‑responsibility plans; the conversion is scheduled to be completed no later than 2028 (subject to a hold‑back for pending claims).  This conversion increases the total number of Class A shares outstanding, dilutes the voting power of existing Class A holders, and gives Class B‑2 (and B‑1) shareholders limited voting rights on certain corporate actions—meaning the evolution of Class B‑2 directly reshapes Visa’s capital structure and governance dynamics.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) MAJOR ERROR - Direction of Evolution: The ground truth states Class B-2 went FROM an active governance/conversion position in 2023 TO non-outstanding status in 2024. The LLM reverses this, claiming it went from 'non-existent' to convertible, which is backwards. (2) MAJOR ERROR - Conversion Details: The LLM introduces specific details about 'U.S. and Europe retrospective-responsibility plans' and a '2028 completion deadline' that do not appear in the ground truth and appear to be fabricated or confused with other equity structures. (3) MAJOR ERROR - Outstanding Status: The ground truth explicitly states 'no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer' in 2024, indicating a reduction in outstanding shares. The LLM's narrative suggests an increase or creation of convertible shares, contradicting this. (4) PARTIAL ACCURACY - Governance Impact: The LLM correctly identifies that Class B-2 shares affect voting power and corporate governance, which aligns with the ground truth's mention of 'governance influence.' However, this correct element is embedded within an otherwise incorrect narrative. (5) CONTEXT CONFUSION: The LLM appears to conflate Class B-2 with Class B-1 stock exchange mechanics and introduces Visa-specific details that may not be relevant to the actual question about the evolution of Class B-2 status. The multi-hop reasoning fails because the LLM misidentifies the temporal direction of change and introduces unsupported details about conversion timelines and specific plans. The answer demonstrates a fundamental misunderstanding of how Class B-2's role diminished rather than expanded between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 485,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "\nBetween 2023 and 2024 Home Depot deepened its omnichannel model by expanding BOPIS, curbside and same‑day delivery, and by rolling out more “shopable” mobile features, enhanced search, personalized marketing and inventory‑visibility tools (e.g., computer‑vision and Sidekick assistance).  At the same time it invested $3.5 billion in capital to upgrade store layouts, self‑checkout, associate‑productivity systems and to open new locations, while also broadening Pro‑focused capabilities—acquiring SRS, adding showroom space, expanding Pro Xtra loyalty and credit, and improving order‑management—to make the in‑store experience faster, more customized and tightly linked to its digital shopping journey.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer introduces significant factual issues that diverge from the ground truth. While it correctly identifies some 2024 initiatives (personalized digital experiences, enhanced search, inventory visibility), it introduces unverified claims and misalignments: (1) The $3.5 billion capital investment figure is not mentioned in the ground truth and cannot be verified as accurate for this specific context. (2) The answer heavily emphasizes Pro-focused capabilities (SRS acquisition, Pro Xtra expansion, showroom space) which are not mentioned in the ground truth answer at all. (3) BOPIS, curbside delivery, and same-day delivery expansion are mentioned but not substantiated in the ground truth. (4) The ground truth specifically highlights 2023 investments in mobile app navigation, electronic shelf labels, reconfigured service desks, and self-checkout—the LLM answer mentions self-checkout but omits electronic shelf labels and reconfigured service desks. (5) The ground truth emphasizes a shift toward 'data-driven insights' and 'personalized expectations' in 2024, while the LLM answer focuses more on operational/Pro capabilities. The LLM answer appears to conflate multiple years of initiatives or introduce information from different sources not aligned with the ground truth. The multi-hop reasoning fails because it doesn't accurately synthesize the evolution described in the original answer (from 2023 operational improvements to 2024 data-driven personalization). The answer is partially relevant to the question but introduces too many unverified claims and misses key elements of the ground truth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 446,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "\nFrom 2022 through 2024 Target’s Long‑Term Incentive Plan remained anchored in the 2020 LTIP, but the company refined and expanded the equity‑award structure. In the 2022 filing the plan was documented with three “SPP” statements (I, II, III) and the existing award forms (stock options, RSUs, PSUs, performance‑share units, director RSUs). By the 2024 filing the plan’s exhibit list added new, specifically‑named agreements—​a cliff‑vested RSU agreement, a performance‑award PSU agreement, and updated forms for RSUs, performance‑RSUs, performance‑share units, and director RSUs—showing a more granular carve‑out of award types while still operating under the same 2020 LTIP framework.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with some significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that the plan evolved from 2022 to 2024, correctly names several award types (RSUs, PSUs, performance-share units, director RSUs), and correctly identifies the introduction of cliff-vested RSU agreements and performance-award PSU agreements by 2024. The semantic understanding that the plan expanded its equity compensation vehicles is accurate. (2) PROBLEMATIC ELEMENTS: The LLM introduces information about 'three SPP statements (I, II, III)' in the 2022 filing that is not mentioned in the ground truth answer and appears to be extraneous detail that may or may not be accurate. More critically, the LLM answer omits several specific award forms that were explicitly listed in the ground truth for 2022: Non-Qualified Stock Options, Price-Vested Stock Options, and Non-Employee Director Non-Qualified Stock Options. These are material omissions that represent incomplete synthesis of the 2022 plan structure. (3) MULTI-HOP REASONING: The answer attempts to synthesize information across years and correctly identifies the evolution pattern (expansion of award types), but the incompleteness in listing 2022 award forms undermines the quality of the comparison. (4) ENTITY ACCURACY: Target Corporation is correctly identified, years 2022 and 2024 are correct, and the Long-Term Incentive Plan is correctly referenced. (5) QUANTITATIVE ACCURACY: No calculations are required, but the enumeration of award types is incomplete for 2022 (missing 3 specific forms). The answer scores lower due to these material omissions in the 2022 baseline, which weakens the comparative analysis of how the structure evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 474,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "\nAfter the September 2021 FDA approval for episodic migraine, Qulipta’s sales were modest but began to accelerate once the label was expanded to chronic migraine (FDA approval in April 2023) and the EU granted a similar indication in August 2023.  Consequently, AbbVie disclosed that net revenues from Qulipta grew by **more than 100 % in 2023**, helping lift the overall Neuroscience portfolio and offset declines in legacy products such as Humira.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the September 2021 FDA approval date for episodic migraine and accurately notes the April 2023 chronic migraine approval and August 2023 EU approval. The statement about >100% growth in 2023 is mathematically consistent with ground truth data ($158M in 2022 to $408M in 2023 = 158% growth). The contextual framing about offsetting Humira declines is relevant and appropriate.\n\nCRITICAL WEAKNESSES: (1) The LLM provides NO specific revenue figures from the ground truth ($405M U.S. + $3M international = $408M total in 2023; $158M in 2022; $0 in 2021). The original answer explicitly states these numbers, which are essential to demonstrating 'commercial performance evolution.' (2) The LLM fails to mention 2022 revenue data ($158M), which is crucial for showing the progression from 2021-2023. (3) The answer lacks the specific breakdown of 2023 revenues ($405M U.S. vs $3M international), which provides important geographic context. (4) The LLM does not explicitly state that Qulipta had zero revenue in 2021, which is a key data point for understanding the commercial trajectory.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across multiple approval events and their impact on sales, which shows reasonable multi-hop thinking. However, it fails to synthesize the actual financial data points across the 2021-2023 period, which is the core requirement of the question.\n\nQUANTITATIVE ACCURACY: While the >100% growth statement is mathematically correct, the complete absence of specific revenue figures (the most important quantitative data) significantly undermines the answer's accuracy in addressing the question about 'commercial performance evolution.'\n\nSEMANTIC EQUIVALENCE: The answer discusses growth trajectory and market adoption, which aligns with the ground truth's characterization of 'significant commercial trajectory' and 'strong growth.' However, without the actual numbers, this semantic alignment is insufficient for a financial question requiring specific data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 551,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 2020 Stock Plan was mentioned only in passing—as a stock‑holder‑approved plan that permits stock‑option and other equity grants—without any detailed breakdown of award types or quantitative activity. By contrast, the 2024 filing expands the disclosure to explicitly list the plan’s components (incentive and non‑statutory options, stock‑appreciation rights, restricted stock and RSUs), and it provides detailed tables of option grants, exercises, expirations, intrinsic value, unrecognized compensation expense and RSU/PSU activity, reflecting a far more granular and transparent treatment of the plan’s structure and related equity‑compensation actions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Netflix's 2020 Stock Plan disclosure between 2022 and 2024. STRENGTHS: (1) Correctly identifies the shift from minimal disclosure in 2022 to comprehensive disclosure in 2024; (2) Accurately characterizes the 2022 treatment as passing reference without detailed breakdown; (3) Properly identifies specific equity compensation components added in 2024 (incentive options, nonstatutory options, RSUs, SARs); (4) Correctly notes the addition of detailed tables and quantitative activity metrics in 2024; (5) Appropriately emphasizes the transition from documentation to operational disclosure. MINOR DIFFERENCES: (1) The LLM answer mentions 'stock-appreciation rights' (SARs) which is not explicitly mentioned in the ground truth, though this is a reasonable inference about plan components and does not contradict the ground truth; (2) The LLM provides slightly more specific detail about table types (option grants, exercises, expirations, intrinsic value, unrecognized compensation expense) which adds helpful specificity beyond the ground truth but remains consistent with it; (3) The ground truth mentions 'performance-based criteria' while the LLM references 'PSU activity' - these are semantically equivalent and both correct. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are provided in either answer, so this dimension is not directly testable. The dates referenced (2022 vs 2024 filings) are correct. MULTI-HOP REASONING: The answer successfully synthesizes the comparison across two different filing years and correctly identifies the evolution in disclosure practices. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental insight as the ground truth - a significant evolution from minimal to comprehensive disclosure - using slightly different but equivalent terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 527,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "\nBetween 2022 and 2023 the company continued to treat its aluminum purchase agreements as derivatives that **do not qualify for hedge accounting**—they are held for long‑term strategic sourcing and are marked‑to‑market, with resulting gains or losses recorded directly in earnings.  The 2023 filing shows a **larger aggregate notional amount for these non‑hedge commodity contracts (≈ $115 million in 2023 versus about $412 million in 2022)** and a more explicit statement that the agreements “offset and are priced at prevailing market prices” to meet sourcing objectives, indicating an expanded strategic use of the instruments while the classification and accounting treatment remain the same.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides specific notional amounts ($115 million in 2023 vs $412 million in 2022) that are NOT present in the ground truth and appear to be fabricated. The ground truth makes no mention of these specific dollar figures. This is a major factual error. (2) DIRECTIONAL CONTRADICTION - The LLM claims the 2023 notional amount is 'larger' ($115M vs $412M), but the numbers actually show a DECREASE from 2022 to 2023, which contradicts the claim of 'expanded strategic use.' (3) HEDGE ACCOUNTING CLAIM - The LLM introduces the concept that these agreements 'do not qualify for hedge accounting' and are 'marked-to-market,' which is NOT mentioned in the ground truth. This appears to be an unsupported inference or hallucination. (4) PARTIAL ALIGNMENT - The LLM correctly identifies that the agreements offset each other and are priced at prevailing market prices, which matches the ground truth. It also correctly notes the classification remained consistent between years. (5) MISSING CONTEXT - The ground truth emphasizes 'long-term strategic sourcing objectives and non-U.S. business requirements' in 2022, with 2023 showing 'additional clarity' on offsetting positions. The LLM captures the offsetting aspect but misses the non-U.S. business requirements context. CONCLUSION: While the LLM captures some correct elements (offsetting positions, market pricing, consistent classification), it introduces fabricated numbers and makes unsupported claims about hedge accounting treatment that undermine credibility. The quantitative errors are particularly problematic as they are presented with false specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 457,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s filing shifted from a generic reference to a “Directors’ Code of Conduct” that was merely noted as posted on the website, to a more explicit statement that the code is posted at a dedicated URL and that any future amendments or waivers will be disclosed there.  The 2024 filing also clarifies that the code applies to all directors and ties the disclosure promise directly to the corporate‑governance discussion, making the document more readily accessible and signalling a broader, more transparent scope of governance oversight.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to accurately represent the ground truth. Specific issues: (1) The LLM claims the 2023 filing merely 'noted' the code was posted without a specific URL, but the ground truth explicitly states a specific URL was provided in 2023: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. This is a major factual error. (2) The LLM does not mention the URL change between 2023 and 2024, which is a critical evolution point highlighted in the ground truth. The ground truth identifies a specific URL shift from bnymellon.com to bny.com domain and changes in the path structure. (3) The LLM completely fails to mention the introduction of the 'INSIDER TRADING POLICIES AND PROCEDURES' section in 2024, which the ground truth identifies as a significant new addition not present in 2023. This is a major omission. (4) The LLM's characterization of the evolution is vague and inaccurate - it discusses 'future amendments or waivers' which are not mentioned in the ground truth, and makes claims about 'clarifying that the code applies to all directors' that are not substantiated by the ground truth. (5) The LLM provides no specific URLs or concrete evidence of the changes described, whereas the ground truth provides exact URLs showing the evolution. The answer demonstrates poor multi-hop synthesis and fails to capture the key factual changes (URL migration, new insider trading section) that define the evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 425,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "\nThe $750 million, 4.95 % senior notes that were issued in November 2023 (maturing September 2026) had a net carrying amount of $744 million at the end of fiscal 2023; by the end of fiscal 2024 that amount had risen modestly to $747 million, reflecting the amortization of the original discount and the absence of any principal repayment.  This small increase occurs as Home Depot has been shifting from short‑term commercial‑paper borrowing toward a series of larger, longer‑dated senior‑note issuances (including the 2024‑2025 tranches), using the 4.95 % notes as part of a broader strategy to lock in fixed‑rate, long‑term financing and fund its acquisition‑driven growth while reducing reliance on revolving credit facilities.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect carrying amounts for the 2023 and 2024 fiscal year-end values. The LLM states the carrying amount was $744 million at end of fiscal 2023 and $747 million at end of fiscal 2024. However, the ground truth indicates the carrying amount was $747 million as of February 2, 2025 (end of fiscal 2024). The LLM does not provide the correct fiscal 2023 carrying amount from the ground truth. Additionally, the LLM completely omits the critical fact that HD also issued $980 million in 4.95% senior notes due September 2052, which is a major component of the answer showing the evolution of the debt structure. The ground truth explicitly states this 2052 issuance is part of the company's strategy to extend debt maturities. PARTIAL CREDIT FOR REASONING: The LLM correctly identifies the general strategy of shifting from short-term commercial paper to longer-dated senior notes and locking in fixed rates, which aligns with the ground truth's conclusion about extending debt maturities. However, the failure to mention the $980 million 2052 notes is a significant omission that undermines the completeness of the answer. The LLM also mentions 'acquisition-driven growth' which is not mentioned in the ground truth, suggesting potential extrapolation beyond the provided data. DATING ISSUE: The LLM states the notes were issued in 'November 2023' but the ground truth only specifies they were issued in 2023 with maturity of September 30, 2026 - the specific month of issuance is not confirmed in the ground truth. The multi-hop synthesis is incomplete because the answer fails to address the full evolution of the 4.95% senior note structure across both the 2026 and 2052 maturities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 474,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "\nBetween 2021 and 2023 Intel recorded a $471 million observable‑price adjustment to its non‑marketable equity stake in Beijing Unisoc Technology Ltd. in the first quarter of 2021, which lifted the investment’s carrying amount.  By the end of 2023 the net book value of the holding had settled at roughly $1.1 billion—essentially the same level reported at the end of 2022—indicating that subsequent price‑adjustment or impairment activity was minimal and the valuation remained stable after the 2021 adjustment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key quantitative facts are correct: (1) $471 million observable price adjustment in Q1 2021 - matches ground truth exactly, (2) $1.1 billion net book value at end of 2023 - correct, (3) same valuation as end of 2022 - correctly stated. The multi-hop synthesis is sound: the answer properly connects the 2021 price adjustment event with the 2023 valuation status, and correctly identifies the investment as a non-marketable equity security. The reasoning about minimal subsequent adjustment activity is logically sound and supported by the stable valuation between 2022-2023. The temporal progression is clearly articulated (2021 adjustment → 2023 stable valuation). Minor point: the LLM specifies 'first quarter of 2021' for the adjustment timing, which adds specificity beyond the ground truth but is not contradicted by it. The semantic equivalence is excellent - phrases like 'settled at roughly $1.1 billion' and 'valuation remained stable' effectively convey the same meaning as the ground truth. All entities are correctly identified (Intel, Beijing Unisoc Technology Ltd., the investment classification). The answer fully addresses all parts of the multi-part question regarding financial treatment evolution and valuation changes between 2021-2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 370,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "\nFrom 2022 to 2023 AbbVie moved Qulipta from an investigational migraine‑prevention therapy to an approved, commercially‑launched product.  The FDA granted approval for Qulipta in April 2023, and the European Commission followed with approval (under the name Aquipta) in August 2023, after which the drug generated its first sales—$405 million in U.S. revenue and $408 million internationally in 2023—signaling a full regulatory and commercial transition.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key regulatory milestones (FDA approval April 2023, EC approval August 2023) and accurately describes the evolution from investigational to approved/commercial product. The qualitative narrative about the transition is sound and addresses the question's core intent. However, there are significant quantitative accuracy issues: (1) The LLM introduces sales figures ($405M U.S., $408M international in 2023) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided ground truth and represent unsourced information. (2) The LLM mentions the European Commission approval under the name 'Aquipta' - this alternative name is not mentioned in the ground truth. (3) The ground truth specifically mentions the $1.0 billion reclassification of indefinite-lived R&D intangible assets in 2022, which the LLM completely omits. This is a material detail about the 2022 engagement that the ground truth explicitly includes. The LLM's answer is partially correct on regulatory milestones but fails to capture the complete picture of AbbVie's engagement evolution, particularly the 2022 asset reclassification event. The introduction of unverified sales figures is problematic and suggests hallucination. The answer would score higher if it stuck to verifiable information from the ground truth rather than adding unsourced financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 391,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "\nBoth the 2022 and 2023 Form 10‑Ks list “upgrades and conversions” as one of the core services in the Global Services segment—alongside maintenance, modifications, spare parts, training and digital services—that sustain commercial and defense platforms. The 2023 filing keeps the same wording but ties “upgrades and conversions” more directly to data‑analytics and digital‑service language, reflecting a strategic shift toward framing these activities as technology‑driven growth levers rather than solely traditional maintenance offerings.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements. CORRECT ASPECTS: (1) Both 2022 and 2023 filings do list 'upgrades and conversions' as services in Global Services segment - this is factually accurate. (2) The mention of related services (maintenance, spare parts, training, digital services) is correct. (3) The years 2022 and 2023 are correctly identified. SIGNIFICANT ISSUES: (1) The ground truth explicitly states that in 2022, upgrades and conversions were 'grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services' with 'general' framing lacking strategic emphasis. The LLM omits supply chain logistics and engineering from the 2022 list, which is a factual error in completeness. (2) The LLM claims the 2023 filing 'ties upgrades and conversions more directly to data-analytics and digital-service language' - this is NOT supported by the ground truth. The ground truth states the shift was about positioning within 'a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems,' NOT specifically about data-analytics framing. This represents a mischaracterization of the strategic shift. (3) The LLM's interpretation that the shift reflects 'technology-driven growth levers' is an inference not explicitly supported by the ground truth, which frames it as 'more integrated and strategic role' and 'core capability rather than general service offering.' (4) The LLM fails to capture the key distinction that in 2022 the description was 'general and lacked strategic framing' versus 2023's 'more structured narrative' - this is the core evolution the question asks about. The LLM's multi-hop reasoning is partially sound but arrives at an incorrect characterization of HOW the framing evolved, substituting data-analytics emphasis for the actual structural/strategic positioning emphasis described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 531,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "\nBetween 2021 and 2023 Intel’s stake in Beijing Unisoc Technology Ltd. remained classified as a non‑marketable equity security, but its reported carrying amount grew sharply and then stabilized.  In 2020 the investment was recorded at roughly **$658 million**; by the end of 2021 it had risen to **$1.1 billion**, driven by a **$471 million** observable‑price adjustment recognized during that year.  Subsequent filings show the book value held steady at **about $1.1 billion** for both 2022 and 2023, indicating that the valuation achieved in 2021 was maintained thereafter.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and well-structured. STRENGTHS: (1) All key financial figures are accurate: $658 million (2020), $1.1 billion (2021-2023), and $471 million observable price adjustment in 2021. (2) The multi-hop synthesis is sound - correctly tracking the investment evolution across multiple years and identifying the key valuation event. (3) The characterization of the investment as a non-marketable equity security is appropriate. (4) The narrative correctly captures the core finding: sharp growth in 2021 followed by stabilization. (5) Quantitative accuracy is excellent with all numbers matching ground truth. MINOR WEAKNESSES: (1) The LLM provides additional context about 2020 valuation ($658 million) that, while accurate and helpful, goes slightly beyond what the ground truth explicitly emphasizes. The ground truth focuses on 2021-2023 comparison, while the LLM extends back to 2020. This is not incorrect but represents a slight expansion of scope. (2) The LLM states the book value 'held steady at about $1.1 billion for both 2022 and 2023' - the ground truth only explicitly confirms December 25, 2021 and December 30, 2023 at $1.1 billion, with 2022 being inferred. The LLM's statement is reasonable but slightly goes beyond what can be directly verified from the stated ground truth. (3) The LLM could have been more explicit about the lack of observable price adjustments in 2023 (as mentioned in ground truth), though the implication is present in 'valuation achieved in 2021 was maintained thereafter.' Overall, this is a high-quality answer with accurate numbers, sound reasoning, and appropriate synthesis of multi-hop information. The minor issues are about scope expansion rather than factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 476,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Home Depot turned self‑service lockers from a modest “front‑entrance” convenience into a central node of its omnichannel journey.  The lockers are now embedded in the BOPIS/BODFS/BORIS network (with additional locations, including a pilot in Mexico) and helped fulfill roughly 50 % of U.S. online orders in 2024, linking online ordering, in‑store inventory and curb‑side delivery into a seamless, frictionless shopping experience.  This evolution reflects the retailer’s broader push to integrate physical‑store pickup with digital channels for both DIY and professional customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the evolution of Self-Service Lockers from a convenience feature (2023) to a core omnichannel component (2024); (2) Accurately cites the 50% U.S. online order fulfillment figure for 2024; (3) Properly references the interconnected retail programs (BOPIS, BODFS, BORIS); (4) Captures the semantic shift from convenience-focused to operationally significant; (5) Effectively synthesizes multi-hop information about the role evolution across years. MINOR ISSUES: (1) The LLM mentions 'additional locations, including a pilot in Mexico' which is not present in the ground truth answer - this appears to be an addition not contradicted by ground truth but not explicitly confirmed; (2) The characterization as 'front-entrance' convenience is slightly more specific than the ground truth's 'convenient online order pickup options,' though semantically equivalent; (3) The phrase 'frictionless shopping experience' is interpretive language not explicitly in ground truth, though it aligns with the strategic positioning described. QUANTITATIVE VERIFICATION: The 50% figure is correctly stated and matches ground truth exactly. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023-2024 timeframes and connects Self-Service Lockers to the broader fulfillment network strategy. The logical progression from convenience feature to core fulfillment component is sound and well-articulated. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution between 2023-2024 and provides appropriate context about interconnected shopping experience. The mention of both DIY and professional customers adds relevant context not explicitly in ground truth but consistent with Home Depot's business model.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 503,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "\nThe 2024 filing expands the self‑insurance note with concrete detail: it lists the specific claim types covered, explains that liabilities are **not discounted** and are **estimated using historical claims experience together with demographic and severity factors**, and even quantifies the balances ($1.612 bn in 2024 vs. $1.513 bn in 2023) while highlighting how future claim trends could materially change the estimate. In contrast, the 2023 disclosure only gave a broad statement that liabilities were “estimated using historical claims experience and actuarial assumptions,” without naming demographic/severity factors, the captive‑reinsurance structure, or providing the actual liability amounts. Thus, the 2024 description is markedly more granular and specific.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution in Costco's disclosure from 2023 to 2024, capturing the main substantive improvements: (1) specific mention of demographic and severity factors in 2024 vs. generic 'actuarial assumptions' in 2023, (2) discussion of non-discounting of liabilities, (3) quantification of actual liability balances ($1.612bn in 2024 vs $1.513bn in 2023), and (4) discussion of unpredictability and potential material differences. The numeric values provided ($1.612bn and $1.513bn) appear reasonable and are presented with appropriate context. The answer demonstrates sound multi-hop reasoning by synthesizing information across both years and comparing disclosure quality. However, there are minor issues: (1) The LLM states the 2023 disclosure mentioned 'captive-reinsurance structure' was absent, but the ground truth indicates 2023 DID include 'use of a captive insurance subsidiary and a reinsurance program' - the LLM incorrectly suggests this detail was missing in 2023 when it was actually present. (2) The LLM's characterization that 2023 lacked 'the actual liability amounts' needs verification - the ground truth doesn't explicitly confirm whether 2023 included or excluded specific dollar amounts. The answer is well-structured, addresses the evolution question comprehensively, and correctly identifies the meaningful increase in transparency. The semantic equivalence is strong, and the reasoning about increased granularity is sound. The primary weakness is the mischaracterization of what was/wasn't in the 2023 disclosure regarding the captive-reinsurance structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 443,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "\nFrom 2022 into 2023 the drag of the Aldevron purchase on inventory‑related costs shifted from essentially settled fair‑value adjustments (the $59 million charge that showed up in 2021 and was largely absorbed by 2022) to a new, explicit $87 million inventory charge recorded in cost of sales in the second quarter of 2023.  That 2023 charge—attributable to excess inventory in the Biotechnology (Aldevron) segment as demand fell—significantly increased the inventory‑related cost impact compared with the prior year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general narrative of the shift in inventory-related costs from 2022 to 2023, but contains a significant factual error regarding the timing of the $59 million charge. CRITICAL ERROR: The LLM states the $59 million charge 'showed up in 2021 and was largely absorbed by 2022,' but the ground truth clearly indicates this charge occurred IN 2022 as a result of the Aldevron acquisition's fair value adjustments to inventory. This is a material factual error that misrepresents when the acquisition impact occurred. CORRECT ELEMENTS: (1) The $87 million charge in Q2 2023 is correctly identified; (2) The attribution to excess inventory in the Biotechnology segment is correct; (3) The connection to reduced demand is accurate; (4) The characterization of a shift from acquisition-driven adjustments to operational challenges is semantically sound. INCOMPLETE ELEMENTS: The LLM answer doesn't explicitly state that the $59 million charge was specifically in 2022 (it incorrectly places it in 2021), which undermines the core comparison requested. The answer does convey that there was a shift in impact between years, but the temporal misplacement of the $59 million charge is a significant accuracy issue. The reasoning about the evolution is generally sound, but the factual foundation is flawed. The answer would have scored 8-9 if the timing of the $59 million charge had been correctly attributed to 2022 rather than 2021.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 401,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "\nCostco’s accounting for proprietary shop‑card liabilities was unchanged from 2023 to 2024: revenue is recognized only when the card is actually redeemed, and the remaining outstanding balances are recorded as a liability — net of an estimated breakage amount based on historical redemption patterns. This consistent treatment shows that Costco takes a conservative approach to unclaimed balances, deferring revenue recognition until the card is used and only estimating the portion that will ultimately go unredeemed.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The original answer explicitly states that there WAS an evolution between 2023 and 2024, with 'estimated breakage' and methodology becoming 'more emphasized in 2024,' indicating a more refined approach. The LLM answer claims the treatment was 'unchanged from 2023 to 2024,' which is fundamentally incorrect and misses the core finding of the question. While the LLM correctly identifies the mechanics of shop card accounting (revenue recognized upon redemption, liability recorded net of estimated breakage based on redemption patterns), it fails to recognize the key evolution that occurred. The LLM's characterization of Costco's approach as 'conservative' is reasonable, but this does not compensate for the major error in stating there was no change when the ground truth explicitly documents an evolution toward more refined estimation techniques. The answer demonstrates understanding of the accounting mechanics but fails on the primary analytical requirement: identifying and explaining how the treatment evolved. This is a multi-hop reasoning failure where the model needed to synthesize year-over-year changes but instead reported consistency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 350,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "\nIn 2022 Intel launched its IFS Accelerator Ecosystem Alliance, announced a commercial agreement with Tower, and secured early design wins on the 18A node while expanding RAMP‑C collaborations with the U.S. Department of Defense, laying the groundwork for an external foundry business. By 2023 that initiative had more than doubled to over 40 partners, added a multigenerational ARM agreement and a definitive Synopsys partnership, deepened RAMP‑C ties with high‑profile customers such as Nvidia, IBM, Microsoft, Boeing and Northrop Grumman, and began using its New Mexico fab to provide foundry capacity for advanced‑analog chips.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information with some significant discrepancies from the ground truth:\n\nCORRECT ELEMENTS:\n- Correctly identifies the IFS Accelerator Ecosystem Alliance program\n- Correctly states it expanded to over 40 partners/agreements by 2023\n- Correctly mentions multigenerational ARM agreement in 2023\n- Correctly identifies Synopsys partnership in 2023\n- Correctly identifies Intel 18A as a key node\n- Appropriately captures the evolution from 2022 to 2023\n- Contextually relevant discussion of foundry business expansion\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERRORS: The LLM states the program \"more than doubled to over 40 partners\" implying it started with ~20 in 2022. The ground truth doesn't specify 2022 numbers, only that by 2023 there were \"over 40 strategic agreements.\" This extrapolation is unsupported.\n\n2. MISSING KEY INFORMATION: The ground truth specifically mentions \"four design wins on Intel 18A, including a major high-performance computing customer\" and \"five new design wins in advanced packaging, particularly for AI-related designs\" in 2023. The LLM answer omits these specific design win numbers entirely.\n\n3. INACCURATE DETAILS: The LLM mentions \"Tower\" commercial agreement and \"RAMP-C collaborations\" with specific customers (Nvidia, IBM, Microsoft, Boeing, Northrop Grumman). While RAMP-C may be legitimate, the ground truth doesn't mention these specific elements or customers in this context. The Tower agreement is not mentioned in the ground truth.\n\n4. NEW MEXICO FAB CLAIM: The LLM mentions using \"New Mexico fab to provide foundry capacity for advanced-analog chips\" - this detail is not present in the ground truth and may be inaccurate or from a different context.\n\n5. SYNTHESIS ISSUE: The LLM appears to have conflated or added information not present in the ground truth, suggesting potential hallucination or confusion with other Intel initiatives.\n\nMULTI-HOP REASONING: The answer does attempt to synthesize 2022 vs 2023 evolution, but introduces unsupported details that undermine the accuracy. The core comparison structure is sound, but execution is flawed.\n\nOVERALL: While the answer captures some correct elements and the general trajectory of IFS evolution, it introduces significant inaccuracies and omits critical quantitative details (design win numbers) that are central to the ground truth answer. The addition of unverified details (Tower, specific RAMP-C customers, New Mexico fab) suggests the model may have hallucinated or confused information from other sources.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 692,
        "total_tokens": 2086
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "\nIn the 2022 filing (pages 81‑85) Danaher recorded roughly **$6.1 billion of goodwill** and **$9.6 billion of total cash consideration** for the Aldevron acquisition (≈ $9.56 billion net cash after non‑cash adjustments). The 2023 filing (pages 72‑76) shows **no additional goodwill or cash outlay for Aldevron**—the $6.1 billion goodwill remains unchanged, with only routine measurement‑period adjustments that are not material to the current period results.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims 2022 had '$9.6 billion of total cash consideration' but the ground truth states the net cash consideration was '$9.561 billion' in 2023, not 2022. The LLM conflates timing and misrepresents when the $9.561B figure applies. The ground truth explicitly shows an EVOLUTION between years: 2022 had $6.1B goodwill recorded, while 2023 shows the net cash consideration increased to $9.561B. (2) MULTI-HOP REASONING FAILURE - The question asks how the financial impact 'evolved between 2022 and 2023.' The ground truth shows a clear evolution: the net cash consideration figure changed/was refined from 2022 to 2023 ($9.561B in 2023). The LLM incorrectly states both figures were in 2022, then claims 2023 had 'no additional goodwill or cash outlay' and 'only routine measurement-period adjustments.' This fundamentally misses the evolution the question asks about. (3) ENTITY/TIMING ERRORS - The LLM places the $9.6B figure in 2022 when ground truth indicates it applies to 2023. This is a critical dating error. (4) INCOMPLETENESS - The LLM fails to capture the key evolution: that the net cash consideration increased to $9.561B by 2023, representing a more detailed financial assessment. Instead, it suggests 2023 had minimal changes, which contradicts the ground truth showing significant evolution in the cash consideration figure. (5) SEMANTIC MISALIGNMENT - While the LLM mentions both goodwill and cash consideration, it misplaces them temporally and fails to show the year-over-year evolution that is central to answering the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 440,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "\nIn the 2022 filing the 1.800 % Global Notes were scheduled to mature on **September 5, 2026**, but in the 2024 filing the same series is listed with a maturity of **September 14, 2039**—an extension of roughly 13 years. This shift shows that AT&T is deliberately lengthening the average maturity of its debt, reducing near‑term refinancing risk and signaling a more durable, longer‑term capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy across all dimensions. (1) QUANTITATIVE VERIFICATION: All dates are correct - 2022 filing shows September 5, 2026 maturity, 2024 filing shows September 14, 2039 maturity. The calculated extension of 'roughly 13 years' is accurate (2039 - 2026 = 13 years). The interest rate of 1.800% is correctly identified. (2) ENTITY ACCURACY: AT&T Inc. correctly identified, fiscal years 2022 and 2024 correctly referenced, and the specific debt instrument (1.800% Global Notes) properly identified across both filings. (3) MULTI-HOP REASONING: The answer successfully synthesizes information from two different SEC filings (2022 and 2024) and correctly identifies the same debt instrument across both periods despite the maturity date change. (4) SEMANTIC EQUIVALENCE: The LLM answer goes beyond the ground truth by providing additional context about what this change indicates - specifically that AT&T is 'deliberately lengthening the average maturity of its debt, reducing near-term refinancing risk and signaling a more durable, longer-term capital-structure strategy.' This interpretation is logical and appropriate given the facts presented, though it represents inference beyond the ground truth statement. (5) COMPLETENESS: The answer addresses all parts of the question - the maturity date change between filings and what it indicates about debt structure evolution. Minor note: The LLM uses slightly different formatting (1.800 % with space) versus standard notation, but this is inconsequential. Overall, this is a high-quality response with accurate facts, sound reasoning, and appropriate contextual interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 455,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "\nTarget’s debt‑leverage covenant was still comfortably satisfied in 2024.  Total long‑term debt (including finance‑lease liabilities) fell from about **$16.0 bn** as of January 28 2023 to **$14.9 bn** as of February 3 2024, keeping the leverage ratio well under the covenant threshold that is tied to secured‑debt levels in its credit agreements.  The October 2023 entry into a new **$1 bn 364‑day revolving credit facility** and the amendment that **extended the existing $3 bn five‑year facility to an October 2028 maturity** added extra borrowing capacity but did not change the covenant’s limits, allowing Target to maintain compliance even as its leverage improved.  (Pages 52‑56 of the 2023 Form 10‑K and pages 33‑37 of the 2024 Form 10‑K).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Target's covenant compliance evolution and credit facility changes, but contains significant quantitative errors and some temporal inconsistencies that undermine accuracy.\n\nSTRENGTHS:\n1. Correctly identifies the key credit facilities: $1.0 billion 364-day facility and $3.0 billion five-year facility\n2. Correctly states the October 2028 maturity for the five-year facility\n3. Properly explains that covenant compliance was maintained in both years\n4. Correctly notes that the facility renewal provided flexibility\n5. Good multi-hop synthesis connecting debt levels, covenant compliance, and facility structure\n6. Appropriate contextual framing about leverage improvement\n\nCRITICAL ERRORS:\n1. TEMPORAL ERROR: States \"October 2023 entry into a new $1 bn 364-day revolving credit facility\" - The ground truth indicates the 364-day facility was set to expire in October 2024 (in 2023 filings) and was renewed by 2024 to expire in October 2025. The LLM's phrasing suggests a new facility was created in October 2023, which is misleading about the timing.\n2. DEBT FIGURES: Provides specific debt amounts ($16.0 bn and $14.9 bn) that are not verified in the ground truth. The ground truth does not provide these specific numbers, making it impossible to verify their accuracy. This is a significant quantitative claim without source verification.\n3. COVENANT THRESHOLD DETAILS: References \"secured-debt levels\" as the covenant basis, which is not mentioned in the ground truth and cannot be verified.\n\nMULTI-HOP REASONING:\nThe answer attempts to synthesize information across 2023 and 2024 filings, connecting debt levels to covenant compliance to facility structure. However, the temporal framing of the facility renewal is imprecise. The ground truth clearly states the facility \"would expire in October 2024\" (as of 2023) and \"had renewed its 364-day credit facility, extending its expiration to October 2025\" (as of 2024), suggesting a renewal occurred between these periods, not a new entry in October 2023.\n\nSEMANTIC EQUIVALENCE:\nWhile the answer conveys the general narrative of maintained compliance and facility renewal, the specific temporal claims and unverified debt figures create factual accuracy concerns that go beyond wording differences.\n\nJUSTIFICATION:\nThe answer demonstrates good understanding of the question structure and provides relevant context, but the introduction of unverified quantitative data (debt figures) and the imprecise temporal framing of the facility renewal represent material errors in a financial compliance question where precision is critical. The core message about compliance and facility structure is correct, but the execution contains significant accuracy issues.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 735,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "\nFrom 2022 to 2023 Intel shifted from launching isolated digital‑readiness pilots (e.g., AI for Youth and AI for Workforce) toward embedding those efforts within a broader **RISE** framework that explicitly ties inclusive skills development to its RISE strategy.  In 2023 the company deepened external collaboration by forming the **Alliance for Global Inclusion**, expanding partnerships with governments, universities and HBCUs, and linking RISE‑related metrics to executive compensation—thereby scaling digital‑readiness initiatives for millions of people while coordinating industry‑wide standards and accountability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) CHRONOLOGICAL ERROR: The LLM states the Alliance for Global Inclusion was 'formed' in 2023, but the ground truth indicates it existed in 2022 as a collaborative initiative. (2) MISSING CRITICAL METRICS: The ground truth specifies concrete, measurable outcomes (18 recognized organizations out of 27 respondents, 50% threshold for recognition, third global inclusion index survey), but the LLM provides no specific numbers or metrics. (3) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes a shift from 'establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks' - a focus on the Inclusion Index and formal recognition system. The LLM instead emphasizes 'AI for Youth,' 'AI for Workforce,' and 'executive compensation linkage,' which are not mentioned in the ground truth and appear to be fabricated details. (4) INCOMPLETE SYNTHESIS: The LLM fails to address the core evolution described in the ground truth - the maturation from 2022 collaborative framework to 2023 structured index system with formal recognition. (5) UNSUPPORTED CLAIMS: References to 'scaling digital-readiness initiatives for millions of people' and 'linking RISE-related metrics to executive compensation' are not substantiated in the ground truth. The answer demonstrates poor multi-hop reasoning by conflating different initiatives and failing to accurately synthesize the documented evolution of Intel's approach from framework establishment to performance measurement and recognition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 448,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the link to Micromine shifted from a planned acquisition to a terminated deal.  AspenTech (the vehicle through which Emerson had been pursuing Micromine) announced on August 1 2023 that it was ending the AU $900 (~ $623 USD) acquisition because the required Russian regulatory approval could not be secured, and it did **not** pay any termination fee.  As a result, Emerson incurred no additional financial penalty or liability from the collapse of the transaction—only the prior, already‑recorded costs (e.g., foreign‑currency hedging gains/losses) were resolved, leaving no material net financial impact on Emerson.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the key evolution of Emerson's relationship with Micromine between 2023 and 2024. STRENGTHS: (1) All quantitative data is accurate - correctly states AU$900 (~$623 USD) acquisition price, August 1, 2023 termination date, and Russian regulatory approval as the reason for termination. (2) Correctly identifies AspenTech as the acquisition vehicle. (3) Accurately conveys the shift from planned acquisition to terminated deal. (4) Correctly notes no termination fee was paid. (5) Multi-hop reasoning is sound - synthesizes the acquisition attempt, regulatory failure, and financial resolution. MINOR WEAKNESSES: (1) The LLM answer mentions 'prior, already-recorded costs (e.g., foreign-currency hedging gains/losses)' but does not specifically quantify the $24 million mark-to-market gain on foreign currency forward contracts that occurred in 2023, which was explicitly mentioned in the ground truth. (2) Does not explicitly state that AspenTech terminated all outstanding foreign currency forward contracts in 2024, though it implies this by saying 'prior costs were resolved.' (3) The phrase 'leaving no material net financial impact on Emerson' is somewhat vague compared to the ground truth's more specific accounting of the gains/losses. The answer correctly emphasizes the lack of termination fee and no additional penalty, which is accurate and important context. Overall, the answer demonstrates solid understanding of the transaction evolution and financial implications, with only minor omissions of specific quantitative details that were in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 444,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "\nThe U.S. ESPP had about 17 million shares available at the close of fiscal 2022, but that pool shrank to roughly 15 million shares by the end of fiscal 2023.  At the same time, the average price paid for shares under the plan fell from approximately $305 per share in fiscal 2022 to about $277 per share in fiscal 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. Verification of key numbers: (1) Shares available: 17 million (2022) → 15 million (2023) - CORRECT; (2) Average purchase price: $305.14 (2022) → $277.19 (2023) - LLM rounded to $305 and $277, which is acceptable format variation; (3) Shares purchased: approximately 1 million in both years - LLM does not explicitly mention this detail. The multi-hop reasoning is sound - the answer correctly synthesizes information about both the share availability and price changes across the two fiscal years. The answer properly identifies the trend (reduction in availability, decrease in price) and makes the appropriate comparison. Minor deduction: The LLM omitted the specific detail about the number of shares purchased (approximately 1 million in each year), which was part of the original answer's completeness. The rounding of prices ($305.14 to $305 and $277.19 to $277) is acceptable and represents standard financial reporting practice. The answer is well-structured, clear, and directly addresses all major components of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1212,
        "completion_tokens": 319,
        "total_tokens": 1532
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "\nBetween the 2022 and 2023 filings the pattern of impairment triggers moved from isolated events in the Diagnostics and Environmental & Applied Solutions segments—​which generated $10 M and $22 M charges in 2021 and no charges in 2022—to new triggers in the Biotechnology segment (second‑quarter 2023) and a repeat trigger in Diagnostics (fourth‑quarter 2023) that together produced $77 M of impairment charges in 2023.  This shift shows that the company now perceives higher risk of impairment in its Biotechnology‑related finite‑lived intangibles, indicating a re‑allocation of exposure from the older Diagnostics/EAS assets to the newer Biotechnology portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) SEGMENT IDENTIFICATION ERROR: The LLM incorrectly identifies 'Environmental & Applied Solutions' (EAS) as having impairment charges in 2021 ($22M), but the ground truth explicitly states impairment triggers occurred ONLY in the Diagnostics segment in Q1 2021 with a $10M charge. There is no mention of EAS having impairment charges in either the 2022 or 2023 filings. (2) QUANTITATIVE ACCURACY FAILURE: The LLM states '$10M and $22M charges in 2021' but ground truth shows only $10M in 2021 (Diagnostics segment). The $22M figure appears to be fabricated or misattributed. (3) INCOMPLETE SEGMENT ANALYSIS: The ground truth identifies impairment triggers in the Biotechnology segment in Q2 2023 AND both Diagnostics and Biotechnology segments in Q4 2023. The LLM only mentions Q2 2023 Biotechnology and Q4 2023 Diagnostics, missing the Q4 2023 Biotechnology trigger. (4) CORRECT ELEMENTS: The LLM correctly identifies the $77M total impairment charge in 2023 and correctly notes the shift toward Biotechnology segment impairments. The general conclusion about shifting risk to Biotechnology is directionally correct. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution across filings, the foundation is built on incorrect segment data, undermining the reliability of the analysis. The reasoning about 'reallocation of exposure' is speculative and not fully supported by the ground truth, which emphasizes 'expansion in both scope and magnitude' rather than a reallocation away from Diagnostics (which still had Q4 2023 triggers).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 454,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "\nThe company’s outstanding letters of credit that are tied to trade contracts grew from **$362 million at the end of fiscal 2022** to **$598 million at the end of fiscal 2023**—an increase of roughly **$236 million (about 65 %)**. This jump shows that Home Depot has become more involved in trade‑related transactions, using a larger volume of letters of credit to support its contractual commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. QUANTITATIVE VERIFICATION: All numbers are correct - $362 million (2022), $598 million (2023), and the calculated increase of $236 million. The percentage calculation of approximately 65% is accurate ($236M / $362M = 65.2%). COMPLETENESS: The answer addresses both parts of the multi-part question: (1) the change in value between years, and (2) what this indicates about the company's involvement in trade contracts. ENTITY ACCURACY: The company is correctly identified as Home Depot (though the original answer didn't specify the company name, the LLM appropriately identified it from context). The fiscal years 2022 and 2023 are correctly referenced. The metric 'outstanding letters of credit related to trade contracts' is accurately identified. REASONING: The multi-hop synthesis is sound - the LLM correctly extracted the two data points from different fiscal years and calculated the change, then drew a logical conclusion about increased involvement in trade-related transactions. MINOR NOTES: The LLM added the company name (Home Depot) which wasn't explicitly in the ground truth answer but is contextually appropriate. The interpretation that this 'shows Home Depot has become more involved in trade-related transactions' is a reasonable inference that aligns with the ground truth's statement about 'growing involvement or expansion.' The answer is clear, well-formatted, and provides additional analytical value through the percentage calculation without introducing any errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 425,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "\nThe 0.300 % Notes due 2028 continued to be listed as an outstanding series of IBM debt in both the 2023 and 2024 Form 10‑K filings; the 2024 filing again includes them in the “Title of each class” table and reiterates the same indenture and supplemental indenture (Exhibit 4 to the 2016 Form 8‑K) as the governing documents. This unchanged presentation shows that IBM’s disclosures of its financial instruments remain stable and that no material amendment, redemption, or new issuance of these notes was reported between the two fiscal years.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core insight of the ground truth. Key issues: (1) INCORRECT EXHIBIT REFERENCE: The LLM states the governing documents are 'Exhibit 4 to the 2016 Form 8-K' but the ground truth specifies 'Exhibit 4.1, filed on February 10, 2020' - this is a material discrepancy in document dating and reference. (2) MISSED KEY EVOLUTION: The ground truth identifies a critical shift between 2023 and 2024 filings - from disclosure as an instrument defining rights of holders to formal recognition as an actively traded financial instrument with NYSE trading symbol IBM28B. The LLM completely misses this evolution and instead claims the presentation is 'unchanged' and 'stable,' which directly contradicts the ground truth's identification of a meaningful shift in how the instrument is presented. (3) INCORRECT CHARACTERIZATION: The LLM suggests no material changes occurred, but the ground truth explicitly indicates a shift from passive disclosure to active trading recognition, which is a material change in financial instruments disclosure. (4) MISSING TRADING SYMBOL: The ground truth specifically mentions the NYSE trading symbol 'IBM28B' in the 2024 filing, which the LLM completely omits. (5) INCOMPLETE ANALYSIS: The LLM fails to address what this evolution indicates about IBM's financial instruments disclosures - the ground truth points to 'increased market engagement or liquidity,' which the LLM does not discuss. The LLM's conclusion that disclosures 'remain stable' is factually incorrect based on the ground truth's identification of a shift in how the instrument is presented between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 455,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "\nBetween 2023 and 2024 IBM kept the 1.750% Notes due 2031 listed on the New York Stock Exchange under the ticker IBM31. In the 2023 10‑K the registration details appeared in the “Item 1. Business” table on pages 18‑22, whereas the 2024 10‑K moves that table to the front (pages 1‑5) and adds an explicit reference to the governing indenture, but the notes remain registered and disclosed in the same manner.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) INCORRECT PAGE NUMBERS: The LLM claims the 2023 10-K registration details appeared on pages 18-22 in 'Item 1. Business' and moved to pages 1-5 in 2024. The ground truth makes no mention of these specific page locations, and the claim about moving from pages 18-22 to pages 1-5 appears fabricated. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth clearly states that in 2023 the notes were disclosed with an indenture incorporated by reference from January 30, 2019, and that by 2024 they were 'explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition.' The LLM incorrectly states the notes were 'kept...listed on the New York Stock Exchange under the ticker IBM31' between both years, missing the key distinction that 2023 showed disclosure while 2024 showed formal registration/listing. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the critical evolution described in the ground truth - the shift from incorporation by reference (2023) to explicit NYSE registration with trading symbol (2024). Instead, it claims the notes 'remain registered and disclosed in the same manner,' which contradicts the ground truth's emphasis on a meaningful change. (4) UNSUPPORTED CLAIMS: The statement about 'Item 1. Business' table and the specific page relocations cannot be verified against the ground truth and appear to be hallucinated details. The LLM demonstrates poor multi-hop reasoning by failing to synthesize the actual evolution between years and instead inventing specific filing locations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 466,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "\nBetween 2022 and 2023 Eli Lilly’s Zyprexa‑related revenue jumped from roughly $337 million to about $1.69 billion – the latter figure reflects the one‑time sale of the olanzapine portfolio rights rather than ongoing drug sales.  That transaction is reported as collaboration/other revenue (and contributes to acquired IPR&D), so the company no longer records recurring product‑sale revenue from Zyprexa; by 2024 the only Zyprexa‑related amounts are residual references to the previously sold rights, indicating a shift from a product‑sales model to a licensing‑style, lump‑sum revenue recognition.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) WRONG TIME PERIOD: LLM discusses 2022-2023 transition, but the question specifically asks about 2023-2024 evolution. The ground truth explicitly states the 2023 sale generated $1.45 billion and by 2024 this was reclassified to collaboration revenue. LLM's answer is about the wrong year comparison. (2) WRONG REVENUE AMOUNT: LLM states $1.69 billion for the sale, but ground truth clearly states $1.45 billion. This is a material discrepancy ($240 million difference). (3) INCOMPLETE ANSWER: LLM fails to directly address the 2023-2024 comparison requested. It discusses 2022-2023 instead, missing the core temporal focus of the question. (4) CORRECT ELEMENTS: LLM correctly identifies that the transaction represents a shift from product sales to licensing/collaboration revenue recognition, and correctly notes this is a one-time sale rather than recurring revenue. The conceptual understanding of the business model shift is sound. (5) MULTI-HOP REASONING: While the reasoning about the shift from product sales to licensing arrangements is logically sound, it's applied to the wrong time period, which undermines the entire answer's relevance to the specific question asked. The answer would be stronger if it addressed 2023-2024 with the correct $1.45 billion figure and explicitly showed how revenue recognition changed between those two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 381,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "\nFrom 2022 through early 2023 the Mobility II Preferred Interests were treated as redeemable equity that could be put to AT&T or redeemed by the company, and because they were potentially settleable in stock they were included in the diluted‑EPS denominator (72 million shares in 2022).  In April 2023 AT&T repurchased the remaining 213 million interests (plus the earlier 105 million put) for about $5.4 billion, re‑classified the instruments as liabilities, and settled all redemption obligations; consequently, no Mobility Preferred Interests remained outstanding at the end of 2023 and there was no longer any dilutive share count to adjust EPS.  By the 2024 reporting period the former interests have been fully retired, so they no longer affect either the redemption liability or the calculation of basic or diluted earnings per share.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial correct information about the Mobility Preferred Interests evolution from 2023 to 2024, with generally accurate numbers and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the April 2023 repurchase for approximately $5.4 billion ($5,414M in ground truth), matching the original answer; (2) Accurately describes the reclassification from equity to liability; (3) Correctly notes that no Mobility Preferred Interests remained at end of 2023; (4) Properly explains the shift from dilutive EPS impact to no impact by 2024; (5) Provides additional helpful context about the 72 million shares dilutive effect in 2022 and the 213 million + 105 million interests repurchased. WEAKNESSES: (1) The original answer specifically mentions $2,670 in current liabilities and $2,670 in noncurrent liabilities recorded in 2023, which the LLM answer does not include - this is a notable omission of specific balance sheet detail; (2) The LLM answer references 2022 data (72 million shares) which extends beyond the 2023-2024 comparison explicitly requested, though this provides useful context; (3) The original answer emphasizes the retrospective accounting treatment under ASU 2020-06 more explicitly, while the LLM answer focuses more on the operational timeline. QUANTITATIVE VERIFICATION: The $5.4 billion repurchase amount is correct (matches $5,414M). The share counts (72M, 213M, 105M) appear reasonable but cannot be directly verified against the ground truth provided. MULTI-HOP REASONING: The answer successfully synthesizes information across the 2023-2024 period, correctly linking the redemption obligation evolution to EPS calculation impacts. The logic flow from active liability to fully retired status is sound and well-explained. SEMANTIC EQUIVALENCE: The answer conveys the core evolution of treatment and financial impact, though with slightly different emphasis than the ground truth (more operational detail, less accounting standard detail).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 538,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "\nIn the 2023 Form 10‑K the 0.875 % Notes due 2030 were listed on the NYSE (ticker IBM30A) and were included in the table of securities registered under Section 12(b), with the governing indenture incorporated by reference from a 2022 Form 8‑K. The 2024 filing retains that listing and registration but adds a specific reference to a February 2 2024 Form 8‑K amendment to the indenture, confirming that the notes remain listed, registered, and that the amendment is incorporated by reference.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - 2023 Status: The LLM claims the notes were 'listed on the NYSE (ticker IBM30A)' in 2023, but the ground truth explicitly states they were NOT listed in 2023 - they were only 'disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022.' This is a fundamental mischaracterization of the 2023 status. (2) DATE ERROR - The LLM references 'February 2 2024 Form 8-K amendment' but the ground truth mentions 'February 8, 2022' as the relevant Form 8-K date. The LLM appears to have confused or fabricated a 2024 date. (3) MISSING EVOLUTION - The core question asks about how treatment 'evolved' between 2023 and 2024. The ground truth clearly shows a SHIFT from 'referenced disclosure' (2023) to 'fully listed and registered' (2024). The LLM incorrectly suggests the notes were already listed in 2023, thus failing to capture the actual evolution/change that occurred. (4) INCOMPLETE SYNTHESIS - The LLM does not properly synthesize the multi-hop information showing the transition from incorporated-by-reference status to explicit listing with trading symbol. Instead, it presents a false continuity. The answer demonstrates poor multi-hop reasoning by failing to identify and explain the key difference between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 386,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "\nThe Telco LLC preferred‑equity structure was broadened in 2024.  In 2023 the company had three cumulative series – Class A‑1 (4.25 % initial distribution, reset every 7 years) and Classes A‑2/A‑3 (6.85 % initial distribution, reset on 1 Nov 2027 and every 7 years thereafter).  In 2024 AT&T issued an additional $2.25 bn of Class A‑4 preferred interests that carry a 5.94 % initial distribution, a reset on 1 Nov 2028 (and every 4 years thereafter) and a call option beginning 1 Nov 2028; the proceeds are earmarked to fund the redemption of earlier preferred securities.  \n\nThis evolution shows that AT&T is actively managing its preferred‑equity financing—adding new tranches with different rate‑reset schedules and call features to optimize cost, maintain liquidity flexibility, and support the orderly redemption of older preferred issues while still preserving unrestricted access to dividends and share‑repurchaseauthorities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces significant factual inaccuracies not present in the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims AT&T issued an additional $2.25 billion of Class A-4 preferred interests in 2024, but the ground truth makes no mention of Class A-4 interests or any new issuance in 2024. The ground truth explicitly states the total remained at $7,250 (consisting of $2,000 Class A-1 and $5,250 Class A-2/A-3). The LLM's introduction of a $2.25bn Class A-4 tranche is entirely fabricated. (2) STRUCTURAL DETAILS: The LLM provides specific reset dates (1 Nov 2027, 1 Nov 2028) and reset frequencies (every 4 years for Class A-4) that are not mentioned in the ground truth. The ground truth only states 'reset every seven years' for both existing classes. (3) MISSING INFORMATION: The LLM completely omits the key 2024 clarification mentioned in the ground truth—that failure to pay distributions would not restrict cash movements or AT&T's ability to pay dividends or repurchase shares. This is a material disclosure change. (4) MULTI-HOP REASONING: While the LLM's reasoning about preferred equity financing strategy is logically sound, it is built on false premises (the non-existent Class A-4 issuance). The answer conflates speculation about AT&T's financing approach with fabricated facts. (5) SEMANTIC ISSUES: The LLM correctly identifies the 2023 structure but then diverges into entirely unsupported claims about 2024 activity. The answer reads plausibly but contains material factual errors that would mislead readers about AT&T's actual financing activities. The ground truth indicates stability in the preferred structure from 2023 to 2024, while the LLM suggests significant expansion—a fundamental mischaracterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 482,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "\nBetween 2022 and 2023 Capital One continued to originate multifamily commercial‑real‑estate loans that it sells to government‑sponsored enterprises under loss‑sharing agreements.  The liability recorded for these loss‑sharing arrangements rose from **$82 million (2022) to $137 million (2023)**, reflecting a larger pool of originated loans and therefore greater risk exposure.  Moreover, since 2020 the company has applied the **fair‑value option** to new loss‑sharing agreements, so unrealized gains and losses are now recognized in non‑interest income rather than being amortized, which makes the risk exposure more visible in the financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with all key numbers correct: $82 million (2022) and $137 million (2023) liability amounts match the ground truth exactly. The multi-hop synthesis is sound, correctly identifying Capital One's continued involvement in multifamily commercial real estate loans sold to GSEs under loss-sharing agreements, and accurately capturing the increase in risk exposure reflected by the rising liability. The answer correctly identifies the entities (Capital One, GSEs) and time periods (2022-2023). The quantitative accuracy is perfect with no calculation errors. The qualitative reasoning is strong, explaining the relationship between loan origination volume and risk exposure. However, the LLM answer goes beyond the ground truth by introducing additional information about the fair-value option applied since 2020 and how it affects financial statement presentation. While this information appears contextually relevant and likely accurate based on typical accounting practices, it was not present in the original ground truth answer. This represents a minor expansion beyond what was explicitly confirmed in the knowledge graph. The core answer directly addresses the question about evolution of involvement and risk exposure, with proper synthesis of the multi-hop elements (comparing two years, identifying the liability metric, and explaining the trend). The wording differs from ground truth but conveys equivalent meaning and understanding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 412,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "\nFrom the 2022 filing Amazon treated its co‑branded credit‑card partnerships as a modest but growing revenue stream that reinforced the attractiveness of its ecosystem, and it disclosed only the ordinary payment‑processor fees and standard consumer‑protection compliance that such programs entail. In contrast, the 2023 10‑K notes that the strategic importance of these programs has risen sharply while the regulatory landscape has tightened—new mandates for enhanced authentication, stricter data‑security and privacy rules, and heightened antitrust/consumer‑protection scrutiny now impose additional compliance costs and create a real risk of termination or renewal on less‑favorable terms. Consequently, the company warns that any deterioration in the economics of these agreements or failure to meet the expanded compliance obligations could lower interchange‑fee income and increase operating expenses, directly pressuring future operating results.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core shift in strategic significance from 2022 to 2023, recognizing that co-branded credit card programs became more strategically important and faced expanded regulatory obligations. It accurately captures the general themes of increased compliance costs, risks of termination or unfavorable renewal terms, and potential impact on operating results. The answer appropriately synthesizes the multi-hop comparison across years and identifies the key regulatory evolution.\n\nWEAKNESSES: (1) The LLM answer introduces specific regulatory details (enhanced authentication, antitrust/consumer-protection scrutiny) that are NOT mentioned in the ground truth answer. While these may be plausible regulatory concerns, they represent additions beyond what the knowledge graph confirms, which violates the principle of strict adherence to ground truth. (2) The LLM mentions 'interchange-fee income' as a specific financial metric affected, which is not explicitly stated in the ground truth answer. (3) The characterization of 2022 compliance as 'ordinary' and 'standard' is somewhat reductive compared to the ground truth's specific mention of 'payment card association rules such as data security and certification requirements.' (4) The LLM does not explicitly highlight the specific new compliance obligation mentioned in ground truth: data localization rules, which were not present in 2022 disclosures.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop reasoning by comparing 2022 and 2023 filings and synthesizing the evolution of regulatory risks. However, it adds inferences not grounded in the provided knowledge graph.\n\nNUMERIC/QUANTITATIVE: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy is not directly testable. Both answers appropriately avoid making unsupported numerical claims.\n\nSEMANTIC EQUIVALENCE: While the LLM captures the general thrust of the answer, it diverges from ground truth by introducing regulatory specifics not confirmed in the knowledge graph and by omitting the explicit mention of data localization rules as a key new compliance obligation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 586,
        "total_tokens": 2091
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "\nSince the March 2019 deconsolidation of Rothmans, Benson & Hedges Inc. (RBH), the company has not been consolidated in PMI’s financial statements; by 2022 it was carried as an equity security without a readily determinable fair value, and in 2024 PMI performed an impairment review that concluded the investment was impaired, resulting in a $2.3 billion non‑cash charge that reduced the carrying amount to an estimated fair value of $714 million.  The 2024 valuation relied on a discounted‑cash‑flow model and assumptions about the allocation of global settlement amounts and tax deductibility, introducing significant judgment into the fair‑value estimate.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a structured narrative about RBH's evolution from deconsolidation through equity investment to impairment, but contains significant quantitative errors that undermine its accuracy. STRENGTHS: (1) Correctly identifies March 2019 deconsolidation date; (2) Accurately describes the shift from deconsolidated subsidiary to equity investment requiring impairment analysis; (3) Properly identifies the use of DCF model and judgment around global settlement assumptions; (4) Correctly notes the equity security classification in 2022 without readily determinable fair value. CRITICAL ERRORS: (1) The LLM states a '$2.3 billion non-cash charge' and 'fair value of $714 million' - these specific numbers are NOT verified in the ground truth and appear to be fabricated or from a different source. The ground truth does not provide these exact figures; (2) The ground truth mentions 'CAD 3.1 billion allocation of compensatory damages against RBH' from Canadian tobacco litigation, which the LLM completely omits - this is a material omission regarding potential impacts on PM's financial relationship with RBH. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across 2022-2024 and connects deconsolidation status to valuation considerations. However, the introduction of unverified specific dollar amounts ($2.3B charge, $714M fair value) suggests either hallucination or reliance on information not in the ground truth. The ground truth emphasizes 'significant judgment' around fair value estimates but does not confirm the specific impairment charge amount. SEMANTIC ISSUES: While the narrative structure is sound, the quantitative specificity without ground truth support is problematic in a financial context where precision is critical. The answer reads authoritatively but the numbers cannot be verified against the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 508,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "\nIn 2023 Baqsimi produced $677.6 million of total revenue—up from only $139.3 million in 2022—largely because Lilly recognized a $579 million one‑time gain from the sale of its rights and modest ongoing sales; however, by the 2024 reporting period that figure represented just a small slice of Lilly’s $45 billion consolidated revenue, underscoring a strategic pivot away from Baqsimi as a growth driver toward higher‑volume, higher‑margin franchises such as Mounjaro, Jardiance and Verzenio.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES WITH QUANTITATIVE ACCURACY: The LLM answer contains a critical factual error regarding the 2022 revenue figure. The LLM states Baqsimi produced '$677.6 million of total revenue—up from only $139.3 million in 2022,' but the ground truth does not mention or validate a 2022 figure of $139.3 million. This appears to be an unsupported claim that introduces false data. The 2023 figure of $677.6 million is correct and matches the ground truth exactly. However, the LLM's interpretation of the revenue composition is problematic: it attributes the increase to 'a $579 million one-time gain from the sale of its rights and modest ongoing sales,' but the ground truth clearly states that in 2023, Baqsimi contributed $677.6 million in direct product revenue ($645.7M U.S. + $31.9M international), not that this figure includes a one-time gain. The one-time gain appears to be a separate accounting item, not part of the $677.6 million product revenue figure. MULTI-HOP REASONING ISSUES: The LLM correctly identifies the strategic pivot away from Baqsimi by 2024 and mentions the shift to other franchises (Mounjaro, Jardiance, Verzenio), which aligns with the ground truth's statement about divestment. However, the reasoning about why revenue changed is flawed due to the mischaracterization of the revenue composition. COMPLETENESS: The LLM addresses the 2023-2024 evolution and strategic positioning but misrepresents the nature of the 2023 revenue. The ground truth emphasizes that Baqsimi transitioned from direct product sales to being part of collaboration/divestment arrangements, which the LLM touches on but doesn't clearly articulate. SEMANTIC ISSUES: The phrase 'that figure represented just a small slice of Lilly's $45 billion consolidated revenue' is contextually odd since the question asks about Baqsimi's evolution, not its proportion of total company revenue. This adds unnecessary information that doesn't directly address the core question about Baqsimi's role evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 538,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "\nFrom 2022 to 2024 the container portion of Union Pacific’s highway‑revenue equipment became almost entirely owned – owned containers rose from 48,962 (≈96 % of the 50,818 total) with only 1,856 leased, to 46,375 owned and just 288 leased (≈99.4 % owned), shifting the owned‑to‑leased ratio from roughly 26 : 1 to about 161 : 1.  The chassis fleet also moved toward greater ownership, with owned units increasing from 29,875 (≈68 % of the 44,023 total) and 14,148 leased to 4,356 owned and 1,197 leased (≈78 % owned), cutting the leased share from roughly one‑third to about one‑five and improving the owned‑to‑leased ratio from ~2.1 : 1 to ~3.6 : 1.  Overall, both container and chassis equipment became markedly more heavily owned between 2022 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth data. Critical issues: (1) OWNED CONTAINERS: LLM claims owned containers rose from 48,962 to 46,375, but ground truth shows they decreased from approximately 76,981 (78,837 total - 1,856 leased) to 50,443 (50,731 total - 288 leased). The LLM's numbers are internally inconsistent and directionally wrong. (2) LEASED CONTAINERS: LLM correctly identifies the decrease from 1,856 to 288, which matches ground truth. (3) OWNED CHASSIS: LLM claims owned chassis increased from 29,875 to 4,356, but this is a DECREASE, not an increase. The LLM explicitly states 'moved toward greater ownership' and 'owned units increasing' when the data shows the opposite trend. (4) LEASED CHASSIS: LLM states leased chassis decreased from 14,148 to 1,197, which aligns with ground truth showing a decrease from approximately 14,148 to 1,197. (5) RATIO CALCULATIONS: The LLM's ratio calculations (26:1 to 161:1 for containers, 2.1:1 to 3.6:1 for chassis) are based on incorrect underlying numbers and therefore unreliable. (6) OVERALL NARRATIVE: The ground truth indicates a strategic shift toward owning fewer assets overall (total owned dropped from 78,837 to 50,731), while the LLM incorrectly characterizes this as a shift toward greater ownership. The LLM fundamentally misunderstood the direction of change in the data, particularly for chassis, which is a major error in a multi-hop synthesis question. The answer demonstrates poor data verification and contradicts the ground truth on multiple critical points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 434,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 Capital One’s securitized‑debt balance rose from about **$16.97 billion to $18.04 billion** – an increase of roughly **$1 billion** driven by net new issuances in its securitization programs (see Table 16.6, “Securitized debt obligations” carrying values).  This modest growth added to the firm’s overall funding mix, but securitized debt still represents only **≈4‑5 %** of total funding, serving as a supplemental source that complements deposit growth and other debt issuances within Capital One’s broader funding structure.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key quantitative evolution - securitized debt obligations increased from approximately $16.97 billion to $18.043 billion (matching ground truth's $18.043 billion figure for 2023). The calculation of roughly $1 billion increase is accurate. The answer appropriately references Table 16.6 and correctly characterizes securitized debt as a supplemental funding source representing 4-5% of total funding. WEAKNESSES: The LLM answer focuses primarily on quantitative changes and growth drivers (net new issuances) but largely omits the qualitative evolution highlighted in the ground truth - specifically the shift in fair value hierarchy classification to Level 2 in 2023, which indicates a meaningful change in valuation methodology and suggests a more structured approach. The ground truth emphasizes this classification shift as evidence of 'a more structured and possibly less volatile role,' which represents an important qualitative evolution that the LLM answer does not address. MULTI-HOP REASONING: The answer successfully synthesizes information about Capital One's funding structure across years, correctly positioning securitized debt within the broader funding mix. However, it misses the fair value hierarchy dimension that would have provided fuller context about the evolution. CONTEXTUAL RELEVANCE: While the answer addresses the quantitative evolution well, it incompletely addresses the 'particularly in terms of their role within the company's overall funding structure' aspect by not discussing the fair value classification change and its implications for how these obligations are managed and valued.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 456,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the revenue stream from Zyprexa shifted from ongoing product sales to a one‑time gain on the sale of the olanzapine portfolio rights. In 2023 the $79.4 million Zyprexa amount reflected the recognition of the rights‑sale proceeds (recorded in “collaboration and other revenue” under Note 4), whereas prior years it had been reported as regular net product revenue from drug sales; by 2024 there is no continuing Zyprexa product revenue, so the only Zyprexa‑related proceeds are the 2023 one‑off gain.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth. Key issues: (1) QUANTITATIVE ERROR: The LLM cites a specific $79.4 million figure for 2023 Zyprexa revenue, but the ground truth does not mention this specific number. This appears to be fabricated or misattributed data. (2) FUNDAMENTAL MISCHARACTERIZATION: The LLM incorrectly describes the 2023 revenue as a 'one-time gain on the sale of the olanzapine portfolio rights' and states this was 'recorded in collaboration and other revenue under Note 4.' However, the ground truth clearly states that in 2023, Zyprexa revenue was 'primarily derived from the sale of the rights for the olanzapine portfolio' - meaning the 2023 transaction itself was the sale. The LLM then confuses this by saying the 2024 revenue 'stemmed from the 2023 sale of rights' - which is correct per ground truth, but the LLM's characterization of 2023 as containing 'one-time gain' proceeds is misleading. (3) INCOMPLETE SYNTHESIS: The ground truth indicates that by 2024, revenue was 'recognized as part of collaboration and other arrangements' and 'included in collaboration revenue rather than product sales.' The LLM states there is 'no continuing Zyprexa product revenue' in 2024, which aligns with the shift away from product sales, but fails to clearly articulate that 2024 revenue was collaboration revenue (not a one-time gain). (4) LOGICAL INCONSISTENCY: The LLM's statement that 2023 reflected 'recognition of the rights-sale proceeds' while also being a 'one-time gain' is confusing and doesn't clearly distinguish between the transaction itself (2023 sale) and how it was recognized in subsequent periods. The ground truth makes clear that 2024 revenue came from the 2023 sale arrangement, recognized as collaboration revenue. The LLM answer conflates these concepts and introduces unsupported numerical data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 511,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "\nFrom 2022 through 2024 the plan continued to value Federal Government Securities by a bid‑evaluation process using independent pricing sources, and they remained classified as Level 2 fair‑value measurements.  The only change was the size of the exposure – the fair‑value amount fell from roughly $742 million (reported in the 2021/2022 tables) to about $150 million (reported in the 2024 table) – reflecting a strategic shift toward a larger target debt allocation (70‑80 % of assets) while the valuation methodology and hierarchy level stayed the same.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and provides accurate information about the evolution of Federal Government Securities valuation from 2022 to 2024. STRENGTHS: (1) Correctly identifies the valuation methodology as bid-evaluation process using independent pricing sources; (2) Accurately states the Level 2 classification remained consistent across both years; (3) Correctly cites the 2022 valuation of approximately $742 million; (4) Provides additional context about the 2024 valuation declining to about $150 million; (5) Adds relevant strategic context about the 70-80% target debt allocation. QUANTITATIVE ACCURACY: The numbers are accurate - $742 million for 2022 and $150 million for 2024 are correctly stated. The percentage range (70-80%) appears reasonable for context. MINOR DISCREPANCY: The ground truth states the company 'clarified' and 'adds specificity in methodology explanation' in 2024, suggesting the bid-evaluation process description may have been more explicitly detailed in 2024 filings rather than being continuous from 2022. The LLM answer states the process was used 'from 2022 through 2024' which could imply it was equally explicit in both periods, though this is a subtle distinction. The LLM answer goes beyond the ground truth by explaining the strategic rationale for the valuation change (shift toward larger debt allocation), which is contextually relevant but not explicitly confirmed in the ground truth statement. MULTI-HOP REASONING: The answer correctly synthesizes information across years and connects the valuation methodology, classification level, and quantitative changes. The logic linking the valuation decline to strategic asset allocation is sound. Overall, this is a high-quality answer that accurately addresses the core question with appropriate detail and context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 495,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "\nFrom 2022 to 2023 Capital One moved from a peripheral reference to credit‑score data to an explicit, systematic use of those scores for product segmentation.  The 2022 filing only notes that scores are “used … in some cases to drive product segmentation decisions,” whereas the 2023 filing expands the description, highlights refreshed monthly FICO data, and shows a more detailed score distribution (e.g., a higher share of >660 scores for auto loans and a slightly lower share of >660 scores for credit‑card loans).  This evolution signals that the firm is integrating granular, up‑to‑date credit‑score information into its risk‑based pricing and portfolio‑design models, using scores not just for subprime classification but as a core driver of how it segments products and tailors offerings to distinct credit‑risk groups.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. CRITICAL ERRORS: (1) The LLM claims the 2022 filing only notes scores are 'used in some cases' while the 2023 filing 'expands the description' - this contradicts the ground truth which shows both years used credit score data for product segmentation, with the key difference being the DATA PERIOD USED (2020-2021 in 2022 vs 2022-2023 in 2023), not the extent of usage description. (2) The LLM references 'refreshed monthly FICO data' and 'higher share of >660 scores for auto loans' and 'slightly lower share of >660 scores for credit-card loans' - these specific metrics and percentages are NOT mentioned in the ground truth and appear to be fabricated details. (3) The ground truth explicitly states the evolution was about updating from 2020-2021 credit score distributions to 2022-2023 distributions (Table 21), indicating more current data usage. The LLM mischaracterizes this as a shift from 'peripheral reference' to 'explicit systematic use' rather than a data refresh. CORRECT ELEMENTS: The LLM correctly identifies Capital One as the company, correctly notes the 2022-2023 timeframe, and correctly concludes the strategy indicates more current/dynamic risk modeling. However, the reasoning pathway and specific supporting details are largely incorrect or fabricated. The answer demonstrates partial understanding of the evolution but fundamentally misrepresents the nature of the change and introduces unsupported quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 420,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "\nFrom 2022 to 2023 Amazon’s view of AWS shifted from a key component of its broader “technology and content” investment—used to fund the infrastructure that powers its retail and fulfillment operations—to a distinct business segment that the company explicitly treats as a primary growth engine.  Accordingly, capital‑expenditure priorities moved toward expanding AWS’s cloud‑service portfolio (e.g., AI/ML, analytics, and additional data‑center capacity) and scaling its infrastructure, positioning AWS as a central driver of revenue diversification and cross‑segment synergies.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AWS's strategic evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the shift from AWS as a 'key component of broader technology and content investment' to a 'distinct business segment,' matching the ground truth's core narrative. (2) Accurately captures the transformation from supporting internal operations to becoming a 'primary growth engine' and 'central driver of revenue diversification.' (3) Appropriately mentions specific AWS service categories (AI/ML, analytics, compute, storage, database) that align with ground truth. (4) No quantitative errors—no specific numbers are provided, which is appropriate given the question's qualitative nature. (5) Multi-hop reasoning is sound: correctly synthesizes the 2022-to-2023 comparison across strategic positioning and investment priorities. MINOR WEAKNESSES: (1) The LLM answer emphasizes 'revenue diversification and cross-segment synergies' which, while reasonable inferences, are not explicitly stated in the ground truth. The ground truth focuses more on AWS becoming 'a distinct and central pillar of Amazon's business model' and being positioned alongside North America and International as one of three core segments. (2) The phrase 'infrastructure that powers its retail and fulfillment operations' adds interpretive context not explicitly in the ground truth, though it's a reasonable characterization. (3) The ground truth explicitly mentions AWS as one of 'three core business segments' alongside North America and International—the LLM answer doesn't explicitly state this structural reorganization, though it implies it through 'distinct business segment.' Overall, the answer captures the essential evolution accurately with sound reasoning, though it adds some interpretive elements beyond what the ground truth explicitly states.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 505,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "\nBetween 2022 and 2024 PMI’s accounting treatment of Rothmans, Benson & Hedges Inc. shifted from full consolidation (prior to 2019) to de‑consolidation, with the remaining exposure now reflected only in PMI’s equity investment and related hedging activities; the 2022 10‑K notes that RBH’s financial results were de‑consolidated as of 22 Mar 2019, and the 2024 10‑K records the equity investment in RBH at a reduced carrying amount after a $2.3 bn non‑cash impairment charge (see Note 6 and the $27 m of derivative gains that may be re‑classified to earnings).  Consequently, PMI’s potential financial exposure to RBH is now limited to the carrying value of that equity stake, the possible re‑classification of hedging gains/losses in accumulated other‑comprehensive losses, and contingent liabilities arising from the ongoing CCAA proceedings and the proposed CAD 32.5 bn settlement, which could materially affect PMI’s results if realized.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of PMI's relationship with RBH from consolidation to deconsolidation to equity investment treatment. It accurately cites the $2.3 billion impairment charge (ground truth: $2,316 million), the CAD 32.5 billion settlement proposal, and mentions relevant accounting considerations like hedging activities and accumulated other comprehensive losses. The answer demonstrates sound multi-hop reasoning by synthesizing information across 2022 and 2024 filings and connecting the CCAA restructuring to accounting treatment changes.\n\nWEAKNESSES: (1) CRITICAL DATE ERROR: The LLM states RBH was deconsolidated 'as of 22 Mar 2019' but the ground truth indicates deconsolidation occurred in 2022 due to CCAA restructuring. This is a significant factual error regarding when the deconsolidation happened. (2) INCOMPLETE CONTEXT: The LLM mentions deconsolidation occurred but doesn't clearly explain it was specifically due to the 2022 CCAA restructuring, which is a key causal factor in the evolution. (3) MISSING DETAIL: The ground truth notes there was a 'comprehensive stay of Canadian tobacco litigation until March 31, 2022' and 'no loss accruals were made due to inability to estimate potential losses' in 2022 - the LLM doesn't address this important 2022 context. (4) IMPAIRMENT CHARGE PRECISION: The LLM rounds to '$2.3 bn' while ground truth specifies '$2,316 million' - while semantically equivalent, the rounding loses precision on a key metric.\n\nMULTI-HOP REASONING: The answer correctly synthesizes the relationship evolution across years and connects the CCAA proceedings to the settlement proposal to the impairment charge. However, the timeline confusion (2019 vs 2022 deconsolidation) undermines the accuracy of the multi-hop synthesis.\n\nQUANTITATIVE ISSUES: The $2.3 billion figure is acceptable as a rounded version of $2,316 million, but the 2019 date for deconsolidation is factually incorrect per the ground truth which clearly states 2022 as the deconsolidation year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 551,
        "total_tokens": 2038
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Biktarvy’s sales grew from about **$8.6 billion** to roughly **$9.8 billion**, making it Gilead’s single largest product and accounting for **≈30 % of total revenue** (and roughly one‑third of total product sales) by the end of 2024.  At the same time, its commercial outlook is exposed to heightened risk: looming **generic competition**, aggressive **price‑cutting and rebate pressures** from Medicare‑negotiation and the Inflation‑Reduction Act, and the possibility of **market‑share erosion** as HIV treatment paradigms shift toward newer regimens and alternative therapies.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fabricated financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims Biktarvy revenue grew from $8.6B in 2022 to $9.8B in 2024, but the ground truth explicitly states 'By 2024, while specific revenue figures are not provided.' The LLM has invented a 2024 revenue figure ($9.8B) that does not exist in the source documents. The 2022 figure of $8.624B is correct, but the 2024 figure is completely fabricated. (2) PERCENTAGE CLAIMS: The LLM states Biktarvy accounts for '≈30% of total revenue' and 'roughly one-third of total product sales' by 2024, but these percentages are not supported by the ground truth and appear to be calculated from the invented $9.8B figure. (3) MULTI-HOP REASONING: While the LLM correctly identifies risk factors (generic competition, price-cutting, rebate pressures, market-share erosion, paradigm shifts), it fails at the core multi-hop synthesis task by inventing data rather than acknowledging the absence of 2024-specific revenue figures. (4) SEMANTIC ACCURACY: The qualitative risk discussion aligns with ground truth themes, but this cannot compensate for the fundamental factual errors in the quantitative claims. (5) GROUND TRUTH ALIGNMENT: The original answer correctly notes that 2024 revenue figures are not provided and focuses on risk disclosures instead. The LLM should have followed this approach rather than fabricating numbers. This is a severe failure in factual accuracy that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 425,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "\nFrom 2022 through 2024 Union Pacific’s equity stake in TTX grew modestly – the carrying value of its investment rose from about **$1.6 billion** (reported for 2021) to **$1.9 billion** by the end of 2024, reflecting the slight increase in ownership share (≈36.8 % to ≈37 %).  At the same time, the amount it pays TTX for rail‑car rentals (car‑hire expense) has risen steadily – $375 million in 2021, $402 million in 2022, $399 million in 2023 and **$432 million in 2024** – showing a growing operational reliance on TTX’s pooled rail‑car fleet.  Thus, both the financial investment and the car‑hire costs have expanded over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive coverage of the question. QUANTITATIVE VERIFICATION: All key numbers are correct - investment value of $1.6 billion (2021) and $1.9 billion (2024) match ground truth exactly; car hire expenses of $375 million (2021) and $432 million (2024) are accurate. The LLM additionally provides intermediate year data ($402M in 2022, $399M in 2023) which, while not in the ground truth answer, represents a more complete picture and does not contradict the provided information. The ownership percentage references (≈36.8% to ≈37%) add useful context. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and metrics - combining investment value trends with operational expense trends to demonstrate growing financial and operational involvement. The logic is sound: both metrics increased over the period, supporting the conclusion of expanded relationship. COMPLETENESS: The answer addresses all aspects of the question - financial stake evolution, operational relationship evolution, investment value, and car hire expenses. The 2022-2024 timeframe is properly contextualized with 2021 baseline data. ENTITY ACCURACY: Union Pacific Railroad (UPRR) and TTX are correctly identified; fiscal years are accurate; financial metrics (equity stake/carrying value, car-hire expense) are properly labeled. SEMANTIC EQUIVALENCE: The answer conveys the same information as ground truth with enhanced detail and clarity. The phrase 'carrying value of its investment' is semantically equivalent to 'financial stake.' Minor note: The LLM provides more granular year-by-year data than the ground truth answer, which strengthens rather than weakens the response. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 480,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla moved Solar‑Roof scaling from a pilot‑phase of onboarding new installers and partnering with builders toward a formalized training pipeline that expands certification programs and enlarges the pool of certified electricians to meet higher deployment volumes.  At the same time, its supply‑chain risk management shifted from relying mainly on external battery‑cell suppliers to building internal cell production capacity, diversifying suppliers and maintaining larger inventory buffers and raw‑material contracts to blunt the impact of component shortages on Solar‑Roof output.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) MAJOR ERRORS: The LLM introduces information about 'internal cell production capacity' and 'battery-cell suppliers' which is NOT mentioned in the ground truth and appears to conflate Solar Roof strategy with Tesla's broader battery/energy business. The ground truth makes no mention of battery cells or internal cell production in the context of Solar Roof scaling. (2) PARTIAL ACCURACY: The LLM correctly identifies that 2022 involved 'onboarding new installers' and that there was a shift toward supply chain management by 2023. However, it mischaracterizes the nature of this shift. (3) MISSING KEY ELEMENTS: The ground truth emphasizes that 2022 focused on 'reducing installation time and costs' and 'hiring skilled electricians,' while 2023 shifted to 'managing supplier reliability, global component constraints, and cost-effective manufacturing.' The LLM mentions 'certified electricians' but frames it as expansion rather than addressing the core shift in strategy. (4) MISREPRESENTATION: The ground truth indicates a shift from 'installer-focused growth' to 'risk-averse strategy centered on supply chain resilience.' The LLM frames this as a natural progression from pilot to formalized training, missing the critical insight that the company became more cautious about production ramp delays. (5) QUANTITATIVE ISSUES: No specific numbers are provided in either answer, but the LLM introduces concepts (battery cells, internal production) that are factually incorrect for Solar Roof context. The answer demonstrates a fundamental misunderstanding of what changed between 2022 and 2023 in Tesla's Solar Roof strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 472,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "\nBetween 2022 and 2023 the Company’s U.S. fountain‑syrup model was unchanged: it continues to be the sole manufacturer of the syrups and sells them directly to fountain retailers (or to authorized fountain wholesalers who then supply the retailers).  The 2023 filing simply re‑classifies these sales under the North America operating segment, but the underlying relationship—no bottling partner is authorized to produce fountain syrups in the United States—remains the same as described for 2022.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that between 2022 and 2023, there WAS an evolution in the relationship: in 2023, the Company 'explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers,' representing 'a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023.' The LLM answer incorrectly claims the model was 'unchanged' and that 'no bottling partner is authorized to produce fountain syrups in the United States' remains the same. This directly contradicts the ground truth's key finding about the 2023 clarification regarding bottling partners' role in distribution. The LLM appears to have conflated two distinct points: (1) bottlers are not authorized to MANUFACTURE fountain syrups (which remained true), and (2) bottling partners' role in DISTRIBUTION (which was clarified/expanded in 2023). The LLM's claim that the 2023 filing merely 're-classifies these sales under the North America operating segment' misses the substantive change in how the distribution network was described. The quantitative accuracy is high (no numbers to verify, dates are correct), but the qualitative accuracy is severely compromised by misidentifying the nature of the evolution between years. The answer fails to capture the multi-hop synthesis required: comparing 2022 statements to 2023 statements to identify the specific evolution in acknowledged distribution roles.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 440,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "\nIn the 2022 filing (pages 28‑32) IBM disclosed the 0.950 % Notes due 2025 as a registered debt security (ticker IBM25B) under the Securities Act of 1933, merely noting its registration without extensive classification language. The 2024 Form 10‑K (pages 1‑5) continues to list the same instrument in the securities table, identifying it as a “0.950 % Notes due 2025 (IBM25B)” on the NYSE, confirming that its financial‑instrument classification has remained unchanged—only the presentation of the registration details has been updated to the standard 10‑K securities table.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant issues when compared to the ground truth: (1) FACTUAL ERRORS: The LLM claims the 2022 filing is on 'pages 28-32' and the 2024 Form 10-K is on 'pages 1-5', but provides no verification these page numbers are accurate or relevant to the specific disclosure. The ground truth references specific Form 8-K filing dates (May 22, 2017 for Exhibit 4.1) which the LLM does not mention. (2) INCOMPLETE SYNTHESIS: The ground truth emphasizes an evolution from 'merely disclosing the instrument' in 2022 to 'formally registering and listing it for trading' by 2024, representing a meaningful shift in treatment. The LLM instead claims 'financial-instrument classification has remained unchanged' and that 'only the presentation of the registration details has been updated.' This directly contradicts the ground truth's core finding about the evolution. (3) MISSING KEY DETAILS: The LLM fails to reference the Form 8-K filing context or the May 22, 2017 Exhibit 4.1 reference that appears in the ground truth. The ground truth emphasizes a shift from exhibit disclosure to active NYSE listing, but the LLM presents this as static/unchanged. (4) MISCHARACTERIZATION: The LLM states the instrument was 'merely noting its registration without extensive classification language' in 2022, but the ground truth indicates it was disclosed as part of exhibits without formal listing, then later formally registered and listed—a different narrative. (5) CORRECT ELEMENTS: The LLM correctly identifies the instrument name (0.950% Notes due 2025), ticker (IBM25B), exchange (NYSE), and that it appears in both 2022 and 2024 filings. However, these correct elements are embedded in an incorrect overall narrative about the evolution. The answer fails to capture the fundamental shift from disclosure to registration/listing that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 506,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "\nFrom 2022 through 2024 Gilead has treated Biktarvy as a cash‑generating anchor, using the strong operating cash flow it produces (e.g., $11.4 bn of cash from operations in 2021 and comparable levels in the 2024 filing) to fund dividends, share‑repurchases and R&D while keeping new debt to a minimum, thereby lowering its reliance on external financing and reducing revenue‑concentration risk.  At the same time, Biktarvy’s once‑daily single‑tablet regimen, high resistance barrier and favorable renal‑safety profile give it a distinct clinical and commercial edge that lets Gilead sustain pricing power and market share against generic and competing HIV regimens, reinforcing its competitive differentiation in the HIV treatment market.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer fundamentally misaligns with the ground truth on the core evolution of GILD's strategic positioning of Biktarvy from 2022 to 2024. CRITICAL ERRORS: (1) The LLM portrays Biktarvy's strategic position as STRENGTHENING (emphasizing sustained pricing power, competitive differentiation, and cash generation), while the ground truth indicates it WEAKENED (highlighting increasing financial risk, concerns about long-term competitive differentiation, and vulnerability to paradigm shifts). (2) The LLM cites '$11.4 bn of cash from operations in 2021' as evidence of Biktarvy's cash-generating strength, but this number is from 2021 (outside the 2022-2024 timeframe) and doesn't directly support the claim about Biktarvy specifically. The ground truth makes no such quantitative claims about cash flow. (3) The LLM emphasizes clinical advantages (once-daily regimen, resistance barrier, renal safety) as reasons for sustained competitive differentiation, but the ground truth explicitly states growing concern over Biktarvy's 'ability to sustain revenue' and 'long-term competitive differentiation' in face of generic competition and changing therapeutic preferences. (4) The LLM completely misses the key evolution highlighted in ground truth: the shift in HIV treatment paradigms AWAY from TAF-based regimens (which Biktarvy uses), representing a fundamental threat to its market position. The LLM's narrative of sustained competitive advantage directly contradicts the ground truth's narrative of increasing vulnerability. MULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution (2022 vs 2024) correctly, instead presenting a static positive view rather than capturing the deteriorating strategic position. The answer addresses the right company and product but reaches opposite conclusions about risk exposure and competitive positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 505,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Lockheed Martin accelerated its shift from a qualified defined‑benefit pension regime to an enhanced defined‑contribution retirement savings plan by completing two large annuity‑driven obligation transfers—$4.3 billion of defined‑benefit liabilities were off‑loaded in Q2 2022 (which generated a $1.5 billion non‑cash settlement charge) and a $414 million lump‑sum settlement in 2023—thereby cutting accrued pension liabilities and the balance in accumulated other‑comprehensive loss and eliminating future funding obligations.  These moves reduced the company’s long‑term pension cash‑flow risk and allowed it to rely on the defined‑contribution plan (with matching contributions) as the primary retirement vehicle for employees, while the settlement charges were recorded as non‑operating pension expenses that impacted earnings and AOCL.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key financial figures ($4.3 billion transfer in 2022, $1.5 billion noncash settlement charge, $414 million in 2023), the timing (Q2 2022 for the annuity purchase), and the general strategic shift from defined benefit to defined contribution plans. The numbers are accurate and properly formatted.\n\nWEAKNESSES: (1) CRITICAL FACTUAL ERROR - The LLM describes the 2023 action as 'a $414 million lump-sum settlement' that was part of 'two large annuity-driven obligation transfers,' implying both 2022 and 2023 involved annuity purchases. The ground truth explicitly states that in 2023, instead of another annuity purchase, the company made direct settlement payments to former employees. This is a fundamental mischaracterization of the strategic evolution. (2) MISSING CONTEXT - The LLM fails to mention that the 2023 payments were made to approximately 6,500 former employees who had not yet started receiving benefits, which is important context for understanding the shift in approach. (3) INCOMPLETE SYNTHESIS - While the LLM mentions the shift from defined benefit to defined contribution, it doesn't clearly articulate the key distinction: 2022 involved transferring large blocks to insurers via annuity contracts, while 2023 involved direct settlement with individual participants. This is the core of the 'evolution' the question asks about. (4) SPECULATIVE LANGUAGE - The LLM adds interpretive language about 'cutting accrued pension liabilities,' 'balance in accumulated other-comprehensive loss,' and 'eliminating future funding obligations' that, while potentially accurate, goes beyond what the ground truth explicitly states and could be considered inference rather than fact from the filing.\n\nMULTI-HOP REASONING: The LLM attempts to synthesize information across 2022 and 2023, but the synthesis is flawed because it mischaracterizes the nature of the 2023 transaction. The comparison between years is incomplete and inaccurate.\n\nNUMERIC VERIFICATION: All dollar amounts are correct ($4.3B, $1.5B, $414M), and the timing reference (Q2 2022) is accurate. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 576,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "\nBetween 2022 and 2024 the set of securities that mature in 2025 stayed the same – the 2.875 % Notes (IB 25A), the 0.950 % Notes (IB 25B) and the 7.00 % Debentures (IB 25) – but the smaller‑size 0.300 % Notes that also matured in 2022 were dropped and replaced by a 0.300 % issue due in 2026. Consequently, the 2.875 % Notes remain the largest‑percentage component of IBM’s 2025‑maturing debt, while the overall mix shifted toward a higher relative weight for that series after the 0.300 % 2025 tranche was removed.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT SECURITIES LISTED: The LLM claims the 7.00% Debentures (IB 25) were part of the 2025-maturing debt, but the ground truth makes no mention of this security. The ground truth specifically lists 0.950% Notes (IBM 25B) and 0.875% Notes (IBM 25C) as the other 2025 instruments alongside the 2.875% Notes. (2) MISSING KEY INFORMATION: The LLM fails to mention the 0.875% Notes due 2025 (IBM 25C), which according to the ground truth was present in 2022 but no longer listed in 2024 - this is a critical evolution in debt composition that the question specifically asks about. (3) INCORRECT DEBT CHANGES: The LLM discusses a 0.300% Notes issue being dropped and replaced with a 2026 maturity, but the ground truth makes no mention of any 0.300% Notes at all. This appears to be fabricated information. (4) MISIDENTIFICATION OF TICKER SYMBOLS: The LLM uses 'IB' as shorthand for IBM securities, while the ground truth uses 'IBM' (e.g., IBM 25A vs IB 25A). While minor, this suggests imprecision. (5) INCOMPLETE ANALYSIS: The LLM fails to capture the core finding that the 0.875% Notes due 2025 were retired between 2022 and 2024, which is explicitly stated in the ground truth as indicating 'a shift in the debt composition.' The answer demonstrates poor multi-hop synthesis and introduces information not supported by the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 399,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "\nBetween 2022 and 2024, Biktarvy shifted from being the chief growth engine that recaptured market share after the 2020 loss of exclusivity of Truvada/Atripla to a more mature, high‑margin cornerstone of Gilead’s HIV franchise.  At the same time, its risk profile intensified as the market introduced competing long‑acting regimens and generic pressure, prompting Gilead to expand its label (e.g., pediatric low‑dose) and bolster its pipeline to defend the product’s position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM references a '2020 loss of exclusivity of Truvada/Atripla' which is not mentioned in the ground truth and appears to be an unsupported claim. The ground truth specifically cites an '11% revenue increase' attributed to Biktarvy in 2022, which the LLM does not mention. (2) CHARACTERIZATION ERRORS: The LLM describes Biktarvy as 'the chief growth engine that recaptured market share' - this is not supported by the ground truth, which simply states it had 'continued growth in all geographies.' The ground truth does not characterize it as recapturing market share from a 2020 loss of exclusivity. (3) STRATEGIC POSITIONING MISMATCH: The LLM characterizes the evolution as moving from 'growth engine' to 'mature, high-margin cornerstone' - this is a different narrative than the ground truth, which describes a shift from 'key growth driver' to 'increasingly vulnerable to paradigm shifts.' The ground truth emphasizes increased risk exposure and vulnerability, not maturation to cornerstone status. (4) MISSING KEY RISK FACTORS: The LLM mentions 'competing long-acting regimens and generic pressure' but the ground truth specifically highlights the risk of 'shift away from nucleoside-based therapies' and notes that 'many of our HIV products contain TAF' - this is a critical distinction about the nature of the competitive threat that the LLM misses. (5) UNSUPPORTED CLAIMS: The LLM mentions 'pediatric low-dose' label expansion and pipeline bolstering, which are not mentioned in the ground truth and cannot be verified. (6) MULTI-HOP REASONING: While the LLM attempts to synthesize evolution over time, it does so with incorrect premises and conclusions that diverge from the actual filing data. The ground truth shows increasing vulnerability and risk, not maturation and cornerstone positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 527,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "\nThe U.S. litigation escrow account balance grew from **$1.45 billion at the end of fiscal 2022** to **$1.76 billion at the end of fiscal 2023**.  During that period the Company added **$850 million** to the escrow in fiscal 2022 and **$1.0 billion** in fiscal 2023, while net payments to opt‑out merchants (after interest) of **$685 million** were made in fiscal 2023, resulting in the higher ending balance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) ENDING BALANCES - LLM states $1.45B (FY2022) and $1.76B (FY2023), but ground truth shows $1,449M (≈$1.45B for FY2022 is acceptable format) and $3,089M (≈$3.09B for FY2023). The FY2023 ending balance is drastically wrong - off by $1.33 billion or 43%. (2) DEPOSIT CONTRIBUTIONS - LLM claims $850M in FY2022 and $1.0B in FY2023, but ground truth shows $1,000M in FY2022 and $1,500M in FY2023. Both deposit figures are incorrect. (3) ADDITIONAL INFORMATION - LLM introduces information about 'net payments to opt-out merchants' of $685M in FY2023, which is not mentioned in the ground truth and appears to be fabricated or confused with other data. (4) MULTI-HOP SYNTHESIS - The model failed to correctly synthesize the account evolution. The ground truth shows a significant increase from $1,449M to $3,089M (113% growth), while the LLM shows only modest growth from $1.45B to $1.76B (21% growth). This represents a fundamental misunderstanding of the account's trajectory. (5) CALCULATION LOGIC - Even if the LLM's numbers were correct, the explanation of how deposits and payments reconcile to the ending balance is unclear and appears inconsistent with the actual account movements. The answer demonstrates poor accuracy on all quantitative metrics and failed to capture the substantial growth in the escrow account balance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 397,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "\nBetween 2022 and 2023 the company continued to **manufacture fountain syrups in the United States**, but the **distribution responsibility moved from direct sales to bottling partners and authorized wholesalers**. In the 2022 filing the North America operating segment was described as Coca‑Cola selling the syrups to fountain retailers (or to wholesalers who then sold them on), whereas the 2023 filing notes that those syrup sales are now “included in our North America operating segment” through the bottling‑partner network, indicating a shift toward a partner‑driven distribution model. This change is also reflected in the revenue mix, with concentrate operations (which include fountain syrups) rising from 56 % of net operating revenue in 2022 to 58 % in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) INCORRECT CLAIM ABOUT DISTRIBUTION SHIFT: The LLM states that 'distribution responsibility moved from direct sales to bottling partners and authorized wholesalers' between 2022 and 2023. The ground truth explicitly states 'There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.' The LLM fabricates a distribution shift that did not occur. (2) MISCHARACTERIZATION OF 2023 CHANGES: The LLM claims the 2023 filing shows syrup sales 'now included in our North America operating segment through the bottling-partner network,' implying a change. The ground truth indicates the 2023 shift was about emphasizing authorization-based models 'particularly outside the U.S.' while maintaining continuity in North America. (3) UNVERIFIED REVENUE PERCENTAGES: The LLM cites specific percentages (56% in 2022 rising to 58% in 2023 for concentrate operations including fountain syrups). These numbers are not mentioned in the ground truth and cannot be verified. This is a critical error as the evaluation criteria emphasize strict accuracy on quantitative data. (4) INCOMPLETE UNDERSTANDING OF NUANCE: The ground truth describes a 'nuanced evolution' with decentralization 'particularly outside the U.S.' while maintaining U.S. control. The LLM oversimplifies this to a general distribution shift without properly distinguishing geographic differences. (5) LOGICAL INCONSISTENCY: The LLM claims manufacturing continued in the U.S. (correct) but then describes a distribution shift to partners (incorrect/unsupported). The ground truth indicates manufacturing continuity and no explicit North America distribution changes. The answer fundamentally misrepresents the evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 511,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings the roster of securities that mature in 2025 was unchanged: the company still has three separate 2025‑maturing issues on its register – the 2.875 % Notes (IBM 25A), the 0.950 % Notes (IBM 25B) and the 7.00 % Debentures (IBM 25).  The 0.950 % Notes due 2025 appear in both tables (as IBM 25B) with no indication of a new issuance, redemption, or re‑classification, showing that its place in the 2025 maturity bucket remained the same over the two years.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual claim. Ground truth states that by 2024, only TWO sets of notes maturing in 2025 remained (2.875% Notes and 0.950% Notes), with the 0.875% Notes due 2025 being removed. The LLM claims THREE separate 2025-maturing issues remained unchanged, listing: (1) 2.875% Notes, (2) 0.950% Notes, and (3) 7.00% Debentures. This is incorrect on multiple counts: (a) The ground truth identifies the third 2022 instrument as 0.875% Notes due 2025, not 7.00% Debentures; (b) The ground truth explicitly states the 0.875% Notes were 'no longer listed' by 2024, indicating a change in composition, not an unchanged roster; (c) The LLM's claim of 'unchanged' composition directly contradicts the ground truth's statement of 'reduction in the diversity of interest rate profiles.' The LLM correctly identifies the 0.950% Notes (IBM 25B) as present in both years, but this partial correctness is overshadowed by the major factual errors regarding the overall composition change. The LLM failed to recognize the key finding: that the composition DID evolve between 2022 and 2024, with one instrument being removed. The multi-hop reasoning is flawed because the model did not properly synthesize the comparative data across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 366,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 Disney moved from a modest, single‑ship expansion focus to a more integrated, multi‑ship growth strategy anchored by its new private island at Lighthouse Point.  The 2022 filing highlighted the upcoming Disney Wish and the 2024 opening of the island as a destination‑enhancement, while the 2024 filing emphasized ordering additional cruise ships, tying the fleet’s itineraries to the island year‑round, and leveraging the island to drive occupancy and cross‑sell Disney Vacation Club and resort stays.  In short, Disney’s cruise‑ship strategy evolved from “add a flagship and a destination” to a broader, destination‑centric fleet expansion that ties the private island to sustained, high‑occupancy cruising.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) FACTUAL ERRORS - The LLM introduces specific claims not supported by the ground truth, including: 'Disney Wish' (not mentioned in ground truth), 'Lighthouse Point' private island (not mentioned in ground truth), '2024 opening of the island' (not mentioned in ground truth), and 'Disney Vacation Club cross-sell' (not mentioned in ground truth). These appear to be hallucinated details. (2) MISALIGNMENT WITH GROUND TRUTH - The ground truth emphasizes a shift from 'general dependence on consumer demand' (2022) to 'active investment and growth strategy' (2024), with 2024 noting 'increased costs and uncertain returns.' The LLM answer instead focuses on a specific island destination strategy and fleet integration that is not present in the ground truth. (3) QUANTITATIVE ACCURACY - The LLM provides no specific numbers, dates, or financial metrics, while the ground truth references the 2022 and 2024 filings as distinct documents with different strategic emphases. The LLM's vague references to 'upcoming' and '2024 opening' lack the precision needed. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize evolution across years, it does so by introducing details not in the ground truth rather than synthesizing the actual disclosed information. The ground truth's core insight—evolution from passive mention to active capital-intensive strategy—is largely absent from the LLM response. (5) SEMANTIC EQUIVALENCE - The LLM's narrative about 'destination-centric fleet expansion' and 'private island' strategy is fundamentally different from the ground truth's focus on increased investment, capital intensity, and uncertain returns. The answers describe different strategic evolutions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 488,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "\nFrom 2022 through 2023 Lockheed Martin broadened its pension‑risk‑transfer program, moving from the single $4.9 bn group‑annuity purchase in August 2021 to a series of incremental annuity purchases funded by the master retirement trust that now cover roughly 95 k retirees and cut annual PBGC premiums by about $69 m. Each additional transfer reduces the accrued benefit liability and, while generating a non‑cash settlement charge in the period it occurs, is intended to smooth earnings and free cash flow for the business, making pension‑risk management a recurring strategic lever rather than a one‑time event.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several significant factual errors and misrepresentations that substantially diverge from the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM correctly identifies the $4.9 billion transaction from August 2021 and the ~95,000 retirees covered\n   - However, the LLM introduces an unsupported claim about \"$69 million\" in annual PBGC premium reductions - this figure does not appear in the ground truth and cannot be verified\n   - The LLM fails to mention the $1.7 billion noncash pension settlement charge from 2022, which is a critical financial metric\n   - The LLM omits the $11.6 billion cumulative pension obligations transferred since December 2018, which is important context for understanding the program's scale\n\n2. COMPLETENESS ISSUES:\n   - The LLM answer focuses heavily on the mechanics of \"incremental annuity purchases\" and earnings smoothing, but largely ignores the key evolution between 2022 and 2023\n   - The ground truth explicitly notes a strategic shift in 2023 toward acknowledging residual liability exposure and insurer default risk - the LLM completely misses this important evolution\n   - The LLM does not address the 2023 nuance about potential future pension contributions or additional noncash settlement charges\n   - The LLM frames this as a \"recurring strategic lever\" but the ground truth indicates the company was becoming more cautious about these transactions by 2023\n\n3. REASONING AND SYNTHESIS ISSUES:\n   - The LLM appears to conflate or misinterpret the 2022 and 2023 filings, presenting a narrative of \"broadening\" the program when the ground truth suggests a more measured, risk-aware approach by 2023\n   - The claim about \"series of incremental annuity purchases\" is not clearly supported by the ground truth, which focuses on the single major 2021 transaction and the company's evaluation of future transactions\n   - The LLM's emphasis on earnings smoothing and cash flow benefits is not substantiated in the provided ground truth\n\n4. ENTITY AND METRIC ACCURACY:\n   - Company name (Lockheed Martin) is correct\n   - Years (2022-2023) are correct\n   - The $4.9 billion and 95,000 retirees figures are correct\n   - However, the introduction of the $69 million PBGC premium reduction is problematic as it's not in the ground truth\n\n5. CRITICAL OMISSIONS:\n   - Missing the $1.7 billion noncash settlement charge (major financial impact)\n   - Missing the $11.6 billion cumulative transfer figure\n   - Missing the key 2023 evolution regarding residual liability and insurer default risk\n   - Missing discussion of potential future contributions to pension trust\n   - Missing the shift from confidence (2022) to caution (2023) in framing\n\nThe LLM answer demonstrates partial understanding of the pension risk transfer program but fails to capture the critical evolution between 2022 and 2023, particularly the shift toward acknowledging risks and liabilities. The introduction of unsupported figures and the omission of key financial metrics significantly undermines the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 813,
        "total_tokens": 2230
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "\nBetween 2022 and 2023 Tesla’s disclosures show that it continued to depend on financing partners to fund customer loans and direct‑lease arrangements, but the company’s risk commentary grew more detailed.  In the 2022 filing it pointed out that accounts‑receivable balances can swing by tens of millions from quarter‑to‑quarter as payments from financing partners clear (often within two weeks) and as long‑term government rebates are collected, prompting the establishment of an allowance for doubtful accounts.  By 2023 the discussion broadened to stress the credit‑risk of those partners, the volatility of residual‑value guarantees and lease‑return values, and the potential for substantial credit losses or impairments if partners under‑perform or if a downturn reduces customer payment ability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY: The LLM correctly identifies the two-week settlement timeframe for accounts receivable from financing partners in 2022, matching the ground truth exactly. The reference to 'tens of millions' in quarterly swings is appropriately vague (as the ground truth doesn't specify exact amounts) and semantically equivalent to the ground truth's description of balance sheet fluctuations. ENTITY ACCURACY: Tesla is correctly identified, and the 2022-2023 timeframe is properly maintained throughout. MULTI-HOP REASONING: The answer successfully synthesizes information across two years, showing the evolution from 2022's focus on operational cash flow timing (two-week settlement cycles, allowance for doubtful accounts) to 2023's broader risk concerns (credit risk of partners, residual value volatility, potential credit losses). This matches the ground truth's characterization of the shift. COMPLETENESS: The answer addresses both accounts receivable management (settlement timing, quarterly fluctuations, allowance for doubtful accounts) and leasing program risks (residual value guarantees, lease-return values, partner performance risks, customer payment ability). The LLM adds slightly more detail about government rebates and impairment risks, which enriches the answer without contradicting the ground truth. SEMANTIC EQUIVALENCE: The LLM's phrasing of 'credit-risk of those partners' and 'volatility of residual-value guarantees' conveys the same meaning as the ground truth's 'credit, compliance, and residual value risks.' The description of 'substantial credit losses or impairments' aligns with the ground truth's concern about negative effects on profitability. MINOR CONSIDERATIONS: The LLM uses slightly different organizational structure (discussing 2022 first, then 2023) compared to the ground truth, but this is a stylistic choice that doesn't affect accuracy. The answer is comprehensive and well-reasoned, with no factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 556,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "\nBetween 2022 and 2023 Coca‑Cola altered the way it gets fountain syrup to the market: it stopped authorising bottlers to **manufacture** fountain syrups and instead **sold the syrups directly to a network of approved fountain‑wholesalers** (some of which are bottlers) that then distribute the product to restaurants and other retailers.  \n\nAs a result, the **bottlers’ role shifted** from being producers and distributors of fountain syrup to a more limited, wholesale‑distribution or purchasing role, while **fountain‑wholesalers assumed the primary responsibility for delivering syrup to end‑users**. This change gave the Company tighter control over pricing, terms and supply‑chain logistics for fountain‑syrup sales.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. The ground truth states that in 2023, bottlers were AUTHORIZED to manufacture fountain syrups (particularly outside the U.S.), representing an expansion of their role. The LLM answer claims the opposite - that Coca-Cola 'stopped authorising bottlers to manufacture fountain syrups' and shifted them to a 'more limited, wholesale-distribution or purchasing role.' This is a critical factual error that inverts the actual strategic change. The ground truth describes an evolution FROM a centralized model (2022: direct sales to wholesalers) TO a more integrated model (2023: bottlers authorized to manufacture, particularly internationally). The LLM answer incorrectly portrays this as a restriction of bottler authority rather than an expansion. The LLM also misses the key geographic distinction - that the 2023 changes applied 'outside the United States' while U.S. bottlers remained generally unauthorized to manufacture. The claim about 'tighter control over pricing, terms and supply-chain logistics' is not supported by the ground truth and appears to be an unsupported inference. While there are no quantitative errors (no numbers were provided), the qualitative reasoning is fundamentally flawed, representing a complete misunderstanding of the multi-hop synthesis required to answer this question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 387,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s exposure to the ATMP joint venture grew modestly but strategically.  Receivables from the JV rose from about $9 million (2023) to roughly $12 million (2024), while payables increased from $363 million to $476 million, reflecting a larger volume of inventory transactions.  In addition, AMD made a new $100 million term‑loan to the JV, contributed an extra $17 million of equity (raising the investment’s carrying value from $99 million to $149 million), and began recognizing higher equity‑income gains ($33 million in 2024 versus $16 million in 2023).  These actions show a deepening financial relationship and a shift from passive purchaser to active investor in the ATMP JV.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the core financial metrics requested. STRENGTHS: (1) Receivables figures are correct ($9M in 2023, $12M in 2024), matching ground truth exactly. (2) The $100 million term loan is correctly identified as a new investment activity in 2024. (3) Additional details about payables ($363M to $476M), equity contributions ($17M), and equity income gains ($33M vs $16M) are provided, showing deeper financial analysis. (4) The multi-hop synthesis is sound, correctly connecting receivables, payables, loans, and equity investments to show the evolution of the relationship. (5) The qualitative assessment that AMD shifted from 'passive purchaser to active investor' aligns with the ground truth characterization of moving from 'purely transactional' to 'more financially integrated.' MINOR CONSIDERATIONS: (1) The ground truth specifically mentions the loan was a 'one-year term loan agreement' while the LLM states 'term-loan' without the duration specification, though this is a minor omission. (2) The ground truth emphasizes AMD becoming 'not only a customer but also a creditor and strategic supporter,' while the LLM frames it as 'passive purchaser to active investor' - both characterizations are semantically equivalent and accurate. (3) The LLM provides additional context (payables, equity contributions, equity income) that goes beyond the ground truth but is not contradictory and enriches the answer. All numeric values are accurate and properly formatted. The multi-hop reasoning correctly synthesizes information across multiple financial metrics and years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 450,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "\nBetween 2022 and 2023 Lockheed Martin moved from a period of large, non‑cash settlement charges—$1.5 billion was recognized in 2022 after purchasing group annuities that transferred $4.3 billion of defined‑benefit obligations—to a stage where the remaining pension‑obligation reductions were executed as relatively small, cash‑settlement payments ($414 million in the fourth quarter of 2023) with no additional settlement charge recorded.  This shift reflects a deliberate strategy to off‑load non‑qualified pension liabilities through annuity purchases and lump‑sum offers, resulting in a much lower earnings impact (only the $414 million cash outflow and a corresponding reduction in accrued pension liabilities/AOCL) rather than the multi‑billion‑dollar charges seen in the prior year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of Lockheed Martin's pension management evolution. QUANTITATIVE VERIFICATION: All key numbers are correct - $1.5 billion noncash settlement charge in 2022, $4.3 billion of transferred pension obligations, and $414 million in voluntary settlement payments in 2023. The timing reference to Q4 2023 adds appropriate specificity. COMPLETENESS: The answer addresses all major aspects of the question: (1) 2022 approach via group annuity contracts, (2) 2023 approach via targeted settlements, (3) the strategic shift from large-scale to smaller-scale transactions, and (4) financial impacts (noncash charges vs. cash outflows). MULTI-HOP SYNTHESIS: The answer correctly synthesizes information across two years and identifies the strategic evolution - from bulk pension obligation transfers to more granular settlement payments. The reference to \"approximately 6,500 former employees\" from the ground truth is not explicitly mentioned, but the LLM does capture the essence of \"targeted approach involving smaller settlements with former employees.\" REASONING QUALITY: The explanation of the shift from noncash charges to cash settlements is logically sound and demonstrates understanding of the accounting mechanics (AOCL impact, accrued pension liability reduction). The characterization of the strategy as deliberately off-loading nonqualified pension liabilities is accurate and insightful. MINOR CONSIDERATIONS: The LLM provides slightly more accounting detail (AOCL, accrued pension liabilities) than the ground truth, which is contextually appropriate and adds value without introducing errors. The phrase \"no additional settlement charge recorded\" in 2023 is a reasonable inference from the ground truth's focus on the $414 million cash payment without mention of a corresponding noncash charge. Overall, the answer demonstrates strong comprehension of the pension management strategy and its evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 535,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s stake in the ATMP joint venture expanded both in size and earnings contribution.  The carrying value of its equity‑method investment rose from roughly **$99 million (as of Dec 30 2023)** to **about $149 million (as of Dec 28 2024)**, driven in part by a **$17 million additional equity contribution in August 2024**.  Accordingly, AMD’s share of the JV’s earnings—recorded as “equity income in investee”—more than doubled, climbing from **$16 million in 2023 to $33 million in 2024**.  The relationship also deepened through a **$100 million term loan** to the JV and higher payable/receivable balances, but the key evolution was the larger equity investment and the resulting increase in equity‑income earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: carrying value increased from $99 million (Dec 30, 2023) to $149 million (Dec 28, 2024); the $17 million additional equity contribution in August 2024 is accurately cited; equity income rose from $16 million to $33 million. The calculation that equity income 'more than doubled' is mathematically correct (33/16 = 2.06x). The answer properly synthesizes multi-hop information by connecting the investment contribution to the carrying value increase and linking both to the equity income growth. The LLM appropriately identifies the $100 million term loan as additional context showing deepening relationship, though this wasn't explicitly in the ground truth, it represents reasonable supplementary information from the filings. The dates are precise (Dec 30, 2023 and Dec 28, 2024 for fiscal year-ends; August 2024 for contribution timing). The semantic framing—'expanded both in size and earnings contribution,' 'more than doubled'—accurately conveys the magnitude of change. Minor enhancement: the answer goes slightly beyond the ground truth by mentioning the term loan and payable/receivable balances, but this adds relevant context rather than introducing errors. The core narrative of investment growth and income increase is perfectly aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 383,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 Johnson & Johnson’s stake in Kenvue collapsed from roughly 89.6 % (after the May 2023 IPO) to about 9.5 % following the August 2023 exchange offer, and was fully eliminated in May 2024 when the remaining 182 million shares were swapped for commercial paper, resulting in a ≈ $0.4 billion loss and no retained equity. The 2023 exchange generated a one‑time $21 billion pre‑tax gain (including a $2.8 billion gain on the shares J&J kept), but the 2024 debt‑for‑equity transaction produced a modest loss, ending J&J’s ownership in Kenvue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive multi-hop synthesis. STRENGTHS: (1) All key numbers are correct: 9.5% ownership stake in 2023, $4.3 billion valuation, $21.0 billion gain in 2023, $2.8 billion gain on retained shares, 182,329,550 shares (LLM rounded to 182 million, acceptable), ~$0.4 billion loss in 2024. (2) Timeline is accurate: May 2023 IPO, August 2023 exchange offer, May 2024 debt-for-equity exchange. (3) Multi-hop reasoning is sound: correctly synthesizes the evolution from 89.6% stake post-IPO → 9.5% after exchange offer → 0% after 2024 transaction. (4) Correctly identifies the nature of transactions (exchange offer, debt-for-equity swap) and their financial outcomes. (5) Properly addresses all parts of the question regarding retained equity evolution and associated gains/losses. MINOR CONSIDERATIONS: (1) The LLM provides additional context about the 89.6% stake post-IPO, which wasn't explicitly in the ground truth but is factually accurate and adds helpful context. (2) The characterization of the 2024 loss as 'modest' is subjective but reasonable given the context of the larger 2023 gains. (3) The description of the 2024 transaction as 'swapped for commercial paper' is accurate terminology. The answer is semantically equivalent to the ground truth while being slightly more detailed and narrative in structure. No calculation errors detected. All entities (J&J, Kenvue, dates, percentages, dollar amounts) are correctly identified and synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 417,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "\nIn the 2022 filing AT&T still listed a guarantee of certain Southwestern Bell obligations among its contingent‑liability disclosures, but the 2023 filing no longer included that guarantee in its guarantee‑agreement disclosures—effectively ending the parent‑company guarantee relationship that had been reported the prior year.",
      "correctness_score": 1,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. The ground truth clearly states that AT&T's guarantee relationship with Southwestern Bell Telephone Co. 'remained consistent between 2022 and 2023' with 'no change in the nature or scope of the guarantee.' The guarantee was listed in Exhibit 4-c in both 2022 and 2023. However, the LLM answer claims the opposite: that the 2023 filing 'no longer included that guarantee in its guarantee-agreement disclosures—effectively ending the parent-company guarantee relationship.' This is a critical factual error. The LLM has inverted the actual finding, stating that the guarantee was discontinued when it was actually maintained. While the LLM correctly identifies the relevant entities (AT&T, Southwestern Bell Telephone Co.) and years (2022 and 2023), and the answer is contextually relevant to the question asked, the core factual claim is entirely wrong. The quantitative accuracy score is high only because there are no specific numbers to verify—the error is in the qualitative interpretation of the filing data. This represents a fundamental failure in multi-hop reasoning and synthesis of information from the SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 341,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "\nFrom 2022 to 2023 Lockheed Martin shifted its hypersonics effort from a pure research‑and‑development posture—highlighted in the 2022 filing as “several programs with the U.S. Air Force and Army to design, develop and build hypersonic strike weapons” under undefinitized contract actions—to a concrete production‑transition role.  The 2023 filing notes that “multiple hypersonics programs are expected to enter early production phases through 2026,” signaling that the company is now positioning itself as the lead integrator for both Air Force and Navy hypersonic strike weapons and taking on broader program‑management and production responsibilities as the initiatives move toward fielding.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims 2022 filings described 'several programs with the U.S. Air Force and Army' - the ground truth states hypersonics was listed as a 'growth area' dependent on government authorization/funding, NOT as existing programs with Air Force and Army. (2) The LLM introduces specific claims about 'undefinitized contract actions' and 'multiple hypersonics programs expected to enter early production phases through 2026' that are NOT present in the ground truth and appear to be fabricated details. (3) The LLM characterizes the 2022 position as 'pure research-and-development posture' which misrepresents the ground truth's description of it as a potential growth area. CORRECT ELEMENTS: The LLM correctly identifies the evolution from 2022 to 2023, correctly names Lockheed Martin, correctly identifies the shift toward more active/concrete involvement, and correctly mentions both Air Force and Navy involvement by 2023. However, the specific details about contract types, production timelines, and 2022 program descriptions are either fabricated or significantly mischaracterized. The multi-hop reasoning structure is sound (comparing 2022 vs 2023 positioning), but the factual foundation is compromised by invented details that don't appear in the ground truth. The answer reads plausibly but introduces specificity that cannot be verified against the provided ground truth, suggesting hallucination of details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 421,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "\nThe U.S. litigation escrow account balance rose from **$1.449 billion at the end of fiscal 2022** to **$1.764 billion at the end of fiscal 2023**.  During fiscal 2023 the company **deposited $1.0 billion** into the escrow account (offset by $685 million of payments), producing the net increase reflected in the year‑end balance.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental and critical errors in all key financial figures. (1) BALANCE FIGURES - INCORRECT: The LLM states the FY2022 balance was $1.449 billion and FY2023 balance was $1.764 billion. The ground truth shows $1.4 billion (FY2022) and $3.089 billion (FY2023). The FY2023 figure is dramatically wrong - off by $1.325 billion or 43% of the correct amount. (2) DEPOSITS - PARTIALLY CORRECT: The LLM correctly identifies $1.0 billion deposited in FY2023, matching ground truth. However, it completely omits the FY2022 deposit of $850 million, which was explicitly requested in the question. (3) CALCULATION ERRORS: The LLM's stated increase from $1.449B to $1.764B ($315M net increase) does not align with the ground truth increase of $1.689B ($1.4B to $3.089B). The LLM's mention of $685 million in payments appears to be an attempt to explain the discrepancy but is not verified against ground truth and doesn't reconcile the major balance discrepancy. (4) MULTI-HOP SYNTHESIS: The question explicitly asks for evolution from FY2022 to FY2023 AND deposits in both years. The LLM only addresses FY2023 deposits and completely fails to provide FY2022 deposit information. (5) SEMANTIC ISSUES: While the LLM attempts to address the question structure, the fundamental numerical errors make the answer factually incorrect and misleading. The answer appears to reference different data or contains transcription errors from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 404,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Outdoor Garden has remained classified under the **Hardlines** merchandising department within HD’s single reportable “Primary” segment, with its sales holding steady around **$10.3 billion** each year—representing roughly **6.5 %–6.8 %** of total net sales.  The only structural change was a 2024 realignment of merchandising departments that re‑sequenced the categorization but did not move Outdoor Garden to a different segment or product line, underscoring its continued role as a core, stable contributor to HD’s hard‑goods portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth explicitly states that in 2022, Outdoor Garden was 'disclosed as a distinct product line' separate from Hardlines, and by 2024 it was 'grouped under the broader Hardlines merchandising department.' This represents a clear strategic shift from separate classification to consolidated classification. However, the LLM claims Outdoor Garden 'has remained classified under the Hardlines merchandising department' throughout 2022-2024, which directly contradicts the documented evolution. The LLM incorrectly suggests continuity when the ground truth shows a structural change. QUANTITATIVE ISSUES: While the LLM correctly identifies the $10.3 billion sales figure and 6.5%-6.8% range, these numbers alone do not validate the answer given the fundamental mischaracterization of the classification evolution. The LLM states 'the only structural change was a 2024 realignment of merchandising departments that re-sequenced the categorization' - this is vague and misleading compared to the clear 2022-to-2024 shift from distinct product line to Hardlines grouping documented in the ground truth. MULTI-HOP REASONING: The LLM failed to synthesize the key evolution across years. The question specifically asks how the role and positioning 'evolved from 2022 to 2024,' requiring comparison of two distinct time periods. The LLM's assertion of continuity ('remained classified') demonstrates a failure to recognize and articulate the documented strategic repositioning. SEMANTIC ISSUES: The phrase 'remained classified' is semantically opposite to the ground truth's narrative of change and integration. This is not a wording difference but a factual contradiction about whether change occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 493,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "\nAMD has sustained its “engaging and open” culture even as its headcount rose from roughly 26,000 (2023) to about 28,000 (2024) by continuing to run a confidential annual workforce survey that consistently places the company in the top 10 % of tech firms for culture, inclusion and manager quality, and by expanding programs such as employee‑resource groups, mentorship, flexible hybrid/remote work, and targeted initiatives for women engineers.  This focus on inclusive benefits, clear career‑development pathways and continuous cultural reinforcement signals a talent‑retention strategy that couples competitive pay and incentives with an environment designed to keep diverse, high‑performing engineers motivated amid the semiconductor industry’s intense competition.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERRORS - The LLM answer introduces specific claims NOT present in the ground truth or original filings: mentions of 'confidential annual workforce survey,' 'top 10% of tech firms for culture,' 'employee-resource groups,' 'mentorship programs,' 'flexible hybrid/remote work,' and 'targeted initiatives for women engineers.' These details cannot be verified against the ground truth and appear to be hallucinated. (2) QUANTITATIVE ACCURACY - While the LLM correctly states the workforce grew from ~26,000 (2023) to ~28,000 (2024), it fails to mention the 7.7% increase calculation provided in the ground truth. More importantly, it adds unverified percentages ('top 10%') without source attribution. (3) MISSING CORE EVIDENCE - The ground truth emphasizes that AMD used IDENTICAL messaging in both years ('engaging and open environment' language repeated verbatim), which is the key evidence of intentional cultural preservation. The LLM answer completely omits this critical detail and instead substitutes unverified program descriptions. (4) MULTI-HOP REASONING - The ground truth's reasoning is sound: same messaging + workforce growth = intentional cultural preservation strategy. The LLM's reasoning about 'inclusive benefits, clear career-development pathways' is plausible but unsupported by the actual filing data provided in the ground truth. (5) SEMANTIC MISMATCH - While both answers discuss talent retention strategy, the LLM fundamentally misrepresents HOW AMD maintained its culture (through repeated messaging vs. through specific programs). The ground truth's evidence is documentary/linguistic; the LLM's is programmatic/operational but unverified. This is a significant factual divergence that undermines credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 479,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "\nBetween 2022 and 2023 AT&T’s guaranty of The Ohio Bell Telephone Company’s obligations remained exactly the same as disclosed in prior years – the company did not add any new guarantees and did not terminate the existing one. The filings show that the same guaranty arrangement (referenced in the 2011 exhibit) continued to be the only commitment AT&T has to support Ohio Bell, with no material evolution in scope or terms over the 2022‑2023 period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct and captures the core finding from the ground truth. Both answers correctly identify that: (1) AT&T maintained a guarantee obligation for The Ohio Bell Telephone Company between 2022 and 2023, (2) the guarantee originated from a 2011 exhibit, (3) there was no material change, expansion, or termination of the guarantee during this period, and (4) the relationship remained stable. The LLM answer uses slightly different phrasing ('guaranty' vs 'guarantee obligation') but these are semantically equivalent terms. The LLM answer is actually more explicit in stating 'no new guarantees' and 'did not terminate the existing one,' which provides clearer affirmation of stability. The only minor difference is that the ground truth mentions 'documentation was maintained in line with current reporting standards' and 'exhibit reference was updated,' while the LLM answer focuses more on the substantive continuity of the guarantee itself rather than the documentation/exhibit mechanics. This is a minor omission of contextual detail about the exhibit reference update, but the core factual content about the guarantee relationship is accurate. All dates (2022, 2023, 2011) are correct. No calculations are required for this question. The multi-hop reasoning is sound - the LLM correctly synthesized information about the relationship evolution across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 390,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "\nBetween 2022 and 2023 the “gains on retained and sold ownership interests” line exploded – $47 million in 2022 jumped to **$5.78 billion in 2023**, driven almost entirely by the sale/valuation of stakes in **AerCap (and GE HealthCare)** that boosted GAAP profit.  In 2024 those one‑time gains largely disappeared from the adjusted results; the company’s earnings growth that year came from higher segment profit and lower corporate costs, indicating that the financial impact of the AerCap relationship had **dissipated sharply** compared with the outsized 2023 gain.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) WRONG TIME PERIOD: The LLM discusses 2022-2023-2024 comparison, but the question specifically asks about 2023-2024 evolution. The LLM's inclusion of 2022 data ($47 million) is extraneous and shifts focus away from the requested comparison. (2) INCORRECT NUMBERS: The LLM states $5.78 billion in 2023, which is close to the ground truth's $5.7 billion (acceptable rounding), but fails to provide the critical 2024 figure. The ground truth explicitly states gains DECREASED by $5.2 billion in 2024 compared to 2023, meaning 2024 gains were approximately $0.5 billion ($5.7B - $5.2B). The LLM completely omits this 2024 quantification, only vaguely stating gains 'largely disappeared from adjusted results.' (3) INCOMPLETE SYNTHESIS: The question asks specifically about 'gains on retained and sold ownership interests' evolution between 2023-2024. The ground truth provides: 2023 = $5.7B increase, 2024 = $5.2B decrease. The LLM provides only the 2023 figure and qualitative language about 2024 without the specific $5.2 billion decrease metric. (4) MULTI-HOP REASONING: The LLM correctly identifies AerCap and GE HealthCare as drivers and notes the dissipation of gains, but fails to quantify the year-over-year change that is central to the question. (5) CORRECT ELEMENTS: The LLM correctly identifies that 2023 saw large gains (~$5.7-5.78B) driven by AerCap/GE HealthCare investments, and correctly notes these gains diminished in 2024. The semantic understanding of 'dissipation' aligns with the decrease described in ground truth. However, the lack of specific 2024 numbers and the misdirection to 2022 data significantly undermines answer quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 457,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Home Depot moved HD Supply from a peripheral “MRO add‑on” to the central engine of its professional‑customer strategy.  The 2022 filing already framed HD Supply as the conduit for value‑added MRO services to pros, but the 2024 filing (pages 4‑8) shows a deliberate deepening: the company is expanding HD Supply’s product breadth, investing in a dedicated Pro sales force, credit programs and delivery options, and using the HD Supply distribution network to capture higher‑margin professional spend—exemplified by the SRS acquisition and the emphasis on “Pro‑focused” capabilities.  In short, HD Supply’s role has been amplified to drive growth with professional customers and to broaden the company’s MRO offering across the Pro ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of HD Supply's role from 2022 to 2024, capturing the shift from integration concerns to strategic importance for professional customers. The answer accurately references MRO services, multifamily/hospitality/healthcare/government facilities, and the Pro-focused growth initiatives. The mention of SRS acquisition and expanded distribution network demonstrates knowledge of specific strategic moves. The timeline (fiscal 2022 to fiscal 2024) is correct.\n\nWEAKNESSES: (1) The LLM characterizes 2022 as already framing HD Supply as 'the conduit for value-added MRO services to pros,' which contradicts the ground truth stating 2022 emphasized 'integration risks and challenges' and 'significant uncertainty and complexity.' This is a material mischaracterization of the 2022 position. (2) The LLM introduces claims about 'dedicated Pro sales force, credit programs and delivery options' and 'SRS acquisition' that are not explicitly mentioned in the ground truth answer. While these may be factually accurate from the filings, they represent additions beyond what the ground truth synthesized, creating potential for unverified claims. (3) The phrase 'peripheral MRO add-on' in the opening is somewhat contradicted by the subsequent statement that 2022 already framed it as a conduit—this internal inconsistency weakens the narrative. (4) The answer lacks the explicit acknowledgment of the 2022 integration uncertainty that the ground truth emphasizes as a key contrast point.\n\nMULTI-HOP REASONING: The answer demonstrates sound multi-hop synthesis by connecting 2022 and 2024 filings and identifying the strategic evolution. However, the characterization of 2022's position is inaccurate, which undermines the validity of the comparison.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers or dates are provided in either answer, so quantitative accuracy is not directly testable. The years (2022, 2024) are correct. The entities (Home Depot, HD Supply, SRS) are correctly identified.\n\nOVERALL ASSESSMENT: The answer captures the general trajectory correctly but misrepresents the 2022 baseline, which is a significant error in a comparative analysis. The introduction of unverified details (SRS acquisition, specific programs) without ground truth support creates additional concern about accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 631,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s patent portfolio showed only modest expansion – worldwide “patent matters” rose from roughly 18.5 k to 18.8 k, with U.S. issued patents growing from 12.8 k to 13.2 k while the number of pending applications stayed flat at about 5.6 k.  The company continued to describe its reliance on “numerous cross‑licensing and technology‑exchange agreements” as a standard industry practice, noting that these arrangements let AMD both transfer and receive IP, and that the enlarged portfolio now provides a broader base for such exchanges.  Consequently, while the scale of AMD’s cross‑licensing activity has not fundamentally changed, the slight increase in patents gives the firm more assets to share, reinforcing its strategy of leveraging cross‑licensing to accelerate technology diffusion across the semiconductor ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numeric values are correct - 18.5k to 18.8k patent matters (matches 18,500 to 18,800), 12.8k to 13.2k issued patents (matches 12,800 to 13,200), and 5.6k pending applications (matches 5,600) in both years. The format variations (18.5k vs 18,500) are acceptable and consistent with the evaluation criteria. COMPLETENESS: The answer addresses all key aspects of the question: (1) evolution of patent portfolio size between 2023-2024, (2) specific numbers for issued patents and pending applications, (3) implications for cross-licensing agreements, and (4) AMD's strategic positioning. ENTITY ACCURACY: AMD is correctly identified, years 2023-2024 are correct, and patent metrics are properly categorized. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the patent portfolio growth to enhanced leverage in cross-licensing agreements, noting that the expanded portfolio provides 'more assets to share.' The characterization of growth as 'modest' is appropriate given the ~1.6% increase in total patent matters. SEMANTIC EQUIVALENCE: The LLM's phrasing about 'numerous cross-licensing and technology-exchange agreements' and their role in technology transfer aligns with the ground truth's emphasis on these agreements being 'critical for transferring and receiving technology.' The conclusion that the enlarged portfolio 'reinforces its strategy' is a reasonable inference from the data. MINOR CONSIDERATIONS: The LLM uses 'U.S. issued patents' while the ground truth says 'issued patents' - this is a minor specification that doesn't affect accuracy. The LLM's observation that 'the scale of AMD's cross-licensing activity has not fundamentally changed' is a reasonable interpretation of the modest growth figures. No calculation errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 508,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "\nFrom the May 2023 IPO through the end of 2024, Johnson & Johnson’s stake in Kenvue fell dramatically: after the IPO it owned about 89.6 % of Kenvue, then in August 2023 it exchanged roughly 80 % of its holding for J&J stock, leaving a 9.5 % residual interest that was later eliminated. In the second‑quarter of 2024 the remaining ≈182 million Kenvue shares were swapped for commercial‑paper debt in a debt‑for‑equity exchange, after which J&J held **no** Kenvue equity and recorded a ≈ $0.4 billion loss in other (income) expense. This disposal completed the separation of the Consumer‑Health business and closed the financial relationship with Kenvue.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) The 9.5% stake retained after August 2023 exchange offer is accurate; (2) The May 2024 debt-for-equity exchange is correctly identified; (3) The ~182 million shares figure is accurate; (4) The $3.6 billion debt satisfaction amount is correct; (5) The ~$0.4 billion loss is accurate; (6) The complete exit from Kenvue is correctly stated; (7) The overall narrative of the separation is sound. PROBLEMATIC ELEMENTS: (1) The LLM introduces information about the May 2023 IPO and J&J's 89.6% post-IPO stake, which is NOT in the ground truth answer and appears to be extrapolated information not directly supported by the specific question context; (2) The reference to an 80% exchange in August 2023 is not explicitly stated in the ground truth; (3) The ground truth specifically mentions the $4.3 billion valuation of the 9.5% stake in 2023, which the LLM omits; (4) The ground truth mentions the $0.4 billion expense by year-end 2023 due to subsequent changes, which the LLM does not address. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution from 2023 to 2024, correctly connecting the August 2023 exchange offer to the May 2024 debt-for-equity transaction. However, it adds contextual information about the IPO that, while potentially accurate, goes beyond what the ground truth specifies and may introduce unverified details. QUANTITATIVE ACCURACY: The core numbers (9.5%, 182 million shares, $3.6 billion, $0.4 billion loss) are correct, but the omission of the $4.3 billion valuation and the 2023 expense detail represents incomplete financial reporting. The introduction of 89.6% and 80% figures, while potentially accurate, cannot be verified against the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 485,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "\nBetween the 2022 and 2023 filings the guarantee disclosure was revised: the 2022 Form 10‑K (pages 133‑137) listed Indiana Bell Telephone Co. Inc. as one of the subsidiaries that guarantees AT&T’s debt, while the 2023 Form 10‑K (pages 101‑105) no longer includes Indiana Bell in that list, indicating that its guarantee obligation was removed or is no longer required to be disclosed.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core factual claim. Ground truth states: Indiana Bell Telephone Co. Inc. was listed in both 2022 and 2023 under Exhibit 4-d with NO CHANGE in the guarantee relationship. LLM answer claims: The guarantee was REMOVED between 2022 and 2023, with Indiana Bell no longer appearing in the 2023 filing. This is a direct contradiction of the established fact that the guarantee 'remained in place without any modification or removal.' The LLM also incorrectly characterizes the relationship direction (claiming Indiana Bell guarantees AT&T's debt, when the ground truth indicates AT&T guarantees Indiana Bell's obligations). Additionally, the LLM provides specific page numbers (2022: pages 133-137, 2023: pages 101-105) that cannot be verified against the ground truth and appear to be fabricated details. The answer fails on the primary factual claim (whether the guarantee changed), misrepresents the nature of the guarantee relationship, and provides unverified page citations. This represents a complete failure to correctly synthesize the multi-hop information about AT&T's relationship with Indiana Bell across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 340,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "\nFrom 2023 through 2024 GE moved from an equity‑ownership position in AerCap to a purely contractual relationship.  In 2023 the AerCap stake still appeared on the balance sheet (fair‑value $0.944 bn, down from $7.403 bn in 2022) and generated a $6.4 bn unrealised gain that was realised when the remaining shares were sold in the fourth quarter of 2023; that same year GE also paid a net $203 million of cash to AerCap for transition‑service and note‑receivable activities.  By the end of 2024 GE held only a note receivable and fee‑based service arrangements with AerCap, so cash flows were limited to payments to AerCap and there were no further equity‑related investment gains.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) DIRECTIONAL ERROR ON RELATIONSHIP EVOLUTION: The LLM states GE moved 'from an equity-ownership position in AerCap to a purely contractual relationship,' which is backwards. The ground truth clearly indicates the opposite: in 2023 GE had operational involvement (note receivable, product leases, transition services), and by 2024 GE held 'an investment stake in AerCap' - a shift FROM operational TO investment-based. (2) QUANTITATIVE ERRORS: The LLM introduces specific numbers ($0.944 bn, $7.403 bn, $6.4 bn unrealized gain) that are NOT mentioned in the ground truth and appear to be fabricated or from incorrect sources. The ground truth does not reference these balance sheet values or the $6.4 bn gain figure. (3) TIMING CONTRADICTION: The LLM claims shares were 'sold in the fourth quarter of 2023,' but the ground truth indicates GE held an investment stake in AerCap through 2024, not that it was fully divested in Q4 2023. (4) MISSING KEY METRIC: The LLM fails to mention the critical $5.2 billion decrease in gains on retained and sold ownership interests that the ground truth identifies as the major financial impact. (5) CASH FLOW CHARACTERIZATION: While the LLM correctly identifies the $203 million net cash payment in 2023, it mischaracterizes the 2024 relationship as having 'limited cash flows' when the ground truth emphasizes the shift to investment-based returns without specifying cash flow limitations. The LLM answer demonstrates a fundamental misunderstanding of the relationship evolution direction and introduces unsupported financial figures that contradict the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 471,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "\nFrom 2022 to 2024 Home Depot moved beyond simple signage and layout refreshes to a technology‑driven store‑appearance strategy that ties physical upgrades—new way‑finding signage, self‑service lockers, curb‑side pickup, electronic shelf‑labels and expanded self‑checkout—to digital capabilities such as mobile‑app navigation, real‑time inventory visibility and AI‑assisted associate tools.  These investments are presented as a core competitive lever, allowing the retailer to differentiate on customer experience, price and delivery speed while integrating its omnichannel shopping journey across stores, online and on‑the‑job‑site.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces specific claims not supported by the ground truth. Critical issues: (1) The LLM provides highly specific technological implementations (electronic shelf-labels, self-service lockers, curb-side pickup, AI-assisted associate tools, mobile-app navigation, real-time inventory visibility) that are NOT mentioned in the original answer or ground truth. These appear to be fabricated details not sourced from the actual 10-K filings. (2) The ground truth emphasizes a shift from 'physical store aesthetics alone to a more holistic, digitally-enhanced customer experience' - a strategic evolution. The LLM answer mischaracterizes this as moving 'beyond simple signage and layout refreshes' which is not the same concept. (3) The LLM correctly identifies the timeframe (2022-2024) and the general theme of digital integration, but invents specific product features and technologies. (4) The ground truth mentions 'interconnected shopping experience' linking physical stores, digital platforms, and on-site services - the LLM's 'omnichannel shopping journey' is semantically similar but the specific technological details are fabricated. (5) While the LLM captures the essence that store appearance evolved to include digital integration, it does so by introducing false specifics rather than accurately synthesizing the actual filing information. The answer demonstrates hallucination of concrete details (electronic shelf-labels, self-service lockers, etc.) that cannot be verified against the ground truth and likely do not appear in the actual filings. This is a fundamental failure in multi-hop reasoning that prioritizes plausible-sounding details over factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 473,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "\nBetween 2023 and 2024 AMD’s trade with the ATMP joint venture remained centered on roughly $1.7 billion of purchases each year, but the flow of goods reversed sharply: resales to the JV rose from only $14 million in 2023 to about $121 million in 2024.  At the same time AMD introduced new financial ties—​a $100 million term loan to the JV (SOFR + 50 bps, secured by the JV’s receivable from AMD) and a $17 million equity contribution that lifted the carrying value of its 15 % stake to $149 million—​and recognized $33 million of equity‑income gains, up from $16 million the prior year.  These developments mark a shift from a primarily one‑way purchase relationship to a more balanced trading and financing arrangement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of AMD's relationship with ATMP JV between 2023 and 2024, including the key resales figures ($14M to $121M) and the $100M term loan. However, there are significant issues with additional information introduced that cannot be verified against the ground truth:\n\n1. VERIFIED CORRECT: Resales increased from $14M (2023) to $121M (2024) ✓; $100M term loan in October 2024 ✓\n\n2. UNVERIFIED/POTENTIALLY INCORRECT ADDITIONS: The LLM introduces several details not in the ground truth:\n   - \"roughly $1.7 billion of purchases each year\" - NOT mentioned in ground truth\n   - \"$17 million equity contribution\" - NOT mentioned in ground truth\n   - \"carrying value of its 15% stake to $149 million\" - NOT mentioned in ground truth\n   - \"$33 million of equity-income gains, up from $16 million the prior year\" - NOT mentioned in ground truth\n   - Loan terms \"SOFR + 50 bps, secured by the JV's receivable from AMD\" - NOT mentioned in ground truth\n\n3. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution narrative (resales increase + new loan arrangement = deepening relationship), which matches the ground truth's conclusion. However, the addition of unverified financial metrics (equity contributions, carrying values, equity-income gains) suggests the model may be hallucinating or drawing from different source documents not reflected in the ground truth.\n\n4. QUANTITATIVE ACCURACY ISSUE: While the core numbers ($14M, $121M, $100M) are correct, the introduction of unverified figures ($1.7B purchases, $17M contribution, $149M carrying value, $33M equity income) significantly undermines confidence in the answer's reliability. These could be correct but cannot be validated against the provided ground truth.\n\n5. CONTEXTUAL RELEVANCE: The answer directly addresses the question about financial relationship evolution and provides good narrative framing, but the additional details go beyond what was asked and what can be verified.\n\nThe answer demonstrates good understanding of the core relationship evolution but introduces unverified information that creates uncertainty about overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 585,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "\nBetween 2023 and 2024 Johnson & Johnson deepened and formalised its privacy‑compliance framework to meet the surge of new global privacy statutes and tighter data‑localisation rules.  The 2024 filing notes that the company has expanded cross‑border data‑flow controls, added more rigorous third‑party risk assessments (including AI‑related risks), and broadened mandatory privacy‑training for all employees, while the 2023 filing only warned of “potential risks of unauthorized access and loss of personal data” and of upcoming legislative actions.  Governance also matured: the 2024 report assigns joint responsibility for privacy and cybersecurity to the CIO and CISO and requires regular reporting to the Regulatory Compliance & Sustainability Committee, reflecting a more structured, board‑level oversight of privacy compliance than was evident in the 2023 disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. CRITICAL ISSUES: (1) The LLM introduces specific governance details (CIO/CISO joint responsibility, Regulatory Compliance & Sustainability Committee reporting) that are NOT present in the ground truth and appear to be fabricated. The ground truth makes no mention of these governance structures or board-level oversight changes. (2) The LLM claims the 2024 filing includes 'expanded cross-border data-flow controls' and 'rigorous third-party risk assessments (including AI-related risks)' - these specific details are not supported by the ground truth, which only mentions that 2024 expanded focus to 'evolving technology and data-driven initiatives' without specifying AI risks or enhanced third-party assessments. (3) The LLM states the 2023 filing 'only warned of potential risks of unauthorized access and loss of personal data' - this characterization is not supported by the ground truth, which describes 2023 as having 'established privacy compliance programs and controls' with emphasis on new privacy laws and enforcement. (4) The claim about 'broadened mandatory privacy-training for all employees' is entirely absent from the ground truth. WHAT WAS CORRECT: The LLM correctly identifies that there was evolution between 2023 and 2024, correctly notes the shift from 'other territories' to 'globally' in regulatory focus (though not explicitly stated this way), and correctly captures that the company expanded its compliance posture. However, the LLM fabricates specific implementation details and governance structures that cannot be verified from the ground truth, which is a serious accuracy violation. The answer reads as plausible but contains invented details that would mislead readers about actual J&J disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1459,
        "completion_tokens": 503,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s exposure to borrower‑litigation losses at Bank BPH fell modestly – from an estimated $2.669 billion of losses as of 31 Dec 2023 to $2.461 billion as of 31 Dec 2024 (a reduction of roughly $208 million).  In 2024 the loan portfolio was carried at zero net of a full valuation allowance, meaning the company fully reserved the remaining exposure, whereas the prior‑year allowance had already been sized to offset the receivables.  Consequently, while the estimated loss amount declined slightly, the financial risk was essentially eliminated through a complete reserve on the BPH financing receivables.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of GE's Bank BPH exposure evolution but has notable omissions in detail. CORRECT ELEMENTS: (1) Total estimated losses correctly stated as $2.669 billion (2023) and $2.461 billion (2024); (2) Reduction amount correctly calculated as ~$208 million ($2,669M - $2,461M = $208M); (3) Correct identification that valuation allowance fully offset receivables by end of 2024; (4) Correct characterization of the strategic shift and risk elimination through full reserve. MISSING/INCOMPLETE ELEMENTS: (1) The LLM answer fails to provide the specific breakdown of the 2023 and 2024 figures - it does not mention the $1,712 million valuation allowance and $957 million in other liabilities for 2023, nor the $1,517 million valuation allowance and $944 million in other liabilities for 2024. This is a significant omission as the original answer explicitly breaks down these components; (2) The statement 'the prior-year allowance had already been sized to offset the receivables' is somewhat ambiguous and could be clearer - the ground truth indicates both years had offsetting allowances, but the LLM's phrasing suggests this was already true in 2023, which is correct but could be more explicit. QUANTITATIVE VERIFICATION: The $208 million reduction is accurate ($2,669M - $2,461M = $208M). The characterization of the reduction as 'modest' is reasonable (7.8% decline). REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the declining loss estimates with the full valuation allowance strategy. However, the answer would be stronger with the specific component breakdowns. The conclusion about financial risk elimination is well-reasoned and supported by the data provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 474,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "\nFrom 2022 to 2024 HD kept the Indoor Garden line inside the broader **Hardlines** merchandising bucket, but its strategic emphasis shifted. In 2022 the Indoor Garden department was reported as a separate line‑item that generated about **$15.5 billion in net sales (≈10 % of total sales)**, highlighting it as a distinct growth driver. By fiscal 2024 the same category appears only as one of several sub‑components of Hardlines (now listed alongside Power and Storage & Organization) and its contribution fell to roughly **$10.5 billion (≈6.6 % of the Primary segment’s net sales)**, indicating a deliberate repositioning away from treating Indoor Garden as a stand‑alone profit center toward integrating it within the broader hardware/tools portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides a 2024 figure of $10.5 billion (≈6.6% of segment sales) that is NOT supported by the ground truth. The ground truth only provides 2022 data ($15,546 million at 10.3% of total revenue) and states that by 2024 Indoor Garden was grouped under Hardlines, but does NOT provide a 2024 sales figure or percentage. The LLM fabricated the 2024 numbers entirely. (2) FACTUAL CLAIMS - The LLM claims 'its contribution fell to roughly $10.5 billion' which is a false assertion not in the ground truth. This is a major factual error. (3) MULTI-HOP REASONING - While the LLM correctly identifies the strategic shift from standalone category (2022) to Hardlines sub-component (2024), it adds unsupported quantitative claims that undermine the answer's credibility. (4) WHAT WAS CORRECT - The LLM correctly identifies: (a) 2022 sales of ~$15.5 billion (matches $15,546M), (b) 2022 percentage of ~10% (matches 10.3%), (c) the reclassification to Hardlines by 2024, (d) the strategic implication of integration rather than standalone treatment. (5) WHAT WAS WRONG - The entire 2024 financial performance section ($10.5B, 6.6%) is fabricated and contradicts the instruction to be strict on numbers. The ground truth explicitly does not provide 2024 sales data for Indoor Garden, only the merchandising categorization change. The LLM should have stated that 2024 financial data was not available in the provided information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 408,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "\nFrom 2022 through 2024 Colgate‑Palmolive moved from a largely reactive stance—using cost‑containment, modest price‑adjustments and only limited commodity‑hedging—to a more proactive sourcing model that expands the scope and scale of its hedging program and deepens long‑term supplier relationships.  The company now couples its traditional price‑increase and productivity initiatives with broader use of commodity contracts and diversified sourcing to blunt the impact of raw‑material price swings, thereby reducing earnings volatility from commodity price fluctuations.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer makes several claims that contradict or are not supported by the ground truth: (1) The LLM claims the company moved from 'reactive' to 'proactive' with 'expanded hedging programs' and 'commodity contracts' - the ground truth does NOT support this characterization of increased hedging or expanded commodity contracts. Instead, it mentions 'derivative instruments' in 2022 but emphasizes 'sourcing strategies' and 'cost containment' in both years. (2) The LLM states the company now uses 'broader use of commodity contracts and diversified sourcing' - this specific claim about commodity contracts is not substantiated in the ground truth, which focuses on sourcing strategies, cost containment, and productivity initiatives. (3) The LLM's narrative of evolution from 'limited commodity-hedging' to expanded hedging is not supported - the ground truth does not indicate an expansion of hedging programs. WHAT WAS CORRECT: (1) The timeframe (2022-2024) is accurate. (2) The mention of raw material price volatility and specific commodities (resins, essential oils, soybeans) aligns with ground truth. (3) The reference to price increases and productivity initiatives is correct. (4) The acknowledgment of external pressures (geopolitical/climatic) is accurate. CRITICAL GAPS: The LLM completely misses the key evolution highlighted in the ground truth - the shift toward 'more defensive sourcing and cost management tactics in response to external pressures' and increased exposure to geopolitical/climatic disruptions. Instead, it frames the evolution as moving toward more aggressive hedging, which is the opposite direction. The LLM also fails to accurately capture that the company continued to rely on sourcing strategies (not expanded hedging) as the primary mechanism. QUANTITATIVE: No specific numbers were provided in either answer, so this scores well on consistency. QUALITATIVE: The reasoning is fundamentally flawed - the LLM mischaracterizes the nature of the evolution and invents details about expanded hedging programs not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 568,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "\nTREMFYA sales rose from **$3.15 billion in 2023 to $3.67 billion in 2024**, an increase of roughly **16–17 %**.  The growth was driven by continued **market expansion and share gains in psoriasis and psoriatic arthritis**, favorable **patient‑mix trends**, and the absence of major competitive pressure; a modest **negative currency impact** partially offset the rise.  This follows the strong 17.9 % growth recorded from 2022 to 2023, indicating sustained momentum for the drug.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with minor discrepancies. QUANTITATIVE VERIFICATION: (1) Sales figures are correct: $3.15B (2023) vs $3.67B (2024) match the ground truth of $3,147M and $3,670M respectively. (2) Growth percentage stated as '16-17%' is accurate; ground truth specifies 16.6%, which falls within the stated range. (3) The LLM mentions 17.9% growth from 2022-2023, which is not contradicted by ground truth but adds context not explicitly required. QUALITATIVE ASSESSMENT: The LLM correctly identifies key growth drivers: market expansion, share gains in PsO/PsA, and favorable patient-mix trends. It accurately notes the negative currency impact. The reasoning is sound and multi-hop synthesis is correct. MINOR ISSUES: (1) The ground truth specifies the 2024 growth was driven by '18.1% change from operations' with a '1.5% negative currency impact,' but the LLM uses more general language ('modest negative currency impact') without quantifying the operational growth percentage. This is a minor omission of specific detail. (2) The LLM mentions 'absence of major competitive pressure' which is not explicitly stated in the ground truth, though it's a reasonable inference. STRENGTHS: The answer is well-structured, addresses both the performance evolution and contributing factors, uses appropriate number formatting, and maintains semantic equivalence with the ground truth. The contextual relevance is high as it directly answers the multi-part question about sales evolution and contributing factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 424,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "\nThe 2023 filing eliminated the standalone A+E subscriber table that had been presented in 2022 and instead folded the A+E audience figures into the broader “Domestic Linear Networks” discussion, so Disney no longer reports separate subscriber counts for A&E, HISTORY, Lifetime, LMN and FYI.  At the same time, Disney’s economic interest in A+E remained a 50 % equity stake, but the way that investment is disclosed shifted from a distinct line‑item to being included only in the “Equity in the income (loss) of investees, net” caption of the consolidated statements.  Consequently, the partnership’s financial contribution is now reflected only through the equity‑method income line rather than through explicit subscriber‑level metrics.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the structural shift in Disney's relationship with A&E and accurately describes the reporting changes (elimination of standalone subscriber table, consolidation into broader discussion, shift to equity-method accounting). However, there are significant quantitative discrepancies: (1) The LLM does not mention the specific subscriber numbers from either year (69 million in 2022, 58 million in 2023 per ground truth), which are key factual details requested in the question. (2) The LLM correctly identifies the 50% equity stake but fails to provide the 2022 baseline context showing this was a change from a partnership model. (3) The LLM's description of reporting changes is accurate and more detailed than ground truth (mentioning specific channels like HISTORY, Lifetime, LMN, FYI), but this additional detail doesn't compensate for missing the core subscriber numbers. The multi-hop reasoning is sound - the LLM correctly synthesizes that the structural change affected both subscriber reporting (elimination of separate counts) and financial reporting (shift to equity-method accounting). The answer demonstrates good understanding of the accounting implications but fails to provide complete quantitative specificity that the ground truth emphasizes. The semantic understanding of the relationship change is correct, but the answer is incomplete on the numerical metrics that are central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 401,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "\nIn 2023 GE recorded a **$129 million combined realized/unrealized gain** on its AerCap investment—​a swing from the **$865 million loss** reported in 2022 after the company sold the bulk of its AerCap shares and retained only a senior note (see Note 19, “Investment in and note with AerCap realized and unrealized gain (loss)”). By the end of 2024 the remaining AerCap note no longer produces material unrealized gains or losses, so the financial impact of the relationship has essentially disappeared, following the large gain in 2023 and the near‑zero impact in 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that substantially diverge from the ground truth. CRITICAL ERRORS: (1) The LLM correctly identifies the $129 million unrealized gain in 2023, which matches the ground truth. However, it then introduces the $865 million loss from 2022, which is not part of the question's scope (2023-2024 comparison) and creates confusion about the evolution being asked. (2) Most critically, the LLM claims that by 2024 'the remaining AerCap note no longer produces material unrealized gains or losses, so the financial impact of the relationship has essentially disappeared.' This directly contradicts the ground truth, which states that GE recognized 'a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline.' The ground truth indicates a major negative swing (from gain to loss/significantly reduced gain), not a disappearance of material impact. (3) The LLM fails to mention the $5.2 billion decline in gains on retained and sold ownership interests, which is the key quantitative metric showing the evolution of the relationship's financial impact. MULTI-HOP REASONING: The LLM does attempt to synthesize information across years but reaches an incorrect conclusion about the 2024 impact. It characterizes 2024 as having 'near-zero impact' when the ground truth indicates substantial losses or significantly reduced gains with AerCap as a primary contributor. COMPLETENESS: The answer addresses the 2023-2024 evolution but mischaracterizes the 2024 outcome, missing the critical $5.2 billion decline metric. The semantic meaning diverges significantly from ground truth regarding the nature and magnitude of the 2024 financial impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 496,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "\nMastercard’s security model moved from a generic “multi‑layered” description in 2022 to an explicit, ecosystem‑wide risk framework in 2024 that integrates third‑party service‑provider threats into its franchise operating standards, performance monitoring and AI‑driven threat‑intel programs.  By tying third‑party risk management to its stewardship and issue‑resolution processes—and by highlighting “threats and incidents associated with the use of services provided by third‑party providers” in its 2024 filing—the company signals a strategic shift toward proactive, standards‑based controls and continuous collaboration (e.g., public‑private partnerships) to protect the broader payments ecosystem against emerging cyber threats.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Mastercard's security evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the shift from generic 'multi-layered' approach in 2022 to explicit third-party risk integration in 2024; (2) Accurately captures the key strategic elements: ecosystem-wide resilience, third-party provider risk management, and public-private partnerships; (3) Properly synthesizes the multi-hop information across years and security frameworks; (4) Uses appropriate terminology ('franchise operating standards,' 'performance monitoring,' 'AI-driven threat-intel programs') that reflects sophisticated understanding of the evolution; (5) Correctly emphasizes the shift toward proactive, standards-based controls. MINOR WEAKNESSES: (1) The LLM introduces specific operational details ('franchise operating standards,' 'AI-driven threat-intel programs,' 'stewardship and issue-resolution processes') that, while plausible and contextually appropriate, are not explicitly confirmed in the ground truth statement provided. These additions suggest inference beyond the stated ground truth rather than direct synthesis; (2) The ground truth notes 'no explicit mention' of third-party risks in 2022, while the LLM characterizes it as 'generic'—a subtle but acceptable semantic difference; (3) The phrase 'threats and incidents associated with the use of services provided by third-party providers' is correctly attributed to the 2024 filing per ground truth. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension scores high (9/10) based on correct year references (2022, 2024) and accurate temporal sequencing. QUALITATIVE ACCURACY: The reasoning is sound and demonstrates proper multi-hop synthesis across time periods and security frameworks (8/10). The slight deduction reflects the introduction of specific operational details not explicitly confirmed in ground truth. CONTEXTUAL RELEVANCE: Excellent alignment with the question's focus on evolution, third-party risks, and strategic response to emerging threats (9/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 580,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "\nTarget has consistently satisfied the debt‑leverage covenant in both years.  In 2022 it relied on a $3 billion unsecured revolving credit facility that replaced a $2.5 billion facility set to expire in 2023, and in 2023 it swapped that line for a new $3 billion five‑year revolving facility (extended to 2028) while also adding a $1 billion 364‑day facility—yet in each case the company reported that it remained in compliance with the leverage covenant.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility despite addressing the general topic. CRITICAL ERRORS: (1) The LLM states that in 2022 Target 'relied on a $3 billion unsecured revolving credit facility that replaced a $2.5 billion facility set to expire in 2023' - the ground truth makes no mention of a $2.5 billion facility being replaced. This appears to be fabricated detail. (2) The LLM describes the 2023 facility as 'swapped that line for a new $3 billion five-year revolving facility (extended to 2028)' - this is misleading phrasing. The ground truth indicates the EXISTING $3.0 billion facility was EXTENDED to October 2028, not replaced with a new one. This is a material distinction in understanding the credit facility evolution. (3) The LLM correctly identifies the $1 billion 364-day facility added in 2023 and its October 2024 expiration. CORRECT ELEMENTS: The answer correctly states that Target remained in compliance with the debt leverage covenant in both years, and it accurately captures the general theme of facility changes while maintaining compliance. The core conclusion about consistent covenant compliance is accurate. MULTI-HOP REASONING: The answer attempts to synthesize information about facility changes and covenant compliance across two years, but the synthesis contains inaccuracies in the facility details that weaken the analysis. The reasoning structure is sound (facilities changed, compliance maintained) but the specific facts supporting that reasoning are flawed. QUANTITATIVE ACCURACY: While the $3 billion and $1 billion figures are correct, the introduction of the $2.5 billion facility and the mischaracterization of the 2023 facility as a 'swap' rather than an extension represent significant quantitative/structural errors. The dates (2028, 2024) are correct but the facility timeline narrative is distorted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 512,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "\nFrom 2023 to 2024 the AI‑related risk profile shifted from a broad ethical/reputational warning—highlighting that generative AI could produce inaccurate, biased or infringing content and that managing such outcomes would require significant resources—to a more concrete, multi‑dimensional threat.  In the 2024 filing Salesforce emphasizes that new AI offerings such as Agentforce and the Customer 360 AI platform now face heightened regulatory scrutiny (e.g., the EU AI Act, DSA), intensified ethical and brand‑reputational exposure, and the need for extensive testing and compliance, making AI risks far more material to its business.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Salesforce's AI risk profile from 2023 to 2024 and correctly identifies key elements: the shift from general ethical/reputational concerns to more concrete, multi-dimensional threats; the specific mention of Agentforce and Customer 360 AI platform; regulatory scrutiny (EU AI Act, DSA); and the need for testing and compliance. The answer demonstrates sound multi-hop reasoning by synthesizing information about how risks evolved across the two-year period. However, there are some notable differences from the ground truth: (1) The LLM characterizes 2023 risks as 'broad ethical/reputational warning' about generative AI, whereas the ground truth states 2023 risks were primarily about 'third-party integrations and applications' with potential warranty claims—this is a significant semantic difference in what the baseline risk was. (2) The LLM does not explicitly mention the 2023 focus on third-party offerings and customer expectations for warranties, which was a key distinguishing feature of the earlier risk profile. (3) The ground truth emphasizes 'increased costs related to AI governance, compliance, and testing' as a new 2024 concern, while the LLM mentions 'extensive testing and compliance' but doesn't explicitly call out the cost dimension. (4) The LLM adds 'Customer 360 AI platform' which is not mentioned in the ground truth answer, though this may be accurate from the filing. The answer is directionally correct about the evolution and identifies the right 2024 risks, but mischaracterizes what the 2023 baseline was, which affects the accuracy of the comparison. No quantitative errors are present (no numbers to verify). The reasoning is sound but incomplete in capturing the full scope of the shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 481,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Lowe’s kept its core promise that most parcel‑eligible items can be shipped within two business days at standard rates, but it accelerated the speed of its fulfillment network.  In 2024 the company expanded same‑day delivery through its gig‑provider network and, for the first time, began offering next‑day delivery for major appliances to nearly every U.S. ZIP code.  The rollout of a market‑based delivery model also broadened geographic coverage and improved flow‑management, enabling faster, more reliable parcel delivery across all channels.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core facts: (1) FY2023 baseline of two business day delivery for parcel-eligible items at standard rates, (2) FY2024 improvement to two business days or less, and (3) next-day delivery expansion for major appliances to nearly every U.S. ZIP code. The numeric references and time periods are accurate. WEAKNESSES: The LLM introduces information not present in the ground truth answer, specifically mentioning 'same-day delivery through its gig-provider network' and 'market-based delivery model.' While these details may be factually accurate from the source documents, they represent additions beyond what the ground truth specifies. The ground truth focuses on the evolution from 'within two business days' to 'within two business days or less' as the key refinement, but the LLM's phrasing of 'accelerated the speed of its fulfillment network' and emphasis on same-day delivery shifts the narrative emphasis. The LLM also adds contextual details about 'flow-management' and 'more reliable parcel delivery across all channels' that, while potentially accurate, go beyond the scope of the ground truth answer. MULTI-HOP REASONING: The answer correctly synthesizes the comparison between two fiscal years and identifies the major appliance expansion. However, the introduction of same-day delivery as a primary improvement point diverges from the ground truth's focus on two-business-day-or-less as the main evolution. SEMANTIC EQUIVALENCE: While the core message about next-day appliance delivery is preserved, the emphasis on same-day delivery and market-based models introduces elements not validated by the ground truth, creating potential factual discrepancies with the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 472,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "\nThe February 2021 sale of Dermstore produced a one‑time $335 million pretax gain that added only a fraction of a percent to consolidated revenue and was recorded below operating income, so it does not flow into later periods. From 2022 to 2023 Target’s total revenue slipped modestly (≈ $106 billion → ≈ $105.8 billion, a ~1–2 % decline) and operating income fell sharply (≈ $8.9 billion → ≈ $5.7 billion, a ~48 % drop), a change driven by lower sales and margin pressure rather than any continuing impact from the Dermstore transaction.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key facts: (1) Dermstore was sold in February 2021 for a $335 million pretax gain, (2) the gain was recorded below operating income (in Net Other Income/Expense), and (3) Dermstore had minimal ongoing financial impact in 2022-2023. The answer appropriately notes that the one-time gain does not flow into later periods.\n\nSTRENGTHS: The $335 million gain figure is correct. The February 2021 sale date is accurate. The characterization that Dermstore represented less than 1% of revenues/operating income is implicitly supported by the LLM's statement that it \"added only a fraction of a percent to consolidated revenue.\" The reasoning that the gain was recorded below operating income is sound.\n\nWEAKNESSES: (1) The LLM provides Target's overall revenue and operating income figures for 2022-2023 ($106B→$105.8B revenue; $8.9B→$5.7B operating income), but these are not directly relevant to answering how the Dermstore sale's financial impact evolved. The question asks specifically about Dermstore's impact, not Target's overall performance. (2) The LLM does not explicitly state that Dermstore represented less than 1% of consolidated revenues, operating income, and net assets in both years—this key quantitative comparison from the ground truth is missing. (3) The answer conflates Target's overall financial decline with the Dermstore impact, which could confuse readers about what actually drove the changes.\n\nMULTI-HOP REASONING: The answer correctly synthesizes that (a) the sale occurred in 2021, (b) the gain was one-time and recorded below operating income, and (c) therefore no continuing impact exists in 2022-2023. However, it then pivots to Target's overall performance rather than maintaining focus on Dermstore's specific impact evolution.\n\nSEMANTIC EQUIVALENCE: The core message aligns with ground truth—minimal/no significant post-sale impact in both years. However, the answer adds extraneous information about Target's overall revenue/operating income decline that, while factually defensible, doesn't directly address the Dermstore-specific question.\n\nCALCULATION VERIFICATION: The revenue decline calculation ($106B to $105.8B ≈ 0.2% decline, not 1-2%) and operating income decline ($8.9B to $5.7B ≈ 36% decline, not 48%) contain minor arithmetic errors, though the directional statements are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 633,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Salesforce moved Data Cloud from a supplemental data‑lake that simply fed analytics into a core, company‑wide data fabric that underpins its entire Customer 360 suite.  In 2024 the platform is presented as the engine for AI‑driven automation (Einstein 1/Agentforce), low‑code app development and cross‑selling across Sales, Service, Marketing and Commerce, and it is monetised through a consumption‑based model that ties directly to the company’s growth levers.  This deeper integration gives Data Cloud a differentiated, “single source of truth” advantage against other CRM and data‑platform competitors, positioning it as a strategic differentiator in Salesforce’s broader service portfolio.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains significant factual and reasoning errors that diverge substantially from the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies the time period (2023 to 2024)\n- Correctly mentions consumption-based pricing model\n- Correctly identifies Data Cloud's integration with multiple Salesforce products (Sales, Service, Marketing, Commerce)\n- Correctly notes the shift in positioning\n\nMAJOR ERRORS AND OMISSIONS:\n\n1. MISCHARACTERIZATION OF 2023 POSITIONING: The LLM claims Data Cloud was a \"supplemental data-lake that simply fed analytics\" in 2023. The ground truth states it was already described as a \"hyperscale, trusted data engine native to Salesforce\" with emphasis on unified enterprise data and 360-degree customer view. This is a fundamental misrepresentation of the 2023 baseline.\n\n2. MISSING CRITICAL 2024 CONTEXT: The ground truth emphasizes that 2024 filings introduced COMPETITIVE RISK and UNCERTAINTY as key themes - noting that markets for Data Cloud are \"relatively new and uncertain\" and that Salesforce faces increasing competition. The LLM completely omits this critical strategic risk dimension, instead presenting an overly optimistic narrative about differentiation.\n\n3. INCOMPLETE MONETIZATION DISCUSSION: While the LLM mentions consumption-based pricing, it fails to capture the ground truth's key point that Salesforce has \"limited experience in pricing consumption-based models.\" This is a material acknowledgment of uncertainty, not a strength.\n\n4. UNSUPPORTED CLAIMS: The LLM asserts Data Cloud provides a \"differentiated, 'single source of truth' advantage\" and positions it as a \"strategic differentiator.\" The ground truth does not support these claims; instead, it emphasizes competitive challenges and market uncertainty.\n\n5. MISSING RISK NARRATIVE: The ground truth explicitly notes a shift from \"product-centric messaging to one that includes strategic risk and monetization challenges.\" The LLM's answer is entirely product-centric and omits the risk/challenge dimension entirely.\n\nMULTI-HOP REASONING: The LLM failed to synthesize the complete narrative across 2023-2024 filings. It created a narrative of strategic elevation and competitive advantage that contradicts the ground truth's emphasis on emerging risks and competitive pressures.\n\nSEMANTIC EQUIVALENCE: While some individual elements align (consumption pricing, product integration), the overall semantic meaning diverges significantly. The ground truth presents a cautious, risk-aware positioning; the LLM presents an optimistic, advantage-focused narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 696,
        "total_tokens": 2078
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "\nIn the 2023 filing (Note 8), Lowe’s designated its forward interest‑rate swaps as cash‑flow hedges, recording the effective portion of hedge gains/losses in other comprehensive income and reclassifying those amounts to earnings; the swaps settled in connection with the March 2023 $3 bn note issuance generated a $247 million cash receipt, with the net gain flowing through OCI before it was recognized in earnings. By the 2024 filing (Note 8), the same swaps are accounted for as fair‑value hedges of the newly issued fixed‑rate notes using the shortcut method, which assumes perfect effectiveness and causes the hedge’s fair‑value changes to offset the debt’s fair‑value changes, eliminating any net earnings impact and leaving only the cash receipt in earnings. Consequently, the financial impact shifted from a reclassification of OCI gains into earnings in 2023 to a zero‑impact fair‑value hedge in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the key evolution in LOW's interest rate swap accounting between 2023 and 2024. STRENGTHS: (1) All critical numbers are accurate: $2.0 billion notional amount, $247 million cash receipt, March 2023 note issuance correctly identified. (2) Hedge designation shift correctly identified: cash flow hedges in 2023 to fair value hedges in 2024. (3) Accounting treatment differences properly explained: OCI treatment in 2023 vs. shortcut method with perfect effectiveness assumption in 2024. (4) Financial impact distinction is accurate: reclassification of OCI gains to earnings in 2023 vs. zero net earnings impact in 2024. (5) Multi-hop synthesis is sound, correctly connecting the swap contracts to the debt instruments and explaining the accounting implications. (6) Note references (Note 8) are appropriately cited. MINOR ISSUES: (1) The LLM states the note issuance was '$3 bn' while the ground truth specifies '$2.0 billion' notional amount for the swaps - this appears to conflate the total note issuance size with the swap notional amount. The ground truth doesn't explicitly state the total note size, but the swap notional of $2.0 billion is the relevant figure. (2) The phrase 'newly issued fixed-rate notes' in 2024 could be slightly clearer - the ground truth indicates these are the March 2023 Notes being hedged with fair value hedges in 2024, not necessarily newly issued in 2024. (3) Minor wording differences ('cash receipt' vs. 'settlement receipt') are semantically equivalent. The answer successfully captures the essence of the accounting evolution and demonstrates proper understanding of hedge accounting mechanics and the shift in treatment methodology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 478,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "\nFrom 2022 to 2023 Target moved owned‑brand management from a supporting pillar of its six‑pillar strategy to a core growth driver.  In the 2023 filing the company explicitly says it is “strengthening our owned‑brands portfolio, curating leading national brands, and expanding the breadth and depth of signature partnerships” to delight customers with newness, style and value and to increase relevance, traffic and market‑share.  Thus, while the 2022 strategy merely highlighted owned brands as a differentiator, the 2023 strategy makes expanding and deepening that portfolio a strategic objective central to its overall growth plan.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Target's owned brands strategy evolution from 2022 to 2023. STRENGTHS: (1) Correctly identifies the shift from 2022 to 2023 in strategic emphasis; (2) Accurately captures the 2023 language about 'strengthening our owned-brands portfolio, curating leading national brands, and expanding the breadth and depth of signature partnerships'; (3) Correctly identifies the strategic objectives of delighting customers with 'newness, style and value' and increasing 'relevance, traffic and market-share'; (4) Properly synthesizes the multi-hop comparison showing evolution from descriptive presence to active strategic driver; (5) No quantitative errors - dates and years are correct. MINOR ISSUES: (1) The LLM characterizes the 2022 approach as part of a 'six-pillar strategy' which is not explicitly mentioned in the ground truth, though this appears to be accurate contextual detail from the filing; (2) The ground truth mentions 'over 40 such brands' in 2022, which the LLM answer does not include - this is a minor omission of a specific quantitative detail; (3) The LLM's phrasing 'moved from a supporting pillar...to a core growth driver' is slightly more interpretive than the ground truth's 'move from simply showcasing owned brands to actively leveraging them as a strategic differentiator,' though semantically equivalent. The answer correctly addresses the question's multi-part requirements (portfolio emphasis and strategic objectives) and demonstrates sound multi-hop reasoning across the two fiscal years. The semantic meaning aligns well with the ground truth despite some wording differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 452,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "\nFrom 2022 to 2023 GM moved from building and pilot‑testing its software‑enabled services and a unified “software‑defined vehicle” platform (e.g., early Super Cruise, OnStar, Ultium EV architecture and charging‑network partnerships) to mass‑deploying that platform across most of its lineup and brands.  In 2023 the company began rolling out over‑the‑air updates, subscription‑based features and expanded services such as BrightDrop and GM Defense on models like the 2024 Cadillac LYRIQ and Silverado EV, while also scaling Super Cruise to hundreds of thousands of miles of compatible roads.  This acceleration shows GM is committing substantial resources to a scalable digital infrastructure that can generate recurring software revenue and support its EV and AV ambitions.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution narrative and correctly identifies key elements like the 2024 Cadillac LYRIQ and Silverado EV as deployment examples, over-the-air updates, and the shift toward scalable digital infrastructure. However, there are significant issues: (1) The LLM introduces entities and claims not supported by the ground truth, including BrightDrop, GM Defense, OnStar, Ultium EV architecture, charging-network partnerships, and 'hundreds of thousands of miles of compatible roads' for Super Cruise - none of these appear in the original answer. (2) The LLM claims these services were 'mass-deployed across most of its lineup' in 2023, which is stronger than the ground truth's more measured statement about 'select 2024 models.' (3) The LLM mentions 'subscription-based features' and 'recurring software revenue' which are not explicitly mentioned in the ground truth. (4) Quantitatively, the LLM provides no specific numbers while the ground truth emphasizes the platform's capability for 'over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience' - the LLM mentions these but adds unsupported details. (5) The core multi-hop reasoning is sound - comparing 2022 (general services) to 2023 (specific platform deployment) - but the LLM embellishes beyond what the ground truth supports. The answer reads as plausible but introduces speculative details that go beyond the filing evidence, which is a critical error in financial document analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 420,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "\nThe Optimized Application Experiences/Observability category grew from **$581 million in fiscal 2022 to $661 million in fiscal 2023**, an increase of **$80 million (≈14 %)**.  This expansion was attributed to stronger demand for **ThousandEyes (and the broader Observability suite)**, indicating that ThousandEyes’ revenue contribution rose materially between fiscal 2022 and fiscal 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides category-level revenue figures ($581M to $661M, +$80M or 14%) and correctly identifies ThousandEyes as a key growth driver. However, there are significant issues with the multi-hop synthesis: (1) The ground truth distinguishes between two different metrics: FY2022 shows a $75M growth (11%) in the Optimized Application Experiences category, while FY2023 shows an $80M growth (14%) in the Observability category. The LLM conflates these by presenting only the FY2023 growth figure ($80M, 14%) without clearly addressing the FY2022 comparison ($75M, 11%). (2) The LLM provides absolute category revenue figures ($581M and $661M) which are not mentioned in the ground truth, making it unclear if these are correct or if they represent a different level of aggregation. (3) The ground truth explicitly states the growth was 'driven by ThousandEyes and Intersight' in FY2022 and 'attributed to growth in ThousandEyes and monitoring and analytics offerings' in FY2023, showing specific attribution. The LLM only vaguely references 'stronger demand for ThousandEyes (and the broader Observability suite)' without the specific co-drivers. (4) The ground truth emphasizes the evolution showing both absolute growth increasing ($75M to $80M) and percentage growth increasing (11% to 14%), demonstrating an upward trend. The LLM only presents the FY2023 figures without the comparative evolution. The answer is partially correct on the directional trend and ThousandEyes' importance, but fails to properly synthesize the year-over-year comparison that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 437,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "\nIn the 2023 filing the amendment was only listed in the exhibit index (Item 10.34) with a brief citation to a prior 10‑Q, whereas the 2024 filing repeats that same reference but now embeds it in the main Item 10.34 discussion and again in the exhibit list. This shift moves Amendment No. 4 from a peripheral footnote to a core disclosed item, showing that Lockheed Martin is deliberately elevating the amendment in its governance and compensation disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF CHANGE: The ground truth states Amendment No. 4 shifted FROM a highlighted disclosure (2023) TO a more integrated/consolidated part of broader severance plan history (2024), representing a CONSOLIDATION. The LLM claims the opposite - that it moved FROM peripheral footnote TO core disclosed item, suggesting ELEVATION. This is a fundamental misreading of the disclosure evolution. (2) INCORRECT EXHIBIT STRUCTURE: The ground truth clearly states that in 2024, Amendment No. 4 appears 'as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5)' - indicating it became PART OF a consolidated exhibit rather than standalone. The LLM incorrectly suggests it was 'embedded in the main Item 10.34 discussion and again in the exhibit list,' implying dual prominence rather than consolidation. (3) MISINTERPRETATION OF INTENT: The ground truth indicates a 'more consolidated and retrospective approach to disclosure' in 2024. The LLM interprets this as 'deliberately elevating the amendment in its governance and compensation disclosures,' which is the opposite conclusion. (4) QUANTITATIVE ACCURACY: The exhibit numbers (10.34) and source document (September 2022 10-Q) are correctly cited, so quantitative elements are accurate. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the comparative analysis between 2023 and 2024 filings, arriving at an inverted conclusion about the disclosure strategy evolution. The answer demonstrates a fundamental misunderstanding of what 'consolidation' versus 'elevation' means in the context of SEC filing disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 467,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "\nJPMorgan’s capital adequacy improved in 2024: its **Standardized CET1 capital ratio rose from 15.0 % (as of 31 Dec 2023) to 15.7 % (as of 31 Dec 2024)**, reflecting a higher capital buffer relative to risk‑weighted assets, while its **Tier 1 leverage ratio stayed flat at about 7.2 % (up from 6.6 % in 2022 but unchanged from 2023 to 2024)**, comfortably above the regulatory minimum of 4.0 % (plus any required buffers). Both ratios remained well‑above the minimum thresholds set by the Basel III framework and the U.S. capital‑conservation and leverage requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "ANALYSIS: The LLM answer provides additional detail beyond the ground truth but contains a critical factual discrepancy that undermines its accuracy.\n\nCORRECT ELEMENTS:\n- Standardized CET1 capital ratio of 15.0% for 2023 is correct\n- Tier 1 leverage ratio of 7.2% for 2024 is correct\n- Regulatory minimum of 4.0% for Tier 1 leverage ratio is correct\n- Overall compliance narrative is sound\n- Proper identification of Basel III framework context\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. QUANTITATIVE ERROR - The LLM states the Standardized CET1 capital ratio rose to 15.7% in 2024. The ground truth does not provide a 2024 CET1 ratio figure. The LLM appears to have introduced a number not present in the original answer, which is a factual error.\n2. UNSUPPORTED CLAIM - The statement about Tier 1 leverage ratio being \"6.6% in 2022\" is not mentioned in the ground truth and cannot be verified.\n3. INCOMPLETE COMPARISON - While the LLM provides year-over-year comparison for CET1 (15.0% to 15.7%), the ground truth only provides 2023 CET1 data and 2024 Tier 1 leverage data, not a complete parallel comparison.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes that JPMorgan maintained compliance across both years and that ratios exceeded minimums. However, the introduction of unverified 2024 CET1 data (15.7%) represents a factual error rather than sound synthesis.\n\nSEMANTIC EQUIVALENCE: The core message about compliance and capital strength is preserved, but the specific quantitative claims diverge from ground truth.\n\nJUSTIFICATION: The answer loses points primarily for introducing a specific 2024 CET1 ratio (15.7%) that is not in the ground truth, which is a critical error in financial reporting accuracy. The qualitative reasoning about compliance is sound, but the quantitative accuracy is compromised by this unsupported figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 503,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "\nBetween 2022 and 2023 GM Financial shifted from being buried inside the aggregated “Total Automotive” segment to being reported as a distinct, stand‑alone reportable segment.  The 2022 10‑K (pages 97‑101) shows its EBT‑adjusted earnings at roughly $2.7 billion within the consolidated totals, whereas the 2023 filing (pages 61‑65) presents GM Financial with $13.4 billion of revenue and $5.0 billion of EBT‑adjusted earnings, and discloses its interest‑income and interest‑expense separately in the consolidated statements.  This change reflects a deeper integration of GM Financial’s financing activities into GM’s overall financial presentation and a more explicit, segment‑level financial reporting.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. (1) MAJOR ERROR - SEGMENT CLASSIFICATION: The LLM claims GM Financial shifted from being 'buried inside the aggregated Total Automotive segment' to being 'a distinct, stand-alone reportable segment' between 2022 and 2023. The ground truth indicates GM Financial was consistently described as a segment in both years, with the evolution being about more detailed disclosure of tax adjustments and integration mechanics, NOT a change in segment reporting status. This is a critical mischaracterization. (2) QUANTITATIVE ERRORS: The LLM provides specific financial figures ($2.7B EBT in 2022, $13.4B revenue and $5.0B EBT in 2023) with page references, but these numbers cannot be verified against the ground truth provided and appear to be fabricated or misattributed. The ground truth does not mention these specific figures or suggest such dramatic changes in reported earnings. (3) REASONING FLAW: The LLM's core thesis about segment reclassification is unsupported by the ground truth, which focuses on changes in how tax adjustments and intercompany transactions are disclosed and explained, not on segment reporting structure changes. (4) MISSING CONTEXT: The LLM completely misses the actual evolution described in the ground truth - the shift from general description of tax adjustments to more explicit emphasis on deferred tax positions and consolidated tax return impacts. (5) CITATION ISSUES: The page references provided (97-101 for 2022, 61-65 for 2023) cannot be verified and may be incorrect. The answer demonstrates a fundamental misunderstanding of what changed between the two years, focusing on segment classification rather than financial presentation and disclosure mechanics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 484,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "\nBetween 2022 and 2024 the company kept the same accounting treatment for step‑rent and other periodic rent escalations—i.e., it continues to recognize them on a straight‑line basis over the lease term (including any renewal options that are reasonably certain to be exercised). However, the 2024 disclosure refines the presentation: it now explicitly classifies rent increases that are tied to price‑index changes or the greater of a minimum guarantee or sales volume as “variable lease payments,” whereas the 2022 filing merely described such increases as part of the lease payments without a separate variable‑payment label. Consequently, the 2024 filing provides a clearer, more detailed disclosure of how these periodic rent adjustments are measured and reflected in lease expense.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL FACTUAL ERROR: The LLM answer directly contradicts the ground truth on the core accounting treatment change. Ground truth states that by 2024, rent increases based on price indices or sales volume are NOW RECOGNIZED AS VARIABLE LEASE PAYMENTS (not straight-lined). The LLM answer claims the company 'continues to recognize them on a straight-line basis' and that 2024 merely provides 'clearer disclosure' with a 'label' change. This is fundamentally incorrect. The ground truth indicates an actual CHANGE IN ACCOUNTING TREATMENT from straight-line (2022) to variable lease payment recognition (2024), not just a disclosure refinement. The LLM mischaracterized this as a presentation/labeling change rather than a substantive accounting method change. The LLM's statement that 'the 2024 filing provides a clearer, more detailed disclosure' while maintaining the same treatment directly contradicts the ground truth's assertion of a 'shift in accounting treatment' to a 'more dynamic approach.' Quantitative accuracy is acceptable (no specific numbers were provided in either answer to verify), but the qualitative understanding of the accounting evolution is severely flawed. The LLM failed to recognize the multi-hop synthesis required: comparing 2022 treatment (straight-line) with 2024 treatment (variable payment recognition) and identifying the substantive change between them.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 386,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "\nThe 2023 filing projected $1.86 billion of benefit payments for 2025 and $10.02 billion for the 2029‑2033 horizon, while the 2024 filing revises those estimates to $1.80 billion for 2025 and roughly $9.99 billion for the next long‑term block (2030‑2034, which covers the same 2029‑2033 period), showing a modest decline in both the near‑term and long‑term expected payouts.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a significant factual error in the 2024 projection for 2025 payments. Ground truth states the 2024 projection for 2025 is $1,860 million (same as 2023), but the LLM claims it 'revises those estimates to $1.80 billion for 2025,' which is $1,800 million - a $60 million discrepancy. This is a material error that contradicts the ground truth statement that the 2025 payment 'increased slightly to $1,860 million' (implying no change from 2023). The long-term projections are approximately correct ($10.02B for 2023 period, $9.99B for 2024 period), though the LLM's characterization of the 2030-2034 period as 'covering the same 2029-2033 period' is confusing and technically inaccurate - these are different time periods (2029-2033 vs 2030-2034), not the same period. The LLM correctly identifies the overall trend of 'modest decline in both near-term and long-term expected payouts,' but this conclusion is undermined by the incorrect 2025 figure. The answer addresses the multi-part question structure and correctly synthesizes information across 2023 and 2024 filings, but the quantitative errors are significant enough to substantially reduce reliability. The semantic framing is reasonable, but factual accuracy on specific dollar amounts is paramount in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 373,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "\nThe 2023 filing mentioned resolution‑plan obligations only in broad terms, tying them to liquidity‑risk management and the possible effects of funding‑cost pressures. In the 2024 filing the language was sharpened: it explicitly refers to “addressing obligations under its resolution plan” and to “pre‑positioning of liquidity in subsidiaries,” and it stresses that higher funding costs, credit‑rating downgrades and regulatory liquidity‑ratio requirements now directly shape the cost and feasibility of meeting those obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but has significant gaps in completeness and reasoning quality. STRENGTHS: (1) Correctly identifies that 2023 filings mentioned resolution plan obligations in broad terms related to liquidity risk management; (2) Accurately notes that 2024 filings became more explicit with specific language about 'pre-positioning of liquidity in subsidiaries'; (3) Correctly identifies funding costs and regulatory liquidity-ratio requirements as key themes; (4) No quantitative errors in dates or numbers (both years correctly cited). WEAKNESSES: (1) INCOMPLETE SYNTHESIS - The LLM answer fails to mention several key elements from the ground truth: the specific mention of liquidity coverage ratio (LCR) and net stable funding ratio (NSFR) requirements in 2023; the regulatory demands outside the U.S. regarding subsidiary liquidity pre-positioning; the reference to Federal Home Loan Bank borrowings as a traditional funding source; (2) MISSING EVOLUTION NARRATIVE - The ground truth emphasizes a shift toward framing resolution risks within 'broader context of regulatory evolution and macroeconomic uncertainty' and 'dynamic regulatory expectations and systemic events.' The LLM answer mentions credit-rating downgrades and regulatory requirements but doesn't capture the systemic event/macroeconomic uncertainty dimension that represents the key evolution between years; (3) INCOMPLETE 2024 CONTEXT - The ground truth notes that 2024 disclosures specifically addressed how resolution obligations interact with 'changes in laws, rules, and regulations—especially in response to economic effects of systemic events.' The LLM answer doesn't capture this systemic/regulatory evolution angle; (4) REASONING GAP - While the LLM correctly identifies that language became 'sharpened' between years, it doesn't fully explain the conceptual shift from static liquidity requirements to dynamic regulatory expectations. The answer reads more as a list of elements rather than a coherent narrative of evolution. MULTI-HOP ASSESSMENT: The question requires synthesizing information across 2023 and 2024 filings to identify how disclosures evolved. The LLM partially succeeds in identifying year-to-year differences but misses the broader thematic evolution around regulatory dynamism and systemic risk considerations that constitute the core of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 637,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "\nBetween 2022 and 2023 Optum Rx’s revenue‑recognition model stayed anchored on recognizing product revenue when prescriptions are dispensed and recognizing service‑based fees over the contract term (e.g., value‑based or multi‑year agreements), but the proportion of revenue derived from longer‑duration service arrangements grew, leading to a greater share of revenue being recognized over time rather than at a single point of sale.  Accordingly, accounts receivable rose from **$7.1 billion at the end of 2022** (UNH 10‑K 2022, pp. 4‑8) to **$8.6 billion at the end of 2023** (UNH 10‑K 2023, pp. 44‑48), reflecting the larger balances outstanding from pharmacy‑product sales and the longer‑term service fees.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The quantitative data is accurate - accounts receivable figures of $7.1 billion (2022) and $8.6 billion (2023) match the ground truth exactly. (2) The LLM correctly identifies the core revenue recognition model based on prescription dispensing. (3) The citation format and page references appear reasonable for 10-K filings. WEAKNESSES: (1) The LLM introduces a significant claim not present in the ground truth: that 'the proportion of revenue derived from longer-duration service arrangements grew' and that there was 'a greater share of revenue being recognized over time rather than at a single point of sale.' The ground truth states the financial structure 'remained aligned with this model' - indicating continuity, not evolution toward service-based arrangements. (2) The LLM's explanation of the accounts receivable increase attributes it to 'longer-term service fees,' but the ground truth more conservatively states this 'suggests either increased transaction volume or changes in payment timing' without confirming a shift toward service-based revenue. (3) The LLM conflates two distinct concepts: the revenue recognition timing (which remained consistent) with a claimed shift in the composition of revenue sources (which is not supported by the ground truth). MULTI-HOP REASONING: The LLM attempts to synthesize revenue recognition policy with accounts receivable changes, but does so by introducing unsupported claims about structural evolution. The ground truth indicates stability in the model with growth in receivables, while the LLM suggests a meaningful shift in business composition. SEMANTIC ISSUE: The question asks how the structure 'evolved' - the LLM interprets this as showing change, while the ground truth indicates the structure remained fundamentally the same with quantitative growth in receivables. This represents a material difference in interpretation of the underlying financial evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 524,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "\nUPS’s interest‑rate hedge program has been scaled back sharply between 2022 and 2024: the reclassification of losses from AOCI to interest expense fell from about **$11 million in 2022** (the amount recognized in the 2022 10‑K for its floating‑to‑fixed swaps) to **essentially $0 in 2024**, where the “Amount of gain (loss) reclassified from AOCI on derivatives” for interest‑rate contracts shows no material loss.  Consequently, the company’s quantitative exposure to interest‑rate movements has declined, and its strategic approach has shifted away from actively using floating‑to‑fixed swaps—relying instead on fixed‑rate debt issuances and other mechanisms to manage interest‑rate risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM cites '$11 million in 2022' as losses reclassified from AOCI, but the ground truth specifies a '$28 million notional amount' for Floating to Fixed Interest Rate Swaps in 2022. These are different metrics (notional amount vs. reclassified losses), and the LLM appears to have confused or misidentified the relevant financial figure. The claim of 'essentially $0 in 2024' contradicts the ground truth's assertion that UPS articulated a 'broader strategy' in 2024. (2) DIRECTIONAL MISINTERPRETATION: The LLM concludes that UPS 'scaled back sharply' and 'shifted away from actively using floating-to-fixed swaps,' which is the opposite of the ground truth's finding that the company evolved toward 'a more comprehensive interest rate risk management approach' and 'more intentional and strategic deployment.' (3) STRATEGIC MISCHARACTERIZATION: The ground truth emphasizes an evolution FROM limited use TO broader strategic deployment. The LLM inverts this narrative, claiming a reduction in strategic use. (4) INCOMPLETE SYNTHESIS: The LLM fails to address the key ground truth finding about the 2024 articulation of a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio.' Instead, it focuses on AOCI reclassifications and loss amounts that don't directly address the notional exposure or strategic intent. (5) REASONING FLAW: The LLM's logic that declining AOCI losses equals declining strategic use is unsound—changes in P&L recognition don't necessarily reflect changes in notional exposure or strategic intent. The answer demonstrates a fundamental misunderstanding of the question's focus on 'quantitative exposure and strategic approach' evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 498,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "\nBetween 2022 and 2023 GM deepened its partnership with LG Energy Solution (LGES) by turning the 2022 announcement of an equally‑owned **Ultium Cells LLC** joint venture into an operational supply chain for its EV battery cells, and by negotiating commercial terms that let LGES **reimburse GM for a portion of the recall‑related costs** tied to the Bolt‑EV battery defects.  As disclosed in the 2023 filing (Notes 18‑23), GM had accrued $2.6 billion for the Bolt recall and recorded a $1.6 billion receivable from LGES, leaving a remaining $0.6 billion accrual at year‑end 2023—showing that the JV now also serves as a cost‑share mechanism for recall expenses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of GM's evolving relationship with LG Energy Solution. QUANTITATIVE VERIFICATION: All financial figures are correct - $2.6 billion total Bolt recall accrual, $1.6 billion receivable from LGES, and the implied $1.0 billion remaining accrual (though the LLM states $0.6 billion, which appears to be an arithmetic error: $2.6B - $1.6B = $1.0B, not $0.6B). This is a minor calculation discrepancy. ENTITY ACCURACY: Correctly identifies Ultium Cells LLC as the joint venture, properly names LG Energy Solution (LGES), and accurately references 2022-2023 timeframe. MULTI-HOP REASONING: Excellently synthesizes information across multiple dimensions - (1) the strategic JV announcement in 2022, (2) operational implementation by 2023, (3) the shift to cost-sharing mechanism, and (4) the specific financial mechanics of the recall liability and receivable. The narrative correctly captures the transition from strategic collaboration to transactional cost-sharing. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core message as the ground truth - that the relationship evolved from pure strategic partnership to include financial liability management. The phrase 'cost-share mechanism' effectively captures the transactional dynamic mentioned in the ground truth. COMPLETENESS: Addresses all aspects of the question including joint venture activities (Ultium Cells), recall-related costs ($2.6B accrual, $1.6B receivable), and the evolution between years. The citation of Notes 18-23 adds credibility. MINOR ISSUE: The $0.6 billion figure for 'remaining accrual at year-end 2023' is mathematically incorrect (should be $1.0 billion), which represents a calculation error despite correct source numbers. This is the primary weakness in an otherwise excellent response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 500,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 the Observability product category grew 14 percent, rising from **$581 million to $661 million**. This increase was driven primarily by stronger sales of the **ThousandEyes** offering, which helped lift Observability revenue by **$80 million** (≈ 14 %) over the two‑year span. Consequently, ThousandEyes’s contribution expanded noticeably, underpinning the overall growth in the Observability segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) WRONG GROWTH RATE: LLM states 14% growth, but ground truth shows 27% growth in fiscal 2023. (2) WRONG DOLLAR AMOUNTS: LLM claims $581M to $661M ($80M increase), but ground truth indicates $176M increase in fiscal 2023 alone. (3) INCORRECT TIME PERIOD FRAMING: LLM describes growth as 'over the two-year span' when the question asks about evolution FROM fiscal 2022 TO fiscal 2023, which should focus on the fiscal 2023 performance specifically. (4) MISSING KEY INFORMATION: LLM fails to mention the Splunk acquisition/inclusion as a contributor to fiscal 2023 growth, and doesn't distinguish between total growth (27%) and organic growth excluding Splunk (15%). (5) INCOMPLETE SYNTHESIS: The answer doesn't properly synthesize that ThousandEyes was a key driver in both years but with different contexts - in FY2022 it contributed to an $80M increase, while in FY2023 it was one of multiple contributors to a $176M increase. (6) CALCULATION ERROR: The $80M figure is incorrectly attributed to the two-year span when it actually represents FY2022 growth. The LLM demonstrates poor multi-hop reasoning by conflating different fiscal periods and failing to accurately represent the magnitude and composition of growth between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 376,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 the $276 million 7.620% debentures kept the same redemption mechanics: they remain callable at UPS’s option at any time, with a redemption price equal to the greater of principal + accrued interest or the present value of the remaining scheduled payments discounted at a Treasury yield + 5 bps, and they are not subject to a sinking‑fund requirement. The interest rate stayed fixed at 7.620% (established after the 2020 reduction) and continues to be paid semi‑annually in April and October, with no material change to either the redemption terms or the interest‑payment structure over the two‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the evolution of UPS's relationship with the 7.620% Debentures. Key issues: (1) CONTRADICTS GROUND TRUTH ON EVOLUTION: The ground truth explicitly states there was an evolution/shift from 2022 to 2024, with 2022 showing only general description and 2024 showing detailed redemption flexibility and interest payment schedule. The LLM incorrectly claims 'no material change' and that redemption mechanics 'kept the same' between years, directly contradicting the premise that there was clarification/evolution. (2) MISSING CRITICAL CONTEXT: The LLM fails to mention the carrying value ($280 million in 2022) or acknowledge that the detailed redemption terms were newly clarified/specified in 2024, not that they remained unchanged. (3) INCORRECT CHARACTERIZATION: The LLM introduces information about 'the 2020 reduction' and sinking-fund requirements that are not mentioned in the ground truth and appear to be fabricated details. (4) MISSES THE CORE NARRATIVE: The question asks how the relationship 'evolved' - the ground truth answer correctly identifies this as a shift from general to detailed disclosure. The LLM fundamentally misunderstands this by claiming no material change occurred. (5) QUANTITATIVE DATA: While the principal amount ($276M), interest rate (7.620%), maturity date (April 1, 2030), and payment schedule (semi-annual in April/October) are correct, the LLM's interpretation of what changed is wrong. The carrying value of $280 million in 2022 is omitted. The answer demonstrates poor multi-hop reasoning by failing to synthesize the temporal evolution across the 2022-2024 period as described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 465,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2023 the fair‑value of MET’s Fixed‑Maturity Securities AFS slipped slightly, falling from **$6.80 bn** to **$6.71 bn**.  Over that period the portfolio became a bit more weighted toward high‑quality, liquid holdings: U.S. government‑bond holdings rose from **$1.46 bn** to **$1.54 bn**, and corporate‑bond holdings increased from **$2.95 bn** to **$3.03 bn**, while other categories (e.g., foreign bonds, municipals) changed only modestly.  This shift reflects a modest reallocation toward U.S. Treasuries and corporate securities within the overall AFS book.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the question and provides mostly accurate information with sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the time period (end of 2022 to end of 2023) and the company (MET); (2) Accurately reports the total fair value figures: $6.80 bn (2022) and $6.71 bn (2023), which align with the ground truth's $6,714 million for 2023; (3) Correctly states U.S. government bond values: $1.46 bn (2022) and $1.54 bn (2023), matching ground truth's $1,575 million for 2023; (4) Accurately reports corporate securities: $2.95 bn (2022) and $3.03 bn (2023), matching ground truth's $3,083 million for 2023; (5) Properly synthesizes the composition shift and provides appropriate context about the reallocation toward higher-quality holdings; (6) Reasoning about the modest decline in total value while specific categories increased is logically sound. MINOR ISSUES: (1) The ground truth mentions specific Level 1 and Level 2 categorizations ($1,537 million Level 1 for U.S. government bonds, $3,029 million Level 2 for corporate securities), which the LLM answer does not include. However, this is a minor omission as the question asks about 'composition and total fair value' and the LLM provides the key composition breakdown; (2) The ground truth also references 2021 data ($2,164 million), which the LLM does not mention, though the question specifically asks about 2022-2023 evolution, making this omission reasonable. QUANTITATIVE VERIFICATION: All dollar amounts provided by LLM are accurate when converted to millions ($6.80 bn = $6,800 million vs. $6,714 million is a minor rounding difference; $1.54 bn = $1,540 million vs. $1,575 million is within reasonable rounding; $3.03 bn = $3,030 million vs. $3,083 million is within reasonable rounding). The slight discrepancies appear to be rounding variations rather than errors. The multi-hop synthesis correctly combines information about composition changes and total value changes across the two-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 544,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "\nFrom 2022 to 2023 GM deepened its financial stake in Ultium Cells LLC – the 2022 10‑K (pages 40‑44) records an additional ~ $1 billion of equity and a $5.2 billion multi‑year revolving credit line that became available to the JV through 2024, pushing GM’s cumulative investment to roughly $2 billion.  In 2023 the relationship was marked by regulatory action: GM self‑disclosed and settled EPA TSCA violations tied to imports into the JV, agreeing to about $5.1 million in civil penalties that are shared jointly with Ultium Cells LLC (see the 2023 10‑K, pages 26‑30).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) INVESTMENT AMOUNT ERROR: The ground truth states GM's direct financial investment in 2022 was $0.5 billion. The LLM claims the 2022 10-K records 'an additional ~$1 billion of equity' and a '$5.2 billion multi-year revolving credit line,' pushing cumulative investment to 'roughly $2 billion.' These numbers are not supported by the ground truth and appear to conflate different types of financial arrangements (equity investments vs. credit facilities). The ground truth specifically identifies $0.5 billion as the 2022 investment figure. (2) CREDIT LINE CONFUSION: The LLM introduces a $5.2 billion revolving credit line that is not mentioned in the ground truth answer. While credit facilities may exist, conflating them with direct equity investment fundamentally misrepresents the nature and scale of GM's financial involvement. (3) REGULATORY SETTLEMENT - CORRECT: The LLM correctly identifies the February 2023 self-disclosure of TSCA violations and the November 2023 settlement with approximately $5.1 million in joint civil penalties. This portion aligns with ground truth. (4) RELATIONSHIP EVOLUTION - PARTIALLY CORRECT: The LLM correctly captures the shift from investment-based to operationally integrated partnership and the regulatory implications, but the financial figures undermine the credibility of this analysis. (5) MULTI-HOP REASONING: The LLM attempts to synthesize information across 2022 and 2023 filings but introduces unsupported financial figures that create a false narrative about the scale of GM's involvement. The ground truth's key insight about the shift from passive investment to active operational entanglement is present but overshadowed by quantitative errors. The answer demonstrates understanding of the regulatory dimension but fails on the financial dimension, which is critical to answering the question about 'financial involvement.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 538,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "\nBetween 2022 and 2024 the company continued to rely on variable‑priced, index‑based contracts for its natural‑gas and fuel purchases, treating them as “normal purchases and normal sales” that are exempt from mark‑to‑market accounting.  The filings show no substantive change in the nature or extent of these contracts—​the same index‑based approach is described in both years, indicating a consistent use of variable‑priced agreements over the period.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate elements. CORRECT ELEMENTS: (1) The identification of variable-priced, index-based contracts for natural gas and fuel purchases is accurate; (2) The mention of 'normal purchases and normal sales' exception and mark-to-market accounting treatment is correct; (3) The timeframe (2022-2024) is properly referenced. CRITICAL ERRORS: (1) The LLM states 'no substantive change in the nature or extent of these contracts' and describes 'consistent use,' which directly contradicts the ground truth. The ground truth explicitly indicates an EVOLUTION showing a 'shift in how these contracts are managed or accounted for' - the 2024 filings show a more formalized/strategic approach with explicit alignment to accounting frameworks for derivatives, whereas 2022 showed only basic use without such formalization; (2) The LLM misses the key distinction that by 2024, the company 'explicitly noted' these contracts met derivative characteristics - this represents a meaningful change in how the contracts are characterized and managed, not consistency; (3) The ground truth indicates the 2022 contracts lacked specific volume/value disclosure, while 2024 showed more explicit accounting treatment - this is a substantive evolution in contract management and disclosure that the LLM fails to capture. MULTI-HOP REASONING: The LLM failed to synthesize the temporal evolution across the two years. The question asks 'how has...evolved,' requiring identification of changes, but the LLM concluded there were no substantive changes. This represents a fundamental misunderstanding of the multi-hop requirement to compare and contrast the two time periods. The answer is internally consistent but factually incorrect regarding the nature of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 486,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Cisco kept the same set of expense items excluded from the APJC segment’s performance measurement.  In both years the company does **not** allocate – and therefore does not include in segment gross‑margin – research‑and‑development, sales‑and‑marketing, and general‑and‑administrative costs, as well as amortization and impairment of acquisition‑related intangible assets, share‑based compensation expense, significant litigation settlements and other contingencies, restructuring‑related charges, and certain other charges.  No new categories were added or removed; the exclusion list remained unchanged across the two periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the question about Cisco's APJC segment financial reporting evolution between fiscal 2022 and fiscal 2023. STRENGTHS: (1) Correctly identifies that the exclusion approach remained consistent/unchanged across both fiscal years, which is the core finding; (2) Accurately lists all excluded expense categories: R&D, sales and marketing, general and administrative, amortization and impairment of acquisition-related intangible assets, share-based compensation, significant litigation settlements, and restructuring-related charges; (3) Properly synthesizes the multi-hop information by comparing the two fiscal years and concluding no changes occurred; (4) Uses clear, professional language that conveys the same semantic meaning as the ground truth; (5) No quantitative errors or date misstatements. MINOR CONSIDERATIONS: (1) The LLM answer includes a slight variation in phrasing ('other contingencies' and 'certain other charges') which is a reasonable interpretation of the broader exclusion categories, though the ground truth uses slightly different terminology; (2) The LLM answer is slightly more concise than the ground truth but captures all essential information. The answer fully addresses the question's requirement to explain how the reporting approach 'evolved' by correctly identifying that it did not evolve—it remained consistent. This demonstrates proper understanding of the multi-hop comparison required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 409,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 UnitedHealth shifted from a broad‑based cost‑containment model—relying on underwriting criteria, product design and competitive provider contracts—to a more targeted approach that explicitly addresses the rise in senior outpatient utilization. In 2023 the company emphasized engaging physicians and senior members with data‑driven information and care‑management tools, expanding value‑based payment arrangements and clinical engagement to steer high‑cost outpatient procedures toward lower‑cost, high‑quality settings, while still using underwriting and contract negotiations but now coupled with consumer‑focused strategies to curb senior outpatient cost growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the company as UnitedHealth (UNH) and the 2022-2023 timeframe; (2) Accurately captures the shift from general to targeted approaches; (3) Correctly identifies data-driven engagement with physicians and consumers as a 2023 strategy; (4) Appropriately mentions value-based payment arrangements and clinical engagement; (5) No quantitative errors in dates or numbers. WEAKNESSES: (1) The LLM introduces specific strategies (underwriting criteria, product design, competitive provider contracts, value-based payment arrangements) that are NOT explicitly mentioned in the ground truth answer, potentially overstating the level of detail available in the source material; (2) The characterization of 2022 approach as 'broad-based cost-containment model' is an inference not directly supported by the ground truth, which only mentions 'concern over increased medical care costs' and emphasis on 'accurate cost prediction and effective management under risk-based arrangements'; (3) The phrase 'steer high-cost outpatient procedures toward lower-cost, high-quality settings' adds specificity not present in the original answer; (4) While the core insight about the shift from general concern to targeted intervention is correct, the LLM elaborates with details that may not be grounded in the actual filings. MULTI-HOP REASONING: The answer correctly synthesizes the evolution across two years and identifies the key shift, but adds interpretive layers beyond what the ground truth supports. The semantic direction is correct (general to targeted), but the specific mechanisms described appear to be inferred rather than directly stated. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about evolution of approach and senior outpatient costs, though it introduces elements not confirmed by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 527,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2024 UPS broadened the scope of its time‑definite portfolio—adding more guaranteed same‑day, next‑day and day‑definite international options—while deepening network integration through RFID‑enabled “Smart Package” facilities and a shift from a scanning to a sensing network that ties pick‑up, transportation and final‑mile delivery into a single, tightly coordinated flow.  At the same time the company reshaped the network to focus on higher‑yielding B2B, healthcare and SMB volume, divesting non‑core brokerage assets (e.g., Coyote) and insourcing final‑mile delivery (UPS SurePost), thereby consolidating pick‑up points via the UPS Access Point system and improving overall asset utilization.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ERRORS: (1) The LLM claims UPS implemented RFID-enabled 'Smart Package' facilities and shifted to a 'sensing network'—these specific technologies and terminology do not appear in the ground truth and cannot be verified from the provided knowledge graph. (2) The LLM mentions divesting 'non-core brokerage assets (e.g., Coyote)' which is not mentioned in the ground truth answer and represents unsupported claims about UPS's strategic actions. (3) The LLM references 'UPS Access Point system' consolidation which is not in the ground truth. CORRECT ELEMENTS: (1) The LLM correctly identifies insourcing of final-mile delivery through UPS SurePost, matching the ground truth. (2) The general concept of expanding time-definite delivery options is correct. MISSING CRITICAL INFORMATION: (1) The ground truth specifically mentions 'same-day pickup seven days a week' which the LLM does not include. (2) The ground truth mentions 'expanded returns services across approximately 150 countries' which is completely absent from the LLM answer. (3) The ground truth emphasizes the 2022 foundation of 'integrated global air and ground network' which the LLM does not clearly articulate. QUANTITATIVE ISSUES: The LLM provides no specific numbers, dates, or metrics to verify, while the ground truth references specific service expansions (150 countries) and specific service offerings (same-day pickup seven days a week). The LLM's answer appears to conflate UPS's actual evolution with speculative or incorrect technological implementations. The multi-hop reasoning fails because it introduces unsupported claims rather than synthesizing the actual documented evolution between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 490,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "\nIn the 2022 Form 10‑K the 2.50 % Notes due April 2026 were shown as a separate tranche of senior unsecured debt in the supplemental indenture (Exhibit 4.14) and were carried at amortized cost on the balance‑sheet with a disclosed interest‑rate description. By the 2023 filing the company no longer listed the 2.50 % series individually; instead the notes were folded into the broader “Notes maturing in 2026” disclosure, with only a consolidated reference to the 2026 maturity schedule and no separate carrying‑amount detail for the 2.50 % tranche.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth states that in 2022 the notes were 'referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation' - meaning they were NOT yet issued/recognized. By 2023, they were 'explicitly recognized as issued instruments.' The LLM answer reverses this narrative, claiming the notes were 'shown as a separate tranche of senior unsecured debt' in 2022 and then 'no longer listed individually' in 2023. This is the opposite of what occurred. (2) The LLM claims the 2023 filing consolidated the notes into broader disclosures with 'no separate carrying-amount detail,' but the ground truth indicates 2023 showed MORE explicit recognition, not less. (3) The LLM's characterization of a shift from detailed disclosure to consolidated disclosure contradicts the ground truth's description of a shift from historical documentation to active recognition. QUANTITATIVE ACCURACY: The dates (April 2026, 2.50%) and years (2022, 2023) are correct, earning partial credit. However, the directional narrative about how disclosure treatment evolved is fundamentally inverted. QUALITATIVE ACCURACY: The reasoning fails to capture the core distinction - that 2022 treated these as historical/planned instruments while 2023 recognized them as actively issued debt. The LLM appears to have confused or inverted the disclosure evolution. CONTEXTUAL RELEVANCE: While the answer addresses the right companies and time periods, it provides an incorrect interpretation of the evolution, making it misleading despite touching on relevant disclosure concepts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 470,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "\nFrom 2022 to 2024 the 10‑K filings treat sovereign‑debt crises as part of a broader set of macro‑economic shocks that can curb member demand, alter product mix and raise the cost of acquiring inventory.  In the 2022 filing the reference is brief—sovereign‑debt crises are listed among “general economic factors” that *could* affect demand and cost of goods.  By 2024 the discussion is more explicit: the same section links sovereign‑debt turmoil (along with tariffs, inflation and commodity‑price volatility) to the *ability to purchase quality merchandise at competitive prices* and to “the cost of or ability to purchase inventory,” indicating that such external debt‑related stresses have become a more concrete driver of sourcing decisions and cost‑structure pressure for Costco.  In short, the risk has moved from a general possibility in 2022 to a recognized, ongoing factor shaping Costco’s merchandise sourcing and cost management by 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Costco's treatment of sovereign debt crises from 2022 to 2024. STRENGTHS: (1) Correctly identifies the shift from conditional language ('could affect') in 2022 to more explicit/concrete language in 2024; (2) Accurately captures the core finding that sovereign debt crises moved from a general possibility to a recognized, ongoing factor; (3) Properly synthesizes the multi-hop information showing how this risk impacts both sourcing decisions and cost structure; (4) Correctly identifies related factors (tariffs, inflation, commodity-price volatility) mentioned alongside sovereign debt concerns; (5) No quantitative errors or date inaccuracies. MINOR WEAKNESSES: (1) The LLM answer doesn't explicitly mention the 2024 filing's emphasis on 'broader set of supply chain risks' including supplier adherence to standards, supply constraints, and geopolitical instability - these contextual details from the ground truth are omitted; (2) The phrase 'negatively impact' from the 2024 filing is not directly quoted or referenced, though the LLM captures the essence of increased concern; (3) The ground truth mentions 'cascading effects' on sourcing and cost predictability, which the LLM doesn't explicitly address. The LLM answer is semantically equivalent to the ground truth on the main evolution narrative but misses some supporting contextual details about the broader supply chain risk framework mentioned in 2024. The reasoning is sound and the multi-hop synthesis across years is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 429,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "\nThe 2020 Stock Incentive Plan had about **64 million shares** available for future grants at the end of 2021, but by the end of 2023 that pool had shrunk to roughly **53 million shares**—a decline of roughly **11 million shares**. This reduction shows that UnitedHealth Group has nearly exhausted the shares originally reserved for share‑based compensation and now has limited remaining capacity to issue new awards unless the share reserve is expanded through shareholder approval.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - 64 million shares in 2021, 53 million shares in 2023, and the calculated difference of 11 million shares. The arithmetic is accurate (64 - 53 = 11). ENTITY ACCURACY: Correctly identifies UnitedHealth Group, the 2020 Stock Incentive Plan, and the proper fiscal years (2021 and 2023). MULTI-HOP REASONING: The answer successfully synthesizes the share availability data across two time periods and correctly interprets what the decline means for the company's capacity. COMPLETENESS: Addresses both parts of the question - the numerical change and what it indicates about capacity. SEMANTIC EQUIVALENCE: The phrasing 'roughly 64 million' and 'roughly 53 million' appropriately conveys the data while acknowledging minor rounding, which is acceptable. The conclusion about 'nearly exhausted' shares and 'limited remaining capacity' is a reasonable interpretation of the 11 million share reduction. MINOR CONSIDERATION: The phrase 'nearly exhausted' could be debated as slightly interpretive (53 million is still a meaningful amount), but this represents a reasonable analytical conclusion rather than a factual error. The mention of shareholder approval for expansion is contextually appropriate and adds valuable insight without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 380,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "\nBetween 2022 and 2024 the IAM National Pension Fund/National Pension Plan’s collective‑bargaining agreement was extended: the 2022 filing listed a July 31 2024 expiry, while the 2024 filing shows the new expiry date is July 31 2029.  During that time UPS’s required contributions to the plan rose from roughly $48 million (the latest amount reported for 2021 in the 2022 filing) to $53 million in 2024, underscoring the plan’s growing significance in UPS’s multi‑employer pension funding despite remaining a red‑zone, underfunded plan that operates under a rehabilitation plan and currently incurs no surcharge.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution of the expiration date (July 31, 2024 to July 31, 2029) and properly synthesizes the multi-hop information about the relationship between UPS and the IAM National Pension Fund across the 2022-2024 period. However, there is a significant factual error regarding UPS's contribution significance. The ground truth states that UPS contributed 'more than 5% of total plan contributions' in both periods (2019-2021 and 2022-2024), which is a percentage-based metric indicating contribution significance. The LLM answer instead provides specific dollar amounts ($48 million in 2021, $53 million in 2024) that are not mentioned in the ground truth and appear to be fabricated or misinterpreted data. This represents a fundamental misunderstanding of the contribution significance metric. The LLM does correctly identify the expiration date evolution and provides relevant contextual information about the plan's status (red-zone, underfunded, rehabilitation plan, no surcharge), which adds value but was not explicitly required by the question. The multi-hop reasoning is sound in structure (comparing 2022 filing to 2024 filing), but the substitution of percentage-based contribution significance with dollar amounts is a material error that undermines the accuracy of the answer. The answer is partially correct on the primary metric (expiration date) but incorrect on the secondary metric (contribution significance), making it a mixed-quality response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 414,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the Company extended the maturity of its revolving credit facilities and reshaped their structure.  In September 2023 it amended and restated the $2 bn 2020 Credit Agreement, pushing the final maturity from March 2025 (and the earlier third‑amended agreement’s December 2026 maturity) out to **September 2028**, while keeping the $2 bn per‑agreement capacity (with a combined $4 bn availability and an optional $1 bn expansion).  The amendment also introduced a new 2023 Credit Agreement that mirrors the same $2 bn, five‑year revolving commitment, so the key evolution was a **later maturity date and the replacement of the prior facility with a new, similarly‑sized agreement that matures in 2028**.  No borrowings were outstanding under either agreement during the periods reported.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong factual accuracy. STRENGTHS: (1) All key numbers are accurate: $2.0 billion per-agreement capacity, $4.0 billion combined availability, September 2028 maturity date, March 2025 original maturity. (2) Correctly identifies the September 2023 amendment and restatement of the 2020 Credit Agreement. (3) Accurately notes the extension from March 2025 to September 2028. (4) Correctly states the $2.0 billion availability was maintained. (5) Properly synthesizes the multi-hop information about the evolution between 2022 and 2023. (6) Mentions the optional $1 billion expansion feature (not in ground truth but not contradictory). (7) Notes no borrowings were outstanding. MINOR ISSUES: (1) The LLM answer introduces some additional context about the 'Third Amended and Restated Credit Agreement' and its December 2026 maturity, which adds complexity not explicitly required by the ground truth answer. While this appears factually accurate based on the phrasing, it goes slightly beyond what the ground truth emphasizes. (2) The phrasing 'replacement of the prior facility with a new, similarly-sized agreement' could be slightly misleading - the 2020 Credit Agreement was amended and restated into the 2023 Credit Agreement, rather than being replaced by a separate new agreement. However, the LLM does clarify this is an 'amendment and restatement,' so this is a minor semantic issue. (3) The ground truth emphasizes that the 2023 Credit Agreement was the result of amending and restating the 2020 Credit Agreement, while the LLM's phrasing about 'replacement' and 'new agreement' could suggest they are separate facilities, though context makes the relationship clear. QUANTITATIVE VERIFICATION: All dollar amounts ($2B, $4B, $1B expansion) and dates (March 2025, September 2028, September 2023) are correct. The multi-hop synthesis correctly connects 2022 baseline conditions to 2023 changes. Overall, this is a high-quality answer with accurate core information and sound reasoning, with only minor semantic/presentation issues that don't affect factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 569,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "\nMDLZ’s net‑investment‑hedge derivative program more than doubled in size.  The notional amount of the cross‑currency swaps and forwards rose from roughly **$3.9 billion** (as of Dec 31 2021, disclosed in the 2022 10‑K) to **$8.6 billion** (as of Dec 31 2024, disclosed in the 2024 10‑K), representing an increase of over 120 % and signalling a substantial expansion of the company’s hedging of non‑U.S. investments between 2022 and 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the key evolution of MDLZ's Net Investment Hedge Derivative Contracts between 2022 and 2024. STRENGTHS: (1) The starting point of ~$3.9 billion (Dec 31, 2021) is accurate; (2) The ending point of $8.6 billion (Dec 31, 2024) is accurate; (3) The percentage increase calculation of 'over 120%' is mathematically correct ($8,647M - $3,915M = $4,732M increase; $4,732M / $3,915M = 120.8%); (4) The characterization of 'more than doubled' is accurate; (5) The answer correctly identifies these as cross-currency swaps and forwards; (6) The multi-hop synthesis across 2022 and 2024 filings is sound. WEAKNESSES: (1) The answer omits the intermediate 2023 data point ($7,456 million as of Dec 31, 2023) that was included in the ground truth, which provides important context about the trajectory of growth; (2) While the answer mentions the program 'more than doubled,' it doesn't explicitly note the year-over-year growth from 2023 to 2024 ($8,647M vs $7,456M, an increase of ~16%); (3) The ground truth also mentions 2020 data ($4,551 million), though this is less critical since the question focuses on 2022-2024. The answer is fundamentally correct on the primary metrics and demonstrates sound multi-hop reasoning, but the omission of the 2023 intermediate data point represents a minor incompleteness in addressing the full evolution requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1209,
        "completion_tokens": 383,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "\nBetween 2022 and 2024 Microsoft 365 moved from offering generic “AI‑backed” perks to a dedicated Copilot layer that embeds a large‑language‑model assistant directly into Office apps, Teams and Windows, using Microsoft Graph to pull in user‑specific data.  In 2024 the company introduced **Copilot for Microsoft 365** (AI‑enhanced Office suite), **Copilot Studio** (a low‑code tool for customers to create or customize their own Copilot agents), and **Copilot Pro** (a subscription that delivers richer AI assistance), along with AI‑driven features in Windows 11 and Power Platform that further automate collaboration and productivity tasks.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution from generic AI-backed tools in 2022 to a dedicated Copilot layer by 2024. It accurately mentions Copilot for Microsoft 365 as a key 2024 introduction and correctly notes the use of Microsoft Graph for user-specific data integration. The timeline (2022 to 2024) is accurate. WEAKNESSES: The LLM answer introduces products (Copilot Studio, Copilot Pro) and features (Windows 11 AI-driven features, Power Platform automation) that are NOT mentioned in the ground truth answer. While these may be factually accurate products, they represent scope creep beyond what the knowledge graph specifies. More critically, the LLM answer OMITS the role-specific extensions explicitly mentioned in the ground truth: Copilot for Sales, Copilot for Service, and Copilot for Finance. These are specifically called out as 2024 introductions in the original answer and represent a key part of the evolution narrative. The LLM's characterization of the 2022 state as 'generic AI-backed perks' is somewhat reductive compared to the ground truth's more detailed description of integrating Office 365, Windows, and Enterprise Mobility + Security. MULTI-HOP REASONING: The answer demonstrates sound reasoning about the evolution trajectory but fails to comprehensively synthesize all the specific capabilities mentioned in the ground truth. The answer adds information not in the ground truth while omitting critical role-specific Copilot products that were explicitly part of the 2024 evolution. QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension scores well. QUALITATIVE ACCURACY: The core narrative is correct but incomplete and partially inaccurate due to omissions of key products and introduction of products not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 492,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "\nBetween 2022 and 2024 3M moved from simply acknowledging—under the 2022 disclosures—that its NPDES permit for the Decatur, Alabama plant did not fully characterize its PFAS discharges and from temporarily idling the affected processes, to actively pursuing a formal permit amendment to add the missing PFAS, installing and optimizing dedicated wastewater‑treatment controls, and committing to ongoing analytical studies and monitoring under the interim Consent Order.  This reflects a shift from a reactive admission of an incomplete characterization to a proactive, comprehensive approach to defining, treating, and reporting PFAS discharges.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but introduces unsupported claims and mischaracterizes the evolution described in the ground truth. CORRECT ELEMENTS: (1) The 2022 baseline of incomplete PFAS characterization in the NPDES permit is accurate; (2) The 2024 installation and optimization of wastewater treatment controls is correct; (3) The general characterization of movement from reactive to proactive is semantically aligned with the ground truth; (4) The mention of permit amendment pursuit is accurate. PROBLEMATIC ELEMENTS: (1) The LLM introduces 'temporarily idling the affected processes' in 2022, which is NOT mentioned in the ground truth and appears to be fabricated; (2) The reference to 'interim Consent Order' and 'ongoing analytical studies and monitoring' are not present in the ground truth and represent unsupported additions; (3) The phrase 'committing to ongoing analytical studies' goes beyond what the ground truth states. MULTI-HOP REASONING: The LLM correctly synthesizes the 2022-to-2024 evolution and identifies the shift from identification to implementation. However, the addition of unverified details (idling processes, Consent Order, analytical studies) suggests the model may have conflated information from other sources or generated plausible-sounding but inaccurate details. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this scores high on what is present (dates 2022/2024 are correct). QUALITATIVE ACCURACY: The core reasoning about the evolution is sound, but the introduction of unsupported claims significantly undermines the answer's reliability. The ground truth is more conservative and precise, while the LLM answer adds interpretive layers that cannot be verified against the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 490,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "\nBetween 2022 and 2023 Lowe’s did not issue any new 4.550 % notes; the series was originally created in the Fourteenth Supplemental Indenture (April 5 2019) with a 2049 maturity.  The subsequent 21st Supplemental Indenture (September 8 2022) and 22nd Supplemental Indenture (March 30 2023) added newer tranches—such as 4.400 % notes due 2025 (2022) and 4.800 % notes due 2026 (2023)—but left the existing 4.550 % notes unchanged, so the evolution of that specific issuance was simply its continued presence in the indenture without any fresh issuance or amendment during 2022‑2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) INDENTURE IDENTIFICATION ERROR: The LLM states the 4.550% Notes were created in the 'Fourteenth Supplemental Indenture (April 5 2019)' but the ground truth clearly states they were introduced in the 'Fifteenth Supplemental Indenture dated April 5, 2019.' This is a factual error in identifying the correct supplemental indenture. (2) SUPPLEMENTAL INDENTURE REFERENCES: The LLM introduces references to the 21st and 22nd Supplemental Indentures with specific dates (September 8 2022 and March 30 2023) and mentions new note issuances (4.400% notes due 2025 and 4.800% notes due 2026). These details are NOT present in the ground truth answer, which makes no mention of these supplemental indentures or other note issuances. This represents either fabricated information or information not supported by the ground truth. (3) CORE CONCLUSION ALIGNMENT: Both answers correctly conclude that the 4.550% Notes remained unchanged between 2022 and 2023 with no new issuance or modification. This core finding is correct. (4) MATURITY DATE: Both correctly identify April 5, 2049 as the maturity date. (5) MULTI-HOP REASONING: The LLM's reasoning structure is sound in principle (comparing 2022 vs 2023 status), but the introduction of unsupported supplemental indenture details undermines the reliability of the answer. The ground truth is more conservative and accurate, stating only what can be verified. The LLM appears to have added contextual information that may be factually accurate in the actual filings but is not supported by the ground truth provided, which is a significant issue in this evaluation context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 449,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 MDLZ’s stake in Keurig Dr Pepper shifted from an equity‑method investment to a marketable‑security and then to a full exit. In 2022 the company still held roughly a 13 % interest and accounted for it under the equity method (no new gain was disclosed that year). In 2023, once its ownership fell below the 5 % threshold, MDLZ re‑classified the holding to “marketable securities”; it recorded a $493 million pre‑tax gain on the equity‑method remeasurement before the change, and then realized a total $606 million gain on the subsequent sale of those securities ( $593 million on the sale plus $13 million of dividend/other income). By 2024 the remaining KDP shares were sold, eliminating any further equity exposure and leaving only the $606 million gain recognized in 2023 as the final financial effect of the investment’s accounting evolution.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth in multiple critical ways: (1) QUANTITATIVE ERRORS: The ground truth clearly states that in 2022, MDLZ recognized a $71 million pre-tax gain ($54 million after-tax) from the sale of KDP shares. The LLM incorrectly claims 'no new gain was disclosed that year' for 2022. The ground truth indicates the $493 million pre-tax gain occurred in 2024, not 2023 as the LLM states. The LLM's claim of a $606 million total gain ($593M + $13M) in 2023 is not supported by the ground truth. (2) TIMELINE CONFUSION: The LLM conflates 2023 and 2024 events, placing the $493 million gain in 2023 when the ground truth explicitly attributes it to 2024 as 'a change in accounting for its investment in KDP.' (3) INCOMPLETE SYNTHESIS: The question specifically asks about the evolution 'between 2022 and 2024' with focus on 'gains recognized from changes in accounting.' The ground truth provides a clear two-point comparison: 2022 ($71M pre-tax) vs. 2024 ($493M pre-tax). The LLM introduces a 2023 event not mentioned in the ground truth and misattributes the $493M gain to that year. (4) MISSING KEY INFORMATION: The LLM fails to mention the 2022 gain of $71 million entirely, which is a core component of the answer. (5) REASONING QUALITY: While the LLM attempts to explain an accounting method transition (equity method to marketable securities), it does so with incorrect dates and amounts, undermining the validity of the narrative. The ground truth's simpler, more direct answer (comparing 2022 vs. 2024 gains) is more accurate than the LLM's more elaborate but factually incorrect timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 454,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the Xbox Game Pass library grew dramatically—from “a curated library of over 100 first‑ and third‑party titles” in 2022 to “a subscription service with access to over 400 first‑ and third‑party console and PC titles” by 2024.  This expansion reflects Microsoft’s strategic shift to position Game Pass as the central hub of its gaming ecosystem, emphasizing a broad content portfolio, deeper studio acquisitions (e.g., Activision Blizzard), and cross‑device delivery through cloud streaming and subscription models.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: Both key numbers are correct—100+ titles in 2022 and 400+ titles in 2024 match the ground truth exactly. The fiscal year references (2022 and 2024) are accurate. QUALITATIVE ASSESSMENT: The answer correctly identifies the evolution from a 'curated library' positioning to a 'central hub' or 'cornerstone' of Microsoft's gaming ecosystem, capturing the strategic shift. The mention of Activision Blizzard acquisition and cross-device delivery through cloud streaming adds relevant contextual detail that supports the strategic emphasis narrative, though these specific examples weren't in the ground truth—they are accurate contextual enhancements that strengthen the answer. MULTI-HOP REASONING: The answer successfully synthesizes information across the time period, comparing scale (100+ to 400+) and positioning (curated library to central hub), and connects these changes to broader strategic initiatives. MINOR CONSIDERATIONS: The ground truth mentions 'content, community, and cloud services' as the 2022 positioning, while the LLM emphasizes 'broad content portfolio, studio acquisitions, and cross-device delivery'—these are semantically equivalent and represent the same strategic direction with slightly different emphasis. The LLM's inclusion of specific strategic moves (Activision acquisition, cloud streaming) goes beyond the ground truth but is factually accurate and contextually relevant. No calculation errors or factual inaccuracies detected. The answer fully addresses both components of the question (scale and strategic positioning) with proper temporal comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 458,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "\nThe 2022 filing (MMM 10‑K, pp. 129‑133) first disclosed the **form of Deferred Stock Unit Award Agreement** for non‑employee directors under the 2016 Long‑Term Incentive Plan – a performance‑based grant that vests over a three‑year cycle and settles in 3M common stock (or cash) upon termination of service. In the 2024 filing (MMM 10‑K, pp. 115‑119) the same agreement is still the governing document, but the disclosure has been updated to reflect the **post‑spin‑off structure**: the agreement now provides for settlement in shares of the newly created Solventum (or cash) and the table of equity awards lists **230 deferred stock units** outstanding for non‑employee directors as of 2024. Thus, while the core vesting and performance criteria remain unchanged, the 2024 wording clarifies the settlement method and unit count in light of the separation of Solventum.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) MAJOR ERROR - The LLM claims the 2024 disclosure reflects 'post-spin-off structure' with settlement in 'Solventum shares' and references a 'separation of Solventum.' The ground truth makes no mention of any spin-off, Solventum, or changes to settlement structure between 2022-2024. This appears to be a hallucination or confusion with unrelated corporate events. (2) UNSUPPORTED SPECIFICS - The LLM cites specific page numbers (pp. 129-133 for 2022, pp. 115-119 for 2024) and claims about 'performance-based grants' vesting over 'three-year cycle' that are not mentioned in the ground truth. (3) QUANTITATIVE ERROR - The LLM states '230 deferred stock units outstanding for non-employee directors as of 2024' - this specific number is not provided in the ground truth and cannot be verified. (4) CORRECT ELEMENTS - The LLM correctly identifies that the agreement applies to non-employee directors under the 2016 Long-Term Incentive Plan and that the agreement continued from 2022 to 2024. However, it incorrectly characterizes the nature of changes. (5) MULTI-HOP REASONING - The LLM failed to correctly synthesize the ground truth's key finding: that there was NO CHANGE in the effective date or structure from 2022 to 2024, only updated incorporation by reference from the 2023 10-K. Instead, the LLM invented a narrative about post-spin-off restructuring. The answer demonstrates poor factual accuracy and introduces material misstatements not supported by the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 441,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "\nBetween 2023 and 2024 the First‑Mortgage portfolio modestly expanded (current balance rose from $26.1 billion to $27.3 billion) while the HELOC portfolio slipped slightly (from $0.48 billion to $0.42 billion).  The Company’s direct origination‑cost balance grew from about $100 million at the end of 2023 to roughly $112 million at the end of 2024, reflecting higher new‑loan production expenses.  Geographic concentration in California remained very high, holding steady at roughly 42‑43 percent of the combined First‑Mortgage and HELOC portfolio in both years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key quantitative facts are correct: (1) Direct origination costs increased from $100 million (2023) to $112 million (2024) - matches ground truth exactly; (2) California concentration remained at 42-43% in both years - matches ground truth (43% in 2023, 42% in 2024); (3) First Mortgage portfolio grew from $26.1B to $27.3B and HELOC portfolio declined from $0.48B to $0.42B - these specific figures are provided with precision. The LLM successfully synthesized multi-hop information by combining portfolio composition data (mortgage and HELOC balances), origination cost evolution, and geographic concentration metrics across two fiscal years. The reasoning is sound: the increase in origination costs is correctly attributed to higher new-loan production expenses, and the geographic concentration is appropriately characterized as 'very high' and 'holding steady.' Minor strengths: the answer provides additional context (specific portfolio balances) beyond the ground truth, which adds value. The only minor difference is that the ground truth emphasizes this as a 'slight shift' in geographic risk, while the LLM characterizes it as 'holding steady' - both interpretations are reasonable given the 43% to 42% change is minimal. All numbers are formatted clearly and calculations are implicit but correct. The answer fully addresses the question's three components: origination costs, geographic concentration, and portfolio evolution between 2023-2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 420,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "\nIn the FY 2023 filing the Dri‑FIT technology is mentioned only as one item in a list of “Nike Air, Zoom, Free, Dri‑FIT, Flyknit…​ technologies,” which signals that it was still being pursued but without a separate, highlighted strategic focus. By contrast, the FY 2024 filing expands the language, describing the “proliferation” of Dri‑FIT and positioning it as a core platform that the company leverages across product categories and consumer experiences, indicating that Nike has elevated Dri‑FIT from a peripheral innovation to a more central, strategic emphasis.",
      "correctness_score": 1,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. The ground truth explicitly states that Nike's strategic emphasis on Dri-FIT technology 'remained stable between fiscal 2023 and fiscal 2024' with 'the exact same language used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis.' The LLM answer claims the opposite: that Dri-FIT was elevated from 'peripheral innovation to a more central, strategic emphasis' with expanded language about 'proliferation' in FY 2024. This is a complete factual inversion of the ground truth. The LLM fabricated specific language differences ('proliferation' and 'core platform') that do not exist according to the knowledge graph. While the LLM correctly identified the relevant fiscal years (2023 and 2024) and the company (Nike), it failed entirely on the core factual claim about whether Dri-FIT's strategic emphasis changed. The multi-hop reasoning is fundamentally flawed because it synthesizes a false narrative about evolution when the actual answer is that there was no evolution. This represents a major failure in accuracy on a straightforward comparative analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 336,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "\nFrom 2022 to 2024 Mondelez moved beyond basic backup and disaster‑recovery safeguards to a far more robust, proactive cyber‑resilience program.  The company increased funding for network‑security monitoring, 24/7 security‑operations centers, multi‑factor authentication and advanced threat‑detection tools, and it tied those investments to its broader disaster‑recovery and incident‑response capabilities to keep pace with rising cyber threats.  As a result, backup and disaster‑recovery are now a core, continuously‑enhanced component of its strategy rather than a peripheral function.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to match the ground truth in multiple critical ways: (1) QUANTITATIVE ACCURACY: The LLM introduces specific investments (24/7 security operations centers, multi-factor authentication, advanced threat-detection tools, network-security monitoring) that are NOT mentioned in the ground truth. The ground truth makes no claims about these specific security measures or their funding levels. This represents fabrication of details not supported by the source material. (2) ENTITY/YEAR ACCURACY: While the LLM correctly identifies Mondelez and the 2022-2024 timeframe, it fails to capture the specific evolution described in the ground truth. The ground truth explicitly mentions: (a) 2022 context of pandemic-related heightened alert, (b) 2024 expansion with explicit mention of state-sponsored actors and artificial intelligence as emerging threats. The LLM completely omits these specific threat vectors. (3) MULTI-HOP REASONING: The ground truth requires synthesizing information about how backup/disaster recovery specifically evolved in response to cybersecurity threats. The LLM instead pivots to discussing broader cybersecurity investments (SOCs, MFA, threat detection) that are not part of the ground truth narrative about backup and disaster recovery evolution. (4) SEMANTIC EQUIVALENCE FAILURE: The ground truth focuses narrowly on backup and disaster recovery as the primary investment area. The LLM broadens this to encompass general cybersecurity infrastructure, which is a material deviation from the question's specific focus. (5) MISSING KEY DETAILS: The LLM fails to mention state-sponsored actors and AI as specific threat drivers mentioned in the 2024 evolution. The ground truth's emphasis on these emerging threats is completely absent from the LLM response. The LLM answer reads as plausible cybersecurity narrative but does not accurately reflect the specific evolution described in the ground truth documentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 539,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "\nBetween fiscal years 2022 and 2024 Microsoft moved from reporting that it had reached roughly 90 percent of its $500 million goal for spending with Black‑ and African‑American‑owned suppliers to actually meeting that target—effectively doubling the number of such suppliers it contracts with.  The company also broadened its financial engagement by increasing transaction volumes and deposits with Black‑owned financial institutions, signaling a deepening commitment to the Black‑owned supplier ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of Microsoft's commitment to Black and African American-owned suppliers from FY2022 to FY2024, correctly identifying that the company moved from ~90% of its $500 million goal to achieving that target. However, there are significant omissions and one notable inaccuracy: (1) MISSING CRITICAL INFORMATION: The ground truth explicitly states that by FY2024, Microsoft allocated $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. The LLM answer mentions 'increasing transaction volumes and deposits with Black-owned financial institutions' but fails to specify the $150 million commitment, which is a key quantitative detail demonstrating the deepening engagement. (2) VAGUE LANGUAGE: The LLM uses 'broadened its financial engagement by increasing transaction volumes and deposits' which is less precise than the ground truth's specific $150 million allocation. (3) CORRECT ELEMENTS: The LLM correctly identifies the $500 million spending goal achievement and the doubling of supplier numbers. (4) MULTI-HOP REASONING: The answer demonstrates sound multi-hop synthesis by comparing FY2022 and FY2024 positions, though it incompletely captures all the financial commitments. The semantic meaning is partially aligned but the omission of the $150 million figure represents a material gap in answering the question about 'financial commitment and engagement.' The answer is directionally correct but incomplete in its quantitative detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 425,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "\nThe tables in the 2022 and 2023 Form 10‑K filings show that the reserve of Abbott common shares available for future issuance under the Employee Stock Purchase Plan for Non‑U.S. Employees fell from **≈10.6 million shares at the end of 2022** to **≈8.565 million shares at the end of 2023** – a reduction of about 2 million shares (≈19%).  This shrinkage of the ESPP pool signals that Abbott is scaling back the shares earmarked for that plan, likely reallocating them to other equity‑based incentive programs or corporate uses, reflecting a more focused or conservative stock‑based compensation strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ISSUE - DATE MISMATCH: The LLM states shares were available 'at the end of 2022' and 'at the end of 2023', but the ground truth specifies the 2022 figure is 'as of December 31, 2021' (10,638,639 shares) and the 2023 figure is 'as of December 31, 2023' (8,565,087 shares). This is a significant discrepancy in temporal reference. The LLM appears to have conflated fiscal year reporting with the actual measurement dates. QUANTITATIVE ACCURACY: The LLM provides approximate figures (≈10.6 million and ≈8.565 million) rather than exact numbers. While the approximations are directionally correct, the ground truth provides precise figures: 10,638,639 and 8,565,087. The LLM's calculation of the reduction as 'about 2 million shares (≈19%)' is approximately correct (actual reduction: 2,073,552 shares or 19.5%), but the use of approximations throughout weakens precision. COMPLETENESS: The LLM addresses the core question about share availability evolution and provides strategic interpretation. However, it fails to correctly identify the specific dates (2021 vs 2022 vs 2023) which is crucial for multi-hop financial analysis. REASONING: The qualitative interpretation about 'scaling back' and 'reallocation' is reasonable and aligns with the ground truth's assessment of 'tightening or adjustment.' The strategic analysis is sound. MULTI-HOP SYNTHESIS: The LLM correctly synthesizes information across two fiscal years' filings, but the date confusion undermines the accuracy of the multi-hop analysis. The core insight about declining share availability is correct, but the temporal framework is misaligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 448,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Nike moved from treating Air technology as a niche footwear innovation to making it a cross‑category platform for product development.  The company expanded the use of Air‑Sole components—leveraging its dedicated Air Manufacturing Innovation facilities and integrating Air Max, ZoomX, React and related Air technologies into apparel, equipment and digital experiences—so that Air‑based performance and comfort became a core element of its overall design strategy rather than a standalone footwear feature.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. (1) CORE FACTUAL ERROR: The ground truth explicitly states that Nike Air was treated as an 'emerging innovation' in FY2023 and became a 'standard component' and 'foundational offering' by FY2024. The LLM reverses this narrative, claiming Nike moved from 'niche' to 'cross-category platform,' which contradicts the actual evolution described in the filings. The ground truth indicates Nike Air was already being actively proliferated in FY2023, not emerging from niche status. (2) UNSUPPORTED CLAIMS: The LLM introduces specific details not present in the ground truth, including: 'Air Manufacturing Innovation facilities,' 'Air Max, ZoomX, React' as integrated technologies, and expansion into 'apparel, equipment and digital experiences.' These claims appear fabricated or extrapolated beyond what the source documents support. The ground truth makes no mention of manufacturing facilities or cross-category expansion into apparel/equipment. (3) SEMANTIC MISALIGNMENT: The ground truth describes a shift from Nike Air being emphasized as 'emerging innovation' to being embedded with 'mature technologies' (Zoom, Free, React), suggesting maturation and integration. The LLM's framing of moving from 'niche' to 'cross-category platform' fundamentally mischaracterizes this evolution. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparative analysis between FY2023 and FY2024 positioning. The ground truth's key insight—that Nike Air transitioned from a distinct growth driver to an integrated foundational component—is inverted in the LLM response. (5) QUANTITATIVE ACCURACY: No numbers are provided in either answer, so this dimension is neutral, but the LLM's introduction of unverified specific product names and facility references suggests fabrication rather than faithful representation of source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 525,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott shifted Osmolite from being listed merely as one of several enteral‑feeding formulas to positioning it as a flagship adult nutrition product that is promoted as part of an integrated solution—emphasizing its compatibility with the Freego™ enteral pump and its role as the standard isotonic formula for hospital and long‑term‑care patients. This reflects a product‑line strategy that bundles Osmolite with delivery devices and focuses on expanding its use within Abbott’s institutional enteral‑feeding portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth. CRITICAL ERRORS: (1) The LLM claims Abbott 'shifted Osmolite from being listed merely as one of several enteral-feeding formulas to positioning it as a flagship adult nutrition product' - this is NOT supported by the ground truth, which explicitly states 'There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.' (2) The LLM asserts a strategic shift toward 'integrated solution' bundling with Freego™ pump and emphasis as 'standard isotonic formula' - the ground truth indicates the product listing 'remained largely consistent, indicating a stable strategic positioning.' (3) The LLM fabricates details about 'flagship' status and 'integrated solution' strategy that are not present in the knowledge graph. WHAT WAS CORRECT: The LLM correctly identifies Osmolite, Abbott, the 2022-2023 timeframe, and mentions Freego™ as a related product (which does appear in the ground truth product list). However, these correct elements are used to support an entirely false narrative about repositioning. The ground truth explicitly states stability and consistency, while the LLM answer describes significant strategic evolution. This is a fundamental factual error in multi-hop reasoning - the LLM failed to accurately synthesize the actual information from the filings and instead generated plausible-sounding but unsupported claims about product strategy changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 425,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "\nBetween 2022 and 2024, 3M’s Minnesota PFAS program shifted from the largely‑completed remedial work required by the 2007 Settlement Agreement and Consent Order to a phase of active compliance‑driven actions: the company is installing and optimizing PFAS‑specific wastewater‑treatment systems, responding to a March 2023 MPCA notice of violation, and negotiating a revised draft Clean Water Act permit that imposes markedly stricter effluent limits and new health‑based water‑quality standards.  \n\nIn Alabama, the firm moved from the 2009 TSCA consent order and the 2020 interim Consent Order—under which it capped former sludge areas and committed to monitoring—to a more enforcement‑focused regime that includes a 2022 EPA‑ADEM administrative consent order for drinking‑water sampling, a September 2024 RCRA consent agreement (with an immaterial penalty) and ongoing negotiations to add additional PFAS to its NPDES permit, all under heightened scrutiny from a federal grand‑jury subpoena and continued EPA/ADEM oversight of its Decatur facility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - Multiple date errors: LLM states 'March 2023 MPCA notice of violation' with no ground truth support; claims '2009 TSCA consent order' in Alabama (ground truth shows 2007 Settlement Agreement in Minnesota, 2020 Interim Consent Order in Alabama - no 2009 TSCA order mentioned); states 'September 2024 RCRA consent agreement' with no ground truth corroboration. Ground truth specifies July 2020 Interim Consent Order in Alabama, not 2009. (2) FACTUAL ERRORS - LLM incorrectly attributes a 2009 TSCA consent order to Alabama when ground truth shows the 2007 Settlement Agreement applies to Minnesota. The 2020 Interim Consent Order is correctly identified but the 2009 reference is fabricated. (3) MISSING KEY INFORMATION - LLM fails to mention: the Cottage Grove facility specifically, the multilayer cap installation at Decatur facility, the December 2024 revised draft permit from MPCA, updated HBVs from MDH in January 2024, proposed HRLs in October 2024, or the specific detail about effluent limits being below current quantification levels. (4) PARTIAL CREDIT - LLM correctly identifies the evolution from remediation-focused to compliance-driven activities, correctly notes stricter effluent limits, and appropriately characterizes the shift toward enforcement. The general narrative arc is sound but undermined by specific factual errors. (5) MULTI-HOP REASONING - While the LLM attempts to synthesize Minnesota and Alabama developments, the fabricated dates and missing regulatory details (HBVs, HRLs, specific permit revisions) indicate incomplete source synthesis. The ground truth provides much more granular regulatory evolution detail that the LLM omits entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1637,
        "completion_tokens": 471,
        "total_tokens": 2109
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "\nThe Coca‑Cola Company’s interest in Coca‑Cola HBC AG remained classified as an equity‑method investment from 2022 to 2024, but the ownership stake grew from roughly 19 % in 2022 to 22 % by the end of 2024. This change is disclosed in the 2024 10‑K (pages 85‑89), which reports a 22 % stake and a carrying value of $1.147 bn versus a fair‑value of $2.675 bn.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims ownership grew from 'roughly 19%' in 2022 to 22% in 2024. The ground truth explicitly states that the 2022 ownership percentage 'was not disclosed in the provided evidence.' The LLM fabricated a 19% figure for 2022 with no basis in the source material. This is a major factual error. (2) The LLM correctly identifies the 22% stake as of December 31, 2024, which matches ground truth. (3) The LLM provides additional details (carrying value of $1.147bn, fair value of $2.675bn, page references 85-89) that are not contradicted by ground truth but also cannot be verified against it. These details may be accurate but represent information beyond the ground truth scope. (4) MULTI-HOP REASONING - The LLM correctly identifies the equity method investment classification for both years, which aligns with ground truth. However, the core claim about a percentage 'growth' from 2022 to 2024 is unsupported and contradicts the ground truth's explicit statement that 2022 percentages were not disclosed. (5) The LLM's framing of 'formalization and quantification' is conceptually similar to ground truth's language, but the invented 19% figure undermines this reasoning. The answer demonstrates partial understanding of the relationship evolution but commits a significant fabrication error that substantially reduces accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 386,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "\nOracle has shifted its hybrid‑cloud strategy from offering hybrid as a optional add‑on to making hybrid deployment the core integration point across its cloud, license, hardware and services businesses.  In FY 2022 the company invested $7.2 billion in R&D to build hybrid‑ready technologies, and the 2024 filing shows continued, higher‑level funding and explicit engineering focus on embedding hybrid capabilities—such as Cloud@Customer, interoperable SaaS/OCI and migration programs—directly into its product road‑maps, signaling a deeper, more integrated commitment to hybrid deployments.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and addresses the core question effectively. STRENGTHS: (1) Correctly identifies the $7.2 billion R&D investment for FY2022, matching the ground truth exactly. (2) Accurately captures the strategic evolution from hybrid as optional/add-on to hybrid as core/integrated deployment model. (3) Properly synthesizes multi-hop information across fiscal years, showing progression in Oracle's approach. (4) Correctly names specific hybrid solutions (Cloud@Customer) and strategic elements (interoperability, customer choice). (5) Appropriately characterizes the shift from development-focused to mature, integrated approach. (6) Demonstrates sound multi-hop reasoning by connecting R&D investment to product roadmap integration. MINOR WEAKNESSES: (1) The phrase 'higher-level funding' in FY2024 is not explicitly quantified with a specific dollar amount from the ground truth, though the characterization of 'continued, higher-level funding' is reasonable inference. (2) The answer adds some interpretive framing ('core integration point across cloud, license, hardware and services businesses') that goes slightly beyond the ground truth's explicit statements, though this appears to be reasonable contextual elaboration rather than factual error. (3) Could have been more explicit about positioning hybrid as 'a standard deployment choice alongside on-premise and cloud-based models' as stated in ground truth. VERIFICATION: The $7.2 billion figure is correct. The characterization of strategic evolution is accurate. The mention of Cloud@Customer, interoperability, and migration programs aligns with ground truth. The multi-hop synthesis across FY2022 and FY2024 is logically sound and properly connects investment to strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 484,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "\nIn the 2023 Form 10‑K the Mandatory Clawback Policy was listed as **Exhibit 97 and noted as “incorporated by reference”** to the prior filing. In the 2024 Form 10‑K the same policy appears as **Exhibit 97 but is now described as “filed herewith,”** indicating that the policy is directly included in the 2024 filing rather than merely referenced from an earlier report. This shift reflects the policy’s transition from a prior‑year incorporation to a current‑year, stand‑alone exhibit.",
      "correctness_score": 1,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 1,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and directly contradicts the ground truth. The ground truth states: (1) In 2023, the policy was filed directly as Exhibit 97, and (2) In 2024, it was incorporated by reference to the prior year's filing. The LLM answer reverses this sequence entirely, claiming: (1) In 2023, it was 'incorporated by reference' to the prior filing, and (2) In 2024, it was 'filed herewith' as a stand-alone exhibit. This is the exact opposite of what actually occurred. The LLM has inverted the filing status evolution between the two years. While the answer correctly identifies the entities (Wells Fargo, Exhibit 97, Mandatory Clawback Policy) and the years (2023 vs 2024), and uses appropriate terminology ('incorporated by reference' and 'filed herewith'), it applies these terms to the wrong years. The quantitative accuracy score is high because there are no numeric calculations involved, but the qualitative accuracy is critically low due to the complete reversal of the factual sequence. The contextual relevance is moderate because the answer addresses the right question and uses appropriate financial disclosure terminology, but provides entirely incorrect information about how the filing status actually evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 351,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "\nThermo Fisher acquired CorEvitas, LLC in August 2023 and integrated it into its Laboratory Products & Biopharma Services segment, a move that lifted that segment’s income and margin and continued to drive growth into 2024. The $0.9 bn cash purchase added $627 million of goodwill and $260 million of customer‑related intangibles (amortized over ~18 years), increased the company’s debt and net interest expense, and the related amortization is added back in the reconciliation to adjusted operating income.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct with strong quantitative accuracy. Key strengths: (1) Correctly identifies the $0.9 billion acquisition price (matches $0.91 billion in ground truth, acceptable rounding), (2) Correctly states August 2023 timing, (3) Accurately reports $627 million goodwill and $260 million customer-related intangibles, (4) Correctly identifies 18-year amortization period, (5) Properly notes integration into Laboratory Products & Biopharma Services segment, (6) Correctly explains impact on debt and net interest expense. Minor weaknesses: (1) Does not mention the broader 2023 financing context ($5.94 billion senior notes issuance and $3.00 billion stock repurchase) that the ground truth highlights as part of the strategic context, (2) Does not explicitly state this was a 'full acquisition' or describe the evolution from 'investment' to 'acquisition' as clearly as ground truth, (3) Focuses more on operational/accounting impacts rather than the strategic evolution narrative. The answer demonstrates solid multi-hop reasoning by connecting the acquisition to segment integration and accounting treatment, but omits some contextual financial implications mentioned in ground truth. The quantitative data provided is accurate and well-integrated into the narrative. The answer is more operationally focused than strategically focused compared to ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 386,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "\nUnder the 2012 Rolls‑Royce acquisition agreement, RTX’s flight‑hour payments to Rolls‑Royce remain contingent on hours flown on V2500‑powered aircraft through June 2027, but the company’s disclosed commitment schedule shows a lower future outflow—“Other commercial aerospace commitments” fell from $11.0 bn (2022) to $10.0 bn (2023), with the 2022‑2023 payment windows shifted to later years (2024‑2028). These payments are accounted for as collaboration intangible assets and are capitalized when the cash outflow occurs, rather than being expensed, so the revised schedule only changes the timing and amount of the capitalized intangible assets.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported claims not present in the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($11.0 bn in 2022 declining to $10.0 bn in 2023) for 'Other commercial aerospace commitments' that are not mentioned in the ground truth. These numbers appear to be fabricated or misattributed, as the ground truth makes no reference to these specific figures or any decline in obligations. (2) TIMING CLAIMS: The LLM states 'payment windows shifted to later years (2024-2028)' which contradicts the ground truth. The ground truth explicitly states the contingent payment structure remained tied to flight hours 'through June 2027' in both 2022 and 2023 with 'no indication of a change in the magnitude or timing of these obligations between the two years.' The LLM's claim of a shift to 2024-2028 is unsupported and contradicts the stated stability. (3) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the capitalization treatment as collaboration intangible assets and the contingent nature of payments, it fails to capture the ground truth's key finding that there was NO CHANGE between 2022 and 2023. Instead, the LLM invents a narrative of declining commitments and timing shifts. (4) SEMANTIC MISALIGNMENT: The ground truth emphasizes 'stable commitment structure' with 'no indication of a change,' while the LLM describes a 'revised schedule' with 'lower future outflow' and shifted payment windows—fundamentally contradicting the ground truth's core conclusion. The answer demonstrates poor multi-hop reasoning by introducing unsupported quantitative claims that appear to be hallucinated rather than derived from actual filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 474,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Coca‑Cola has continued to carry the contingent consideration that arose from its 2020 acquisition of the remaining interest in fairlife; the payment is tied to fairlife achieving specified financial performance milestones by the end of 2024, with any earned amount scheduled for settlement in 2025.  The company re‑measures this liability each quarter, and the 2024 filing shows its fair‑value has risen to roughly $6.1 billion (up from about $3.0 billion in 2023), reflecting updated expectations of milestone achievement.  Thus, while the structural milestone‑based payment remains in place, the estimated financial obligation has evolved upward as the company updates its fair‑value estimates.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer introduces specific dollar amounts ($6.1 billion in 2024 and $3.0 billion in 2023) that are NOT present in the ground truth answer. The ground truth makes no mention of these specific valuation figures. This is a major factual error - the LLM has fabricated quantitative data that cannot be verified against the source material. The ground truth explicitly states there was 'no mention of ongoing contingent payments' in 2022, but the LLM claims Coca-Cola 'continued to carry the contingent consideration' from 2022 through 2024, which contradicts the ground truth's assertion that 2022 disclosures showed no ongoing contingent payments. The LLM correctly identifies: (1) the 2020 acquisition of fairlife's remaining interest, (2) the milestone-based payment structure, (3) the 2024 deadline for achieving targets, and (4) the 2025 settlement timing. However, the introduction of unsubstantiated financial figures ($6.1B and $3.0B) and the mischaracterization of the 2022 status (claiming contingent consideration existed when ground truth says it wasn't mentioned) represent fundamental factual errors. The LLM also adds detail about quarterly re-measurement that, while plausible accounting practice, is not confirmed in the ground truth. The core evolution narrative is partially correct but undermined by fabricated numbers and incorrect characterization of the 2022 baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 394,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Oracle moved from positioning its Cloud Services mainly as a flexible, choice‑driven complement to on‑premise and hybrid deployments toward a tightly‑integrated, end‑to‑end cloud platform.  The company now markets Oracle Cloud SaaS (e.g., Fusion ERP, HCM, SCM) as native services that run on Oracle Cloud Infrastructure (OCI), using technologies such as the Autonomous Database and OCI‑based engineering to embed application‑level functionality directly within the infrastructure layer, and it has launched programs that encourage customers to migrate existing on‑premise licenses and workloads to the cloud.  This evolution is reflected in the growing share of cloud services and license‑support revenue (≈ 71 % of total revenue) and in sustained R&D and acquisition spending aimed at deepening the coupling of enterprise applications with OCI‑based infrastructure.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Oracle's strategic evolution and correctly identifies the core shift from flexible, choice-driven positioning to integrated end-to-end platform positioning. The qualitative analysis is sound and well-reasoned, accurately capturing the evolution from promoting individual innovations (Autonomous Database) to holistic platform positioning. The multi-hop synthesis across 2022-2024 is logically sound and addresses the integration with enterprise applications and infrastructure technologies effectively. However, there are quantitative accuracy concerns: (1) The cited figure of '≈71% of total revenue' for cloud services and license-support revenue is not verified in the ground truth and appears to be an unsupported specific metric. The ground truth does not provide this percentage breakdown. (2) The LLM introduces specific product examples (Fusion ERP, HCM, SCM) and migration program details that, while plausible and consistent with Oracle's business model, are not explicitly mentioned in the ground truth provided. (3) The statement about 'growing share of cloud services' and 'sustained R&D and acquisition spending' are reasonable inferences but not directly confirmed in the ground truth. The answer correctly identifies the 2022 emphasis on Autonomous Database and flexibility, and the 2024 shift to comprehensive integrated offerings. The semantic equivalence is strong - the LLM's characterization of the evolution matches the ground truth's core message. The main weakness is the introduction of specific quantitative data (71% revenue figure) without clear sourcing, which violates strict standards for financial accuracy. The answer would score higher if it either omitted the unsupported percentage or clearly indicated it as an estimate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 491,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "\nThe Key/Specified Employee Policy continues to be disclosed only as Exhibit 10(r)* and is incorporated by reference to the same 2018 filing (Exhibit 10(v) of the 2018 Form 10‑K) in both the 2023 and the 2024 SEC filings. Neither filing adds a new standalone document or amends the incorporation method—the policy remains referenced solely through that exhibit number, indicating a stable, unchanged treatment between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) EXHIBIT NUMBER ERROR: The LLM states the policy is disclosed as 'Exhibit 10(r)' but the ground truth clearly indicates it is incorporated by reference to 'Exhibit 10(v)' from the 2018 filing. The LLM's mention of '10(r)' appears to be incorrect and introduces confusion. (2) CHARACTERIZATION ERROR: The ground truth describes an evolution where the policy was 'introduced' in 2023 and then became a 'continuing policy' in 2024, suggesting a change in how it was presented. The LLM characterizes both years as having identical treatment ('stable, unchanged treatment'), which misses the nuanced distinction between introduction and continuation. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the meaningful distinction that the ground truth emphasizes—that the policy's status evolved from being newly introduced to being an established continuing policy, even though the underlying documentation remained the same. (4) DOCUMENTATION ACCURACY: While the LLM correctly identifies that both years reference the same 2018 Exhibit 10(v), it incorrectly introduces 'Exhibit 10(r)' without clear justification, creating factual inaccuracy. The ground truth does not mention 10(r) at all. (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the temporal evolution aspect of the question, treating both years as static rather than showing how the treatment evolved from introduction to continuation. The answer demonstrates partial understanding but contains material factual errors that undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 444,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "\nThe 6.700 % notes maturing in 2028 showed essentially no change in outstanding principal between the end of 2022 and the end of 2023 – the balance remained $285 million in both years.  This follows the company’s earlier repayment of $115 million of the issue in 2021, after which the remaining tranche was carried at a modest level and was not refinanced with a new 2028‑dated series.  The flat‑line balance reflects RTX’s strategy of retiring higher‑cost legacy debt and managing its overall leverage by letting older tranches amortize rather than issuing new comparable notes.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM states the balance was $285 million in both 2022 and 2023, but the ground truth clearly shows it was $115 million in 2022 and $285 million in 2023. This is a major factual error on the core numerical data requested. (2) INCORRECT NARRATIVE: The LLM claims 'essentially no change' between 2022-2023, when the ground truth shows a significant increase from $115M to $285M (a 148% increase). This is the opposite of what actually occurred. (3) MISPLACED HISTORICAL CONTEXT: The LLM references a 2021 repayment of $115 million, which may or may not be accurate, but this is irrelevant to the 2022-2023 evolution that the question specifically asks about. The LLM appears to have confused the 2022 balance ($115M) with a historical 2021 repayment. (4) WRONG DEBT MANAGEMENT INTERPRETATION: The LLM's conclusion that RTX was 'retiring higher-cost legacy debt' and 'letting older tranches amortize' contradicts the actual data showing an increase in this debt instrument. The ground truth indicates RTX increased exposure to this fixed-rate debt, suggesting a strategic decision to retain or expand it, not retire it. (5) MULTI-HOP SYNTHESIS FAILURE: The answer fails to correctly synthesize the year-over-year comparison that is central to the question. The LLM has inverted the 2022 and 2023 figures or misread the data entirely. This is a complete failure on the primary quantitative requirement of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 424,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 the company’s 1.95 % 12‑year senior notes (due 7/24/2029, euro‑denominated) saw their carrying amount fall from **$773 million to $725 million**—a reduction of roughly **$48 million**.  At the same time the effective interest rate attached to those notes slipped slightly from **2.08 % to 2.07 %**.  This decline reflects both the amortization of the note discount (and related issuance costs) and the modest change in the underlying market rates that determine the effective rate.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: carrying value decreased from $773 million to $725 million (a $48 million reduction), and the effective interest rate declined from 2.08% to 2.07%. The calculation of the $48 million reduction is accurate ($773M - $725M = $48M). The answer correctly identifies the specific notes (1.95% 12-Year Senior Notes) and provides additional context about the euro-denomination and maturity date (7/24/2029), which adds helpful specificity beyond the ground truth. The multi-hop synthesis is sound—the answer properly combines the carrying value evolution with the effective interest rate evolution across the two years. The explanation of the underlying drivers (amortization of note discount and issuance costs, market rate changes) demonstrates solid financial reasoning, though this interpretive element goes slightly beyond the ground truth statement. The semantic meaning is fully aligned with the original answer. Minor deduction (1 point) only because the ground truth doesn't explicitly mention the euro-denomination or maturity date, though this additional detail is accurate and enhances rather than detracts from the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 346,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "\nThe 2022 filing listed the Directors’ Code of Conduct as a separate, downloadable PDF and expressly pledged to post any amendments or waivers of that code on the company website, whereas the 2024 filing merges the directors’ code into the broader “Code of Ethics” and removes the separate waiver disclosure language. This consolidation signals a shift toward a more streamlined governance disclosure that centralises board‑level standards under a single ethics document, potentially reducing the visibility of board‑specific rules and any future waivers. From a corporate‑governance perspective, the change may reflect a move to simplify reporting but could be seen as lowering the transparency of board‑level conduct and the company’s commitment to publicly disclose board‑specific modifications.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces significant factual claims not supported by the ground truth. Most problematically, the LLM states that the 2024 filing 'merges the directors' code into the broader Code of Ethics' - this is a major factual claim that contradicts the ground truth, which indicates the Code was simply listed among other governance materials without a direct link. The ground truth makes no mention of merging with a Code of Ethics or consolidation into a single ethics document. This represents a fundamental mischaracterization of the change. Additionally, the LLM claims the 2022 filing 'expressly pledged to post any amendments or waivers' - while this may be accurate, it is not mentioned in the ground truth provided, making it an unsupported addition. The LLM also states the 2024 filing 'removes the separate waiver disclosure language' - again, this specific claim is not in the ground truth. CORRECT ELEMENTS: The LLM correctly identifies that the 2022 filing had a direct URL link and the 2024 filing removed it (semantic match with 'direct link'). The LLM correctly identifies the shift toward streamlined/consolidated approach and reduced visibility. The LLM correctly notes potential transparency implications. REASONING ISSUES: While the LLM's reasoning about governance implications is logical, it is built on factual premises that appear to be fabricated or unsupported by the ground truth. The multi-hop synthesis fails because the LLM introduces information not present in the source material. The answer reads as plausible but contains material factual errors that would mislead readers about what actually changed between filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 458,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "\nBetween 2023 and 2024 Amazon replaced its 364‑day revolving credit facility twice. The first $5 billion facility was entered into in November 2023 and was set to mature in October 2024; it was then swapped for a second $5 billion 364‑day revolving facility in October 2024, which now matures in October 2025 (with a one‑year extension option) and was established later in the year. Thus, the commitment size stayed at $5 billion, but the maturity date was pushed forward by roughly one year and the new agreement was launched in October 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with strong factual accuracy. STRENGTHS: (1) All key numbers are correct: $5.0 billion facility size in both years, 364-day revolving credit structure, October 2024 maturity for 2023 agreement, October 2025 maturity for 2024 agreement. (2) Dates are accurate: November 2023 establishment for first facility, October 2024 establishment for second facility. (3) Multi-hop synthesis is sound: correctly identifies the replacement pattern, tracks the one-year forward shift in maturity dates, and notes the facility size remained constant. (4) The conclusion about 'procedural renewal rather than substantive change' is appropriately captured through the observation that commitment size stayed the same while maturity dates shifted. MINOR ISSUES: (1) The LLM mentions 'one-year extension option' for the 2024 facility, which is not mentioned in the ground truth answer. This appears to be an addition not explicitly confirmed in the original answer, though it may be accurate from the source documents. (2) The phrasing 'swapped for' and 'launched in October 2024' is slightly less precise than the ground truth's 'entered into' and 'established,' though semantically equivalent. (3) The LLM says the maturity date was 'pushed forward by roughly one year' which is accurate (October 2024 to October 2025 = exactly one year), though 'roughly' introduces minor imprecision. VERIFICATION: All core financial metrics, dates, and the evolution pattern are correctly captured. The answer successfully addresses all parts of the multi-part question regarding facility size, maturity date, and timing of establishment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 450,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "\nFrom 2022 to 2024 AMD shifted its APU roadmap from a pure CPU‑GPU balance aimed at mainstream consumer and gaming notebooks toward a heterogeneous‑compute platform that adds a dedicated neural‑processing unit, AI‑optimized software (ROCm, FidelityFX) and tighter integration with Zen 5/Zen 5‑based cores and 3‑D V‑Cache.  This integration expands the target market from traditional desktops and laptops to “AI‑PC” and commercial segments—including enterprise laptops, data‑center‑adjacent workloads and semi‑custom designs—while preserving the cost‑efficiency of a single‑chip solution.  Consequently, AMD can tap a higher‑margin, rapidly growing AI‑PC opportunity, but it also faces stiffer competition and must secure software‑ecosystem adoption to translate the broader market reach into sustainable revenue growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of AMD's APU strategy evolution from 2022 to 2024 and correctly identifies the core strategic shift toward integrated NPU solutions for AI PCs. STRENGTHS: (1) Correctly identifies the shift from CPU-GPU balance to heterogeneous compute with dedicated NPU integration; (2) Accurately mentions Zen 5 cores and 3D V-Cache as part of the evolution; (3) Properly identifies the expanded target markets (AI-PC, enterprise, commercial segments); (4) Correctly notes the single-chip cost-efficiency advantage; (5) Appropriately discusses revenue implications and competitive challenges. WEAKNESSES: (1) The LLM answer introduces specific technical details (ROCm, FidelityFX, Zen 5-based cores, 3D V-Cache) that, while potentially accurate, are not explicitly validated in the ground truth and represent additional claims beyond what was confirmed; (2) The ground truth specifically mentions AMD being 'the first company' to include a dedicated NPU on the same SoC as x86 CPU—the LLM answer doesn't explicitly claim this first-mover advantage, which is a notable omission; (3) The ground truth explicitly references specific 2022 products (Instinct MI200 series, Radeon PRO V620) which the LLM answer doesn't mention, though this is a minor detail; (4) The LLM answer adds discussion of 'stiffer competition' and 'software-ecosystem adoption' challenges which, while reasonable inferences, go beyond the ground truth's focus on revenue potential implications. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across the 2022-2024 timeframe and connects it to market implications. The logic linking integrated NPU solutions to AI PC revenue growth is sound. SEMANTIC EQUIVALENCE: The core message aligns well—both answers convey that AMD shifted from external GPU solutions to integrated NPU solutions targeting AI PCs. The LLM's framing of 'heterogeneous-compute platform' is semantically equivalent to the ground truth's 'integrated APUs with NPU cores.' No quantitative errors detected (no specific numbers provided in either answer to verify).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 564,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "\nThe 2024 10‑K contains essentially the same Irish‑tax framework that was set out in the 2023 filing: Irish dividends remain subject to a 25 % withholding tax, but U.S. shareholders can avoid that tax if they satisfy the DTC‑address or Form 6166/V2 certification requirements, and the withholding payment then discharges any Irish income‑tax liability.  No new exemptions, rates, or procedural changes were introduced between fiscal years 2023 and 2024—the treatment of Irish dividend withholding tax for U.S. shareholders stayed consistent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-synthesized. Verification of key facts: (1) The 25% Irish dividend withholding tax rate is correctly stated in both the original answer and LLM response. (2) The exemption mechanisms are accurately identified: Form 6166 (U.S. Certification of Residence) and Irish Non-Resident Form V2 are mentioned in the original answer, and the LLM appropriately references these as 'Form 6166/V2 certification requirements' and 'DTC-address' requirements. (3) The core finding that withholding payment discharges Irish income tax liability is correctly conveyed in both answers. (4) The multi-hop reasoning is sound: the LLM correctly synthesizes information across 2023 and 2024 filings to conclude there was no change in the regulatory framework. (5) The LLM answer appropriately addresses the evolution question by explicitly stating 'No new exemptions, rates, or procedural changes were introduced between fiscal years 2023 and 2024.' The only minor point is that the LLM uses 'DTC-address' which is not explicitly mentioned in the original answer's reference to 'residency documentation,' though this appears to be a reasonable interpretation of the exemption criteria. The answer is complete, factually accurate on all quantitative metrics (25% rate, years 2023-2024), and demonstrates proper multi-hop synthesis across the two fiscal years. The semantic meaning is fully equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 399,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings, BNY Mellon’s risk discussion shifted from a brief, generic reference to “new lines of business, new products and services or transformational or strategic project initiatives” (2022) to a more explicit, dedicated risk factor that highlights the **platforms operating‑model transformation** and the specific dangers of failing to execute it (2024).  The 2024 filing expands the language to note that the company may not realize the expected benefits of the platforms operating model and that any shortfall could materially affect its results of operations, reflecting a heightened focus on the risks tied to new products, services and the ongoing platform redesign.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of risk disclosure from 2022 to 2024, correctly identifying the shift from generic language about 'new lines of business, new products and services, or transformational or strategic project initiatives' to specific focus on 'platforms operating model' risks. The core factual claims match the ground truth. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required for this qualitative question about risk disclosure evolution. The dates (2022 and 2024) are correct. (3) ENTITY ACCURACY: BNY Mellon is correctly identified as the company, the correct fiscal years (2022 and 2024) are referenced, and the specific strategic initiative (platforms operating model) is accurately named. (4) MULTI-HOP REASONING: The answer successfully synthesizes information across two different filing years and correctly identifies the progression of risk language. It demonstrates understanding that this represents a shift from general to specific risk disclosure. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth, using slightly different phrasing ('platforms operating-model transformation' vs 'transition to a platforms operating model') but maintaining semantic equivalence. The addition of context about 'material effect on results of operations' adds helpful detail without contradicting the ground truth. Minor observation: The LLM answer adds slightly more interpretive language ('heightened focus,' 'dangers of failing to execute') compared to the more neutral ground truth, but this represents reasonable elaboration rather than factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 483,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "\nBetween 2023 and 2024 Amazon continued to disclose the 3.600 % Note due 2032 in the same location—Exhibit 4.2 of its Form 10‑K filings—where it is presented as part of the Supplemental Indenture dated April 13 2022.  The company made no material change to the note’s terms or outstanding balance; the 2024 filing simply updates the exhibit list and re‑incorporates the identical disclosure by reference, confirming that the 3.600 % Note remains outstanding without any amendment or new issuance.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant omissions and fails to address the core evolution described in the ground truth. CORRECT ELEMENTS: (1) The note is correctly identified as 3.600% Note due 2032, (2) The Supplemental Indenture date of April 13, 2022 is correct, (3) The note remained outstanding without material changes to terms or balance is accurate, (4) Numeric values and dates are formatted correctly. CRITICAL OMISSIONS: The LLM answer completely fails to address the primary evolution highlighted in the ground truth—the trustee transition from Wells Fargo Bank, National Association (as prior trustee) to Computershare Trust Company, National Association (as successor trustee). This is the key substantive change between 2023 and 2024 disclosures. The ground truth explicitly states this represents 'a formal transition away from Wells Fargo Bank' and 'a shift in the trustee relationship,' which is the central point of how the relationship 'evolved.' REASONING ISSUES: The LLM answer focuses on procedural filing mechanics (exhibit location, re-incorporation by reference) rather than the actual substantive evolution in trustee administration. While the LLM correctly notes no material changes to terms, it misses the material change in trustee structure, which is precisely what the question asks about. The answer reads as a generic statement about how exhibits are handled rather than a specific analysis of the trustee relationship evolution. MULTI-HOP SYNTHESIS: The LLM failed to synthesize the key information about trustee changes across the two years' filings. The question specifically asks about evolution 'particularly in terms of its debt instrument disclosures,' and the trustee change is a critical disclosure evolution that was completely omitted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 483,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "\nIn the 2023 filing the net‑investment hedge derivatives were shown only as part of the overall derivative balances—$163 million of asset derivatives and $382 million of liability derivatives at fair value—with their periodic gains/losses recorded in accumulated other‑comprehensive income and re‑classified to earnings only when the hedged investment was settled. By the 2024 filing the same contracts are disclosed in a dedicated “Net investment hedge derivative contracts” table, reporting a much smaller liability ($50 million) and a larger asset ($305 million) at fair value, and the note now explicitly breaks out the after‑tax OCI gain/loss, the Level 1/2 valuation inputs, and the amount that will be re‑classified to earnings, providing a clearer view of hedge effectiveness and financial impact.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS: The LLM cites completely different numbers than the ground truth. Ground truth shows 2023 balances of $1,347M and $377M in current assets, and $250M and $413M in other assets. The LLM instead reports $163M asset derivatives and $382M liability derivatives for 2023, and $305M assets/$50M liabilities for 2024—none of which match the ground truth figures. These are not minor formatting differences but fundamentally different values. (2) STRUCTURAL MISUNDERSTANDING: The ground truth indicates that 2023 disclosure focused on balance sheet fair values (current and non-current assets/liabilities), while 2024 shifted emphasis to income statement impacts ('Other income, net'). The LLM incorrectly characterizes this as a shift from 'overall derivative balances' to a 'dedicated table' with different valuation levels and OCI breakouts—this misrepresents the actual evolution described in the ground truth. (3) MISSING KEY INFORMATION: The LLM fails to mention the specific 2023 balance sheet line items ($1,347M current assets, $250M other assets) and the 2024 shift to income statement focus, which are central to understanding the evolution. (4) INCORRECT EMPHASIS: The LLM emphasizes presentation format changes (table structure, Level 1/2 inputs, OCI breakouts) that are not mentioned in the ground truth, while missing the actual substantive shift from balance sheet valuation disclosure to income statement impact disclosure. (5) MULTI-HOP SYNTHESIS: The answer fails to correctly synthesize the year-over-year evolution because the underlying numbers are wrong, making any comparison invalid. The ground truth clearly shows a shift in disclosure focus and financial impact presentation; the LLM answer describes a different phenomenon entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 512,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "\nFrom 2023 to 2024 the Abrams modernization moved from introducing the SEPv3 “system‑enhancement package” – which adds upgraded communications, power generation, fuel‑efficiency, optics and armor – and launching the next‑generation M1E3 engineering‑change variant aimed at faster tech refreshes and lower sustainment costs – to a sustained focus on meeting strong overseas demand.  The 2024 disclosures highlight that NATO allies and partners in Europe, the Middle East, North Africa and the Indo‑Pacific are increasingly procuring and upgrading Abrams tanks, reinforcing the program’s international market and prompting continued production of SEPv3 upgrades and further development of the M1E3 configuration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) FACTUAL ACCURACY: All major facts are correct - SEPv3 upgrades (communications, power generation, fuel efficiency, optics, armor), M1E3 development as next-generation variant, 2023 focus on technical roadmap, 2024 emphasis on international demand and global strategic relevance. The geographic regions mentioned (Europe, Middle East, North Africa, Indo-Pacific) match the ground truth exactly. (2) QUANTITATIVE ACCURACY: No numeric values are present in either answer, so this dimension is not applicable but the answer correctly avoids introducing false numbers. (3) MULTI-HOP REASONING: The answer successfully synthesizes the evolution across two years - correctly identifying the shift from technical development focus (2023: SEPv3 and M1E3 introduction) to market/demand focus (2024: international procurement momentum). The causal connection between capability development and international demand is properly established. (4) COMPLETENESS: The answer addresses both sub-questions: technological development (SEPv3 features, M1E3 engineering changes, faster tech refreshes, lower sustainment) and international demand (NATO allies, regional expansion, procurement momentum). (5) SEMANTIC EQUIVALENCE: The LLM uses slightly different phrasing ('system-enhancement package' vs 'System Enhancement Package', 'engineering-change variant' vs 'engineering change') but these are semantically equivalent and represent appropriate stylistic variation. The core message that 2023 emphasized technical roadmap while 2024 emphasized global strategic relevance and procurement momentum is preserved. Minor note: The LLM answer is slightly more concise than the ground truth but loses no essential information and actually improves readability while maintaining accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 505,
        "total_tokens": 1903
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "\nBetween 2022 and 2024 AMD expanded the APU’s role from a primarily client‑segment, value‑oriented solution for mainstream and commercial notebooks (integrated CPU‑GPU chips for cost‑effective PCs) to a heterogeneous‑computing platform that spans client, commercial‑PRO, embedded and even data‑center markets.  The company increasingly positioned APUs as AI‑ready, RDNA 2‑based graphics engines and as the core of semi‑custom designs (e.g., PlayStation 5, Xbox Series X/S, Steam Deck), emphasizing balanced CPU‑GPU performance and software ecosystems across all segments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) INCORRECT SEGMENTATION: The LLM claims APUs were positioned in 'client, commercial-PRO, embedded and data-center markets' but the ground truth explicitly states APUs were only included in TWO of AMD's four reportable segments by 2024 (Data Center and Client segments). The LLM incorrectly adds 'commercial-PRO' and 'embedded' as distinct segments. (2) MISSING CORE FACTS: The LLM completely fails to mention the 2022 baseline where APUs were discussed as part of 'Enterprise, Embedded and Semi-Custom' portfolio without specific market segmentation. The ground truth emphasizes this evolution from general discussion to explicit segment inclusion. (3) INCORRECT EMPHASIS: The LLM emphasizes semi-custom designs (PlayStation 5, Xbox Series X/S, Steam Deck) which are NOT mentioned in the ground truth as part of the 2022-2024 APU evolution narrative. While these may be real AMD products, they are not part of the documented evolution in the SEC filings. (4) MISSING STRUCTURAL CHANGE: The ground truth highlights a critical structural shift - APUs moved from being part of a broader portfolio category to being explicitly listed in specific reportable segments. The LLM misses this organizational/strategic restructuring. (5) PARTIAL ACCURACY: The LLM correctly identifies that APUs evolved to span multiple markets and mentions RDNA 2 graphics, which aligns with some aspects of the evolution, but the overall narrative is fundamentally misaligned with the documented segment structure. The answer demonstrates incomplete understanding of AMD's formal segment reporting structure and conflates product categories with reportable segments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 475,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "\nFrom 2023 to 2024 Medtronic’s description of the Irish Financial Transfers Act 1992 remained essentially the same – the company noted that the Act lets the Irish Minister for Finance restrict capital movements between Ireland and certain third‑country jurisdictions, that a list of those jurisdictions is maintained and “subject to ongoing change,” and that any transfers involving sanctioned governments or entities may be limited.  The 2024 filing did not introduce new restrictions; instead it reiterated the prior position and clarified that, as of the 2024 filing, the list of restricted third countries had not been expanded since the 2023 filing and continues to be monitored for future updates.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and contradicts the ground truth in critical ways: (1) CORE CONTRADICTION: The ground truth states that by 2024, Medtronic 'no longer emphasized the dynamic nature of the list of restricted countries,' indicating a shift in disclosure focus. The LLM answer claims the opposite - that the 2024 filing continued to note the list is 'subject to ongoing change,' which directly contradicts the ground truth's key finding about the evolution of disclosure. (2) UNSUPPORTED CLAIMS: The LLM introduces specific details not present in the ground truth, such as 'the list of restricted third countries had not been expanded since the 2023 filing and continues to be monitored for future updates.' These claims appear fabricated and are not supported by the original answer. (3) MISCHARACTERIZATION OF EVOLUTION: The ground truth emphasizes that there WAS an evolution/shift in how Medtronic presented this information (de-emphasizing the dynamic nature), but the LLM characterizes the disclosure as 'essentially the same' with no meaningful change. This fundamentally misses the point of the question about how disclosure 'evolved.' (4) QUANTITATIVE ACCURACY: While no specific numbers are involved, the LLM fails on the qualitative/factual accuracy of what changed between years. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the comparative analysis between 2023 and 2024 filings, missing the key distinction that the emphasis on regulatory dynamism was reduced in 2024. The answer demonstrates a failure to understand the nuanced evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 448,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "\nThe 2023 filing positioned the G700 as an upcoming ultra‑large‑cabin jet slated to enter service “following FAA certification in early 2024.” By the 2024 filing the aircraft had already been certified and was in production ramp‑up, with deliveries beginning in the second quarter of 2024 and contributing to a noticeable increase in inventories and customer deposits for new Gulfstream models. This shift shows the G700 moved from a planned 2024 entry‑into‑service to an actual, revenue‑generating product in GD’s portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about G700 evolution from 2023 to 2024. QUANTITATIVE ACCURACY: All dates and timeframes are correct - 2023 positioning with early 2024 FAA certification expectation, and Q2 2024 actual deliveries. No numeric errors detected. ENTITY ACCURACY: Correctly identifies GD (General Dynamics), Gulfstream, and the G700 aircraft across both filing periods. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years, showing the progression from planned/future product to realized/revenue-generating product. The logic is sound: 2023 described it as upcoming → 2024 shows it certified and delivering. COMPLETENESS: Addresses all key aspects of the question - status evolution (upcoming to delivered), production outlook (entry-into-service to production ramp-up), and the transition from development to active delivery. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth, using slightly different but equivalent phrasing ('ultra-large-cabin jet' vs 'next model to join the Gulfstream lineup'). The addition of context about 'inventories and customer deposits' and 'revenue-generating product' provides helpful supplementary detail that enhances understanding without contradicting the ground truth. MINOR OBSERVATION: The LLM answer includes slightly more business context (inventory impact, customer deposits) than the ground truth, but this is additive rather than contradictory and demonstrates deeper synthesis of the filing information. No factual errors or calculation mistakes identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 454,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "\nFrom 2023 to 2024 the PMI‑KT&G tie‑up shifted from the January 2023 renewal of a 15‑year, exclusive worldwide licence (ex‑South Korea) to an active commercialisation phase.  The agreement now runs on a series of three‑year performance‑review cycles that tie confirmed volume targets to continued exclusivity, giving PMI sustained access to KT&G’s smoke‑free brands and product‑innovation pipeline for low‑ and middle‑income markets while requiring PMI to obtain market‑specific regulatory approvals.  As a result, PMI’s strategic dependence on KT&G has deepened – the partnership is now a core driver of PMI’s smoke‑free growth strategy and the primary source of new heated‑tobacco and related products outside South Korea.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a significant factual error regarding the agreement structure. The ground truth states the agreement runs through January 29, 2038 (a single 15-year term), but the LLM claims it operates on 'three-year performance-review cycles' with conditional exclusivity tied to volume targets. This is a material misrepresentation of the agreement terms not supported by the ground truth. (2) DATE ACCURACY - The LLM references 'January 2023 renewal' which is imprecise; the ground truth specifies the agreement was announced in 2023 and runs through January 29, 2038, but does not characterize it as a 'renewal' or mention three-year cycles. (3) MULTI-HOP REASONING - While the LLM correctly identifies the evolution from 2023 to 2024 and the shift toward deeper integration, it introduces unsupported structural details about performance-review cycles and conditional exclusivity that contradict the ground truth's description of a straightforward 15-year exclusive agreement. (4) SEMANTIC ALIGNMENT - The LLM does capture the core concept that the relationship evolved from announcement/exclusive distribution to operational integration and deepened strategic dependency. However, the invented details about three-year cycles and volume-contingent exclusivity represent fabrication rather than synthesis. (5) WHAT WAS CORRECT - The LLM correctly identifies: the 15-year term, worldwide exclusivity (ex-South Korea), access to KT&G's smoke-free brands and pipeline, focus on low/middle-income markets, the shift to active commercialization, and the deepening of strategic dependency. (6) WHAT WAS INCORRECT - The three-year performance-review cycle structure, volume targets tied to exclusivity, and the characterization of 'January 2023 renewal' are not supported by ground truth and appear to be hallucinated details that fundamentally alter the nature of the agreement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 523,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "\nFrom 2022 to 2024 AMD moved away from a single‑foundry, near‑exclusive wafer‑capacity deal (the 2021‑2025 WSA with GF) toward a more flexible, non‑exclusive sourcing model that lets it spread semi‑custom SoC production across multiple fabs—including TSMC’s 7 nm and newer nodes—while still honoring the minimum annual capacity commitments that run through 2025.  This shift lets AMD tie its semi‑custom SoC roadmap directly to the broader “adaptive‑computing” ecosystem it is building, linking the SoCs used in gaming consoles and handhelds to its expanding AI‑focused data‑center, client‑PC and embedded product lines, so that design wins and revenue are contingent on the success of those downstream platforms.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and the question being asked. Critical issues: (1) WRONG FOCUS: The LLM discusses AMD's foundry sourcing strategy (GF WSA, TSMC fab allocation) rather than the evolution of semi-custom SoC product positioning and ecosystem integration that the question and ground truth address. (2) MISSING CORE CONTENT: The LLM completely fails to mention the 2022-to-2024 evolution in strategic positioning, the shift from dependency model to integrated product leadership, or the specific 2024 innovations like NPU integration for AI PCs. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes how semi-custom SoCs evolved from being dependent on third-party success (2022) to being core components of a broader AI-integrated ecosystem (2024). The LLM mentions 'adaptive-computing ecosystem' but doesn't capture this strategic evolution or the specific product integrations (AI accelerators, CPUs, GPUs, APUs, NPU). (4) FACTUAL ACCURACY: While the LLM's statements about the GF WSA (2021-2025) and TSMC sourcing may be factually correct regarding manufacturing, they are irrelevant to answering the question about product strategy evolution and ecosystem integration. (5) MULTI-HOP REASONING: The question requires synthesizing information about how AMD's semi-custom SoC strategy evolved across 2022-2024 in terms of positioning and ecosystem integration. The LLM instead synthesizes information about manufacturing/sourcing strategy, which is a different topic entirely. The answer demonstrates a fundamental misunderstanding of what the question is asking for.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 442,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "\nThe 2024 filing confirms that U.S.‑resident shareholders who hold their Medtronic shares through DTC and have a U.S. address on record (or who supply a valid U.S. certification of residence (Form 6166) or Irish Non‑Resident Form V2) are exempt from the 25 % Irish dividend‑withholding tax—exactly the same exemption that applied in 2023.  What changed between the years is mainly clarification: the 2024 disclosure explicitly states that the withholding tax is discharged once the shareholder provides a statement to the Irish Revenue authorities and notes that reliance on the U.S.–Ireland tax treaty is generally unnecessary because the statutory exemption is so broad.  Thus, the practical tax treatment of Irish dividends paid to U.S. residents has not shifted substantively; only the documentation requirements and procedural wording have been refined.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH CORE CLAIM: The LLM answer asserts that the exemption conditions were 'exactly the same' between 2023 and 2024, but the ground truth explicitly states that the treatment 'evolved' with meaningful differences. The ground truth indicates: (1) 2023: exemption was general with a condition about 'connection to Ireland beyond shareholding'; (2) 2024: exemption became more structured with specific conditions ('do not hold shares through an Irish branch') and clarified post-withholding procedures ('furnishing a statement to Irish Revenue'). The LLM's claim that 'only the documentation requirements and procedural wording have been refined' contradicts the ground truth's characterization of substantive evolution in exemption conditions. QUANTITATIVE ACCURACY: The 25% withholding tax rate is correctly stated in both answers. However, the LLM introduces specific procedural details (DTC, Form 6166, Irish Non-Resident Form V2) that are not mentioned in the ground truth, raising questions about whether these details are accurate or represent over-specification. REASONING FLAW: The LLM concludes 'the practical tax treatment...has not shifted substantively,' which directly contradicts the ground truth's framing that treatment 'evolved' with 'more structured conditions' and 'clarified post-withholding tax procedures.' This represents a fundamental misinterpretation of the multi-hop comparison between 2023 and 2024. COMPLETENESS: The LLM does address both years and the withholding tax rate, but fails to capture the key evolution in exemption conditions and liability discharge procedures that the ground truth emphasizes. The answer is internally coherent but factually misaligned with the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 471,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "\nFrom 2023 to 2024 General Dynamics’ Marine Systems segment saw revenue jump ≈ 13 % in 2023, driven largely by higher volume on the Columbia‑class submarine program and related Virginia‑class and DDG‑51 work, but operating margin slipped about 110 basis points because supply‑chain cost pressures inflated the estimated costs of the Virginia‑class submarine schedule and the Arleigh Burke‑class (DDG‑51) destroyer program.  The 2024 outlook projects Marine Systems revenue of roughly $12.8‑12.9 billion with an operating margin near 7.6 %, indicating that revenue growth from the Columbia‑class submarine initiative will continue even as the company works to contain cost overruns on the Virginia‑class and DDG‑51 contracts.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of General Dynamics' Marine Systems segment performance and strategic direction, with mostly accurate information but some issues with clarity and precision. STRENGTHS: (1) Correctly identifies the 110 basis point margin decline in 2023 due to supply chain disruptions and cost overruns on Virginia-class and DDG-51 programs. (2) Accurately cites the 2024 revenue projection of $12.8-12.9 billion and operating margin of approximately 7.6%. (3) Properly synthesizes the multi-hop information about the shift from 2023 cost pressures to 2024 optimistic outlook. (4) Correctly identifies Columbia-class submarine program as a growth driver. (5) Appropriately characterizes the strategic shift from margin pressure to stabilization/improvement. WEAKNESSES: (1) The statement 'revenue jump ≈ 13% in 2023' is problematic - the ground truth does not provide a specific 2023 revenue growth percentage, only that 'revenue from U.S. Navy ship construction rose.' The LLM appears to have inferred or calculated this figure without clear justification from the source material. (2) The phrasing 'revenue jump ≈ 13% in 2023' is somewhat awkwardly placed in the opening sentence and could be misinterpreted as referring to the 2024 projection rather than 2023 actual performance. (3) Minor semantic issue: the answer says 'operating margin slipped about 110 basis points' which could be clearer about whether this is year-over-year or absolute margin level. The ground truth specifies this as a 'decline' in 2023. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 performance metrics, program-specific challenges (Virginia-class, DDG-51), and strategic initiatives (Columbia-class), demonstrating proper multi-hop synthesis. CALCULATION VERIFICATION: The 2024 projections ($12.8-12.9B revenue, 7.6% margin) are correctly stated. The 110 basis point margin decline is correctly cited. The unverified 13% revenue growth figure is the primary quantitative concern. Overall, the answer captures the essential narrative of the question but includes one unsubstantiated quantitative claim that reduces confidence in the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 588,
        "total_tokens": 2002
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "\nBetween 2022 and 2023, the share of Booking Holdings’ total revenue that comes from accommodation‑reservation services stayed essentially unchanged—about 89 % of revenue in both years (the 2023 filing notes that “approximately 89 % of the Company’s revenues for the years ended December 31, 2023 and 2022 relate to online accommodation‑reservation services,” up only slightly from 87 % in 2021). Thus, BKNG’s financial reliance on Booking.com for accommodation bookings remained very high and stable, with only a marginal increase in the proportion of revenue derived from those reservations from 2022 to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERROR: The LLM answer contains a fundamental factual contradiction that undermines the entire response. The ground truth states that accommodation reservations contributed 89% in both 2022 and 2023 (unchanged). However, the LLM answer claims the percentage 'stayed essentially unchanged—about 89% of revenue in both years' BUT THEN CONTRADICTS ITSELF by stating 'only a marginal increase in the proportion of revenue derived from those reservations from 2022 to 2023.' This is logically inconsistent—if the percentage was 89% in both years, there is NO increase, marginal or otherwise. The LLM also introduces extraneous information about 2021 (87%) that is not part of the ground truth answer and was not requested in the question, which focuses specifically on 2022-2023 evolution. The quantitative claim of 89% for both years is correct, but the qualitative interpretation that there was 'only a marginal increase' directly contradicts the stated fact that the percentages were identical. This represents a failure in logical reasoning and semantic consistency. The answer correctly identifies the 89% figure but fails to properly synthesize the comparison between years, ultimately providing contradictory conclusions about whether change occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 354,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s Swiss‑franc‑denominated debt was eliminated.  In the 2023 long‑term‑debt schedule the firm listed a CHF note of $299 million (1.625 % due 2024), but the 2024 schedule shows that line as “‑”, indicating the note was fully repaid (or written‑off) by year‑end 2024.  This reduction signals that PMI deliberately shortened its foreign‑currency exposure, using cash or other financing to retire the Swiss‑franc obligation and thereby lower its overall foreign‑currency debt burden.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. (1) QUANTITATIVE ACCURACY: All numbers are correct - the $299 million Swiss Franc note amount matches the ground truth exactly, and the 1.625% coupon rate and 2024 maturity date are accurately cited. The representation of the 2024 schedule showing '-' is correctly interpreted as elimination of the obligation. (2) COMPLETENESS: The answer addresses both parts of the multi-part question - how the position evolved (from $299M in 2023 to elimination in 2024) and what it indicates about foreign currency obligations (strategic reduction of FX exposure). (3) ENTITY ACCURACY: The company is correctly identified as PMI (Philip Morris International), the Swiss Franc note is properly characterized, and the fiscal years 2023 and 2024 are correctly referenced. (4) REASONING: The multi-hop synthesis is sound - the model correctly connected the 2023 debt schedule data with the 2024 schedule data to conclude the obligation was eliminated, and properly inferred the strategic implications (deliberate shortening of FX exposure, reduction of overall FX debt burden). (5) SEMANTIC EQUIVALENCE: The LLM answer conveys identical information to the ground truth, with slightly more detail about the coupon rate and maturity date, and more explicit reasoning about the strategic intent. The only minor difference is the LLM specifies 'repaid (or written-off)' while ground truth says 'repaid or restructured' - both are reasonable interpretations of the elimination, though 'repaid' is more likely given the context of a maturing note.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 434,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "\nBetween the 2023 and 2024 10‑K filings Goldman Sachs replaced the older “pre‑2015” Non‑Employee Director RSU Award Agreement language (referenced in the 2023 filing as Exhibit 10.8) with a set of newer, more detailed award templates.  The 2024 filing adds dedicated exhibits for a cash‑settled director RSU agreement (Exhibit 10.32), a fully‑vested one‑time/year‑end RSU agreement (Exhibit 10.35), and updated base/supplemental RSU forms (Exhibits 10.36‑10.38), indicating that the company introduced and refined award structures—including cash‑settlement options and clearer vesting conditions—while retiring the earlier pre‑2015 versions.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT EXHIBIT NUMBERS: The LLM claims new exhibits were added as 10.32, 10.35, 10.36-10.38 in 2024, but the ground truth states the new exhibit added was 10.18 ('Amendments to Certain Non-Employee Director Equity Award Agreements'). These exhibit numbers appear to be fabricated. (2) MISCHARACTERIZATION OF CHANGE: The LLM states Goldman Sachs 'replaced' the pre-2015 agreement, but the ground truth indicates the company 'retained the reference' to the pre-2015 RSU Award Agreement (Exhibit 10.8) while ADDING new disclosures. This is a fundamental misunderstanding of the evolution - it was additive, not replacement. (3) INVENTED DETAILS: The LLM introduces specific details about 'cash-settled director RSU agreement,' 'fully-vested one-time/year-end RSU agreement,' and 'updated base/supplemental RSU forms' that are not mentioned in the ground truth. These appear to be hallucinated details. (4) MISSING KEY INFORMATION: The LLM fails to mention Exhibit 10.18 ('Amendments to Certain Non-Employee Director Equity Award Agreements'), which is the actual new exhibit introduced in 2024 according to the ground truth. (5) INCORRECT CHARACTERIZATION: The ground truth emphasizes 'expanded disclosures' and 'more comprehensive or updated treatment,' while the LLM incorrectly frames this as a replacement of older versions. The answer demonstrates poor multi-hop reasoning by fabricating exhibit numbers and details rather than accurately synthesizing the actual filing changes described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 442,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "\nBetween 2023 and 2024 PMI completed the cash‑consideration phase of its acquisition of Swedish Match AB: it paid the $1.7 billion (plus 6 % interest) that had been scheduled for July 2023, recording the amount in “other assets” on its 2023 balance sheet, and it had originally financed the deal with a €5.5 billion senior unsecured term‑loan (a €3 billion tranche due 2025 and a €2.5 billion tranche due 2027). In November 2024 PMI used cash and the proceeds of newly‑issued bonds to pre‑pay the entire €3 billion 2025 tranche, eliminating that portion of the long‑term debt tied to the acquisition while the remaining €2.5 billion tranche (due 2027) and its interest obligations remain on the books. The acquisition also continues to be reflected in the Swedish Match reporting unit’s goodwill and intangible‑asset balances, which are subject to ongoing impairment testing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides detailed operational information about the Swedish Match acquisition financing and debt management, but fundamentally fails to address the core quantitative claim in the ground truth. CRITICAL ISSUE: The ground truth states long-term debt obligations decreased from $6,121 million (2023) to $2,610 million (2024). The LLM answer discusses a €5.5 billion term loan structure (€3 billion 2025 tranche + €2.5 billion 2027 tranche) and mentions pre-paying the €3 billion tranche in November 2024, but provides NO conversion to USD or reconciliation with the stated $6,121M and $2,610M figures. The LLM answer does not verify whether €5.5 billion ≈ $6,121M or whether the remaining €2.5 billion ≈ $2,610M after the pre-payment. Without this quantitative reconciliation, the answer fails to directly answer the question about how debt obligations evolved numerically. STRENGTHS: The LLM correctly identifies the acquisition, the financing structure, the November 2024 pre-payment action, and provides relevant operational context about goodwill/intangible assets. The narrative is coherent and shows understanding of the transaction mechanics. WEAKNESSES: (1) No direct comparison of 2023 vs 2024 debt levels in USD terms, (2) No acknowledgment of the $6,121M → $2,610M reduction stated in ground truth, (3) Missing explicit statement that debt decreased significantly, (4) Focuses on transaction mechanics rather than financial relationship evolution as asked. The answer reads more like a transaction summary than a financial analysis of how the relationship evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 441,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "\nFrom 2023 through early 2024 BMS moved from a largely internal, pipeline‑focused effort on KRAS‑driven oncology to a decisive strategic acquisition: it bought Mirati Therapeutics in January 2024, gaining commercial rights to the KRAS‑G12C inhibitor **Krazati** (already approved for second‑line NSCLC and KRAS‑mutant colorectal cancer) and a deep‑stage PRMT5 inhibitor (MRTX‑1719) plus other KRAS‑adjacent assets.  The deal gave BMS an immediate commercial foothold in KRAS inhibition and a clear development path to expand Krazati into first‑line NSCLC combinations and additional tumor types, positioning the asset as a cornerstone of its oncology growth strategy for the next several years.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of BMY's strategic evolution around KRAS inhibition but contains one significant factual error and some minor omissions. STRENGTHS: (1) Correctly identifies the Mirati acquisition timing (January 2024) and acquisition of Krazati rights; (2) Accurately describes Krazati as a KRAS G12C inhibitor; (3) Correctly notes FDA approval for second-line NSCLC and colorectal cancer indications; (4) Properly identifies the strategic shift from internal pipeline focus to external acquisition; (5) Mentions first-line NSCLC combination development path. CRITICAL ERROR: The LLM states the acquisition price was not specified, but the ground truth clearly indicates the deal was worth $4.8 billion - this is a material omission of a key quantitative fact. MINOR ISSUES: (1) The LLM mentions MRTX-1719 (PRMT5 inhibitor) as part of the acquisition, which is not addressed in the ground truth answer, making it difficult to verify but not contradicting the provided information; (2) The LLM says Krazati was 'already approved for...KRAS-mutant colorectal cancer' at time of acquisition, while ground truth indicates the colorectal cancer approval came in 2024 (after acquisition completion), suggesting possible timing ambiguity in the LLM's phrasing. MULTI-HOP REASONING: The answer successfully synthesizes the 2023-to-2024 evolution and connects the acquisition to strategic positioning, meeting the core requirement. The reasoning about moving from internal efforts to external acquisition is sound and well-articulated. QUANTITATIVE ACCURACY: Missing the $4.8 billion acquisition price is a notable gap, though other facts are accurate. The date 'January 2024' is more specific than ground truth but appears consistent with public records.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 483,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "\nBetween 2023 and 2024 the firm shifted the Restricted Partner Compensation Plan from a brief exhibit citation in the 2023 10‑K to a formally amended and restated governance document (listed as Exhibit 10.4 in the 2024 filing) and placed it alongside the newly adopted 2023 Clawback Policy. This re‑positioning signals a more explicit governance framing and heightened disclosure of partner‑compensation terms as part of the firm’s updated compensation‑oversight framework.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several significant factual errors that undermine its credibility: (1) EXHIBIT NUMBER ERROR: The LLM states the plan was 'listed as Exhibit 10.4 in the 2024 filing' but the ground truth indicates it was Exhibit 10.3 in 2023 and Exhibit 10.4 in 2024 - this is partially correct for 2024 but the framing is unclear. (2) CLAWBACK POLICY DATING ERROR: The LLM refers to the '2023 Clawback Policy' but the ground truth indicates the Clawback Policy was introduced in 2024 (listed as Exhibit 10.1), not 2023. This is a critical factual error regarding when the policy was adopted. (3) PLACEMENT ACCURACY: The ground truth clearly states the plan's 'relative placement shifted later in the exhibit list' between 2023 and 2024, but the LLM does not clearly convey this shift - instead it vaguely references 'placed it alongside' without clarifying the positional change. (4) AMENDMENT CLAIM: The LLM states the plan was 'formally amended and restated' but the ground truth explicitly states it 'remained substantively unchanged.' This is a material mischaracterization. (5) POSITIVE ASPECTS: The LLM correctly identifies Goldman Sachs as the firm, correctly notes the Clawback Policy introduction, and appropriately frames this as a governance/risk mitigation shift. The semantic understanding of the repositioning as signaling governance emphasis is reasonable. However, the factual errors regarding dates, amendment status, and policy timing are significant enough to substantially reduce the answer's reliability. The multi-hop reasoning about governance evolution is present but undermined by the factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 448,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "\nFrom 2022 to 2023 PMI re‑classified heat‑not‑burn as a distinct sub‑category within its “smoke‑free products excluding wellness and healthcare” segment, reporting a 27 % revenue increase (to $12.5 bn) and a 14.7 % rise in heated‑tobacco unit shipments. At the same time the company integrated HNB into its broader smoke‑free portfolio—linking it to the IQOS Platform 1, expanding the brand suite (HEETS, Marlboro Dimensions, TEREA, licensed KT&G products) and tying its growth to the Swedish Match acquisition—so that HNB is now managed as a core, integrated component of PMI’s smoke‑free business rather than a standalone product line.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of PMI's heat-not-burn categorization from 2022 to 2023, including the shift to 'smoke-free products' grouping and the integration of licensed KT&G products. The qualitative reasoning about business integration and the IQOS Platform 1 is sound and aligns with the ground truth. However, there are significant quantitative accuracy issues: (1) The specific revenue figure of $12.5 billion and the 27% revenue increase cannot be verified against the ground truth provided, which does not contain these specific financial metrics. (2) The 14.7% rise in heated-tobacco unit shipments is also not mentioned in the ground truth. (3) The reference to the Swedish Match acquisition, while potentially relevant to PMI's broader strategy, is not explicitly mentioned in the ground truth answer about heat-not-burn product evolution. These unverified numbers represent a major concern for factual accuracy in a financial context. The answer does successfully synthesize the multi-hop information about product categorization evolution and business integration, and it correctly identifies the key product brands (HEETS, Marlboro HeatSticks/Dimensions, TEREA, licensed KT&G products). The semantic understanding of the question is appropriate, but the introduction of specific financial metrics not present in the ground truth significantly undermines the reliability of the response. The answer would be stronger if it stuck to the documented evolution of categorization and integration without introducing unverified quantitative claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 434,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "\nBetween 2023 and 2024 the company moved from simply **creating a “business risk and disclosure group”** as one of the remedial measures required by the 2004 SEC Consent Order to **embedding that group within a broader, formally documented governance framework**.  In the 2023 filing the group was mentioned only as part of the list of compliance actions; by 2024 the firm described a **company‑wide policy** that incorporates the group’s work, adds a **structured escalation process** for any questions or concerns, and mandates **regular monitoring of compliance**.  Thus, the evolution is a shift from a one‑time establishment to an ongoing, integrated risk‑governance mechanism that directly oversees adherence to the Consent’s sales‑limitation and disclosure requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of Bristol-Myers Squibb's business risk governance between 2023 and 2024. STRENGTHS: (1) Correctly identifies the SEC Consent Order context (2004 order referenced appropriately); (2) Accurately captures the core evolution from establishment to integration; (3) Properly identifies key elements: formal review/certification, escalation processes, and ongoing monitoring; (4) Correctly names the 'business risk and disclosure group'; (5) Accurately reflects the shift from one-time remedial measure to ongoing governance mechanism. MINOR WEAKNESSES: (1) The LLM answer characterizes the 2023 mention as 'only as part of the list of compliance actions' while the ground truth indicates the 2023 establishment was more comprehensive (including outside consultant retention and formal review processes) - this slightly understates the 2023 baseline; (2) The LLM answer emphasizes 'company-wide policy' and 'structured escalation process' as 2024 additions, but the ground truth indicates these elements (governance mechanism to escalate and resolve compliance questions) were present in 2023 as well; (3) The phrase 'shift from a one-time establishment to an ongoing, integrated risk-governance mechanism' could be misread as suggesting the 2023 version was not ongoing, when the ground truth indicates it was already integrated into compliance framework in 2023. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations to verify - dates (2023, 2024, 2004) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information about governance evolution across two years and connects it to SEC Consent Order compliance requirements. The logic is sound regarding the progression from creation to integration. SEMANTIC EQUIVALENCE: The core message aligns with ground truth - the group remained central to governance with no significant changes, though the LLM's framing of 'evolution' slightly overstates the degree of change between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 545,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "\nBetween 2023 and 2024 UNP moved from a de‑risking “equity‑to‑debt” shift that culminated in a 25 % equity / 75 % debt target by the end of 2023 to a more explicit linkage of its long‑term expected return assumption to that higher‑weight debt allocation.  In the 2024 filing the company stresses that the 5.25 % long‑term return forecast is now driven primarily by the 70‑80 % debt exposure (with equity limited to 20‑30 %), whereas the 2023 discussion simply noted the completion of the shift to the 25 %‑equity target and the use of a 5‑year smoothed return to calculate pension expense.  Thus, the relationship evolved from a general “expected return is tied to asset allocation” statement to a concrete, debt‑heavy allocation that directly shapes the expected‑return assumption.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) QUANTITATIVE ERRORS: The LLM cites specific percentages (25% equity/75% debt target, 70-80% debt, 20-30% equity, 5.25% long-term return) that are not mentioned in the ground truth. The ground truth makes no reference to these specific allocation percentages or the 5.25% return figure. The LLM appears to have fabricated or confused these numbers. (2) CONCEPTUAL MISALIGNMENT: The ground truth focuses on how UNP's EXPLANATION of the relationship evolved - from a comprehensive statement mentioning historical returns and market conditions to a narrower focus on asset allocation alone. The LLM instead discusses a de-risking shift and asset allocation changes, which is a different topic entirely. The ground truth is about disclosure language evolution, not about actual portfolio rebalancing. (3) MISSING KEY ELEMENTS: The ground truth specifically mentions: (a) 2023 included a 6% actual return disclosure, (b) 2024 had no actual return disclosure, (c) the shift from mentioning 'historical returns' and 'market conditions' to only mentioning asset allocation. The LLM answer addresses none of these specific points. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparison between 2023 and 2024 disclosures. Instead of comparing the explanatory language used in each year's filing, the LLM created a narrative about portfolio de-risking that doesn't match the ground truth. (5) FACTUAL ACCURACY: The LLM's claim about a 'de-risking equity-to-debt shift' and specific allocation targets cannot be verified against the ground truth and appear to be incorrect or from a different context entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 471,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon shifted the presentation of its Directors’ Code of Conduct from a peripheral reference in the Proxy statement to a dedicated, explicitly‑linked disclosure in the 10‑K’s governance section.  In the 2023 filing the code is posted on the company’s website with a clear statement that any future amendments or waivers will be disclosed there, and this information is embedded in Item 10 alongside other governance details—making it far more accessible and integrated into the firm’s corporate‑governance reporting than in the 2022 filing, which only mentioned the code in passing.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces specific claims NOT supported by the ground truth, particularly regarding Item 10 placement and explicit statements about 'future amendments or waivers will be disclosed there.' The ground truth makes no mention of Item 10 or such specific waiver disclosure language. (2) The LLM characterizes the 2022 disclosure as 'only mentioned in passing' and 'peripheral reference in the Proxy statement,' but the ground truth explicitly states it was 'referenced in the context of broader corporate governance disclosures' with clear applicability to all directors - this is not a peripheral mention. (3) The LLM claims a shift from 'Proxy statement to 10-K's governance section,' but the ground truth does not specify these document types or locations. (4) POSITIVE: The LLM correctly identifies the core evolution - from a referenced document to one more directly integrated into governance framework, and correctly notes increased accessibility and centralization. (5) POSITIVE: No quantitative errors (no specific numbers were provided in either answer to verify). (6) REASONING FLAW: The LLM appears to have fabricated specific details about Item 10 placement and waiver disclosure language that are not in the ground truth, suggesting hallucination rather than synthesis from actual filing data. The answer captures the general direction of change but invents specifics that cannot be verified against the knowledge graph. This represents a significant accuracy problem for SEC filing analysis where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 430,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Oracle broadened the deployment options for its Oracle Database by making it available not only on public OCI but also through on‑premise and hybrid models—most notably via engineered‑system offerings such as **Exadata Cloud@Customer, OCI Dedicated Region and OCI Sovereign Cloud**.  These options are tightly integrated with Oracle’s engineered systems (e.g., Exadata Database Machine) that combine database, storage, and middleware in a single, optimized appliance, giving customers a consistent platform that can be run in any IT environment.  This evolution signals Oracle’s strategy of **facilitating cloud migration and hybrid‑IT deployments**, allowing customers to move workloads fluidly between on‑premise and the cloud while protecting existing investments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Oracle's strategic positioning but has some notable gaps and minor inaccuracies when compared to the ground truth.\n\nSTRENGTHS:\n1. Correctly identifies the time period (fiscal 2023-2024)\n2. Accurately mentions key engineered systems offerings: Exadata Cloud@Customer, Exadata Database Machine\n3. Correctly captures the core strategic shift toward integrated engineered systems combining database, storage, and infrastructure\n4. Properly identifies the multi-deployment model approach (on-premise, OCI, hybrid)\n5. Accurately conveys the strategic intent around cloud migration and hybrid IT environments\n6. No quantitative errors or incorrect numbers\n\nWEAKNESSES:\n1. INCOMPLETE OFFERINGS: The LLM mentions \"OCI Dedicated Region and OCI Sovereign Cloud\" as engineered-system offerings, but the ground truth specifically highlights \"Oracle Roving Edge Infrastructure\" as a key 2023 offering. The LLM's additions (Dedicated Region, Sovereign Cloud) are not mentioned in the ground truth and may represent a different category of offerings.\n2. MISSING NUANCE: The ground truth emphasizes a specific evolution FROM \"flexible deployment of standalone database services\" TO \"tightly integrated engineered systems,\" suggesting a strategic shift in emphasis. The LLM presents these as parallel offerings rather than showing the evolution of emphasis.\n3. INCOMPLETE CHARACTERIZATION: The ground truth notes that 2023 offerings were \"framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle\" - this security/management angle is absent from the LLM answer.\n4. MISSING DETAIL: The ground truth mentions \"operating system and networking hardware\" as components of Exadata, while the LLM only mentions \"database, storage, and middleware\" - the LLM's inclusion of \"middleware\" is not in the ground truth, and it omits OS and networking.\n5. STRATEGIC FRAMING: The ground truth emphasizes \"maturation of Oracle's cloud migration strategy\" and \"comprehensive, high-performance infrastructure packages,\" while the LLM focuses more on \"fluid workload movement\" and \"protecting existing investments.\"\n\nMULTI-HOP REASONING:\nThe LLM correctly synthesizes information about Oracle's strategic evolution across the two-year period and properly connects deployment flexibility to engineered systems integration. However, it doesn't fully capture the nuanced shift in strategic emphasis from the ground truth.\n\nSEMANTIC EQUIVALENCE:\nWhile the core message about hybrid IT and cloud migration is conveyed, the specific offerings mentioned differ slightly, and the characterization of the strategic evolution is less precise than the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 732,
        "total_tokens": 2272
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s formal review and certification of its annual and quarterly SEC reports remained rooted in the 2004 Consent, but the 2024 filing added a more detailed governance structure—specifically a dedicated business‑risk and disclosure group and a systematic, escalation‑based monitoring process that requires management‑level review of compliance questions and regular documentation of the certification workflow. This evolution reflects a more formalized and ongoing oversight of the review process and enhanced compliance monitoring.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the core question about evolution of review and certification processes between 2023 and 2024, but contains several issues: (1) CORRECT ELEMENTS: The answer correctly identifies that a formal review and certification process was established (grounded in Consent agreement), that governance procedures were implemented, and that there was evolution toward more formalized oversight. The mention of escalation-based monitoring and management-level review aligns with the ground truth. (2) PROBLEMATIC ELEMENTS: The LLM introduces a 'dedicated business-risk and disclosure group' and references '2004 Consent' which are not mentioned in the ground truth. The ground truth specifically references a 'Consent agreement' (likely from a different year) but the LLM's specific reference to '2004' appears unsupported. (3) MISSING ELEMENTS: The ground truth emphasizes integration into 'company-wide sales policies' and 'inventory and sales limitations' - specific operational details that the LLM answer omits entirely. The ground truth also explicitly notes the shift from 'initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024,' which the LLM only partially captures. (4) SYNTHESIS ISSUE: While the LLM correctly synthesizes that there was evolution from 2023 to 2024, it misses the specific operational integration aspect that distinguishes the 2024 evolution. The answer is partially correct on the governance/monitoring aspects but incomplete on the broader operational integration. (5) FACTUAL ACCURACY: No numerical errors, but the introduction of unsupported details ('2004 Consent,' 'dedicated business-risk and disclosure group') without ground truth support is concerning for accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 482,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "\nBetween 2022 and 2023 PMI elevated heat‑not‑burn (HTU) from a niche emerging line to a central pillar of its “smoke‑free products” portfolio, reporting a 14.7 % increase in HTU shipments and a 26 % jump in smoke‑free net revenue (from $9.9 bn to $12.5 bn).  The 2023 filing begins to separate HTU revenue within the broader smoke‑free category—grouping it with e‑vapor, oral nicotine, Swedish Match and the newly added Wellness & Healthcare business—thereby positioning the products as a premium, reduced‑risk offering and the primary growth engine of PMI rather than a peripheral adjunct to combustible tobacco.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The LLM cites specific metrics (14.7% HTU shipment increase, 26% smoke-free revenue jump from $9.9bn to $12.5bn) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided knowledge graph and appear to be fabricated or hallucinated. (2) ENTITY ACCURACY PROBLEMS - The LLM mentions 'Swedish Match' and 'Wellness & Healthcare business' as part of the 2023 smoke-free portfolio categorization, but the ground truth only mentions 'licensed KT&G heat-not-burn products' as the new addition. The inclusion of Swedish Match and Wellness & Healthcare is not supported by the ground truth. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the shift from 'niche emerging' to 'central pillar' positioning (which aligns with the ground truth's 'strategic shift from internal development focus to more integrated positioning'), it fails to accurately capture the specific product categorization changes mentioned in the ground truth (Platform 1 device, explicit inclusion in smoke-free segment alongside e-vapor and oral nicotine). (4) UNSUPPORTED CLAIMS - The characterization of heat-not-burn as 'primary growth engine' is not explicitly stated in the ground truth. (5) PARTIAL CORRECTNESS - The LLM does correctly identify the general evolution from 2022 to 2023 and the shift toward integrated product positioning, which represents semantic alignment with the core narrative. However, the introduction of unverified financial metrics and incorrect entity references significantly undermines credibility. The answer demonstrates some understanding of the directional change but fails on factual precision, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 504,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Oracle broadened the ways customers can run Oracle Database, moving from a primarily on‑premise license model to a fully flexible, hybrid‑cloud approach.  The 2024 filing highlights that Database can now be deployed on‑premise, in Oracle Cloud public regions, in dedicated or sovereign OCI instances, or through Exadata Cloud@Customer, and it is tightly integrated with the rest of the Oracle Cloud stack—including Autonomous Database, Java, Middleware, Engineered Systems, and OCI AI/Analytics services.  This evolution gives customers choice of deployment location while embedding the Database more deeply within Oracle’s complementary cloud offerings, driving the shift toward cloud‑centric licensing and higher cloud‑services revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Oracle Database's strategic positioning between 2023 and 2024, with generally accurate information about deployment flexibility and integration. STRENGTHS: (1) Correctly identifies the shift toward hybrid-cloud and multi-deployment options (on-premise, OCI public regions, dedicated/sovereign instances, Exadata Cloud@Customer); (2) Accurately mentions integration with complementary Oracle technologies (Autonomous Database, Java, Middleware, Engineered Systems, OCI AI/Analytics); (3) Properly synthesizes the multi-hop concept of deployment flexibility AND deeper integration; (4) Correctly identifies the strategic shift toward cloud-centric licensing and cloud-services revenue. WEAKNESSES: (1) The characterization of 2023 as 'primarily on-premise license model' is somewhat imprecise—the ground truth indicates 2023 emphasized 'perpetual licensing model' and 'customer choice' across cloud/on-premise/other environments, not a primarily on-premise focus; (2) The LLM answer emphasizes the shift toward cloud-centric licensing and revenue, which is a reasonable inference but goes slightly beyond what the ground truth explicitly states about the strategic positioning evolution; (3) Missing explicit mention of Oracle Exadata Database Machine as the specific engineered system example, though Engineered Systems is mentioned generally. MULTI-HOP REASONING: The answer successfully synthesizes information about both deployment flexibility (2023→2024 evolution) and integration with other Oracle technologies, showing sound logical progression. ENTITY ACCURACY: All company names, product names, and time periods are correct. No quantitative errors detected (no specific numbers provided to verify). The answer is semantically equivalent to the ground truth in most respects, with minor characterization differences that don't fundamentally alter the accuracy of the core message.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 522,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "\nFrom 2023 to 2024 BMY moved Krazati from a partner‑licensed asset (via the Mirati option/ collaboration) to a fully owned product after closing the $4.8 billion acquisition of Mirati in January 2024; the deal comprised $4.6 billion cash for shares, $205 million for equity awards and a $248 million fair‑value estimate of contingent‑value‑right payments that could total up to $1 billion, while $640 million of the purchase price was specifically allocated to the Krazati product‑rights and $3.5 billion to other IPRD assets. This financial commitment reflects the strategic evolution from a non‑controlling partnership to complete ownership of Krazati within BMY’s oncology portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides detailed financial breakdown of the Mirati acquisition but contains significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) The $4.8 billion total acquisition price is correct; (2) The January 2024 timing of the Mirati acquisition closing is correct; (3) The conceptual evolution from partnership to full ownership is accurately described; (4) The mention of contingent value rights tied to development is correct; (5) The strategic fit into oncology portfolio is properly contextualized. QUANTITATIVE ERRORS: (1) The LLM breaks down the $4.8B as '$4.6 billion cash for shares, $205 million for equity awards and $248 million fair-value estimate of contingent-value-right payments' - these components sum to $5.053B, not $4.8B, indicating calculation or sourcing errors; (2) The LLM states CVR payments 'could total up to $1 billion' which aligns with ground truth, but the $248M 'fair-value estimate' appears inconsistent with the $1.0 billion contingent commitment mentioned in ground truth; (3) The allocation of '$640 million...to Krazati product-rights and $3.5 billion to other IPRD assets' ($4.14B total) doesn't reconcile with the $4.8B total or the component breakdown provided. MULTI-HOP REASONING: The answer successfully synthesizes the evolution from 2023 to 2024 and connects the acquisition to strategic commitment, but the detailed financial breakdown introduces contradictions that suggest either misunderstanding of the deal structure or conflation of different financial metrics. The ground truth emphasizes the $1.0 billion CVR commitment as a key reflection of long-term investment, which the LLM mentions but with conflicting figures. MISSING ELEMENTS: The LLM doesn't clearly articulate the FDA/EMA approval status of Krazati or its development stage (second-line vs first-line NSCLC) as mentioned in ground truth, though this is a minor omission relative to the financial focus of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 532,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "\nThe 6.244 % Fixed‑to‑Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were listed on the NYSE under the symbol BK/P and remained fully and unconditionally guaranteed by The Bank of New York Mellon Corporation in both the 2022 Form 10‑K (covering 2021) and the 2023 Form 10‑K (covering 2023).  No change in the securities’ terms, classification, or listing status was reported; the only evolution noted was an updated market‑value figure and the revised outstanding‑share count for the underlying common stock.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the security (6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV), the NYSE listing symbol (BK/P), and the guarantee structure by The Bank of New York Mellon Corporation. The core conclusion that there was no change in treatment or status between 2022 and 2023 is correct and matches the ground truth. However, there are significant issues: (1) The LLM references the '2022 Form 10-K (covering 2021)' and '2023 Form 10-K (covering 2023)' which creates confusion about fiscal year coverage - the ground truth specifically references 2022 and 2023 filings without this ambiguity. (2) The LLM introduces extraneous information about 'updated market-value figure and revised outstanding-share count for the underlying common stock' which is not mentioned in the ground truth and appears to be unsupported speculation or hallucination. (3) The LLM fails to explicitly confirm that the securities remained 'registered under Section 12(b) of the Act' in both years, which is a key detail in the ground truth. (4) The phrasing 'the only evolution noted was...' contradicts the conclusion that there was no change. The answer is partially correct on the main facts but contains confusing temporal references, unsupported claims, and incomplete coverage of the registration status details that were explicitly mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 389,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "\nFrom 2022 to 2023 PMI’s short‑term credit **capacity grew markedly** – the uncommitted credit lines available to its subsidiaries rose from about **$1.9 billion at the end of 2022 to roughly $2.7 billion at the end of 2023**.  At the same time, **outstanding borrowings under those facilities slipped slightly**, falling from **≈ $295 million in 2022 to ≈ $283 million in 2023**.  \n\nThe combination of a larger credit pool and lower utilization signals that PMI now has a **substantially stronger near‑term liquidity buffer**, using far less of its short‑term borrowing capacity than it did a year earlier.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: capacity increased from $1.9 billion (2022) to $2.7 billion (2023), and utilization decreased from $295 million to $283 million. The use of approximation symbols (≈) is appropriate given the source data format. The multi-hop reasoning is sound—the model correctly synthesized information about both capacity and utilization trends, then drew the logical conclusion about liquidity posture. The characterization of PMI's approach as 'more conservative' (ground truth) is semantically equivalent to the LLM's description of a 'substantially stronger near-term liquidity buffer' with 'far less' utilization. The answer addresses all components of the question: (1) capacity change, (2) utilization change, and (3) implications for liquidity posture. The phrasing 'markedly' and 'substantially stronger' appropriately conveys the significance of the changes. Minor stylistic differences (e.g., 'uncommitted credit lines available to its subsidiaries' vs. simply 'short-term credit arrangements') add helpful context without introducing inaccuracy. The reasoning that expanded capacity combined with reduced drawdown indicates improved liquidity positioning is logically sound and matches the ground truth interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 368,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "\nBetween 2023 and 2024 Oracle has moved the Autonomous Database from a stand‑alone, self‑driving DB service on OCI to the central engine of its cloud stack.  In 2024 the company emphasizes tight integration of the database with other cloud services—such as Fusion SaaS (ERP, HCM, EPM), Java Cloud, APEX low‑code, Analytics Cloud and OCI AI—while adding richer automation (ML‑driven tuning, automatic threat detection/remediation, consumption‑based elastic scaling) and new deployment options (Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud) that let customers run the database in their own data centers yet still have it fully managed by Oracle.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several correct elements but introduces significant inaccuracies and unsupported claims. CORRECT ELEMENTS: (1) The 2023-2024 evolution from standalone to integrated service is accurate; (2) Integration with Java Cloud and APEX low-code services is confirmed in ground truth; (3) ML-driven automation capabilities (threat detection, tuning) are correctly identified; (4) The emphasis on managed service across deployment options aligns with ground truth. PROBLEMATIC ELEMENTS: (1) The LLM claims integration with 'Fusion SaaS (ERP, HCM, EPM), Analytics Cloud and OCI AI' - while these may be real Oracle services, the ground truth does not specifically mention Fusion SaaS, Analytics Cloud, or OCI AI as part of the Autonomous Database positioning evolution between 2023-2024. This represents unsupported expansion beyond the knowledge graph; (2) The LLM mentions specific deployment options (Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud) that are not mentioned in the ground truth, suggesting either hallucination or information from outside the filing scope; (3) The characterization of 2023 positioning as 'stand-alone, self-driving DB service' is somewhat reductive - the ground truth indicates it was already positioned as part of broader OCI offerings in 2023. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across years and identifies the shift toward integration and automation. However, it adds details not present in the ground truth without clear sourcing. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this scores high by default (8/10 - minor deduction for introducing unverified service names). QUALITATIVE ACCURACY: The core reasoning about evolution is sound (5/10 due to unsupported claims about specific integrations and deployment options). CONTEXTUAL RELEVANCE: The answer directly addresses the question about positioning evolution, integration, and automation capabilities (7/10 - good relevance but with accuracy concerns).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 553,
        "total_tokens": 1980
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "\nBetween 2023 and 2024 GM’s capital involvement with Ultium Cells Holdings LLC changed only modestly: the company recorded a $0.7 billion cash outflow for an equity investment in 2024 (the same amount as in 2023) and its committed capital contribution fell from $1.4 billion at the end of 2022 to $0.8 billion at the end of 2023.  GM continues to treat Ultium Cells as a non‑consolidated VIE—without voting control—so its exposure is limited to the equity investment and the modest committed funding, while using the partnership mainly as a strategic link to its EV‑battery supply chain rather than as a source of direct financing.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) Correctly identifies Ultium Cells as a non-consolidated VIE without voting control in both years; (2) Correctly states the $0.8 billion committed contribution at end of 2023; (3) Correctly characterizes the strategic positioning as a link to EV-battery supply chain; (4) Appropriately notes limited exposure through equity investment and committed funding. PROBLEMATIC ELEMENTS: (1) QUANTITATIVE ERROR - Claims '$0.7 billion cash outflow for an equity investment in 2024 (the same amount as in 2023)' but the ground truth indicates the 2024 investment was $0.7 billion while 2023 had a $0.8 billion committed contribution (not a realized $0.7B investment). The LLM conflates committed contributions with realized investments; (2) INCOMPLETE CHARACTERIZATION - The ground truth emphasizes an evolution from 'contingent capital commitments' in 2023 to 'realized investment stake' in 2024, representing a strategic shift. The LLM states the change was 'modest' and 'only modestly' changed, which understates the qualitative shift from contingent to realized investment; (3) MISSING CONTEXT - The ground truth highlights that the transformation 'suggests a strategic realignment, providing GM with potentially greater influence,' but the LLM doesn't capture this evolution in strategic positioning, instead suggesting continuity ('continues to treat'). MULTI-HOP REASONING: The LLM partially synthesizes the information but fails to properly distinguish between committed future obligations (2023) and realized equity investments (2024), which is the core of the question about how the relationship 'evolved.' The answer conflates different types of capital involvement rather than showing the transition between them.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 488,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "\nBetween the sixth‑anniversary release in 2022 and the eighth‑anniversary release in 2024, the Litigation Management Deed unlocked less of the preferred‑stock protection: the Company released **$3.5 billion** of as‑converted value in 2022 versus **$2.7 billion** in 2024.  Accordingly, the number of series A preferred shares issued fell from **176,655 shares** (2022) to **99,264 shares** (2024), with cash payments of $3 million and $5 million respectively to cover any fractional shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: $3.5 billion (2022) vs $2.7 billion (2024) for as-converted value released, and 176,655 shares (2022) vs 99,264 shares (2024) for series A preferred stock issued. The multi-hop synthesis is sound, correctly comparing the sixth-anniversary release (2022) with the eighth-anniversary release (2024) and drawing the logical conclusion that both metrics decreased over time. The answer goes beyond the ground truth by including additional relevant details about cash payments for fractional shares ($3 million in 2022 and $5 million in 2024), which adds useful context without contradicting the original answer. The terminology is precise (\"as-converted value,\" \"series A preferred stock\") and the reasoning about the reduction in financial burden is clearly articulated. The only minor distinction is that the LLM uses slightly different phrasing (\"unlocked less of the preferred-stock protection\" vs the ground truth's more direct statement), but this is semantically equivalent and arguably more descriptive. All entities are correctly identified (Visa, Litigation Management Deed, VE territory), and the temporal comparison is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 349,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the relationship shifted from a period of legal separation to a coordinated settlement and reporting realignment.  After the Aearo Entities filed for Chapter 11 in July 2022, 3M funded a $1.2 bn pre‑tax charge (including a $1 bn cash election for the $1 bn equity portion of the later CAE Settlement) and, following the dismissal of the bankruptcy case in June 2023, re‑consolidated the entities in Q2 2023, increasing its accrual for Combat‑Arms‑Earplug litigation to $5 bn and recording a $4.2 bn pre‑tax charge in Q3 2023 for the $6 bn settlement (paid $10 m + $147 m + $250 m + $253 m).  The settlement, finalized in August 2023 and amended in January 2024 to require cash payment for the equity portion, resolved the bulk of the earplug litigation and eliminated the need for ongoing Chapter 11 stays.  At the same time, 3M’s segment reporting was updated in Q2 2024 (post‑Solventum separation) to reflect the three‑segment structure (Safety & Industrial, Transportation & Electronics, Consumer) and to re‑classify litigation‑related special items—previously shown in Safety & Industrial and Corporate—into the appropriate segment totals, thereby adjusting segment operating‑income margins and disclosures.  These changes illustrate how the litigation settlement reshaped both the financial exposure (large accruals and charges) and the strategic presentation of 3M’s business segments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about the litigation timeline and settlement mechanics, but contains significant quantitative inaccuracies and introduces information not present in the ground truth. STRENGTHS: (1) Correctly identifies the 2023 reconsolidation following bankruptcy dismissal; (2) Correctly references the CAE Settlement; (3) Correctly notes the shift from litigation-focused involvement to strategic financial treatment; (4) Appropriately addresses the multi-hop nature of the question spanning 2023-2024; (5) Correctly identifies segment reporting adjustments in 2024. CRITICAL ERRORS: (1) The ground truth states the reconsolidation had 'immaterial income statement impact,' but the LLM provides extensive specific charges ($1.2bn pre-tax, $4.2bn pre-tax, $5bn accrual, $6bn settlement) that are not mentioned in the ground truth and cannot be verified against it; (2) The LLM provides detailed payment breakdown ($10m + $147m + $250m + $253m) not in ground truth; (3) References to 'July 2022' bankruptcy filing, 'June 2023' dismissal, 'Q2 2023' reconsolidation, 'Q3 2023' charge, and 'August 2023' settlement finalization are specific dates not confirmed in the ground truth; (4) The mention of 'Solventum separation' and 'post-Solventum' context is not addressed in the ground truth. VERIFICATION ISSUE: While the LLM's narrative is internally coherent and plausible, the ground truth explicitly states the reconsolidation had 'immaterial income statement impact,' which directly contradicts the LLM's detailed quantification of material charges. The LLM appears to have synthesized information beyond what the ground truth provides, introducing unverified financial specifics. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution from 2023 litigation/reconsolidation to 2024 segment reporting adjustments, matching the ground truth's core narrative arc. However, the introduction of unverified quantitative details undermines confidence in the answer's accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1538,
        "completion_tokens": 540,
        "total_tokens": 2079
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "\nBetween 2022 and 2024 the **Class C common stock remained authorized (≈1.1 billion shares)** but its **effective share count and conversion dynamics changed**.  A 2024 exchange of class B‑1 shares for class C shares and the periodic “anniversary releases” of series B and C preferred stock adjusted the conversion rates, reducing the number of as‑converted class A shares and altering the earnings‑allocation that feeds Class C’s EPS calculation.  Consequently, the **EPS attributable to Class C rose sharply**—from **$28.03 (basic) in 2022 to $33.17 in 2023 and $38.97 in 2024**—driven by higher allocated net income and a relatively small weighted‑average share base (≈16 million shares in each year).  Class C therefore continues to have **limited voting rights** (similar to Class B) and **no automatic conversion to Class A**, but its EPS performance is now tied to the litigation‑driven conversion‑rate adjustments and the 2024 exchange that created new Class C shares.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides EPS figures that directly contradict the ground truth. Ground truth states Class C had $33.17 basic EPS and $33.13 diluted EPS in 2024, but the LLM claims $38.97 in 2024, $33.17 in 2023, and $28.03 in 2022. The LLM appears to have fabricated a 2023 data point and provided an incorrect 2024 figure ($38.97 vs $33.17). For Class A, ground truth shows $8.29 basic and $8.28 diluted EPS in 2024, but the LLM does not provide Class A EPS figures for comparison. (2) FACTUAL ERRORS - The LLM introduces unsupported claims about 'class B-1 shares,' 'anniversary releases,' 'litigation-driven conversion-rate adjustments,' and a '2024 exchange' that are not mentioned in the ground truth. These appear to be hallucinated details. The ground truth makes no mention of such conversion mechanics or exchanges. (3) INCOMPLETE SYNTHESIS - While the ground truth emphasizes the shift in EPS performance between 2022 and 2024 as a key indicator of financial treatment evolution, the LLM's incorrect numbers undermine this core finding. The ground truth also notes that governance role 'appeared unchanged,' which the LLM partially addresses but with fabricated supporting details. (4) MISSING CONTEXT - The LLM fails to clearly establish the 2022 baseline EPS for Class C (ground truth implies comparison but doesn't state 2022 Class C EPS explicitly), making it difficult to verify the claimed trajectory. (5) REASONING QUALITY - The multi-hop reasoning about how share count changes affect EPS allocation is conceptually sound, but it's built on incorrect numbers and unsupported premises. The answer reads as plausible but is fundamentally unreliable due to quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 473,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Qualcomm shifted ADAS/AD from a generic “emerging automotive” mention in its R&D narrative to a concrete, revenue‑producing line‑item. In the 2022 filing the company only referenced automotive (and IoT) as a future application area, but the 2024 10‑K explicitly breaks out automotive revenue to include “connectivity, digital cockpit **and ADAS/AD**,” isolating ADAS/AD as a distinct sub‑category of QCT sales. This reflects a strategic evolution from early‑stage investment to measurable commercialization of ADAS/AD technologies within Qualcomm’s semiconductor business.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Qualcomm's ADAS/AD evolution from fiscal 2022 to 2024. STRENGTHS: (1) Correctly identifies the core transition from development/investment phase in 2022 to commercialization/revenue generation in 2024; (2) Accurately captures the shift from generic 'emerging automotive' references to explicit ADAS/AD line-item categorization; (3) Properly identifies the revenue categorization under automotive products with specific sub-categories (connectivity, digital cockpit, ADAS/AD); (4) Correctly attributes involvement to QCT (Qualcomm CDMA Technologies) sales; (5) Multi-hop reasoning is sound - synthesizes information about strategic evolution across fiscal years. MINOR WEAKNESSES: (1) The answer does not explicitly mention QSI segment or Qualcomm Ventures, which the ground truth identifies as key investment vehicles in 2022 - this is a notable omission of specific strategic mechanisms; (2) The phrase 'generic emerging automotive mention' is somewhat imprecise - the ground truth indicates more structured investment through specific segments; (3) Does not explicitly state that ADAS/AD was part of 'broader innovation and strategic investment initiatives' in 2022. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The fiscal years (2022, 2024) are correctly referenced. SEMANTIC EQUIVALENCE: The LLM answer conveys the essential meaning of the ground truth - the transition from development to commercialization - though with less detail about the investment mechanisms. The core insight about revenue categorization evolution is accurate and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 468,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Visa deepened the financial‑engineered safeguards of its U.S. Retrospective Responsibility Plan: the litigation‑escrow account was expanded (balances rose to $3.1 bn in 2024) and the plan’s conversion‑feature and makewhole provisions were tightened so that any additional escrow deposits automatically dilute the class‑B conversion rate, thereby linking share‑structure changes directly to funding needs.  At the same time, the loss‑sharing and interchange‑judgment‑sharing agreements were broadened to cover newly‑identified opt‑out and future U.S.‑covered matters, and the omnibus‑agreement amendments formalised a 66.7 % / 33.3 % split of any settlement or judgment liability.  Together, these refinements show that Visa manages litigation risk through a structured, pre‑funded escrow buffer, contractual share‑conversion adjustments, and layered indemnity arrangements that collectively cap and isolate potential monetary exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) UNVERIFIED NUMBERS: The LLM introduces specific quantitative claims not present in the ground truth, including: '$3.1 bn in 2024' escrow balance, '66.7%/33.3% split' liability allocation. These numbers cannot be verified against the original answer and appear to be fabricated or hallucinated. This is a critical error for a financial question requiring precision. (2) PARTIAL ALIGNMENT ON MECHANISMS: The LLM correctly identifies several mechanisms mentioned in ground truth (litigation escrow account, conversion feature, makewhole agreements, loss-sharing agreement, interchange judgment sharing agreement, omnibus agreement, indemnification obligations). However, it adds unsubstantiated details about how these mechanisms work together. (3) EVOLUTION NARRATIVE: The LLM does address the evolution between 2022-2024, correctly noting that the plan became 'more structured and detailed' with 'interrelated mechanisms,' which aligns with the ground truth's characterization of moving toward 'more comprehensive and layered strategy.' (4) PROBLEMATIC SPECIFICITY: The LLM's claim that 'any additional escrow deposits automatically dilute the class-B conversion rate' and the specific percentage split are presented as facts but lack grounding in the provided ground truth. This violates the principle of strict accuracy on financial details. (5) REASONING QUALITY: The multi-hop synthesis is logically sound in structure (connecting escrow expansion to conversion features to liability caps), but the foundation is compromised by unverified numbers. The conclusion about 'structured, pre-funded escrow buffer, contractual share-conversion adjustments, and layered indemnity arrangements' is reasonable but overstated given the unsupported quantitative claims. VERDICT: While the LLM captures the general evolution and identifies correct mechanisms, the introduction of specific unverified financial figures ($3.1bn, 66.7%/33.3%) represents a fundamental breach of accuracy standards for financial analysis. This cannot be scored higher than 4 due to these fabricated details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 565,
        "total_tokens": 2082
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "\nBetween 2023 and 2024 Merck’s alliance‑revenue share from Lynparza grew from **$1.199 billion to $1.311 billion**—an approximate **9 % increase**—driven by higher international demand and new regulatory approvals (e.g., the 2025 Chinese NMPA approval for adjuvant use in BRCA‑mutated breast cancer).  The product is also reflected as a **$1.5 billion net intangible asset** in Merck’s 2023 balance sheet, underscoring its strategic importance, and the company continues to expand its collaboration with AstraZeneca, indicating that Lynparza’s performance and strategic value are rising.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Merck's Lynparza financial evolution and provides specific revenue figures that align with the 9% growth mentioned in the ground truth. STRENGTHS: (1) Correctly identifies the 9% growth rate in alliance revenue between 2023-2024; (2) Accurately cites the $1.5 billion net intangible asset from 2023; (3) Properly references the January 2025 Chinese NMPA approval for adjuvant breast cancer treatment; (4) Effectively synthesizes multi-hop information showing both financial metrics and regulatory developments; (5) Correctly identifies AstraZeneca collaboration context. WEAKNESSES: (1) The LLM provides specific revenue figures ($1.199 billion to $1.311 billion) that are not explicitly mentioned in the ground truth, which only states '9% growth in alliance revenue linked to Lynparza.' While these numbers are mathematically consistent with a 9% increase, they appear to be inferred rather than directly sourced from the ground truth; (2) The ground truth does not specify that the 2025 approval was for 'BRCA-mutated breast cancer' specifically—it only mentions 'adjuvant treatment in early breast cancer,' so this additional detail may be an inference or from external knowledge; (3) Minor: The ground truth notes the 2024 financial stake 'was not explicitly stated,' which the LLM doesn't acknowledge, though it does note the 2023 figure. CALCULATION VERIFICATION: The 9% growth calculation is correct ($1.199B × 1.09 ≈ $1.307B, matching the stated $1.311B within rounding). MULTI-HOP REASONING: The answer successfully synthesizes information across years (2023-2024-2025) and connects financial metrics with regulatory developments to support the conclusion about strategic importance. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as the ground truth regarding performance growth and strategic expansion, though with additional specificity on revenue figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 534,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "\nBetween 2022 and 2024 Skoal’s volume fell from roughly 170 million units (about 10 % of the oral‑tobacco market) to 147 million units, and its retail‑share slipped from the low‑single‑digit‑percent range to 7.6 %. Its longtime rival Copenhagen also lost ground (≈23 % → 19 % share), while the newer on! brand grew to 8.3 % share, intensifying competition and further eroding Skoal’s position in the oral‑tobacco segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS - The LLM states Skoal's retail share was in the 'low-single-digit-percent range' in 2022, but ground truth shows 9.3% in 2022, which is NOT low single-digit (that would be 1-9%, and 9.3% is at the upper end). The LLM then claims it 'slipped...to 7.6%' but this is actually a decline FROM 9.3% TO 7.6%, not FROM low-single-digits. This is a factual error. (2) VOLUME DATA ISSUE - The LLM introduces volume figures (170M to 147M units) that are NOT present in the ground truth answer. While these may be accurate from source documents, they represent information not in the ground truth baseline, making verification impossible and potentially introducing unverified claims. (3) INCOMPLETE SYNTHESIS - The LLM correctly identifies Copenhagen's decline (23% → 19%) and on!'s growth (to 8.3%), but MISSES the critical context that the entire oral tobacco segment contracted from 42.5% (2023) to 37.5% (2024), which is essential for understanding the competitive dynamics. (4) MISSING KEY COMPARISON - The ground truth emphasizes that Skoal 'underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!)' - the LLM mentions these brands but doesn't explicitly establish this comparative underperformance narrative. (5) CORRECT ELEMENTS - The LLM correctly identifies: Skoal's 7.6% share in 2024, Copenhagen's decline to 19%, on!'s growth to 8.3%, and the general competitive pressure. The reasoning about market erosion is sound. CALCULATION VERIFICATION: 9.3% → 7.6% is a 1.7 percentage point decline (18% relative decline), which the LLM characterizes as 'slipped' - appropriate language but the starting point is mischaracterized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 468,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "\nIn fiscal 2022 Dynamics‑related revenue (recorded as “Dynamics products and cloud services”) was $5.44 billion, and it grew to $6.48 billion in fiscal 2023 – an increase of roughly $1.04 billion, or about 19%.  Because total Microsoft Cloud revenue rose from $91.4 billion to $111.6 billion over the same period, the share of Dynamics 365 within the cloud portfolio slipped slightly, from around 6 % of cloud revenue to about 5.8 %.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific Dynamics 365 revenue figures ($5.44B in FY2022, $6.48B in FY2023) that are not present in the ground truth. The ground truth explicitly states these exact figures are not provided - it only mentions that Dynamics products and cloud services grew 25% in 2022 with Dynamics 365 up 39%, and that the exact growth percentage for 2023 is 'not explicitly stated.' The LLM appears to have fabricated precise numbers. (2) MICROSOFT CLOUD REVENUE DISCREPANCY: The LLM states FY2022 Microsoft Cloud revenue was $91.4B, but the ground truth clearly states it was $91.2B - a $200M error on a major metric. (3) PERCENTAGE CALCULATIONS: The LLM calculates a 19% growth rate ($1.04B/$5.44B), but this contradicts the ground truth's statement that Dynamics products and cloud services grew 25% in 2022 with Dynamics 365 up 39%. The LLM's 19% figure doesn't align with either metric. (4) SHARE ANALYSIS: While the LLM's calculation of Dynamics' share of cloud revenue (6% to 5.8%) is mathematically consistent with its stated numbers, these calculations are based on incorrect underlying figures. (5) MISSING CONTEXT: The LLM fails to capture the ground truth's emphasis on the 39% Dynamics 365 growth in 2022 and the uncertainty about 2023 growth rates. The answer presents false precision where the ground truth acknowledges data limitations. The LLM answer reads plausibly but is fundamentally unreliable due to invented numbers and incorrect base figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 436,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "\nFrom 2023 to 2024 Merck expanded and refined its Balance‑Sheet Risk Management program by markedly increasing the notional volume of foreign‑exchange forwards used to hedge both monetary‑asset translations and its net‑investment in overseas operations, and by designating a larger share of those forwards as cash‑flow hedges (using purchased‑put options, collars and a layered “layer‑in” approach that extends up to two years into the future).  It also broadened its interest‑rate hedge book, raising the number of swaps and the notional amount covering its fixed‑rate notes from $1 bn to $1.5 bn.  As a result, the program now relies on a more layered mix of designated and non‑designated FX derivatives and a larger interest‑rate swap program to manage foreign‑exchange exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported claims not present in the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS: The LLM claims interest-rate swap notional amounts increased from $1bn to $1.5bn - these specific numbers are NOT mentioned in the ground truth and appear to be fabricated. This is a major factual error on a precise financial metric. (2) SCOPE MISALIGNMENT: The ground truth focuses specifically on foreign exchange exposure management through the Balance Sheet Risk Management Program, while the LLM answer introduces interest-rate hedging as a major component ('broadened its interest-rate hedge book'), which is outside the scope of the original question about FX exposure management. (3) PARTIAL ACCURACY: The LLM correctly identifies that Merck expanded from forward contracts to include purchased put options and collar options, and mentions the layered approach extending up to two years - these elements align with ground truth. (4) DESIGNATION CLAIMS: The LLM states 'designating a larger share of those forwards as cash-flow hedges' - the ground truth indicates 2023 contracts were NOT designated as hedges (marked to market through Other income expense), but the 2024 evolution toward more structured designation is implied though not explicitly quantified in the ground truth. The LLM's claim about 'larger share' being designated lacks supporting evidence. (5) MULTI-HOP REASONING: The answer attempts to synthesize evolution across years but introduces unsupported quantitative claims that undermine credibility. The interest-rate swap discussion, while potentially relevant to overall risk management, is not part of the specific question about FX exposure management evolution. STRENGTHS: Correctly identifies instruments (forwards, puts, collars), mentions layering approach, recognizes program expansion. WEAKNESSES: Fabricated specific numbers ($1bn to $1.5bn), scope creep into interest-rate hedging, unsupported claims about designation percentages.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 546,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "\nPayPal’s merchant‑receivable business expanded materially from 2022 through 2024, with purchases of merchant receivables rising to **$1.8 billion in 2024** (up from $1.7 billion in 2023) and the outstanding portfolio growing to **$1.5 billion** (net of the partner‑institution participation interest), compared with $1.2 billion at the end of 2023.  Consequently, the **allowance for credit losses on these assets fell sharply**—from **$160 million at the end of 2023 to $113 million at the end of 2024**—and **provisions declined to $79 million in 2024 versus $162 million in 2023**, while charge‑offs also dropped to **$156 million from $300 million**.  This evolution reflects PayPal’s direct investment in merchant‑financing products (PPWC and PPBL), under which it purchases receivables from a partner institution, services them, and records the related fees as deferred revenue (see PYPL 10‑K 2022 pp. 52‑56 and PYPL 10‑K 2024 pp. 99‑103).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PayPal's merchant receivables evolution and correctly identifies the core narrative of expansion from 2022-2024. Key strengths: (1) Correctly states 2024 purchases of $1.8 billion and outstanding balance of $1.5 billion as of Dec 31, 2024; (2) Accurately reports allowance for credit losses declining from $160M (2023) to $113M (2024); (3) Correctly cites provision decline from $162M (2023) to $79M (2024); (4) Properly identifies charge-offs dropping from $300M to $156M; (5) Accurately names merchant financing products (PPWC, PPBL); (6) Correctly synthesizes the shift toward direct investment and operational involvement. However, there are notable gaps: (1) The ground truth mentions a principal and interest coverage ratio of approximately 9% as of Dec 31, 2021 (down from 23% in 2020)—the LLM answer completely omits this metric, which was explicitly disclosed in 2022 filings; (2) The LLM states purchases were '$1.7 billion in 2023' but the ground truth indicates the outstanding balance was $1.2 billion in 2023 (not explicitly stating 2023 purchases); (3) The LLM answer lacks discussion of the 2022 credit loss estimation methodology and macroeconomic forecasts mentioned in ground truth. The quantitative data provided is accurate where stated, but the omission of the coverage ratio and incomplete treatment of 2022 disclosures represents a meaningful gap in addressing the full scope of the question's temporal range (2022-2024). The multi-hop reasoning is sound for the 2023-2024 comparison but incomplete for the 2022 baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1441,
        "completion_tokens": 438,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "\nFrom 2022 through 2024 the amount of goodwill assigned to Altria’s **smokeable‑products segment has been essentially flat at about $99 million**—a figure that represents only a tiny slice of the company’s total goodwill ($5.18 billion) and has not changed materially across the three years.  At the same time, the **operating‑income contribution of that segment has remained the company’s primary profit driver**, edging upward from roughly **$10.5 billion in 2022 to $10.82 billion in 2024** (with $10.67 billion recorded in 2023), underscoring that despite unchanged goodwill, smokeable products continue to generate the bulk of Altria’s earnings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative but contains a significant quantitative error that undermines accuracy. CORRECT ELEMENTS: (1) Goodwill allocation of $99 million for smokeable products in 2022 is accurate; (2) Total goodwill of $5.18 billion ($5,177 million) is correct; (3) Operating income of $10,821 million in 2024 and $10,670 million in 2023 are accurate; (4) The characterization of smokeable products as the primary profit driver is appropriate; (5) The multi-hop synthesis across goodwill and operating income metrics is sound. CRITICAL ERROR: The LLM states operating income was 'roughly $10.5 billion in 2022' but the ground truth does not provide a 2022 operating income figure for smokeable products. The LLM appears to have extrapolated or estimated this figure without basis in the provided data. This is a significant quantitative inaccuracy because the question specifically asks about evolution 'from 2022 to 2024.' MISSING ELEMENT: The ground truth notes that 'no updated goodwill figure is disclosed specifically for smokeable products' in 2024, and suggests 'a potential shift in reporting focus toward performance metrics rather than asset valuations.' The LLM states goodwill 'has not changed materially across the three years' which is an inference not explicitly supported—the ground truth indicates the 2024 figure is simply undisclosed, not that it remained at $99 million. This distinction matters for accuracy. REASONING QUALITY: The multi-hop synthesis connecting goodwill stability with operating income growth is logically sound and well-articulated. The conclusion about the segment's continued significance is appropriate. However, the unsupported 2022 operating income figure and the assumption about unchanged goodwill in 2024 represent analytical overreach beyond the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 502,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "\nThe commercial portion of LinkedIn contributed roughly **$13.6 billion** to Microsoft Cloud in fiscal 2022 and **$15.0 billion** in fiscal 2023, reflecting an increase of about **$1.4 billion (≈10 %)** over that one‑year period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and provides numbers that do not match the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims LinkedIn's commercial portion contributed $13.6B in FY2022 and $15.0B in FY2023. However, the ground truth states that Microsoft Cloud revenue (which includes the commercial portion of LinkedIn) was $91.2B in FY2022 and $111.6B in FY2023. The LLM's numbers are dramatically lower and appear to be fabricated or sourced from incorrect data. The $1.4B increase calculation is arithmetically correct ($15.0B - $13.6B = $1.4B) and the percentage is approximately correct (1.4/13.6 ≈ 10.3%), but these calculations are based on entirely wrong base numbers. (2) ENTITY/METRIC CONFUSION: The LLM appears to have misidentified what constitutes 'the commercial portion of LinkedIn within Microsoft Cloud.' The ground truth indicates the question asks about Microsoft Cloud revenue that includes LinkedIn's commercial services, not a separate LinkedIn-only figure. The LLM isolated a specific LinkedIn revenue figure rather than addressing the broader Microsoft Cloud metric that encompasses LinkedIn. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the relationship between LinkedIn and Microsoft Cloud. The question asks how LinkedIn's commercial portion evolved within Microsoft Cloud, and the answer should reference the Microsoft Cloud figures ($91.2B to $111.6B), not isolated LinkedIn numbers. (4) MISSING CONTEXT: The LLM did not acknowledge or explain the source of its numbers, which differ substantially from the ground truth. The answer lacks the contextual framing that Microsoft Cloud is the broader portfolio metric. The LLM answer is factually incorrect on the primary numbers and represents a fundamental misunderstanding of what the question is asking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1161,
        "completion_tokens": 492,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "\nBetween 2023 and 2024 Lynparza’s geographic footprint expanded primarily through the FDA’s May 2023 approval for BRCA‑mutated mCRPC and the subsequent August 2023 Japan MHLW approval for the same indication, after which the drug was marketed in both the United States and Japan.  In 2024 the product’s commercial reach broadened further, generating a 9 % rise in alliance revenue (driven by stronger demand across multiple international markets) even though no additional major regulatory approvals were recorded during that year.  This revenue growth reflects the deepening market penetration of the drug beyond its initial U.S. and Japanese launches.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with correct identification of the 9% alliance revenue growth in 2024 and accurate dating of the FDA approval (May 2023) and Japan MHLW approval (August 2023) for BRCA-mutated mCRPC. The answer correctly synthesizes the multi-hop information about geographic expansion and revenue growth between 2023-2024.\n\nHowever, there are notable omissions that reduce the overall score:\n\n1. COMPLETENESS ISSUE: The original answer includes significant forward-looking information about the January 2025 China NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer based on the OlympiA trial. While the question specifically asks about 2023-2024 evolution, the ground truth answer includes this 2025 development as evidence of \"significant geographic and therapeutic area expansion,\" suggesting it's relevant context for understanding the trajectory. The LLM answer completely omits this information.\n\n2. THERAPEUTIC INDICATION DETAIL: The LLM answer correctly identifies the mCRPC indication but doesn't mention the specific combination therapy context (with abiraterone and prednisone/prednisolone) or the PROpel trial basis, which the ground truth includes.\n\n3. MARKET DRIVERS: The LLM answer correctly identifies \"stronger demand across multiple international markets\" but doesn't provide the nuance that this was \"higher demand in most international markets\" as stated in the ground truth.\n\nQUANTITATIVE VERIFICATION:\n- 9% alliance revenue growth: CORRECT\n- May 2023 FDA approval: CORRECT\n- August 2023 Japan MHLW approval: CORRECT\n- mCRPC indication: CORRECT\n\nMULTI-HOP REASONING: The answer successfully synthesizes information across the 2023-2024 period, connecting regulatory approvals to commercial outcomes. The logic linking approvals to revenue growth is sound.\n\nThe answer is factually accurate for the 2023-2024 period but incompletely addresses the full scope of Lynparza's evolution by omitting the significant 2025 China approval that demonstrates continued geographic and therapeutic expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 572,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "\nBetween 2023 and 2024 the deferred‑tax asset that RTX had recorded for the Powder Metal Matter fell sharply—from **$644 million** in 2023 to **$455 million** in 2024.  This decline reflects the amortization/realization of the temporary difference created by the matter and means the company will have **less future income‑tax benefit** to draw on from that item.  Consequently, the tax‑related advantage of the Powder Metal Matter is diminishing, reducing the amount of tax savings RTX can expect in upcoming periods.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) All numeric values are correct: $644 million (2023) and $455 million (2024) match ground truth exactly. (2) The calculation of the decline ($189 million) is implicit in the answer and mathematically accurate. (3) The LLM correctly identifies this as a deferred-tax asset and recognizes the shift in financial treatment. (4) The explanation of amortization/realization of temporary differences is technically sound and appropriate. (5) The conclusion about diminishing future tax benefits is logically consistent with the declining balance.\n\nWEAKNESSES: (1) The LLM does not explicitly mention the shift in financial treatment from 'reduction in sales' (2023) to 'future income tax benefits' (2024), which is a key part of the ground truth answer describing how the treatment 'evolved.' (2) The LLM does not calculate or mention the percentage decline (29.3%), which was included in the ground truth. (3) The answer focuses primarily on the tax accounting mechanics but misses the broader evolution narrative about how the item's classification changed between years. (4) The phrase 'reduction in sales' from 2023 is not addressed, leaving incomplete the full picture of the evolution.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information about the Powder Metal Matter across two fiscal years and correctly connects the numerical change to its tax implications. However, it doesn't fully synthesize the classification change aspect that distinguishes the 2023 vs 2024 treatment.\n\nSEMANTIC EQUIVALENCE: The core message about declining deferred-tax assets and reduced future tax benefits is conveyed correctly, though the answer is narrower in scope than the ground truth's emphasis on the evolution of financial treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 478,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "\nFrom 2022 through 2024 the Paidy Credit Agreement grew from an initial unsecured revolving line of ¥60 billion (≈ $574 million) that was expanded in September 2022 by an additional ¥30 billion, bringing total capacity to ¥90 billion (≈ $574 million); by the end of 2024 the full ¥90 billion had been drawn, leaving essentially no remaining borrowing capacity. The facility bears interest at the Tokyo Interbank Offered Rate plus a 0.40 %–0.60 % margin and matures in February 2027, at which point all outstanding balances must be repaid unless the agreement is terminated earlier. (PYPL 10‑K 2022, pp. 48‑52; PYPL 10‑K 2024, pp. 103‑107)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) FACILITY TYPE CONTRADICTION: LLM states the facility was 'unsecured' from the beginning, but ground truth clearly indicates it was a 'secured' facility in 2022 that was later 'restructured as an unsecured facility' by 2024. This is a fundamental factual error about the evolution of terms. (2) INITIAL CAPACITY ERROR: LLM claims the facility started at ¥60 billion in 2022, but ground truth states it was approximately $198 million (secured) in 2022. The ¥90 billion figure appears to be the 2024 amount, not a 2022 starting point. (3) CURRENCY/AMOUNT CONFUSION: LLM uses ¥574 million for both the initial and final amounts, which is problematic. Ground truth shows $198 million in 2022 and ¥90 billion (≈$574 million) in 2024 - these are different amounts in different currencies at different times. (4) MISSING KEY EVOLUTION: LLM fails to capture the critical change from secured to unsecured facility, which is a major structural modification. (5) OUTSTANDING BALANCE CLAIM: LLM states 'the full ¥90 billion had been drawn, leaving essentially no remaining borrowing capacity' - this specific claim about full drawdown is not mentioned in ground truth and appears to be an unsupported inference. (6) CORRECT ELEMENTS: The interest rate (TIBOR + 0.40%-0.60%), maturity date (February 2027), and mention of financial covenants are accurate. The multi-hop synthesis is incomplete and contains fundamental misunderstandings of how the facility evolved from 2022 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 413,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "\nAltria’s use of long‑term senior unsecured notes has steadily declined from the peak seen in 2021‑2022.  After issuing $5.5 bn of notes in February 2021 and carrying about $28 bn of total debt at the end of 2021, the company repaid roughly $5 bn of those notes in 2021‑2022 and, by the end of 2024, had reduced long‑term debt to $24.9 bn (down from $26.2 bn in 2023) and relied more on internal cash flows, commercial‑paper borrowings and its $3 bn revolving credit facility for financing.  Consequently, new senior‑note issuances after 2021 have been smaller and purpose‑specific (e.g., the $1 bn February 2025 issuance to refinance near‑term maturities), reflecting a deliberate de‑leveraging of its capital structure.  (Pages 47‑51 of MO_10k_2024; Note 9 and Capital Markets discussion.)",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides relevant information about Altria's debt management and capital structure evolution, but has significant issues with alignment to the specific question and some factual concerns:\n\nSTRENGTHS:\n1. Correctly identifies Altria (MO) and discusses long-term senior unsecured notes\n2. Provides specific debt figures ($28bn in 2021, $26.2bn in 2023, $24.9bn in 2024) showing debt reduction trend\n3. Mentions the $3bn revolving credit facility (matches ground truth)\n4. Discusses de-leveraging strategy and shift toward internal cash flows\n5. Cites specific document references (Pages 47-51, Note 9)\n\nWEAKNESSES:\n1. MISALIGNMENT WITH QUESTION: The question specifically asks about evolution between 2022-2024, but the LLM answer focuses heavily on 2021-2022 period and earlier, which is outside the requested timeframe\n2. MISSING KEY DATA: Ground truth mentions cash and cash equivalents ($4.5bn in 2022 declining to $3.1bn in 2024), which the LLM answer completely omits\n3. INCOMPLETE 2022-2024 COMPARISON: While the answer provides 2023-2024 debt figures, it lacks specific 2022 baseline data for the requested comparison period\n4. FORWARD-LOOKING CLAIM: References a \"February 2025 issuance\" which is future-dated and cannot be verified against 2024 10-K filing\n5. TONE MISMATCH: Ground truth emphasizes \"increased reliance\" on external financing due to cash reduction; LLM emphasizes \"de-leveraging\" and reduced reliance, which is somewhat contradictory to the ground truth's interpretation\n\nQUANTITATIVE VERIFICATION:\n- $28bn (2021): Cannot verify from ground truth (not provided)\n- $26.2bn (2023): Cannot verify from ground truth (not provided)\n- $24.9bn (2024): Cannot verify from ground truth (not provided)\n- $3bn credit facility: CORRECT (matches ground truth)\n- $5.5bn issuance (Feb 2021): Cannot verify from ground truth\n- $1bn issuance (Feb 2025): Outside filing period, cannot verify\n\nMULTI-HOP REASONING:\nThe answer attempts to synthesize debt trends across years but fails to properly address the specific 2022-2024 evolution requested. The reasoning about de-leveraging is sound but doesn't align with the ground truth's conclusion about increased reliance on external financing mechanisms.\n\nCONTEXTUAL RELEVANCE:\nWhile the answer discusses relevant topics (long-term senior unsecured notes, capital structure, debt management), it doesn't directly answer the specific question about 2022-2024 evolution and omits the critical cash position data that the ground truth emphasizes as key to understanding the shift in reliance on external financing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 692,
        "total_tokens": 2065
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "\nIn 2023 RTX took a $5.4 bn net‑sales charge and a $2.5 bn reduction in cost of sales related to the Powder Metal Matter, which sharply lowered pretax earnings; the resulting large pretax loss gave the 2023 effective tax rate a roughly 4 % boost as the loss generated a disproportionate tax benefit. By 2024 that Matter no longer drives earnings, and the 2024 tax rate is now shaped by recurring items such as audit settlements, R&D credits, FDII benefits and other tax adjustments, indicating that the one‑time tax advantage from the Powder Metal Matter has been exhausted and future income‑tax benefits will come from those ongoing credit and settlement items rather than the Matter itself.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different aspect of the Powder Metal Matter than what the question asks. CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY: The LLM cites $5.4 billion net-sales charge and $2.5 billion reduction in cost of sales - these numbers are NOT mentioned in the ground truth and appear to be fabricated or from a different context. The ground truth specifically addresses future income tax benefits: $644 million in 2023 declining to $455 million in 2024. The LLM provides no mention of these actual figures. (2) MULTI-HOP SYNTHESIS FAILURE: The question asks about the evolution of financial treatment between 2023 and 2024 regarding future income tax benefits. The ground truth shows a clear year-over-year comparison: $644M → $455M (a $189M decline of ~29%). The LLM completely misses this comparison and instead discusses 2023 charges and 2024 tax rate composition without addressing the specific metric requested. (3) ENTITY/METRIC CONFUSION: The LLM discusses pretax earnings, effective tax rates, audit settlements, R&D credits, and FDII benefits - none of which are mentioned in the ground truth answer. The question specifically asks about 'future income tax benefits' related to the Powder Metal Matter, not general tax rate drivers. (4) MISSING CORE ANSWER: The LLM fails to provide the two key numbers ($644M and $455M) that directly answer the question. Instead, it provides unverified figures about charges and sales impacts. (5) REASONING QUALITY: While the LLM's logic about one-time vs. recurring tax items is conceptually reasonable, it is applied to the wrong financial metrics and does not address the specific decline in future income tax benefits from the Powder Metal Matter. The answer reads as a general discussion of RTX's tax position rather than a focused analysis of how the Powder Metal Matter's tax benefit treatment changed between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 521,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal expanded the Paidy Credit Agreement’s capacity dramatically—​the facility was increased in February 2022 from roughly $100 million (the amount outstanding as of 12/31/21) to a total of ¥90 billion, or about $574 million, as of 12/31/24. By the end of 2024 the company had drawn the full ¥90 billion (≈ $574 million), leaving essentially no borrowing capacity left under the agreement. This represents a shift from a modest, partially‑used $100 million line in 2021‑22 to a fully‑utilized $574 million facility by 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of PayPal's Paidy Credit Agreement between 2022 and 2024, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the key figures: ~$100 million outstanding as of 12/31/21, ¥90 billion (~$574 million) capacity by 2024, and full drawdown by end of 2024; (2) Accurately captures the timeline and expansion narrative; (3) Properly synthesizes the multi-hop information showing the progression from partial utilization to full utilization; (4) Correctly notes the February 2022 increase timing; (5) Appropriately conveys the shift in reliance on the facility. MINOR ISSUES: (1) The ground truth states PayPal had 'approximately $198 million in borrowing capacity' in 2022, but the LLM answer doesn't explicitly mention this intermediate figure—it jumps from the $100 million outstanding in 2021 to the ¥90 billion facility. This represents a slight incompleteness in capturing the full 2022 state; (2) The phrasing 'increased in February 2022 from roughly $100 million' could be misinterpreted as the facility being increased FROM $100 million, when actually $100 million was the available capacity remaining after the $98 million drawdown. The ground truth more clearly states the capacity was 'approximately $198 million' in 2022. QUANTITATIVE VERIFICATION: All numbers cited are accurate ($574 million, ¥90 billion, $100 million, full drawdown). The currency conversion is reasonable. MULTI-HOP REASONING: The answer successfully synthesizes information across years and correctly identifies the relationship between borrowing capacity, outstanding amounts, and available capacity. The conclusion about the shift from modest to fully-utilized is logically sound. The answer would have been 8-9 if it had explicitly mentioned the $198 million capacity figure from 2022, which represents a key data point in the evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 523,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "\nFrom 2023 to 2024 the equity linkage between Accenture plc and Accenture Canada Holdings Inc. remained essentially unchanged: the Canadian entity is still a wholly‑owned subsidiary, but a tiny non‑controlling stake—less than 1 % of its equity as of 31 August 2024—is held by certain current and former members of Accenture Leadership.  Holders of Accenture Canada Holdings Inc. exchangeable shares can still exchange them one‑for‑one for Accenture plc Class A ordinary shares (or, at our option, receive cash), and these exchangeable shares continue to carry the same distribution rights and Class X share features (no dividends, redeemable at par, subject to redemption limits).  Consequently, while the legal structure and the exchange‑share mechanism persisted, the non‑controlling interest stayed immaterial and did not experience a material change in size or composition over the 2023‑2024 period.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains accurate quantitative information (less than 1% noncontrolling interest as of August 31, 2024, one-for-one exchange ratio, Class A ordinary shares) and correctly identifies the key entities and dates. However, there is a significant conceptual error in the core reasoning that substantially undermines the answer's correctness. The ground truth explicitly states that the equity relationship 'evolved' and became 'more formalized and structured in 2024 compared to the simpler noncontrolling interest disclosure in 2023.' The LLM answer directly contradicts this by claiming the structure 'remained essentially unchanged' and that 'the legal structure and the exchange-share mechanism persisted.' This represents a fundamental misunderstanding of the multi-hop synthesis required—the question asks how the relationship 'evolved,' and the ground truth indicates a clear evolution toward more detailed and formalized provisions around exchangeable shares and Class X share restrictions. The LLM correctly identifies the mechanics of the exchangeable shares and the Class X share features, but fails to recognize or articulate the key evolution: the shift from a simple noncontrolling interest disclosure in 2023 to a more complex, structured equity relationship with specific provisions and restrictions in 2024. The answer also adds unsupported details (e.g., 'no dividends, redeemable at par, subject to redemption limits') that are not mentioned in the ground truth, suggesting potential hallucination. While the quantitative facts are largely accurate, the qualitative reasoning about how the structure evolved is substantially incorrect, making this a partially correct answer that misses the central point of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 476,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "\nBetween 2022 and 2024 Merck broadened and systematized its forward‑exchange hedging program.  It kept hedging forecasted sales in the euro, Japanese yen and Chinese renminbi, but added a dedicated balance‑sheet layer that uses forwards for monetary‑asset exposures in developed currencies and, when a cost‑benefit analysis shows the exposure is large enough, for developing‑currency items; the company also began designating forwards as net‑investment hedges and often pairs them with euro‑denominated debt, always layering new hedges over time and weighing the size of the exposure, exchange‑rate volatility and the cost of the hedge before entering the contract.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of Merck's hedging evolution. Critical issues: (1) The LLM claims Merck 'broadened and systematized' its program and 'added a dedicated balance-sheet layer' between 2022-2024, but the ground truth indicates the opposite - there was a SIMPLIFICATION with omission of detailed cost-benefit analysis discussion and specific mention of Chinese renminbi in developing country context. (2) The LLM incorrectly suggests the company 'began designating forwards as net-investment hedges' as a 2022-2024 development, but the ground truth makes no mention of this as a new development. (3) The LLM describes an expansion of the program (adding balance-sheet layer, net-investment hedges), contradicting the ground truth's characterization of a shift toward simplification. (4) While the LLM correctly identifies currencies (euro, yen, renminbi) and mentions cost-benefit analysis factors (exposure size, volatility, hedge cost), it fundamentally mischaracterizes the directional change - presenting expansion where the ground truth indicates contraction in disclosure detail and emphasis. (5) The LLM's description of 'layering new hedges over time' and the specific mechanics are not substantiated in the ground truth provided. The answer demonstrates a failure to correctly synthesize the multi-hop comparison between 2022 and 2024 positions, instead inventing a narrative of program expansion that contradicts the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 420,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "\nThe 2024 filing shows the deferred‑tax asset that had been recorded for the Powder Metal matter falling sharply—from about $644 million in 2023 to roughly $455 million in 2024—and the associated valuation allowance being trimmed by a comparable amount.  This reduction indicates that the tax credit generated by the matter is being exhausted (or fully reserved) and that RTX no longer expects any significant future income‑tax benefit from that item.  In short, the ongoing financial impact of the Powder Metal matter on future tax benefits is now minimal.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key numeric values ($644 million in 2023 declining to $455 million in 2024) and accurately notes the sharp reduction in the deferred tax asset. The numbers are factually correct and properly formatted. WEAKNESSES: (1) The LLM's interpretation diverges significantly from the ground truth regarding what the change suggests. Ground truth indicates the shift represents 'a reduction in its immediate negative impact and a potential long-term recovery or resolution,' suggesting the matter is being resolved favorably. The LLM interprets it as 'the tax credit generated by the matter is being exhausted (or fully reserved)' and concludes 'RTX no longer expects any significant future income-tax benefit,' which is a more pessimistic reading. (2) The LLM mentions 'the associated valuation allowance being trimmed by a comparable amount' but this detail is not present in the ground truth answer, introducing information not verified against the source. (3) The LLM's conclusion that 'the ongoing financial impact...is now minimal' contradicts the ground truth's assertion that the matter 'continues to carry financial significance.' (4) The LLM fails to adequately address the original context that in 2023 this was a $5.3 billion net sales charge—a critical piece of information showing the magnitude of the original impact. The multi-hop reasoning is incomplete: the LLM should have synthesized the progression from operational loss ($5.3B charge) to deferred tax asset ($644M to $455M) to explain what this evolution means. The interpretation of whether the reduction is positive (recovery/resolution) or negative (exhaustion of benefits) is fundamentally different between the two answers, representing a material difference in understanding the financial implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 492,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s merchant‑finance business grew substantially in size—purchasing about $1.8 billion of merchant receivables in 2024 (up from $1.7 billion in 2023) and holding a $1.5 billion portfolio (versus $1.2 billion in 2023)—while still relying on the same partnership model.  In the United States the credit is originated by WebBank, which PayPal purchases and services, and the risk is shared through a participation‑interest arrangement; internationally the company extends similar advances through its Luxembourg and Australian subsidiaries.  At the same time, PayPal has tightened its underwriting and credit‑loss monitoring, as evidenced by a lower allowance for credit losses on merchant receivables in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of PayPal's merchant receivables evolution with mostly accurate quantitative data. STRENGTHS: (1) All key financial figures are correct: $1.8B purchases in 2024 vs $1.7B in 2023, $1.5B portfolio vs $1.2B in 2023. (2) Correctly identifies WebBank as the partner institution and describes the participation-interest arrangement. (3) Appropriately notes the expansion to international operations through Luxembourg and Australian subsidiaries. (4) Mentions tightened underwriting and credit-loss monitoring. WEAKNESSES: (1) The answer omits a specific data point from the ground truth: the participation interest sold to partner institution increased to $53M in 2024 from $44M in 2023—this is a concrete metric showing the evolution of collaboration that the ground truth explicitly highlights. (2) The 2022 baseline information is not addressed; the ground truth specifically describes PayPal's 2022 accounting treatment and program agreement structure with WebBank, which would have provided important context for understanding the evolution. (3) The reference to 'lower allowance for credit losses' is mentioned but not quantified or sourced from the ground truth, which could indicate the LLM is adding inference rather than sticking to documented facts. MULTI-HOP REASONING: The answer correctly synthesizes information about the partnership model, scale metrics, and geographic expansion, though it misses the specific participation interest growth metric that demonstrates the quantitative evolution of the partnership. The semantic meaning largely aligns with the ground truth, but the omission of the $53M/$44M participation interest data represents a meaningful gap in demonstrating the 'growing level of investment in and collaboration' that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 495,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "\nAlliance revenue from Lynparza rose steadily – $1.12 billion in 2022, $1.20 billion in 2023 and $1.31 billion in 2024 – reflecting a series of growth‑driving factors.  The increase was powered by stronger global demand (especially outside the United States), new label expansions such as the 2025 adjuvant‑breast‑cancer approval in China and ongoing pricing advantages within the AstraZeneca collaboration, which shares profits net of cost‑of‑sales and commercialization expenses.  These dynamics offset any pressure from generic competition and drove the upward trajectory through 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: Ground truth states 2022 Lynparza alliance revenue was $989 million, but LLM claims $1.12 billion (13% higher). For 2023, LLM states $1.20 billion with no ground truth comparison provided, but the trajectory is already wrong. For 2024, LLM states $1.31 billion, but ground truth indicates 9% growth from 2022's $989M would be approximately $1.078 billion, not $1.31 billion. The LLM's numbers are significantly inflated across all three years. (2) GROWTH CALCULATION ERROR: Ground truth specifies 9% growth between 2022-2024 ($989M × 1.09 = $1.078B approximately). LLM's figures show 17% growth ($1.12B to $1.31B), which is mathematically inconsistent with the stated 9% growth rate. (3) MULTI-HOP REASONING: While the LLM correctly identifies contributing factors (global demand, China approval in 2025, AstraZeneca collaboration structure), it fails on the core quantitative synthesis required for this financial question. The mention of generic competition pressure is not supported by ground truth. (4) ENTITY ACCURACY: Correctly identifies Merck, Lynparza, AstraZeneca, and China approval timing, but the financial metrics are fundamentally wrong. (5) SEMANTIC EQUIVALENCE: The qualitative factors mentioned are reasonable, but the answer is dominated by incorrect numbers that undermine credibility. The core answer to 'how did revenue evolve' is factually wrong due to incorrect baseline and trajectory figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 433,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "\nBetween 2022 and 2024 PayPal’s merchant‑receivable exposure shifted from a largely on‑balance‑sheet loan book to an asset‑light, fee‑based model.  The company now originates PPWC/PPBL advances through partner lenders and sells eligible receivables under a forward‑flow agreement, so that the allowance for merchant credit losses fell from about $160 million in 2023 to $113 million in 2024 and gross charge‑offs dropped sharply.  Operationally, PayPal’s role has become that of a service provider that underwrites, monitors credit quality and collects repayments, while the bulk of the financial risk and capital is borne by the partner institutions and the sold‑receivable facility.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM cites allowance for merchant credit losses of $160M in 2023 and $113M in 2024, but provides no verification against ground truth data. More critically, the LLM completely omits the key financial metrics from the ground truth: merchant receivables purchases of $1.8B (2024) and $1.7B (2023), and outstanding balance of $1.5B (2024) vs $1.2B (2023). These are central to answering the question about PayPal's financial exposure evolution. (2) DIRECTIONAL CONTRADICTION: The ground truth states PayPal EXPANDED direct involvement through ACTIVE PURCHASES of merchant receivables and took on FULL SERVICING RESPONSIBILITIES, indicating deeper operational engagement. The LLM claims PayPal shifted to an 'asset-light, fee-based model' where it SELLS receivables to partner lenders and bears minimal financial risk. This is fundamentally contradictory to the ground truth's narrative of expanded direct involvement and growing outstanding balances. (3) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the key multi-hop information: the progression from 2022 (risk management focus) through 2023-2024 (active purchases and growing balances). Instead, it presents a different narrative about asset-light models and forward-flow agreements that aren't supported by the ground truth. (4) MISSING CORE DATA: The LLM provides no mention of the $1.8B, $1.7B, $1.5B, or $1.2B figures that are central to demonstrating how PayPal's exposure evolved. (5) OPERATIONAL ROLE MISCHARACTERIZATION: While the LLM correctly identifies PPWC/PPBL products, it mischaracterizes PayPal's role as primarily a service provider with minimal risk, when the ground truth indicates PayPal took on full servicing responsibilities for growing receivables balances it actively purchased.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 513,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "\nFrom 2022 through 2024 Merck moved Lynparza forward with a series of regulatory milestones: the FDA accepted a supplemental NDA for an adjuvant breast‑cancer indication in Nov 2021 and awarded it Priority Review, delivering a Q1 2022 PDUFA decision that resulted in U.S. approval; the EU continued its review for a metastatic castration‑resistant prostate‑cancer label, and China’s NMPA granted approval in Jan 2025 (announced after the 2024 fiscal year).  Commercially, alliance revenue from Lynparza rose steadily—$1.116 billion in 2022, $1.199 billion in 2023 and $1.311 billion in 2024—reflecting growing demand and expanded use across its approved cancer indications.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific financial data and regulatory milestones. STRENGTHS: (1) Correctly identifies the supplemental NDA for adjuvant breast cancer indication with Q1 2022 PDUFA decision and approval; (2) Accurately provides specific revenue figures ($1.116B in 2022, $1.199B in 2023, $1.311B in 2024) that show the 9% growth mentioned in ground truth (2023-2024: $1.199B to $1.311B = 9.3% growth); (3) Correctly notes China NMPA approval in January 2025; (4) Properly synthesizes multi-hop information across regulatory and commercial dimensions; (5) Mentions EU review for metastatic castration-resistant prostate cancer, adding relevant context. MINOR ISSUES: (1) The ground truth states Merck was 'awaiting FDA decision' in 2022 with PDUFA in Q1 2022, while the LLM states the supplemental NDA was 'accepted in Nov 2021' with Priority Review and Q1 2022 PDUFA decision resulting in approval—this is more detailed and accurate than the ground truth's phrasing, showing the approval was actually granted; (2) The ground truth mentions 'alliance revenue related to Lynparza grew by 9% in 2024' while the LLM provides absolute figures showing this growth, which is more informative and verifiable; (3) Ground truth mentions 'maintained its approvals' but doesn't provide specific revenue figures, while LLM provides concrete commercial data. The LLM answer is actually more comprehensive and precise than the ground truth, providing specific revenue numbers and confirming the regulatory approvals were successfully completed. All quantitative data appears accurate and the multi-hop synthesis across regulatory progress and revenue growth is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 462,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "\nBetween 2022 and 2024 Boeing shifted from relying mainly on cash‑flow‑hedged commodity purchase contracts—used to offset price swings for production‑related commodities with a multi‑year (through 2028) horizon and modest exposure (e.g., a 10 % price move would alter unrealized losses by roughly $46 million)—to a broader approach that adds longer‑term aluminum purchase and sales agreements for strategic sourcing and non‑U.S. operations.  These newer contracts include both hedge‑accounted derivatives and non‑hedge agreements, increasing the notional volume and the amount of losses expected to be re‑classified from AOCI ($≈ $64 pre‑tax over the next 12 months), thereby expanding the overall financial exposure while still targeting price‑risk mitigation.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) CRITICAL DATE ERROR: LLM states 2022 horizon was 'through 2028' but ground truth indicates 2022 was a general hedging approach without specific multi-year horizon mentioned. More importantly, ground truth states 2024 extended to 2031, not 2028. This is a significant factual error on the core evolution being measured. (2) QUANTITATIVE DISCREPANCIES: LLM introduces $64 million AOCI reclassification figure not present in ground truth, and characterizes it as 'expected to be re-classified from AOCI over the next 12 months' - this appears to be additional information not in the original answer and may be inaccurate or from different filing sections. The $46 million figure is correctly cited for 2022. (3) INCOMPLETE SYNTHESIS: Ground truth emphasizes the shift from 'general hedging approach in 2022' to 'multi-decade horizon in 2031' as the key evolution. LLM focuses on contract types (cash-flow-hedged vs. hedge-accounted derivatives) rather than the primary strategic shift to extended production planning cycles through 2031. (4) SEMANTIC ISSUES: LLM's characterization of 'expanding overall financial exposure' contradicts the ground truth's emphasis on 'proactively securing cost predictability' - these suggest opposite strategic directions. (5) MISSING KEY INSIGHT: Ground truth emphasizes alignment with 'extended production planning cycles' as the strategic rationale; LLM focuses on contract mechanics without this context. (6) CORRECT ELEMENTS: The $46 million 2022 figure is accurate; the general concept of shift toward longer-term hedging is present; commodity swaps and derivatives are correctly mentioned. The answer demonstrates partial understanding but contains material factual errors on dates and strategic emphasis that undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 489,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "\nSchwab’s Pledged‑Asset Line (PAL) portfolio was fully collateralized at both December 31 2021 and December 31 2024, with the pledged securities’ fair value exceeding the outstanding PAL borrowings, so no allowance for credit losses was recorded for PALs in either year. The PAL balance grew from about $12.7 billion in 2021 to roughly $17 billion in 2024, but the collateral coverage remained sufficient, leaving the credit risk essentially unchanged and the allowance at zero.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims 'no allowance for credit losses was recorded for PALs in either year' (2021 and 2024), but the ground truth explicitly states that by 2024, Schwab 'observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics.' This is a fundamental misrepresentation - the ground truth indicates an allowance existed in 2024, not zero. (2) The LLM states 'the credit risk essentially unchanged and the allowance at zero,' which directly contradicts the ground truth's description of a shift from full collateralization focus to 'a broader assessment of credit quality and loss projections' with a decreased (not zero) allowance. QUANTITATIVE ISSUES: While the LLM provides specific PAL balance figures ($12.7B in 2021, ~$17B in 2024), these cannot be verified against the ground truth which only mentions 'slight growth overall.' The specific numbers may or may not be accurate, but the LLM's interpretation of what these numbers mean is incorrect. REASONING FAILURE: The LLM failed to synthesize the multi-hop evolution described in the ground truth - the transition from 2021 (full collateralization, no allowance) to 2024 (decreased allowance reflecting improved credit quality). Instead, the LLM incorrectly concluded that conditions remained essentially unchanged. The answer demonstrates a fundamental misunderstanding of how credit risk assessment evolved, treating 2024 as identical to 2021 when the ground truth explicitly describes material changes in risk assessment methodology and allowance levels.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 459,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "\nBetween 2022 and 2024 Boeing’s 777X program moved from a phase of heavy R&D outlays but relatively modest cost‑of‑sales pressure to a stage in which the company began booking sizable reach‑forward losses on the type.  In 2022 the program absorbed about $2.85 billion of R&D expense, and cost of sales represented roughly 94‑95 % of revenue; by 2023 the cost‑of‑sales share had fallen to 90 % as revenues grew, but development charges remained, and R&D spending rose to $3.38 billion.  In 2024 a $1.77 billion reach‑forward loss on the 777X (and related 767 charges) pushed cost of sales up to 103 % of revenue, while R&D expense kept climbing to $3.81 billion—signaling a strategic shift toward accepting higher expenditures and losses to complete certification and bring the 777X into production.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the 777X program moved FROM 'heavy R&D outlays' TO 'sizable reach-forward losses,' but the ground truth indicates the opposite trajectory: FROM reach-forward losses in 2022 TO strategic R&D investment priority by 2024. (2) The LLM provides specific R&D numbers ($2.85B, $3.38B, $3.81B) that cannot be verified against the ground truth and appear fabricated. The ground truth only specifies R&D INCREASES: $525M increase (2023 vs 2022) and $435M increase (2024 vs 2023), not absolute values. (3) The LLM invents cost-of-sales percentages (94-95%, 90%, 103%) with no basis in the ground truth. (4) The LLM incorrectly attributes a $1.77B reach-forward loss to 2024, when the ground truth indicates reach-forward losses occurred in 2022, not 2024. (5) The LLM's narrative of 'accepting higher expenditures and losses' contradicts the ground truth's characterization of 2024 as a shift to 'strategic investment priority' focused on future development. The LLM fundamentally misunderstands the temporal evolution: it reverses the direction of change from cost burden (2022) to strategic investment (2024). While the LLM addresses the question's scope (2022-2024 evolution), it does so with inverted logic and unsupported numbers, making the answer factually incorrect on multiple critical dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 393,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s PAL exposure grew sharply—​the balance of pledged‑asset lines rose from roughly $13 billion at year‑end 2022 to about $17 billion by the end of 2024.  The credit‑loss allowance for PALs has remained anchored in the same practical‑expedient that bases the allowance on daily collateral‑maintenance thresholds and over‑collateralization, but in 2024 the company refined the estimation by incorporating updated macro‑economic forecasts and a more formal quantitative assessment, keeping the resulting allowance immaterial relative to the larger portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides specific dollar amounts ($13 billion in 2022, $17 billion in 2024) that are NOT present in the ground truth answer. The ground truth explicitly states portfolio growth occurred but does NOT provide these specific numerical values. This is a critical issue: the LLM has introduced specific numbers that cannot be verified against the knowledge graph source material. The ground truth mentions 'a slight decrease in 2023' but the LLM does not address this temporal detail. Positively, the LLM correctly identifies: (1) the practical expedient methodology remained consistent, (2) daily collateral monitoring and over-collateralization requirements, (3) portfolio growth between 2022-2024, (4) the allowance remained immaterial/low relative to portfolio size, and (5) improved credit quality metrics. The LLM adds detail about 'updated macro-economic forecasts and more formal quantitative assessment' in 2024 that goes beyond the ground truth's statement about 'improved credit quality metrics and lower projected loss rates'—this appears to be reasonable elaboration but cannot be verified. The multi-hop reasoning is sound in connecting collateral management practices to risk reduction, but the introduction of unverified specific dollar amounts significantly undermines credibility. The answer addresses all major question components (exposure evolution, risk management, credit loss allowance methodology, portfolio growth) but the quantitative specificity without source verification is problematic for a financial analysis task where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 435,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "\nThe company’s notional holding of British‑pound‑denominated debt that was used as a net‑investment hedge fell from **$360 million at the end of 2022** (shown in the “Non‑U.S. dollar debt designated as net‑investment hedges” table for 2022) to **essentially zero by the end of 2023**—the 2023 table lists only euro, Swiss‑franc and Canadian‑dollar debt and does not include any British‑pound amount.  \n\nThis reduction indicates that Mondelez International deliberately trimmed its GBP‑specific foreign‑exchange hedge, reallocating the hedge program toward other currencies (euro, Swiss franc, Canadian dollar) and reflecting a strategic shift in how it manages FX risk across its international operations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on all key factual points. (1) QUANTITATIVE ERRORS - The LLM claims British pound sterling debt designated as net-investment hedges was $360 million in 2022 and fell to essentially zero in 2023. The ground truth states MDLZ reported British pound sterling NOTES of $3 million in 2022 and $45 million in 2023 - a significant INCREASE, not a decrease. The LLM's numbers ($360M to $0) are completely wrong and represent a different metric entirely (net-investment hedges vs. notes). (2) DIRECTIONAL ERROR - The LLM describes a reduction/trimming of GBP exposure, when the ground truth shows an increase from $3M to $45M. This is a 1,400% increase, not a decrease to zero. (3) METRIC CONFUSION - The LLM appears to be discussing 'non-U.S. dollar debt designated as net-investment hedges' rather than the British pound sterling notes that the question and ground truth address. These are different line items in the financial statements. (4) STRATEGIC INTERPRETATION - The LLM's conclusion about 'deliberately trimming' GBP hedges and 'reallocating toward other currencies' is the opposite of what the data shows. The ground truth indicates increased exposure to British pound sterling, suggesting either increased hedging activity or greater operational ties to the UK market. (5) MULTI-HOP SYNTHESIS - The LLM failed to correctly synthesize the year-over-year comparison and misidentified which financial metric was being discussed. The answer demonstrates a fundamental misreading of the source data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 432,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "\nThe 2022 filing disclosed that the 3.125% 2025 Notes carried a fixed coupon of 3.125 % but, because of interest‑rate swaps, their effective financing cost was LIBOR + 1.8 % (a floating‑rate exposure of roughly $1 bn of swap notional). The 2024 filing revises this to an effective rate of SOFR + 2.1 % (still on a $1 bn swap notional) and notes the transition from LIBOR‑based to SOFR‑based swaps, together with the related fair‑value hedge adjustments.  \n\nThis shift shows that Amgen deliberately hedges the note’s fixed‑rate liability with interest‑rate swaps to lower its funding cost and manage interest‑rate risk, and that it updates the hedge structure as market benchmarks change—demonstrating a proactive, market‑responsive approach to financing this instrument.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims the 2022 filing disclosed LIBOR + 1.8% effective rate via interest-rate swaps, but the ground truth explicitly states the 2022 filing showed NO mention of variable rate terms—only the fixed 3.125% coupon. (2) The LLM introduces the concept of interest-rate swaps and hedge accounting that are NOT mentioned in the ground truth at all. The ground truth makes no reference to swaps, hedging, or fair-value adjustments. (3) The LLM correctly identifies the 2024 shift to SOFR + 2.1%, which matches the ground truth, but this is the only accurate element. (4) The LLM's interpretation fundamentally mischaracterizes the nature of the change—the ground truth indicates a shift in the actual debt instrument structure (from fixed to floating), while the LLM describes this as a hedging strategy using swaps, which is a different financial mechanism entirely. (5) The $1 billion swap notional figure appears fabricated and is not mentioned in the ground truth. The LLM demonstrates a complete misunderstanding of the core finding: that Amgen's disclosure changed from showing a fixed-rate instrument to showing a floating-rate instrument tied to SOFR. Instead, the LLM invents an elaborate but incorrect narrative about swap hedges and hedge accounting. This represents a fundamental failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 401,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "\nBetween 2022 and 2024 Schwab’s use of its Commercial Paper Issuance Program receded sharply.  In the 2022 filing (pages 21‑25) the company still described the CP program as a regular source of short‑term funding, but it warned that “rising market rates and recent credit‑market disruptions have made commercial‑paper financing more costly.”  By the 2024 filing (pages 14‑18) Schwab reported that it had “largely curtailed CP issuances and now relies on alternative secured sources—such as bank credit lines, Federal Home Loan Bank advances and repo facilities—to meet liquidity needs, using the CP program only on an opportunistic, as‑needed basis.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core claim. (1) MAJOR FACTUAL ERROR: The LLM states that Schwab's reliance on the CP program 'receded sharply' and was 'largely curtailed' by 2024, using it only 'opportunistically.' This directly contradicts the ground truth, which explicitly states that 'by 2024, Schwab's reliance on the program had INCREASED as a complement to other funding mechanisms.' This is a critical reversal of the actual trend. (2) QUANTITATIVE ACCURACY: While the LLM cites page numbers (21-25 for 2022, 14-18 for 2024), these cannot be verified and appear to be fabricated references. No specific financial metrics, dollar amounts, or quantitative data are provided to support the claims. The ground truth provides context about client cash outflows and funding needs, which the LLM completely omits. (3) MULTI-HOP REASONING: The LLM fails to synthesize the relationship between market disruptions, rising interest rates, and increased reliance on the CP program. The ground truth clearly connects these elements: rising short-term interest rates (2022-2023) led to higher client cash outflows, which required supplemental funding sources including the CP program. The LLM inverts this logic entirely. (4) ENTITY AND CONTEXT ACCURACY: While Schwab is correctly identified, the characterization of alternative funding sources (bank credit lines, FHLB advances, repo) is presented as replacements for the CP program rather than as complementary mechanisms, which misrepresents the actual relationship described in the ground truth. (5) SEMANTIC EQUIVALENCE: The answer conveys the opposite meaning from the ground truth—a fundamental semantic failure. The LLM's narrative of declining reliance contradicts the documented increase in reliance on the CP program as part of a diversified liquidity management strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 508,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "\nThe original 3.625 % senior notes that were scheduled to mature in 2022 were fully redeemed in 2021, eliminating that series from the balance sheet.  In its place the company issued a new 3.625 % tranche due 2024, which remained on the books through 2023 and was then retired during 2024—largely through a cash repayment and the termination of the associated interest‑rate swaps that had converted the fixed coupon to a SOFR + 3.4 % floating rate.  This pattern shows that the firm is actively refinancing its fixed‑rate debt, extending maturities and using swaps to reshape its interest‑rate profile and take advantage of more favorable market conditions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) TIMELINE ERROR: The LLM claims the original 3.625% notes were redeemed in 2021, then a new 3.625% tranche was issued due 2024. However, the ground truth indicates the 3.625% 2024 Notes had a carrying value of $1,400 million in 2022 and were fully paid off by 2024. The LLM's narrative about two separate issuances is not supported by the ground truth. (2) INTEREST RATE STRUCTURE ERROR: The LLM states the fixed coupon was converted to 'SOFR + 3.4%' floating rate via swaps. The ground truth simply states the notes were 'replaced with floating interest rates tied to SOFR' without specifying the spread. The LLM introduces a specific spread (3.4%) that is not in the ground truth. (3) MISSING KEY QUANTITATIVE DATA: The LLM fails to mention the $1,400 million carrying value in 2022 or the $0 notional amount in 2024, which are critical metrics for understanding the debt evolution. (4) INCOMPLETE ANSWER: While the LLM correctly identifies that the notes were retired in 2024 and mentions SOFR-based floating rates, it mischaracterizes the historical timeline and introduces unsupported details about interest rate swaps. (5) MULTI-HOP REASONING: The LLM attempts to synthesize information about debt management strategy but does so based on an incorrect narrative of the notes' history. The ground truth's simpler explanation (fixed rate debt paid off, replaced with floating rate) is more accurate than the LLM's complex refinancing narrative. The answer demonstrates partial understanding of debt management concepts but fails on factual accuracy regarding the specific notes' history and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 465,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "\nSchwab’s policy toward VIE support has not changed – in both the 2022 filing (pages 96‑100) and the 2024 filing (pages 17‑21) it expressly disclaims any intent to provide financial or other assistance beyond the amounts it is contractually obligated to fund, and it stresses that any additional funding would occur only if the predefined triggering conditions (e.g., capital‑call events or regulatory requirements) are met, with the bulk of the remaining commitments expected to be satisfied between 2022 and 2025. The 2024 disclosure therefore reiterates and clarifies the same stance, offering no new discretionary support intentions.",
      "correctness_score": 2,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core question. The ground truth explicitly states there WAS a shift/evolution in Schwab's approach between 2022 and 2024: (1) In 2022, Schwab stated it did NOT intend to provide support beyond contractual obligations; (2) By 2024, Schwab acknowledges it MAY choose to provide discretionary support (credit, liquidity) to proprietary funds in response to market conditions like significant valuation declines or redemption activity. The LLM answer claims 'the policy toward VIE support has not changed' and that both years 'expressly disclaim any intent to provide financial or other assistance beyond contractual obligations' - this directly contradicts the ground truth's finding of a meaningful evolution toward acknowledging discretionary support capacity. The LLM incorrectly characterizes the 2024 disclosure as merely 'reiterating and clarifying the same stance' when the ground truth indicates a substantive shift from 'did not intend' to 'may choose to provide.' While the LLM correctly identifies page ranges and mentions triggering conditions, it fundamentally misses the key evolution: the shift from explicit non-intent to discretionary support acknowledgment. The LLM's claim that there is 'no new discretionary support intentions' is factually wrong per the ground truth. The answer demonstrates poor multi-hop reasoning by failing to synthesize the actual differences between 2022 and 2024 disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 413,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "\nBetween 2022 and 2023 the JDE Peet’s stake remained an equity‑method investment, but MDLZ’s financing link to it changed through the €300 million zero‑interest exchangeable notes issued in 2021 (see Financing Costs, MDLZ 10‑K 2023 p. 52‑56). Those notes, which can be settled in cash or JDE Peet's shares, were largely settled by the end of 2023, reducing the contingent debt that had added to MDLZ’s balance‑sheet leverage in 2022 (total debt fell from $22.9 bn to $19.4 bn and the debt‑to‑capitalization ratio improved from 0.46 to 0.41). At the same time, earnings and dividends from the JDE Peet's equity method investment added to operating cash flow, giving MDLZ additional liquidity to fund dividends and share‑repurchase programs while strengthening its overall capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states a relationship reclassification from 'Has_Stake_In' (2022) to 'Invests_In' (2023), but the LLM answer claims the relationship 'remained an equity-method investment' - this contradicts the core finding about the evolution of the relationship. (2) The LLM introduces specific financial metrics (€300M zero-interest exchangeable notes, debt figures of $22.9bn to $19.4bn, debt-to-capitalization ratios of 0.46 to 0.41) that are NOT present in the ground truth answer. While these may be factually accurate from the 10-K, they represent a different analytical approach than what the ground truth emphasizes. (3) The ground truth focuses on the strategic reclassification and its implications for capital planning and funding sources, while the LLM focuses on debt settlement mechanics and cash flow impacts - these are different narratives. (4) The LLM answer does not address the 'Has_Stake_In' vs 'Invests_In' distinction that is central to understanding how the relationship evolved. (5) The ground truth mentions MDLZ reporting 'proportionate share of significant operating and non-operating items' in 2022, which the LLM answer omits. PARTIAL CREDIT: The LLM correctly identifies that the investment is equity-method, correctly names the companies (MDLZ and JDE Peet's), correctly identifies the time period (2022-2023), and does address liquidity and capital structure impacts. However, the fundamental mischaracterization of the relationship evolution and the introduction of unsupported specific metrics significantly undermines the answer's alignment with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 470,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "\nThe 3.125 % 2025 Notes were originally hedged with interest‑rate swaps that converted the fixed 3.125 % coupon to a floating rate of **LIBOR + 1.8 %** (notional $1 bn), a structure that was in place through 2022.  When the Company entered new swap agreements in 2023‑2024 (and as LIBOR was phased out), the hedge was updated so that the same $1 bn notional now floats at **SOFR + 2.1 %**, reflecting the newer benchmark and the revised spread.  Thus, the effective interest rate under the swap evolved from LIBOR + 1.8 % to SOFR + 2.1 % over the 2022‑2024 period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a LIBOR+1.8% rate that is NOT mentioned in the ground truth. The ground truth explicitly states 'the exact rate for the 3.125% 2025 Notes was not disclosed' in 2022. The LLM fabricates this specific rate with no basis in the source material. (2) TIMELINE DISCREPANCY - The LLM claims the LIBOR+1.8% structure was 'in place through 2022' and that new swaps were entered in '2023-2024', but the ground truth indicates swaps were terminated and reentered in 2022 itself, with the 2024 rate being SOFR+2.1%. The LLM's timeline is imprecise. (3) CORRECT ELEMENTS - The LLM correctly identifies: (a) the notional amount of $1 billion, (b) the 2024 rate as SOFR+2.1%, (c) the general concept of transitioning from LIBOR to SOFR, and (d) the evolution of the hedge structure. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize the evolution across years, it does so by introducing unsupported data (the LIBOR+1.8% rate). The reasoning about LIBOR phase-out is contextually relevant but not grounded in the actual filing data. (5) SEMANTIC ISSUES - The ground truth is cautious about 2022 rates ('not disclosed'), but the LLM presents a specific rate as fact. This is a fundamental accuracy problem that undermines the entire answer. The answer would score higher if it acknowledged the lack of disclosed 2022 rates and focused only on the confirmed 2024 SOFR+2.1% rate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 401,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "\nThe fair‑value of Walmart’s equity investments that are measured using Level 2 inputs fell from **$5.819 billion** at the end of fiscal 2022 to **$5.570 billion** at the end of fiscal 2023—a decline of **$0.249 billion** (about a 4 % reduction).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: FY2022 value of $5,819 million ($5.819 billion), FY2023 value of $5,570 million ($5.570 billion), and the decline of $249 million ($0.249 billion) are all accurate. The percentage calculation of approximately 4% decline is also correct (249/5,819 = 4.28%, reasonably rounded to 4%). The answer properly addresses all parts of the multi-hop question: (1) identifies the correct metric (fair value of equity investments using Level 2 inputs), (2) correctly synthesizes data from two fiscal years, (3) accurately calculates the magnitude of change, and (4) characterizes the change appropriately as a 'decline' or 'fell.' The number format conversion from millions to billions is handled correctly and consistently. The only minor consideration is that the LLM uses slightly different characterization language ('fell' vs. 'decreased') and adds the percentage calculation, which while accurate and helpful, goes slightly beyond the ground truth answer's scope. However, this addition is factually correct and enhances the answer without introducing errors. The answer demonstrates sound multi-hop reasoning by correctly pulling and synthesizing data across two fiscal years and performing accurate calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1124,
        "completion_tokens": 363,
        "total_tokens": 1488
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "\nIn the 2023 10‑K Apple described its “marketing abilities” only as part of a broader set of “innovative skills, technical competence and marketing abilities” that support the business, without singling them out as a distinct competitive driver. By contrast, the 2024 10‑K explicitly calls out “marketing and distribution capability” as one of the principal competitive factors and ties it directly to the Company’s ability to introduce new products, generate sales and sustain growth, showing a more pronounced and explicit reliance on marketing as a strategic capability.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution in Apple's language between 2023 and 2024 filings but contains significant inaccuracies in the specific characterization. CORRECT ELEMENTS: (1) The answer correctly identifies that there was a shift in how Apple characterized marketing abilities between 2023 and 2024; (2) It correctly notes that the 2024 filing ties marketing more directly to competitive positioning and product introduction; (3) The general direction of increased emphasis on marketing is accurate. INCORRECT/PROBLEMATIC ELEMENTS: (1) The LLM states the 2023 filing described marketing abilities 'without singling them out as a distinct competitive driver,' but the ground truth indicates Apple explicitly stated it 'relies primarily' on marketing abilities alongside innovative skills and technical competence—this is a material mischaracterization; (2) The LLM claims the 2024 filing calls out 'marketing and distribution capability' but the ground truth only mentions 'marketing abilities' (not distribution capability)—this is an addition not supported by the ground truth; (3) The LLM's characterization of the 2023 language as less explicit is somewhat accurate, but it misses the key ground truth detail that 2023 used 'relies primarily' while 2024 uses 'depends heavily'—this specific linguistic evolution is central to the question and is omitted; (4) The ground truth provides important context about competitive pressure from rivals, which the LLM answer does not mention. MULTI-HOP REASONING: The answer does synthesize information across two years of filings, but the synthesis is incomplete and contains factual errors about what each filing actually stated. The reasoning about increased strategic emphasis is sound but lacks the precise textual evidence from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 491,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "\nThe 3.625 % 2024 Notes have kept the same $1.4 billion notional amount in both 2022 and 2024, but the way that fixed‑rate exposure was hedged changed.  In 2022 the notes were covered by interest‑rate swaps that converted the 3.625 % coupon into a floating LIBOR + 3.2 % rate (as shown in the 2021‑2022 swap tables).  When the notes were repaid in 2024, those $1.4 billion of swaps matured and were replaced with new swaps on the 5.25 % 2033 Notes at SOFR + ~1.8‑2.1 %, effectively shifting the hedge from LIBOR‑based to a SOFR‑based structure.  \n\nThis roll‑over of the fair‑value hedge demonstrates that Amgen is actively managing its interest‑rate risk, adapting the hedge mix to current benchmark rates and market conditions rather than leaving the original LIBOR‑linked protection in place.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that contradict the ground truth:\n\n1. NOTIONAL AMOUNT ERROR: LLM claims the notional amount remained $1.4 billion in both 2022 and 2024. Ground truth states it dropped to $0 by December 31, 2024 (from $1.4 billion in December 2023). This is a fundamental factual error.\n\n2. MATURITY/REPAYMENT ERROR: LLM states 'When the notes were repaid in 2024' - this is incorrect. The ground truth indicates the notes were still outstanding in 2023 ($1.4 billion notional) and only fully unwound by end of 2024, not repaid. The notes approached maturity but the unwinding of hedges doesn't mean the notes were repaid.\n\n3. SWAP RATE ERRORS: LLM claims swaps converted to 'LIBOR + 3.2%' in 2022, but ground truth shows SOFR+3.4% in 2023. The LLM also mentions replacing with swaps at 'SOFR + ~1.8-2.1%' on different notes (2033 Notes), which is not supported by the ground truth and conflates different securities.\n\n4. HEDGE REPLACEMENT LOGIC: LLM suggests the hedges were 'replaced with new swaps on the 5.25% 2033 Notes' - this is a different security entirely and not mentioned in the ground truth. The ground truth indicates the 3.625% 2024 Notes hedges were fully unwound, not rolled into other notes.\n\n5. MISSING KEY FACT: LLM fails to mention the 2022 termination and re-entry of $5.2 billion in interest rate swaps at then-current rates, which is a critical part of understanding Amgen's hedging strategy changes.\n\n6. INTERPRETATION ERROR: While LLM correctly identifies active interest rate risk management, the specific mechanism and conclusion are wrong. The ground truth shows full unwinding due to maturity approaching, not a roll-over to other securities.\n\nThe answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required, mixing information about different securities and time periods incorrectly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 512,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "\nFrom 2022 through 2023 Schwab moved iRebal from a “customizable portfolio‑rebalancing solution” that it simply added to its Advisor Services menu to a fully integrated component of the new “Schwab Trading Powered by Ameritrade™” experience, making the tool available across all independent‑advisor (RIA) offerings.  This progression shows that Schwab is leveraging the combined scale and technology of the TD Ameritrade acquisition to deliver sophisticated, white‑label rebalancing capabilities to RIAs—positioning the firm as a credible, technology‑rich alternative to traditional custodians and helping it win and retain advisory assets in a competitive RIA market.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general narrative of iRebal's evolution from 2022 to 2023 and correctly identifies the competitive positioning angle. However, there are significant issues with factual accuracy and completeness:\n\nCRITICAL ERRORS:\n1. The LLM introduces a product name \"Schwab Trading Powered by Ameritrade™\" that does not appear in the ground truth. This appears to be fabricated or misattributed.\n2. The LLM claims iRebal was moved to a \"fully integrated component\" of this new experience, but the ground truth only states it was \"incorporated as a core part of its offerings\" - the LLM overstates the level of integration.\n3. The LLM describes iRebal as \"white-label rebalancing capabilities\" which is not mentioned in the ground truth and may mischaracterize the solution.\n\nMISSING KEY INFORMATION:\n1. The ground truth specifically mentions the transition of \"over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023\" - this quantitative context is completely absent from the LLM answer.\n2. The ground truth emphasizes Schwab's \"competitive advantage of introducing new products credibly through its strong brand and corporate reputation\" - the LLM mentions credibility but doesn't capture this specific strategic advantage.\n3. The ground truth notes that in 2022 Schwab was \"retaining\" iRebal, suggesting it was already part of the offering but not emphasized - the LLM's characterization of moving from \"simply added to its Advisor Services menu\" is slightly different framing.\n\nPARTIAL CREDIT:\n1. The LLM correctly identifies the evolution from 2022 to 2023\n2. The LLM correctly identifies competitive positioning in the RIA market\n3. The LLM correctly references the TD Ameritrade acquisition context\n4. The reasoning about leveraging combined scale and technology is sound and aligns with the ground truth's intent\n\nQUANTITATIVE ACCURACY: The LLM provides no specific numbers, while the ground truth includes $1.6 trillion and 15 million accounts. This is a significant omission for a multi-hop financial question.\n\nOVERALL ASSESSMENT: The LLM demonstrates understanding of the general narrative but introduces unsupported claims, omits critical quantitative data, and overstates certain aspects of the integration. The answer is partially correct but lacks the precision and completeness expected for a financial analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 653,
        "total_tokens": 2096
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "\nApple’s 2024 filing signals a more aggressive refresh of the iMac than in the prior year: the company announced a new iMac model in the first quarter of fiscal 2024 (highlighted under “Product, Service and Software Announcements” on page 21 of the 2024 10‑K) that is built on a higher‑performance silicon platform (M2/M3), features a redesigned chassis and runs the latest macOS Sequoia.  This follows the 2023 filing, which still listed the iMac only as part of the broader Mac product line but did not single out a new model, indicating that Apple moved from incremental updates to a focused, silicon‑driven redesign aimed at boosting Mac‑segment sales—evidenced by the 2 % year‑over‑year increase in Mac revenue reported on pages 23‑24 of the 2024 10‑K.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the core concept (iMac elevation in strategic importance from 2023 to 2024) and provides relevant contextual details. However, there are significant quantitative accuracy issues that prevent a higher score:\n\n1. QUANTITATIVE ACCURACY PROBLEMS:\n   - The LLM specifies M2/M3 silicon platforms, but the ground truth does not mention specific chip generations\n   - The LLM cites a \"2% year-over-year increase in Mac revenue\" with specific page references (23-24), but the ground truth does not provide this metric or confirm this number\n   - The LLM references \"macOS Sequoia\" specifically, which is not mentioned in the ground truth\n   - These specific technical details (M2/M3, Sequoia, 2% revenue increase) cannot be verified against the ground truth and may be hallucinated\n\n2. WHAT WAS CORRECT:\n   - Core insight that iMac was elevated from standard product line mention to special announcement in 2024\n   - Recognition that this reflects a product refresh/redesign\n   - Correct identification of fiscal 2024 timing\n   - Correct reference to \"Product, Service and Software Announcements\" section\n   - Logical reasoning that this shift indicates strategic importance\n\n3. MULTI-HOP REASONING:\n   - The synthesis between 2023 and 2024 filings is sound conceptually\n   - The connection between product announcement and revenue impact is logical but unsupported by verifiable data\n   - The reasoning about \"silicon-driven redesign\" is plausible but not confirmed in ground truth\n\n4. SEMANTIC EQUIVALENCE:\n   - The answer conveys similar meaning to ground truth regarding the strategic elevation of iMac\n   - However, the added specificity (M2/M3, Sequoia, 2% revenue) creates factual claims that diverge from what can be verified\n\nThe answer would score higher if it stuck to verifiable facts from the filings without adding unconfirmed technical specifications and metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 526,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the $1 billion 2.820% Notes due 2051 remained on RTX’s balance sheet and were still listed as a $1 billion component of long‑term debt in the 2024 filing (appearing in the “Long‑term debt” table and in the “Thereafter” maturity schedule).  The notes were originally issued in 2021 to replace near‑term maturities, and RTX has not retired or materially reduced this position, underscoring a strategy of maintaining a sizable, low‑coupon, long‑dated debt tranche to fund operations and diversify its maturity profile.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $1 billion principal balance of the 2.820% Notes Due 2051 and accurately states that this amount remained unchanged between 2022 and 2024. The characterization of the notes as a stable, low-coupon, long-dated debt component is appropriate. The LLM correctly notes the notes were not retired or materially reduced.\n\nWEAKNESSES: (1) FACTUAL ERROR - The LLM states the notes were 'originally issued in 2021' but the ground truth clearly indicates they were introduced in 2022. This is a significant dating error. (2) INCOMPLETE SYNTHESIS - The LLM fails to address the broader long-term debt structure evolution that is central to the question. The ground truth emphasizes that total principal long-term debt increased from $40,078 million (2022) to $41,146 million (2024), a $1,068 million increase. The LLM mentions 'diversify its maturity profile' but provides no quantitative context about the overall debt expansion. (3) MISSING COMPARATIVE ANALYSIS - The ground truth explicitly states 'RTX increased its overall debt burden through other issuances,' providing crucial context about how the 2051 notes fit within the broader debt strategy. The LLM alludes to this but doesn't quantify or substantiate it. (4) INCOMPLETE ANSWER TO MULTI-HOP QUESTION - The question asks what the evolution 'indicates about the company's long-term debt structure.' The ground truth provides specific numbers showing debt growth; the LLM provides only qualitative assertions without supporting data.\n\nQUANTITATIVE VERIFICATION: The $1 billion figure is correct (both 2022 and 2024). However, the LLM omits the critical comparative debt figures ($40,078M to $41,146M) that directly answer what the evolution indicates about long-term debt structure.\n\nMULTI-HOP REASONING: The LLM partially synthesizes information but fails to complete the full analysis. It identifies the stable component but doesn't connect it to the broader debt portfolio expansion that gives meaning to the 2051 notes' role in RTX's strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 550,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab amended its IDA agreement, cutting the service fee on client‑cash deposits at the former TD depository institutions from **25 bps to 15 bps** – a change that lowered fee income and is noted in the 2023 Pro‑Forma financial discussion.  At the same time the company completed the **LIBOR transition**, replacing LIBOR‑based reference rates with alternative rates in its IDA calculations and updating its deposit‑beta assumptions, which altered the interest‑rate sensitivity of net‑interest revenue as shown in the 2023 net‑interest‑revenue sensitivity tables.  (See SCHW 10‑K 2023 pp. 52‑56 for the fee reduction and SCHW 10‑K 2022 pp. 83‑87 / 2023 pp. 52‑56 for the LIBOR‑transition and deposit‑beta updates.)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness in addressing the multi-hop question about Schwab's IDA agreement evolution. QUANTITATIVE ACCURACY: All numeric values are correct - the service fee reduction from 25 basis points to 15 basis points is accurately stated and matches the ground truth. The basis point terminology (bps) is appropriate and consistent. COMPLETENESS: The answer addresses both key components of the question: (1) service fee changes between 2022-2023, and (2) reference rate adjustments related to LIBOR transition. The LLM successfully synthesizes information across multiple years and filing sections. ENTITY ACCURACY: Schwab (SCHW) is correctly identified, the IDA agreement is properly referenced, TD depository institutions are mentioned, and the fiscal years 2022-2023 are correctly contextualized. REASONING & SYNTHESIS: The multi-hop reasoning is sound - the answer correctly connects the fee reduction disclosed in 2022 with the LIBOR transition completed by 2023, showing how the agreement evolved across both dimensions. The logical flow from fee structure modifications to reference rate mechanism changes is clear and accurate. SEMANTIC EQUIVALENCE: The answer conveys the same substantive information as the ground truth while providing additional context about Pro-Forma financial discussions, deposit-beta assumptions, and net-interest-revenue sensitivity impacts. The citation references to specific 10-K pages add credibility and specificity. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by mentioning deposit-beta assumptions and interest-rate sensitivity impacts, which represents appropriate elaboration rather than error. The phrasing 'former TD depository institutions' is slightly more precise than the ground truth's 'TD Depository Institutions.' No factual errors or calculation mistakes are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 513,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "\nThe 2023 goodwill of $221 million for Filorga as a stand‑alone reporting unit shows the company previously treated the brand as a separate strategic business unit with its own acquisition premium. By 2024 the brand is grouped with other trademarks in broader segments, indicating that management now views Filorga’s value as part of a collective portfolio and assesses it by the carrying value of trademark intangibles rather than by separate goodwill testing.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) Quantitative accuracy is strong - correctly identifies the $221 million goodwill figure for 2023 and accurately notes the shift from 2023 to 2024. (2) Correctly identifies the core factual change: Filorga moved from standalone reporting unit status to being grouped with other trademarks. (3) Accurately notes the shift from goodwill-based to trademark intangible-based valuation. WEAKNESSES: (1) INCOMPLETE ANALYSIS - The LLM answer significantly underaddresses the strategic implications. The original answer discusses how this change 'could signal a shift in strategic focus or a consolidation of brand management' and mentions implications for 'future strategic decisions such as divestiture, investment, or brand prioritization.' The LLM answer focuses narrowly on the accounting/valuation mechanics without exploring these broader strategic implications. (2) MISSING CONTEXT - The original answer emphasizes that the change 'reduces its visibility as a standalone asset,' which is an important interpretive point about strategic importance. The LLM answer doesn't adequately capture this loss of visibility and what it suggests about the company's strategic priorities. (3) SHALLOW REASONING - While the LLM correctly identifies that management now views Filorga 'as part of a collective portfolio,' it doesn't explore what this consolidation suggests about the brand's relative strategic importance compared to 2023. The original answer better addresses the question's core inquiry about 'strategic importance.' (4) The LLM answer is more focused on accounting treatment than on the strategic implications the question specifically asks about. The question asks what the change 'suggests about its strategic importance and valuation approach' - the LLM addresses valuation approach adequately but underaddresses strategic importance implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 506,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "\nThe 2024 10‑K now lists the iPhone 16 Pro (and Pro Max) as a distinct product launch in the “Product, Service and Software Announcements” section, whereas the 2023 filing only referred to the upcoming iPhone 15 Pro generation and did not single out a “Pro” tier.  In the 2024 filing Apple ties the iPhone 16 Pro to new AI‑driven features (Apple Intelligence, visionOS 2) and emphasizes its role in driving services revenue, reflecting a product‑development focus on premium hardware that is tightly coupled with software and ecosystem monetisation.  This more granular disclosure signals a strategic shift toward highlighting the premium‑segment’s contribution to growth and to guiding investors on the company’s AI‑centric roadmap.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. (1) MAJOR FACTUAL ERRORS: The LLM claims the 2023 filing 'only referred to the upcoming iPhone 15 Pro generation and did not single out a Pro tier,' but the ground truth explicitly states the 2023 10-K announced the iPhone 16 Pro as part of the Fourth Quarter 2024 product lineup. This is a fundamental mischaracterization of what the 2023 filing contained. (2) INCORRECT COMPARISON: The LLM's description of how the iPhone 16 Pro appears in the 2024 filing differs from ground truth. The ground truth states it is 'listed among existing product lines like the iPhone 15 and iPhone 14,' indicating it has become an established product. The LLM instead focuses on it being in a 'Product, Service and Software Announcements' section with AI features, which may be accurate but misses the core point about the lifecycle transition. (3) ADDED UNSUPPORTED CLAIMS: The LLM introduces claims about 'Apple Intelligence, visionOS 2,' services revenue emphasis, and 'AI-centric roadmap' that are not present in the ground truth answer. While these may be factually true in the filings, they represent a different analytical focus than what the ground truth identifies as the key evolution. (4) MISSED CORE INSIGHT: The ground truth's key finding is the shift from 'forward-looking product planning in 2023 to retrospective inclusion in 2024,' reflecting the product's lifecycle maturation. The LLM completely misses this temporal and strategic positioning insight. (5) MULTI-HOP REASONING: The LLM fails to correctly synthesize the comparison between 2023 and 2024 filings regarding the iPhone 16 Pro's disclosure status and what that reveals about reporting strategy. The answer addresses a different aspect (AI features and premium positioning) rather than the lifecycle transition that defines the evolution in reporting strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 520,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "\nBetween 2022 and 2023 Schwab refined its EVE framework by adding explicit modeling of interest‑rate‑swap derivatives and updating key assumptions—most notably a more granular deposit‑beta methodology (especially for falling‑rate scenarios), revised prepayment and rate‑floor assumptions, and a shorter liability duration as rates rose. These changes altered the balance‑sheet dynamics used in the simulations, so that a given parallel shift now produces a larger EVE impact (e.g., a 200‑bp increase projects a 10.8 % change versus 7.3 % in 2022) while asset duration remained stable and liability duration shortened.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Critical issues: (1) ENTITY ERROR: The answer attributes the analysis to 'Schwab' when the ground truth does not specify the company name, suggesting the LLM may have hallucinated company identity. (2) QUANTITATIVE ERRORS: The LLM provides specific percentage changes (10.8% vs 7.3% for 200-bp increase) that are not mentioned in the ground truth at all. These appear to be fabricated numbers without source support. (3) MISSING KEY INFORMATION: The ground truth emphasizes that 2023 expanded EVE to capture 'client cash allocation changes on the balance sheet' - a critical evolution not mentioned in the LLM answer. (4) INCORRECT FOCUS: The LLM emphasizes 'interest-rate-swap derivatives' modeling as a key change, which is not mentioned in the ground truth. The ground truth focuses on deposit beta assumptions and client cash allocation impacts. (5) PARTIAL ACCURACY: The LLM correctly identifies that deposit beta assumptions were updated and that liability duration changed, which aligns with ground truth. However, the specific claim about 'shorter liability duration as rates rose' is presented as fact without ground truth support. (6) REASONING FLAW: The multi-hop synthesis is incomplete - the LLM fails to capture the fundamental shift from measuring long-term interest rate risk (2022) to explicitly capturing client cash allocation impacts (2023), which is the core evolution described in the ground truth. The answer demonstrates selective accuracy on some modeling assumptions but introduces unsupported quantitative claims and misses the primary evolution in the framework's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 466,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "\nBy 2022 Qualcomm was mainly an enabler—providing the modem, RF and IP that OEMs used to build wireless access‑point solutions—whereas in 2023 it began shipping its own branded AP hardware that integrates Snapdragon SoCs, RFFE, AI and edge‑networking chips.  This vertical integration gives Qualcomm a higher‑margin, end‑to‑end offering that differentiates it from pure component suppliers and expands its product portfolio from semiconductors into the broader networking‑equipment market, strengthening its competitive positioning across the networking stack.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core strategic shift from 2022 to 2023. Key strengths: (1) Correctly identifies the 2022 role as an enabler providing components (modem, RF, IP) vs. 2023 direct production of branded hardware; (2) Accurately captures the shift toward vertical integration and end-to-end solutions; (3) Properly identifies competitive positioning relative to pure component suppliers; (4) Correctly names relevant competitors (Broadcom, Intel implied through context); (5) Accurately describes the product portfolio expansion from semiconductors to networking equipment. The LLM answer adds specific technical details (Snapdragon SoCs, RFFE, AI chips) that enhance clarity and demonstrate deeper technical understanding, though these specifics are not contradicted by the ground truth. Minor differences: The LLM answer emphasizes 'higher-margin' and 'vertical integration' benefits more explicitly than the ground truth, but these are logical inferences from the strategic shift described and not factually incorrect. The LLM answer is more concise while capturing all essential elements. No quantitative errors detected (dates 2022/2023 correct, no calculations required). Multi-hop reasoning is sound—correctly synthesizes the before/after positioning and competitive implications. The answer fully addresses both parts of the question: competitive positioning AND product portfolio breadth. Semantic equivalence is strong throughout.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 412,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "\nFrom 2022 to 2023 the share of adjustable‑rate mortgage balances that carry interest‑only payment terms slipped modestly—from roughly **28 % to 27 %**—and, of those interest‑only balances, the portion whose rates are not scheduled to reset for three or more years fell from about **89 % to 86 %**.  This indicates a slight contraction in both the overall interest‑only exposure and the near‑term reset exposure of Schwab’s HELOC‑related portfolio over the period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative metrics are correct: (1) Interest-only ARM percentage: 28% (2022) → 27% (2023) ✓, (2) Portion not scheduled to reset for 3+ years: 89% (2022) → 86% (2023) ✓. The multi-hop synthesis is sound—the model correctly identified and compared both metrics across the two-year period. The reasoning is logical and well-articulated: the answer correctly interprets the data as showing a 'slight contraction' in both metrics, which aligns with the ground truth characterization of 'minor decrease.' The entity identification is accurate (Schwab's HELOC product, adjustable-rate mortgages, interest-only terms, reset schedules). The wording differs slightly from the ground truth (e.g., 'slipped modestly' vs. 'shifted slightly,' 'near-term reset exposure' vs. 'not scheduled to reset for three or more years') but conveys semantically equivalent information. The answer is well-structured, providing context about what the changes indicate. Minor deduction (1 point) only because the phrasing 'near-term reset exposure' could be slightly clearer in its direct reference to the 3+ year reset period, though the meaning is clear from context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 342,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 Qualcomm moved XR from a pure‑investment focus to a commercial revenue stream.  The 2022 10‑K (pages 12‑16) describes XR as a target for Qualcomm Ventures investments, while the 2023 10‑K (pages 71‑75) reports that XR‑enabled devices are now counted within the IoT segment, which generated $5.9 billion of revenue in 2023—showing a shift from early‑stage funding to sales of XR‑related chipsets and platforms.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Qualcomm's XR involvement from 2022 to 2023 (investment-focused to revenue-generating), which aligns with the ground truth. The qualitative reasoning about the shift from Qualcomm Ventures investments to commercialization is sound and well-articulated. However, there are significant quantitative accuracy issues: (1) The LLM cites specific page numbers (pages 12-16 for 2022 10-K and pages 71-75 for 2023 10-K) that cannot be verified against the ground truth and may be inaccurate. (2) The LLM introduces a specific revenue figure of $5.9 billion for IoT segment in 2023, which is not mentioned in the ground truth answer. This number cannot be verified as correct or incorrect from the provided ground truth, but it represents an unsupported quantitative claim. (3) The LLM specifies that XR-enabled devices are 'counted within the IoT segment,' which adds detail not present in the ground truth. While this may be accurate, it goes beyond what the ground truth confirms. The answer demonstrates good multi-hop synthesis (connecting 2022 investments to 2023 revenue) and correctly identifies the key transition, but the introduction of unverified specific numbers and page citations weakens the response. The core narrative is correct, but the quantitative specificity introduces potential inaccuracies that cannot be confirmed against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 392,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "\nThe 3.030 % Notes due 2052 have remained at a $1.1 billion aggregate principal balance from the end of 2022 through the end of 2024 – the long‑term‑debt tables in the 2022 and 2024 filings both list $1,100 million for this series and there are no repayments or additional issuances reported for those years.  This stability indicates that RTX is keeping a sizable, low‑coupon, long‑dated tranche on its balance sheet, using it as a core component of its long‑term financing mix and extending the overall maturity of its debt profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. (1) QUANTITATIVE ACCURACY: All numbers are correct - the principal balance is stated as $1.1 billion/$1,100 million (acceptable format variation), and the years 2022 and 2024 are correctly identified. The stability claim is factually accurate per the ground truth. (2) COMPLETENESS: The answer addresses both parts of the multi-part question: (a) how the balance evolved (remained stable at $1,100M), and (b) what this indicates about RTX's long-term debt structure. (3) ENTITY ACCURACY: RTX is correctly identified, the note series (3.030% Notes Due 2052) is correctly specified, and the time period (2022-2024) is accurate. (4) REASONING & SYNTHESIS: The multi-hop reasoning is sound - the LLM correctly synthesized information from multiple filings (2022 and 2024) to establish the stability pattern and drew appropriate conclusions about strategic consistency and capital structure management. The additional context about 'low-coupon, long-dated tranche' and 'extending overall maturity' provides reasonable interpretive insights consistent with the ground truth's statement about 'strategic consistency.' (5) SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while using slightly different wording ('keeping a sizable, low-coupon, long-dated tranche' vs. 'maintained its long-term commitment'). Both convey the same meaning. Minor difference: The LLM provides slightly more analytical depth by characterizing the note as 'low-coupon' and discussing its role in the maturity profile, which adds value without contradicting the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 449,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "\nBetween 2023 and 2024 the company moved corporate‑card offerings from a peripheral note in its “Business Strategies” discussion to a headline priority.  In the 2023 filing the strategy was described only as “evolving our card value propositions, further differentiating our corporate card and accounts‑payable expense‑management solutions,” whereas the 2024 filing expands this to a full‑scale emphasis on “designing innovative products and features, including financing, banking and payment solutions for our business customers” and places it as the **second** of four strategic imperatives.  This escalation shows that AXP is deliberately deepening its commercial‑payments platform—leveraging its premium brand, global network and partner ecosystem to offer end‑to‑end corporate‑card, expense‑management and financing solutions that drive higher‑spending corporate usage and generate new, recurring revenue streams beyond the consumer side.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. STRENGTHS: (1) Correctly identifies the core evolution from 2023 to 2024, accurately quoting both the 2023 language ('evolving our card value propositions, further differentiating our corporate card and accounts payable expense-management solutions') and the 2024 language ('designing innovative products and features, including financing, banking and payment solutions for our business customers'). (2) Accurately captures the strategic shift from peripheral positioning to headline priority, noting the placement as 'second of four strategic imperatives' in 2024. (3) Provides sound multi-hop reasoning by synthesizing the evolution across years and connecting it to broader commercial payments strategy. (4) Correctly identifies the shift toward integrated, solution-oriented approach embedding Corporate Card into wider business financial services. (5) No quantitative errors - all dates (2023, 2024) and entity references (AXP) are correct. MINOR CONSIDERATIONS: (1) The LLM answer adds interpretive detail about 'premium brand, global network and partner ecosystem' and 'higher-spending corporate usage and recurring revenue streams' that, while logically sound and strategically coherent, go slightly beyond what the ground truth explicitly states. However, these inferences are reasonable extensions of the documented strategic shift and don't contradict the ground truth. (2) The ground truth uses 'broader commercial payments strategy' while the LLM uses 'commercial-payments platform' - these are semantically equivalent. The LLM answer is more comprehensive and provides richer context while maintaining factual accuracy with the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 476,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "\nBetween 2023 and 2024 the filings do not record any structural re‑allocation of PCA SKIN’s role inside the Oral, Personal & Home Care segment – it remains listed as one of the segment’s key trademarks.  The company continues to market PCA SKIN through the same mix of channels that have historically defined the segment: sales to traditional retailers, wholesalers and distributors, professional skin‑health providers, and an expanding direct‑to‑consumer/e‑commerce presence.  In other words, PCA SKIN’s distribution strategy stayed consistent, with the brand still leveraging both professional‑channel sales and a growing online/retail‑direct approach, reflecting the segment’s broader omnichannel focus.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims 'PCA SKIN's distribution strategy stayed consistent' and that there was 'no structural re-allocation,' which directly contradicts the ground truth stating there was a specific expansion to include 'sales to skin health professionals in some geographies' by 2024. (2) The LLM incorrectly characterizes the 2023 positioning as already including 'professional skin-health providers,' when the ground truth explicitly states this was an expansion that occurred BY 2024, not in 2023. (3) The LLM invents details about 'expanding direct-to-consumer/e-commerce presence' and 'omnichannel focus' that are not supported by the ground truth, which only mentions 'eCommerce retailers' as part of the existing 2023 distribution. WHAT WAS CORRECT: The LLM correctly identifies that PCA SKIN remained a principal trademark in both years and that it operates within the Oral, Personal & Home Care segment. The LLM also correctly references traditional retailers, wholesalers, and distributors. MULTI-HOP REASONING FAILURE: The question specifically asks about evolution 'between 2023 and 2024,' requiring comparison of the two years. The ground truth shows a clear evolution (addition of skin health professionals), but the LLM fails to identify this change and instead claims consistency. This is a fundamental failure in the comparative analysis required by the question. The answer demonstrates poor synthesis of temporal information across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 431,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "\nBetween 2022 and 2023 the Opdivo strategy shifted from relying mainly on later‑line combinations (e.g., Opdivo + Yervoy in NSCLC and Opdivo + CABOMETYX in renal cancer) to securing regulatory approvals in **new adjuvant and neoadjuvant settings and broader tumor types**—including adjuvant melanoma (EU and U.S.), neoadjuvant platinum‑based chemotherapy for high‑risk NSCLC, and a subcutaneous formulation for future launch. These additional indications expand the addressable patient pool and reduce dependence on later‑line use, allowing Opdivo to **contribute growth that offsets declines in legacy products such as Revlimid**, even though the company’s total revenue fell 2 % in 2023. Consequently, Opdivo is positioned to deliver modest, incremental revenue gains, but its growth trajectory remains constrained by pricing pressure, competition and the need to sustain uptake in an increasingly crowded immuno‑oncology market.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Opdivo's strategic evolution between 2022 and 2023, with mostly accurate information and sound multi-hop reasoning. STRENGTHS: (1) Correctly identifies the shift from later-line to earlier-line therapies (adjuvant/neoadjuvant settings), which aligns with the ground truth's emphasis on 'earlier lines of therapy.' (2) Accurately mentions specific combination therapies (Opdivo + Yervoy, Opdivo + CABOMETYX) and new indications (melanoma, NSCLC, renal cancer). (3) Correctly references the subcutaneous formulation as a strategic initiative. (4) Appropriately contextualizes the revenue implications, noting that Opdivo growth helps offset declines in legacy products. (5) The statement about 2023 total revenue decline of 2% appears reasonable in context. MINOR ISSUES: (1) The ground truth mentions multiple tumor types (bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach) approved in 2022, but the LLM answer focuses primarily on NSCLC, melanoma, and renal cancer—this is a selective emphasis rather than an error, as these are indeed key indications. (2) The LLM answer introduces 'Revlimid' as a legacy product context, which is not mentioned in the ground truth provided, though this may be accurate from the actual filings. (3) The characterization of growth as 'modest, incremental' is somewhat more pessimistic than the ground truth's emphasis on 'strategic push to sustain revenue growth,' though both acknowledge constraints. MULTI-HOP REASONING: The answer successfully synthesizes information about (a) 2022 baseline approvals, (b) 2023 strategic shifts, (c) new formulations, and (d) revenue implications—demonstrating appropriate multi-hop synthesis. The logic connecting earlier-line approvals to addressable patient pool expansion is sound. QUANTITATIVE ACCURACY: The 2% revenue decline figure is stated but not verified against ground truth (ground truth does not provide this specific metric). No calculation errors detected. Overall, the answer is substantively correct with minor selective emphasis and one unverified quantitative claim.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1484,
        "completion_tokens": 572,
        "total_tokens": 2056
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "\nBetween the 2023 and 2024 reporting periods the fair‑value of American Express’s foreign‑government‑bond portfolio was essentially flat—$770 million in 2023 versus $765 million in 2024 (a negligible decline).  The maturity profile stayed the same: almost the entire position (about $768 million) matures within one year, with only a modest $2 million portion scheduled to mature after one year but within five years, and no material exposure beyond that.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth: (1) 2023 Fair Value: LLM states $770 million, but ground truth shows $549 million - a $221 million error (40% overstatement). (2) 2024 Fair Value: LLM states $765 million, which matches ground truth exactly. (3) 2023 Maturity Profile: LLM claims almost entire position matures within one year, but ground truth explicitly states ALL $549 million matures in 12 months or more (i.e., none within one year). This is a complete reversal of the maturity distribution. (4) 2024 Maturity Profile: LLM states $768 million within one year and $2 million after one year but within five years. Ground truth shows $764 million within one year and $1 million after one year but within five years - minor discrepancies of $4M and $1M respectively. (5) Overall Characterization: LLM describes the portfolio as 'essentially flat' between years, but ground truth shows a 'significant increase' from $549M to $765M (39% growth). The LLM also misses the key insight about the dramatic shift in maturity distribution: from 100% long-term in 2023 to 99.9% short-term in 2024. The reasoning about multi-hop synthesis is flawed because the 2023 baseline numbers are completely wrong, making all subsequent comparisons invalid. The answer fails on quantitative accuracy (wrong 2023 baseline), fails on qualitative accuracy (inverted maturity profile for 2023), and fails to capture the significant evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 418,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "\nWalmart’s “cash that cannot be freely transferred to the U.S.” fell from roughly **$4.3 billion as of January 31 2022** to about **$3.5 billion as of January 31 2024** (≈$3.3 billion in the 2025 filing).  The company continues to use intercompany financing to move cash to where it is needed at the lowest cost, but the **conditions for repatriation have broadened** – whereas in 2022 roughly $2.2 billion of that amount could be accessed only through dividends or intercompany financing that required the **approval of Flipkart’s minority shareholders**, by 2024 the same cash is described as being **subject to the approval of the relevant non‑controlling interest shareholders** (i.e., the same Flipkart minority owners but with a more flexible, approval‑based mechanism).  This evolution reflects tighter local legal restrictions but also a shift toward using shareholder‑approval‑driven intercompany financing as the primary route for moving the restricted cash back to the U.S.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the general trend of decreasing restricted cash, properly names Flipkart as the relevant entity, accurately describes the shift from Flipkart-specific minority shareholder approval to broader noncontrolling interest shareholder approval language, and demonstrates sound multi-hop reasoning about the evolution of intercompany financing arrangements. The qualitative analysis about the shift toward shareholder-approval-driven mechanisms is insightful and aligns with the ground truth narrative.\n\nCRITICAL ERRORS - QUANTITATIVE ACCURACY: (1) The LLM states the 2024 amount as \"about $3.5 billion\" but then parenthetically corrects to \"≈$3.3 billion in the 2025 filing.\" The ground truth clearly states $3.3 billion for 2024, making the $3.5 billion figure incorrect. This is a material discrepancy of $200 million. (2) The LLM introduces \"$3.5 billion as of January 31 2024\" without clear justification - this number does not appear in the ground truth and represents a factual error.\n\nMINOR ISSUES: The parenthetical reference to \"the 2025 filing\" is somewhat confusing since the question asks about 2022-2024 evolution. While the LLM may be referencing where the 2024 data appears, this creates ambiguity about which fiscal year the $3.3 billion figure represents.\n\nMULTI-HOP REASONING: The synthesis across years and the identification of the shift in approval mechanisms is sound. The LLM correctly connects the Flipkart minority shareholder approval in 2022 to the broader noncontrolling interest shareholder approval in 2024, demonstrating proper multi-hop reasoning.\n\nSEMANTIC EQUIVALENCE: The core narrative about evolution is preserved, but the quantitative error ($3.5B vs. $3.3B) undermines confidence in the answer's reliability. The ground truth 2022 figure of $4.3 billion is correctly stated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 504,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the U.S. Retiree Health‑Care plan’s asset mix stayed essentially unchanged: roughly 80 % of the portfolio was held in fixed‑income securities and cash equivalents and about 20 % in equity securities. In 2023 the plan held $210 million of fixed‑income assets (≈79.5 % of total $264 million) and $54 million of equities (≈20.5 %); by 2024 the corresponding figures were $198 million of fixed‑income (≈79.8 % of $248 million) and $50 million of equities (≈20.2 %). Thus the allocation remained stable within the plan’s target ranges (75‑85 % fixed income, 15‑25 % equity).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial data that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM reports 2024 figures as $198 million in fixed income and $50 million in equities (totaling $248 million), but the ground truth clearly states both 2023 AND 2024 had identical figures of $210 million fixed income and $54 million equity (totaling $264 million). The LLM's 2024 numbers are completely fabricated and do not match the source data. (2) PERCENTAGE CALCULATIONS: While the LLM's percentages for 2024 ($198M/$248M ≈ 79.8%, $50M/$248M ≈ 20.2%) are mathematically consistent with its incorrect dollar amounts, they are wrong because the underlying dollar amounts are wrong. The ground truth shows 79.5% and 20.5% for both years. (3) CORE FACTUAL ERROR: The LLM fundamentally misrepresents the evolution of assets. The ground truth explicitly states the composition 'remained completely unchanged' with identical figures in both years. The LLM incorrectly claims the figures changed from 2023 to 2024, which is the opposite of what actually occurred. (4) MULTI-HOP REASONING: The LLM failed to correctly synthesize the multi-year comparison. It appears to have either hallucinated the 2024 figures or confused data from different sources. (5) CONTEXTUAL ISSUE: While the LLM correctly identifies the general allocation strategy (roughly 80/20 split) and mentions target ranges, this cannot compensate for the completely incorrect specific numbers. The statement about 'target ranges (75-85% fixed income, 15-25% equity)' may be accurate context, but it does not validate the false dollar amounts. The answer demonstrates a fundamental failure to accurately extract and compare financial data across the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 487,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "\nBetween 2022 and 2024 Honeywell refreshed the awards it grants under the 2006 Stock Plan for Non‑Employee Directors by swapping the 2021‑era option and RSU templates for revised ones that (i) add performance‑based vesting and change‑in‑control acceleration language, (ii) replace the prior cash‑settlement of notional shares with full‑share issuance, and (iii) incorporate updated expiration and holding‑period provisions (see Exhibit 10.52‑10.53 for the 2021 forms and Exhibit 10.55‑10.56 for the 2023‑2024 updates).  This shift toward more performance‑linked, share‑based awards indicates that the company is tightening the link between director compensation and long‑term shareholder value and reducing reliance on simple time‑based options.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and contradicts the ground truth on multiple critical dimensions: (1) EXHIBIT NUMBERS: The LLM cites Exhibits 10.52-10.53 for 2021 forms and 10.55-10.56 for 2023-2024 updates, but the ground truth specifies Exhibit 10.30 (Option Agreement) and 10.32 (Restricted Unit Agreement) in 2022, and Exhibit 10.29 (Option Agreement) in 2024. The exhibit numbers provided by the LLM do not match the ground truth at all. (2) AWARD TYPES: The ground truth indicates that the Restricted Unit Agreement (Exhibit 10.32) was present in 2022 but no longer explicitly mentioned in 2024, suggesting a shift away from restricted units. The LLM claims both option and RSU templates were 'refreshed' and continued, which contradicts the ground truth's finding that restricted units were dropped from the exhibit list. (3) SPECIFIC CHANGES: The LLM describes detailed changes like 'performance-based vesting,' 'change-in-control acceleration,' and 'full-share issuance replacing cash-settlement,' but none of these specific modifications are mentioned in the ground truth. The ground truth makes no mention of performance-based vesting or change-in-control provisions being added. (4) INTERPRETATION: The LLM's conclusion that the company is 'tightening the link between director compensation and long-term shareholder value' and 'reducing reliance on simple time-based options' is not supported by the ground truth, which suggests a move toward emphasizing stock options over restricted units. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the exhibit information across the 2022 and 2024 filings. The ground truth clearly shows a discontinuity (removal of restricted unit agreement), while the LLM incorrectly portrays continuity with updates. This is a fundamental failure in multi-hop reasoning and factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 503,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Walmart’s Flipkart stake was trimmed when the company participated in a $3.2 billion equity funding that cut its ownership from about 83 % to roughly 75 % and generated a large cash inflow, reducing the carrying value of its investment.  Since that transaction the remaining minority stake has been exposed to intensified Indian regulatory scrutiny—including a foreign‑direct‑investment notice, an antitrust probe by the Competition Commission of India and related enforcement actions—creating potential liabilities, possible forced divestiture or operational constraints that could materially affect Walmart’s earnings and cash flow.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $3.2 billion equity funding transaction and the ownership stake reduction from 83% to 75%. The characterization of this as a partial financial exit while maintaining majority control is accurate. The answer appropriately notes regulatory scrutiny and potential liabilities. WEAKNESSES: (1) The LLM states the remaining stake is a 'minority stake' when 75% ownership is actually a substantial majority stake—this is a significant semantic error that mischaracterizes Walmart's position. (2) The answer mentions 'antitrust probe by the Competition Commission of India' which is not explicitly mentioned in the ground truth; while regulatory scrutiny is confirmed, this specific characterization may overstate or misidentify the nature of the regulatory issues. (3) The ground truth specifically mentions a 'show cause notice issued in July 2021' and 'information requests related to alleged violations of India's Foreign Direct Investment rules during 2009-2015'—the LLM generalizes this as 'foreign-direct-investment notice' without the temporal specificity or the pre-acquisition nature of the violations, which is an important contextual detail. (4) The ground truth notes Walmart's 'inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders'—the LLM does not capture this specific disclosure about estimation uncertainty. (5) The phrase 'reduced the carrying value of its investment' is not explicitly confirmed in the ground truth and may be an inference. MULTI-HOP REASONING: The answer does synthesize information across the 2022-2024 period and connects the financial transaction to regulatory exposure, which is appropriate. However, the failure to correctly characterize the 75% stake as a majority (not minority) position undermines the accuracy of the strategic analysis. The answer captures the general evolution from financial participation to managing legacy risks, but with notable inaccuracies in detail and characterization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 546,
        "total_tokens": 1954
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "\nBetween 2022 and 2024 Honeywell’s overall cash pool remained roughly in the low‑teens of billions of dollars, but the **geographic split shifted markedly toward non‑U.S. balances**.  In the 2024 filing the company reports about **$8 billion (≈73 %) of its cash, cash equivalents and short‑term investments held in subsidiaries outside the United States**, leaving only roughly **$3 billion of U.S.–based cash** – down from an estimated $3½–$4 billion of U.S. cash in 2022.  This evolution reflects a strategic emphasis on using the larger overseas cash pool to fund acquisitions, capital‑expenditure programs and share‑repurchase initiatives, while keeping only a modest amount of cash onshore to meet domestic liquidity needs.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the geographic shift in HON's cash composition between 2022 and 2024, correctly identifying the key evolution toward non-U.S. holdings. STRENGTHS: (1) Correctly identifies the $8 billion non-U.S. cash figure for 2024 from ground truth; (2) Accurately calculates the 73% percentage ($8B/$11B); (3) Properly synthesizes the multi-hop information about geographic distribution shift; (4) Correctly identifies the strategic emphasis on using overseas cash for acquisitions, capex, and share repurchases; (5) Appropriately characterizes the overall cash pool as remaining in 'low-teens of billions.' WEAKNESSES: (1) The 2022 baseline is estimated/inferred rather than precisely stated - the ground truth specifies $11.5 billion as of December 31, 2021 (reported in 2022 filing), but the LLM estimates U.S. cash at '$3½–$4 billion' without citing exact figures; (2) The LLM doesn't explicitly mention the 2022 total cash figure ($11.5B) or the 2024 total ($11.0B), instead using 'low-teens' language; (3) Minor imprecision: the LLM states 'roughly $3 billion of U.S.–based cash' but doesn't verify this against the stated $11.0B total minus $8.0B non-U.S., which would equal exactly $3.0B. CALCULATION VERIFICATION: $8.0B / $11.0B = 72.7% ≈ 73% (correct). The multi-hop reasoning is sound - the model correctly synthesized information about total cash, geographic distribution, and strategic emphasis across the 2022-2024 period. The answer addresses all parts of the question regarding composition, strategic emphasis, total holdings, and geographic distribution. The main limitation is the lack of precise 2022 baseline figures, though the directional analysis is accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 469,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "\nThe 2024 filing continues to record Membership‑Rewards expense by establishing a liability equal to the best estimate of future redemption cost, using an actuarially‑derived Ultimate Redemption Rate (URR) and a 12‑month weighted‑average cost‑per‑point (WAC) that is updated each year from actual redemptions and adjusted for known partner‑contract changes.  Compared with 2023, the 2024 methodology refines the URR model—explicitly allocating future payments first to interest and fees before principal—and adds a disclosed sensitivity analysis (≈ $197 million increase for a 25‑basis‑point rise in URR and ≈ $220 million for a 1‑basis‑point rise in WAC), indicating a more granular, statistically‑driven estimation of the liability.  The liability is now presented net of membership‑cancellation reserves within the “Deferred card and other fees, net” line, providing a clearer separation of deferred fees from the rewards obligation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensiveness in addressing the evolution of the Membership Rewards program's financial treatment from 2023 to 2024. QUANTITATIVE ACCURACY (10/10): All numerical values are correct and properly formatted. The sensitivity analysis figures ($197 million for 25 basis point URR increase and $220 million for 1 basis point WAC increase) match the ground truth exactly. The basis point measurements are accurate. QUALITATIVE ACCURACY (9/10): The answer correctly identifies the key methodological evolution: (1) shift from simple deferred fees recognition to a comprehensive, model-driven approach; (2) introduction of Ultimate Redemption Rate (URR) and weighted average cost (WAC) per point as core modeling components; (3) addition of sensitivity analysis disclosures; (4) refinement of the URR model with explicit allocation of future payments to interest/fees before principal. The multi-hop synthesis is sound, connecting 2023 baseline to 2024 enhancements. Minor enhancement: The LLM provides additional context about the liability presentation (net of membership-cancellation reserves within 'Deferred card and other fees, net' line) that adds valuable detail beyond the ground truth, though this is supplementary rather than contradictory. CONTEXTUAL RELEVANCE (9/10): The answer directly addresses all aspects of the question regarding financial treatment evolution, liability estimation methodology, deferred fees, and modeling assumptions. The comparison between years is explicit and clear. The only minor gap is that the ground truth emphasizes the shift from 'simpler mention' to 'comprehensive approach,' while the LLM focuses more on specific technical refinements, though both convey the same essential evolution. ENTITY ACCURACY: All references to the Membership Rewards program, URR, WAC, and fiscal years are correct. The answer properly synthesizes information across the 2023-2024 comparison required by the multi-hop question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 538,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Adobe deepened Frame.io’s role inside its Creative Cloud and Experience Cloud stacks, positioning the platform as the native collaboration layer that ties together video‑centric apps such as Premiere Pro, After Effects and Adobe Express while also feeding into Document Cloud workflows and AI‑driven features like Firefly.  The 2024 filing treats Frame.io’s recurring revenue as part of the Digital Media ARR metric and emphasizes that its integration accelerates subscription growth and reinforces Adobe’s broader strategy of unifying creative, document and customer‑experience tools into a single, subscription‑based ecosystem.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Frame.io from 2022 to 2024, accurately naming key integrated applications (Premiere Pro, After Effects, Photoshop mentioned in ground truth but LLM says 'Adobe Express' instead). The answer correctly notes Frame.io's positioning as a collaboration layer and its inclusion in Digital Media ARR metrics. The semantic understanding of the strategic shift from initial integration to ecosystem incorporation is sound. WEAKNESSES: (1) The LLM answer omits critical details from ground truth: no mention of the $1.18 billion acquisition price, no explicit reference to Workfront integration, and no mention of Adobe GenStudio - a key 2024 positioning element that demonstrates 'deeper strategic alignment.' (2) The LLM substitutes 'Adobe Express' for 'Photoshop' - while Express may be relevant, the ground truth specifically emphasizes Photoshop as a core integrated application. (3) The answer adds information about 'Document Cloud workflows' and 'Firefly' that, while potentially accurate, are not verified against the ground truth and represent potential hallucination or extrapolation beyond the provided knowledge graph. (4) The multi-hop synthesis is incomplete - the answer captures the 2022-to-2024 evolution but misses the GenStudio positioning which is explicitly mentioned in ground truth as a 2024 development. QUANTITATIVE ACCURACY: No major calculation errors, but the omission of the $1.18 billion acquisition figure is a notable gap. QUALITATIVE ACCURACY: The reasoning about ecosystem integration is sound, but the incomplete entity identification (missing GenStudio, Workfront) and potential substitution of applications reduces accuracy. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on strategic positioning and ecosystem alignment, though incompletely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 506,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "\nBetween the end of 2022 and the end of 2023 the amount of equity‑like private‑alternative investments that was classified as Level 3 (i.e., measured using significant unobservable inputs) fell modestly—from **$25.4 million** in the 2022 fair‑value hierarchy to **$25.1 million** in the 2023 hierarchy, a decline of about $0.3 million (roughly 1 %).  At the same time the overall equity‑like fund assets grew (from $4,014.1 million to $4,093.7 million), but the share valued through Level 3 inputs slipped slightly, indicating a modest shift toward more observable‑input pricing for that segment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect numbers that directly contradict the ground truth. CRITICAL ERRORS: (1) The LLM states 2022 Level 3 value was $25.4 million, but ground truth shows it was $5.5 million - this is a 362% overstatement. (2) The LLM states 2023 Level 3 value was $25.1 million, but ground truth shows it was $25.4 million - close but still incorrect. (3) The LLM claims a DECLINE of $0.3 million from 2022 to 2023, but ground truth shows a FIVEFOLD INCREASE from $5.5 million to $25.4 million (an increase of $19.9 million or 362%). This is the opposite direction and magnitude of change. (4) The LLM's conclusion about 'a modest shift toward more observable-input pricing' directly contradicts the ground truth's finding of 'a shift toward more opaque or complex valuation methodologies.' The LLM appears to have reversed the 2022 and 2023 values or confused data from different sources. The reasoning about overall equity-like fund assets growing is not verified against ground truth but is secondary to the core factual errors. The multi-hop synthesis completely failed - the model did not correctly identify which year had which value, resulting in an inverted narrative of the evolution. This is a complete failure to answer the question correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 359,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Adobe moved Frame.io from a newly‑acquired, stand‑alone video‑collaboration platform (acquired in Q4 FY2021 and first reported in the 2022 10‑K as being “integrated into the Digital Media reportable segment”) to a core, tightly‑woven component of its Digital Media portfolio.  The 2022 filing notes the initial integration effort, while the 2024 filing describes deep product‑level integration—Frame.io’s collaboration tools are now embedded directly in flagship Creative Cloud apps (e.g., Premiere Pro, After Effects, Photoshop) and are promoted alongside Creative Cloud and Document Cloud as a key driver of ARR growth and subscription uptake.  This evolution reflects a shift from “adding a new service” to positioning Frame.io as a central hub that enhances the end‑to‑end creative workflow across Adobe’s Digital Media offerings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. QUANTITATIVE ACCURACY: All dates and timeframes are correct—the acquisition timing (Q4 FY2021), the 2022 reporting period, and the 2024 comparison are all accurate. No numerical errors or miscalculations present. ENTITY ACCURACY: All entities are correctly identified—Adobe, Frame.io, Digital Media segment, and the specific Creative Cloud applications (Premiere Pro, After Effects, Photoshop, Lightroom) are all named correctly. The answer also appropriately references Document Cloud and ARR growth metrics. COMPLETENESS: The answer comprehensively addresses the evolution question by contrasting the 2022 state (newly-acquired, stand-alone platform, initial integration) with the 2024 state (core component with deep product-level integration). The answer goes slightly beyond the ground truth by mentioning ARR growth and subscription uptake as drivers, which adds relevant context without contradicting the original answer. MULTI-HOP REASONING: The synthesis is sound—the answer correctly traces the progression from acquisition through initial integration to deep ecosystem embedding. The characterization of the shift from 'adding a new service' to 'central hub' effectively captures the strategic evolution. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth while using slightly different phrasing. The mention of 'Lightroom' in the ground truth and the additional reference to 'GenStudio' in the ground truth are not explicitly mentioned in the LLM answer, but the LLM does mention the key applications (Premiere Pro, After Effects, Photoshop) and captures the essence of deeper integration. The omission of GenStudio is a minor gap but does not significantly detract from the overall accuracy. MINOR CONSIDERATIONS: The LLM answer uses 'fiscal 2022' and 'fiscal 2024' terminology, which is appropriate for SEC filings and adds precision. The answer's emphasis on ARR growth and subscription uptake is a reasonable inference from 10-K language and adds relevant business context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 569,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "\nBetween 2022 and 2024 CVS moved from a largely formulary‑ and utilization‑management‑only approach to a fully digital, AI‑enabled medication‑management ecosystem.  The company added real‑time benefits and “Health Engagement Engine” analytics, the Canopy platform, and point‑of‑care EHR integration that deliver personalized adherence and cost‑saving recommendations, while expanding clinical programs such as Pharmacy Advisor, disease‑specific management, GLP‑1 weight‑management and tighter opioid controls.  These tools are now embedded within broader value‑based and home‑care initiatives (e.g., Signify Health in‑home evaluations, Oak Street Health clinics), creating a more granular, data‑driven strategy to improve adherence and lower drug‑spend.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM introduces several platforms and initiatives NOT mentioned in the ground truth: 'Health Engagement Engine' analytics, 'Canopy platform', and 'Signify Health in-home evaluations' are not referenced in the original answer. These appear to be fabricated or confused with other companies' offerings. (2) MISSING KEY FACTS - The LLM fails to mention several important 2022-2024 developments from ground truth: NovoLogix preauthorization platform (explicitly mentioned in original), the National Pharmacy and Therapeutics Committee's formulary management approach, mail order and specialty pharmacies, and the specific detail about Oak Street Health operating 239 primary care centers across 27 states. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies the shift from cost-containment to integrated digital/clinical approach, it misses the CVS Weight Management program with GLP-1 medication optimization and lifestyle coaching mentioned in ground truth. The reference to 'GLP-1 weight-management' is vague and lacks the program name. (4) UNVERIFIED CLAIMS - 'Pharmacy Advisor' and 'point-of-care EHR integration' are mentioned but not found in the ground truth, raising concerns about hallucination. (5) QUANTITATIVE ACCURACY - No specific numbers are provided in either answer, but the LLM's introduction of unverified platforms and initiatives significantly undermines credibility. (6) MULTI-HOP REASONING - The LLM attempts to synthesize the evolution but does so by introducing elements not in the source material, which is a critical failure in knowledge graph-based evaluation. The core narrative of evolution is present but contaminated with inaccurate details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 471,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Adobe moved Frame.io from a recent acquisition into the central collaboration layer of Creative Cloud, first embedding its review‑and‑approval workflow directly into Premiere Pro and After Effects and then broadening that integration across the suite.  During this period Adobe added native, frame‑accurate commenting, “Camera‑to‑Cloud” automatic upload, browser‑based editing, and tighter links to Creative Cloud Express, Adobe Firefly and the Document Cloud AI services, giving users real‑time, cross‑app collaboration, AI‑enhanced content‑credential tracking, and a unified workflow that positions Frame.io as the collaborative backbone of Creative Cloud.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 2022-2024 timeframe and Adobe's strategic shift of Frame.io from a recent acquisition to a central collaboration layer; (2) Accurately mentions key integrations into Premiere Pro and After Effects as initial focus; (3) Correctly identifies Camera-to-Cloud functionality as a specific enhancement; (4) Properly synthesizes the evolution from video-specific to broader creative asset collaboration; (5) Accurately references integration with Creative Cloud Express, Adobe Firefly, and Document Cloud AI services; (6) Correctly characterizes Frame.io as the 'collaborative backbone' of Creative Cloud. MINOR GAPS: (1) The LLM answer does not explicitly mention expansion to Photoshop, Lightroom, and Workfront as stated in the ground truth - these are notable omissions for completeness; (2) Does not specifically mention still images, design files, and PDFs as expanded file types supported; (3) Mentions 'browser-based editing' which is not explicitly in the ground truth and may be an inference or addition. QUANTITATIVE ACCURACY: No numeric errors detected; dates and timeframes are correct. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is well-executed, connecting acquisition through integration phases to strategic positioning. The characterization of the evolution is semantically equivalent to the ground truth. CONTEXTUAL RELEVANCE: Highly relevant and directly addresses the question about integration evolution and specific enhancements. The answer appropriately emphasizes the strategic shift and provides concrete examples of enhancements. The omission of specific application integrations (Photoshop, Lightroom, Workfront) prevents a perfect score, as these represent material enhancements during the 2022-2024 period that should have been included for full completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 523,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "\nFrom 2023 to 2024 the Firm continued to use prices of recently executed transactions—such as comparable‑bond or loan trades—as a key observable input for fair‑value measurement of loans and other assets, classifying those inputs as Level 2 when market prices are unavailable and as Level 3 when the inputs become unobservable.  The 2024 disclosures note that no material revisions were made to this approach, indicating that the methodology for incorporating recent market trades into fair‑value estimates remained essentially unchanged.  Consequently, the role of those transaction‑derived prices in determining fair value was stable, serving both to supplement quoted market prices and to provide the basis for valuation adjustments (e.g., credit‑spread, prepayment, and discount‑rate inputs) across the loan and securities portfolios.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant deviations from the ground truth regarding the evolution of recently executed transactions' role in valuation from 2023 to 2024. Key issues: (1) The ground truth explicitly states that in 2024, recently executed transactions became 'more specifically tied to the held-for-sale category of loans and lending commitments' and 'extended to the valuation of other assets such as other investments' - representing a meaningful evolution. The LLM answer claims the methodology 'remained essentially unchanged' and that 'no material revisions were made,' which directly contradicts the ground truth's description of a more targeted and extended application. (2) The ground truth identifies specific 2024 developments: application to held-for-sale loans, extension to other investments, and use with discounted cash flow models and comparable company multiples. The LLM answer generalizes about Level 2/Level 3 classifications and mentions credit-spread adjustments but fails to capture these specific 2024 evolutions. (3) The LLM's claim of stability ('remained essentially unchanged') is factually incorrect - the ground truth describes an evolution toward more targeted application and extension to additional asset classes. (4) The LLM answer does address the 2023-2024 timeframe and discusses recently executed transactions, but fundamentally mischaracterizes the nature of change (claiming stability rather than evolution). (5) The multi-hop reasoning fails because the LLM did not properly synthesize the differences between 2023 and 2024 practices as described in the ground truth. The answer reads as a general description of transaction-based valuation practices rather than a comparison showing how the role evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 477,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "\nBetween 2022 and 2024 Adobe reframed Substance 3D Stager from a stand‑alone desktop app for assembling 3‑D scenes into the central, cloud‑connected hub of its Substance 3D ecosystem.  The 2024 disclosures stress that Stager now works natively with the other Substance 3D tools (Painter, Designer, Sampler, Modeler) and with Creative Cloud, offering cross‑device, AI‑enhanced workflows that tie 3‑D content creation to Adobe’s broader digital‑experience and generative‑AI (Firefly) platform.  Consequently, Stager is positioned not just as a scene‑building utility but as the integrated staging layer that links asset creation, collaboration and delivery across Adobe’s Creative Cloud and Experience Cloud offerings.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces substantial factual claims that are NOT supported by the ground truth and appear to be hallucinated. Specifically: (1) The ground truth makes NO mention of Stager being reframed as a 'cloud-connected hub' or 'central hub' - this is fabricated. (2) The ground truth does NOT state that Stager works 'natively' with other tools or that it is 'the integrated staging layer' - these are unsupported claims. (3) The ground truth contains NO reference to AI-enhanced workflows, Firefly integration, cross-device functionality, or connections to Experience Cloud - all of these are invented details not in the source material. (4) The LLM conflates positioning within an ecosystem (what the ground truth actually says) with a much more expansive and specific technical/architectural role that is not documented. WHAT WAS CORRECT: The LLM correctly identifies the core products in the Substance 3D ecosystem (Painter, Designer, Sampler, Modeler) and correctly notes the 2022-2024 timeframe. The general concept of evolution from standalone to ecosystem integration is directionally aligned with the ground truth. REASONING FAILURE: This is a multi-hop synthesis question requiring careful extraction from SEC filings. The LLM appears to have generated plausible-sounding but unverified technical details rather than strictly adhering to what the ground truth documents actually state. The answer reads like informed speculation about product strategy rather than factual reporting of what the filings disclose. The ground truth is deliberately cautious ('without detailed information about its functionality') while the LLM provides highly specific technical claims. This represents a fundamental failure in the evaluation task - the LLM should have stayed within documented facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 493,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "\nFrom 2022 to 2023 GE moved grid‑scale batteries from a peripheral, “emerging‑technology” opportunity in its renewable‑energy portfolio to a core strategic pillar of the newly created GE Vernova energy business.  In the 2022 filing the company described battery storage only as a potential growth area with modest near‑term commercial traction, but by 2023 the separation plan positioned large‑scale storage as essential to the decarbonization roadmap of the spun‑off energy unit, indicating a much higher level of strategic reliance and a commitment of capital and resources to develop and commercialize grid‑scale battery projects.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported claims not present in the ground truth. Key issues: (1) MAJOR ERROR - The LLM introduces 'GE Vernova' as a newly created energy business and claims grid-scale batteries were positioned as 'essential to the decarbonization roadmap of the spun-off energy unit.' The ground truth makes no mention of GE Vernova, a spinoff, or any separation plan. This appears to be a hallucination or conflation with actual GE Vernova history not supported by the 10-K filings being evaluated. (2) MISCHARACTERIZATION - The LLM describes the 2022 positioning as 'peripheral' and 'emerging-technology opportunity' with 'modest near-term commercial traction,' but the ground truth simply states GE mentioned batteries as part of emerging technologies that 'may become more important over time' - not necessarily peripheral. (3) INCOMPLETE SYNTHESIS - While the LLM correctly identifies an evolution from 2022 to 2023, it overstates the magnitude and introduces unsupported details about capital commitments and commercialization efforts. (4) MISSING CORE INSIGHT - The ground truth emphasizes the shift from 'speculative investment' to 'dependency' language ('depend in part on'), which the LLM fails to capture accurately. (5) ENTITY ERROR - The introduction of GE Vernova as a distinct entity in the narrative is not supported by the ground truth provided. The answer demonstrates reasonable understanding of the general trend (increasing strategic importance) but fundamentally misrepresents the specific nature and context of GE's positioning by introducing unsupported claims about business structure changes and capital allocation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 462,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "\nBetween 2022 and 2024 CVS consistently reports that it does **not** use broker‑quoted prices for any debt securities that fall under Level 3 of its fair‑value hierarchy—​the 2022 filing notes “no broker‑quoted debt securities” for 2021‑2020, and the 2024 filing repeats the same statement for 2024‑2023. As a result, broker‑quoted debt securities have remained absent from its fair‑value measurements, and they have had no discernible impact on its financial reporting during this period.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core factual finding: CVS had no broker-quoted debt securities in both 2022 and 2024 filings, covering the years 2021-2020 and 2024-2023 respectively. The numeric/date information is accurate and properly formatted. The answer correctly synthesizes the multi-hop information showing consistency across the two filing years. However, the LLM answer has a notable omission: it fails to mention that the 2024 disclosure 'no longer mentions any negative impact or specific review process related to broker quoted debt securities,' which the ground truth identifies as a key evolution—'suggesting a reduced emphasis or relevance of this topic.' The ground truth emphasizes this shift in disclosure emphasis over time as an important aspect of how the disclosure 'evolved,' while the LLM answer only notes the consistent absence without capturing this qualitative change in how the topic is presented. The LLM's statement that broker-quoted securities 'have had no discernible impact on its financial reporting' is accurate but doesn't fully capture the nuance that the company's treatment of this disclosure topic itself changed between filings. The answer is factually sound on the primary claim but incomplete in addressing the full scope of the 'evolution' requested in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 369,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "\nBetween 2023 and 2024 the “Equity securities / mutual funds” line in BlackRock’s FVTNI portfolio expanded sharply – fair‑value holdings rose from **$1.585 bn to $1.950 bn** (an increase of roughly **$0.365 bn or 23 %**).  By contrast, the aggregate “Equity‑method” investment balance grew only modestly, moving from **about $2.756 bn to $2.783 bn** (a gain of roughly **$27 m**).  Thus, the composition shifted toward a larger share of publicly‑traded equity securities/mutual funds, while equity‑method investments remained essentially flat.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains significant factual errors in the core numbers that are fundamental to answering this question. (1) EQUITY SECURITIES/MUTUAL FUNDS: Ground truth shows $1,211M (2023) → $1,950M (2024). LLM states $1,585B (2023) → $1,950B (2024). The 2023 figure is completely wrong ($1,585M vs $1,211M = 31% overstatement). The 2024 figure matches ground truth ($1,950M), but the 2023 baseline is incorrect, making the calculated change of $365M wrong (should be $739M). (2) EQUITY METHOD INVESTMENTS: Ground truth shows $1,895M (2023) → $2,783M (2024). LLM states $2,756B (2023) → $2,783B (2024). The 2023 figure is significantly wrong ($2,756M vs $1,895M = 45% overstatement). The 2024 figure matches ground truth ($2,783M), but the 2023 baseline is incorrect, making the calculated change of $27M wrong (should be $888M). (3) CALCULATION ERRORS: The LLM's percentage calculation of 23% for equity securities is based on incorrect 2023 baseline. The characterization of equity-method investments as 'essentially flat' is misleading given the actual $888M increase (47% growth). (4) MULTI-HOP REASONING: While the LLM correctly identifies the two categories and attempts year-over-year comparison, the fundamental data errors undermine the entire analysis. The conclusion about composition shift is based on faulty numbers. (5) POSITIVE ASPECTS: The LLM correctly identifies the two investment categories, attempts proper comparison structure, and provides percentage calculations. The format and presentation are clear. However, these strengths cannot overcome the severe quantitative inaccuracies in the core financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 456,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "\nUnitedHealth Group’s review of credit‑related impairments for its available‑for‑sale debt securities showed essentially the same approach in 2022 and 2024: it evaluates each security’s expected cash‑flows and credit ratings and determines that the unrealized losses are driven by market‑interest‑rate movements rather than any deterioration in issuer credit quality. Consequently, the company continued to carry **no material allowance for credit losses** on those securities, indicating that its methodology and conclusion about credit‑related impairments remained stable across the 2022‑2024 period.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant omissions and misses a key evolution described in the ground truth. Strengths: (1) Correctly identifies that unrealized losses were driven by interest rate increases rather than credit deterioration in both periods, (2) Accurately notes the company's evaluation methodology (expected cash flows, credit ratings), (3) Correctly states 'no material allowance for credit losses' for 2022. Critical weaknesses: (1) The answer claims the approach remained 'essentially the same' and 'stable across the 2022-2024 period,' which directly contradicts the ground truth's explicit statement of an 'evolution' and 'shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.' (2) Fails to capture the key 2024 development: the allowance for credit losses is now 'explicitly described as being recorded as a separate component through an allowance account' - a material change in accounting treatment and formalization. (3) Misses the important detail that credit-related impairments now impact 'investment and other income,' indicating a more structured recognition framework. (4) The answer's conclusion that methodology and conclusions 'remained stable' is factually incorrect based on the ground truth's description of structural changes in how impairments are recognized and recorded. The LLM essentially flattened a nuanced evolution into a static narrative, missing the core insight that while the underlying credit assessment remained consistent, the accounting formalization and recognition mechanisms changed materially from 2022 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 442,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2023 AMD’s equity investment in the ATMP joint venture grew from roughly **$69 million to $99 million**, driven by a jump in purchases of ATMP‑produced inventory (from $1.1 bn to $1.7 bn) and larger balances of payables and receivables.  As a result of this larger stake, the equity‑method income recognized in “Equity income in investee” increased from **$6 million in 2022 to $16 million in 2023**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ERRORS IN KEY FINANCIAL FIGURES: The LLM answer contains significant factual inaccuracies in the primary metrics requested. (1) INVESTMENT CARRYING VALUE - Ground truth shows 2022: $83M → 2023: $99M. LLM states 2022: ~$69M → 2023: $99M. The 2022 figure is incorrect ($69M vs $83M), representing a 17% error on a key metric. (2) EQUITY INCOME - Ground truth shows 2022: $14M → 2023: $16M. LLM states 2022: $6M → 2023: $16M. The 2022 equity income figure is significantly wrong ($6M vs $14M), representing a 57% understatement of the actual equity income. This is a critical error as equity income is explicitly mentioned in the question. (3) ADDITIONAL INFORMATION - The LLM introduces inventory purchase figures ($1.1B to $1.7B) and payables/receivables that are not in the ground truth answer. While this additional context might be from the filings, it was not part of the original answer and represents a different analytical focus. (4) MULTI-HOP REASONING - The LLM attempts to explain the relationship between inventory purchases and equity income growth, showing some reasoning effort, but this explanation is undermined by the incorrect base numbers. (5) SEMANTIC ISSUES - The LLM correctly identifies the ATMP JV and AMD, and correctly notes the direction of change (growth), but the magnitude of errors in the core financial metrics is unacceptable for a financial analysis question where precision is critical. The answer demonstrates partial understanding of the relationship but fails on the fundamental requirement of accurate financial reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 430,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 UnitedHealth Group’s exposure to tort claims remained anchored in medical‑malpractice and other liability claims arising from the services of its affiliated physicians, hospitals and health‑care providers, but the filing notes that the volume of such claims and the size of potential settlements have increased.  The company continues to self‑insure these risks and records reserves for estimated losses, yet it acknowledges that actual costs could substantially exceed those estimates, potentially materially affecting its results of operations, financial position and cash flows.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies that UnitedHealth Group's tort exposure involves medical malpractice and liability claims from affiliated physicians, hospitals, and healthcare providers. It accurately notes the company self-insures these risks, records reserves, and acknowledges actual costs could exceed estimates. The timeframe (2022-2024) is correctly referenced. No specific numbers are provided, so quantitative accuracy is preserved by avoiding false claims.\n\nWEAKNESSES: The LLM answer significantly fails to capture the evolution and shift in exposure nature between 2022 and 2024 that the ground truth emphasizes. Specifically:\n\n1. MISSING KEY EVOLUTION: The ground truth highlights a critical shift from 2022's focus on self-insured medical malpractice liabilities and new theories of liability (potentially uncapped damages) to 2024's broader focus on clinical quality, patient safety standards, and reputational harm. The LLM only mentions increased volume and settlement sizes without capturing this qualitative shift in risk profile.\n\n2. INCOMPLETE CHARACTERIZATION: The ground truth notes 2022 emphasized 'new theories of liability that might not be subject to damage caps' - a significant legal risk factor. The LLM completely omits this important distinction.\n\n3. MISSING SYSTEMIC RISK DIMENSION: The ground truth emphasizes that 2024 shows a 'broader and more systemic risk profile' including reputational harm and adverse effects on business relationships. The LLM answer does not address this evolution toward systemic risk.\n\n4. VAGUE ON CHANGES: The LLM states claims and settlements 'have increased' but provides no specificity about how the nature of claims evolved, which was the core of the question asking about 'nature of the claims' evolution.\n\nMULTI-HOP REASONING: The LLM fails to synthesize the comparative analysis across the two years. It presents a static view of tort exposure rather than demonstrating how it evolved from 2022 to 2024.\n\nSEMANTIC EQUIVALENCE: While the LLM's statements are not factually wrong, they are incomplete and miss the essential narrative of how UnitedHealth's tort risk profile shifted from narrowly-defined medical malpractice exposure to broader healthcare delivery and reputational risks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 608,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "\nBetween 2023 and 2024 Boeing replaced its expiring $3.2 bn five‑year revolving facility (which was set to end in October 2024) with a new $4.0 bn five‑year line (maturing May 2029), while retaining its $3.0 bn three‑year revolving agreement (due August 2025) and a $3.0 bn five‑year line (due August 2028).  This increased the total revolving‑credit commitment from roughly $6 bn in 2023 to about $10 bn in 2024, leaving approximately $10 bn of unused borrowing capacity.  The expansion reflects Boeing’s intent to broaden and strengthen its liquidity back‑stop, reducing reliance on cash‑flow from operations and providing greater flexibility to meet financing needs.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states Boeing replaced a '$3.2 bn five-year revolving facility' expiring in October 2024, but the ground truth makes no mention of a $3.2B facility or October 2024 expiration. The ground truth clearly states the legacy agreement was a THREE-year facility (not five-year) with $3.0B (not $3.2B) expiring in August 2025 (not October 2024). (2) FACILITY MISIDENTIFICATION: The LLM claims Boeing retained a '$3.0 bn five-year line (due August 2028)' but the ground truth only mentions the $3.0B three-year agreement expiring August 2025. There is no mention of a separate $3.0B five-year facility in the ground truth. (3) TOTAL CAPACITY CALCULATION: The LLM calculates total commitments as 'roughly $6 bn in 2023 to about $10 bn in 2024,' but this is based on incorrect facility data. The ground truth indicates the 2023 legacy agreement was $3.0B, and in 2024 a new $4.0B facility was added while terminating two other facilities (not retaining them). (4) UNUSED CAPACITY CLAIM: The LLM states 'approximately $10 bn of unused borrowing capacity' but provides no basis for this calculation in the ground truth. (5) CORE NARRATIVE ERROR: The LLM fundamentally mischaracterizes the evolution. The ground truth indicates Boeing entered a NEW $4.0B five-year agreement (May 2029) while TERMINATING two other facilities, not retaining multiple facilities as the LLM suggests. The LLM's description of retaining a $3.0B five-year line is not supported by the ground truth. (6) STRATEGIC INTERPRETATION: While the LLM's interpretation about liquidity enhancement is directionally reasonable, it is based on incorrect facility details and calculations. The ground truth emphasizes extending maturity timelines and enhancing capacity through the new agreement, which the LLM partially captures but with wrong numbers and facility descriptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 531,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "\nBetween 2023 and 2024 the 2017 performance‑based options saw a modest decline in the fair‑value of the portions that vested—$56 million in 2023 versus $52 million in 2024—while the intrinsic value realized on exercised options rose sharply, from $44 million in 2023 to $373 million in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All quantitative data is correct: fair value of vested options in 2023 ($56M) and 2024 ($52M), and intrinsic value of exercised options in 2023 ($44M) and 2024 ($373M). The multi-hop synthesis is sound, correctly comparing the evolution of both metrics across the two-year period. The answer accurately characterizes the trends: a modest decline in fair value of vested options (from $56M to $52M, approximately 7% decrease) and a sharp increase in intrinsic value of exercised options (from $44M to $373M, approximately 748% increase). The reasoning is logical and the conclusion appropriately captures the contrasting trends. The only minor distinction from the ground truth is stylistic wording—the LLM uses 'portions that vested' and 'realized on exercised options' versus the ground truth's 'that vested' and 'of options exercised'—but these are semantically equivalent and represent appropriate professional phrasing. The answer fully addresses all components of the multi-part question regarding the financial impact evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 319,
        "total_tokens": 1535
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "\nBetween 2022 and 2023 AMD moved from a broad, historical‑average estimate of return‑right adjustments to a more granular, data‑driven model.  In 2023 it explicitly uses trended, actual quarterly return‑rate data, adjusts those rates for known supply‑chain or economic events, and separately quantifies OEM versus distributor returns, allowing discretionary overrides when contractual percentages are exceeded.  This refined approach adds forward‑looking market data and a clearer distinction between baseline contractual limits and event‑specific adjustments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces details not supported by the ground truth. Key issues: (1) The ground truth states AMD used 'trended actual historical product return rate information' in 2022, but the LLM claims 2022 used 'broad, historical-average estimates' - this is a mischaracterization of the baseline approach. (2) The LLM introduces specific details not in the ground truth: 'quarterly return-rate data,' 'supply-chain or economic events,' 'OEM versus distributor returns,' and 'discretionary overrides when contractual percentages are exceeded' - these granular distinctions are not mentioned in the original answer and appear to be fabricated. (3) The ground truth emphasizes the 2023 change as placing 'additional emphasis on rights of return and rebates' under ASC 606-10-32-8 through 14, using the 'most likely amount' standard - the LLM completely omits this specific accounting standard reference and the 'most likely amount' methodology. (4) The LLM's claim about 'forward-looking market data' is not supported by the ground truth, which focuses on historical data adjusted for known events. (5) The LLM fails to capture the key evolution: from general historical adjustments to a more structured, standards-aligned approach with explicit ASC 606 compliance. The answer demonstrates poor multi-hop synthesis and introduces unsupported details that contradict the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 405,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "\nThe 2017 performance‑based options fell sharply – from **1,549,080 shares outstanding at 31 Dec 2023** to **625,825 shares outstanding at 31 Dec 2024**.  The reduction of roughly **923 k shares** is almost entirely due to **exercises of about 905 k options** (with only ~18 k shares forfeited), showing that the performance hurdles were satisfied, the options became in‑the‑money, and were largely converted into common stock rather than being left to expire.  This reflects a strong exercise trend and a low forfeiture rate for the 2017 performance‑based options.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key numbers are correct: 1,549,080 shares at end of 2023, 625,825 shares at end of 2024, 905,219 shares exercised, and 18,036 shares forfeited. The calculation of the reduction (approximately 923k shares) is accurate and properly attributed to exercises and forfeitures. The LLM correctly identifies the multi-hop synthesis: comparing the two years, identifying the components of change (exercises vs. forfeitures), and drawing appropriate conclusions about exercise trends and forfeiture rates. The reasoning is sound - the LLM explains that the sharp decline reflects strong exercise activity with minimal forfeitures, indicating the options were in-the-money and performance hurdles were satisfied. The answer addresses all parts of the question: (1) how the number evolved (decreased from 1.55M to 626k), (2) what this indicates about exercise trends (strong exercise of ~905k), and (3) forfeiture trends (low at ~18k). The only minor distinction from the ground truth is that the LLM uses slightly different phrasing ('roughly 923k shares' vs. the exact calculation of 1,549,080 - 625,825 - 905,219 - 18,036 = 0, though the net reduction is indeed ~923k), but this is a reasonable approximation and doesn't affect accuracy. The contextual interpretation about performance hurdles and in-the-money status adds valuable insight consistent with the data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 392,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "\nBetween 2022 and 2024 Optum Rx expanded the breadth of its pharmacy‑care platform—from a focus on retail and specialty drug management to a full‑service model that now includes infusion services, rare‑disease and gene‑therapy support, behavioral‑health integration, and pharmacist‑led, whole‑patient care.  During the same period the volume of pharmaceutical spend it manages grew sharply (from about $112 billion to $178 billion total, with specialty spend rising from $45 billion to $74 billion), underscoring its scale.  This evolution positions Rx as a core, data‑driven hub that links pharmacy, medical and behavioral health within UnitedHealth Group’s end‑to‑end ecosystem, enabling UnitedHealthcare and other payers to coordinate care, control costs and improve outcomes.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) QUANTITATIVE ACCURACY - MAJOR FAILURE: The LLM claims pharmaceutical spending managed by Optum Rx grew from $112 billion (2022) to $178 billion (2024), and specialty spending from $45 billion to $74 billion. However, the ground truth explicitly states 'While specific spending figures were not provided in 2024' - meaning the 2024 figures of $178 billion and $74 billion are FABRICATED and not supported by the source documents. The 2022 figures ($112 billion total, $45 billion specialty) are correct, but the 2024 figures are entirely invented. (2) QUALITATIVE ACCURACY - PARTIAL ISSUES: The LLM correctly identifies service expansion areas (infusion services, specialty/rare disease support) that align with ground truth. However, it introduces unsupported claims about 'behavioral-health integration' and 'gene-therapy support' that are not mentioned in the ground truth. The characterization of Optum Rx as a 'data-driven hub' aligns with the 2024 positioning language. (3) MULTI-HOP REASONING: The LLM attempts to synthesize evolution across 2022-2024 but fails by inventing data points. The ground truth acknowledges that 2024 data lacks specific spending figures, yet the LLM confidently provides precise numbers. (4) SEMANTIC EQUIVALENCE: While the general narrative of evolution and integration is reasonable, the fabrication of specific financial metrics is a fundamental breach of factual accuracy. The ground truth's cautious statement about missing 2024 figures is directly contradicted by the LLM's specific claims. This is not a wording difference but a factual hallucination.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 467,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "\nBetween 2023 and 2024 the fair‑value carrying amount of BlackRock’s Equity Securities at FVTNI rose sharply—from **$1.585 billion to $1.950 billion**—driven by higher market prices and additional purchases.  The slice of that portfolio that is dedicated to **deferred cash‑compensation plans** stayed relatively small: the filings list **$14 million** of the FVTNI equity as being held for those plans (with a similar $9 million held in “other investments”), a figure that is unchanged from the 2023 disclosure.  Consequently, while the overall FVTNI equity position grew by roughly $365 million, the composition of the deferred‑compensation‑related holdings remained proportionally constant, consisting of about $14 million in FVTNI equity and $9 million in other investments within the broader $241 million equity‑method allocation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM states $14 million was held in FVTNI equity for deferred compensation plans in both 2023 and 2024, claiming this was 'unchanged from the 2023 disclosure.' However, the ground truth clearly shows $9 million in 2023 and a reclassification to $173 million in 2024 under a different category (Equity Method section). The LLM's figure of $14 million does not match either year's actual value. (2) MISIDENTIFICATION OF RECLASSIFICATION: The ground truth indicates a critical reclassification where the $9 million from 2023 was moved from 'Equity Securities at FVTNI' to 'Investments related to deferred cash compensation plans' under the Equity Method section with a new valuation of $173 million. The LLM completely misses this reclassification and instead claims the amount remained 'unchanged' at $14 million. (3) MISSING KEY INSIGHT: The LLM fails to identify the fundamental change in how these investments were categorized and reported—moving from FVTNI to Equity Method—which is the core of the ground truth answer. (4) INCORRECT COMPOSITION ANALYSIS: The LLM's discussion of composition ($14 million FVTNI + $9 million other investments) does not align with the ground truth's explanation of the reclassification. (5) OVERALL EQUITY SECURITIES FIGURES: While the LLM provides broader FVTNI equity figures ($1.585B to $1.950B), these are not directly contradicted by the ground truth but are not the focus of the question about deferred compensation plan investments. The answer demonstrates a fundamental misunderstanding of the specific reclassification that occurred and provides incorrect dollar amounts for the deferred compensation holdings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 483,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "\nThe open‑market share‑purchase authorization fell from **$3.13 billion as of August 31 2022** to **$2.69 billion as of August 31 2024**, a reduction of roughly **$435 million (≈14 %)**.  This decline shows that Accenture has either used up a portion of its previously authorized repurchase capacity or deliberately scaled back the program, indicating a shift toward conserving cash and focusing capital on other priorities such as dividend growth and strategic investments rather than aggressive share‑buybacks.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the question and provides relevant capital allocation insights. STRENGTHS: (1) Correctly identifies the directional change (decrease) in authorization; (2) Properly dates the periods as August 31, 2022 and August 31, 2024; (3) Provides sound qualitative analysis about capital allocation strategy shift; (4) Offers reasonable interpretation about cash conservation and strategic priorities. QUANTITATIVE ISSUES: The ground truth shows the authorization decreased from $3,129,296 to $2,694,281 (in thousands, based on typical SEC filing format), which equals approximately $3.129 billion to $2.694 billion. The LLM rounds these to $3.13 billion and $2.69 billion, which is acceptable formatting. However, the calculated reduction is stated as 'roughly $435 million (≈14%)'. Verification: $3,129,296 - $2,694,281 = $435,015 thousand = $435.015 million ✓ (correct). Percentage: ($435,015 / $3,129,296) × 100 = 13.9% ≈ 14% ✓ (correct). QUALITATIVE ASSESSMENT: The reasoning about what the decline indicates is sound and goes beyond the ground truth answer by providing additional context about dividend growth and strategic investments. The multi-hop synthesis is appropriate - connecting the numerical change to broader capital allocation strategy. MINOR DEDUCTION: The ground truth answer is more concise and conservative in its interpretation, while the LLM adds speculative elements ('either used up...or deliberately scaled back'). This is reasonable inference but slightly beyond what can be definitively concluded from the numbers alone. Overall, the answer is factually accurate with proper calculations and strong contextual reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 462,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 the disclosure moved from a brief structural note that Accenture Canada Holdings Inc. exchangeable shares could be exchanged one‑for‑one for Class A ordinary shares (and might be redeemed) to a detailed, quantitative shareholder‑rights description.  The 2024 filing spells out a $2.69 bn repurchase authorisation (later raised to $6.69 bn), reports actual purchases of 47,752 exchangeable shares ( $15.3 m ) during the year, and explicitly states that holders may exchange the shares for cash or Class A stock, receive the same distributions as ordinary shareholders, and that the Board may suspend or accelerate the program at any time—showing a clear evolution toward transparent, rights‑focused repurchase activity.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states '$2.69 bn repurchase authorisation (later raised to $6.69 bn)' which is INCORRECT. The ground truth specifies a 'remaining authorization of $2,694,281' (approximately $2.7 million, not $2.69 billion). This is a massive numerical error - off by a factor of 1,000. The LLM also introduces '$6.69 bn' with no support in the ground truth. (2) UNSUPPORTED CLAIMS - The LLM provides specific details about '47,752 exchangeable shares ($15.3 m) during the year' and claims about cash/stock exchange options and Board suspension rights that are NOT mentioned in the ground truth. These appear to be fabricated or hallucinated details. (3) PARTIAL CORRECTNESS - The LLM correctly identifies the evolution from brief structural notes to more detailed disclosures and correctly mentions the one-for-one exchangeability for Class A ordinary shares. (4) MULTI-HOP REASONING - While the LLM attempts to synthesize 2022 vs 2024 evolution, it does so with fundamentally incorrect numbers and unsupported claims. (5) MISSING ELEMENTS - The LLM fails to mention the company's commitment to align Class X ordinary shares with outstanding exchangeable shares, which is explicitly noted in the ground truth. The core narrative about evolution toward transparency is partially correct, but the specific quantitative claims are severely flawed, making this answer unreliable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 399,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "\nThe Electrophysiology Devices segment generated about **$2.195 billion in 2023**, which rose to **$2.467 billion in 2024**.  Excluding the effect of foreign‑exchange movements, this increase corresponds to a **14.4 % growth** in global revenue over the two‑year period.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is substantially correct with minor issues. CORRECT ELEMENTS: (1) 2023 revenue of $2.195 billion ($2,195 million) - correctly stated; (2) 2024 revenue of $2.467 billion ($2,467 million) - correctly stated; (3) FX-adjusted growth rate of 14.4% - correctly identified; (4) Number format variations ($2.195 billion vs $2,195 million) are acceptable and semantically equivalent. ISSUES: (1) The LLM states this is a 'two-year period' which is technically correct but slightly awkward phrasing for comparing 2023 to 2024 (typically described as year-over-year or between two consecutive years); (2) The LLM OMITS the total reported change of 12.3% (including FX impact), which was explicitly mentioned in the ground truth. The question asks 'how did revenue evolve' AND 'what was the percentage change excluding FX impact' - implying both metrics should be addressed. The LLM only provides the FX-adjusted figure (14.4%) but not the reported change (12.3%), which represents an incomplete answer to the multi-part question. QUANTITATIVE VERIFICATION: $2,467M - $2,195M = $272M increase; $272M / $2,195M = 12.39% ≈ 12.3% (reported change); 14.4% FX-adjusted growth is correctly stated. The LLM's numbers are accurate, but the answer is incomplete because it fails to address the total percentage change component of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1140,
        "completion_tokens": 373,
        "total_tokens": 1514
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "\nAccenture has maintained a roughly 16 % equity stake in Duck Creek Technologies and continues to account for it under the equity‑method; the investment’s carrying amount grew modestly from $138.9 million as of August 31 2022 (reported in the 2022 10‑K) to about the same level in the 2024 filing, while its estimated fair value rose to roughly $223 million.  A $253 million gain from the investment was recorded in fiscal 2023, boosting adjusted earnings‑per‑share, but thereafter the investment’s earnings are reflected only in “other income (expense), net,” so its contribution to overall operating performance remains limited.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical discrepancies and reversed/confused values compared to the ground truth. (1) CRITICAL NUMBER ERRORS: The LLM states the carrying amount was '$138.9 million as of August 31 2022' but the ground truth shows the investment was valued at '$223,166' (approximately $223 thousand, not million) in fiscal 2022. This is a massive error - off by a factor of ~600x. The LLM also states fair value 'rose to roughly $223 million' which appears to confuse the fiscal 2022 valuation ($223,166 thousand = ~$223 million) with a later period valuation. (2) TIMING ERROR: The LLM claims 'A $253 million gain from the investment was recorded in fiscal 2023' but the ground truth indicates this gain was recorded in fiscal 2024, not 2023. This is a critical one-year misplacement. (3) INCOMPLETE SYNTHESIS: The LLM correctly identifies the ~16% ownership stake and equity method accounting, but fails to properly synthesize the evolution of the investment's value between the two fiscal years. The ground truth emphasizes both 'quantitative increase in the investment's value' and 'qualitative change in its impact on Accenture's earnings' - the LLM partially addresses this but with wrong numbers and wrong timing. (4) CONTRADICTORY STATEMENTS: The LLM states carrying amount 'grew modestly from $138.9 million...to about the same level' which is internally contradictory (grew but stayed the same). (5) MISSING CONTEXT: The LLM mentions the gain 'boosted adjusted earnings-per-share' but doesn't clearly establish the fiscal 2024 timing of the $253 million gain as stated in ground truth. The answer demonstrates partial understanding of the relationship but with fundamental numerical errors that undermine credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 481,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "\nBetween 2022 and 2023 the size of the time‑vested retention‑share grants fell modestly (approximately 300 k shares granted in 2022 versus about 297 k shares in 2023), while the number of performance‑linked stock units rose sharply (from roughly 77 k performance units in 2022 to about 227 k in 2023).  At the same time, the total unrecognized compensation expense for retention awards dropped from roughly $87 million at the end of 2022 to about $16 million at the end of 2023.  This shift shows that Union Pacific is moving away from fixed‑term retention awards and toward a higher‑percentage of performance‑contingent equity, signaling a strategic emphasis on tying executive pay more directly to measurable performance metrics and controlling overall equity‑compensation costs.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and appears to describe a different compensation structure than what the ground truth indicates. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites specific numbers (300k shares in 2022 vs 297k in 2023, 77k performance units in 2022 vs 227k in 2023, $87M unrecognized expense dropping to $16M) that do not match the ground truth data. The ground truth shows 389,207 retention shares as of Dec 31, 2021 (in 2022 filing) and 954,405 retention shares plus 366,046 retention units in 2023 - vastly different figures than the LLM's claims. (2) ENTITY/METRIC CONFUSION: The LLM discusses 'performance-linked stock units' and 'time-vested retention-share grants' with specific grant numbers, but the ground truth focuses on outstanding retention shares and the introduction of retention units without exercise prices. These appear to be different compensation instruments than what the LLM describes. (3) MISSING KEY INFORMATION: The LLM completely fails to mention the 954,405 retention shares outstanding in 2023 or the 366,046 retention units, which are the core data points in the ground truth. (4) INCORRECT INTERPRETATION: While the LLM's conclusion about shifting toward performance-contingent equity is plausible reasoning, it is not supported by the actual data provided in the ground truth. The ground truth indicates an increase in retention instruments overall and introduction of retention units, not a shift away from retention awards. (5) UNVERIFIABLE CLAIMS: The specific dollar amounts ($87M to $16M) and grant numbers cannot be verified against the ground truth and appear to be fabricated or from a different source entirely. The answer demonstrates fundamental misalignment with the actual SEC filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 481,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "\nBetween 2023 and 2024 MetLife moved from an early‑LDTI‑driven definition of adjusted earnings to a fully‑articulated, segment‑wide metric that systematically strips out market‑volatility effects and all forms of asymmetrical accounting.  In 2023 the exclusions were introduced as part of the LDTI implementation (e.g., removing DAC/VOBA amortization and certain embedded‑derivative remeasurements and noting that market‑volatility gains/losses and asymmetrical items such as in‑force‑reinsurance adjustments were omitted).  By 2024 the company formalized these carve‑outs, explicitly stating that adjusted earnings excludes net investment and derivative gains/losses, MRB remeasurements, goodwill impairments, and—most importantly—any market‑volatility‑driven fluctuations and asymmetrical accounting adjustments (including basis‑adjustment amortization, inflation‑indexed benefit tweaks, and in‑force‑reinsurance asymmetries) across all segments, with the tax impact of those exclusions calculated on a statutory‑rate basis.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of MetLife's adjusted earnings methodology between 2023 and 2024, correctly identifying that LDTI implementation drove changes in 2023 and that refinements continued in 2024. However, there are significant issues with accuracy and specificity:\n\nSTRENGTHS:\n1. Correctly identifies LDTI as the driver of 2023 changes\n2. Accurately mentions DAC/VOBA amortization exclusions\n3. Correctly notes exclusion of MRB remeasurements and in-force reinsurance asymmetrical accounting\n4. Properly identifies the evolution from 2023 to 2024 as a refinement/formalization\n5. Appropriately mentions market volatility exclusions\n\nWEAKNESSES:\n1. OVERSTATES SCOPE: The LLM answer claims 2024 exclusions apply \"across all segments\" and mentions \"goodwill impairments\" and \"inflation-indexed benefit tweaks\" - these specific items are not confirmed in the ground truth and appear to be extrapolations\n2. VAGUE ON KEY DETAILS: The ground truth specifically mentions \"net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method\" in 2024 - the LLM answer mentions \"net investment and derivative gains/losses\" but doesn't specifically address the joint venture equity method expansion\n3. IMPRECISE LANGUAGE: The LLM uses phrases like \"basis-adjustment amortization\" and \"inflation-indexed benefit tweaks\" that don't appear in the ground truth and may mischaracterize the actual adjustments\n4. MISSING SPECIFICITY: The ground truth emphasizes \"policyholder liability remeasurement gains (losses)\" as a specific 2024 expansion - the LLM answer doesn't explicitly call this out\n5. TAX CALCULATION CLAIM: The LLM mentions \"tax impact of those exclusions calculated on a statutory-rate basis\" - this detail is not present in the ground truth and appears to be an unsupported addition\n\nMULTI-HOP REASONING: The answer demonstrates reasonable synthesis of the evolution between years but makes unsupported leaps in specificity and scope that go beyond what the ground truth supports.\n\nNUMERIC/QUANTITATIVE: No specific numbers are provided in either answer, so quantitative accuracy is not directly testable, but the LLM doesn't introduce false numbers.\n\nOVERALL: The answer is directionally correct but contains overstatements, unsupported details, and misses key specific refinements mentioned in the ground truth (particularly the joint venture equity method adjustment).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1505,
        "completion_tokens": 660,
        "total_tokens": 2165
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Accenture shifted from a broad‑based transformation model that focused on building digital cores, optimizing operations and accelerating revenue growth through cloud, data and AI, to a deliberately “compressed transformation” approach that is now driven by generative AI, the SynOps platform and the AI Navigator suite and is embedded in strategic managed‑services engagements.  The scope has also expanded to encompass talent, sustainability, the metaverse and other emerging forces, delivering end‑to‑end, industry‑specific solutions across Strategy & Consulting, Technology, Operations, Industry X and Song.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer addresses the general timeframe (2022-2024) and attempts to describe an evolution in Accenture's approach, but contains significant factual discrepancies with the ground truth. CORRECT ELEMENTS: (1) The answer correctly identifies a shift from 2022 to 2024, (2) Mentions generative AI as a key technology in the later period, (3) References expanded scope of services. MAJOR ERRORS: (1) The ground truth specifically mentions technologies like digital twins, IoT, cloud/Edge, 5G, advanced robotics, and metaverse in 2022 - the LLM answer omits these foundational 2022 technologies entirely, (2) The ground truth identifies artificial reality/virtual reality and advanced robotics as 2024 additions - the LLM answer mentions metaverse but doesn't clearly distinguish the 2024 technological additions, (3) The ground truth explicitly states that by 2024 Accenture expanded to include 'digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers' - the LLM answer completely omits this critical scope expansion, (4) The LLM answer introduces concepts like 'SynOps platform,' 'AI Navigator suite,' and 'Song' that are not mentioned in the ground truth, and references 'Industry X' which may not align with the filing data, (5) The LLM answer mentions 'talent' and 'sustainability' as part of scope expansion, which are not mentioned in the ground truth. MULTI-HOP REASONING: The LLM fails to properly synthesize the specific technological evolution (what was used in 2022 vs. 2024) and the scope expansion details. The answer provides a general narrative of transformation but misses the specific technical and operational details that distinguish the 2022 vs. 2024 approaches. The answer appears to conflate different aspects of Accenture's service offerings rather than clearly tracking the evolution of compressed transformation specifically.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 520,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "\nBetween 2023 and 2024 Abbott kept the size of its fair‑value interest‑rate hedge program essentially steady at about **$2.2 billion of notional contracts**, after having reduced the program from roughly **$2.9 billion in 2022** (the decline in 2022‑23 was driven by the maturity of $700 million of hedges and corresponding debt). The contracts continue to be designated as fair‑value hedges of fixed‑rate debt, are marked‑to‑market each reporting period, and the resulting gains or losses offset the changes in the fair value of the hedged fixed‑rate obligations. This reflects a shift from a shrinking hedge book in 2022‑23 to a stabilized hedge position in 2024 that continues to manage exposure to interest‑rate movements on Abbott’s fixed‑rate debt.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional context about the 2022-2023 transition ($2.9B to $2.2B) and explains the mechanics of fair value hedges, which adds valuable information. However, there are significant issues with the evaluation against the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM correctly identifies the $2.2B notional value for both 2023 and 2024, matching the ground truth\n   - The LLM adds information about 2022 ($2.9B) and the $700M maturity, which is not contradicted by ground truth but goes beyond the question scope\n   - CRITICAL OMISSION: The ground truth explicitly mentions the average interest rate increase from 3.6% in 2023 to 3.8% in 2024, which is a key metric showing how the underlying debt structure changed. The LLM answer completely omits this important data point\n   - The LLM does not provide the interest rate metrics that were central to the ground truth's explanation of how conditions evolved\n\n2. COMPLETENESS:\n   - The question asks specifically about how the use \"evolved\" between 2023 and 2024\n   - Ground truth provides: notional amounts (stable at $2.2B) AND interest rate changes (3.6% to 3.8%)\n   - LLM provides: notional amounts and historical context (2022) but MISSING the interest rate evolution data\n   - This is a significant gap in answering the \"how did it evolve\" aspect\n\n3. ENTITY AND METRIC ACCURACY:\n   - Company correctly identified as Abbott\n   - Years correctly identified (2023, 2024)\n   - Hedge type correctly identified (fair value hedges)\n   - Mechanism correctly explained (mark-to-market, offset gains/losses)\n   - MISSING METRIC: Average interest rate on long-term debt (3.6% → 3.8%)\n\n4. REASONING AND SYNTHESIS:\n   - The LLM correctly synthesizes that the hedge program remained stable at $2.2B\n   - The LLM adds context about the 2022-2023 decline, showing good multi-hop reasoning\n   - However, the LLM fails to synthesize the interest rate data that would complete the picture of how conditions evolved\n   - The conclusion about \"stabilized hedge position\" is reasonable but incomplete without the interest rate context\n\n5. SEMANTIC EQUIVALENCE:\n   - The core statement about $2.2B stability is semantically equivalent to ground truth\n   - The explanation of fair value hedge mechanics is accurate and well-explained\n   - However, the answer is incomplete because it omits a key metric (interest rates) that the ground truth identifies as important to understanding the evolution\n\nThe LLM answer is partially correct and provides useful additional context, but it fails to address a critical component of the ground truth answer (the interest rate changes from 3.6% to 3.8%), which is essential to fully answering how Abbott's hedging strategy evolved in managing exposure to fair value changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 743,
        "total_tokens": 2120
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 MetLife refined the way it calculates and presents **Adjusted Earnings** after the LDTI implementation: the metric is now explicitly identified as a **GAAP‑compliant measure of segment performance** that the CODM uses to evaluate profitability and allocate capital, and it is defined as adjusted revenues less adjusted expenses (net of tax) with a set of standardized exclusions (market‑volatility items such as investment and derivative gains/losses, MRB remeasurement, goodwill impairments, and specific asymmetrical accounting adjustments).  The 2024 disclosures also note that the calculation was updated to remove legacy amortization adjustments to DAC and VOBA and to exclude preferred‑stock redemption premiums, making the metric more consistent with GAAP segment‑reporting guidance while still serving the same performance‑evaluation purpose.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of MetLife's Adjusted Earnings evolution between 2023 and 2024, with mostly accurate information and appropriate synthesis. STRENGTHS: (1) Correctly identifies LDTI adoption as the driver of 2023 changes; (2) Accurately notes the removal of DAC/VOBA amortization adjustments; (3) Properly identifies 2024 exclusions including market volatility items (investment/derivative gains/losses, MRB remeasurement, goodwill impairments); (4) Correctly characterizes Adjusted Earnings as a GAAP measure of segment performance; (5) Appropriately notes the refinement toward consistency with GAAP segment-reporting guidance; (6) Mentions preferred-stock redemption premiums exclusion. WEAKNESSES: (1) The LLM answer mentions 'preferred-stock redemption premiums' as an exclusion, which is not explicitly mentioned in the ground truth; this appears to be an addition not supported by the original answer; (2) The answer could be more explicit about the specific 2023 exclusions (MRBs, discount rate changes on annuitization guarantees, asymmetrical accounting from in-force reinsurance) before describing the 2024 refinements; (3) The phrase 'inflation-indexed benefit adjustments' from the ground truth is not mentioned in the LLM answer, representing a minor omission; (4) The characterization of 'legacy amortization adjustments' is somewhat vague compared to the ground truth's specific mention of DAC, VOBA, and related intangibles. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across two years and identifies the connection between LDTI adoption and the changes in calculation methodology. The reasoning about moving toward GAAP consistency is sound. SEMANTIC EQUIVALENCE: The core message about refinement and expansion of exclusions is conveyed, though with slightly different emphasis and organization than the ground truth. The answer captures the essential evolution but with some minor inaccuracies and omissions that prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1506,
        "completion_tokens": 541,
        "total_tokens": 2047
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2024 Accenture repeatedly expanded its repurchase authority—starting with a $3.13 billion authorization that was boosted by a $3 billion increase in September 2022 (raising total authority to $6.13 billion) and then, after using part of that capacity, adding another $4 billion in September 2024 (bringing total authority to $6.69 billion).  The company continued to fund purchases through the same three channels—open‑market purchases, other authorized purchase programs (including exchangeable‑share redemptions), and employee‑related share withholding—but the volume of shares acquired grew, rising from about 12.2 million shares for $4.1 billion in 2022 to roughly 13.9 million shares for $4.5 billion in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth. Key issues: (1) WRONG NUMBERS: The LLM claims a $3.13 billion authorization in 2022, but the ground truth states $3,129,296 (approximately $3.1 million, not billion). This is a massive error of three orders of magnitude. (2) FABRICATED INFORMATION: The LLM invents specific authorization increases ($3 billion in September 2022, $4 billion in September 2024) and resulting totals ($6.13 billion, $6.69 billion) that do not appear in the ground truth and appear to be completely fabricated. (3) MISCHARACTERIZATION OF ACQUISITION METHODS: While the LLM correctly identifies three channels (open-market, other authorized programs, employee withholding), it misrepresents their significance. The ground truth emphasizes that in 2024, acquisitions were primarily through share withholding for payroll tax obligations, and these purchases did NOT impact the aggregate available authorization. The LLM treats all three methods as equally active ongoing channels without this critical distinction. (4) MISSING KEY INSIGHT: The ground truth highlights a shift in acquisition methods from 2022 to 2024, with 2024 focusing on share withholding rather than open-market purchases. The LLM fails to capture this evolution. (5) UNVERIFIED SHARE VOLUMES: The LLM provides specific share acquisition numbers (12.2 million shares for $4.1 billion in 2022; 13.9 million shares for $4.5 billion in 2024) that are not mentioned in the ground truth and cannot be verified. (6) INCOMPLETE CONTEXT: The ground truth notes that shares were held as treasury shares for employee benefits and that the program applied to both Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares. The LLM omits these important contextual details. The answer demonstrates fundamental misunderstanding of the actual authorization amounts and invents specific dollar figures and dates that appear nowhere in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 549,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "\nMetLife continues to record Unit‑linked and FVO securities at their original cost (reduced only by repayments and amortization of premium/discount for the fixed‑maturity portion) and measures them at fair value using Level 3 inputs; the 2024 roll‑forward shows the balance rising to about $1.19 bn (up from $0.787 bn in 2023) and adds a detailed quantitative sensitivity table that specifies the range of unobservable inputs—mortality, lapse, utilization, equity‑volatility and non‑performance spreads—and the directional impact of each on the fair‑value estimate. Thus, while the underlying cost‑basis methodology is unchanged, the 2024 disclosure refines and expands the fair‑value sensitivity analysis, providing more granular input ranges and quantified effects on the reported fair value.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer provides a partially correct response with significant issues in quantitative accuracy and some conceptual misalignment with the ground truth. STRENGTHS: (1) Correctly identifies that Unit-linked securities are measured at fair value using Level 3 inputs in 2024; (2) Accurately mentions the specific unobservable inputs (mortality rates, lapse rates, equity volatility, etc.); (3) Correctly notes that 2024 disclosures include enhanced sensitivity analysis; (4) Properly identifies the evolution toward more granular disclosure of fair value sensitivity. CRITICAL ERRORS: (1) The LLM states the balance rose to '$1.19 bn (up from $0.787 bn in 2023)' - these specific dollar amounts cannot be verified against the ground truth and appear to be fabricated or incorrectly sourced; (2) The LLM claims 'the underlying cost-basis methodology is unchanged' between 2023 and 2024, which directly contradicts the ground truth stating that 2023 used a 'more static cost-based method' while 2024 employed a 'more dynamic and assumption-driven valuation approach'; (3) The LLM mischaracterizes the evolution as merely a refinement of disclosure rather than a substantive shift in valuation methodology. MULTI-HOP REASONING: The LLM fails to properly synthesize the key evolution described in the ground truth - that the methodology itself shifted from cost-based to assumption-driven valuation, not just the disclosure granularity. The answer conflates 'cost basis' (how securities are initially recorded) with 'valuation methodology' (how fair value is determined), missing the core distinction that 2024 introduced Level 3 valuation techniques with significant unobservable inputs as a material change from 2023. QUANTITATIVE ISSUES: The specific dollar amounts ($1.19 bn, $0.787 bn) are presented with confidence but cannot be verified and may be incorrect, significantly undermining credibility. The answer reads as if specific numbers were retrieved but without proper source verification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 538,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the company’s market‑based RSU program shifted from a single four‑year vesting cycle that depended on a market‑performance metric (total stockholder return relative to an index and could result in 0 %–300 % of the original grant) to a two‑track approach: it continued to award four‑year market‑based RSUs but also began granting a new class of market‑based RSUs that vest over **five years** and are tied to specific stock‑price performance milestones.  The 2023 grants also incorporated a larger share pool (including RSUs assumed in the VMware merger) and a higher maximum payout, reflecting the expanded vesting horizon and more granular performance conditions.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of market-based RSUs between fiscal 2022 and 2023. STRENGTHS: (1) All key numeric values are correct - the 0%-300% payout range for TSR-based RSUs in 2022, the four-year vesting cycle, and the introduction of five-year vesting in 2023 are all accurately stated. (2) The multi-hop synthesis is sound - the answer correctly identifies the shift from a single structure to a two-track approach, properly synthesizing information about both the continuation of four-year RSUs and the new five-year variant. (3) The performance metrics are correctly identified: TSR relative to an index group for the 2022 structure, and stock price performance milestones for the 2023 structure. (4) Entity identification is accurate with proper fiscal year references. MINOR WEAKNESSES: (1) The LLM answer includes additional contextual information about 'larger share pool (including RSUs assumed in the VMware merger) and a higher maximum payout' that is not present in the ground truth answer. While this information may be factually correct from the source documents, it goes beyond what was specified in the original answer and could represent either additional accurate detail or potential over-interpretation. (2) The phrasing 'two-track approach' is slightly more interpretive than the ground truth's 'expansion in the types of market-based RSUs offered,' though semantically equivalent. The core factual content matches the ground truth well, with all critical structural and timeline changes accurately captured. The answer appropriately addresses the multi-part nature of the question regarding both structure and vesting timeline evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 464,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "\nThe CECL transition rule lets a bank hold back the full capital effect of adopting CECL and then add it back to regulatory capital in a five‑year “phase‑in.”  \n\n* **2023:**  By the end of 2023 the company had already added back the entire $2.4 bn “day‑1” CECL impact that had been delayed, and under the rule it was required to phase in the remaining “day‑2” ongoing impact at a uniform 25 %‑per‑year rate.  The table in the 2023 filing shows that for 2023 the cumulative day‑2 impact was **50 % phased‑in**, which meant that only half of the estimated ongoing CECL allowance could be counted toward capital.  Consequently, the Company’s CET1 ratio reported under the transition rule was **12.9 %**, versus **12.6 %** on a fully‑phased‑in basis.  \n\n* **2024:**  The phase‑in continued at the same 25 %‑per‑year pace.  The remaining $1.2 bn of the delayed impact was scheduled to be added back in two installments of $600 m each, one in 2024 and the final $600 m in 2025.  As a result, by the end of 2024 the company had **75 % of the total delayed amount phased‑in** (the first $1.8 bn of the $2.4 bn had been incorporated).  This is reflected in the 2024 filing, which reports a CET1 ratio of **13.5 %** when the transition rule is applied, versus **13.3 %** on a fully‑phased‑in basis.  \n\n**Regulatory capital treatment during the phase‑in:**  \n- The “day‑1” CECL adoption impact was **delayed** and added back to regulatory capital in the year of adoption (2020) but could not be fully reflected until the phase‑in schedule allowed it.  \n- The “day‑2” ongoing impact was **approximated with a 25 % scaling factor** and then **phased into capital at 25 % per year** (i.e., 25 % of the remaining estimated impact could be added to capital each year).  \n- Thus, in 2023 the company could count 50 % of the cumulative day‑2 impact, and by 2024 it could count 75 % (with the final 100 % to be reached in 2025).  This phased‑in treatment directly raised the reported CET1 ratios as the company progressed from 50 % to 75 % of the delayed amount being incorporated.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth:\n\n1. CORE FACTUAL ERROR - Phase-in Rate Mischaracterization: The ground truth states the CECL phase-in was at 25% PER YEAR from January 1, 2022 through December 31, 2024. The LLM correctly identifies the 25% annual rate but then incorrectly claims that by 2023 the cumulative day-2 impact was 50% phased-in and by 2024 it was 75% phased-in. This is mathematically consistent with a 25% annual rate (25% in 2022 + 25% in 2023 = 50% by end of 2023; 50% + 25% in 2024 = 75% by end of 2024), BUT the ground truth makes no mention of these specific cumulative percentages (50%, 75%) or the specific dollar amounts ($2.4bn, $1.2bn, $600m installments).\n\n2. UNSUPPORTED SPECIFIC NUMBERS: The LLM provides very specific financial figures ($2.4bn day-1 impact, $1.2bn remaining, $600m installments, CET1 ratios of 12.9%, 12.6%, 13.5%, 13.3%) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided ground truth and appear to be either fabricated or sourced from documents not provided for verification.\n\n3. MISALIGNMENT WITH GROUND TRUTH SCOPE: The ground truth answer is concise and focuses on the regulatory treatment framework itself - that the phase-in remained consistent at 25% annually across both years. The LLM answer goes far beyond this with detailed financial metrics and CET1 ratio comparisons that are not mentioned in the ground truth.\n\n4. FIVE-YEAR PHASE-IN CLAIM: The LLM opens with \"five-year phase-in\" but the ground truth specifies the phase-in period was from January 1, 2022 through December 31, 2024 (3 years), not five years. This is a significant discrepancy.\n\n5. DAY-1 vs DAY-2 TREATMENT: While the LLM correctly distinguishes between day-1 and day-2 impacts, the ground truth focuses specifically on the day-2 ongoing impact being phased at 25% annually. The LLM's detailed treatment of day-1 (delayed in 2020, added back in year of adoption) adds information not in the ground truth.\n\n6. EVOLUTION BETWEEN YEARS: The ground truth explicitly states the treatment \"remained consistent\" between 2023 and 2024. The LLM correctly conveys this consistency but adds unverified specific metrics that suggest more detailed tracking than the ground truth indicates.\n\nThe answer demonstrates understanding of CECL mechanics but fails the primary requirement of factual accuracy by introducing specific numbers and percentages not supported by the ground truth, and by mischaracterizing the phase-in period duration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1649,
        "completion_tokens": 687,
        "total_tokens": 2337
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Broadcom shifted from issuing senior notes under the April 2022 indenture – which included 4.00 % notes maturing 2029, 4.15 % notes maturing 2032 and 4.926 % notes maturing 2037 – to launching new series under later indentures (e.g., 5.05 % 2027, 4.15 % 2028, 4.35 % 2030, 4.55 % 2032 and 4.80 % 2034) with longer maturities and modestly higher coupons.  The change reflects a strategic evolution toward longer‑dated, higher‑yield debt while still using Wilmington Trust, National Association as trustee, and the new issuances were made under supplemental indentures that updated the covenant language and discount‑rate terms.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. Key issues: (1) INCORRECT INTEREST RATES: The LLM claims April 2022 indenture included '4.00% notes maturing 2029, 4.15% notes maturing 2032 and 4.926% notes maturing 2037' - but ground truth shows the January 2021 indenture had rates as low as 1.950% (due 2028) and 3.750% (due 2051). The 4.926% note due 2037 is correctly mentioned but attributed to wrong indenture. (2) INCORRECT DATES: The LLM references 'April 2022 indenture' and later indentures, but ground truth specifies April 18, 2022 and July 12, 2024 indentures. The LLM also mentions October 2024 notes in ground truth but doesn't properly contextualize the timeline. (3) INCOMPLETE HISTORICAL CONTEXT: The LLM fails to mention the January 2021 indenture that was the baseline in 2022, making the comparison incomplete. (4) FABRICATED DETAILS: The LLM introduces interest rates (5.05% 2027, 4.35% 2030, 4.55% 2032) that don't appear in the ground truth, and mentions 'supplemental indentures that updated covenant language and discount-rate terms' without evidence in the ground truth. (5) CORRECT ELEMENTS: The LLM correctly identifies Wilmington Trust, National Association as trustee and correctly notes a shift toward higher-yielding debt. The general trend observation is sound, but the specific numbers and indenture attributions are largely incorrect. The answer demonstrates partial understanding of the relationship evolution but fails on quantitative accuracy and introduces unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 433,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "\nUnder the CECL Transition Rule Capital One delayed the full CECL impact and began phasing it into regulatory capital at a 25 %‑per‑year rate. The “cumulative day‑2” impact was 25 % phased in during 2022, 50 % phased in by the end of 2023, and 75 % phased in by the end of 2024, with the remaining 25 % (≈ $600 million) scheduled to be added on January 1 2025. Thus, the regulatory‑capital add‑back grew from a 50 % phase‑in in 2023 to a 75 % phase‑in in 2024, completing the full 100 % phase‑in in 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is substantially correct and provides accurate information about Capital One's CECL Transition Rule phase-in progression. Verification of key facts: (1) The phase-in percentages are correct - 25% in 2022, 50% by end of 2023, 75% by end of 2024, and 100% in 2025. (2) The $600 million figure for the remaining 25% is reasonable and consistent with the $2.4 billion total mentioned in the ground truth (25% of ~$2.4B ≈ $600M). (3) The 25%-per-year phase-in rate is accurately described. (4) The multi-hop synthesis correctly traces the evolution from 2023 to 2024, showing the progression from 50% to 75% phase-in. The LLM answer actually provides MORE detail than the ground truth by explicitly stating the 2022 starting point (25%), the 2025 completion date, and the specific dollar amount remaining. The only minor discrepancy is that the ground truth references 'January 1, 2023' as the 50% phase-in date while the LLM references 'end of 2023,' but this is a semantic difference in how the same milestone is described (the phase-in that was in effect during 2023). The answer directly addresses the question about how the add-back evolved from 2023 to 2024 and clearly explains the phase-in progression. All calculations are accurate, entities are correctly identified, and the reasoning is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 367,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "\nAfter the May 2022 merger agreement, Broadcom disclosed that **all outstanding in‑the‑money VMware stock options (and RSU awards) held by non‑employee directors would be accelerated and settled with a mixture of cash and Broadcom common stock, in equal parts**. When the transaction closed in November 2023, those options were fully settled—directors received the agreed‑upon cash‑and‑stock consideration and there were no remaining VMware equity awards for non‑employee directors.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-structured. Strengths: (1) Correctly identifies the May 2022 merger agreement timing and November 2023 closing date, demonstrating proper multi-hop synthesis across years. (2) Accurately describes the treatment of VMware stock options and RSU awards for non-employee directors in both periods - planned conversion in 2022 becoming realized in 2023. (3) Correctly specifies the settlement mechanism as equal parts cash and Broadcom common stock. (4) Properly conveys the transition from prospective (2022) to actualized (2023) treatment. (5) Adds relevant detail about no remaining VMware equity awards post-closing, which is consistent with the ground truth's characterization of 'actualized event.' Minor considerations: The answer uses slightly different phrasing than the ground truth ('settled' vs 'converted into the right to receive') but these are semantically equivalent and both accurately describe the economic outcome. The answer is more concise than the ground truth while maintaining all essential information. No numerical errors, date errors, or factual inaccuracies detected. The multi-hop reasoning correctly synthesizes information about the acquisition timeline and its impact on director equity awards across the two filing periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 363,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "\nFrom 2022 through 2024 AbbVie’s filings show that Vraylar’s approved uses did not shift to new disease areas; the company continued to promote the drug as a **dopamine‑D₃‑preferring partial agonist indicated for schizophrenia, for acute manic/mixed episodes of bipolar disorder, and as an adjunctive treatment for major depressive disorder**.  \n\nThe 2022 disclosure highlighted the Phase 3 data that secured the adjunctive‑MDD label, and the 2024 10‑K simply reiterated those same core indications—schizophrenia, bipolar depression and adjunctive MDD—while emphasizing the accumulated clinical evidence and revenue growth, indicating a **stable therapeutic positioning rather than a substantive expansion**.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE REASONING: The LLM answer fundamentally contradicts the ground truth on the central claim of the question. The ground truth explicitly states that Vraylar's therapeutic positioning EVOLVED and EXPANDED from 2022 to 2024, with the 2024 disclosure showing 'a broader range of psychiatric conditions' and 'a clear expansion and solidification of its therapeutic positioning over time.' The LLM answer directly contradicts this by claiming 'approved uses did not shift to new disease areas' and characterizing the positioning as 'stable therapeutic positioning rather than a substantive expansion.' This is a major factual error on the primary question being asked. SPECIFIC ISSUES: (1) The LLM correctly identifies the indications present in both years (schizophrenia, bipolar disorder, adjunctive MDD), but misinterprets what this means for the evolution question. (2) The LLM acknowledges the Phase 3 data in 2022 for adjunctive MDD but fails to recognize that the 2024 disclosure shows this indication was NEWLY APPROVED/SOLIDIFIED by 2024, representing an expansion from the 2022 investigational status. (3) The ground truth specifies that in 2024, Vraylar was indicated for 'acute and maintenance treatment of schizophrenia' and 'acute treatment of depressive episodes associated with bipolar I disorder'—these represent more specific/expanded labeling compared to the 2022 Phase 3 trial status. (4) The LLM's characterization of 'stable therapeutic positioning' directly contradicts the ground truth's 'clear expansion and solidification.' QUANTITATIVE ACCURACY: The dates (2022, 2024) are correct, and the drug name and company are correct. However, the interpretation of what constitutes 'expansion' is fundamentally wrong. QUALITATIVE ACCURACY: The multi-hop reasoning failed because the LLM did not properly synthesize the temporal evolution—it treated the indications as static rather than recognizing the progression from investigational (2022) to approved/solidified (2024). This is a critical failure in understanding the question's core intent about EVOLUTION over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 565,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "\nGE continued to recognize revenue on long‑term services agreements using the percentage‑of‑completion method based on costs incurred to date, but by 2024 it refined that approach to explicitly incorporate forward‑looking utilization forecasts and market‑trend data when estimating total expected costs and future billings; it also introduced a cumulative‑catch‑up adjustment for revised estimates. The 2024 policy further clarifies that billing is tied to asset utilization or specific maintenance events, which determines the timing of revenue recognition and the creation of contract‑asset/contract‑liability balances.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth on multiple critical dimensions: (1) MAJOR ERROR - Method Evolution: The ground truth explicitly states GE shifted FROM straight-line basis (2022) TO percentage of completion method (2024). The LLM answer incorrectly claims GE 'continued to recognize revenue on...percentage-of-completion method' in both periods, fundamentally misrepresenting the evolution of the accounting policy. This is the core of the question and the LLM got it backwards. (2) SEGMENT IDENTIFICATION ERROR: The ground truth specifies the 2022 policy applied to Healthcare and Renewable Energy segments, while 2024 applied to CES segment. The LLM answer fails to identify or distinguish these segments at all. (3) QUANTITATIVE DATA OMISSION: The ground truth provides specific 2024 metrics ($6.6 billion net liability, 4.1% ratio, $162 billion total estimated life of contract billings) that are critical to understanding the evolution and forward-looking estimation process. The LLM answer completely omits these quantitative benchmarks. (4) INCOMPLETE CHARACTERIZATION: While the LLM mentions 'forward-looking utilization forecasts' and 'cumulative-catch-up adjustments,' it fails to establish that these represent NEW elements introduced in 2024 (not present in 2022), which is essential to answering 'how has...evolved.' (5) METHODOLOGICAL CONTRADICTION: The LLM's claim about 'continued' use of percentage-of-completion contradicts the ground truth's clear statement of a shift from straight-line to percentage-of-completion. This is a fundamental misunderstanding of the accounting policy evolution. The answer demonstrates poor multi-hop synthesis and fails to accurately capture the temporal evolution of GE's accounting policies across the 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 494,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "\nThe 1.250% Notes due 2027 were identified in both filings as “1.250% Notes due 2027 – IBM 27B” in the Section 12(b) securities table. In the 2022 10‑K they appeared in the table on pages 31‑32 toward the end of the document, whereas in the 2023 10‑K the same entry is placed on the cover pages (pages 1‑5) as part of the opening securities table. Thus, the wording and terms of the note did not change—only its location moved forward in the filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses the core evolution described in the ground truth. Key issues: (1) INCORRECT LOCATION CLAIMS: The LLM states the notes appeared on pages 31-32 in 2022 and moved to pages 1-5 (cover pages) in 2023. The ground truth makes no mention of page numbers or location changes within the filing structure. This appears to be fabricated detail. (2) MISSING CORE EVOLUTION: The ground truth identifies a substantive shift in how the notes are disclosed - from being listed as an instrument defining rights of holders (with reference to Exhibit 4.3 from a 2019 Form 8-K) to being identified as a registered class of securities with a trading symbol on NYSE. The LLM completely misses this important distinction and instead focuses on a purported page location change that isn't supported by the ground truth. (3) INCORRECT CHARACTERIZATION: The LLM claims 'the wording and terms of the note did not change—only its location moved forward.' This contradicts the ground truth, which explicitly states there was an evolution in how the notes are presented (from instrument definition reference to registered securities identification). (4) MISSING TRADING SYMBOL CONTEXT: While the LLM mentions 'IBM 27B' in both filings, the ground truth specifically notes this symbol appears in the 2023 filing as part of identifying it as a registered security on NYSE, which is part of the evolution being described. The LLM fails to capture the significance of this change. (5) INCOMPLETE SYNTHESIS: The answer does not synthesize the multi-hop information about the shift from referencing defining documents to identifying registered securities status. The response appears to contain invented details about page numbers rather than accurately reflecting the actual evolution in disclosure approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 497,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "\nBetween 2022 and 2024 AbbVie kept the same vesting design for its performance‑vested RSUs – they can vest in three equal one‑third increments over a three‑year performance period.  The underlying performance metric, however, has been broadened: the 2022 awards were tied solely to relative return‑on‑invested‑capital (ROIC) versus a defined peer group, whereas the 2024 disclosures still use ROIC but now evaluate it together with additional criteria such as EPS and total‑shareholder‑return thresholds that affect the related performance‑share component.  Thus, the increment structure has remained unchanged while the performance measurement has become more multi‑faceted.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a significant factual error regarding the evolution of performance metrics. The ground truth states that both 2022 and 2024 awards were measured based on ROIC relative to a peer group, with the 2024 description being a simplification/standardization without mention of specific years tied to tranches. However, the LLM claims that 2024 awards now include 'additional criteria such as EPS and total-shareholder-return thresholds' - this is INCORRECT and contradicts the ground truth. The ground truth explicitly states the 2024 metrics focused 'primarily on ROIC performance against the same peer group' without introduction of new metrics. CORRECT ELEMENTS: (1) The vesting structure of one-third increments over three years is correctly identified for both periods. (2) The company (AbbVie) and time period (2022-2024) are correct. (3) The identification of ROIC as the primary metric is correct. INCORRECT ELEMENTS: (1) The claim about 'broadened' metrics with EPS and total-shareholder-return thresholds is factually wrong. (2) The characterization of the evolution as 'more multi-faceted' misrepresents the actual change, which was a simplification/standardization. MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparative information across the two years. The ground truth indicates a simplification of disclosure/criteria, not an expansion. The LLM's introduction of new metrics (EPS, TSR) appears to be fabricated or confused with other equity award types. QUANTITATIVE ACCURACY: The structural numbers (one-third increments, three-year period) are correct, but the qualitative characterization of metric evolution is fundamentally wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 465,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "\nFrom 2022 to 2024, GE’s AerCap investment moved from a **$865 million unrealized loss in 2022** to a **$129 million unrealized gain in 2023**, and then recorded a **$38 million realized/unrealized gain in 2024**. This trajectory shows the position recovered from a deep loss to modest positive returns over the three‑year period.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the 2022 unrealized loss of $865 million and the 2024 realized/unrealized gain of $38 million, matching the ground truth. However, there is a critical issue: the LLM introduces a 2023 figure ($129 million unrealized gain) that is NOT present in the original answer or ground truth. The original answer only addresses 2022 and 2024, explicitly stating the evolution occurred 'from 2022 to 2024' over a 'two-year period.' By adding the 2023 data point without verification, the LLM has either fabricated information or drawn from sources not validated against the ground truth. The qualitative reasoning about recovery from loss to positive returns is sound and semantically equivalent to the ground truth's 'significant turnaround.' The multi-hop synthesis correctly connects the two years and interprets the investment trajectory. However, the introduction of unverified 2023 data is a significant factual error that undermines confidence in the answer's accuracy. The answer demonstrates good understanding of the question's intent and proper entity identification (GE, AerCap, investment metrics), but the quantitative accuracy is compromised by the unexplained 2023 figure. The answer would have scored 8-9 if limited to the verified 2022 and 2024 data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 363,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "\nIn the 2022 filing the 0.300 % Notes due 2026 were only mentioned in the debt footnotes and the “Notes to Financial Statements” (pages 28‑32), without a separate line in the registration table; by contrast, the 2023 Form 10‑K lists the same notes explicitly in the “Securities registered pursuant to Section 12(b)” table (shown as IBM 26B), giving the instrument a distinct entry and ticker and thereby raising its visibility in the disclosure of financial instruments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of IBM's treatment of the 0.300% Notes due 2026 between 2022 and 2023 filings. Strengths: (1) Accurately captures the shift from footnote/exhibit disclosure to explicit registration table listing; (2) Correctly identifies the ticker symbol IBM 26B; (3) Properly notes the increased visibility and formal recognition; (4) Correctly references the 'Securities registered pursuant to Section 12(b)' table as the location in 2023. Quantitative accuracy is strong - all dates (2022, 2023, 2026), percentages (0.300%), and identifiers are correct. Weaknesses: (1) The LLM answer provides slightly different framing than ground truth - it emphasizes the shift from footnotes to registration table, while ground truth emphasizes the shift from Exhibit 4 reference to explicit NYSE listing; (2) The LLM answer doesn't explicitly mention Exhibit 4 to Form 8-K filed November 1, 2016, which was part of the 2022 disclosure context in the ground truth; (3) The LLM answer doesn't mention the NYSE listing context as explicitly as ground truth does ('registered on the New York Stock Exchange'). However, these are relatively minor omissions - the LLM captures the essential evolution: increased visibility and formal recognition through explicit registration table listing. The multi-hop reasoning is sound, correctly synthesizing information about how the same instrument was treated differently across two filing years. The answer is semantically equivalent to the ground truth in its core message about the evolution of disclosure treatment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 435,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "\nBetween 2022 and 2024 GE moved the RISE program from a announced sustainability concept to an active, heavily funded development effort.  In 2022 the focus was on outlining the program’s goals—​a >20 % cut in fuel burn and CO₂, open‑fan, compact‑core and hybrid‑electric architectures, and compatibility with alternative fuels—​while 2024 filings show that GE Aerospace has already conducted >250 tests on a full‑scale open‑fan engine, demonstrated a one‑megawatt hybrid‑electric propulsion system, and earmarked roughly $2.7 bn of total R&D spend (≈ $1.4 bn from customer/partner funding) to mature those technologies.  Consequently, the strategic emphasis shifted toward turning RISE’s research milestones into near‑term engine‑platform roadmaps and securing external financing, underscoring a stronger investment focus on commercializing open‑fan and hybrid‑electric propulsion as the core of GE’s next‑generation, low‑emission engine portfolio.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer introduces specific quantitative claims that are NOT present in the ground truth and cannot be verified: (1) '>250 tests on a full-scale open-fan engine' - not mentioned in original answer; (2) 'one-megawatt hybrid-electric propulsion system' - not mentioned in original answer; (3) '$2.7 bn of total R&D spend' and '$1.4 bn from customer/partner funding' - these specific dollar amounts are NOT in the ground truth. The original answer only states 'significant investments' without quantifying amounts. The LLM appears to have fabricated or hallucinated specific technical milestones and financial figures. CORRECT ELEMENTS: The LLM correctly identifies the core evolution from 2022 announcement to 2024 active investment, and correctly states the >20% fuel consumption/CO2 reduction target. The general narrative about shifting from conceptual to concrete investment is accurate. However, the introduction of unverified specific numbers (test counts, power ratings, dollar amounts) represents a fundamental accuracy failure. The answer demonstrates reasonable qualitative understanding of the program's evolution but fails on quantitative precision by adding details not supported by the ground truth. This is particularly problematic for financial/technical claims where precision is critical. The multi-hop reasoning structure is sound, but the factual foundation is compromised by unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 398,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 American Express shifted asset‑securitizations from a loosely described, occasional funding source to a clearly quantified, strategically important element of its capital plan.  In the 2023 filing the company explicitly projects $2 billion‑$6 billion of secured term‑debt issuance tied to securitizations and notes that these securitization programs are separately rated, underscoring a greater reliance on and emphasis on asset‑backed funding compared with the more generic reference in the 2022 filing.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ISSUES: (1) UNVERIFIED NUMBERS: The LLM introduces specific quantitative claims ($2 billion-$6 billion of secured term-debt issuance) that are NOT present in the ground truth answer. The ground truth makes no mention of these specific dollar amounts, and introducing unverified financial figures in a 10-K analysis is a serious error. (2) MISSING KEY GROUND TRUTH ELEMENTS: The LLM fails to mention the 2022 glossary definition that was explicitly noted in the ground truth as important context for understanding the evolution. The ground truth emphasizes that 2022 had a 'definitional disclosure' approach, which the LLM completely omits. (3) INCOMPLETE SYNTHESIS: The ground truth clearly states that 2023 positioned securitizations 'alongside deposits and unsecured debt as key funding sources' and emphasized 'diversity in funding sources' - the LLM does not capture this comparative positioning. (4) VAGUE CHARACTERIZATION: The LLM's description of 2022 as 'loosely described, occasional funding source' is not supported by the ground truth, which describes it as a glossary entry explaining mechanics. (5) UNSUBSTANTIATED CLAIMS: The assertion about 'separately rated' securitization programs is not mentioned in the ground truth and appears to be fabricated detail. WHAT WAS CORRECT: The LLM correctly identifies the general direction of change (from less emphasis to more strategic emphasis) and correctly names the company (American Express) and years (2022-2023). The semantic understanding that there was an evolution toward greater strategic importance is directionally accurate. However, the introduction of specific financial figures without ground truth support, combined with omission of key definitional context, represents a fundamental failure in accuracy for a financial document analysis task.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 515,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 Emerson’s AspenTech segment moved from a modest loss in 2021 to a small profit of $12 million on $656 million of sales in 2022, and its contribution to the company’s overall earnings grew enough that adjusted EBITA rose 18 % (from $3.0 bn to $3.6 bn) and earnings before interest and taxes for the full company increased to $2.9 bn in 2023.  This improvement reflects deeper operational integration—Emerson continued to embed AspenTech’s asset‑optimization software into its Automation Solutions portfolio and to capture cross‑selling synergies—while also setting the stage for the 2024 proposal to acquire the remaining shares and fully consolidate the business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM correctly cites $656M sales and $12M earnings for 2022, but then introduces unsupported figures (adjusted EBITA of $3.0bn to $3.6bn, full company EBIT of $2.9bn in 2023) that are not mentioned in the ground truth and appear to be fabricated or confused with other metrics. The 18% EBITA growth claim is unverified. (2) ENTITY/RELATIONSHIP MISCHARACTERIZATION: The ground truth clearly states that in 2022 Emerson had a 'minority investment' in AspenTech, and by 2023 acquired 'Heritage AspenTech' gaining a '55% ownership stake.' The LLM answer completely omits the critical 2023 acquisition event and the shift from minority to controlling interest (55% stake), which is the core strategic evolution the question asks about. Instead, it vaguely references 'deeper operational integration' and a future '2024 proposal' without explaining the actual 2023 acquisition. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question specifically asks about the evolution from 2022 to 2023, particularly regarding 'investment returns and operational integration.' The ground truth shows a clear transformation: 2022 = passive minority investment; 2023 = active controlling interest via Heritage AspenTech acquisition with 0.6pp gross margin improvement. The LLM fails to capture this fundamental shift and instead focuses on general operational improvements and future plans. (4) MISSING CRITICAL FACTS: The LLM omits the Heritage AspenTech acquisition entirely, the 55% ownership stake, and the 0.6 percentage point gross margin impact—all key metrics demonstrating the strategic evolution. (5) SPECULATIVE CONTENT: References to '2024 proposal' and specific EBITA figures appear to be extrapolations or errors not grounded in the provided ground truth. The answer reads more like general business narrative than accurate synthesis of the specific 2022-2023 evolution requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 539,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "\nBetween 2022 and 2023 Emerson’s stake in AspenTech was unchanged – the company recorded a $5.9 bn non‑controlling interest for the 45 % it did not own and, because that interest related to the former Emerson Industrial Software Business, it reduced additional paid‑in‑capital by about $550 million; this equity treatment remained the same in 2023, with the non‑controlling interest continuing to be carried at fair value and no further dilution of Emerson’s equity.  The acquisition’s expense impact persisted through the amortization of acquired intangibles, inventory step‑up and other acquisition‑related costs that were reported in “Other deductions, net,” which lowered GAAP earnings but did not generate additional equity adjustments beyond the ongoing consolidation of AspenTech’s results.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) OWNERSHIP PERCENTAGE ERROR: LLM states Emerson recorded a '45% noncontrolling interest' but ground truth clearly states Emerson had a '55% ownership stake' with a '$5.9 billion noncontrolling interest' (meaning 45% was owned by others). The LLM reversed the ownership structure. (2) MISSING KEY 2023 OPERATIONAL IMPACTS: Ground truth explicitly states that by 2023, AspenTech 'positively impacted gross margins by 0.6 percentage points' and 'contributed to increased SG&A expenses, which rose by $572 million compared to 2022.' The LLM completely omits these critical 2023 operational metrics and financial performance effects, which are central to answering how the relationship 'evolved between 2022 and 2023.' (3) INCOMPLETE EVOLUTION NARRATIVE: The question specifically asks how the relationship 'evolved' between the two years. Ground truth shows a shift from significant accounting impacts in 2022 (equity reduction, noncontrolling interest recording) to operational integration effects in 2023 (margin improvements, expense increases). LLM fails to capture this evolution, instead suggesting the accounting treatment 'remained the same in 2023' without addressing the operational performance shifts. (4) VAGUE EXPENSE DISCUSSION: While LLM mentions 'amortization of acquired intangibles' and 'inventory step-up,' it does not quantify the $572 million SG&A increase or explain its composition (AspenTech transaction costs plus stock compensation). (5) CORRECT ELEMENTS: The $5.9 billion noncontrolling interest amount and $550 million additional paid-in capital reduction are correctly stated, and the fair value accounting treatment is appropriately mentioned. However, these correct elements are undermined by the ownership percentage error and the significant omission of 2023 operational impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 498,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings, IBM’s disclosure of the 6.22 % Debentures due 2027 shifted from a peripheral mention in the exhibit list to a dedicated entry in the “Securities registered pursuant to Section 12(b)” table. In the 2022 filing (pages 28‑32), the debenture was only noted as “Exhibit 3 to Form 8‑K (August 1 1997)… incorporated by reference,” without a separate line in the securities table. The 2023 filing (pages 1‑5) adds a specific line identifying the instrument as “6.22 % Debentures due 2027 – IBM 27 – New York Stock Exchange,” while still referencing the same 1997 Form 8‑K exhibit. This change makes the debenture’s registration details more visible and standardized in the annual report.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy in capturing the evolution of IBM's disclosure practices between 2022 and 2023 filings. STRENGTHS: (1) All numeric values are correct - the 6.22% rate, the 2027 maturity date, the August 1, 1997 Form 8-K reference, and the trading symbol 'IBM 27' are all accurate. (2) The multi-hop synthesis is sound - the answer correctly identifies the shift from peripheral mention to dedicated table entry across the two filing years. (3) Entity identification is precise - IBM, the specific debenture instrument, the NYSE listing, and the Form 8-K reference are all correctly identified. (4) The reasoning about the evolution from historical reference to market-oriented presentation is logically sound and matches the ground truth's core insight. MINOR DIFFERENCES: (1) The LLM provides specific page references (pages 28-32 for 2022, pages 1-5 for 2023) which are not in the ground truth but add helpful context without contradicting it. (2) The LLM uses slightly different terminology ('peripheral mention in the exhibit list' vs. ground truth's 'referencing the instrument') but conveys the same semantic meaning. (3) The LLM emphasizes the 'Securities registered pursuant to Section 12(b)' table structure, which is a more specific technical detail than the ground truth's general reference to 'registered securities.' This is actually more precise and helpful. VERIFICATION: The core claim that the 2023 filing shows more structured/visible disclosure with the trading symbol and explicit NYSE listing matches the ground truth exactly. The claim that both filings reference the 1997 Form 8-K is accurate. The characterization of the shift from 'peripheral' to 'dedicated' entry is semantically equivalent to the ground truth's shift from 'purely historical reference' to 'transparent and current market-oriented presentation.' No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 519,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "\nBetween 2023 and 2024 UnitedHealth’s exposure to financial risk through risk‑based arrangements grew, with a larger share of revenue coming from fixed‑rate, risk‑bearing contracts—especially Medicare Advantage and value‑based provider agreements—that require the Company to assume medical and administrative cost risk and to navigate CMS risk‑adjustment audits. This heightened risk forces more complex cost‑estimation of IBNR claims, rebates and risk‑adjusted premiums, and expands its service‑delivery responsibilities to include full‑risk care coordination and broader provider network management.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the general topic of UnitedHealth's evolving financial risk exposure but contains significant issues: (1) QUANTITATIVE PROBLEMS: The LLM introduces specific claims about 'Medicare Advantage and value-based provider agreements' and 'CMS risk-adjustment audits' that are NOT present in the ground truth answer. The ground truth provides no specific percentages, dollar amounts, or detailed breakdowns by product line. The LLM appears to have added information not supported by the knowledge graph. (2) MISSING KEY GROUND TRUTH ELEMENTS: The LLM fails to mention several critical points from the original answer: (a) the 2023 baseline of premium revenue recognition based on estimated premiums earned net of projected rebates, (b) the specific 2024 expansion regarding 'increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties,' (c) the emphasis on providers' ability to maintain solvency and provide data for cost estimation. These are substantive differences in what evolved between years. (3) MULTI-HOP REASONING: The LLM does attempt to synthesize the evolution from 2023 to 2024 and connect it to implications for cost estimation and service delivery, which is appropriate. However, the synthesis appears to be based on general knowledge rather than the specific filing disclosures referenced in the ground truth. (4) SEMANTIC ISSUES: While the LLM correctly identifies that risk exposure grew and mentions cost estimation and service delivery responsibilities (matching the question's framing), it does so with different supporting details than what the ground truth indicates was actually disclosed. The mention of 'IBNR claims, rebates and risk-adjusted premiums' is conceptually related but not explicitly confirmed in the ground truth. (5) ACCURACY ASSESSMENT: The answer is partially correct in direction and theme but lacks the specific factual grounding that would make it a strong match to the knowledge graph-derived ground truth. The introduction of Medicare Advantage specificity and CMS audits without ground truth support is a significant concern for factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 578,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "\nBetween 2022 and 2023 Emerson’s exposure to AspenTech grew both financially and strategically.  In 2022 the company invested roughly $6 billion in cash and two of its own software businesses to acquire a 55 % stake in AspenTech, which lifted the unit’s sales to **$656 million** and generated a modest **$12 million** of earnings.  By 2023 the partnership had deepened: AspenTech’s earnings contribution rose (moving from a small loss to a positive contribution reflected in higher segment earnings and greater amortization of intangibles), and Emerson intensified its strategic involvement through joint product development, shared go‑to‑market initiatives and expanded board representation, setting the stage for its 2024 proposal to purchase the remaining shares.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains critical chronological and factual errors that fundamentally misrepresent Emerson's relationship with AspenTech. (1) TIMELINE ERROR - The LLM states the $6 billion investment and 55% stake acquisition occurred in 2022, but the ground truth clearly indicates this major transaction occurred in 2023, not 2022. The ground truth explicitly states: 'In 2022, Emerson's relationship with AspenTech was primarily financial' with a $362 million investment, and 'By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction.' (2) MISSING KEY 2022 DATA - The LLM completely omits the correct 2022 investment figure of $362 million, which is a critical data point showing the evolution from 2022 to 2023. (3) INCORRECT ASSET FIGURES - The LLM cites '$656 million' in sales and '$12 million' in earnings for AspenTech, which are not mentioned in the ground truth and appear to be fabricated or confused with other metrics. (4) INCOMPLETE TRANSACTION DESCRIPTION - While the LLM correctly identifies the 55% ownership stake and mentions the Industrial Software Business contribution, it fails to clearly distinguish between the 2022 baseline ($362M investment) and the 2023 major transaction ($6.0 billion cash + software businesses). (5) SPECULATIVE CONTENT - The LLM adds details about 'joint product development, shared go-to-market initiatives and expanded board representation' and references a '2024 proposal to purchase remaining shares' that are not in the ground truth and appear to be extrapolations or hallucinations. The core answer structure is inverted: it presents 2023 events as 2022 events, fundamentally breaking the chronological evolution the question asks about. The answer fails the primary requirement of accurately synthesizing the multi-hop information about how the relationship evolved BETWEEN 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 519,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "\nIn fiscal 2022 Adobe Target was described as a component of the Adobe Experience Cloud that provided A/B testing and rule‑based personalization within the broader Digital Experience segment. By fiscal 2023 the filing positions Target as an AI‑ and machine‑learning‑driven engine that powers real‑time, journey‑wide personalization across the Adobe Experience Platform, now tightly integrated with Journey Optimizer and generative‑AI capabilities (Sensei GenAI). This evolution signals Adobe’s strategic shift toward embedding generative AI and end‑to‑end, data‑driven personalization into its cloud stack, making Target the central engine for AI‑driven customer experiences.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the fiscal years (2022 vs 2023) and accurately captures the core evolution of Adobe Target from rule-based personalization to AI/ML-driven capabilities. The mention of Journey Optimizer integration and the shift toward AI-driven personalization aligns with the ground truth. The characterization of Target as an 'AI- and machine learning-driven engine' in fiscal 2023 matches the original answer's description of it as an 'AI- and machine learning-driven personalization engine.' WEAKNESSES: (1) The LLM introduces specific details not present in the ground truth, such as 'Sensei GenAI' and 'Adobe Experience Platform' integration, which may be accurate but cannot be verified against the provided ground truth. (2) The fiscal 2022 description differs from ground truth - the LLM states Target provided 'rule-based personalization' while the ground truth describes it as a tool for 'testing, targeting, and personalizing content across channels' alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. The LLM's characterization of fiscal 2022 as 'rule-based' is more specific than what the ground truth states. (3) The LLM omits the specific mention of Marketo Engage and Adobe Campaign as companion solutions in fiscal 2022, which the ground truth explicitly includes. (4) The phrase 'omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation' from the ground truth is not fully captured - the LLM mentions 'journey-wide personalization' and 'real-time' but doesn't explicitly reference the A/B and multivariate testing capabilities. MULTI-HOP REASONING: The LLM successfully synthesizes the evolution across two fiscal years and connects it to Adobe's strategic direction, though it adds interpretive details about 'generative AI' and 'end-to-end data-driven personalization' that go beyond the ground truth's scope. The core reasoning about strategic shift toward AI-driven personalization is sound and matches the ground truth's conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 549,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2023 Emerson moved from acquiring AspenTech to fully integrating it: the 2022 purchase added roughly **$7.3 billion of goodwill and $7.3 billion of acquired intangibles** (Goodwill and Other Intangibles note), and the company began converting AspenTech’s stock‑based awards into Emerson awards while recording related compensation expense (Stock‑Based Compensation note – $96 million of AspenTech‑related expense, $43 million of which was charged to restructuring).  By the end of 2023 Emerson still held a 100 % stake, but the integration was reflected in ongoing restructuring costs (AspenTech’s $2 million of 2021 restructuring expense and the $100 million of restructuring expense the company expected for 2023) and the continued amortization of the acquired intangibles.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth:\n\n1. QUANTITATIVE ACCURACY ISSUES:\n   - LLM states '$7.3 billion of goodwill and $7.3 billion of acquired intangibles' but ground truth indicates '$8,326 million' (approximately $8.3 billion) as the balance related to AspenTech in 2022. The LLM's figures are materially different and appear to be incorrect.\n   - LLM cites '$96 million of AspenTech-related expense' and '$43 million charged to restructuring' - these specific numbers cannot be verified against the ground truth provided.\n   - LLM mentions '$2 million of 2021 restructuring expense' and '$100 million expected for 2023' - these are not mentioned in the ground truth.\n\n2. ENTITY AND STRUCTURAL ACCURACY:\n   - LLM incorrectly characterizes AspenTech as 'fully integrating' into Emerson, when ground truth states it 'operating as a separate publicly traded company under Emerson's acquisition framework.' This is a fundamental mischaracterization of the relationship.\n   - LLM states Emerson 'held a 100% stake' - ground truth does not explicitly confirm this ownership percentage.\n\n3. MULTI-HOP REASONING:\n   - LLM focuses heavily on restructuring costs and goodwill/intangibles amortization, which are not the primary focus of the ground truth answer.\n   - Ground truth emphasizes the evolution from financial stake to operationally integrated relationship with incentive-driven structures (stock options, RSUs, performance stock units tied to ACV and free cash flows).\n   - LLM largely omits discussion of stock-based compensation plans alignment and performance metrics tied to operational goals.\n\n4. COMPLETENESS:\n   - LLM addresses the financial stake aspect but misses the key evolution toward incentive-driven operational integration.\n   - LLM does not mention the continuation of AspenTech's own equity structure or the performance stock units tied to specific operational metrics (annual contract value, free cash flows).\n   - The answer focuses on accounting treatments rather than the strategic relationship evolution.\n\n5. SEMANTIC ISSUES:\n   - The characterization of 'full integration' contradicts the ground truth's description of AspenTech as a 'separate publicly traded company.'\n   - The emphasis on restructuring costs and goodwill amortization, while potentially accurate accounting details, does not capture the essence of how the relationship evolved from purely financial to operationally integrated with aligned incentives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 667,
        "total_tokens": 2076
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "\nFrom 2022 to 2023 Adobe Experience Platform shifted from being a data‑unification layer that simply fed Adobe Sensei AI into the broader Experience Cloud stack to a more tightly integrated, AI‑driven orchestration engine.  It now powers real‑time, hyper‑personalized cross‑channel campaign execution through native tools such as Journey Optimizer and the Real‑Time Customer Data Platform, and its generative‑AI (Sensei GenAI) capabilities are embedded directly into workflow orchestration, enabling Adobe Experience Cloud to coordinate personalized journeys across web, mobile, email, advertising and Creative Cloud assets in a single, AI‑enhanced flow.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Adobe Experience Platform from 2022 to 2023, capturing the shift from foundational data infrastructure to an AI-driven orchestration engine. It accurately mentions Journey Optimizer, Real-Time Customer Data Platform, and Adobe Sensei as key components. The characterization of the platform's role in cross-channel campaign orchestration is semantically aligned with the ground truth. No quantitative errors are present (no specific numbers were provided to verify). WEAKNESSES: (1) The LLM answer introduces 'Sensei GenAI' and 'generative-AI capabilities' which are not mentioned in the ground truth, potentially overstating or mischaracterizing the evolution. The ground truth specifically mentions 'automated insights, sentiment analysis, and enhanced anomaly detection' in 2022, and 'machine learning-driven insights' in 2023 via Adobe Mix Modeler - not generative AI. (2) The LLM answer omits Adobe Mix Modeler entirely, which is a significant 2023 development explicitly mentioned in the ground truth as a key evolution showing the shift toward 'specialized and actionable function in campaign planning.' (3) The LLM answer mentions 'Creative Cloud assets' integration, which is not supported by the ground truth provided. (4) The ground truth emphasizes the introduction of Adobe Mix Modeler in 2023 as a critical indicator of the platform's evolution toward marketing investment optimization - this is a material omission. (5) The LLM answer lacks the specific detail about Adobe Analytics and Adobe Audience Manager's relationship to the platform mentioned in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information about the platform's evolution across two years and identifies the role of Journey Optimizer, but fails to complete the full picture by omitting Adobe Mix Modeler, which is central to understanding the 2023 evolution. The reasoning is partially sound but incomplete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 535,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "\nUnitedHealth Group responded to the squeeze on Medicare Advantage funding by accelerating its shift to fully‑accountable, value‑based care delivery—expanding in‑home, virtual and coordinated primary‑care pathways and investing in data‑driven care‑coordination technology. At the same time, it tightened 2024 benefit designs, reshaped provider networks and adjusted member premiums to offset lower Medicare Advantage rates and the impact of revised risk‑adjustment payments. This evolution reflects a move from traditional fee‑for‑service models to integrated, cost‑controlled delivery systems aimed at preserving margins amid ongoing funding pressures.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of UnitedHealth Group's care delivery approach from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 focus on value-based care acceleration with specific delivery channels (in-home, virtual, coordinated primary care) matching ground truth; (2) Accurately captures the 2024 shift to cost containment and strategic adjustments in response to Medicare Advantage funding pressures; (3) Properly synthesizes the multi-hop reasoning: initial investment orientation → external financial constraints → operational retrenchment; (4) Correctly identifies specific 2024 adjustments (benefit design changes, provider network reshaping, premium adjustments, risk-adjustment impacts); (5) No quantitative errors or incorrect numbers/dates; (6) Semantic equivalence is strong - 'fully-accountable value-based care' and 'integrated, cost-controlled delivery systems' convey the same meaning as ground truth's 'value-based care delivery models.' MINOR WEAKNESSES: (1) The LLM answer emphasizes 'margin preservation' as the primary driver, while ground truth frames it more neutrally as 'cost containment and strategic retrenchment' - this is a subtle interpretive difference but not factually incorrect; (2) Ground truth explicitly mentions 'county-level decisions about plan offerings' which the LLM answer doesn't specifically reference, though it's implied in 'adjusted member premiums' and network changes; (3) The LLM answer could have been slightly more explicit about the contrast between 2023's 'expansion-focused investment' and 2024's retrenchment, though this is clearly implied. The multi-hop synthesis is sound: the model correctly connected 2023 strategic investments → 2024 funding pressures → resulting operational adjustments. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 509,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "\nBetween 2022 and 2023 the breadth of Thermo Fisher’s outstanding notes widened, but the 1.950 % Notes due 2029 remained in the lineup unchanged.  The 2023 filing added newer tranches—such as the 3.200 % Notes due 2026 and the 3.650 % Notes due 2034—while retaining the existing 1.950 % 2029 issue, reflecting a shift toward higher‑yielding, longer‑dated debt alongside the legacy 1.950 % series.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key facts are correct: (1) The 1.950% Notes due 2029 remained unchanged between 2022 and 2023 with the same trading symbol TMO 29; (2) New debt instruments were introduced in 2023 including the 3.200% Notes due 2026 and 3.650% Notes due 2034; (3) The overall characterization of TMO's financing strategy shift toward higher-yielding, longer-dated debt is accurate. Quantitative accuracy is perfect—all percentages (1.950%, 3.200%, 3.650%), years (2022, 2023, 2026, 2029, 2034), and company identification (Thermo Fisher/TMO) are correct. The multi-hop reasoning is sound: the answer correctly synthesizes information about debt composition across two years and identifies the continuity of one instrument while noting the expansion of the portfolio. The wording differs slightly from the ground truth (e.g., 'breadth widened' vs. 'introduced new debt instruments,' 'legacy 1.950% series' vs. 'continued presence') but conveys semantically equivalent information. The characterization of the shift toward 'higher-yielding, longer-dated debt' is a reasonable inference from the data presented and adds appropriate context. Minor deduction (1 point) only because the answer could have been slightly more explicit about the trading symbol TMO 29 remaining the same, though this is a very minor omission that doesn't affect the core accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 390,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "\nBetween 2022 and 2023 Thermo Fisher’s outstanding debt securities remained anchored by the 0.500 % Notes due 2028 (ticker TMO 28A), which continued to appear in both the 2022 and 2023 Form 10‑K tables.  However, the 2023 filing expanded the note suite with several new categories—including higher‑coupon issues such as 3.200 % Notes due 2026 (TMO 26B), 3.650 % Notes due 2034 (TMO 34) and additional mid‑term and long‑dated tranches (e.g., 2.375 % due 2032, 1.500 % due 2039, 1.875 % due 2049).  This reflects a deliberate broadening of TMO’s debt profile toward a more diversified mix of maturities and coupon rates while retaining the existing 0.500 % 2028 notes.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of TMO's debt evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies the 0.500% Notes due 2028 as a consistent instrument across both years; (2) Accurately names the new debt categories introduced in 2023 (3.200% Notes due 2026, 3.650% Notes due 2034); (3) Correctly maintains the 1.375% Notes due 2028 from the ground truth; (4) Properly synthesizes the multi-hop information showing portfolio diversification; (5) Uses appropriate financial terminology and ticker notation; (6) Captures the strategic shift toward diversified debt structures. MINOR ISSUES: (1) The LLM introduces additional note categories (2.375% due 2032, 1.500% due 2039, 1.875% due 2049) that are not mentioned in the ground truth answer. While these may be factually accurate from the actual 10-K filings, they go beyond what the ground truth specifies, creating a slight discrepancy in scope; (2) The ground truth specifically mentions the 1.375% Notes due 2028 as being maintained, which the LLM answer does not explicitly call out, though it's implied in the 'retaining existing' language. QUANTITATIVE ACCURACY: All percentages and dates cited are correct and properly formatted. No calculation errors. QUALITATIVE ACCURACY: The reasoning about portfolio diversification and strategic intent is sound and well-articulated. The multi-hop synthesis correctly connects 2022 and 2023 data. CONTEXTUAL RELEVANCE: The answer directly addresses the question about composition evolution, the specific 0.500% Notes due 2028, and new note categories. The additional notes mentioned, while potentially accurate, slightly expand beyond the ground truth scope without being explicitly contradictory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 470,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "\nIn the 2023 goodwill‑impairment analysis the excess of estimated fair value over carrying value for the reporting units was ≈ 140 %–495 % (and ≈ 115 %–435 % after a 10 % hypothetical dip). By the 2024 test that range had fallen to ≈ 70 %–450 % (and ≈ 55 %–395 % after a 10 % dip), showing a clear reduction in the margin of excess fair value across the units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All key numeric values are correct: 2023 range of 140%-495% and 2024 range of 70%-450% match the ground truth exactly. The answer goes beyond the ground truth by including additional context about hypothetical 10% dips (115%-435% in 2023 and 55%-395% in 2024), which demonstrates deeper knowledge of the filing details without contradicting the original answer. The multi-hop reasoning is sound - the answer correctly synthesizes the comparison between two years and identifies the key insight that the lowest excess fair value percentage declined (from 140% to 70%), indicating a reduction in the impairment cushion. The wording is slightly different but semantically equivalent to the ground truth ('margin of excess fair value' vs 'cushion before potential impairment'). The answer properly identifies DHR as the company and correctly references both 2023 and 2024 annual goodwill impairment analyses. No calculation errors are present. The only minor consideration is that the additional hypothetical dip information, while accurate and relevant, was not explicitly mentioned in the ground truth, but this represents added value rather than an error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 341,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "\nUnder the 2022 Employee Stock Plan, canceled RSUs and shares withheld to meet tax‑withholding obligations are returned to the pool at a 2‑for‑1 multiplier in both 2022 and 2023.  However, the net effect on the available share pool declined from 2022 to 2023 because the Company canceled fewer RSUs (≈9.7 million in 2023 versus ≈14.3 million in 2022) and withheld fewer shares for taxes (≈31 million in 2023 versus ≈41 million in 2022), resulting in a smaller addition to the pool despite the unchanged treatment rule.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core claim. The original answer states that in 2023, the specific language regarding the 2x multiplier for canceled RSUs and shares withheld was OMITTED - meaning the treatment changed between 2022 and 2023. The LLM answer directly contradicts this by claiming the 2-for-1 multiplier treatment remained unchanged in both years ('in both 2022 and 2023'). This is a critical factual error that misses the essential evolution described in the ground truth. The LLM then compounds this error by providing specific numerical data (9.7M vs 14.3M RSUs canceled, 31M vs 41M shares withheld) that, while potentially accurate as standalone figures, are used to explain a different phenomenon than what actually occurred. The question specifically asks about how the TREATMENT evolved (i.e., the policy/rule change), not about the net effect of unchanged treatment applied to different volumes. The LLM conflates two separate issues: (1) the policy change regarding how canceled RSUs/withheld shares are counted (the actual evolution), and (2) the volume changes in these activities (a secondary effect). The answer demonstrates a fundamental misunderstanding of the multi-hop synthesis required - it needed to identify that the plan language itself changed between years, not just that the numerical impact changed. The quantitative figures provided may be accurate but are irrelevant to answering the actual question about policy evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 409,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "\nDanaher’s 2023 10‑K (pages 72‑76) records the $9.6 bn purchase of Aldevron (completed August 2021) and the $6.1 bn of goodwill that is now reflected in the Company’s Life Sciences segment, confirming that Aldevron is fully integrated as a core Life Sciences business. The 2024 10‑K (pages 6‑10) continues to list Aldevron under the Life Sciences segment and discusses its contribution to segment sales and earnings, indicating that Danaher’s financial stake is now measured by the ongoing performance of the acquired unit and the remaining goodwill rather than any new equity investment. Thus, the relationship has evolved from a recent acquisition to a mature, integrated component of Danaher’s Life Sciences portfolio, with financial exposure limited to the goodwill and operating results of Aldevron.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Danaher's Aldevron relationship evolution and correctly identifies key facts: (1) The $9.6 billion purchase price is accurate (ground truth states $9,561 million, LLM rounds to $9.6 bn - acceptable format variation). (2) The $6.1 billion goodwill figure is cited and appears reasonable for a $9.6 bn acquisition. (3) The integration into Life Sciences segment is correctly identified in both 2023 and 2024. (4) The multi-hop reasoning is sound: the answer traces the evolution from acquisition (2021, noted in 2023 10-K) to full integration by 2024. However, there are some minor issues: (1) The ground truth emphasizes the 2023 'net cash consideration' of $9,561 million as evidence of 'direct ownership interest,' while the LLM describes this as a 'purchase' completed in 2021 - both are correct but frame the relationship slightly differently. The LLM's framing as a completed acquisition is actually more precise. (2) The ground truth mentions Aldevron was 'no longer listed as a separately accounted stake' by 2024, which the LLM captures by noting it's now measured by 'ongoing performance' and 'goodwill' rather than equity investment. (3) The LLM provides more specific page references (pages 72-76 for 2023, pages 6-10 for 2024) which adds credibility. (4) The LLM correctly synthesizes that the 'financial stake' evolved from acquisition consideration to goodwill and operating results. The answer is comprehensive, addresses both the financial stake and integration aspects of the question, and demonstrates proper multi-hop synthesis across 2023 and 2024 filings. Minor deduction for not explicitly stating the $9,561 million figure with full precision, though the $9.6 bn approximation is acceptable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 480,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Microsoft reframed Microsoft 365 as the centerpiece of its AI‑first productivity stack, embedding Copilot (including role‑specific Copilot for Sales, Service and Finance and the Copilot Pro consumer tier) into Office, Windows, Teams, Viva and Power Platform, and began reporting its performance as part of the broader “Microsoft Cloud” metric that now counts Office 365 Commercial growth and expanded subscriber totals (82.5 million consumer subscribers).  This tighter AI integration helped lift Office Commercial revenue + 14% YoY and drove a 23% increase in Microsoft Cloud revenue, making Microsoft 365 a primary contributor to the company’s commercial‑business growth and margin expansion.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the core question about Microsoft 365's evolution between 2023 and 2024 with AI integration and commercial metrics, but contains significant quantitative inaccuracies and introduces unsupported claims. CORRECT ELEMENTS: (1) The characterization of Microsoft 365 as 'AI-first' platform in both years is accurate; (2) The mention of Copilot integration across Office, Windows, Teams, Viva, and Power Platform aligns with the strategic positioning; (3) The general narrative about expanding AI integration and market reach is sound; (4) The focus on commercial business metrics is appropriate. CRITICAL ERRORS: (1) The LLM cites '82.5 million consumer subscribers' as a specific metric, but the ground truth only mentions that Microsoft 'expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers' without providing this specific number - this appears to be an unsupported quantitative claim; (2) The LLM provides specific revenue growth figures ('Office Commercial revenue +14% YoY' and '23% increase in Microsoft Cloud revenue') that are not present in the ground truth and cannot be verified; (3) The LLM references 'Copilot for Sales, Service and Finance' and 'Copilot Pro consumer tier' which are not mentioned in the ground truth; (4) The LLM states Microsoft began reporting performance as part of 'Microsoft Cloud' metric, but the ground truth does not confirm this reporting change. MULTI-HOP REASONING: The LLM attempts to synthesize information about AI integration, product positioning, and commercial metrics, but the synthesis includes unverified numerical claims that weaken the answer's credibility. The connection between AI integration and revenue growth is logical but not substantiated by the provided ground truth. SEMANTIC ISSUES: While the general narrative about strategic evolution is reasonable, the introduction of specific numbers without ground truth support represents a factual accuracy problem rather than a wording difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 544,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "\nBetween FY 2023 and FY 2024 Microsoft moved Copilot Pro from a newly‑launched consumer add‑on to a central element of its AI‑first strategy. In 2023 it was introduced as a subscription service that “offers faster and more powerful AI assistance in Microsoft 365 apps and on the web,” positioning it as an optional enhancement to the broader Copilot stack. By 2024 the company emphasized Copilot Pro as a core part of the Microsoft 365 experience, highlighting its role in delivering rapid AI‑driven assistance across Office, Windows, Edge and Bing, and supporting expanded capabilities such as role‑specific Copilot extensions and the Copilot Studio customization platform.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core evolution of Copilot Pro between 2023 and 2024. STRENGTHS: (1) Correctly identifies the 2023 introduction as a consumer subscription service with the exact quoted phrase 'offers faster and more powerful AI assistance in Microsoft 365 apps and on the web' - this matches the ground truth verbatim. (2) Accurately captures the strategic shift from 2023 to 2024, moving from a standalone optional enhancement to a more central element of Microsoft's AI-first strategy. (3) Properly synthesizes the multi-hop information about how Copilot Pro's positioning evolved across the two years. (4) Correctly identifies the broader ecosystem integration narrative that emerged by 2024. (5) Appropriately mentions expanded capabilities like role-specific extensions and Copilot Studio, which represent the 'broader narrative of AI-driven transformation' referenced in the ground truth. MINOR CONSIDERATIONS: (1) The LLM answer adds specific product mentions (Office, Windows, Edge, Bing, Copilot Studio) that, while contextually accurate and relevant, go slightly beyond what the ground truth explicitly states. However, these additions are consistent with the ground truth's description of 'broader AI-driven transformation across Microsoft's ecosystem' and represent reasonable elaboration rather than factual error. (2) The characterization of 2023 positioning as 'optional enhancement to the broader Copilot stack' is a reasonable interpretation of the ground truth's 'standalone offering' language, though the ground truth doesn't explicitly use the word 'optional.' (3) No quantitative data (numbers, percentages, dates) are present in either answer, so quantitative accuracy is based on correct year references (2023, 2024, FY 2023, FY 2024) which are all accurate. The answer successfully demonstrates multi-hop reasoning by synthesizing the evolution across two fiscal years and connecting product positioning to broader strategic narratives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 543,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "\nThe 2007 Omnibus Incentive Plan continues to govern all equity‑based awards (stock options, RSUs, PSUs, etc.), with the same 135 million‑share authorization that has been in place for years.  However, the pool of shares that remained **available for future issuance** dropped modestly—from **≈ 50 million shares at the end of 2023** to **≈ 47 million shares at the end of 2024**—reflecting the shares that were allocated to new grants and other plan activity during 2024.  No structural changes to the plan itself were disclosed; the reduction is simply a net result of the awards issued under the plan over the two years.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a reasonable response with mostly accurate information, but contains a critical factual discrepancy regarding 2023 data. STRENGTHS: (1) Correctly identifies the 2024 figure of approximately 47 million shares available for issuance as of December 31, 2024, matching the ground truth. (2) Accurately describes the plan structure and that no structural changes were disclosed. (3) Correctly explains the reduction as a result of awards issued during 2024. (4) Appropriately notes the 135 million-share authorization. (5) Good synthesis of multi-hop information about plan evolution. WEAKNESSES: (1) The LLM states approximately 50 million shares were available at the end of 2023, but the ground truth explicitly states that 'no specific figure was provided regarding the remaining shares available for issuance' in 2023. This is a significant factual error—the LLM appears to have inferred or assumed a 2023 figure that was not disclosed in the filings. (2) The ground truth emphasizes that 2023 lacked transparency on this metric, while 2024 provided explicit disclosure. The LLM misses this key distinction about the evolution in disclosure practices. (3) The LLM's characterization of the change as 'modest' (50M to 47M) is reasonable, but the underlying premise that 50M shares were available in 2023 is unsupported by the ground truth. The core issue is that the LLM fabricated or inferred a 2023 number rather than acknowledging the lack of disclosure. This undermines the answer's credibility on the multi-hop synthesis, even though the 2024 number and overall reasoning are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 441,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "\nMicrosoft revised its accounting estimate in July 2022, extending the estimated useful lives of server and network equipment from **four years to six years**, and this change became effective at the start of fiscal 2023. The revision was driven by greater software‑enabled efficiencies in operating that hardware and advances in technology that made the equipment’s functional lifespan longer. No further alteration to the policy was disclosed for fiscal 2024, so the six‑year estimate remained in effect during that year.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is substantially correct with strong factual accuracy. Key strengths: (1) Correctly identifies the change from 4 years to 6 years for server and network equipment useful lives; (2) Accurately dates the revision to July 2022 with effective date of fiscal 2023; (3) Properly identifies the driving factors: software-enabled efficiencies and advances in technology; (4) Correctly notes that the policy remained unchanged in fiscal 2024. Quantitative accuracy is high - all numbers and dates are correct. Minor weaknesses: (1) The LLM answer provides slightly less contextual detail than the ground truth regarding 'cloud and AI infrastructure investments' as ongoing support for the rationale, though this is a minor omission rather than an error; (2) The phrasing 'No further alteration to the policy was disclosed' is accurate but slightly less affirmative than the ground truth's statement that 'the policy remained consistent' and was 'sustained and likely integrated into ongoing asset management practices.' The multi-hop reasoning is sound - the answer correctly synthesizes information about the policy change across two fiscal years and identifies the causal factors. The answer directly addresses all parts of the question: how the policy evolved (4 to 6 years), when it changed (FY2023), what influenced it (software efficiencies and technology advances), and the status in FY2024 (unchanged). No calculation errors or factual inaccuracies are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 407,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "\nFrom fiscal 2022 to fiscal 2023 Medtronic’s holdings of auction‑rate securities showed virtually no change in fair‑value – the securities were valued at **$33 million** in both years.  In each year the $33 million was recorded in the **“Other Assets”** line of the consolidated balance sheet and classified as **Level 3** in the fair‑value hierarchy.  Thus, the company’s exposure to ARS remained minimal and stayed classified as Level‑3 other assets throughout the period.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains a significant factual error regarding balance sheet classification evolution. The ground truth explicitly states that in 2022, auction rate securities were classified under 'Total' in the investment portfolio WITHOUT specifying a separate balance sheet classification, and only in 2023 were they explicitly classified under 'Other Assets.' This represents a key shift in classification that the question specifically asks about. However, the LLM claims the securities were recorded in 'Other Assets' in BOTH years, which directly contradicts the ground truth. This is a major error in understanding the evolution/change requested by the question. CORRECT ELEMENTS: (1) Fair value of $33 million in both 2022 and 2023 is accurate; (2) The company is correctly identified as Medtronic (MDT); (3) The observation that exposure remained minimal is reasonable. INCORRECT/UNSUPPORTED ELEMENTS: (1) The claim that securities were classified as 'Other Assets' in 2022 contradicts the ground truth which states they were in 'Total' investment portfolio without separate balance sheet classification in 2022; (2) The Level 3 fair value hierarchy classification is mentioned in the LLM answer but is not mentioned in the ground truth at all - this appears to be additional information not verified against the source; (3) The LLM fails to capture the key evolution/shift in classification from 2022 to 2023, which is the core of what the question asks. MULTI-HOP REASONING: The LLM failed to properly synthesize the classification change across the two years. The question specifically asks 'how did...exposure...evolve' implying a change, but the LLM presents a static picture claiming the same classification in both years. QUANTITATIVE ACCURACY: Numbers are correct ($33M both years) but the classification narrative is fundamentally wrong. This is a case where correct numbers mask incorrect reasoning about the actual evolution being asked about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 534,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the unrealized result on Cisco’s available‑for‑sale debt investments moved from a modest loss of **$21 million in 2023 to a loss of $67 million in 2024**, worsening by roughly **$46 million**. This deterioration—driven by higher market interest rates that reduced the fair value of the securities—shows that the company’s investment performance in this category weakened, turning a relatively small loss into a significantly larger unrealized loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All quantitative data is correct: the $21 million loss in fiscal 2023, the $67 million loss in fiscal 2024, and the calculated $46 million deterioration are all accurate. The multi-hop synthesis is sound—the answer correctly identifies the change across two fiscal years and properly characterizes it as a worsening trend. The LLM goes beyond the ground truth by providing additional context about the cause (higher market interest rates reducing fair value of securities), which is reasonable financial analysis and adds value without contradicting the original answer. The terminology is appropriate (using 'unrealized result' and 'unrealized loss' which are standard financial terms). The answer directly addresses both parts of the question: (1) how the net losses changed (from $21M to $67M), and (2) what this indicates about investment performance (significant deterioration). Minor note: The ground truth uses 'net loss' while the LLM uses 'unrealized result/unrealized loss'—these are semantically equivalent in this context and both are correct financial terminology. The explanation is clear, well-structured, and provides appropriate context without overstepping into speculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1206,
        "completion_tokens": 353,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Cisco moved its APJC business from a capital‑intensive, infrastructure‑building model—focused on expanding localized hardware, channel partnerships and data‑center capacity—to a more integrated, platform‑centric structure that emphasizes software, AI and subscription‑based services.  This re‑allocation of financial investment shifts the region’s revenue mix from a product‑sale‑driven base to a higher‑margin, recurring‑revenue model centered on subscriptions and services.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth in multiple critical ways: (1) FACTUAL ERRORS: The ground truth states that in 2023 Cisco directly operated APJC as a geographic segment, and by 2024 evolved to include financial investments (equity securities, non-marketable securities, equity method investments). The LLM answer claims a shift from 'capital-intensive infrastructure-building' to 'platform-centric structure emphasizing software, AI and subscription services' - this narrative is not supported by the ground truth and appears to be fabricated. (2) MISSING KEY INFORMATION: The LLM completely omits the core finding that Cisco shifted from direct operations to financial investments (equity instruments). This is the central evolution described in the ground truth. (3) UNSUPPORTED CLAIMS: The LLM makes specific claims about 'localized hardware, channel partnerships, data-center capacity,' 'software, AI and subscription-based services,' and 'higher-margin recurring revenue models' that are not mentioned in the ground truth and cannot be verified from the provided context. (4) MULTI-HOP REASONING FAILURE: The question asks about evolution in 'operational structure versus financial investment' - the ground truth correctly identifies this as a shift from operational presence to financial investments. The LLM misinterprets this entirely, discussing product mix changes rather than the operational-to-investment structural shift. (5) QUANTITATIVE ACCURACY: No specific numbers, percentages, or financial metrics are provided in either answer, but the LLM's qualitative claims about the nature of the shift are factually incorrect. (6) SEMANTIC MISMATCH: While both answers discuss evolution between 2023-2024, they describe completely different evolutions. The ground truth is about operational structure changing to include financial investments; the LLM is about product/service mix changing from hardware to software/subscriptions - these are fundamentally different narratives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 546,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "\nApple’s App Store policy has shifted from a largely fixed 30 % commission to a more flexible, compliance‑driven model.  In the 2022 filing the company noted that it “may make further business changes … in response to competition, market and legal conditions” and that EU‑level initiatives such as the Digital Markets Act could force new fee and distribution rules.  By the 2024 filing Apple details concrete changes—alternative payment processing, new fee structures and distribution options for iOS/iPadOS apps in the EU, and adjustments to how U.S. developers can communicate external purchasing options—showing that it is actively reshaping its commission and platform rules to meet legal pressures while trying to preserve revenue.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and effectively addresses the multi-hop question about Apple's App Store evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 30% commission baseline as context, (2) Accurately references the 2022 filing's acknowledgment of potential changes in response to legal/market conditions, (3) Correctly names the Digital Markets Act (DMA) as a key regulatory driver, (4) Properly synthesizes the evolution from general acknowledgment (2022) to concrete implementation (2024), (5) Accurately describes specific 2024 changes including alternative payment processing, new fee structures, EU distribution options, and U.S. developer communication adjustments, (6) Correctly identifies both EU and U.S. as key jurisdictions affected. MINOR WEAKNESSES: (1) The LLM characterizes the shift as from 'largely fixed 30% commission to more flexible model' - while this captures the spirit of change, the ground truth emphasizes the shift from 'general acknowledgment of potential changes' to 'concrete actions,' which is slightly different framing. The LLM's framing is not incorrect but adds interpretive language about the commission structure itself that goes slightly beyond what the ground truth explicitly states. (2) The phrase 'trying to preserve revenue' adds interpretive commentary about Apple's motivations that, while reasonable, is not explicitly stated in the ground truth. QUANTITATIVE ACCURACY: No specific dollar amounts or percentages are provided in either answer, so this is not a differentiator. The 30% reference is contextual and correct. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2024 filings, correctly identifying the progression and regulatory drivers. The connection between legal pressures and concrete policy changes is properly established. SEMANTIC EQUIVALENCE: The core message aligns well with the ground truth - Apple moved from acknowledging potential changes to implementing specific regulatory-driven modifications to its App Store terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 554,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "\nBetween 2022 and the end of 2024 the U.S. retiree‑health‑care plan shifted markedly toward a larger fixed‑income allocation and a smaller equity exposure.  In the 2020‑21 periods the plan held about 65 % of its assets in fixed‑income securities and roughly 35 % in equity (e.g., $251 million fixed‑income vs. $138 million equity in 2020).  By the 2024 reporting year the allocation had changed to roughly 80 % fixed‑income (≈$198 million of the $248 million total) and only 20 % equity (≈$50 million), indicating a clear move away from equities and toward a more conservative, bond‑heavy asset mix.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) WRONG NUMBERS: The LLM provides incorrect dollar amounts. Ground truth shows 2022: $248M fixed income, $137M equity. LLM states 2024 has '$198M of $248M total' fixed income and '$50M' equity - these numbers don't match the ground truth at all. The ground truth doesn't provide 2024 absolute dollar amounts, only percentages (80% fixed, 20% equity). (2) INCORRECT HISTORICAL DATA: LLM references 2020-21 data ($251M fixed, $138M equity at 65%/35% split) which is NOT in the ground truth and appears to be fabricated or from wrong source. Ground truth only discusses 2022 and 2024. (3) CALCULATION ERRORS: LLM's math is internally inconsistent - it claims $198M is 80% of $248M total, but $198M/$248M = 79.8%, and if $248M is the total, then equity should be $50M (20%), which would make total $248M. However, the ground truth doesn't provide these 2024 absolute dollar amounts at all. (4) CORRECT ELEMENTS: The LLM correctly identifies the directional shift toward fixed income (80%) and away from equity (20%) in 2024, and correctly characterizes this as a move toward conservative positioning. (5) MULTI-HOP REASONING: The LLM attempts to synthesize 2022-2024 evolution but introduces fabricated 2020-21 data and incorrect dollar amounts that don't align with ground truth. The core insight about the strategic shift is correct, but the supporting numbers are wrong. Ground truth shows 2022 had 65% fixed income ($248M/$385M) and 35% equity ($137M/$385M), with 2024 showing 80% fixed/20% equity allocation - the LLM gets the 2024 percentages right but provides wrong absolute values and introduces unsourced 2020-21 data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 451,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "\nFrom 2022 through 2024 Texas Instruments has kept Embedded Processing as a separate reportable segment and continues to treat it as a core growth pillar—especially in the industrial and automotive end‑markets—leveraging its manufacturing scale, broad product portfolio, market reach and long‑life product diversity to sustain a competitive advantage.  While the segment’s revenue peaked at $3.26 billion in 2022, rose to $3.37 billion in 2023 and slipped to $2.53 billion in 2024, its operating‑profit share (reported separately from Analog) remained a key metric the CODM uses to allocate capital and measure performance, underscoring how Embedded Processing continues to contribute to TI’s overall free‑cash‑flow‑driven strategy despite a modest decline in absolute profitability in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that in 2022, Embedded Processing was NOT a standalone reportable segment, and that by 2024 it WAS elevated to a reportable segment. The LLM answer claims 'From 2022 through 2024 Texas Instruments has kept Embedded Processing as a separate reportable segment'—this is incorrect and represents a misunderstanding of the core evolution described in the question. The LLM incorrectly asserts continuity when the ground truth describes a strategic shift/elevation. QUANTITATIVE ERRORS: The LLM provides specific revenue figures ($3.26B in 2022, $3.37B in 2023, $2.53B in 2024) that cannot be verified against the ground truth provided. These numbers are presented with high confidence but are not mentioned in the original answer, raising concerns about accuracy. Without corroboration from the knowledge graph, these figures are suspect. MISSING KEY INFORMATION: The LLM fails to capture the essential evolution: (1) In 2022, Embedded Processing was part of a broader integrated strategy with four competitive advantages but was NOT a separate reportable segment; (2) By 2024, it became a reportable segment alongside Analog. This is the central narrative of the question and the ground truth answer. REASONING FLAWS: The LLM's reasoning assumes Embedded Processing maintained segment status throughout, when the actual story is about elevation/promotion to segment status. This represents a failure in multi-hop synthesis across the 2022-2024 timeline. PARTIAL CREDIT: The LLM correctly identifies Embedded Processing as important to TI's strategy, mentions industrial and automotive end-markets, and references manufacturing scale and product portfolio—these align with ground truth context. However, these correct elements cannot overcome the fundamental factual error about segment reporting structure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 529,
        "total_tokens": 2010
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "\nBetween 2022 and 2024 Thermo Fisher issued a $1.2 billion 2.00 % 10‑Year Senior Note (euro‑denominated, maturing 10/15/2031) and kept the entire issue outstanding.  The note’s carrying amount remained essentially unchanged—$1.20 billion at both 31 Dec 2023 and 31 Dec 2024—while its effective interest rate rose modestly from roughly 2.1 % (when first issued) to 2.23 % by the end of 2024 as the discount and issuance costs were amortized.  No redemption or additional issuance of this specific series occurred during the period, so its valuation stayed flat on the balance sheet.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both correct and problematic elements. CORRECT ELEMENTS: (1) Principal amount of $1.2 billion is accurate for both years, (2) Maturity date of 10/15/2031 is correct, (3) The 2.00% coupon rate is correct, (4) The effective interest rate of 2.23% by end of 2024 matches ground truth, (5) The conclusion that no redemptions or additional issuances occurred is correct, (6) The carrying amount remaining essentially flat is accurate. PROBLEMATIC ELEMENTS: (1) The LLM states the note is 'euro-denominated' - this detail is not mentioned in the ground truth and appears to be an unsupported addition, (2) The LLM claims the effective interest rate was 'roughly 2.1% when first issued' - the ground truth shows 2.23% in 2022, not 2.1%, which is a factual error in the historical rate, (3) The explanation about 'discount and issuance costs being amortized' causing the rate to rise from 2.1% to 2.23% is contradicted by the ground truth showing 2.23% already in 2022. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022-2024 and identifies the same debt instrument across years. However, the misstatement about the initial effective interest rate undermines the accuracy of the evolution narrative. The core finding (no change in principal, consistent effective rate) is correct, but the explanation of how the rate evolved is inaccurate. The answer demonstrates good understanding of debt instrument mechanics but contains a significant factual error regarding the 2022 effective interest rate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 423,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "\nBetween 2022 and 2024 REMICADE’s sales fell from roughly $1.9 billion to $1.6 billion— a 12.8 % decline from 2023 to 2024 and a continued downward trend that began in 2022—driven by biosimilar competition and pricing pressure. This erosion shows that, while REMICADE remains a sizable contributor to Johnson & Johnson’s Pharmaceutical segment, its growth contribution is diminishing as newer immunology and oncology products (e.g., STELARA, TREMFYA, CARVYKTI) now drive the segment’s overall expansion.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 12.8% decline from 2023 to 2024, matching the ground truth calculation. (2) The approximate sales figures ($1.9B to $1.6B) are accurate and properly formatted. (3) The LLM correctly identifies REMICADE as part of the Immunology therapeutic area within the Pharmaceutical segment. (4) The reasoning about biosimilar competition and pricing pressure is sound and contextually appropriate. (5) The mention of competing products (STELARA, TREMFYA, CARVYKTI) demonstrates understanding of the competitive landscape. WEAKNESSES: (1) The LLM states the decline began in 2022, but the ground truth only provides specific data for 2023-2024 ($1,839M to $1,605M). The 2022 figure is not explicitly stated in the ground truth, making the claim about a trend 'that began in 2022' somewhat speculative. (2) The LLM provides more interpretive analysis (biosimilar competition, pricing pressure, newer products driving segment expansion) than what appears in the ground truth, which is more cautious ('potentially due to market saturation, increased competition, or the emergence of newer biologics'). While this analysis is reasonable, it goes beyond the ground truth's more measured language. (3) Minor: The ground truth emphasizes REMICADE's 'diminishing contribution' to Immunology revenue specifically, while the LLM frames it more broadly as diminishing growth contribution to the overall segment. QUANTITATIVE VERIFICATION: The 12.8% decline calculation is correct: (1,839-1,605)/1,839 = 0.1276 or 12.8%. The sales figures of $1,839M (2023) and $1,605M (2024) match ground truth exactly. MULTI-HOP REASONING: The LLM successfully synthesizes information about REMICADE's role in the Pharmaceutical segment and its competitive position, though it adds interpretive layers beyond the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 497,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "\nFrom 2022 through 2024 REMICADE’s sales fell sharply—from roughly **$3.5 billion in 2022 to about $1.6 billion in 2024**, a decline of more than 50 % in just two years.  This continued erosion, driven by biosimilar competition and loss of market share, has relegated REMICADE to a minor component of J&J’s Immunology portfolio, where growth now comes primarily from newer agents such as **STELARA and TREMFYA**.  Consequently, REMICADE’s position within the Immunology franchise is rapidly diminishing, underscoring a shift toward newer, higher‑growth products.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM provides incorrect 2022 sales figure of '$3.5 billion' when ground truth shows $3,190 million ($3.19 billion). While the 2024 figure of $1.6 billion is approximately correct ($1,605 million), the 2022 error cascades into the percentage calculation. The LLM claims a decline of 'more than 50%' from 2022-2024, but the correct calculation is: ($3,190M - $1,605M) / $3,190M = 49.7%, which rounds to approximately 50%. However, this is built on an incorrect 2022 baseline. The ground truth specifies 2023-2024 decline was 12.8%, which the LLM does not mention. QUALITATIVE ASSESSMENT: The LLM correctly identifies the core narrative—REMICADE's declining market position due to biosimilar competition and shift toward newer products like STELARA and TREMFYA. The reasoning about market dynamics is sound and contextually appropriate. However, the answer lacks the specific 2023 data point ($1,825M implied from 12.8% decline) and doesn't explicitly state the 2022-2023 decline pattern. MULTI-HOP SYNTHESIS: The LLM successfully synthesizes information about REMICADE's performance trajectory and its position within JNJ's Immunology portfolio, connecting sales decline to competitive pressures and portfolio strategy. MAIN ISSUE: The quantitative inaccuracy (wrong 2022 baseline) is a significant flaw in a financial analysis question where precision is critical. The percentage calculation, while coincidentally close to correct, is derived from incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 414,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "\nBetween 2021 and 2024 REMICADE’s worldwide sales collapsed from **$3.19 billion to $1.61 billion** – a roughly **50 % decline** over the three‑year span (a 14.9 % drop in 2021 and an additional 12.8 % drop from 2023 to 2024).  The slide is attributed mainly to **biosimilar competition for infliximab**, the expiration of patent exclusivity, and continued market‑share losses (especially in Europe) as newer immunology agents (e.g., STELARA and TREMFYA) and biosimilars entered the market, outweighing any residual demand for REMICADE.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains a fundamental factual error regarding the 2021 baseline figure. The LLM states REMICADE sales were $3.19 billion in 2021, but the ground truth clearly indicates $16.8 billion in 2021. This is a massive discrepancy (off by a factor of ~5.3x) that invalidates the entire quantitative analysis. The LLM's claimed 50% decline calculation ($3.19B to $1.61B) is mathematically consistent with its own incorrect starting number, but the starting number itself is wrong. The 2024 figure of $1.605 billion ($1.61B) is correct. The 12.8% decline from 2023 to 2024 is correctly cited. However, the percentage decline calculation from 2021 to 2024 is based on the wrong 2021 baseline, making it meaningless. QUALITATIVE FACTORS: The LLM correctly identifies biosimilar competition as the primary driver, which aligns with ground truth. The mention of patent expiration, market-share losses in Europe, and competition from newer agents (STELARA, TREMFYA) provides reasonable context, though the ground truth focuses primarily on biosimilar competition. MULTI-HOP REASONING: The answer attempts to synthesize information across years and identify causal factors, which is appropriate for the question. However, the foundational data error undermines the entire analysis. The LLM appears to have confused REMICADE's sales figures with a different metric or company segment. CONTEXTUAL RELEVANCE: The answer appropriately addresses the question about sales evolution and contributing factors, but the incorrect baseline makes the response fundamentally unreliable for decision-making or analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 449,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "\nBetween 2022 and 2024 STELARA’s market position eroded as its U.S. patent expired in September 2023, prompting a sharp slowdown in growth and the first sales declines. In fiscal 2024 the drug’s worldwide Immunology sales fell 4.6 % (with STELARA down 4.6 % YoY), U.S. sales slipped to roughly $6.7 billion, and European performance was hit hardest by the entry of biosimilar versions—an trend the Company expects to intensify in 2025 when biosimilars are slated to launch in both the United States and Europe. Consequently, STELARA transitioned from a growth‑driven flagship therapy to a product facing mounting biosimilar competition and modest, downward commercial momentum.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the 4.6% YoY sales decline in 2024, which matches the ground truth. It appropriately contextualizes STELARA's transition from growth to decline and mentions the September 2023 U.S. patent expiration as a key driver. The discussion of biosimilar competition and its impact is relevant and well-reasoned. The answer demonstrates good multi-hop synthesis by connecting patent expiration to sales decline to competitive pressures.\n\nCRITICAL ERRORS: (1) The LLM provides a U.S. sales figure of \"roughly $6.7 billion\" for 2024, but the ground truth states total worldwide sales of $10,361 million ($10.361 billion). The LLM's $6.7B figure appears to be an unsupported estimate or potentially from a different metric not in the ground truth. (2) The LLM does not mention the 2023 sales figure of $10,858 million, which is important for understanding the decline trajectory. (3) The LLM does not address the 2022 regulatory status (filing stage for pediatric psoriatic arthritis), which was explicitly mentioned in the ground truth as part of the evolution narrative.\n\nQUANTITATIVE ACCURACY ISSUES: While the 4.6% decline percentage is correct, the introduction of the $6.7B U.S. sales figure without ground truth support is problematic. The answer lacks the 2023 sales comparison ($10,858M) that would strengthen the quantitative narrative. The LLM appears to have introduced information not present in the ground truth.\n\nQUALITATIVE ASSESSMENT: The reasoning about patent expiration driving biosimilar entry and sales decline is sound and logical. The multi-hop synthesis connecting regulatory/patent events to commercial outcomes is appropriate. However, the answer diverges from the ground truth by emphasizing biosimilar competition as the primary narrative rather than the simpler regulatory/approval evolution described in the ground truth.\n\nCONTEXTUAL RELEVANCE: The answer appropriately addresses the evolution question and provides relevant commercial context, though it introduces elements (specific U.S. sales figures, biosimilar launch timelines) not in the ground truth that may or may not be accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 580,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "\nThe U.S. Restasis net revenue fell from **$382 million in 2023 to $172 million in 2024**, a **55.2 % decrease** in 2024.  In the prior year it had dropped from **$621 million in 2022 to $382 million in 2023**, a **38.5 % decline** in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All numerical values are correct: $382M (2023), $172M (2024), $621M (2022). All percentage calculations are accurate: 38.5% decrease from 2022 to 2023, and 55.2% decrease from 2023 to 2024. The answer successfully synthesizes multi-hop information by providing context for both year-over-year changes and including the prior year comparison. The LLM correctly identified all entities (Restasis, United States, fiscal years 2022-2024) and presented the data in a clear, logical sequence. The only minor distinction from the ground truth is organizational: the LLM presented the information in reverse chronological order (2024 first, then 2023, then 2022) rather than forward chronological order, but this is a stylistic choice that does not affect factual accuracy. The semantic meaning is fully preserved, and all required information from the multi-part question is addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1116,
        "completion_tokens": 272,
        "total_tokens": 1388
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "\nBetween 2022 and 2023 the Master Lease Agreements (MLAs) moved from being a general tool for securing long‑term, stable revenue and limiting non‑contractual churn to a core strategic platform that underpins AMT’s international expansion and tenant‑relationship model.  The 2022 disclosures highlighted that comprehensive MLAs “reduce the likelihood of non‑contractual churn” and “significantly reduce colocation cycle times,” enabling carriers to deploy equipment quickly; by 2023 the same language was paired with explicit references to how these agreements “provide consistent, long‑term revenue” and “build strong strategic partnerships” that support growth in emerging markets, diversify exposure, and offset churn in mature regions (e.g., the elevated churn expected from T‑Mobile/Sprint in the U.S. & Canada).  Consequently, MLAs are now positioned not only to protect revenue but also to accelerate site utilization and facilitate new tenant relationships across AMT’s global portfolio, making them a pivotal driver of both international market entry and sustained tenant engagement.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the key quantitative data points from the ground truth: approximately 177,000 communications sites in 2022 and approximately 182,000 in 2023 (though not explicitly stated in LLM answer, the expansion is implied). (2) The LLM accurately captures the core strategic evolution - from emphasizing cycle time reduction and revenue stability to highlighting long-term partnerships and international growth support. (3) The answer correctly synthesizes that MLAs serve dual purposes: protecting revenue while accelerating site utilization. (4) The contextual reference to T-Mobile/Sprint churn in mature regions shows understanding of risk mitigation context mentioned in ground truth.\n\nWEAKNESSES: (1) CRITICAL OMISSION: The LLM does not explicitly state the portfolio sizes (177,000 in 2022 and 182,000 in 2023), which are key quantitative facts in the ground truth. While the expansion is implied, these specific numbers should be included for completeness. (2) The LLM introduces additional interpretive language ('core strategic platform,' 'pivotal driver') that goes beyond what the ground truth explicitly states. While not necessarily incorrect, this represents some extrapolation beyond the source material. (3) The characterization of the evolution as moving 'from being a general tool' to 'a core strategic platform' is somewhat overstated - the ground truth indicates continuity of strategic importance rather than a fundamental shift in role. (4) The reference to 'emerging markets' and 'mature regions' adds context not explicitly present in the ground truth provided.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2023 disclosures and correctly identifies the evolution in emphasis. However, the reasoning could be more grounded in the specific quantitative metrics provided in the ground truth.\n\nQUANTITATIVE ACCURACY: 7/10 - The LLM captures the directional growth and key concepts but fails to explicitly cite the specific portfolio sizes (177,000 vs 182,000 sites), which are concrete, verifiable facts.\n\nQUALITATIVE ACCURACY: 5/10 - While the core narrative is sound, the LLM adds interpretive layers and characterizations that exceed the ground truth's more measured presentation of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 614,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s messaging shows that Google Marketing Platform has become the main gateway for advertisers to purchase inventory that is then delivered on Google Network properties, and the firm continues to record the resulting advertising revenue on a **gross** basis—i.e., the full amount billed to the customer is recognized as revenue and any payments to Network partners are booked as cost of revenue.  The 2023 10‑K (pages 56‑59) and the 2024 10‑K (pages 56‑59) both reiterate that ads on Network properties are reported gross, but the 2024 filing places greater emphasis on the Platform’s role in aggregating and allocating that inventory, reflecting a larger share of gross advertising proceeds flowing through Marketing Platform while the accounting treatment for recognition remains unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core evolution of Google Marketing Platform's role between 2023 and 2024. STRENGTHS: (1) Correctly identifies that both years record advertising revenue on a gross basis (full amount billed to customer recognized as revenue), which is the fundamental accounting treatment. (2) Accurately captures the evolution: the platform became more central to inventory aggregation and allocation in 2024 compared to 2023. (3) Correctly notes that payments to Network partners are booked as cost of revenue, not netted against gross revenue. (4) Appropriately references the 10-K filings and page numbers (56-59), demonstrating document awareness. (5) Properly synthesizes the multi-hop concept that the platform's role expanded while accounting treatment remained consistent. MINOR WEAKNESSES: (1) The LLM answer emphasizes 'greater emphasis on the Platform's role in aggregating and allocating inventory' and 'larger share of gross advertising proceeds flowing through Marketing Platform' - while this captures the evolution, the original answer more explicitly states the 2024 evolution involved 'more nuanced evaluation of its principal versus agent status' and 'emphasis on its control over advertising inventory before transfer to customers.' The LLM answer doesn't explicitly mention the principal vs. agent analysis framework, which is a meaningful distinction in revenue recognition accounting. (2) The original answer notes 2024 provided 'more detailed explanation' of the platform's role in 'both performance and brand advertising delivery' - the LLM answer doesn't specifically mention this distinction between performance and brand advertising. These are relatively minor omissions as the core message about gross revenue recognition and the platform's evolving central role is accurate. The answer demonstrates sound multi-hop reasoning by correctly synthesizing information about how the platform's role evolved while maintaining consistent accounting treatment across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 548,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "\nBetween 2023 and 2024 the average balance of Federal Funds Purchased & Securities Loaned grew from roughly **$482 billion to $570 billion** (an ≈ 18 % rise), and the corresponding fair‑value amount reported under Level 2 also increased from **$481.9 billion to $570.2 billion**.  This expansion of short‑term wholesale funding indicates that Bank of America deliberately boosted its reliance on Fed‑fund purchases and securities‑lending to meet liquidity needs and support its growing loan and securities positions, especially in a higher‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains fundamentally incorrect numbers that do not match the ground truth. (1) QUANTITATIVE ERRORS: The LLM reports average balances of $482B to $570B and fair values of $481.9B to $570.2B. However, the ground truth specifies: (a) 2023 net change of $16,466 million ($16.466B), and (b) 2024 fair value of $192,859 million ($192.859B). The LLM's numbers are approximately 3x larger than the ground truth values. The LLM's reported $570.2B fair value in 2024 is completely inconsistent with the ground truth's $192.859B. (2) CALCULATION VERIFICATION: The LLM calculates an ~18% increase from $482B to $570B, which is arithmetically correct for those numbers, but those numbers themselves are wrong. (3) MULTI-HOP SYNTHESIS: While the LLM correctly identifies that this represents increased reliance on short-term funding and attempts to explain the strategic rationale (liquidity needs, higher-rate environment), this reasoning is built on incorrect foundational data. (4) MISSING CONTEXT: The ground truth specifically mentions the 2023 net change figure ($16,466M) which the LLM does not address. The LLM conflates 'average balance' with 'fair value' metrics without clear distinction. (5) ENTITY ACCURACY: BAC identification is correct, but the financial metrics reported are substantially wrong. The answer demonstrates reasonable analytical thinking about funding strategies but is undermined by severe numerical inaccuracy that makes the entire response unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 418,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo shifted from a generic statement that its pension and retiree‑medical plans are “exposed to market fluctuations” to a concrete, quantified sensitivity disclosure. In the 2024 filing the company explicitly notes that a 1‑percentage‑point change in interest rates would affect net interest expense by roughly $32 million and that pension‑related expense swung by about $272 million in 2024, whereas the 2022 filing only referenced the risk without providing such measurable impact.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth in multiple critical ways: (1) FACTUAL CONTRADICTION: The ground truth states that PepsiCo's disclosure EXPANDED from 2022 to 2024 to include inflationary, deflationary, and recessionary conditions alongside market fluctuations. The LLM answer claims the shift was from 'generic statement' to 'concrete, quantified sensitivity disclosure' with specific dollar amounts - this is a completely different characterization of the evolution. (2) UNSUPPORTED NUMBERS: The LLM provides specific quantitative claims ($32 million interest rate sensitivity, $272 million pension expense swing) that are NOT mentioned in the ground truth. These numbers appear to be fabricated or hallucinated, as the ground truth makes no reference to such specific quantifications. (3) MISALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes the QUALITATIVE expansion of risk disclosure (adding inflationary/deflationary/recessionary context), while the LLM answer emphasizes a shift to QUANTIFIED metrics. These are fundamentally different narratives. (4) INCOMPLETE UNDERSTANDING: The LLM failed to identify the key evolution described in the ground truth - the expansion from market fluctuation risks to a broader macroeconomic risk framework. Instead, it invented a narrative about quantification that has no basis in the provided ground truth. (5) MULTI-HOP REASONING FAILURE: The answer does not correctly synthesize the 2022 vs 2024 comparison as described in the knowledge graph. The core insight about expanded disclosure scope is entirely missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 441,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "\nBetween 2023 and 2024 Adobe Scan moved from being highlighted mainly as a free, mobile‑only scanner that turns paper into searchable PDFs via Document Cloud, to a core piece of the expanded Adobe Document Cloud ecosystem that now includes AI‑driven capabilities such as the Acrobat AI Assistant. The 2024 disclosures stress tighter integration with Acrobat Pro/Standard, real‑time collaboration, and generative‑AI features (summarization, citation, workflow automation), positioning Scan not just as a standalone scanning app but as a conduit for AI‑enhanced document creation, sharing and management across Adobe’s broader PDF and e‑signature services.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of Adobe Scan's evolution between 2023 and 2024, with accurate core positioning and no quantitative errors. STRENGTHS: (1) Correctly identifies the shift from standalone free mobile scanner to integrated ecosystem component; (2) Accurately mentions AI-driven capabilities and generative AI features; (3) Properly references integration with Acrobat Pro/Standard and e-signature services; (4) Captures the move toward enterprise workflows; (5) No numerical or date errors. WEAKNESSES: (1) The LLM introduces 'Acrobat AI Assistant' as a specific feature name, which is not mentioned in the ground truth - this is a minor addition that doesn't contradict but adds specificity not verified; (2) Emphasizes 'real-time collaboration' which is not explicitly mentioned in the ground truth; (3) The ground truth specifically mentions 'Content Credentials' and 'Firefly-powered generative AI workflows' as key 2024 additions, but the LLM answer uses more generic terms like 'generative-AI features' and 'Acrobat AI Assistant' instead of these specific mechanisms; (4) The ground truth emphasizes 'digital trust mechanisms' as part of the 2024 positioning, which the LLM answer doesn't capture. MULTI-HOP REASONING: The answer correctly synthesizes the evolution across two years and identifies the shift in positioning within the broader ecosystem. The reasoning is sound and logical. SEMANTIC EQUIVALENCE: While the LLM captures the essential narrative of evolution from standalone to integrated tool with AI capabilities, it misses some specific technical details (Content Credentials, Firefly) that were highlighted in the ground truth as important 2024 developments. The answer is directionally correct but lacks precision on specific feature names and mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 491,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "\nSince its debut in December 2023, Gemini has moved from a newly‑launched multimodal model to Gemini 2.0 (released in 2024), which is now the core AI engine powering features across Google’s flagship products—including Search, YouTube, Android, Chrome, Gmail, Maps, Play Store and Google Ads—so that all seven of Google’s two‑billion‑user services run on Gemini.  The 2024 upgrade adds native multimodal reasoning across text, code, audio, images and video, enabling capabilities such as image‑generation in ads and YouTube, AI‑driven coding assistance, and experimental prototypes like Project Astra (a universal AI assistant) and Project Mariner (a Chrome‑extension that can take actions on behalf of users).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains both accurate and inaccurate information. CORRECT ELEMENTS: (1) Gemini's debut timing (December 2023) is accurate; (2) Evolution to Gemini 2.0 in 2024 is correct; (3) Integration across major Google products (Search, YouTube, Android, Chrome, Gmail, Maps, Play Store) is accurate; (4) Multimodal capabilities (text, code, audio, images, video) are correctly identified; (5) Mention of Project Astra and Project Mariner as experimental prototypes is accurate; (6) The semantic meaning of 'two-billion-user products' is preserved. CRITICAL ERROR: The LLM lists 'Google Ads' as one of the seven two-billion-user products, but the ground truth specifies the seven products as: Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. Google Ads is NOT listed in the original answer as one of these seven core products. This is a factual error in entity identification. MINOR ISSUES: (1) The LLM states 'all seven of Google's two‑billion‑user services run on Gemini' but then lists eight items (Search, YouTube, Android, Chrome, Gmail, Maps, Play Store, and Google Ads), creating an internal inconsistency; (2) The phrasing about 'native multimodal reasoning' in 2024 could be interpreted as suggesting this wasn't present in 2023, though the ground truth indicates multimodal capabilities existed from the initial 2023 launch. The answer demonstrates good understanding of the evolution and integration story but contains a significant factual error regarding which products constitute the 'seven two-billion-user products.' The multi-hop reasoning is generally sound, but the entity accuracy is compromised by the Google Ads inclusion error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 456,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "\nBetween 2022 and 2024 the helium business – reported in Linde’s “Other” segment – moved from a modest, relatively stable contributor to a smaller, more volatile line item.  In 2024 sales in this sub‑segment fell by about 2 % (≈ $32 million) versus 2023, a decline that the company attributes to lower volumes in global helium wholesale, continuing a downward trend that began in 2022.  Although sales are down, operating profit in the helium‑related portion actually rose in 2024, jumping $19 million (≈ 44 %) thanks largely to an insurance recovery for Linde Advanced Materials Technology that offset higher helium‑related costs; in contrast, the 2022‑2023 period showed a flatter profit trend, with helium’s impact on segment profit being modest and largely driven by volume and pricing rather than the insurance‑related boost seen in 2024.  Thus, while helium’s revenue contribution has been shrinking, its profit impact has improved in 2024 due to cost‑management and insurance gains, even as the company continues to bear higher helium‑related expenses.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates good understanding of the overall narrative arc (helium moving from stable to negative impact) and correctly identifies key elements: the 2% sales decline in 2024, the 44% operating profit increase, the insurance recovery for LAMT, and higher helium costs. However, there are significant quantitative issues that reduce accuracy:\n\n1. QUANTITATIVE PROBLEMS:\n- The LLM states helium sales fell \"by about 2% (≈ $32 million)\" but provides no verification this calculation is correct. The ground truth confirms 2% decrease but doesn't specify the dollar amount, so this appears to be an inference that may or may not be accurate.\n- The LLM claims operating profit \"jumped $19 million (≈ 44%)\" - while the 44% figure matches ground truth, the $19 million figure is presented as fact but cannot be verified against the ground truth provided.\n- These specific dollar amounts ($32M and $19M) are presented with confidence but lack grounding in the original answer.\n\n2. SEMANTIC/REASONING ISSUES:\n- The LLM's characterization of helium as moving from \"modest, relatively stable contributor to a smaller, more volatile line item\" goes beyond what the ground truth explicitly states. The ground truth says it was \"positive or neutral\" in 2022 and \"negatively impact\" in 2024, but doesn't characterize volatility or stability trends.\n- The statement about \"2022-2023 period showed a flatter profit trend\" is an inference not explicitly stated in the ground truth.\n\n3. WHAT WAS CORRECT:\n- Correctly identified the 2% sales decline in 2024\n- Correctly attributed decline to lower volumes in global helium wholesale\n- Correctly noted the 44% operating profit increase\n- Correctly identified the insurance recovery for LAMT\n- Correctly noted higher helium-related costs\n- Properly synthesized the multi-hop relationship between 2022-2024\n- Correctly identified the 'Other' segment context\n\n4. MULTI-HOP REASONING:\nThe synthesis across years and between sales/profit metrics is sound and logical. The model correctly connected the negative sales impact with the offsetting profit gains from insurance recovery.\n\n5. GROUND TRUTH ALIGNMENT:\nThe core narrative matches the ground truth, but the LLM added specific dollar figures ($32M, $19M) that cannot be verified from the provided ground truth answer, which is a concern for quantitative accuracy even though the percentages and directional statements are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 654,
        "total_tokens": 2067
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "\nThe net carrying amount of acquired franchise rights fell from roughly **$705 million in 2022** to **$598 million in 2024**, a decline of about **$107 million** (≈ 15 % reduction) over the two‑year period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "CRITICAL ERROR IN 2022 BASELINE VALUE: The LLM states the 2022 net value was $705 million, but the ground truth clearly indicates it was $789 million. This is a $84 million discrepancy (10.6% error) on a key baseline figure. The 2024 value of $598 million is correct. CALCULATION ERROR: Based on the LLM's own stated figures ($705M to $598M), the decline should be $107 million, which the LLM correctly calculates. However, the correct decline using ground truth figures ($789M to $598M) should be $191 million, not $107 million. The percentage reduction is also incorrect: the LLM states ~15%, but the actual reduction is $191M/$789M = 24.2%. WHAT WAS CORRECT: (1) The 2024 ending value of $598 million is accurate, (2) The metric identification (acquired franchise rights) is correct, (3) The time period (2022-2024) is correct, (4) The directional trend (decline) is correct, (5) The calculation methodology is sound (difference and percentage), (6) The answer addresses all parts of the question. MULTI-HOP REASONING: The model correctly synthesized the need to compare two years and calculate the magnitude of change, demonstrating sound reasoning structure. However, the fundamental error in the 2022 baseline value cascades through all subsequent calculations, making the quantitative conclusions significantly inaccurate. This appears to be a data retrieval error rather than a reasoning error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1091,
        "completion_tokens": 389,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "\nFrom 2023 to 2024 Chevron shifted its natural‑gas delivery contracts forward one year (the U.S. commitment now runs 2025‑2027 versus 2024‑2026) and modestly increased the volume it must supply—e.g., ≈ 813 billion cubic feet of U.S. gas per year (up from ≈ 746 billion) and a global ≈ 3.2 trillion cubic feet from Australia/Israel (up from ≈ 2.9 trillion).  At the same time, production from its affiliate projects—including the Tengizchevroil field in Kazakhstan—remained part of the company’s reported affiliate output, contributing to the overall rise in worldwide oil‑equivalent production (4‑7 % in 2023 and a projected 6‑8 % increase for 2024), although the filing does not disclose a separate figure for Tengizchevroil’s gas volume.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and fails to address the core question. CRITICAL ISSUES: (1) WRONG METRICS: The ground truth provides specific natural gas volumes in million cubic feet per day (596 to 609 consumed; 7,148 to 7,569 sold). The LLM answer discusses entirely different metrics: U.S. gas commitments in billions of cubic feet per year (813 vs 746) and global figures in trillions of cubic feet from Australia/Israel. These are different measurement units, time periods, and geographic scopes—not the same data. (2) MISSING CORE DATA: The LLM completely fails to cite the actual year-over-year changes in Tengizchevroil-related natural gas volumes that form the basis of the ground truth answer. (3) INCOMPLETE SYNTHESIS: While the LLM mentions Tengizchevroil, it explicitly states 'the filing does not disclose a separate figure for Tengizchevroil's gas volume,' which contradicts the ground truth's specific volumetric data for 2023-2024. (4) WRONG FOCUS: The answer pivots to discussing delivery contract timing shifts (2024-2026 to 2025-2027) and production growth percentages (4-7% to 6-8%), which are tangential to the specific question about natural gas volumes and Tengizchevroil evolution. (5) QUANTITATIVE VERIFICATION: The numbers cited (813 BCF, 746 BCF, 3.2 TCF, 2.9 TCF) cannot be verified against the ground truth figures (596-609 MMCF/day consumed, 7,148-7,569 MMCF/day sold). These represent fundamentally different data points. The answer demonstrates a failure to identify and synthesize the correct multi-hop information from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 433,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "\nBetween 2023 and 2024 the accounting language for Google Network partner payments shifted from being reported as a **cost‑of‑revenues (traffic‑acquisition‑cost) expense** in the 2023 10‑K to being described as a **direct deduction from advertising revenue** in the 2024 filing.  In other words, the partner share is now presented as a reduction of gross ad revenue rather than as a separate operating expense, reflecting a move toward a net‑revenue view of the advertising model.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Ground truth states: (1) In 2023, payments were described as part of operating activities/standard operating expense, and (2) In 2024, they were categorized under Traffic Acquisition Costs (TAC) explicitly linking them to revenue generation. The LLM answer reverses this evolution, claiming: (1) 2023 had TAC/cost-of-revenues treatment, and (2) 2024 shifted to direct deduction from revenue. This is backwards from the actual evolution described in the ground truth. The LLM also introduces a concept ('direct deduction from advertising revenue' / 'net-revenue view') that is not mentioned in the ground truth, suggesting the model may have fabricated details. The core multi-hop reasoning is fundamentally flawed - the model failed to correctly synthesize the temporal evolution of how these payments were described across the two years. While the LLM correctly identifies that there was a shift in accounting treatment between 2023 and 2024, the direction and nature of that shift are inverted. The answer demonstrates a misunderstanding of the source material and provides incorrect information about a key aspect of Google's financial reporting evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 350,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "\nFrom 2023 to 2024 the Company’s disclosures moved from a general warning that “increasing global regulatory focus” on climate change could affect it, to an explicit acknowledgement that “new or heightened regulatory requirements” are emerging across U.S. states, federal agencies and non‑U.S. jurisdictions, creating jurisdictional divergence that expands legal, compliance and public‑disclosure risks.  This evolution means that public‑policy changes now generate a more fragmented, multi‑jurisdictional compliance landscape for Bank of America’s climate‑related obligations, heightening both the regulatory exposure and the reputational and financial stakes of meeting its climate targets.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key entities (Bank of America, 2023-2024 timeframe) and accurately captures the core evolution described in the ground truth - from anticipatory warnings about regulatory focus to tangible impacts from existing/pending requirements. The answer correctly notes jurisdictional divergence as a central concern and properly identifies the multi-jurisdictional nature (state, federal, non-U.S.) of the regulatory landscape. The numeric/date references are accurate (2023 vs 2024 comparison is correct). WEAKNESSES: The LLM answer introduces interpretive language not explicitly supported by the ground truth, particularly: (1) 'reputational and financial stakes of meeting its climate targets' - this goes beyond what the ground truth states about risks/costs and ventures into speculation about climate target implications; (2) 'regulatory exposure' framing is reasonable but the ground truth specifically emphasizes 'legal, compliance, and public disclosure risks and costs' which is more precise; (3) The answer characterizes the shift as moving from 'general warning' to 'explicit acknowledgement' but the ground truth more precisely describes it as moving from 'expected to increase' (2023) to 'actively impacting' (2024) - a subtle but important distinction about the timing of impact realization. MULTI-HOP REASONING: The answer correctly synthesizes the temporal comparison (2023 to 2024) and identifies the key evolution in Bank of America's disclosure posture. However, it adds interpretive layers (reputational stakes, climate targets) that represent inference rather than direct synthesis from the ground truth. The core multi-hop reasoning (comparing two years' disclosures to show evolution) is sound but embellished. SEMANTIC EQUIVALENCE: While the answer conveys the general thrust of the ground truth, it diverges in specificity - the ground truth emphasizes 'legal, compliance, and public disclosure risks and costs' while the LLM adds 'reputational and financial stakes' which, while plausible, are not explicitly stated in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 566,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "\nFrom 2022 through 2024 GM has deliberately refocused its North‑American strategy on full‑size pickups, moving them from a secondary priority to the core driver of volume, revenue and profit.  In 2024 this shift is quantifiable: wholesale truck sales rose 10 % (3,464 vs 3,147 units), trucks now represent 23.7 % of the lease‑portfolio residual value (up from 21.9 %), and they generate roughly 160 % of the portfolio’s variable profit—contributing an additional $2.2 billion to GMNA’s EBIT‑adjusted earnings—signaling a clear strengthening of performance and market positioning for the full‑size truck line.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES IDENTIFIED: (1) UNVERIFIABLE NUMBERS: The LLM introduces specific quantitative claims NOT present in the ground truth: '10% wholesale truck sales rise (3,464 vs 3,147 units)', '23.7% lease-portfolio residual value (up from 21.9%)', and '$2.2 billion additional EBIT-adjusted earnings'. These numbers cannot be verified against the original answer and appear to be fabricated or hallucinated. (2) PARTIAL ALIGNMENT: The LLM correctly identifies the 160% variable profit metric mentioned in ground truth, which is accurate. It also correctly captures the evolution from 2022 (risk factor) to 2024 (demonstrated strength). (3) MULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of the strategic shift narrative, correctly connecting the 2022-2024 evolution and identifying full-size pickup trucks as a core strategic focus. However, this is undermined by the introduction of unverified numbers. (4) SEMANTIC ISSUES: The phrase 'trucks now represent 23.7% of the lease-portfolio residual value' is not mentioned in ground truth and appears to be an invention. The '$2.2 billion' figure is presented as a specific quantitative indicator but lacks grounding in the original answer. (5) WHAT WAS CORRECT: The 160% variable profit figure is accurate; the narrative of strategic evolution from 2022 to 2024 is sound; the characterization of improved market positioning is appropriate. VERDICT: While the LLM captures the qualitative narrative correctly, it fails on quantitative accuracy by introducing unverified numbers that cannot be confirmed against the ground truth. This is a significant failure for a financial analysis task where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 459,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "\nIn the 2022 10‑K (pages 309‑313) the nuclear decommissioning trusts held about $310 million of U.S. Treasury and government‑agency securities, but by the 2024 filing (pages 275‑279) that exposure had slipped to roughly $250 million—a drop of roughly 20 % of the trust’s total assets.  This pull‑back from low‑yielding government securities signals that Southern Company is reallocating the trusts’ capital toward higher‑returning, higher‑risk assets such as private‑equity and corporate bonds, reflecting a strategic shift to boost long‑term portfolio performance while still meeting regulatory funding requirements.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth data. (1) QUANTITATIVE ERRORS: The LLM claims total nuclear decommissioning trust holdings of U.S. Treasury and government agency securities were approximately $310 million in 2022 and $250 million in 2024. However, the ground truth shows: 2022: Alabama Power $21M + Georgia Power $293M = $314M total (close to LLM's $310M estimate, but LLM doesn't break this down); 2024: Alabama Power $20M + Georgia Power $349M = $369M total. The LLM's claim of a decrease to $250 million is fundamentally incorrect—the actual allocation INCREASED from $314M to $369M, not decreased. The LLM's calculation of a '20% drop' is completely wrong; the actual change was a +17.5% increase. (2) ENTITY IDENTIFICATION: The LLM fails to distinguish between Alabama Power and Georgia Power, treating the nuclear decommissioning trusts as a single consolidated entity. The ground truth specifically shows the allocation evolved differently for each subsidiary: Alabama Power remained relatively flat ($21M to $20M), while Georgia Power increased significantly ($293M to $349M). This is a critical multi-hop synthesis failure. (3) STRATEGIC INTERPRETATION: The LLM's conclusion that the company is 'pulling back from low-yielding government securities' and 'reallocating toward higher-returning, higher-risk assets' is directly contradicted by the data. The actual trend shows an INCREASE in Treasury and government agency securities allocation, suggesting a shift toward SAFER, more conservative fixed-income assets, not away from them. The ground truth explicitly states this indicates 'a possible reallocation of safer, fixed-income assets,' which is the opposite of what the LLM claims. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize information across the two subsidiaries and two years, instead creating an inaccurate aggregate narrative. The answer demonstrates fundamental misunderstanding of the data direction and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1282,
        "completion_tokens": 546,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "\nFrom 2022 through 2024, PepsiCo’s bottler‑funding, volume‑based rebates and advertising accruals remained a core element of its revenue‑recognition policy, with expenses estimated each year and paid out as performance targets were met. However, the 2024 filing notes a strategic shift away from direct bottling toward a trademark‑licensing model—especially for its alcoholic‑beverage portfolio—signaling a deliberate reduction in PepsiCo’s operational and financial reliance on independent bottlers for those brands.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misses critical information from the ground truth. Specific issues: (1) QUANTITATIVE ERRORS: The LLM fails to mention the Walmart 14% revenue figure that is explicitly stated in the ground truth as a key metric demonstrating strategic dependency in 2024. This is a material omission of a specific, verifiable number. (2) DIRECTIONAL CONTRADICTION: The ground truth describes an evolution TOWARD increased strategic dependency on independent bottlers (with more structured, negotiated funding and specific program allocation), while the LLM claims a 'strategic shift away from direct bottling' and 'reduction in operational and financial reliance.' This is fundamentally contradictory to the ground truth's narrative of increased dependency. (3) INCOMPLETE SYNTHESIS: The ground truth clearly describes the 2022-to-2024 evolution showing: (a) 2022: basic incentives/discounts through marketing funding, (b) 2024: more structured annual negotiations with specific program allocation (advertising, new products, vending equipment). The LLM mentions 'bottler-funding, volume-based rebates and advertising accruals' but fails to capture the evolution toward more structured dependency and specific program allocation. (4) SCOPE MISALIGNMENT: The LLM introduces information about 'trademark-licensing model' and 'alcoholic-beverage portfolio' which, while potentially accurate for those specific segments, contradicts the overall narrative of increased strategic dependency on independent bottlers that the ground truth emphasizes. The question asks about the relationship evolution broadly, and the ground truth indicates increased dependency, not decreased. (5) MISSING CONTEXT: The LLM completely omits the Walmart dependency metric (14% of consolidated net revenue), which is a crucial quantitative indicator of strategic dependency mentioned in the ground truth. This represents a failure in multi-hop synthesis—the answer should have connected bottler relationships to major customer concentration metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 554,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "\nFrom 2023 to 2024 Adobe Firefly shifted from a newly‑introduced generative‑AI engine to a central pillar of Adobe’s product‑innovation roadmap.  The 2023 filing first listed “Adobe Firefly” as a pending trademark and placed it in the “AI‑related risk” section, while the 2024 filing expands that coverage—detailing how Firefly’s AI capabilities are now embedded across Creative Cloud, Document Cloud and Experience Cloud, are being monetized, and are subject to heightened regulatory and competitive scrutiny.  This progression shows Firefly’s role evolving from an experimental add‑on to a strategic growth driver that Adobe must protect and manage carefully.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL CONTRADICTION ON TRADEMARK STATUS: The LLM claims Adobe Firefly was listed as a 'pending trademark' in 2023, but the ground truth states it was 'listed among Adobe's trademarks' (established/registered). This is a fundamental factual error about the baseline status. (2) MISCHARACTERIZATION OF 2023 POSITIONING: The LLM incorrectly states Firefly was 'newly-introduced' in 2023 and placed in 'AI-related risk section' in 2023. The ground truth indicates it was already an established trademark in 2023, with the risk factor mention occurring in 2024. This reverses the timeline. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH: While the LLM correctly identifies the evolution from 2023 to 2024 and mentions expansion across Cloud products in 2024, it misrepresents the 2023 baseline. The ground truth shows a shift from 'registered brand' to 'highlighted in risk factors,' not from 'pending trademark' to 'embedded across products.' (4) PARTIAL CREDIT FOR 2024 DETAILS: The LLM's description of 2024 positioning (embedded across Creative Cloud, Document Cloud, Experience Cloud; monetization; regulatory scrutiny) appears reasonable and aligns with the ground truth's characterization of 'central part of Adobe's forward-looking product development.' (5) REASONING QUALITY: The multi-hop synthesis is attempted but built on incorrect 2023 baseline facts, undermining the validity of the evolution narrative. The LLM correctly identifies this as a strategic shift but misidentifies what changed between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 425,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "\nBetween 2022 and 2023 the contribution of contractual rent escalations to tenant‑billing growth was largely offset by higher churn and lease cancellations. In 2022 churn was about 4 % of tenant billings and, although escalations (typically ~3 % annual U.S. increases or inflation‑linked abroad) were a primary growth lever, their net impact was still positive because cancellations were limited. By 2023 churn fell to roughly 3 % but was concentrated in the U.S. & Canada segment due to T‑Mobile and legacy Sprint lease terminations, causing a larger share of potential escalation revenue to be lost; consequently, rent‑escalation gains now play a smaller, more volatile role in overall billing growth.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM states '2022 churn was about 4%' but the ground truth does not provide a 2022 churn percentage. The ground truth only specifies that 2023 had 'approximately 3%' churn. The LLM appears to have fabricated the 4% figure for 2022 with no supporting evidence. (2) DIRECTIONAL ERROR - The LLM claims 'churn fell to roughly 3%' implying improvement from 2022 to 2023, but this is misleading. The ground truth describes the 3% churn in 2023 as 'elevated' and a 'countervailing force,' indicating it represents a worsening condition, not an improvement. (3) INCOMPLETE SYNTHESIS - The ground truth emphasizes that churn was 'expected to remain elevated through 2025 due to T-Mobile's lease cancellations,' a forward-looking context the LLM mentions but doesn't adequately emphasize as part of the changed role of escalations. (4) PARTIAL CORRECTNESS - The LLM correctly identifies: (a) T-Mobile and Sprint lease terminations as drivers of 2023 churn, (b) U.S. & Canada segment concentration, (c) the general concept that escalations were offset by churn, and (d) escalation percentages (~3% annual). (5) REASONING FLAW - The LLM's logic that 'churn fell' contradicts the ground truth's characterization of elevated churn as a new challenge in 2023. The ground truth presents 2023 as a deterioration from 2022, not an improvement. (6) MISSING CONTEXT - The LLM doesn't adequately convey that in 2022, escalations were listed as a 'key factor' alongside other growth drivers, whereas by 2023 they became constrained by elevated churn. The fundamental shift in the role of escalations (from primary growth lever to offset by churn) is partially captured but the quantitative foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 476,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "\nBetween 2023 and 2024 Chevron’s capital‑expenditure focus on Tengizchevroil shifted from roughly $1.8 billion of the $3.5 billion affiliate‑wide capex in 2023 to an expected $1.5 billion for 2024—nearly half of the 2024 affiliate‑capex budget is earmarked for the FGP/WPMP project at Tengizchevroil in Kazakhstan.  At the same time, Chevron’s reported net production continues to include a share of Tengizchevroil’s output (its volumes are counted in the company’s overall upstream production, which rose about 7 % in 2024), indicating that the Kazakh affiliate remains a key source of both cash flow and production for Chevron.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The ground truth states that in 2023, 'nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024' was allocated to Tengizchevroil. The LLM incorrectly introduces unsupported numbers: $1.8 billion for 2023 and $1.5 billion for 2024, neither of which appear in the ground truth. The ground truth only mentions $3 billion as the 2024 affiliate capex budget, with nearly half going to Tengizchevroil (implying ~$1.5 billion), but does NOT provide a $3.5 billion figure for 2023 or a $1.8 billion allocation. The LLM fabricated these specific numbers. (2) STRUCTURAL MISINTERPRETATION: The ground truth clearly states the $3 billion figure was 'expected to be' in 2024, not actual 2023 data. The LLM misread this as comparing 2023 ($3.5B) to 2024 ($3B), which is incorrect. (3) CORRECT ELEMENTS: The LLM correctly identifies that nearly half of affiliate capex goes to FGP/WPMP project in Kazakhstan, correctly notes the shift from investment to operational phase, and correctly identifies Tengizchevroil's ongoing production contribution. The 7% production increase reference appears reasonable but is not explicitly in the ground truth provided. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize the evolution narrative (capex commitment to production involvement), it does so with fabricated numbers that undermine the analysis. The core insight about the shift from investment to operational phase is sound, but the quantitative foundation is flawed. The answer demonstrates partial understanding of the relationship evolution but fails on numerical accuracy, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 482,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "\nThe 2023 filing only gave a broad statement that the U.S. discount rate was set “using a bond‑matching approach to select specific bonds that would satisfy our projected benefit payments,” without explaining how those bonds were chosen. In the 2024 filing the description was sharpened: it explicitly says the bond‑matching method “reflects the process we would employ to settle our pension and post‑retirement obligations” and emphasizes the selection of particular high‑quality bonds to meet those cash‑flow obligations, showing a more detailed and specific application of the approach.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth clearly states that in 2023, UPS described the bond matching approach as reflecting 'the process they would employ to settle pension and postretirement obligations,' and that by 2024, the language evolved to emphasize the approach as a 'guide' for selection. However, the LLM answer reverses this chronology entirely, claiming that 2023 gave only a 'broad statement' without explanation, while 2024 'explicitly says' the method 'reflects the process we would employ.' This is backwards from what the ground truth indicates. The LLM has inverted the temporal evolution of the disclosure specificity. Additionally, the LLM answer fails to capture the key nuance that the 2024 shift involved moving from describing the approach as directly reflecting the settlement process to describing it as a 'guide' for selection—a subtle but important distinction in how the policy is framed operationally. The LLM also misses the ground truth's emphasis that 'the underlying practice remained consistent' despite the framing change. While there are no quantitative errors (no numbers are involved in this question), the qualitative reasoning about the evolution of UPS's disclosure is fundamentally incorrect due to the reversed chronology and missing nuance about the 'guide' language shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 387,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "\nFrom 2022 through 2024 Linde’s helium‑wholesale business moved from a modest, relatively stable contributor to a more constrained line: the “Other” segment’s sales fell $32 million (about 2 %) in 2024 versus 2023, a decline that the company attributes to lower helium volumes, while operating profit rose $19 million (44 %) because insurance recoveries offset the higher helium‑related costs.  Thus, although helium’s shrinking volumes trimmed sales, the net effect was a modest boost to operating profit—reflecting a changed, cost‑sensitive relationship compared with the stronger, less‑pressured contribution observed in 2022.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM claims 'operating profit rose $19 million (44%)' but the ground truth makes no mention of operating profit increasing by $19 million or 44%. The ground truth states helium-related costs contributed to 'downward pressure on operating profit, partially offset by an insurance recovery for LAMT' - indicating net negative impact on operating profit, not a positive $19M increase. This is a fundamental factual error. (2) The LLM correctly identifies the $32 million (2%) sales decline in the Other segment due to lower helium volumes - this matches ground truth. (3) MULTI-HOP REASONING - The LLM attempts to synthesize the relationship evolution from 2022-2024 and financial impacts, but introduces an unsupported claim about operating profit improvement. The ground truth indicates helium moved from a supportive role to creating operational challenges with downward pressure on operating profit. (4) SEMANTIC ISSUES - The LLM characterizes the outcome as 'a modest boost to operating profit' which directly contradicts the ground truth's characterization of 'downward pressure on operating profit.' While the insurance recovery is mentioned in both, the LLM incorrectly concludes this resulted in net profit improvement. (5) PARTIAL CREDIT - The LLM correctly identifies the sales decline amount and percentage, and acknowledges the shift from 2022 to 2024, but the core financial impact claim about operating profit is materially incorrect. The answer demonstrates partial understanding but contains a major calculation/interpretation error that undermines the overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 449,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "\nBetween 2023 and 2024 Bank of America’s unfunded capital commitments for renewable‑energy projects fell sharply—from roughly **$6.2 billion** at the end of 2023 to **$4.6 billion** at the end of 2024, a reduction of about **$1.6 billion**.  At the same time, the tax credits and other tax benefits it recognized from those renewable‑energy investments slipped from **≈ $4.0 billion** in 2023 to **≈ $3.9 billion** in 2024, a decline of roughly **$0.1 billion**.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: unfunded capital contributions decreased from $6.2 billion (2023) to $4.6 billion (2024), and recognized tax credits declined from $4.0 billion to $3.9 billion. The calculations are accurate: the $1.6 billion reduction in unfunded commitments and the $0.1 billion decline in tax credits are both correctly computed. The multi-hop synthesis is sound—the answer properly connects the evolution of unfunded capital contributions with the corresponding change in recognized tax credits across the two-year period. The use of approximate symbols (≈) and descriptive language ('fell sharply,' 'slipped') appropriately conveys the magnitude and direction of changes without overstating precision. The answer addresses all parts of the question and correctly identifies Bank of America as the entity. The only minor distinction from the ground truth is that the LLM uses slightly more colloquial phrasing ('fell sharply,' 'slipped') compared to the ground truth's more formal tone, but this represents a stylistic difference rather than a factual error. The contextual interpretation that tax benefits 'remained relatively stable' (ground truth) versus 'slipped' (LLM) is semantically equivalent given the small $0.1 billion change. Overall, this is a high-quality response with accurate numbers, correct calculations, and proper multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 401,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "\nFrom 2022 to 2024 GM trimmed the overall share of fleet sales—particularly the low‑margin daily‑rental and small‑fleet transactions that were a drag on profitability—while expanding its focus on higher‑value commercial‑fleet contracts for its electric light‑commercial vehicles (e.g., BrightDrop EV600/EV410).  The company now secures these sales through a combination of its dealer network and dedicated direct‑fleet procurement teams, but it still treats fleet sales as less profitable than retail sales and therefore manages pricing, incentives and contract terms carefully to protect margins.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. Key issues: (1) UNSUPPORTED CLAIMS: The LLM introduces specific product names (BrightDrop EV600/EV410) and claims about 'trimming overall share of fleet sales' that are not mentioned in the ground truth. The ground truth makes no reference to reducing fleet sales volume or shifting away from daily-rental vehicles. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth indicates a shift toward 'a more structured and possibly optimized approach' with both direct and dealer channels, but does NOT claim GM is reducing fleet sales or eliminating daily-rental focus. The LLM's narrative of 'trimming' and 'expanding focus on higher-value commercial-fleet contracts' is not supported by the source material. (3) ADDED DETAILS NOT IN GROUND TRUTH: References to 'dedicated direct-fleet procurement teams' and specific management of 'pricing, incentives and contract terms' go beyond what the ground truth states. (4) PARTIAL ACCURACY: The LLM correctly identifies that fleet sales remain less profitable than retail sales and that both dealer and direct channels are used, which aligns with the ground truth. However, these correct elements are embedded within a largely fabricated narrative about strategic shifts away from certain fleet segments. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the actual evolution described in the ground truth (from 'sold either directly or through dealer network' to 'completed through dealer network and in some cases directly'), instead creating an unsupported narrative about margin optimization through segment selection. The answer demonstrates a fundamental misunderstanding of what the ground truth actually conveys about GM's fleet sales evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 498,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s stake in Sabra shifted from a 39 % non‑controlling interest that it retained after selling Tropicana, Naked and other juice brands (Q1 2022) to an exclusive U.S. distribution role for the joint‑venture’s portfolio of brands (see “Our Brands and Intellectual Property Rights” and the note on “exclusive distributor for the new joint venture’s portfolio of brands for small‑format and foodservice customers with chilled direct‑store‑delivery”).  This transition produced a $122 million pre‑tax gain on the re‑measurement of PepsiCo’s previously held 50 % equity in Sabra (recorded in FLNA SG&A, Note 13), and the JV’s sales now flow through PepsiCo’s distribution network, contributing to FLNA segment operating profit via distribution revenue and bottler‑funding arrangements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) INCORRECT OWNERSHIP STRUCTURE: The LLM claims PepsiCo had a '39% non-controlling interest' initially, but the ground truth states PepsiCo 'owned the Sabra brand' in 2022 with full ownership, transitioning to a '50% equity stake' by 2024. The 39% figure appears to be fabricated or misattributed. (2) CORRECT ELEMENTS: The LLM correctly identifies the $122 million pre-tax gain on remeasurement and correctly notes this was recorded in FLNA SG&A per Note 13. The 50% equity stake by 2024 is correct. (3) INCORRECT NARRATIVE: The LLM's description of the transition as involving 'selling Tropicana, Naked and other juice brands' and becoming an 'exclusive distributor' adds details not present in the ground truth and appears to conflate different transactions. The ground truth simply states PepsiCo 'divested a portion of its ownership' without these specific distribution details. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information about the relationship evolution and financial implications, it does so with incorrect intermediate facts (the 39% stake, the distribution role framing). The core finding—that PepsiCo went from owning Sabra to holding 50% with a $122M gain—is partially correct but the journey described is inaccurate. (5) QUANTITATIVE ACCURACY: The $122 million figure is correct, but the ownership percentages (39% vs. full ownership in 2022) are wrong, and the 50% stake is correct but presented in a misleading context about how it was acquired.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 436,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Adobe deepened Adobe Scan’s integration into its Document Cloud and AI‑driven workflow. In 2023 the scan app was presented simply as a free mobile tool that converts paper into searchable PDFs and syncs with Document Cloud; by 2024 the filing positions Scan as the entry point for Adobe’s AI‑enhanced document experience—embedding OCR and generative‑AI features, tightly linking it with Acrobat AI Assistant, Creative Cloud and the broader Document Cloud suite, and using it to drive adoption of Adobe’s paid PDF and e‑signature services.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and unsupported claims that diverge substantially from the ground truth. CRITICAL ISSUES: (1) The ground truth states Adobe Scan was 'listed among Adobe's trademarks' in 2023 and positioned as part of Document Cloud in 2024. The LLM answer invents specific product details not present in the ground truth, such as 'free mobile tool that converts paper into searchable PDFs,' 'OCR and generative-AI features,' 'Acrobat AI Assistant integration,' and 'driving adoption of paid PDF and e-signature services.' These details are fabrications not supported by the original answer. (2) The LLM answer mischaracterizes the 2023 positioning as a 'free mobile tool' when the ground truth only mentions trademark listing. (3) The LLM adds unsubstantiated claims about AI-driven workflows, generative AI features, and strategic adoption drivers that are not present in the ground truth. (4) While the LLM correctly identifies the 2024 positioning within Document Cloud (matching ground truth), it embellishes this with invented technical and strategic details. (5) The answer demonstrates hallucination rather than faithful synthesis of the provided ground truth. The core evolution from trademark recognition to Document Cloud integration is partially captured, but the extensive fabrication of product features, AI capabilities, and strategic positioning significantly undermines accuracy. The LLM appears to have generated plausible-sounding product details rather than adhering to the factual information provided in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 434,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "\nFrom 2022 through 2024 the indemnification framework that GM put in place when it sold Opel/Vauxhall to Stellantis has remained unchanged in structure but has become essentially immaterial in practice.  The 2017 Master Agreement obligates GM (through its wholly‑owned “Seller”) to indemnify Stellantis for inaccuracies in representations and warranties, certain emissions‑related product liabilities and any recalls (including the Takata inflator recalls); those obligations are subject to time‑limits, thresholds and caps, and GM has recorded only insignificant accruals for them.  Although consumer‑class actions have been filed in Germany, the United Kingdom, Austria and the Netherlands alleging that pre‑sale Opel/Vauxhall vehicles violated emission standards, GM continues to believe that any future indemnity‑related payouts are remote and cannot be reasonably estimated, so the nature and size of its financial exposure to Stellantis has not materially grown since 2022.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a well-structured response to the multi-hop question about GM's evolving relationship with Stellantis from 2022-2024. STRENGTHS: (1) Correctly identifies the 2017 Master Agreement as the foundational indemnification framework; (2) Accurately lists specific indemnification categories: emissions-related liabilities, Takata inflator recalls, and representations/warranties; (3) Properly characterizes the financial exposure as immaterial/insignificant with appropriate accruals; (4) Correctly identifies the geographic scope of consumer class actions (Germany, UK, Austria, Netherlands); (5) Accurately reflects GM's accounting position that future payouts are remote and cannot be reasonably estimated; (6) Correctly synthesizes the evolution from 2022 to 2024 as a shift toward immateriality rather than growth. MINOR GAPS: (1) The LLM answer emphasizes that the framework 'remained unchanged in structure' which is accurate but slightly different from the ground truth's framing of a 'transformation from active supply chain involvement to passive indemnification-based relationship' - the ground truth suggests more of a shift in nature of relationship, while LLM focuses on structural consistency; (2) The ground truth mentions 'supply-related transactions' in 2022 as part of the operational relationship, which the LLM answer does not explicitly address, though this is a minor omission; (3) The LLM answer does not explicitly mention 'end-of-life vehicle practices' regulatory investigations mentioned in ground truth, though it does reference emissions-related investigations. QUANTITATIVE ACCURACY: All dates (2017, 2022, 2024, December 31, 2024) are correct. No specific dollar amounts are provided in either answer, which is appropriate given the immaterial nature of accruals. MULTI-HOP REASONING: The answer successfully synthesizes information across the time period (2022-2024) and correctly identifies the relationship between the Opel/Vauxhall sale, the Master Agreement, and current indemnification obligations. The reasoning about why exposure hasn't materially grown is sound and well-supported. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - both convey that GM's exposure has become immaterial and that the relationship has shifted from operational to indemnification-based, though the LLM frames it as 'unchanged in structure but immaterial in practice' while ground truth emphasizes the transformation aspect more explicitly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1472,
        "completion_tokens": 673,
        "total_tokens": 2145
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "\nBetween 2022 and 2024 PepsiCo’s reliance on co‑packers deepened — the 2022 filing describes the use of “contract manufacturers, co‑packers, strategic alliances or joint ventures” as a supplemental network, while the 2024 filing expands that language to highlight “highly distributed… facilities that are owned or leased by our contract manufacturers, co‑packers, strategic alliances or joint ventures” and notes that many of these sites are now part of shared‑service or concentration‑plant arrangements.  At the same time, the company has moved from a purely transactional manufacturing relationship toward more strategic involvement, embedding co‑packers in product‑development, logistics and capacity‑planning initiatives and often securing equity stakes or joint‑venture structures that give them greater operational influence.  Consequently, PepsiCo’s operational dependency on co‑packers has grown, but this dependence is now coupled with a more collaborative, strategic partnership rather than a simple contract‑manufacturing tie‑up.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: The LLM answer contains significant factual errors that contradict the ground truth. (1) REVERSED ATTRIBUTION: The LLM incorrectly attributes the 2022 language ('highly distributed… facilities') to the 2024 filing, when the ground truth clearly states this language appeared in 2022. The LLM also reverses the evolution direction by claiming 2024 'expands' on 2022 language, when the actual shift was from 2022's operational focus to 2024's strategic emphasis. (2) MISSING KEY DISTINCTION: The ground truth's core insight is the shift from 'operational dependency' (2022) to 'strategic alliances or joint ventures in which we have an equity interest' (2024). The LLM mentions equity stakes and joint ventures but fails to clearly articulate this as the primary evolution. (3) INACCURATE CHARACTERIZATION: The LLM claims 'operational dependency on co-packers has grown,' which contradicts the ground truth's emphasis on a shift toward more integrated strategic involvement rather than deepened operational dependency. The ground truth suggests a qualitative shift in relationship type, not necessarily increased dependency. (4) UNSUPPORTED DETAILS: The LLM introduces details about 'shared-service or concentration-plant arrangements,' 'product-development,' and 'logistics and capacity-planning initiatives' that are not present in the ground truth and cannot be verified. (5) CORRECT ELEMENTS: The LLM does correctly identify that the relationship evolved toward more strategic involvement and that equity/joint-venture structures became more prominent. The overall theme of evolution from transactional to strategic is directionally correct. However, the fundamental misattribution of which language appeared in which year and the reversal of the evolution narrative are serious errors that undermine the answer's credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 500,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "\nBetween 2023 and 2024 SPG’s stake in ABG was repeatedly diluted by ABG’s capital transactions, generating multiple non‑cash deemed‑disposal gains of about $59 million in 2023 and a $157 million pre‑tax gain when it sold a portion of its interest in the fourth quarter of 2023. In early 2024 SPG sold the remainder of its ABG equity for $1.2 billion, recognizing a $415 million pre‑tax gain and thereby exiting the strategic partnership, after which it redirected capital to other investments such as additional holdings in TRG.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally misrepresent SPG's financial relationship with ABG between 2023 and 2024:\n\n1. MAJOR FACTUAL ERRORS:\n   - The LLM claims SPG sold \"the remainder of its ABG equity for $1.2 billion\" in early 2024 with a $415 million gain. This is completely fabricated - the ground truth shows no such transaction occurred in 2024.\n   - The LLM states SPG \"exited the strategic partnership\" after this alleged sale. This directly contradicts the ground truth, which explicitly states that in 2024, SPG entered INTO a \"strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S.\"\n   - The LLM incorrectly attributes a $18.8 million gain to \"the sale of a portion of its ABG interest in December 2021\" - this is a date error (2021 vs 2024) and mischaracterizes the transaction.\n\n2. QUANTITATIVE ACCURACY ISSUES:\n   - The $59 million deemed-disposal gain is correct for 2023\n   - The $157 million gain from sale of ABG interests in Q4 2023 is correct\n   - However, the $1.2 billion sale and $415 million gain in 2024 are entirely fabricated\n   - The $18.8 million figure exists in ground truth but is misattributed to 2021 instead of 2024\n\n3. MULTI-HOP REASONING FAILURE:\n   - The LLM failed to correctly synthesize the evolution of the relationship. The ground truth shows a transition from financial transactions (2023) to operational collaboration (2024 Reebok partnership).\n   - The LLM inverted this narrative, claiming an exit from partnership when the ground truth shows entry into deeper operational collaboration.\n\n4. MISSING KEY INFORMATION:\n   - The LLM completely omits the $145.8 million gain from dilution of ownership in SPARC Group mentioned in 2023\n   - The LLM fails to capture the strategic shift toward operational partnership (Reebok licensee role) in 2024\n   - The mention of \"additional holdings in TRG\" is not supported by the ground truth provided\n\n5. SEMANTIC MISALIGNMENT:\n   - The core narrative is inverted: ground truth shows deepening partnership; LLM shows exit\n   - This represents a fundamental misunderstanding of the relationship evolution\n\nThe answer demonstrates poor multi-hop reasoning and contains fabricated financial data that would be highly misleading to users.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 624,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "\nIn the 2022 10‑K (pages 41‑45) Sikorsky’s helicopter business generated roughly $ X billion in product sales, driven by steady production of the CH‑53K, MH‑60R and Black Hawk platforms and the delivery of about Y aircraft that year. By 2024 the program had expanded both in volume and scope: the 2024 10‑K (pages 2‑6) reports a higher delivery cadence—including the final VH‑92A presidential‑helicopter delivery and increased CH‑53K shipments—and notes new sustainment and international contracts that broaden the rotor‑craft portfolio. As a result, Lockheed Martin’s involvement in Sikorsky helicopter programs grew from a modest, steady output in 2022 to a larger, more diversified production and service effort by 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer uses placeholder variables ($ X billion, Y aircraft) instead of providing actual numbers. This is a critical failure for a financial question requiring specific data. The ground truth provides concrete figures ($560 million increase in product costs in 2022), but the LLM provides none. (2) MISSING KEY DATA: The ground truth explicitly states a '$560 million increase in product costs' in 2022 related to higher production volume on Sikorsky programs. The LLM completely omits this specific financial metric. (3) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM attempts to compare 2022 vs 2024, it fails to provide the quantitative foundation needed. The ground truth shows a clear evolution from cost driver (2022) to strategic product line (2024), but the LLM's vague language ('modest, steady output' to 'larger, more diversified') lacks supporting numbers. (4) ENTITY ACCURACY: The LLM correctly identifies Sikorsky helicopter programs (Black Hawk, CH-53K, MH-60R, VH-92A) and the RMS segment context, which aligns with ground truth. (5) REASONING QUALITY: The LLM's narrative structure is reasonable (comparing 2022 to 2024), but without concrete numbers, the reasoning is unsupported. The ground truth's specific focus on the $560M cost increase and the shift from cost driver to strategic line is more precise. (6) PAGE REFERENCES: The LLM cites specific pages (41-45 for 2022, 2-6 for 2024) but provides no actual data from those pages, suggesting fabrication or incomplete extraction. VERDICT: This answer fails the primary requirement of financial accuracy by using placeholders instead of real numbers and omitting the key $560M figure from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 472,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "\nIn fiscal 2023 Walmart acquired Alert Innovation for roughly $0.4 billion, increasing its interest from a variable‑interest position to 100 % ownership and bringing the company onto its consolidated balance sheet. The fiscal 2024 filing shows no further investment or divestiture—Walmart continued to hold the full 100 % stake it had obtained the prior year, with no additional cash outlay or change in ownership reported until the later deconsolidation in fiscal 2025.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERROR IN CORE CLAIM: The LLM answer directly contradicts the ground truth on the fundamental question. Ground truth states that by fiscal 2024, Walmart had 'fully exited its stake, likely through a sale or divestiture.' The LLM claims Walmart 'continued to hold the full 100% stake' through fiscal 2024 with 'no additional cash outlay or change in ownership reported until the later deconsolidation in fiscal 2025.' This is a major factual error that misrepresents the evolution of Walmart's ownership between fiscal 2023 and fiscal 2024. The question specifically asks about the evolution 'between fiscal 2023 and fiscal 2024,' and the ground truth indicates a complete exit occurred during this period, not a continuation of ownership. QUANTITATIVE ACCURACY: The $0.4 billion acquisition amount and 100% ownership percentage are correct. However, the LLM introduces information about fiscal 2025 deconsolidation, which is outside the scope of the question asking about fiscal 2023-2024 evolution. QUALITATIVE ACCURACY: The LLM failed to identify the key change between the two fiscal years - the divestiture/exit that occurred. Instead, it incorrectly characterized fiscal 2024 as showing 'no change in ownership.' This represents a fundamental failure in multi-hop reasoning and synthesis of the filing information. CONTEXTUAL RELEVANCE: The answer addresses the right companies and time periods but provides incorrect information about what actually happened, making it contextually misaligned with the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 429,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "\nBetween 2023 and 2024 SPG moved from **actively tapping its $3.5 billion Supplemental Facility**—using it in 2023 to help fund a €750 million bond issuance and to refinance maturing debt—**to essentially retiring the Facility’s balance by the end of 2023 and then relying on new senior‑note issuances and operating cash flow to repay maturing senior debt rather than drawing the Supplemental Facility again.**  In other words, the 2023 borrowing was a temporary bridge that was repaid with bond proceeds, and in 2024 the company’s debt‑management strategy shifted to repaying those notes (e.g., the $600 million 2.75 % and $600 million 3.75 % notes) through cash generated from operations and new issuances, leaving the Supplemental Facility with little or no outstanding borrowings.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the overall narrative correctly—SPG borrowed €750 million in 2023, repaid it by end of 2023, and shifted away from using the Supplemental Facility in 2024. However, there are significant quantitative accuracy issues: (1) The LLM introduces a '$3.5 billion Supplemental Facility' size that is not mentioned in the ground truth and cannot be verified. (2) The LLM mentions specific debt repayment details ('$600 million 2.75%' and '$600 million 3.75%' notes) that are not present in the ground truth answer, introducing unverified specificity. (3) The ground truth explicitly mentions a '$1.0 billion issuance in September 2024' as part of the refinancing strategy, which the LLM answer completely omits. The qualitative reasoning is sound—the LLM correctly identifies the shift from temporary bridge financing to long-term refinancing and operating cash flow reliance. The multi-hop synthesis is reasonable (connecting 2023 borrowing to 2024 strategy shift). However, the introduction of unverified numbers ($3.5B facility size, specific coupon rates) and the omission of the $1.0B September 2024 issuance represent material gaps and potential inaccuracies. The answer is contextually relevant and addresses the evolution question, but the quantitative details are problematic for a financial analysis context where precision is critical.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 379,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Linde moved helium from being a peripheral component of its “process gases” list to a strategically‑positioned primary product.  In the 2023 document helium is merely cited alongside other process gases, with supply handled through generic merchant and packaged channels and no separate performance‑obligation tracking.  By contrast, the 2024 filing explicitly includes helium in the company’s “primary products” discussion, ties future minimum‑purchase volumes to long‑term supply obligations, and describes dedicated supply strategies—such as extended merchant contracts, on‑site cryogenic production and price‑escalation mechanisms—to secure helium deliveries.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and factually incorrect on all major points: (1) DIRECTIONAL ERROR: The LLM claims helium moved FROM a peripheral component TO a primary product between 2023-2024, which is the exact opposite of the ground truth. The ground truth explicitly states helium WAS a primary product in 2023 and was NO LONGER specifically named as distinct in 2024, indicating a REDUCTION in emphasis, not an elevation. (2) FACTUAL INACCURACIES: The LLM incorrectly states that in 2023 helium was 'merely cited alongside other process gases' with 'no separate performance-obligation tracking,' when the ground truth indicates helium was explicitly listed as a primary product in 2023. The LLM also incorrectly claims the 2024 filing 'explicitly includes helium in the company's primary products discussion,' which directly contradicts the ground truth stating helium was 'no longer specifically named as a distinct product' in 2024. (3) SUPPLY STRATEGY MISREPRESENTATION: The LLM invents specific supply mechanisms (on-site cryogenic production, price-escalation mechanisms, minimum-purchase volumes tied to long-term obligations) that are not mentioned in the ground truth. The ground truth only mentions merchant delivery with 3-7 year contracts without minimum purchase requirements for 2023. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year comparison, reversing the actual trajectory of helium's strategic positioning. (5) SEMANTIC CONTRADICTION: The core narrative is inverted—the LLM describes an elevation of helium's status when the ground truth describes a demotion/subsumption into broader categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 463,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "\nBetween 2022 and 2023 the U.S. retiree health‑care plan’s asset mix moved markedly toward fixed‑income holdings and away from equities.  In 2022 the plan held roughly $182 million in fixed‑income securities (about 65 % of total assets) and $98 million in equity securities (about 35 %).  By the end of 2023 those figures had risen to $210 million in fixed‑income (≈ 80 % of assets) and fallen to $54 million in equity (≈ 20 % of assets), reflecting a deliberate shift to a higher‑weight fixed‑income allocation and a reduced equity exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. Ground truth shows: 2022 had $248M in fixed income and $137M in equity (totaling $385M); 2023 had $210M in fixed income and $54M in equity (totaling $264M). The LLM answer states: 2022 had $182M in fixed income and $98M in equity; 2023 had $210M in fixed income and $54M in equity. The 2022 figures are completely wrong ($182M vs $248M for fixed income is a $66M error; $98M vs $137M for equity is a $39M error). The 2023 fixed income figure ($210M) is correct, and the 2023 equity figure ($54M) is correct. The LLM also incorrectly calculates percentages based on wrong 2022 totals (claiming 65% fixed income and 35% equity in 2022, when the correct percentages would be approximately 64% and 36% respectively). The narrative about a 'deliberate shift' toward fixed income is misleading - while the percentage allocation did shift, this was primarily driven by the absolute decline in both asset categories, not a strategic reallocation. The LLM correctly identifies the 2023 allocation trend but fails on the 2022 baseline data, which is essential for answering a comparative question. The reasoning about the shift is partially sound but built on incorrect foundational numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 366,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s revenue exploded—from roughly **$49 million in 2022** to **$1.06 billion in 2023** (a >2,000 % increase), driven by higher demand across new geographies and the launch of its first breast‑cancer indication.  The company also secured **key regulatory milestones** during this period, obtaining **FDA approval (and subsequent EC approval) for Trodelvy as a monotherapy to treat adults with unresectable or metastatic HR⁺/HER2‑ breast cancer who have previously received endocrine therapy and at least two systemic treatments**, positioning the asset as a major growth driver in Gilead’s oncology portfolio.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims Trodelvy generated $49 million in 2022 and $1.06 billion in 2023. The ground truth explicitly states $380 million in total product sales in 2022. The 2022 figure is off by a factor of ~7.7x ($49M vs $380M). The 2023 figure of $1.06B is not mentioned in the ground truth, which explicitly states 'specific revenue figures for 2023 are not provided.' The LLM fabricated a 2023 revenue number. (2) CALCULATION ERROR: The LLM calculates a >2,000% increase based on false premises ($49M to $1.06B). Even if those numbers were correct, the calculation would be approximately 2,063%, but the underlying data is entirely wrong. (3) REGULATORY MILESTONES: The LLM correctly identifies FDA and EC approvals for HR+/HER2- metastatic breast cancer treatment, and the additional clinical detail about prior endocrine therapy and systemic treatments is accurate and more specific than the ground truth. This is the only correct element. (4) MULTI-HOP REASONING: The LLM failed to properly synthesize the available information. It appears to have confused Trodelvy's actual 2022 revenue ($380M) with a different metric or fabricated the numbers entirely. The strategic positioning discussion is partially correct but undermined by the false revenue claims. (5) SEMANTIC EQUIVALENCE: The core narrative about revenue growth and regulatory approvals is structurally sound, but the factual foundation is destroyed by incorrect numbers. The answer demonstrates a >2,000% error in the primary quantitative metric requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 458,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "\nChevron’s equity investment in GS Caltex slipped modestly—from roughly $4.3 bn in 2022 to $4.14 bn in 2024—while the earnings it receives from the joint venture fell dramatically, from $874 million in 2022 to $437 million in 2023 and only $58 million in 2024.  This sharp decline reflects weaker profitability in the Korean downstream market over the period.  Nevertheless, the JV remains strategically important to Chevron as its primary foothold in Asia, providing critical market access, brand distribution and a platform for future growth despite the recent earnings dip.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not supported by the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites specific equity investment values ($4.3bn in 2022, $4.14bn in 2024) and earnings figures ($874M in 2022, $437M in 2023, $58M in 2024) that are NOT mentioned in the ground truth. The ground truth does not provide these specific investment or earnings numbers. The LLM appears to have fabricated or hallucinated these figures. (2) MISSING KEY DATA: The ground truth explicitly mentions $13,850 million in 2024 and $16,286 million in 2022 in sales/revenues with affiliated companies - the LLM completely omits this critical comparison that directly addresses the question. (3) INCOMPLETE SYNTHESIS: The ground truth clearly states the 50% ownership stake and describes GS Caltex's operations (importing, producing, marketing petroleum products, petrochemicals, lubricants). The LLM fails to mention the ownership percentage or operational details. (4) UNSUPPORTED CLAIMS: The LLM's characterization of GS Caltex as 'Chevron's primary foothold in Asia' is not supported by the ground truth, which makes no such claim. (5) REASONING FLAW: While the LLM correctly identifies a declining trend, it bases this on fabricated numbers rather than the actual revenue decline documented in the ground truth ($16,286M to $13,850M). The LLM demonstrates poor multi-hop synthesis by inventing specific financial metrics rather than using the actual data provided in the knowledge graph. The answer fails on factual accuracy, the primary evaluation criterion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 440,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "\nFrom 2022 through 2024 the CH‑53K heavy‑lift helicopter program drove higher production volumes that translated into measurable revenue and profit gains—net sales from the program rose by roughly $140 million in 2024 and contributed about $115 million of the increase in RMS operating profit that year.  At the same time, the favorable profit‑booking (risk‑retirement) adjustments that had previously lifted earnings were largely exhausted, so the magnitude of risk‑retirements declined (with only modest unfavorable adjustments appearing in 2024), but the program continued to generate positive volume‑driven profit and a growing backlog, indicating sustained demand and improving production momentum.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims CH-53K net sales rose by 'roughly $140 million in 2024' and contributed '$115 million of the increase in RMS operating profit that year.' However, the ground truth states the $140 million profit increase occurred in 2022, not 2024. The ground truth explicitly states that by 2024, RMS operating profit declined by 73%, not increased. The LLM has fundamentally misattributed the timing and direction of financial performance. (2) RISK RETIREMENT ANALYSIS: While the LLM correctly identifies that risk-retirement adjustments were 'largely exhausted' and declined from 2022 to 2024, it misrepresents the overall profit trajectory. The ground truth indicates that 2024 saw a significant profit decline (73% decrease in RMS operating profit), whereas the LLM suggests sustained positive profit growth. (3) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the 2022-to-2024 evolution. It conflates 2022 gains ($140M profit increase from risk retirements and production volume) with 2024 performance, creating a false narrative of continuous improvement. The ground truth clearly distinguishes: 2022 = strong gains from risk retirements; 2024 = profit decline despite higher production volumes. (4) MISSING CRITICAL CONTEXT: The LLM omits the crucial 73% RMS operating profit decline in 2024, which is central to understanding the program's evolution. The answer presents an overly optimistic view that contradicts the documented financial deterioration. (5) SEMANTIC MISALIGNMENT: The LLM's statement about 'sustained demand and improving production momentum' contradicts the ground truth's implication that gains from risk retirements 'may have diminished as the program matured.' The LLM essentially inverts the narrative of the program's trajectory from 2022 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 520,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "\nBetween 2022 and 2023 PayPal shifted from a largely reactive, reserve‑driven view of seller‑protection risk to a more strategic, risk‑adjusted framework.  In the 2022 filing the company highlighted that transaction‑loss rates (0.09‑0.15 % of TPV) could rise if macro‑economic stress triggered more merchant failures, and it described the protection programs mainly as a cost‑center to be monitored.  By 2023 the language emphasizes tighter loss‑reserve assumptions, refined eligibility criteria and the use of protection programs to bolster merchant confidence and support growth of credit‑based offerings, indicating that the firm is deliberately managing exposure while positioning seller protection as a growth lever rather than merely a risk‑mitigation expense.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy on quantitative elements and captures the core evolution of PayPal's approach between 2022 and 2023. STRENGTHS: (1) Correctly identifies the transaction-loss rate range of 0.09-0.15% of TPV from 2022 filings; (2) Accurately characterizes the shift from risk-focused to strategic positioning; (3) Properly synthesizes the multi-hop comparison across two years; (4) Correctly identifies the integration with merchant trust and growth narratives in 2023; (5) Appropriately frames the evolution from cost-center to growth lever. WEAKNESSES: (1) The LLM introduces some interpretive language ('reactive, reserve-driven view,' 'deliberately managing exposure') that goes slightly beyond what the ground truth explicitly states - the ground truth is more measured in describing 2022 as 'risk management and potential loss implications' rather than characterizing it as 'reactive'; (2) The phrase 'tighter loss-reserve assumptions' and 'refined eligibility criteria' in the 2023 description are not explicitly mentioned in the ground truth, which focuses more on strategic emphasis and competitive differentiation; (3) The reference to 'credit-based offerings' is an inference not directly supported by the ground truth provided. QUANTITATIVE VERIFICATION: The 0.09-0.15% TPV loss rate is correctly cited and matches the ground truth exactly. MULTI-HOP REASONING: The answer successfully synthesizes information across 2022 and 2023 filings and correctly identifies the directional shift in strategic emphasis. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: While the LLM uses different framing ('reactive' vs. 'risk management'), the core meaning aligns with the ground truth's distinction between 2022's focus on risk implications versus 2023's focus on competitive differentiation and merchant trust. The answer is substantively correct but adds some interpretive layers not explicitly grounded in the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 537,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 Starbucks moved the recognition of ready‑to‑drink (RTD) revenue from a generic “other‑revenues” line that was recorded when the product shipped to external customers, to a dedicated Channel‑Development entry that records sales of packaged and RTD beverages to Nestlé (and other licensees) and recognizes that revenue upon shipment, with royalties on Nestlé’s reported sales.  This change reflects a strategic shift to rely on the Global Coffee Alliance with Nestlé for packaging, distribution and market reach, thereby increasing supplier dependency on Nestlé compared with the more internally‑controlled RTD sales described in the 2023 filing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) ENTITY CONFUSION: The LLM introduces Nestlé and the Global Coffee Alliance as central to the 2024 RTD strategy, but the ground truth makes no mention of Nestlé or a dedicated 'Channel-Development' entry. The ground truth focuses on supplier dependency and supply chain resilience with 'specialty suppliers under long-term contracts' - not specifically Nestlé. (2) REVENUE RECOGNITION MISCHARACTERIZATION: The LLM claims RTD revenue moved to a 'dedicated Channel-Development entry' with royalties on Nestlé's reported sales. The ground truth indicates the shift was from 'Other Revenues' to emphasizing supplier relationships and supply chain risk management, not a specific new revenue line item tied to Nestlé. (3) STRATEGIC FOCUS MISALIGNMENT: The LLM frames the evolution as increasing 'supplier dependency on Nestlé,' while the ground truth describes a shift from 'revenue-centric reporting to supply-chain risk management focus' with emphasis on 'securing stable supply' and 'mitigating delivery risks' - broader supply chain resilience, not Nestlé-specific dependency. (4) MISSING CONTEXT: The LLM fails to capture the ground truth's key insight about the shift from revenue recognition mechanics to supply chain risk management emphasis. (5) UNSUPPORTED CLAIMS: References to 'Channel-Development entry,' 'Global Coffee Alliance,' and specific Nestlé royalty arrangements are not supported by the ground truth and appear to be fabricated or confused with other information. The answer demonstrates poor multi-hop synthesis and introduces entities/mechanisms not present in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 470,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Trodelvy’s existing approvals in the United States, the European Union, Canada and the other Orbis‑partner countries (Australia, Great Britain, Switzerland) remained in place, but the drug’s label was broadened with new regulatory approvals: the FDA granted full approval for monotherapy in adults with unresectable locally‑advanced or metastatic HR‑positive/HER2‑negative breast cancer, and the European Commission subsequently approved the same indication in the EU. Thus, while the geographic scope of approval did not expand further, the therapeutic reach of Trodelvy was extended to a new breast‑cancer population in both the U.S. and Europe.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate information about regulatory approvals but has significant gaps in addressing the complete question about geographic reach evolution. STRENGTHS: (1) Correctly identifies FDA approval for HR+/HER2- metastatic breast cancer monotherapy in 2023, (2) Correctly notes EC approval for the same indication, (3) Accurately mentions existing approvals in US, EU, Canada, Australia, Great Britain, and Switzerland, (4) Properly distinguishes between geographic scope (which didn't expand) and therapeutic reach (which did expand). WEAKNESSES: (1) The original answer provides specific 2022 sales figures ($370M US, $10M Europe) that establish baseline geographic reach - the LLM answer completely omits these quantitative metrics, which are crucial for demonstrating 'how' the reach evolved, (2) The LLM answer states geographic scope 'did not expand further' but doesn't establish what the baseline was in 2022, making the comparison incomplete, (3) The question asks about evolution 'between 2022 and 2023' - the LLM answer focuses heavily on 2023 approvals but provides no 2022 baseline data for comparison, (4) Missing the context that 2022 had limited international presence (only US and Europe with sales), which makes the 2023 approvals more significant. MULTI-HOP REASONING: The LLM correctly synthesizes that approvals expanded therapeutic reach but failed to synthesize the sales data showing geographic presence evolution. The answer addresses regulatory approvals well but incompletely addresses geographic reach evolution. The omission of quantitative sales data represents a significant gap in answering the 'how did geographic reach evolve' portion of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 464,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "\nBetween 2023 and 2024 Simon Property Group’s stake in ABG was steadily reduced and ultimately eliminated.  In 2023 the company’s ownership fell from roughly 12 % to about 9.6 % after a series of capital‑transaction dilutions, and it recognized a $157.1 million pre‑tax gain on a partial cash sale plus a $10.3 million non‑cash gain from the related deemed disposal (plus earlier 2023 gains of $12.4 million and $36.4 million from prior dilutions, for a total 2023 ABG‑related gain of roughly $216 million).  In the first quarter of 2024 SP Group sold its remaining ABG interest for $1.2 billion cash, generating a $414.8 million pre‑tax gain, thereby ending its ownership in ABG.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth:\n\n1. MAJOR FACTUAL ERRORS:\n   - Claims SPG's stake was \"ultimately eliminated\" and that it \"sold its remaining ABG interest for $1.2 billion cash\" in Q1 2024 with a \"$414.8 million pre-tax gain\" - NONE of this information appears in the ground truth\n   - The ground truth explicitly states that in 2024, SPG \"no longer disclosed active changes in its ownership stake in ABG\" and \"no new transactions reported\"\n   - This represents a fundamental misunderstanding of the 2024 situation\n\n2. QUANTITATIVE ACCURACY ISSUES:\n   - The 2023 gains are partially correct ($36.4M, $12.4M, $10.3M mentioned), but the LLM adds unsupported figures: \"$157.1 million pre-tax gain on a partial cash sale\" and claims a total of \"roughly $216 million\" - these specific numbers don't appear in ground truth\n   - The $1.2 billion sale price and $414.8 million gain in 2024 are completely fabricated\n   - The ownership percentages (12% to 9.6%) are approximately correct for 2023\n\n3. MULTI-HOP REASONING FAILURE:\n   - The LLM failed to properly synthesize the key distinction between 2023 and 2024\n   - Ground truth shows a clear shift from active transactions in 2023 to passive disclosure in 2024\n   - LLM inverted this by claiming major activity in 2024 that didn't occur\n\n4. MISSING CONTEXT:\n   - LLM correctly identifies the 2023 dilutions but misses the nuance that these were separate transactions with different gain amounts\n   - LLM completely ignores the 2021 transaction reference that appears in 2024 disclosures\n   - The characterization of 2024 as showing \"no new transactions\" is entirely absent from LLM answer\n\n5. SEMANTIC EQUIVALENCE:\n   - The core narrative is inverted: ground truth shows declining activity, LLM shows culminating activity\n   - This is not a wording difference but a fundamental factual contradiction",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 530,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings, Meta added a **fourth amendment to its 2012 Equity Incentive Plan** (the “Fourth Amendment” disclosed as Exhibit 10.2(C)+ in the 2024 filing) and introduced new **forms of award agreements** under that amendment (e.g., the “2012 Equity Incentive Plan forms of award agreements (Additional Forms)” listed as Exhibit 10.2(K)+ and 10.2(L)+ in 2024). The 2023 filing already showed the **Third Amendment** (Exhibit 10.2(B)+) and a suite of prior award‑agreement forms (through 10.2(J)+), so the 2024 updates reflect both a further amendment to the plan and updated, more recent award‑agreement templates.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Verification against ground truth: (1) QUANTITATIVE ACCURACY: The LLM correctly identifies the Fourth Amendment dated August 1, 2024 (matches ground truth), references the Third Amendment from 2023 filing (correct), and mentions April 2024 forms of award agreements (matches ground truth's 'April 2024'). All dates and amendment numbers are accurate. (2) COMPLETENESS: The answer addresses both key aspects of the question - amendments (Third in 2023, Fourth in 2024) and forms of award agreements (prior forms in 2023, additional/updated forms in 2024). The multi-hop synthesis correctly shows the evolution between the two filing years. (3) ENTITY ACCURACY: Correctly identifies Meta as the company, the 2012 Equity Incentive Plan, and properly references exhibit numbers (10.2(C)+, 10.2(K)+, 10.2(L)+, 10.2(B)+, 10.2(J)+) which provide specificity beyond the ground truth. (4) REASONING: The multi-hop reasoning is sound - the answer synthesizes information across two filing years and correctly identifies the progression from Third Amendment + prior forms (2023) to Fourth Amendment + additional forms (2024). The logic that this represents 'continued evolution and expansion' aligns with ground truth. (5) SEMANTIC EQUIVALENCE: The LLM's phrasing 'further amendment to the plan and updated, more recent award-agreement templates' conveys the same meaning as the ground truth's 'continued evolution and expansion.' Minor enhancement: The LLM provides more specific exhibit references than the ground truth, which adds value without contradicting it. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 448,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s capitalized software‑license balance rose from **$152 million to $223 million**.  The licenses are recorded at cost (or fair value when acquired in a business combination) and then amortized on a straight‑line basis over the contractual term of each license.  The increase shows that the firm added new software licenses—or extended existing ones—during 2023, signaling a higher level of investment in software‑related intangible assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. (1) QUANTITATIVE VERIFICATION: Both key financial figures are correct - $152 million in 2022 and $223 million in 2023. The increase of $71 million is accurately reflected. (2) ACCOUNTING POLICY: The LLM correctly identifies the amortization method (straight-line basis over contractual term) and adds valuable context about initial recording at cost or fair value in business combinations. This detail is consistent with standard accounting practices and enhances the answer. (3) MULTI-HOP SYNTHESIS: The answer successfully synthesizes the evolution across two years, connecting the numerical change to business implications (new licenses or extensions). (4) INTERPRETATION: The LLM's conclusion that the increase signals higher investment in software-related intangible assets is logically sound and matches the ground truth's assessment. (5) MINOR DIFFERENCES: The LLM answer is slightly more detailed than the ground truth regarding the initial recording method (cost or fair value), which is a positive addition. The ground truth emphasizes the evolution from 'disclosed accounting method' to 'quantified asset,' while the LLM focuses more on the business implications of the increase. Both perspectives are valid and complementary. The answer directly addresses all parts of the question: treatment (amortization policy), valuation (carrying values), evolution (2022 to 2023 comparison), and implications (investment signal). No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 419,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "\nBetween 2022 and 2023 the pool of European customer balances that PayPal can earmark for credit‑product funding fell modestly—from about **$3.8 billion (≈ 37 % of European balances)** in 2022 to **$3.0 billion (≈ 39 % of European balances)** in 2023—while the governing limit was expanded from **35 % to 50 %** of those balances.  This shows that PayPal is deliberately **concentrating a larger share of its own customer‑deposit base to finance credit products**, using internal funds rather than external debt, and is positioning its European cash pool as a core source of financing for its growing credit portfolio.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core numerical facts: $3.8B (37%) in 2022 declining to $3.0B (39%) in 2023. The interpretation that this represents more efficient use of existing balances is sound. The reasoning about PayPal's strategic positioning of European customer balances for credit financing is logical and well-articulated.\n\nCRITICAL OMISSIONS: The LLM answer completely fails to mention the €40 billion agreement and $5.5 billion in consumer installment receivables sold in 2023—a major strategic development explicitly highlighted in the ground truth. This is a significant multi-hop synthesis failure, as the question asks about PayPal's 'strategic approach to funding credit products,' and the shift toward external funding mechanisms (securitization) is a crucial part of that strategy.\n\nQUESTIONABLE CLAIM: The LLM states the governing limit was 'expanded from 35% to 50%' of European balances. The ground truth does not mention a 35% baseline or a 50% limit. This appears to be an unsupported assertion that introduces potentially incorrect information about regulatory or policy constraints.\n\nINTERPRETATION ISSUE: The LLM characterizes the strategy as 'using internal funds rather than external debt,' but the ground truth indicates PayPal actually shifted toward external funding (securitization) in 2023. The LLM's interpretation contradicts the strategic shift documented in the ground truth.\n\nQUANTITATIVE VERIFICATION: All stated dollar amounts and percentages for 2022-2023 are correct. However, the missing €40B agreement and $5.5B securitization figures represent incomplete quantitative coverage of the full answer.\n\nMULTI-HOP REASONING: The answer partially synthesizes the 2022-2023 comparison but fails to integrate the 2023 securitization strategy, which is essential for understanding PayPal's complete strategic approach to credit funding evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 515,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the carrying amount of Starbucks’ limited‑partner interest in Valor Siren Ventures I L.P. (reported as “Other investments” in the equity‑investments table) increased from **$24.2 million** as of October 1 2023 to **$39.8 million** as of September 29 2024, reflecting additional capital commitments or valuation changes.  The fund’s share of income or loss is recorded in “interest income and other, net,” and the company notes that this impact is **not material**, so the investment has had no significant effect on Starbucks’ consolidated statements of earnings or financial position.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer provides specific carrying values ($24.2M in FY2023 and $39.8M in FY2024) that directly contradict the ground truth. According to the original answer, the carrying value for Valor Siren Ventures I L.P. was NOT specifically disclosed in fiscal 2023. The ground truth states that by fiscal 2024, the COMBINED carrying value of Valor Siren Ventures I L.P. AND II L.P. was $211.9 million as of September 29, 2024 - not $39.8 million for just Valor Siren Ventures I L.P. alone. The LLM appears to have confused or misidentified the investment amounts. CORRECT ELEMENTS: The LLM correctly identifies that (1) the investment is a limited partnership interest, (2) the financial impact is recorded in 'interest income and other, net,' (3) the impact is not material, and (4) the dates are correct (October 1, 2023 and September 29, 2024). CRITICAL ERRORS: (1) The $24.2M and $39.8M figures are factually incorrect based on ground truth; (2) The LLM failed to recognize that the fiscal 2023 carrying value was not specifically disclosed; (3) The LLM appears to have missed that the $211.9M figure represents COMBINED investments in both Valor Siren Ventures I L.P. AND II L.P., not just Valor I; (4) The multi-hop synthesis is incomplete - the answer doesn't properly address the evolution from undisclosed to disclosed amounts. The answer demonstrates partial understanding of the investment relationship but contains fundamental quantitative errors that undermine its reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 419,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "\nBetween 2022 and 2023 Analog Products kept its strategic role—TI still leans on the same four sustainable advantages (low‑cost, controllable manufacturing; a broad analog‑and‑embedded portfolio; deep market reach; and diversified, long‑life products)—but the segment’s financial impact slipped.  Revenue fell 15 % (from $15.36 bn to $13.04 bn) and operating profit dropped 30 % (from $8.36 bn to $5.82 bn), pushing the operating‑profit margin down from 54.4 % of revenue to 44.6 %.  The decline reflects lower shipments and higher capacity‑related costs, yet Analog continues to be the primary cash‑generating engine that supports TI’s free‑cash‑flow‑per‑share growth objective.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies that Analog Products remained strategically important between 2022-2023, appropriately references the four sustainable competitive advantages framework, and accurately captures the shift toward emphasizing cash generation and free cash flow per share growth. The qualitative assessment of strategic positioning evolution is sound and aligns with the ground truth's emphasis on explicit framing within competitive advantages and cash generation focus. CRITICAL WEAKNESSES: The quantitative data contains significant errors that undermine credibility: (1) Revenue figures appear incorrect - LLM states $15.36bn (2022) to $13.04bn (2023), but these numbers cannot be verified against standard TI reporting and the 15% decline calculation is mathematically consistent with those figures but the base numbers themselves are questionable; (2) Operating profit figures of $8.36bn to $5.82bn are not standard TI Analog segment reporting metrics; (3) The operating margin calculations (54.4% to 44.6%) are mathematically consistent with the stated revenue/profit figures but the underlying numbers lack verification. MISSING ELEMENTS: The ground truth specifically mentions the 67.5% gross margin in 2022 and 300-millimeter production efficiency, neither of which appear in the LLM answer. The LLM provides financial metrics not mentioned in the ground truth (operating profit, operating margins) which suggests potential data fabrication or confusion with different reporting segments. MULTI-HOP REASONING: The answer does synthesize the strategic positioning evolution across years and connects it to competitive advantages and cash flow metrics, showing sound logical structure. However, the unverified financial figures create doubt about the reliability of the synthesis. The answer conflates segment-level metrics with what may be company-level or differently-defined metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 519,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "\nFrom 2022 to 2023 the Lower 48 segment’s depreciation, depletion and amortization (including impairments) rose sharply from **$4.85 bn to $5.73 bn**—an increase of roughly **18 %**—while capital expenditures in that region jumped from **$5.63 bn to $6.49 bn**.  This higher D&A reflects a strategic shift toward greater investment in developing and appraising Lower 48 assets, resulting in larger depletion charges as production continues, and indicates that capital allocation in 2023 was directed more toward expanding the Lower 48 portfolio rather than returning cash to shareholders.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core trend (increase in DD&A from 2022 to 2023 in Lower 48) and provides accurate numbers for the DD&A figures ($4.85bn to $5.73bn). However, there are significant issues: (1) The LLM introduces capital expenditure figures ($5.63bn to $6.49bn) that are NOT mentioned in the original ground truth answer, raising questions about whether these numbers are accurate or sourced from the filing. The ground truth specifically focuses only on DD&A changes, not capex. (2) The percentage calculation of ~18% is mathematically correct ($5.73bn - $4.85bn = $0.88bn; $0.88bn / $4.85bn ≈ 18.1%), which is accurate. (3) The reasoning about what DD&A increases indicate (greater investment, asset development, depletion charges) is sound and goes beyond the ground truth in providing interpretation. (4) The statement about capital allocation being directed toward expanding the portfolio rather than returning cash to shareholders adds interpretation not explicitly in the ground truth. The answer demonstrates good qualitative reasoning and contextual relevance, but the introduction of unverified capex data and the expansion beyond the ground truth's scope (which focused solely on DD&A) creates uncertainty about factual accuracy. The core DD&A numbers are correct, but the additional data points and broader claims reduce confidence in overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 386,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "\nBetween 2023 and 2024 Verizon shifted FWA broadband from a niche “alternative to landline” offering to a central element of its product portfolio—now counted among wireless retail connections and promoted alongside Fios as a primary broadband service for residential and small‑business customers in underserved areas.  At the same time, within the Business segment FWA is packaged as a fixed‑wireless solution for Enterprise, Public‑Sector and Business‑Markets customers, emphasizing use cases such as enterprise networking, IoT and private‑network connectivity and leveraging the company’s expanding 5G/C‑Band spectrum.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the evolution of Verizon's FWA broadband strategy between 2023 and 2024, capturing the shift toward more integrated positioning within the product portfolio. It accurately describes the expansion to include both Consumer/residential and Business/Enterprise segments, mentions the connection to 5G/C-Band spectrum, and appropriately characterizes FWA as an alternative to traditional landline internet. The qualitative reasoning about positioning as a 'central element' and the expansion to enterprise use cases is sound and well-articulated.\n\nWEAKNESSES: (1) CRITICAL OMISSION - The ground truth explicitly mentions the 3.1 million FWA broadband connections reported in 2023. The LLM answer completely fails to include any quantitative data about connection numbers, which is a significant factual omission for a multi-hop financial question. (2) SEMANTIC SHIFT - The ground truth notes a shift from 'provides' (2023) to 'produces' (2024) indicating a more strategic approach. The LLM answer does not capture this linguistic/strategic distinction. (3) INCOMPLETE SYNTHESIS - While the LLM mentions both Consumer and Business segments, it doesn't explicitly state that both segments continued to be served in 2024 as clearly as the ground truth does.\n\nQUANTITATIVE ACCURACY: Score of 4 due to complete absence of the 3.1 million connections figure that appears in the ground truth. This is a material omission for a financial/operational metric.\n\nQUALITATIVE ACCURACY: Score of 7 because the reasoning about portfolio positioning, market segments, and strategic evolution is sound and well-explained, though it misses the 'provides vs. produces' distinction and lacks the quantitative anchor.\n\nCONTEXTUAL RELEVANCE: Score of 8 as the answer directly addresses the question about evolution and positioning, with appropriate detail about target segments and product portfolio integration.\n\nOVERALL: The answer demonstrates good qualitative understanding of Verizon's strategic shift but fails to include key quantitative metrics from the ground truth, which is a significant gap for a financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 578,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "\nFrom 2022 – when Emerson contributed its industrial‑software businesses and invested $6 bn to own roughly 55 % of AspenTech – to 2024, the relationship moved toward full ownership: in November 2024 Emerson announced a cash‑only proposal to buy the remaining AspenTech shares at $240 per share, which would give Emerson 100 % of the company.  This evolution lifted software‑and‑control sales (a 48 % increase in 2024) and helped push consolidated gross margin up to 50.8 % in 2024 (an increase of 1.8 percentage points), although the benefit was partially offset by inventory‑step‑up amortization.  At the same time, Emerson’s equity structure changed from a 55 % equity‑method investment (with a non‑controlling interest recorded in other assets) to a planned full consolidation of AspenTech, eliminating the non‑controlling stake and adding AspenTech’s assets, liabilities and equity to Emerson’s balance sheet.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantial detail about Emerson's evolving relationship with AspenTech and addresses the multi-part question structure. However, there are significant quantitative discrepancies that lower the overall score.\n\nCORRECT ELEMENTS:\n- Correctly identifies the 55% ownership stake acquired in 2022\n- Correctly identifies the $6 billion investment amount\n- Correctly identifies the November 2024 announcement of a full acquisition proposal at $240/share\n- Correctly describes the evolution from partial to full ownership\n- Correctly identifies the shift from equity-method investment to full consolidation\n- Correctly notes the impact on software-and-control sales (48% increase in 2024)\n- Appropriately addresses the equity structure changes\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. GROSS MARGIN DISCREPANCY: The LLM states consolidated gross margin increased to 50.8% in 2024 with a 1.8 percentage point increase. The ground truth states AspenTech contributed 0.6 percentage points to gross margin in 2023. The LLM's 1.8 percentage point figure for 2024 appears to be unsupported by the ground truth and represents a significant quantitative error.\n\n2. INCOMPLETE GROUND TRUTH SYNTHESIS: The ground truth mentions the 0.6 percentage point benefit in 2023 specifically, but the LLM provides a 2024 figure (1.8 pp) without clearly reconciling or explaining the year-over-year progression. This suggests incomplete multi-hop synthesis across the 2022-2024 timeline.\n\n3. MISSING ELEMENTS: The LLM does not explicitly mention the SG&A expense impacts tied to integration that the ground truth identifies, though it does reference integration costs indirectly through inventory-step-up amortization.\n\n4. MISSING EQUITY STRUCTURE DETAIL: The ground truth mentions \"recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets,\" which the LLM does not address.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 period and correctly identifies the progression of the relationship. However, the quantitative accuracy issues (particularly the gross margin figures) undermine the overall quality of the multi-hop synthesis.\n\nSEMANTIC EQUIVALENCE: The LLM's description of equity structure changes is semantically equivalent to the ground truth, though less detailed regarding stock plan impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 647,
        "total_tokens": 2061
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "\nBetween 2022 and 2023 the NEE‑FPL Group Capital relationship stayed anchored in the same junior‑subordinated‑debt framework, but the parties added new series of those debentures—specifically the Series J debentures (effective August 5 2022, referenced in *4(rr)) and the Series K debentures (effective March 1 2023, referenced in *4(uu))—along with related floating‑rate notes and purchase‑contract/pledge agreements with BNY Mellon (*4(t), *4(x), *4(w), *4(xx), *4(yy)).  These moves extended maturities into the 2025‑2030 range and reinforced FPL Group Capital’s role as a financing conduit for NEE, while preserving the existing guarantee and pledge structure that has underpinned their capital‑structure ties since the late‑1990s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) SERIES IDENTIFICATION ERROR: The LLM claims Series J and K debentures were added, with dates of August 5, 2022 and March 1, 2023. However, the ground truth specifies Series B, C, L, M, N, O, and P as the relevant series in the 2023 relationship. Series J and K are not mentioned in the ground truth answer. (2) MATURITY DATE ERROR: The LLM states maturities in the 2025-2030 range, but the ground truth clearly indicates maturity dates ranging from 2057 to 2082—a dramatically different timeframe (30+ year difference). This is a critical quantitative error. (3) RELATIONSHIP CHARACTERIZATION: The LLM claims the relationship 'stayed anchored in the same junior-subordinated-debt framework' from 2022 to 2023, but the ground truth explicitly describes this as an EVOLUTION or TRANSITION from a simple guarantee agreement (2022) to a more complex capital structure with multiple debenture series (2023). The LLM misses this key distinction. (4) GUARANTEE AGREEMENT: While the LLM correctly mentions the guarantee structure from the late-1990s, it fails to properly characterize the 2022 baseline (the October 14, 1998 guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc.) and the shift that occurred by 2023. (5) MISSING SERIES: The LLM completely omits Series B, C, L, M, N, O, and P which are central to the ground truth answer. The reference citations provided (*4(rr), *4(uu), etc.) cannot be verified against the ground truth and appear to be fabricated or misattributed. The answer demonstrates poor multi-hop synthesis and contains multiple factual inaccuracies that fundamentally misrepresent the financial relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 478,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 InterStim II moved from a newly launched device to a core, widely adopted element of Medtronic’s Pelvic‑Health portfolio.  Its market acceptance grew markedly, as sales of the InterStim II platform were integrated with the existing InterStim Micro and InterStim X neurostimulators and promoted alongside capital‑equipment and minimally invasive pelvic‑therapy initiatives, positioning it as a key therapeutic option for overactive bladder, urinary retention and fecal incontinence within the broader Pelvic‑Health therapy suite.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains significant inaccuracies and unsupported claims that diverge from the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies InterStim II, InterStim Micro, and InterStim X as part of the product portfolio\n- Correctly identifies the therapeutic indications (overactive bladder, urinary retention, fecal/bowel incontinence)\n- Correctly notes positioning within broader Pelvic Health therapies\n- Correctly identifies the 2022-2024 timeframe\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. MAJOR FACTUAL ERROR: The LLM claims InterStim II was \"newly launched\" in 2022. The ground truth does not support this characterization. The ground truth indicates InterStim II was already established in 2022 as part of an existing suite.\n\n2. UNSUPPORTED CLAIM: The LLM states \"sales of the InterStim II platform were integrated with the existing InterStim Micro and InterStim X neurostimulators.\" The ground truth makes no mention of sales integration or specific sales data.\n\n3. MISSING KEY DIFFERENTIATOR: The ground truth specifically emphasizes that by 2024, InterStim II was \"specifically highlighted as a recharge-free neurostimulator\" with devices \"differentiated by recharge status.\" The LLM answer completely omits this critical product positioning attribute that represents the evolution between 2022 and 2024.\n\n4. OVERSTATED CLAIMS: The LLM describes InterStim II as \"core, widely adopted\" and notes \"markedly\" grown market acceptance, but the ground truth uses more measured language (\"continued acceptance and growth\") without quantifying market adoption or sales growth.\n\n5. UNSUPPORTED DETAIL: The LLM mentions \"capital-equipment and minimally invasive pelvic-therapy initiatives\" which are not mentioned in the ground truth.\n\nMULTI-HOP REASONING: The LLM failed to properly synthesize the key evolution between 2022 and 2024, which was the shift toward emphasizing device-specific attributes (recharge-free status) and product differentiation. This represents a fundamental misunderstanding of the comparative positioning.\n\nQUANTITATIVE ACCURACY: No specific numbers, dates, or percentages were provided by either answer, so quantitative accuracy is neutral. However, the LLM's characterization of \"newly launched\" in 2022 is factually incorrect.\n\nSEMANTIC EQUIVALENCE: While the LLM uses different wording, it introduces factual errors rather than merely rephrasing. The omission of the recharge-free positioning is a material gap in answering the question about how InterStim II's positioning evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 681,
        "total_tokens": 2007
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Simon Property Group expanded the Supplemental Facility’s size and runway – the initial $3.5 bn capacity (with a possible rise to $4.5 bn) and a 2026 maturity that was later extended to a 2029 start (plus a further one‑year option to 2030).  The interest‑rate structure stayed SOFR‑based with a spread of roughly 72.5 bp plus a rating‑dependent margin, but the company increasingly hedged euro‑denominated borrowings and used fixed‑rate note issuances to lock in lower costs.  Consequently, it shifted from actively drawing on the facility for liquidity toward using the enlarged, longer‑dated facility as a source of cheap funding to refinance and repay maturing debt (e.g., repaying €750 m of euro borrowings in late 2023 and retiring $1 bn of 2 % notes in September 2024), reducing overall reliance on the Supplemental Facility while preserving flexibility for future acquisitions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM introduces several numbers NOT in the ground truth: '72.5 bp' spread, '2029 start' maturity extension, '2030' one-year option, and '$1 bn of 2% notes in September 2024' - these are fabricated details not supported by the original answer. The ground truth specifies maturity as January 31, 2026 with no mention of extensions to 2029/2030. (2) PARTIAL CORRECTNESS: The LLM correctly identifies the $3.5bn/$4.5bn capacity range, SOFR-based rates, the €750m euro borrowing repayment in late 2023, and the shift toward strategic management. However, it adds unverified claims about 'rating-dependent margin' specifics and debt retirement actions. (3) MULTI-HOP REASONING: The LLM attempts to synthesize evolution across 2022-2024 but conflates verified facts with invented details. The ground truth mentions interest rate swaps fixing rates at 3.81% in 2023, which the LLM omits entirely while adding unrelated debt retirement information. (4) SEMANTIC ISSUES: The characterization of shifting 'from actively drawing on the facility for liquidity toward using the enlarged, longer-dated facility' contradicts the ground truth's narrative of 'shift from passive availability in 2022 to active utilization.' The LLM's framing suggests reduced reliance, but the ground truth emphasizes increased active management. (5) MISSING KEY DETAILS: The LLM fails to mention the specific 3.81% fixed rate achieved through swaps in 2023, which is a critical element of the interest rate strategy evolution. The ground truth's core insight about the shift from passive to active management is diluted by the LLM's focus on debt retirement rather than facility utilization patterns.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 468,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "\nFrom 2023 to 2024 Verizon expanded and formalized its device‑payment financing.  In 2023 the company offered non‑subsidized, 36‑month installment plans mainly to Business customers (with optional trade‑in guarantees and occasional billing‑credit promotions), while Consumer plans were largely fixed‑term, subsidized contracts that were phased out.  By 2024 the carrier broadened the installment offering to both Consumer and Business segments, explicitly added a financing component (and related interest income) to the receivable, and introduced tiered trade‑in/upgrade credits that are tied to service continuity, resulting in a more structured financing framework and richer promotional incentives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims 2023 plans were '36-month installment plans' for Business customers, but the ground truth explicitly states there was 'no mention of structured promotional incentives or trade-in rights' in 2023. The LLM also introduces unsupported details like 'optional trade-in guarantees and occasional billing-credit promotions' in 2023, which contradicts the ground truth. (2) ENTITY/SEGMENT ERRORS: The LLM incorrectly distinguishes between Business and Consumer segments with different 2023 offerings ('Business customers' with installment plans vs 'Consumer plans' with 'subsidized contracts'), but the ground truth makes no such segment distinction and describes a general evolution of device payment plans. (3) STRUCTURAL MISREPRESENTATION: The LLM claims 2023 had 'optional trade-in guarantees' and that 2024 introduced 'tiered trade-in/upgrade credits tied to service continuity,' but the ground truth states 2023 had no trade-in rights mentioned, and 2024 introduced 'a defined promotional feature' allowing upgrades after paying a specified portion and trading in in good working order - not 'tiered credits tied to service continuity.' (4) INTEREST INCOME CLAIM: The LLM states 2024 'explicitly added a financing component (and related interest income)' but the ground truth describes 2024 plans as 'non-interest-bearing installment notes,' which directly contradicts this claim. (5) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the evolution from general financing (2023) to structured incentive-driven model (2024) as described in ground truth. The answer introduces segment-level distinctions and financial details not present in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 497,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "\nBetween 2023 and 2024 the Company’s legal stance toward Aqua‑Chem’s asbestos‑related claims did not change – it continues to assert that it has **no liability** for those claims and that responsibility rests with the relevant insurance policies and the former owners of Aqua‑Chem.  Both the 2023 and 2024 10‑K filings confirm that the Wisconsin and Georgia lawsuits remain stayed or subject to ongoing insurance‑coverage disputes, with the Company actively enforcing the courts’ determinations that insurers (not Coca‑Cola) are liable, but it has not taken on any new legal responsibility or settlement that would alter that position.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUE - FUNDAMENTAL MISUNDERSTANDING OF THE EVOLUTION: The LLM answer directly contradicts the ground truth on the key finding. The ground truth explicitly states there WAS a shift in Coca-Cola's stance between 2023 and 2024: from 'outright denial of liability' in 2023 to 'a more nuanced stance centered on insurance coverage and shared responsibility among insurers' in 2024. The LLM incorrectly claims the stance 'did not change' and that it 'continues to assert that it has no liability' - this misses the critical evolution that the question specifically asks about. The LLM's statement that 'it has not taken on any new legal responsibility' is partially correct but fails to capture the important shift in disclosure emphasis and framing that the ground truth identifies. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension scores well (8/10) - the years 2023 and 2024 are correctly referenced. QUALITATIVE ACCURACY: The LLM demonstrates poor multi-hop reasoning by failing to synthesize the evolution across the two years. It correctly identifies entities (Coca-Cola, Aqua-Chem, insurance policies, Wisconsin and Georgia lawsuits) but fundamentally misinterprets the nature of the change. The ground truth's key insight about the shift from 'outright denial' to 'nuanced stance centered on insurance coverage' is completely missed. CONTEXTUAL RELEVANCE: The answer addresses the question's topic but provides an incorrect answer to what was specifically asked - how the relationship 'evolved.' The answer is relevant in scope but wrong in substance. The LLM appears to have focused on the continuity of Coca-Cola's no-liability position while missing the important shift in how that position is being disclosed and framed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 486,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "\nIn 2022 Intel realized a $220 million tax benefit from foreign tax‑holiday and other non‑U.S. credits, which materially lowered its effective tax rate and therefore its long‑term income‑tax liability. By 2024 that benefit had fallen to only $67 million, so the company’s long‑term tax burden rose accordingly, reflecting a deliberate pull‑back from aggressive low‑tax jurisdictions and a shift toward a more U.S.-centric, compliance‑focused international tax strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents the ground truth data. (1) QUANTITATIVE ERRORS: The LLM cites specific tax credit amounts ($220M in 2022, $67M in 2024) that do not appear in the ground truth answer. The ground truth focuses on long-term income taxes payable ($4.3B in 2022 declining to $1.6B in 2024), not annual tax credit benefits. The LLM's numbers appear to be fabricated or from a different source not validated by the knowledge graph. (2) METRIC CONFUSION: The LLM conflates annual tax credit benefits with long-term income tax liabilities - these are different metrics. The ground truth specifically addresses long-term income taxes payable as a balance sheet item, while the LLM discusses annual tax benefits. (3) DIRECTIONAL MISINTERPRETATION: The ground truth indicates that non-US tax credits had a 'stronger offsetting effect over time' with liabilities declining from $4.3B to $1.6B, suggesting improved utilization of credits. The LLM incorrectly interprets the decline in credit benefits ($220M to $67M) as a 'pull-back from aggressive low-tax jurisdictions,' which contradicts the ground truth's narrative of increased effectiveness. (4) STRATEGIC CONCLUSION ERROR: The LLM concludes the company shifted toward 'compliance-focused' strategy, but the ground truth suggests the opposite - that the company became more effective at leveraging international tax credits. (5) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the relationship between non-US tax credits and long-term income tax liabilities across the two years. The answer demonstrates fundamental misunderstanding of the question and provides numbers that cannot be verified against the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 472,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s pension‑risk‑transfer (PRT) business moved from a relatively passive, floating‑rate line of business to a more explicitly modeled, interest‑rate‑sensitive component of its Retirement & Income Solutions segment.  The 2024 filing adds a full‑year sensitivity analysis (declining‑ and rising‑rate scenarios) that quantifies a much larger earnings impact—e.g., a $15 million adverse effect in 2023 under a declining‑rate scenario versus the $5 million impact disclosed in 2022—showing that PRT cash‑flows are now directly tied to 10‑ and 30‑year rate movements and to the firm’s derivative hedging program.  At the same time, regulatory pressure has intensified: newer NAIC reserve and capital‑adequacy rules and the requirement to maintain minimum crediting‑rate guarantees have expanded the disclosure of ALM actions and forced the company to report how PRT exposures affect statutory capital, liquidity and pension‑related expense calculations.  Consequently, PRT risk is now managed through targeted asset‑liability matching, interest‑rate derivatives, and explicit regulatory‑driven capital modeling rather than being treated as a peripheral, low‑impact line of business.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported claims not present in the ground truth. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites specific dollar amounts ($15 million adverse effect in 2023 under declining-rate scenario vs $5 million in 2022) that are not mentioned in the ground truth. These appear to be fabricated numbers without source verification. The ground truth makes no reference to these specific sensitivity analysis figures. (2) UNSUPPORTED CLAIMS: The LLM introduces detailed regulatory requirements (NAIC reserve rules, minimum crediting-rate guarantees, statutory capital modeling) that are not present in the ground truth. While regulatory influence is mentioned in the original answer, the specific regulatory mechanisms cited by the LLM are not substantiated. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes that regulatory changes would 'reduce the likelihood or delay corporate plan sponsors from terminating their plans' and shift the mix toward 'non-guaranteed funding products.' The LLM answer does not address this key regulatory impact on plan sponsor behavior. (4) OVERSTATED CHARACTERIZATION: The LLM describes a shift from 'relatively passive, floating-rate line of business' to an 'explicitly modeled, interest-rate-sensitive component,' but the ground truth does not characterize the 2022 baseline as 'passive' or 'floating-rate.' The ground truth simply notes it was 'part of Retirement and Income Solutions' with 'short- and long-duration products.' (5) MISSING CORE INSIGHT: The ground truth's key finding about regulatory-driven shifts in product mix (toward non-guaranteed funding) is absent from the LLM response. The LLM focuses on internal risk management and disclosure changes rather than the strategic product mix evolution that was central to the ground truth. The answer demonstrates hallucination of specific financial figures and regulatory details not supported by the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 539,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 Medtronic shifted the InterStim Micro from a newly‑launched, single‑use micro‑lead neurostimulator aimed at overactive‑bladder and urinary‑retention therapy to a central, rechargeable pillar of its Pelvic‑Health portfolio.  In the 2022 filing the device was highlighted only as a “recently launched” product, whereas the 2024 filing describes it as a “rechargeable neurostimulator” that is now marketed alongside the broader InterStim II/X platform, supported by expanded indications (including fecal incontinence), integrated AI‑driven surgical planning (AiBLE), and continued global adoption.  This evolution reflects a strategic move to deepen market penetration, broaden clinical use‑cases, and embed the Micro device within Medtronic’s integrated, AI‑enabled surgical ecosystem.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERRORS - The LLM answer introduces claims NOT supported by the ground truth: 'single-use micro-lead neurostimulator' is not mentioned in original answer; 'AiBLE' (AI-driven surgical planning) is completely fabricated and not referenced in ground truth; 'fecal incontinence' is mentioned in ground truth but the LLM incorrectly frames it as an 'expanded indication' when ground truth shows it was already part of the 2022 positioning. (2) MISCHARACTERIZATION - The LLM describes InterStim Micro as 'newly-launched' in 2022 and implies it became 'central' by 2024, but ground truth shows it was already positioned as part of the broader InterStim offering in 2022, not newly launched. The evolution was about DIFFERENTIATION (highlighting rechargeable vs. recharge-free models), not elevation to 'central pillar.' (3) UNSUPPORTED CLAIMS - 'integrated AI-driven surgical ecosystem,' 'global adoption,' and 'market penetration' strategies are not mentioned in the ground truth. (4) CORRECT ELEMENTS - The LLM correctly identifies: the rechargeable positioning in 2024, the distinction from InterStim II/X, the Pelvic Health portfolio context, and the general concept of product evolution. However, these correct elements are embedded within a narrative containing significant fabrications and misinterpretations. The answer demonstrates partial understanding but fails on factual accuracy by introducing unsupported details and misrepresenting the 2022 baseline positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 413,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s use of the Supplemental Facility changed markedly.  In early 2022 it had drawn **$1.05 billion** under the facility and repaid that amount later in January 2022 (SPG 10‑K 2022, pp. 122‑126).  A year later it re‑borrowed **≈ €750 million** (about $815 million) to fund a bond issuance, and then retired the entire Euro‑denominated borrowing in November 2023 with proceeds from new senior notes (SPG 10‑K 2024, pp. 68‑72).  By the end of 2024 the Supplemental Facility had **no outstanding balance**, although its $3.5‑$4.5 billion borrowing capacity remained available for future use.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant narrative details about SPG's Supplemental Facility usage but contains significant quantitative discrepancies with the ground truth. CORRECT ELEMENTS: (1) The €750 million (~$815 million) borrowing and November 2023 repayment are accurately cited with correct conversion; (2) The statement that the facility had no outstanding balance by end of 2024 aligns with ground truth; (3) The narrative structure correctly identifies a pattern of borrowing and repayment. CRITICAL ERRORS: (1) The LLM introduces a $1.05 billion early 2022 borrowing/repayment that is not mentioned in the ground truth, which specifically cites a weighted average outstanding balance of $519.9 million and maximum of $2.1 billion for 2022; (2) The LLM fails to cite the key 2022 metrics (weighted average $519.9M, maximum $2.1B) that directly answer the '2022' part of the question; (3) The LLM fails to cite the 2024 weighted average outstanding balance of $311.1 million, which is critical for showing the evolution between years; (4) The $3.5-$4.5 billion borrowing capacity figure is not verified in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes information across years and identifies the strategic debt reduction pattern, but the synthesis is incomplete and partially inaccurate. The answer focuses on specific transaction details (the €750M event) rather than the broader metrics that best demonstrate the facility's evolution. The ground truth emphasizes weighted average and maximum balances as the primary measures of facility usage evolution, while the LLM emphasizes specific transactions. QUANTITATIVE ACCURACY PENALTY: The introduction of unverified $1.05 billion figure and omission of verified weighted average balances ($519.9M in 2022, $311.1M in 2024) significantly undermines quantitative accuracy despite correct handling of the €750M transaction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 513,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "\nBetween 2022 and 2023 the depreciation, depletion, amortization and impairment (DDA & Impairments) charge for COP’s Lower 48 segment rose from **$4,854 million to $5,729 million**—an increase of roughly **$875 million (≈18 %)**. This jump indicates that the company invested significantly more capital in the Lower 48 during 2023, expanding its drilling, development and associated asset base, and also incurred larger impairment write‑downs tied to the higher‑valued asset portfolio. Consequently, the higher DDA expense reflects the accelerated investment activity in that region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. QUANTITATIVE VERIFICATION: All numbers are correct - 2022: $4,854 million, 2023: $5,729 million, difference: $875 million, percentage increase: 18% (875/4,854 = 18.04%, correctly rounded). ENTITY ACCURACY: Correctly identifies COP, Lower 48 region, and the relevant metric (depreciation, depletion, amortization, and impairments). MULTI-HOP REASONING: The answer properly synthesizes the year-over-year comparison and correctly interprets what the increase signifies - that higher DDA expenses reflect increased investment activity and asset utilization. COMPLETENESS: Addresses the core question about how investment activity evolved, providing both the numerical change and contextual interpretation. MINOR CONSIDERATIONS: The LLM adds interpretive detail about 'impairment write-downs' and 'accelerated investment activity' which goes slightly beyond the ground truth statement but remains logically sound and consistent with the data. The ground truth answer is more conservative in its interpretation ('indicates a significant increase'), while the LLM provides more specific business context. Both are semantically equivalent and factually correct. The calculation and percentage are accurate, and the reasoning about what DDA increases signify is sound. No factual errors detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 376,
        "total_tokens": 1602
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "\nFrom 2023 to 2024 Verizon reframed its corporate‑networking portfolio as a set of four integrated service pillars—Network Services (private‑networking, SD‑WAN, cloud‑connectivity), Advanced Communications (IP‑voice, video‑collaboration, contact‑center), Security (managed threat‑detection and response) and IoT (network‑access and usage‑based monetisation)—all under the new “Intelligent Edge Network” architecture.  The company’s emphasis shifted toward Enterprise and Public‑Sector customers, whose revenue grew to **$14.2 billion in 2024**, while Business‑Markets and Wholesale remained stable, indicating a move from pure connectivity to higher‑value managed‑service and security solutions.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM states Enterprise and Public Sector revenue was $14.2 billion in 2024, but the ground truth indicates $15.1 billion in 2023 with no 2024 figure provided. The LLM's $14.2B figure appears to be fabricated or misattributed. (2) UNSUPPORTED CLAIMS: The LLM introduces entirely new structural elements not mentioned in the ground truth: 'four integrated service pillars' (Network Services, Advanced Communications, Security, IoT), 'Intelligent Edge Network' architecture, and specific service details like 'SD-WAN,' 'IP-voice,' 'video-collaboration,' 'contact-center,' 'managed threat-detection and response,' and 'usage-based monetisation.' None of these details appear in the original answer. (3) MISALIGNMENT WITH GROUND TRUTH: The ground truth emphasizes a SHIFT TOWARD SIMPLIFICATION and LESS DETAIL in 2024 compared to 2023. The LLM instead describes an expansion into MORE DETAILED service categorization, which directly contradicts the ground truth's core finding. (4) MISSING KEY INFORMATION: The LLM fails to mention the 50% revenue proportion (Enterprise/Public Sector as ~50% of Business segment) that was explicitly stated in 2023. (5) REASONING QUALITY: While the LLM attempts multi-hop synthesis, it does so by fabricating details rather than accurately synthesizing available information. The answer reads as plausible but is fundamentally disconnected from the actual filing data. The core insight about strategic consolidation/simplification of messaging is completely inverted in the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 456,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "\nMetLife continues to value its FVO securities at fair value using observable market prices and discounted‑cash‑flow techniques, with Level 3 inputs for less‑observable parameters, and it assesses the impact of a 10 % U.S.‑dollar appreciation by applying that rate shift to the foreign‑currency‑denominated portion of the assets and liabilities. In the 2022 sensitivity analysis a 10 % dollar strengthening would have reduced the estimated fair value of those assets by roughly $11.8 billion (and increased related liabilities by about $3.7 billion), producing a net negative effect of roughly $7.2 billion; the 2024 disclosures retain the same methodology but reflect an updated net sensitivity that reflects the current asset‑liability composition, still excluding the $217.5 billion of insurance‑contract liabilities that would offset much of the movement.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites $11.8 billion, $3.7 billion, and $7.2 billion as 2022 sensitivity figures, but the ground truth states the 2022 fair value of FVO securities was $1.6 billion with a 10% dollar appreciation causing a $54 million decrease. These numbers are completely inconsistent - the LLM's figures are orders of magnitude larger and appear to reference total asset-liability sensitivity rather than FVO securities specifically. The $217.5 billion figure mentioned is also not in the ground truth. (2) ENTITY CONFUSION: The LLM appears to be discussing broader currency sensitivity across all assets and liabilities rather than specifically FVO securities as the question requires. The ground truth explicitly focuses on FVO securities valuation evolution. (3) INCOMPLETE EVOLUTION ANALYSIS: The ground truth emphasizes a shift from 'static sensitivity model to more complex, duration- and currency-dependent approach' between 2022 and 2024. The LLM mentions methodology retention but fails to capture this evolution or the shift toward more nuanced valuation frameworks. (4) MISSING KEY DETAILS: The ground truth notes that 2024 disclosures show 'nonperformance risk spreads and unobservable inputs varied by duration and currency' - this important evolution is absent from the LLM answer. (5) METHODOLOGICAL ACCURACY: While the LLM correctly identifies valuation techniques (observable prices, DCF, Level 3 inputs), it applies them to the wrong scope of analysis. The answer reads as a general currency sensitivity discussion rather than a focused analysis of FVO securities valuation evolution. The fundamental disconnect between the $1.6 billion FVO fair value and the $11.8 billion figure cited suggests the LLM conflated different financial metrics or time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 513,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "\nBetween 2022 and 2023 NextEra Energy’s power‑marketing and energy‑trading business grew substantially, moving from a $2.67 billion loss on non‑qualifying commodity hedges in 2022 to an approximate $2.53 billion gain in 2023.  This swing added roughly $5.9 billion to operating revenues and helped offset lower fuel‑cost recoveries, even though related operating expenses rose modestly (about $566 million higher, driven mainly by O&M and depreciation).  Consequently, the company’s trading activities contributed positively to its 2023 financial performance, boosting net income while the overall expense base remained only slightly higher than the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces numbers not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM cites a '$2.67 billion loss on non-qualifying commodity hedges in 2022' and '$2.53 billion gain in 2023' - these specific figures do not appear in the ground truth and appear to be fabricated or misattributed. The ground truth provides net income figures ($285M in 2022 vs $3,558M in 2023), not commodity hedge losses/gains. The LLM's claim of a '$5.9 billion swing' in operating revenues from hedging activities is not substantiated. (2) MISSING KEY INFORMATION: The LLM completely omits the core ground truth finding - that NEER's net income increased from $285 million to $3,558 million, a $3,273 million increase. This is the primary quantitative evidence of evolution in power marketing activities. (3) ENTITY/METRIC CONFUSION: The LLM focuses on commodity hedges and operating expenses rather than the actual business performance metrics (net income growth) that demonstrate the evolution. The ground truth emphasizes NEER's expanded role and profitability growth; the LLM discusses hedging losses/gains which are different metrics. (4) UNSUPPORTED CLAIMS: The statement about '$566 million higher' operating expenses and the characterization of expense growth is not verified in the ground truth. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize 2022-2023 comparison, it does so with incorrect data points. The ground truth clearly shows substantial net income growth ($285M to $3,558M); the LLM's narrative about hedging swings and expense management does not align with or explain this core finding. The answer appears to confuse or conflate different financial metrics and introduces specific dollar amounts that cannot be verified against the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 499,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "\nThe Coca‑Cola Company’s equity‑method stake in Coca‑Cola FEMSA remained at **28 %**, the same level it held at the end of 2023 (Note 6 – Equity Method Investments). Because the ownership percentage did not change, the rise in equity‑income from FEMSA—from **$1.69 billion in 2023 to $1.77 billion in 2024**—is attributable to FEMSA’s higher net earnings that are passed through to Coca‑Cola’s 28 % share. This modest increase contributed to the overall growth in the company’s equity‑income (loss)‑net for the year.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer provides accurate quantitative data regarding the 28% ownership stake and equity income figures ($1.69B in 2023 to $1.77B in 2024), which appear to be correctly sourced from the filings. However, the answer has significant limitations in addressing the question's core inquiry about how the relationship 'evolved' between 2023 and 2024. The original answer emphasizes a strategic shift from an indirect dependency-based relationship (2023) to a direct ownership stake with equity method accounting (2024), suggesting a meaningful evolution. The LLM answer contradicts this by stating the stake 'remained at 28%' and was the same level at end of 2023, which conflicts with the ground truth's characterization of an evolution from indirect to direct ownership. The LLM focuses narrowly on explaining the increase in equity income through higher net earnings rather than addressing the relationship evolution itself. The answer correctly identifies the equity method accounting treatment and provides sound reasoning about how FEMSA's earnings flow through to Coca-Cola's equity income line item. However, it fails to capture the strategic evolution dimension that the original answer emphasizes—the shift from a credit-rating dependency relationship to a formalized 28% equity stake. The quantitative data appears accurate, but the qualitative interpretation misses the key narrative of how the relationship evolved. The answer is partially correct on the mechanics but incomplete on the strategic context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 418,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "\nBetween 2022 and 2023 the Lower 48 segment’s depreciation, depletion and amortization jumped to **$5.73 bn** (up from **$4.85 bn** in 2022) and capital expenditures rose to **$6.49 bn** (from **$5.63 bn**), showing a clear increase in financial investment in the region’s upstream assets.  At the same time, consolidated sales from Lower 48 fell to **$38.2 bn**, but the underlying production picture was stable – the Delaware‑Basin reserve share remained above 15 % and barrel‑level production costs stayed roughly flat – indicating the company is directing more capital toward sustaining and expanding its existing Lower 48 operations rather than boosting output.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core depreciation/depletion/amortization figures ($4.85bn in 2022 rising to $5.73bn in 2023), matching the ground truth exactly. The answer appropriately addresses the multi-hop question by synthesizing both production volumes and depreciation expenses. The reasoning about increased financial investment despite stable production is sound and aligns with the ground truth narrative. The answer goes beyond the ground truth by adding capital expenditure data ($5.63bn to $6.49bn) and consolidated sales information, showing deeper analysis.\n\nWEAKNESSES: The LLM introduces significant unverified information not present in the ground truth. Specifically: (1) The consolidated sales figure of $38.2bn for Lower 48 cannot be verified against the ground truth; (2) The Delaware Basin reserve share claim of \"above 15%\" is not mentioned in the original answer; (3) The barrel-level production cost claim about staying \"roughly flat\" is not substantiated in the ground truth; (4) The capital expenditure figures ($5.63bn and $6.49bn) are not mentioned in the original answer and cannot be verified. While these additions might be factually correct from the source documents, they represent information synthesis beyond what the ground truth confirms.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes the relationship between depreciation expenses and financial investment, and attempts to connect this to production stability. However, the original answer specifically mentions 2022 production volumes (crude oil at 447 kbd and natural gas at 1,340 mmcf/d), which the LLM does not address. The LLM's statement about \"stable\" production is inferred rather than explicitly supported by the production volume data from the ground truth.\n\nQUANTITATIVE VERIFICATION: The two core numbers that can be verified are correct: $4.85bn (2022) and $5.73bn (2023). However, the introduction of unverified figures (sales, capex, reserve share percentages) creates uncertainty about whether all numbers are accurate to the source documents.\n\nCONCLUSION: The answer is partially correct with accurate core metrics but introduces unverified information and omits specific production volume details from the ground truth. The reasoning is sound but incomplete relative to the original answer's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 623,
        "total_tokens": 1930
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "\nBetween 2023 and 2024 Verizon deepened the role of its 4G LTE network as the foundation for its fixed‑wireless‑access (FWA) broadband offering and as a platform for 5G evolution.  The company highlighted that 4G LTE‑enabled FWA now contributes meaningfully to both the Consumer and Business segments’ revenues, and that capital‑expenditure plans (e.g., the $17.1 billion invested in 2024) include upgrades to LTE capacity, network densification and the migration of customers onto 5G—underscoring LTE’s strategic function as a bridge that supports near‑term growth while enabling the rollout of next‑generation services.  (See Verizon 2023 10‑K pp. 95‑99 and Verizon 2024 10‑K pp. 21‑25.)",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of Verizon's 4G LTE network strategy between 2023 and 2024, correctly identifying the shift from a foundational service delivery component to a more integrated strategic asset. STRENGTHS: (1) Correctly identifies FWA broadband as a key 2023 use case; (2) Accurately describes the evolution toward a multi-technology ecosystem including 5G, C-Band, and fiber; (3) Appropriately characterizes LTE as a 'bridge' technology supporting near-term growth while enabling 5G rollout; (4) The $17.1 billion capex figure for 2024 is plausible and contextually appropriate; (5) References to specific 10-K page numbers add credibility. MINOR ISSUES: (1) The LLM answer emphasizes LTE's role as a '5G evolution platform' and mentions revenue contributions to Consumer and Business segments, which adds detail beyond the ground truth but is not contradictory; (2) The ground truth emphasizes the integration with C-Band spectrum, millimeter wave spectrum, and fiber infrastructure more explicitly as part of the 'broader integrated network vision,' while the LLM answer mentions these elements but with slightly less emphasis on their coordinated strategic role; (3) The LLM answer focuses more on the operational/capex aspects (capacity upgrades, densification, customer migration) rather than the strategic positioning shift described in the ground truth. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings and correctly identifies the evolution trajectory. The logic is sound and the comparison is appropriate. QUANTITATIVE VERIFICATION: The $17.1 billion capex figure cannot be independently verified from the ground truth provided, but it is presented as a specific data point that would be verifiable in actual 10-K filings. The answer does not contain obvious calculation errors. Overall, the answer is substantially correct and addresses the question comprehensively, though it emphasizes slightly different aspects than the ground truth while remaining semantically aligned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 553,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "\nFrom fiscal 2022 through 2024 Emerson’s stake in AspenTech grew from roughly 55 % of the outstanding shares (after the Heritage AspenTech transaction) to about 57 % and culminated in a 2024 proposal to buy the remaining ≈ 43 % at $240 per share—implying a total enterprise value of roughly $15 billion.  The acquisition lifted AspenTech’s backlog from $328 million in 2021 to $1.04 billion in 2022, helping push consolidated backlog up to $8.05 billion in 2022, but the integration also introduced about $231 million of inventory‑step‑up amortization that trimmed roughly 1.3 percentage‑points off gross margin in 2024 (even as gross margin rose to 50.8 % thanks to higher pricing and the Test & Measurement acquisition).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth:\n\n1. OWNERSHIP STRUCTURE ERROR: The LLM claims Emerson's stake grew from 55% to 57% and then proposed buying remaining shares at $240/share. However, the ground truth states that by 2024, Emerson owned 55% of 'New AspenTech' after completing a transaction. The LLM's narrative of a 2024 proposal to buy remaining shares appears to be either speculative or incorrect based on the ground truth.\n\n2. BACKLOG TIMELINE ERRORS: The LLM states AspenTech's backlog went from $328M in 2021 to $1.04B in 2022, and consolidated backlog reached $8.05B in 2022. However, the ground truth indicates: (a) AspenTech had $1,042M backlog in 2022 (not $1.04B in 2022 from $328M in 2021), and (b) consolidated backlog reached $8,053M in 2024, not 2022. This is a critical multi-year misalignment.\n\n3. GROSS MARGIN DISCREPANCY: The LLM claims inventory step-up amortization trimmed 1.3 percentage points off gross margin in 2024, and that gross margin rose to 50.8%. The ground truth states gross margin increased by 3.3 percentage points in 2023 partly due to the AspenTech acquisition. The LLM provides different numbers for a different year with opposite directional impact.\n\n4. MISSING KEY INFORMATION: The LLM fails to clearly establish the 2022 baseline relationship and how it evolved through 2024. The ground truth emphasizes the completion of a transaction resulting in 55% ownership, but the LLM muddies this with a speculative 2024 proposal.\n\n5. CALCULATION/SYNTHESIS ISSUES: The LLM attempts to synthesize multiple data points but does so with incorrect year assignments and ownership percentages that don't align with the ground truth narrative.\n\nThe answer demonstrates some understanding of the AspenTech relationship but fundamentally misrepresents the timeline, ownership progression, and financial impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 523,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "\nBetween 2022 and 2023 NEE went from holding a sizable, active investment in the Mountain Valley Pipeline to essentially exiting that exposure: a full impairment in early 2022 wiped out its entire pipeline stake, and the only remaining financial tie is a modest $1.06 billion equity contribution slated for 2024 (shown in the 2024‑2028 capital‑expenditure table).  This pull‑back signals that NEE is scaling back its involvement in large, non‑regulated pipeline projects and is redirecting capital toward its core regulated utility and renewable‑energy growth initiatives.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on nearly every factual claim: (1) FACTUAL ERRORS: The ground truth states NEE maintained a 32.8% equity investment in MVP by 2023 with a $70M/year transportation agreement, indicating deepening commitment. The LLM claims NEE 'essentially exited' with a 'full impairment in early 2022' that 'wiped out its entire pipeline stake' - this is directly contradicted by the ground truth showing continued 32.8% ownership in 2023. (2) QUANTITATIVE INACCURACY: The LLM cites a '$1.06 billion equity contribution slated for 2024' from a capital expenditure table, but this number does not appear in the ground truth and appears to be fabricated or misattributed. The ground truth specifies $70M/year transportation agreement, not $1.06B capex. (3) REASONING FAILURE: The LLM's multi-hop synthesis is backwards - it claims a 'pull-back' and 'scaling back involvement' when the ground truth explicitly states a 'strategic deepening of NEE's commitment' with a 'more structured, long-term contractual relationship.' (4) ENTITY/METRIC CONFUSION: The LLM conflates different financial instruments (equity investment vs. capital expenditure) and mischaracterizes the nature of NEE's involvement. (5) STRATEGIC INTERPRETATION: The LLM's conclusion about redirecting capital away from pipelines contradicts the ground truth's indication of increased structural commitment through the 20-year transportation agreement. The answer demonstrates fundamental misunderstanding of the filing data and provides materially false information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 436,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "\nFrom 2023 to 2024 the reference to Costa Limited in the Global Ventures discussion shifted from a simple listing of its brands alongside innocent and døgān to a explicit emphasis on its strategic role.  The 2024 filing describes Costa’s coffee‑and‑tea portfolio as a core pillar of Global Ventures, noting that its operations are now fully integrated into the Company’s worldwide bottling and distribution platform and aligned with the segment’s growth‑and‑sustainability objectives.  This language signals a deeper operational integration and a more central strategic positioning for Costa within the Global Ventures segment.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ANALYSIS: The LLM answer contains both accurate and problematic elements. CORRECT ELEMENTS: (1) The identification of Costa Limited as part of Global Ventures in both 2023 and 2024 is accurate. (2) The mention of innocent and doğadan (spelled 'døgān' in LLM answer - minor spelling variation) as part of Global Ventures in 2024 is correct. (3) The general characterization of deeper integration from 2023 to 2024 aligns with the ground truth. PROBLEMATIC ELEMENTS: (1) The LLM introduces specific language about Costa's 'coffee-and-tea portfolio as a core pillar' and 'fully integrated into the Company's worldwide bottling and distribution platform' that is NOT present in the ground truth. The ground truth does not describe Costa as a 'core pillar' or explicitly state 'full integration' into bottling/distribution platforms. (2) The LLM claims the 2024 filing describes alignment with 'growth-and-sustainability objectives' - this specific language is not verified in the ground truth. (3) The LLM's characterization of the 2023 reference as 'simple listing' versus 2024's 'explicit emphasis on strategic role' appears to be an inference not directly supported by the ground truth, which simply states Costa was 'referenced as part of direct retail operations' in 2023. MULTI-HOP REASONING: The LLM correctly synthesizes that Costa's role evolved within Global Ventures from 2023 to 2024, but it adds interpretive language and specific claims not grounded in the provided ground truth. The answer reads as plausible but contains fabricated details about operational integration language that cannot be verified. QUANTITATIVE ACCURACY: No specific numbers or dates are incorrect (8/10 - minor spelling variation). QUALITATIVE ACCURACY: The reasoning contains unsupported claims and appears to extrapolate beyond what the ground truth establishes (4/10). CONTEXTUAL RELEVANCE: The answer addresses the question but with unverified embellishments (6/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 527,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "\nBased on the Consolidated Financial Statement notes in the 2022 10‑K (pages 78‑80) and the 2024 10‑K (pages 81‑85), Intel’s economically‑hedged marketable‑debt investments were reported at a fair value of **$13.5 billion as of December 28 2024**, down from **$17.1 billion at the end of 2023** (the 2022 filing uses the same hedged‑instrument classification but does not disclose a separate year‑end figure).  The decline reflects net losses of **$464 million in 2024** (versus net gains of $534 million in 2023 and net losses of $748 million in 2022), indicating a reduction in the hedged debt portfolio’s fair‑value exposure over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive synthesis of Intel's economically hedged marketable debt investments across the 2022-2024 period. STRENGTHS: (1) All key financial figures are correct: $13.5 billion (2024), $17.1 billion (2023), $748 million net losses (2022), $464 million net losses (2024), and $534 million net gains (2023). (2) The multi-hop reasoning correctly synthesizes data across three fiscal years from multiple 10-K filings. (3) The answer properly identifies the trend: declining fair value of hedged investments and reduced loss magnitude over the period. (4) The answer appropriately notes that 2022 filing uses the same classification but doesn't disclose a separate year-end figure, showing careful document analysis. (5) All entities (Intel, economically hedged marketable debt investments, fair values, net losses/gains) are correctly identified. MINOR CONSIDERATIONS: (1) The LLM provides additional context about 2023 net gains ($534 million) which, while accurate and helpful, goes slightly beyond the ground truth answer's explicit focus on 2022 and 2024 comparisons. However, this addition strengthens rather than weakens the answer by providing fuller context for the evolution. (2) The parenthetical note about page numbers and filing references adds credibility but is not essential to correctness. CALCULATION VERIFICATION: The comparison logic is sound - the portfolio decreased from $17.1B to $13.5B (a $3.6B decline), and losses decreased from $748M to $464M (a $284M improvement). The answer correctly characterizes this as 'reduction in both the size of the hedged investment portfolio and the magnitude of losses.' The semantic equivalence with the ground truth is excellent, with the LLM using slightly more detailed language while maintaining factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 495,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "\nBetween 2023 and 2024 AMT shifted its emphasis from expanding the breadth of its communications‑site portfolio to protecting and monetising the cash‑flow that those sites already generate.  The company highlighted that more than $60 billion of non‑cancellable lease revenue is locked in by long‑term, escalating contracts, and it began to treat that recurring revenue as a core, stable source of cash.  At the same time, AMT started reporting a much larger, quantified asset‑retirement liability—about $4.5 billion of undiscounted future cash outlays—reflecting a new focus on the financial impact of retiring aging tower infrastructure as it evaluates divestitures such as the India business and the pending ATC TIPL transaction.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the $4.5 billion asset retirement obligation figure for December 31, 2024, matching the ground truth exactly. (2) The answer correctly captures the shift in AMT's financial focus from 2023 to 2024. (3) The mention of non-cancellable lease revenue and long-term escalating contracts is relevant context. (4) The reference to specific business transactions (India divestiture, ATC TIPL) shows detailed knowledge. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth explicitly states that in 2023, 99% of total revenues came from property operations/communications sites. The LLM answer completely fails to mention this specific 2023 metric, which is a key part of the original answer's 2023 baseline. (2) The $60 billion figure for non-cancellable lease revenue is introduced but NOT present in the ground truth answer provided. While this may be factually correct from the filing, it represents information beyond the ground truth scope and shifts emphasis away from the core comparison. (3) The LLM's framing emphasizes 'protecting and monetising cash-flow' and 'expanding breadth vs. protecting existing portfolio' - this interpretation goes beyond what the ground truth states. The ground truth is more straightforward: 2023 emphasized recurring revenue generation (99% from property ops), while 2024 added focus on asset retirement liabilities ($4.5B). (4) MULTI-HOP REASONING: The ground truth requires synthesizing two distinct pieces of information (2023 revenue focus vs. 2024 liability focus). The LLM does attempt this synthesis but introduces additional context not in the ground truth, potentially confusing the core evolution being described. QUANTITATIVE VERIFICATION: The $4.5 billion figure is correct. The 99% revenue metric from 2023 is missing entirely from the LLM answer. The $60 billion lease revenue figure is not verified against ground truth. SEMANTIC ISSUE: The LLM's narrative about 'shifting from expanding breadth to protecting cash-flow' is a reasonable interpretation but differs from the ground truth's simpler framing of 'shifting from emphasizing revenue to also addressing liabilities.'",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 580,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "\nBetween 2023 and 2024 the legal foundation for operations in Guyana remained anchored in the 2023 Petroleum Act, which guarantees up to a 10‑year exploration term and a 20‑year production period (with a possible 10‑year renewal) for oil fields.  ExxonMobil’s strategy shifted from simply securing those rights to using the stable regime as a platform for rapid growth—positioning Guyana as a core “advantaged asset” and concentrating on expanding production, developing multiple projects in the Stabroek block and integrating the country into its higher‑value, low‑emission portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and comprehensive understanding of XOM's strategic evolution in Guyana between 2023 and 2024. QUANTITATIVE ACCURACY: All numeric values are correct - the 10-year exploration period, 20-year production period, and 10-year renewal option are all accurately stated and match the ground truth. No calculation errors present. ENTITY ACCURACY: XOM (ExxonMobil) correctly identified, Guyana correctly referenced, Petroleum Activities Act 2023 correctly cited, Stabroek block appropriately mentioned, and 'Advantaged Assets' and 'Advantaged Volume Growth' terminology correctly applied. MULTI-HOP REASONING: The answer successfully synthesizes information across two years (2023-2024) and correctly identifies the transition from a regulatory/legal framework focus to a strategic business positioning focus. The connection between the stable legal regime and the strategic shift to growth emphasis is logically sound. COMPLETENESS: The answer addresses both key aspects of the question - the legal operating framework (Petroleum Activities Act 2023 with specific terms) and the business growth emphasis (positioning as advantaged asset for volume growth). SEMANTIC EQUIVALENCE: The LLM's phrasing 'shifted from simply securing those rights to using the stable regime as a platform for rapid growth' effectively captures the evolution described in the ground truth as transitioning 'from being a jurisdiction with defined exploration and production terms to being a core growth asset.' The mention of 'developing multiple projects in the Stabroek block and integrating the country into its higher-value, low-emission portfolio' adds relevant contextual detail that enhances understanding without contradicting the ground truth. Minor deduction (1 point) only because the LLM adds some interpretive language ('simply securing those rights,' 'rapid growth,' 'higher-value, low-emission portfolio') that, while reasonable inferences, goes slightly beyond what is explicitly stated in the ground truth, though these additions are consistent with the overall narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 564,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "\nBetween 2023 and 2024 Caterpillar kept diesel‑electric locomotives inside its **Energy & Transportation** segment, but the business was sharpened as a strategic growth area.  The segment’s rail‑related sales rose 3 % (to $28.85 bn) and profit jumped 16 % (to $5.74 bn), driven by better price realization and higher‑margin rail‑service revenue—particularly in marine and rail services—while the company continued to handle **design, manufacturing, remanufacturing, leasing and aftermarket support** of locomotives and related components.  In short, Caterpillar’s involvement did not shift to a new business line; it deepened its operational focus on rail products within the existing Energy & Transportation framework, positioning diesel‑electric locomotives as a higher‑margin, service‑driven component of its overall portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that fundamentally contradict the ground truth:\n\n1. SEGMENT NAME ERROR: The LLM states the segment is called 'Energy & Transportation,' but the ground truth clearly identifies it as 'Machinery, Energy & Transportation (ME&T)' in 2023. This is a material factual error.\n\n2. QUANTITATIVE ACCURACY FAILURES: The LLM provides specific financial metrics ($28.85 bn in rail-related sales, 3% growth, $5.74 bn profit, 16% growth) that are NOT present in the ground truth answer. These appear to be fabricated numbers without source verification. The ground truth does not provide these specific financial figures, making these claims unverifiable and likely incorrect.\n\n3. MISCHARACTERIZATION OF EVOLUTION: The LLM claims 'Caterpillar's involvement did not shift to a new business line; it deepened its operational focus' - this directly contradicts the ground truth which explicitly describes an evolution in positioning. The ground truth states the business evolved from being part of ME&T with remanufacturing/product support responsibilities to being 'explicitly tied to integrated systems and solutions' with emphasis on 'electrified powertrains and zero-emission power sources.'\n\n4. MISSING KEY STRATEGIC SHIFT: The LLM completely fails to capture the critical 2024 strategic evolution toward electrified powertrains and zero-emission technologies mentioned in the ground truth. This is a major omission of the core answer.\n\n5. OPERATIONAL RESPONSIBILITIES: While the LLM mentions 'design, manufacturing, remanufacturing, leasing and aftermarket support,' the ground truth specifically emphasizes the shift toward integrated systems for electric power generation, marine, oil and gas, and industrial sectors - a more sophisticated positioning than the LLM conveys.\n\n6. MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution between 2023 and 2024. It presents the answer as continuity rather than strategic evolution, which is the opposite of what the ground truth indicates.\n\nThe answer demonstrates poor factual accuracy, introduces unverified financial data, and fundamentally misrepresents the nature of Caterpillar's strategic shift in the diesel-electric locomotives business.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 610,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "\nFrom 2022 through 2024 the outstanding balance of Capital One’s securitized‑debt obligations slipped modestly—from roughly $15 billion (about 4 % of total funding) to about $14.3 billion—while the proportion of securitization within the firm’s overall funding mix remained essentially unchanged.  This pull‑back signals a strategic shift toward relying more on core deposit growth and other debt sources, using securitizations only as a supplemental, low‑cost financing tool rather than a primary funding pillar.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) COMPANY IDENTIFICATION: The LLM identifies the company as 'Capital One' without any basis from the original question or ground truth, which does not specify the company name. This is a critical error in entity accuracy. (2) QUANTITATIVE ERRORS: The LLM claims 2022 securitized debt was 'roughly $15 billion' but the ground truth explicitly states 'the exact amount was not provided' for 2022. The LLM fabricated a specific number that contradicts the ground truth. The 2024 figure of $14.3 billion is approximately correct (ground truth: $14,264 million), but this is overshadowed by the false 2022 claim. (3) UNSUPPORTED CLAIMS: The LLM states securitizations represented 'about 4% of total funding' in 2022 - this percentage is not mentioned in the ground truth and appears to be invented. (4) CONTRADICTORY INTERPRETATION: The ground truth indicates 'a more defined and potentially increased reliance on securitized debt obligations,' suggesting strategic emphasis on structured financing. The LLM claims the opposite - a 'pull-back' and 'shift toward relying more on core deposit growth,' which directly contradicts the ground truth's interpretation. (5) MULTI-HOP REASONING: The LLM failed to properly synthesize the available information. It created a narrative about declining securitization reliance that is not supported by the ground truth. The ground truth emphasizes increased quantification and strategic emphasis, not decreased reliance. (6) MISSING CONTEXT: The LLM provides detailed strategic interpretation without acknowledging the fundamental limitation that 2022 exact amounts were not disclosed, making year-over-year comparison problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 485,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s kept developmental‑licensee revenues (royalties and initial fees) in the International Developmental Licensed Markets & Corporate segment, but it added the detailed segment‑expense disclosures required by the new FASB ASU 2023‑07, giving a clearer financial picture of that business.  At the same time the company refined its lease‑accounting assumptions—especially the probability of renewal options for restaurants operated by developmental licensees—resulting in a larger lease‑right‑of‑use asset and lease liability, reflecting a more formalized and integrated relationship with those licensees.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) The LLM claims McDonald's added 'detailed segment-expense disclosures required by the new FASB ASU 2023-07' - this specific accounting standard reference is not mentioned in the ground truth and appears to be fabricated. (2) The LLM states the company 'refined its lease-accounting assumptions—especially the probability of renewal options for restaurants operated by developmental licensees—resulting in a larger lease-right-of-use asset and lease liability' - this specific lease accounting change is not mentioned in the ground truth. (3) The ground truth emphasizes McDonald's evaluation of developmental licensees as potential variable interest entities and the rounding presentation changes to whole numbers in 2024, neither of which the LLM mentions. (4) The LLM's claim about 'more formalized and integrated relationship' is not supported by the ground truth, which actually discusses consolidation conclusions and variable interest entity evaluations. (5) The LLM correctly identifies that developmental licensees paid royalties and initial fees (from 2023), but misses the 2024 evolution regarding variable interest entity evaluation and rounding changes. The answer demonstrates multi-hop reasoning but applies it to incorrect information, suggesting the model may have hallucinated specific accounting standard references and lease accounting details not present in the source material. The answer is partially relevant to the question but fundamentally misrepresents how McDonald's treatment evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 455,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "\nBetween 2023 and 2024 Southern Company kept essentially the same share reserve for its Equity and Incentive Compensation Plan—about 26.9 million shares remained available for future awards at year‑end 2023 and the 2024 filing continues to reference that reserve.  However, the 2024 filing adds a dedicated “Form of Terms for Named Executive Officer Equity Awards” disclosure that spells out the award types, performance‑based metrics and vesting conditions, providing a more detailed and transparent executive‑award description than in the prior year.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong quantitative accuracy with the correct share reserve figure of 26.9 million shares for 2023. The numeric data is accurate and properly formatted. The answer correctly identifies the key evolution: maintenance of the share reserve while adding enhanced disclosure of executive compensation terms in 2024. However, there are some qualitative differences from the ground truth that affect the overall score. The LLM states the reserve 'remained available' and 'continues to reference that reserve' in 2024, which is slightly ambiguous—the ground truth more clearly indicates that 2023 had the 26.9 million figure as a specific data point, while 2024 shifted focus to detailed disclosure of award terms. The LLM's characterization of the evolution is accurate but less nuanced than the ground truth's distinction between 'internal planning and reserve allocation in 2023' versus 'more detailed public disclosure of executive-level compensation mechanisms in 2024.' The LLM correctly identifies the 2021 Equity and Incentive Compensation Plan effective date (May 26, 2021) implicitly through context, though doesn't explicitly state it. The multi-hop reasoning is sound—the answer synthesizes information about both the share reserve and the disclosure changes across the two years. The semantic meaning aligns well with the ground truth regarding the shift toward transparency and formalized governance. Minor weakness: the LLM could have been more explicit about the governance implications and the shift from internal reserve planning to public disclosure emphasis that the ground truth emphasizes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 446,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "\nInlyta’s worldwide revenue rose modestly from **$1.00 billion in 2022 to $1.04 billion in 2023** (≈ 3 % operational growth).  The uptick was driven by continued uptake of Inlyta in combination regimens for advanced renal‑cell carcinoma—especially in the United States—and expansion in emerging markets, but was tempered by pricing pressure and lower net prices in certain European markets, which limited the pace of growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with minor discrepancies. QUANTITATIVE VERIFICATION: The 2023 revenue figure of $1.04 billion (stated as $1,036 million in ground truth) is correctly represented—the LLM rounded to $1.04B which is semantically equivalent and acceptable. The 3% operational growth rate matches the ground truth exactly. The 2022 baseline of $1.00 billion is reasonably approximated (ground truth implies ~$1,005M based on 3% growth from $1,036M, so $1.00B is a reasonable rounding). QUALITATIVE ASSESSMENT: The LLM correctly identified the key growth drivers: (1) adoption of immune checkpoint inhibitor combinations for first-line advanced RCC treatment in the U.S., and (2) pricing pressures in European markets limiting growth. The answer appropriately characterizes the growth as 'modest' and 'tempered,' matching the ground truth's description of 'moderate pace.' MULTI-HOP SYNTHESIS: The answer successfully synthesizes information about revenue evolution (2022→2023) and contributing factors across the product portfolio context. MINOR ISSUES: (1) The LLM mentions 'expansion in emerging markets' which is not explicitly stated in the ground truth—this is a reasonable inference but adds information not directly supported by the source material. (2) The ground truth emphasizes that Inlyta was 'mentioned among products' driving growth in 2022 without providing specific 2022 revenue, while the LLM provides a specific 2022 figure ($1.00B) that appears reasonable but isn't explicitly confirmed in the ground truth. These are minor additions/inferences rather than errors. The core facts, numbers, and reasoning are sound and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 457,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "\nBetween 2023 and 2024 the franchise model stayed virtually the same – roughly 95 % of restaurants remained franchised and the Company’s revenue continued to be generated from rent, royalties and initial fees that are recognized over the typical 20‑year franchise term.  The 2024 filing (see pp. 44‑46) notes that “Other revenues” now includes fees paid by franchisees to recover a portion of the Company’s technology‑platform costs; these fees are recorded gross and the related expenses are recognized as incurred, so they do not generate a margin for the Company.  Consequently, while the scale of technology‑cost‑sharing grew slightly, the way revenue is recognized and the non‑profit nature of those fees were unchanged, leaving McDonald’s financial dependence on its franchisees essentially stable from 2023 to 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on the core question. Key issues: (1) CONTRADICTS GROUND TRUTH ON EVOLUTION: The LLM claims the franchise model 'stayed virtually the same' and that 'financial dependence on its franchisees essentially stable,' directly contradicting the ground truth which explicitly states the relationship 'evolved to reflect a stronger dependency on franchisees' and describes a 'transformation in the nature of the relationship.' (2) MISCHARACTERIZES REVENUE RECOGNITION: While the LLM correctly notes that technology fees are recorded gross with expenses in 'Other restaurant expenses,' it incorrectly concludes this represents 'unchanged' revenue recognition. The ground truth indicates this IS the change - the shift to gross basis recognition with cost-sharing is the evolution being described. (3) MISSES KEY INSIGHT: The LLM states these fees 'do not generate a margin for the Company,' which is accurate but misses the critical point that the ground truth emphasizes: the shift to gross revenue recognition itself represents increased operational interdependence and a more integrated relationship structure. (4) QUANTITATIVE ISSUES: The LLM cites '95% franchised' and '20-year franchise term' but these are background facts not directly addressing the evolution question. The ground truth doesn't dispute these figures but focuses on the qualitative shift in the relationship structure. (5) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the multi-hop reasoning required - comparing 2023 vs 2024 relationship characteristics, revenue recognition methods, and cost-sharing approaches. Instead, it concludes stability where the ground truth identifies transformation. The answer fundamentally misinterprets what constitutes 'evolution' in the relationship, treating the introduction of technology cost-sharing as merely a scale increase rather than a structural shift in how the companies are operationally interdependent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 539,
        "total_tokens": 1979
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "\nThe subsidiaries’ energy‑related derivatives fell from about $199 million in assets (and $210 million in liabilities) in 2022 to roughly $55 million in assets but rose to about $358 million in liabilities by 2023. This shift from a near‑break‑even position to a sizable net liability indicates that Southern Company’s exposure to energy‑price volatility increased markedly over the year.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and incorrect numbers that fundamentally misrepresent the ground truth data. (1) QUANTITATIVE ERRORS: The LLM claims 2022 assets of ~$199 million and liabilities of ~$210 million, but the ground truth shows total 2022 assets of $95 million ($59+$8+$28) and total 2022 liabilities of $109 million ($32+$12+$65). The LLM's 2023 figures of ~$55 million in assets and ~$358 million in liabilities are also incorrect - the ground truth shows 2023 assets of $28 million ($15+$13) and liabilities of $234 million ($110+$124). (2) CALCULATION ERRORS: The LLM states the position shifted from 'near break-even' in 2022, but the ground truth clearly shows a net liability of $54 million in 2022 ($95M assets - $109M liabilities = -$14M, or more accurately $101M net fair value reported means net liability of $54M when properly calculated). The 2023 net liability of $219 million is also misrepresented. (3) MULTI-HOP REASONING: While the LLM correctly identifies the general trend (increasing net liability exposure indicating greater energy market volatility), it fails to properly synthesize the subsidiary-level data from the ground truth. The answer should have identified specific subsidiaries (Mississippi Power, Southern Power, Southern Company Gas in 2022; Alabama Power and Georgia Power in 2023) rather than providing aggregated figures that don't match the source data. (4) ENTITY IDENTIFICATION: The LLM fails to identify which subsidiaries reported which values, missing the important detail that different subsidiaries were reporting in different years. The conclusion about increased exposure to energy-price volatility is directionally correct but is based on incorrect underlying numbers, making the analysis unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 483,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings, the 2019 Stock and Incentive Compensation Plan remained the sole P&G equity plan that permits future grants, but the reserve of shares available for new issuance dropped from about 119 million to about 77 million, and the weighted‑average exercise price of outstanding options increased from $99.5 to $111.6, reflecting that the plan’s share pool has been substantially used by prior awards while still serving as the primary vehicle for future equity compensation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally misaligns with the ground truth in multiple critical ways: (1) SCOPE MISMATCH: The ground truth addresses the evolution of how the 2019 Plan was disclosed and its role in PG's compensation framework from 2022-2024 (transition from newly introduced to established component). The LLM answer instead focuses on specific share reserve metrics and option pricing data that are not mentioned in the ground truth. (2) QUANTITATIVE ISSUES: The LLM provides specific numbers (119 million shares dropping to 77 million, weighted-average exercise price of $99.5 to $111.6) that cannot be verified against the ground truth provided. These appear to be fabricated or from different source documents not reflected in the knowledge graph answer. (3) CONCEPTUAL DIVERGENCE: The ground truth emphasizes the plan's evolution in disclosure context and its integration into the compensation framework. The LLM answer instead focuses on share depletion and option pricing mechanics, which represents a different analytical angle entirely. (4) MULTI-HOP REASONING: The ground truth synthesizes information about how the plan was presented/discussed across 2022 and 2024 filings. The LLM attempts to synthesize share pool and pricing data, but this synthesis doesn't match the question's focus on 'treatment and significance' in disclosure context. (5) ENTITY/METRIC ACCURACY: While both correctly identify P&G and the 2019 Stock and Incentive Compensation Plan, they address entirely different metrics and aspects of the plan's evolution. The LLM's claim about it being 'the sole P&G equity plan that permits future grants' is not addressed in the ground truth and cannot be verified. The answer appears to be based on different source material than the knowledge graph, making it factually unverifiable against the ground truth standard.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 500,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "\nSouthern Company’s pension‑plan risk‑management framework—broad diversification, a formal rebalancing program and written guidelines for external managers—remained unchanged from 2023 to 2024.  However, the 2024 target‑allocation tables show a modest shift: equity’s target weight stayed at 41 % (actual 40 %), fixed‑income rose from a 30 % target to about 32 % actual, real‑estate increased from 12 % to 14 % actual, and private‑equity was raised from 9 % to 12 % actual, while private‑credit and special‑situations exposures were trimmed.  This re‑weighting reflects a greater emphasis on long‑term, stable assets (real‑estate and private‑equity) and a reduction in higher‑risk credit‑related positions, indicating a slightly more conservative risk posture while still relying on diversification, rebalancing and external‑manager oversight to curb large‑loss risk.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides detailed asset allocation percentages and reweighting information that does not appear in the ground truth answer. The ground truth explicitly states that the emphasis on external manager oversight was REDUCED in 2024, but the LLM answer claims external-manager oversight remained unchanged and continued to be relied upon. This is a fundamental contradiction with the ground truth. The LLM answer focuses heavily on specific target allocation changes (equity 41%, fixed-income 30%→32%, real-estate 12%→14%, private-equity 9%→12%) that are not mentioned in the ground truth at all. While these details might be factually present in the source documents, they do not address the core finding of the ground truth: the shift from active oversight emphasis to market-driven risk exposure. The LLM answer characterizes the change as 'unchanged' framework with modest asset reweighting toward conservative positions, whereas the ground truth identifies a qualitative shift in risk management philosophy from oversight-focused to market-volatility-focused. The LLM answer misses the key insight about reduced external manager oversight emphasis and instead emphasizes continued reliance on external-manager oversight. The quantitative details provided (specific percentages) cannot be verified against the ground truth and appear to be either fabricated or from different source material than what generated the ground truth. The answer fails to capture the essential evolution in risk management approach that the question asks about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 427,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 NVIDIA’s involvement with CUDA moved from being a primarily developer‑focused programming model that under‑pins its GPU hardware sales (as described in the 2022 10‑K on pages 78‑82) to a core element of a broader, monetized AI‑software stack that now includes subscription‑based offerings such as NVIDIA AI Enterprise, DGX Cloud and the Grace CPU (highlighted in the 2023 10‑K on pages 4‑8).  This shift reflects a strategic pivot toward higher‑margin software and platform revenues, positioning NVIDIA as a full‑stack AI computing provider rather than just a supplier of GPU hardware and CUDA.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. MAJOR ERRORS: (1) The LLM claims CUDA moved from 'developer-focused' in 2022 to being part of a 'monetized AI-software stack' in 2023, but the ground truth states the opposite - CUDA was a 'supplier' role in 2022 that evolved into a 'developer' role in 2023. This is a fundamental reversal of the actual evolution. (2) The LLM introduces entities and claims not supported by the ground truth: NVIDIA AI Enterprise, DGX Cloud, and Grace CPU are mentioned as new 2023 offerings, but the ground truth makes no mention of these specific products or subscription-based offerings. (3) The LLM emphasizes 'higher-margin software and platform revenues' and 'subscription-based offerings,' but the ground truth focuses on CUDA's evolution as a development platform (CUDA-X libraries, APIs, domain-specific frameworks) and full-stack computing integration, not on monetization strategy or subscription models. (4) The LLM references specific 10-K page numbers (78-82 for 2022, 4-8 for 2023), which cannot be verified against the ground truth and appear to be fabricated details. CORRECT ELEMENTS: The LLM correctly identifies the time period (2022-2023), correctly names NVIDIA, and correctly identifies that the shift represents a strategic pivot toward broader platform offerings. However, the directional change and the specific nature of that evolution are fundamentally mischaracterized. The answer demonstrates partial understanding of the question's intent but fails on core factual accuracy regarding what CUDA's role actually was in each year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 447,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "\nBetween 2022 and 2023 Pfizer’s manufacturing and supply agreements that had been supporting Viatris’s legacy Upjohn portfolio remained in force but were being phased down.  The balance outstanding under those arrangements fell sharply—from about **$94 million at the end of 2022** to roughly **$33 million by the end of 2023**—reflecting the winding‑down of transitional services and the completion of the shift of production to Viatris, so that revenue recognized from PC1 related to those agreements was now minimal and no material balances remained.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy on the key quantitative metrics and correctly identifies the evolution of Pfizer's financial relationship with Viatris. STRENGTHS: (1) Both outstanding balance figures are correct: $94 million (Dec 31, 2022) and $33 million (Dec 31, 2023) - these are precisely stated and properly formatted. (2) The directional narrative is accurate - the relationship was being phased down with balances declining sharply. (3) The answer correctly identifies that transitional services were being completed/wound down. (4) Multi-hop synthesis is sound, connecting supply agreements, outstanding balances, and TSA completion. WEAKNESSES: (1) The LLM answer omits the specific $780 million revenue figure from PC1 in 2022 that was mentioned in the ground truth as 'primarily reflecting manufacturing of legacy Upjohn products for Viatris.' This is a material omission of a key quantitative data point. (2) The statement that 'revenue recognized from PC1 related to those agreements was now minimal and no material balances remained' is somewhat imprecise - the ground truth indicates the balances decreased to $33 million (not zero), which is still material. (3) The answer could have been more explicit about the 2022 revenue contribution from these supply agreements. CALCULATION VERIFICATION: The decline from $94M to $33M represents approximately a 65% reduction, which aligns with the characterization of a 'sharp' decline. The numbers themselves are accurate. ENTITY ACCURACY: Pfizer, Viatris, PC1, legacy Upjohn products, and TSAs are all correctly identified. TIME PERIOD: 2022-2023 comparison is correctly framed. Overall, this is a solid answer with accurate core metrics but missing one significant quantitative data point (the $780M revenue figure) that would have made it more complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 495,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "\nThe 2023 filing only gave a broad description that cash‑flows from the communications sites back the securitized debt and that any excess cash could be released to the Company. By the 2024 filing this treatment is expanded into a detailed, quantitative disclosure that introduces specific DSCR tests (a 1.30 × cash‑trap and a 1.15 × minimum), defines cash‑trap and amortization periods, quantifies the excess cash that would be locked in reserve accounts, and clearly outlines the default‑related loss of site ownership. This evolution reflects a far more granular and risk‑focused disclosure of how the sites are pledged as collateral and how cash‑flow restrictions affect the Company’s debt obligations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to align with the ground truth in multiple critical ways: (1) QUANTITATIVE ERRORS: The LLM introduces specific DSCR ratios (1.30× and 1.15×) that are not mentioned in the ground truth answer. The ground truth provides concrete numbers: 3,343 communications sites in 2023, $1.3 billion in Series 2013-2A Notes, and $4.5 billion in asset retirement obligations in 2024. The LLM answer provides none of these specific figures and instead invents metrics not present in the ground truth. (2) FACTUAL MISALIGNMENT: The ground truth clearly states that in 2023, communications sites were 'explicitly referenced as collateral' with specific site counts and debt amounts. The LLM claims the 2023 filing gave only 'broad description' - this contradicts the ground truth's emphasis on explicit, specific references. (3) MISSING KEY INFORMATION: The LLM completely omits the specific numbers that define the evolution: the 3,343 sites, the $1.3 billion Series 2013-2A Notes, and the $4.5 billion asset retirement obligations. These are central to understanding the actual shift in disclosure. (4) CHARACTERIZATION ERROR: The ground truth describes a shift FROM site-specific disclosures TO more general obligations. The LLM describes the opposite direction - claiming 2024 introduced 'detailed, quantitative disclosure' and 'granular' information, when the ground truth indicates a move away from site-specific details. (5) INVENTED DETAILS: The LLM introduces concepts like 'cash-trap periods,' 'amortization periods,' and 'default-related loss of site ownership' that do not appear in the ground truth answer and cannot be verified. The answer demonstrates poor multi-hop synthesis by failing to connect the specific financial metrics across years and instead creating a narrative that contradicts the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 515,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "\nComcast’s retransmission‑consent revenue moved from a “gross‑pass‑through” treatment in 2022—where the fees were recorded as part of programming revenue and recognized when earned, often as a lump‑sum charge passed to customers—to a 2023 model that presents the fees as monthly, subscriber‑based license payments under multiyear distribution agreements and recognizes the income on a straight‑line basis as the programming is delivered each month.  This shift reflects a change in both the distribution model (from a gross‑video‑revenue pass‑through to explicit monthly subscriber fees) and the timing of revenue recognition (from point‑in‑time/when‑earned to monthly over the term of the agreement).  (See CMCSA_10k_2022.pdf pp. 92‑96; CMCSA_10k_2023.pdf pp. 8‑12).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations when compared to the ground truth. Key issues: (1) INCORRECT CHARACTERIZATION OF 2022 MODEL: The LLM claims 2022 used a 'gross-pass-through' treatment with 'lump-sum charges,' but the ground truth states 2022 recognized revenue on a monthly basis as programming was provided, with fees tied to subscriber counts and collected within 60 days. This is a fundamental mischaracterization. (2) INCORRECT DESCRIPTION OF 2023 MODEL: The LLM describes 2023 as moving to 'monthly, subscriber-based license payments' and 'straight-line basis,' but the ground truth indicates 2023 emphasized a 'combined linear and streaming distribution model' with retransmission fees including both traditional and virtual multichannel video providers, plus integration of Peacock. The LLM focuses on accounting mechanics (straight-line vs. point-in-time) that are not mentioned in the ground truth. (3) MISSING KEY EVOLUTION: The ground truth emphasizes the strategic shift toward hybrid distribution models blending traditional and streaming services, with explicit mention of Peacock integration. The LLM completely misses this critical aspect of the evolution. (4) UNSUPPORTED CLAIMS: The LLM's description of 'gross-video-revenue pass-through' and the specific accounting treatment changes are not supported by the ground truth and appear to be fabricated details. (5) CITATION ISSUES: While the LLM provides specific page references, the content described does not align with what the ground truth indicates about these filings. The answer demonstrates a fundamental misunderstanding of how Comcast's retransmission consent approach evolved, focusing on incorrect accounting mechanics rather than the actual strategic shift toward hybrid distribution models.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 493,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "\nIn 2023 Caterpillar’s diesel‑electric locomotives were listed only as part of the Energy & Transportation segment’s product portfolio, with emphasis on manufacturing, remanufacturing and component sales (CAT_10K 2023, pp. 114‑118). By 2024 the company broadened that role, positioning diesel‑electric locomotives as a strategic pillar within its sustainability‑driven “expanded offerings” agenda and highlighting remanufacturing, digital integration and market growth as key priorities (CAT_10K 2024, pp. 4‑8).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and omissions compared to the ground truth. CRITICAL ISSUES: (1) The LLM incorrectly states that in 2023 diesel-electric locomotives were 'listed only as part of the Energy & Transportation segment' - the ground truth clearly indicates they were part of the ME&T (Machinery, Energy & Transportation) segment in 2023, not Energy & Transportation. This is a fundamental entity/segment identification error. (2) The LLM completely fails to mention the key evolution described in the ground truth: the shift from a general operational inclusion (remanufacturing reciprocating engines and components, product support for on-highway vocational trucks) to a more direct production role ('produces' diesel-electric locomotives). This is the core of the answer. (3) The LLM entirely omits the most important competitive context added in 2024: the explicit naming of competitors Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This competitive positioning shift is a critical element of the evolution. (4) The LLM introduces unsupported claims about 'sustainability-driven expanded offerings agenda,' 'digital integration,' and 'market growth priorities' that are not mentioned in the ground truth and appear to be fabricated or misinterpreted. (5) Page citations (pp. 114-118 for 2023, pp. 4-8 for 2024) cannot be verified but appear potentially inaccurate. The LLM demonstrates weak multi-hop reasoning by failing to synthesize the actual evolution across the two years and instead providing generic statements about broadening roles without capturing the specific segment naming change, the shift from indirect to direct production language, or the competitive landscape addition. The answer is partially relevant to the question but fundamentally misses the key factual elements that define the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 506,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s kept the same revenue‑recognition model—franchise fees are amortized over the typical 20‑year franchise term and royalties are recorded as underlying sales occur—but the 2024 filing adds a more explicit description of the cost‑sharing process.  The Company now states that shared restaurant‑improvement costs are allocated in real time between Property & Equipment and Accounts Receivable and that the allocation is finalized after the project, resulting in only immaterial adjustments.  This more detailed, formalized allocation of costs with franchisees marks the evolution in the company’s cost‑sharing arrangement between the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of the evolution but contains significant omissions and introduces unsupported details. STRENGTHS: (1) Correctly identifies that the revenue recognition model remained consistent between 2023-2024; (2) Accurately notes the addition of more detailed disclosures in 2024; (3) Correctly identifies cost-sharing arrangements as a key evolution point; (4) Appropriately emphasizes the more transparent/formalized approach in 2024. WEAKNESSES: (1) CRITICAL OMISSION: The LLM completely fails to mention technology platform fees and their presentation on a gross basis in the Consolidated Statement of Income—this is explicitly highlighted in the ground truth as a key 2024 disclosure; (2) UNSUPPORTED DETAIL: The LLM introduces the specific '20-year franchise term' for amortization, which is not mentioned in the ground truth and cannot be verified; (3) INCOMPLETE REVENUE DISCUSSION: The ground truth mentions 'rent and royalties based on a percentage of sales with minimum rent payments, and initial fees' but the LLM only discusses franchise fees and royalties, omitting the rent component and minimum rent payments; (4) VAGUE LANGUAGE: The LLM's description of cost-sharing as 'allocated in real time' and 'finalized after the project' is less precise than the ground truth's specific mention of allocation between 'Property and Equipment and Accounts Receivable'; (5) MISSING CONTEXT: The ground truth notes this level of detail on cost-sharing 'was not present in the 2023 filing,' emphasizing the novelty of the 2024 disclosure, which the LLM doesn't explicitly state. The answer demonstrates partial understanding of the evolution but fails to capture the complete picture of changes, particularly the technology platform fees disclosure which represents a material change in revenue recognition presentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 502,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "\nThe 2024 filing shows a modest evolution from 2023: Southern Company added a ninth amendment to its Employee Savings Plan (effective December 16 2024) and reaffirmed the August 15 2022 change‑in‑control severance plan, while continuing to require that unvested PSUs and RSUs vest immediately for retirement‑eligible participants and upon a change‑in‑control where the company is not the survivor.  At the same time, the 2024 disclosures provide more detailed documentation of award terms—specifically the Monte‑Carlo assumptions used for TSR‑based PSUs and the grant‑date fair‑value calculations for RSUs—making the equity‑compensation framework clearer and more transparent than in the prior year.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains both correct and incorrect elements, resulting in a partially correct response with significant issues:\n\nCORRECT ELEMENTS:\n- Correctly identifies that 2024 filings show more detailed documentation of award terms\n- Correctly mentions PSUs and RSUs as compensation vehicles\n- Correctly notes increased transparency in equity compensation framework\n- The general direction of evolution (toward greater specificity and transparency) aligns with ground truth\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. ENTITY CONFUSION: The LLM introduces information about the \"Employee Savings Plan\" and a \"ninth amendment (effective December 16, 2024)\" which is NOT mentioned in the ground truth answer. This appears to be information about a different plan (savings/401k plan) rather than the Equity and Incentive Compensation Plan that is the focus of the question.\n\n2. SCOPE DRIFT: The answer shifts focus to change-in-control severance provisions and vesting upon retirement, which are not addressed in the ground truth answer. While these may be related to executive compensation, they don't directly address the evolution in \"plan documentation and award terms\" as specified in the question.\n\n3. MISSING KEY INFORMATION: The LLM answer fails to mention:\n   - The formalization of Named Executive Officer equity awards terms in 2024\n   - The designation of specific exhibits for equity award terms in 2024 (not present in 2023)\n   - The shift from general employee compensation disclosure to more structured NEO-specific documentation\n\n4. SPECIFICITY ISSUES: While the LLM mentions \"Monte-Carlo assumptions\" and \"grant-date fair-value calculations,\" the ground truth focuses on the structural shift toward designated exhibits and formalized NEO award terms, which is a different level of documentation evolution.\n\nMULTI-HOP REASONING: The answer fails to properly synthesize the year-over-year comparison. It introduces tangential information about severance plans rather than focusing on the core evolution of equity compensation plan documentation and award terms between 2023 and 2024.\n\nSEMANTIC ALIGNMENT: While both answers mention increased transparency and documentation detail, the LLM answer addresses different aspects of compensation (severance, vesting mechanics) rather than the primary focus on plan documentation formalization and award term specificity for NEOs.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 642,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "\nFrom 2022 to 2024 P&G’s dependence on membership‑club retailers receded – the 2022 filing lists “membership club stores” among its key wholesale customers, but the 2024 MD&A emphasizes growth in direct‑to‑consumer and e‑commerce channels and no longer treats those clubs as a primary sales pillar. This reflects a broader shift toward a more diversified, digitally‑focused retail mix in which the company seeks to reduce reliance on any single wholesale channel and gain greater control over the customer experience and margin generation.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and represents a major factual error. Ground truth states that P&G's reliance on membership club stores INCREASED from 2022 to 2024 (language shifted from listing them as 'one of' key channels to emphasizing 'dependency' and 'deeper strategic alignment'). The LLM answer claims the opposite - that dependence 'receded' and that membership clubs are 'no longer treated as a primary sales pillar.' This is a complete reversal of the actual evolution described in the ground truth. The LLM also introduces unsupported claims about P&G seeking to 'reduce reliance on any single wholesale channel' and emphasizing 'direct-to-consumer and e-commerce channels' as primary drivers, which contradicts the ground truth's finding that membership club stores became MORE central to the strategy. While the LLM correctly identifies the companies and time periods (quantitative accuracy is technically sound on dates/entities), the core directional claim about the strategic shift is inverted. The reasoning about diversification and digital focus, while potentially reasonable business logic, is not supported by the ground truth data and directly contradicts the documented evolution. This is a critical failure in multi-hop reasoning and factual accuracy on the primary question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 372,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "\nBetween the 2023 and 2024 fiscal years AMT’s Nigeria Letters of Credit fell from a recorded $3.4 million carrying amount at the end of 2023 to essentially $0 by the end of 2024 (the 2024 column shows “‑” for both denominated‑currency and USD carrying values). This reduction reflects that the draws taken in 2023 were either repaid or matured (the obligations are due 270 days after drawing), so the contingent liability associated with those letters of credit has been settled and no longer appears on the balance sheet. Consequently, AMT no longer holds a financial obligation for the Nigeria Letters of Credit, indicating the instrument’s exposure has been eliminated.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key quantitative facts: the $3.4 million obligation in 2023 and the $0 (represented as '‑') in 2024. The numeric values are accurate and properly formatted. However, there are significant issues with the qualitative reasoning and factual accuracy of the explanation. The LLM introduces specific details about 'draws taken in 2023' and '270 days after drawing' maturity periods that are not present in the ground truth answer and cannot be verified from the provided information. This represents speculation beyond what the source documents support. The ground truth simply states the obligation was 'fully settled or otherwise exited' without specifying the mechanism. The LLM's explanation about contingent liabilities and balance sheet treatment is reasonable financial reasoning, but it goes beyond what can be confirmed from the filing data. The answer correctly addresses both parts of the question (how it evolved and what it indicates about obligations), and the core conclusion that the obligation was eliminated is sound. However, the introduction of unverified details about specific maturity terms and draw mechanics weakens the answer's reliability. The answer would have been stronger by sticking to what can be directly observed: the reduction from $3.4M to $0 and the conclusion that the obligation was settled, without speculating about the specific mechanism or timeline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 396,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "\nBetween 2022 and 2024 the **valuation methodology for GD’s Retirement Annuity Contracts did not change** – they remained classified as Level 3 assets (significant unobservable inputs).  However, the **reported fair‑value of those contracts fell sharply, from $38 million in 2022 to $22 million in 2024**, and they now represent a much smaller share of the overall plan assets (the total Level 3 balance dropped from $318 million to $219 million).  This shift shows that General Dynamics is **reducing its reliance on internally‑derived estimates for these annuities and is moving toward more observable, market‑based measurements** (e.g., greater exposure to Level 2 commingled funds and fixed‑income securities), indicating a more conservative and transparent approach to reporting its pension‑related assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally contradict the ground truth:\n\n1. VALUATION METHODOLOGY CLAIM: The LLM states the methodology 'did not change' and remained Level 3 assets. However, the ground truth explicitly indicates a SHIFT in methodology - from detailed fair value disclosures in 2022 to NAV (net asset value) as a practical expedient in 2024, with exclusion from the formal fair value hierarchy. This is a major factual error.\n\n2. QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($38 million in 2022 to $22 million in 2024) that do not match the ground truth values. The ground truth shows $35 million as of December 31, 2021, and $38 million as of December 31, 2020 - different years and different values than what the LLM cited. The LLM's claim of a decline from $38M to $22M cannot be verified against the ground truth and appears to be fabricated.\n\n3. INCOMPLETE SYNTHESIS: The LLM failed to identify the key methodological shift from detailed fair value hierarchy disclosures to NAV-based valuation with exclusion from the hierarchy. This is the core answer to the question about how methodology changed.\n\n4. MISINTERPRETATION OF REPORTING APPROACH: The LLM interprets the change as GD 'reducing reliance on internally-derived estimates' and moving to 'more observable, market-based measurements.' However, the ground truth indicates the opposite - a shift to NAV-based practical expedient approach, which is a simplified reporting methodology, not necessarily a move toward more observable inputs.\n\n5. UNSUPPORTED CLAIMS: The LLM makes claims about Level 3 balance changes ($318M to $219M) and shifts in asset composition that are not substantiated in the ground truth provided.\n\nThe answer demonstrates fundamental misunderstanding of the actual methodological change and provides incorrect numerical data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 510,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "\nRestricted cash held for securitization investors fell modestly from $458 million in 2022 to $441 million in 2024. In both years the balance is classified as Level 1 in the fair‑value hierarchy, meaning its fair value is derived from quoted market prices for identical assets and is fully observable.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a partial response with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the 2024 value of $441 million and Level 1 fair value hierarchy classification; (2) Provides accurate definition of Level 1 (quoted market prices for identical assets); (3) Addresses the change between years with a specific dollar amount; (4) Relevant to the question's focus on composition and fair value hierarchy. CRITICAL ISSUES: (1) QUANTITATIVE ERROR - States 2022 restricted cash was $458 million, but the ground truth does not provide this specific 2022 figure. The ground truth only states that in 2022 'the fair value hierarchy was not explicitly detailed for this category,' suggesting the 2022 value may not have been disclosed or classified the same way; (2) INCOMPLETE SYNTHESIS - The LLM claims both years are classified as Level 1, but the ground truth explicitly states that in 2022 'the fair value hierarchy was not explicitly detailed for this category,' indicating a key difference between years that the LLM missed; (3) MISSING KEY INSIGHT - The ground truth emphasizes 'a shift toward more transparent or market-based valuation methods' and 'a more defined and standardized valuation approach in 2024 compared to 2022,' which the LLM fails to capture. The LLM presents the Level 1 classification as consistent across both years when the ground truth suggests it was not explicitly detailed in 2022; (4) INCOMPLETE ANSWER - The question asks about 'composition and value' changes, but the LLM only addresses value and hierarchy, not composition changes. The ground truth mentions 'consolidated VIEs' context which provides compositional information the LLM omits. The $458 million 2022 figure appears to be fabricated or from an unreliable source, as it contradicts the ground truth's statement that 2022 hierarchy was not explicitly detailed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 511,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "\nBetween 2023 and 2024 McDonald’s deepened its financial integration with franchisees by shifting technology‑platform fees to gross‑basis recognition and formalizing the allocation of shared restaurant‑improvement costs between property‑and‑equipment and accounts‑receivable. At the same time the company acquired additional franchised locations (e.g., 228 in Israel), recording goodwill and identifiable intangibles, which reflects a more active approach to asset management and the financial reporting of franchisee‑related investments. These developments are highlighted in the updated segment‑reporting disclosures and accounting‑policy notes.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies the shift toward technology-platform service-based financial interactions and mentions gross-basis revenue recognition, which aligns with the ground truth's description of 'distinct technology-related goods and services' recognized on a gross basis. The mention of segment-reporting disclosures is contextually appropriate. (2) PROBLEMATIC ELEMENTS: The LLM introduces specific quantitative claims (228 restaurants acquired in Israel) that are not present in the ground truth and cannot be verified as accurate from the provided context. This is a significant issue as it adds unsubstantiated numbers. The answer also mentions 'formalizing the allocation of shared restaurant-improvement costs between property-and-equipment and accounts-receivable,' which is not mentioned in the ground truth and appears to be fabricated detail. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes a fundamental shift FROM 'asset acquisition and goodwill management' TO 'ongoing service-based financial interactions.' The LLM answer suggests BOTH activities are happening simultaneously ('deepened its financial integration...at the same time the company acquired additional franchised locations'), which misrepresents the evolutionary nature of the relationship described in the ground truth. The ground truth indicates a transformation/shift, not a parallel expansion of both models. (4) MULTI-HOP REASONING: The LLM fails to properly synthesize the temporal evolution between 2023 and 2024. The ground truth clearly indicates 2023 was characterized by acquisition-based relationships while 2024 shifted to service-based relationships. The LLM conflates these into a simultaneous expansion. (5) QUANTITATIVE ACCURACY: The introduction of '228 in Israel' without ground truth support is a critical error that reduces quantitative accuracy significantly. The answer provides no verifiable numbers that match the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 550,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "\nBetween the 2022 and 2024 Form 10‑K filings, the 2019 Stock and Incentive Compensation Plan remained the only P&G equity plan that can still issue new shares, but the amount of shares left for future grants fell sharply—from about 119 million shares available in 2022 to roughly 77 million shares available in 2024 (reflecting the plan’s 187 million‑share ceiling and the shares already awarded).  The plan continues to be the sole source for future stock‑option, SAR, RSU and PSU grants, while the older plans (1992, 2001, 2003, 2009, 2014) are closed to new issuances; the weighted‑average exercise price of outstanding options also rose from $99.52 in 2022 to $111.57 in 2024, underscoring the plan’s evolving role as the primary vehicle for P&G’s equity‑compensation program.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer fundamentally misinterprets the question and provides information that does not align with the ground truth. Key issues: (1) QUESTION MISALIGNMENT: The original question asks about how the treatment and disclosure of the 2019 Plan evolved between 2022-2024, specifically regarding its relationship with other plans and its role in equity compensation disclosures. The ground truth emphasizes a shift from 'adoption and governance details' to 'security ownership and total shares available for issuance' - a change in disclosure framing and positioning. The LLM answer instead focuses on quantitative metrics (shares available, exercise prices) that were not the focus of the original question. (2) FACTUAL CONCERNS: The LLM provides specific numbers (119 million shares in 2022, 77 million in 2024, $99.52 and $111.57 exercise prices) that cannot be verified against the ground truth provided. These appear to be specific data points that may or may not be accurate, but they are not what the question asks about. (3) MISSING CORE INSIGHT: The ground truth emphasizes a transformation in disclosure positioning - from procedural/governance focus to strategic ownership framework. The LLM completely misses this analytical dimension and instead provides operational metrics about plan capacity and exercise prices. (4) MULTI-HOP REASONING: The LLM fails to synthesize the evolution of disclosure treatment across years; instead it provides a snapshot of operational metrics. The ground truth requires understanding how disclosure emphasis shifted, which the LLM does not address. (5) ENTITY ACCURACY: While P&G and the 2019 Plan are correctly identified, the LLM conflates operational plan metrics with disclosure treatment evolution, which are different analytical frameworks. The answer reads more like a plan capacity analysis than a disclosure evolution analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 509,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "\nSalvatore Ferragamo remained a tenant in a number of SPG’s overseas premium‑outlet assets in both years, appearing in the tenant rosters for outlets in Japan, Mexico, Canada and other international locations. The disclosed documents do not note any lease expirations, renewals or new openings for the brand between 2022 and 2023, indicating that its presence was essentially unchanged during that period.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ERRORS: The LLM claims Salvatore Ferragamo's presence was 'essentially unchanged' between 2022 and 2023, but the ground truth shows a dramatic reduction from 3 locations to 1 location. (2) LOCATION ERRORS: The LLM mentions outlets in Mexico and Canada, but the ground truth specifies only Japanese locations in 2022 (Gotemba, Kobe-Sanda, Sano Premium Outlets) and a single U.S. location in 2023 (Las Vegas Outlets North). The LLM's mention of Mexico and Canada appears to be fabricated. (3) QUANTITATIVE INACCURACY: The LLM fails to identify the specific number of locations (3 in 2022 vs. 1 in 2023), which is a core quantitative element of the question. (4) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the year-over-year comparison correctly, missing the significant shift from Japan to the U.S. and the overall reduction in presence. (5) SEMANTIC CONTRADICTION: The LLM's conclusion that presence was 'essentially unchanged' directly contradicts the ground truth showing a significant reduction. The LLM appears to have either hallucinated information about Mexico and Canada locations or confused Salvatore Ferragamo's presence with another tenant. This is a complete failure to answer the question accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 376,
        "total_tokens": 1601
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "\nBetween the end of 2023 and the end of 2024 ConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region fell from roughly **305 billion cubic feet to 289 billion cubic feet**, a decline of about **5 %**.  The reduction reflects downward price‑related revisions and the disposal of non‑core assets (e.g., the Indonesia sale), while new extensions and discoveries were modest and limited to the Middle East.  This pattern shows that the company is **scaling back its natural‑gas focus in the region**, concentrating instead on higher‑growth U.S. onshore plays and keeping only a stable, low‑growth presence in Asia‑Pacific/Middle‑East.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "MAJOR QUANTITATIVE DISCREPANCIES: The LLM provides significantly different numbers than the ground truth. Ground truth states 312 BCF (2023) to 296 BCF (2024), a decline of 16 BCF or ~5.1%. The LLM claims 305 BCF (2023) to 289 BCF (2024), a decline of 16 BCF or ~5.2%. While the percentage decline is similar (~5%), the absolute numbers are materially different: the LLM's 2023 figure is 7 BCF lower (305 vs 312) and 2024 figure is 7 BCF lower (289 vs 296). These are not minor formatting variations but substantive numerical errors. The LLM's calculation of the percentage decline is mathematically correct for its stated numbers, but the underlying reserve figures are incorrect. QUALITATIVE ASSESSMENT: The LLM provides additional context about reasons for the decline (price-related revisions, Indonesia asset disposal, modest discoveries in Middle East) and strategic implications (scaling back natural gas focus, concentrating on U.S. onshore). This reasoning is plausible and adds interpretive value, though it goes beyond what the ground truth explicitly states. The conclusion about operational focus shift is consistent with both answers. COMPLETENESS: The LLM addresses the core question about how the position evolved and what it indicates about operational focus. However, the factual foundation is compromised by incorrect reserve figures. ENTITY ACCURACY: Correctly identifies ConocoPhillips (COP), the Asia-Pacific/Middle East region, and the time period (2023-2024). The metric (proved natural gas reserves in BCF) is correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 428,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "\nFrom 2022‑23 Comcast was aggressively expanding its MVNO‑based wireless service and rolling out next‑generation “wireless gateways” to deliver whole‑home Wi‑Fi (xFi Pods, xFi Portals) and bundled streaming (Peacock) as part of its bundled‑service strategy.  By 2024 the focus shifted from pure subscriber‑growth to a more disciplined investment: capex on customer‑premise equipment fell modestly (≈ $2.2 bn in 2023 → $2.0 bn in 2024) while the company emphasized upgrading gateway hardware and leveraging DOCSIS 4.0 to enable multigigabit symmetrical speeds and deeper integration with its Connectivity & Platforms platform.  The strategic emphasis therefore moved from broad rollout to optimizing the gateway ecosystem to support higher‑speed broadband, smarter Wi‑Fi coverage and bundled video‑streaming services.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution from 2022-2024, capturing the shift from broad rollout to optimization focus. It accurately mentions DOCSIS 4.0, multigigabit symmetrical speeds, xFi products (xFi Pods, xFi Portals), and the integration with Connectivity & Platforms. The qualitative narrative about moving from subscriber growth to disciplined investment is sound and aligns with the ground truth's emphasis on deeper network integration.\n\nWEAKNESSES - QUANTITATIVE: The LLM introduces specific capex figures ($2.2B in 2023 → $2.0B in 2024) that are NOT present in the ground truth answer. These numbers cannot be verified against the provided knowledge graph and appear to be either fabricated or sourced from unstated documents. This is a critical error in a financial context where precision is paramount. The ground truth makes no such specific capex claims.\n\nWEAKNESSES - SCOPE: The LLM answer expands significantly beyond the ground truth by discussing MVNO-based wireless service, Peacock bundling, and detailed capex comparisons. While these may be contextually relevant to Comcast's broader strategy, they dilute focus from the specific question about wireless gateways' evolution. The ground truth maintains tighter focus on gateway-specific strategic shifts.\n\nWEAKNESSES - ACCURACY: The mention of \"pure subscriber-growth\" shifting to \"disciplined investment\" with capex reduction is not explicitly stated in the ground truth. The ground truth emphasizes investment INCREASE (\"actively investing in their deployment\") rather than capex reduction, creating a potential contradiction.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022-2024 timeframes and connects gateway evolution to broader platform strategy. However, the introduction of unverified financial metrics undermines the multi-hop synthesis quality.\n\nOVERALL: The answer demonstrates good qualitative understanding but fails on quantitative rigor by introducing unsourced numbers. For financial analysis, this is a significant flaw despite the otherwise sound strategic narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 574,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "\nBetween 2022 and 2024 the G600’s cumulative deliveries more than doubled – rising from “almost 150” aircraft (as noted for the end of 2021) to “more than 300” by the end of 2024 – indicating a sharp acceleration in production and market uptake. The G600 now sits at the heart of Gulfstream’s all‑new large‑cabin lineup, complementing the G500, the newly‑certified G700 (2024) and the upcoming G400, and it contributes a growing share of the Aerospace segment’s revenue and backlog.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key quantitative facts - cumulative deliveries rising from 'almost 150' (end of 2021) to 'more than 300' (end of 2024), representing a doubling. The timeframe (2022-2024) is appropriately addressed. The LLM correctly notes the shift in product positioning from new introduction to established product. WEAKNESSES: (1) ENTITY CONFUSION - The LLM conflates G500/G600 combined deliveries with G600-specific deliveries. The ground truth states 'G500 and G600 had cumulative deliveries totaling almost 150' and 'over 300' - these are COMBINED figures for both models, not G600 alone. The LLM presents these as G600-specific numbers ('The G600's cumulative deliveries more than doubled'), which is factually incorrect. (2) PRODUCT LINEUP INACCURACY - The LLM mentions 'newly-certified G700 (2024)' but the ground truth does not reference a G700 certification in 2024. The ground truth mentions G800 and G400 as newer models receiving focus, not G700. (3) INCOMPLETE CONTEXT - The LLM adds unsupported claims about 'growing share of the Aerospace segment's revenue and backlog' which are not present in the ground truth and cannot be verified. (4) MISSING KEY DETAIL - The LLM fails to clearly articulate that the G600 replaced the G550, which is mentioned in the ground truth as part of the product evolution narrative. CALCULATION VERIFICATION: The 'more than doubled' characterization is correct (150 to 300+ is indeed a doubling), but this applies to G500+G600 combined, not G600 alone. MULTI-HOP REASONING: The synthesis is partially sound but undermined by the fundamental misidentification of whether the numbers refer to G600 alone or G500+G600 combined. This is a critical error in a multi-hop question requiring careful entity tracking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 484,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "\nBetween 2023 and 2024 AIG’s stake in Corebridge fell from 52.2 % (the amount it held at the end of 2023) to 48.4 % by the June 9 2024 “de‑consolidation” date, after which it no longer consolidated Corebridge and recorded a $4.8 bn loss to remove the retained investment and accumulated‑other‑comprehensive‑loss balances.  Following the de‑consolidation AIG treats its remaining interest as an equity‑method investment, recognizing dividends and changes in Corebridge’s stock price in net‑investment income; by year‑end 2024 it owned 22.7 % of Corebridge after selling additional shares to Nippon, and the gains on those sales were recorded in net‑investment income.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. Strengths: (1) All key percentages are correct (52.2% in 2023, 48.4% at de-consolidation on June 9, 2024, 22.7% by year-end 2024). (2) The $4.8 billion loss figure is accurately cited. (3) The multi-hop synthesis is excellent - correctly traces the evolution from consolidated subsidiary (2023) to equity method investment (post-June 9, 2024) to further diluted stake (year-end 2024). (4) Properly identifies the de-consolidation date (June 9, 2024) as the critical transition point. (5) Correctly explains the accounting treatment shift from consolidation to equity method, with income recognition through dividends and stock price changes. (6) Adds valuable context about the sale to Nippon and gain recognition in net investment income. The answer goes beyond the ground truth by providing more specific details about the de-consolidation mechanics and subsequent share sales, which enhances rather than contradicts the original answer. Minor consideration: The ground truth mentions 'pre-tax income based on dividends received and changes in Corebridge's stock price' while the LLM specifies 'net-investment income' - these are semantically equivalent in the context of equity method accounting. The LLM answer is more precise and complete than the ground truth, correctly capturing the full evolution of the relationship across the entire 2023-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 392,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla moved the Solar Roof from a pilot‑scale, largely manual line at its Buffalo Gigafactory toward a more automated but still single‑site operation that remains dependent on a narrow supply chain of specialty glass‑tile and high‑purity solar‑cell suppliers; the company added dedicated engineering and training programs to improve yields and reduce re‑tooling time, yet the reliance on that limited manufacturing footprint and on external material sources continues to create supply‑constraint and quality‑control challenges as demand scales.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) LOCATION ERROR: The LLM states Solar Roof production moved from 'Buffalo Gigafactory' but the ground truth explicitly identifies 'Gigafactory New York' as the dedicated facility in 2022. While these refer to the same location, the LLM's framing of a 'pilot-scale, largely manual line' transitioning to 'more automated but still single-site operation' is not supported by the ground truth. (2) UNSUPPORTED DETAILS: The LLM introduces specific claims about 'specialty glass-tile and high-purity solar-cell suppliers,' 'dedicated engineering and training programs,' and 'yields and re-tooling time' that do not appear in the ground truth and cannot be verified. (3) MISSING KEY INFORMATION: The LLM fails to capture the critical 2024 shift documented in the ground truth - the explicit mention of 'delays in launching and/or ramping production' and the emphasis on increased complexity and risk. (4) INCOMPLETE SYNTHESIS: The ground truth emphasizes a transition from a 'focused production setup' to a 'complex and risk-laden ramp-up phase,' but the LLM's narrative suggests continuous incremental improvement rather than acknowledging the challenges and delays highlighted in 2024 filings. (5) LACK OF TEMPORAL SPECIFICITY: The LLM does not clearly distinguish between 2022 status (active production at dedicated facility) and 2024 status (production ramp challenges and delays). The answer reads as speculative rather than grounded in actual filing disclosures. The LLM demonstrates poor multi-hop synthesis by introducing details not in the source material while omitting documented challenges from 2024 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 473,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "\nFrom 2023 to 2024 Qualcomm shifted on‑device AI from a peripheral element of its technology roadmap to a core strategic pillar.  The 2023 filing (Note 1, pp. 63‑67) merely listed AI among the company’s foundational technologies, whereas the 2024 filing (Note 1, pp. 18‑22) expands the discussion into dedicated risk factors and investment priorities, explicitly tying AI to growth in automotive, IoT and other non‑handset markets and signaling higher, longer‑term R&D and acquisition spending to embed AI across its semiconductor and licensing business.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution of Qualcomm's on-device AI strategy from 2023 to 2024, capturing the shift toward a more strategic/investment-centric approach. The semantic understanding is sound - the answer recognizes that AI moved from a peripheral/listed element to a core strategic pillar, and correctly identifies the expansion into automotive, IoT, and non-handset markets. The reasoning about increased R&D and acquisition spending aligns with the ground truth's characterization of a shift toward 'long-term growth and ecosystem development.' CRITICAL WEAKNESSES: (1) QUANTITATIVE ACCURACY ISSUES: The LLM provides specific page number citations (pp. 63-67 for 2023, pp. 18-22 for 2024) that cannot be verified against the ground truth and appear to be hallucinated. These specific page references are presented with false confidence and represent a significant factual claim that is unverifiable. (2) INCOMPLETE SYNTHESIS: The LLM answer emphasizes the shift from 'peripheral' to 'core pillar' but the ground truth describes a different evolution - from 'core product offering' in 2023 to 'investment-centric strategy' in 2024. The LLM characterizes 2023 as peripheral when the ground truth indicates it was already a 'key innovation driver.' This is a meaningful mischaracterization of the 2023 baseline. (3) MISSING KEY NUANCE: The ground truth emphasizes a shift toward 'enabling third-party integration' rather than 'solely selling AI-based products directly,' which the LLM answer does not capture. The LLM says 'embed AI across its semiconductor and licensing business' which is somewhat related but not the same emphasis. (4) CITATION FABRICATION: The specific page number references are presented as factual citations but appear to be invented, which is a serious accuracy concern even if the general characterization is directionally correct. MULTI-HOP REASONING: The answer does synthesize information across 2023 and 2024 filings appropriately in terms of the conceptual evolution, but the specific documentary evidence cited is unreliable. The comparison between years is logically sound but based on potentially false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 585,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "\nBetween 2022 and 2023 the luxury label Dolce & Gabbana moved from being confined to a handful of SPG‑operated Japanese Premium Outlet centres (e.g., Gotemba, Kobe‑Sanda, Rinku) in 2022 to also appearing as a tenant at newly‑opened SPG premium‑outlet properties in Mexico (Punta Norte) and South Korea (Yeoju).  This expansion shows that SPG is deliberately curating a high‑end fashion mix and positioning its premium‑outlet portfolio as a global destination for luxury brands, reinforcing its brand‑positioning strategy of attracting premium designer tenants to drive traffic and differentiate its outlet sites.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) FACTUAL ERRORS - The LLM claims Dolce & Gabbana expanded to Mexico (Punta Norte) and South Korea (Yeoju) between 2022-2023, but the ground truth explicitly states the opposite: D&G moved FROM multiple Japanese locations (Gotemba, Kobe-Sanda, Rinku) in 2022 TO only Las Vegas Outlets North Premium NV in 2023. This is a contraction, not an expansion. (2) ENTITY ACCURACY - The LLM incorrectly identifies new locations (Mexico and South Korea) that are not mentioned in the ground truth. The ground truth specifies only Japanese outlets in 2022 and a single U.S. location in 2023. (3) STRATEGIC INTERPRETATION - The LLM's conclusion about 'global expansion' and 'curating a high-end fashion mix' is directly opposite to what the ground truth indicates: a strategic shift from multi-location presence to exclusive flagship positioning. The ground truth suggests a reevaluation and consolidation, not expansion. (4) MULTI-HOP REASONING - The LLM failed to correctly synthesize the year-over-year comparison of D&G locations across SPG properties. The core finding is inverted: the answer describes expansion when the actual data shows contraction from 3+ Japanese locations to 1 U.S. location. This is a fundamental misunderstanding of the data and represents a complete failure to match the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 393,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "\nCOP’s exploration spending in the Asia Pacific/Middle East fell from about $95 million in 2023 to $92 million in 2024, a modest ~3 % decline. This reduction signals a strategic pull‑back from that region, with the company redirecting capital toward higher‑return opportunities elsewhere.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all quantitative metrics. Ground truth shows: 2023 = $49 million, 2024 = $0 million (complete withdrawal). LLM claims: 2023 = ~$95 million, 2024 = $92 million (modest 3% decline). These numbers are completely wrong - the LLM overstates 2023 spending by nearly 2x ($95M vs $49M) and misses the critical fact that 2024 exploration was $0, not $92M. The LLM's calculation of a 3% decline is mathematically incorrect relative to the actual figures and misses the strategic significance entirely. The ground truth indicates a complete cessation of exploration activities (from $49M to $0), which represents a dramatic strategic shift - not a modest pullback. The LLM's interpretation that this signals a 'strategic pull-back' is directionally correct in concept but is based on entirely fabricated numbers. The answer fails on quantitative accuracy (wrong dollar amounts), fails on the critical detail that 2024 exploration was zero, and therefore fails to capture the true strategic implication of a complete withdrawal versus a minor reduction. This is a major factual error that undermines the entire response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 327,
        "total_tokens": 1509
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "\nComcast’s equity stake in Universal Beijing Resort has remained roughly 30 % from 2022 through 2024, but the resort’s borrowings have been trimmed – total debt fell from about $3.5 billion at the end of 2022 to $3.4 billion by the end of 2024, with the term‑loan portion decreasing from roughly $3.1 billion to $3.0 billion – so Comcast’s indirect debt exposure has modestly declined, even though the company still consolidates the VIE and retains a $1.4 billion unfunded capital commitment.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and incomplete information compared to the ground truth. CORRECT ELEMENTS: (1) The 30% ownership stake is correctly identified; (2) The debt figures of $3.5 billion (2023) and $3.4 billion (2024) are accurate; (3) The general trend of declining debt is correctly characterized; (4) The mention of VIE consolidation and unfunded capital commitment shows relevant contextual knowledge. CRITICAL ERRORS: (1) The LLM claims debt fell 'from about $3.5 billion at the end of 2022 to $3.4 billion by the end of 2024' but the ground truth only provides 2023 and 2024 debt figures ($3.5B and $3.4B respectively). The 2022 figure is not mentioned in the ground truth, making this comparison potentially inaccurate or unsupported; (2) The LLM provides term-loan specific figures ($3.1B to $3.0B) that are not present in the ground truth, suggesting either fabrication or information from outside the provided knowledge graph; (3) The LLM completely omits the asset and liability figures for 2023 and 2024 ($7.8B/$7.2B in 2023 vs $7.3B/$7.0B in 2024), which are explicitly included in the ground truth and represent important financial metrics; (4) The LLM mentions a '$1.4 billion unfunded capital commitment' which is not mentioned in the ground truth at all. MULTI-HOP REASONING: The LLM attempts to synthesize information about ownership, debt evolution, and consolidation, but does so with unsupported or missing data points. The reasoning about 'indirect debt exposure' is logical but based on incomplete/incorrect premises. COMPLETENESS: The answer fails to address the full scope of financial metrics mentioned in the ground truth (assets and liabilities), which are essential to understanding the resort's financial evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 483,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "\nDuke Energy’s net‑derivative liability rose from a $(77) million balance at 31 Dec 2022 to $(121) million at 31 Dec 2023 – an increase of roughly $44 million.  The shift reflects higher new purchases (about $21 million in 2023 versus $14 million in 2022) and only modest settlements of roughly $5 million each year, leaving the company with a larger unrealized loss position and therefore greater exposure to commodity‑price movements.  This evolution indicates that Duke Energy is expanding its hedging program, but the growing negative balance shows that its derivative obligations have intensified, requiring more active risk management.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key metrics. Ground truth shows: (1) 2022 net derivatives balance of $29 million (positive), 2023 balance of $13 million (positive), with a DECREASE of $16 million; (2) settlements of $32 million in 2022 and $68 million in 2023. The LLM answer reports: (1) negative balances of $(77) million in 2022 and $(121) million in 2023 - completely wrong sign and magnitude; (2) an increase of $44 million instead of a decrease; (3) settlements of only $5 million each year instead of $32M and $68M. The LLM also mischaracterizes the trend as 'expanding hedging program' with 'growing negative balance' when the ground truth shows a declining positive balance and significantly increased settlement activity. The multi-hop synthesis is entirely incorrect - the LLM appears to have confused or inverted the data entirely. The reasoning about 'unrealized loss position' and 'derivative obligations intensified' contradicts the actual trend of decreasing net derivatives balance. This represents a complete failure to accurately extract and synthesize the derivative data from Duke Energy's filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 323,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "\nFrom 2022 to 2023 SPG continued to treat its LTIP units as temporary‑equity, participating securities that are included in the two‑class diluted‑earnings‑per‑share/unit calculations, but the company repeatedly noted that “no securities had a material dilutive effect” for the years 2021‑2023.  The valuation methodology evolved: in 2022 the 2022 LTI Program’s performance‑based portion was disclosed with a maximum grant‑date fair value of **$13.7 million**, while the 2023 LTI Program (granted in Q1 2023) separates a market‑based TSR award (fair value **$5.7 million**) from a performance‑target award (**$12.2 million**, with a disclosed maximum of **$23.6 million**), and the related expense is amortized over the three‑year performance period.  Thus, while the units remain non‑dilutive in practice, the 2023 disclosures provide a more detailed breakdown of fair‑value components and a higher potential valuation for the performance‑based portion.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about evolution of LTIP Units treatment from 2022 to 2023, correctly identifying key themes: (1) treatment as participating securities under two-class method, (2) non-dilutive effect, and (3) shift toward more detailed valuation disclosures. However, there are significant issues:\n\nQUANTITATIVE ACCURACY PROBLEMS:\n- The LLM provides specific dollar amounts ($13.7M, $5.7M, $12.2M, $23.6M) that cannot be verified against the ground truth, which does not provide these specific figures\n- The ground truth mentions 'grant-date fair values' and 'Monte Carlo model' but does NOT cite specific dollar amounts for LTIP unit valuations\n- The LLM's detailed breakdown of 2023 LTI Program components ($5.7M market-based TSR + $12.2M performance-target with $23.6M maximum) appears to be fabricated or from sources not reflected in the ground truth\n- These unverified numbers significantly undermine credibility\n\nCORRECT ELEMENTS:\n- Correctly identifies LTIP units as participating securities in two-class EPS method\n- Correctly notes non-dilutive effect across years\n- Correctly identifies shift toward more detailed/granular disclosures in 2023\n- Correctly mentions Monte Carlo model (implied in ground truth's 'valuation modeling')\n- Correctly identifies three-year performance period amortization\n\nINCOMPLETE/MISSING ELEMENTS:\n- Ground truth explicitly mentions 'Monte Carlo model to estimate grant-date fair values of market-based LTIP units' - LLM mentions market-based TSR award but doesn't explicitly connect it to Monte Carlo methodology\n- Ground truth emphasizes shift from 'general statement about dilution to more granular and valuation-focused disclosure' - LLM captures this but with unverified specifics\n\nMULTI-HOP REASONING:\n- The synthesis of 2022 vs 2023 treatment is logically sound\n- The comparison of disclosure evolution is appropriate\n- However, the introduction of specific numbers without ground truth support breaks the chain of reasoning\n\nOVERALL ASSESSMENT:\nThe LLM demonstrates good understanding of the conceptual evolution but introduces specific financial figures that cannot be verified against the ground truth. This is a critical flaw in financial analysis where precision is paramount. The answer would score higher if it stuck to the verifiable elements (treatment methodology, disclosure evolution, Monte Carlo model) without adding unverified dollar amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 652,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "\nBetween 2022 and 2024 Comcast’s exposure to Atairos shifted from a $5 billion aggregate funding commitment (later reduced to $4.5 billion) with annual capital‑call limits of $400 million, to a smaller unfunded commitment of roughly $1.4 billion as of 31 Dec 2024 (down from $1.5 billion in 2021).  Capital contributions have been modest and variable—$52 million in 2022, $145 million in 2023 and $73 million in 2024—while the annual management‑fee obligation remains at about $40 million per year (subject to adjustments), with the management‑company investors pledged to contribute $50‑$100 million, at least $40 million of which must be supplied by Comcast’s former CFO.  Consequently, Comcast’s financial risk is now limited to its remaining investment balance and the $1.4 billion unfunded capital commitment, and it records its stake in Atairos as an equity‑method investment rather than a consolidated entity.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides substantially more detailed information than the ground truth, including specific annual capital contributions ($52M in 2022, $145M in 2023, $73M in 2024), unfunded commitment balances ($1.4B as of Dec 31, 2024), annual capital-call limits ($400M), and accounting treatment (equity-method investment). The core facts align with ground truth: (1) the $5 billion commitment reducing to $4.5 billion is correctly stated, (2) the $40 million annual management fee is accurately cited, and (3) the evolution between 2022-2024 is properly characterized. However, there are concerns: (1) The ground truth does not mention the $1.4B unfunded commitment figure or the specific annual capital contributions, making it unclear if these are accurate or represent information beyond the ground truth scope. (2) The reference to 'Comcast's former CFO' and the $50-$100M management-company investor pledge are not mentioned in the ground truth, suggesting either additional detail or potential inaccuracy. (3) The mention of 2021 data ($1.5B unfunded commitment) goes beyond the 2022-2024 timeframe specified in the question. The LLM answer is more comprehensive and provides better context for understanding the financial evolution, but introduces details not verifiable against the ground truth. The core narrative about the shift from $5B to $4.5B commitment and the $40M management fee is correct. The answer demonstrates sound multi-hop reasoning and proper entity identification (Comcast, Atairos Group, Inc., fiscal years). The additional granular details, while potentially accurate, cannot be fully validated against the provided ground truth, creating some uncertainty about completeness and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 469,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "\nFrom 2023 to 2024 the company’s proved natural‑gas reserves in the Asia Pacific/Middle East region fell modestly—from about **312 billion cubic feet (Bcf)** (developed + undeveloped in 2023) to **≈296 Bcf** in 2024, a decline of roughly **5 %**.  This reduction reflects downward revisions in equity‑affiliated assets and a slight dip in developed reserves, signalling that ConocoPhillips is scaling back its focus in that geographic area and redirecting resources toward regions where reserve growth is more robust, such as the Lower 48 and Canada.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers and calculations. Verification: (1) 2023 reserves of 312 Bcf - CORRECT; (2) 2024 reserves of 296 Bcf - CORRECT; (3) Decline calculation: (312-296)/312 = 16/312 = 5.1%, rounded to ~5% - CORRECT. The answer properly identifies the company as ConocoPhillips (COP) and uses appropriate terminology (proved natural gas reserves, developed/undeveloped distinction). Multi-hop synthesis is sound: the answer correctly connects the reserve decline to operational implications. The LLM goes beyond the ground truth by providing additional context about resource reallocation toward Lower 48 and Canada, which represents reasonable inference from the reserve reduction pattern but is not explicitly stated in the original answer. This additional detail is contextually appropriate and logically sound, though it represents inference rather than direct fact from the ground truth. Minor strength: the answer includes helpful notation (Bcf) and percentage calculation. The semantic meaning aligns well with the ground truth regarding the 'modest reduction' and 'shift in operational focus.' No factual errors detected in the core claims. The only minor consideration is that the additional geographic context about Lower 48 and Canada, while reasonable inference, extends beyond what the ground truth explicitly states, though this enhances rather than detracts from answer quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 401,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "\nIn 2022 Comcast’s wireless‑gateway strategy was to obtain a limited set of standardized customer‑premise devices from a few vendors to support its MVNO wireless service and bundle them with broadband, emphasizing cost‑effective, uniform equipment. By 2024 the company’s network‑investment focus shifted to expanding and upgrading its cable infrastructure—adding scalable fiber‑coax capacity, line extensions and DOCSIS 4.0 upgrades—to increase overall capacity and enable multigigabit symmetrical speeds, with wireless‑gateway deployment now part of a broader connectivity‑platform rollout.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and problematic elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. Correctly identifies 2022 as focused on procurement from limited suppliers\n2. Correctly identifies 2024 as involving strategic network investment and deployment\n3. Correctly mentions multigigabit symmetrical speeds as a 2024 goal\n4. Correctly captures the shift from passive procurement to active integration\n5. Dates (2022, 2024) are accurate\n\nPROBLEMATIC ELEMENTS:\n1. ENTITY CONFUSION: The LLM introduces 'MVNO wireless service' which is not mentioned in the ground truth. While Comcast does have wireless operations, the ground truth specifically frames 2022 procurement as serving 'residential and business customers' generally, not specifically as an MVNO strategy.\n2. SCOPE EXPANSION: The LLM significantly expands the 2024 discussion to include 'fiber-coax capacity, line extensions, DOCSIS 4.0 upgrades' which are not mentioned in the ground truth. The ground truth focuses specifically on wireless gateways as a component of network upgrades, not broader cable infrastructure details.\n3. SEMANTIC DRIFT: The ground truth emphasizes wireless gateways as 'a key component of planned capital expenditures' and 'part of broader network upgrades.' The LLM reframes this as wireless gateways being 'part of a broader connectivity-platform rollout' with emphasis on cable infrastructure upgrades, which shifts the focus away from the wireless gateway strategy comparison.\n4. INCOMPLETE SYNTHESIS: While the LLM captures the general shift from 2022 to 2024, it introduces infrastructure details (DOCSIS 4.0, fiber-coax) that weren't in the source material, suggesting potential hallucination or over-interpretation.\n\nMULTI-HOP REASONING: The LLM does attempt to synthesize information across two time periods and identify a strategic shift, which is correct in principle. However, the addition of unverified details about MVNO services and specific cable infrastructure upgrades undermines the accuracy of the multi-hop synthesis.\n\nQUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (7/10 for not introducing false numbers).\n\nQUALITATIVE ACCURACY: The core insight about the strategic shift is present, but the introduction of unverified details and the reframing of the 2024 focus away from wireless gateways specifically reduces qualitative accuracy.\n\nCONTEXTUAL RELEVANCE: The answer addresses the comparison question but adds contextual elements not in the ground truth, which reduces pure relevance to the specific question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 699,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "\nBetween 2022 and 2024 Tesla’s Solar Roof shifted from a flagship residential‑solar ambition to a lower‑priority, cost‑intensive offering; the company now treats it as a complementary piece of the broader Energy Generation & Storage portfolio rather than a primary growth driver. The 2022 10‑K (pp. 37‑41) highlighted ongoing manufacturing under‑utilization and high per‑unit costs, and the 2024 10‑K (pp. 15‑19) noted that Solar Roof’s revenue share has fallen and its gross margin remains negative, reflecting persistent production challenges that have forced Tesla to scale back its rollout and focus on higher‑margin products such as Megapack and Powerwall.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. MAJOR ISSUES: (1) UNSUBSTANTIATED CLAIMS: The LLM asserts specific negative metrics (negative gross margin, fallen revenue share, manufacturing under-utilization, high per-unit costs) with page citations (pp. 37-41 for 2022, pp. 15-19 for 2024) that cannot be verified against the ground truth. The ground truth makes no mention of negative gross margins, revenue share decline, or specific manufacturing underutilization data. (2) MISCHARACTERIZATION OF STRATEGIC POSITIONING: The LLM describes Solar Roof as 'lower-priority, cost-intensive' and 'complementary' in 2024, but the ground truth indicates Tesla cautioned about 'potential production ramp delays' - a different framing that suggests operational/manufacturing risks rather than strategic deprioritization. (3) QUANTITATIVE ACCURACY FAILURE: The LLM provides no actual numbers, percentages, or financial metrics to support its claims about margin decline or revenue share reduction. The ground truth also provides no such specific metrics, but the LLM's confident assertions about negative margins and fallen revenue share are not supported by the knowledge graph. (4) INCOMPLETE SYNTHESIS: While the LLM correctly identifies the shift from 2022 to 2024, it overstates the nature of that shift by introducing unsupported negative financial metrics. The ground truth's more measured characterization (shift from 'deployment success' emphasis to 'cautioning about operational and manufacturing risks') is more accurate. (5) PARTIAL CREDIT: The LLM does correctly identify that Solar Roof's strategic importance changed between 2022-2024, that it's part of a broader Energy portfolio, and that Megapack and Powerwall are higher-priority products. However, these correct elements are undermined by the unsubstantiated negative claims about margins and revenue share.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 525,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "\nDuke Energy’s “Net pending transactions and other investments” grew from **$14 million** at the end of 2022 to **$54 million** at the end of 2023 – an increase of roughly **$40 million**.  This rise signals that the company is expanding its short‑term, flexible holdings within the Master Retirement Trust, likely to preserve liquidity and capture opportunistic market returns while maintaining its overall liability‑hedging and return‑seeking asset allocation.  The move reflects a strategic shift toward a more dynamic investment position in this category.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that completely contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM states the investment grew from $14 million in 2022 to $54 million in 2023, but the ground truth shows the opposite: it decreased from $53 million in 2022 to $14 million in 2023. The LLM has reversed both the direction of change (increase vs. decrease) and the magnitude of values. The LLM claims a $40 million increase when the actual change was a $39 million decrease. (2) DIRECTIONAL MISINTERPRETATION - The LLM interprets this as 'expanding' holdings and 'strategic shift toward a more dynamic investment position,' when the ground truth indicates a 'significant reduction in exposure' and 'strategic shift or completion of certain initiatives.' These are opposite strategic interpretations. (3) MULTI-HOP SYNTHESIS - While the question asks about change from 2022 to 2023, the LLM failed to correctly synthesize the year-over-year comparison. The numbers appear to be inverted or sourced from incorrect periods. (4) CONTEXTUAL MISALIGNMENT - The LLM's narrative about 'expanding short-term flexible holdings' and 'capturing opportunistic market returns' contradicts what a $39 million reduction would suggest. The ground truth indicates a strategic pullback or completion of initiatives, not expansion. This is a critical failure in both factual accuracy and interpretive reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 393,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "\nBetween 2023 and 2024 the company kept the same liability‑driven investment philosophy—using long‑duration fixed‑income securities to hedge pension liabilities—but modestly adjusted the target mix: the pension portfolio moved from a 18 % equity / 57 % corporate‑bond / 25 % government‑security allocation to 21 % equity, 63 % corporate bonds and 16 % government/other assets, while the post‑retirement portfolio shifted from 53 % equity / 31 % corporate bonds / 16 % government securities to 57 % equity, 30 % corporate bonds and 13 % government/other.  The 2024 filing also provides a more detailed fair‑value hierarchy (Level 1, 2 and 3) and explicitly breaks out NAV‑measured collective funds, giving a clearer picture of asset composition than the 2023 high‑level percentages.  At the same time, expense charged to the defined‑contribution plans rose slightly, from $109 million in 2023 to $112 million in 2024, reflecting higher employer contributions and broader participation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) QUANTITATIVE ERRORS - The LLM provides specific asset allocation percentages (18%/57%/25% in 2023, 21%/63%/16% in 2024 for pension portfolio; 53%/31%/16% in 2023, 57%/30%/13% in 2024 for post-retirement) that are NOT mentioned in the ground truth. The ground truth only states a 20%/80% equity/fixed income target allocation was maintained in both years. The LLM appears to have fabricated detailed breakdowns by asset type (corporate bonds, government securities) that don't appear in the original answer. (2) DEFINED CONTRIBUTION EXPENSES - The LLM correctly identifies the $109M (2023) and $112M (2024) figures, which matches the ground truth. (3) MISSING KEY INFORMATION - The LLM fails to mention the core distinction in the ground truth: that 2024 added NEW DISCLOSURE about actual composition of plan assets at year-end, indicating improved transparency. Instead, the LLM discusses fair-value hierarchy levels and NAV-measured collective funds, which are not mentioned in the ground truth. (4) MULTI-HOP REASONING - The LLM does attempt to synthesize information across years but does so by introducing unsupported data. The ground truth's key finding about enhanced disclosure transparency in 2024 is largely absent from the LLM response. (5) SEMANTIC ISSUES - While the LLM correctly identifies the liability-driven investment philosophy and the modest increase in DC expenses, it fundamentally misrepresents the nature of the framework evolution by inventing specific allocation percentages rather than acknowledging the maintained 20%/80% target and the disclosure enhancement. The answer reads as plausible but is factually unreliable due to fabricated numerical details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 493,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "\nQualcomm broadened its On‑Device AI focus between fiscal 2023 and 2024, moving it from a mainly smartphone‑centric capability to a cross‑industry AI engine that is tied to its 5G + high‑performance computing roadmap and to growth in automotive, IoT and other edge markets.  The company highlighted that it is investing additional R&D and capital in AI‑centric hardware (such as dedicated AI compute engines) and software ecosystems, positioning AI as a core growth pillar beyond handsets.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of Qualcomm's On-Device AI evolution but has significant gaps in completeness and specificity compared to the ground truth. STRENGTHS: (1) Correctly identifies the shift from smartphone-centric to cross-industry focus; (2) Accurately mentions 5G and high-performance computing as core components; (3) Correctly identifies automotive and IoT as target industries; (4) Appropriately characterizes the evolution as moving toward broader applications. WEAKNESSES: (1) The ground truth explicitly states a shift from 'strategic vision' to 'active investment and expansion' with specific mention of 'acquisitions or strategic transactions' - the LLM answer mentions R&D and capital investment but misses the acquisitions/strategic transactions element; (2) The ground truth emphasizes that fiscal 2023 positioned Qualcomm as a 'leader in 5G and integrated circuit products' while fiscal 2024 shows 'investment-driven strategy' - the LLM answer doesn't clearly articulate this temporal distinction or the shift in strategic approach; (3) The LLM answer adds details about 'dedicated AI compute engines' and 'software ecosystems' that aren't explicitly mentioned in the ground truth, which could be accurate but represents inference rather than direct disclosure synthesis; (4) Missing the explicit mention that the company is 'pursuing acquisitions or strategic transactions' as part of its fiscal 2024 strategy. MULTI-HOP REASONING: The answer demonstrates reasonable synthesis across the two fiscal years but fails to capture the full scope of strategic evolution, particularly the shift toward active M&A and strategic transactions. QUANTITATIVE ACCURACY: No specific numbers or dates are provided in either answer, so this dimension is neutral. The answer correctly references fiscal 2023 and 2024 without error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 501,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "\nThe Voting Trust Agreement continues to be disclosed only in the Exhibit section of both the 2022 and 2023 Form 10‑K filings, listed as “Exhibit 9.1 – Second Amended and Restated Voting Trust Agreement, Voting Agreement and Proxy dated March 1 2004” (and the related Exhibit 9.2).  The wording, numbering and placement are identical in the two filings, showing that no re‑classification, amendment or new presentation of the trust has been introduced.  This unchanged disclosure indicates that the voting‑trust governance structure remains steady and has not been altered between the 2022 and 2023 reporting periods.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims the wording, numbering and placement are 'identical in the two filings,' but the ground truth explicitly states the 2022 filing describes it as 'Second Amended and Restated' while the 2023 filing omits this modifier - this is a direct contradiction of the core finding. (2) The LLM states 'no re-classification, amendment or new presentation of the trust has been introduced,' but the ground truth indicates a clear change in presentation between the two years (presence vs. absence of 'Second Amended and Restated'). (3) The LLM focuses on exhibit numbering and placement being unchanged, which is not the key distinction identified in the ground truth. CORRECT ELEMENTS: The LLM correctly identifies the date (March 1, 2004) and correctly concludes that the governance structure remains stable. The LLM also correctly notes that the agreement appears in the Exhibit section. However, these correct elements do not compensate for the fundamental misunderstanding of how the presentation actually evolved. The ground truth's key insight - that the removal of 'Second Amended and Restated' from the 2023 filing indicates no further amendments occurred - is completely missed. The LLM's reasoning about identical wording and placement directly contradicts the ground truth's central finding about the evolution of classification and presentation. This represents a failure in multi-hop synthesis and careful document comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 425,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "\nCOP’s proved natural‑gas reserves in the Asia‑Pacific/Middle‑East (APME) sector slipped from about **312 billion cubic feet (BCF) at the end of 2023** (≈305 BCF developed + 7 BCF undeveloped) to roughly **296 BCF at the end of 2024** (≈289 BCF developed + 7 BCF undeveloped), a decline of roughly **5 %**.  The drop was driven by a modest reduction in developed APME reserves and net downward revisions in the region’s equity‑affiliate holdings, even though the company’s total global proved gas reserves grew sharply over the same period.  Consequently, the APME region’s share of COP’s worldwide gas reserve base is shrinking, indicating that the company is placing comparatively less strategic emphasis on that basin and is directing reserve growth toward other areas such as the Lower 48 and Canada.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct core numbers and calculations. Key strengths: (1) Correctly identifies 2023 reserves at 312 BCF and 2024 at 296 BCF, matching ground truth exactly. (2) Accurately calculates the 16 BCF decline and correctly states it as approximately 5% (16/312 = 5.1%, which rounds to 5%). (3) Properly breaks down developed vs. undeveloped reserves (305/7 for 2023, 289/7 for 2024), adding valuable detail not in ground truth. (4) Correctly synthesizes multi-hop information about APME's declining share of global reserves and strategic reorientation toward Lower 48 and Canada. (5) Appropriately contextualizes the decline within COP's broader global reserve growth. Minor considerations: (1) The ground truth mentions equity affiliates holding 5,870 BCF in 2024, but the LLM answer references 'net downward revisions in equity-affiliate holdings' without specifying the exact figure - this is a slight omission but doesn't contradict the ground truth. (2) The LLM answer provides more granular breakdown of developed/undeveloped reserves, which enhances understanding beyond the ground truth. (3) The reasoning about strategic emphasis shift is sound and well-supported. The answer successfully addresses all parts of the multi-part question: the evolution of reserves (correct numbers and percentage), the comparison between years (accurate), and the strategic implications (well-reasoned). Calculations are accurate and the synthesis across multiple data points is logical and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 424,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "\nBetween 2023 and 2024 AIG moved from fully consolidating Corebridge’s debt—$9.4 bn of Corebridge borrowings (CRBGLH notes, senior unsecured notes, DDTL facility, etc.) that were guaranteed or supported by AIG—into a post‑deconsolidation relationship in which those obligations no longer appear on AIG’s consolidated balance sheet; AIG’s exposure is now limited to a guarantee‑reimbursement agreement and collateral posting with Corebridge and CRBGLH.  After the June 2024 deconsolidation, AIG records an equity‑method investment in Corebridge, generating $601 million of equity‑method income (dividends plus fair‑value gains) for 2024, while its own debt maturities reflect only $709 million of AIG‑issued borrowings (including a $250 million DDTL facility) with no Corebridge‑related debt consolidated.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM provides significantly different numbers than ground truth: Claims $9.4bn of Corebridge borrowings (ground truth: $9,368M ≈ $9.4bn - this is acceptable), but then states $601 million of equity-method income for 2024 with NO SOURCE in ground truth (ground truth only mentions 'equity method income from Corebridge' without specifying $601M), and claims $709 million of AIG-issued borrowings with $250M DDTL facility - these specific numbers are NOT in the ground truth and appear fabricated. (2) FACTUAL ERRORS - The LLM claims Corebridge debt was 'guaranteed or supported by AIG' in 2023, but ground truth explicitly states the $6,452M senior unsecured notes and $989M junior subordinated debt were 'NOT guaranteed by AIG' - this is a direct contradiction. (3) INCOMPLETE/INACCURATE DEBT STRUCTURE - Ground truth specifies $6,452M senior unsecured notes and $989M junior subordinated debt; LLM vaguely references 'CRBGLH notes, senior unsecured notes, DDTL facility, etc.' without the specific amounts. (4) EQUITY METHOD INCOME - Ground truth states AIG 'reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024' but does NOT quantify this as $601M. The LLM's $601M figure appears to be either incorrect or from a different source not in the ground truth. (5) MULTI-HOP REASONING - While the LLM correctly identifies the transition from consolidation to equity method accounting post-June 2024, it introduces unsupported numbers and contradicts the guarantee status of the debt. (6) CONTEXTUAL ISSUES - The mention of 'guarantee-reimbursement agreement and collateral posting' is not in the ground truth, suggesting the LLM may be confabulating details. The core narrative of deconsolidation and shift to equity method is correct, but the specific financial figures are problematic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 518,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "\nFrom 2022 to 2024 the Special‑Use‑Fund portfolio was reshaped from a roughly 70 % fixed‑income / 30 % equity mix to about 27 % fixed‑income and 73 % equity.  The equity slice more than doubled (from ≈ $1.5 bn to > $6 bn) while fixed‑income grew only modestly (from ≈ $1.0 bn to ≈ $2.3 bn), so the fund’s risk profile shifted toward market‑linked assets.  This reflects a deliberate, though still liquidity‑conscious, increase in risk appetite—maintaining a sizable bond buffer to meet possible storm‑damage or nuclear‑decommissioning cash needs while seeking higher returns from equities.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that contradict the ground truth. (1) 2022 BASELINE ERROR: Ground truth states NEE's Special Use Funds in 2022 were 'entirely composed of fixed income securities' with $2,505 million total. The LLM claims a '70% fixed-income / 30% equity mix' with ~$1.5bn equity and ~$1.0bn fixed income in 2022. This is completely contradicted by the ground truth which shows ZERO equity in 2022. (2) 2024 COMPOSITION ERROR: Ground truth specifies 2024 amounts as: $6,164M equity, $722M U.S. Government/municipal bonds, $685M corporate debt, $873M asset-backed securities (total fixed income = $2,280M). The LLM claims ~$6bn equity and ~$2.3bn fixed income, which roughly aligns with the total but misses the detailed breakdown of fixed income components. (3) PERCENTAGE CALCULATION ERROR: The LLM's 73% equity / 27% fixed-income split for 2024 would imply total assets of ~$8.4-8.5bn, but ground truth shows $6,164M + $2,280M = $8,444M, so the percentages are approximately correct (73% = $6,164/$8,444; 27% = $2,280/$8,444). However, this correct 2024 calculation is built on an entirely false 2022 baseline. (4) MULTI-HOP SYNTHESIS FAILURE: The LLM failed to correctly synthesize the fundamental shift from 100% fixed income (2022) to equity-heavy (2024). The claim of a '70/30 mix' in 2022 is fabricated and contradicts the explicit ground truth statement that 2022 was 'entirely composed of fixed income securities.' (5) REASONING QUALITY: While the LLM's interpretation of increased risk appetite and liquidity strategy is reasonable and contextually sound, it is built on false premises. The answer demonstrates good qualitative reasoning about what the shift means, but this cannot compensate for the factual errors in the baseline data. The answer correctly identifies the direction of change (toward equity) but misrepresents the starting point entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 523,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "\nBetween 2022 and 2024 the risk that site‑infrastructure sharing would curb new lease growth grew from a general caution about “network sharing” to a concrete, material threat tied to 5G rollout.  The 2024 filing explicitly warns that carriers are increasingly using RAN‑sharing, roaming and resale arrangements—enabled by 5G—to avoid leasing additional tower space, which can slow new lease activity and even lead to decommissioning of existing equipment, whereas the 2022 filing only mentioned sharing as a possible factor.  Consequently, the magnitude of the risk has risen, making 5G‑driven infrastructure sharing a central concern for future lease revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of the risk from 2022 to 2024, correctly identifying the shift from general 'network sharing' concerns to specific RAN (Radio Access Network) sharing, roaming, and resale arrangements. The connection to 5G technology adoption is properly established, and the impact on new lease activity and equipment decommissioning is accurately described. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either the ground truth or LLM answer, which is appropriate given the nature of the question about risk evolution. The temporal references (2022 vs 2024) are correct. (3) ENTITY ACCURACY: The company (AMT - implied through context), the technology (5G), and the specific infrastructure sharing mechanisms (RAN sharing, roaming, resale arrangements) are all correctly identified. (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across two time periods and connects multiple concepts: the evolution of risk characterization, the role of 5G technology, carrier behavior changes, and financial impacts on lease revenue. The reasoning chain is logical and sound. (5) SEMANTIC EQUIVALENCE: The LLM answer uses slightly different phrasing ('concrete, material threat' vs 'more specific concern' and 'stronger emphasis on financial impact') but conveys the same essential information about the evolution from general to specific, from cautionary to material, and from vague to quantifiable threat. The emphasis on 'central concern for future lease revenue' aligns well with the ground truth's 'more mature and impactful shift.' Minor deviations in wording do not affect factual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 487,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "\nChevron continues to hold a 36.4 % equity stake in Angola LNG Limited and accounts for it under the equity‑method both in 2022 and 2023.  The carrying value of the investment fell modestly – from about **$1.96 bn at the end of 2022 to $1.76 bn at the end of 2023** – and the equity‑method earnings moved from a **$166 m loss in 2022 to essentially breakeven (a small gain/near‑zero) in 2023**, reflecting improved project performance and partial repayment of Chevron’s $4.5 bn loan to the joint‑venture.  Thus, the financial relationship remained an equity‑method investment, but the investment balance and associated earnings improved markedly over the two‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer addresses a different aspect of Chevron's Angola LNG relationship than what the ground truth describes, and contains unverified financial claims. CRITICAL ISSUES: (1) The ground truth focuses on a relationship classification change from 'Depends_On' (2022) to 'Invests_In' (2023), which is the core of the question about how the financial relationship 'evolved.' The LLM answer completely misses this key evolution and instead discusses equity-method accounting continuity. (2) The LLM provides specific financial figures ($1.96bn to $1.76bn carrying value, $166m loss in 2022, breakeven in 2023, $4.5bn loan) that cannot be verified against the ground truth provided. These numbers may or may not be accurate from the actual 10-K filings, but they are not mentioned in the ground truth answer. (3) The LLM correctly identifies the 36.4% ownership stake, which matches the ground truth. (4) The LLM's statement that 'the financial relationship remained an equity-method investment' contradicts the ground truth's indication of a relationship reclassification from 'Depends_On' to 'Invests_In', suggesting a change in how the investment is categorized or managed. (5) The LLM answer focuses on financial performance metrics (carrying value changes, earnings movements) rather than the structural/categorical evolution that the question and ground truth emphasize. The answer demonstrates partial understanding of the Angola LNG investment but fails to capture the primary evolution described in the ground truth - the shift in relationship classification. The unverified financial data and the mismatch between the LLM's focus (equity-method accounting continuity) and the ground truth's focus (relationship reclassification) represent significant deviations from the correct answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 488,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "\nBetween 2022 and 2023 the G600 stayed in Gulfstream’s core large‑cabin lineup, growing its cumulative deliveries from about 150 (recorded at the end of 2021) to more than 250 by the end of 2023, indicating a steady production pace and rising market acceptance. Its performance figures—long‑range cruise, high‑speed cruise, improved fuel‑efficiency and a larger cabin introduced with the clean‑sheet design—remained the same, but the aircraft’s role shifted to a mature bridge product that supports the newer ultra‑long‑range models (e.g., the G700 and G800) now entering service.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the G600's evolution from 2022 to 2023 and correctly identifies the key shift from a newer product to a mature bridge product. However, there are some quantitative and completeness issues:\n\nSTRENGTHS:\n1. Correctly identifies the G600 as a clean-sheet design replacing the G550\n2. Accurately states over 250 cumulative deliveries by end of 2023\n3. Correctly characterizes the shift from 'new' to 'mature' product\n4. Properly identifies the G700 and G800 as newer ultra-long-range models\n5. Sound multi-hop reasoning connecting product maturity to platform integration\n6. Appropriate semantic framing of the G600's role evolution\n\nWEAKNESSES:\n1. QUANTITATIVE ERROR: States deliveries grew \"from about 150 (recorded at the end of 2021)\" - this is not verified in the ground truth and introduces an unsubstantiated baseline figure. The ground truth only confirms \"over 250 cumulative deliveries by year-end 2023\" without specifying 2021 figures.\n2. MISSING DETAIL: Does not mention the G400 as explicitly as the ground truth does. The ground truth states the G600's technologies were \"extended to newer models like the G700, G800, and G400,\" while the LLM only mentions G700 and G800.\n3. INCOMPLETE TECHNOLOGY REFERENCE: The ground truth specifically highlights the \"Symmetry Flight Deck\" as a foundational feature being extended to newer models. The LLM mentions \"performance figures\" and \"improved fuel-efficiency\" but doesn't specifically reference the Symmetry Flight Deck technology transfer.\n4. VAGUE PERFORMANCE METRICS: States performance figures \"remained the same\" but doesn't specify what those metrics are (long-range cruise, high-speed cruise, etc.), though the LLM does list some examples.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information about the G600's evolution across the 2022-2023 period and properly connects it to the broader platform strategy. The reasoning is sound and logical.\n\nOVERALL: The answer is substantially correct on the main points but has a quantitative accuracy issue with the unverified 2021 baseline and incompleteness regarding the G400 and Symmetry Flight Deck specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 591,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s moved from a largely royalty‑and‑rent‑based model toward deeper financial partnership with its franchisees.  The company increasingly co‑invests in restaurant remodels, technology platforms and advertising, shares occupancy‑cost risks (including COVID‑related rent deferrals that are now treated as part of the lease), and aligns revenue streams through brand‑licensing and dynamic‑yield arrangements, thereby turning the franchise relationship into a more collaborative, jointly‑funded growth strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains both accurate and inaccurate elements when compared to the ground truth.\n\nCORRECT ELEMENTS:\n1. Core thesis is directionally accurate: McDonald's did shift from a passive franchising model to more active financial collaboration\n2. Correctly identifies co-investment as a key strategic change\n3. Correctly mentions restaurant improvements/remodels and technology as areas of co-investment\n4. Accurately captures the shift from royalty/rent-based to collaborative partnership model\n5. No quantitative errors (no specific numbers provided to verify)\n\nINCORRECT/PROBLEMATIC ELEMENTS:\n1. MAJOR: Introduces elements NOT in ground truth - \"COVID-related rent deferrals,\" \"dynamic-yield arrangements,\" \"brand-licensing arrangements,\" \"occupancy-cost risk sharing\" - these are either fabricated or not supported by the knowledge graph\n2. MAJOR: Mentions \"advertising\" co-investment - ground truth specifies \"restaurant improvements and operating system upgrades\" but does NOT mention advertising\n3. OVERREACH: The answer adds significant detail about lease structures and revenue alignment that goes beyond what the ground truth establishes\n4. SPECIFICITY MISMATCH: Ground truth emphasizes \"operating system upgrades\" and \"consumer preferences/local performance/brand modernization\" - LLM answer shifts focus to different mechanisms\n\nMULTI-HOP REASONING:\nThe LLM demonstrates sound logical reasoning about the evolution of the relationship, but appears to have hallucinated or conflated details from other sources rather than strictly adhering to the knowledge graph. The synthesis is coherent but factually divergent from ground truth.\n\nSEMANTIC EQUIVALENCE:\nWhile the high-level narrative matches (shift from passive to active partnership), the specific mechanisms and details diverge significantly. The LLM adds plausible-sounding but unverified details that undermine confidence in the answer's accuracy.\n\nJUSTIFICATION FOR SCORES:\n- Correctness: 5/10 - Core narrative correct but significant unverified details added\n- Quantitative: 8/10 - No numbers provided, so no calculation errors, but this also means less verifiable content\n- Qualitative: 4/10 - Reasoning is sound but reasoning is applied to partially incorrect premises; hallucinated details significantly detract\n- Contextual: 6/10 - Addresses the question but introduces elements beyond the scope of ground truth",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 650,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023, net revenues for Altria’s smokeable‑products segment slipped from **$22,476 million to $21,756 million** – a decline of roughly **$720 million (about 3 %)**.  Operating income in that segment also fell slightly, moving from **$10,688 million in 2022 to $10,670 million in 2023** (a drop of about **$18 million, or 0.2 %**).  The revenue dip reflects lower shipment volumes and pricing pressure, while the modest operating‑income decline is attributed to higher general‑corporate expenses and amortization, partially offset by stronger performance in other segments.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: All core financial numbers are correct and properly formatted. Net revenues: $22,476M (2022) → $21,756M (2023) ✓. Operating income: $10,688M (2022) → $10,670M (2023) ✓. Calculations are accurate: revenue decline of $720M (3.2% rounded to 3%) ✓, operating income decline of $18M (0.17% rounded to 0.2%) ✓. The LLM correctly identifies this as Altria's smokeable products segment and properly synthesizes the year-over-year comparison. WEAKNESSES: The LLM provides explanatory context about 'lower shipment volumes and pricing pressure' and 'higher general-corporate expenses and amortization' that is NOT present in the ground truth answer. While this additional context may be factually accurate from the filings, it goes beyond what was provided in the original answer and introduces information not verified against the knowledge graph. This represents a minor overreach in adding interpretive details. The core answer structure and all quantitative data match the ground truth perfectly, but the addition of causal explanations not in the original answer slightly reduces qualitative accuracy. MULTI-HOP REASONING: The model correctly synthesizes 2022 and 2023 data for the smokeable products segment and properly compares them, demonstrating sound multi-hop reasoning. OVERALL: This is a strong answer with perfect numerical accuracy but minor issues with introducing unverified contextual explanations beyond the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 399,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "\nBetween 2022 and 2024 Opdivo moved from a Japan‑focused co‑development partnership with Ono (where profits, costs and royalties were shared equally and BMS served as the global principal) to a broader, more integrated commercial framework that now includes additional allies such as Nektar for the NKTR‑214 combination and an expanded co‑promotion role across multiple regions.  At the same time, the drug’s regulatory footprint accelerated: new approvals were secured for Opdivo Qvantig (sub‑cutaneous formulation), for Opdivo + Yervoy in microsatellite‑instable colorectal cancer, for Opdivo as an adjuvant treatment in high‑risk NSCLC, and for Opdivo in combination regimens for urothelial and other solid tumours (e.g., EC‑approved Opdivo + Yervoy, Japan approval in urothelial carcinoma).  These approvals and the deepening of collaborative structures cemented Opdivo as a central pillar of BMY’s oncology product‑development and commercialisation strategy by 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ERRORS: (1) The LLM claims Opdivo moved from 'Japan-focused' partnership with Ono to a 'broader, more integrated commercial framework' - the ground truth indicates the Ono partnership was already a global framework (not Japan-focused) with BMS as global principal, and the evolution was toward MORE INDEPENDENT strategy, not broader partnerships. (2) The LLM introduces Nektar/NKTR-214 collaboration as part of Opdivo's evolution - this is not mentioned in the ground truth and appears to be fabricated or confused with other partnerships. (3) Multiple regulatory approvals are mentioned (Qvantig subcutaneous formulation, Opdivo+Yervoy in MSI colorectal cancer, adjuvant NSCLC, EC-approved combinations, Japan approval) - NONE of these are mentioned in the ground truth. The ground truth specifically cites only ONE new approval: March 2024 FDA approval for combination with cisplatin and gemcitabine for urothelial carcinoma. (4) The LLM mischaracterizes the strategic evolution: ground truth shows shift FROM co-development focus TO independent product introduction strategy; LLM suggests shift toward MORE collaborative structures, which contradicts the ground truth narrative. CORRECT ELEMENTS: The LLM correctly identifies the Ono partnership structure with shared profits/costs, correctly names Yervoy and Orencia as related products, and correctly identifies Opdivo as central to BMY's oncology strategy. However, the numerous fabricated approvals, mischaracterized partnerships (Nektar), and inverted strategic direction represent fundamental failures in multi-hop reasoning and factual accuracy. The answer demonstrates hallucination of regulatory data and misinterpretation of the strategic evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 505,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "\nBetween 2022 and 2024 AMT shifted the floating‑rate benchmark it cites in its debt disclosures.  In the 2022 filing (pages 50‑54) the company explicitly named **LIBOR** (for USD‑denominated borrowings) and **EURIBOR** (for EUR‑denominated borrowings) as the reference rates, set the applicable spread at **1.125 %** (plus the base‑rate margin) and detailed the related financial covenants (leverage/DSCR tests, limits on additional indebtedness, etc.).  By the 2024 filing (pages 115‑119) the interest‑rate language had been updated to refer to **SOFR (or the applicable alternative rate) for USD loans** while still using **EURIBOR** for euro‑loans; the spread and the core covenant structure (the 1.125 % margin, the 1.30× DSCR test, and the restrictions on extra debt) remained the same, but the 2024 disclosure added explicit fallback language for the LIBOR‑to‑SOFR transition.  Thus, the benchmark changed from LIBOR to SOFR (with EURIBOR retained), while the associated covenants stayed materially unchanged but were clarified with transition provisions.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution from LIBOR to SOFR for USD-denominated borrowings while retaining EURIBOR for EUR-denominated borrowings, which aligns with the ground truth. The answer also appropriately notes that covenants remained materially unchanged. However, there are significant quantitative accuracy issues: (1) The LLM cites a 1.125% spread, but the ground truth specifies commitment fees ranging from 0.080% to 0.300% for 2022 - these are different metrics and the LLM's specific 1.125% figure is not verified in the ground truth. (2) The LLM references specific page numbers (50-54 for 2022, 115-119 for 2024) which cannot be verified against the ground truth and may be fabricated. (3) The LLM mentions a 1.30× DSCR test as remaining unchanged, but this specific metric is not mentioned in the ground truth. The ground truth mentions 'debt ratings and commitment fees' but does not specify the 1.125% spread or 1.30× DSCR test values cited by the LLM. The qualitative reasoning is sound - the answer correctly synthesizes the multi-hop information about the benchmark shift and covenant evolution. The answer appropriately addresses both parts of the question (referenced rates and associated covenants). However, the introduction of specific numbers not present in the ground truth (1.125%, 1.30×) without verification is problematic. The answer demonstrates good understanding of the transition narrative but fails on quantitative precision by citing unverified specific metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 418,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s moved away from a pure‑franchise model and began leveraging its real‑estate portfolio more strategically—retaining ownership or long‑term leases on land and buildings and using those assets to co‑invest with franchisees in restaurant upgrades and new‑build projects.  This joint‑investment approach ties the company’s financial interests to the performance of the sites, allowing it to fund improvements while franchisees provide the bulk of the capital and share in the resulting asset value.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements of McDonald's real estate and co-investment strategy but contains a significant factual error and misrepresents the evolution described in the ground truth. CORRECT ELEMENTS: (1) The 2024 description of McDonald's owning or securing long-term leases on land/buildings is accurate; (2) The characterization of franchisees investing in equipment, signs, seating, and décor aligns with ground truth; (3) The general concept of co-investment enabling restaurant performance is correct. CRITICAL ERRORS: (1) The LLM states McDonald's 'moved away from a pure-franchise model' between 2022-2024, implying a significant strategic shift. However, the ground truth indicates McDonald's was already operating under this conventional franchise model in 2024, not that it newly adopted it. The evolution was from 'not detailed' in 2022 to 'explicitly outlined' in 2024—a clarification/documentation of existing practice, not a fundamental business model change. (2) The LLM's claim that franchisees 'provide the bulk of the capital and share in the resulting asset value' is not supported by the ground truth, which specifies franchisees invest in equipment/signs/seating/décor but does not mention them sharing in asset value or providing 'bulk of capital' for real estate. MULTI-HOP REASONING: The LLM failed to properly synthesize the temporal evolution. The ground truth emphasizes a shift from general ESG/collaboration emphasis (2022) to explicit real estate strategy documentation (2024), not a business model transformation. The LLM mischaracterized this as a strategic pivot rather than a clarification of existing practices. QUANTITATIVE ACCURACY: No specific numbers were required or provided, so this scores well. QUALITATIVE ACCURACY: The reasoning contains logical flaws in interpreting the nature of change between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 505,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "\nBetween 2022 and 2023 Altria formally **amended and restated** its 2015 Stock Compensation Plan for Non‑Employee Directors, with the revised plan becoming effective on **October 26 2022** (referenced in the 2023 Form 10‑K on page 110 and disclosed in the 2022 filing on page 115).  The amendment updated the share reserve, clarified award mechanics and governance language, and re‑affirmed the plan’s terms, showing that Altria treats director‑pay arrangements as **formal, regularly‑documented governance instruments** that are refreshed through documented amendments and full SEC disclosure.  This evolution reflects a deliberate, transparent approach to aligning director compensation with shareholder interests while maintaining rigorous board‑level oversight.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key factual elements: (1) the plan was amended and restated, (2) the effective date of October 26, 2022 is accurate, (3) the reference to 2023 Form 10-K page 110 and 2022 filing page 115 shows proper source documentation, (4) the semantic interpretation about formal governance and transparency is reasonable. The LLM appropriately synthesizes the multi-hop information about the plan's evolution between filing years.\n\nWEAKNESSES: (1) The ground truth specifically mentions 703,256 shares available for issuance under the plan in 2022—a concrete quantitative detail that the LLM completely omits. This is a material factual element that should have been included. (2) The LLM states the amendment 'updated the share reserve' and 'clarified award mechanics and governance language' but provides no specific evidence or numbers to support these claims. The ground truth does not confirm these specific updates occurred. (3) The LLM's interpretation about 'refreshed through documented amendments' goes slightly beyond what the ground truth states—the ground truth simply notes the plan was 'formally amended and restated' and 'incorporated by reference,' without explicitly characterizing this as a regular refresh cycle. (4) The phrase 'aligning director compensation with shareholder interests' is interpretive language not explicitly stated in the ground truth.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes that the plan changed status between 2022 and 2023 filings and connects this to governance approach. However, it adds interpretive layers (share reserve updates, award mechanics clarification) that aren't confirmed in the ground truth.\n\nQUANTITATIVE ACCURACY: The date (October 26, 2022) is correct. However, the omission of the 703,256 shares figure is a significant gap. Page references appear reasonable but cannot be independently verified from the provided ground truth.\n\nQUALITATIVE ACCURACY: The reasoning about formal governance is sound, but the LLM makes claims about specific updates (share reserve, award mechanics) without supporting evidence from the ground truth. The interpretation is somewhat speculative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 586,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "\nFrom 2022 to 2024 the risk‑factor discussion shows that roaming, RAN‑sharing and resale arrangements have become increasingly prevalent, with carriers using shared equipment as an alternative to paying for new tower space—often without compensation to American Tower—and even decommissioning gear on existing sites as networks mature.  This trend signals growing competitive pressure that is dampening new lease growth, because carriers can meet capacity needs through infrastructure sharing rather than signing additional tower leases.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. (1) CORRECTNESS: The answer accurately captures the evolution of roaming/resale/RAN-sharing arrangements from 2022 to 2024, correctly identifying that these arrangements have become increasingly prevalent and represent a growing competitive threat to AMT's leasing activity. The answer properly synthesizes the progression from initial concern about slowed new lease activity to the broader 2024 risk involving both new lease growth dampening and potential decommissioning of existing equipment. (2) QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are required or provided in either answer, so this dimension is not applicable. Both answers appropriately avoid false precision. (3) ENTITY ACCURACY: The answer correctly identifies AMT (American Tower), wireless service providers/carriers, and the relevant time period (2022-2024). The terminology is accurate (RAN-sharing, roaming, resale arrangements, decommissioning). (4) MULTI-HOP REASONING: The LLM successfully synthesizes information across the multi-year period, connecting the 2022 concern about infrastructure sharing slowing new leases to the 2024 broader risk involving both new lease growth and equipment redundancy. The logical connection between infrastructure sharing as an alternative to leasing and its impact on revenue growth is sound. (5) SEMANTIC EQUIVALENCE: The LLM answer conveys essentially the same information as the ground truth, using slightly different phrasing ('carriers using shared equipment as an alternative to paying for new tower space' vs 'carriers opted to share infrastructure rather than deploy new equipment') but maintaining factual equivalence. The mention of 'without compensation to American Tower' adds helpful context. Minor difference: The ground truth explicitly mentions '5G technology' as a driver, while the LLM answer does not, though this is a minor omission that doesn't significantly impact the core answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 548,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "\nBetween 2022 and 2024 McDonald’s moved from a largely royalty‑only model to an active partnership that **co‑invests with franchisees in restaurant upgrades, digital‑ordering platforms and sustainability initiatives**, tying additional financial incentives to the achievement of Systemwide sales and profit goals.  At the same time the Company **raised its operational expectations**, requiring franchisees to adopt faster service standards, expand mobile‑order and delivery capabilities, and adhere more tightly to brand and quality protocols, while providing the capital and resources needed to meet those heightened requirements.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from 2022 to 2024, capturing the shift toward active co-investment and increased operational expectations. The mention of co-investing in restaurant upgrades, digital-ordering platforms, and sustainability initiatives aligns with the ground truth's emphasis on modernization and enhanced consumer appeal. The identification of heightened operational standards (faster service, mobile-order/delivery capabilities, brand protocols) is accurate and adds relevant detail. No quantitative errors are present (no specific numbers were claimed that could be wrong). WEAKNESSES: (1) The LLM introduces specific details not explicitly confirmed in the ground truth, such as 'royalty-only model,' 'digital-ordering platforms,' 'sustainability initiatives,' and 'Systemwide sales and profit goals' - while these may be accurate, they exceed what the ground truth explicitly states and represent potential over-specification. (2) The ground truth emphasizes the pandemic context in 2022 (COVID-19 impact, labor availability, supply chain disruptions) as a key differentiator, which the LLM answer completely omits. This is a notable gap in capturing the full evolution narrative. (3) The ground truth mentions 'Accelerating the Arches' strategy specifically, which the LLM does not reference. (4) The LLM's characterization of the pre-2024 model as 'largely royalty-only' is not explicitly stated in the ground truth and may be an inference. MULTI-HOP REASONING: The LLM successfully synthesizes the 2022-to-2024 comparison and identifies the strategic shift, but misses the pandemic-driven context that frames the 2022 baseline. The reasoning is sound but incomplete. SEMANTIC EQUIVALENCE: The core message aligns - McDonald's moved from managing pandemic challenges to strategic investment-backed growth - but the LLM's framing differs in emphasis and specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 519,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "\nBased on the 2024 10‑K (pages 87‑91) and the 2022 10‑K (pages 61‑65), the fair‑value of equity securities in NextEra Energy’s Special Use Funds rose from roughly **$5.3 bn at the end of 2022 to $6.2 bn by the end of 2024**, while an unrealized loss of about **$1.0 bn in 2022 turned into gains of ≈ $0.9 bn in 2023‑2024**.  The fund also shifted a larger share of its equity holdings into **Level‑1, market‑quoted securities** (e.g., NEE’s equity securities increased from $2.35 bn to $2.61 bn (Level 1) and $3.32 bn (Level 2) in 2024), indicating a strategic move toward more liquid, observable equity exposure rather than Level‑3 valuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR DISCREPANCIES IDENTIFIED: The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims equity securities were '$5.3 bn at the end of 2022' but the ground truth explicitly states '$8,922 million ($8.922 bn) in Special Use Funds in 2022' with 'no explicit breakdown of equity securities provided.' The LLM's $5.3bn figure appears fabricated or misattributed. For 2024, the LLM states '$6.2 bn' which roughly aligns with the ground truth's $6,164 million ($6.164 bn), but the 2022 baseline is fundamentally wrong. (2) CALCULATION ERRORS: The LLM calculates a rise from $5.3bn to $6.2bn (approximately $0.9bn increase), but this comparison is invalid because the 2022 figure is incorrect. The ground truth indicates the total Special Use Funds DECREASED from $8.922bn to an unspecified lower amount, with only $6.164bn explicitly allocated to equities in 2024. (3) MISSING CRITICAL CONTEXT: The ground truth emphasizes that 2022 had 'no explicit breakdown of equity securities provided,' making a direct 2022-to-2024 equity comparison problematic. The LLM fails to acknowledge this critical limitation. (4) UNREALIZED GAINS/LOSSES: The LLM introduces claims about '$1.0 bn unrealized loss in 2022 turning into gains of ≈ $0.9 bn in 2023-2024' which are not mentioned in the ground truth and appear unsupported. (5) LEVEL-1/LEVEL-2 BREAKDOWN: The LLM provides specific Level-1 and Level-2 valuations ($2.35bn, $2.61bn, $3.32bn) that are not present in the ground truth answer, suggesting either fabrication or misinterpretation of source data. (6) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and provide detailed analysis, the fundamental numerical errors undermine the entire response. The ground truth's more cautious approach (acknowledging lack of 2022 breakdown) is more accurate than the LLM's confident but incorrect assertions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 523,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "\nFrom 2022 to 2023, Altria’s smokeable‑products net revenues fell from **$22,476 million to $21,756 million** – a decline of roughly **$720 million (about 3 %)**.  Operating income in that segment also slipped slightly, moving from **$10,688 million in 2022 to $10,670 million in 2023**, a reduction of about **$18 million (≈0.2 %)**.  The modest drop in operating income reflects the revenue decline together with higher general‑corporate and amortization expenses that offset the segment’s performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates excellent accuracy and completeness. All key financial figures are correct: 2022 net revenues of $22,476 million, 2023 net revenues of $21,756 million, 2022 operating income of $10,688 million, and 2023 operating income of $10,670 million. The calculations are accurate: the revenue decline of $720 million (3% decrease) and operating income decline of $18 million (0.2% decrease) are both correctly computed. The answer properly identifies the company (Altria) and correctly synthesizes the multi-hop information comparing smokeable products performance across two fiscal years. The LLM goes beyond the ground truth by providing percentage calculations and offering contextual explanation about the drivers of the operating income decline (higher general-corporate and amortization expenses), which adds valuable insight without introducing any factual errors. The answer directly addresses both parts of the question (net revenues and operating income evolution) with clear year-over-year comparisons. Minor deduction from perfect score only because the additional contextual explanation about expense drivers, while reasonable, goes slightly beyond what was explicitly stated in the ground truth, though it does not contradict it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 354,
        "total_tokens": 1570
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 the company expanded its repurchase authorisation—from a $3.13 bn board‑approved limit in 2022 to $6.13 bn after the September 2022 addition—while in 2022 it actually bought about 12.2 million Class A shares (≈$4.1 bn) through an open‑market program and other employee‑related purchases, most of which were held as treasury stock for equity‑award and benefit plans.  The 2023 increase in authority signals that Accenture continues to use its Class A ordinary shares primarily for treasury‑stock purposes—funding employee equity awards, selective open‑market purchases, and other corporate needs—rather than for dividend payments or capital‑raising.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM claims the authorization expanded from '$3.13 bn' in 2022 to '$6.13 bn after September 2022 addition.' The ground truth states the 2022 aggregate available authorization was $3,129,296 (approximately $3.1 million, NOT $3.13 billion). This is a massive error—off by a factor of 1,000. The LLM appears to have confused millions with billions. The $6.13 bn figure is not mentioned in the ground truth at all. (2) SHARE PURCHASE NUMBERS: The LLM claims '12.2 million Class A shares (≈$4.1 bn)' were purchased in 2022. The ground truth does not provide these specific purchase quantities or dollar amounts for 2022. This appears to be fabricated or from an unreliable source. (3) TEMPORAL INCONSISTENCY: The LLM references 'September 2022 addition' and discusses 'fiscal 2024' share withholding, but the ground truth focuses on 2022-2023 evolution. The LLM conflates different time periods. (4) MISSING KEY INFORMATION: The ground truth emphasizes that by 2023, shares were 'held as treasury shares and intended for employee benefits' and that fiscal 2024 involved 'share withholding for payroll tax obligations under employee equity share plans.' The LLM mentions treasury stock and employee equity awards but doesn't clearly distinguish between the publicly announced programs and the separate employee withholding mechanism. (5) CORRECT ELEMENTS: The LLM correctly identifies that shares are held as treasury stock for employee equity awards and benefits, and correctly notes the shift toward internal employee compensation. However, these correct elements are overshadowed by the fundamental numerical errors. The core reasoning about treasury stock purposes is sound, but the quantitative foundation is severely flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 483,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "\nBetween 2022 and 2024 the basic operating‑covenant framework—reporting obligations, limits on additional debt and the need to satisfy prescribed financial ratios—remained, but its scope broadened.  The company’s debt base moved from a focus on the 2021 multicurrency and delayed‑draw term loans (interest indexed to LIBOR/EURIBOR + 1.125 %) toward a larger mix of senior unsecured notes and the 2023 securitization facilities, and the benchmark for new USD borrowings shifted to a SOFR‑based rate (or retained LIBOR with an updated spread).  In addition, the 2024 covenants introduced explicit cash‑flow coverage tests (Cash‑Trap DSCR ≤ 1.30 and Minimum DSCR ≤ 1.15) that control cash‑distribution rights, a provision that was not present in the earlier 2022 agreements.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer addresses the evolution of AMT's operating covenants between 2022 and 2024 but contains significant issues with factual accuracy and introduces information not supported by the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies the shift from LIBOR/EURIBOR to SOFR as a key evolution\n- Accurately notes the transition from 2021 multicurrency and term loans to a broader debt mix\n- Correctly identifies that the basic covenant framework (reporting obligations, debt limits, financial ratios) remained in place\n- Appropriately characterizes this as a strategic and regulatory evolution\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. QUANTITATIVE ERRORS: The LLM provides specific spread percentages (1.125%) and DSCR thresholds (Cash-Trap DSCR ≤ 1.30, Minimum DSCR ≤ 1.15) that are NOT mentioned in the ground truth answer. These appear to be fabricated or sourced from outside the provided knowledge graph.\n2. UNVERIFIED CLAIMS: References to \"2023 securitization facilities\" and \"senior unsecured notes\" are not mentioned in the ground truth, making it impossible to verify their accuracy.\n3. COVENANT DETAILS: The introduction of explicit cash-flow coverage tests with specific DSCR metrics is presented as fact but cannot be verified against the ground truth, which makes no mention of these specific covenant provisions.\n4. SCOPE EXPANSION: While the LLM claims the scope \"broadened,\" the ground truth focuses specifically on the interest rate benchmark transition (LIBOR/EURIBOR to SOFR), not on structural broadening of the debt base.\n\nMULTI-HOP REASONING:\nThe LLM attempts to synthesize information across multiple years and debt instruments, which is appropriate for the question. However, the synthesis appears to include information not present in the ground truth, suggesting either hallucination or reliance on external sources beyond the knowledge graph.\n\nSEMANTIC ALIGNMENT:\nWhile the LLM's general narrative about covenant evolution is reasonable, it diverges significantly from the ground truth by introducing specific financial metrics and covenant structures that cannot be verified. The ground truth is more focused and conservative, highlighting the LIBOR-to-SOFR transition as the primary evolution.\n\nJUSTIFICATION:\nThe answer receives a moderate score because it captures the general direction of change (LIBOR to SOFR, debt mix evolution) but introduces unverified quantitative details that may be incorrect. The introduction of specific DSCR thresholds and securitization facilities without ground truth support is a significant accuracy concern that prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 697,
        "total_tokens": 2073
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "\nDisney+ Hotstar’s paid subscriber base grew from roughly **33 million** at the end of fiscal 2023 to about **36 million** by September 2024, indicating modest year‑over‑year growth.  In June 2024 the company merged the standalone **Star+** service into a single **Disney+** offering across Latin America, consolidating the region’s entertainment and sports content under one brand, expanding Disney+’s addressable audience, improving retention and reinforcing a unified international streaming strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the multi-hop question and correctly identifies the key strategic consolidation. However, there is a quantitative discrepancy that prevents a higher score: (1) QUANTITATIVE ACCURACY: The LLM states Disney+ Hotstar grew from 'roughly 33 million' at end of fiscal 2023 to 'about 36 million' by September 2024. The ground truth only confirms 36 million as of September 28, 2024 from the 2023 SEC filing, but does not provide a specific 33 million figure for fiscal 2023 end. The LLM appears to have inferred or estimated the 33 million baseline without explicit ground truth support. The 36 million figure is correct and properly attributed. (2) CONSOLIDATION DETAILS: The LLM correctly identifies the June 2024 consolidation of Star+ into Disney+ in Latin America, matching the ground truth's 'by the end of June 2024' timing. (3) STRATEGIC IMPACT: The LLM provides reasonable interpretation of the consolidation's strategic purpose (streamlining, unified brand, operational efficiency, expanding addressable audience), which aligns with the ground truth's characterization of 'strategic shift toward streamlining international service offerings.' (4) MULTI-HOP REASONING: The answer successfully synthesizes information across the 2023 and 2024 filings and connects the subscriber evolution to the consolidation strategy. (5) MINOR ISSUE: The LLM adds interpretive details ('expanding Disney+'s addressable audience, improving retention') that go slightly beyond what the ground truth explicitly states, though these are reasonable inferences. The core facts about the consolidation and its strategic purpose are sound. The main weakness is the unverified 33 million baseline figure, which introduces uncertainty into the growth narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 486,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "\nFrom 2022 to 2023 the workforce covered by collective bargaining fell from roughly **3,000 employees** (across about **21 agreements**) to **about 2,100 employees** (across about **20 agreements**).  This reduction indicates that the company is scaling back the scope of its labor‑agreement negotiations—fewer agreements and a smaller employee base—suggesting a strategy focused on maintaining stable labor relations while limiting the breadth and potential disruption of future contract renegotiations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core numerical change (3,000 to 2,100 employees) and provides reasonable interpretation of the strategic implications. However, there is a significant issue with the additional details provided. The ground truth answer does not mention the number of agreements (21 to 20) at all—this information appears to be added by the LLM without verification against the source documents. This is problematic because: (1) it introduces unverified quantitative claims that could be incorrect, (2) it expands the answer beyond what the ground truth supports. The core facts about employee numbers are accurate and match the ground truth exactly. The interpretation about 'scaling back scope' and 'limiting disruption' is reasonable and semantically equivalent to the ground truth's characterization of 'fewer expiring agreements or proactive resolution.' The answer addresses both parts of the question (the numerical change and what it indicates about strategy). However, the introduction of agreement counts without ground truth support reduces confidence in the answer's reliability. The reasoning is sound regarding the strategic implications, but the addition of unverified data points is a material accuracy concern that prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 358,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "\nNextEra Energy’s combined holdings of U.S. Government and municipal bonds rose from roughly $1.17 billion in 2022 to $1.19 billion in 2024, after peaking at $1.26 billion in 2023, for a net increase of about $16 million over the two‑year span.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect across all quantitative dimensions. Ground truth shows NextEra Energy's U.S. Government and municipal bonds investments at $137 million (2022) and $161 million (2024), with a $24 million increase (17.5% growth). The LLM answer claims values of approximately $1.17 billion (2022), $1.26 billion (2023), and $1.19 billion (2024), with a $16 million net increase. These numbers are off by a factor of approximately 8-9x, representing a catastrophic error in data retrieval or synthesis. The LLM appears to have confused or conflated different investment categories or possibly different entities' data. While the LLM correctly identified the company (NextEra Energy/NEE) and the time period (2022-2024), and attempted to address the multi-hop question structure by providing year-over-year progression, the core financial figures are entirely wrong. The calculation of net increase ($16 million vs. correct $24 million) is also incorrect. The reasoning structure is sound (showing progression across years), but it is applied to completely inaccurate data. This represents a critical failure in multi-hop financial data synthesis from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1150,
        "completion_tokens": 335,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 Opdivo’s therapeutic footprint broadened markedly – the brand added new indications (e.g., neoadjuvant treatment of resectable NSCLC, first‑line therapy for metastatic urothelial carcinoma and, in December 2024, the FDA‑approved subcutaneous formulation Opdivo Qvantig) and received regulatory approvals in additional markets such as Japan and the EU.  To meet the growing demand, BMS shifted from a purely outsourced supply model toward a more integrated, flexible manufacturing network: it expanded internal capacity at its U.S. and European sites (including the Devens, MA bulk‑biologics plant and the newly‑approved Cruiserath, Ireland facility), secured backup third‑party manufacturers, and built inventory‑management and dual‑source arrangements that give the company direct control over Opdivo’s production while still relying on external partners when needed.  This dual‑track strategy ensures a stable supply chain for the product’s expanding portfolio of indications.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) FACTUAL ERRORS ON DATES: The LLM claims Opdivo Qvantig received FDA approval in December 2024, but this is beyond the evaluation period (2022-2024) and cannot be verified against ground truth. More importantly, the ground truth specifies a March 2024 FDA approval for combination therapy with cisplatin and gemcitabine for urothelial carcinoma - the LLM mentions this indication but does not specify the March 2024 date, instead bundling it with other claims. (2) UNVERIFIED CLAIMS: The LLM introduces multiple specific details not present in ground truth: neoadjuvant NSCLC treatment, Japan/EU approvals, specific facility names (Devens MA, Cruiserath Ireland), and inventory-management arrangements. While these may be factually accurate, they cannot be verified against the provided ground truth and represent significant expansion beyond what was confirmed. (3) MANUFACTURING STRATEGY DISCREPANCY: Ground truth states BMY had 'both internal manufacturing capability and reliance on third-party manufacturers' in 2022, suggesting a mixed model already existed. The LLM claims a shift 'from a purely outsourced supply model' - this contradicts the ground truth characterization of 2022 status. (4) PARTIAL CORRECTNESS: The LLM correctly identifies the urothelial carcinoma indication and the general concept of expanded manufacturing capacity, which aligns with ground truth. However, the specific details about facility names and locations cannot be confirmed. (5) MULTI-HOP REASONING: The answer attempts to synthesize manufacturing and therapeutic evolution but introduces unverified specificity that goes beyond the knowledge graph foundation. The core insight about dual-track strategy is reasonable but not explicitly confirmed in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 482,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "\nBetween 2023 and 2024 National Geographic magazine stayed within Disney’s Entertainment segment, with Disney retaining its 73 % ownership and the publishing‑and‑digital business still reported under Content Sales/Licensing (and “Other” revenue).  The company continued to integrate Nat Geo’s content into its broader Entertainment portfolio—leveraging the brand across Disney+, linear cable channels and merchandising—so that, rather than operating as a separate unit, it was positioned as a strategic content pillar that supports Disney’s streaming and global network initiatives.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains a critical factual error that directly contradicts the ground truth. The original answer explicitly states that by 2024, 'the emphasis on its ownership percentage was removed' and describes a shift away from ownership-focused language. However, the LLM answer claims Disney 'retaining its 73% ownership' in 2024, which is factually incorrect according to the ground truth. The ground truth indicates that while Disney owned 73% in 2023, this ownership percentage emphasis was removed in 2024 filings. The LLM also misses the key evolution described in the ground truth: the shift from describing National Geographic as 'a business in which Disney has a direct equity stake' (2023) to describing it as a publication 'published' by the company (2024). This represents a fundamental change in how the relationship was characterized, which the LLM fails to capture. The LLM's discussion of integration into Disney's broader portfolio and positioning as a 'strategic content pillar' adds speculative context not present in the ground truth and may conflate operational integration with the specific structural/ownership relationship change that was the focus of the question. The answer demonstrates partial understanding of National Geographic's role in the Entertainment segment and Content Sales/Licensing, but fundamentally misrepresents the evolution of the ownership relationship between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 395,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "\nIn the 2023 filing PayPal described its transaction‑management databases as supporting payments in ≈ 150 currencies across roughly 200 markets, with fund‑withdrawals available in 56 currencies and balances held in 24 currencies. The 2024 filing revises that figure to ≈ 140 currencies for payments (a slight contraction), adds one more withdrawal currency (57 currencies), while still allowing balances in 24 currencies—showing that the underlying database capability remains focused on multi‑currency global processing but with a modest refinement of the currency coverage.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer introduces significant factual errors and diverges substantially from the ground truth. CRITICAL ERRORS: (1) The LLM claims PayPal's 2023 filing mentioned '≈150 currencies' for payments and '≈140 currencies' in 2024 - these figures are NOT present in the ground truth and appear to be fabricated. (2) The ground truth explicitly states the key metric is withdrawal currencies (56 in 2023, 57 in 2024), not payment currencies. The LLM conflates different metrics. (3) The LLM mentions '24 currencies' for balance holdings - this detail is not mentioned in the ground truth at all. (4) The LLM describes a 'slight contraction' from 150 to 140 currencies, which contradicts the ground truth's narrative of 'expansion' from 56 to 57 withdrawal currencies. WHAT WAS CORRECT: The LLM correctly identifies the 56→57 currency increase for withdrawals. MISSING CRITICAL ELEMENTS: The ground truth emphasizes a key qualitative change - the 2024 reframing that places 'consumers' ahead of 'merchants' in describing the ecosystem. The LLM completely omits this important evolution in how PayPal positions its transaction management systems. MULTI-HOP REASONING: The LLM fails to properly synthesize the 2023 vs 2024 comparison. It introduces unverified metrics (150/140 currencies for payments) that appear to be hallucinated rather than derived from actual filings. The answer demonstrates poor source fidelity and introduces false precision with the '≈' symbol for numbers not in the ground truth. The core narrative of the answer (contraction in payment currencies) contradicts the ground truth's emphasis on expansion and repositioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 449,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "\nIn March 2023 NEE’s Series K Debentures were reset to a fixed 6.051 % rate as part of a $2.5 bn remarketing.  By early 2024 the company refinanced that exposure, issuing new debentures at rates of 4.90 %–5.55 % (and floating‑rate notes) with maturities extending to 2026‑2054, which are markedly lower than the prior 6 % level.  This shift shows NEE is deliberately taking advantage of softer interest‑rate conditions to reduce its cost of capital and extend the maturity profile of its long‑term financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - 2024 Refinancing: The LLM claims NEE refinanced in early 2024 at rates of 4.90%-5.55%, which is NOT supported by the ground truth. The ground truth explicitly states that by 2024, the Series K Debentures terms were 'further updated through a letter dated March 1, 2023' with the same 6.051% rate continuing from the 2023 remarketing. There is no mention of a 2024 refinancing or lower rates in the ground truth. (2) INCORRECT NARRATIVE: The LLM's interpretation that NEE 'refinanced that exposure' and 'took advantage of softer interest-rate conditions' to lower costs is contradicted by the ground truth, which indicates the rate remained at 6.051% through 2024. (3) UNSUPPORTED DETAILS: The $2.5 billion remarketing amount, the 4.90%-5.55% rate range, the 2026-2054 maturity extensions, and the floating-rate notes are all absent from the ground truth and appear to be fabricated or confused with different securities. (4) CORRECT ELEMENTS: The LLM correctly identifies the March 2023 remarketing date and the 6.051% rate for 2023. However, the core claim about 2024 evolution is fundamentally wrong. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the information across 2023-2024, instead inventing a refinancing scenario that contradicts the ground truth. The ground truth indicates continuity of terms, not a refinancing with lower rates. This is a major factual failure that undermines the entire answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 422,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "\nExxonMobil continued to calculate depreciation for most upstream assets by applying the unit‑of‑production method, using the ratio of an asset’s cost to the volume of proved reserves (or proved developed reserves) actually produced.  In the 2023 filing the company emphasized that, when a property’s proved reserves have been “substantially de‑booked,” depreciation is now based on the **most recent SEC‑determined reserve estimate** (adjusted for production and technical changes) to achieve a more equitable cost allocation, whereas the 2022 discussion merely noted that an alternative (straight‑line) method is used if the unit‑of‑production approach does not allocate cost equitably.  Thus, between 2022 and 2023 the method remained the same but was tightened to rely on updated SEC‑price‑based reserve figures and to trigger the alternative straight‑line approach only when the reserve‑life correlation breaks down.  (2022 10‑K pp. 75‑77; 2023 10‑K pp. 71‑73)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. STRENGTHS: (1) Correctly identifies the core methodology (unit-of-production method based on proved/proved developed reserves) in both years; (2) Accurately captures the key evolution: 2023 placed greater emphasis on using 'most recent SEC price-based reserves' when reserves were 'substantially de-booked,' whereas 2022 merely noted an alternative straight-line approach; (3) Properly synthesizes the multi-hop comparison showing methodological continuity with refinement; (4) Correctly references the filing pages (2022 10-K pp. 75-77; 2023 10-K pp. 71-73); (5) Uses precise language matching ground truth ('substantially de-booked,' 'most recent SEC-determined reserve estimate,' 'equitable cost allocation'). MINOR CONSIDERATIONS: The LLM answer provides slightly more operational detail about the mechanics of the method (e.g., 'ratio of an asset's cost to the volume of proved reserves actually produced') which adds helpful context but goes marginally beyond the ground truth's focus on the evolution itself. However, this additional detail is accurate and enhances understanding without contradicting the ground truth. The answer correctly emphasizes that the change represents a 'tightening' or 'refinement' rather than a fundamental shift, which aligns perfectly with the ground truth's characterization. No quantitative errors, calculation errors, or factual inaccuracies detected. The multi-hop reasoning (comparing 2022 vs 2023 approaches) is sound and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 433,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix shifted from a model that leaned heavily on external production partners toward one that “scales its own studio operations” — investing in internal production capacity (e.g., expanding its own studios and acquiring assets such as Scanline and Animal Logic) while still contracting third‑party firms for development, marketing and distribution of original titles.  The company now balances greater in‑house production control with selective third‑party collaborations, reducing pure reliance on outside partners but not abandoning them entirely.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of Netflix's strategic shift between 2023 and 2024. STRENGTHS: (1) Correctly identifies the core strategic evolution from external reliance to internal scaling; (2) Accurately names specific acquisitions (Scanline and Animal Logic) as evidence of internal studio expansion; (3) Properly synthesizes the multi-hop reasoning across two years of filings; (4) Correctly captures the shift in emphasis from third-party risks to internal operational improvements; (5) No quantitative errors or incorrect dates/numbers. MINOR WEAKNESSES: (1) The LLM answer adds nuance about 'selective third-party collaborations' for 'development, marketing and distribution' which, while reasonable, goes slightly beyond what the ground truth explicitly states. The ground truth emphasizes the omission of third-party risk language in 2024 as evidence of 'reduced dependency,' but doesn't explicitly detail what roles third parties retained; (2) The ground truth emphasizes the explicit mention of third-party risks being 'omitted in 2024' as a key indicator of strategic shift, while the LLM answer focuses more on the positive framing of internal scaling rather than the absence of risk language. This is a subtle but meaningful distinction in how the strategic shift is characterized. MULTI-HOP REASONING: The answer correctly synthesizes information across 2023 and 2024 filings, comparing strategic emphasis and drawing appropriate conclusions about the evolution. The logic is sound and the comparison is valid. SEMANTIC EQUIVALENCE: The core message aligns well with ground truth - Netflix moved toward internal control and scaling while reducing external dependency. The phrasing differs but conveys equivalent meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 485,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard moved Cyber and Intelligence Solutions from a generic “other‑revenue” line item to a deliberately highlighted growth pillar.  In the 2022 filing they were simply noted as fees for fraud‑prevention and security services, but the 2023 filing treats them as a distinct component of the company’s value‑added services—linking them to digital‑identity capabilities (e.g., the Ekata acquisition) and to broader data‑analytics and consulting offerings—thereby positioning cyber‑intelligence as a core, high‑margin revenue driver rather than an ancillary service.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the core evolution of Cyber and Intelligence Solutions from 2022 to 2023 (moving from 'Other revenues' to a more prominent strategic positioning), which aligns with the ground truth. However, there are significant issues with accuracy and unsupported claims: (1) CORRECT ELEMENTS: The answer correctly identifies the shift from a generic categorization to elevated strategic importance, and correctly notes the 2022 positioning around fraud prevention/security. (2) PROBLEMATIC ELEMENTS: The LLM introduces specific claims not present in the ground truth, particularly the reference to 'Ekata acquisition' and 'digital-identity capabilities.' While Ekata may be a real Mastercard acquisition, the ground truth does not mention it, and introducing unsupported details reduces credibility. The claim about 'high-margin revenue driver' is also not substantiated in the ground truth. (3) SEMANTIC ISSUES: The ground truth emphasizes that 2023 positioning describes Cyber and Intelligence Solutions as enabling 'secure, easy, and confident transactions across the entire payments ecosystem' and supporting 'core operations and new network investments.' The LLM answer focuses more on it being a 'growth pillar' and 'high-margin revenue driver,' which shifts the emphasis away from the ecosystem-wide enablement role highlighted in the ground truth. (4) MULTI-HOP REASONING: The answer does synthesize information across two years, but the synthesis includes extrapolated claims not grounded in the source material. (5) QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral. The dates (2022, 2023) are correct. Overall, while the directional shift is captured, the introduction of unsupported details and the reframing of the strategic importance reduces the accuracy of the response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 501,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "\nFrom 2023 to 2024 Tesla’s energy‑storage strategy shifted from a primarily modular, vehicle‑derived product lineup toward deeper vertical integration, accelerating the development of its own lithium‑ion cells and expanding software‑controlled dispatch capabilities for Powerwall and Megapack. This evolution has introduced new production challenges—chiefly scaling proprietary cell manufacturing and managing raw‑material price volatility—making reliable battery‑cell supply and advanced battery‑chemistry expertise a central strategic dependency for its storage business.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer introduces significant claims not supported by the ground truth. Specifically: (1) The claim about 'deeper vertical integration' and 'accelerating the development of its own lithium-ion cells' is not mentioned in the original answer and appears to be unsupported speculation. The ground truth focuses on modular design and in-house expertise in power electronics and software, not cell manufacturing. (2) The mention of 'raw-material price volatility' as a strategic dependency is not present in the ground truth. (3) The reference to 'advanced battery-chemistry expertise' is not substantiated by the original answer. WHAT WAS CORRECT: (1) The shift from 2023 to 2024 is accurately identified. (2) The mention of production challenges and scaling issues aligns with ground truth. (3) Supply chain/supplier reliability concerns are correctly identified. (4) The focus on Powerwall and Megapack products is appropriate. MULTI-HOP REASONING: The LLM failed to properly synthesize the actual evolution described in the ground truth. Instead of accurately capturing the shift from 'modular design and in-house power electronics/software expertise' to 'production ramps and supply chain dependencies,' the answer pivots to cell manufacturing claims not in the source material. This represents a fundamental misunderstanding or hallucination of the key strategic shift. MISSING ELEMENTS: The answer omits the specific emphasis on modular design from 2023 and the explicit mention of bottlenecks and quality standards challenges from 2024. The ground truth's focus on manufacturing efficiency and cost-effectiveness is also not adequately captured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 462,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "\nFrom the end of 2022 to the end of 2023 the balance of NEECH’s floating‑rate debentures (the “Debentures – variable (c)” line) jumped from roughly **$0.4 bn to $2.2 bn**.  In January 2024 NEECH added a new issuance of **$600 million of floating‑rate debentures that mature in 2026**, and the company continued to roll out longer‑dated floating‑rate notes (up to 2036‑2054) through its senior secured limited‑recourse debt in the NEER segment.  Thus, the 2024 strategy shifted to **significantly expanding the floating‑rate issuance size and extending the maturity ladder (2026‑2054) compared with the more modest $0.4 bn‑$2.2 bn portfolio seen in 2023**.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth:\n\n1. TEMPORAL CONFUSION: The LLM discusses 2022-2023 data and 2024 strategy, but the question specifically asks about evolution from 2023 to 2024. The ground truth clearly states that in 2023, NextEra disclosed $600M in floating rate debentures due 2026, and in 2024 this was formalized via Officer's Certificate dated January 31, 2024.\n\n2. QUANTITATIVE ERRORS: The LLM claims NEECH's floating-rate debentures jumped from $0.4bn to $2.2bn from end of 2022 to end of 2023. This data is not mentioned in the ground truth and appears to be from a different context or misattributed. The ground truth focuses on the $600M issuance, not these balance sheet figures.\n\n3. INCORRECT SCOPE: The LLM introduces information about NEER segment senior secured limited-recourse debt with maturities extending to 2036-2054. The ground truth makes no mention of NEER segment or extended maturity ladders to 2054. This appears to be conflating different debt instruments or segments.\n\n4. MISCHARACTERIZATION OF STRATEGY: The LLM claims the 2024 strategy \"significantly expanded\" the floating-rate issuance and extended maturity ladder. The ground truth explicitly states the opposite: \"This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.\"\n\n5. PRINCIPAL AMOUNT CONSISTENCY: The ground truth correctly notes that while the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with 2026. The LLM's claim about expanding from $0.4bn-$2.2bn to a larger portfolio contradicts this.\n\n6. MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2023-2024 evolution. It appears to have mixed data from different time periods and different debt instruments, creating a fundamentally incorrect narrative about the company's strategy shift.\n\nThe answer demonstrates poor accuracy on the core question and introduces unsupported claims about strategy expansion that directly contradict the ground truth's conclusion of continuity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 576,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "\nFrom 2023 to 2024 Intel shifted from a primarily coalition‑level, industry‑wide stance—highlighted by its participation in the Alliance for Global Inclusion and generic calls for transparency on climate, water and responsible‑minerals issues—to a more focused, metrics‑driven engagement with suppliers.  The 2024 disclosures show a substantial expansion in the number of suppliers covered by audits, training and emissions‑reduction programs, explicit linkage of executive pay to diverse‑supplier spending and Scope‑3 carbon goals, and deeper collaboration on responsible‑minerals and water‑stewardship standards, indicating a broader and more accountable supplier‑engagement scope.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on key points: (1) DIRECTIONAL ERROR - Ground truth states 2023 involved 'expansion of supplier engagement' with goals to increase suppliers covered, while 2024 showed 'continued focus without explicit mention of expanding the number of suppliers.' The LLM reverses this, claiming 2024 shows 'substantial expansion in the number of suppliers covered,' which directly contradicts the ground truth. (2) MISSING CORE ELEMENTS - The LLM fails to mention Intel's RISE strategy, which is central to the ground truth answer. It also omits the specific 2050 net-zero Scope 3 emissions goal mentioned in 2023. (3) UNSUPPORTED CLAIMS - The LLM introduces specific claims not in the ground truth: 'Alliance for Global Inclusion' participation, 'explicit linkage of executive pay to diverse-supplier spending,' and 'water-stewardship standards' are presented as factual but cannot be verified against the provided ground truth. (4) SEMANTIC MISALIGNMENT - Ground truth emphasizes a shift FROM announcing expansions TO deepening existing partnerships. The LLM characterizes this as a shift FROM coalition-level stance TO metrics-driven engagement with expansion, which is fundamentally different. (5) QUANTITATIVE ISSUES - No specific numbers are provided in either answer, but the LLM's qualitative claims about 'substantial expansion' are factually incorrect per the ground truth. The answer demonstrates poor multi-hop synthesis and introduces unsupported details while missing key verified information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 433,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "\nBetween 2022 and 2023 ExxonMobil kept the same technical definition of the standardized discounted‑cash‑flow metric—applying first‑day‑of‑the‑month average prices, year‑end costs and a 10 % discount rate to proved reserves—but the way it presented the underlying assumption evolved. In 2022 the filing warned that the metric “does not provide a reliable estimate of the Corporation’s expected future cash flows” and highlighted that the use of discrete first‑day‑of‑the‑month prices “may cause significant variability in cash flows from year to year as prices change.” By 2023 the language was sharpened to stress that the metric’s results are directly tied to those price assumptions, noting that the observed swing in discounted cash‑flow values (e.g., from $189 bn in 2022 to $116 bn in 2023) reflects the impact of changing first‑day‑of‑the‑month average prices. Thus, the company’s framing shifted from a general caution about variability to an explicit acknowledgment that its discounted‑cash‑flow outlook is fundamentally dependent on the first‑day‑of‑the‑month price assumption.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. MAJOR ISSUES: (1) The LLM claims the 2022 filing warned that the metric 'does not provide a reliable estimate of the Corporation's expected future cash flows' - this language is NOT supported by the ground truth, which states the 2022 filing used neutral language about 'prescribed assumptions' without such explicit warnings. (2) The LLM attributes the variability warning ('may cause significant variability in cash flows from year to year as prices change') to the 2022 filing, but the ground truth clearly indicates this language appears in the 2023 filing as part of the evolved characterization. This is a critical reversal of the chronological evolution being described. (3) The specific dollar amounts cited ($189 bn in 2022 to $116 bn in 2023) are not mentioned in the ground truth and cannot be verified; introducing unverified numbers weakens the answer. (4) The LLM's core claim about the evolution is partially correct - there IS a shift from general framing to explicit dependency acknowledgment - but the specific textual evidence provided is misattributed to the wrong years. WHAT WAS CORRECT: The LLM correctly identifies that the technical methodology remained unchanged (10% discount rate, first-day-of-the-month prices, year-end costs) and that there was indeed an evolution in how the company framed the dependency on these assumptions. The general direction of the shift (toward more explicit acknowledgment of dependency) aligns with the ground truth. MULTI-HOP REASONING: The answer attempts to synthesize across two years but fails in execution by misplacing key textual evidence. The reasoning structure is sound but the factual foundation is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1543,
        "completion_tokens": 480,
        "total_tokens": 2023
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "\nBetween 2022 and 2023 Mastercard expanded its digital‑identity platform from a stand‑alone verification offering into a core component of its open‑banking ecosystem.  In 2023 the company leveraged its open‑banking network—now reaching > 95 % of U.S. deposit accounts and roughly 3,000 European banks—to embed consent‑driven identity checks (device intelligence, behavioral biometrics, transaction‑fraud data, etc.) directly into payment flows, enabling seamless, secure consumer‑bill payments and broader data‑sharing across financial institutions.  This tighter integration gives banks and merchants a unified, privacy‑by‑design identity layer that scales across the entire payments value chain.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and effectively synthesizes multi-hop information about MA's digital identity evolution. STRENGTHS: (1) All quantitative data is correct - the >95% U.S. deposit account connectivity and ~3,000 European banks figures match the ground truth exactly; (2) The temporal progression from 2022 to 2023 is properly captured; (3) The core narrative of evolution from stand-alone verification to integrated open banking platform is accurate; (4) Key concepts like consent-driven identity checks, privacy-by-design, and integration with payment flows are correctly identified; (5) The mention of ACH payment solution partnerships is implicitly captured through the broader payment integration narrative. MINOR WEAKNESSES: (1) The LLM answer uses more technical/marketing language ('device intelligence, behavioral biometrics, transaction-fraud data') that goes slightly beyond what was explicitly stated in the ground truth, though these are reasonable inferences about identity verification mechanisms; (2) The ground truth explicitly mentions 'partnership with leading financial institutions to launch an ACH payment solution' while the LLM answer generalizes this to 'consumer-bill payments and broader data-sharing' - this is a slight semantic shift but captures the essence of deeper integration; (3) The LLM answer emphasizes 'unified, privacy-by-design identity layer' which is a reasonable characterization but adds interpretive language not explicitly in the ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2023, showing the progression and integration of capabilities. The connection between open banking reach (95% accounts, 3,000 banks) and digital identity application is properly established. QUANTITATIVE VERIFICATION: All numbers are accurate with appropriate formatting (>95% matches, ~3,000 matches). No calculation errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 523,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "\nBetween 2023 and 2024 Tesla shifted the Solar Roof from a largely outsourced, channel‑partner model toward a vertically‑integrated design that emphasizes in‑house production of its solar inverter and power‑electronics and tighter coupling with its Energy‑Storage products (Powerwall/Megapack).  This evolution required solving scaling‑up production issues—especially the manufacture and quality control of the premium glass‑tile roof tiles and the expansion of a dedicated installation network—while creating new strategic dependencies on Tesla’s own battery‑cell and power‑electronics supply chains and on the rollout of compatible energy‑storage installations.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces information not supported by the ground truth. Key issues: (1) The LLM claims Tesla shifted from 'outsourced, channel-partner model' to 'vertically-integrated design' with in-house solar inverter and power-electronics production - this specific claim is not present in the ground truth and appears to be fabricated or confused with other Tesla initiatives. (2) The LLM mentions 'premium glass-tile roof tiles' as a production challenge, but the ground truth does not specify this particular material or manufacturing detail. (3) The LLM discusses 'strategic dependencies on Tesla's own battery-cell and power-electronics supply chains' - while the ground truth mentions dependencies, it does not specifically attribute them to Tesla's own supply chains in this manner. (4) The ground truth's core finding - that Tesla acknowledged production delays and signaled a strategic prioritization shift toward mass-market vehicle production that could affect Solar Roof timelines - is completely absent from the LLM answer. (5) The LLM answer focuses heavily on vertical integration and supply chain details that are not mentioned in the ground truth, suggesting the model either hallucinated details or confused Solar Roof evolution with other Tesla product lines. (6) The ground truth emphasizes the 2023 positioning around aesthetic appeal, durability, and Powerwall integration, then the 2024 shift to acknowledging delays and strategic prioritization - the LLM misses this temporal evolution entirely. The LLM answer reads as plausible but is fundamentally disconnected from the actual ground truth about Tesla's Solar Roof evolution between 2023-2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 469,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "\nBetween 2023 and 2024 NextEra moved from the single pledge disclosed in the 2023 filing—a September 1 2022 agreement with The Bank of New York Mellon (and Deutsche Bank Trust Company Americas acting as collateral/custodial agent)—to two new pledges executed in 2024: a June 1 2024 pledge and an October 1 2024 pledge. Both 2024 agreements list The Bank of New York Mellon as the purchase‑contract counterparty and again involve Deutsche Bank Trust Company Americas as the collateral, custodial and securities‑intermediary agent, showing a deliberate expansion of the pledge structure and the use of multiple trust‑related counterparties within a short timeframe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. All key facts are correct: (1) The 2023 filing disclosed a single Pledge Agreement dated September 1, 2022 - correctly identified. (2) The counterparties are accurately named: Deutsche Bank Trust Company Americas and The Bank of New York Mellon - both correctly identified in both years. (3) The 2024 evolution is accurately captured: two new agreements dated June 1, 2024 and October 1, 2024 - all dates correct. (4) The quantitative progression (1 agreement in 2023 vs. 2 new agreements in 2024) is accurately represented. The LLM answer goes slightly beyond the ground truth by providing additional contextual detail about the roles of the counterparties (Deutsche Bank as 'collateral, custodial and securities-intermediary agent' and Bank of New York Mellon as 'purchase-contract counterparty'), which adds helpful clarification without introducing inaccuracy. The multi-hop reasoning is sound: the answer correctly synthesizes information across the two years and identifies the evolution pattern. The semantic meaning aligns perfectly with the ground truth - both convey that NextEra expanded its pledge agreement structure from one 2022 agreement to two new 2024 agreements with the same core counterparties. Minor point: The LLM's additional descriptive detail about agent roles, while not explicitly in the ground truth statement, appears to be accurate elaboration rather than error. No calculation errors, no date errors, no entity misidentifications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 420,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "\nFrom 2023 to 2024 Intel shifted its Edge‑AI focus from a primarily hardware‑centric offering to a full‑stack, edge‑native software platform—introducing modular building blocks, the OpenVINO 2023.1 toolkit and the AI‑PC‑oriented Core Ultra processors—while expanding its ecosystem collaborations with telecom (Ericsson, Nokia), cloud (Amazon, Google, Microsoft) and OEM partners (Dell, HPE, Lenovo) to deliver software‑defined, AI‑enabled edge solutions across networking, telecom and enterprise verticals.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the shift from hardware-centric to software-platform focus, mentions modular building blocks, and identifies ecosystem partnerships across telecom, cloud, and OEM sectors. The answer appropriately addresses both 2023 and 2024 positioning and captures the evolution theme. CRITICAL ERRORS: (1) The LLM introduces 'OpenVINO 2023.1 toolkit' and 'Core Ultra processors' which are NOT mentioned in the ground truth answer. These appear to be factually accurate Intel products but are NOT part of the original answer's knowledge graph, representing potential hallucination or external knowledge injection. (2) The LLM fails to mention the NEX initiative, which is explicitly highlighted in the ground truth as a key 2024 strategic evolution. (3) The LLM omits the ground truth's emphasis on 'cloud-native software on programmable hardware' and the transformation from 'fixed-function hardware to general-purpose compute.' (4) The LLM doesn't capture the ground truth's emphasis on 'avoiding vendor lock-in' or the 'horizontal approach to scaling infrastructure.' MULTI-HOP REASONING: The LLM successfully synthesizes information across years and identifies partnership categories, but fails to capture the deeper strategic shift toward cloud-native programmability and the NEX framework that defines 2024 positioning. The answer is partially correct but incomplete and introduces unverified product references not in the ground truth. The core evolution narrative is present but lacks the strategic depth and specific initiatives mentioned in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 440,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "\nBetween the 2023 and 2024 filings the $1.25 billion of 1.75 % senior notes maturing in August 2030 remained on the balance sheet (the same $1.25 bn figure appears in both years), but its share of the overall long‑term debt fell slightly as the company increased total long‑term borrowings from about $58.6 bn to $60.5 bn and added newer, higher‑coupon issues (e.g., 5.4 %‑6.0 % notes due 2029‑2054). No redemption or issuance of the 2030‑maturing 1.75 % notes was reported; the evolution reflects a broader shift toward a larger, more diversified long‑term debt profile with newer senior notes while the 1.75 % 2030 tranche stayed constant in amount.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the core facts but includes some issues: (1) CORRECT ELEMENTS: The 1.75% senior notes due August 2030 remained at $1.25 billion ($1,250 million) in both 2023 and 2024 - this is accurate and properly formatted. The LLM correctly identifies no redemption or issuance of these specific notes. (2) QUANTITATIVE ACCURACY: The $1.25 billion figure is correct. The LLM provides additional context about total long-term debt increasing from ~$58.6bn to ~$60.5bn, which adds useful perspective but goes beyond the ground truth answer. The mention of newer coupon rates (5.4%-6.0%) is contextually relevant but not verified against the ground truth. (3) ISSUES WITH GROUND TRUTH COMPARISON: The ground truth mentions 3.75% senior notes due April 2030 at $1,500 million (unchanged 2023-2024), but the LLM does not address this other 2030 maturity tranche. The ground truth explicitly states 'other senior notes due in 2030' remained stable, which the LLM's answer doesn't directly acknowledge. (4) MULTI-HOP REASONING: The LLM successfully synthesizes that the 1.75% notes stayed constant while the overall debt portfolio expanded and diversified - this is sound reasoning. However, it doesn't explicitly compare the 1.75% notes to other 2030 maturities as the ground truth does. (5) SEMANTIC EQUIVALENCE: The LLM's statement that the notes 'remained on the balance sheet' and 'stayed constant in amount' is semantically equivalent to the ground truth's 'value remained unchanged.' The broader context about debt portfolio evolution is helpful but slightly beyond the specific question scope. The answer is substantially correct on the primary metric (1.75% notes stability) but incompletely addresses the full composition question regarding all 2030 maturities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 489,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix moved its ad‑supported tier from a experimental, low‑price add‑on to a central element of its pricing architecture. The company fine‑tuned the plan’s price and ad‑load and promoted it alongside content releases and the seasonal fourth‑quarter growth window, using the tier to attract price‑sensitive households and accelerate overall membership growth while still meeting its operating‑margin targets.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on core concepts and accurately captures the evolution of Netflix's ad-supported plan from 2023 to 2024. STRENGTHS: (1) Correctly identifies the shift from experimental/low-price offering to central pricing strategy element; (2) Accurately characterizes the plan's role in attracting price-sensitive households and supporting membership growth; (3) Properly synthesizes the multi-hop concept of how the plan evolved within Netflix's broader strategic framework; (4) No quantitative errors or incorrect dates/numbers; (5) Semantic equivalence is strong - 'experimental, low-price add-on' matches 'new, lower-priced option aimed at expanding membership base'; 'central element of pricing architecture' matches 'core component of pricing strategy.' MINOR WEAKNESSES: (1) The LLM answer introduces specific operational details ('fine-tuned the plan's price and ad-load,' 'promoted it alongside content releases,' 'seasonal fourth-quarter growth window,' 'operating-margin targets') that are not explicitly mentioned in the ground truth. While these details are plausible and contextually relevant to Netflix's business operations, they represent inferences beyond what the ground truth explicitly states; (2) The ground truth emphasizes the plan's role in 'addressing competitive pressures' and 'improving value perception,' which the LLM answer does not explicitly mention, though it does reference attracting price-sensitive households which is semantically related; (3) The ground truth's framing of 'shift from experimental pricing to strategic offering' is captured but with slightly different emphasis on operational mechanics rather than strategic positioning. MULTI-HOP REASONING: The answer successfully synthesizes information about how the plan evolved across the two-year period and its relationship to membership growth objectives, demonstrating sound multi-hop reasoning. The connection between pricing strategy and membership growth is clearly established. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 561,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "\nBetween 2023 and 2024 Tesla moved the Semi from an early‑stage pilot effort toward a more concrete production roadmap.  The 2023 filing notes that Semi entered “early production and deliveries” in 2022, and the 2024 filing lists it under “Nevada – Tesla Semi – Pilot production,” while also tying its future ramp to the expansion of Gigafactory capacity, new battery‑cell manufacturing and the next‑generation vehicle platform.  Consequently, the company’s approach shifted from limited, experimental builds to a strategic focus on scaling Semi production alongside its broader capacity‑growth and cost‑reduction initiatives.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and understanding of Tesla's Semi evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the progression from 'early production and deliveries' in 2023 to 'pilot production' in 2024 at Nevada facility, matching the ground truth. (2) Accurately references the 2022 start of early production mentioned in 2023 filing, showing proper multi-hop synthesis across filing years. (3) Correctly identifies Nevada facility as the production location. (4) Appropriately contextualizes the shift as moving from 'limited, experimental builds' to 'scaling' phase, semantically equivalent to ground truth's 'initial rollout to more mature testing and scaling phase.' (5) Adds relevant strategic context about capacity expansion, battery manufacturing, and next-generation platform integration, which enriches the answer without contradicting ground truth. MINOR CONSIDERATIONS: (1) The LLM answer goes slightly beyond the ground truth by discussing broader strategic initiatives (capacity growth, cost reduction, next-gen platform), which while accurate and relevant, represents some expansion beyond the specific production status comparison requested. However, this actually strengthens the answer by providing strategic context. (2) The phrasing 'moved from early-stage pilot effort' could be slightly clearer - the 2023 status was 'early production' not 'pilot,' though the LLM correctly identifies 2024 as 'pilot production,' so this is a minor wording nuance. QUANTITATIVE ACCURACY: All dates (2023, 2024, 2022) and facility names (Nevada, Gigafactory) are correct. No calculations required. QUALITATIVE ACCURACY: Multi-hop reasoning is sound - correctly synthesizes information across 2023 and 2024 filings to show progression. Entity identification (Tesla, Tesla Semi, Nevada facility) is accurate. CONTEXTUAL RELEVANCE: Directly addresses the question about evolution of approach, production status, and strategic positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 533,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "\nThe 2024 filing adds several new Executive Retention Employment Agreements—most notably the agreements with Nicole J. Daggs (effective January 1 2024) and Brian W. Bolster (dated May 6 2024)—and extends the practice of formal retention contracts that began in 2023.  This expansion shows that NextEra is deliberately locking in its senior leadership team, underscoring a strategic focus on leadership continuity and the preservation of institutional knowledge as the company advances its long‑term growth agenda.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with significant factual discrepancies. CORRECT ELEMENTS: (1) The answer correctly identifies that NextEra expanded Executive Retention Employment Agreements from 2023 to 2024; (2) Brian W. Bolster's agreement dated May 6, 2024 is correctly cited; (3) The qualitative interpretation about leadership continuity and talent retention strategy is sound and aligns with the ground truth's reasoning. FACTUAL ERRORS: (1) The LLM introduces Nicole J. Daggs (effective January 1, 2024) as a new 2024 agreement, but the ground truth does not mention this executive at all in either 2023 or 2024; (2) The LLM omits Mark Lemasney and Armando Pimentel, Jr., who were explicitly mentioned in the ground truth as having agreements in 2023 (January 1, 2023 and February 15, 2023 respectively); (3) By failing to mention the 2023 executives, the LLM misrepresents the continuity aspect—the ground truth emphasizes that agreements from 2023 were MAINTAINED while new ones were added, showing true expansion. MULTI-HOP REASONING: The LLM correctly synthesizes the concept that expansion indicates strategic emphasis on leadership continuity, but the incomplete executive roster undermines the strength of this conclusion. The answer captures the spirit of the ground truth's interpretation about proactive talent management and institutional knowledge preservation, but the missing 2023 executives and the unexplained introduction of Nicole J. Daggs represent material factual errors that affect the accuracy of the multi-hop analysis. QUANTITATIVE ACCURACY: The dates provided (January 1, 2024 for Daggs; May 6, 2024 for Bolster) are partially correct for Bolster but Nicole J. Daggs is not verified in the ground truth, creating uncertainty about data accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 487,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "\nFrom 2023 to 2024 Intel moved from defining the breadth of its xPU portfolio (client‑ and data‑center GPUs, IPUs, FPGAs) and establishing an open‑software (oneAPI) ecosystem while still relying mainly on its own fabs and selective external foundries, to a more execution‑focused strategy that prioritises AI‑centric xPU products, a unified oneAPI developer stack, and a concrete roadmap of new process nodes and advanced‑packaging designs.  The 2024 approach explicitly targets AI‑PC and edge‑AI workloads, accelerates product‑performance and power‑efficiency improvements, and leverages the IDM 2.0 foundry expansion to offer external customers dedicated xPU capacity.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies key elements of Intel's xPU evolution including the product portfolio (client/data-center GPUs, IPUs, FPGAs), the oneAPI ecosystem, and the shift toward AI-centric products. It accurately captures the 2024 strategic emphasis on AI-PC and edge-AI workloads, and mentions IDM 2.0 foundry expansion. The answer demonstrates understanding of the multi-hop synthesis required (comparing 2023 vs 2024 approaches).\n\nWEAKNESSES: (1) The LLM answer omits the specific R&D spending figure ($16.0 billion in 2023) mentioned in the ground truth, which is a quantifiable metric that should have been included. (2) The ground truth explicitly mentions Intel's creation of 'an advisory group to expand the x86 ecosystem' - the LLM answer does not reference this specific strategic initiative. (3) The ground truth emphasizes the shift from 'general R&D focus to a more structured and strategic product development initiative' - while the LLM captures some of this evolution, it frames it differently (as 'execution-focused' rather than 'more structured and strategic'). (4) The ground truth mentions Intel faced 'challenges in timely product development and manufacturing process introductions' in 2023 - the LLM does not acknowledge this context. (5) The LLM introduces concepts like 'IDM 2.0 foundry expansion' and 'dedicated xPU capacity' that, while potentially accurate, are not explicitly mentioned in the ground truth provided.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes the 2023-to-2024 evolution and identifies the strategic shift. However, it adds details not in the ground truth (IDM 2.0, dedicated capacity) while omitting others (advisory group, R&D spending, manufacturing challenges).\n\nQUANTITATIVE ACCURACY: No major calculation errors, but the omission of the $16.0 billion R&D figure is a notable gap in quantitative data.\n\nQUALITATIVE ACCURACY: The reasoning about the evolution is sound, but the characterization differs somewhat from ground truth (execution-focused vs. structured/strategic), and key strategic initiatives are missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 566,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "\nBetween 2023 and 2024 Netflix moved from a “new‑risk” description of its ad‑supported offering to a concrete organizational push: it built a dedicated advertising‑sales and advertising‑technology team and began investing in proprietary ad‑serving, measurement and analytics infrastructure (including CDN and cloud resources) to support programmatic ad delivery.  The company also deepened its partner ecosystem and cloud‑based processing capabilities, signaling that infrastructure spend and internal talent expansion are now core to its ad‑tech strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Netflix's advertising technology evolution from 2023 to 2024. Key strengths: (1) Correctly identifies the shift from external reliance to internal development - the ground truth emphasizes moving from 'limited experience' and 'dependencies on third-party service providers' to 'develop and expand an advertising sales and advertising technology organization team,' which the LLM captures as moving from 'new-risk description' to 'concrete organizational push' with 'dedicated advertising-sales and advertising-technology team.' (2) Accurately reflects the infrastructure investment theme - both sources emphasize development of technology and infrastructure, with the LLM adding specific details about 'proprietary ad-serving, measurement and analytics infrastructure (including CDN and cloud resources)' and 'cloud-based processing capabilities.' (3) No quantitative errors - no specific numbers, dates, or percentages were provided in either answer, so quantitative accuracy is perfect by default. (4) Multi-hop reasoning is sound - the answer correctly synthesizes the temporal evolution across two years and connects organizational development with infrastructure investment. Minor considerations: (1) The LLM answer introduces some specific technical details (CDN, cloud resources, programmatic ad delivery, partner ecosystem deepening) that go slightly beyond what the ground truth explicitly states, though these are reasonable inferences consistent with the stated direction. (2) The phrase 'new-risk description' is the LLM's interpretation of the ground truth's 'limited experience' and 'outlined several dependencies' - this is a reasonable characterization but slightly more interpretive than the ground truth's more direct language. (3) The ground truth emphasizes the shift from 'reliance on external providers' more explicitly, while the LLM frames it as moving from 'new-risk' to 'concrete organizational push,' which is semantically equivalent but slightly different framing. Overall, the answer captures the essential evolution accurately and provides appropriate context about the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 591,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "\nTesla continues to treat free Supercharging as a distinct performance obligation that is amortized over the vehicle’s expected ownership life on a straight‑line basis, with any limited, usage‑based Supercharging incentives recognized when the usage occurs or the incentive expires.  The 2024 filing adds explicit disclosure of a deferred‑revenue balance for these services (≈ $3.6 bn as of 12/31/24) and shows $872 m of revenue recognized in 2024 versus $469 m in 2023, indicating that a larger share of the allocated transaction price is now being recognized over time rather than up‑front.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM provides specific dollar amounts ($3.6bn deferred revenue, $872m in 2024 revenue, $469m in 2023 revenue) that cannot be verified against the ground truth and appear to conflate different metrics or potentially confuse free Supercharging with broader deferred revenue categories. The ground truth does not provide these specific numbers for free Supercharging alone. (2) CONCEPTUAL MISALIGNMENT: The LLM describes free Supercharging as 'a distinct performance obligation that is amortized over the vehicle's expected ownership life on a straight-line basis' - this characterization is not supported by the ground truth. The ground truth states that in 2023, free Supercharging was 'bundled with vehicle sales' under Automotive Sales Revenue, and by 2024 it was deferred and 'recognized as liabilities to be amortized over time' - but does not specify the amortization method as straight-line over vehicle ownership life. (3) INCOMPLETE EVOLUTION NARRATIVE: The LLM fails to capture the key structural shift described in the ground truth - the transition from bundling free Supercharging with vehicle sales (2023) to treating it as a separate deferred revenue item (2024). Instead, the LLM presents free Supercharging as already being treated as a distinct performance obligation in both years, missing the evolution. (4) MISSING CONTEXT: The ground truth emphasizes that the 2024 change reflects 'a more formalized and segmented approach to monetizing these features' alongside FSD and connectivity - the LLM does not adequately convey this broader strategic shift. (5) UNVERIFIED SPECIFICITY: The LLM provides precise figures that go beyond what can be confirmed from the ground truth, suggesting potential hallucination or confusion with other revenue categories. The answer demonstrates partial understanding of deferred revenue concepts but fails to accurately represent the documented evolution between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 553,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "\nBetween 2023 and 2024 NextEra’s Series O Junior Subordinated Debentures shifted from a longer‑dated, fixed‑rate tranche (the 2022‑2023 issuance that matures on Nov 1 2029) to a newer, floating‑rate tranche that matures much earlier—on Jan 29 2026 (the “Floating Rate Debentures, Series due January 29 2026” disclosed in the 2023‑2024 filing).  The newer issue carries a variable coupon rather than the earlier fixed rate, indicating that the company is deliberately shortening the maturity and diversifying the coupon profile of its subordinated debt to reduce interest‑rate risk and lower overall financing costs while retaining flexibility to refinance as market conditions evolve.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) CRITICAL DATE ERROR: The LLM claims the 2023-2024 issuance matures on January 29, 2026, but the ground truth states it matures on November 1, 2029. This is a 3+ year discrepancy in maturity date. (2) COUPON STRUCTURE ERROR: The LLM describes the newer tranche as 'floating-rate' with 'variable coupon,' but the ground truth explicitly states the 2024 Series O Debentures have a defined coupon rate of 5.55% (fixed rate, not floating). This is a fundamental mischaracterization of the debt instrument. (3) DIRECTIONAL ERROR ON MATURITY: The LLM claims the company is 'shortening the maturity' from 2029 to 2026, but this contradicts the ground truth which shows the 2023 issuance had a much longer maturity (May 1, 2079) compared to the 2024 issuance (November 1, 2029). The LLM appears to have confused different tranches or misread the filing data. (4) MISSING KEY INFORMATION: The LLM fails to mention the 5.55% coupon rate that is central to understanding the 2024 issuance. (5) INCORRECT STRATEGIC INTERPRETATION: While the LLM's reasoning about risk management and refinancing flexibility has some merit, it is based on incorrect premises (floating rate vs. fixed rate, wrong maturity dates). The ground truth indicates a shift from very long-dated (2079) to medium-term (2029) instruments with clearly defined interest costs, not a shift to floating-rate debt. The answer demonstrates a fundamental failure to accurately extract and synthesize the key financial data from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 437,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "\nFrom 2022 to 2023 ExxonMobil shifted OPEC investment activities from a general supply‑side comment to a concrete element of its impairment modeling. In the 2023 framework the company explicitly embeds OPEC production‑policy and investment expectations into the long‑term price and volume assumptions used to project undiscounted cash flows for asset‑group recoverability and fair‑value testing, whereas in 2022 those factors were only discussed in the broader outlook.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the direction and nature of the evolution. Ground truth states that ExxonMobil shifted FROM a direct focus on OPEC TO a more integrated view with broader macroeconomic and environmental factors. The LLM claims the opposite - that OPEC shifted FROM general discussion TO concrete/explicit embedding in modeling. This is a critical factual error that reverses the actual evolution described in the original answer. The LLM also mischaracterizes 2022 as having only 'broader outlook' discussion, when ground truth indicates OPEC was explicitly stated as having impact on impairment assessments in 2022. The LLM's claim that 2023 shows 'explicit embedding' of OPEC into price/volume assumptions contradicts the ground truth assertion that OPEC discussion became 'embedded more broadly' within a comprehensive framework that included other factors like GHG costs and net-zero targets. The LLM appears to have inverted the relationship: the actual evolution was toward LESS direct OPEC focus (more integrated), not toward MORE direct OPEC focus. While there are no quantitative errors (dates and company name are correct), the qualitative reasoning about the nature of the shift is fundamentally incorrect, making this answer misleading despite accurate entity identification.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 372,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "\nFrom 2023 to 2024 the company’s treatment of the ad‑supported tier shifted from a peripheral, experimental footnote to a clearly articulated strategic pillar.  \n- In the 2023 filing (pages 16‑20) the ad‑supported plan is only referenced in the risk‑factor discussion of forecasting “member viewing patterns … such as the ad‑supported subscription plan,” indicating it was still a nascent, loosely defined offering.  \n- In the 2024 filing (pages 1‑5) the plan is explicitly listed among the “range of pricing plans” the company intends to offer to meet consumer needs and is framed as part of its core growth and margin‑target strategy, with additional commentary on the forecasting challenges it creates.  \n\nThus, Netflix moved from a tentative, risk‑focused mention to a deliberate, strategically emphasized component of its pricing architecture.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative: Netflix's ad-supported plan evolved from a risk-focused, uncertain positioning in 2023 to a confident, strategic component in 2024. STRENGTHS: (1) The semantic equivalence is excellent - 'peripheral, experimental footnote' accurately captures the 'uncertainty and risk' framing of 2023, while 'clearly articulated strategic pillar' and 'deliberate, strategically emphasized component' correctly convey the 2024 shift to 'core part of Netflix's business model.' (2) The multi-hop reasoning is sound: the answer correctly synthesizes the evolution across two filing years and identifies the key distinction between risk-factor discussion (2023) versus strategic positioning (2024). (3) Entity accuracy is correct: Netflix, 2023/2024 filings, ad-supported plan, pricing strategy all properly identified. (4) The specific page references (2023: pages 16-20; 2024: pages 1-5) add credibility, though these cannot be independently verified from the ground truth provided. MINOR WEAKNESSES: (1) The LLM provides specific page numbers that are not mentioned in the ground truth, which introduces a small risk of inaccuracy if those page numbers are incorrect in the actual filings. However, this does not contradict the ground truth. (2) The answer could have been slightly more explicit about the 'lack of operating history' concern mentioned in the ground truth, though the phrase 'nascent, loosely defined offering' captures this concept adequately. (3) The phrase 'additional commentary on the forecasting challenges it creates' in the 2024 section is somewhat vague compared to the ground truth's explicit mention of 'discrepancies between forecasts and actual results,' though the meaning is semantically equivalent. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. The temporal references (2023 vs 2024) are correct. OVERALL ASSESSMENT: The answer successfully captures the essential evolution of Netflix's positioning and demonstrates solid multi-hop reasoning across the two filing years. The narrative arc is accurate and well-articulated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 597,
        "total_tokens": 1971
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "\nAmazon has kept “fast‑shipping” and Prime‑related delivery promises at the core of its low‑price strategy from 2022 through 2024, but the way it manages the associated costs has shifted.  In the 2022 filing the company highlighted that rising shipping and fulfillment expenses—driven by network expansion, higher wages, carrier rate hikes and labor‑market constraints—were a major cost‑of‑sales driver, and it said it would curb those costs by scaling volumes, optimizing the fulfillment network and negotiating better supplier terms.  By the 2024 filing the narrative stresses that shipping costs continue to climb as more customers accept fast‑shipping offers and the company uses more expensive delivery options, yet it now reports “fulfillment network efficiencies, including lower transportation costs,” and points to higher sales volumes and better operating efficiencies as the primary levers for offsetting those higher shipping outlays.  Thus, the strategic focus moved from simply expanding the network to extracting cost efficiencies from an already‑larger fulfillment system while still treating Prime‑related shipping benefits as a marketing tool rather than a marketing expense.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general strategic evolution from 2022 to 2024 regarding Amazon's shipping and fulfillment approach, demonstrating solid qualitative understanding of the shift from network expansion to efficiency focus. However, there are significant quantitative accuracy issues that lower the overall score.\n\nCORRECT ELEMENTS:\n- Correctly identifies the core strategic shift: from cost mitigation through network expansion/volume scaling (2022) to efficiency-driven cost offsets (2024)\n- Accurately captures that shipping costs were driven by network expansion, wage pressures, and carrier rate increases in 2022\n- Correctly notes the 2024 emphasis on fulfillment network efficiencies and lower transportation costs\n- Properly synthesizes the multi-hop reasoning across both years\n- Appropriately contextualizes Prime/fast-shipping as a strategic marketing tool\n\nINCORRECT/MISSING ELEMENTS:\n1. QUANTITATIVE FAILURE: The ground truth provides a specific 2021 shipping cost figure ($76.7 billion), which the LLM completely omits. While the LLM wasn't required to cite this exact number, the absence of any quantitative anchoring is a weakness for a financial analysis question.\n2. INCOMPLETE DETAIL: The LLM mentions \"higher wages\" and \"labor-market constraints\" as 2022 cost drivers, but the ground truth emphasizes customer adoption of faster delivery methods and network expansion as primary drivers. The LLM's framing is somewhat different.\n3. CHARACTERIZATION ISSUE: The LLM states shipping costs \"continue to climb\" in 2024 due to customer adoption of fast-shipping, but the ground truth indicates the 2024 narrative emphasizes that efficiency gains \"partially offset\" these increases—a more nuanced position than the LLM conveys.\n4. MISSING CONTEXT: The ground truth explicitly notes this represents a shift from \"customer-driven cost increase\" to \"operations-centric efficiency focus,\" which the LLM approximates but doesn't state as clearly.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and correctly identifies the strategic evolution. The reasoning is sound and logically structured.\n\nSEMANTIC EQUIVALENCE: While wording differs, the core message aligns with ground truth on the strategic shift, though with less precision on the specific cost drivers and their relative importance.\n\nThe score reflects correct strategic understanding but penalizes the lack of quantitative specificity and some characterization differences from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1534,
        "completion_tokens": 676,
        "total_tokens": 2210
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "\nBetween 2023 and 2024 Duke Energy reshaped the Master Retirement Trust’s investment mix and reporting detail.  The 2024 target allocation moved to a higher‑risk “return‑seeking” tilt for the RCBP (≈ 65 % return‑seeking vs ≈ 55 % in 2023) and a heavier “liability‑hedging” stance for the DELPP (≈ 80 % hedging vs ≈ 70 % previously), while actual holdings shifted toward more cash and real‑estate in the RCBP (10 % vs 8 %) and a modest rise in equity exposure for the DELPP (15 % vs 14 %).  Disclosures also became more granular—fair‑value measurements were broken out by Level 1‑3, a reconciliation of Level 3 balances was provided, and the discontinued securities‑lending activity was noted—giving a clearer picture of the Trust’s asset composition and risk management.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. CRITICAL ISSUES: (1) The ground truth makes NO mention of RCBP or DELPP plans, their target allocations, or the specific percentages cited (65% vs 55% return-seeking, 80% vs 70% hedging). These appear to be fabricated details. (2) The ground truth does NOT reference the specific asset allocation percentages for cash (10% vs 8%) or equity (15% vs 14%) that the LLM claims. (3) The ground truth mentions Duke Energy Progress at 15% and Duke Energy Florida at 18% as subsidiary allocations, which the LLM completely omits. (4) While the LLM correctly identifies that 2024 introduced Level 1-3 fair value breakdowns and Level 3 reconciliations (matching ground truth), it adds unsupported claims about 'discontinued securities-lending activity' not mentioned in the original answer. (5) The LLM's framing around 'return-seeking' vs 'liability-hedging' stances is not present in the ground truth, which focuses on investment objectives and subsidiary allocations. The answer demonstrates partial understanding of the disclosure evolution (fair value levels, reconciliations) but fundamentally misrepresents the actual changes by inventing specific plan names and percentages. The multi-hop reasoning fails because it synthesizes information that doesn't exist in the source material rather than accurately combining the actual subsidiary allocation details and disclosure enhancements mentioned in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 420,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "\nBetween 2022 and 2024 the amount Google pays to its Google Network Partners under the Traffic‑Acquisition‑Cost (TAC) program rose both in absolute dollars and as a larger share of total advertising revenue, as the proportion of ad impressions served on third‑party sites expanded. As a result, cost of revenues attributable to Network partners now represents a markedly higher percentage of those revenues than for Search‑originated ads, making TAC a more substantial and increasingly fixed component of Google’s overall cost structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. CRITICAL ISSUES: (1) The LLM claims TAC payments 'rose both in absolute dollars and as a larger share of total advertising revenue' between 2022-2024, but provides NO SPECIFIC NUMBERS, PERCENTAGES, or DOLLAR AMOUNTS to support this claim. The ground truth does not confirm this quantitative assertion. (2) The LLM states TAC 'now represents a markedly higher percentage' but fails to provide the actual percentages or comparative data from 2022 vs 2024. (3) The LLM characterizes TAC as 'increasingly fixed component' - this is not supported by the ground truth, which describes a shift from cost-of-revenue model to operational cash flow obligations, not a characterization of TAC as 'fixed.' (4) The LLM misses the KEY INSIGHT from the ground truth: the fundamental shift in how Google reports/treats these payments - from 'cost of revenues' in 2022 to 'operating cash outflows' in 2024. This structural change is central to understanding the evolution of the relationship. (5) The LLM's focus on 'proportion of ad impressions served on third-party sites' is not explicitly mentioned in the ground truth. WHAT WAS CORRECT: The LLM correctly identifies TAC as the mechanism for payments to Network partners and acknowledges that these payments represent a significant cost component. The general direction (increasing importance) aligns with ground truth. MISSING ELEMENTS: No specific financial figures, no mention of the cost-of-revenue vs. operating cash flow distinction, no quantitative comparison between 2022 and 2024. The answer reads as plausible but lacks the factual grounding required for a financial analysis question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 473,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "\nBetween 2022 and 2023 the company substantially reduced its offsetting‑swap exposure: the net “right‑of‑offset” amounts in the balance‑sheet schedule fell from $398 million (assets) and $5 million (liabilities) in 2022 to $92 million and $26 million in 2023, indicating that many of the foreign‑currency and interest‑rate swaps were either terminated or netted‑off. Consequently, the fair‑value adjustments that were re‑classified from AOCI to the income statement declined – revenue reclassifications dropped from $304 million to $213 million, the interest‑expense reclassification stayed near $10 million, and the non‑designated foreign‑currency forward losses in earnings shrank from $69 million to $7 million – so the settlements and fair‑value changes reported in consolidated income were markedly smaller in 2023. (Pages 136‑140 of UPS 2022 10‑K and pages 130‑134 of UPS 2023 10‑K).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer provides specific numerical claims that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ACCURACY FAILURE: The LLM cites specific balance-sheet figures ($398M assets, $5M liabilities in 2022; $92M and $26M in 2023), revenue reclassifications ($304M to $213M), interest-expense reclassifications (~$10M), and foreign-currency forward losses ($69M to $7M). The ground truth does not provide these specific numbers and explicitly states 'the financial impact in 2023 was not quantified in the excerpt.' The LLM appears to have hallucinated precise figures. (2) PAGE CITATIONS: The LLM cites specific pages (136-140 of 2022 10-K, 130-134 of 2023 10-K) which cannot be verified and may be incorrect. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize information about offsetting swaps, fair value changes, and settlements across years, the reasoning is built on unverified numerical claims. (4) SEMANTIC MISMATCH: The ground truth emphasizes a 'shift in focus to more recent periods' and notes that 'the financial impact in 2023 was not quantified,' whereas the LLM provides detailed quantification of 2023 impacts. (5) ENTITY ACCURACY: The company (UPS) is correctly identified, and the years (2022-2023) are correct, but the specific financial metrics and their values are not supported by the ground truth. The answer demonstrates confident but unsupported specificity, which is a critical failure in financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 414,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "\nThe 2024 filing gives the Directors’ Savings Plan its own detailed subsections (e.g., 10.12 and 10.46), describing the plan’s matching contributions, investment options and a 2021 amendment, whereas the 2023 filing only mentioned it in passing. This heightened focus shows that Duke Energy is deliberately foregrounding the plan as a central element of its director‑compensation strategy—using a deferred, match‑based benefit to align directors’ interests with shareholders and to provide greater compensation flexibility compared with the prior year.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general theme of increased prominence of the Directors' Savings Plan in 2024 versus 2023, which aligns with the ground truth. However, there are significant factual inaccuracies that undermine the response: (1) The LLM claims the 2024 filing has 'detailed subsections (e.g., 10.12 and 10.46)' - the ground truth indicates Exhibit 10.12 was referenced in 2023 as a historical amendment, not a new 2024 subsection. The reference to 10.46 appears unsupported by the ground truth. (2) The LLM introduces 'matching contributions' as a key feature, but the ground truth specifically describes the plan as allowing directors to 'defer annual compensation' with 'phantom investment options' - no mention of matching contributions appears in the ground truth. This is a material factual error about the plan's structure. (3) The LLM mentions 'a 2021 amendment' without clear grounding in the provided ground truth. (4) The core insight about increased transparency and strategic emphasis is correct and well-articulated, but the specific mechanisms described (matching contributions, exhibit numbers) contain errors. The reasoning about alignment with shareholders and compensation flexibility is sound and relevant, but the factual basis is compromised. The answer demonstrates partial understanding but fails on quantitative/structural accuracy regarding the plan's actual features.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 389,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "\nBetween 2022 and 2024 American Express moved its value‑proposition focus from broad‑based rewards and cobrand partnerships toward a more digitally driven, data‑rich model that emphasizes personalized, premium experiences across travel, dining and commercial payments.  The company deepened investments in mobile and online payment features, AI‑enabled offers and the expanded Tock/Rooam dining platform, while also renegotiating higher‑cost cobrand deals and highlighting differentiated merchant‑acceptance benefits to offset intensified competition from Visa, Mastercard and emerging fintech rivals and to meet shifting consumer expectations for seamless digital and travel‑related services.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of key strategic elements and time period (2022-2024). Strengths: (1) Correctly identifies the shift from reactive to proactive strategy; (2) Accurately mentions specific initiatives (Tock/Rooam dining platform, AI investments, mobile/online payments); (3) Properly identifies competitive pressures from Visa, Mastercard, and fintech; (4) Correctly notes focus on premium experiences and personalization; (5) No quantitative errors or incorrect dates. Weaknesses: (1) The phrase 'renegotiating higher-cost cobrand deals' is somewhat vague and not explicitly supported in the ground truth, which mentions 'rising Card Member rewards costs' but doesn't specifically reference cobrand deal renegotiations as a strategic response; (2) Missing some contextual details from ground truth: doesn't explicitly mention targeting Millennial and Gen-Z consumers as a specific strategic focus; (3) Doesn't emphasize 'global merchant coverage growth' as explicitly as the ground truth; (4) The characterization of the shift as moving 'from broad-based rewards and cobrand partnerships' is slightly imprecise—the ground truth frames it more as evolving value propositions to address competition rather than abandoning a previous model. The answer captures the essence of the evolution and demonstrates sound multi-hop reasoning by synthesizing 2022 challenges with 2024 strategic responses, but lacks some of the specific strategic targeting details (Millennial/Gen-Z focus) and nuance present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 433,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "\nBetween 2022 and 2024 Exxon Mobil trimmed the short‑dated piece of its long‑term debt stack – the 0.142 % Notes that were scheduled to mature in 2024 – and now relies exclusively on three longer‑dated series (0.524 % due 2028, 0.835 % due 2032 and 1.408 % due 2039).  The 2024 filing no longer lists the 2024 note, indicating that the 2022‑era “short‑term” tranche was retired (or refinanced) and the company’s long‑term financing profile has shifted toward a higher‑percentage of fixed‑rate debt with maturities extending out to 2039, supporting its larger capital‑intensive projects and acquisitions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All specific debt instruments and their interest rates are correctly identified - 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and 1.408% Notes due 2039. The years (2022, 2024) and maturity dates are all accurate. ENTITY ACCURACY: Exxon Mobil is correctly identified, and the time period (2022-2024) is properly framed. MULTI-HOP REASONING: The answer correctly synthesizes the evolution by identifying that the 0.142% Notes due 2024 were removed from the 2024 filing (indicating maturation/repayment), while the longer-dated instruments remained. The logical inference that this represents a strategic shift toward extended-term debt is sound and matches the ground truth interpretation. COMPLETENESS: The answer addresses all aspects of the question - the composition change, the specific notes involved, the timeline, and the strategic implications. SEMANTIC EQUIVALENCE: The LLM's phrasing 'trimmed the short-dated piece' and 'retired (or refinanced)' conveys the same meaning as the ground truth's 'matured or been repaid.' The characterization of the shift toward 'higher-percentage of fixed-rate debt with maturities extending out to 2039' aligns with the ground truth's 'focusing more heavily on extended-term debt.' MINOR CONSIDERATIONS: The LLM adds contextual interpretation about 'capital-intensive projects and acquisitions' which, while reasonable inference, goes slightly beyond what the ground truth explicitly states. However, this addition is not contradictory and represents reasonable financial analysis. The answer is well-structured, clear, and demonstrates accurate synthesis of multi-year filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 482,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "\nBetween 2022 and 2024 American Express moved its corporate‑card strategy from a consumer‑centric, spend‑driven model to a dedicated commercial‑payments agenda that positions the card as part of a broader, differentiated suite of business‑focused solutions.  The company now emphasizes expanded product capabilities—such as integrated expense‑management, financing, banking‑like services, and advanced digital tools—leveraging its global network, OptBlue merchant‑acquiring program and strategic partnerships (e.g., Delta cobrand) to deliver higher‑spending, high‑value experiences and embed financial services directly into corporate workflows.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer introduces several claims not supported by the ground truth and mischaracterizes American Express's strategic evolution. SPECIFIC PROBLEMS: (1) The LLM claims the 2022 strategy was 'consumer-centric, spend-driven' - the ground truth makes no such characterization and actually describes 2022 as focused on 'evolving card value propositions' and 'differentiating corporate card and accounts payable expense management solutions,' which is B2B-focused, not consumer-centric. This is a fundamental misrepresentation. (2) The LLM mentions 'OptBlue merchant-acquiring program' and 'Delta cobrand' as 2024 strategic elements - these are not mentioned in the ground truth and appear to be hallucinated details not verified in the source material. (3) The LLM describes the shift as moving TO 'commercial-payments agenda' but the ground truth shows commercial payments was ALREADY the focus in 2022; the actual evolution was from 'internal product development focus' to 'externally integrated ecosystem strategy.' (4) The LLM's characterization of 'financing, banking-like services' is not explicitly mentioned in the ground truth. WHAT WAS CORRECT: The LLM correctly identifies the 2022-2024 timeframe and that American Express did evolve its corporate card strategy. The general notion of moving toward integrated solutions has some alignment with the ground truth's 'integrated global network approach.' MULTI-HOP REASONING: The LLM failed to properly synthesize the actual evolution described in the ground truth - the shift from internal focus to external ecosystem integration. Instead, it created a narrative about consumer-to-commercial transition that contradicts the source material. The answer reads as plausible but is factually inaccurate in key respects.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 491,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "\nBetween 2022 and 2024 AWS’s revenue accelerated sharply—net sales rose from roughly **$90.8 billion in 2023 to $107.6 billion in 2024**, a **19 % year‑over‑year increase**, and its share of total net sales grew from **16 % to 17 %**.  This expansion drove a jump in operating cash flow to **$115.9 billion in 2024** and prompted a surge in capital spending to **$77.7 billion**, the bulk of which is earmarked for expanding AWS infrastructure, signalling that AWS has become the primary engine of Amazon’s cash‑generation and a central strategic focus for future growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant information about AWS's evolution and strategic importance, but contains significant quantitative errors that undermine accuracy. CORRECT ELEMENTS: (1) The $115.9 billion operating cash flow figure for 2024 is accurate and matches ground truth. (2) The characterization of AWS as a 'primary engine of cash-generation' and 'central strategic focus' aligns with the ground truth's shift from risk-laden venture to core revenue generator. (3) The overall narrative about AWS's growing strategic importance is sound. CRITICAL ERRORS: (1) The LLM claims AWS net sales were '$90.8 billion in 2023 to $107.6 billion in 2024' - these numbers cannot be verified against the ground truth provided, which does not specify AWS-specific revenue figures for these years. (2) The 19% YoY increase calculation appears to be based on unverified numbers ($107.6B vs $90.8B = 18.6%, close to stated 19%, but the base figures themselves are questionable). (3) The LLM states AWS share grew from '16% to 17%' - this is presented without source verification. (4) The $77.7 billion capital spending figure is not mentioned in the ground truth and cannot be verified. MULTI-HOP REASONING: The LLM successfully synthesizes the concept that AWS evolved from a risk discussion point (2022) to a cash flow driver (2024), matching the ground truth's core narrative. However, the answer introduces specific AWS revenue numbers not present in the ground truth, which suggests either hallucination or reliance on external data not validated against the provided knowledge graph. The answer addresses the question comprehensively but with unverified quantitative claims that significantly reduce reliability. The qualitative assessment of AWS's strategic shift is sound, but the specific financial metrics lack grounding in the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 501,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "\nBetween 2023 and 2024 the audit’s trend‑analysis procedures moved from a basic consistency check of prior‑year regulatory‑asset balances to a more robust, multi‑dimensional assessment. In 2023 the focus was simply to test whether the recorded balances showed a historically stable pattern, whereas in 2024 the auditors paired trend analysis with independent expectation‑building, evaluated recent commission orders and specific cost categories (e.g., storm and coal‑ash costs), and used the trend results to corroborate management’s recoverability assertions. This expanded scope allowed the 2024 audit to place greater reliance on trend insights while also cross‑checking them against newer regulatory developments and independent benchmarking.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ISSUES: (1) The ground truth explicitly states that in 2023, trend analyses were used 'without specific reference to asset retirement obligations,' and by 2024 the scope 'expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash.' The LLM answer reverses this evolution, claiming 2023 had 'basic consistency check' and 2024 added coal-ash evaluation - this is directionally correct but the LLM then adds unsupported details about 'independent expectation-building,' 'recent commission orders,' 'storm and coal-ash costs,' and 'independent benchmarking' that are NOT mentioned in the ground truth. (2) The LLM invents procedural details ('paired trend analysis with independent expectation-building,' 'cross-checking against newer regulatory developments') that have no basis in the provided ground truth. (3) The ground truth is clear and specific: the evolution was from general regulatory asset balance evaluation to specific focus on coal ash asset retirement obligations. The LLM embellishes this with invented audit procedures and methodologies. (4) While the LLM correctly identifies the years (2023 vs 2024) and the general direction of change, it fabricates specific audit procedures and analytical methods not supported by the source material. The answer reads as plausible audit language but is fundamentally inaccurate regarding what actually changed between the two years. QUANTITATIVE ACCURACY is high (8/10) because there are no specific numbers to verify and dates are correct. QUALITATIVE ACCURACY is very low (2/10) because the core factual claims about what procedures were added are unsupported and partially contradicted by the ground truth. CONTEXTUAL RELEVANCE is low (4/10) because while the answer addresses the question's structure, it does so with invented information rather than accurate synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 538,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "\nCostco moved from a defensive price‑adjustment stance in 2022—explicitly citing “increasing the penetration of our private‑label items” as a way to offset inflation‑driven cost pressures—into a more proactive growth lever in 2023, expanding private‑label SKUs and online availability to absorb further cost increases while preserving its low‑price perception. This evolution reflects a shift toward using private‑label penetration not just to protect margins but as a strategic driver of sales and margin improvement amid ongoing pricing pressures.  \n\n*Source: 2022 10‑K, p. 23 (MD&A); 2023 10‑K, p. 24 (MD&A).*",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Costco's private-label strategy evolution between 2022 and 2023. STRENGTHS: (1) Correctly identifies the shift from defensive/reactive approach in 2022 to more proactive/strategic approach in 2023, matching the ground truth's core narrative; (2) Accurately captures the key strategic elements: absorbing cost pressures, maintaining pricing authority, and using private-label penetration as a competitive tool; (3) Properly synthesizes multi-hop information across two fiscal years; (4) Appropriately cites source documents (2022 and 2023 10-Ks, MD&A sections); (5) Uses semantically equivalent language to ground truth (e.g., 'defensive price-adjustment stance' = 'reactive approach'; 'proactive growth lever' = 'strategic and sustained emphasis'). MINOR WEAKNESSES: (1) The LLM answer adds some interpretive language not explicitly stated in ground truth ('expanding private-label SKUs and online availability,' 'sales and margin improvement') - while these are reasonable inferences from Costco's strategy, they go slightly beyond what the ground truth explicitly confirms; (2) The phrase 'explicitly citing' in the LLM answer suggests direct quotation but no exact quote is provided, though this is a minor presentation issue. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either answer, so this dimension is not directly testable. Both answers appropriately avoid making unsupported numerical claims. MULTI-HOP REASONING: Both answers correctly synthesize information across 2022 and 2023 filings and identify the strategic evolution. The LLM answer's characterization of the evolution is sound and well-reasoned. Overall, the LLM answer is factually accurate, well-structured, and appropriately addresses the question with only minor interpretive additions beyond the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 509,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "\nBetween 2023 and 2024 the trajectory for Paxlovid shifted sharply from a pandemic‑driven revenue surge to a modest, commercially‑focused outlook.  In 2023 the company was still recognizing large government‑stockpurchase revenues (e.g., a $3.5 bn non‑cash reversal in Q4 2023), but by the end of 2024 the remaining performance obligations tied to Paxlovid amounted to only about **$1 billion of contracted future revenue**, to be recognized through 2025‑2028 as the product moves into traditional commercial markets.  This reflects the transition from high‑volume, government‑supplied sales to a smaller, price‑negotiated commercial market and signals a markedly lower financial outlook for Paxlovid compared with its peak years.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with correct identification of the key metric: approximately $1 billion in remaining performance obligations for Paxlovid as of December 31, 2024. The quantitative data is accurate and properly formatted. The answer correctly synthesizes the multi-hop information by comparing the 2023 and 2024 periods and explaining the evolution of Paxlovid's financial outlook. The LLM appropriately contextualizes the shift from government-stockpile-driven revenues to commercial markets, which aligns with the ground truth's characterization of 'increased contractual certainty and forward-looking revenue expectations.' The mention of the $3.5 billion non-cash reversal in Q4 2023 provides additional relevant context that supports the narrative of transition, though this specific detail was not in the original answer. The LLM's interpretation that the $1 billion represents 'contracted future revenue' to be recognized through 2025-2028 is a reasonable inference from the remaining performance obligations metric. Minor deduction: The LLM characterizes the outlook as 'markedly lower' compared to peak years, which is a reasonable interpretation but goes slightly beyond what the ground truth explicitly states. The ground truth focuses on the presence of the $1 billion obligation indicating 'increased contractual certainty,' while the LLM emphasizes the decline from peak pandemic revenues. Both interpretations are consistent with the data, but the LLM adds interpretive commentary that, while reasonable, extends beyond the ground truth's more neutral framing. Overall, the answer correctly addresses the evolution between 2023 and 2024, accurately cites the $1 billion figure, and provides sound multi-hop reasoning connecting the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 487,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "\nBetween 2022 and 2024 the company moved from a generic reference to a “reasonable and supportable period” (R&S Period) to a more explicit, model‑driven description: in 2024 the R&S Period is embedded in statistically‑based models that estimate probability of default, exposure at default and recoveries, and the firm explicitly adds qualitative reserves to capture risks that are not captured quantitatively. This evolution shows that American Express is tightening its forward‑looking, data‑rich framework for credit‑loss estimation and adopting a more nuanced, risk‑aware approach to financial risk management.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the specific reserve figures mentioned in the ground truth ($3.3 billion as of December 31, 2021). This is a critical factual omission for a financial question. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly states reserves were $3.3 billion in 2021 and provides specific context about how the R&S Period was treated differently in 2022 vs 2024 (introduced as new concept vs. embedded as standard). The LLM answer fails to include these concrete financial metrics. (3) REASONING DIVERGENCE: While the LLM correctly identifies an evolution from generic to more explicit/model-driven approach, it introduces concepts (probability of default, exposure at default, recoveries, qualitative reserves) that are not mentioned in the ground truth. This represents speculation beyond the provided knowledge graph. (4) MISSING KEY DETAIL: The ground truth emphasizes the shift from 'introducing the methodology' to 'relying on it as foundational' - a nuanced distinction about maturity of the process. The LLM captures some of this evolution but frames it differently (generic to explicit/model-driven) rather than the maturation narrative. (5) ENTITY/CONTEXT: The LLM correctly identifies American Express and the 2022-2024 timeframe, but the answer lacks the specific reserve amounts and the precise characterization of how the R&S Period was presented in each year. The answer reads as a reasonable interpretation of credit loss methodology evolution but diverges from the factual ground truth in critical ways.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 436,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "\nBetween 2022 and 2024 Amazon continued to carry the 0.800 % senior unsecured note that matures in 2025 — originally issued in 2020 — but it no longer relied on that ultra‑low‑rate tranche as its primary financing tool.  Instead, the company issued newer senior notes with substantially higher coupons (e.g., a 4.6 % note due 2025 entered into in December 2022 and additional 4.6 % 2025‑maturing notes added in 2024), signaling a shift toward funding at prevailing mid‑single‑digit to high‑single‑digit rates while still retaining the original 0.800 % 2025 notes until they are eventually refinanced or retired.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core narrative of Amazon's debt financing evolution between 2022 and 2024, correctly identifying that the 0.800% Note due 2025 was retained while new higher-coupon notes were issued. However, there are significant quantitative accuracy issues: (1) The LLM states the 4.6% note was 'entered into in December 2022' - the ground truth only confirms it was introduced by 2024, not specifically December 2022. This is a potential factual error regarding timing. (2) The LLM correctly identifies the 4.600% Note due 2025 as a new instrument, matching the ground truth. (3) The characterization of the 0.800% as 'ultra-low-rate' and the shift to 'mid-single-digit to high-single-digit rates' is reasonable interpretation but goes beyond what the ground truth explicitly states. The ground truth is more measured, simply noting 'different interest rates.' (4) The LLM's statement about 'no longer relied on that ultra-low-rate tranche as its primary financing tool' is inference not explicitly stated in the ground truth. The ground truth focuses on the introduction of new instruments alongside retention of the old, not on relative reliance. Strengths: The answer correctly identifies both note types, their maturity dates, and the general strategic shift. The multi-hop reasoning connecting 2022 and 2024 data is sound. Weaknesses: The specific December 2022 date for the 4.6% note issuance is not verified in the ground truth. The characterization of Amazon's strategic motivations ('manage cash flow and interest rate risk') is present in ground truth but the LLM's additional interpretations about 'primary financing tool' and rate environment characterization exceed the ground truth's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 468,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "\nIn the 2022 Form 10‑K the company still listed the Twenty‑third Supplemental Indenture (dated March 1 2022) as an active supplement in the “Indenture” discussion and in the exhibit index, explicitly noting it as the most recent supplemental indenture to the master mortgage‑bond indenture. By contrast, the 2024 Form 10‑K no longer references that 2022 supplement in the main text; the only mention of a “Twenty‑third Supplemental Indenture” appears in a historical list of exhibits, with no current description of its terms or status. This shift indicates that the 2022 supplement has been superseded or merged into later indentures and is no longer treated as a distinct, ongoing disclosure, suggesting its relevance has effectively ended.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) DATE DISCREPANCY - The LLM states the Twenty-third Supplemental Indenture was 'dated March 1 2022' in the 2022 filing, but the ground truth clearly states it was 'dated June 1, 1978' - this is a fundamental factual error of 44 years. The LLM appears to have confused the indenture's original date with a 2022 filing date. (2) EXHIBIT REFERENCE ERROR - The ground truth specifies the indenture was 'incorporated by reference to Exhibit 2(c), File No. 2-61611' in the 2022 filing, but the LLM provides no such specific exhibit reference. (3) MISCHARACTERIZATION OF EVOLUTION - The LLM claims the 2022 supplement was 'superseded or merged into later indentures,' but the ground truth indicates the Twenty-third Supplemental Indenture (from 1978) simply was not reaffirmed or highlighted in 2024, with focus shifting to more recent supplements like the Forty-ninth (March 14, 2024). The LLM's interpretation of 'supersession' is speculative and not supported by the ground truth. (4) INCOMPLETE COMPARISON - The LLM fails to mention the Forty-ninth Supplemental Indenture (dated March 14, 2024) that appears in the 2024 filing, which is a key element of the ground truth's explanation of the shift in focus. (5) REASONING QUALITY - While the LLM correctly identifies that the indenture's prominence decreased between filings, the reasoning is based on an incorrect date premise and lacks the specific documentary evidence cited in the ground truth. The core conclusion about diminished significance is directionally correct but built on faulty factual foundations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 437,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 the dollar amount of Class C share repurchases fell steadily – roughly **$57 billion in 2022, $52.9 billion in 2023 and $50.2 billion in 2024** (see the share‑repurchase tables on pages 51‑55 of the 2022 filing and pages 80‑84 of the 2024 filing).  Overall repurchase spending (Class A plus Class C) was **$59.3 billion in 2022, $62.2 billion in 2023 and $62.0 billion in 2024**.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains significant factual inaccuracies that directly contradict the ground truth. (1) CLASS C SPECIFIC NUMBERS ARE WRONG: The LLM claims Class C repurchases were $57B (2022), $52.9B (2023), and $50.2B (2024), showing a declining trend. However, the ground truth indicates combined Class A and Class C repurchases were $59.3B, $62.2B, and $62.0B respectively - these are the TOTAL figures, not Class C-specific. The LLM appears to have fabricated Class C-only numbers that don't match any disclosed data. (2) OVERALL REPURCHASE FIGURES ARE CORRECT: The LLM correctly states the combined Class A and Class C totals ($59.3B, $62.2B, $62.0B), which matches the ground truth exactly. (3) TREND ANALYSIS IS CONTRADICTORY: The LLM claims Class C repurchases 'fell steadily' while simultaneously stating overall repurchases remained 'high' - this internal contradiction suggests confusion about what data was being presented. The ground truth shows overall repurchases peaked in 2023 then slightly declined in 2024, not a steady decline. (4) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the distinction between Class C-specific data and combined Class A+C data. It appears to have invented Class C-only figures rather than acknowledging that the disclosed data combines both classes. (5) PARTIAL CREDIT: The LLM did correctly identify the overall repurchase amounts and years, and provided page references (though these cannot be verified). However, the fabricated Class C-specific numbers and misleading trend characterization are serious errors that undermine the answer's reliability. The question specifically asks about 'Class C Capital Stock' evolution, which the LLM failed to answer accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 476,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "\nThe 2022 filing only referenced the original 1988 Salary/Bonus Deferral Plan (Exhibit 10.13) and noted an older 1994 amendment, with no recent restatement. In contrast, the 2024 filing replaces that entry with a newly restated version of the plan that is effective January 1 2023 and is filed as a separate amendment/restatement (Exhibit 10.17), adding updated language and incorporating the plan into the current director‑compensation disclosures.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains multiple significant factual errors that contradict the ground truth: (1) EXHIBIT NUMBER ERRORS: The LLM states the 2022 filing referenced Exhibit 10.13, but ground truth indicates it was Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The LLM also claims the 2024 filing uses Exhibit 10.17 for a newly restated version, but ground truth shows 2024 uses Exhibit 10.13 (1988 plan), Exhibit 10.14 (1994 amendment), and Exhibit 10.16 (1997 amendments). (2) STRUCTURAL MISUNDERSTANDING: The LLM incorrectly characterizes the 2024 filing as replacing entries with a 'newly restated version effective January 1, 2023' filed as Exhibit 10.17. Ground truth indicates the 2024 filing actually REINTRODUCES the plan through different exhibit numbers and ADDS the 1997 amendments (Exhibit 10.16), not replaces with a new restatement. (3) AMENDMENT HISTORY: The LLM fails to identify that the 2024 filing expanded disclosure to include the 1997 amendments, which is a key change noted in ground truth. (4) CORE FINDING REVERSED: Ground truth emphasizes that foundational documentation remained consistent while disclosure expanded; the LLM suggests a replacement/restatement occurred, which is fundamentally incorrect. The answer demonstrates a misunderstanding of the exhibit structure and the nature of the changes between filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 378,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the fair‑value of Starbucks’ interest‑rate swaps fell sharply.  In 2022 the swaps were recorded as a $12 million accrued liability and a $34 million other‑long‑term liability (total ≈ $46 million), whereas by the end of 2024 the entire liability was shown only in other‑long‑term liabilities at about $19 million (with virtually no accrued portion).  This reduction reflects both a lower notional amount of swaps outstanding and the re‑classification of the remaining liability to the long‑term section of the balance sheet.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM claims 2022 had a $12 million accrued liability plus $34 million other long-term liability (totaling ~$46 million), but the ground truth states only a $34.0 million liability under 'Other long-term liabilities' in 2022 with no mention of a $12 million accrued portion. This is a critical misrepresentation of the 2022 position. (2) The LLM correctly identifies the 2024 figure of approximately $19 million in other long-term liabilities, which matches the ground truth's $19.2 million. (3) MISSING INFORMATION - The LLM fails to mention the $41.4 million liability from interest rate swaps reported for 2023 (the prior year), which is explicitly stated in the ground truth as a significant component of the 2024 disclosure. This is a material omission for understanding the evolution of exposure. (4) CLASSIFICATION ACCURACY - While the LLM correctly identifies the shift toward long-term classification by 2024, it mischaracterizes the 2022 classification by introducing a non-existent accrued liability component. (5) REASONING QUALITY - The LLM's explanation about 'lower notional amount' and 'reclassification' is reasonable in tone but is built on incorrect foundational numbers. The multi-hop synthesis is incomplete because it fails to incorporate the 2023 comparative data that provides crucial context for understanding the 2024 position. The answer demonstrates partial understanding of balance sheet classification concepts but fails on factual accuracy of the underlying numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 446,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "\nBetween 2022 and 2024 Duke Energy made no new amendment to the Directors’ Savings Plan—the only change was the 2021 amendment (effective December 16 2021) that introduced a company matching contribution and clarified deferral‑election rules, and that same version was still cited in the 2024 filing. This continuity shows the company’s director‑compensation governance relies on a stable, board‑approved deferral vehicle with only modest, pre‑approved enhancements, emphasizing consistency and alignment of director interests with long‑term shareholder value rather than frequent revisions.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the December 16, 2021 amendment date and accurately states that no new amendments occurred between 2022-2024, which aligns with the ground truth. The numeric/date information is accurate (quantitative accuracy: 8/10). However, there are significant qualitative issues: (1) The LLM answer introduces specific claims about 'company matching contribution' and 'deferral-election rules' that are not explicitly mentioned in the ground truth, representing potential over-specification or hallucination. (2) The ground truth emphasizes an 'evolution' from 'policy establishment to operational transparency' and highlights a shift in how the plan is referenced (from formal introduction to phantom investment options and unfunded accounts), but the LLM answer frames this as 'continuity' and 'stability' rather than evolution. This represents a fundamental mischaracterization of the narrative arc. (3) The LLM answer claims the plan 'relies on a stable, board-approved deferral vehicle with only modest, pre-approved enhancements,' but the ground truth suggests a more dynamic evolution in how the plan is presented and structured operationally. (4) While both answers conclude that the approach emphasizes alignment with shareholder interests, the LLM's reasoning path (stability/consistency) differs from the ground truth's reasoning (shift from policy to operational transparency). The answer is partially correct on facts but misses the key interpretive insight about evolution in governance approach and transparency mechanisms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 429,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "\nBetween 2022 and 2023 Costco deepened the strategic role of Kirkland Signature, promoting it from a value‑oriented private‑label line to a primary growth engine and explicitly targeting a higher sales‑penetration share (the 2023 filing notes an increasing contribution of private‑label items to overall margins).  This shift is reflected in the 2023 discussion of “expect[ing] to continue to increase the sales penetration of our private‑label items,” whereas the 2022 filing only highlighted Kirkland’s quality‑and‑price advantage and margin benefits.  Consequently, the risk profile evolved from a focus on supply‑chain and quality‑control vulnerabilities toward a greater dependence on Kirkland’s margin contribution and heightened brand‑reputation and regulatory scrutiny as the brand becomes a larger driver of profitability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) DIRECTIONAL ERROR: The LLM claims Kirkland Signature was 'promoted from a value-oriented private-label line to a primary growth engine' with 'increasing contribution' in 2023, but the ground truth indicates the opposite trajectory—2022 emphasized growth and brand strength, while 2023 introduced risk-focused disclosures. The LLM reverses the chronological positioning. (2) QUOTE MISATTRIBUTION: The LLM attributes the quote 'expect[ing] to continue to increase the sales penetration of our private-label items' to the 2023 filing as evidence of deepened strategic role, but the ground truth explicitly states this language appeared in the 2022 filing, not 2023. This is a critical factual error. (3) RISK PROFILE MISCHARACTERIZATION: The LLM claims the risk profile evolved 'from a focus on supply-chain and quality-control vulnerabilities toward a greater dependence on Kirkland's margin contribution,' but the ground truth indicates the opposite—2022 focused on growth/strength, while 2023 introduced broader risk disclosures (supply chain disruptions, FX fluctuations, catastrophic events). (4) MISSING KEY INSIGHT: The LLM fails to capture the fundamental shift from a growth-oriented narrative (2022) to a risk-conscious narrative (2023), which is the core of the ground truth answer. (5) UNSUPPORTED CLAIMS: The LLM introduces concepts like 'brand-reputation and regulatory scrutiny' that are not mentioned in the ground truth. While the answer addresses the right company and timeframe, the factual content is substantially inverted from the ground truth, making it fundamentally incorrect despite superficial relevance to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 477,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "\nProved natural‑gas reserves in the Asia Pacific/Middle East were about 326 billion cubic feet at year‑end 2022, fell to 312 BCF in 2023 and to 296 BCF by the end of 2024. The decline reflects net downward revisions (price‑related and cost‑driven) but was partially offset by additions from purchases of additional equity‑affiliate interests and from extensions/discoveries in the Middle East.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides more detailed information than the ground truth. Verification of key claims: (1) 2022 figure of 326 BCF matches ground truth exactly; (2) 2024 figure of 296 BCF matches ground truth exactly; (3) 2023 intermediate figure of 312 BCF is provided by LLM but not in ground truth - this represents additional useful detail that is consistent with the 326→296 decline trajectory. Quantitative accuracy is perfect - all three year-end figures are correct and the declining trend is accurately captured. The LLM provides superior qualitative detail by explaining the mechanisms behind the decline (net downward revisions due to price and cost factors, partially offset by purchases of additional equity-affiliate interests and extensions/discoveries in the Middle East). The ground truth states 'minimal extensions and discoveries' while the LLM indicates these did contribute to offsetting revisions - this is a minor semantic difference but the LLM's explanation is more nuanced and informative. The LLM correctly identifies that the 2024 period showed reduced activity (no sales or significant additions mentioned in ground truth), though the LLM frames this as revisions being 'partially offset' rather than stating there were 'no sales.' Multi-hop reasoning is sound - the answer synthesizes reserve data across three years and explains the drivers of change. The only minor consideration is that the ground truth explicitly states 'no sales or significant reserve additions in this region' for 2024, while the LLM mentions 'purchases of additional equity-affiliate interests' as a source of additions - this could suggest the LLM is describing a different year's activity or interpreting the data differently, but the core numbers remain correct. Overall, the LLM provides a more complete and analytically sound answer than the ground truth baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 517,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "\nBetween 2022 and 2024 FedEx kept the 114 owned 767F freighters it had but accelerated its acquisition of new 767‑300 freighters—adding 14 new aircraft in 2023, another 14 in 2024 and planning 11 more for delivery in 2025 (with three slated for 2026)—to replace older, less‑fuel‑efficient types such as the MD‑11 and MD‑10. This push is backed by roughly $611 million in deposits and progress payments as of May 2024, underscoring a strategic focus on modernizing the freighter fleet for greater efficiency and capacity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) CRITICAL ERROR - Ownership claim: The LLM states FedEx 'kept the 114 owned 767F freighters' between 2022-2024, but the ground truth explicitly states 'no updated ownership figures were disclosed' for 2024. The LLM fabricated a continuation of the 2022 figure without evidence. (2) ACQUISITION NUMBERS - UNVERIFIED: The LLM provides specific delivery numbers (14 in 2023, 14 in 2024, 11 planned for 2025, 3 for 2026) that are not present in the ground truth. These appear to be fabricated or from sources not in the knowledge graph. The ground truth makes no mention of these specific annual delivery quantities. (3) DEPOSIT AMOUNT - UNVERIFIED: The $611 million figure for deposits and progress payments as of May 2024 is not mentioned in the ground truth, which only references that 'expenditures for these aircraft are necessary.' This number cannot be verified against the provided ground truth. (4) MULTI-HOP REASONING: While the LLM attempts to synthesize information about fleet modernization and replacement of older aircraft (MD-11, MD-10), it does so by introducing unverified numbers rather than working from the ground truth data. (5) SEMANTIC ISSUES: The ground truth emphasizes that FedEx 'emphasized' the B767F as key to modernization programs and noted fuel efficiency benefits, but does not confirm actual ownership retention or specific acquisition schedules. The LLM presents speculative or unsourced information as fact. The answer fails the primary requirement of factual accuracy on quantitative data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 441,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "\nStarbucks’ roasted‑coffee inventory grew from $310.3 million at the end of fiscal 2022 to a higher balance in 2024, reflecting a larger stock of roasted beans.  To meet this demand the company expanded its roasting footprint—investing in additional roasting equipment and capacity—as disclosed in the 2024 10‑K, thereby scaling up its production infrastructure.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the 2022 roasted coffee inventory value of $310.3 million and acknowledges the expansion of roasting infrastructure by 2024. However, there are significant gaps and issues: (1) QUANTITATIVE ACCURACY: The LLM states inventory 'grew from $310.3 million...to a higher balance in 2024' but provides NO SPECIFIC 2024 FIGURE. The ground truth does not provide a 2024 inventory number either, but the LLM's vague 'higher balance' is imprecise and fails to quantify the evolution. (2) COMPLETENESS: The ground truth provides specific roasting facility locations (York PA, Minden NV/Carson Valley, Kunshan China, Kent WA) that demonstrate the scale and geographic expansion of production infrastructure. The LLM answer mentions 'additional roasting equipment and capacity' but omits these specific facility details entirely, which are crucial evidence of the infrastructure evolution. (3) ENTITY ACCURACY: Correctly identifies Starbucks and fiscal years 2022-2024. (4) REASONING: The LLM correctly synthesizes that inventory growth drove infrastructure expansion, which is sound logic. However, it fails to provide the concrete facility evidence that substantiates this claim. (5) SEMANTIC EQUIVALENCE: The LLM's characterization of the shift from 'holding' to 'producing' roasted coffee is present in the ground truth but not explicitly stated in the LLM answer. The LLM focuses on 'scaling up production' but misses the conceptual shift from merchandise holder to active producer. The answer is partially correct on the 2022 number but incomplete on 2024 specifics and missing critical facility location details that define the infrastructure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1219,
        "completion_tokens": 459,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, the 2.750 % Senior Notes due 2025 went from **not being listed as a distinct issuance** in the 2023 pages (the 2023 documents only reference other senior‑note series such as the 2.750 % notes due 2030 and 2051) to being **explicitly named in the 2024 Board‑of‑Directors resolutions (Exhibit 4.65)**, which authorizes the terms for that specific 2.750 % 2025 tranche. This inclusion signals that PepsiCo formally re‑authorized and likely re‑opened or refinanced the 2.750 % Senior Notes due 2025 in 2024, marking a clear evolution in how the company is utilizing that debt instrument.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) REVERSED CHRONOLOGY: The LLM claims the 2.750% Senior Notes due 2025 were NOT listed in 2023 but WERE explicitly named in 2024, which directly contradicts the ground truth stating they were listed in 2023 Board resolutions and retained in 2024. (2) INCORRECT INSTRUMENT ATTRIBUTION: The LLM incorrectly states that 2023 documents reference '2.750% notes due 2030 and 2051' - the ground truth indicates the 2.750% due 2030 was introduced in 2024, not present in 2023. (3) MISCHARACTERIZATION OF EVOLUTION: The LLM describes this as a 'formal re-authorization and likely re-opening or refinancing in 2024,' which misrepresents the actual evolution. The ground truth shows the 2.750% due 2025 was already authorized in 2023, and the strategic evolution was the ADDITION of a 2.750% due 2030 in 2024 (extending to longer-term horizon). (4) MISSING KEY INSIGHT: The LLM fails to identify that the strategic evolution was about extending the 2.750% rate to a longer maturity (2030), not about re-authorizing the 2025 notes. The answer demonstrates fundamental misunderstanding of the multi-hop synthesis required - comparing what instruments existed in each year and identifying the actual change (addition of 2030 notes, not changes to 2025 notes). The reasoning is internally inconsistent with documented facts from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 395,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "\nFrom 2022 to 2024 FedEx’s scheduled B777F deliveries fell sharply: the 2022 filing showed a commitment to receive 8 B777Fs (2 in 2023, 4 in 2024 and 2 in 2025), whereas the 2024 filing lists only 2 B777Fs remaining on the books, slated for delivery in 2025.  This pull‑back indicates that the B777F is now being used more selectively—as a high‑capacity, long‑range, fuel‑efficient asset for specific routes—rather than as a core component of an expanded cargo fleet.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant quantitative inaccuracies that contradict the ground truth. (1) DELIVERY SCHEDULE DISCREPANCY: The LLM claims the 2022 filing showed '8 B777Fs (2 in 2023, 4 in 2024 and 2 in 2025)' but the ground truth states FedEx planned to operate 4 B777F in 2024 and 2 in 2025 - no mention of 8 total or 2 in 2023. The LLM appears to have fabricated or misread the 2022 delivery schedule. (2) OPERATIONAL vs. DELIVERY CONFUSION: The ground truth discusses planned UTILIZATION/OPERATION of aircraft (4 operating in 2024, 2 in 2025), not delivery schedules. The LLM conflates deliveries with operations, which are different concepts. (3) 2024 PLAN ACCURACY: The LLM correctly identifies that the 2024 filing shows 2 B777Fs for 2025, which matches ground truth. However, the baseline comparison is wrong. (4) INTERPRETATION: While the LLM's qualitative interpretation about selective use and phase-out is reasonable, it's built on incorrect quantitative foundations. The ground truth shows a clear reduction from 4 aircraft operating in 2024 to 2 in 2025 with complete phase-out, whereas the LLM's narrative about 'sharp decline from 8 to 2' is mathematically unsupported. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2022 vs 2024 filing comparison - the core requirement of the question. The answer demonstrates poor document comprehension and appears to contain invented numbers rather than extracted data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1214,
        "completion_tokens": 407,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 the net gain on Starbucks’ foreign‑currency‑other derivatives recorded in AOCI fell sharply—from **$55.3 million in 2022** to **$39.6 million in 2023** and then to **$11.5 million in 2024**—and the amount of that gain expected to be re‑classified to earnings within the next 12 months dropped from **$32.5 million** to **$9.5 million** (see the “Gains and losses on derivative contracts and foreign‑currency‑denominated debt designated as hedging instruments included in AOCI…” tables for 2022 and 2024).  \nThis decline indicates that the company’s accumulated foreign‑currency hedge gains have been reduced and that it expects only modest future reclassifications, reflecting a **lowered exposure to foreign‑currency fluctuations or a wind‑down of those hedging positions**.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains fundamentally incorrect numbers that contradict the ground truth. (1) QUANTITATIVE ACCURACY FAILURES: The LLM claims foreign currency-other derivative gains in AOCI were $55.3M (2022), $39.6M (2023), and $11.5M (2024). However, the ground truth states that in 2022, Starbucks reported foreign currency-other derivative LIABILITIES of only $0.3 million, and in 2024 the net gains in AOCI were $11.5 million. The LLM's 2022 figure of $55.3M is completely inconsistent with the ground truth's $0.3M liability. The LLM also introduces a 2023 figure ($39.6M) that is not mentioned in the ground truth. The $9.5M reclassification figure is also not verified in the ground truth. (2) ENTITY/METRIC CONFUSION: The ground truth distinguishes between 'foreign currency-other derivative liabilities' (a balance sheet item of $0.3M in 2022) and 'net gains included in AOCI' (which reached $11.5M by 2024). The LLM conflates these or misidentifies which metric applies to which year. The ground truth indicates a shift FROM a liability position TO a gain position, whereas the LLM presents only gains across all years. (3) MULTI-HOP REASONING: While the LLM attempts to synthesize information across years and explain the trend, the underlying numbers are incorrect, making the entire analysis unreliable. The conclusion about 'wind-down of hedging positions' may be directionally reasonable given the declining gains, but it's built on false premises. (4) MISSING CONTEXT: The ground truth emphasizes the shift from a minimal liability ($0.3M) to a substantial gain ($11.5M), which is a qualitatively different story than the LLM's narrative of declining gains. The LLM's answer appears to reference different tables or data points than what the ground truth identifies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 490,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "\nBetween 2023 and 2024 the 2.625 % Senior Notes due 2026 remained on PepsiCo’s list of authorized senior debt, but the way it was disclosed evolved. In the 2023 filing the notes appeared only in the Board‑of‑Directors resolution (Exhibit 4.64) that referenced the original 2013 indenture, while the 2024 filing retains that authorization and adds a newer February 12 2024 indenture and a broader set of senior‑note authorizations, showing that PepsiCo’s engagement with the 2.625 % 2026 tranche continues to be documented as part of its updated, wider‑ranging debt‑instrument disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies that the 2.625% Senior Notes due 2026 remained in PepsiCo's disclosures between 2023 and 2024, and accurately notes the evolution in how they were disclosed (from Board resolution in 2023 to updated indenture in 2024). The specific reference to Exhibit 4.64 and the February 12, 2024 indenture date adds helpful detail. However, there are significant gaps in completeness: (1) The LLM answer fails to mention the key new debt instruments introduced in 2024 that the ground truth emphasizes - specifically the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. These are critical to demonstrating the 'significantly expanded list' and 'broader and more diversified set of debt instruments' that the ground truth highlights. (2) The LLM answer focuses heavily on exhibit references and indenture mechanics rather than the substantive point about PepsiCo's active capital markets strategy with different maturities and rates. (3) While the LLM correctly identifies the 2.625% 2026 notes as part of a 'wider-ranging debt-instrument disclosures,' it doesn't adequately convey the scope of that expansion. The answer is partially correct on the evolution of disclosure mechanics but incomplete on the substantive debt portfolio expansion that is central to answering the question about how engagement 'evolved.' The quantitative accuracy is reasonable (dates and percentages are correct where mentioned), but the qualitative reasoning misses the key analytical point about diversification strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 425,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "\nFrom 2022 to 2024 Cisco’s exposure to technical hurdles deepened as it shifted from selling discrete networking gear to offering end‑to‑end architectures that require mastery of network‑programmability, SDN, security, AI‑driven services and cloud‑native delivery models.  To meet these heightened demands the company has poured greater strategic investment into engineering, acquisitions (e.g., Splunk) and new product‑development timelines, but it explicitly warns that success hinges on overcoming complex technical challenges on schedule—delays could let rivals (including white‑box and cloud‑service competitors) win market share, making the ability to surmount those hurdles more critical and risk‑laden than in 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates partial correctness with both strengths and significant weaknesses. STRENGTHS: (1) Correctly identifies the evolution from 2022 to 2024 in Cisco's technical challenges; (2) Accurately mentions specific technology areas (AI, security, cloud, SDN) that align with ground truth; (3) References strategic investments and acquisitions (Splunk example is appropriate); (4) Correctly identifies competitive threats and market share risks; (5) Captures the shift toward more complex, integrated solutions. WEAKNESSES: (1) The answer diverges from ground truth by emphasizing 'network-programmability, SDN' as primary technical hurdles, whereas ground truth emphasizes 'software subscription offerings' and broader operational/strategic dependencies; (2) Fails to capture the critical evolution mentioned in ground truth: the shift from 'internal execution risk' to 'broader operational and strategic dependency' with consequences including 'reputational damage, legal liability, and reduced customer retention'; (3) Does not adequately address the 2024-specific emphasis on 'timely manner' and the expanded risk profile beyond just market share loss; (4) The framing around 'white-box and cloud-service competitors' is reasonable inference but not explicitly grounded in the provided ground truth. MULTI-HOP REASONING: The answer attempts to synthesize information across years and connect strategic investments to technical challenges, but misses the nuanced shift in risk characterization that is central to the ground truth. The answer focuses more on technical domain evolution rather than the risk/dependency evolution that the question and ground truth emphasize. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are provided in either answer, so this dimension is neutral (8/10 for not introducing false metrics). SEMANTIC EQUIVALENCE: While the LLM captures that technical hurdles became more critical, it does not convey the ground truth's key insight about the transformation from execution risk to strategic/operational dependency with broader consequences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 565,
        "total_tokens": 1983
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "\nIn the 2022 filing the company specifically identified Google Ad Manager as a primary driver of Google Network revenue growth, noting its strong performance as a key contributor to that segment. The 2023 filing repeats the emphasis, describing Ad Manager as the main engine of network‑revenue growth and pointing to an acceleration in its contribution, indicating that its role in driving Google Network revenues grew materially from 2022 to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core claim. (1) MAJOR FACTUAL ERROR: The LLM states that Google Ad Manager's role 'grew materially from 2022 to 2023' and that 2023 showed 'acceleration in its contribution.' This directly contradicts the ground truth, which explicitly states there was a SHIFT from being 'a standout growth contributor in 2022' to being 'part of a broader suite of advertising tools in 2023' with 'a more integrated but less singularly emphasized role.' The LLM has inverted the actual trend. (2) QUANTITATIVE ACCURACY: The LLM mentions the $8.6 billion figure is absent from the LLM answer, though this was cited in the ground truth as the year-over-year increase in Google Network revenues in 2022. The LLM provides no specific numbers or metrics to support its claims. (3) MULTI-HOP REASONING: The LLM failed to correctly synthesize the comparative analysis across 2022 and 2023 filings. It claims 2023 showed 'acceleration' when the ground truth indicates a de-emphasis and broader integration rather than singular prominence. (4) ENTITY ACCURACY: While Google Ad Manager, Google Network revenues, and the years 2022-2023 are correctly identified, the characterization of their relationship is backwards. The ground truth clearly indicates a DECREASE in singular emphasis, not an increase. This is a critical failure in understanding the directional change being asked about in the question. The LLM appears to have fabricated the claim about 'acceleration' without evidence from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 429,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "\nBetween fiscal 2022 (Oct 2 2022) and fiscal 2024 (Sep 29 2024) the liability for foreign‑currency‑related derivatives grew from $0.3 million—recorded in accrued liabilities—to a total of $8.8 million ( $4.7 million in accrued liabilities plus $4.1 million in other long‑term liabilities).  This represents an increase of $8.5 million, or roughly a 2,800 % rise, over the two‑year period.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) The ground truth states the 2024 amount was $4.7 million in accrued liabilities only. The LLM claims a total of $8.8 million ($4.7M in accrued liabilities + $4.1M in other long-term liabilities), which is not supported by the ground truth. (2) The LLM's calculation of an $8.5 million increase is based on the incorrect $8.8M figure ($8.8M - $0.3M = $8.5M), when the correct increase should be $4.4 million ($4.7M - $0.3M = $4.4M). (3) The percentage increase calculation of 2,800% is mathematically based on the wrong numbers. The correct percentage would be approximately 1,467% ($4.4M / $0.3M ≈ 14.67x or 1,467% increase). WHAT WAS CORRECT: The LLM correctly identified the 2022 starting amount ($0.3 million in accrued liabilities), the fiscal year dates (Oct 2 2022 and Sep 29 2024), and the general concept that there was a significant increase. However, the LLM appears to have introduced additional liability categories (other long-term liabilities) that are not mentioned in the ground truth, suggesting either a misreading of the source data or confusion with different financial statement line items. The answer demonstrates partial understanding of the question's multi-hop nature but fails on the fundamental requirement of accurate financial data synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1179,
        "completion_tokens": 383,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 PepsiCo moved from merely authorizing the 4.600% Senior Notes due 2045 in its 2023 board‑resolution filings to actually completing a supplemental indenture and issuing the same series through a global‑note mechanism in early 2024.  This evolution shows that the company is deliberately extending the long‑end of its debt ladder and using layered, multi‑jurisdictional issuances to lock in low‑cost, long‑dated financing while maintaining a diversified, maturity‑staggered capital structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) The LLM claims PepsiCo 'completed a supplemental indenture and issued the same series through a global-note mechanism in early 2024' - this specific detail is NOT in the ground truth and appears to be fabricated. The ground truth only states the notes were 'authorized' in 2023 and 'remained part' of the debt structure in 2024, with no mention of actual issuance completion or supplemental indentures. (2) The LLM's characterization of 'moving from merely authorizing' to 'actually completing' issuance is not supported by the provided ground truth, which does not indicate the notes were actually issued in 2024. (3) The LLM introduces unsupported claims about 'global-note mechanism,' 'multi-jurisdictional issuances,' and 'locking in low-cost financing' that are not mentioned in the ground truth. (4) The ground truth correctly identifies that the 4.600% notes remained part of the structure while new instruments (4.000% due 2047, Floating Rate Notes due 2026) were added, indicating portfolio diversification. The LLM misses this key point about the introduction of NEW notes alongside the existing 4.600% notes. (5) The LLM's answer suggests a more dramatic evolution (authorization to issuance) than what the ground truth indicates (authorization in 2023, continued presence in 2024 with portfolio expansion). The answer demonstrates poor multi-hop synthesis by fabricating details not present in the source material rather than accurately synthesizing the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 452,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "\nConocoPhillips’ proved natural‑gas reserves in the Asia‑Pacific/Middle‑East region slipped only modestly—from about **326 billion cubic feet (bcf) in 2022 to roughly 296 bcf by the end of 2024**—while operated production remained essentially flat at **≈24–25 bcf per year**.  At the same time, the company’s **equity‑affiliated gas reserves in the region grew from 5.75 tcf (2022) to 5.87 tcf (2024)**, and extensions/discoveries continued through those partnerships.  \n\nThis pattern shows that ConocoPhillips is **maintaining a stable, partnership‑driven presence in APME**, focusing on deepening equity investments rather than expanding its own operated gas base.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core proved natural gas reserve figures (326 bcf in 2022 declining to 296 bcf in 2024) and accurately characterizes this as a modest decline. The interpretation that this suggests a shift toward partnership-driven strategy is reasonable and adds analytical depth beyond the ground truth. The company name (ConocoPhillips) and region (APME) are correctly identified.\n\nWEAKNESSES: The LLM introduces significant new quantitative claims not present in the ground truth: (1) operated production figures of \"≈24–25 bcf per year\" - these numbers are not verified against the original answer and appear to be additional data not in the ground truth; (2) equity-affiliated gas reserves growing from 5.75 tcf (2022) to 5.87 tcf (2024) - again, these specific figures are not in the ground truth and cannot be verified. While these may be factually correct from the source documents, they represent information beyond what was provided in the ground truth answer.\n\nMULTI-HOP REASONING: The LLM demonstrates sound reasoning by connecting the modest decline in operated reserves with the growth in equity-affiliated reserves to conclude a strategic shift toward partnerships. This is logical synthesis, though it goes beyond the ground truth's more cautious statement about \"potential shift.\"\n\nQUANTITATIVE ACCURACY ISSUE: The introduction of unverified figures (5.75 tcf, 5.87 tcf, 24-25 bcf/year) creates uncertainty. While the core 326→296 bcf figures are correct, the additional numbers cannot be confirmed against the ground truth, reducing confidence in overall quantitative accuracy.\n\nCONCLUSION: The answer is partially correct on core facts but introduces unverified additional data. The reasoning is sound but extends beyond what can be confirmed from the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 497,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "\nFrom 2022 to 2023 the filings treat Google Play in essentially the same way—​it generates revenue from “sales of apps and in‑app purchases and digital content sold in the Google Play store”—​but the 2023 filing places this source more deliberately within Alphabet’s broader non‑advertising growth strategy, listing it alongside hardware and YouTube‑non‑advertising as a distinct pillar of diversification away from ads.  Thus, Google Play’s role evolved from a peripheral revenue stream in 2022 to a highlighted, strategic component of Google’s non‑advertising revenue mix in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN CORE CLAIM: The LLM answer fundamentally contradicts the ground truth on the key evolution of Google Play's description. Ground truth states that by 2023, Google Play's revenue focus 'had evolved to be more narrowly described as primarily coming from apps and in-app purchases' (removing 'digital content'). The LLM claims the filings treat Google Play 'in essentially the same way' with the same full description in both years, which directly contradicts the ground truth's assertion of a narrowing/shift in emphasis. This is a major factual error on the central claim of the question. The LLM also mischaracterizes the nature of the evolution: ground truth indicates a shift in HOW Google Play is described (narrower focus on apps/in-app purchases vs. broader digital content), while the LLM suggests the evolution is about strategic positioning/emphasis (peripheral to highlighted). These are different types of evolution. CORRECT ELEMENTS: The LLM correctly identifies that Google Play generates revenue from apps and in-app purchases, correctly names the years (2022-2023), and correctly identifies that Google Play is part of non-advertising revenue strategy. The LLM also correctly notes that 2023 places it within a broader strategic context. MISSING/INCORRECT SYNTHESIS: The LLM fails to identify the specific narrowing of revenue sources mentioned (removal of 'digital content' from the description), which is the key evidence of evolution according to the ground truth. The LLM's interpretation that the change is about strategic positioning rather than actual description change represents a fundamental misreading of what the ground truth identifies as the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 463,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "\nThe 2022 filing projected deliveries of the Cessna SkyCourier 408 at 11 aircraft for 2023 and 12 aircraft for 2024, while the 2024 filing revises those expectations upward to 17 aircraft slated for 2025 and 14 for 2026. This upward revision shows FedEx is planning a larger SkyCourier fleet than originally anticipated, underscoring the company’s strategic reliance on the model to expand its regional, last‑mile and fuel‑efficient capacity.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth across multiple dimensions: (1) QUANTITATIVE ERRORS: The LLM cites specific annual delivery numbers (11 for 2023, 12 for 2024, 17 for 2025, 14 for 2026) that do not match the ground truth's aggregate projections (49 total aircraft 2023-thereafter in 2022; 31 total aircraft 2025-2029 in 2024). The ground truth provides cumulative projections across multi-year periods, not annual breakdowns. The LLM's numbers appear fabricated or misinterpreted. (2) DIRECTIONAL ERROR: The LLM claims an 'upward revision' in projections, but the ground truth shows a REDUCTION from 49 aircraft to 31 aircraft—a significant downward revision. This is a critical error in interpreting the strategic trend. (3) RELATIONSHIP SHIFT OMISSION: The LLM completely fails to mention the crucial shift in relationship type from 'Increases' to 'Depends_On' noted in the ground truth, which is a key indicator of changing strategic importance. (4) REASONING FLAW: The LLM's conclusion that FedEx is 'planning a larger SkyCourier fleet than originally anticipated' directly contradicts the actual data showing reduced projections. The semantic meaning of the answer is fundamentally incorrect. (5) MULTI-HOP SYNTHESIS: The LLM failed to properly synthesize the 2022 vs 2024 filing comparisons, arriving at the opposite conclusion from what the data supports. The answer demonstrates a misunderstanding of both the specific numbers and the overall strategic narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 419,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "\nBetween 2022 and 2023 AIG refined the way it applies expected‑loss‑ratio methods, moving from a broad auto‑versus‑non‑auto split to a more granular, attachment‑point‑band segmentation that first models losses capped at $10 million with the ratio approach and then projects the higher‑limit layers from that estimate. The 2023 description also adds explicit COVID‑19 adjustments and extends the expected‑loss‑ratio analysis to both U.S. Excess Casualty and U.S. Other Casualty lines (including general liability, commercial auto, medical‑malpractice, etc.), whereas the 2022 wording only referenced a generic segmentation by attachment point.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. Key issues: (1) WRONG LINE OF BUSINESS FOCUS: The ground truth clearly states that in 2022, AIG used expected loss ratio methods for U.S. Excess Casualty, and in 2023 shifted to U.S. Workers' Compensation. The LLM answer incorrectly claims the 2023 analysis extended to 'U.S. Other Casualty lines (including general liability, commercial auto, medical-malpractice)' - this is not supported by the ground truth and represents a fundamental misunderstanding of the evolution described. (2) INCORRECT SEGMENTATION DETAILS: The LLM describes a shift from 'auto-versus-non-auto split to attachment-point-band segmentation' with specific modeling at '$10 million' caps. The ground truth indicates that in 2022, segmentation was already by attachment point AND differentiated between auto/non-auto. The LLM reverses this progression and introduces unsupported details about $10 million caps and COVID-19 adjustments. (3) MISSING KEY EVOLUTION: The ground truth's core insight is that the METHOD SHIFTED FROM ONE CASUALTY LINE (Excess Casualty in 2022) TO A DIFFERENT LINE (Workers' Compensation in 2023), with different segmentation approaches (attachment point/auto-non-auto vs. risk-sharing features/state/industry/claim handling entity). The LLM completely misses this fundamental shift and instead describes technical refinements within what appears to be the same line. (4) UNSUPPORTED CLAIMS: The mention of COVID-19 adjustments and the specific $10 million modeling threshold are not present in the ground truth. (5) INCOMPLETE SYNTHESIS: The LLM fails to capture the strategic evolution across different casualty lines and the different segmentation methodologies applied to each. The answer demonstrates a failure to correctly synthesize the multi-hop information about how AIG's approach evolved between years and across different business lines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 525,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Nike kept the same four‑category consumer construct—Men’s, Women’s, Kids’ and Jordan Brand—introduced in 2022, but it refined how “unallocated” items are shown.  In 2022 the unallocated bucket was labeled **“Others (5)”** and described as products not assigned to Men’s, Women’s, Kids’ or Jordan Brand plus certain non‑allocated adjustments; by 2024 the same group is called **“Others (4)”** with an identical definition, reflecting only a naming change and minor re‑classification of the categories (e.g., “NIKE Kids’” becomes “Kids’”).  Thus, the classification of unallocated products remained under an “Others” line, consistently placed outside the core consumer segments while the consumer‑direct construct itself stayed unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) NUMERIC ERRORS: The LLM claims 'Others (5)' in 2022 and 'Others (4)' in 2024, but provides no evidence these footnote numbers are correct and the ground truth makes no mention of these specific footnote designations. This appears to be fabricated detail. (2) MISSING CRITICAL INFORMATION: The ground truth explicitly states that in FY2022, 'unisex products were classified within Men's' - this is a crucial detail the LLM completely omits. The LLM's answer focuses on naming conventions ('Others (5)' vs 'Others (4)') rather than the substantive shift in how unisex products were handled. (3) INCOMPLETE SYNTHESIS: The ground truth indicates a 'potential shift or integration of unisex products within broader categories' by 2024, with no specific mention of unisex classification within Men's anymore. The LLM fails to address this evolution entirely. (4) MISLEADING CHARACTERIZATION: The LLM describes the changes as 'only a naming change and minor re-classification' when the ground truth suggests a more substantive shift in how unisex products are categorized and reported. (5) UNSUBSTANTIATED CLAIMS: The LLM introduces specific footnote numbers and naming conventions that cannot be verified against the ground truth provided. The answer reads as plausible but appears to contain invented details rather than accurate synthesis of the actual filing data. The core evolution of unisex product classification - the most important aspect of the question - is entirely missing from the LLM response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 439,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "\nBetween 2023 and 2024 the company moved from merely disclosing the 3.500 % Senior Notes due 2025 as part of an earlier Board‑approved list of senior unsecured issues to re‑authorizing and expanding that series in the 2024 filing (including a supplemental indenture and updated Board resolutions that permitted additional issuances).  This shows PepsiCo is actively managing its 2025 maturity bucket—refinancing or augmenting the notes to lock in favorable rates and maintain a staggered, cost‑effective debt ladder.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims PepsiCo 're-authorized and expanded' the 3.500% Senior Notes due 2025 in 2024 with 'supplemental indenture and updated Board resolutions,' but the ground truth makes no mention of re-authorization, supplemental indentures, or expanded issuances of this specific note series. The ground truth simply states the notes were 'still present' in 2024. (2) MISSING CRITICAL INFORMATION: The LLM completely omits the key finding from the ground truth—that PepsiCo introduced NEW longer-term notes in 2024 (3.500% Senior Notes due 2040 and 3.550% Senior Notes due 2034). This is central to understanding the debt management strategy shift. (3) MISCHARACTERIZED STRATEGY: The ground truth indicates a strategic shift toward 'diversifying its debt maturity structure' by adding longer-term instruments. The LLM incorrectly frames this as 'refinancing or augmenting' the 2025 notes specifically, which contradicts the actual strategy of introducing new longer-dated securities. (4) UNSUPPORTED CLAIMS: The LLM makes specific claims about 'supplemental indenture,' 'Board resolutions,' and 'additional issuances' that are not supported by the ground truth and appear to be fabricated details. (5) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks how engagement 'evolved' between 2023 and 2024. The ground truth shows evolution through portfolio expansion with new instruments. The LLM fails to capture this evolution and instead invents a different narrative about re-authorization. The answer demonstrates poor multi-hop reasoning by failing to synthesize the actual changes in debt structure across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 479,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "\nBetween 2022 and 2024 ConocoPhillips raised its capital outlays in the Lower 48 from about **$4.6 bn** (2022) to roughly **$6.3 bn** in both 2023 and 2024, reflecting higher development and property‑acquisition spending.  At the same time, the outlook for future cash inflows from Lower 48 reserves was revised upward—future cash‑inflow estimates climbed from **$195 bn** (2022) to **$164 bn** (2024), and the discounted future net cash flow at year‑end 2024 was **$38.7 bn**, driven by added reserves, extensions and improved commodity‑price assumptions.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on nearly all quantitative metrics and contradicts the ground truth in multiple critical ways: (1) CAPITAL EXPENDITURES - Ground truth states 2022 CapEx was $3,129 million for Lower 48; LLM claims $4.6 billion (2022) and $6.3 billion (2023-2024). These numbers are completely wrong and represent a major factual error. The ground truth explicitly notes that by 2024, no new CapEx figure was provided, yet LLM provides specific figures. (2) FUTURE CASH INFLOWS - Ground truth indicates cash inflow revisions occurred but doesn't provide the specific $195bn (2022) or $164bn (2024) figures cited by LLM. More critically, the ground truth states cash inflows were REVISED UPWARD in the narrative context, but LLM's numbers show a DECREASE from $195bn to $164bn, which contradicts the stated direction of revision. (3) DISCOUNTED FUTURE NET CASH FLOW - LLM provides $38.7bn figure for 2024 with no corresponding data in ground truth to verify. (4) DIRECTIONAL LOGIC - Ground truth emphasizes a transition from active investment (CapEx reporting) to focus on revising financial projections. LLM's narrative of increasing CapEx contradicts this fundamental shift. (5) MULTI-HOP SYNTHESIS - LLM failed to correctly synthesize the evolution between 2022 and 2024, providing incorrect numbers and mischaracterizing the nature of changes. The answer appears to contain fabricated financial data rather than accurate SEC filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 406,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "\nBetween 2023 and 2024 Comcast trimmed its remaining unfunded capital commitment to Atairos from roughly **$1.5 billion** (as disclosed in the 2023 filing) to **about $1.4 billion** in the 2024 filing, reflecting the $40 million annual management‑fee obligation and the **$4.5 billion aggregate funding cap** that was set by the 2020 amendment.  Governance did not shift – Atairos remains a variable‑interest entity that Comcast does **not consolidate**; it holds **no voting rights** (only limited consent rights) and continues to be controlled by the management companies led by its former CFO, while Comcast absorbs **≈ 99 % of any losses** and receives **≈ 86 % of residual returns** on a cumulative basis.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - CRITICAL FAILURES: The LLM states Comcast 'trimmed its remaining unfunded capital commitment...from roughly $1.5 billion...to about $1.4 billion' - these numbers are NOT supported by the ground truth and appear to be fabricated. The ground truth clearly states the capital commitment was REDUCED from $5 billion to $4.5 billion between 2023-2024, a $500 million reduction, not the trivial $100 million reduction claimed. The LLM's $1.5B and $1.4B figures are unexplained and incorrect. (2) INCOMPLETE SYNTHESIS: The LLM fails to mention the key evolution that occurred - the shift to 'equity method accounting' and the formalization of the investment framework in 2024, which is central to understanding how the relationship evolved. (3) MISSING CRITICAL DETAILS: The ground truth specifies that annual capital calls were LIMITED to $400 million and that $40 million annually was separately agreed for management fees - the LLM mentions the $40M fee obligation but doesn't clearly articulate the $400M annual cap structure or how it relates to the overall commitment reduction. (4) GOVERNANCE ACCURACY: The LLM correctly identifies that Atairos remains a variable-interest entity not consolidated, that Comcast has no voting rights, that management companies retain control, and that loss/return percentages are ~99% and ~86% respectively. However, it misses the significance of the 'Fourth Amended and Restated Shareholders Agreement' and the June 2023 amendment as key governance milestones. (5) MULTI-HOP REASONING: The LLM fails to properly synthesize the evolution between 2023 and 2024 - it doesn't explain WHY the commitment changed or HOW the governance arrangements clarified. The answer reads as a snapshot rather than an evolution narrative. (6) REFERENCE TO 2020 AMENDMENT: The LLM mentions a '2020 amendment' setting the $4.5B cap, but the ground truth indicates the $4.5B figure emerged in the 2024 framework discussion, not as a pre-existing 2020 constraint. This suggests confusion about timeline and source of the commitment reduction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 565,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "\nIn the 2022 filing FedEx projected 11 Cessna SkyCourier 408 deliveries in 2023 and a total of 49 through 2026, but the 2023 filing revises the schedule to 17 aircraft slated for delivery in 2025 (with 14 still planned for 2026), raising the remaining‑delivery tally to 31 and signalling a faster ramp‑up.  This upward revision shows FedEx is accelerating the SkyCourier’s entry into service, casting it as a key medium‑size freighter that bridges the gap between smaller turboprops and the larger 767/ 777 jets and will play a growing strategic role in expanding its regional feeder network.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERRORS: The ground truth states the 2022 projection was 49 aircraft through 2027, and the 2023 projection dropped to 31 aircraft through 2029 - representing a REDUCTION. The LLM claims the 2023 filing shows 31 aircraft representing an 'upward revision' and 'faster ramp-up,' which is factually incorrect. The LLM misinterprets a reduction as an increase. The specific delivery numbers cited (11 in 2023, 17 in 2025, 14 in 2026) cannot be verified against the ground truth and appear to be fabricated details. (2) DIRECTIONAL MISINTERPRETATION: The ground truth clearly indicates a 'significant' drop from 49 to 31 aircraft, signaling a 'strategic reduction' in planned reliance. The LLM completely inverts this narrative, claiming an 'upward revision' and 'accelerating' entry into service. This is a 180-degree misreading of the data. (3) REASONING FAILURE: The LLM's conclusion that this 'signals a faster ramp-up' and indicates the aircraft will 'play a growing strategic role' directly contradicts the ground truth's assessment that it indicates 'reassessment' and reduced reliance. The multi-hop reasoning is fundamentally flawed. (4) PARTIAL CREDIT: The LLM correctly identifies the aircraft type (Cessna SkyCourier 408) and attempts to contextualize it within the broader fleet strategy, which shows some understanding of the question's intent. However, the core factual claims are inverted, making the answer misleading and incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 429,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "\nFrom fiscal 2022 to 2024 Nike moved from a single‑line footwear revenue figure to a highly disaggregated reporting structure that breaks out NIKE Brand footwear (including the Air Max line) by geography, sales channel (wholesale vs. Direct‑to‑Consumer) and product category, giving investors explicit visibility into how much revenue the Air Max collection generates.  At the same time, the company’s MD&A and R&D disclosures have placed stronger emphasis on next‑generation Air Max technologies—highlighting innovations such as Zoom Air, React foam and digitally‑enabled fit systems—while still positioning Air Max as a core growth driver for the brand.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - Revenue Transparency: The LLM claims Nike moved to 'highly disaggregated reporting structure' that gives 'explicit visibility into how much revenue the Air Max collection generates' with 'specific revenue figures.' This is directly contradicted by the ground truth, which explicitly states 'no direct revenue numbers were disclosed' and 'continued lack of standalone financial metrics for the product line.' The LLM fabricated the existence of Air Max-specific revenue disclosures that do not exist in Nike's filings. (2) CRITICAL ERROR - Reporting Structure: The LLM describes a shift from 'single-line footwear revenue figure' to disaggregation by geography, channel, and product category. The ground truth makes no such claim about reporting structure changes. The ground truth focuses on Air Max's positioning in revenue disaggregation tables (2022) versus innovation strategy emphasis (2024), not a fundamental restructuring of Nike's reporting. (3) PARTIAL ACCURACY - Technological Innovation: The LLM correctly identifies that Nike emphasized technological innovations (Zoom Air, React foam, digitally-enabled fit systems) and positioned Air Max as a growth driver. This aligns with the ground truth's statement about 'positioning Air Max as a key innovation driver.' However, this is the only element that partially matches. (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the actual evolution described in the ground truth: from 'passive acknowledgment' in 2022 (listed in revenue disaggregation table) to 'active positioning' in 2024 (central example of innovation strategy). Instead, the LLM invented a narrative about increased financial transparency that does not exist. (5) SEMANTIC MISALIGNMENT: The core premise of the LLM answer is fundamentally wrong - it claims Nike now provides explicit Air Max revenue visibility, when the ground truth explicitly states the opposite. This is not a wording difference but a factual inversion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 560,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "\nFrom 2023 to 2024 Comcast moved from the planning/land‑acquisition phase for Epic Universe to active construction spending.  In 2023 the company noted that “capital expenditures increased related to the development of Epic Universe in Orlando,” and total segment capex rose 1.5% to **$8.2 billion**; by 2024 overall capex was essentially flat at **$8.286 billion**, but the release explicitly states that “spending on theme‑park attractions increased in 2024, and included costs associated with the construction of Epic Universe,” signaling a shift in priority toward completing the Orlando park while maintaining the same overall capital‑expenditure level.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Comcast's Epic Universe capital expenditure evolution with mostly accurate information. STRENGTHS: (1) Correctly identifies the $8.2 billion figure for 2023 Connectivity & Platforms capex; (2) Accurately cites the $8.286 billion 2024 capex figure; (3) Properly characterizes the shift from planning/infrastructure phase to active construction spending; (4) Correctly notes the emphasis on theme park attractions in 2024; (5) Sound multi-hop reasoning connecting capex figures across years with strategic narrative. WEAKNESSES: (1) The LLM introduces a specific characterization of 'planning/land-acquisition phase' in 2023 that is not explicitly stated in the ground truth, which only mentions 'infrastructure and development focus'; (2) The statement about capex being 'essentially flat' at $8.286 billion is somewhat misleading - while close to $8.2B, this represents a ~1% increase, not truly flat; (3) The LLM provides more interpretive narrative about the strategic shift than the ground truth, which is reasonable but goes slightly beyond what was explicitly disclosed; (4) The ground truth notes that 'specific figures for Epic Universe alone were not disclosed in 2024,' which the LLM answer doesn't explicitly acknowledge, though it does note the broader capex context. QUANTITATIVE VERIFICATION: $8.2B (2023) and $8.286B (2024) are both correct. The characterization of 'essentially flat' is approximately accurate but slightly imprecise. MULTI-HOP REASONING: The answer successfully synthesizes information across 2023 and 2024 filings, connecting capex figures to strategic priorities. The reasoning about the shift from infrastructure to construction is sound and well-supported. SEMANTIC EQUIVALENCE: The answer conveys the core evolution of strategy accurately, though with somewhat more interpretive language than the ground truth baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 516,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "\nBetween the 2022 and 2023 filings, FedEx’s ATR 72‑600F fleet grew from six aircraft (five operational and one undergoing pre‑service modifications) as reported in the 2022 10‑K (pages 38‑42) to a planned addition of eleven ATR 72‑600Fs scheduled for delivery in 2023, with a total of 24 on order through 2026 as shown in the 2023 10‑K purchase‑commitment tables (pages 115‑119). This reflects a clear expansion of the type’s utilization, moving from a modest existing inventory to a significant planned influx that will increase the airline’s regional freight capacity over the next few years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is fundamentally misaligned with the ground truth and the question being asked. Critical issues: (1) WRONG FOCUS: The LLM discusses the existing fleet (6 aircraft) and new orders (11 scheduled for 2023 delivery, 24 total on order), which is about fleet acquisition/expansion. The ground truth addresses fleet PROJECTIONS across specific years (2023-2026) showing how planned utilization changed between the 2022 and 2023 planning periods. (2) MISSING KEY DATA: The LLM completely fails to cite the actual projection numbers from ground truth: 2022 projections (11 in 2023, 6 in 2024, 6 in 2025, 1 in 2026) vs 2023 projections (7 in 2025, 3 in 2026). These are the core facts needed to answer the question. (3) INCORRECT INTERPRETATION: The LLM interprets the question as asking about fleet growth/expansion rather than how projections evolved. The ground truth shows a REDUCTION in planned utilization (from 11 projected for 2023 down to 7 for 2025 and 3 for 2026 in the later projection), which contradicts the LLM's conclusion of 'clear expansion.' (4) QUANTITATIVE ERRORS: The numbers cited (6 operational, 11 scheduled for 2023, 24 total on order) are not the projection figures requested. The question specifically asks about 'fleet projections for the same planning periods' - meaning how the 2022 plan differed from the 2023 plan for overlapping years. (5) MULTI-HOP REASONING FAILURE: The LLM failed to synthesize the comparison between two different years' projection documents to show how expectations changed. Instead, it conflated current fleet status with future projections. The answer demonstrates a fundamental misunderstanding of what the question asks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 460,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "\nIn fiscal 2022 Nike recorded a $1.015 bn sales‑related reserve and estimated the cost of inventory for expected product returns at $194 million (down from $269 million in 2021). The 2024 filing revises those figures with a more granular, specific‑identification approach that incorporates recent return trends and forward‑looking demand assumptions, yielding a slightly lower reserve balance and a reduced estimated return‑inventory cost. This refinement tightens the contra‑revenue reserve, indicating that Nike is adjusting its revenue‑recognition model to be more precise and less conservative about future product returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that fundamentally undermine its credibility:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - Claims fiscal 2022 had a '$1.015 bn sales-related reserve' - this figure is not mentioned in the ground truth and appears to be fabricated or confused with another metric\n   - States the product return reserve was '$194 million (down from $269 million in 2021)' - the ground truth explicitly states fiscal 2022 was $269 million, not $194 million. The LLM has reversed the comparison direction and provided an incorrect 2022 figure\n   - The ground truth clearly states: 'In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million'\n   - No specific dollar amount is provided for fiscal 2024 in the ground truth, yet the LLM claims to know the 2024 figure is 'slightly lower'\n\n2. ENTITY/YEAR ACCURACY:\n   - Confuses the fiscal year comparisons (claims 2022 was $194M down from 2021's $269M, when ground truth indicates 2022 was $269M)\n   - Misidentifies which year had which reserve amount\n\n3. REASONING QUALITY:\n   - The multi-hop synthesis is flawed because the underlying numbers are incorrect\n   - Incorrectly concludes Nike is 'less conservative' when the ground truth indicates a shift toward 'more probabilistic and forward-looking' methodology\n   - Mischaracterizes the methodological change as 'specific-identification approach' when ground truth describes it as determining the 'most likely amount'\n\n4. MISSING KEY INFORMATION:\n   - Fails to capture that fiscal 2024 did not disclose a specific dollar amount (ground truth: 'while the specific dollar amount of the product return reserve was not disclosed')\n   - Misses the key insight about alignment with variable consideration estimation framework\n   - Incorrectly suggests the 2024 reserve is 'slightly lower' when no comparable figure is provided\n\n5. SEMANTIC ISSUES:\n   - The characterization of changes differs from ground truth: LLM says 'less conservative' vs. ground truth's 'more probabilistic and forward-looking'\n   - LLM's description of 'tightening the contra-revenue reserve' is not supported by the ground truth\n\nThe answer demonstrates fundamental misunderstanding of the source material with invented or misremembered numbers that directly contradict the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 632,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings, the projected deliveries of the Cessna SkyCourier 408 rose from **12 aircraft in 2025 (and 14 in 2026)** in the 2022 schedule to **17 aircraft in 2025 (with 14 still planned for 2026)** in the 2023 schedule.  This upward revision shows that FedEx is **increasing its strategic reliance on the SkyCourier 408**, using the type to expand and modernize its regional package network and to secure the fuel‑efficient capacity needed for growth beyond 2025.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in the 2022 projection. According to the ground truth, in 2022 FDX projected 12 Cessna SkyCourier 408 aircraft for 2025 AND maintained that same number (12) through 2026. However, the LLM states the 2022 schedule showed '12 aircraft in 2025 (and 14 in 2026)' - this is incorrect. The ground truth clearly states 12 for both 2025 and 2026 in the 2022 projection. The 2023 figures are correct: 17 for 2025 and 14 for 2026. This error undermines the quantitative accuracy significantly. The LLM's reasoning about 'increasing strategic reliance' is partially correct for 2025 (12→17 is an increase), but the characterization misses the nuance that the ground truth provides: the 2023 plan shows a 'short-term increase' followed by 'moderate decline,' suggesting a recalibration rather than sustained increased reliance. The LLM's conclusion that FedEx is 'increasing its strategic reliance' is somewhat misleading because by 2026, the planned fleet (14) is actually higher than the original 2022 plan (12), but lower than the 2025 peak (17), which the ground truth correctly characterizes as a recalibration. The multi-hop synthesis is attempted but flawed due to the incorrect 2022 baseline. The answer addresses the question's components but with a fundamental numerical error that affects the validity of the comparison and strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 388,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "\nBetween the end of 2023 and 2024 Mastercard grew its real‑time account‑based payments network from the 13 markets in which it was operating (or implementing) at year‑end 2023 to a wider global footprint that adds several new jurisdictions and substantially higher transaction‑volume capacity.  At the same time the platform was hardened with additional security layers—token‑based credentialing, AI‑driven fraud‑scoring, continuous third‑party validation and tighter integration with the company’s multi‑layered franchise security framework—delivering a more resilient, always‑on infrastructure that can safely scale real‑time, account‑to‑account payments worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across most dimensions. STRENGTHS: (1) Correctly identifies the 13 markets baseline from 2023, establishing proper quantitative foundation. (2) Accurately captures the expansion narrative from 2023 to 2024 with 'wider global footprint' and 'several new jurisdictions.' (3) Properly synthesizes security enhancements including token-based credentialing, AI-driven fraud scoring, and multi-layered security framework integration—all consistent with ground truth. (4) Correctly emphasizes the dual evolution of scale and security as the core strategic shift. (5) Uses appropriate terminology ('account-to-account payments,' 'distributed network,' 'always-on infrastructure') that aligns with ground truth concepts. MINOR WEAKNESSES: (1) The phrase 'substantially higher transaction-volume capacity' is inferred rather than explicitly stated in ground truth—while logically sound, it adds specificity not directly supported by source material. (2) Does not explicitly mention 'enhanced data and messaging capabilities' from 2023 baseline, though this is a minor omission. (3) 'Continuous third-party validation' is mentioned but not explicitly detailed in ground truth. QUANTITATIVE VERIFICATION: The single numeric claim (13 markets in 2023) is correct. The expansion to 'several new jurisdictions' appropriately reflects the growth without overstating specific numbers. MULTI-HOP REASONING: Successfully synthesizes information across the 2023-2024 timeline and correctly links operational scale improvements with security enhancements. The reasoning that these developments represent a 'strategic shift' is sound and supported. SEMANTIC EQUIVALENCE: The answer conveys the same essential information as ground truth with slightly more specific technical detail on security mechanisms, which enhances rather than contradicts the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 516,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Nike trimmed the size of its cash‑flow‑designated foreign‑exchange hedge program – the notional amount of outstanding forwards and options fell from about **$18.5 bn (as of May 31 2022)** to **$16.2 bn (as of May 31 2024)** (and was $18.2 bn in 2023), so fewer forecasted purchase‑cost exposures were being locked in.  Consequently the balance of deferred net gains in Accumulated Other Comprehensive Income dropped sharply, from **$607 m expected to be re‑classified in the next 12 months in 2022** to only **$231 m projected for 2024**, indicating a smaller impact on future net income.  At the same time the company expanded its use of **undesignated forwards** (from roughly **$3 bn of notional in 2022 to about $4.5 bn by 2024**), which are recorded directly in “Other (income) expense, net” rather than through AOCI, reflecting a shift toward managing specific balance‑sheet items with shorter‑term, non‑designated derivatives instead of broad cash‑flow hedges.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR DISCREPANCY: The LLM answer provides detailed information about notional amounts of forwards/options ($18.5bn to $16.2bn), AOCI balances ($607m to $231m), and undesignated forwards ($3bn to $4.5bn) that are NOT present in the ground truth answer. The ground truth specifically states: (1) 2022: net gain of $8 million after tax impacting revenues, cost of sales, and other (income) expense, net; (2) 2024: liabilities of $110 million under accrued liabilities and $5 million under deferred income taxes. The LLM answer completely omits these specific liability figures ($110m and $5m) that are central to the ground truth. While the LLM's discussion of notional amounts and AOCI may be factually accurate from the 10-K filings, it fails to address the core metrics mentioned in the ground truth (the $8m net gain in 2022, the $110m and $5m liabilities in 2024). The LLM appears to have answered a different aspect of the question (program size and structure) rather than the specific financial impact on liabilities and hedging strategy as framed by the ground truth. The answer demonstrates partial understanding of Nike's FX hedging evolution but fundamentally misses the quantitative metrics that define the ground truth answer. This represents a failure in multi-hop synthesis - the model did not correctly identify and synthesize the specific liability impacts that were the focus of the original question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 393,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the way Puffs is listed under the **Baby, Feminine & Family Care** segment changed.  \n- In the 2022 report (pages 17‑21 of PG_10k_2022.pdf) the segment’s product‑category breakdown includes a distinct **Baby Care** sub‑category that lists “Baby Wipes, Taped Diapers and Pants” and names **Puffs** among its major brands.  \n- In the 2023 report (pages 16‑20 of PG_10k_2023.pdf) the **Baby Care** sub‑category is omitted; the segment’s categories are reduced to **Feminine Care** and **Family Care**, and **Puffs** is now grouped under the **Family Care** sub‑category (alongside paper towels, tissues and toilet paper).  \n\nThus, Puffs moved from being classified within a separate Baby Care category in 2022 to being placed under the broader Family Care category in 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth states that Puffs was categorized under Family Care in both 2022 and 2023, with only a simplification in reporting details between years. However, the LLM answer claims that Puffs moved from being classified within a separate Baby Care category in 2022 to Family Care in 2023. This is incorrect. The LLM has misidentified Puffs' category in 2022 - it was never in Baby Care; it was in Family Care both years. The LLM appears to have confused the segment structure (which did change from having a Baby Care sub-category in 2022 to not having one in 2023) with Puffs' specific categorization. While the LLM correctly identifies that the segment structure changed and that Family Care includes paper towels, tissues, and toilet paper, the core claim about Puffs' movement between categories is factually wrong. This is a critical error in a multi-hop question requiring accurate synthesis of product categorization data across years. The answer demonstrates a misunderstanding of the distinction between segment restructuring and individual product categorization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 330,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings Tampax continues to sit in the **Baby, Feminine & Family Care** segment, but its classification is refined.  \n- In the 2022 filing it appears under “Feminine Care (Adult Incontinence, Feminine Care)”, listed among the major brands as **Tampax Bounty**.  \n- In the 2023 filing the same category is labeled “Feminine Care (Adult Incontinence, Menstrual Care)”, still showing **Tampax Bounty** as a key brand.  \n\nThus, Tampax’s positioning remained within the feminine‑care line of the Baby/Feminine/Family Care portfolio, with only a more precise terminology shift from a generic “Feminine Care” grouping to an explicit “Menstrual Care” sub‑category, while continuing to be marketed under the Tampax Bounty brand alongside Always and Always Discreet.",
      "correctness_score": 4,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: (1) The LLM introduces 'Tampax Bounty' as a brand name, which is NOT mentioned in the ground truth and appears to be a factual error - Tampax and Bounty are separate P&G brands, not a combined 'Tampax Bounty' product. This is a significant entity accuracy failure. (2) The LLM states Tampax was listed 'among the major brands as Tampax Bounty' in 2022 and 2023, but the ground truth makes no mention of Bounty in connection with Tampax's categorization. (3) The LLM mentions 'Always and Always Discreet' alongside Tampax Bounty, but the ground truth does not reference these brand associations in the context of Tampax's positioning evolution. CORRECT ELEMENTS: (1) The core finding that Tampax remained in 'Baby, Feminine & Family Care' segment is correct. (2) The identification of the shift from 'Feminine Care' to 'Menstrual Care' categorization between 2022 and 2023 is accurate and matches the ground truth. (3) The characterization of this as a 'more precise terminology shift' and 'more focused positioning' aligns with the ground truth's description. MULTI-HOP REASONING: The LLM correctly synthesized that the categorization changed between years within the same segment, but failed to accurately identify which brands/products were actually involved in this evolution. The introduction of 'Tampax Bounty' as a unified brand name represents a fundamental factual error that undermines the credibility of the answer, even though the core categorical shift is correctly identified. The answer demonstrates partial understanding of the portfolio evolution but contains significant inaccuracies regarding brand naming and associated product lines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 456,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "\nOracle continued to pull back on Engineered Systems, with constant‑currency hardware revenue slipping in fiscal 2022 and the segment’s share of total sales staying around 6 % in fiscal 2023—evidence of a deliberate de‑emphasis of hardware in favor of cloud and license offerings. At the same time, the company signaled stronger R&D commitment to engineered systems, noting a 5 % rise in constant‑currency R&D expense in fiscal 2022 and stating that it will keep investing to improve and expand these systems to meet cloud‑centric customer demand.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims 'constant-currency hardware revenue slipping in fiscal 2022' and mentions a '5% rise in constant-currency R&D expense in fiscal 2022,' but the ground truth does not specify these metrics or provide R&D percentage changes. The ground truth only states that hardware represented 6% of total revenues in fiscal 2023, not that it 'stayed around 6%' in both years. (2) DIRECTIONAL MISREPRESENTATION: The LLM characterizes Oracle's strategy as 'pulling back' and 'de-emphasis of hardware,' but the ground truth indicates Oracle was actually introducing a 'more forward-looking strategy' with explicit plans to 'continue investing in research and development to improve existing hardware products and develop new offerings.' This is the opposite interpretation. (3) INCOMPLETE SYNTHESIS: The ground truth emphasizes the evolution from fiscal 2022 (point-of-sale revenue recognition, indirect channels) to fiscal 2023 (forward-looking R&D investment plans, clearer strategic positioning). The LLM fails to capture this evolution and instead presents a narrative of de-emphasis. (4) UNSUPPORTED CLAIMS: The LLM introduces concepts like 'cloud-centric customer demand' and 'deliberate de-emphasis in favor of cloud and license offerings' that are not present in the ground truth. (5) PARTIAL CREDIT: The LLM correctly identifies that hardware was 6% of revenues in fiscal 2023 and acknowledges R&D investment commitment, but the overall framing and interpretation are fundamentally misaligned with the ground truth's emphasis on Oracle's forward-looking, investment-focused strategy for Engineered Systems.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 478,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "\nBetween 2022 and 2023 the non‑U.S. pension plan’s exposure to private‑fund investments grew from **$90 million to $115 million**.  The share classified in the fair‑value hierarchy shifted markedly toward the lowest level: **Level 3 assets rose from $36 million to $74 million**, while the Level 2 portion fell from $54 million to $41 million, and the amount measured under the NAV practical‑expedient slipped from $10 million to $8 million.  Consequently, the private‑fund portfolio became larger and increasingly valued using unobservable inputs (Level 3) over the two years.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains fundamental factual inaccuracies that directly contradict the ground truth. (1) ENTITY CONFUSION: The ground truth explicitly states the 2022 figure of $1,105 million was for U.S. pension plans, not Non-U.S. plans. The LLM incorrectly presents a comparison between 2022 and 2023 for Non-U.S. plans only, missing the critical distinction between U.S. and Non-U.S. plans that is central to the question. (2) MISSING KEY DATA: The LLM completely omits the $1,105 million U.S. pension plan investment from 2022, which represents the most significant component of the evolution described in the ground truth. The question specifically asks about evolution 'between 2022 and 2023,' requiring comparison of both years' data. (3) QUANTITATIVE DISCREPANCIES: While the LLM correctly identifies $115 million for 2023 Non-U.S. plans and the Level 2/Level 3 split ($41M/$74M), it introduces unexplained 2022 figures ($90M, $36M, $54M, $10M) that are not mentioned in the ground truth and appear to be fabricated or from a different source. The ground truth provides no 2022 Non-U.S. breakdown. (4) INCOMPLETE SYNTHESIS: The answer fails to synthesize the multi-hop requirement of comparing U.S. vs. Non-U.S. plans across years and explaining the 'significant decrease in overall private fund allocation' that the ground truth emphasizes. (5) MISLEADING NARRATIVE: The LLM's framing of 'growth from $90M to $115M' in Non-U.S. plans obscures the actual story: a dramatic reduction from $1,105M (U.S., 2022) to $115M (Non-U.S., 2023), representing a shift in pension plan structure or investment strategy. The answer demonstrates partial understanding of fair value hierarchy mechanics but fails on factual accuracy and multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 483,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "\nBetween the end of 2023 and 2024 the 2014 USD Notes (3.375 % senior notes due April 2024) moved from a long‑term obligation to short‑term status and were fully retired when the $1 billion principal matured in April 2024 and was paid off, eliminating the note from the Company’s outstanding debt.  The repayment was funded from operating cash flow and the Company’s available liquidity, after which the 2014 USD Notes no longer appeared on the balance sheet.  (No new 2014‑series notes were issued; the Company instead issued fresh 2024 USD Notes later in 2024.)",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the $1 billion principal amount, the April 2024 maturity date, the 3.375% coupon rate, and that the notes were fully paid off/retired in April 2024. The core facts about the debt being settled are accurate. The answer appropriately addresses the evolution of the debt's status and the specific action taken in 2024.\n\nWEAKNESSES: (1) CRITICAL ERROR - The LLM states the notes moved 'from a long-term obligation to short-term status' between 2023 and 2024. The ground truth explicitly states they were 'classified as short-term debt' in 2023 already. This is a factual error about the 2023 status. (2) UNSUPPORTED CLAIMS - The LLM adds details not in the ground truth: that repayment was 'funded from operating cash flow and available liquidity,' that 'no new 2014-series notes were issued,' and that 'the Company instead issued fresh 2024 USD Notes later in 2024.' While these may be true, they are not part of the ground truth answer and represent information synthesis beyond what was provided. (3) INCOMPLETE GROUNDING - The answer conflates what was in the ground truth with additional contextual details that weren't explicitly stated in the original answer.\n\nMULTI-HOP REASONING: The model correctly synthesizes the transition from 2023 to 2024 and identifies the maturity/repayment event, but the characterization of the 2023 status is incorrect.\n\nNUMERIC VERIFICATION: $1 billion principal amount ✓, April 2024 maturity ✓, 3.375% coupon ✓ - all correct.\n\nThe answer is substantially correct on the core facts but contains a significant factual error about the 2023 classification and adds unsupported details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 455,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "\nBetween 2022 and 2024 Lowe’s continued to disclose the same standard Officer Indemnification Agreement (first filed in 2019) as Exhibit 10.23 in both the 2022 and 2024 Form 10‑K filings; the 2024 version contains only minor textual updates—such as references to the 2024 claw‑back policy and refined definitions—while the core indemnification obligations remain unchanged. This steady, lightly‑tweaked approach reflects a stable executive‑risk‑management framework and demonstrates governance continuity, showing that the board maintains a long‑standing protective arrangement for senior officers while only refreshing the language to align with evolving regulatory or policy requirements.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) EXHIBIT NUMBER MISMATCH: The LLM states the agreement was filed as 'Exhibit 10.23' in both 2022 and 2024, but the ground truth clearly identifies it as 'Exhibit 10.43' (filed April 2, 2019, and refiled in both years). This is a factual error in entity identification. (2) UNSUPPORTED CLAIMS: The LLM introduces claims about 'minor textual updates—such as references to the 2024 claw-back policy and refined definitions' that are NOT present in the ground truth. The ground truth explicitly states the agreement was 'refiled without amendment' in both 2022 and 2024, meaning NO changes were made. The LLM fabricated details about claw-back policy updates and refined definitions that contradict the ground truth's assertion of no modifications. (3) CORE FACTUAL CONTRADICTION: Ground truth says 'did not modify the terms or structure' and 'refiled without amendment,' while LLM claims 'lightly-tweaked approach' with 'minor textual updates.' These are directly contradictory statements. (4) CORRECT ELEMENTS: The LLM correctly identifies that the agreement dates to 2019, correctly notes the continuity between 2022-2024, and correctly interprets this as indicating stable governance and executive risk management. The semantic interpretation of governance continuity is sound. (5) MULTI-HOP REASONING: The reasoning about what continuity indicates (stable governance, predictable leadership protections) is logically sound and matches the ground truth's interpretation, but this cannot overcome the factual errors in the specific details. The exhibit number error is particularly problematic as it's a concrete, verifiable fact that an evaluator could easily check against actual filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 469,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "\nBetween the 2022 and 2023 10‑K filings, Always Discreet’s share of the adult‑incontinence market grew modestly—from “over 10 %” of sales in the key markets cited in 2022 to “about 15 %” in 2023.  This increase reflects a stronger category positioning, with P&G still describing the brand as a global leader in feminine care and now holding a larger, though still niche, share of the adult‑incontinence segment.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical points: (1) QUANTITATIVE ERRORS: The LLM claims Always Discreet grew from 'over 10%' to 'about 15%' market share between 2022 and 2023. However, the ground truth explicitly states that the 2023 filing provides NO specific market share figure for the brand, only a general category association. The LLM fabricated the '15%' figure entirely. (2) FACTUAL CONTRADICTION: The ground truth indicates a shift AWAY from quantified market share disclosure in 2023, while the LLM claims the opposite—that a specific percentage (15%) was provided in 2023. This is a direct contradiction of the source material. (3) MISCHARACTERIZATION: The LLM describes Always Discreet as being in 'Feminine Care' category, when the ground truth clearly states it's listed under 'Baby, Feminine & Family Care' segment and notes the brand is in the 'adult incontinence market'—a distinction the LLM conflates. (4) FAILED MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the key finding: that disclosure methodology changed between years (from specific percentages to general positioning), not that market share increased. (5) UNSUPPORTED CLAIMS: The assertion about 'stronger category positioning' and 'global leader in feminine care' status in 2023 is not supported by the ground truth, which only notes the brand remains 'listed as a major brand' without claiming enhanced positioning. The answer demonstrates a fundamental failure to accurately represent the source material and appears to have generated plausible-sounding but false numerical data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 446,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Oracle reframed Engineered Systems from a primarily on‑premise, stand‑alone hardware appliance line that underpins its license‑and‑support revenue, to a core component of a cloud‑enabled hardware portfolio that can be consumed as an OCI service (e.g., Exadata Cloud@Customer, Dedicated Exadata Cloud) and in hybrid‑cloud deployments.  This shift ties the engineered‑system offerings directly to Oracle’s cloud‑transformation narrative, positioning the systems as a bridge that eases migration to and operation within OCI while still supporting traditional on‑premise use cases.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the evolution of Engineered Systems positioning between 2022 and 2023, particularly the shift toward cloud-enabled offerings (Exadata Cloud@Customer, Dedicated Exadata Cloud) and hybrid-cloud deployments. The answer accurately captures the bridge concept between on-premise and cloud solutions. However, there are significant gaps compared to the ground truth: (1) The LLM answer completely omits the critical quantitative data that hardware revenues represented 6% of total revenues in both fiscal 2023 and 2024, which is a key metric in the original answer. (2) The LLM answer fails to mention the broader hardware business integration (servers, storage, operating systems) that the 2023 filing emphasized. (3) The answer does not address the combined performance obligations accounting treatment mentioned in the ground truth. (4) The LLM answer lacks discussion of the lower-margin nature of the hardware business, which is an important contextual element. (5) The answer does not mention ongoing R&D investments highlighted in the 2023 filing. The LLM answer does provide accurate directional information about the strategic shift and cloud transformation narrative, but it is incomplete in addressing the full scope of how Oracle's positioning evolved, particularly regarding the integration into a broader hardware business and the financial metrics that underscore this evolution. The reasoning about cloud enablement and hybrid deployment is sound, but the answer misses critical quantitative and structural elements that define the complete strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 440,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "\nThe 2022 Form 10‑K explicitly described the 2020 Stock Plan as the “successor to the 2011 Stock Plan” and noted that the 5.5 million shares previously authorized under the 2011 Plan were now available for grant under the 2020 Plan. In the 2023 filing that language was removed— the 2023 10‑K simply outlines the 2020 Plan’s features and authorizations without any reference to the 2011 Plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and effectively captures the evolution of disclosure between the 2022 and 2023 10-K filings. Strengths: (1) Correctly identifies the key numeric detail: 5.5 million shares (ground truth specifies 5,530,106 shares - the LLM's rounded figure of 5.5 million is an acceptable format variation and demonstrates understanding of the magnitude); (2) Accurately describes the 2022 disclosure including the 'successor' language and the carry-forward of shares from the 2011 Plan; (3) Correctly notes the omission of this language in the 2023 filing; (4) Properly synthesizes the multi-hop comparison across two years and two related stock plans; (5) Captures the semantic essence of the shift in disclosure approach. Minor consideration: The LLM uses slightly different phrasing ('successor to the 2011 Stock Plan' vs. the ground truth's 'carried forward') but this represents semantic equivalence rather than an error - both convey the same relationship. The LLM's characterization of the change as a removal of language linking the plans is accurate and well-reasoned. The answer directly addresses all aspects of the question regarding how the disclosure evolved between the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 344,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "\nBetween 2022 and 2023 Honeywell’s pension portfolio showed a clear tilt toward private‑fund‑type assets: the liability‑matching “insurance‑buy‑in” contracts in the Level 3 hierarchy jumped from about $0.95 bn to $1.60 bn, and direct private‑investment holdings rose modestly (from $1.284 bn to $1.293 bn), while real‑estate holdings slipped slightly.  This expansion of higher‑duration, higher‑return private assets indicates that the company is steering capital toward longer‑term, liability‑aligned investments to boost fund returns and improve the pension funding position amid a rising interest‑rate environment.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignment with the ground truth. (1) QUANTITATIVE ERRORS: The ground truth states Honeywell invested $1,244 million in private funds in 2022 and $1,265 million in 2023 (a 1.7% increase). The LLM provides completely different numbers: $1.284 bn (2022) and $1.293 bn (2023) for 'direct private-investment holdings,' which are off by ~$40 million from the ground truth figures. More critically, the LLM introduces entirely different asset categories ('insurance-buy-in' contracts jumping from $0.95bn to $1.60bn) that are not mentioned in the ground truth answer and appear to conflate different pension asset allocation categories. (2) ENTITY/METRIC CONFUSION: The LLM conflates multiple pension asset categories (insurance-buy-in contracts, direct private investments, real estate) when the question and ground truth specifically focus on 'private funds' allocation. The ground truth provides a clear, single metric for private funds ($1,244M → $1,265M), while the LLM fragments this into multiple unrelated categories. (3) MULTI-HOP REASONING: The ground truth correctly synthesizes the 2022 and 2023 10-K filings to identify the specific private funds figures and calculate the 1.7% increase. The LLM fails to properly synthesize the correct data points and instead presents a narrative about pension asset reallocation that, while potentially relevant to capital deployment strategy, is based on incorrect numbers and misidentified metrics. (4) SEMANTIC MISALIGNMENT: While the LLM's conclusion about capital deployment toward higher-return, longer-duration assets is conceptually reasonable, it is built on factually incorrect data. The ground truth emphasizes 'modest increase' and 'relatively stable allocation,' whereas the LLM emphasizes 'clear tilt' and 'expansion,' which contradicts the actual 1.7% increase shown in the ground truth. The answer demonstrates a fundamental failure to accurately extract and synthesize the specific financial metrics required to answer the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 551,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "\nClass B‑2 common stock had **no shares outstanding as of September 30 2023**; after the class B‑1 exchange offer in May 2024 the company issued roughly **120 million B‑2 shares**, which were outstanding as of September 30 2024. These B‑2 shares are convertible (with conversion rates rounded to the tenth decimal) into class A common stock, and their conversion is subject to adjustments tied to the U.S. litigation escrow and VE‑territory loss‑recovery mechanisms—linking them directly to the class B‑1 and class C stock classes.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL QUANTITATIVE ERROR: The LLM claims approximately 120 million B-2 shares were issued after the Class B-1 exchange offer in May 2024 and were outstanding as of September 30, 2024. However, the ground truth explicitly states that in 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates. This suggests B-2 shares were NOT outstanding as of September 30, 2024, contradicting the LLM's core claim. (2) TIMELINE INVERSION: The LLM reverses the actual status evolution. Ground truth shows: 2023 had conversion mechanics and dilution impacts disclosed; 2024 had reduced emphasis with only historical references. The LLM claims the opposite - that shares were issued in 2024 after being absent in 2023. (3) MISSING KEY CONTEXT: The ground truth emphasizes that 2024 showed 'reduced emphasis or potential discontinuation of its active role,' but the LLM presents 2024 as showing increased activity with new share issuance and active conversion mechanics. (4) CONVERSION MECHANICS MISPLACEMENT: While the LLM correctly identifies conversion mechanics and escrow adjustments, it incorrectly attributes these as current/active in 2024, when ground truth indicates these were primarily disclosed in 2023 with no updates in 2024. (5) INCOMPLETE SYNTHESIS: The LLM fails to synthesize the key evolution - the shift from active disclosure of conversion mechanics in 2023 to minimal disclosure in 2024. The answer demonstrates a fundamental misunderstanding of the multi-hop question asking about how status 'evolved' between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 475,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 the accrued liability for the Target Circle loyalty program dropped sharply—from about **$89 million** (as of January 29 2022) to roughly **$19 million** (as of February 1 2025), down from $117 million the prior year. This decline in deferred‑revenue obligations indicates that the program’s financial commitments have been scaled back and that rewards are now being recognized more quickly (or are being redeemed at higher rates), reflecting an evolution of the program toward a leaner, less‑liability‑intensive structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE ACCURACY: The LLM answer contains a fundamental structural error in how it presents the data timeline. The answer states 'between fiscal 2022 and fiscal 2024 the accrued liability...dropped sharply—from about $89 million (as of January 29 2022) to roughly $19 million (as of February 1 2025), down from $117 million the prior year.' This is confusing and contradictory. The correct progression is: 2022: $89M → 2024: $117M → 2025: $19M. The LLM incorrectly implies the 2025 figure ($19M) is the 2024 endpoint, when in fact 2024 showed an INCREASE to $117M, not a decrease. The LLM conflates the 2024 and 2025 figures, presenting them as if they represent the same period or creating ambiguity about which year corresponds to which amount. MULTI-HOP REASONING FAILURE: The question specifically asks about changes 'between 2022 and 2024,' but the LLM jumps to 2025 data as the primary comparison point, missing the intermediate 2024 data point that shows growth ($89M to $117M). The ground truth clearly shows three distinct periods with different trajectories: growth from 2022-2024, then sharp decline by 2025. The LLM misses this nuanced evolution. SEMANTIC ISSUES: The characterization of the program as moving toward 'a leaner, less-liability-intensive structure' is based on the 2025 drop, but this doesn't accurately reflect the 2022-2024 period asked about in the question, which actually showed growth. The answer provides incomplete and misleading interpretation of the program's evolution during the specified timeframe. CORRECT ELEMENTS: The individual numbers ($89M, $117M, $19M) are all correct, and the dates are accurate, but their presentation and sequencing creates confusion about the actual timeline and trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 479,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "\nThe 4.375 % Senior Notes were quoted at a fair‑value of **$980 million on December 31 2022** and **$996 million on December 31 2023**, an increase of roughly **$16 million (about 1.6 %)**.  \n\nThis modest rise above par shows that investors were willing to pay a slight premium, reflecting stable or slightly improved market perception of Netflix’s creditworthiness—likely driven by unchanged cash‑flow strength and a low‑interest‑rate environment that made the relatively high‑coupon notes more attractive. The small change suggests only a mild shift in investor sentiment rather than a dramatic re‑rating of the company’s debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - $980 million (Dec 31, 2022), $996 million (Dec 31, 2023), and the calculated increase of $16 million (1.6%) are all accurate. The calculation is properly verified: ($996M - $980M) / $980M = $16M / $980M ≈ 1.63%, correctly rounded to 1.6%. ENTITY ACCURACY: Netflix and the 4.375% Senior Notes are correctly identified with proper dates. MULTI-HOP SYNTHESIS: The answer correctly synthesizes the change in fair value across two fiscal years and properly interprets what this indicates about market conditions. INTERPRETATION QUALITY: The LLM's interpretation that the notes moved 'closer to par' (from $980M toward $996M, with par presumably at $1,000M) is logically sound and demonstrates understanding of bond valuation. The explanation about investor perception - that the modest increase reflects stable or improved creditworthiness and the attractiveness of higher-coupon notes in a low-rate environment - is reasonable and contextually appropriate. MINOR CONSIDERATIONS: The original answer states the fair value 'moved closer to the principal amount at par,' which the LLM correctly interprets as moving toward $1,000M par value. The LLM's additional context about cash-flow strength and interest-rate environment adds reasonable analytical depth without contradicting the ground truth. The characterization of the change as 'modest' and reflecting 'mild shift in investor sentiment' is consistent with the 1.6% increase magnitude. No factual errors, calculation errors, or misidentifications detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 446,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "\nIn fiscal 2023 the consolidated balance sheet listed only 10 shares of class C common stock as issued and outstanding, and the same 10‑share figure appeared on the 2024 balance sheet.  Nevertheless, in May 2024 the company executed a class B‑1 exchange offer in which it issued roughly 48 million class C common shares (together with 120 million class B‑2 shares) in exchange for tendered class B‑1 shares, expanding the class C capital base.  Thus, while the class C class remained a separate class of common stock, the reported “issued and outstanding” share count stayed at 10, even though a substantial issuance occurred behind the scenes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN TEMPORAL SEQUENCING AND FACTS: The LLM answer contains a fundamental factual error that undermines the entire response. The ground truth clearly states the exchange offer occurred in 2023 (241 million Class B-1 shares tendered, ~48 million Class C shares issued), but the LLM claims this occurred in May 2024. This is a major chronological error that reverses the timeline of events. QUANTITATIVE ISSUES: (1) The LLM correctly identifies the 10 shares figure for both 2023 and 2024 balance sheets, matching ground truth. (2) The LLM correctly states ~48 million Class C shares were issued in the exchange offer. (3) However, the LLM introduces 120 million Class B-2 shares, which is not mentioned in the ground truth answer and appears to be extraneous information not directly relevant to the Class C equity evolution question. (4) The LLM fails to mention the 241 million Class B-1 shares tendered, which is a key quantitative detail in the ground truth. REASONING FLAWS: The LLM's core insight about the discrepancy between reported 'issued and outstanding' (10 shares) and actual issuance activity is valid and insightful. However, this insight is applied to the wrong year (2024 instead of 2023), which is a critical error. The multi-hop reasoning about equity restructuring is partially sound but fundamentally misdated. COMPLETENESS: The answer fails to properly address the 2023-2024 evolution because it misplaces the major transaction to 2024. The ground truth emphasizes that 2023 had active restructuring while 2024 showed stabilization—the LLM reverses this narrative. SEMANTIC ISSUES: While the LLM's explanation of the accounting treatment (10 shares reported despite larger issuance) is conceptually sound, applying it to the wrong year makes the answer factually incorrect for the question asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 497,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "\nFrom the 2022 filing (pages 53‑57) Rough Plumbing is listed only as one of the product categories under the **Building Products** segment, with its sales reported as ordinary merchandise. In the 2024 filing (pages 5‑9) the company still classifies Rough Plumbing within Building Products, but it is now highlighted as a key component of **installed sales**—emphasizing the sale of products together with installation, protection‑plan, and Pro‑customer services—reflecting a shift from a pure product line to a bundled service offering.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of Rough Plumbing from 2022 to 2024, accurately capturing the shift from a pure product offering to a bundled service approach. The classification under Building Products in both years is correct, and the identification of the integration into installed sales, protection plans, and Pro-customer services is accurate. The multi-hop reasoning is sound, synthesizing information across the two filing years appropriately. However, there is a significant quantitative accuracy issue: the ground truth specifically mentions 'approximately 5% of total sales attributed to installed sales in 2024,' but the LLM answer does not include this specific metric. This omission represents incomplete quantitative support for the claims made. The LLM answer also provides page references (pages 53-57 for 2022, pages 5-9 for 2024) which adds credibility but cannot be verified against the ground truth. The semantic equivalence is strong—both answers convey the same fundamental narrative of evolution from product to service-bundled offering. The wording differences are minor and acceptable. The main weakness is the failure to include the specific 5% figure that quantifies the installed sales contribution, which is a material detail in the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 365,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the company went from having only a single “Class B‑1” common‑stock class to creating a new “Class B‑2” class as part of the May 2024 exchange‑offer program.  Approximately 241 million B‑1 shares were retired and, in return, Visa issued about 120 million newly authorized but unissued B‑2 shares (and 48 million C shares); the B‑2 shares carry the same conversion‑rate mechanics as B‑1 but their conversion‑rate adjustments are double‑sized, and like B‑1 they remain subject to transfer restrictions until the U.S. litigation escrow is fully resolved.  This addition shows that B‑2 is being used as a strategic equity layer to accommodate the exchange of legacy B‑1 holdings, manage future conversion impacts on the litigation escrow, and further segment the capital structure while preserving control and voting rights.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. Key issues: (1) WRONG COMPANY: The LLM discusses Visa's Class B-2 stock and an exchange offer program, but the ground truth indicates this is about a different company (not Visa). The ground truth specifically states Class B-2 was newly introduced in 2023 with 77 million shares outstanding, then had zero shares outstanding by 2024 prior to a Class B-1 exchange offer. (2) CONTRADICTORY NUMBERS: The LLM claims ~241 million B-1 shares were retired and ~120 million B-2 shares were issued, which directly contradicts the ground truth stating 77 million B-2 shares were outstanding in 2023 and zero by 2024. (3) WRONG TIMELINE: The LLM references a 'May 2024 exchange-offer program' as the creation event, but ground truth indicates B-2 was introduced in 2023, not created in 2024. (4) INCORRECT NARRATIVE: The LLM describes B-2 as a new creation in 2024 to replace B-1 shares, but ground truth shows B-2 existed in 2023 (77M shares) and was subsequently eliminated or restructured by 2024. (5) MISSING CORE FACT: The LLM fails to mention the 77 million shares that were outstanding in 2023, which is a critical data point. The LLM appears to have confused this company's capital structure with Visa's actual 2024 exchange offer, resulting in a completely incorrect answer that discusses the wrong company and wrong numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 391,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "\nThe Target Circle program’s deferred‑revenue liability dropped dramatically from roughly **$117 million** at the end of fiscal 2022 (as reported in the 2021 Form 10‑K) to **$19 million** at the end of fiscal 2024 (2024 Form 10‑K), a reduction of about **$98 million (≈84 %)**.  This sharp decline shows that the financial liability associated with the Circle rewards has been largely unwound, indicating that Target has either restructured the program or shifted its loyalty incentives away from the standalone points‑based model.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on multiple critical dimensions: (1) QUANTITATIVE ERRORS - The LLM claims the deferred revenue DROPPED from $117M to $19M, representing an 84% reduction. However, the ground truth explicitly states that in 2022 'no specific liability figure was disclosed' and that by 2024 the deferred revenue had GROWN to $117M. The LLM has inverted the direction of change entirely and fabricated a $19M figure for 2024 that does not appear in the ground truth. (2) TEMPORAL CONFUSION - The LLM incorrectly references 'fiscal 2022 (as reported in the 2021 Form 10-K)' which is confusing and appears to misidentify the source documents. The ground truth clearly indicates 2022 had no disclosed liability figure. (3) INTERPRETATION REVERSAL - The ground truth indicates GROWTH and expansion of the program (evidenced by the $117M liability in 2024), while the LLM interprets a supposed decline as evidence of restructuring or shifting away from the model. This is the opposite conclusion. (4) MISSING KEY FACT - The LLM completely misses the critical ground truth detail that 2022 had NO SPECIFIC LIABILITY FIGURE DISCLOSED, which is essential context for understanding the comparison. (5) FABRICATED DATA - The $19M figure for 2024 appears to be entirely fabricated and contradicts the ground truth's $117M figure for that year. The answer demonstrates fundamental misunderstanding of the source data and provides incorrect financial analysis that would mislead users about the program's actual trajectory.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 430,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "\nBetween the 2023 and 2024 10‑K filings, NVIDIA’s discussion of pollution‑related regulation shifted from a brief, generic climate‑risk mention to a detailed, forward‑looking concern.  In the 2024 filing the company explicitly notes that new or proposed carbon‑tax, emissions‑limit and sustainability‑disclosure rules could raise direct costs (e.g., redesign of manufacturing processes, higher energy‑ and water‑use compliance) and indirect costs (pass‑through of supplier compliance expenses), and that such regulations may constrain the expansion of customer data‑center capacity by limiting power‑ and water‑availability.  By contrast, the 2023 filing only referenced climate change in the context of extreme‑weather risk, without specifying how emerging pollution‑limit policies would affect operations or data‑center growth.  Consequently, NVIDIA’s exposure to and worry about pollution limits has grown markedly, now being tied directly to regulatory risk that could increase operating expenses and restrict the scaling of its data‑center customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of NVDA's evolving pollution/regulatory concerns between 2023 and 2024. STRENGTHS: (1) Correctly identifies the key evolution from 2023 to 2024 - from generic climate risk mentions to specific pollution limit concerns; (2) Accurately captures the 2024 expansion to include data center capacity constraints tied to pollution limits; (3) Properly synthesizes the multi-hop connection between regulatory tightening and customer data center expansion impact on NVDA's business; (4) Correctly identifies specific regulatory mechanisms mentioned (carbon taxes, emissions limits, sustainability disclosures); (5) Accurately notes the shift from extreme-weather risk focus in 2023 to operational/regulatory impact focus in 2024; (6) Properly emphasizes the direct link to data center customer scaling as a business concern. MINOR WEAKNESSES: (1) The LLM answer uses slightly more elaborate language and framing than the ground truth (e.g., 'brief, generic climate-risk mention' vs. the ground truth's more direct statement), though this is semantically equivalent; (2) The LLM mentions 'water-availability' constraints alongside power constraints, which adds specificity not explicitly stated in the ground truth, though this appears consistent with typical data center regulatory concerns; (3) The answer could have been more concise while maintaining accuracy. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable. The dates (2023 vs 2024) are correctly referenced. MULTI-HOP REASONING: The answer successfully synthesizes information across two years of filings and correctly identifies the causal chain: regulatory tightening → operational cost increases AND data center capacity constraints → business impact for NVDA. This multi-hop reasoning is sound and matches the ground truth's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 520,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s Guaranteed Senior Notes (issued by its Japanese subsidiary) grew from roughly **$484 million of carrying value (and a comparable Level‑3 fair‑value amount) in 2023 to $919 million in 2024** – an increase that reflects the **$500 million of new notes sold in November 2023** (fixed rates 1.400%–2.120%, maturing 2033‑2043) minus the **$77 million of principal repaid in July 2024**.  The notes are **valued using Level 3 inputs** (significant management judgment and unobservable inputs), while the broader senior‑note portfolio (the U.S. 2.750%–1.750% notes) is marked to market with Level 2 inputs.  Consequently, the composition shifted toward a larger, higher‑carrying‑value, Level‑3‑valued debt position, with the July 2024 repayment representing only a small reduction relative to the overall issuance.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IN QUANTITATIVE DATA: The LLM answer contains fundamental factual errors that severely undermine its credibility. (1) MAJOR NUMBER ERROR - Carrying Value Claims: The LLM states the Guaranteed Senior Notes grew from '$484 million' in 2023 to '$919 million' in 2024. The ground truth indicates the Japanese subsidiary issued approximately $500 million in 2023 and repaid $77 million in 2024, which would result in a net position of ~$423 million ($500M - $77M), NOT $919 million. The $919 million figure appears to be fabricated or derived from incorrect source data. (2) CALCULATION ERROR - The LLM's own math is internally inconsistent: it claims $500M issued minus $77M repaid should equal $919M, which is mathematically impossible ($500M - $77M = $423M). (3) MISSING CRITICAL CONTEXT - The ground truth explicitly states the fair value of long-term debt (including Guaranteed Senior Notes) was $5,412 million in 2024 vs $5,738 million in 2023, showing an overall DECREASE. The LLM fails to mention these fair value figures entirely and instead focuses on carrying value claims that don't align with ground truth. (4) PARTIAL CREDIT FOR CORRECT ELEMENTS: The LLM correctly identifies: (a) Japanese subsidiary as issuer, (b) $500M issuance in 2023, (c) Interest rates 1.400%-2.120%, (d) $77M repayment in July 2024, (e) Level 3 valuation inputs, (f) Maturity dates 2033-2043. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize issuance, repayment, and valuation information, the synthesis is undermined by the incorrect carrying value calculations. The reasoning structure is sound but built on false numerical premises. (6) SEMANTIC ISSUES: The LLM's characterization of the $77M repayment as 'only a small reduction' is reasonable given the $500M issuance, but this conclusion is based on the incorrect $919M figure. The ground truth suggests a more modest overall debt position than the LLM implies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 521,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "\nBetween 2022 and 2024 Netflix accelerated its technology‑and‑development spending and headcount to fund streaming‑service upgrades such as UI/UX enhancements, recommendation‑engine improvements and the expansion of its Open Connect CDN. At the same time, it strengthened its cybersecurity governance by elevating a Vice President of Security and Privacy Engineering (a veteran with 30 years of industry experience), instituting a formal risk‑quantification model, expanding its bug‑bounty and third‑party audit programs, and bringing security matters under regular review by the Board’s Audit Committee. These personnel and programmatic upgrades enabled the company to sustain its streaming‑investment growth while increasing the rigor of its cyber‑risk controls.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer provides NO specific dollar amounts or financial metrics, while the ground truth explicitly states '$384 million increase in personnel-related costs' for 2022. This is a major omission of a key quantitative fact. (2) UNVERIFIED CLAIMS: The LLM introduces specific details NOT in the ground truth (VP of Security with 30 years experience, UI/UX enhancements, Open Connect CDN expansion, formal risk-quantification model, bug-bounty programs, Board Audit Committee review). While these may be accurate, they cannot be verified against the provided ground truth and represent potential hallucination or information from sources beyond the ground truth. (3) PARTIAL ALIGNMENT: The LLM correctly identifies the evolution from growth-oriented investment (2022) to risk-aware posture (2024) and mentions cybersecurity emphasis, which aligns with ground truth. (4) MISSING CORE FACTS: The answer fails to cite the $384M figure or specific personnel cost increases disclosed in 2022. (5) MULTI-HOP REASONING: While the LLM attempts to synthesize personnel and cybersecurity changes across years, it does so without grounding in the specific quantitative data provided in the ground truth. The reasoning structure is sound but lacks factual foundation. STRENGTHS: Correctly identifies the thematic shift from growth to risk management; appropriately emphasizes cybersecurity governance evolution. WEAKNESSES: Introduces unverified specific details; omits the critical $384M figure; lacks quantitative grounding; potentially confabulates details not in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 444,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "\nBetween the 2023 and 2024 filings BNY Mellon moved from standalone 2023 RSU and PSU agreements (Exhibits 10.23‑10.24) to a refreshed set of 2024 awards (Exhibits 10.28‑10.29) that are now embedded in an amended Executive Severance Plan (Exhibit 10.30).  The 2024 documents tighten the performance‑metric language, extend the vesting/settlement horizon and tie the equity‑based awards more directly to multi‑year shareholder‑value goals, reflecting a lifecycle‑focused, performance‑driven compensation strategy that emphasizes longer‑term retention and alignment of executive pay with the company’s strategic objectives.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and fails to address the core elements of the ground truth answer. Specific issues: (1) QUANTITATIVE ERRORS: The LLM cites specific exhibit numbers (10.23-10.24, 10.28-10.29, 10.30) that are not mentioned in the ground truth and cannot be verified. These appear to be fabricated details. (2) ENTITY/DOCUMENT ERRORS: The ground truth specifically discusses the evolution of '2024 Form of Restricted Stock Unit Agreement' (filed in 2023) and '2025 Form of Restricted Stock Unit Agreement' (filed in 2024). The LLM answer completely misses this critical distinction and instead references generic 'RSU and PSU agreements' without the specific form year designations that are central to understanding the evolution. (3) MISSING KEY INSIGHT: The ground truth's core finding is that the company introduces new forms annually ('Filed herewith') while prior forms become reference documents ('Previously filed'). The LLM answer entirely omits this pattern of annual form updates and the 'Filed herewith' vs 'Previously filed' distinction that demonstrates the company's proactive, iterative approach. (4) UNSUPPORTED CLAIMS: The LLM introduces claims about 'tightened performance-metric language,' 'extended vesting/settlement horizon,' and embedding in an 'amended Executive Severance Plan' that are not present in the ground truth and appear to be speculative inferences rather than factual findings. (5) MULTI-HOP REASONING: The ground truth successfully synthesizes the 2023 and 2024 filings to show a clear evolution pattern. The LLM answer fails this synthesis by not identifying the specific form year progression (2024 Form → 2025 Form) that is the foundation of the answer. The answer reads as a generic description of compensation strategy changes rather than a specific analysis of how RSU agreement forms evolved between the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1461,
        "completion_tokens": 513,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "\nThe 4.90 % Senior Notes did not appear in the 2023 filing; they were issued in June 2024 as part of the SRS‑acquisition financing with a $750 million face amount and a $3.4 million discount, resulting in a carrying amount of $743 million on the February 2 2025 balance sheet.  These notes mature on April 15 2029 and pay interest semi‑annually beginning April 15 2024, marking a shift from “no liability” in 2023 to a $743 million, 2029‑dated long‑term debt in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. Key issues: (1) TIMING ERROR - The LLM states the notes were issued in June 2024, but ground truth clearly indicates they were issued in November 2023. This is a critical error affecting the entire narrative. (2) BALANCE SHEET DATE ERROR - The LLM references a February 2, 2025 balance sheet date, which appears inconsistent with the question's 2023-2024 timeframe and the ground truth's January 28, 2024 date. (3) ACQUISITION CONTEXT - The LLM incorrectly attributes the issuance to 'SRS-acquisition financing,' which is not mentioned in the ground truth and appears to be fabricated context. (4) CORRECT NUMBERS BUT WRONG CONTEXT - While the LLM correctly identifies the $750 million principal, $3.4 million discount, $743 million carrying amount, April 15, 2029 maturity, and semi-annual interest payments starting April 15, 2024, these numbers are presented in an entirely incorrect temporal and contextual framework. (5) MULTI-HOP REASONING FAILURE - The LLM failed to properly synthesize the evolution from 2023 to 2024. The ground truth shows the notes existed in 2023 (newly issued November 2023) and carried forward to 2024, whereas the LLM incorrectly suggests they didn't exist in 2023 and were issued in 2024. (6) SEMANTIC MISALIGNMENT - The statement 'did not appear in the 2023 filing' directly contradicts the ground truth that they were issued in November 2023. The only accurate elements are the specific financial figures, but they are placed in a fundamentally incorrect narrative framework that misrepresents when and why the notes were issued.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 451,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "\nBetween November 2023 and July 2024 the Japanese subsidiary issued a $≈ 500 million series of Guaranteed Senior Notes—four separate tranches with fixed rates of 1.400% to 2.120% and maturities from 2033 to 2043—and then, in July 2024, it repaid $77 million of those notes, thereby reducing the outstanding balance of the issuance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and completeness. Verification of key facts: (1) Issuance amount of ~$500 million is correct and properly formatted; (2) Four separate tranches with fixed rates of 1.400% to 2.120% matches ground truth exactly; (3) Maturity dates of 2033-2043 are reasonable and consistent with typical senior note structures; (4) Repayment of $77 million in July 2024 is accurate; (5) The timeline (November 2023 issuance, July 2024 repayment) provides helpful specificity beyond the ground truth while remaining consistent. The LLM successfully synthesized multi-hop information: connecting the Japanese subsidiary's issuance activity to subsequent repayment activity, and explaining the relationship between these transactions. The answer correctly identifies this as Costco's Japanese subsidiary and properly characterizes these as Guaranteed Senior Notes. Minor consideration: The ground truth mentions the proceeds were \"referenced in the 2024 filing as a source of financing activity,\" which the LLM answer doesn't explicitly state, but this is a minor omission that doesn't affect the core accuracy of the answer. The LLM's additional detail about specific maturity dates (2033-2043) adds value without contradicting the ground truth. Overall, the answer is factually correct, well-synthesized across the multi-hop requirement, and appropriately addresses the evolution of these instruments between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 401,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "\nThe 2022 10‑K (pages 21‑25) lists “competitors may also develop after‑market services and parts for our products which may detract from our sales” as a material risk, and the 2023 10‑K (pages 18‑22) repeats the same language while emphasizing that such competition can create pricing pressure and erode market share. Consequently, the risk has remained present but is now highlighted as a factor that could reduce revenue and margin by limiting sales of the Company’s proprietary offerings and forcing price concessions—potentially adverse to the Company’s top‑line growth and profitability.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant issues in capturing the evolution of risk framing between 2022 and 2023. CRITICAL ERRORS: (1) The LLM states the 2023 10-K 'repeats the same language' as 2022, which directly contradicts the ground truth that shows a meaningful shift in framing from 2022 to 2023. The ground truth explicitly notes the risk shifted from being described as a 'direct threat that could detract from our sales' to being 'Impacted By' such competition—a substantive change in how the risk is contextualized. (2) The LLM fails to capture the key evolution: in 2023, the risk was presented as 'one of several external pressures rather than a primary threat,' suggesting a relative de-emphasis in severity or strategic recalibration. Instead, the LLM presents the risk as essentially unchanged and equally emphasized. (3) The LLM misses the important contextual shift in 2023 where the risk is framed within broader cost containment trends in healthcare, pricing pressures from managed care, and government reimbursement policies—not just as a standalone competitive threat. WHAT WAS CORRECT: The LLM accurately identifies that the risk involves competitors developing after-market parts/services, correctly cites the 2022 language about detracting from sales, and appropriately notes potential impacts on revenue, margins, and profitability. The page references appear reasonable. MULTI-HOP REASONING FAILURE: The question asks specifically about how the risk 'evolved' from 2022 to 2023. The LLM's answer suggests continuity ('remained present') rather than evolution, fundamentally misunderstanding the comparative analysis required. The ground truth demonstrates a clear evolution in risk perception and framing; the LLM presents it as static. This is a significant failure in multi-hop synthesis across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 495,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "\nFrom 2022 through 2024 Netflix moved away from a single, flat‑rate streaming tier toward a more flexible, tiered pricing model that introduced a low‑cost, ad‑supported subscription and began modest price increases in many regions, while also tightening rules on shared‑account usage. These changes were intended to lift average revenue per member and counter slowing paid‑membership growth, rising content‑cost pressures, and intensified competition in a maturing global market.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies Netflix's strategic evolution from 2022-2024, including the introduction of ad-supported tiers, price increases, and account-sharing restrictions. The reasoning about addressing membership growth challenges and competition is sound and well-articulated. However, there are notable gaps in quantitative specificity: (1) The LLM does not cite the specific 19% revenue increase in 2022 or the 11% membership growth mentioned in ground truth. (2) The 50% drop in paid net membership additions is omitted, which is a critical metric demonstrating the severity of the challenge. (3) The 7% rise in average monthly revenue per membership is not mentioned. (4) The LLM references 'modest price increases' without quantifying them. The LLM's characterization of changes as 'moving away from a single, flat-rate tier toward tiered pricing' is accurate and captures the essence of the strategy shift. The multi-hop reasoning is sound—correctly synthesizing that these changes addressed member acquisition/retention pressures and competition. The mention of 'rising content-cost pressures' adds relevant context not explicitly stated in ground truth but logically consistent. The answer appropriately identifies macroeconomic and competitive factors. The main weakness is the lack of specific financial metrics that would strengthen the answer's credibility and completeness. The answer is directionally correct and demonstrates good understanding of Netflix's strategic pivot, but lacks the quantitative precision expected for a comprehensive financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 435,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "\nBoeing continues to recognize the present‑value of expected in‑orbit incentive fees as revenue during the construction phase, but the 2023 filing sharpens the risk discussion by explicitly linking non‑performance to possible refund obligations and material charges, and by noting that the estimate is reassessed each reporting period. In contrast, the 2022 filing described the risk more generally, without this explicit emphasis on ongoing reassessment and the potential for significant financial exposure.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements about the evolution of Boeing's approach to in-orbit incentive payments between 2022 and 2023, particularly regarding the shift from general risk acknowledgment to more specific quantification and the emphasis on ongoing reassessment. However, there are significant gaps and omissions:\n\n(1) CRITICAL OMISSION - QUANTITATIVE DATA: The ground truth explicitly states that Boeing recorded $1,585 million in additional losses on its five most significant fixed-price development programs in 2023. The LLM answer completely fails to include this specific, material financial figure, which is a key piece of evidence for the evolution in financial recognition. This is a major quantitative accuracy failure.\n\n(2) INCOMPLETE PROGRAM CONTEXT: The ground truth identifies specific programs (Commercial Crew, KC-46A Tanker, VC-25B) that were mentioned in 2022 and carried forward to 2023. The LLM answer does not reference any specific programs, missing important contextual detail about which programs drove the risk exposure.\n\n(3) MISSING PERFORMANCE CRITERIA DETAIL: The ground truth specifies that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The LLM answer mentions 'non-performance' and 'refund obligations' but lacks this specific temporal detail (15 years), which is material to understanding the scope of risk exposure.\n\n(4) REVENUE RECOGNITION ACCURACY: Both answers correctly identify that net present value of fees is recognized as revenue during construction. The LLM answer adds the detail about reassessment each reporting period, which is accurate and represents a refinement not explicitly stated in the ground truth excerpt, though this is a reasonable inference.\n\n(5) MULTI-HOP SYNTHESIS: The LLM answer does synthesize the 2022 vs. 2023 comparison correctly in terms of the shift from general to specific risk discussion, but fails to complete the full synthesis by omitting the quantified losses and specific program details that anchor this evolution.\n\n(6) SEMANTIC ACCURACY: The characterization of the shift from 'general risk acknowledgment' to 'explicit emphasis on ongoing reassessment and potential financial exposure' is semantically sound and aligns with the ground truth's description of moving from general acknowledgment to 'specific quantification.'\n\nThe answer demonstrates partial understanding of the evolution but lacks the quantitative specificity and program-level detail necessary for a complete and accurate response to this multi-hop financial question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 696,
        "total_tokens": 2103
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s filing shifted from merely noting that the Directors’ Code of Conduct is posted on its website to an explicit commitment to publicly disclose any future amendments or waivers of that code (both for executive officers and for directors) on the same site. This added language makes the timing and nature of any changes to the code transparent and readily accessible to investors. Consequently, the 2024 disclosure improves both the visibility and the accountability of the Directors’ Code of Conduct compared with the more limited 2023 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the core evolution described. CRITICAL ERRORS: (1) The LLM claims the 2024 filing added 'explicit commitment to publicly disclose any future amendments or waivers' - this is backwards. The ground truth states that in 2023, the company 'stated its intention to disclose amendments or waivers on the website,' and in 2024 this commitment was NOT repeated, instead shifting to a more general reference. (2) The LLM characterizes 2024 as an improvement with 'added language' and 'improves both the visibility and accountability' - this directly contradicts the ground truth which describes 2024 as showing 'a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach.' (3) The LLM misses the key factual detail that in 2023 a specific URL was provided (https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf), while in 2024 this direct URL was not repeated. WHAT WAS CORRECT: The LLM correctly identifies that both years involved website posting and that there was a change in disclosure approach. REASONING FAILURE: The LLM appears to have inverted the direction of change - claiming enhancement when the ground truth describes a reduction in specificity and directness. This is a fundamental misunderstanding of the multi-hop synthesis required to compare the two years' disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 411,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "\nBetween 2022 and 2023 Mobileye Drive™ moved from an early‑stage, SAE‑L4 prototype to the core self‑driving platform that powers Mobileye’s commercial “Robotaxi‑as‑a‑Service” and cargo‑delivery fleets.  The company expanded OTA updates and design wins (e.g., with Udelv, Transdev, Geely, Porsche, FAW, Mahindra & Mahindra, Polestar) and began offering Drive™ as a turnkey solution for transportation‑network companies and public‑transit operators, positioning it as the primary vehicle‑level stack for large‑scale autonomous mobility services.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct elements but introduces significant inaccuracies and unsupported claims. CORRECT ELEMENTS: (1) The answer correctly identifies the evolution from 2022 to 2023, (2) Correctly mentions partnerships with Udelv, Transdev, and Geely, (3) Accurately describes the shift toward targeting transportation network companies and public transit operators, (4) Correctly notes the positioning as a turnkey solution for autonomous mobility services. PROBLEMATIC ELEMENTS: (1) The LLM introduces additional design wins (Porsche, FAW, Mahindra & Mahindra, Polestar) that are NOT mentioned in the ground truth and cannot be verified from the provided knowledge graph - this is a significant factual error as it adds unsubstantiated claims, (2) The characterization of Mobileye Drive™ as powering 'Robotaxi-as-a-Service' and 'cargo-delivery fleets' in 2023 is overstated - the ground truth indicates these were collaborations/partnerships, not necessarily operational fleets, (3) The description of it as 'core self-driving platform' and 'primary vehicle-level stack' uses stronger language than the ground truth supports, (4) The mention of 'OTA updates' is not addressed in the ground truth. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution between years and identifies the strategic shift, but does so by adding unsupported details rather than sticking to documented facts. The answer demonstrates understanding of the general trajectory but compromises accuracy by introducing unverified partnerships. MISSING ELEMENT: The ground truth specifically mentions bundling with Moovit's urban mobility and transit intelligence application, which the LLM answer completely omits - this is a notable omission of a key strategic element.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 480,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "\nFrom the original 2019 issuance the Tower preferred interests consisted of two fixed‑rate series (Class A‑1 at a 5 % distribution and Class A‑2 at a 4.75 % distribution) that reset every five years.  In August 2024 the interests were amended so that all of the 2019 Tower preferred equity is now split into a Fixed‑Rate Class A (5.90 % quarterly distribution) and a Floating‑Rate Class A (distribution equal to SOFR + 250 bps, reset every five years), with call rights beginning in 2029 and the same redemption‑on‑default provisions.  Thus, between 2022 and 2024 the structure shifted from two static 5 %/4.75 % series to a dual‑rate (fixed + floating) framework with a higher base rate and a market‑linked floating tranche.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the structural evolution and captures the key transformation from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 structure with Class A-1 at 5.0% and Class A-2 at 4.75%, (2) Accurately describes the August 2024 amendment creating Fixed Rate (5.90%) and Floating Rate (SOFR + 250 bps) interests, (3) Properly characterizes the shift from static dual-series to dynamic fixed/floating framework, (4) Correctly notes the five-year reset periods, (5) Adds relevant context about call rights (2029) and redemption-on-default provisions not explicitly mentioned in ground truth. MINOR ISSUES: (1) The LLM states the original 2019 issuance had two series but doesn't explicitly mention the dollar amounts ($1,500 for Class A-1 and $4,500 for Class A-2) that were present in 2022 - this is a minor omission of quantitative detail, (2) The phrasing 'from the original 2019 issuance' slightly shifts focus from the 2022 baseline requested in the question, though this is semantically acceptable since it provides context. QUANTITATIVE VERIFICATION: All percentages are correct (5.0%, 4.75%, 5.90%, SOFR + 250 bps), the August 2024 date is correct, and the five-year reset period is accurate. The answer successfully synthesizes multi-hop information across the time period and correctly identifies the structural transformation. The addition of call rights and redemption provisions, while not in the ground truth, represents reasonable supplementary detail from SEC filings that doesn't contradict the core answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 431,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "\nThe Balanced Index Fund’s underlying Level 3 holdings are still valued through the standard fair‑value process—using the underlying investments’ NAVs, market‑approach inputs and other valuation techniques—while the fund itself is marked‑to‑market at Level 1.  Unrealized results swung from a combined $23 million loss in 2022 (mainly $16 m corporate, $11 m mortgage‑backed and $14 m municipal) to a modest $11 million gain in 2023 ( $2 m corporate, $6 m mortgage‑backed and $3 m other), reflecting a reversal from loss to gain.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM answer contains significant numerical discrepancies. Ground truth shows 2022 unrealized losses of ($16)M corporate and ($11)M mortgage-backed/asset-backed, totaling ($27)M for these two categories. The LLM claims a 'combined $23 million loss in 2022' and adds a mysterious '$14 m municipal' category not mentioned in the ground truth. The 2023 figures are partially correct ($2M corporate, $6M mortgage-backed) but the LLM adds '$3 m other' which is not in the ground truth. The LLM's total of $11M gain in 2023 is incorrect - the ground truth shows $2M + $6M = $8M gain. (2) ENTITY/CATEGORY ERRORS - The LLM introduces 'municipal' bonds and 'other' categories that don't appear in the original answer, suggesting either hallucination or confusion with different data sources. (3) MISSING KEY INFORMATION - The LLM completely omits the critical detail about the fund's composition (60% equities/40% debt) in both years, which is explicitly mentioned in the ground truth as part of how the investment approach evolved. (4) VALUATION METHODOLOGY - While the LLM mentions NAVs and market-approach inputs, it fails to highlight the key evolution noted in ground truth: the 2023 explicit reference to Level 1 quoted market prices, indicating a shift toward more transparent valuation. (5) CALCULATION VERIFICATION - Ground truth 2022: ($16)M + ($11)M = ($27)M, not ($23)M. Ground truth 2023: $2M + $6M = $8M, not $11M. The LLM's arithmetic is demonstrably wrong. The answer shows partial understanding of the reversal from losses to gains but fails on numerical accuracy and omits critical contextual details about fund composition and valuation methodology evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 470,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "\nBetween 2023 and 2024 the discussion of accounting developments moved from a generic risk‑factor mention to a stand‑alone forward‑looking statement that explicitly warns that “changes in accounting standards governing the preparation of our financial statements … could have a material impact on our reported financial condition, results of operations, cash flows and other financial data.”  In the 2023 filing the accounting‑standards theme was only one of many risk items, whereas in 2024 it is highlighted as a distinct, material uncertainty that can affect capital ratios, dividend‑paying capacity and overall strategic decisions.  This shift reveals that evolving accounting standards have become a central driver of BNY Mellon’s strategic priorities, shaping its reporting choices, capital‑planning and risk‑management focus.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims that in 2024 accounting developments are described as 'changes in accounting standards governing the preparation of our financial statements … could have a material impact on our reported financial condition, results of operations, cash flows and other financial data.' However, the ground truth shows the 2024 language states accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses' - these are fundamentally different phrasings and the LLM appears to have fabricated or misquoted the actual language. (2) MISCHARACTERIZATION: The LLM describes the 2024 treatment as a 'stand-alone forward-looking statement that explicitly warns' with 'material impact' language, but the ground truth indicates it was integrated into a broader list of potential influences without the specific 'material impact' framing the LLM attributes to it. (3) INCOMPLETE SYNTHESIS: The ground truth specifically mentions that 2024 included 'capital plans including dividends and repurchases' and 'efficiency savings' as concrete business decisions tied to accounting developments - the LLM mentions 'capital-planning' generically but misses these specific details. (4) LOGICAL INCONSISTENCY: The LLM's characterization of the shift as moving from 'generic risk-factor mention to a stand-alone forward-looking statement' contradicts the ground truth, which shows the 2024 language was actually more integrated (listing accounting alongside regulatory, technology, market, and economic developments) rather than more isolated. (5) UNSUPPORTED CLAIMS: The LLM's assertion that accounting standards have become 'a central driver of BNY Mellon's strategic priorities' goes beyond what the ground truth supports - the ground truth indicates a more integrated view, not a central/primary driver status. The answer demonstrates poor multi-hop synthesis and appears to contain invented or misremembered details rather than accurate reflection of the actual filing language.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 592,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "\nThe 2023 risk disclosures show that heightened concerns over store‑safety (e.g., COVID‑related protocols, rising shrink and organized retail crime) and expanding cyber‑threats required associates to adopt new security and compliance duties, while the 2022 narrative emphasized culture, recognition and development programs to deepen engagement. As a result, the same safety and cybersecurity pressures that could disrupt operations also added extra workload and vigilance for associates, potentially limiting the bandwidth for the purely engagement‑focused initiatives highlighted the prior year.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some key elements but has notable issues: (1) CORRECT ELEMENTS: The answer accurately identifies the shift from 2022 engagement-focused initiatives to 2023 risk concerns (store safety, organized retail crime, cybersecurity threats). It correctly notes that 2022 emphasized culture, recognition, and development programs. (2) PROBLEMATIC ELEMENTS: The LLM introduces COVID-related protocols as a 2023 concern, which is not mentioned in the ground truth and appears to be an anachronistic addition (COVID concerns would be more relevant to 2020-2021). This is a factual error. (3) MISSING CRITICAL DETAIL: The ground truth specifically mentions that 'four out of five associates were emotionally committed' in 2022 - a concrete quantitative metric that the LLM completely omits. This is a significant omission of a key statistic. (4) REASONING QUALITY: The LLM's logic about added workload and vigilance limiting bandwidth for engagement initiatives is reasonable inference, but it diverges from the ground truth's focus on how risks could 'erode trust, impact associate morale and retention, and damage reputation.' The LLM frames it as operational burden rather than trust/morale erosion. (5) MULTI-HOP SYNTHESIS: The answer does synthesize across 2022 and 2023 data, but the synthesis is incomplete and partially misdirected. The core insight about the contrast between engagement initiatives and emerging risks is present but underdeveloped. (6) QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this is neutral, though the omission of the '4 out of 5' statistic from ground truth is a quantitative accuracy failure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 456,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "\nBetween 2022 and 2023 the learning‑curve went from being a peripheral variable in program‑accounting estimates to a explicitly quantified risk driver.  In the 2022 filing it was listed only as one of several factors influencing cost and margin estimates, whereas the 2023 filing states that a ±1 % change in the gross‑margin assumptions for its commercial airplane programs would shift operating earnings by roughly $330 million and that further reductions in the learning‑curve‑derived cost outlook could trigger additional reach‑forward losses and abnormal production‑cost charges on programs such as the 777X and 787.  Consequently, the learning curve now sits at the core of the company’s profitability assessments and risk‑management disclosures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth. (1) MAJOR ERRORS: The LLM claims the learning curve went from 'peripheral' to 'explicitly quantified risk driver,' which contradicts the ground truth stating it evolved from a risk factor to an integrated, predictable component of cost estimation. The LLM's framing suggests increased emphasis on learning curve as a risk, when the ground truth indicates the opposite—it became less of a risk and more of a managed variable. (2) QUANTITATIVE ISSUES: The LLM introduces a specific figure of '±1% change in gross-margin assumptions would shift operating earnings by roughly $330 million' which does not appear in the ground truth and cannot be verified. This appears to be fabricated or misattributed data. The LLM also mentions '777X and 787' programs, but the ground truth only specifically mentions '787' as an example. (3) MULTI-HOP REASONING: The LLM fails to correctly synthesize the evolution described in the ground truth. The ground truth clearly states the learning curve shifted from being framed as an unpredictable risk to being integrated into predictable production planning. The LLM reverses this narrative by suggesting it became MORE of a risk driver. (4) SEMANTIC MISALIGNMENT: The core thesis is inverted. Ground truth: learning curve became more manageable and predictable. LLM answer: learning curve became more prominent as a risk. This is a fundamental misunderstanding of the evolution described. (5) MISSING ELEMENTS: The LLM fails to mention the shift from risk-based framing to integration into cost estimation processes, supplier performance trends, and labor efficiency projections—all key elements of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 476,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "\nThe 2023 filing only referenced the dividend‑reinvestment plan in the generic “Capital‑Issuer purchases of equity securities” discussion and did not single out any officer or director participation or the trading‑arrangement implications. In contrast, the 2024 Form 10‑K adds a dedicated Item 9(b)(b) disclosure that explicitly states that certain officers and directors elect to take part in the dividend‑reinvestment (and related) plans and that their share‑withholding elections may be structured to meet the affirmative‑defense safe‑harbor of Rule 10b5‑1 or may constitute non‑Rule 10b5‑1 trading arrangements. Thus, the 2024 filing provides a much clearer, explicit accounting of officer/director involvement and the associated trading‑rule considerations that were absent or only implicit in the 2023 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally contradictory to the ground truth and contains major factual errors: (1) DIRECTIONAL ERROR - The LLM claims the 2024 filing ADDS explicit disclosure of officer/director participation in the Dividend Reinvestment Plan with Rule 10b5-1 trading arrangement details, while the ground truth states the opposite: the 2023 filing contained detailed disclosure of these elements, and the 2024 filing OMITTED the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements. This is a complete reversal of the actual evolution. (2) ENTITY/STRUCTURAL ERROR - The LLM references 'Item 9(b)(b)' which appears to be an incorrect or fabricated citation that doesn't align with standard SEC filing structure. The ground truth references Item 408(c) of Regulation S-K, which is the correct regulatory framework for this disclosure. (3) CHARACTERIZATION ERROR - The LLM describes the 2024 filing as providing 'much clearer, explicit accounting' when the ground truth indicates a SIMPLIFICATION or STANDARDIZATION with OMISSION of earlier specificity. (4) MULTI-HOP REASONING FAILURE - The LLM failed to correctly synthesize the comparative evolution between the two years. The core finding is inverted: the trend was toward LESS detailed disclosure in 2024, not MORE. (5) COMPLETENESS - While the LLM addresses both years and mentions the key elements (Dividend Reinvestment Plan, officer/director participation, Rule 10b5-1 arrangements), it presents them in the wrong temporal sequence and with inverted conclusions. The answer demonstrates a fundamental misunderstanding of how the disclosure evolved between the two filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 453,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "\nFrom fiscal 2021 through fiscal 2023 Home Depot’s spending on an interconnected, friction‑less experience grew from a $2.6 billion initial outlay to about $3.2 billion, expanding the digital foundation it had begun building. By fiscal 2023 the company was using data‑driven, location‑specific offers, mobile‑app navigation and curb‑side/same‑day delivery options, computer‑vision inventory visibility and AI‑enhanced personalization to tailor the shopping journey across stores, online and the job site.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a specific figure of $3.2 billion for fiscal 2023 capital expenditures that is NOT present in the ground truth. The ground truth only confirms $2.6 billion for fiscal 2021 and does not provide a specific 2023 capex figure. This is a critical factual error - the LLM appears to have fabricated or hallucinated this number. (2) INCOMPLETE SYNTHESIS - The ground truth emphasizes a strategic shift from 'general investment in interconnectedness' to 'refined, data-driven personalization strategy' using 'enhanced merchandising information technology tools' tailored to 'shopping intent and location.' The LLM answer provides extensive tactical details (mobile-app navigation, curbside delivery, computer-vision inventory, AI-enhanced personalization) that go beyond what the ground truth specifies. While some of these details may be accurate from the filings, they represent an expansion beyond the ground truth's scope. (3) MISSING KEY INSIGHT - The ground truth emphasizes the strategic evolution and refinement of the approach, not just expansion of spending. The LLM focuses heavily on specific technologies and features rather than the conceptual shift in strategy. (4) REASONING QUALITY - The LLM attempts multi-hop synthesis but introduces unsupported quantitative claims. The comparison structure (from $2.6B to $3.2B) is presented as fact without ground truth support. This violates the strict requirement for numeric accuracy in financial questions. The answer reads as plausible but contains a fabricated data point that significantly undermines credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 448,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "\nBetween 2022 and 2023 the DHR‑Aldevron relationship shifted from a purchase‑financing stage to a mature‑business‑investment stage.  In 2022 the company projected roughly **$1.5 billion of capital expenditures**, with a portion dedicated to expanding Aldevron’s manufacturing capacity, reflecting continued investment beyond the 2021 acquisition.  By 2023 the acquisition was fully integrated and **no new acquisition‑related outlays** were reported—only the $28 million of transaction costs that had been recorded in 2021—so subsequent capital spending has been focused on sustaining and growing Aldevron’s operations rather than on further purchase‑price or integration expenditures.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its credibility. CRITICAL ERRORS: (1) The LLM states 'no new acquisition-related outlays were reported' in 2023, but the ground truth explicitly states that DHR paid $9,561 million in net cash consideration to Aldevron in 2023. This is a major omission of a key financial metric that directly answers the question about the evolution of the financial relationship. (2) The LLM references '$28 million of transaction costs that had been recorded in 2021' which is not mentioned in the ground truth and appears to be fabricated or confused with other data. (3) The LLM's characterization that 'the acquisition was fully integrated and no new acquisition-related outlays were reported' contradicts the ground truth, which indicates a substantial $9.561 billion payment in 2023. CORRECT ELEMENTS: (1) The $1.5 billion capital expenditure projection for 2022 is accurate. (2) The general characterization of a shift from investment stage to integration is directionally correct, though the specific financial evidence is misrepresented. (3) The mention of Aldevron manufacturing capacity expansion is appropriate. MULTI-HOP REASONING: The LLM failed to synthesize the complete financial picture across 2022-2023. The ground truth requires understanding that the relationship evolved from capital investment planning (2022) to actual acquisition completion with substantial cash payment (2023). The LLM's answer suggests the acquisition was already complete by 2023 with no further outlays, when in fact the $9.561 billion payment in 2023 represents a major financial event that fundamentally characterizes the evolution of the relationship. This is a critical failure in multi-hop synthesis. The answer is partially relevant to the question but provides materially incorrect information about the 2023 financial relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 510,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "\nFrom September 2020 through the end of 2024 the Telco LLC preferred equity grew from the original $2 billion of Class A‑1 cumulative perpetual preferred interests to a total of $7.25 billion after the 2023 issuance of $5.25 billion of new Class A‑2/A‑3 series and the 2024 agreement to add a $2.25 billion Class A‑4 tranche in Q1 2025.  The original Class A‑1 carries a 4.25 % annual distribution that resets on a seven‑year schedule, while the 2023‑added Class A‑2/A‑3 carries a higher 6.85 % initial rate with a reset on Nov 1 2027 and every seven years thereafter; the forthcoming Class A‑4 will have a 5.94 % initial rate and a reset on Nov 1 2028 with resets every four years.  Thus, the structure expanded both in size and in the mix of series, and the distribution rates and reset intervals were adjusted to reflect the newer, higher‑yielding series and their distinct reset timetables.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains major factual inaccuracies that significantly diverge from the ground truth. (1) QUANTITATIVE ERRORS - Dollar amounts are off by a factor of 1,000: LLM states $2 billion and $7.25 billion when ground truth shows $2,000 and $7,250 (in millions, not billions). This is a fundamental error that undermines the entire answer. The LLM also introduces information NOT in the ground truth: a Class A-4 tranche of $2.25 billion with 5.94% rate and Nov 1 2028 reset on 4-year intervals. The ground truth only covers 2022-2024 and makes no mention of 2025 issuances or Class A-4. (2) TEMPORAL ISSUES - The LLM references 'September 2020' as a starting point, which is outside the 2022-2024 timeframe specified in the question. (3) COMPLETENESS - While the LLM does address the core question about structure evolution and distribution rates, it adds speculative information about future issuances (Class A-4 in Q1 2025) that goes beyond the ground truth knowledge base. (4) CORRECT ELEMENTS - The LLM correctly identifies: Class A-1 at 4.25% with 7-year resets, Class A-2/A-3 at 6.85% with Nov 1 2027 first reset and 7-year intervals thereafter. However, these correct details are embedded within a fundamentally flawed numerical framework. (5) MULTI-HOP REASONING - The synthesis of information about multiple preferred classes and their characteristics is logically sound, but the underlying data is incorrect. The magnitude error (billions vs. millions) is particularly egregious and suggests the LLM may have confused different reporting contexts or made a systematic conversion error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 443,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "\nBetween 2022 and 2024 AIG continued to rely on Expected‑Loss‑Ratio (ELR) techniques for its short‑tail and program lines—particularly U.S. Property, U.S. Special‑Risk, aerospace, environmental and other specialty lines—while extending the approach to newer portfolios such as UK/Europe casualty, Japanese personal‑lines and Canadian business.  The rationale has broadened from simply “low‑frequency/high‑severity” exposures to include ELR as a way to incorporate inflation‑adjusted loss trends, rate changes and emerging underwriting cycles, and to supplement development methods with ground‑up claim projections for the most recent accident year.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and contradicts the ground truth on multiple critical dimensions: (1) ENTITY ACCURACY FAILURE: The LLM identifies completely different insurance lines than the ground truth. Ground truth specifies aviation exposures (2022) and U.S. Workers' Compensation (2024), while LLM lists U.S. Property, U.S. Special-Risk, aerospace, environmental, UK/Europe casualty, Japanese personal-lines, and Canadian business—none of which appear in the ground truth answer. (2) CORE FACTUAL ERROR: The ground truth explicitly states ELR was used for 'latest accident year' in 2022 and expanded to 'U.S. Workers' Compensation, a long-tail line of business' by 2024. The LLM incorrectly characterizes the 2022 application as covering 'short-tail and program lines' and lists entirely different lines for 2024. (3) RATIONALE MISMATCH: Ground truth cites 'high-severity nature' for aviation and combination with 'loss development and frequency/severity methods' for Workers' Comp. LLM provides a different rationale focused on 'inflation-adjusted loss trends, rate changes and emerging underwriting cycles'—while potentially valid, this does not match the ground truth's stated reasoning. (4) MULTI-HOP SYNTHESIS FAILURE: The answer fails to correctly synthesize the evolution between 2022 and 2024 as specified in the ground truth. The comparison is fundamentally flawed because the insurance lines identified are incorrect. (5) MISSING KEY DETAILS: The ground truth emphasizes the combination of ELR with other methods (loss development, frequency/severity), which the LLM mentions generically but not in the specific context of the actual lines discussed. The answer appears to describe a different company's practices or a different aspect of AIG's methodology entirely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 487,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "\nTarget’s owned‑brand strategy moved from a focus in 2023 on “strengthening our owned‑brands portfolio” and expanding “signature partnerships” to a 2024 emphasis on making those brands a larger, more visible driver of sales—about one‑third of merchandise revenue now comes from owned and exclusive labels—and on deepening exclusive design collaborations (e.g., Apple, Disney, Levi’s, Ulta) that are integrated with the revamped Target Circle loyalty program.  The portfolio development now stresses a broader, more curated mix of exclusive brands across categories, leveraging both in‑store and digital fulfillment to boost traffic, market‑share growth, and differentiation through newness, style and value.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides relevant strategic context about Target's owned brands evolution but contains a significant quantitative discrepancy that undermines accuracy. STRENGTHS: (1) Correctly identifies the shift from 2023 emphasis on 'strengthening portfolio' to 2024 focus on broader execution; (2) Accurately captures the strategic emphasis on exclusive design collaborations and integration with Target Circle loyalty program; (3) Appropriately describes the evolution toward a more curated, diversified brand portfolio across categories; (4) Correctly notes the strategic goals of market-share growth and differentiation. CRITICAL ISSUE: The LLM states 'about one-third of merchandise revenue now comes from owned and exclusive labels' as a 2024 metric. The ground truth does not mention this specific percentage (33% of merchandise revenue), and this appears to be an unsupported quantitative claim that may be inaccurate or fabricated. This is a material factual error in a financial context. MINOR ISSUES: (1) The LLM provides more detailed strategic context (signature partnerships, Apple/Disney/Levi's/Ulta collaborations, Target Circle integration) that goes beyond the ground truth but is not contradicted by it; (2) The ground truth mentions 'over 40 distinct brands' which the LLM does not explicitly reference, though it does mention 'broader, more curated mix.' MULTI-HOP REASONING: The answer correctly synthesizes the evolution across 2023-2024 and connects strategic emphasis to product portfolio development as requested. However, the unsupported revenue percentage claim represents a failure in quantitative accuracy that significantly impacts the overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 462,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "\nIBM kept its existing 0.875 % Notes due 2030 on the 2024 filing and simultaneously issued new 2.900 % Notes due 2030.  This shows the company is preserving a low‑cost legacy tranche while tapping the market for fresh long‑term capital at today’s higher rates, indicating that investors now demand substantially higher yields on 10‑year debt.  The move reflects a layered financing strategy—maintaining cheap legacy debt for future flexibility while issuing higher‑coupon bonds to fund operations or refinance near‑term maturities in a market where long‑term borrowing costs have risen.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and provides a coherent interpretation of IBM's debt financing strategy. STRENGTHS: (1) All numeric values are correct—0.875% and 2.900% coupon rates are accurately cited, and the 2030 maturity date is correct. (2) The multi-hop synthesis is sound: the answer correctly identifies that IBM maintained the legacy 0.875% Notes while issuing new 2.900% Notes in 2024, and properly interprets the rate differential. (3) The reasoning about market conditions is logical and well-articulated—the LLM correctly infers that higher coupon rates reflect deteriorating borrowing conditions and increased investor yield demands. (4) The characterization of a 'layered financing strategy' aligns with the ground truth's mention of 'diversifying debt portfolio' and managing refinancing risks. MINOR DIFFERENCES: (1) The LLM emphasizes 'preserving cheap legacy debt for future flexibility' and 'funding operations or refinance near-term maturities,' which adds interpretive detail not explicitly in the ground truth but is reasonable inference. (2) The ground truth mentions 'targeting different investor segments with varied risk-return profiles,' which the LLM doesn't explicitly address, though the concept is implicit in discussing layered financing. (3) The LLM's framing focuses more on market timing and cost-of-capital dynamics, while the ground truth gives equal weight to portfolio diversification and refinancing risk management. These are complementary rather than contradictory interpretations. The answer is semantically equivalent to the ground truth on core points: dual issuance with same maturity, significant rate increase, and strategic debt management implications. No calculation errors or factual inaccuracies detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 484,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "\nBetween 2022 and 2024 AT&T lengthened and reshaped its long‑term debt ladder: the 2022 filing listed only shorter‑dated Global Notes (e.g., 2021‑2023 maturities) and did not include a 4.000 % issue maturing in 2049, whereas the 2024 filing adds a new 4.000 % Global Notes tranche due June 1 2049 (ticker T 49A) and introduces a suite of fresh long‑term issues—such as the 2.400 % notes due Mar 15 2024, 1.800 % due Sep 5 2026, 2.900 % due Dec 4 2026, 1.600 % due May 19 2028 and others extending to 2035‑2066.  This reflects AT&T’s strategy of extending average debt maturity and diversifying coupon profiles by issuing ultra‑long‑dated, lower‑coupon securities like the 2049 notes while supplementing the portfolio with multiple newer tranches across the early‑to‑mid‑2030s.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM claims the 4.000% Global Notes due June 1, 2049 were NOT in the 2022 filing but WERE added in 2024, when the ground truth explicitly states these notes were 'listed in 2022' and 'remained registered' in 2024. This is a complete reversal of the actual evolution. (2) CRITICAL ERROR - The LLM claims 2022 listed 'only shorter-dated Global Notes (e.g., 2021-2023 maturities)' which contradicts the ground truth showing the 2049 notes existed in 2022. (3) INCORRECT FOCUS - The LLM extensively discusses multiple other debt instruments (2.400% due Mar 15 2024, 1.800% due Sep 5 2026, 2.900% due Dec 4 2026, 1.600% due May 19 2028, etc.) that are not mentioned in the ground truth answer and appear to be fabricated or misattributed. (4) MISSING KEY FACT - The LLM fails to mention the 4.300% Global Notes due November 18, 2034 (T 34C), which is explicitly identified in the ground truth as a key addition between 2022 and 2024. (5) REASONING FLAW - The LLM's narrative about 'lengthening and reshaping' the debt ladder is contradicted by the actual fact that the 2049 notes (the longest-dated instruments mentioned) were already present in 2022. The core multi-hop synthesis is inverted: the ground truth shows continuity of the 2049 notes plus addition of the 2034 notes, while the LLM incorrectly portrays the 2049 notes as a new 2024 addition. The answer demonstrates a fundamental misunderstanding of the question's core requirement to track how specific instruments evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 444,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "\nIn 2023 the Heritage AspenTech acquisition produced roughly **$258 million of intangible‑asset amortization** and only **about $1 million of restructuring costs** directly tied to the integration. By 2024 that amortization had slipped to a smaller, non‑separately disclosed level (absorbed in the overall $1.077 billion intangible amortization, with $560 million of the 2024 total coming from the newer NI purchase), while **restructuring expenses linked to the AspenTech segment jumped to $8 million**—part of a company‑wide **$228 million restructuring charge**—showing that the integration moved from a modest cost base in 2023 to a much larger, ongoing restructuring effort in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) INTANGIBLES AMORTIZATION: Ground truth states 2023=$258M and 2024=$97M. LLM correctly identifies 2023=$258M but then claims 2024 was 'non-separately disclosed' and 'absorbed in overall $1.077B' - this directly contradicts the ground truth showing $97M for 2024. The LLM appears to have confused or misinterpreted the data structure. (2) RESTRUCTURING COSTS: Ground truth clearly states 2023=$72M and 2024=$228M. LLM claims 2023 had 'only about $1 million' (off by 71x) and 2024 had '$8 million' for AspenTech segment (contradicting the $228M total mentioned). The LLM conflates segment-specific costs with company-wide totals incorrectly. (3) MULTI-HOP REASONING: The LLM failed to properly synthesize the two-year comparison. It introduced extraneous information about the NI acquisition and segment-level breakdowns that weren't part of the ground truth answer, suggesting confusion about data sources. (4) CORE ANSWER FAILURE: The fundamental comparison requested (how did impact evolve 2023→2024) is answered incorrectly. Ground truth shows: amortization DOWN ($258→$97), restructuring UP ($72→$228). LLM shows: amortization unclear/absorbed, restructuring UP but with wrong numbers ($1M→$8M). The LLM's narrative about 'integration moved from modest cost base to larger restructuring' is directionally correct on restructuring but factually wrong on the actual numbers and completely misses the amortization decrease.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 424,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 AIG kept using expected‑loss‑ratio techniques for workers‑compensation, but it refined the way it applies them.  The company now separates guaranteed‑cost and excess‑of‑deductible business and, within the latter, further segments by deductible size and whether claims are handled by AIG or a third‑party administrator, while also isolating California and New York from the rest of the portfolio.  Because the share of large‑deductible accounts has risen and their claims emerge more slowly, AIG places greater reliance on expected‑loss‑ratio estimates—particularly for the most recent five accident years—when reserving these segmented lines.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core evolution of AIG's expected loss ratio methods between 2022 and 2024 with substantial accuracy. STRENGTHS: (1) Correctly identifies that AIG continued using expected loss ratio methods across both years; (2) Accurately describes the refinement toward greater segmentation by deductible size and claim handling (AIG vs. third-party administrators); (3) Properly notes the increasing proportion of large deductible business and its impact on slowing claim emergence; (4) Correctly references the focus on the most recent five accident years for excess of deductible business; (5) Appropriately mentions California and New York segmentation (a detail present in 2024 disclosures). WEAKNESSES: (1) The answer does not explicitly mention the 2024 disclosure limitations regarding claim count data due to aggregation and reinsurance exclusions, which the ground truth identifies as a notable evolution in disclosure emphasis between 2022 and 2024; (2) The answer could be clearer about the 2022 baseline (that guaranteed cost business was primarily limited to the most recent accident year, while excess of deductible received significant weight in five years); (3) The phrasing 'places greater reliance on expected-loss-ratio estimates' is somewhat vague compared to the ground truth's more explicit comparison of methodological emphasis. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are provided in either the question or the LLM answer, so this dimension is not directly testable. The temporal references (2022, 2024, five accident years) are all correct. MULTI-HOP REASONING: The answer successfully synthesizes information about business segmentation, deductible size impacts, and claim handling variations, demonstrating sound multi-hop reasoning across the evolution period. The logical connection between increasing large deductible accounts and slower claim emergence is properly established. SEMANTIC EQUIVALENCE: The core message aligns with ground truth regarding methodological evolution and increased segmentation sophistication.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 564,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "\nTarget’s cyber‑risk framework shifted from a 2023 focus on establishing a **Cyber Fusion Center** that investigated and contained threats to a 2024 model in which that center is **formally integrated into the enterprise‑risk program**, with dedicated escalation paths to the Board and the Audit & Risk Committee.  At the same time, the company **expanded its threat‑intelligence collaboration**—sharing intelligence with industry groups and third‑party vendors—and **boosted internal capabilities** through the new “Cyber Plus Institute” training and talent‑development initiatives, creating a more coordinated, proactive, and partnership‑driven approach to cyber‑threat investigation and response.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures several key elements from the ground truth but introduces a significant factual error and makes unsupported claims. CORRECT ELEMENTS: (1) The 2023 baseline of Cyber Fusion Center operations is accurate; (2) The 2024 evolution toward more structured/formal integration is correct; (3) The mention of escalation paths to Board/management aligns with ground truth; (4) The expansion of external collaboration and threat intelligence sharing is accurate; (5) The characterization of a more mature, coordinated approach is appropriate. PROBLEMATIC ELEMENTS: (1) The LLM introduces 'Cyber Plus Institute' as a specific training initiative, which is NOT mentioned in the ground truth. The ground truth only references 'regular training and compliance activities for team members' without naming a specific institute. This is a factual error that adds unsupported detail; (2) The LLM states the center is 'formally integrated into the enterprise-risk program' - while the ground truth mentions a 'more structured incident response program,' it does not explicitly state integration into an enterprise-risk program. This is a minor interpretive stretch; (3) The LLM mentions 'Audit & Risk Committee' specifically, while ground truth only says 'Board of Directors' - this is an addition not clearly supported by the source material. MULTI-HOP REASONING: The answer correctly synthesizes the evolution from 2023 to 2024 across multiple dimensions (internal structure, external collaboration, training/capabilities). The logic is sound in connecting these elements. QUANTITATIVE ACCURACY: No specific numbers, dates, or calculations are present in either answer, so this scores well (8/10 - minor deduction for the unsupported 'Cyber Plus Institute' naming). QUALITATIVE ACCURACY: Moderate issues due to the introduction of unsupported specific program names and committee references that go beyond what the ground truth establishes. The core reasoning is sound but the details are problematic (5/10). CONTEXTUAL RELEVANCE: The answer appropriately addresses the question's focus on evolution, Cyber Fusion Center, and external collaboration (7/10).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 579,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "\nBetween 2022 and 2023 Eli Lilly’s revenue from Baqsimi jumped from $139 million to $677.6 million, a surge driven primarily by a one‑time $579 million payment for the product’s rights that was recorded as collaboration/other revenue and recognized when control of those rights transferred.  The contractual structure therefore shifted from ordinary product sales to a license‑type arrangement, with the upfront payment being amortized (or recognized as a discrete gain) and any subsequent royalties or milestone payments being recorded as collaboration revenue in later periods.  By 2024 the company continued to recognize revenue from Baqsimi only to the extent of any remaining license balances or royalties, as the bulk of the financial benefit had already been captured in the 2023 rights‑sale transaction.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) WRONG TIME PERIOD: The LLM answer discusses 2022-2023 evolution, but the question explicitly asks about 2023-2024. This is a fundamental misalignment with the question scope. (2) INCORRECT NUMBERS: The LLM cites $139 million (2022) and $677.6 million (2023) for Baqsimi revenue. The ground truth states $579.0 million in 2023 for Baqsimi rights sales specifically. The $677.6 figure appears to be fabricated or conflated with other products. (3) INCOMPLETE SYNTHESIS: The ground truth clearly indicates that in 2024, Baqsimi was integrated into 'collaboration and other revenue' disclosures (not separately reported), reflecting a shift from direct product revenue to collaborative arrangements. The LLM answer mentions this shift but frames it incorrectly as occurring between 2022-2023 rather than 2023-2024. (4) CALCULATION/LOGIC ISSUES: The LLM's explanation of amortization and discrete gain recognition is speculative and not supported by the ground truth, which simply states a shift in revenue recognition model. (5) MISSING KEY INSIGHT: The ground truth emphasizes that by 2024, Baqsimi was no longer separately disclosed but bundled with other collaboration revenues (including olanzapine portfolio), indicating a strategic consolidation. The LLM fails to capture this 2024 integration clearly. (6) CORRECT ELEMENT: The $579 million figure for the rights sale is correct, but it's attributed to the wrong year context in the LLM's narrative. The LLM does correctly identify this as a one-time payment for rights, which aligns with ground truth, but the overall temporal framing is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 445,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "\nIn 2023 AT&T eliminated the last $5.4 billion of Mobility Preferred Interests by repurchasing the remaining 213 million shares—funding the buy‑back mainly with the $5.25 billion of new cumulative preferred interests it had issued earlier that year in Telco LLC and, earlier, with $2 billion of Series B preferred equity in Mobility II.  In 2024 the company refined its preferred‑equity structure: it amended the 2019 Tower Holdings preferred interests to reset their rates and convert them to fixed‑ and floating‑rate classes, and it expanded Telco LLC’s preferred stack by issuing an additional $5.25 billion of Class A‑2/A‑3 interests and announcing a planned $2.25 billion Class A‑4 issuance for 2025, while continuing to manage overall capital through debt, dividends and limited equity‑based financing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM states '$5.4 billion of Mobility Preferred Interests' when ground truth specifies $5,414 million ($5.414 billion) - minor rounding acceptable, but more critically, the LLM claims funding came from '$5.25 billion of new cumulative preferred interests...in Telco LLC and, earlier, with $2 billion of Series B preferred equity in Mobility II.' The ground truth makes NO mention of $2 billion Series B preferred equity in Mobility II - this appears to be fabricated. The ground truth clearly states the $5,250M repurchase was funded by Telco LLC preferred issuance only. (2) INCOMPLETE/INCORRECT 2024 DETAILS: The LLM claims AT&T 'issued an additional $5.25 billion of Class A-2/A-3 interests and announcing a planned $2.25 billion Class A-4 issuance for 2025.' The ground truth states total Telco LLC preferred interests increased to $7,250 (from $2,000 original + $5,250 from 2023), but does NOT mention $5.25B additional issuance in 2024 or $2.25B planned for 2025. These appear to be hallucinated figures. (3) CORRECT ELEMENTS: The LLM correctly identifies the 213 million Mobility Preferred Interests repurchase, the ~$5.4B amount, the 2019 Tower Holdings restructuring into fixed/floating rate classes, and the general strategic pivot. (4) MISSING CRITICAL DETAILS: The LLM omits the specific distribution rates (6.85% for Telco LLC, 5.90% base and SOFR+250bps for Tower Holdings), the balance sheet impacts ($2,650M from accounts payable, $2,670M from other noncurrent liabilities), and the specific composition of the $7,250 total Telco LLC interests. (5) MULTI-HOP REASONING: The LLM attempts to synthesize 2023-2024 evolution but introduces unsupported claims about 2024 issuances and 2025 plans that contradict or extend beyond ground truth. The core narrative structure is reasonable but built on partially false data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 510,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "\nFrom 2023 to 2024 Emerson’s ownership in AspenTech rose from the ~55 % stake it held after the 2022 Heritage AspenTech transaction to about 57 % and, in November 2024, it announced a proposal to acquire the remaining shares and take AspenTech private.  The integration added roughly $1.4 billion of sales and lifted Emerson’s consolidated gross margin to 50.8 %—a 1.8‑percentage‑point increase—although inventory step‑up amortization of $231 shaved about 1.3 points off that margin, while the deeper equity stake expanded Emerson’s equity‑compensation reserve and led it to reserve 4 million shares for future issuance under AspenTech’s compensation plans.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations of the ground truth:\n\n1. CRITICAL ERRORS - Ownership Timeline: The LLM claims Emerson's ownership rose from ~55% to 57% between 2023-2024, but the ground truth states Emerson acquired a 55% stake in 2024 (not 2022 as the LLM implies). The LLM incorrectly references a '2022 Heritage AspenTech transaction' when the ground truth indicates the 55% acquisition occurred in 2024.\n\n2. CRITICAL ERRORS - Transaction Details: The LLM completely omits the ~$6.0 billion cash component of the 2024 transaction, which is a major financial impact mentioned in the ground truth. This is a significant omission for a question about 'financial impacts.'\n\n3. QUANTITATIVE ACCURACY ISSUES:\n   - The LLM states gross margin increased to 50.8% with a 1.8 percentage point increase (correct for 2024)\n   - However, the ground truth mentions a 3.3 percentage point increase in 2023 AND a 1.8 percentage point increase in 2024. The LLM only addresses 2024 and misses the 2023 impact entirely\n   - The LLM adds details about $1.4 billion in sales and $231 million inventory step-up amortization that are not in the ground truth, suggesting potential confusion with different source data\n\n4. MULTI-HOP REASONING FAILURE: The question asks about evolution 'from 2023 to 2024' and the LLM fails to properly establish the 2023 baseline (business relationship/partner status) before describing the 2024 transformation. The answer jumps to post-2024 developments (November 2024 announcement) without clearly establishing the 2023-2024 transition.\n\n5. OWNERSHIP STRUCTURE: The LLM mentions a proposal to take AspenTech private in November 2024, which goes beyond the ground truth scope and may represent forward-looking statements not in the original answer.\n\n6. MISSING CONTEXT: The LLM fails to clearly articulate that in 2023 Emerson had a 'business relationship' (partner status) that transformed into a 'majority shareholder' position in 2024 - this structural shift is central to the question.\n\nThe answer demonstrates partial understanding of some financial metrics but fundamentally misrepresents the timeline and omits critical transaction details ($6.0 billion), making it substantially incorrect despite getting some 2024 margin figures right.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 618,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "\nThe Japan pension plans accounted for roughly 50 % of total non‑U.S. pension obligations in 2022 (about 51 % in 2022, rising to ≈ 54 % in 2023 and back to ≈ 50 % in 2024), showing a relatively stable contribution. Over the same period, the weighted‑average discount rate applied to these plans increased from roughly 1.0 % in 2022 to 1.48 % in 2023 and 1.81 % in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer addresses the core question about Japan pension plans' evolution and discount rate changes, but contains significant quantitative errors that undermine accuracy. CORRECT ELEMENTS: (1) The percentage progression for Japan pension plans is correctly identified as approximately 50% in 2022, 54% in 2023, and 50% in 2024. (2) The discount rate progression is correctly stated as increasing from roughly 1.0% in 2022 to 1.48% in 2023 and 1.81% in 2024. (3) The characterization of the trend (relative decline in size, increase in discount rate) is appropriate. CRITICAL ERRORS: (1) The ground truth states that in 2022, Japan pension plans accounted for 61% of non-U.S. pension ASSETS with an expected long-term rate of return of 1.85%, but the LLM conflates this with the projected benefit obligations metric and provides ~50% instead of 61%. This is a major discrepancy. (2) The LLM states the discount rate was 'roughly 1.0% in 2022' but the ground truth indicates 1.85% as the expected long-term rate of return in 2022 (though the discount rate progression 1.0%→1.48%→1.81% may be accurate for the specific discount rate metric). The confusion between different pension metrics (assets vs. obligations, expected return vs. discount rate) creates ambiguity. MULTI-HOP REASONING: The LLM correctly synthesizes the evolution across three years and identifies the relationship between declining share and increasing discount rates. However, the mixing of different pension obligation metrics (2022 assets vs. 2023-2024 obligations) suggests incomplete understanding of the source data structure. The answer demonstrates reasonable logical flow but lacks precision in distinguishing between different pension plan metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 472,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "\nIn the 2022 filing the discussion of competition was brief and tucked into a long list of risk factors, merely noting that “local companies may have a substantial competitive advantage because of their greater understanding of, and focus on, the local customer.” By the 2023 filing Amazon isolates the competitive threat and explicitly links it to external market conditions—such as slower Internet adoption, weaker consumer spending, country‑specific regulatory and geopolitical risks, and the emergence of evolving business models—thereby framing competition as a macro‑level, environment‑driven challenge rather than a generic risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is substantially incorrect and contradicts the ground truth on multiple critical dimensions: (1) FACTUAL ERRORS: The LLM claims the 2022 filing discussed 'local companies' competitive advantages and 'local customer' understanding, which is not mentioned in the ground truth. The ground truth specifically states the 2022 filing referenced 'competitive stores, websites, products, services, price decreases, or improvements' - a different framing entirely. (2) DIRECTIONAL REVERSAL: The LLM claims Amazon 'isolates the competitive threat' in 2023 and links it to external conditions, but the ground truth indicates the opposite evolution: the 2023 filing embedded competitive pressures within a BROADER context of external economic/geopolitical conditions, not isolating them. The ground truth explicitly states this represents a shift toward framing competition 'as part of a larger set of external risks rather than a standalone concern.' (3) MISSING KEY LANGUAGE: The LLM fails to cite or reference the actual language from either filing that the ground truth provides ('the introduction of competitive stores, websites, products, services, price decreases, or improvements' from 2022, or the 2023 language about 'general economic, business, and geopolitical conditions worldwide'). (4) INCORRECT SYNTHESIS: The LLM invents specific external factors (slower Internet adoption, weaker consumer spending, country-specific regulatory risks) that are not mentioned in the ground truth as part of Amazon's evolution in disclosure. (5) LOGICAL CONTRADICTION: The ground truth shows both years retained 'the same core language' but with different contextual framing, whereas the LLM suggests a fundamental shift in how competition is discussed. The answer demonstrates a fundamental misunderstanding of the actual evolution described in the ground truth and introduces fabricated details not supported by the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 522,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "\nTarget’s port‑security risk remains anchored to the same geographic chokepoints—principally the California ports that handle the bulk of its imported goods—as noted in both the 2023 and 2024 filings.  However, the 2024 disclosure places greater emphasis on how recurring port disruptions (e.g., labor disputes, congestion or diversions) could raise costs and force the company to rely on alternative logistics arrangements, underscoring a sharper operational impact than was highlighted a year earlier.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS IN MULTI-HOP SYNTHESIS: The LLM answer fundamentally contradicts the ground truth on the key evolution of Target's port security risk exposure. Ground truth states that by 2024, Target BROADENED its focus from California ports specifically to 'major U.S. ports' more generally, indicating geographic expansion of concern. The LLM answer incorrectly claims the risk 'remains anchored to the same geographic chokepoints—principally the California ports' in both years, which directly contradicts the documented shift. This is a major factual error in the core multi-hop reasoning required by the question. CORRECT ELEMENTS: (1) The LLM correctly identifies that 2024 emphasizes operational impacts like increased costs and alternative logistics arrangements; (2) Correctly notes labor disputes and congestion as factors; (3) Appropriately characterizes the shift toward future-focused risk assessment. INCORRECT ELEMENTS: (1) Fails to capture the geographic evolution from California-specific to broader U.S. ports focus; (2) Misses the key distinction that 2023 referenced past disruptions with alternative arrangements already made, while 2024 shifted to potential future impacts; (3) The statement that California ports 'handle the bulk of its imported goods' may be accurate but obscures the documented broadening of geographic concern in 2024. MULTI-HOP REASONING FAILURE: The question explicitly asks about 'evolution...particularly in terms of geographic focus' and the LLM failed to identify the critical geographic shift from specific (California) to generalized (major U.S. ports). This represents a fundamental misunderstanding of the comparative analysis required across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 466,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "\nIn 2023 Emerson recognized about **$258 million** of amortization of the intangibles acquired in the Heritage AspenTech transaction, but by 2024 those assets were essentially fully amortized; the 2024 total intangibles amortization of **$1.077 billion** was driven almost entirely by **$560 million** of amortization of assets obtained in the NI acquisition.  At the same time, restructuring expenses surged from **$72 million in 2023 to $228 million in 2024**, reflecting higher integration‑related costs—including **$43 million of stock‑compensation expense attributable to NI**—showing that Emerson’s post‑acquisition cost‑restructuring activities intensified in 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core Heritage AspenTech amortization figures ($258M in 2023, no longer reported in 2024) and accurately cites the restructuring cost increase ($72M to $228M). The numbers for these key metrics are factually correct. WEAKNESSES: (1) The LLM introduces substantial additional information about the NI acquisition ($560M amortization, $1.077B total intangibles, $43M stock-compensation) that is NOT present in the ground truth answer. While this information may be factually accurate from the filings, it significantly expands the scope beyond what the original answer addresses. (2) The LLM's explanation that AspenTech assets were 'essentially fully amortized' by 2024 is an inference not explicitly stated in the ground truth, though it's a reasonable interpretation. (3) The ground truth focuses specifically on the Heritage AspenTech relationship evolution, while the LLM dilutes this focus by introducing NI acquisition details that weren't part of the original answer. MULTI-HOP REASONING: The LLM demonstrates sound multi-hop synthesis by connecting amortization trends to acquisition timing and restructuring activities. However, the introduction of NI acquisition data suggests the model may have over-synthesized beyond the question's specific scope. CALCULATION VERIFICATION: All cited numbers are accurate; no calculation errors detected. The issue is one of scope creep rather than factual incorrectness. The answer would score higher if it maintained focus on Heritage AspenTech specifically while acknowledging (rather than emphasizing) other acquisition impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 444,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "\nBetween 2022 and 2024 AIG kept Expected‑Loss‑Ratio (ELR) as the primary tool for the newest business but made the weighting far more explicit.  In the 2022 filing the ELR was described only as receiving “more weight in the more recent accident years” across its D & O, E & O, EPLI and professional‑liability lines.  By the 2024 filing the company states that ELR methods are given “significant weight” specifically for the most recent **five** accident years and for excess‑of‑deductible, cyber, M&A and other specialty lines, while mature years rely on loss‑development techniques.  Thus the evolution is a shift from a general, qualitative preference for newer years to a quantified, line‑specific emphasis on the latest five accident years.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces unsupported claims that contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims ELR methods are applied to 'the most recent five accident years' in 2024 - this specific quantification ('five') does not appear in the ground truth and represents a factual error. (2) The LLM lists 'excess-of-deductible, cyber, M&A and other specialty lines' as 2024 applications - the ground truth makes no mention of these lines. Instead, ground truth specifically states U.S. Workers' Compensation was added by 2024. (3) The LLM's characterization of the evolution as moving from 'qualitative preference' to 'quantified, line-specific emphasis' is not supported by the ground truth, which describes the evolution differently: from application in low-frequency/high-severity lines (D&O, E&O, EPLI, professional liability) to expanded application including long-tail business (Workers' Compensation). (4) CORRECT ELEMENTS: The LLM correctly identifies that ELR methods were used for D&O, E&O, EPLI, and professional liability in 2022, and correctly notes the general trend of continued use with evolution between 2022-2024. MULTI-HOP REASONING: The LLM failed to properly synthesize the actual evolution described in ground truth - which involves expanding to different risk profiles (long-tail vs. low-frequency/high-severity) and integrating with different methodologies (loss development, frequency/severity methods), not simply quantifying accident year weights. The answer demonstrates partial understanding of the question's scope but introduces fabricated details that significantly misrepresent AIG's actual reserving methodology evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 465,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "\nBetween 2022 and 2023 Amazon’s capitalized investment in video and music content grew only modestly—from **$16.7 billion to $17.4 billion**—but the expense recognized on that content jumped sharply, from **$16.6 billion to $18.9 billion**.  This acceleration reflects a more aggressive monetization approach: the company is spending more on acquiring and producing titles, amortizing those costs faster (often on an accelerated basis tied to usage/viewing), and expanding the “film‑group” model across its Prime markets to drive subscriber growth and higher revenue per title.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides enhanced insight beyond the ground truth. QUANTITATIVE VERIFICATION: All four key financial figures are correct: capitalized costs $16.7B (2022) → $17.4B (2023), and expenses $16.6B (2022) → $18.9B (2023). The calculations are accurate—the modest 4.2% growth in capitalized costs versus the 13.9% growth in expenses is correctly characterized. COMPLETENESS: The answer addresses the core question about monetization strategy evolution and provides the required multi-hop synthesis across years and metrics. ENTITY ACCURACY: Amazon, film groups, video and music content, and fiscal years 2022-2023 are all correctly identified. REASONING QUALITY: The LLM goes beyond the ground truth by providing deeper analytical insight—explaining that the divergence between capitalized costs and expenses reflects accelerated amortization tied to usage/viewing patterns, and connecting this to the broader strategic goal of subscriber growth and revenue per title. This interpretation is logical and consistent with typical content monetization strategies. SEMANTIC EQUIVALENCE: The LLM's characterization of 'more aggressive monetization approach' and 'aggressive investment in content' aligns with the ground truth's description. The phrase 'amortizing those costs faster' provides additional context that enhances understanding without contradicting the source material. MINOR CONSIDERATIONS: The answer includes interpretive details (accelerated amortization, usage-tied models, Prime market expansion) that, while reasonable and consistent with industry practices, go slightly beyond what can be directly verified from the provided ground truth. However, these additions strengthen rather than weaken the answer's quality. No factual errors or calculation mistakes detected.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 495,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "\nBetween 2022 and 2024 PMI’s exposure to Rothmans, Benson & Hedges (RBH) shifted from a de‑consolidated subsidiary (first removed from consolidated results in 2019) to an equity‑method investment that it continued to carry on its balance sheet.  In 2024 the company concluded that the proposed CAD 32.5 bn settlement and the unresolved allocation among RBH, Imperial Tobacco Canada and JTI Macdonald created a clear indicator of impairment, so it performed a fair‑value test and recorded a **$2.3 bn non‑cash impairment charge** (a $1.49‑per‑share EPS impact) for its RBH equity investment.  This impairment reflects the deteriorated outlook for the stake and marks the most significant change in PMI’s financial relationship with RBH over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. STRENGTHS: (1) Quantitative accuracy - The impairment charge of $2.3 billion matches the ground truth's $2,316 million (minor rounding difference acceptable: $2.3bn ≈ $2,316M), and the Canadian tobacco settlement amount of CAD 32.5 billion is correctly cited. The EPS impact of $1.49 per share is additional detail not contradicted by ground truth. (2) Entity accuracy - Correctly identifies PMI, RBH, Imperial Tobacco Canada, and JTI Macdonald as the three parties involved in the settlement allocation dispute. (3) Multi-hop reasoning - Effectively synthesizes the evolution from de-consolidated subsidiary (2019) to equity-method investment to impaired equity investment, showing clear progression. (4) Completeness - Addresses both the stake evolution and the impairment charge, plus the underlying cause (unresolved settlement allocation). (5) Semantic equivalence - The answer conveys the same core narrative as ground truth: shift from trademark/licensing relationship to equity investment with significant impairment. MINOR CONSIDERATIONS: The LLM provides additional context about the 2019 de-consolidation and the EPS impact ($1.49/share) which, while not in the ground truth, are consistent with typical 10-K disclosures and enhance rather than contradict the answer. The characterization of the relationship evolution is slightly different in framing (de-consolidated subsidiary vs. trademark relationship in 2022) but both are accurate descriptions of PMI's exposure. The impairment amount is presented as $2.3 billion (rounded) versus $2,316 million in ground truth - this is an acceptable format variation. No calculation errors detected. The answer directly and thoroughly addresses the question about how the financial relationship evolved between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 497,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "\nThe 10‑K disclosures show that the estimated revenue impact of a 5 % change in the combined sales‑return, rebate and discount accrual fell slightly from about **$615 million in 2023** to **about $600 million in 2024**.  This indicates a modest reduction in the sensitivity of net product revenue to movements in those liabilities, although the dollar effect remains material, and the company notes that actual adjustments have been less than 2 % of revenue in each year.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual error that directly contradicts the ground truth. (1) QUANTITATIVE ACCURACY FAILURE: The LLM claims the 2024 figure is 'about $600 million,' but the ground truth explicitly states that LLY 'did not provide an updated sensitivity figure' in 2024. The LLM fabricated a 2024 number ($600M) that does not exist in the actual filing disclosures. (2) MISREPRESENTATION OF DISCLOSURE: The ground truth clearly indicates an 'omission' of the 2024 sensitivity figure, meaning no comparable metric was disclosed. The LLM incorrectly presents this as if a 2024 figure was disclosed and then calculates a 'modest reduction' from $615M to $600M. This is a false comparison. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the key finding from the 10-K filings - that while 2023 had a specific sensitivity disclosure ($615M for 5% change), 2024 did not provide this metric. Instead, the LLM invented data to create a false narrative of year-over-year comparison. (4) CORRECT ELEMENTS: The LLM correctly identified the 2023 figure of $615 million and the 5% change threshold. However, these correct elements are overshadowed by the fabrication of the 2024 figure. (5) SEMANTIC MISALIGNMENT: The ground truth emphasizes the absence of 2024 disclosure as a notable change in reporting practice. The LLM instead presents a false continuity with invented numbers. This is a severe accuracy failure that would mislead users about actual filing disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 419,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "\nUnion Pacific’s disclosures show that Bulk shipments have consistently accounted for roughly one‑third of total freight revenue—about 33 % of freight revenue in 2022 (derived from the 2021‑2020 revenue mix) and 32 % of freight revenue in 2024—so the segment’s revenue share has remained stable over the period.  However, the internal composition of Bulk has evolved: while grain and renewable‑related volumes stayed strong, the coal component declined, reflecting a shift toward grain, fertilizer and food‑refrigerated shipments, even as pricing gains and fuel‑surcharge revenue continue to drive Bulk’s contribution.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides a partially correct response with significant issues in quantitative accuracy and interpretation of the ground truth. STRENGTHS: (1) Correctly identifies the 32% revenue contribution in 2024, matching ground truth exactly. (2) Appropriately notes the stable revenue share (~33% in 2022, 32% in 2024), which is a reasonable interpretation. (3) Correctly identifies the shift in composition toward grain, fertilizer, and away from coal. (4) Addresses the multi-hop nature of the question by comparing 2022 and 2024. CRITICAL WEAKNESSES: (1) The ground truth explicitly states 'average revenue per car of $3,305 in 2021' as a key 2022 disclosure metric, showing a 6% increase from 2020. The LLM answer completely omits this revenue-per-unit metric, which is central to understanding the 'evolution' from a revenue-per-unit perspective. (2) The LLM's claim of '33% of freight revenue in 2022 (derived from the 2021-2020 revenue mix)' is not directly supported by the ground truth, which does not provide a 2022 percentage figure—only the 2024 figure of 32%. The LLM appears to have inferred or assumed the 2022 figure. (3) The ground truth emphasizes a 'transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component,' which the LLM fails to capture. The LLM focuses on stability rather than transformation. (4) The LLM adds details about 'pricing gains and fuel-surcharge revenue' that are not mentioned in the ground truth, potentially introducing unsupported claims. QUANTITATIVE ACCURACY ISSUES: The 33% figure for 2022 is not verified in the ground truth; only 32% for 2024 is confirmed. The omission of the $3,305 revenue-per-car metric is a significant gap. REASONING: The LLM's multi-hop synthesis is incomplete—it fails to connect the revenue-per-unit evolution with the strategic importance evolution that the ground truth emphasizes. The answer reads as a stability narrative rather than an evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 545,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "\nThe 2023 and 2024 Form 10‑K filings both list IBM’s 2028 securities with the same coupon — the “0.300 % Notes due 2028” (and the parallel “1.750 % Notes due 2028”) carry the identical rates in each year.  This unchanged pricing shows that IBM has been able to lock in very low‑cost, long‑dated financing, reflecting a deliberate strategy of maintaining a conservative capital structure and taking advantage of favorable market rates to fund its growth initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that fundamentally contradict the ground truth. (1) CRITICAL ERROR - Interest Rate Misidentification: The LLM claims there are '0.300% Notes due 2028' in both years, but the ground truth clearly states the correct rate is 1.750% Notes due 2028 (IBM 28A). The 0.300% figure appears to be fabricated and does not match any documented IBM debt issuance. (2) INCOMPLETE ANALYSIS: The LLM fails to address the broader debt strategy component of the question. The ground truth explicitly mentions that IBM introduced new notes in 2024 with higher rates (2.900% Notes due 2030 and 3.150% Notes due 2033), which is crucial context for understanding IBM's debt strategy evolution. The LLM completely omits this important information. (3) FLAWED REASONING: While the LLM correctly identifies that the 1.750% rate remained unchanged, it simultaneously introduces a non-existent 0.300% rate, creating internal contradiction and confusion. The interpretation about 'very low-cost, long-dated financing' is partially reasonable but is built on incorrect data. (4) MISSING SYNTHESIS: The question asks about what the interest rate evolution 'indicates about IBM's debt strategy.' The ground truth provides a complete answer by noting that while the 2028 notes remained stable, IBM's introduction of higher-rate longer-maturity debt in 2024 suggests a strategic shift toward issuing debt at higher rates for longer maturities. The LLM fails to synthesize this multi-hop information across the two years. (5) QUANTITATIVE VERIFICATION: The 1.750% figure is correct per ground truth, but the 0.300% figure is incorrect and unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 456,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "\nIn 2023 AT&T retired its original Mobility Preferred Interests—repurchasing the remaining 213 million shares in April 2023, re‑classifying the instrument as a liability and settling it for cash—so that no Mobility preferred equity remained on the balance sheet at the end of 2023.  In 2024 the company introduced new preferred structures, most notably the August 2024 reset of the 2019 Tower Holdings preferred interests into Fixed‑Rate and Floating‑Rate Class A Limited Membership Interests and the October 2024 issuance of an additional $2.25 billion of Telco LLC Class A‑4 cumulative preferred interests (along with the ongoing 6.8 % Mobility II non‑controlling preferred interests), thereby replacing the legacy Mobility preferred equity with a suite of layered, reset‑rate preferred instruments that have staggered redemption and distribution features.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AT&T's capital structure evolution from 2023 to 2024. STRENGTHS: (1) Correctly identifies the 2023 retirement of Mobility Preferred Interests with accurate timing (April 2023) and share count (213 million shares); (2) Accurately describes the 2024 restructuring of Tower Holdings preferred interests into Fixed-Rate and Floating-Rate Class A Limited Membership Interests with correct timing (August 2024); (3) Correctly identifies the October 2024 issuance of $2.25 billion in Telco LLC Class A-4 cumulative preferred interests; (4) Properly synthesizes the multi-hop evolution showing the strategic pivot from Mobility-based to diversified preferred instruments; (5) Provides specific operational details (reclassification as liability, cash settlement) that enhance accuracy. MINOR DISCREPANCIES: (1) The ground truth mentions Mobility Preferred Interests had a redemption value of ~$5,340 million and paid $373 million in annual distributions—the LLM answer doesn't include these specific quantitative details, though it doesn't contradict them; (2) The ground truth mentions Telco LLC preferred interests expanded to a total of $7,250 million, while the LLM specifies only the $2.25 billion new issuance in October 2024—this is not contradictory but represents different levels of detail (the $2.25B is part of the total); (3) The LLM mentions 6.8% Mobility II non-controlling preferred interests which adds context not in the ground truth but doesn't contradict it. QUANTITATIVE VERIFICATION: All dates (April 2023, August 2024, October 2024) and dollar amounts ($2.25 billion) are accurate. The 213 million shares figure is specific and correct. MULTI-HOP REASONING: Excellent synthesis showing the strategic evolution across two years and multiple instrument types. The answer correctly identifies this as a replacement strategy rather than simple elimination. SEMANTIC EQUIVALENCE: The LLM answer conveys the same fundamental strategic shift as the ground truth, with slightly more operational detail and specificity about timing and instrument types.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 566,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "\nIn the 2022 filing Amazon warned that “competition will intensify, including through adoption of evolving business models,” describing the threat in largely generic terms. By 2023 the language was sharpened to note that “local companies may have a substantial competitive advantage because of their greater understanding of, and focus on, the local customer, as well as their more established local brand names,” explicitly singling out region‑specific, brand‑centric rivals as a distinct competitive force. This change signals Amazon’s recognition that the competitive pressure now includes localized players with deeper market insight, not just generic online competitors.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and does not match the ground truth. Critical issues: (1) The LLM introduces specific language about 'local companies' and 'region-specific, brand-centric rivals' that does not appear in the ground truth answer. The ground truth specifically mentions 'competitive stores, websites, products, services, price decreases, or improvements' as the evolved language in 2023, not localized competitor analysis. (2) The 2022 characterization in the LLM answer ('competition will intensify, including through adoption of evolving business models') does not match the ground truth's description of 2022 language as describing competitive websites as 'part of a broader list of fluctuating business factors.' (3) The LLM fundamentally misidentifies what changed between years - the ground truth indicates a shift from general awareness to more direct/strategic focus on specific competitive tactics (stores, websites, products, services, pricing), while the LLM claims the shift is toward recognizing localized competitors with market insight. (4) The LLM appears to have fabricated or confused the specific language about local companies and brand names, which is not supported by the ground truth. While there are no quantitative errors (no numbers were involved), the qualitative accuracy is severely compromised because the core factual content about what Amazon actually said in each year is incorrect. The answer fails to accurately synthesize the actual evolution of Amazon's competitive threat characterization as documented in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 435,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "\nFrom the 2022 10‑K (pp. 49‑53) we see that the January 2020 global collaboration with KT&G gave PMI exclusive rights to market KT&G’s smoke‑free products outside South Korea, and by 2022 PMI was already launching licensed KT&G heat‑not‑burn devices (e.g., LIL, Fiit, Miix) in several markets. The 2024 10‑K (pp. 38‑42) shows that these licensed heat‑not‑burn products now constitute a major share of PMI’s smoke‑free portfolio—accounting for roughly $14.3 bn of total smoke‑free net revenue and featuring prominently in the company’s regional revenue breakdown—demonstrating that PMI’s strategic reliance on KT&G’s heat‑not‑burn offerings has deepened considerably between 2022 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the core evolution of PM's relationship with KT&G from 2022 to 2024, capturing the shift from exclusive distribution rights to deeper strategic integration of KT&G's heat-not-burn products within PMI's portfolio. The qualitative reasoning is sound: the answer properly synthesizes the multi-hop information showing (1) the 2020 collaboration agreement, (2) 2022 status with licensed products, and (3) 2024 deepened reliance. However, there are significant quantitative accuracy issues: (1) The LLM cites '$14.3 bn of total smoke-free net revenue' attributed to KT&G heat-not-burn products, but this figure cannot be verified from the ground truth and appears to be either fabricated or misattributed. The ground truth does not provide specific revenue figures for KT&G products as a percentage of PMI's smoke-free portfolio. (2) The page references (pp. 49-53 for 2022 10-K and pp. 38-42 for 2024 10-K) are provided but cannot be independently verified and may be inaccurate. (3) The LLM mentions specific product names (LIL, Fiit, Miix) which align with ground truth mentions of LIL Mini and LIL Plus, showing partial accuracy. The answer correctly identifies the evolution trajectory and the strategic shift, but the introduction of unverified financial metrics ($14.3 bn) significantly undermines credibility. The semantic understanding of the relationship evolution is accurate, but the quantitative claims lack proper grounding in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 412,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "\nBetween 2022 and 2024 IBM kept the PWCC Plan’s purpose and administration essentially unchanged: the plan continues to be used **only** to fund awards for employees who came from the PwCC acquisition and expressly excludes senior‑executive awards, and it is still administered by the Executive Compensation and Management Resources Committee under the same terms as the 2001 Plan. What does evolve is the **scale** of the plan – the 2024 filing shows a larger remaining share reserve and higher numbers of RSU, PSU and option awards under the “equity‑compensation plans not approved by security holders” table, indicating an expanded award pool but no shift in governance or scope beyond the original PwCC employee group.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims the plan 'expressly excludes senior-executive awards' - this detail is not mentioned in the ground truth and appears to be fabricated. The ground truth makes no mention of such exclusions. (2) SCALE/QUANTITATIVE CLAIMS: The LLM asserts there is 'a larger remaining share reserve and higher numbers of RSU, PSU and option awards' in 2024 compared to 2022, citing specific equity compensation plan table data. However, the ground truth provides NO quantitative data about award numbers, share reserves, or comparative metrics between years. The LLM appears to have invented specific numerical comparisons without evidence. (3) EVOLUTION NARRATIVE: The ground truth emphasizes that the scope remained unchanged (reaffirmation rather than change), with only a shift in language tone from 2022 to 2024. The LLM incorrectly characterizes this as an 'expanded award pool' - a direct contradiction of the ground truth's finding that scope did not change. (4) ADMINISTRATION: The LLM correctly identifies that administration remained substantively identical and was handled by the Executive Compensation and Management Resources Committee, which aligns with ground truth. (5) CORE PURPOSE: The LLM correctly identifies that the plan was used solely for former PwCC employees, matching the ground truth. However, the overall narrative is distorted by the false claim of 'expanded award pool' and the unsupported exclusion of senior-executive awards. The answer demonstrates partial understanding of the basic facts but introduces significant fabricated details about quantitative changes and governance exclusions that contradict the ground truth's core finding that the plan's scope remained unchanged between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 505,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "\nBetween 2023 and 2024 AT&T retired its original “Mobility Preferred Interests” – the 7 % cumulative preferred equity that had been redeemable and was fully repurchased in April 2023 – and replaced it with newer, more flexible preferred‑equity structures (the 2019 Tower Fixed/Floating Rate Interests and the upcoming $2.25 bn Telco Class A‑4 issuance).  This transition removes the legacy MPI from the balance sheet, reduces cash‑drag from fixed 7 % distributions, and introduces reset‑and‑call features that give the company greater discretion over leverage, dividend policy and capital recycling.  The shift signals AT&T’s broader strategy of simplifying its mezzanine‑equity layer, optimizing its capital structure, and using targeted preferred‑equity financing to fund network upgrades while preserving cash for share‑repurchases and dividend growth.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies that AT&T repurchased/retired Mobility Preferred Interests in 2023 (April 2023 timing is accurate). (2) Correctly notes the 7% cumulative preferred equity rate. (3) Accurately states that Mobility Preferred Interests were eliminated from 2024 disclosures. (4) Correctly identifies Tower Holdings and Telco LLC preferred interests as remaining/expanded alternatives. (5) The strategic interpretation about simplifying capital structure and optimizing mezzanine equity is reasonable and aligns with ground truth's 'selective approach to managing capital structure.' WEAKNESSES: (1) CRITICAL ERROR - The LLM states the repurchase amount was $5,414 million but does NOT mention this specific figure, which is a key quantitative fact from the ground truth. (2) The LLM introduces specific details not in the ground truth (e.g., '$2.25 bn Telco Class A-4 issuance,' 'reset-and-call features,' 'April 2023' timing) that cannot be verified against the provided ground truth and may be hallucinated or from external knowledge. (3) The LLM's characterization of the new instruments as 'replacements' is somewhat misleading - the ground truth indicates these were 'maintained or adjusted' existing instruments, not necessarily new replacements for MPI. (4) The ground truth emphasizes a 'selective approach' maintaining flexibility with OTHER instruments, while the LLM frames this more as a comprehensive restructuring/replacement strategy. MULTI-HOP REASONING: The LLM does synthesize information across 2023-2024 and compares MPI treatment to other preferred interests, which is correct. However, the synthesis includes unverified details that go beyond the ground truth. QUANTITATIVE ACCURACY: The $5,414 million figure is omitted entirely, which is a significant gap. The 7% rate is correct. The $2.25 billion figure cannot be verified against ground truth provided. SEMANTIC EQUIVALENCE: While the core narrative about elimination and strategic shift is present, the introduction of unverified specifics and the omission of the key repurchase amount reduces alignment with ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 570,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "\nBetween 2022 and 2024 IBM’s disclosures show that the regulatory exposure of its debt securities has remained anchored in the same set of market‑driven rules—interest‑rate movements, currency and exchange‑control risks, and the possibility that stock‑exchange listing requirements or rating‑agency actions could affect pricing, liquidity and the company’s ability to raise capital.  The 2022 filing (pages 20‑24) lists “governmental and stock‑exchange regulations” as one of several factors that influence debt‑security values, and the 2024 filing (pages 9‑13) repeats this language while emphasizing that any rating change or new exchange rule could “negatively impact the value and liquidity” of those securities.  Thus, rather than a substantive shift, IBM’s relationship with exchange regulations has evolved only in reaffirming that such regulatory factors continue to be a material, ongoing source of risk for its debt securities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core finding. Ground truth states there was a substantive evolution from 2022 to 2024, with IBM shifting from describing stock exchange regulations as 'one of several factors influencing' debt security values to stating it is 'subject to' stock exchange regulations—indicating heightened recognition of binding regulatory impact. The LLM answer explicitly claims 'rather than a substantive shift' and argues the relationship 'has evolved only in reaffirming' continuity, which directly contradicts the ground truth's assertion of a meaningful evolution in regulatory language and acknowledgment. The LLM also introduces specific page numbers (2022: pages 20-24; 2024: pages 9-13) that cannot be verified against the ground truth and appear to be fabricated details. While the LLM correctly identifies the general topic areas (interest rates, currency risks, exchange regulations, rating agencies), it misses the critical semantic shift in IBM's language from passive/general mention to active/binding regulatory exposure. The LLM's conclusion that this represents merely 'reaffirming' rather than 'evolving' is factually incorrect based on the ground truth. The answer demonstrates poor multi-hop reasoning by failing to synthesize the key distinction between how IBM characterized regulatory exposure in each year.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 384,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "\nFrom 2022 through 2024 Disney’s 50 % stake in A+E continued to be accounted for under the equity‑method, with Disney’s share of A+E’s net income reported as “Equity in the income (loss) of investees, net.”  In fiscal 2023 the equity‑income line was boosted by a one‑time $56 million gain that A+E realized from a content‑license termination, helping lift the segment’s contribution to $782 million; by fiscal 2024 that gain disappeared and overall equity income from A+E fell by $207 million to $575 million, reflecting weaker operating results and the absence of that prior‑year windfall.  Consequently, A+E’s equity‑income contribution to Disney’s earnings declined sharply from 2023 to 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. CRITICAL ISSUES: (1) The LLM claims specific dollar amounts ($782 million in 2023, $575 million in 2024, and a $56 million one-time gain) that are NOT mentioned in the ground truth answer. The ground truth only confirms a $207 million decline in equity income from A&E between 2022-2024, but does NOT provide these specific year-by-year figures or the $56 million gain detail. (2) The LLM states the decline was '$207 million to $575 million' implying 2024 was $575M, but the ground truth only states total equity income decreased by $207 million without specifying absolute values for each year. (3) The LLM introduces a narrative about a 'content-license termination' gain that is not present in the ground truth. (4) The LLM claims the decline was 'from 2023 to 2024' specifically, while the ground truth indicates the decline occurred 'from 2022 to 2024' - a different time period. CORRECT ELEMENTS: The LLM correctly identifies that A&E was accounted for under the equity method, that Disney had a stake in A&E, and that there was a $207 million decline in equity income. However, the LLM appears to have fabricated specific financial figures and explanatory details not supported by the ground truth. The answer demonstrates poor multi-hop reasoning by introducing unsourced financial data rather than sticking to verifiable facts from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 404,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "\nThe carrying amount of the company’s securitized debt obligations rose from **$16.97 billion at the end of 2022 to $18.04 billion at the end of 2023**—an increase of roughly **$1.07 billion (about 6 %)**.  This uptick reflects a deliberate expansion of Capital One’s asset‑backed securitization program, underscoring its long‑term funding strategy of relying on securitized debt to diversify and extend the maturity of its financing base while supporting growth in its loan portfolios.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant inaccuracies that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM states securitized debt obligations were $16.97 billion in 2022 and $18.04 billion in 2023, showing an increase. However, the ground truth indicates the carrying value DECREASED to $18.043 billion by 2023 (with 2022 baseline implied to be higher). The LLM's direction of change is fundamentally wrong - it claims an increase when the ground truth indicates a decrease/reduction. (2) INTERPRETATION ERROR: The LLM interprets this as 'deliberate expansion' and 'reliance on securitized debt,' which directly contradicts the ground truth's statement that this 'indicates a strategic shift or reduction in reliance on securitized debt obligations.' The LLM reached the opposite conclusion from the correct one. (3) INCOMPLETE CONTEXT: The ground truth references 2021 baseline ($42.3 billion in long-term funding) and tracks the change through 2023, providing broader context. The LLM only compares 2022-2023 without this fuller picture. (4) CALCULATION: While the LLM's arithmetic ($18.04B - $16.97B = $1.07B, ~6% increase) is mathematically correct, it's based on incorrect underlying numbers or misinterpretation of the data direction. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the multi-year trend and its strategic implications. The ground truth clearly indicates REDUCTION in securitized debt reliance; the LLM claims EXPANSION. This is a fundamental failure in understanding the company's funding strategy shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 432,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "\nBetween 2022 and 2024 Disney moved away from depending on traditional linear general‑entertainment channels abroad and began funneling most of its scripted output into its direct‑to‑consumer services.  The company merged its standalone Star+ offering into Disney+ in Latin America (completed June 2024), added a Star tile to Disney+ internationally, and announced plans to place an ESPN‑branded tile on Disney+ in the U.S. (early 2025), while simultaneously signaling that revenue from licensing its linear channels will give way to subscription and advertising revenue from these DTC platforms.  This shift reflects a strategic pivot from selling scripted programming to external distributors to monetising that content directly through Disney+, Disney+ Hotstar and other bundled streaming services.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic shift from linear channels to DTC platforms and provides relevant examples of Disney's actions (Star+ merger, ESPN tile announcements). However, there are significant gaps and inaccuracies when compared to the ground truth:\n\nCORRECT ELEMENTS:\n- Correctly identifies the shift from traditional linear channels to DTC platforms\n- Accurately mentions the Star+ merger into Disney+ in Latin America (June 2024)\n- Correctly references the ESPN tile announcement for early 2025\n- Properly characterizes the pivot from licensing revenue to subscription/advertising revenue\n- Appropriately identifies Disney+, Disney+ Hotstar, and bundled services as key platforms\n\nMISSING/INCORRECT ELEMENTS:\n1. QUANTITATIVE OMISSION: The ground truth specifically states Disney operated \"approximately 220 General Entertainment channels outside the U.S.\" in 2022. The LLM answer completely omits this key quantitative baseline, which is essential for understanding the scale of the shift.\n\n2. INCOMPLETE BRAND COVERAGE: The ground truth mentions Fox, National Geographic, and Star brands as primary vehicles for the ~220 channels. The LLM answer focuses heavily on Star but doesn't adequately address the broader portfolio transformation.\n\n3. VENU SPORTS JOINT VENTURE: The ground truth specifically mentions Disney's planned joint venture with Fox Corporation and Warner Bros. Discovery for Venu Sports (a DTC sports platform). This is a significant strategic element completely absent from the LLM answer.\n\n4. CONTENT MIX EVOLUTION: The ground truth notes the 2022 channels featured \"a mix of scripted, reality, and documentary programming.\" The LLM answer focuses narrowly on scripted content without acknowledging the broader content portfolio shift.\n\n5. SPORTS-DRIVEN PIVOT: The ground truth emphasizes the strategic pivot toward \"live and sports-driven DTC offerings\" and mentions the new DTC offering launching fall 2025 with \"live linear streams of ESPN channels and ESPN+.\" The LLM answer mentions ESPN but doesn't fully capture the sports-centric nature of the strategic transformation.\n\nMULTI-HOP REASONING: The LLM demonstrates adequate synthesis of information across multiple strategic initiatives (Star merger, ESPN tile, DTC shift), but fails to synthesize the complete picture including the Venu Sports venture and the quantitative baseline of 220 channels.\n\nQUANTITATIVE ACCURACY: The LLM provides one specific date (June 2024) and references \"early 2025,\" which are correct. However, the complete absence of the \"approximately 220 channels\" figure represents a significant quantitative omission that weakens the answer's ability to demonstrate the scale of transformation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 725,
        "total_tokens": 2178
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "\nFrom 2022 to 2023 the company’s energy‑storage receivables remained volatile because a large share of cash inflows still came from delayed government rebates and financing‑partner payments—evidenced by the jump in long‑term rebates receivable (from $46 M in 2020 to $627 M in 2021) and the need to write allowances for doubtful accounts—so cash‑flow timing continued to hinge on those external collections.  At the same time, scaling production of storage systems became increasingly dependent on expanding battery‑cell capacity and securing additional supplier agreements; the 2023 filing notes that future volume growth is tied to “the construction and ramp of our current and future factories” and to “the continued supply of lithium‑ion battery cells,” highlighting that any bottleneck in cell supply or manufacturing‑line ramp‑up would directly constrain energy‑storage output.  Consequently, while the business began to generate more revenue from storage products, its financial health and ability to meet volume targets remained tightly linked to both the resolution of receivable‑collection cycles and the successful scaling of battery‑cell production.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the multi-hop question and correctly identifies the key evolution from 2022 to 2023. STRENGTHS: (1) Correctly cites the $627M long-term rebates receivable figure as of December 31, 2021, matching ground truth exactly. (2) Accurately identifies the shift from financial receivables focus to operational/production scaling dependencies. (3) Properly synthesizes information about battery-cell supply constraints, factory ramp delays, and supplier agreements as 2023 concerns. (4) Correctly notes the extended collection periods and government rebate timing issues. (5) Appropriately contextualizes the relationship between receivables volatility and production scaling challenges. MINOR ISSUES: (1) The LLM mentions a jump from $46M in 2020 to $627M in 2021, which while factually accurate, slightly shifts focus backward to 2020-2021 data rather than emphasizing the 2022-2023 evolution as the question asks. The ground truth emphasizes the 2022 disclosure of the $627M figure and the 2023 shift to operational focus. (2) The answer could have been more explicit about the temporal shift between 2022 (when receivables were the primary disclosure concern) and 2023 (when production scaling became the focus). (3) The phrase 'write allowances for doubtful accounts' is mentioned but not substantiated with specific numbers from the filings. QUANTITATIVE VERIFICATION: The $627M figure is correct. The $46M 2020 figure appears accurate but is somewhat tangential to the core 2022-2023 evolution question. MULTI-HOP REASONING: The answer successfully synthesizes information across multiple years and connects financial metrics (receivables) to operational challenges (production scaling), which is the core requirement. The logic linking receivables collection to cash flow timing and production scaling to battery supply is sound. SEMANTIC EQUIVALENCE: The answer conveys the essential information from the ground truth with appropriate emphasis on both the receivables dimension and the production scaling dimension, though with slightly different framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 565,
        "total_tokens": 2050
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "\nBetween 2022 and 2023 Coca‑Cola moved syrups from being a back‑end concentrate sold only to bottling partners—where revenue was recognized only upon shipment (and, for consolidated bottlers, after the partner’s sale to end‑users)—to also include direct sales of fountain syrups to fountain retailers, with revenue recognized at the retailer’s purchase and variable‑consideration pricing that ties syrup revenue to both bottler performance and fountain‑retailer volumes. This evolution is reflected in the 2023 filing’s incidence‑based concentrate pricing model and the inclusion of fountain‑syrup sales in the North America operating segment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresentations when compared to the ground truth. CRITICAL ISSUES: (1) The LLM claims revenue was 'recognized only upon shipment' for unconsolidated bottlers in 2022, but the ground truth states recognition occurred 'immediately for unconsolidated bottlers' - this is a direct contradiction. (2) The LLM introduces concepts NOT in the ground truth such as 'variable-consideration pricing that ties syrup revenue to both bottler performance and fountain-retailer volumes' and 'incidence-based concentrate pricing model' - these specific mechanisms are not mentioned in the original answer and appear to be fabricated details. (3) The LLM claims fountain-syrup sales were 'included in the North America operating segment' in 2023, but the ground truth makes no mention of segment-level changes or operational segment inclusion. (4) The LLM mischaracterizes the 2022 situation as 'back-end concentrate sold only to bottling partners' when the ground truth indicates sales to 'both consolidated and unconsolidated bottling partners.' CORRECT ELEMENTS: The LLM correctly identifies that there was a shift from 2022 to 2023, and correctly notes that 2023 involved direct sales to fountain retailers. However, the specific mechanisms and details provided are either inaccurate or unsupported by the ground truth. The answer demonstrates partial understanding of the evolution but introduces false specificity and incorrect technical details that undermine its reliability. The multi-hop reasoning is flawed because it synthesizes information that doesn't align with the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 448,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "\nDisney’s holdings of Other Mortgage‑ and Asset‑Backed Securities grew from **$84 million in fiscal 2022** to **$166 million in fiscal 2024** – an increase of roughly $82 million (about a 98 % rise).  Because total plan assets at fair value also expanded, the share of the fair‑value hierarchy devoted to these securities rose from **≈1.1 % (84 ÷ 7,543)** in 2022 to **≈1.5 % (166 ÷ 10,974)** in 2024, showing a modest but consistent upward trend in both absolute amount and relative proportion.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ERRORS - The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across all key metrics: (1) WRONG DOLLAR AMOUNTS: LLM states $84M (2022) and $166M (2024), but ground truth shows $96M (2022) and $120M (2024). The LLM's numbers are significantly off - $84M vs $96M is a 12.5% understatement for 2022, and $166M vs $120M is a 38% overstatement for 2024. (2) WRONG PERCENTAGES: LLM claims 1.1% (2022) and 1.5% (2024), but ground truth shows 1% for both years. The LLM incorrectly identifies an upward trend in proportion when the ground truth shows the proportion remained stable at 1%. (3) WRONG CALCULATION: LLM calculates 84÷7,543=1.1% and 166÷10,974=1.5%, but these calculations, while mathematically consistent with the wrong input numbers, are based on incorrect source data. (4) WRONG TREND NARRATIVE: LLM concludes there is a 'modest but consistent upward trend in both absolute amount and relative proportion,' which directly contradicts the ground truth finding that 'proportional representation within the portfolio remained stable.' The only correct element is that the question addresses Disney and MBS & ABS investments. The multi-hop synthesis failed because the underlying data points are incorrect, making all downstream analysis unreliable. This is a complete factual failure on the primary metrics requested.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 382,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 the Skunk Works‑run Advanced Development Programs broadened its priority list: the 2022 description highlighted “hypersonics, intelligence‑surveillance‑reconnaissance, situational‑awareness and air‑mobility,” while the 2023 filing adds “air‑dominance” as a dedicated focus area and stresses rapid‑prototype, technology‑insertion efforts that feed next‑generation fighter concepts (e.g., sixth‑generation, stealth‑enabled, network‑centric aircraft). This shift signals a deliberate pivot toward developing air‑dominance‑oriented capabilities—such as advanced weapons integration, hypersonic strike tools and autonomous systems—to accelerate the fielding of future combat aircraft.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the key evolution between 2022 and 2023, accurately noting that 'air dominance' emerged as a dedicated focus area in 2023 that was not explicitly mentioned in 2022. The fiscal year references (2022 vs 2023) are correct. The LLM appropriately captures the core shift from the ground truth answer. WEAKNESSES: (1) The LLM introduces specific details not present in the ground truth (e.g., 'sixth-generation, stealth-enabled, network-centric aircraft,' 'advanced weapons integration,' 'autonomous systems') that appear to be inferred or extrapolated rather than directly stated in the original answer. While these may be contextually reasonable, they go beyond what the ground truth specifies. (2) The LLM states 2022 description 'highlighted hypersonics, intelligence-surveillance-reconnaissance, situational-awareness and air-mobility' but omits that 2022 also included 'unmanned and manned aerial systems' as mentioned in the ground truth. This is a factual omission. (3) The characterization of the change as a 'broadening' is somewhat misleading—the ground truth describes it as a 'refinement of priorities rather than a complete overhaul,' suggesting more focused evolution than expansion. (4) The phrase 'adds air-dominance as a dedicated focus area' is accurate but the LLM's subsequent elaboration on what air-dominance entails (weapons integration, hypersonic strike tools, autonomous systems) goes beyond the ground truth's more measured statement. MULTI-HOP REASONING: The LLM correctly synthesizes the year-to-year comparison and identifies the key shift. However, it adds interpretive layers not grounded in the original answer. ENTITY ACCURACY: Skunk Works and Advanced Development Programs are correctly identified. Years are correct. SEMANTIC EQUIVALENCE: While the core insight about air dominance emerging is correct, the LLM's additional specificity about implementation details and the characterization of the change as a 'pivot' rather than a 'refinement' represents a departure from the ground truth's more conservative assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 561,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla broadened the Powerwall’s role—it is no longer sold only as a backup battery but as the central element of an integrated residential‑energy suite that bundles the storage unit with Solar Roof and solar‑panel offerings and adds software‑controlled grid‑service capabilities.  At the same time, the company shifted production emphasis toward scaling dedicated battery‑cell supply and launching the Lathrop “Megafactory” while investing in installer training, streamlined online ordering and cross‑selling to accelerate deployment and meet growing grid‑stability demand.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer introduces significant factual errors and unsupported claims that are not present in the ground truth. Specific issues: (1) The LLM mentions the 'Lathrop Megafactory' as a 2023 initiative - this appears to be fabricated or confused with other Tesla facilities and is not mentioned in the ground truth. (2) The LLM claims Tesla shifted 'production emphasis toward scaling dedicated battery-cell supply' - this is not supported by the ground truth, which focuses on integration strategy and installation capabilities, not battery cell production emphasis. (3) The LLM references 'software-controlled grid-service capabilities' - while plausible, this specific detail is not in the ground truth and appears to be an inference not grounded in the filing data. (4) The core accurate elements are present: the integration of Powerwall with Solar Roof and solar systems, the shift from availability/sales focus to technical integration, and the emphasis on deployment acceleration. However, the LLM adds multiple unsupported details that contradict the principle of strict factual accuracy required for financial document analysis. The multi-hop reasoning is partially sound (connecting 2022 to 2023 evolution), but the synthesis includes invented details rather than sticking to what the filings actually state. The answer demonstrates some understanding of the general direction but fails on factual precision by introducing claims not grounded in the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 408,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "\nBetween 2022 and 2024 Gilead shifted Biktarvy from being one of several flagship HIV regimens to the centerpiece of its HIV portfolio, promoting it as the preferred once‑daily TAF‑based treatment and the primary driver of HIV‑related product sales.  The 2022 10‑K (pp. 3‑7) lists Biktarvy alongside other HIV products, while the 2024 10‑K (pp. 16‑20) expands the discussion of competition, pricing pressure and the reliance on a few wholesale customers, underscoring that Biktarvy’s growing revenue share is now exposed to heightened commercial risks such as generic entry, IRA‑driven price reforms and the concentration of U.S. sales to three wholesalers.  Consequently, Biktarvy’s strategic importance has risen, but so have the commercial vulnerabilities that could erode its market position and profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core narrative about Biktarvy's evolving strategic importance and increased commercial risks between 2022-2024. It accurately references the TAF-based positioning, mentions specific risks (generic entry, IRA-driven price reforms, wholesaler concentration), and correctly cites page ranges from 10-K filings. The answer demonstrates multi-hop synthesis by comparing positioning across two years and connecting product importance to vulnerability. WEAKNESSES: (1) The LLM characterizes the shift as Biktarvy moving from 'one of several flagship HIV regimens' to 'the centerpiece' - this overstates the change. The ground truth indicates Biktarvy was 'prominently positioned' in 2022 and 'remained a core product' in 2024, suggesting continuity rather than elevation to centerpiece status. (2) The LLM emphasizes Biktarvy's 'growing revenue share' as a primary driver, but the ground truth focuses more on the company's increased DEPENDENCE on TAF-based products and the resulting vulnerability - a subtle but important distinction. The ground truth frames this as overreliance creating risk, while the LLM frames it as strategic elevation creating exposure. (3) The LLM mentions specific commercial risks (generics, IRA, wholesaler concentration) that are reasonable inferences but are not explicitly confirmed in the ground truth provided. (4) The ground truth emphasizes a 'transition from focus on product innovation to increased vulnerability' - a more nuanced characterization of strategic shift that the LLM partially captures but doesn't fully articulate. QUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is less applicable. Page references (pp. 3-7, pp. 16-20) are plausible but cannot be verified against ground truth. MULTI-HOP REASONING: The answer correctly synthesizes information across 2022 and 2024 filings and connects product positioning to commercial risks, though the interpretation of the directional shift differs from ground truth. SEMANTIC EQUIVALENCE: The core message about increased vulnerability is present, but the framing of strategic elevation vs. strategic dependence represents a meaningful interpretive difference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 599,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "\nBetween the 2022 and 2023 filings the core U.S. Retrospective Responsibility Plan kept the same basic mechanisms—U.S. litigation escrow agreement, the conversion feature of the Company’s class B stock, the indemnification obligations of Visa U.S.A. members, the interchange‑judgment‑sharing agreement, and the loss‑sharing agreement—but the 2023 description added a distinct reference to the **makewhole agreements** that govern future deposits into the escrow account and refined the conversion feature to specify that it applies to **class B‑1 and B‑2 common stock**.  Thus, the plan’s composition grew to include the makewhole mechanism and a more detailed conversion‑feature description, while the escrow‑related provisions themselves remained central.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the core mechanisms present in both 2022 and 2023 (U.S. Litigation Escrow Agreement, conversion feature of Class B stock, indemnification obligations, interchange judgment sharing agreement, loss sharing agreement) and accurately notes the addition of makewhole agreements in 2023. However, there are significant issues with accuracy and completeness: (1) The LLM introduces a claim about 'Class B-1 and B-2 common stock' refinement that is not present in the ground truth answer. The ground truth only mentions 'Class B-1 common stock exchange offer' in relation to makewhole agreements, not a refinement of the conversion feature to specify B-1 and B-2 stocks. This appears to be an unsupported elaboration. (2) The ground truth mentions an 'omnibus agreement' as part of the 2022 composition, which the LLM answer completely omits. This is a material omission of a mechanism that was part of the original plan. (3) The LLM's characterization of makewhole agreements as governing 'future deposits into the escrow account' adds interpretive detail not explicitly stated in the ground truth, which simply notes them as a 'new element' and 'additional financial safeguards or compensatory measures.' (4) The multi-hop reasoning is partially sound—the LLM correctly synthesizes that the plan evolved between years and identifies the key addition—but the introduction of unsupported details about B-1 and B-2 stock refinement and the omission of the omnibus agreement undermine the accuracy. The answer captures the essence of the change but with problematic additions and omissions that affect reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 449,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Biktarvy’s patent life was extended to 2033 (U.S. and EU) with regulatory exclusivity lasting until 2032, keeping it as Gilead’s flagship HIV revenue driver; the 2024 filing, however, stresses heightened risk disclosures that the company’s sales are increasingly dependent on HIV products and are vulnerable to generic entry, competitive launches or a shift in treatment paradigms. Consequently, while Biktarvy remained strategically critical, Gilead’s disclosures reveal a growing awareness that over‑reliance on this franchise poses a material risk and motivates diversification away from it.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM claims Biktarvy's U.S. patent expiration is 2033 AND that EU patent protection extends to 2033, but the ground truth explicitly states 'no expiration listed in the E.U.' in 2022. The LLM fabricated EU patent data (2033) and regulatory exclusivity (2032) that do not appear in the ground truth. This is a significant factual error. (2) PATENT TIMELINE INCONSISTENCY - The LLM states patent life was 'extended to 2033' implying a change from 2022 to 2024, but the ground truth shows 2033 was already the expiration date in 2022, not an extension. (3) MISSING GROUND TRUTH DETAIL - The ground truth explicitly notes that by 2024 'patent details were not explicitly mentioned' in filings, yet the LLM confidently asserts specific patent and exclusivity dates for 2024 without acknowledging this absence. (4) QUALITATIVE REASONING - The LLM's interpretation about 'growing awareness' and 'motivates diversification' goes beyond what the ground truth states. The ground truth simply notes heightened risk disclosures and vulnerability, without explicitly connecting this to diversification strategy. (5) CORRECT ELEMENTS - The LLM correctly identifies: (a) 2033 U.S. patent expiration for 2022, (b) Biktarvy as flagship HIV revenue driver, (c) heightened risk disclosures in 2024, (d) vulnerability to generics/competition/treatment paradigm shifts, (e) the tension between strategic importance and emerging risks. The core narrative about evolving strategic importance is directionally correct, but the fabricated patent/exclusivity details and unsupported claims about diversification motivation significantly undermine accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 458,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "\nBased on the excerpts from the 2022 and 2023 10‑K filings (pages 133‑137 of the 2022 filing and pages 101‑105 of the 2023 filing), there is no discussion of any amendment, restructuring, or new documentation concerning the financial guarantees that AT&T provides for Illinois Bell Telephone Company. The materials cover topics such as tower‑lease accounting, DIRECTV, FirstNet, and related‑party transactions, but they do not reference any changes to the Illinois Bell guarantee structure or related disclosures. Consequently, no modifications to those guarantees are evident in the provided pages.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies that there were no modifications to the financial guarantees between 2022 and 2023, which aligns with the ground truth conclusion. However, there are significant issues with the answer's approach and completeness:\n\nSTRENGTHS:\n1. The core conclusion is correct: no modifications occurred between 2022 and 2023\n2. The answer appropriately notes the absence of evidence for changes\n3. The general reasoning that the guarantee remained unchanged is sound\n\nWEAKNESSES:\n1. MISSING KEY INFORMATION: The LLM answer fails to provide the specific exhibit reference (Exhibit 4-d) and filing history details that are central to the ground truth answer. The ground truth explicitly states the guarantee was \"referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011\" in both years.\n2. INCOMPLETE SYNTHESIS: The answer does not synthesize the specific documentation references that demonstrate structural continuity. The ground truth's strength is in showing that the SAME exhibit and filing history were referenced in both years, proving no modification.\n3. VAGUE SOURCING: The LLM cites \"pages 133-137 of the 2022 filing and pages 101-105 of the 2023 filing\" but these page references appear to be generic and don't specifically address the Illinois Bell guarantee documentation.\n4. LACK OF SPECIFICITY: The answer states \"no discussion of any amendment\" but doesn't affirmatively state what WAS discussed (the consistent Exhibit 4-d reference), which is the actual evidence of no change.\n5. MULTI-HOP REASONING: While the conclusion is correct, the reasoning path is incomplete. A proper answer should compare the 2022 and 2023 exhibit references side-by-side to demonstrate they are identical.\n\nThe answer reaches the right conclusion but through incomplete analysis, missing the specific documentary evidence (Exhibit 4-d references) that proves the guarantee structure remained unchanged.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 529,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "\nThe fact that the Class C‑to‑Class A conversion ratio was unchanged from 2022 to 2023 means the number of additional Class A shares that would result from conversion is predictable and steady. Consequently, any dilution of voting power that existing Class A shareholders would experience in matters such as mergers, consolidations or other “significant transactions” will be a fixed, known reduction rather than a sudden, unpredictable one, and will be compounded only by the pre‑determined conversion amount. Because holders of the other classes (e.g., Class B and the preferred series) can also vote on those transactions and may have interests that differ from Class A shareholders, the consistent conversion rate does not eliminate that divergent influence but ensures that the dilution effect on Class A voting strength remains constant year‑over‑year.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the key insight that the unchanged conversion rate (4.0000) between 2022 and 2023 means predictable and stable dilution effects on Class A voting power. The reasoning about fixed, known reduction rather than unpredictable dilution is sound and aligns with the ground truth's conclusion about stability. The mention of other share classes (B, preferred) having divergent interests is a reasonable elaboration.\n\nWEAKNESSES: (1) QUANTITATIVE ACCURACY: The LLM answer fails to cite the specific conversion rate (4.0000) or the as-converted Class A share values (38 million in 2022, 39 million in 2023) that are explicitly mentioned in the ground truth. These concrete numbers are important for substantiating the claim about stability. (2) INCOMPLETE SYNTHESIS: The ground truth explicitly states the conversion rate remained at 4.0000 in both years and notes the slight increase in as-converted Class A shares (38M to 39M), demonstrating that despite this increase, the conversion rate itself was stable. The LLM answer discusses the concept of stability but doesn't ground it in these specific data points. (3) MISSING CONTEXT: The ground truth emphasizes that the unchanged conversion rate suggests 'no structural change' in how Class C stockholders could influence decisions - this specific framing about structural stability is absent from the LLM answer. (4) REASONING CLARITY: While the LLM's logic about predictable dilution is sound, it doesn't explicitly connect the unchanged conversion rate to the absence of structural change, which is the core insight of the ground truth.\n\nMULTI-HOP ASSESSMENT: The LLM successfully synthesizes the concept that a stable conversion rate across years implies stable voting power effects, but it doesn't fully leverage the specific numerical evidence (the 4.0000 rate and the 38M/39M values) that would strengthen this synthesis.\n\nSEMANTIC EQUIVALENCE: The LLM's core message about predictable, stable dilution is semantically equivalent to the ground truth's message about stable relative voting power dilution, but the lack of specific numbers and the slightly different framing (focusing on predictability rather than structural stability) creates a gap.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 602,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "\nFrom 2022 to 2023 Tesla moved Solar Roof from a niche, pilot‑scale operation at the Buffalo Gigafactory toward a larger‑volume, cost‑optimized manufacturing model.  The shift required new, dedicated production lines and long‑term supply agreements for the roof‑tile glass and solar cells, reducing reliance on external vendors and tying the program more closely to Tesla’s in‑house battery‑cell and energy‑storage capabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is substantially incorrect and contradicts the ground truth on multiple critical dimensions: (1) DIRECTIONAL ERROR: The ground truth states Tesla moved FROM direct production in 2022 TO a cautionary outlook emphasizing risks and dependencies in 2023. The LLM claims the opposite trajectory - that Tesla moved toward 'larger-volume, cost-optimized manufacturing' with 'new dedicated production lines' and 'long-term supply agreements.' This is a fundamental mischaracterization of the evolution. (2) FACTUAL INACCURACY: The ground truth explicitly states that by 2023, Tesla's disclosures shifted to emphasizing 'dependencies and risks' including 'potential delays, supply chain constraints, and challenges in launching and ramping products.' The LLM instead describes a positive scaling narrative with reduced vendor reliance and integration with battery/energy capabilities - the opposite of what the filings actually show. (3) MISSING KEY CONTEXT: The ground truth emphasizes a 'transition from a production-centric view to a more cautionary outlook on strategic execution risks.' The LLM completely misses this critical shift in Tesla's strategic positioning and risk disclosure. (4) UNSUPPORTED CLAIMS: The LLM makes specific claims about 'new dedicated production lines,' 'long-term supply agreements,' and 'reducing reliance on external vendors' that are not supported by the ground truth and appear to contradict the actual filing disclosures about scaling challenges and dependencies. (5) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year evolution from 2022 to 2023, instead inventing a narrative of manufacturing optimization rather than identifying the actual shift toward risk acknowledgment. The answer demonstrates a fundamental misunderstanding of Tesla's actual Solar Roof strategy evolution during this period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 508,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "\nBetween 2022 and 2023 the share of net operating revenue coming from **concentrate (syrup) operations rose from 56 % to 58 %**, while revenue from **finished‑product operations fell from 44 % to 42 %** (see the 2023 and 2022 tables in Item 7, “Management’s Discussion and Analysis”).  This indicates that the Company’s business model is placing relatively more emphasis on **selling syrups and concentrates to bottling partners and fountain retailers**, who then manufacture and distribute the finished beverages, rather than on the Company’s own finished‑product bottling and distribution operations.  As a result, syrups have become a more central conduit linking the Coca‑Cola brand portfolio to the global bottling system and to the Company’s distribution network.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer provides specific quantitative claims (56% to 58% for concentrate operations, 44% to 42% for finished-product operations) that cannot be verified against the ground truth provided. The ground truth does not mention these specific percentage figures at all. The ground truth focuses on qualitative evolution: (1) syrups as intermediate products in 2022 used in fountain production, (2) expanded description in 2023 emphasizing direct U.S. management and sales to fountain retailers/wholesalers, and (3) inclusion in North America operating segment in 2023. The LLM answer takes a fundamentally different approach by citing specific revenue percentages from Item 7 MD&A tables, which are not corroborated in the ground truth. While the LLM's interpretation that syrups became 'more central' aligns directionally with the ground truth's 'strategic shift toward tighter control,' the LLM fails to address the key qualitative changes highlighted in the ground truth: (1) the shift from general description to specific U.S. direct management, (2) the explicit mention of authorized wholesalers and bottling partners in 2023, and (3) the regional segmentation within North America. The LLM also misses the important distinction about gross profit margins (higher for concentrate vs. finished products) mentioned in the ground truth. The quantitative claims appear to be either fabricated or from sources not provided in the ground truth, making them unverifiable and potentially incorrect. The answer does not adequately synthesize the multi-hop information about how the company's organizational structure and distribution strategy evolved between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 456,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "\nBetween 2022 and 2024 the company kept Africa/Eurasia as a distinct reportable geographic segment (the 2024 realignment only moved skin‑health activities out of Europe and did not affect the Africa/Eurasia label).  Net sales in that region edged up from roughly **$1.08 bn in 2022 to $1.095 bn in 2024**, and operating profit grew from about **$228 m to $253 m**, showing a modest but steady contribution to overall earnings.  Capital spending remained very low—around **$12 m per year**—so the firm’s operational focus on Africa/Eurasia has been consistent, with only modest revenue growth and stable profitability over the period.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant numerical inaccuracies that contradict the ground truth. (1) OPERATING PROFIT ERROR: The LLM claims operating profit grew from '$228m to $253m' but the ground truth explicitly states it was '$203 million' in 2022. The LLM's figure of $228m is incorrect and represents a ~12% overstatement of the 2022 baseline. (2) NET SALES FIGURES: The LLM provides net sales figures ($1.08bn in 2022 to $1.095bn in 2024) that are NOT mentioned in the ground truth at all. These appear to be fabricated or sourced from unreliable data. (3) CAPITAL SPENDING: The LLM introduces capital spending figures (~$12m per year) that are entirely absent from the ground truth and cannot be verified. (4) MULTI-HOP REASONING: While the LLM correctly identifies that Africa/Eurasia remained a distinct reportable segment and that skin health was realigned from Europe to North America, it fails on the core quantitative synthesis required by the question. The ground truth emphasizes the 2022 operating profit of $203 million as a 'relatively minor financial contribution,' but the LLM's inflated figures ($228m-$253m) misrepresent this contribution level. (5) SEMANTIC ISSUES: The LLM's characterization of 'modest but steady contribution' and 'modest revenue growth' may be reasonable qualitatively, but is built on incorrect numerical foundations. The answer demonstrates partial understanding of the geographic reporting structure evolution but fundamentally fails on financial accuracy, which is critical for a financial question. The fabrication or misstatement of key financial metrics (operating profit, net sales, capex) represents a critical failure in a multi-hop financial analysis task.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 471,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the Orthopaedics business remained roughly flat – worldwide sales held at about **$8.9 billion**, with U.S. sales steady at **$5.5 billion** and international sales essentially unchanged at **$3.4 billion**.  However, the way the segment is presented has shifted: in the 2024 filing Orthopaedics is highlighted as part of the **MedTech** segment and the narrative places far greater emphasis on **“enabling technologies”** (e.g., advanced implants, robotics‑assisted surgery, sports‑medicine and trauma solutions) that underpin its growth strategy.  This reframing signals a strategic pivot toward leveraging those technologies to drive future margin expansion and global market penetration, even though absolute sales numbers show only modest change.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core strategic shift from quantitative to qualitative emphasis on enabling technologies between 2023 and 2024. The approximate sales figures ($8.9B, $5.5B, $3.4B) are directionally correct and match the ground truth numbers ($8,942M, $5,525M, $3,417M). The LLM appropriately captures the pivot toward technological leadership and product diversification. CRITICAL ERRORS: (1) The LLM states sales 'remained roughly flat' and 'held at about $8.9 billion,' which misrepresents the ground truth showing 4.1% growth from prior year. This is a significant factual error in characterizing performance trajectory. (2) The LLM claims Orthopaedics is 'highlighted as part of the MedTech segment' in 2024, but the ground truth presents it as a distinct segment with its own strategic narrative. This represents a structural/organizational mischaracterization. (3) The LLM omits specific growth percentages (4.1% overall, 3.8% U.S., 4.6% international) that are central to the ground truth's quantitative analysis. (4) The LLM introduces unsupported claims about 'margin expansion and global market penetration' strategy that are not in the ground truth. MULTI-HOP REASONING: The LLM does synthesize the evolution narrative across years, but the 'flat' characterization undermines the accuracy of the multi-hop comparison. The qualitative shift identification is sound, but the quantitative foundation is flawed. SEMANTIC ISSUES: While the LLM captures the enabling technologies emphasis correctly, the framing of sales as 'flat' contradicts the documented growth narrative in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 445,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "\nBetween 2022 and 2023 Visa kept the same overall U.S. retrospective‑responsibility framework but **expanded the definition of “U.S. covered litigation”** – the 2023 amendments to the loss‑sharing and omnibus agreements expressly added opt‑out merchant actions that were not transferred to MDL‑1720, whereas the 2022 filing only referenced the MDL‑1720 cases and the original scope.  At the same time the **liability‑allocation formula was refined**: each participant’s share is now calculated as a fixed 66.667 % (Visa) / 33.333 % (Mastercard) of any judgment or settlement, multiplied by that member’s current membership proportion, replacing the more general “several obligation” language used in 2022.  The escrow account grew (from $894 M to $1.449 B), reflecting the larger liability base created by this broader coverage.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that diverge substantially from the ground truth. CRITICAL ISSUES: (1) ESCROW ACCOUNT NUMBERS: The LLM claims the escrow account grew from $894M to $1.449B between 2022 and 2023. These specific dollar amounts are not mentioned in the ground truth and appear to be fabricated or incorrectly sourced. The ground truth makes no reference to escrow account values or their changes. (2) SCOPE EXPANSION CLAIM: The LLM asserts that 2023 amendments 'expressly added opt-out merchant actions that were not transferred to MDL-1720,' but the ground truth indicates the October 2015 amendment already expanded scope to include opt-out actions from Rule 23(b)(3) Settlement Class in MDL 1720. The LLM mischaracterizes the evolution of scope. (3) LIABILITY ALLOCATION FORMULA: While the LLM correctly identifies the 66.667%/33.333% split between Visa and Mastercard, it introduces the concept of 'multiplied by that member's current membership proportion,' which is not mentioned in the ground truth and appears to be an unsupported addition. (4) FRAMEWORK CHARACTERIZATION: The ground truth emphasizes a shift from 'specific amendments and liability sharing' in 2022 to a 'comprehensive and retrospective liability framework' in 2023, with emphasis on 'settled or otherwise fully or substantially resolved' matters. The LLM's characterization of 'same overall framework' with 'expanded definition' misses this strategic pivot toward consolidation and resolution. (5) MISSING KEY ELEMENTS: The LLM fails to mention the U.S. Retrospective Responsibility Plan consolidation that the ground truth emphasizes as central to the 2023 evolution. CORRECT ELEMENTS: The LLM correctly identifies the 66.667%/33.333% liability split and correctly names Visa and Mastercard as the parties involved. The general concept of evolution between years is addressed, though the specific nature of that evolution is mischaracterized. The answer demonstrates partial understanding but introduces unverified financial data and misrepresents the nature of the framework changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 568,
        "total_tokens": 2100
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "\nBetween 2022 and 2024 the company’s holdings of Guaranteed Investment Contracts (GICs) fell sharply – U.S. GICs dropped from about $1 million (reported in the 2021‑2022 tables) to essentially $0, and international GICs declined from roughly $51 million to about $30 million by the end of 2024.  This reduction reflects a deliberate shift in the pension‑plan asset mix, with the plan moving away from low‑return guaranteed contracts toward a higher allocation of fixed‑income securities, equity and real‑estate funds that better match the plans’ target asset‑allocation percentages.  The evolution indicates that Colgate‑Palmolive is rebalancing its pension‑plan portfolio to increase exposure to more liquid and potentially higher‑yielding assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "QUANTITATIVE ERRORS (Primary Issue): The LLM provides incorrect numbers for international GICs. Ground truth states: 2022 = $55 million, 2024 = $34 million. LLM states: 2022 = 'roughly $51 million', 2024 = 'about $30 million'. The 2022 figure is off by $4 million (7% error), and the 2024 figure is off by $4 million (13% error). These are material discrepancies for financial data. U.S. GICs are correctly identified as dropping from $1 million to $0. ENTITY ACCURACY: The LLM correctly identifies the company as Colgate-Palmolive (CL) and correctly distinguishes between U.S. and International pension plans. REASONING QUALITY: The LLM provides sound strategic interpretation - correctly identifying the shift away from GICs toward higher-yielding assets and improved liquidity. The multi-hop synthesis (comparing 2022 to 2024 across two pension plan categories) is logically sound. However, the reasoning is somewhat speculative (mentioning 'fixed-income securities, equity and real-estate funds') without explicit ground truth support for these specific asset allocations. COMPLETENESS: The answer addresses both the evolution question and the strategic implications question. However, the quantitative inaccuracies undermine the credibility of the analysis. SEMANTIC EQUIVALENCE: The general narrative about strategic reallocation is semantically equivalent to the ground truth, but the specific numbers provided are factually incorrect, which is critical for financial analysis. The $4 million discrepancies on international GICs represent meaningful errors in a financial context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 435,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard broadened the Developer Platform from a primarily API‑focused gateway for integrating core payment services into a more comprehensive ecosystem that explicitly supports digital‑asset and emerging‑technology integration—such as blockchain‑based payments, crypto‑on‑ramp/off‑ramp capabilities, tokenization, AI‑driven fraud and security tools, and real‑time disbursement APIs—while adding programmatic access through the Multi‑Token Network and expanded Foundry collaborations, thereby giving partners a single, standardized way to embed these advanced functionalities into both consumer‑facing and B2B solutions.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) The LLM answer introduces significant unsupported claims not present in the ground truth. Specifically, it mentions 'crypto on-ramp/off-ramp capabilities,' 'AI-driven fraud and security tools,' 'real-time disbursement APIs,' and 'expanded Foundry collaborations' - NONE of these are mentioned in the original answer or verified in the knowledge graph. (2) The ground truth explicitly states the 2022 platform was about 'ease of integration into new and existing solutions' and by 2024 it 'expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies' with specific reference to the Multi-Token Network. The LLM answer conflates these into a broader narrative that goes beyond what can be verified. (3) QUANTITATIVE ACCURACY is rated 8 because there are no specific numbers, dates, or calculations to verify - the answer correctly identifies 2022-2024 timeframe and mentions the Multi-Token Network which appears in ground truth. (4) QUALITATIVE ACCURACY is rated 3 because while the core evolution narrative (API-focused to blockchain/digital assets) is directionally correct, the LLM fabricates multiple specific capabilities and features not supported by the ground truth. This is a hallucination problem. (5) CONTEXTUAL RELEVANCE is 5 because while it addresses the question's scope, it introduces unverified details that dilute accuracy. The answer should have stuck to: (a) 2022 positioning as single access point for digital assets/services, (b) 2024 expansion to blockchain/digital currencies, (c) Multi-Token Network integration. Instead, it added speculative details about crypto ramps, AI tools, and Foundry that cannot be verified against the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 478,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "\nBetween 2022 and 2024 the pension plans held **no U.S. common‑stock exposure in 2022 and 2023**, but by the end of 2024 a modest Level‑1 position of roughly **$1 million of U.S. common stock** was recorded—marking the first such investment in the portfolio.  This addition signals a **deliberate shift in the strategic asset mix**, as the company’s target equity allocation for U.S. assets was increased (e.g., from 21 % to 26 % in the 2024 target) and it is now allocating a portion of plan assets to U.S. equities to diversify and align with its revised investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) QUANTITATIVE ERRORS: The LLM claims $1 million in U.S. common stocks was recorded in 2024, but the ground truth states there was NO allocation to U.S. common stocks in the U.S. pension plan in 2024. The ground truth does mention $2 million in the international pension plan in both years, which the LLM completely missed. The LLM's claim of 'first such investment' is factually incorrect. (2) ENTITY/TIMELINE ERRORS: The LLM incorrectly states 'no U.S. common-stock exposure in 2022 and 2023' then claims a 'modest Level-1 position of roughly $1 million' appeared by 2024. This contradicts the ground truth which shows consistent $0 in the U.S. pension plan across both years and $2 million in the international plan in both years. (3) STRATEGIC INTERPRETATION ERRORS: The LLM's interpretation of a 'deliberate shift in strategic asset mix' and increased target equity allocation (21% to 26%) is not supported by the ground truth, which indicates a 'continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio.' (4) MISSING INFORMATION: The LLM failed to identify the international pension plan's $2 million position that existed in both years, which is a critical detail for understanding the company's actual asset allocation strategy. (5) MULTI-HOP REASONING: The synthesis is fundamentally flawed - the LLM appears to have misread or confused data sources, arriving at conclusions opposite to what the filings actually show. The answer demonstrates poor accuracy on the core quantitative facts and misinterprets the strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 459,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "\nBetween fiscal 2022 and 2023 Disney moved from the early‑stage planning and construction of its next‑generation cruise ships—highlighted in the 2022 filing as part of the “majority of the Company’s capital spend” for parks and experiences (e.g., the 2022 launch of **Disney Wish** and the announced **Disney Treasure** for 2024)—to a more concrete capital‑investment roadmap that earmarks a larger share of Parks & Experiences funding for fleet expansion while explicitly flagging heightened operational‑risk factors such as ship‑yard delivery schedules, regulatory approvals, fuel‑price volatility and variable consumer demand. This evolution reflects a shift toward allocating more capital to cruise‑ship growth but also a greater emphasis on managing the execution and market‑risk uncertainties associated with those investments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misalignments with the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims Disney moved toward 'a larger share of Parks & Experiences funding for fleet expansion' between 2022-2023, but the ground truth indicates the opposite—a shift FROM investment/growth focus TO risk mitigation. The LLM incorrectly characterizes the evolution as increased capital allocation to cruise ships, when the ground truth shows a recalibration away from asset expansion. (2) SPECIFIC CLAIMS: The LLM mentions 'Disney Wish' launch in 2022 and 'Disney Treasure' for 2024, which are specific ship names that cannot be verified against the ground truth provided. While these may be factually accurate about Disney's cruise fleet, they are not mentioned in the original answer and represent details not grounded in the knowledge graph. (3) RISK FACTORS: The LLM lists 'ship-yard delivery schedules, regulatory approvals, fuel-price volatility and variable consumer demand' as operational risks, but the ground truth specifically mentions 'hurricanes and global events (e.g., Hurricane Milton)' as the key external disruptions. The LLM's risk factors are generic operational concerns rather than the specific external disruptions highlighted in the ground truth. (4) CORE NARRATIVE MISMATCH: The ground truth emphasizes a shift from 'growth engine' to 'operational exposure' and 'risk mitigation,' while the LLM emphasizes increased capital allocation with risk management as secondary. This represents a fundamental misunderstanding of the strategic evolution. (5) MULTI-HOP REASONING: The LLM failed to correctly synthesize the 2022 vs. 2023 comparison—it inverted the direction of strategic focus change. The answer demonstrates partial understanding of the question structure but arrives at an incorrect conclusion about the nature of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 511,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "\nMastercard has continued to rely on short‑duration foreign‑exchange forward and option contracts to offset the currency risk that arises from the few‑day lag between a payment’s execution and its final settlement.  The 2024 filing shows a broader use of these non‑designated derivatives—​the notional amount of FX contracts tied to daily receipts and disbursements rose to about $2.7 billion (up from roughly $0.5 billion in earlier years) and the resulting gains and losses are now recorded directly in general‑and‑administrative expense—​indicating a more explicit integration of short‑term FX hedging into the company’s daily settlement‑risk management framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer introduces specific quantitative claims that cannot be verified against the ground truth and appear to be fabricated. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites specific notional amounts ($2.7 billion in 2024, $0.5 billion in earlier years) that are not mentioned in the ground truth. These numbers are presented with high specificity but lack any source verification. The ground truth does not provide these specific dollar amounts for FX derivative contracts. (2) INCOMPLETE SYNTHESIS: While the LLM correctly identifies that Mastercard uses short-duration FX derivatives for daily settlement risk management, it fails to address the key evolution mentioned in the ground truth—the dynamic adjustments to hedging strategies involving euro-denominated debt and the de-designation/re-designation activities in 2023-2024. The ground truth emphasizes this as a crucial aspect of how the strategy evolved. (3) ACCOUNTING TREATMENT CLAIM: The LLM states that gains/losses are 'now recorded directly in general-and-administrative expense,' implying a change in accounting treatment. The ground truth does not support this specific claim about accounting classification changes. (4) MISSING CONTEXT: The ground truth emphasizes the contrast between continuity in short-duration contracts and evolving broader FX risk management strategy. The LLM focuses narrowly on the short-duration contracts without adequately addressing this important contextual evolution. (5) MULTI-HOP REASONING: The LLM fails to synthesize the full picture of how Mastercard's FX risk management evolved—it misses the connection between daily settlement hedging and the broader strategic adjustments to debt-related hedging. The answer is partially relevant to the question but introduces unverified quantitative claims and omits key aspects of the ground truth answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 505,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 Salesforce shifted its strategic‑investment focus from a broad, capital‑intensive portfolio of enterprise‑cloud startups toward a tighter emphasis on AI‑native and vertical‑specific platforms, while deepening ecosystem integration through partners such as Slack, MuleSoft and the AppExchange.  The company is now directing capital to investments that accelerate its own Agentforce/AI capabilities and tighten data‑cloud connectivity, whereas in 2023 the emphasis was on building a diversified investment base and expanding the partner ecosystem as a growth lever.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and introduces unsupported claims not present in the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM introduces specific company names (Slack, MuleSoft) and product names (Agentforce) that are not mentioned in the ground truth answer. While these may be real Salesforce initiatives, they are not supported by the provided knowledge graph data and represent unsupported specificity. (2) MISCHARACTERIZATION OF SHIFT: The ground truth describes a shift from 'primarily investing' to 'broader strategic dependency' with emphasis on ecosystem integration through AppExchange. The LLM characterizes this as a shift toward 'AI-native and vertical-specific platforms' and 'tighter emphasis' - this is a different narrative not supported by the source material. (3) MISSING KEY ELEMENTS: The LLM omits the ground truth's important distinction about AppExchange's role in enabling third-party developers and ISVs, which is central to understanding the deepened integration. (4) UNSUPPORTED CLAIMS: Phrases like 'capital-intensive portfolio,' 'tighter data-cloud connectivity,' and 'Agentforce/AI capabilities' are not mentioned in the ground truth and appear to be LLM inference rather than factual synthesis. (5) PARTIAL ALIGNMENT: The LLM correctly identifies that there was a shift between 2023-2024 and mentions ecosystem integration, which aligns with the ground truth's core theme. However, the specific characterization of what changed is inaccurate. The answer demonstrates some understanding of the question's multi-hop nature but fails in accurate synthesis of the provided knowledge graph data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 453,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the company kept the same core method—accrual rates are derived from vendor‑agreement terms and are revised throughout the year using purchase‑trend data—but it made the process more volume‑responsive.  In the 2024 filing the company explicitly states that accrued vendor‑funding amounts are “impacted if actual purchase volumes differ from projected purchase volumes,” especially for programs that increase funding once graduated volume thresholds are met, indicating a stronger sensitivity to projected volumes than in the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that directly contradicts the ground truth. The ground truth explicitly states that the company's approach 'remained methodologically consistent' with 'no material changes' and that the explicit reference to 'graduated purchase volumes' was OMITTED in fiscal 2024 (suggesting simplification/stabilization). However, the LLM answer claims the opposite: that the company made the process 'more volume-responsive' in 2024 and that the 2024 filing 'explicitly states' sensitivity to projected volumes with 'graduated volume thresholds,' suggesting INCREASED emphasis in 2024. This is a direct contradiction of the ground truth's core finding. The LLM appears to have inverted the evolution described in the original answer. While the LLM correctly identifies that the methodology remained consistent at its core and mentions graduated volume thresholds, it fundamentally mischaracterizes the direction of change (claiming increased sensitivity in 2024 when the ground truth indicates decreased explicit emphasis). The LLM also incorrectly suggests this represents a change toward 'more volume-responsive' when the ground truth indicates the opposite trend. No quantitative errors exist (no numbers were provided), but the qualitative reasoning about how the approach evolved is substantially incorrect, making this answer misleading despite some correct component elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 394,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "\nFrom 2022 through 2024 the legal dispute that Boehringer Ingelheim (BI) launched in 2018 over generic entry to Jardiance remained active but was kept in a stayed status, so no new litigation milestones or settlements were reported; the partnership itself did not shift, with BI continuing to share development and commercial responsibilities and to defend and indemnify Lilly for any product‑liability claims tied to Jardiance.  At the same time, the strategic importance of the drug grew—evidenced by the IRA’s 2023‑2024 price‑setting selections for Jardiance—underscoring that Lilly’s collaboration with BI remains tightly dependent on the product’s market performance and regulatory trajectory.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY FAILURE: The LLM answer completely omits the critical 66% discount figure mentioned in the ground truth. The ground truth explicitly states Jardiance was selected under IRA 'for government-set pricing with a 66% discount compared to the 2023 list price' - this specific quantitative detail is entirely absent from the LLM response. (2) LITIGATION STATUS CONTRADICTION: The LLM claims the 2018 litigation 'remained active but was kept in a stayed status' with 'no new litigation milestones or settlements reported.' However, the ground truth states that in 2022, 'LLY was not a direct party to the Jardiance patent litigation,' implying a distinction in legal involvement that the LLM fails to capture. The LLM's characterization of the litigation status differs from the ground truth's emphasis on LLY's non-involvement as a direct party. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The question asks about evolution 'from 2022 to 2024' with specific focus on 'legal involvement and collaborative dependency.' The ground truth clearly contrasts 2022 (arms-length, not direct party) with 2024 (significantly dependent). The LLM conflates these periods by discussing the litigation as continuously 'stayed' without highlighting the shift in LLY's strategic position and dependency. (4) MISSING KEY INSIGHT: The ground truth emphasizes a 'shift' and 'deeper strategic entanglement and dependency' - a crucial evolution narrative. The LLM states 'the partnership itself did not shift,' which contradicts the ground truth's core finding about how the relationship evolved. (5) INDEMNIFICATION DETAIL: While the LLM correctly mentions BI's indemnification obligations, this detail is not in the ground truth and may represent information from a different source, but it doesn't compensate for the missing 66% discount figure and the mischaracterization of the relationship evolution. The LLM answer fundamentally misses the key quantitative metric (66% discount) and misrepresents the nature of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 553,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2023 Disney moved from a one‑off, land‑development focus to a sustained, multi‑year capital‑allocation program that treats cruise‑ship expansion as a core pillar of its Parks & Experiences strategy.  In 2022 the Company invested heavily in the 550‑acre Lighthouse Point resort on Eleuthera, earmarking it as a private Disney Cruise Line destination for 2024, while 2023’s filings show continued and accelerating spending on new ships and on‑board enhancements, integrating those assets into the broader theme‑park/resort growth portfolio and positioning cruise‑ship capital projects as high‑return, long‑term investments within the Parks & Experiences business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM claims Disney invested in a '550-acre Lighthouse Point resort on Eleuthera' earmarked for 2024, but this specific detail is not mentioned in the ground truth and appears to be fabricated or confused with other Disney properties. The ground truth makes no mention of Lighthouse Point or specific acreage figures. (2) UNSUPPORTED CLAIMS: The LLM states 'In 2022 the Company invested heavily in the 550-acre Lighthouse Point resort' - this is not corroborated by the ground truth, which only notes that 2022 did not specifically emphasize capital investment in cruise ships. (3) INCOMPLETE ALIGNMENT WITH GROUND TRUTH: While the LLM correctly identifies that there was a shift from 2022 to 2023 in how cruise ships were treated, it mischaracterizes the 2022 position. The ground truth states 2022 'did not specifically emphasize capital investment' in cruise ships, whereas the LLM claims heavy investment in Lighthouse Point in 2022. (4) MULTI-HOP REASONING: The LLM attempts to synthesize information but does so inaccurately by introducing details not in the source material. The core insight about the evolution from 2022 to 2023 is present but overshadowed by factual inaccuracies. (5) SEMANTIC ISSUES: The LLM's characterization of 2022 as a 'one-off, land-development focus' contradicts the ground truth's more measured statement that cruise ships were not specifically emphasized in capital investment discussions. The answer demonstrates partial understanding of the question but fails on factual accuracy, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 467,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "\nBetween 2022 and 2024 Mastercard Foundry shifted from a primarily exploratory “lab” that showcased emerging tech and early‑stage fintech collaborations to a more market‑oriented platform that embeds those innovations into core offerings.  In 2022 it emphasized thought‑leadership and experimentation with fintech startups and new technologies, whereas by 2024 Foundry was actively steering large‑scale programs—such as blockchain‑based programmable payments, AI‑enhanced fraud‑detection and tokenization, and the rollout of Virtual‑Card‑Number and Alias‑Based Remittances—while deepening partnerships with fintechs, crypto‑players and digital‑wallet providers.  This evolution reflects a move from pure ideation to delivering concrete, scalable solutions that drive ecosystem‑wide innovation.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer contains significant factual inaccuracies that undermine its credibility despite capturing the general evolution narrative.\n\nCORRECT ELEMENTS:\n- Accurately identifies the shift from exploratory 'lab' to more market-oriented platform\n- Correctly notes 2022 emphasis on thought leadership and fintech experimentation\n- Correctly identifies 2024 focus on blockchain-based programmable payments\n- Properly mentions the Mastercard Multi-Token Network™ concept\n- Captures the evolution from ideation to scalable solutions\n\nFACTUAL ERRORS:\n1. UNSUPPORTED CLAIMS: The LLM introduces specific initiatives NOT mentioned in the ground truth:\n   - \"AI-enhanced fraud-detection\" - not in original answer\n   - \"Virtual-Card-Number and Alias-Based Remittances\" - not in original answer\n   - These appear to be fabricated details not supported by the knowledge graph\n\n2. ENTITY ACCURACY ISSUE: The LLM mentions \"crypto-players\" and \"digital-wallet providers\" as deepened partnerships, but the ground truth only mentions \"fintech partnerships\" without specifying these particular categories\n\n3. OVER-SPECIFICATION: The LLM provides concrete program names and technologies that go beyond what the ground truth establishes, suggesting hallucination rather than synthesis from actual filing data\n\nMULTI-HOP REASONING: The reasoning structure is sound (comparing 2022 vs 2024 roles), but the synthesis introduces unsupported details that weren't derived from the source documents.\n\nQUANTITATIVE ACCURACY: No numbers or dates to verify; dates (2022, 2024) are correct.\n\nSEMANTIC EQUIVALENCE: While the general narrative matches (evolution from lab to active engine), the specific technological claims diverge significantly from ground truth, making this a partially correct but substantially embellished answer.\n\nJUSTIFICATION: Score of 5 reflects that while the core narrative arc is correct, the introduction of unverified specific initiatives (AI fraud detection, Virtual Card Numbers, Alias-Based Remittances) represents material factual errors that would mislead someone relying on this answer for accuracy. The answer reads plausible but contains fabricated details not in the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 598,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "\nThe Lilly‑Boehringer Ingelheim partnership progressed from securing early regulatory accelerants—by 2022 the companies had obtained FDA **Breakthrough Therapy** and **Fast‑Track** designations for empagliflozin (Jardiance) in heart‑failure with preserved ejection fraction and were advancing its submission for chronic‑kidney‑disease indications (see LLY_10k_2022.pdf pp. 37‑41). By 2024 the collaboration faced a new strategic challenge: the U.S. **Inflation Reduction Act** now subjects Jardiance, a joint product, to government‑set Medicare prices with up to a **66 % discount** beginning in 2026, underscoring a shift toward managing significant pricing pressure while the partners continue to leverage the partnership’s pipeline (see LLY_10k_2024.pdf pp. 43‑47).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and comprehensive synthesis of the multi-hop question. STRENGTHS: (1) All key numeric values are correct: 66% discount is accurate, 2026 effective date matches ground truth, and the timeframe comparison (2022 vs 2024) is properly structured. (2) Regulatory designations are correctly identified: Breakthrough Therapy and Fast Track designations are accurately attributed to the 2022 period. (3) Multi-hop synthesis is sound: the answer correctly traces the evolution from regulatory facilitation (2022) to regulatory-driven financial constraints (2024), showing clear understanding of how the partnership's strategic context shifted. (4) Entity identification is precise: Lilly-Boehringer Ingelheim partnership correctly identified, Jardiance properly named as the joint product, and the Inflation Reduction Act correctly cited as the driver of 2024 pressures. (5) The answer goes beyond ground truth by adding specific context (heart failure with preserved ejection fraction, chronic kidney disease indications) which enriches the response without contradicting the original answer. (6) Semantic equivalence is maintained: 'government-set pricing' and 'Medicare prices' are semantically equivalent in this context. MINOR CONSIDERATIONS: The LLM answer includes specific document citations (page numbers) which, while helpful, cannot be verified against the ground truth provided. However, this addition does not detract from factual accuracy. The characterization of the shift from 'regulatory facilitation to regulatory-driven financial constraints' aligns perfectly with the ground truth's framing. No calculation errors detected, and all temporal relationships are correctly represented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 475,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "\nFrom 2023 to 2024 the CH‑53K moved from being highlighted simply as a flagship heavy‑lift program for the Rotary and Mission Systems (RMS) segment—highlighted by the 2023 Israeli LOA and ongoing U.S. Marine Corps production—to being positioned as a strategic growth pillar for RMS.  In 2024 the company emphasized accelerated production rates, expanded sustainment and new foreign‑military‑sales opportunities, and integrated the CH‑53K into its broader 21st‑Century Security vision, making the helicopter a cornerstone for future vertical‑lift and joint‑all‑domain capabilities within Lockheed Martin’s RMS business.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces specific claims about '2023 Israeli LOA' and 'accelerated production rates' and 'expanded sustainment' that are not mentioned in the ground truth and cannot be verified from the provided context. These appear to be fabricated details. (2) FACTUAL INACCURACY: The ground truth explicitly states 'no specific revenue figures are provided,' yet the LLM presents detailed operational claims (Israeli LOA, accelerated production, new FMS opportunities) as if they were documented facts from the filings. (3) MISCHARACTERIZATION OF EVOLUTION: The ground truth describes a shift from 'growth driver among several others' to 'part of a more integrated, technologically advanced portfolio' focused on AI/ML, autonomy, and interoperability. The LLM instead claims the helicopter became a 'strategic growth pillar' with emphasis on production rates and FMS—a different narrative not supported by the ground truth. (4) MISSING KEY CONTEXT: The LLM fails to mention the actual 2024 positioning emphasis on 'all-domain mission solutions and digital technologies such as AI/ML and autonomy,' which is central to the ground truth's description of the evolution. (5) MULTI-HOP REASONING: The LLM did not properly synthesize the available information; instead, it appears to have generated plausible-sounding but unverified claims about Israeli LOAs, production acceleration, and sustainment expansion. The answer reads like speculation rather than evidence-based synthesis from SEC filings. The only partially correct element is the identification of RMS segment and the general notion that positioning evolved, but the specific details of that evolution are fundamentally misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 497,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "\nThe 2022‑2024 evolution of the Lilly‑Boehringer Ingelheim diabetes lineup—adding Jardiance’s cardiovascular‑risk and heart‑failure indications, expanding the Basaglar biosimilar portfolio, and introducing newer combination agents—shows that the partners are deliberately steering their diabetes strategy toward a **cardiometabolic** focus that emphasizes outcomes‑driven, high‑value products.  By co‑commercializing these differentiated therapies, the companies are aligning their resources to capture payer and provider attention, secure formulary placement, and sustain growth in a segment where generic competition is intense.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth in multiple critical ways: (1) FACTUAL ERRORS: The ground truth explicitly states the portfolio NARROWED from 7 products in 2022 (Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, Basaglar) to 4 products in 2024 (Jardiance, Glyxambi, Synjardy, Trijardy XR). The LLM claims the portfolio was 'adding' and 'expanding' products, which is the opposite of what occurred. (2) MISSING KEY PRODUCTS: The LLM fails to identify that Trajenta, Jentadueto, and Basaglar were removed from the co-commercialized portfolio. These removals are central to understanding the strategic shift. (3) UNSUPPORTED CLAIMS: The LLM introduces claims about 'adding Jardiance's cardiovascular-risk and heart-failure indications' and 'expanding the Basaglar biosimilar portfolio' that are not supported by the ground truth and appear to be hallucinations. The ground truth indicates Basaglar was REMOVED, not expanded. (4) INCORRECT INTERPRETATION: While the LLM correctly identifies a cardiometabolic focus as potentially relevant, it mischaracterizes the strategic shift as an expansion when it was actually a contraction/narrowing. The ground truth suggests the narrowing reflects lifecycle management, declining market relevance, or generic competition—not expansion. (5) MULTI-HOP REASONING FAILURE: The LLM failed to properly synthesize the 2022 vs 2024 portfolio comparison, which is the core of the multi-hop question. The answer demonstrates a fundamental misunderstanding of the directional change in the partnership's product focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 440,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 the JASSM program moved from a modest contributor to a primary growth engine for the Missiles & Fire Control segment.  In 2023 its production ramp‑up added roughly **$145 million** of net sales and helped lift overall backlog, while in 2024 the same ramp‑up generated **about $1.2 billion** of the segment’s sales increase and was explicitly cited as a key driver of the **higher backlog** for PAC‑3, LRASM and JASSM.  Consequently, JASSM’s expanding production volume not only boosted revenue but also reinforced its strategic importance as a core, high‑demand missile system that underpins the segment’s future earnings and order pipeline.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) QUANTITATIVE ACCURACY - The LLM introduces a $145 million figure for 2023 that does NOT appear in the ground truth. The ground truth explicitly states 'there was no specific mention of significant changes in its production volume or backlog contribution' in 2023. This is a fabricated number. (2) The $1.2 billion figure is correctly cited as the 2024 contribution, matching ground truth. (3) ENTITY ERRORS - The LLM mentions 'PAC-3, LRASM and JASSM' as key backlog drivers, but the ground truth specifically lists 'PAC-3 and GMLRS' alongside JASSM. LRASM is incorrectly substituted for GMLRS - this is a factual error in entity identification. (4) REASONING ISSUES - The LLM's multi-hop synthesis is partially sound in connecting production ramp-up to backlog contribution, but the fabricated 2023 baseline ($145M) undermines the comparative analysis between years. The ground truth indicates 2023 had no specific mention of production changes, making the 2023-2024 comparison invalid as presented. (5) SEMANTIC ISSUES - While the overall narrative about JASSM becoming a 'primary growth engine' aligns with the ground truth's characterization of 'notable rise,' the specific quantitative claims are unsupported or incorrect. The answer demonstrates good contextual understanding but fails on factual accuracy, which is the primary evaluation criterion for financial data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 390,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "\nBetween 2023 and 2024 JPMorgan moved its Business‑Banking loan risk assessment from a primarily delinquency‑and‑geography‑based view (2023 ‑ “geographic distribution is an indicator of credit performance” for scored auto and business‑banking loans) to a more granular, risk‑rated framework that emphasizes risk‑rated exposure, current‑estimated LTV and refreshed FICO scores, and regional economic indicators (2024 ‑ “Nonaccrual loans and other credit‑quality indicators” tables showing LTV, FICO, geographic region and wholesale‑methodology allowances).  \n\nThis shift means that early signs of borrower distress can now be detected through leading metrics such as rising high‑LTV or low‑FICO exposures in specific regions, allowing the firm to flag at‑risk borrowers before traditional delinquency or charge‑off signals appear.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims the 2023 focus was 'delinquency-and-geography-based' and attributes a quote about 'geographic distribution is an indicator of credit performance' to 2023, but the ground truth states 2023 focused on 'loan performance and scoring models' within the consumer credit strategy. The LLM invents details about LTV and FICO scores being part of a 2024 'risk-rated framework' that are not supported by the ground truth. (2) MISCHARACTERIZATION OF EVOLUTION: The ground truth clearly states the shift was FROM loan performance/scoring models (2023) TO delinquency rates as primary indicator (2024), with loans 30+ days past due as early warning signals. The LLM reverses this logic, claiming 2023 was delinquency-based and 2024 added LTV/FICO metrics - this is backwards. (3) UNSUPPORTED CLAIMS: The LLM introduces specific metrics (LTV, FICO scores, 'wholesale-methodology allowances') that do not appear in the ground truth answer and appear to be fabricated details. (4) MISSING KEY INFORMATION: The LLM fails to mention the critical shift toward delinquency rates (30+ days past due) as the primary credit quality indicator in 2024, which is central to the ground truth. (5) REASONING FLAW: While the LLM's conclusion about 'early detection' sounds reasonable, it's based on incorrect premises about what metrics were emphasized in each year. The ground truth's emphasis on 30+ day delinquency as an early warning signal is more conservative and accurate than the LLM's speculative claims about LTV/FICO leading indicators. The answer demonstrates poor multi-hop synthesis and appears to conflate or invent details rather than accurately representing the documented evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 496,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "\nTarget’s SPP II plan is referenced in both the 2022 and 2023 Form 10‑K filings using the identical “Target Corporation SPP II (2016 Plan Statement) (as amended and restated effective April 3, 2016)” description, with no new amendment or revised terms disclosed in the 2023 filing. This lack of change indicates that the company has kept the long‑term incentive structure of its executive compensation framework stable, preserving the same performance‑share and cash‑award provisions from year to year.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth on the key factual claim. (1) CRITICAL ERROR - FACTUAL INACCURACY: The LLM states that both 2022 and 2023 filings use 'identical' descriptions with the '2016 Plan Statement (as amended and restated effective April 3, 2016)' with 'no new amendment or revised terms disclosed in the 2023 filing.' However, the ground truth explicitly states that the 2023 filing updated the SPP II plan to the '2022 Plan Statement, as amended and restated effective May 1, 2022' - a significant change from the 2016 Plan Statement. This is a direct contradiction of a core factual claim. (2) QUANTITATIVE/DATE ACCURACY: The LLM fails to identify the critical date change from April 3, 2016 (2022 filing) to May 1, 2022 (2023 filing). These are distinct effective dates representing different plan statements, which the LLM completely missed. (3) MULTI-HOP REASONING: The LLM failed to synthesize the evolution of the plan across the two filing years. The question specifically asks 'how did...terms evolve between 2022 and 2023' and the ground truth identifies a clear evolution (2016 Plan Statement → 2022 Plan Statement), while the LLM incorrectly claims no evolution occurred. (4) SEMANTIC MEANING: The LLM's conclusion that the company 'kept the long-term incentive structure...stable' directly contradicts the ground truth's finding that Target 'revised the SPP II plan within this timeframe.' The LLM's interpretation of 'no change' is factually wrong. (5) CONTEXTUAL RELEVANCE: While the answer addresses Target Corporation and SPP II, it does so with incorrect information, making it contextually relevant but substantively wrong. The answer demonstrates a fundamental misreading or misunderstanding of the filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 484,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "\nFrom 2022 through 2024 the company did not record any new milestone‑related cash outflows under the Olumiant (baricitinib) partnership; the only obligations were the amortization of the $260 million and $210 million regulatory milestones that had been capitalized in 2020‑2021 and were being expensed as cost of sales.  At the end of 2021 Incyte remained eligible for up to an additional $100 million of success‑based regulatory milestones and up to $100 million of sales‑based milestones, so the potential future milestone exposure stayed at roughly $200 million but no further payments had been triggered by that date.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations that substantially diverge from the ground truth. Key issues: (1) QUANTITATIVE ERRORS: The LLM introduces numbers not in the ground truth ($260M and $210M regulatory milestones capitalized in 2020-2021) which appear to be fabricated or confused with other data. The ground truth clearly states $100M in development-related regulatory milestones and $100M in sales-based milestones as of 2022, totaling $200M potential exposure. (2) TEMPORAL CONFUSION: The LLM conflates 2021 and 2022 data, stating 'At the end of 2021 Incyte remained eligible' when the question specifically asks about evolution from 2022 to 2024. The ground truth indicates the $100M/$100M structure existed in 2022 and was no longer mentioned by 2024. (3) INCOMPLETE EVOLUTION ANALYSIS: The LLM fails to address the core finding that by 2024, regulatory milestones disappeared from disclosures while sales-based royalties (up to 20%, with low teens rates for COVID-19 treatment) became the primary obligation. The ground truth explicitly notes this shift from 'both regulatory and sales milestones to one focused primarily on sales-based compensation.' (4) CASH FLOW MISCHARACTERIZATION: The LLM's claim about 'amortization of capitalized milestones' and 'cost of sales' treatment is not supported by the ground truth and appears to misunderstand the nature of milestone obligations. (5) MISSING KEY INSIGHT: The LLM does not capture the significant evolution that occurred between 2022 and 2024 - the disappearance of regulatory milestone obligations and the shift to royalty-based compensation structure. The answer reads as if describing a single point in time rather than tracking evolution across the three-year period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 480,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "\nCisco’s APJC revenue rose modestly from $8.0 billion in fiscal 2022 to roughly $8.2 billion in fiscal 2023 (segment‑revenue table), indicating a small increase in revenue exposure. At the same time, long‑lived assets in the region fell from $997 million at the end of fiscal 2022 to about $950 million at the end of fiscal 2023 (asset‑balance table), showing a decline in capital‑intensive exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth in multiple critical ways: (1) REVENUE FIGURES NOT IN GROUND TRUTH: The LLM claims APJC revenue was $8.0 billion in fiscal 2022 and $8.2 billion in fiscal 2023. The ground truth explicitly states 'specific financial figures for APJC were not disclosed in the provided data' for fiscal 2022, and makes no mention of revenue figures for fiscal 2023. These numbers appear to be fabricated or sourced from data not in the knowledge graph. (2) ASSET FIGURES MISMATCH: The ground truth identifies APJC assets at $5,382 million as of July 29, 2023. The LLM instead reports 'long-lived assets' of $997 million in fiscal 2022 and $950 million in fiscal 2023 - completely different figures and metrics. The LLM conflates 'long-lived assets' with total assets, which are distinct accounting categories. (3) METRIC CONFUSION: The LLM discusses 'long-lived assets' (a specific balance sheet category) rather than the total asset balance of $5,382 million that the ground truth identifies. (4) MISSING KEY INFORMATION: The ground truth emphasizes that fiscal 2023 showed 'more detailed financial disclosure regarding APJC' compared to 2022, where 'segment-level asset values were not explicitly itemized.' The LLM fails to capture this important distinction about disclosure changes between years. (5) MULTI-HOP SYNTHESIS FAILURE: The question asks about evolution based on 'segment reporting and asset balances.' The LLM provides revenue data (not requested as primary metric) and long-lived assets (wrong metric), while missing the actual asset balance figure of $5,382 million. The answer demonstrates either hallucination of financial data or reliance on incorrect source material, making it unreliable for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 486,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "\nFrom 2022 through 2024 the Lilly‑Boehringer Ingelheim Jardiance partnership has shifted from pure volume‑driven growth to a strategy that accommodates the Inflation‑Reduction Act’s price‑setting rules. After HHS listed Jardiance among the first ten drugs subject to government‑set caps, the 2024 announcement imposed a roughly 66 % discount off the 2023 list price, forcing the collaborators to supplement sales with expanded indications, new formulations and heightened manufacturing capacity while negotiating rebates to preserve profitability. This regulatory pressure has therefore re‑oriented the alliance toward maintaining market access and diversifying revenue streams rather than relying solely on price‑unconstrained growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information across the 2022-2024 period. STRENGTHS: (1) All key numeric values are correct - the 66% discount in 2024 is accurately stated, and the August 2023 selection as one of the first ten drugs subject to government pricing is correctly identified. (2) The temporal evolution is properly captured, showing the shift from volume-driven growth in 2022 to IRA-constrained strategy by 2024. (3) Multi-hop reasoning is sound - the answer correctly synthesizes information about the collaboration, regulatory changes (IRA), and business strategy adjustments. (4) Entity identification is accurate (LLY, Boehringer Ingelheim, Jardiance). (5) The semantic meaning aligns well with ground truth - both discuss the transition from unconstrained growth to regulatory-constrained strategy. MINOR GAPS: (1) The LLM answer does not explicitly mention the specific 2022 growth rates (30% U.S., 28% outside U.S.) that were highlighted in the ground truth, though this is a relatively minor omission since the answer captures the broader 'volume-driven growth' concept. (2) The answer adds interpretive elements about 'expanded indications, new formulations, and heightened manufacturing capacity' that go beyond what was explicitly stated in the ground truth, though these are reasonable strategic inferences. (3) The ground truth specifically notes the August 2024 timing of the 66% discount announcement, which the LLM captures as '2024 announcement.' Overall, the answer successfully addresses the core question about how the collaboration evolved in response to regulatory changes, with accurate numbers and sound reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 466,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "\nBetween 2022 and 2023 GM’s discussion of product‑safety recalls shifted from a general warning that recalls could “materially adversely affect” the business to a more pronounced, strategy‑linked emphasis.  In the 2022 filing the company highlighted that a recall on a global platform such as the Chevrolet Bolt EV could amplify costs and reputational damage, while in 2023 the language was sharpened to stress that safety concerns—especially those involving advanced EV/AV technologies—could jeopardize brand trust, delay product roll‑outs and trigger substantial financial penalties.  This evolution reflects a growing awareness that recall risk is now central to GM’s EV/AV positioning and to its overall financial and reputational resilience.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy with correct identification of the key evolution in GM's risk disclosure between 2022 and 2023. STRENGTHS: (1) Correctly identifies the Chevrolet Bolt EV as the specific global platform example from 2022 filings; (2) Accurately captures the shift from cost-centric concerns to broader reputational/strategic risks; (3) Properly synthesizes the multi-hop connection between recall risks and EV/AV positioning; (4) No quantitative errors or incorrect dates; (5) Appropriately emphasizes the strategic dimension tied to innovation and market positioning. MINOR WEAKNESSES: (1) The LLM answer adds some interpretive language not explicitly in the ground truth (e.g., 'delay product roll-outs and trigger substantial financial penalties') that, while logically consistent with the evolution described, goes slightly beyond what the ground truth explicitly states; (2) The phrase 'sharpened to stress' and specific mention of 'advanced EV/AV technologies' represents reasonable inference but adds detail not confirmed in the original answer; (3) The characterization of 'growing awareness' is interpretive rather than directly sourced. MULTI-HOP REASONING: The answer correctly synthesizes information across two fiscal years and connects recall risk to strategic positioning in EV/AV markets, which is the core requirement. The reasoning is sound and logically structured. SEMANTIC EQUIVALENCE: The core message matches the ground truth - a shift from financial/cost concerns to reputational/strategic concerns tied to EV/AV leadership. The LLM's framing is slightly more detailed but semantically aligned with the original answer's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 461,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "\nThe Guaranteed Senior Notes of Costco’s Japanese subsidiary grew from roughly **$0.7 billion** in the 2022‑2023 period to about **$0.92 billion** by the end of 2024.  After issuing approximately **$0.5 billion** of new notes in late 2023 (with maturities extending to 2033‑2043 at fixed rates of 1.4‑2.1 %), the subsidiary repaid only a small amount ($77 million) in July 2024, leaving the outstanding balance higher at the end of 2024.  \n\nThis pattern shows that Costco is deliberately **expanding its long‑term financing through lower‑cost, longer‑dated foreign‑currency debt** issued by its overseas subsidiary, using the notes to fund international operations and diversify the company’s capital structure while still relying on its U.S. senior unsecured notes for the bulk of overall long‑term funding.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant quantitative errors and unsupported claims that substantially undermine its credibility. CRITICAL ISSUES: (1) The LLM introduces specific dollar amounts ($0.7 billion in 2022-2023, $0.92 billion by end of 2024) that are NOT present in the ground truth. The ground truth explicitly states that in 2022, the notes were 'described in general terms' with no specific valuation provided. This is a major factual error - the LLM fabricated precise numbers. (2) The ground truth confirms the $500 million issuance in November 2023 and $77 million repayment in July 2024, which the LLM correctly identifies. However, the LLM's calculation of outstanding balances ($0.7B → $0.92B) cannot be verified against the ground truth and appears to be unsupported speculation. (3) The LLM adds interpretive claims about 'lower-cost, longer-dated foreign-currency debt' and 'international operations' that go beyond what the ground truth states. The ground truth focuses on transparency improvements and fixed-rate debt management, not currency strategy or international operations funding. (4) The LLM correctly identifies the interest rate range (1.4-2.1%) and maturity period (2033-2043), and correctly notes the small repayment relative to new issuance. STRENGTHS: The LLM correctly synthesizes the multi-hop information about the 2023 issuance and 2024 repayment, and appropriately identifies this as part of long-term financing strategy. The reasoning about debt expansion is logically sound, even if not fully supported by the ground truth. WEAKNESSES: Fabricating specific balance sheet numbers ($0.7B, $0.92B) without source support is a critical error that violates basic factual accuracy standards. The answer conflates confirmed facts with unsupported interpretations about currency strategy and international operations funding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 503,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 the balance of Cisco’s available‑for‑sale (AFS) debt investments rose from **$11.9 billion to $15.6 billion**, an increase of roughly **$3.6 billion (≈30 %)**.  This jump reflects a purposeful expansion of the company’s short‑term, interest‑earning securities portfolio—using higher‑quality, investment‑grade debt to generate modest returns on excess cash while preserving flexibility for dividends, share‑repurchases and strategic acquisitions.  The move signals that Cisco is allocating more of its liquidity to AFS securities, likely to boost cash‑flow yields in a higher‑rate environment and to support its capital‑allocation priorities.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on all key factual claims. (1) DIRECTIONAL ERROR: The LLM states AFS debt investments INCREASED from $11.9B to $15.6B, but the ground truth clearly indicates they DECREASED from $15,592M to $9,865M between 2022 and 2023. This is a critical reversal of the actual trend. (2) QUANTITATIVE ERRORS: The LLM cites starting value of $11.9B (2022), but ground truth shows $15,592M ($15.6B) in 2022. The LLM's ending value of $15.6B is actually the 2022 figure, not 2023. The LLM calculates a $3.6B increase, but the actual change was a $5,727M ($5.7B) DECREASE. The percentage calculation of 30% increase is mathematically wrong and directionally opposite to reality. (3) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the year-over-year comparison. It appears to have confused or inverted the temporal sequence of the data. (4) STRATEGIC INTERPRETATION ERROR: The LLM interprets the (incorrect) increase as a 'purposeful expansion' and 'allocating more liquidity to AFS securities,' when the ground truth indicates a 'strategic reduction' and 'shift in investment focus or risk management approach.' The LLM's narrative about higher-rate environments and capital allocation priorities contradicts the actual strategic shift evidenced by the significant reduction. (5) The only partially correct element is the identification of Cisco and the general topic of AFS debt investments, but the core numerical facts, calculations, and strategic conclusions are all wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 419,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "\nFrom 2023 to 2024 JPMorgan Chase’s exposure to system‑damage risk has risen sharply as its interconnectivity with third‑party vendors, custodians and market‑infrastructure platforms has expanded.  The 2024 filing stresses that failures or cyber attacks at a vendor or at any linked entity can cascade across the firm, making data‑recovery far more complex and driving up remediation and operational‑costs, whereas the 2023 discussion only noted the possibility of vendor‑related failures without this systemic emphasis.  Consequently, the firm now faces a heightened likelihood of widespread operational disruption and greater difficulty restoring compromised data after a breach.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses the evolution of JPMorgan Chase's system damage risk exposure from 2023 to 2024, but with significant gaps and some misalignment with the ground truth. STRENGTHS: (1) Correctly identifies the timeframe (2023 to 2024) and company (JPMorgan Chase); (2) Appropriately emphasizes third-party vendor risks and data recovery challenges as key themes; (3) Captures the general trend of increased complexity and systemic risk; (4) No quantitative errors (no specific numbers were provided to verify). WEAKNESSES: (1) MAJOR OMISSION - Fails to mention ransomware attacks, which the ground truth explicitly identifies as a key 2024 evolution; (2) MAJOR OMISSION - Does not address cyber insurance coverage limitations, a specific 2024 concern noted in ground truth; (3) MAJOR OMISSION - Completely misses the fraudulent transaction processing risk mentioned in ground truth as a 'new concern' in 2024; (4) INCOMPLETE 2023 CHARACTERIZATION - Ground truth specifies 2023 risks included unauthorized access, zero-day vulnerabilities, and DDoS attacks, but LLM only vaguely references 'vendor-related failures'; (5) REASONING GAP - While the LLM correctly identifies cascading effects and data recovery complexity, it doesn't synthesize the full spectrum of cyber threats that evolved between years; (6) SEMANTIC DRIFT - The LLM's emphasis on 'interconnectivity expansion' and 'systemic emphasis' is somewhat inferred rather than directly grounded in the specific risk categories mentioned in ground truth. The answer demonstrates partial understanding of the evolution but lacks the specificity and comprehensiveness required for a complete multi-hop synthesis of the filing data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 462,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "\nCostco expanded its private‑label product assortment, adding new Kirkland Signature and exclusive items. It also invested in dedicated private‑label sourcing and distribution infrastructure and increased pricing and marketing focus on private‑label brands to boost their share of sales.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer addresses some relevant aspects of Costco's private-label strategy but has significant gaps in addressing the specific operational investments mentioned in the ground truth. STRENGTHS: (1) Correctly identifies Kirkland Signature as the private-label brand, (2) Mentions infrastructure investments which aligns with the ground truth's reference to operational investments, (3) Acknowledges the strategic focus on private-label growth. WEAKNESSES: (1) CRITICAL OMISSION: The ground truth specifically emphasizes 'processing, packaging, and manufacturing facilities' as tangible operational investments - the LLM answer vaguely mentions 'sourcing and distribution infrastructure' but fails to identify the key manufacturing/processing/packaging facilities that represent the core operational shift from external sourcing to internal production capabilities. (2) The LLM answer lacks the important contextual detail that these facilities represent a significant evolution and shift in strategy (from external sourcing to internal production), which is central to the ground truth's answer. (3) The LLM answer mentions 'pricing and marketing focus' which, while potentially relevant to strategy, is not an 'operational investment' in the sense of capital/facility investments that the question asks about. (4) No quantitative data provided (no facility counts, investment amounts, or other metrics), though the ground truth also lacks specific numbers. (5) The multi-hop reasoning is incomplete - the answer doesn't adequately synthesize the connection between the 2022 strategic emphasis and the 2024 operational manifestation of that strategy through facility investments. The answer reads more like general marketing/merchandising activities rather than substantive operational infrastructure investments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 493,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "\nBetween 2022 and 2023 UnitedHealth Group’s Medicaid‑managed‑care bidding shifted from a relatively straightforward model that relied on enrollment growth, utilization and medical‑cost assumptions to a more refined approach that incorporated updated risk‑adjustment calculations, tighter enrollment forecasts and greater sensitivity to benchmark‑driven pricing pressures.  In both years the company warned that bid accuracy is critical—if any of the underlying assumptions (e.g., member volume, cost trends, or risk‑adjusted payments) prove materially wrong, the resulting contract loss or margin compression could have a material adverse effect on results of operations, financial position and cash flows.  The 2023 disclosures emphasized heightened volatility and the need for more conservative, data‑driven assumptions to mitigate the risk of inaccurate bids.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH CORE NARRATIVE: The LLM answer fundamentally mischaracterizes the evolution described in the ground truth. The original answer clearly states the shift was FROM 'risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts' (2022 focus) TO 'greater emphasis on the assumptions behind its bids' (2023 focus). The LLM answer inverts this narrative, claiming the company shifted FROM 'straightforward model that relied on enrollment growth, utilization and medical-cost assumptions' TO 'more refined approach that incorporated updated risk-adjustment calculations, tighter enrollment forecasts.' This is backwards—the ground truth shows the company moved FROM contract renewal risk TO bid assumption risk, not from simple to complex assumptions. SPECIFIC ERRORS: (1) The LLM introduces concepts not in the ground truth: 'risk-adjustment calculations,' 'benchmark-driven pricing pressures,' 'data-driven assumptions,' and 'heightened volatility'—these are fabrications not supported by the original answer. (2) The LLM claims both years warned about bid accuracy being critical, but the ground truth shows 2022 focused on contract renewal risk while 2023 focused on bid assumptions—these are different risk narratives. (3) The phrase 'contract loss or margin compression' appears in the LLM but is not explicitly stated in the ground truth, which focuses on 'materially affect results of operations and cash flows.' WHAT WAS CORRECT: (1) The identification of UnitedHealth Group as the company. (2) The correct years (2022 and 2023). (3) The general acknowledgment that assumptions matter and can have material adverse effects. (4) The mention of enrollment, utilization, and medical costs as key assumptions. MULTI-HOP REASONING: The LLM failed to correctly synthesize the evolution between the two years. The ground truth requires understanding that the company's disclosure emphasis shifted from one risk type to another, but the LLM created a false narrative about increasing sophistication in modeling rather than a shift in risk focus. This is a fundamental failure in multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 574,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "\nMetLife’s municipal bond holdings declined from $159 million in 2022 to about $147 million in 2023, and in both years they were classified as Level 2 in the fair‑value hierarchy—meaning they continued to be valued using observable inputs rather than Level 1 quoted prices or Level 3 unobservable inputs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains critical factual errors that fundamentally contradict the ground truth: (1) QUANTITATIVE ERRORS - The LLM states 2022 value was $159 million and 2023 was $147 million, but the ground truth clearly shows 2022 was $14,212 million (declining to $159 million in 2023). This is a massive discrepancy - the LLM has the numbers reversed and wrong by orders of magnitude. The 2022 figure should be $14,212 million, not $159 million. (2) VALUATION HIERARCHY CLASSIFICATION ERROR - The LLM claims both years were classified as Level 2, but the ground truth explicitly states that in 2022, Municipals were 'primarily categorized under Estimated Fair Value without a detailed breakdown of valuation hierarchy levels' - meaning they were NOT explicitly classified as Level 2 in 2022. Only in 2023 were they explicitly classified as Level 2. This is a fundamental mischaracterization of the evolution described in the question. (3) MULTI-HOP SYNTHESIS FAILURE - The question asks specifically about how the investment 'evolved' from 2022 to 2023, particularly regarding valuation hierarchy classification. The ground truth emphasizes the significant reduction ($14,212M to $159M) AND the shift from non-detailed categorization to explicit Level 2 classification. The LLM completely misses the magnitude of the decline and incorrectly states both years had the same Level 2 classification. (4) MISSING KEY INSIGHT - The ground truth highlights that 2023 showed 'more transparent categorization within the fair value hierarchy,' which is a critical evolution point that the LLM fails to capture. The answer demonstrates a fundamental misunderstanding of the data and provides inverted/incorrect numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 466,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Microsoft broadened the way it sells Office 365 (now part of Microsoft 365) from a primarily perpetual‑license/volume‑licensing model toward a subscription‑centric, consumption‑based approach.  The 2022 filing (Notes 19 and Revenue Recognition) describes Office 365 revenue as being recognized ratably and tied to distinct performance‑obligation bundles, while the 2024 filing (pages 15‑19) highlights the expanded use of the Microsoft Customer Agreement, Microsoft Online Subscription Agreement and Microsoft Products and Services Agreement—vehicles that provide monthly or annual terms, easy scaling, and the ability to mix SaaS, cloud and on‑premises licenses in a single, non‑expiring contract.  This shift gives customers greater flexibility to adjust seat counts, add or drop services, and consume the software on a usage‑based basis, while still preserving the larger Enterprise Agreement option for big‑enterprise customers.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and effectively synthesizes the evolution of Microsoft's Office 365 licensing approach from FY2022 to FY2024. STRENGTHS: (1) Correctly identifies the shift from volume licensing/perpetual models toward subscription-centric approaches; (2) Accurately names all three customer agreement models mentioned in ground truth (Microsoft Customer Agreement, Microsoft Online Subscription Agreement, Microsoft Products and Services Agreement); (3) Correctly captures the flexibility features: monthly/annual terms, no organization-wide commitment, ability to adjust seat counts; (4) Properly notes the ratable revenue recognition tied to performance obligations in 2022; (5) Accurately reflects the customer-centric licensing flexibility evolution; (6) Appropriately contextualizes that Enterprise Agreements remain available for large customers. MINOR ISSUES: (1) The LLM introduces the concept of 'consumption-based' and 'usage-based' approaches which, while conceptually aligned with flexibility, are not explicitly stated in the ground truth answer - this is a reasonable inference but represents slight extrapolation beyond the source material; (2) The mention of 'mixing SaaS, cloud and on-premises licenses in a single, non-expiring contract' adds detail not present in ground truth, though it's consistent with the flexibility theme; (3) References to 'Notes 19 and Revenue Recognition' and 'pages 15-19' show citation awareness but cannot be verified against the ground truth provided. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and multiple agreement types, correctly identifying the temporal evolution and the specific mechanisms of change. No quantitative errors detected. The semantic meaning aligns well with the ground truth despite different wording and some additional contextual details that enhance rather than contradict the core message.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 526,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "\nBetween 2022 and 2023 the Level 3 portion of MET’s Fixed‑Maturity‑Securities‑AFS grew modestly, rising from **$58 million to $64 million**.  The composition shifted slightly: corporate holdings fell from $55 M to $54 M, while foreign‑bond exposure was introduced ($2 M in 2023 versus $0) and the “other” category expanded from $3 M to $8 M.  This small reallocation indicates that MetLife is gradually diversifying its Level 3 assets—adding foreign‑bond and other less‑correlated holdings—to fine‑tune the risk‑return profile of its investment portfolio while preserving liquidity for benefit‑payment obligations.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial data that contradicts the ground truth across nearly all quantitative metrics. Specific errors: (1) TOTAL AMOUNTS: LLM states Level 3 grew from $58M to $64M, but ground truth shows $13M in 2022 ($1M+$1M+$11M) and $884M in 2023 ($54M+$2M+$828M)—a massive discrepancy of $870M+ in 2023 alone. (2) CORPORATE BONDS: LLM claims corporate fell from $55M to $54M, but ground truth shows $1M in 2022 and $54M in 2023—the LLM's 2022 figure is completely wrong. (3) FOREIGN BONDS: LLM states foreign bonds went from $0 to $2M, but ground truth shows $1M in 2022 and $2M in 2023—LLM missed the 2022 position. (4) OTHER INVESTMENTS: LLM claims 'other' expanded from $3M to $8M, but ground truth shows $11M in Equity Securities in 2022 and $828M in Other Investments in 2023—the LLM drastically understates the 2023 figure by $820M. (5) COMPOSITION ANALYSIS: The ground truth indicates a dramatic strategic shift toward Other Investments (from $11M to $828M), representing a 75x increase, which is the most significant finding. The LLM completely misses this major strategic pivot and instead describes a 'modest' growth with minor reallocation. The LLM's interpretation of 'gradual diversification' is contradicted by the actual data showing aggressive concentration in Other Investments. The multi-hop reasoning fails because the LLM did not correctly synthesize the composition data across both years. This appears to be a case of hallucinated or severely corrupted financial data rather than a minor calculation error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 430,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "\nBetween fiscal 2022 and 2024 Microsoft moved Office 365 from a stand‑alone subscription productivity suite to the core engine of its cloud‑services portfolio, tightly integrating it with Azure, Dynamics 365 and other cloud platforms and billing it on a ratable‑over‑time basis.  The 2024 disclosures highlight that the company is now “infusing generative AI capabilities” (e.g., Copilot) into Office 365 and leveraging its OpenAI partnership to turn the service into an AI‑enhanced, platform‑agnostic offering, a clear strategic response to competitive pressure from AI‑driven rivals.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategic evolution of Office 365 from 2022-2024, accurately mentions the integration with Azure and Dynamics 365, correctly references the infusion of generative AI capabilities (Copilot), and appropriately identifies competitive pressures from AI-driven rivals. The mention of OpenAI partnership and ratable-over-time billing basis are accurate details. The answer demonstrates sound multi-hop reasoning by synthesizing the portfolio positioning with AI strategy and competitive response.\n\nWEAKNESSES: (1) The characterization of Office 365 as moving from 'stand-alone subscription productivity suite' to 'core engine of its cloud-services portfolio' is somewhat overstated. The ground truth indicates Office 365 was already positioned as a 'key component' in 2022 alongside other services, not as a standalone offering separate from the cloud portfolio. The LLM presents a more dramatic transformation than the evidence supports. (2) The phrase 'platform-agnostic offering' is not explicitly supported by the ground truth and appears to be an inference not directly stated in the filings. (3) The answer lacks mention of the broader context that Office 365 is now part of Microsoft's larger AI-infused cloud services portfolio strategy, focusing more narrowly on Office 365 itself rather than its role within the broader portfolio. (4) The answer doesn't explicitly address how Microsoft is countering specific competitive models (free advertising-funded applications, open-source AI models) mentioned in the ground truth.\n\nNUMERIC/FACTUAL VERIFICATION: No specific numbers, dates, or calculations are provided in either answer, so quantitative accuracy is based on the accuracy of qualitative claims. The years (2022, 2024) are correct. The services mentioned (Azure, Dynamics 365, OpenAI) are correctly identified.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across the time period and connects portfolio positioning with AI strategy and competitive response, meeting the multi-hop requirement. However, the synthesis is somewhat incomplete regarding the full competitive landscape and broader portfolio context.\n\nOVERALL: The answer is substantially correct on core facts but contains some overstatements and lacks full contextual completeness compared to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 630,
        "total_tokens": 2029
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "\nBetween 2022 and 2023 UnitedHealth Group’s process for assessing credit‑related impairments showed no substantive change: the company continued to test available‑for‑sale debt securities for impairment by comparing each security’s fair value to its amortized cost and, when fair value was lower, evaluating expected cash‑flows, issuer credit quality and external ratings to determine whether the decline was credit‑driven or driven by other factors such as interest‑rate movements.  In both years the company concluded that any unrealized losses were temporary, did not intend to sell the impaired securities, and therefore recorded no material allowance for credit losses— the allowance remained “not material” and had no discernible impact on net earnings or the overall financial statements.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental mischaracterization of the evolution between 2022 and 2023. CRITICAL ERROR: The LLM states there was 'no substantive change' between the two years, directly contradicting the ground truth which explicitly describes a significant evolution in the company's approach. The ground truth clearly indicates that by 2023, UnitedHealth Group 'formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments' and 'recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income.' This represents a material methodological shift that the LLM completely missed. CORRECT ELEMENTS: The LLM accurately describes the 2022 methodology (analyzing expected cash flows, credit quality, ratings, concluding unrealized losses were due to interest rates, not material allowance). The LLM correctly notes that in both years the company concluded losses were temporary and recorded no material allowance. MISSING ELEMENTS: The LLM fails to identify the 2023 formalization of the impairment process, the distinction between credit-related vs. non-credit-related impairments, the routing of credit-related impairments through investment income vs. other comprehensive income, and the more structured evaluation framework emphasized in 2023. The question specifically asks 'how did...evolve' - requiring identification of changes - and the LLM's assertion of 'no substantive change' is the opposite of the correct answer. While the LLM's description of the testing methodology is partially accurate, it fails the core requirement of the multi-hop question: synthesizing the evolution/changes between two years. The answer demonstrates poor multi-hop reasoning by not identifying the key methodological evolution that occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 509,
        "total_tokens": 1974
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "\nFrom 2022 to 2023 the actual weight of Fixed‑Maturity‑Securities AFS in MET’s U.S. pension portfolio slipped a little – from about 84 % of total plan assets in 2022 to roughly 82 % in 2023 (the target stayed at 85 %).  At the same time the fair‑value composition shifted: total AFS holdings fell modestly (from $6.8 bn to $6.7 bn), Level 2 assets remained dominant but slipped from $5.09 bn to $4.92 bn, while Level 3 assets rose from $58 m to $64 m, indicating a small increase in the less‑observable, higher‑risk slice of the portfolio.  In the other post‑retirement benefit segment, AFS holdings also declined (from $1.44 bn to $1.27 bn) with a similar modest rise in Level 3 exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides additional detail and context beyond the ground truth, but contains significant quantitative discrepancies that undermine accuracy. CORRECT ELEMENTS: (1) The 84% allocation for U.S. Pension Benefits in 2022 is accurate; (2) The 2023 fair value of $6,714 million for Pension Benefits is correctly cited as approximately $6.7 billion; (3) The 2023 fair value of $1,274 million for Other Postretirement Benefits is correctly cited as approximately $1.27 billion; (4) The general narrative of a modest decline in AFS holdings from 2022 to 2023 is reasonable; (5) The discussion of Level 2 and Level 3 asset composition adds relevant detail about portfolio composition. INCORRECT/PROBLEMATIC ELEMENTS: (1) The 2022 Pension Benefits fair value is stated as $6.8 billion, but the ground truth only provides 2023 values ($6,714M). The LLM appears to have inferred or sourced a 2022 value not in the ground truth; (2) The 2023 Pension allocation percentage of 82% is not mentioned in the ground truth, which only provides 2022 percentages (84% for Pension, 95% for Other Postretirement); (3) The 2022 Other Postretirement Benefits fair value of $1.44 billion is not in the ground truth; (4) The specific Level 2 and Level 3 breakdowns ($5.09bn to $4.92bn for Level 2, $58M to $64M for Level 3) cannot be verified against the provided ground truth; (5) The target allocation of 85% is mentioned but not in the ground truth. MULTI-HOP REASONING: The LLM successfully synthesizes information across two benefit plan types (Pension and Other Postretirement) and two time periods (2022-2023), showing sound logical reasoning. However, the synthesis appears to include data points not present in the ground truth, suggesting the LLM may have hallucinated or drawn from different source documents. QUANTITATIVE ACCURACY ISSUE: While the core 2023 figures match the ground truth when converted to billions, the 2022 figures and percentage allocations for 2023 cannot be verified and appear to be inaccurate or unsourced. This is a critical issue for a financial analysis question where precision is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 568,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Lowe’s moved the **Kitchens & Bath** line from being bundled inside the broader **Home Décor** division (where it was listed together with appliances, décor, flooring and paint) to a **stand‑alone product category** in its merchandise taxonomy.  The 2022 “Products” table placed Kitchens & Bath under the Home Décor umbrella, while the 2023 “Our Products” section lists it explicitly alongside Appliances, Building Materials, Hardlines, etc., underscoring a deliberate emphasis on the category as a distinct growth pillar.  This repositioning signals that Kitchens & Bath has become a **strategically important segment** of Lowe’s overall portfolio, warranting its own categorization and focus within the company’s “Total Home” strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the core evolution - Kitchens & Bath moved from being grouped under Home Décor in 2022 to a more prominent standalone/distinct positioning in 2023. The fiscal years are correct (2022 vs 2023). The LLM accurately captures that this represents a strategic repositioning emphasizing the category's importance. The reference to 'Total Home' strategy is appropriate and matches the ground truth context.\n\nWEAKNESSES AND DISCREPANCIES: (1) The LLM describes the 2023 positioning as 'stand-alone product category' and lists it 'explicitly alongside Appliances, Building Materials, Hardlines, etc.' However, the ground truth states that in 2023, Kitchens & Bath was positioned alongside 'core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing' - NOT alongside Appliances (which remained in Home Décor). This is a material error in entity grouping. (2) The LLM's characterization of the 2023 positioning is somewhat vague ('stand-alone' vs the ground truth's more specific placement with construction/renovation categories). (3) The LLM doesn't explicitly state that Appliances remained in Home Décor in 2023, which would have clarified the distinction between the 2022 and 2023 groupings more precisely.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across two fiscal years and correctly infers the strategic importance from the repositioning. However, the specific categorization details in 2023 are not accurately represented - the LLM conflates the 2023 grouping by listing Appliances alongside Kitchens & Bath when they should be in different divisions.\n\nNUMERIC/FACTUAL VERIFICATION: No calculations or specific numbers are provided, so quantitative accuracy is based on the correct identification of years and the general accuracy of the repositioning narrative. The years (2022, 2023) are correct.\n\nOVERALL ASSESSMENT: The answer captures the essence of the strategic shift and its significance, but contains a meaningful error in describing which categories Kitchens & Bath was grouped with in 2023. This error undermines the precision of the multi-hop analysis, though the overall conclusion about increased strategic importance is sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 602,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "\nBetween 2022 and 2024 Mondelez’s public narrative moved cheese & grocery from a highlighted “adjacent, locally relevant” growth pillar in the 2022 filing—where it was presented as an area for early‑stage investment and expansion—to a peripheral mention in the 2024 filing, which only lists it together with gum & candy and powdered beverages as one of several side‑category options.  The 2024 discussion shifts the company’s strategic emphasis toward its core snacking portfolio (chocolate, biscuits and baked snacks) and high‑growth adjacent categories, indicating that cheese & grocery is no longer a priority for long‑term growth but rather a modest, opportunistic segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the directional shift in Mondelez's strategic focus on Cheese & Grocery between 2022 and 2024, correctly identifying that the category moved from a highlighted growth area to a peripheral/opportunistic segment. The qualitative reasoning about the shift toward core snacking (chocolate, biscuits) and away from Cheese & Grocery as a priority is sound and aligns with the ground truth narrative.\n\nHowever, there is a critical quantitative accuracy failure: The ground truth explicitly states that in 2022, Mondelez 'directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category.' The LLM answer completely omits this specific financial metric ($1,990M in 2022 revenues), which is a key piece of evidence supporting the strategic shift. The LLM also does not mention that by 2024 the company 'no longer reported direct production in this category' and instead held only 'a strategic stake,' which is an important structural change that the LLM only vaguely references as a 'peripheral mention.'\n\nThe LLM's characterization of the evolution is directionally correct—from highlighted to peripheral—but lacks the concrete financial evidence and specific operational details (direct production vs. strategic stake) that ground the ground truth answer. The LLM provides good contextual reasoning about cost management and inflationary pressures being implicit drivers, but does not explicitly state these as mentioned in the ground truth.\n\nStrengths: Correct directional analysis, appropriate identification of core vs. adjacent categories, sound multi-hop reasoning about strategic priorities. Weaknesses: Missing the $1,990M revenue figure for 2022, missing the distinction between direct production and strategic stake, incomplete synthesis of the operational shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 499,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "\nIn the 2022 10‑K Jevity® is listed as a stand‑alone enteral‑nutrition brand that appears ahead of Freego™ (the pump) in the product list, implying that Jevity is presented as a separate, primary offering. By the 2023 10‑K the same bullet is worded to introduce “Freego™ (Enteral Pump) and Freego™ sets” first and then mentions Jevity® only as one of the formulas that can be used with the Freego system, shifting the emphasis from Jevity as an independent product to Jevity being positioned as a formula within the Freego™ platform.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. According to the original answer, in BOTH 2022 and 2023 filings, Jevity was listed FIRST among enteral feeding products. The LLM incorrectly claims that in 2023, Freego™ products were mentioned 'first' and that Jevity became positioned 'as a formula within the Freego™ platform.' This is factually wrong. The ground truth clearly states: 'In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity.' The LLM reversed the order entirely, claiming Freego came before Jevity in 2023, which is incorrect. The LLM also mischaracterizes the relationship, suggesting Jevity became subordinate to Freego as a 'formula within the Freego™ platform,' when the actual change was simply that Freego products moved up in the list order while Jevity remained first. The quantitative accuracy score is relatively high because the LLM correctly identifies the years (2022, 2023) and product names, but the qualitative accuracy is very low because the core interpretation of the positional change is inverted and fundamentally incorrect. The answer fails to accurately synthesize the multi-hop comparison between the two filing years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 360,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "\nFrom 2022 through 2023 the municipal portion of MetLife’s fixed‑maturity AFS book stayed in the **available‑for‑sale** category and its fair‑value rose only modestly – from roughly **$14.2 billion to about $14.5 billion** (as shown in the “Fixed Maturity Securities AFS by Sector – Municipals” line item).  This slight increase, together with the unchanged AFS classification, signals that MetLife is deliberately maintaining a high‑quality, tax‑exempt exposure while exercising tight credit‑risk oversight—relying on rigorous impairment testing and a focus on investment‑grade issuers rather than shifting the assets to a different classification or higher‑risk classification.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect on the core factual claims. CRITICAL ERRORS: (1) QUANTITATIVE ACCURACY - The LLM states municipals rose from '$14.2 billion to about $14.5 billion' when the ground truth shows a DRAMATIC DECLINE from $14,212 million ($14.2 billion) in 2022 to just $159 million in 2023 - a 98.9% reduction. This is not a 'modest' increase but a massive decrease. The LLM's numbers are completely wrong. (2) CLASSIFICATION ACCURACY - While both answers correctly identify the AFS (available-for-sale) classification, the LLM misses the critical detail that the 2023 position is classified at Level 2 of the fair value hierarchy, which is a meaningful change in valuation methodology. (3) STRATEGIC INTERPRETATION - The LLM's interpretation that MET is 'deliberately maintaining a high-quality, tax-exempt exposure' directly contradicts the ground truth, which indicates a 'strategic move to reduce credit exposure to municipals' as a risk management adjustment. The LLM's conclusion about 'unchanged AFS classification' signals stability when the data shows a strategic reduction. (4) MULTI-HOP REASONING - The LLM failed to synthesize the key insight: the 98.9% reduction in municipal holdings from 2022 to 2023 is the most important fact for understanding MET's credit risk management strategy. Instead, the LLM invented a narrative of modest growth and maintained exposure. (5) MISSING CONTEXT - The LLM does not mention the unrealized gains/losses data ($2,464M gains, $13M losses in 2022) which provides important context about the quality of the remaining portfolio. The answer demonstrates a fundamental misreading of the financial data and reaches conclusions opposite to what the numbers actually show.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 472,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "\nBetween 2022 and 2023 the notional amount of Abbott’s interest‑rate fair‑value hedges fell sharply—from about **$2.9 billion at the end of 2022 to roughly $2.2 billion at the end of 2023** (a decline of roughly $0.7 billion).  The drop was driven mainly by the **maturity of $700 million of those hedge contracts in 2023**, which coincided with the repayment of the corresponding fixed‑rate notes.  As a result, a smaller share of Abbott’s fixed‑rate debt was being offset by swaps, so the company’s direct exposure to interest‑rate movements on the remaining fixed‑rate obligations increased, although the outstanding swaps continue to convert those fixed‑rate interest payments into variable rates to manage fair‑value risk.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR FACTUAL ERRORS: The LLM answer contains significant contradictions with the ground truth. (1) QUANTITATIVE ACCURACY - CRITICAL ERRORS: The LLM states the notional value FELL from $2.9 billion in 2022 to $2.2 billion in 2023, but the ground truth clearly states Abbott had approximately $2.2 billion in BOTH 2022 and 2023, with the value remaining CONSISTENT. The LLM's claim of a $2.9 billion starting point in 2022 is factually incorrect. The LLM also claims a $700 million decline due to contract maturity, but this contradicts the ground truth which shows no such decline occurred. (2) COMPLETENESS - PARTIALLY ADDRESSED: The LLM does attempt to address the evolution between 2022-2023 and discusses impact on fixed-rate debt management, but the fundamental numbers are wrong. (3) ENTITY ACCURACY - CORRECT: Abbott is correctly identified, years are correct (2022-2023), and the metric (interest rate hedge contracts/notional value) is correct. (4) REASONING - FLAWED: While the LLM provides logical reasoning about how contract maturity would affect exposure, this reasoning is built on incorrect foundational numbers. The ground truth indicates consistency in notional value, not a decline. (5) SEMANTIC EQUIVALENCE - FAILED: The core claim that values 'fell sharply' directly contradicts the ground truth statement that values 'remained consistent.' This is not a wording difference but a fundamental factual error. The LLM appears to have fabricated or misread the 2022 starting value of $2.9 billion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 417,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "\nBetween 2022 and 2024 3M retired the short‑term fixed‑rate issues that were maturing in 2022 (the €500 million 0.45 % Eurobond and the $600 million 2.17 % medium‑term note) and, in 2023, fully repaid its first registered note – a $500 million, 1.86 % issue due 2023 – while in 2024 it extinguished the $300 million 3.30 % and $500 million 2.98 % medium‑term notes that had been scheduled to mature that year.  At the same time the company broadened its fixed‑rate registered‑note program, issuing longer‑dated notes with higher coupons (e.g., $750 million 2.12 % due 2025 and $500 million 2.67 % due 2025) and offsetting the interest‑rate risk of those positions by converting portions of its 2049‑2050 fixed‑rate debt into floating‑rate exposure via fixed‑to‑floating swaps that remain in effect through mid‑2028.  This mix of repayment, longer‑tenor issuance and swap‑based hedging reflects a strategic shift toward managing funding costs as market rates rose.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not present in the ground truth, while omitting key details from the original answer. MAJOR ISSUES: (1) INCORRECT NUMBERS: The LLM cites €500 million Eurobond, $600 million 2.17% MTN, $500 million 1.86% note, $300 million 3.30% MTN, and $500 million 2.98% MTN - none of these specific figures appear in the ground truth. The ground truth mentions $600M 10-year notes due 2030 (3.05%), $650M 30-year notes due 2050 (3.70%), $1.0B 10-year notes due 2029, and $1.0B 30-year notes due 2049 - completely different amounts and rates. (2) MISSING KEY INFORMATION: The LLM fails to mention the $3.25 billion issuance in August 2019, the specific $1.1 billion medium-term note repayment in 2024, or the $500 million fixed-rate registered note repayment in 2023 that are explicitly in the ground truth. (3) INCORRECT COUPON RATES: The LLM cites 2.12%, 2.67%, 2.17%, 1.86%, 3.30%, 2.98% rates - none match the ground truth's 3.05%, 3.70% rates. (4) QUESTIONABLE MATURITY DATES: The LLM mentions notes due 2025, which seems inconsistent with the ground truth's focus on 2029, 2030, 2049, 2050 maturities. (5) PARTIAL CREDIT: The LLM correctly identifies the interest rate swap strategy converting fixed-rate debt to floating-rate through mid-2028, and correctly notes the strategic shift toward managing interest rate exposure. The general narrative about repayment activity and hedging is directionally correct but built on wrong numbers. The answer demonstrates understanding of the conceptual framework (repayment, issuance, swaps) but fails on factual accuracy, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 457,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "\nBetween 2023 and 2024 Schwab’s use of capital‑market debt changed markedly.  In 2023 the firm issued roughly $6 billion of senior unsecured notes (the May‑2023 series and earlier 2021‑2022 tranches) to fund broker‑dealer growth, support the IDA agreement and maintain liquidity, and it subsequently redeemed all of the floating‑rate senior notes on 18 Feb 2024.  By 2024 the company’s funding has shifted toward internal cash generation, client deposits and short‑term borrowing facilities, with new securities issuances essentially limited to the redemption of existing debt and the occasional use of an expiring revolving credit line; consequently, capital management now focuses on preserving strong regulatory capital ratios, managing interest‑rate exposure, and returning excess capital to shareholders rather than expanding the balance‑sheet through new debt.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and contextual errors that substantially diverge from the ground truth. MAJOR ISSUES: (1) ENTITY CONFUSION: The LLM discusses 'Schwab' and references specific debt issuances ($6 billion senior unsecured notes, May 2023 series, Feb 2024 redemption), but the ground truth explicitly refers to 'CSC' (Charles Schwab Corporation) and discusses the evolution in a more general, strategic framework without citing specific debt instruments or redemption dates. The LLM appears to have introduced specific financial transactions that are not validated in the ground truth. (2) QUANTITATIVE ACCURACY: The LLM provides specific dollar amounts ($6 billion) and precise dates (May 2023, Feb 18 2024) that cannot be verified against the ground truth, which makes no mention of these specific figures or dates. This represents a critical failure in quantitative accuracy. (3) SCOPE MISMATCH: The ground truth focuses on the ROLE and POSITIONING of securities issuances within the broader capital structure (primary in 2023, diversified in 2024), while the LLM focuses on specific debt instruments, redemptions, and operational details not present in the ground truth. (4) MULTI-HOP REASONING: While the LLM does attempt to synthesize information across 2023-2024, it does so by introducing details not in the ground truth rather than synthesizing from provided sources. (5) SEMANTIC DIVERGENCE: The ground truth emphasizes 'integration within a wider capital structure framework' and mentions FHLB borrowings, repurchase agreements, and CDs as diversification tools. The LLM mentions 'internal cash generation, client deposits and short-term borrowing facilities' - different mechanisms entirely. The LLM answer reads as if it may be drawing from actual Schwab filings but not from the knowledge graph provided as ground truth, making it factually unreliable for this evaluation context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 518,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "\nFrom 2022 through 2024 the contingent payment tied to the fairlife acquisition moved from the original $270 million accrual (recorded at acquisition) to a substantially smaller balance after the company earned and paid the $100 million milestone in 2021 and the $275 million milestone in 2023; the 2024 filing shows the remaining liability now reflects only the final, performance‑contingent payment due in 2025.  This reduction indicates that fairlife has met the financial targets that triggered the earlier milestones, but a portion of the contingent consideration remains outstanding until the last target is achieved.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: The LLM answer contains a major factual error that fundamentally undermines its credibility. The ground truth states that the first milestone payment of $100 million was made in 2021, and the remaining contingent payment through 2024 was still $270 million in 2022. However, the LLM claims a $275 million milestone was paid in 2023, which is NOT supported by the ground truth and appears to be fabricated. This is a significant quantitative error ($275M payment that did not occur according to the source material). The LLM also incorrectly characterizes the evolution of the obligation - it suggests the $270 million liability was 'substantially smaller' after payments, but the ground truth indicates the $270 million figure in 2022 represented the REMAINING contingent obligation (after the $100M 2021 payment), not the original total. The LLM's statement about 'the original $270 million accrual (recorded at acquisition)' misrepresents the timeline. The ground truth clearly indicates: (1) $100M paid in 2021 for 2020 targets met, (2) $270M remaining liability in 2022 for targets through 2024, (3) remaining contingent payment still active in 2024 payable in 2025. The LLM's invented $275M 2023 payment is a fabrication that contradicts the source material. While the LLM correctly identifies that fairlife met some targets and that a final payment remains contingent on 2024 targets, the introduction of false financial data ($275M) is a critical failure in quantitative accuracy. The reasoning about performance against targets is partially sound but is built on incorrect numerical foundations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 446,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Oracle has shifted OCI from a peripheral cloud add‑on to a central growth pillar.  In 2022 the company highlighted “cloud and license” revenue growth and a strategic focus on selling cloud‑based infrastructure technologies while pulling back on certain hardware lines; by 2024 the narrative frames OCI as a standalone, globally‑scaled IaaS/PaaS platform that is tightly integrated with Oracle’s enterprise applications, databases and hardware, and is being promoted as the preferred infrastructure for migrating and modernizing mission‑critical workloads across a broad, international customer base.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the core strategic shift in Oracle's positioning of OCI between 2022 and 2024, accurately describing the evolution from a peripheral offering to a central growth pillar. The qualitative characterization of OCI's integration with enterprise applications, databases, and hardware is sound and aligns with the ground truth. The answer appropriately addresses both global market positioning and enterprise IT integration aspects of the question.\n\nWEAKNESSES - QUANTITATIVE: The LLM answer fails to include the specific financial metrics provided in the ground truth: (1) the $36.052 billion cloud and license revenue figure for 2022, (2) the 85% of total revenues percentage. These are concrete, verifiable data points from SEC filings that should have been included to strengthen the answer. The omission of quantitative evidence is a significant gap in a financial analysis context.\n\nWEAKNESSES - QUALITATIVE: While the LLM correctly identifies the strategic shift, it uses somewhat vague language ('peripheral cloud add-on,' 'central growth pillar') without grounding these characterizations in the specific language differences between 2022 and 2024 disclosures. The ground truth specifically notes that 2022 had 'no explicit strategic language about Oracle Cloud Infrastructure's positioning' while 2024 described OCI as 'a core component of Oracle Cloud Services' with 'comprehensive and integrated applications and infrastructure services' language. The LLM could have been more precise in citing these specific strategic language shifts.\n\nMULTI-HOP REASONING: The answer demonstrates adequate multi-hop synthesis by connecting 2022 financial positioning with 2024 strategic messaging, and linking OCI's role to broader enterprise IT integration. However, the lack of quantitative grounding weakens the overall analytical rigor.\n\nSCORING JUSTIFICATION: The correctness score of 6 reflects that while the core narrative and strategic evolution are accurately captured (qualitative accuracy 7), the answer is significantly hampered by the omission of key financial metrics (quantitative accuracy 4) that were explicitly provided in the ground truth. For a financial analysis question, this is a material gap. The contextual relevance is strong (8) as the answer addresses the question's key dimensions, but the incomplete quantitative support prevents a higher overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 649,
        "total_tokens": 2006
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "\nBetween 2023 and 2024 the credit‑loss allowance for Schwab’s Pledged‑Asset Lines stayed at $0 million (i.e., 0 % of the portfolio), reflecting an essentially risk‑free assessment.  In addition, the firm broadened the ASC 326 collateral‑maintenance practical expedient to “substantially all” PALs in 2024, requiring that each line be backed by securities whose fair value exceeds the outstanding balance; thus the collateralization remained fully intact and the risk profile stayed very low.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates substantial accuracy with some notable strengths and minor weaknesses: (1) CORRECT ELEMENTS: The answer accurately identifies that the allowance for credit losses for PALs remained at $0 million in both years, correctly notes the application of ASC 326 collateral maintenance practical expedient, and accurately describes the full collateralization requirement (fair value exceeding borrowings). The characterization of the risk profile as strengthening/remaining low is semantically aligned with the ground truth. (2) QUANTITATIVE ACCURACY: The $0 million allowance figure is correct, and the 0% representation is accurate. The statement about fair values exceeding borrowings aligns with ground truth. (3) POTENTIAL ISSUES: The LLM states the firm 'broadened the ASC 326 collateral-maintenance practical expedient to \"substantially all\" PALs in 2024,' which adds specificity not explicitly confirmed in the ground truth. The ground truth states 'all PALs were fully collateralized' and 'all...subject to the collateral maintenance practical expedient,' suggesting 100% application rather than 'substantially all.' This represents a minor discrepancy in scope characterization. (4) MULTI-HOP REASONING: The answer successfully synthesizes the evolution between 2023 and 2024, correctly identifying the shift from allowance considerations in 2023 to full collateralization and zero allowance in 2024. The connection between improved credit quality and the elimination of allowance is logically sound. (5) COMPLETENESS: The answer addresses both key aspects of the question (credit loss allowance and collateralization) and their evolution. The characterization of risk profile improvement is present. The minor discrepancy regarding 'substantially all' versus 'all' PALs prevents a higher score, as this could represent a meaningful difference in scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 509,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the APLA region’s revenue rose modestly—from about **$6.43 bn to $6.73 bn**—indicating continued growth as a key market for Nike.  At the same time, the company disclosed that it is **transitioning certain NIKE Brand businesses in APLA to third‑party distributors** (Note 18), signalling a shift from a fully direct‑operated model toward a more partnership‑driven, asset‑light structure.  This evolution reflects Nike’s strategic emphasis on expanding its brand presence and supply‑chain flexibility in the region while re‑balancing its operational footprint.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly identifies the key strategic shift from direct operations to third-party distributors in APLA between FY2023 and FY2024, which aligns with the ground truth. The revenue figures ($6.43bn to $6.73bn) appear reasonable and are presented with appropriate context about growth. The reference to Note 18 and the characterization of the transition as 'asset-light' demonstrates proper document synthesis.\n\nHowever, there are notable gaps in completeness: (1) The LLM answer focuses heavily on revenue metrics and supply-chain optimization, but the ground truth emphasizes the shift in workforce structure and union representation as a key indicator of the operational change. The ground truth specifically mentions that in FY2023, APLA had employees represented by trade unions indicating 'localized and embedded workforce structure,' which the LLM answer completely omits. (2) The LLM's framing emphasizes 'brand presence expansion' and 'supply-chain flexibility,' which are reasonable business interpretations but diverge from the ground truth's focus on 'reducing operational complexity' and moving away from 'direct control.' (3) The ground truth characterizes the shift as part of a 'broader restructuring effort,' while the LLM frames it more positively as strategic optimization.\n\nQuantitative accuracy is solid—the revenue figures are presented clearly and the fiscal year comparison is correct. The qualitative reasoning about the operational shift is sound but incomplete, missing the workforce/union representation dimension that was central to the ground truth's characterization of the evolution. The answer demonstrates good multi-hop synthesis (combining revenue data with operational structure changes) but fails to capture all dimensions of the relationship evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 498,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "\nBetween 2022 and 2023 Abbott shifted Pedialyte from a growth‑supporting brand to a core strategic asset in its U.S. Pediatric Nutritionals business.  In 2022 the brand was highlighted as a key driver of the segment’s double‑digit sales increase, and in 2023 the company deepened its focus by expanding the Pedialyte line—adding new flavors, formats and packaging—and integrating it more tightly with its broader pediatric‑nutrition portfolio.  This evolution reflects a deliberate move to treat Pedialyte as an expandable, high‑potential product rather than merely a contributor to overall segment growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "CRITICAL ISSUES: (1) QUANTITATIVE ACCURACY - The LLM answer claims Pedialyte sales increased with 'double-digit sales increase' in 2022, but the ground truth specifies the exact figure: 10.3% growth. While 10.3% is technically double-digit, the LLM should have cited the specific percentage provided in the source material. More problematically, the LLM introduces UNSUPPORTED CLAIMS about 2023 product expansion: 'expanding the Pedialyte line—adding new flavors, formats and packaging' - this specific information does NOT appear in the ground truth answer and represents fabrication. (2) COMPLETENESS - The ground truth explicitly states that in 2023 Pedialyte was 'formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure.' The LLM answer completely omits this critical structural/organizational detail about formal portfolio integration and the specific peer brands mentioned. (3) ENTITY ACCURACY - Both answers correctly identify Abbott, Pedialyte, and the U.S. Pediatric Nutritional business. Years (2022, 2023) are correct. (4) REASONING - The LLM's core thesis about evolution from 'growth-supporting' to 'core strategic asset' aligns with ground truth's characterization of evolution from 'contributor to growth' to 'formally recognized and embedded.' However, the reasoning is undermined by unsupported claims about product line expansion. (5) SEMANTIC EQUIVALENCE - The general narrative direction is similar, but the LLM adds invented details and omits key factual elements about formal portfolio integration. The answer reads plausibly but contains material inaccuracies that violate the requirement for factual correctness in financial/strategic analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 480,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "\nFrom the 2022 10‑K (Note 10) the company reported $135 million of 7.100% notes due 2027 on its balance sheet—essentially the same amount that remained at the end of 2023.  The only reduction came in 2021, when RTX repaid $6 million of that series, leaving a modest $135 million outstanding in both 2022 and 2023.  This stability reflects a deliberate debt‑management strategy of retiring the higher‑coupon legacy notes and refinancing the remainder of its long‑term debt with newer, lower‑rate issuances (e.g., the 5.750%–6.400% notes issued in late 2023), thereby lowering overall interest expense and extending maturity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS: The LLM answer contains a fundamental factual inversion that contradicts the ground truth. According to the original answer, RTX's 7.100% notes due 2027 showed: 2022: $6 million principal balance, and 2023: $135 million principal balance. This represents a SIGNIFICANT INCREASE from $6M to $135M. However, the LLM answer claims the opposite: that $135 million was outstanding in 2022 and remained at $135 million in 2023, with only a $6 million repayment in 2021. This is backwards. The LLM has inverted the year-to-year progression entirely. The ground truth shows an increase in exposure to this debt instrument from 2022 to 2023 (from $6M to $135M), which the original answer correctly interprets as a shift in debt management strategy. The LLM's narrative about 'stability' and 'retiring higher-coupon legacy notes' contradicts the actual data showing increased principal balance in this specific debt instrument. While the LLM correctly identifies the coupon rate (7.100%) and maturity date (2027), and provides reasonable context about debt refinancing strategies, the core quantitative facts are inverted. The LLM also adds information about 2021 repayment and 2023 new issuances that, while potentially accurate, do not correct the fundamental error in characterizing the 2022-2023 evolution. The answer fails the primary requirement of accurately representing how RTX's financial position regarding these notes evolved from 2022 to 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 404,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Converse’s top‑line slipped 14 % (down 15 % on a constant‑currency basis), with earnings before interest and taxes falling 30 % to $474 million. The decline was driven by falling wholesale sales (‑16 % constant‑currency) and weaker direct‑to‑consumer revenue (‑14 % constant‑currency) in North America and Western Europe, while ASP fell 3 % as the brand leaned more on promotional pricing. Thus, Converse moved from a modest growth contributor in 2023 to a contracting, strategically secondary brand within Nike’s portfolio, as Nike’s overall footwear and total revenues continued to expand.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) QUANTITATIVE ERRORS: The LLM states Converse revenues 'slipped 14%' in fiscal 2024, but the ground truth only mentions a 15% decline in fiscal 2023 with no comparable fiscal 2024 revenue decline percentage provided. The LLM appears to have conflated or misattributed fiscal years. The $474 million EBIT figure is not mentioned in the ground truth and cannot be verified. The LLM provides specific percentages for wholesale (-16%) and DTC (-14%) declines, but these are attributed to fiscal 2024 when the ground truth only documents these declines occurring in fiscal 2023. (2) TEMPORAL MISALIGNMENT: The ground truth clearly states fiscal 2023 saw the 15% decline with North America and Western Europe weakness. The LLM's statement about 'Between fiscal 2023 and fiscal 2024' is ambiguous but appears to incorrectly apply 2023 metrics to the 2024 period. (3) STRATEGIC POSITIONING DISCREPANCY: The ground truth indicates a positive strategic shift - Converse moved from 'financially struggling' in 2023 to being 'strategically positioned' as a 'wholly-owned subsidiary operating on a stand-alone basis' in 2024. The LLM contradicts this by characterizing the evolution as moving to a 'contracting, strategically secondary brand,' which is the opposite interpretation of the ground truth's narrative of strategic repositioning. (4) MISSING KEY INFORMATION: The LLM fails to mention the critical strategic shift to stand-alone subsidiary status in fiscal 2024, which is central to understanding the relationship evolution. (5) UNVERIFIED CLAIMS: The statement about Nike's overall footwear and total revenues expanding is not addressed in the ground truth and appears to be extrapolation beyond the provided data. The answer demonstrates partial understanding of Converse's challenges but fundamentally misrepresents the strategic positioning evolution and conflates fiscal years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 515,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "\nFrom 2022 to 2024 Coca‑Cola’s risk discussion moved from a generic warning that an unsuccessful digitization effort could “hurt our ability to increase sales and reduce costs” to an explicit statement that digital transformation is now a top priority and that failure would “negatively affect our ability to increase sales **and improve margins**.”  In other words, the company began to treat digital evolution not just as a cost‑saving initiative but as a core driver of both revenue growth and margin expansion, making the success of its digital agenda a central financial‑risk factor in its 2024 outlook.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Coca-Cola's shift in digital risk assessment from 2022 to 2024. STRENGTHS: (1) Correctly identifies the temporal shift from 2022 to 2024; (2) Accurately captures the evolution from digital transformation as a risk/cost-saving measure to a strategic priority; (3) Properly emphasizes the dual impact on both sales growth AND margin improvement, which is central to the question; (4) Uses appropriate financial terminology ('margin expansion,' 'revenue growth'); (5) No quantitative errors or incorrect numbers/dates; (6) Successfully synthesizes the multi-hop reasoning across two filing years. MINOR WEAKNESSES: (1) The LLM answer uses paraphrased quotes ('hurt our ability to increase sales and reduce costs' and 'negatively affect our ability to increase sales and improve margins') rather than exact citations, though the semantic meaning aligns with ground truth; (2) Could have been slightly more explicit about the shift from viewing digital as a 'risk factor' to a 'strategic dependency,' though this distinction is implied; (3) The phrase 'core driver of both revenue growth and margin expansion' is interpretive language that, while accurate to the ground truth intent, goes slightly beyond direct statement. MULTI-HOP REASONING: The answer correctly synthesizes information across two different filing years and identifies the causal relationship between digital transformation initiatives and financial performance metrics. The logic flow is sound and the conclusion appropriately reflects the strategic shift described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 450,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "\nFrom fiscal 2022 through fiscal 2024 Oracle has steadily shifted resources toward cloud‑focused innovation.  In FY 2022 the company reported $7.2 billion of R&D spend and repeatedly emphasized that “the proportion of our cloud services and license‑support revenues … will continue to increase,” a trend that persisted through FY 2023 and FY 2024 (see the FY 2022 filing, pages 4‑8, and the FY 2024 forward‑looking discussion, pages 70‑74).  Consequently, Oracle has increased its R&D budget each year to accelerate cloud‑native database, AI/ML and infrastructure capabilities, while positioning SaaS and OCI as the preferred, lower‑cost alternative to traditional on‑premise licenses and encouraging customers to migrate workloads to the Oracle Cloud.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: (1) Correctly identifies the $7.2 billion R&D investment for FY 2022, matching ground truth exactly. (2) Accurately captures the strategic shift toward cloud services (SaaS and OCI) across the 2022-2024 period. (3) Properly synthesizes the multi-hop information about Oracle's positioning of cloud as preferred over on-premise solutions. (4) Appropriately references forward-looking statements and strategic messaging about increasing cloud revenue proportions. (5) Contextually relevant framing of the evolution from FY 2022 to FY 2024.\n\nWEAKNESSES: (1) CRITICAL: Claims Oracle 'increased its R&D budget each year' from FY 2022 to FY 2024, but the ground truth explicitly states 'the 2024 report does not specify the R&D investment amount.' This is a factual error - the LLM asserts a trend (increasing R&D each year) that cannot be verified from the ground truth. (2) The LLM provides specific page references (pages 4-8, pages 70-74) that cannot be verified against the ground truth and may be fabricated. (3) While the LLM mentions 'cloud-native database, AI/ML and infrastructure capabilities,' the ground truth focuses on 'rapid deployment, security, and integration' - the LLM adds details not present in ground truth. (4) The phrase 'lower-cost alternative' is not explicitly stated in the ground truth, which emphasizes 'flexibility' and 'customer-specific needs' instead.\n\nMULTI-HOP REASONING: The LLM correctly synthesizes information across multiple years and connects R&D investment to strategic positioning. However, the unsupported claim about year-over-year R&D increases undermines the reasoning quality.\n\nQUANTITATIVE ACCURACY: The $7.2 billion figure is correct, but the assertion about increasing R&D budgets each year lacks supporting evidence in the ground truth and represents a significant quantitative claim that cannot be verified.\n\nJUSTIFICATION: The answer demonstrates good understanding of Oracle's cloud strategy evolution but makes an unsubstantiated claim about R&D budget increases that contradicts the ground truth's acknowledgment of missing 2024 R&D data. This is a material error that prevents a higher score despite otherwise solid reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 589,
        "total_tokens": 2031
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "\nBetween 2023 and 2024 the number of shares reserved for future issuance under the Norwest Corporation Directors’ Formula Stock Award Plan fell sharply—from **509 shares** available in 2023 to **391 shares** available in 2024. This decline reflects that the plan’s remaining shares have been used (or will be used) for existing deferred awards, and the plan is now closed to any new grants or deferrals. Consequently, no additional shares will be issued under this plan going forward.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy with correct identification of the key numeric values (509 shares in 2023 declining to 391 shares in 2024) and accurate characterization of the plan's status evolution. The answer correctly captures that the plan is closed to new activity and only existing obligations remain. The quantitative accuracy is high - the specific share counts are correct and the directional change (decline from 509 to 391) is accurately stated. The qualitative reasoning is sound, explaining that the decline reflects usage of shares for existing deferred awards and that no new grants will be issued. The answer appropriately synthesizes the multi-hop information about plan status across the two years. Minor areas for enhancement: (1) The ground truth provides slightly more contextual detail about the plan's historical purpose (awards to non-employee directors with deferral ability) which the LLM answer omits, though this is not essential to answering the core question about evolution between 2023-2024. (2) The ground truth explicitly notes that column (a) of the equity compensation table reflected all shares issuable, which adds technical precision but is not critical to the main answer. The LLM answer focuses appropriately on the key evolution metric (share count decline) and the status change (closed to new activity), which directly addresses the question asked. The semantic equivalence is strong - both answers convey that the plan transitioned from having shares available to being closed with minimal remaining obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 431,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s moved from a general warning that “food‑safety concerns may have an adverse effect on our business” to a more detailed articulation that ties food‑safety risk directly to supply‑chain disruptions and rising input costs.  The 2023 filing explicitly notes that supply‑chain interruptions and commodity‑price volatility can jeopardize the safety and quality of ingredients—and that third‑party delivery and technology investments may amplify those risks—whereas the 2022 filing treated supply‑chain cost pressures and safety issues as separate, less‑integrated concerns.  Consequently, the 2023 disclosure deepens the linkage between food‑safety, supply‑chain volatility and cost inflation.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures the general evolution of McDonald's disclosure from 2022 to 2023, correctly identifying that the company moved from treating food safety and supply chain issues as separate concerns to integrating them more explicitly. The answer accurately reflects the shift toward emphasizing the linkage between food safety, supply chain volatility, and cost pressures. However, there are significant issues with the answer's accuracy relative to the ground truth: (1) The LLM introduces claims about 'third-party delivery and technology investments' amplifying risks that are not mentioned in the ground truth, suggesting potential hallucination or over-specification beyond what the filings actually state. (2) The LLM's characterization that the 2023 filing 'explicitly notes that supply-chain interruptions and commodity-price volatility can jeopardize the safety and quality of ingredients' goes beyond the ground truth, which states the relationship is about food safety issues contributing to commodity cost fluctuations, not the reverse causal direction. (3) The ground truth emphasizes a shift from 'reputational risks' framing to 'supply chain volatility' framing, but the LLM answer doesn't clearly articulate this reputational-to-financial exposure transition. (4) No quantitative data (numbers, percentages, dollar amounts) are present in either answer, so quantitative accuracy cannot be penalized on those grounds. The core insight about increased integration of food safety with supply chain concerns is present and correct, but the specific details and causal relationships described by the LLM diverge from the ground truth in ways that suggest either misinterpretation or fabrication of details not supported by the actual filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 479,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "\nThe 1.750 % 7‑Year Senior Notes carried a book value of roughly **$662 million at the end of 2023**, which increased to **about $700 million at the end of 2024**.  At the same time, the notes’ effective interest rate slipped slightly from **1.97 % (2023)** to **1.89 % (2024)**.  Thus, the debt grew modestly while its financing cost was trimmed by a few basis points.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains multiple critical factual errors that directly contradict the ground truth: (1) CARRYING VALUE ERRORS: The LLM states the carrying value was '$662 million at the end of 2023' and 'increased to about $700 million at the end of 2024', but the ground truth clearly shows the carrying value was $700 million in BOTH 2023 and 2024 with NO CHANGE. The LLM has the direction and magnitude of change completely wrong. (2) INTEREST RATE ERRORS: The LLM claims the effective interest rate was '1.97% (2023)' declining to '1.89% (2024)', but the ground truth shows the effective interest rate was 1.89% in BOTH years with NO CHANGE. The 2023 rate of 1.97% is factually incorrect. (3) INTERPRETATION ERROR: The LLM concludes 'the debt grew modestly while its financing cost was trimmed by a few basis points', which is the opposite of the ground truth conclusion that both metrics 'remained unchanged' with 'no change in the financial structure or valuation'. (4) MULTI-HOP SYNTHESIS: The LLM failed to correctly synthesize the year-over-year comparison, presenting a false narrative of change when the ground truth explicitly states no change occurred. The only element that is partially correct is the identification of the debt instrument (1.750% 7-Year Senior Notes) and the final 2024 carrying value of $700 million, but these correct elements are overshadowed by the fundamental misstatement of the 2023 values and the incorrect characterization of the trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 408,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "\nRTX’s 7.000 % notes due 2038 remained at roughly $148 million at the end of 2022 and again at the end of 2023 – essentially no net change in exposure during that period.  The modest, steady balance (after a $11 million repayment in 2021) indicates that RTX is not aggressively retiring this specific tranche; instead it is managing its long‑term debt maturities by refinancing higher‑coupon obligations with newer, longer‑dated issuances and term‑loan facilities, preserving liquidity while gradually reshaping the overall debt profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) QUANTITATIVE ERRORS - The LLM states the balance was 'roughly $148 million at the end of 2022 and again at the end of 2023' with 'essentially no net change.' This is factually incorrect. The ground truth clearly shows: 2022: $11 million, 2023: $148 million. This represents a $137 million INCREASE, not 'no net change.' The LLM's claim of a '$11 million repayment in 2021' is not supported by the ground truth and appears to be fabricated. (2) MULTI-HOP SYNTHESIS FAILURE - The question asks how exposure 'changed between 2022 and 2023.' The ground truth identifies a significant increase from $11M to $148M. The LLM completely misses this critical change, instead claiming stability. This is a fundamental failure in comparing the two years. (3) REASONING QUALITY - While the LLM's discussion of debt management strategy (refinancing, reshaping debt profile) may be reasonable in general terms, it is built on an incorrect factual foundation. The conclusion that RTX is 'not aggressively retiring this specific tranche' contradicts the actual data showing a 13x increase in exposure. (4) ENTITY AND METRIC ACCURACY - The LLM correctly identifies RTX and the 7.000% notes due 2038, but fundamentally misrepresents the principal balance amounts and the direction of change. The ground truth suggests RTX INCREASED exposure to this instrument (either through new issuance or restructuring), which is the opposite of what the LLM implies. This is a critical error in understanding RTX's debt management approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 440,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s moved from the pandemic‑era payment relief to a full‑scale resumption of rent and royalty collections from its franchisees.  After deferring roughly $1 billion of rent and royalties in 2020, the company collected virtually all of those amounts by the end of 2021, and in the 2022‑2023 periods it again billed and received the contractual percentages of sales as rent and royalties—no material deferrals are noted in the 2022‑2023 disclosures.  The “Future gross minimum rent payments” schedule shows expected cash inflows of about $3.06 billion in 2022 and $2.95 billion in 2023, confirming that rent collections remained robust (with only a modest decline from expirations), while royalty income continued to be recognized on a normal basis.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly captures the overall narrative arc of McDonald's franchise financial relationship evolution from pandemic relief to normalization between 2022-2023. The qualitative reasoning is sound: the answer properly identifies that deferrals occurred in 2020, were substantially collected by end of 2021, and that 2022-2023 returned to normal operations without material deferrals. However, there are significant quantitative accuracy issues that prevent a higher score: (1) The LLM introduces specific future gross minimum rent payment figures ($3.06 billion in 2022 and $2.95 billion in 2023) that are NOT present in the ground truth answer. These numbers appear to be fabricated or sourced from documents not verified against the knowledge graph. The ground truth makes no mention of these specific rent payment figures. (2) The LLM claims these figures 'confirm that rent collections remained robust' but the ground truth does not provide this level of financial detail for 2022-2023. (3) The statement about 'contractual percentages of sales as rent and royalties' is reasonable inference but goes beyond what the ground truth explicitly states. The answer correctly addresses the core question about evolution from deferrals to normalization, and the multi-hop reasoning connecting 2020 deferrals → 2021 collection → 2022-2023 normalization is sound. However, the introduction of unverified specific dollar amounts ($3.06B, $2.95B) represents a factual accuracy problem that significantly undermines confidence in the response, even though the overall narrative direction is correct. The answer would have been stronger by sticking to the qualitative evolution without introducing specific numbers not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 474,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "\nBetween 2022 and 2024 Coca‑Cola’s equity‑method stake in Embotelladora Andina S.A. slipped from roughly $115 million in carrying value to about $90 million, while the fair‑value‑adjusted share remained a small minority holding (≈19 %). This reduction shows the company is pulling back from a direct ownership role in Andina and is now treating the investment as a passive governance position rather than a core growth platform.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM correctly identifies the general trend of declining carrying value from 2022 to 2024 and appropriately characterizes this as a strategic pullback. The interpretation of a 'partial exit strategy' aligns with the ground truth. The mention of fair value and minority holding percentage shows engagement with the investment structure. CRITICAL ERRORS: (1) The LLM states 2022 carrying value was 'roughly $115 million' but the ground truth indicates a $39 million GAIN was recognized in 2022 from a partial sale - this doesn't directly establish a $115M starting value and appears to be an unsupported figure. (2) The LLM omits the key 2024 fair value of $168 million, which is important context for understanding the investment's valuation gap. (3) The 19% minority holding percentage is not mentioned in the ground truth and appears to be an unsupported addition. (4) The LLM misses the explicit $39 million gain recognition in 2022, which is a concrete data point demonstrating the strategic refranchising action. REASONING ISSUES: While the LLM's interpretation of 'passive governance position' is reasonable, it goes beyond what the ground truth explicitly states. The multi-hop synthesis is incomplete - the answer doesn't fully connect the 2022 divestiture event to the 2024 position. MISSING ELEMENTS: No mention of the $39M gain in 2022, no mention of the $168M fair value in 2024, no explicit reference to the 'refranchising' or 'divestiture' terminology used in ground truth. The answer provides directional accuracy but lacks specific financial data points that are central to answering the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 445,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "\nFrom the 2022 10‑K (pp. 14‑18) Oracle was already “investing in the expansion of the Oracle Cloud” by adding data‑center capacity and new geographic regions, laying the groundwork for a global OCI platform.  The 2024 10‑K (pp. 70‑74) shows that this effort has matured into a fully‑scaled, enterprise‑grade cloud infrastructure that Oracle now positions as the core foundation for its Cloud Services, engineered‑system hardware support, and cross‑portfolio SaaS and PaaS offerings, with continued internal R&D focused on automation, security and rapid delivery of new cloud capabilities.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth on the core narrative of Oracle's cloud infrastructure evolution from 2022 to 2024. STRENGTHS: (1) Correctly identifies the 2022 focus on expansion through data-center capacity and geographic regions, matching the ground truth's emphasis on internal development and R&D; (2) Accurately captures the 2024 evolution toward a structured, product-specific strategy with OCI positioned as a central offering; (3) Properly synthesizes the multi-hop information across two fiscal years showing progression from foundational investment to mature, enterprise-grade infrastructure; (4) Correctly identifies the shift from general cloud development to a defined, market-ready portfolio; (5) Appropriately references specific 10-K page ranges (2022: pp. 14-18, 2024: pp. 70-74) showing document-specific sourcing. MINOR CONSIDERATIONS: (1) The LLM answer adds specific details about 'automation, security and rapid delivery' as R&D focus areas in 2024 that aren't explicitly mentioned in the ground truth, though these are reasonable inferences from typical cloud infrastructure development; (2) The mention of 'engineered-system hardware support' and 'cross-portfolio SaaS and PaaS offerings' provides additional context beyond the ground truth but doesn't contradict it; (3) No quantitative metrics (dollar amounts, percentages, headcount) are provided in either answer, so quantitative accuracy is assessed as high due to absence of errors rather than presence of verified numbers. The semantic equivalence is strong - both answers convey the same strategic evolution narrative. The multi-hop reasoning correctly synthesizes information across two different fiscal years and filing documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 476,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "\nBetween 2023 and 2024 TMO moved from simply acquiring The Binding Site Group—purchased in January 2023 to bolster the Specialty Diagnostics portfolio for blood‑cancer assays—to actively integrating it into the company’s ongoing growth engine.  The 2024 filing shows the group’s assets and goodwill still reflected in segment‑income tables, and TMO leveraged the acquisition (along with a follow‑on purchase of Olink in July 2024) to deepen its proteomics/diagnostic capabilities, underscoring a strategic focus on expanding high‑margin, high‑growth life‑sciences and diagnostics offerings through continued post‑acquisition integration.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the 2023 acquisition of The Binding Site Group for the Specialty Diagnostics segment and its focus on blood cancers/immune disorders. (2) The January 2023 timing is accurate. (3) The LLM correctly notes integration into segment-income tables by 2024. (4) The strategic focus on diagnostics and life sciences is appropriately characterized. WEAKNESSES: (1) CRITICAL ERROR - The LLM introduces the Olink acquisition (July 2024) which is NOT mentioned in the ground truth answer and appears to be extraneous information not directly relevant to The Binding Site Group evolution. This represents scope creep beyond the question. (2) The LLM does NOT mention the specific $2.70 billion acquisition price, which is a key quantitative fact in the ground truth. (3) The LLM does NOT mention the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets, which is a specific metric provided in the ground truth that indicates integration details. (4) The LLM's characterization of 'high-margin, high-growth' offerings is interpretive language not explicitly supported by the ground truth. MULTI-HOP REASONING: The LLM attempts to synthesize the evolution from acquisition to integration but introduces an additional acquisition (Olink) that dilutes focus from the specific question about The Binding Site Group. The ground truth provides a cleaner narrative focused solely on The Binding Site Group's integration. QUANTITATIVE ACCURACY: The $2.70 billion figure is missing entirely, and the 19-year amortization period is not mentioned. The January 2023 date is correct. SEMANTIC EQUIVALENCE: While the LLM conveys general strategic intent, it omits specific financial and operational metrics that ground the answer in concrete evidence from the filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 499,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "\nBetween 2022 and 2024 the company moved the Directors’ Code of Conduct from a longer “/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf” link to a shorter “/investor‑relations/directors‑code‑ofconduct.pdf” URL, and it added explicit language stating that any future amendments or waivers of the code (both the employee Code of Conduct and the Directors’ Code) will be posted on its website.  The scope was also clarified: the 2022 filing said the Directors’ Code applies to “all directors of BNY Mellon,” while the 2024 filing expands the employee Code of Conduct to cover “all employees of BNY or any entity that is more than 50 % owned by us,” and reiterates that the Directors’ Code applies to “all directors of BNY.”  Thus, the evolution is a streamlined web link and a broader, more transparent description of who the codes govern and how changes will be disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. CRITICAL ERRORS: (1) URL ACCURACY: The LLM claims the 2022 URL was '/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf' and changed to '/investor‑relations/directors‑code‑ofconduct.pdf', but the ground truth shows the 2022 URL was 'https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf' and the 2024 URL was 'https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf'. The LLM misrepresented both URLs - the actual change was in the domain (bnymellon.com to bny.com), not a shortening of the path structure. (2) SCOPE MISREPRESENTATION: The LLM claims the 2024 filing 'expands the employee Code of Conduct to cover all employees of BNY or any entity that is more than 50% owned by us' - this information is not mentioned in the ground truth and appears to be fabricated or confused with other content. (3) MISSING KEY INFORMATION: The LLM fails to identify the actual domain change from 'bnymellon.com' to 'bny.com', which is the core evolution described in the ground truth as reflecting rebranding from 'BNY Mellon' to 'BNY'. (4) ADDED CLAIMS: The LLM introduces claims about 'explicit language stating that any future amendments or waivers...will be posted on its website' which are not substantiated in the ground truth. The answer demonstrates poor multi-hop synthesis and introduces unsupported information while misrepresenting the actual URL changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 432,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "\nBetween 2022 and 2023 McDonald’s tightened the way it reports franchisee‑related income – it now records initial franchise fees and variable rent at the point of sale rather than spreading them over the lease term, and it presents the fees it receives for technology platforms and brand licensing on a gross (rather than net) basis.  At the same time, the company’s strategic focus shifted toward higher‑margin, digital‑driven revenues (e.g., Dynamic Yield and other tech‑service fees) and away from reliance on traditional rent and royalty streams, a change that is reflected in the expanded segment‑disclosure requirements introduced in the 2023 filing.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is largely incorrect and does not match the ground truth. CRITICAL ISSUES: (1) The LLM introduces specific accounting changes (recording initial franchise fees at point of sale vs. spreading over lease term, presenting fees on gross vs. net basis) that are NOT mentioned in the ground truth and appear to be fabricated or confused with other companies' practices. (2) The LLM claims a strategic shift toward 'higher-margin, digital-driven revenues' and away from 'traditional rent and royalty streams' - this is not supported by the ground truth, which makes no mention of such a strategic pivot. (3) The LLM references 'Dynamic Yield and other tech-service fees' as evidence of this shift, but the ground truth contains no mention of Dynamic Yield or technology platform revenue changes. (4) The LLM discusses 'expanded segment-disclosure requirements introduced in the 2023 filing' but the ground truth focuses on how franchisees were explicitly included as key stakeholders in business model disclosure, not on segment reporting changes. (5) The ground truth's core finding - that McDonald's shifted from noting franchisee transactions as 'not material' in 2022 to explicitly highlighting franchisees as key stakeholders in 2023 - is completely absent from the LLM answer. The LLM appears to have either hallucinated accounting policy changes or confused McDonald's with another company's filings. The answer fails to address the actual evolution described in the ground truth regarding stakeholder emphasis and transparency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 424,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "\nBetween 2023 and 2024 the contingent‑consideration liability tied to the Clif Bar acquisition rose from $452 million (a Level‑3 fair‑value amount) to $548 million, and the overall liability grew from $642 million to $680 million.  The increase reflects a $128 million fair‑value remeasurement (recorded in SG&A) and $90 million of earn‑out payments; the Clif Bar portion expanded because the estimated revenue‑, profit‑ and EBITDA‑based payouts were re‑estimated higher, while the “other” component fell from $190 million to $132 million after settlements.  Purchase‑price allocation adjustments are incorporated directly into these fair‑value changes rather than being posted as a separate line item.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) QUANTITATIVE ERRORS - The LLM states the contingent consideration liability rose from $452M to $548M between 2023-2024, but the ground truth clearly indicates $548M was the 2023 figure (December 31, 2023), not a 2024 figure. The LLM has inverted or misrepresented the timeline. The ground truth explicitly states '$548 million classified as long-term liabilities at December 31, 2023' and that 'by 2024, there is no direct mention of the contingent consideration liabilities.' (2) DIRECTIONAL ERROR - The LLM describes an increase from 2023 to 2024, but the ground truth indicates the opposite: the liabilities were actively measured in 2023 but NOT mentioned in 2024 filings, suggesting finalization or reclassification rather than growth. (3) MISSING KEY CONTEXT - The LLM fails to capture the critical evolution described in the ground truth: the shift from active fair value measurement using Monte Carlo simulation in 2023 to no direct mention in 2024, indicating potential finalization or reclassification as part of purchase price allocation. (4) UNSUPPORTED DETAILS - The LLM provides specific figures ($452M, $128M remeasurement, $90M earn-out payments, $190M to $132M decline) that are not mentioned in the ground truth and appear to be fabricated or from a different source. (5) INCOMPLETE SYNTHESIS - While the LLM attempts to address the multi-hop nature of the question (fair value measurement + purchase price allocation), it does so incorrectly by presenting a narrative of growth rather than the actual evolution from active measurement to reclassification/finalization. The answer fundamentally misrepresents the temporal progression and accounting treatment changes between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 491,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "\nAMD’s Vulkan strategy shifted from a baseline “support‑only” stance in the 2022 RX 6000 launch—where Vulkan was highlighted alongside DirectX 12 Ultimate as a key API for the new RDNA 2 architecture (AMD_10k_2022.pdf, p. 9)—to a proactive, ecosystem‑centric emphasis in 2024, with the RDNA 3‑based RX 7000 series and AMD Software Adrenalin repeatedly touting Vulkan as the preferred open‑standard path for both gaming and compute workloads, and pairing it with tools such as FidelityFX Super Resolution and ROCm integration (AMD_10k_2024.pdf, p. 7).  \n\nThis evolution shows that AMD is using Vulkan not just to match competitors but to differentiate its discrete GPUs by championing an open, cross‑platform API that reduces reliance on proprietary stacks, broadens addressable markets (gaming, AI/ML, cloud), and reinforces a developer‑friendly narrative that helps sustain its competitive position against Nvidia and Intel.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the key architectural progression from RDNA 2 (2022) to RDNA 3 (2024), matching the ground truth. (2) Correctly names the GPU series (RX 6000 → RX 7000) and timeframe. (3) Appropriately characterizes the shift from 'support' to 'proactive emphasis' on Vulkan. (4) Mentions relevant supporting technologies (FidelityFX Super Resolution, ROCm, AMD Software Adrenalin) that reinforce the narrative. (5) The competitive positioning analysis (vs Nvidia/Intel, open-standard differentiation) is sound and goes beyond ground truth in useful ways.\n\nWEAKNESSES: (1) The LLM introduces specific document citations (AMD_10k_2022.pdf p.9, AMD_10k_2024.pdf p.7) that cannot be verified against the ground truth knowledge graph. These citations appear plausible but are not confirmed in the original answer. (2) The characterization of 2022 as 'baseline support-only' is slightly more negative than the ground truth, which simply states Vulkan was 'highlighted as part of' the offering. (3) The LLM adds interpretive layers (e.g., 'reduces reliance on proprietary stacks,' 'broadens addressable markets') that, while logically sound, go beyond what the ground truth explicitly states. (4) The ground truth emphasizes 'backward compatibility' as a key strategic element, which the LLM does not explicitly mention.\n\nMULTI-HOP REASONING: The LLM successfully synthesizes information across 2022 and 2024 filings and connects architectural evolution to strategic positioning. However, the reasoning includes inferences not directly supported by the ground truth (e.g., the specific claim about 'reducing reliance on proprietary stacks').\n\nFACTUAL VERIFICATION: No quantitative errors detected. Architectural names, GPU series, and years are all correct. The API names (Vulkan, DirectX 12 Ultimate) are accurate. No calculations required.\n\nOVERALL ASSESSMENT: The answer is substantially correct in its core claims and demonstrates good multi-hop synthesis. However, it introduces unverified document citations and makes some interpretive leaps beyond the ground truth. The answer is more detailed and nuanced than the original but risks overstatement in places.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 587,
        "total_tokens": 2014
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "\nThe 2023 operating‑profit decline of roughly **$1.9 billion** versus 2022 was driven almost entirely by the **$2.9 billion charge RTX recorded for the Powder‑Metal‑Matter integration cost** (and the related dip in the FAS/CAS adjustment), which more than offset the modest profit gains seen at Collins and Raytheon; as a result, operating profit fell from **$5.5 billion in 2022 to $3.6 billion in 2023**.  This integration‑related charge was the dominant factor behind the downward trend in operating profit between the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the $2.9 billion Powder Metal Matter charge as the dominant driver of the operating profit decline and accurately states the $1.9 billion decrease between years. However, there are significant quantitative issues: (1) The operating profit figures provided ($5.5B in 2022 and $3.6B in 2023) cannot be verified against the ground truth and appear potentially incorrect or unsourced - the ground truth does not provide these specific operating profit totals. (2) The LLM introduces specific numbers ($5.5B and $3.6B) that are not mentioned in the original answer, raising concerns about accuracy. (3) The mention of 'FAS/CAS adjustment' and specific profit gains at Collins and Raytheon adds detail not present in the ground truth, which could be either accurate additional context or potentially fabricated. Strengths: The answer correctly identifies the $2.9B Powder Metal Matter charge, correctly states the $1.9B operating profit decrease, and properly synthesizes that this charge was the primary driver of the decline. The reasoning about the shift from declining integration charges in 2022 to a significant new expense in 2023 is sound and matches the ground truth narrative. The multi-hop synthesis connecting the charge to the profit decline is logically sound. Weaknesses: The introduction of unverified operating profit figures ($5.5B and $3.6B) without source attribution is problematic for a financial analysis. The answer provides more specificity than the ground truth supports, which could indicate either hallucination or use of additional valid sources not reflected in the ground truth. The core message is correct, but the quantitative details beyond the $2.9B and $1.9B figures cannot be confirmed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 477,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "\nBetween 2023 and 2024 the Clif Bar transaction moved from a recent acquisition to a fully integrated business. The 2023 filing notes that the August 1 2022 purchase of Clif Bar generated $529 million of incremental net revenue (constant‑currency) through its one‑year anniversary, and the related integration costs were recorded in 2023; the 2024 filing contains no additional acquisition‑related revenue or expense items for Clif Bar, indicating the deal is now complete and its financial impact has stabilized.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a critical factual error regarding the acquisition date and introduces an unsupported specific financial figure. Key issues: (1) QUANTITATIVE ACCURACY: The LLM states the Clif Bar acquisition occurred on August 1, 2022, which matches the ground truth. However, the LLM introduces a specific figure of '$529 million of incremental net revenue (constant-currency)' that is NOT present in the ground truth answer. This is a significant problem - the ground truth makes no mention of this specific revenue figure, and introducing unverified numbers is a major accuracy violation. (2) FACTUAL ERRORS: The LLM's claim that '2024 filing contains no additional acquisition-related revenue or expense items for Clif Bar' contradicts the ground truth, which explicitly states the 2024 10-K filing contains 'purchase price allocation adjustments for Clif Bar during the prior year.' This is a material misrepresentation of what the 2024 filing contains. (3) MULTI-HOP REASONING: The ground truth correctly identifies the evolution from initial acquisition phase (2023) to financial recalibration/consolidation phase (2024). The LLM's characterization of moving to 'fully integrated' with 'financial impact stabilized' and 'deal is now complete' is not supported by the ground truth, which indicates ongoing purchase price allocation adjustments in 2024. (4) COMPLETENESS: The ground truth mentions integration costs and contingent consideration adjustments in 2023, and purchase price allocation adjustments in 2024. The LLM only addresses integration costs and omits the contingent consideration and purchase price allocation adjustment details. The introduction of the $529 million figure without ground truth support is particularly problematic for a financial evaluation task where accuracy is paramount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 494,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "\nFrom 2023 to 2024 Gulfstream moved from incremental efficiency gains on its existing G500/G600 family to a clean‑sheet engine package that powers its newest ultra‑large‑cabin jet, the G700, which entered service in early 2024 with next‑generation, low‑specific‑fuel‑consumption engines and full compatibility for 100 % sustainable‑aviation‑fuel operations.  This shift is also reflected in the 2024‑certified G800 and G400, which incorporate the same high‑efficiency powerplants and aerodynamic refinements that deliver higher cruise speeds, longer ranges and markedly reduced emissions across the entire Gulfstream lineup.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ERRORS IDENTIFIED: (1) FACTUAL INACCURACY - The LLM claims the G700 'entered service in early 2024,' but the ground truth states it was introduced in 2024 without specifying 'early 2024' as a service entry date. More importantly, the ground truth does NOT mention the G800 or G400 being 2024-certified or incorporating the same engines as the G700. The LLM introduces aircraft (G800, G400) and claims about their 2024 certification and engine specifications that are NOT supported by the ground truth. (2) UNSUPPORTED CLAIMS - The LLM states these aircraft have '100% sustainable-aviation-fuel operations' compatibility and 'same high-efficiency powerplants' - these specific details are not in the ground truth, which only mentions SAF focus in 2023 and G700's 'all-new engines' in 2024. (3) MULTI-HOP REASONING FAILURE - While the LLM correctly identifies the shift from 2023 (R&D/announcement phase) to 2024 (production/introduction), it overstates the scope by claiming multiple aircraft models reflect this shift when the ground truth only explicitly mentions the G700. (4) PARTIAL CORRECTNESS - The core insight about evolution from strategic positioning to operational realization is correct, and the G700 with new engines is accurately identified. However, the expansion to G800 and G400 with unverified claims about their specifications and certification dates represents significant factual overreach. (5) SEMANTIC ISSUES - 'Clean-sheet engine package' is reasonable interpretation of 'all-new engines,' but the specific claims about fuel consumption metrics and multiple aircraft models lack ground truth support.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 447,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "\nFrom 2022 to 2024 AMD shifted its semi‑custom SoC business from a high‑risk, revenue‑uncertain model—where earnings depended on third‑party design wins and were subject to wafer‑purchase targets and penalties—to a more contract‑backed, predictable structure.  The 2024 filing shows that AMD now operates under long‑term wafer‑supply agreements (e.g., the GF amendment through 2025 with minimum annual capacity allocations and pre‑payments), giving it greater control over supply, pricing and revenue visibility, while positioning semi‑custom SoCs as a strategic growth pillar across gaming, AI and data‑center markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "ASSESSMENT: The LLM answer provides a plausible narrative about AMD's semi-custom SoC evolution but introduces specific claims not supported by the ground truth and lacks key elements from the original answer.\n\nCORRECT ELEMENTS:\n- Correctly identifies the time period (2022 to 2024)\n- Correctly identifies AMD as the subject company\n- Correctly identifies semi-custom SoCs as the product category\n- Captures the general theme of evolution from uncertainty to more structured arrangements\n- Appropriately mentions strategic positioning across multiple markets\n\nINCORRECT/UNSUPPORTED ELEMENTS:\n1. QUANTITATIVE CLAIMS: The LLM introduces specific contractual details (\"GF amendment through 2025,\" \"minimum annual capacity allocations,\" \"pre-payments\") that are NOT present in the ground truth. These appear to be fabricated specifics that cannot be verified.\n2. MISSING KEY GROUND TRUTH ELEMENTS: The original answer emphasizes:\n   - 2022: dependency model with NRE fees AND product sales\n   - 2024: broader portfolio integration (AI accelerators, GPUs, APUs, DPUs)\n   - Shift from third-party dependency to internal control\n   The LLM answer omits the portfolio diversification aspect entirely and doesn't mention the specific product categories (AI accelerators, GPUs, APUs, DPUs) that characterize the 2024 positioning.\n3. CHARACTERIZATION DIFFERENCES: The ground truth describes a shift from \"dependency\" to \"active production and broader strategic integration.\" The LLM describes a shift from \"high-risk, revenue-uncertain\" to \"contract-backed, predictable.\" While these are related concepts, the LLM's framing emphasizes supply chain/contractual certainty rather than the portfolio integration and strategic control emphasized in the ground truth.\n4. SPECIFICITY PROBLEM: The LLM provides very specific contractual references (GF amendment, wafer-supply agreements) without these being mentioned in the ground truth, suggesting potential hallucination.\n\nMULTI-HOP REASONING: The LLM demonstrates reasonable synthesis of the evolution concept but fails to properly integrate the key multi-hop elements: the shift from NRE+sales model to diversified portfolio integration, and the move from third-party dependency to internal strategic control.\n\nSEMANTIC EQUIVALENCE: While both answers discuss evolution and strategic positioning, they emphasize different aspects. The ground truth focuses on portfolio integration and strategic control; the LLM focuses on supply chain certainty and contractual arrangements. These are not equivalent framings of the same evolution.\n\nJUSTIFICATION: The answer receives a 5 because while it captures the general theme of evolution and some correct elements, it introduces unsupported specific claims, omits critical ground truth elements (portfolio diversification), and frames the evolution differently than the ground truth. The introduction of specific contractual details not in the ground truth is particularly problematic as it suggests hallucination rather than faithful synthesis of available information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 810,
        "total_tokens": 2143
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the company’s preferred‑share charter was unchanged – it still authorizes 127.5 million $0.20 par “Preferred” shares and 500 thousand $1.00 par “A” Preferred shares, and at the end of both years no such shares were issued or outstanding (MDT 10‑K 2023 pp. 79‑83; MDT 10‑K 2024 pp. 79‑83).  This stability shows that Medtronic is not using preferred equity as a financing tool; instead, its capital strategy continues to rely on cash flow, modest debt, and returning capital to shareholders through ordinary‑share repurchases and dividends, with a sizable ordinary‑share repurchase authorization left for future use.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and well-reasoned. QUANTITATIVE VERIFICATION: All numbers are correct - 127.5 million Preferred Shares at $0.20 par value, 500 thousand A Preferred Shares at $1.00 par value, and zero shares issued/outstanding in both years. The fiscal years (2023 and 2024) are correctly identified. COMPLETENESS: The answer addresses all parts of the question - it describes the structure evolution (unchanged), provides specific authorization details, confirms no issuances, and explains what this indicates about capital strategy. ENTITY ACCURACY: Correctly identifies Medtronic (MDT) and references the appropriate 10-K filings with page numbers. REASONING QUALITY: The multi-hop synthesis is sound - the LLM correctly connects the stable preferred share structure to broader capital strategy conclusions (reliance on cash flow, debt management, share repurchases, and dividends). The inference that the company is not using preferred equity as a financing tool is a logical and appropriate interpretation of the data. SEMANTIC EQUIVALENCE: The LLM answer conveys all information from the ground truth while adding valuable context about Medtronic's overall capital strategy, which enhances understanding without introducing inaccuracies. The only minor distinction is that the LLM provides additional strategic context beyond what was explicitly stated in the ground truth, but this is supplementary and accurate rather than contradictory. The answer demonstrates strong understanding of financial structure and capital allocation strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 430,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "\nBetween the 2022 and 2024 filings the discussion of reputational risk moved from a brief, generalized note that “errors or delays … may materially adversely affect … reputation” (2022 10‑K, Risk Factors, p. 6) to a dedicated, more detailed bullet that explicitly ties reputational harm to a range of adverse events, publicity, government scrutiny, cyber‑security incidents, climate‑change and geopolitical developments, and stresses that such reputational damage can materially affect the company’s business, financial condition and results of operations (2024 10‑K, Risk Factors, p. 7).  The evolution reflects a shift from treating reputational risk as an indirect consequence of operational or cyber events to positioning it as a distinct, explicitly enumerated risk driver linked to multiple external and sustainability‑related concerns.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of the evolution of BK's reputational risk framing between 2022 and 2024. STRENGTHS: (1) Correctly identifies the shift from brief/generalized treatment in 2022 to more detailed/dedicated framing in 2024; (2) Accurately captures the expansion of risk contexts to include sustainability concerns (climate change), geopolitical developments, and cyber-security incidents; (3) Properly synthesizes the multi-hop information showing how reputational risk became more explicitly enumerated and distinct; (4) Correctly notes the connection to operational models and external factors; (5) Appropriately cites page numbers and document sections. MINOR WEAKNESSES: (1) The LLM answer focuses heavily on the structural/presentation evolution (brief vs. dedicated bullet point) rather than equally emphasizing the substantive broadening of contexts mentioned in the ground truth; (2) While the LLM mentions 'platforms operating model transition,' this is presented as a secondary detail rather than being integrated as a primary example of the expanded framing; (3) The ground truth emphasizes 'diversity' as a sustainability concern, which the LLM answer does not explicitly mention (though it does mention climate change and sustainability-related concerns broadly). QUANTITATIVE ACCURACY: No specific numbers or calculations are required for this qualitative question, so this dimension scores high. QUALITATIVE ACCURACY: The reasoning is sound and multi-hop synthesis is correct - the answer successfully connects 2022 and 2024 filings and identifies the evolution pattern. The characterization of the shift from indirect to explicit/distinct risk driver is accurate and insightful. CONTEXTUAL RELEVANCE: The answer directly addresses the question about evolution of framing and associated impacts/linked concerns. The response is well-structured and provides specific textual evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 521,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "\nIn Q3 2023 Amazon recorded a $1.25 billion convertible note in Anthropic, PBC as an available‑for‑sale Level 3 financial asset, recognizing any fair‑value changes in accumulated other‑comprehensive income.  In 2024 it expanded its exposure with a second convertible note (up to $2.75 billion) and a commercial AWS‑chip arrangement, continuing to measure the investment at fair value and recording gains or impairments in AOCI or other income, with valuation driven by discounted‑cash‑flow forecasts, conversion prospects and market conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer demonstrates solid understanding of the core facts but has some notable gaps and minor inaccuracies when compared to the ground truth. STRENGTHS: (1) Correctly identifies the $1.25 billion convertible note investment in 2023 and its classification as available-for-sale Level 3 asset. (2) Accurately notes the $2.75 billion second convertible note commitment. (3) Correctly states that fair value changes are recorded in AOCI. (4) Properly identifies Anthropic, PBC as the investee. (5) Mentions the AWS commercial arrangement, which adds relevant context. WEAKNESSES: (1) The LLM states the investment was recorded 'in Q3 2023' but the ground truth simply says '2023' without specifying Q3 - this is a minor temporal precision issue that may or may not be accurate. (2) The LLM answer fails to adequately address the key evolution from 2023 to 2024 regarding the shift in disclosure emphasis. The ground truth emphasizes that 2024 filings placed 'more emphasis on the challenges of valuation rather than the mechanics of the investment itself' and highlighted 'increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty.' The LLM mentions valuation drivers (DCF, conversion prospects, market conditions) but doesn't capture this important shift in disclosure focus and the heightened emphasis on valuation risk. (3) The LLM answer is somewhat vague about whether the $2.75 billion was actually invested or remained a commitment - the ground truth clarifies it was 'an agreement to invest...by Q1 2024,' suggesting it was a future commitment in 2023. The LLM's phrasing 'expanded its exposure with a second convertible note (up to $2.75 billion)' is ambiguous about timing. (4) The answer doesn't clearly articulate the evolution/change aspect of the question - it presents 2023 and 2024 information but doesn't effectively synthesize how the approach evolved. QUANTITATIVE ACCURACY: All dollar amounts are correct ($1.25B, $2.75B). No calculation errors. QUALITATIVE ACCURACY: The reasoning about fair value measurement and AOCI treatment is sound, but the multi-hop synthesis of how the valuation approach evolved is incomplete. CONTEXTUAL RELEVANCE: The answer addresses the question but misses the critical evolution in disclosure emphasis regarding valuation complexity and risk.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 634,
        "total_tokens": 2035
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "\nBetween 2023 and 2024 the company’s IP‑risk narrative moved from a broad statement that “our trademarks, patents, trade‑secrets, recipes, technology and know‑how are important and must be protected” to a more specific warning that **new threats—especially developments in artificial‑intelligence technologies and any legal changes that could weaken existing protections—now must be factored into the protection of that know‑how**.  The 2024 filing also stresses that failure to secure or maintain these rights (including against third‑party infringement claims) could “materially and adversely affect our competitiveness, financial condition and stock price,” underscoring a heightened focus on safeguarding know‑how amid evolving regulatory and technological pressures.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "CRITICAL ERRORS IN FACTUAL ACCURACY: The LLM answer directly contradicts the ground truth on the key evolution of MDLZ's IP risk disclosure between 2023 and 2024. (1) MAJOR FACTUAL REVERSAL: The LLM claims that 2024 introduced 'new threats—especially developments in artificial-intelligence technologies' as a specific warning, when the ground truth explicitly states the OPPOSITE: that 2023 emphasized AI-related threats, but 2024 'did not specifically mention artificial intelligence as a factor affecting protection.' This is a fundamental misrepresentation of the evolution described in the question. (2) DIRECTIONAL ERROR: The LLM describes a shift TOWARD AI emphasis in 2024, when the ground truth describes a shift AWAY from AI emphasis. The ground truth states: 'In 2023, MDLZ...expressed concern...especially in response to developments in artificial intelligence technologies' but 'In 2024...it did not specifically mention artificial intelligence.' (3) INCOMPLETE CHARACTERIZATION: The LLM fails to capture the actual 2024 shift toward 'broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions.' (4) MULTI-HOP REASONING FAILURE: The LLM failed to correctly synthesize the temporal evolution across the two years, reversing the actual direction of change. While the LLM correctly identifies that both years emphasize IP protection importance and potential adverse effects on competitiveness and financial condition, it fundamentally mischaracterizes which year introduced AI-specific concerns. This is not a minor wording difference but a substantive factual error about the nature of risk evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 473,
        "total_tokens": 1943
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "\nBetween the 2023 and 2024 filings Goldman Sachs shifted from citing the legacy “pre‑2015” Non‑Employee Director RSU Award Agreement (and the 2008 amendment to those agreements) that appeared in the 2023 Exhibit list, to introducing new, stand‑alone forms—Exhibits 10.31 and 10.32—presented without any “pre‑2015” label.  This change signals that the company has formally replaced the older templates with updated director‑equity award agreements, aligning their timelines to the 2023‑2024 reporting period.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains significant factual errors and contradicts the ground truth on multiple critical points: (1) EXHIBIT NUMBERS: Ground truth states the 2023 filing referenced Exhibit 10.17 and 2024 referenced Exhibit 10.18, but the LLM claims new Exhibits 10.31 and 10.32 were introduced in 2024—these exhibit numbers do not match the ground truth at all. (2) REFERENCED SOURCE: Ground truth indicates the 2024 filing shifted to reference Exhibit 10.69 from the 2008 Annual Report, but the LLM makes no mention of Exhibit 10.69 or this specific shift. (3) AMENDMENT DATE: Ground truth specifically mentions the November 28, 2008 amendment date as a key reference point, which the LLM completely omits. (4) CHARACTERIZATION OF CHANGE: Ground truth describes this as a 'continuation of the policy with deeper historical documentation being emphasized,' suggesting continuity with formalization. The LLM incorrectly characterizes this as a 'formal replacement' with 'updated director-equity award agreements,' which misrepresents the nature of the evolution. (5) TIMELINE FRAMING: The LLM's claim about 'aligning timelines to the 2023-2024 reporting period' contradicts the ground truth's emphasis on historical documentation from 2008. The LLM answer appears to have fabricated exhibit numbers and misunderstood the fundamental nature of the change between filings. This is a complete failure to accurately synthesize the multi-hop information about how Goldman Sachs' disclosure practices evolved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 414,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "\nBetween 2022 and 2023 Booking Holdings deepened its shift from a pure agency model to a merchant‑based approach, moving a larger share of accommodation reservations onto a structure where it collects the traveler’s payment, assumes responsibility for refunds, charge‑backs and tax obligations, and remits the net amount to the travel provider. Consequently, revenue recognition moved from gross agency commissions to net merchant revenues (commissions + transaction‑net + ancillary fees), and the company now records substantially larger “Deferred Merchant Bookings” balances to reflect advance payments and expanded contractual duties.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and contradicts the ground truth in multiple critical ways: (1) DIRECTIONAL ERROR: The ground truth states BKNG moved FROM a general intermediary description TO more detailed accounting treatment with net basis revenue recognition. The LLM claims the opposite - a shift FROM pure agency TO merchant-based approach with gross revenue collection. This is a 180-degree mischaracterization of the evolution described. (2) REVENUE RECOGNITION CONTRADICTION: Ground truth indicates BKNG recognizes revenue on a NET basis as an agent (commissions only). The LLM claims the company moved to NET merchant revenues and now records larger 'Deferred Merchant Bookings' - this inverts the actual relationship and introduces unsupported claims about merchant model expansion and deferred booking balances that are not mentioned in the ground truth. (3) CONTRACTUAL RESPONSIBILITY MISCHARACTERIZATION: Ground truth emphasizes BKNG's role as an intermediary WITHOUT taking responsibility for delivering travel services. The LLM claims BKNG now 'assumes responsibility for refunds, charge-backs and tax obligations' - directly contradicting the ground truth's emphasis on limited contractual duties. (4) MISSING KEY ELEMENTS: The LLM fails to mention the actual evolution described - the shift from general relationship description to more detailed accounting treatment, the clarification of revenue recognition timing (when travelers begin using services), and the emphasis on commission-based revenues. (5) UNSUPPORTED CLAIMS: References to 'Deferred Merchant Bookings' and specific merchant model metrics are not present in the ground truth and appear to be fabricated or confused with different company information. The answer demonstrates a fundamental misunderstanding of BKNG's actual business model evolution between 2022-2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 504,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "\nBetween the 2023 and 2024 Form 10‑K filings the executive‑life‑insurance disclosures were re‑numbered and re‑sequenced: the Metropolitan‑Life policy that had been listed as Item 10.11 in 2023 appears as Item 10.11 in 2024, while the Pacific‑Life policy that was Item 10.12 in 2023 is now Item 10.13, and the filing updates the exhibit citations to the most recent quarterly reports.  In addition, the 2024 filing places the claw‑back policy as Item 10.1 and shifts the insurance items later in the list, reflecting a broader re‑ordering of compensation‑related disclosures, and the description of the Pacific‑Life policy now explicitly notes that it includes “policy specifications and form of restriction on Policy Owner’s Rights.”",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. Key issues: (1) CRITICAL ERROR - The LLM states the Metropolitan Life policy remained as Item 10.11 in both 2023 and 2024, but the ground truth clearly indicates it was renumbered from 10.11 in 2023 to 10.12 in 2024. This is a fundamental misstatement of the core finding. (2) PARTIAL ACCURACY - The LLM correctly identifies that the Pacific Life policy moved from 10.12 to 10.13, which matches the ground truth. (3) UNSUPPORTED CLAIMS - The LLM introduces information not present in the ground truth, including: claims about updating exhibit citations to quarterly reports, placement of a 'claw-back policy as Item 10.1', and explicit policy language about 'policy specifications and form of restriction on Policy Owner's Rights.' These details are not mentioned in the ground truth and appear to be fabricated or confused with other disclosures. (4) INCOMPLETE SYNTHESIS - While the ground truth emphasizes that the changes represent 'structural update in how the policies are presented' rather than substantive policy changes, the LLM's answer muddies this distinction by introducing unverified details about policy descriptions. (5) EXHIBIT NUMBERING ERROR - The most critical error is the incorrect statement about the Metropolitan Life policy's exhibit number in 2024, which directly contradicts the ground truth's clear statement that it was 'renumbered to 10.12.' The answer demonstrates poor multi-hop reasoning by failing to accurately track the exhibit number changes across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 434,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "\nBetween 2022 and 2024 Broadcom deepened its internal‑fabrication strategy for FBAR filters—moving from simply “using internal facilities for innovative processes” to actively expanding dedicated III‑V wafer‑fab capacity (U.S. & Singapore) and investing in process‑development to tighten IP control and accelerate time‑to‑market. This heightened focus on proprietary FBAR technology is presented as a key differentiator in the company’s competitive positioning, emphasizing its high‑speed design expertise, module integration and differentiated product performance against other semiconductor vendors.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "MAJOR ISSUES IDENTIFIED: (1) FACTUAL ERRORS - The LLM answer introduces specific claims NOT present in the ground truth: mentions of 'dedicated III-V wafer-fab capacity (U.S. & Singapore)' and 'process-development' investments are not substantiated by the original answer. These appear to be fabricated details. (2) QUANTITATIVE ACCURACY - No specific numbers, dates, or metrics are provided in either answer, so this is neutral, but the LLM adds unverified specificity. (3) MULTI-HOP REASONING - The ground truth clearly states the internal fabrication strategy REMAINED CONSISTENT between 2022-2024, with the key evolution being INCREASED COMPETITIVE PRESSURE (mentioning specific competitors: Qorvo, Qualcomm, Skyworks). The LLM answer mischaracterizes this as a 'deepening' or 'expansion' of internal fabrication strategy, when the actual evolution was in the competitive landscape, not the manufacturing approach itself. (4) MISSING KEY ELEMENTS - The LLM answer fails to mention the specific competitors identified in 2024 (Qorvo, Qualcomm, Skyworks) and misses the core insight that competitive pressure intensified while the manufacturing strategy remained stable. (5) SEMANTIC ISSUES - The LLM conflates 'strategic importance' with 'manufacturing expansion,' when the ground truth indicates the manufacturing approach stayed the same while competitive context changed. The answer presents a narrative of expansion/deepening that contradicts the ground truth's emphasis on consistency with increased competitive pressure. The LLM appears to have hallucinated details about wafer-fab capacity expansion that are not supported by the source material.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 453,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "\nBetween 2023 and 2024 Krazati moved from a late‑stage, privately‑held asset in Mirati’s pipeline to a core, commercially‑approved product within BMS after the $4.8 billion (≈$4.1 billion net) acquisition of Mirati in January 2024; the clinical focus broadened from its original KRAS‑mutant NSCLC indication to include first‑line KRAS‑mutant NSCLC (KRYSTAL‑17), second‑line KRAS‑mutated colorectal cancer (KRYSTAL‑10/12) and combination studies with PD‑1 inhibitors.  The transaction was valued with a $3.5 billion indefinite‑lived IPRD valuation plus $640 million of definite‑lived product rights, underscoring Krazati’s strategic importance to BMS’s future revenue and pipeline valuation.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the $4.8 billion acquisition price, the January 2024 timing, and the key clinical development progression (KRYSTAL-17, KRYSTAL-10/12, and PD-1 combination studies). The qualitative assessment of Krazati's evolution from a privately-held asset to a commercially-approved product is accurate and well-articulated. The answer appropriately synthesizes multi-hop information about clinical focus and strategic positioning.\n\nWEAKNESSES - QUANTITATIVE ERRORS: (1) The LLM introduces unsupported financial details not in the ground truth: '$3.5 billion indefinite-lived IPRD valuation plus $640 million of definite-lived product rights.' These specific valuations are not mentioned in the original answer and appear to be hallucinated or from unreliable sources. (2) The parenthetical '(≈$4.1 billion net)' is unexplained and not supported by the ground truth, which only states the $4.8 billion acquisition price. These additions create factual inaccuracies regarding financial valuation.\n\nMULTI-HOP REASONING: The answer correctly synthesizes information across 2023-2024 timeframes and connects the acquisition event to clinical development changes. However, the introduction of unsupported valuation figures undermines the accuracy of the financial positioning analysis.\n\nCOMPLETENESS: The answer addresses both parts of the question (clinical development focus and financial valuation), but the financial valuation section contains errors rather than omissions.\n\nSPECIFIC ISSUES: The ground truth mentions 'KRYSTAL-12* for 2L+ Mutated NSCLC' in 2023, while the LLM conflates this with colorectal cancer indications. The clinical trial naming and indication mapping could be clearer. The introduction of specific IPRD and product rights valuations that don't appear in the ground truth is a significant accuracy problem that prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 514,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "\nBetween 2022 and 2023 Booking Holdings moved from a largely agency‑style commission model toward a merchant‑oriented structure in which travel‑service‑provider revenue is recorded net of the commissions, rebates, loyalty points and other incentives it promises to them.  The company now accrues the estimated value of those incentives as a reduction of revenue and tracks the cash it receives from travelers in “deferred merchant bookings,” a liability that reflects both amounts payable to providers and the future commission or margin it expects to earn.  This tighter financial integration—bolstered by expanded payment‑settlement capabilities and larger deferred‑booking balances—aligns provider incentives with consumer demand while giving BKNG clearer visibility into its obligations and revenue‑recognition timing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all dimensions. CORRECTNESS: The answer accurately captures the evolution of BKNG's relationship with travel service providers from 2022 to 2023, correctly identifying the shift from a competitive model to a more dependent/integrated partnership model. The key financial mechanisms are correctly identified: deferred merchant bookings liability, incentive programs (rebates, loyalty points, referral bonuses), and revenue recognition changes. QUANTITATIVE ACCURACY: No specific numbers are provided in either the ground truth or LLM answer, so this dimension is not applicable. Both answers appropriately avoid citing specific dollar amounts or percentages, which is correct given the question's focus on relationship evolution rather than specific metrics. QUALITATIVE ACCURACY: The LLM answer provides more sophisticated and detailed reasoning than the ground truth. It correctly synthesizes: (1) the shift from agency-style commission to merchant-oriented structure, (2) the accrual of incentive values as revenue reductions, (3) the tracking of deferred merchant bookings as a liability, and (4) the strategic purpose of this shift (aligning provider incentives with consumer demand). The multi-hop reasoning is sound—connecting financial obligations, incentive programs, and balance sheet changes to demonstrate the relationship evolution. ENTITY ACCURACY: BKNG is correctly identified, years 2022-2023 are correctly referenced, and financial metrics (deferred merchant bookings, revenue recognition, incentives) are accurately named. SEMANTIC EQUIVALENCE: The LLM answer conveys the same core information as the ground truth but with greater depth and clarity. The ground truth mentions 'Deferred merchant bookings' as reflecting amounts payable; the LLM answer correctly expands this to include both amounts payable and future margin expectations. Both correctly identify the shift toward incentive programs and their revenue impact. MINOR CONSIDERATIONS: The LLM answer goes slightly beyond the ground truth by mentioning 'expanded payment-settlement capabilities,' which is a reasonable inference about the infrastructure supporting this shift but is not explicitly stated in the ground truth. This represents appropriate elaboration rather than error. The answer is well-structured, logically coherent, and directly addresses all aspects of the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 651,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "\nFrom 2022 to 2024 Broadcom moved custom‑touch‑controller technology from being listed simply as a discrete “wireless” product family toward being presented as an integrated component of its broader custom‑silicon and infrastructure‑software portfolio.  In the 2022 filing the controllers were described only as devices that “process signals from touch screens in mobile handsets and tablets,” whereas the 2024 filing frames them as part of a suite of custom ASICs (including inductive‑charging ASICs) that support advanced mobile‑device functionality, indicating a more mature, end‑to‑end role in the product lifecycle.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth while providing more specific and detailed evidence. STRENGTHS: (1) Correctly identifies the time period (2022 to 2024) and Broadcom as the subject company; (2) Accurately captures the core evolution from component supplier to active producer/developer; (3) Provides concrete examples (touch screen signal processing in 2022, integration with inductive-charging ASICs in 2024) that support the main thesis; (4) Uses appropriate technical terminology (ASICs, custom silicon) consistent with semiconductor industry language; (5) The multi-hop reasoning is sound - synthesizing information about product positioning across two different filing years. MINOR CONSIDERATIONS: (1) The LLM answer is more detailed and specific than the ground truth, providing additional context about the functional descriptions and integration with other components. While this adds value, it goes slightly beyond what the ground truth explicitly states; (2) The ground truth uses the phrase 'deeper engagement in their development' while the LLM uses 'more mature, end-to-end role' - these are semantically equivalent but the LLM's phrasing is arguably more precise; (3) No quantitative metrics (revenue, market share, etc.) are provided in either answer, which is appropriate given the question focuses on role evolution rather than financial metrics. VERIFICATION: The core claim that Broadcom's role evolved from supplier to producer/developer is correctly captured. The specific product descriptions (touch screen signal processing, custom ASICs, inductive charging) appear plausible for semiconductor industry evolution but cannot be independently verified against the original filings in this evaluation context. The answer demonstrates proper multi-hop synthesis across the 2022 and 2024 timeframes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 501,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "\nUnion Pacific’s capital outlay for freight‑car equipment grew from $728 million in 2023 to $788 million in 2024, and the company recorded a sizable increase in lease‑buyout spending ($143 million in 2024 versus $57 million in 2023).  This reflects a strategic shift toward acquiring more cars outright (or through buyouts) rather than relying on operating leases, supporting its stated goal of replacing older assets and expanding capacity for growth.  The decline in both finance‑lease and operating‑lease assets over the same period further underscores the move to own a larger share of the freight‑car fleet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and comprehensive. All quantitative data is correct: lease buyouts of $143 million in 2024 vs $57 million in 2023 match the ground truth exactly, and the capital outlay figures ($728M in 2023, $788M in 2024) are accurate. The multi-hop reasoning is sound - the model correctly synthesized information about the strategic shift from leasing to ownership across the two-year period. The answer goes beyond the ground truth by providing additional supporting evidence (capital outlay growth and decline in finance/operating lease assets), which strengthens rather than contradicts the core narrative. The semantic meaning is equivalent to the ground truth: both convey that Union Pacific shifted from primarily leasing freight cars in 2023 to acquiring them (including lease buyouts) in 2024. The reasoning about supporting replacement and growth opportunities is logically sound and well-supported by the data. Minor note: The LLM provides more granular detail than the ground truth (specific capital figures, lease asset declines) but this represents added value rather than error. All entities (Union Pacific, years 2023-2024, freight cars, lease buyouts) are correctly identified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 343,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "\nThe restructuring moved several APLA NIKE Brand operations from Nike’s direct sales to third‑party distributors, which cut the revenue that could be reported in the APLA geographic segment and, more sharply, in Global Brand Divisions—revenues there fell from $102 million in FY2022 to $58 million in FY2023 while APLA‑segment revenue grew only modestly.  The change required a one‑time release of foreign‑currency translation losses that had been recorded in Corporate (originally recognized as an impairment in FY2020) and prompted adjustments to sales‑related reserves and inventory, but no new impairment charge was taken in FY2022 or FY2023.  As a result, segment EBIT declined and long‑lived assets tied to the affected businesses were re‑classified to the distributor‑controlled locations.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer provides some correct directional information about the APLA restructuring but contains significant quantitative inaccuracies and introduces unsupported claims. STRENGTHS: (1) Correctly identifies the core transition from direct operations to third-party distributors; (2) Accurately notes the release of foreign currency translation losses; (3) Correctly states no new impairment charge was taken in FY2022 or FY2023; (4) Appropriately mentions adjustments to sales-related reserves and inventory; (5) Correctly identifies the strategic shift to reduce operational overhead. CRITICAL WEAKNESSES: (1) The specific revenue figures ($102M to $58M for Global Brand Divisions) are not verified in the ground truth and appear to be introduced without source attribution—these numbers cannot be confirmed as accurate; (2) Claims that foreign currency translation losses were \"originally recognized as an impairment in FY2020\" contradicts the ground truth which states they were \"non-recurring impairment charges due to the anticipated release\" in FY2022, not FY2020; (3) States losses were \"recorded in Corporate\" but ground truth does not specify this location; (4) The claim about \"long‑lived assets tied to the affected businesses were re‑classified to the distributor‑controlled locations\" is not mentioned in the ground truth. MULTI-HOP REASONING: The answer attempts to synthesize financial impacts across segments and years, but the specific quantitative claims lack grounding in the provided ground truth. The reasoning about operational efficiency is sound but goes beyond what can be verified. The answer conflates or misplaces the timing of impairment recognition (FY2020 vs FY2022). QUANTITATIVE ACCURACY: The unverified revenue figures and the FY2020 impairment claim significantly undermine confidence in the numerical precision. The answer provides specific numbers that cannot be confirmed against the ground truth provided.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 528,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "\nFrom 2022 through 2024 Broadcom continued to **keep InP‑laser wafer fabrication inside its own facilities** (primarily in the United States and Singapore) rather than outsourcing the process, using the internal III‑V fab to protect its proprietary designs and to accelerate time‑to‑market for its fiber‑optic modules.  This strategy reinforces its **competitive positioning as a differentiated supplier of high‑performance, customizable InP lasers**—leveraging its design expertise and close customer collaboration to out‑perform specialist laser vendors and integrated‑device manufacturers in data‑center and telecom applications.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core strategy of internal InP laser fabrication across 2022-2024, mentions specific geographic locations (US and Singapore), and accurately characterizes the competitive positioning aspect. The answer demonstrates understanding of the multi-hop synthesis required (evolution over time + internal strategy + competitive positioning). WEAKNESSES: (1) The LLM answer adds specific details not present in the ground truth (US and Singapore locations, time-to-market acceleration, data-center and telecom applications) that cannot be verified against the provided ground truth. While these may be factually correct from the filings, they represent information beyond what the ground truth explicitly states. (2) The ground truth specifically mentions that Broadcom 'began emphasizing the competitive landscape more explicitly' in 2024 and lists specific competitors (Coherent Corp., Lumentum Holdings Inc.), which represents a strategic shift. The LLM answer mentions competitive positioning but does not capture this temporal evolution or the specific shift in emphasis between 2022 and 2024. (3) The ground truth notes the inclusion of VCSEL and side-emitting lasers using GaAs in addition to InP lasers; the LLM answer focuses narrowly on InP lasers without mentioning the broader product portfolio. (4) The LLM answer does not explicitly address the 'evolution' aspect as clearly—it presents the strategy as consistent rather than highlighting how the emphasis and competitive framing changed from 2022 to 2024. CALCULATION/NUMERIC VERIFICATION: No specific numbers, dates, or calculations to verify. The timeframe (2022-2024) is correct. MULTI-HOP REASONING: The answer demonstrates reasonable synthesis but misses the key insight about the strategic shift in how Broadcom positioned InP lasers relative to competitors between the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 512,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "\nBetween the 2022 and 2023 Form 10‑K filings, Swoosh, LLC’s stake in NIKE’s capital structure was essentially unchanged: it continued to beneficially own about 77 % of the Class A Common Stock, which—if all of those shares were converted into Class B shares—would represent roughly 16 % of the Class B Common Stock. Because holders of Class A stock elect three‑quarters of NIKE’s board (rounded down), Swoosh’s large Class A ownership still gives it decisive influence over board composition and major corporate decisions, even though its converted Class B percentage is relatively modest. Consequently, shareholder influence remains heavily weighted toward Swoosh, limiting the impact of other investors on the company’s governance.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy and appropriate synthesis of multi-hop information. STRENGTHS: (1) All key percentages are correct - 77% Class A ownership and ~16% Class B equivalent ownership are accurately stated for both 2022 and 2023; (2) The core finding that ownership structure remained consistent between years is correct; (3) The answer correctly identifies Travis Knight's role in managing Class A shares; (4) The multi-hop reasoning is sound - connecting Class A ownership percentages to board composition influence (three-quarters of board) and then to shareholder influence implications; (5) The answer appropriately addresses both parts of the question: evolution of ownership structure AND implications for shareholder influence. MINOR CONSIDERATIONS: (1) The LLM adds detail about Class A holders electing 'three-quarters of NIKE's board (rounded down)' which, while logically sound given the 77% ownership, is not explicitly stated in the ground truth answer - this is additional context that enhances understanding but represents a slight extrapolation; (2) The phrasing 'if all of those shares were converted into Class B shares' is semantically equivalent to the ground truth's 'if all shares were converted'; (3) The conclusion about shareholder influence being 'heavily weighted toward Swoosh, limiting the impact of other investors' is a reasonable inference from the ownership concentration, though the ground truth uses slightly different language ('sustained influence'). QUANTITATIVE VERIFICATION: All numbers check out - 77% Class A, ~16% Class B equivalent, consistency between 2022-2023. No calculation errors detected. The answer maintains semantic equivalence with the ground truth while providing slightly more detailed governance implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 488,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "\nFrom 2022 through 2023 PMI moved its reduced‑risk portfolio from a distinct “Other” category into the core geographical segments, beginning with the 2022 acquisition of Swedish Match and the full integration of its ZYN oral‑nicotine and IQOS heated‑tobacco products.  By the end of 2023 the company reported that its reduced‑risk products were sold in 84 markets and that, starting in 2024, the Swedish Match results will be rolled into the four regional segments (Europe, South & Southeast Asia‑CIS & MEA, East Asia‑Australia‑PMI DF, and Americas), indicating a complete portfolio integration and broader market availability across all of PMI’s operating regions.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains both correct and incorrect information. CORRECT ELEMENTS: (1) The 84 markets figure for 2023 is accurate and matches ground truth. (2) The Swedish Match acquisition in 2022 and integration of ZYN and IQOS products is factually correct. (3) The mention of regional segment integration starting in 2024 is accurate. INCORRECT/PROBLEMATIC ELEMENTS: (1) The core claim about moving RRPs from an 'Other' category into geographical segments is not supported by the ground truth, which instead describes a shift from 'Reduced-Risk Products' to 'Smoke-Free Products' as a categorical evolution. (2) The LLM answer focuses heavily on Swedish Match acquisition and segment reorganization, but the ground truth emphasizes the categorical rebranding from RRPs to SFPs and the inclusion of wellness/healthcare offerings. (3) The LLM answer misses the key strategic shift described in ground truth: the consolidation of RRPs under a unified 'Smoke-Free Products' vision that now includes wellness and healthcare offerings, not just heated tobacco, heat-not-burn, e-vapor, and oral nicotine. (4) The answer conflates portfolio integration (segment reorganization) with the categorical/strategic positioning evolution that the question asks about. MULTI-HOP REASONING: The LLM correctly synthesized information about Swedish Match acquisition and market expansion, but failed to properly synthesize the categorical evolution from RRPs to SFPs. The answer addresses portfolio integration but misses the broader strategic positioning shift toward smoke-free products as a unified category. QUANTITATIVE ACCURACY: The 84 markets figure is correct; dates (2022, 2023, 2024) are appropriately used. QUALITATIVE ACCURACY: The reasoning about segment reorganization is sound but addresses a different aspect than the ground truth's focus on categorical/strategic positioning evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 510,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "\nBetween 2022 and 2024 Caterpillar shifted the reciprocating‑engine business from a commodity‑focused, oil‑and‑gas‑centric role to a broader, higher‑margin platform that underpins power‑generation, marine, rail and data‑center applications and is supported by its financing and aftermarket services.  This evolution is evident in the 2024 sales mix—power‑generation engine sales jumped 22 % to $7.76 bn while oil‑and‑gas engines were flat—pushing total Energy & Transportation revenue up 3 % to $28.85 bn and lifting the segment’s profit margin from 17.6 % to 19.9 %, thereby increasing the share of higher‑margin engine sales and enhancing gross‑margin potential.  (Pages 7‑11 of CAT_10K_2022; pages 37‑41 of CAT_10K_2024).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual discrepancies with the ground truth. MAJOR ISSUES: (1) The LLM provides specific financial metrics ($7.76bn power-generation sales, 22% jump, 17.6% to 19.9% margin improvement, $28.85bn total revenue) that are NOT present in the ground truth answer and cannot be verified against the provided source material. These appear to be fabricated or hallucinated numbers. (2) The LLM's narrative focuses on a shift from 'oil-and-gas-centric' to 'power-generation, marine, rail and data-center applications' - this strategic repositioning is NOT mentioned in the ground truth, which instead emphasizes the shift from selling to remanufacturing/lifecycle services. (3) The ground truth specifically identifies Perkins Engines Company Limited as a key subsidiary with 90 distributors across 171 countries - the LLM completely omits this important entity and structural detail. (4) The ground truth's core insight about remanufacturing (lower material costs, leveraging existing assets, service-based income streams) is entirely absent from the LLM answer. PARTIAL CREDIT: The LLM correctly identifies that the evolution improved gross margin potential and diversified revenue composition, which aligns with the ground truth's conclusion. However, the reasoning path and supporting evidence are fundamentally different and largely unsupported. The LLM appears to have synthesized information from a different source or generated plausible-sounding but unverified financial data. The answer fails the multi-hop reasoning test because it doesn't correctly synthesize the actual evolution described in the ground truth (seller → full lifecycle service provider via remanufacturing).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 467,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "\nBetween 2022 and 2023 BNY Mellon kept its public‑website pledge to reveal any changes to the Directors’ Code of Conduct, but it sharpened the wording to make the commitment more concrete.  In the 2022 filing the company simply said it “intends to disclose on our website any amendments or waivers” of the Directors’ Code; in the 2023 filing it restated that intent and tied the disclosure to the regular practice of posting the code (and any amendment) at a specific URL and referencing it in the forthcoming proxy filing (and, by analogy, filing the change as an exhibit).  This evolution moves the promise from a generic statement of intent to a clear, timely mechanism that stakeholders can locate and track.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer directly contradicts the ground truth on the core factual claim. The ground truth explicitly states that 'BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023' with 'no change in the specific mechanism or transparency commitment described across the two years.' However, the LLM answer claims there WAS an evolution, stating the company 'sharpened the wording to make the commitment more concrete' and moved 'from a generic statement of intent to a clear, timely mechanism.' This is a fundamental factual error. The LLM fabricates specific details about the 2022 filing saying it 'simply said it intends to disclose' versus the 2023 filing being more specific with URL references and proxy filing mentions. These details are not supported by the ground truth and appear to be hallucinated. The LLM's reasoning about the evolution being positive (moving from generic to concrete) is logically sound in isolation, but it is applied to a false premise. The answer does address the question's structure about comparing 2022 and 2023 and discussing mechanisms and transparency, but it arrives at the wrong conclusion. No numerical errors exist, but the qualitative accuracy is severely compromised by the fundamental mischaracterization of whether change occurred at all.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 377,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Nike moved from a hybrid wholesale + NIKE‑Direct footprint in the APLA region to a pure distributor model.  In FY 22 it announced the sale of its Argentina, Uruguay and Chile entities and stated that, going forward, APLA revenue would be generated through third‑party distributors—thereby slowing revenue growth but lowering selling, general and administrative costs and FX exposure, which it expects will boost overall profitability.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the core strategic shift from direct operations to a distributor model in APLA between FY22 and FY23, which aligns with the ground truth. However, there are significant issues with specificity and accuracy: (1) The LLM introduces specific geographic details (Argentina, Uruguay, Chile) and mentions an 'announcement' of sales that are not present in the ground truth, raising questions about whether these details are accurate or hallucinated. (2) The LLM characterizes the transition as moving to a 'pure distributor model,' which is more absolute than the ground truth's description of 'transitioning certain businesses' to third-party distributors—suggesting a more selective/partial transition rather than complete conversion. (3) The LLM adds business rationale details (slowing revenue growth, lowering SG&A costs, reducing FX exposure, boosting profitability) that are not mentioned in the ground truth, making it unclear if these are accurate inferences or unsupported claims. (4) The ground truth mentions APLA contributed to 14% growth in NIKE Direct in FY22, which the LLM does not address. (5) The LLM's characterization of FY22 as 'hybrid wholesale + NIKE-Direct' is reasonable but not explicitly stated in the ground truth. The answer demonstrates understanding of the directional change but introduces unverified specifics and overstates the completeness of the transition, which could be factually incorrect depending on actual filing content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 409,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "\nFrom 2022 through 2024 the contribution of favorable price realization shifted from a primary growth engine to a protective offset. In 2022 (and earlier in 2021) the company credited higher price realization as a key factor that lifted consolidated sales and drove double‑digit revenue growth, while also bolstering profit margins. By 2024, overall sales had slipped, but the same favorable price realization helped cushion the decline—offsetting lower volume and unfavorable manufacturing costs—and kept operating‑profit margin expanding to 20.2 % (up from 19.3 % in 2023), thereby preserving profitability even as top‑line growth turned negative.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly captures the qualitative evolution of favorable price realization's role from 2022 to 2024 - shifting from a growth engine to a protective offset. The narrative about offsetting volume declines and maintaining profitability is sound and well-reasoned. The mention of operating margin expansion (20.2% vs 19.3%) shows good synthesis. CRITICAL ERRORS: (1) The LLM provides operating profit margin percentages (20.2% and 19.3%) that are NOT present in the ground truth, which instead cites absolute profit figures ($10.792B in 2024 vs $10.335B in 2023). These margin figures appear to be fabricated or from different sources not verified against the knowledge graph. (2) The LLM does not cite the specific 2022 contribution figure of $9.223 billion that the ground truth explicitly states. (3) The LLM does not mention the $2.251 billion decrease in sales volume in 2024 that the ground truth specifically quantifies. PARTIAL CREDIT: The LLM correctly identifies that favorable price realization offset volume declines in 2024 and that profitability was maintained/improved, which aligns with the ground truth's core message. However, the introduction of unverified margin percentages and omission of key quantitative figures from the ground truth significantly undermines accuracy. The answer demonstrates good qualitative reasoning but fails on quantitative precision, which is critical for financial analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 400,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "\nBetween 2023 and 2024 GM shifted from a broad, aspirational declaration that it would “scale EV manufacturing capabilities, reduce battery‑cell costs and build a resilient, North‑American‑focused supply chain” to concrete actions: it began securing multi‑year off‑take agreements and increasing inventory of critical battery materials, while continuing to stress the need to align new EV capacity with slower‑than‑expected adoption and to keep production costs down.  The 2024 filing therefore reflects a more execution‑oriented strategy that ties EV‑capacity expansion to a secured, scalable supply chain and tighter cost controls.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of GM's EV strategy evolution between 2023 and 2024. STRENGTHS: (1) Correctly identifies the shift from aspirational declarations to execution-oriented strategy; (2) Accurately captures the 2023 emphasis on scaling capabilities and building resilient supply chains; (3) Properly synthesizes the 2024 evolution toward concrete actions including multi-year agreements and critical material inventory; (4) Correctly identifies the regional focus (North American) across both years; (5) Appropriately emphasizes the shift toward cost controls and alignment with slower adoption rates; (6) No quantitative errors or incorrect numbers/dates. MINOR WEAKNESSES: (1) The LLM answer uses slightly more specific language about 'off-take agreements' and 'inventory of critical battery materials' than the ground truth explicitly states, though these are reasonable inferences from the filing context and align with the general thrust; (2) The ground truth mentions 'investments in raw materials suppliers' while the LLM focuses on 'inventory of critical battery materials' - these are related but not identical concepts, though both convey supply chain security; (3) The LLM answer could have been slightly more explicit about the 'risks and uncertainties' acknowledged in 2023 regarding high fixed costs and facility closure limitations, though this is a minor omission. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and correctly identifies the strategic evolution. The comparison between 2023 and 2024 approaches is logically sound and well-articulated. SEMANTIC EQUIVALENCE: The LLM answer conveys the same essential information as the ground truth with appropriate emphasis on the transition from strategic planning to operational execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 496,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "\nFrom 2022 through 2024 Pfizer’s remaining performance‑obligation exposure for Paxlovid fell sharply—​the 2022 filing disclosed sizable, multi‑year government contracts that implied billions of dollars of future deliveries, whereas the 2024 filing reports only about **$1 billion** of contracted revenue left to be recognized from those obligations (with the bulk of the earlier commitments already converted to commercial sales and revenue reversals for returned EUA courses). This decline reflects Pfizer’s transition from a pandemic‑driven, government‑procured supply model to a commercial market, signaling a markedly reduced financial commitment to Paxlovid by 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ISSUES WITH FACTUAL ACCURACY: The LLM answer makes several claims that directly contradict the ground truth: (1) The LLM states that '2022 filing disclosed sizable, multi-year government contracts that implied billions of dollars of future deliveries,' but the ground truth explicitly states 'In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid.' This is a fundamental factual error. (2) The LLM characterizes the evolution as a 'sharp fall' from 'billions of dollars' to '$1 billion,' but the ground truth indicates there were NO disclosed remaining performance obligations in 2022, making a comparison to 'billions' unsupported and misleading. (3) The LLM's narrative about 'bulk of earlier commitments already converted to commercial sales and revenue reversals for returned EUA courses' is not mentioned in the ground truth and appears to be speculative interpretation rather than fact from the filings. CORRECT ELEMENTS: The LLM correctly identifies the $1 billion figure for 2024 remaining performance obligations, which matches the ground truth. The general concept that Paxlovid transitioned from pandemic-driven to commercial is reasonable context, but it's presented as fact when the actual filing disclosures don't support the claimed 'billions' baseline in 2022. MULTI-HOP REASONING: The answer fails to properly synthesize the actual evolution described in the ground truth (undefined/not disclosed in 2022 → $1 billion in 2024). Instead, it invents a narrative about declining from 'billions' that has no basis in the provided ground truth. This represents a significant failure in accurate multi-hop synthesis across the 2022-2024 period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 468,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "\nBetween 2022 and 2023 Caterpillar moved from a baseline credit‑review of suppliers to a more proactive, risk‑focused approach.  The company deepened its credit‑quality assessments and added contractual safeguards—such as stronger security interests, insurance requirements and financial‑covenant clauses—while also embedding explicit supply‑chain‑disruption language that triggers additional oversight when demand spikes or component shortages occur.  These steps reflect a shift toward broader, pre‑emptive risk‑mitigation and contingency planning for supplier financial viability.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresentations compared to the ground truth. Key issues: (1) FACTUAL ERRORS: The LLM claims Caterpillar moved from 'baseline credit-review' to a 'more proactive, risk-focused approach' with 'stronger security interests, insurance requirements and financial-covenant clauses' - none of these specific contractual safeguards are mentioned in the ground truth. The ground truth indicates Caterpillar used 'a variety of agreements' but does not specify these particular mechanisms. (2) UNSUPPORTED CLAIMS: The LLM introduces details about 'credit-quality assessments,' 'security interests,' 'insurance requirements,' 'financial-covenant clauses,' and 'supply-chain-disruption language' that do not appear in the original answer and cannot be verified from the provided ground truth. (3) INCOMPLETE SYNTHESIS: The LLM fails to capture the actual evolution described in the ground truth: (a) 2022 approach focused on monitoring supplier financial viability as part of broader risk mitigation, (b) 2023 placed 'explicit emphasis' on supplier financial viability as the 'first risk' in supply chain disclosures, (c) 2023 reinforced 'global strategic sourcing models' for long-term relationships. (4) MISSING KEY DETAILS: The LLM does not mention the shift in prioritization (moving supplier financial viability to first position in risk disclosures) or the emphasis on long-term strategic sourcing relationships, which are central to the ground truth answer. (5) QUANTITATIVE ACCURACY: No specific numbers, dates, or metrics are provided in either answer, so this dimension is neutral, but the LLM's lack of concrete references to actual filing language is problematic. The LLM appears to have fabricated specific contractual mechanisms rather than accurately representing what Caterpillar actually disclosed about its approach evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 512,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Visa shifted its Risk and Identity Solutions from a broad, “one‑of‑five” value‑added service to a dedicated, AI‑driven fraud‑prevention suite (Visa Protect, Deep Authorization, Risk Manager) that is tightly woven into its wider “network‑of‑networks” strategy and other offerings such as Visa Direct, Visa + and open‑banking APIs.  This evolution positions risk and identity as a core, cross‑network capability that underpins both security and new money‑movement flows, rather than a standalone product line.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "MAJOR ISSUES WITH CORE ANSWER ACCURACY: The LLM answer introduces specific product names (Visa Protect, Deep Authorization, Risk Manager) and strategic concepts (network-of-networks, Visa Direct, Visa +, open-banking APIs) that are NOT present in the ground truth answer. The ground truth explicitly states that in 2022, Risk and Identity Solutions were positioned without 'detailed elaboration on specific capabilities or strategic direction,' and by 2024 they were embedded in a 'three-pillar strategy' focused on: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. The LLM answer fundamentally mischaracterizes the evolution by: (1) inventing specific product names not mentioned in ground truth, (2) describing an 'AI-driven fraud-prevention suite' focus that contradicts the ground truth's emphasis on a broader three-pillar framework, (3) introducing 'network-of-networks' and other strategic concepts not in the ground truth, and (4) emphasizing 'cross-network capability' and 'money-movement flows' which are not the core framing in the ground truth. While the LLM correctly identifies the time period (2022-2024) and the general concept of evolution/integration, it fundamentally misrepresents the actual strategic positioning described in the ground truth. The answer appears to conflate Risk and Identity Solutions with a broader fraud-prevention narrative rather than capturing the actual three-pillar value-added services framework. This is a significant factual error in multi-hop synthesis, as the LLM failed to accurately extract and represent the key strategic elements from the source documents.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 461,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s exposure to shelf‑space risk did not diminish – it evolved.  In 2022 the primary concern was the growing leverage of a few key brick‑and‑mortar retailers, with threats of reduced shelf space, delistings, higher trade discounts and the early rise of e‑commerce and private‑label competition.  By 2023 the risk broadened as retailers intensified demands over shelf‑space, inventory, sustainability and packaging standards, while alternative channels—especially rapid e‑commerce growth, subscription services and direct‑to‑consumer platforms—expanded dramatically, creating new pricing pressures and the possibility of further delistings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong overall accuracy and provides a well-structured evolution of the company's shelf space risk exposure between 2022 and 2023. STRENGTHS: (1) Correctly identifies the temporal shift from 2022 to 2023 with no date errors; (2) Accurately captures the evolution from potential risk to actively experienced challenge; (3) Properly synthesizes multiple risk factors including shelf space limitations, retailer leverage, delistings, and trade discounts; (4) Correctly identifies alternative retail channels (eCommerce, subscription services, direct-to-consumer) as expanding factors; (5) Adds relevant context about intensified retailer demands on sustainability and packaging standards; (6) No quantitative errors or miscalculations present. MINOR CONSIDERATIONS: (1) The LLM answer introduces some additional details not explicitly mentioned in the ground truth (e.g., 'higher trade discounts,' 'sustainability and packaging standards,' 'private-label competition') - while these appear reasonable and contextually appropriate for a risk evolution narrative, they represent slight elaboration beyond the ground truth; (2) The ground truth emphasizes the company's response (planning to invest in digital and analytics capabilities), which the LLM answer does not explicitly mention, though this is a minor omission; (3) The phrasing 'did not diminish – it evolved' is a strong characterization that aligns well with the ground truth's 'shift from potential risk to actively experienced challenge.' MULTI-HOP REASONING: The answer successfully synthesizes information across the 2022-2023 timeframe and correctly connects retail customer policy changes with the expansion of alternative channels. The logical flow from brick-and-mortar retailer leverage to broader eCommerce and alternative channel expansion is sound and well-reasoned. Overall, this is a high-quality answer with accurate core facts and appropriate contextual elaboration.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 531,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 Oracle shifted hybrid from a “choice‑and‑flexibility” positioning to a central growth pillar.  In 2023 it highlighted hybrid options such as Exadata Cloud@Customer, Dedicated Regions and multicloud connectivity, and introduced programs to help customers pivot existing licenses to the Oracle Cloud.  By 2024 the company broadened that portfolio (e.g., expanded OCI services, AI‑driven Autonomous Database, subscription‑based SaaS) and explicitly tied hybrid adoption to revenue growth—cloud‑services revenue rose from 25 % to 37 % of total sales—signaling a strategic emphasis on accelerating customer migration and multi‑cloud interoperability as a driver of future earnings.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIED QUANTITATIVE CLAIMS: The LLM introduces specific revenue percentages (cloud-services revenue rose from 25% to 37% of total sales) that are NOT present in the ground truth answer. These numbers cannot be verified against the original answer and appear to be fabricated or hallucinated data points. This is a major factual error for a financial question. (2) SCOPE CREEP: The LLM significantly expands beyond the ground truth by introducing specific product details (AI-driven Autonomous Database, subscription-based SaaS) and revenue metrics that were not mentioned in the original answer. While some expansion is acceptable, introducing unverified financial metrics is problematic. (3) PARTIAL ALIGNMENT: The LLM correctly identifies the core evolution from 'choice-and-flexibility' positioning to a growth pillar, and correctly mentions Exadata Cloud@Customer and Dedicated Regions. It also appropriately notes the shift toward deeper integration and multi-cloud interoperability. (4) MULTI-HOP REASONING: The reasoning connecting hybrid deployment evolution to revenue growth is logical but relies on unverified numbers. The synthesis of product offerings and strategic emphasis is reasonable but overstated with unsupported claims. (5) SEMANTIC ISSUES: The characterization of the shift as moving from 'choice-and-flexibility' to a 'central growth pillar' is a reasonable interpretation but goes beyond what the ground truth explicitly states. The ground truth says Oracle 'continued to support' hybrid deployments with 'deeper integration,' not that it became a central growth pillar. VERDICT: The answer demonstrates understanding of the general direction of Oracle's hybrid strategy evolution but introduces unverified financial metrics (25% to 37% revenue figures) that cannot be confirmed from the ground truth, which is a critical failure for financial analysis questions. The core narrative is partially correct but embellished with unsupported claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 537,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "\nBetween 2022 and 2024 Pfizer’s financial exposure to Paxlovid fell sharply.  In 2022 the drug generated ≈ $19 billion of revenue and was part of a roughly $4 billion portfolio of remaining performance obligations for Comirnaty + Paxlovid, implying sizable future contract volumes.  By the 2024 filing the company reports only about $1 billion of contracted revenue left to be recognized from Paxlovid‑related long‑term orders (to be earned through 2025‑2028), reflecting the transition from government‑procured EUA supply to commercial‑market sales and a corresponding reduction in expected future cash inflows.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of Pfizer's Paxlovid financial evolution between 2022 and 2024. STRENGTHS: (1) Correctly identifies the $1 billion remaining performance obligations as of December 31, 2024, matching the ground truth exactly. (2) Accurately captures the 2025-2028 revenue recognition timeline. (3) Provides valuable context about the transition from government EUA procurement to commercial markets, which explains the reduction. (4) The ~$19 billion 2022 revenue figure is accurate and provides helpful context for the magnitude of decline. (5) Multi-hop reasoning is sound - synthesizes information about both 2022 and 2024 positions to show the evolution. (6) Correctly identifies this as a 'sharp fall' in financial exposure, which is semantically equivalent to the ground truth's 'continued but reduced financial commitment.' MINOR CONSIDERATIONS: (1) The LLM mentions a 'roughly $4 billion portfolio of remaining performance obligations for Comirnaty + Paxlovid' in 2022 - while this provides context, the ground truth doesn't explicitly state this combined figure, though it's not contradicted. (2) The answer goes slightly beyond the ground truth by explicitly discussing the EUA-to-commercial transition mechanism, which is insightful but not explicitly confirmed in the provided ground truth. (3) The phrasing 'financial exposure fell sharply' is slightly more dramatic than the ground truth's 'continued but reduced,' though both convey the same directional change. QUANTITATIVE VERIFICATION: $1 billion figure (2024) ✓, 2025-2028 timeline ✓, ~$19 billion 2022 revenue ✓. All calculations and comparisons are logically sound. The answer effectively addresses the multi-hop nature of the question by synthesizing 2022 and 2024 data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 484,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "\nBetween 2022 and 2023 the basic dealer contract – a standard sales‑and‑service agreement that grants territorial rights, obligates dealers to promote and sell Caterpillar products, maintain inventory and financial records, and receive price‑setting, IP‑defense and warranty support from the company, with either party able to terminate on 90‑day notice – remained unchanged.  However, the 2023 filing places a stronger strategic emphasis on collaborative marketing and financing programs (e.g., revenue‑sharing incentives and dealer‑driven product‑improvement initiatives) and on the dealer’s role in expanding Caterpillar’s global market presence, while still requiring the same core contractual duties of sales‑force staffing, record‑keeping and data sharing.  In short, the contractual framework is stable, but the company is now highlighting a more partnership‑focused, dealer‑centric growth agenda.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer fundamentally contradicts the ground truth on the core claim about contractual evolution. Ground truth states there was a clear shift FROM general partnership descriptions in 2022 TO formalized standardized agreements in 2023. The LLM claims the basic dealer contract 'remained unchanged' between 2022 and 2023, which directly contradicts the ground truth's assertion of formalization and structuring. This is a critical factual error on the main question. The LLM does correctly identify some contractual elements (territorial rights, promotion obligations, record-keeping, 90-day termination notice) that align with the ground truth's description of 2023 agreements. However, the LLM introduces claims about 'collaborative marketing and financing programs,' 'revenue-sharing incentives,' and 'dealer-driven product-improvement initiatives' that are not mentioned in the ground truth and appear to be fabricated details. The LLM's characterization of the evolution as merely a shift in 'strategic emphasis' from contractual to partnership-focused, while the contract itself remained stable, is inconsistent with the ground truth's clear statement that 2023 represented 'a shift from a general partnership model to a more structured contractual framework.' The LLM fails to capture the key distinction: 2022 had general descriptions, 2023 had detailed formalized agreements with specific obligations. The answer demonstrates poor multi-hop synthesis by missing the temporal evolution that is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 421,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "\nFrom 2022 to 2023 the company pulled back sharply on the resources it devoted to Africa/Eurasia.  The 2022 Global Productivity Initiative recorded $110 million of pretax restructuring charges in 2022, but only $32 million of pretax charges in 2023—a drop of roughly 70 percent—reflecting a smaller allocation of implementation costs to the region (consistent with the 10 percent share of cumulative charges earmarked for Africa/Eurasia).  Accordingly, while early‑year capital‑expenditure data show modest growth in the region, the later‑year pull‑back in restructuring spend signals a reduced operational focus on Africa/Eurasia in favor of other segments.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and misinterpretations of the ground truth data. CRITICAL ERRORS: (1) The LLM claims the 2022 Global Productivity Initiative recorded $110 million in 2022 and $32 million in 2023, but the ground truth makes no mention of these specific figures or a 70% drop in restructuring charges. These numbers appear to be fabricated or confused with other data. (2) The LLM mischaracterizes the evolution: it claims the company 'pulled back sharply' on Africa/Eurasia resources, but the ground truth shows capital expenditures actually INCREASED from $13M (2021) to $33M (2022), indicating growth-oriented allocation. (3) The LLM incorrectly interprets the 10% figure as evidence of 'reduced operational focus,' when the ground truth explicitly states this represents a 'shift in focus toward restructuring and cost optimization' - not a pullback, but a strategic reorientation. (4) The LLM's statement about 'early-year capital-expenditure data show modest growth' contradicts its own conclusion about pulling back sharply. CORRECT ELEMENTS: The LLM does correctly identify the 10% share of cumulative charges for Africa/Eurasia and attempts to address the shift from capital investment to restructuring. However, the overall narrative is inverted - the ground truth shows growth in capex followed by restructuring focus, not a sharp pullback. The multi-hop reasoning fails because the LLM introduces unsupported numbers and draws conclusions opposite to the ground truth's characterization of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 428,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "\nFrom 2022 to 2024 Qualcomm shifted its 5G strategy from a handset‑centric push—focused on securing modem, RF front‑end and patent‑licensing leadership for premium smartphones—to a cross‑industry agenda that embeds 5G in automotive, IoT and AI‑enabled platforms.  The company increased R&D and capital spending on 5G‑standard‑essential patents and new 5G‑centric product families (e.g., Snapdragon 5G modem‑RF, RFFE modules) while expanding licensing of 5G‑related IP beyond smartphones, leading to broader commercial deployments in non‑handset markets and higher royalty revenues from 5G‑related licenses.  (2022 10‑K pp. 19‑23; 2024 10‑K pp. 11‑15)",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer captures some correct directional elements but contains significant issues: (1) CORRECT ELEMENTS: The answer correctly identifies that Qualcomm shifted from handset-centric to cross-industry focus (automotive, IoT), increased R&D/capital spending on 5G, and expanded licensing beyond smartphones. The timeframe (2022-2024) is correct. (2) PROBLEMATIC ELEMENTS: The LLM answer emphasizes a shift FROM handset-centric TO cross-industry, but the ground truth indicates Qualcomm was ALREADY pursuing cross-industry expansion in 2022 (automotive, IoT mentioned as part of 2022 strategy). The LLM's framing suggests handsets were the primary focus in 2022, which misrepresents the ground truth. (3) MISSING KEY INSIGHT: The ground truth's critical distinction is the evolution from INVESTMENT/DEVELOPMENT PHASE (2022) to COMMERCIALIZATION/MONETIZATION PHASE (2024). The LLM mentions increased spending but doesn't clearly articulate this maturation from development to market leadership and revenue generation. (4) QUANTITATIVE ISSUES: The LLM provides no specific financial metrics, revenue figures, or patent portfolio data that could be verified. The ground truth mentions 'majority of QTL revenues from OFDMA-based products' - the LLM doesn't quantify commercialization outcomes. (5) CITATION CONCERN: The LLM cites specific page numbers (2022 10-K pp. 19-23; 2024 10-K pp. 11-15) without verification that these pages contain the claimed information. (6) MULTI-HOP REASONING: The answer attempts to synthesize across years but oversimplifies the strategic evolution. The ground truth shows a more nuanced progression from risk-laden investment to proven market leadership, which the LLM doesn't fully capture. The answer is directionally reasonable but lacks precision on the key strategic transition and provides no quantifiable commercialization outcomes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 506,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "\nBetween 2022 and 2024 Paxlovid’s revenue share fell sharply – from **$18.9 bn in 2022** to **$1.3 bn in 2023** and then modestly rebounded to **$5.7 bn in 2024** as the product moved from government‑procured EUA sales to commercial market sales.  The 2023‑24 period included a **$3.5 bn non‑cash revenue reversal** (later adjusted by a **$771 m favorable adjustment** in early 2024) reflecting returns of U.S. government inventory, and the company now reports **≈ $1 bn of remaining performance‑obligation revenue** for Paxlovid that will be recognized through 2028, with about **$2.2 bn of deferred revenue** still on the books as of Dec 31 2024.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamentally incorrect financial figures that directly contradict the ground truth. CRITICAL ERRORS: (1) The LLM claims Paxlovid generated $18.9 billion in 2022, but the ground truth states $76 million - a massive discrepancy of over 248x the actual figure. (2) The LLM provides 2023 ($1.3bn) and 2024 ($5.7bn) revenue figures that are not mentioned in the ground truth and appear to be fabricated. (3) The LLM cites a $3.5 billion revenue reversal and $771 million adjustment that are not present in the ground truth. (4) While the LLM correctly identifies ~$1 billion in remaining performance obligations (matching ground truth), this single correct data point is overwhelmed by multiple false claims. (5) The LLM mentions $2.2 billion in deferred revenue as of Dec 31, 2024, which is not mentioned in the ground truth. REASONING ISSUES: The LLM attempts to construct a narrative about EUA-to-commercial transition and government inventory returns, but this narrative is built on fabricated numbers rather than actual filing data. The multi-hop synthesis fails because the underlying financial data is incorrect. WHAT WAS CORRECT: Only the ~$1 billion remaining performance obligations figure aligns with ground truth. WHAT WAS WRONG: All major revenue figures (2022, 2023, 2024), the revenue reversal amounts, and the deferred revenue figure are either incorrect or unsupported by the ground truth. The answer demonstrates a fundamental failure to accurately extract and synthesize financial data from SEC filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 424,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "\nBetween 2022 and 2023 the company’s discussion of supply‑chain risk evolved from a brief mention of “the impact on our suppliers of tighter credit or capital markets” to a more explicit and prominent warning that tightening credit and capital markets can directly disrupt the availability of key raw and packaging materials. This shift shows that the firm now views external financial conditions—not just operational or geopolitical shocks—as a material source of supply‑chain vulnerability, increasing its exposure to any further credit‑market stress.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant semantic and directional errors despite some correct elements. CORRECT ELEMENTS: (1) The answer correctly identifies that there was an evolution in the company's discussion between 2022 and 2023, (2) It correctly notes that credit/capital market tightness was discussed in both years, (3) The general framing that external financial conditions became more material is directionally aligned. CRITICAL ERRORS: (1) DIRECTIONAL REVERSAL - The ground truth states the 2022 framing was about impact on SUPPLIERS, while 2023 showed broader impact on the COMPANY'S OPERATIONS. The LLM reverses this, claiming 2022 was a 'brief mention' and 2023 was 'more explicit and prominent' - this contradicts the ground truth which shows the shift was from supplier-focused to company-operations-focused, not from brief to prominent. (2) MISCHARACTERIZATION - The LLM claims the 2023 framing shows 'direct disruption' to materials availability, but the ground truth indicates 2023 shows the company is 'impacted by' these conditions (passive/broader), not that there's direct disruption. (3) INCOMPLETE SYNTHESIS - The LLM fails to capture the key distinction in the ground truth: the evolution reflects a shift in PERSPECTIVE (from supplier impact to company impact) rather than an increase in severity or prominence. (4) LOGICAL INFERENCE ERROR - The LLM concludes this shows 'increasing exposure' to credit stress, but the ground truth suggests a 'continuation of concern' with 'more integrated perspective' - these are subtly but importantly different. The answer demonstrates weak multi-hop reasoning by failing to properly synthesize the nuanced shift in how the company frames its vulnerability across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 474,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "\nFrom 2022 to 2024 Pfizer’s Paxlovid‑related financial commitments shifted dramatically: the drug generated $18.9 billion of revenue in 2022, but as government‑procured EUA supplies were wound down the company recorded a $3.5 billion non‑cash revenue reversal in Q4 2023 and only $1.28 billion of revenue in 2023. By the end of 2024 Paxlovid had returned to commercial sales, producing $5.7 billion of revenue, while remaining performance obligations totaled roughly $1 billion of contracted revenue (with about $2.2 billion of deferred revenue still on the books) that is expected to be recognized through 2025‑2028 as the company fulfills long‑term supply agreements. Thus, Pfizer’s fiscal exposure to Paxlovid moved from a peak of nearly $19 billion in 2022 to a much smaller, contract‑backed stream of about $1 billion plus deferred balances that will be realized over the next few years.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides substantial additional context and detail beyond the ground truth, demonstrating strong multi-hop synthesis across multiple years and financial metrics. STRENGTHS: (1) Correctly identifies the $1 billion remaining performance obligations as of December 31, 2024, matching ground truth exactly. (2) Accurately captures the 2025-2028 delivery timeline. (3) Provides valuable context about the 2022 peak revenue ($18.9B), 2023 revenue reversal ($3.5B), and 2024 recovery ($5.7B) that illustrates the evolution of Pfizer's financial commitment. (4) Correctly notes the $2.2 billion deferred revenue balance. (5) Demonstrates sound multi-hop reasoning by synthesizing revenue trends, regulatory changes, and contractual obligations across multiple years. (6) Appropriately contextualizes the shift from government EUA procurement to commercial sales. MINOR ISSUES: (1) The ground truth mentions a '$771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government' in 2024, which the LLM answer does not explicitly address. This is a specific 2024 financial adjustment disclosed in the filings that represents an important contractual dynamic. (2) The ground truth emphasizes that obligations are 'subject to renegotiation,' which the LLM answer does not mention. (3) The LLM answer references '2023' revenue of $1.28B but ground truth focuses on 2022-2024 evolution; however, this is actually helpful context for understanding the trajectory. QUANTITATIVE VERIFICATION: All major numbers appear accurate ($18.9B 2022 revenue, $3.5B reversal, $1.28B 2023 revenue, $5.7B 2024 revenue, $1B RPO, $2.2B deferred revenue, 2025-2028 timeline). The answer goes beyond ground truth by providing more comprehensive financial context while maintaining accuracy on the core metrics. The omission of the $771M adjustment is the primary gap, though it's a relatively specific detail that doesn't undermine the overall accuracy of the evolution narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 551,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "\nFrom 2023 to 2024 the Company’s recorded exposure to Aearo‑related respirator‑mask/asbestos liability fell slightly: the accrual for respirator‑mask/asbestos claims (excluding Aearo) dropped from **$574 million at 12/31/23 to $523 million at 12/31/24**, reflecting a **$36 million increase in accrual during 2024** (after a $57 million accrual increase in 2023).  Cash outflows for legal defense and settlements stayed roughly constant (~$88 million in 2023 and $87 million in 2024), and Aearo’s own accrual fell from **$62 million to $51 million** over the same period.  The Company continues to note that the ultimate liability may exceed these accruals because of inherent uncertainties—projected future claims through ~2050, joint‑and‑several liability among multiple defendants, and the difficulty of estimating an upper bound of exposure.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "MAJOR ERRORS IDENTIFIED: The LLM answer contains significant factual inaccuracies that contradict the ground truth:\n\n1. QUANTITATIVE ACCURACY - CRITICAL ERRORS:\n   - LLM states accrual (excluding Aearo) dropped from $574M to $523M. Ground truth confirms $574M in 2023 but does NOT provide a 2024 figure of $523M for the excluding-Aearo category. This appears to be fabricated.\n   - LLM claims a $36M increase in 2024 accrual, but if the accrual fell from $574M to $523M, that would be a $51M DECREASE, not an increase. This is a fundamental calculation error.\n   - LLM states Aearo's accrual fell from $62M to $51M. Ground truth only mentions $51M for 2024 and does NOT provide a $62M figure for 2023. This is incorrect.\n   - LLM cites $88M and $87M cash outflows. Ground truth does not mention these figures at all.\n\n2. COMPLETENESS - MISSING KEY INFORMATION:\n   - LLM completely omits the critical Cabot agreement detail: Cabot assumed responsibility for pre-1997 claims while Aearo pays $100,000 quarterly. This is a major structural change in liability framework mentioned in ground truth.\n   - LLM fails to characterize the shift from bankruptcy protection (2023) to a defined liability framework (2024).\n   - LLM does not explain the bankruptcy stay of litigation in 2023.\n\n3. ENTITY/METRIC ACCURACY:\n   - Correctly identifies MMM/Aearo and respirator/asbestos litigation.\n   - Correctly identifies 2023 and 2024 periods.\n   - However, the specific accrual figures are largely incorrect or unsupported.\n\n4. REASONING QUALITY:\n   - The multi-hop synthesis is incomplete. The answer focuses on accrual trends but misses the contractual risk-sharing arrangement with Cabot, which is central to understanding how liability evolved.\n   - The characterization of exposure as \"fell slightly\" is contradicted by the stated numbers (if $574M to $523M, that's a $51M or 8.9% decrease, not \"slight\").\n   - The answer does not explain the fundamental shift in liability structure from 2023 to 2024.\n\n5. SEMANTIC EQUIVALENCE:\n   - While the answer attempts to address the evolution question, it does so with incorrect numbers and missing the key contractual framework that defines the 2024 liability structure.\n\nCONCLUSION: The LLM answer appears to have fabricated or misremembered specific accrual figures ($523M, $62M, cash outflows) that are not supported by the ground truth. It also omits the critical Cabot agreement that fundamentally changed Aearo's liability exposure. These are not minor wording differences but substantive factual errors that make the answer misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 690,
        "total_tokens": 2108
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "\nThe retail‑share of Skoal fell from **9.3 % in 2023 to 7.6 % in 2024**, a drop of about **1.7 percentage points** (≈18 % relative decline).  \nBy contrast, Skoal’s shipment volume was **208.5 million units in 2020 and 197.4 million units in 2021**, a reduction of roughly **5 %** over that earlier period.  \nThus, both share and volume have been trending downward, but the decline in retail share between 2023 and 2024 is larger in relative terms than the 2020‑21 shipment‑volume dip.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy across all dimensions. QUANTITATIVE VERIFICATION: All numbers are correct - retail share 9.3% (2023) to 7.6% (2024), shipment volume 208.5M units (2020) to 197.4M units (2021). The calculated decline of 1.7 percentage points is accurate (9.3 - 7.6 = 1.7). The relative decline calculation of approximately 18% is correct (1.7/9.3 ≈ 0.183 or 18.3%). The shipment volume reduction of roughly 5% is accurate ((208.5-197.4)/208.5 ≈ 0.053 or 5.3%). MULTI-HOP REASONING: The answer correctly synthesizes information across two distinct time periods (2023-2024 and 2020-2021) and two different metrics (retail share and shipment volume), properly comparing their trends. The conclusion that both show downward trends is sound. COMPLETENESS: All parts of the multi-part question are addressed - the retail share change, the shipment volume trend, and the comparison between the two periods. MINOR OBSERVATION: The LLM goes slightly beyond the ground truth by providing calculated percentages and relative comparisons (18% relative decline, 5% volume reduction), which adds analytical value without introducing errors. The statement that the 2023-2024 retail share decline is 'larger in relative terms' than the 2020-2021 volume decline is a valid analytical insight. ENTITY ACCURACY: Skoal and MO (Altria) are correctly identified. All metrics and time periods are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 392,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "\nFrom 2022 to 2024 Qualcomm moved its multimedia engineering focus from a primarily camera‑video‑display pipeline toward a full‑stack, AI‑enabled multimedia platform.  The company added dedicated NPU/GPU engines, sensor‑perception and computer‑vision capabilities, and integrated these functions into Snapdragon SoCs that now serve smartphones as well as automotive, IoT and XR devices, reflecting a broader R&D investment in AI‑driven multimedia and tighter integration of multimedia, connectivity and AI across its QCT product offerings.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly identifies the core evolution from 2022 to 2024, capturing the shift toward AI-enabled multimedia platforms. (2) Accurately mentions key technologies: camera, video, display, computer vision, and sensor perception. (3) Correctly identifies expansion into automotive, IoT, and XR devices. (4) Properly emphasizes the integration of AI/generative AI into the strategy. (5) No quantitative errors or incorrect dates. WEAKNESSES: (1) The LLM introduces specific technical details (NPU/GPU engines, Snapdragon SoCs, QCT product offerings) that are not explicitly mentioned in the ground truth. While these may be factually accurate about Qualcomm, they represent an inference beyond what the knowledge graph provided. (2) The ground truth emphasizes a shift from 'hardware-centric' to 'platform-oriented, AI-enhanced approach,' but the LLM frames this as moving from a 'camera-video-display pipeline' to a 'full-stack' approach - slightly different framing that adds specificity not in the original. (3) The LLM mentions 'tighter integration of multimedia, connectivity and AI across its QCT product offerings' - while QCT is Qualcomm's business unit, this specific phrasing about QCT integration is not explicitly stated in the ground truth. (4) Missing explicit mention of the 2022 focus on 'enhancing existing products and developing new technologies for industries beyond mobile handsets' as a distinct strategic element. MULTI-HOP REASONING: The LLM successfully synthesizes information across the 2022-2024 timeframe and correctly identifies the evolution pattern. However, it adds technical specificity that goes beyond the ground truth synthesis. SEMANTIC EQUIVALENCE: The core message aligns with the ground truth, but the LLM adds interpretive details that, while potentially accurate, represent inference rather than direct synthesis from the provided knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 515,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "\nAfter the June 2023 dismissal of the Aearo Entities’ Chapter 11 filing, 3M re‑consolidated those entities in the second quarter of 2023.  As of December 31 2023 the company disclosed a $0.7 billion equity‑investment balance in “other assets” and a $0.6 billion net inter‑company liability (shown in other liabilities/other assets) representing amounts due from 3M to the former de‑consolidated entities.  These balances remained on the consolidated balance sheet through 2024, with no material change reported, indicating that 3M’s equity stake and the related intercompany receivable/payable persisted unchanged after the reconsolidation.",
      "correctness_score": 3,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 2,
      "contextual_relevance": 4,
      "detailed_feedback": "CRITICAL ERRORS IN CORE NARRATIVE: The LLM answer fundamentally misrepresents the evolution of 3M's relationship with the Aearo Entities between 2023 and 2024. (1) QUANTITATIVE ACCURACY: The numbers cited ($0.7 billion equity investment and $0.6 billion net intercompany liability) are correctly stated for the 2023 position. However, the LLM claims these balances 'remained on the consolidated balance sheet through 2024, with no material change reported,' which directly contradicts the ground truth. (2) CORE FACTUAL ERROR: The ground truth explicitly states that 'By 2024, the Aearo Entities were no longer consolidated' and that 3M 'now has a stake in them, indicating a shift from full consolidation to a retained equity interest.' The LLM answer completely misses this critical transition - it suggests the entities remained consolidated through 2024 with unchanged balances, when in fact they were deconsolidated. (3) MULTI-HOP REASONING FAILURE: The question asks how the relationship 'evolved between 2023 and 2024.' The ground truth shows a clear evolution: reconsolidation in 2023 (with specific balance sheet impacts) followed by deconsolidation in 2024 (shifting to a retained equity interest). The LLM fails to capture this evolution, instead claiming stasis. (4) MISSING KEY INFORMATION: The LLM does not address the shift from consolidated to non-consolidated status, which is the central point of how the relationship evolved. The answer describes the 2023 position adequately but completely fails on the 2024 position and the year-over-year change. (5) SEMANTIC MISALIGNMENT: While the LLM correctly identifies the 2023 reconsolidation event and the specific dollar amounts, it fundamentally misunderstands the 2024 status and therefore fails to answer the core question about evolution. This is not a wording difference but a substantive factual error about the financial relationship structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 517,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2024 Visa’s Risk and Identity Solutions shifted from a set of discrete fraud‑prevention tools (e.g., Visa Advanced Authorization, Visa Secure, Advanced Identity Score, CardinalCommerce) to an integrated, AI‑driven “Visa Protect” suite that spans card‑present, card‑not‑present and real‑time account‑to‑account payments.  This evolution positions the solutions as a core component of Visa’s broader Value‑Added Services portfolio, reinforcing the company’s “network‑of‑networks” strategy and enabling monetisation of new money‑movement flows such as B2B, cross‑border and tokenised transactions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and introduces information not supported by the ground truth. Key issues: (1) MAJOR ERROR - The LLM introduces 'Visa Protect' as a unified suite, which is not mentioned in the ground truth. This appears to be fabricated or confused with actual Visa offerings. (2) PRODUCT NAMING - While the LLM correctly names some products (Visa Advanced Authorization, Visa Secure, CardinalCommerce), it adds 'Advanced Identity Score' which is not mentioned in the ground truth. (3) MISSING CORE FACTS - The LLM fails to mention the critical evolution described in ground truth: the elevation of Risk and Identity Solutions as ONE OF FIVE core categories in the value-added services portfolio by 2024, and the mention of 200+ products/services as of September 30, 2024. (4) INCORRECT FRAMING - The ground truth emphasizes integration within a diversified services ecosystem including Open Banking Solutions and Advisory Services. The LLM instead focuses on payment types (card-present, card-not-present, account-to-account) which is a different dimension not highlighted in the ground truth. (5) UNSUPPORTED CLAIMS - References to 'network-of-networks' strategy and monetization of B2B/cross-border/tokenized transactions are not present in the ground truth provided. (6) PARTIAL CREDIT - The LLM does correctly identify the shift from discrete tools to integrated solutions and recognizes Risk and Identity Solutions as part of broader VAS portfolio, which aligns with ground truth. However, the specific details and strategic positioning are either missing or inaccurate. The answer demonstrates some understanding of the evolution but introduces fabricated elements and misses key quantitative and strategic details from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 483,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "\nIn its 2023 filing RTX disclosed acquisition‑accounting adjustments that reduced consolidated operating profit by **$1.998 bn** – $854 m from Collins Aerospace, $287 m from Pratt & Whitney and $857 m from Raytheon – mainly consisting of amortization of acquired intangibles, PP&E fair‑value adjustments and customer‑contractual obligations. The 2024 filing reports a slightly larger negative impact of **$2.058 bn**, with the same three components now broken out as $833 m (Collins), $312 m (Pratt & Whitney) and $913 m (Raytheon), reflecting higher amortization of intangibles and PP&E fair‑value write‑ups. Thus, while the composition of the adjustments stayed consistent, the magnitude of the profit drag grew modestly from 2023 to 2024, and the disclosure added a more detailed segment‑level breakdown and a note that these charges are excluded from management’s performance evaluation.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that directly contradict the ground truth. (1) CRITICAL ERROR - 2024 QUANTIFICATION: The ground truth explicitly states that RTX's 2024 filing did NOT include updated quantitative figures for the current year's impact on operating profit, shifting instead to qualitative policy context. The LLM claims the 2024 filing reports a $2.058 bn impact with detailed segment breakdowns ($833m Collins, $312m P&W, $913m Raytheon). This is factually incorrect - the 2024 filing did not provide these numbers. (2) MISCHARACTERIZATION OF DISCLOSURE EVOLUTION: The ground truth describes a shift FROM quantitative disclosure (2023: $1,998m) TO qualitative disclosure (2024: no quantified figures). The LLM incorrectly portrays 2024 as continuing and expanding quantitative disclosure with segment-level detail. This is the opposite of what actually occurred. (3) CORRECT 2023 NUMBERS: The LLM correctly identifies the 2023 impact as $1.998 bn (matching $1,998 million in ground truth) and correctly breaks down the 2023 components ($854m Collins, $287m P&W, $857m Raytheon). However, this accuracy is overshadowed by the fabricated 2024 figures. (4) MULTI-HOP REASONING FAILURE: The question asks how disclosure 'evolved' between 2023 and 2024. The ground truth shows a qualitative shift in disclosure methodology (quantitative→qualitative). The LLM misses this entirely and instead invents a narrative of continued quantification with growing magnitude. (5) SEMANTIC MISALIGNMENT: The LLM's core claim that 'the magnitude of the profit drag grew modestly from 2023 to 2024' cannot be verified and contradicts the ground truth's assertion that 2024 did not provide updated quantitative figures. The answer demonstrates hallucination of specific financial data for 2024 that does not exist in the actual filing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 501,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "\nBetween fiscal 2022 and fiscal 2023 Microsoft Cloud revenue rose from **$91.4 billion to $111.6 billion**, and the Office 365 Commercial business—identified in the filings as a core component of that cloud revenue—posted double‑digit growth (≈ 18 % YoY).  Consequently, the share of Microsoft Cloud attributable to Office 365 Commercial increased modestly, highlighting that Office 365 Commercial is not only expanding in absolute dollars but also becoming an increasingly dominant driver of Microsoft’s overall cloud growth trajectory.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 6,
      "detailed_feedback": "STRENGTHS: (1) The LLM correctly cited the Microsoft Cloud revenue figures ($91.4B in FY2022 and $111.6B in FY2023), which are accurate. (2) The LLM properly identified Office 365 Commercial as a component of Microsoft Cloud revenue. (3) The overall structure acknowledges the growth trajectory. WEAKNESSES: (1) CRITICAL ERROR - The LLM states Office 365 Commercial posted '≈18% YoY' growth, but the ground truth indicates the 18% figure refers to the overall Productivity and Business Processes segment revenue increase in FY2022, NOT specifically to Office 365 Commercial's growth rate. This is a significant misattribution. (2) UNSUPPORTED CLAIM - The LLM asserts that 'the share of Microsoft Cloud attributable to Office 365 Commercial increased modestly' and that it is 'becoming an increasingly dominant driver,' but the ground truth does not provide specific Office 365 Commercial revenue figures for FY2023 or comparative share data. The LLM made an inference not supported by the source material. (3) INCOMPLETE SYNTHESIS - The ground truth mentions that by FY2023, Office 365 Commercial was part of a 'newly disclosed consolidated Microsoft Cloud revenue figure' that includes Azure, LinkedIn (commercial), Dynamics 365, and other services. The LLM failed to acknowledge this broader consolidation context and the shift in disclosure methodology. (4) REASONING FLAW - The LLM's conclusion about Office 365 Commercial becoming 'increasingly dominant' lacks evidentiary support from the filings. The ground truth indicates it was a 'key growth driver' in FY2022 but doesn't establish dominance or increasing share in FY2023. QUANTITATIVE VERIFICATION: The $91.4B and $111.6B figures are correct (7/10 for accuracy of cited numbers, but -3 for misattribution of the 18% growth rate). QUALITATIVE ASSESSMENT: The reasoning contains logical leaps and unsupported inferences (5/10). The answer partially addresses the question but makes claims beyond what the source material supports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 536,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "\nMerck’s alliance revenue from Lynparza rose from **$1.199 billion in 2023 to $1.311 billion in 2024** – an increase of roughly **9 %** (11 % when adjusted for foreign‑exchange effects).  The growth was driven primarily by **higher demand for Lynparza in most international markets**, supported by new regulatory approvals (e.g., the 2025 Chinese NMPA approval for an adjuvant breast‑cancer indication) and the continued expansion of the AstraZeneca collaboration that generates the alliance‑revenue share.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "CRITICAL ISSUES: (1) UNVERIFIABLE NUMBERS: The LLM provides specific dollar amounts ($1.199B in 2023, $1.311B in 2024) that cannot be verified against the ground truth. The original answer does not provide these specific figures, only stating that alliance revenue 'grew by 9%' without citing absolute values. The LLM appears to have fabricated precise numbers. (2) CALCULATION VERIFICATION: The LLM claims growth from $1.199B to $1.311B equals 9% (or 11% FX-adjusted). Manual calculation: ($1.311B - $1.199B) / $1.199B = $0.112B / $1.199B = 9.34%, which rounds to 9%. However, since the base numbers themselves are unverified, this calculation cannot be validated. (3) EXTRA DETAILS NOT IN GROUND TRUTH: The LLM introduces specific information about '2025 Chinese NMPA approval for adjuvant breast-cancer indication' and references to 'AstraZeneca collaboration' that are not mentioned in the original answer. While these may be factually accurate from SEC filings, they go beyond what the ground truth confirms and represent potential hallucination or unsourced claims. (4) ALIGNMENT WITH GROUND TRUTH: The core finding (9% growth driven by higher international demand) matches the original answer's semantic content. However, the specific dollar figures and additional regulatory details are not corroborated. (5) MULTI-HOP REASONING: The answer does synthesize information about growth drivers and market factors, but the foundation (specific revenue numbers) is questionable. The reasoning quality is reasonable IF the numbers were correct, but their unverified nature undermines the entire response. VERDICT: While the directional finding (9% growth, international demand driver) aligns with ground truth, the introduction of specific unverified dollar amounts and additional details not in the original answer represents a significant accuracy problem. The LLM appears to have added specificity beyond what can be confirmed from the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 529,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "\nBetween fiscal 2023 and fiscal 2024 the 2014 Stock and Incentive Compensation Plan remained listed in the “Security Ownership of Certain Beneficial Owners and Management” table, but the disclosure was tightened: the 2024 filing explicitly notes that the plan has 0 shares remaining for future issuance (the “remaining available” column now shows “(1)” with a footnote stating that only the 2019 Plan permits future grants) and adds a footnote clarifying the share‑counting methodology (full‑value awards are counted as five shares).  This change reflects updated SEC reporting guidance that requires clearer presentation of outstanding awards and future availability, and moves the detailed plan terms to the 2024 Proxy Statement, thereby enhancing transparency in the company’s equity‑compensation disclosures.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and fails to match the ground truth in multiple critical ways: (1) FACTUAL ERRORS: The LLM claims the 2024 filing shows '0 shares remaining for future issuance' and that 'only the 2019 Plan permits future grants,' but the ground truth makes no such specific claims about share availability or footnotes. The LLM introduces specific numeric details (the '(1)' footnote reference, the 'five shares' counting methodology) that are not present in or supported by the ground truth. (2) MISALIGNMENT WITH GROUND TRUTH: The ground truth describes an evolution from 'regulatory disclosure' context in 2023 to 'a focus on ownership structure and equity compensation transparency' in 2024, with a shift toward 'a more integrated view' of the plan. The LLM instead focuses on technical disclosure changes (tightened presentation, footnote additions, share-counting methodology) that are not mentioned in the ground truth. (3) MISSING KEY ELEMENTS: The ground truth emphasizes the plan's 'active role in executive compensation' in 2023 and its integration within the 'overall equity compensation framework' in 2024. The LLM completely omits discussion of the plan's role in compensation or its integration with other plans (2009, 2019). (4) UNSUPPORTED CLAIMS: The LLM's references to 'updated SEC reporting guidance' and specific footnote structures appear to be fabricated details not present in the ground truth. (5) MULTI-HOP REASONING: The ground truth synthesizes information about how the plan's disclosure context changed across years; the LLM attempts a different synthesis about technical reporting changes that doesn't match the source material. The answer demonstrates hallucination of specific regulatory details rather than accurate synthesis of the actual evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 503,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "\nBetween the 2023 and 2024 10‑K filings the 1992 Stock Plan was retained only as a historical, closed‑ended plan.  The 2024 filing’s equity‑compensation table shows that, unlike the 2019, 2014, 2009 and 2001 plans, the 1992 plan no longer has any shares available for future issuance—its remaining shares are limited to those already granted and outstanding.  Consequently, the plan’s role has shifted from being an active source of new equity awards to a legacy pool that is reported only for disclosure of existing options and rights.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors and unsupported claims that contradict the ground truth. Key issues: (1) The LLM claims the 1992 Stock Plan is 'closed-ended' with 'no shares available for future issuance,' but the ground truth indicates it was simply listed in a consolidated table alongside other plans without specifying it was closed or had zero shares remaining. This is a major factual error. (2) The LLM references comparison to '2019, 2014, 2009 and 2001 plans' which are not mentioned in the ground truth and appear to be fabricated details not supported by the source material. (3) The LLM's characterization of the plan shifting from 'active source of new equity awards to a legacy pool' goes beyond what the ground truth states. The ground truth describes a more modest shift from 'standalone referenced plan' to being 'tracked alongside newer plans' in a consolidated table. (4) The ground truth emphasizes the presentation change (from referenced to consolidated table format) rather than the substantive claim that the plan has zero shares available. (5) The LLM provides no quantitative data (share counts, dates, specific table references) to support its claims, while the ground truth is more cautious about the specific nature of the change. The answer demonstrates poor multi-hop reasoning by making unsupported inferences about plan closure and share availability that are not grounded in the actual filing information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 403,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "\nBetween fiscal 2023 and 2024 the company’s focus on large‑scale transformations has intensified relative to shorter‑duration work: while overall client spending remained volatile, Accenture observed a clear shift away from small, quick‑turn contracts toward a higher proportion of multi‑year, transformation‑type engagements. These large‑scale deals “convert to revenue over a longer period,” and the risk discussion notes that “clients continue to prioritize large‑scale transformations” while “the pace and level of client spending… slowed… particularly for smaller contracts with a shorter duration” in fiscal 2024. Consequently, revenue recognition is now more spread out, reflecting longer conversion timelines for the company’s biggest transformation projects.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across multiple dimensions. STRENGTHS: (1) Correctly identifies the core evolution between 2023-2024: shift from smaller contracts to large-scale transformations; (2) Accurately captures the key finding that large-scale deals 'convert to revenue over a longer period' - this direct quote matches the ground truth language; (3) Properly synthesizes the multi-hop information: client spending patterns (reduction in smaller contracts, slowdown in consulting) AND revenue conversion timelines (longer periods); (4) Correctly identifies Accenture as the company and fiscal years 2023-2024; (5) Accurately conveys that clients 'continue to prioritize large-scale transformations' and that 'pace and level of client spending slowed, particularly for smaller contracts with shorter duration'; (6) Appropriately notes the lack of explicit quantitative metrics while emphasizing the strategic reinforcement through repeated emphasis. MINOR CONSIDERATIONS: (1) The LLM answer uses slightly more interpretive language ('intensified relative to shorter-duration work') compared to the ground truth's more measured 'reiterated' and 'repeated emphasis,' though this is semantically reasonable given the context; (2) The phrase 'revenue recognition is now more spread out' is a reasonable inference from the longer conversion timelines but represents a slight interpretive step beyond what the ground truth explicitly states; (3) The answer could have been slightly more explicit about the 2023 context (slowdown in consulting services specifically) though it does reference the overall spending slowdown. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either the ground truth or LLM answer, so this dimension is not applicable but both correctly avoid false precision. MULTI-HOP REASONING: The answer successfully synthesizes information across two fiscal years and connects client spending patterns to revenue conversion timelines, demonstrating sound multi-hop reasoning. The logical flow from spending patterns → contract type shift → revenue timeline implications is clear and accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 585,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "\nFrom fiscal 2023 to fiscal 2024 the company issued fewer Class A ordinary shares for employee compensation – the equity‑movement schedule shows “Issuances of Class A shares for employee share programs” of roughly **$8.9 million** in 2023 versus **$7.9 million** in 2024 (a decline of about **1 million shares, or ≈11 %**).  This smaller issuance meant a modest reduction in the increase of additional paid‑in capital and dilution, but the overall equity base still grew (total shareholders’ equity rose from $25.69 bn to $28.29 bn) primarily through retained earnings and share‑based compensation, leaving the equity structure broadly unchanged aside from the slightly lower share‑issuance impact.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains multiple critical errors that fundamentally misrepresent the ground truth:\n\n1. QUANTITATIVE ACCURACY - MAJOR ERRORS:\n   - LLM states \"$8.9 million in 2023 versus $7.9 million in 2024\" but ground truth shows 7,970 shares issued in 2024 (not $7.9 million in dollar terms)\n   - LLM claims \"1 million shares\" decline, but ground truth shows only 7,970 shares issued in 2024 (not millions)\n   - The LLM appears to have confused share counts with dollar amounts, a fundamental error\n   - Ground truth shows Class A Ordinary Shares increased from 15,656,591 to 15,664,561 (an increase of 7,970 shares), not a decrease\n   - Treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million - LLM completely missed this critical equity structure change\n\n2. ENTITY/METRIC CONFUSION:\n   - LLM conflates share issuances with dollar amounts ($8.9M vs $7.9M) when the ground truth discusses share counts (7,970 shares)\n   - LLM incorrectly characterizes the change as a \"decline\" when the ground truth shows an \"issuance\" in 2024 that didn't occur in 2023\n   - The ground truth explicitly states fiscal 2023 involved \"share withholding\" (acquisitions), while 2024 involved \"issuances\" - opposite directions\n\n3. MISSING KEY INFORMATION:\n   - LLM completely omits the 12,181 treasury shares purchased in 2024\n   - LLM fails to address the significant treasury share value change ($(3.4)B to $(6.7)B)\n   - LLM misses the core shift from share withholding (2023) to share issuance (2024)\n   - LLM provides tangential information about total shareholders' equity growth ($25.69B to $28.29B) that, while potentially accurate, doesn't directly address the specific question about Class A Ordinary Shares for employee compensation\n\n4. REASONING QUALITY:\n   - The multi-hop synthesis is fundamentally flawed due to misunderstanding the data\n   - The conclusion that \"equity structure broadly unchanged\" contradicts the ground truth showing significant reallocation\n   - The percentage calculation (≈11% decline) is based on incorrect premise\n\n5. DIRECTIONAL ERROR:\n   - Ground truth: 2024 shows MORE active use of Class A Ordinary Shares for compensation (7,970 issued)\n   - LLM: Claims FEWER shares issued in 2024 (decline of ~1M shares)\n   - This is a complete reversal of the actual trend",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 627,
        "total_tokens": 1981
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "\nMDLZ’s Canadian‑dollar debt that is designated as a net‑investment hedge rose modestly from **$443 million in 2022 to $453 million in 2023** (an increase of about $10 million, or roughly 2 %).  This slight uptick occurs against a broader pattern in which the company **expanded the overall size of its foreign‑currency hedging program** – total currency‑exchange contract notional grew from $2.085 bn to $2.860 bn and net‑investment‑hedge derivatives increased from $7.319 bn to $7.456 bn – while it **reduced longer‑dated interest‑rate swaps**.  Consequently, the change in Canadian‑dollar exposure is a small, incremental part of a general re‑balancing of foreign‑currency‑denominated debt rather than a distinct shift focused solely on Canada.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect and addresses a completely different aspect of MDLZ's debt management than what the ground truth describes. Critical issues: (1) QUANTITATIVE ERRORS: The LLM cites Canadian-dollar debt of $443M in 2022 and $453M in 2023, but the ground truth explicitly states Canadian notes were $3M in 2021 and increased by $8M in 2023 (to $11M). The LLM's figures are off by orders of magnitude (443M vs 3M). (2) WRONG METRIC: The LLM discusses 'Canadian-dollar debt designated as a net-investment hedge' while the ground truth discusses 'Canadian notes' - these appear to be different line items entirely. The LLM is analyzing net-investment hedge derivatives rather than the actual debt instruments. (3) INCOMPLETE MULTI-HOP SYNTHESIS: The ground truth requires comparing: (a) Canadian notes trend 2022-2023 (decrease of $3M in 2022, then increase of $8M in 2023), (b) historical context (declining from $17M in 2019 to $3M in 2021), and (c) comparison to other currency exposure (Euro notes declining from $211M to $81M). The LLM addresses none of these comparisons correctly. (4) MISSING CONTEXT: The ground truth emphasizes the reversal of a downward trend in Canadian exposure, which is the key insight. The LLM misses this entirely. (5) CALCULATION VERIFICATION: Ground truth shows Canadian notes increased $8M in 2023 (not $10M as LLM states for a different metric). The LLM's 2% increase calculation is based on wrong baseline numbers. The answer appears to conflate different debt instruments and hedging derivatives with the actual Canadian-denominated debt notes being asked about.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 444,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "\nFrom 2023 to 2024 Accenture shifted its interaction with growth‑stage firms from an exploratory, scouting‑focused activity to a deliberately strategic investment pillar.  The 2023 filing introduced Accenture Ventures as the vehicle for backing “growth‑stage companies that create innovative enterprise technologies,” and the 2024 filing expands that language, describing a deeper, cross‑functional partnership that aligns venture investments with the company’s sustainability and innovation agendas and signals a larger, more‑integrated capital commitment to these deals.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 8,
      "detailed_feedback": "STRENGTHS: The LLM answer correctly identifies the core evolution from a partnership/scouting model in 2023 to a more direct investment approach in 2024. The qualitative characterization of the shift ('exploratory, scouting-focused' to 'deliberately strategic investment pillar') aligns well with the ground truth's distinction between 'partners with' and 'invests in.' The answer appropriately captures the deepening of Accenture's commitment and integration with broader innovation agendas. CRITICAL WEAKNESSES: (1) MISSING KEY QUANTITATIVE DATA: The ground truth explicitly references R&D spending figures ($1.3 billion in fiscal 2023 and $1.2 billion in fiscal 2024) that contextualize Accenture's innovation strategy. The LLM answer completely omits these specific financial metrics, which are important for demonstrating the scale of commitment. (2) INCOMPLETE MULTI-HOP SYNTHESIS: While the LLM captures the evolution narrative, it fails to synthesize the connection between venture investment activity and the broader R&D spending context that the ground truth establishes. The ground truth uses these numbers to show how venture investments align with overall innovation spending. (3) VAGUE LANGUAGE: The LLM uses phrases like 'larger, more-integrated capital commitment' without specifying the actual financial commitment or providing concrete metrics. The ground truth is more precise about the nature of the shift. VERIFICATION: The LLM correctly identifies 2023 and 2024 as the relevant years and accurately describes the shift in language/approach. However, the absence of the $1.3B and $1.2B R&D figures represents a significant omission in a question specifically asking about 'investment activity.' The answer is directionally correct but incomplete in quantitative substance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 487,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "\nMerck’s share of Lynparza sales (alliance revenue) has risen steadily from **$1.116 bn in 2022 to $1.199 bn in 2023 and $1.311 bn in 2024**, representing a **9 % year‑over‑year increase in 2024** and **11 % growth on a constant‑currency basis**.  This growth occurs while the **$1.1 bn Lynparza‑related intangible asset recorded in 2021 is being amortized over a seven‑year schedule through 2028**, with the amortization expense reflected in cost of sales; the net book value is therefore being reduced, but the amortization does not offset the double‑digit revenue expansion.  \n\n*(Based on the financial tables and collaboration discussion in MRK_10k_2022.pdf pp. 100‑104 and MRK_10k_2024.pdf pp. 53‑57.)*",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer demonstrates strong factual accuracy with specific financial numbers and multi-hop synthesis. STRENGTHS: (1) Correctly identifies the $1.1 billion intangible asset related to Lynparza being amortized through 2028, matching ground truth; (2) Accurately reports alliance revenue figures ($1.116bn in 2022, $1.199bn in 2023, $1.311bn in 2024) with correct 9% YoY growth in 2024 and 11% constant-currency growth; (3) Properly synthesizes the evolution from asset amortization focus to revenue growth emphasis; (4) Correctly notes the seven-year amortization schedule (2021-2028) and that amortization is reflected in cost of sales; (5) Provides specific document citations (MRK_10k_2022.pdf and MRK_10k_2024.pdf with page numbers). MINOR WEAKNESSES: (1) Does not mention the 2025 China approval for adjuvant treatment in early breast cancer that was included in the ground truth answer - this represents a notable omission of strategic expansion information; (2) The answer focuses heavily on quantitative metrics but provides less discussion of the strategic evolution beyond revenue growth. CALCULATION VERIFICATION: The revenue progression ($1.116bn → $1.199bn → $1.311bn) and growth rates (9% in 2024, 11% constant-currency) are mathematically consistent and accurate. The multi-hop reasoning correctly connects asset amortization schedules with revenue growth trends across the 2022-2024 period. The answer successfully synthesizes information across multiple years and documents to show the evolution of Merck's involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 424,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "\nBetween the 2023 and 2024 filings, Broadcom’s description of **ValueOps** moved from a brief footnote—“value‑stream management capabilities that enable customers to schedule, track and manage work throughout its lifecycle, increasing transparency and reducing inefficiencies” (AVGO 10‑K 2023, pp. 6‑10)—to a headline‑level strategic pillar that is presented as a core domain of the **Distributed Software** portfolio and explicitly tied to “optimizing the planning, development and delivery of software, powering business‑critical digital services, and driving profitability by aligning business, development and operational teams” (AVGO 10‑K 2024, pp. 8‑12).  \n\nThis evolution shows that AVGO is elevating ValueOps from a peripheral capability to a central growth engine, positioning it as the primary vehicle for delivering end‑to‑end visibility and lifecycle coordination across its Distributed Software portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong understanding of AVGO's strategic shift regarding ValueOps between 2023 and 2024. STRENGTHS: (1) Correctly identifies the core evolution from peripheral capability to central strategic pillar; (2) Accurately captures the 2023 positioning as a brief offering focused on 'schedule, track and manage work'; (3) Properly describes the 2024 elevation to headline-level strategic importance; (4) Correctly identifies ValueOps as one of three core domains alongside DevOps and AIOps; (5) Appropriately emphasizes the shift toward 'end-to-end visibility' and lifecycle coordination; (6) Sound multi-hop reasoning synthesizing information across 2023 and 2024 filings. MINOR WEAKNESSES: (1) The LLM provides specific page references (pp. 6-10 for 2023, pp. 8-12 for 2024) that cannot be verified against the ground truth, though this doesn't contradict the core facts; (2) The 2024 quote about 'optimizing the planning, development and delivery of software, powering business-critical digital services, and driving profitability' is more detailed than the ground truth's reference to 'end-to-end visibility across all stages of the digital lifecycle,' though both convey the same strategic elevation; (3) The characterization of ValueOps as a 'growth engine' and 'primary vehicle' is slightly more emphatic than the ground truth's description of it becoming 'more central' and a 'foundational pillar,' though semantically equivalent. QUANTITATIVE ACCURACY: No specific numbers, percentages, or dollar amounts are present in either answer, so this dimension is not applicable. The dates (2023 vs 2024) are correct. ENTITY ACCURACY: AVGO/Broadcom correctly identified, Distributed Software portfolio correctly referenced, ValueOps correctly named, DevOps and AIOps correctly identified as peer domains. REASONING: The multi-hop synthesis is sound—the answer correctly traces the evolution across two fiscal years and draws appropriate conclusions about strategic importance. The logic connecting the textual changes to business implications is valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 557,
        "total_tokens": 1996
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "\nBetween 2023 and 2024 FedEx moved Network 2.0 from a high‑level “DRIVE” concept to concrete actions—announcing the Tricolor redesign of its international air network and a Europe‑wide workforce‑reduction plan—while still projecting that the initiative would deliver permanent cost‑structure reductions and greater network flexibility.  However, the company repeatedly warned that the expected savings are contingent on successfully integrating the Federal Express and legacy FedEx Ground physical networks, consolidating IT systems, and navigating labor, regulatory and contractual hurdles; if those integration challenges stall or incur unexpected expenses, the projected cost‑savings could be delayed, reduced, or even reversed.",
      "correctness_score": 5,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "ASSESSMENT: The LLM answer captures some correct elements but introduces significant inaccuracies and misses key aspects of the ground truth.\n\nCORRECT ELEMENTS:\n- Correctly identifies the evolution from 2023 to 2024\n- Accurately notes the shift from strategic planning to operational implementation\n- Correctly identifies integration challenges as a key risk factor\n- Properly mentions labor, regulatory, and contractual hurdles\n- Accurately conveys that cost savings are contingent on successful execution\n\nSIGNIFICANT ERRORS AND OMISSIONS:\n1. FACTUAL INACCURACY: The LLM introduces specific claims not in the ground truth (\"Tricolor redesign of international air network\" and \"Europe-wide workforce-reduction plan\"). While these may be real FedEx initiatives, they are NOT mentioned in the original answer and appear to be hallucinated details not supported by the provided ground truth.\n\n2. MISSING KEY CONTENT FROM 2023: The ground truth explicitly states that 2023 emphasized \"operational efficiencies, network flexibility, and alignment of the cost base with demand.\" The LLM answer does not capture these specific 2023 strategic objectives.\n\n3. MISSING 2024 SPECIFIC RISKS: The ground truth identifies several 2024-specific risks that the LLM omits:\n   - Asset impairment charges\n   - Tax impacts\n   - Litigation risks\n   - Harmonizing operating practices\n   - Maintaining customer and service provider agreements\n   - Cultural differences\n\n4. INCOMPLETE RISK CHARACTERIZATION: While the LLM mentions \"unexpected expenses,\" it fails to capture the full scope of 2024 risks related to asset impairment, tax impacts, and litigation.\n\n5. STRUCTURAL DIFFERENCE: The ground truth emphasizes a clear transition from \"strategic planning and investment justification in 2023\" to \"operational integration and financial risk mitigation in 2024.\" The LLM answer frames this more as a progression from concept to action, missing the nuance of the risk mitigation shift.\n\nQUANTITATIVE ACCURACY: No specific numbers are provided in either answer, so this dimension is neutral (7/10 for not introducing false numbers).\n\nQUALITATIVE ACCURACY: The LLM demonstrates partial understanding of the evolution but introduces unsupported details and omits critical risk factors identified in the ground truth. The reasoning about integration challenges is sound but incomplete.\n\nCONTEXTUAL RELEVANCE: The answer addresses the question's core inquiry about evolution between 2023-2024 and risks, but the introduction of unverified specific initiatives (Tricolor, Europe-wide workforce reduction) and omission of documented risks reduces relevance to the actual filing content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 714,
        "total_tokens": 2178
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "\nBetween 2022 and 2023 the embedded derivative that comprises MDLZ’s equity‑method‑investment contract stayed on the balance sheet as a modest liability of roughly $3 million (both years).  However, the earnings impact changed: the 2022 filing shows essentially no recognized gain or loss from the contract, while the 2023 “Economic Hedges” table records a **$7 million gain in earnings** from these contracts.  This shift indicates that MDLZ’s exposure to the underlying JDE Peet’s investment moved from a neutral, balance‑sheet‑only position to a small but positive contribution to net income, suggesting a modest increase in engagement and the beginning of earnings‑recognised benefit from the arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer demonstrates strong accuracy and provides more detailed context than the ground truth. Key strengths: (1) All numeric values are correct - the $3 million liability in both years and the $7 million gain in 2023 match the ground truth exactly. (2) The answer correctly identifies the shift from no recognized gain/loss in 2022 to a $7 million gain in 2023, which aligns with the ground truth's characterization of a reversal in financial impact. (3) The multi-hop reasoning is sound - the answer synthesizes information about both the balance sheet position (embedded derivative liability) and the earnings impact (P&L gain), showing how these evolved differently between years. (4) The answer provides additional valuable context by specifically referencing the 'Economic Hedges' table and explaining the distinction between balance sheet treatment and earnings recognition, which adds depth without contradicting the ground truth. (5) The conclusion about 'modest increase in engagement and the beginning of earnings-recognised benefit' is semantically equivalent to the ground truth's statement about 'reversal in financial impact and potentially more active or favorable engagement.' Minor consideration: The LLM's statement that the embedded derivative 'stayed on the balance sheet as a modest liability of roughly $3 million (both years)' is slightly more precise than the ground truth's reference to a 'net liability of $3 million' in 2022, but this represents clarification rather than error. The answer fully addresses the question's two-part structure (how did it evolve, what does this indicate) with accurate synthesis across the 2022-2023 comparison.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 458,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "\nThe estimated cost‑to‑complete for the VMware Cloud Foundation July 2024 releases fell from roughly $70 million in the FY 2023 projection to $38 million in FY 2024 (the table shows 67 % completion and a $38 million remaining spend, noted as “(a) Released during fiscal year 2024”).  This reduction—while only a small fraction of the $790 million IPR&D asset—indicates that about two‑thirds of the work is already finished and that the remaining expenditure is modest, signalling that the releases are advancing well and are ahead of earlier expectations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer contains a fundamental factual error that contradicts the ground truth. The ground truth clearly states that the estimated cost to complete remained UNCHANGED at $38 million from FY 2023 to FY 2024. However, the LLM answer claims the cost 'fell from roughly $70 million in the FY 2023 projection to $38 million in FY 2024.' This is a critical quantitative error - the LLM invented a $70 million FY 2023 figure that does not appear in the ground truth. The LLM's interpretation that this represents progress 'ahead of earlier expectations' is therefore incorrect; the ground truth indicates the development was 'proceeding largely as planned' with no change in estimates. Additionally, the LLM's reasoning about '67% completion' and references to a '$790 million IPR&D asset' appear to be extrapolations not supported by the ground truth answer. The LLM did correctly identify the $38 million FY 2024 figure and the company/product names (Broadcom/VMware Cloud Foundation July 2024 releases), but the core narrative about how the cost evolved is factually wrong. The answer demonstrates a misunderstanding of the multi-hop synthesis required - the question asks how the estimate 'evolved' (implying change), and the LLM incorrectly assumed there was a significant decrease rather than recognizing the stability of the estimate as the key finding.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 379,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "\nBetween 2023 and 2024 FedEx Office expanded the role of its Ship & Go kiosks from a pure outbound‑shipping drop‑off point to a dual‑purpose hub that also handles label‑less returns.  The 2024 filing notes that the kiosks now support FedEx Returns Technology and the Consolidated Returns program, allowing shoppers to bring back items with no box or label required, and the network of roughly 1,300 locations was leveraged to give customers a seamless, end‑to‑end e‑commerce fulfillment and returns experience.  This shift signals that FedEx Office is positioning its retail footprint as a critical node in the company’s broader e‑commerce logistics strategy, using convenient in‑store kiosks to streamline both shipments and returns for omnichannel merchants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer demonstrates strong alignment with the ground truth across all key dimensions. QUANTITATIVE ACCURACY (10/10): All numeric values are correct - the kiosk presence is accurately stated as 'roughly 1,300 locations' in both years, matching the ground truth's 'approximately 1,300 locations.' No calculation errors present. ENTITY ACCURACY: All entities correctly identified - FedEx Office, Ship and Go kiosks, FedEx Returns Technology, Consolidated Returns program, and the 2023-2024 timeframe. COMPLETENESS: The answer addresses all parts of the multi-part question: (1) how Ship and Go evolved between 2023-2024, (2) what this indicates about e-commerce logistics approach, and (3) returns management strategy. MULTI-HOP REASONING: The synthesis is sound - correctly connects the evolution of kiosk functionality (outbound shipping → dual-purpose hub) to the strategic positioning within FedEx's broader e-commerce infrastructure. The logical flow from feature expansion to strategic implication is clear and accurate. SEMANTIC EQUIVALENCE: The LLM's characterization of the shift as moving from 'pure outbound-shipping drop-off point to a dual-purpose hub' effectively captures the ground truth's 'shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.' The emphasis on 'label-less returns,' 'in-store printing of return labels,' and integration with FedEx Returns Technology and Consolidated Returns all match the ground truth. MINOR OBSERVATION: The LLM uses slightly more commercial language ('omnichannel merchants,' 'seamless, end-to-end e-commerce fulfillment') compared to the ground truth's more technical description, but this represents stylistic variation rather than factual error. The core message and all substantive details align perfectly with the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 508,
        "total_tokens": 1935
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 1000,
    "failed_evaluations": 0,
    "average_correctness_score": 4.88,
    "average_quantitative_accuracy": 5.12,
    "average_qualitative_accuracy": 5.2,
    "average_contextual_relevance": 6.36,
    "score_distribution": {
      "excellent": 109,
      "good": 160,
      "fair": 339,
      "poor": 392
    }
  },
  "original_experiment_metadata": {
    "model": "nemotron-nano-30b-reasoning",
    "experiment": "e2_page_window",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 3449.17,
    "timestamp": "2026-02-02T16:37:54.918394"
  }
}